the	O
impact	O
of	O
deployment	B-T052
on	O
parental	O
,	O
family	O
and	O
child	O
adjustment	O
in	O
military	O
families	O
since	O
9/11	O
,	O
military	O
service	O
in	O
the	O
united	O
states	O
has	O
been	O
characterized	O
by	O
wartime	B-T079
deployments	B-T052
and	O
reintegration	O
challenges	O
that	O
contribute	O
to	O
a	O
context	O
of	O
stress	B-T033
for	O
military	O
families	O
.	O
	
research	B-T062
indicates	O
the	O
negative	B-T033
impact	I-T033
of	O
wartime	O
deployment	B-T052
on	O
the	O
well	B-T078
being	I-T078
of	O
service	O
members	B-T098
,	O
military	O
spouses	O
,	O
and	O
children	O
.	O
	
yet	O
,	O
few	O
studies	O
have	O
considered	O
how	O
parental	O
deployments	B-T052
may	O
affect	O
adjustment	O
in	O
young	O
children	O
and	O
their	O
families	O
.	O
	
using	O
deployment	B-T052
records	O
and	O
parent	O
-	O
reported	O
measures	O
from	O
primary	O
caregiving	O
n	O
=	O
680	O
and	O
military	O
n	O
=	O
310	O
parents	O
,	O
we	O
examined	O
the	O
influence	O
of	O
deployment	B-T170
on	O
adjustment	O
in	O
military	O
families	O
with	O
children	O
ages	O
0-10	O
years	O
.	O
	
greater	O
deployment	O
exposure	O
was	O
related	O
to	O
impaired	O
family	O
functioning	O
and	O
marital	O
instability	O
.	O
	
parental	O
depressive	O
and	O
posttraumatic	O
stress	O
symptoms	O
were	O
associated	O
with	O
impairments	O
in	O
social	O
emotional	O
adjustment	O
in	O
young	O
children	O
,	O
increased	O
anxiety	O
in	O
early	O
childhood	O
,	O
and	O
adjustment	O
problems	O
in	O
school-age	O
children	O
.	O
	
conversely	O
,	O
parental	O
sensitivity	O
was	O
associated	O
with	O
improved	O
social	O
and	O
emotional	O
outcomes	O
across	O
childhood	O
.	O
	
these	O
findings	O
provide	O
guidance	O
to	O
developing	O
preventive	O
approaches	O
for	O
military	O
families	O
with	O
young	O
children	O
beyond	O
neutral	O
and	O
forbidden	O
links	O
morphological	B-T082
matches	B-T080
and	O
the	O
assembly	B-T078
of	O
mutualistic	O
hawkmoth	O
-	O
plant	O
networks	B-T169
a	O
major	O
challenge	O
in	O
evolutionary	O
ecology	O
is	O
to	O
understand	O
how	O
co-evolutionary	O
processes	O
shape	O
patterns	B-T082
of	O
interactions	B-T169
between	O
species	O
at	O
community	O
level	B-T080
.	O
	
pollination	O
of	O
flowers	O
with	O
long	O
corolla	O
tubes	O
by	O
long-tongued	O
hawkmoths	O
has	O
been	O
invoked	O
as	O
a	O
showcase	O
model	O
of	O
co-evolution	O
.	O
	
recently	O
,	O
optimal	O
foraging	O
models	O
have	O
predicted	O
that	O
there	O
might	O
be	O
a	O
close	O
association	B-T080
between	O
mouthparts'	B-T081
length	I-T081
and	O
the	O
corolla	O
depth	B-T082
of	O
the	O
visited	O
flowers	O
,	O
thus	O
favouring	O
trait	O
convergence	B-T052
and	O
specialization	O
at	O
community	O
level	O
.	O
	
here	O
,	O
we	O
assessed	B-T052
whether	O
hawkmoths	O
more	O
frequently	O
pollinate	O
plants	O
with	O
floral	O
tube	O
lengths	B-T081
similar	O
to	O
their	O
proboscis	O
lengths	B-T081
morphological	B-T082
match	B-T080
hypothesis	B-T078
against	O
abundance	B-T080
-based	O
processes	O
neutral	B-T078
hypothesis	I-T078
and	O
ecological	O
trait	O
mismatches	B-T080
constraints	O
forbidden	O
links	O
hypothesis	B-T078
,	O
and	O
how	O
these	O
processes	O
structure	B-T082
hawkmoth	O
-	O
plant	O
mutualistic	B-T169
networks	I-T169
from	O
five	O
communities	O
in	O
four	O
biogeographical	O
regions	O
of	O
south	O
america	O
.	O
	
we	O
found	O
convergence	B-T052
in	O
morphological	B-T082
traits	O
across	O
the	O
five	O
communities	O
and	O
that	O
the	O
distribution	B-T169
of	O
morphological	B-T082
differences	O
between	O
hawkmoths	O
and	O
plants	O
is	O
consistent	O
with	O
expectations	O
under	O
the	O
morphological	B-T082
match	B-T080
hypothesis	B-T078
in	O
three	O
of	O
the	O
five	O
communities	O
.	O
	
in	O
the	O
two	O
remaining	O
communities	O
,	O
which	O
are	O
ecotones	O
between	O
two	O
distinct	O
biogeographical	O
areas	O
,	O
interactions	B-T169
are	O
better	O
predicted	O
by	O
the	O
neutral	B-T078
hypothesis	I-T078
.	O
	
our	O
findings	B-T169
are	O
consistent	O
with	O
the	O
idea	O
that	O
diffuse	O
co-evolution	O
drives	O
the	O
evolution	O
of	O
extremely	O
long	O
proboscises	O
and	O
flower	O
tubes	O
,	O
and	O
highlight	O
the	O
importance	O
of	O
morphological	B-T082
traits	O
,	O
beyond	O
the	O
forbidden	O
links	O
hypothesis	B-T078
,	O
in	O
structuring	O
interactions	B-T169
between	O
mutualistic	B-T078
partners	I-T078
,	O
revealing	O
that	O
the	O
role	O
of	O
niche-based	O
processes	O
nosocomial	B-T047
pneumonia	I-T047
caused	O
by	O
methicillin-resistant	O
staphylococcus	O
aureus	O
treated	B-T061
with	I-T061
linezolid	B-T109
or	O
vancomycin	B-T116
a	O
secondary	O
economic	O
analysis	O
of	O
resource	B-T078
use	I-T078
from	O
a	O
spanish	O
perspective	O
adopting	O
a	O
unique	O
spanish	O
perspective	O
,	O
this	O
study	B-T062
aims	O
to	O
assess	O
healthcare	B-T078
resource	I-T078
utilization	I-T078
hcru	B-T078
and	O
the	O
costs	B-T081
of	O
treating	B-T169
nosocomial	B-T047
pneumonia	I-T047
np	B-T047
produced	O
by	O
methicillin-resistant	O
staphylococcus	O
aureus	O
mrsa	O
in	O
hospitalized	B-T033
adults	I-T033
using	O
linezolid	B-T109
or	O
vancomycin	B-T116
.	O
	
an	O
evaluation	O
is	O
also	O
made	O
of	O
the	O
renal	B-T047
failure	I-T047
rate	B-T081
and	O
related	O
economic	B-T169
outcomes	I-T169
between	O
study	O
groups	O
.	O
	
an	O
economic	O
post	O
hoc	O
evaluation	O
of	O
a	O
randomized	B-T062
,	O
double-blind	B-T062
,	O
multicenter	B-T062
phase	I-T062
4	I-T062
study	I-T062
was	O
carried	O
out	O
.	O
	
nosocomial	B-T047
pneumonia	I-T047
due	O
to	O
mrsa	O
in	O
hospitalized	B-T033
adults	I-T033
.	O
	
the	O
modified	B-T169
intent	I-T169
to	I-T169
treat	I-T169
mitt	B-T169
population	B-T098
comprised	O
224	O
linezolid	B-T109
-	O
and	O
224	O
vancomycin	B-T116
-	O
treated	B-T061
patients	O
.	O
	
costs	B-T081
and	O
hcru	B-T078
were	O
evaluated	O
between	O
patients	O
administered	B-T169
either	O
linezolid	B-T109
or	O
vancomycin	B-T116
,	O
and	O
between	O
patients	O
who	O
developed	O
renal	B-T047
failure	I-T047
and	O
those	O
who	O
did	O
not	O
.	O
	
analysis	O
of	O
hcru	B-T078
outcomes	B-T169
and	O
costs	B-T081
.	O
	
total	O
costs	B-T081
were	O
similar	O
between	O
the	O
linezolid	B-T109
-	O
17	O
and	O
vancomycin	B-T116
-	O
treated	B-T061
patients	O
17	O
p=	O
.	O
	
the	O
renal	B-T047
failure	I-T047
rate	B-T081
was	O
significantly	O
lower	O
in	O
the	O
linezolid	B-T109
-	O
treated	B-T061
patients	O
4%	O
vs	O
.	O
	
15%	O
p<	O
.	O
	
the	O
total	O
costs	B-T081
tended	O
to	O
be	O
higher	O
in	O
patients	O
who	O
developed	O
renal	B-T047
failure	I-T047
19	O
vs	O
.	O
	
17	O
p=	O
.	O
	
among	O
the	O
patients	O
who	O
developed	O
renal	B-T047
failure	I-T047
,	O
hcru	B-T078
days	B-T079
on	O
mechanical	B-T061
ventilation	I-T061
13.2	O
vs	O
.	O
	
7.6	O
days	B-T079
p=	O
icu	B-T079
stay	I-T079
14.4	O
vs	O
.	O
	
9.9	O
days	B-T079
p=	O
hospital	B-T079
stay	I-T079
19.5	O
vs	O
.	O
	
16.1	O
days	B-T079
p=	O
and	O
cost	B-T081
17	O
vs	O
.	O
	
20	O
p=	O
tended	O
to	O
be	O
lower	O
in	O
the	O
linezolid	B-T109
-	O
vs	O
.	O
	
vancomycin	B-T116
-	O
treated	B-T061
patients	O
.	O
	
there	O
were	O
no	O
statistically	O
significant	O
differences	O
in	O
costs	B-T081
per	O
patient	O
-	O
day	B-T079
between	O
cohorts	B-T098
after	O
correcting	O
for	O
mortality	B-T081
1000	O
vs	O
.	O
	
1	O
p=	O
.	O
	
from	O
a	O
spanish	O
perspective	O
,	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
in	O
total	O
costs	B-T081
between	O
the	O
linezolid	B-T109
and	O
vancomycin	B-T116
pneumonia	B-T047
cohorts	B-T098
.	O
	
the	O
drug	B-T081
cost	I-T081
corresponding	O
to	O
linezolid	B-T109
was	O
partially	O
offset	B-T081
by	O
fewer	O
renal	B-T047
failure	I-T047
adverse	O
events	O
.	O
	
herg1	B-T116
potassium	B-T116
channel	I-T116
expression	O
in	O
potentially	B-T080
malignant	O
disorders	O
of	O
the	O
oral	O
mucosa	O
and	O
prognostic	B-T170
relevance	B-T080
in	O
oral	O
squamous	O
cell	O
carcinoma	O
herg1	B-T116
potassium	B-T116
channel	I-T116
plays	O
a	O
critical	B-T080
role	O
in	O
the	O
cell	O
proliferation	O
.	O
	
herg1	B-T116
protein	I-T116
expression	O
was	O
analyzed	B-T062
by	O
immunohistochemistry	O
ihc	O
in	O
62	O
patients	O
with	O
oral	O
leukoplakias	O
and	O
100	O
patients	O
with	O
oral	O
squamous	O
cell	O
carcinomas	O
oscc	O
.	O
	
herg1	O
mrna	O
levels	B-T080
were	O
assessed	B-T052
by	O
real-time	O
reverse	O
transcriptase-polymerase	O
chain	O
reaction	O
rt-pcr	O
in	O
22	O
patients	O
with	O
primary	B-T080
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
hnscc	O
.	O
	
statistically	B-T081
significant	I-T081
associations	B-T080
were	O
found	O
between	O
herg1	B-T116
expression	O
and	O
tobacco	O
consumption	O
,	O
disease	O
stage	O
,	O
tumor	O
differentiation	O
,	O
tumor	O
recurrence	O
,	O
and	O
reduced	B-T080
survival	B-T052
.	O
	
there	O
was	O
no	B-T169
association	B-T080
between	O
herg1	B-T116
expression	O
and	O
the	O
risk	B-T078
of	O
progression	O
from	O
oral	O
leukoplakia	O
to	O
oscc	O
.	O
	
in	O
addition	O
,	O
a	O
high	B-T080
proportion	B-T081
of	O
tumors	O
80%	O
showed	O
increased	B-T081
herg1	O
mrna	O
levels	B-T080
compared	B-T052
to	O
normal	O
mucosa	O
from	O
nononcologic	O
patients	O
.	O
	
aberrant	B-T080
herg1	B-T116
expression	O
increases	B-T169
as	O
oral	O
tumorigenesis	O
progresses	O
from	O
oral	O
hyperplasia	O
to	O
oscc	O
.	O
	
increased	B-T081
herg1	O
mrna	O
levels	B-T080
were	O
also	O
frequently	O
detected	B-T033
in	O
oscc	O
and	O
other	O
hnscc	O
subsites	B-T082
.	O
	
herg1	B-T116
expression	O
emerges	O
as	O
a	O
clinically	B-T080
relevant	B-T080
feature	B-T080
during	O
tumor	O
progression	O
and	O
a	O
potential	B-T080
poor	B-T080
prognostic	B-T170
biomarker	O
for	O
oscc	O
.	O
	
nationwide	B-T082
reduction	B-T081
in	O
the	O
number	O
of	O
corneal	B-T061
transplantations	I-T061
for	O
keratoconus	B-T047
following	O
the	O
implementation	B-T052
of	O
cross-linking	B-T061
keratoconus	B-T047
is	O
characterized	O
by	O
corneal	B-T047
ectasia	I-T047
and	O
irregular	B-T047
astigmatism	I-T047
,	O
which	O
can	O
lead	O
to	O
diminished	B-T047
vision	I-T047
and	O
corneal	B-T033
scarring	I-T033
.	O
	
approximately	O
10-20%	O
of	O
patients	O
with	O
keratoconus	B-T047
eventually	O
require	O
a	O
corneal	B-T061
transplant	I-T061
.	O
	
corneal	B-T061
cross-linking	I-T061
cxl	B-T061
is	O
a	O
relatively	O
new	O
treatment	B-T061
that	O
may	O
help	O
prevent	O
the	O
need	O
for	O
corneal	B-T061
transplantation	I-T061
.	O
	
here	O
,	O
we	O
investigated	B-T169
whether	O
the	O
introduction	B-T169
of	O
cxl	B-T061
has	O
reduced	O
the	O
number	O
of	O
corneal	B-T061
transplants	I-T061
performed	B-T169
annually	B-T079
.	O
	
data	B-T078
regarding	O
the	O
transplantation	B-T061
procedures	I-T061
performed	B-T169
in	O
patients	O
under	O
the	O
age	O
of	O
50	O
years	B-T079
were	O
extracted	O
from	O
the	O
dutch	B-T170
national	I-T170
organ	I-T170
transplant	I-T170
registry	I-T170
.	O
	
the	O
number	O
of	O
corneal	B-T061
transplants	I-T061
performed	B-T169
prior	O
to	O
i.e	O
.	O
	
in	O
2005	O
through	O
2007	O
and	O
following	O
the	O
introduction	B-T169
of	O
cxl	B-T061
i.e	O
.	O
	
in	O
2012	O
through	O
2014	O
were	O
compared	B-T052
.	O
	
furthermore	O
,	O
a	O
trend	O
analysis	O
on	O
annual	B-T079
keratoplasties	B-T061
over	O
time	O
was	O
performed	B-T169
.	O
	
approximately	O
25%	O
fewer	O
corneal	B-T061
transplants	I-T061
were	O
performed	B-T169
in	O
the	O
3-	O
year	B-T079
period	O
following	O
the	O
introduction	B-T169
of	O
cxl	B-T061
compared	B-T052
to	O
the	O
3-	O
year	B-T079
period	O
prior	O
to	O
the	O
introduction	B-T169
of	O
cxl	B-T061
201	O
versus	O
269	O
transplants	B-T061
,	O
respectively	O
p	O
=	O
0.005	O
.	O
	
age	O
,	O
gender	O
and	O
visual	O
acuity	O
were	O
similar	O
between	O
the	O
patient	O
groups	O
in	O
the	O
two	O
time	B-T079
periods	I-T079
.	O
	
trend	O
analysis	O
also	O
demonstrated	O
a	O
significant	O
decrease	B-T081
in	O
the	O
amount	O
of	O
corneal	B-T061
transplants	I-T061
p	O
=	O
0.001	O
.	O
	
significantly	O
fewer	O
corneal	B-T061
transplants	I-T061
were	O
performed	O
for	O
treating	O
keratoconus	B-T047
following	O
the	O
nationwide	B-T082
introduction	B-T169
of	O
cxl	B-T061
.	O
	
this	O
reduction	B-T081
suggests	O
that	O
corneal	B-T061
cross-linking	I-T061
can	O
significantly	O
reduce	B-T080
the	O
need	O
for	O
corneal	B-T061
transplantation	I-T061
.	O
	
basal	O
and	O
maximal	B-T080
metabolic	O
rates	O
differ	O
in	O
their	O
response	O
to	O
rapid	O
temperature	B-T080
change	I-T080
among	O
avian	O
species	O
in	O
birds	O
,	O
acclimation	O
and	O
acclimatization	O
to	O
temperature	B-T081
are	O
associated	O
with	O
changes	O
in	O
basal	O
bmr	O
,	O
summit	O
msum	O
and	O
maximal	B-T080
mmr	O
metabolic	O
rates	O
but	O
little	O
is	O
known	O
about	O
the	O
rate	O
at	O
which	O
species	O
adjust	O
their	O
phenotype	O
to	O
short-term	B-T079
temperature	B-T081
variations	B-T080
.	O
	
our	O
aims	B-T078
were	O
1	O
to	O
determine	O
the	O
pattern	B-T082
of	O
metabolic	B-T169
adjustments	O
following	O
a	O
rapid	O
temperature	B-T080
change	I-T080
,	O
2	O
to	O
determine	O
whether	O
performance	O
varies	O
at	O
similar	O
rates	O
during	O
exposure	B-T080
to	I-T080
warm	O
or	O
cold	O
environments	O
,	O
and	O
3	O
to	O
determine	O
if	O
bmr	O
,	O
msum	O
and	O
mmr	O
change	O
at	O
comparable	O
rates	O
during	O
thermal	O
acclimation	O
.	O
	
we	O
measured	O
these	O
parameters	O
in	O
white-throated	O
sparrows	O
zonotrichia	O
albicollis	O
,	O
black-capped	O
chickadees	O
poecile	O
atricapillus	O
,	O
and	O
snow	O
buntings	O
plectrophenax	O
nivalis	O
after	O
acclimation	O
to	O
10	O
c	O
day	B-T079
0	O
and	O
on	O
the	O
4th	O
and	O
8th	O
days	B-T079
of	O
acclimation	O
to	O
either	O
-5	O
or	O
28	O
c	O
.	O
	
birds	O
changed	O
their	O
metabolic	B-T169
phenotype	O
within	O
8	O
days	B-T079
with	O
patterns	B-T082
differing	O
among	O
species	O
.	O
	
sparrows	O
expressed	O
the	O
expected	O
metabolic	B-T169
increases	B-T169
in	O
the	O
cold	O
and	O
decreases	O
at	O
thermoneutrality	B-T078
while	O
performance	O
in	O
chickadees	O
and	O
buntings	O
was	O
not	O
influenced	O
by	O
temperature	B-T081
but	O
changed	O
over	O
time	O
with	O
inverse	O
patterns	B-T082
.	O
	
our	O
results	B-T033
suggest	O
that	O
bmr	O
varies	O
at	O
comparable	O
rates	O
in	O
warm	O
and	O
cold	O
environments	O
but	O
changes	O
faster	O
than	O
msum	O
and	O
mmr	O
,	O
likely	O
due	O
to	O
limitations	B-T169
in	O
the	O
rate	O
of	O
change	O
in	O
organ	O
size	O
and	O
function	B-T169
.	O
	
they	O
also	O
suggest	O
that	O
maximal	B-T080
metabolic	B-T169
capacity	B-T081
is	O
lost	B-T169
faster	O
in	O
a	O
warm	O
environment	O
than	O
it	O
is	O
gained	B-T081
in	O
a	O
cold	O
environment	O
.	O
	
with	O
the	O
expected	O
increase	O
in	O
temperature	B-T081
stochasticity	B-T081
at	O
northern	O
latitudes	O
,	O
a	O
loss	B-T081
of	O
thermogenic	O
capacity	B-T081
during	O
warm	O
winter	B-T079
days	B-T079
could	O
,	O
therefore	O
,	O
be	O
detrimental	O
if	O
birds	O
are	O
slow	O
to	O
readjust	O
their	O
phenotype	O
with	O
the	O
return	O
of	O
cold	O
days	B-T079
.	O
	
a	O
prime	O
a	O
day	O
keeps	O
calories	B-T081
away	O
the	O
effects	B-T080
of	I-T080
supraliminal	O
priming	O
on	O
food	B-T052
consumption	I-T052
and	O
the	O
moderating	B-T170
role	I-T170
of	O
gender	O
and	O
eating	B-T170
restraint	I-T170
the	O
link	O
between	O
intentions	O
and	O
action	B-T052
in	O
weight	B-T061
control	I-T061
is	O
weaker	O
than	O
previously	O
thought	O
,	O
so	O
recent	O
research	B-T062
has	O
called	O
for	O
further	O
investigation	O
of	O
ways	O
to	O
improve	O
weight	B-T061
control	I-T061
that	O
bypass	O
conscious	O
intentions	O
.	O
	
priming	O
has	O
been	O
shown	O
to	O
have	O
effects	O
on	O
individual	O
behavior	O
in	O
a	O
variety	O
of	O
contexts	O
by	O
influencing	O
subconscious	O
cognition	O
.	O
	
this	O
paper	O
investigates	O
the	O
effects	B-T080
of	I-T080
semantic	B-T169
priming	I-T169
using	O
healthy	B-T080
body	O
image	O
,	O
goal-oriented	B-T170
words	I-T170
on	O
food	B-T052
consumption	I-T052
.	O
	
the	O
moderating	B-T170
role	I-T170
of	O
both	O
restrained	B-T170
eating	I-T170
and	O
gender	O
is	O
investigated	O
.	O
	
161	O
participants	B-T098
were	O
involved	O
in	O
an	O
experiment	B-T062
using	O
a	O
novel	O
version	O
of	O
a	O
scrambled	O
sentence	B-T170
priming	O
game	O
.	O
	
the	O
outcome	O
measure	O
was	O
the	O
number	O
of	O
kilocalories	B-T081
consumed	B-T061
,	O
examined	O
using	O
a	O
between	O
subjects	O
ancova	B-T081
with	O
priming	O
,	O
gender	O
,	O
restrained	B-T170
eating	I-T170
index	I-T170
,	O
self-reported	B-T062
bmi	O
,	O
and	O
two	O
interaction	B-T169
terms	O
priming	O
x	O
gender	O
,	O
and	O
priming	O
x	O
restrained	B-T170
eating	I-T170
index	I-T170
.	O
	
there	O
was	O
no	O
main	O
effect	B-T080
of	I-T080
priming	O
but	O
there	O
was	O
an	O
interaction	B-T169
of	O
priming	O
with	O
gender	O
.	O
	
females	O
consumed	O
significantly	O
fewer	O
kilocalories	B-T081
after	O
being	O
exposed	O
to	O
priming	O
words	B-T170
related	O
to	O
a	O
healthy	B-T080
body	O
image	O
i.e	O
.	O
	
"""slim"""	O
,	O
"""fit"	O
compared	O
to	O
females	O
receiving	O
the	O
neutral	O
prime	O
,	O
with	O
a	O
medium	O
effect	O
size	O
d	O
=	O
0.58	O
.	O
	
the	O
body	O
image	O
prime	O
did	O
not	O
significantly	O
affect	O
food	O
intake	O
for	O
males	O
,	O
nor	O
did	O
it	O
have	O
a	O
differential	O
effect	O
on	O
restrained	B-T098
eaters	I-T098
.	O
	
this	O
study	O
shows	O
that	O
priming	O
can	O
be	O
an	O
effective	O
method	O
for	O
influencing	O
females	O
to	O
reduce	O
food	O
intake	O
,	O
regardless	O
of	O
whether	O
they	O
are	O
restrained	B-T098
or	O
unrestrained	B-T098
eaters	I-T098
.	O
	
future	O
studies	O
could	O
investigate	O
whether	O
different	O
priming	O
words	B-T170
related	O
to	O
a	O
male's	O
healthy	B-T080
body	O
image	O
goal	O
i.e	O
.	O
	
"""buff"	O
""""	O
muscles	O
""""	O
etc	O
would	O
similarly	O
reduce	O
food	O
intake	O
for	O
neurotrophins	B-T116
and	O
specific	B-T116
receptors	I-T116
in	O
the	O
oviduct	O
tracts	O
of	O
japanese	O
quail	O
coturnix	O
coturnix	O
japonica	O
neurotrophins	B-T116
ngf	B-T116
,	O
bdnf	B-T116
and	O
nt-3	B-T116
and	O
their	O
specific	B-T116
receptors	I-T116
trka	B-T116
,	O
trkb	B-T116
and	O
trkc	B-T116
were	O
studied	B-T062
in	O
the	O
oviduct	O
of	O
egg	O
laying	O
quails	O
.	O
	
neurotrophins	B-T116
nts	B-T116
are	O
mainly	O
involved	O
in	O
the	O
development	B-T169
and	O
maintenance	B-T169
of	O
neuronal	O
populations	O
in	O
the	O
central	O
and	O
peripheral	O
nervous	O
system	O
,	O
but	O
also	O
in	O
reproductive	O
system	O
.	O
	
in	O
this	O
survey	O
,	O
we	O
first	O
studied	B-T062
the	O
morphological	B-T080
organization	O
of	O
the	O
quail	O
oviduct	O
,	O
distinguished	O
in	O
infundibulum	O
,	O
magnum	O
,	O
isthmus	O
,	O
uterus	O
and	O
vagina	O
,	O
and	O
then	O
we	O
analyzed	B-T062
the	O
expression	O
and	O
localization	O
of	O
nts	B-T116
and	O
trks	B-T116
receptors	I-T116
in	O
the	O
whole	O
tracts	O
.	O
	
by	O
western	O
blotting	O
we	O
detected	O
that	O
the	O
investigated	B-T169
nts	B-T116
and	O
trks	B-T116
receptors	I-T116
are	O
expressed	O
in	O
all	O
oviductal	O
tracts	O
.	O
	
by	O
immunohistochemistry	O
we	O
were	O
able	O
to	O
define	O
the	O
distribution	O
of	O
nts	B-T116
and	O
trks	B-T116
.	O
	
specifically	O
,	O
ngf	B-T116
,	O
bdnf	B-T116
and	O
nt3	B-T116
were	O
localized	O
in	O
lining	B-T082
and	O
ductal	O
epithelial	O
cells	O
,	O
and	O
ngf	B-T116
was	O
also	O
detected	O
in	O
secretory	O
cells	O
of	O
tubular	O
glands	O
and	O
in	O
nervous	O
fibers	O
of	O
vessel	O
wall	O
.	O
	
trka	B-T116
and	O
trkb	B-T116
were	O
present	O
in	O
the	O
lining	B-T082
and	O
ductal	O
epithelium	O
trka	B-T116
and	O
trkc	B-T116
were	O
present	O
in	O
nervous	O
fibers	O
of	O
vessel	O
wall	O
in	O
all	O
oviductal	O
tracts	O
.	O
	
furthermore	O
,	O
we	O
also	O
observed	O
ngf	B-T116
and	O
bdnf	B-T116
co-localized	O
with	O
trka	B-T116
and	O
trkb	B-T116
in	O
cells	O
of	O
the	O
lining	B-T082
and	O
ductal	O
epithelium	O
,	O
suggesting	O
an	O
autocrine	O
mechanism	O
of	O
the	O
influence	O
of	O
liposomal	B-T109
formulation	O
on	O
the	O
incorporation	B-T169
and	O
retention	B-T169
of	O
pna	O
oligomers	O
liposomal	B-T109
formulations	O
composed	O
of	O
phospholipids	B-T109
with	O
different	O
unsaturation	B-T080
degrees	I-T080
,	O
head	B-T169
groups	I-T169
and	O
at	O
different	O
cholesterol	O
content	O
have	O
been	O
tested	O
for	O
the	O
encapsulation	O
of	O
peptide	O
nucleic	O
acid	O
pna	O
oligomers	O
.	O
	
the	O
best	B-T081
loading	I-T081
capability	I-T081
177μg	O
,	O
er	B-T081
%=87	O
was	O
obtained	O
for	O
pure	O
liposomes	B-T109
of	O
phosphatidylglycerol	B-T109
dopg	B-T109
with	O
negatively	O
charged	O
head	B-T169
group	I-T169
.	O
	
the	O
insertion	O
of	O
a	O
10-20%	O
of	O
cholesterol	B-T109
in	O
dopg	B-T109
based	O
liposomes	B-T109
provides	O
a	O
slight	O
decrease	B-T081
160μg	O
of	O
the	O
pna	O
loading	B-T052
.	O
	
on	O
the	O
other	O
hand	O
,	O
the	O
cholesterol	B-T109
addition	B-T169
20-30%	O
slows	O
down	O
the	O
pna's	O
release	O
27%	O
in	O
fetal	O
bovine	O
serum	O
from	O
the	O
liposomal	B-T109
formulation	O
.	O
	
based	O
on	O
the	O
encapsulation	O
and	O
the	O
release	O
properties	O
,	O
pegylated	B-T109
dopg	B-T109
liposomes	B-T109
with	O
a	O
percentage	O
of	O
cholesterol	B-T109
of	O
10-20%	O
are	O
the	O
optimal	B-T062
formulation	I-T062
for	O
the	O
loading	B-T052
of	O
histopathology	O
of	O
the	O
filum	O
terminale	O
in	O
children	O
with	O
and	O
without	B-T080
tethered	B-T047
cord	I-T047
syndrome	I-T047
with	O
attention	O
to	O
the	O
elastic	O
tissue	O
within	O
the	O
filum	O
to	O
compare	B-T052
histologically	B-T169
transected	B-T169
fila	O
from	O
pediatric	B-T080
patients	O
with	O
tethered	B-T047
cord	I-T047
syndrome	I-T047
tcs	B-T047
,	O
with	O
and	O
without	B-T080
a	O
low	O
conus	O
,	O
with	O
controls	O
,	O
focusing	O
on	O
collagenous	O
and	O
elastic	O
tissue	O
.	O
	
thirty	O
fila	O
from	O
patients	O
with	O
tcs	B-T047
,	O
including	O
5	O
where	O
minimal	B-T080
cautery	B-T061
was	O
used	O
prior	O
to	O
filum	O
section	O
,	O
were	O
compared	B-T052
with	O
fila	O
from	O
27	O
pediatric	B-T080
cadavers	O
without	B-T080
tcs	B-T047
controls	O
.	O
	
sections	O
of	O
fila	O
were	O
stained	O
with	O
h	O
,	O
masson	O
trichrome	O
and	O
verhoeff	O
von	O
gieson	O
elastic	O
stains	O
,	O
and	O
7	O
with	O
gordon	O
and	O
sweet's	O
reticulin	O
stain	O
.	O
	
fila	O
from	O
controls	O
showed	O
loose	B-T080
fibrous	O
connective	O
tissue	O
fct	O
with	O
thin	B-T080
and	O
evenly	B-T169
dispersed	I-T169
elastic	O
fibers	O
efs	O
.	O
	
reticulin	B-T116
fibers	I-T116
rfs	B-T116
were	O
seen	O
in	O
blood	O
vessel	O
walls	O
and	O
nerve	O
twigs	O
.	O
	
fat	B-T109
was	O
identified	B-T080
microscopically	B-T080
in	O
2	O
fila	O
.	O
	
all	O
fila	O
from	O
patients	O
with	O
tcs	B-T047
had	O
dense	O
fct	O
.	O
	
the	O
efs	O
were	O
in	O
normal	B-T080
numbers	O
in	O
17	O
,	O
and	O
focally	B-T082
or	O
diffusely	B-T080
decreased	B-T081
in	O
13	O
.	O
	
all	O
25	O
patients	O
where	O
the	O
fila	O
were	O
cauterized	B-T061
during	O
resection	B-T061
had	O
thick	B-T080
and	O
coiled	B-T082
efs	O
.	O
	
coiling	B-T082
was	O
not	O
seen	O
when	O
minimal	B-T080
cautery	B-T061
was	O
applied	O
.	O
	
rfs	B-T116
were	O
seen	O
in	O
blood	O
vessel	O
walls	O
and	O
nerve	O
twigs	O
.	O
	
fat	B-T109
was	O
identified	B-T080
in	O
19	O
patients	O
.	O
	
findings	B-T033
were	O
similar	B-T080
,	O
whether	O
the	O
conus	O
termination	O
was	O
normal	B-T080
or	O
low	B-T082
.	O
	
the	O
fila	O
of	O
all	O
patients	O
with	O
tcs	B-T047
,	O
whether	O
or	O
not	O
the	O
conus	O
was	O
low	B-T082
,	O
showed	O
abnormal	B-T033
fct	O
.	O
	
efs	O
were	O
decreased	B-T081
in	O
48	O
%	O
of	O
patients	O
however	O
,	O
there	O
were	O
thick	B-T080
and	O
coiled	B-T082
efs	O
in	O
all	O
patients	O
.	O
	
coiling	B-T082
of	O
efs	O
,	O
initially	O
thought	O
to	O
be	O
an	O
abnormality	B-T033
in	O
patients	O
,	O
is	O
considered	O
most	O
likely	O
to	O
be	O
a	O
result	B-T033
of	O
cautery	B-T061
i.e	O
,	O
artifactual	O
/	O
iatrogenic	B-T080
coiling	B-T082
.	O
	
clinical	B-T033
value	I-T033
of	O
pathologic	O
examination	O
of	O
non-neoplastic	O
kidney	O
in	O
patients	O
with	O
upper	O
urinary	O
tract	O
malignancies	O
while	O
surgical	B-T061
resection	I-T061
remains	O
the	O
standard	O
of	O
care	B-T052
in	O
the	O
treatment	B-T061
of	O
upper	O
urinary	O
tract	O
malignancies	O
,	O
nephrectomy	B-T061
is	O
a	O
risk	B-T033
factor	I-T033
for	O
the	O
development	B-T169
of	O
chronic	B-T047
kidney	I-T047
disease	I-T047
ckd	B-T047
.	O
	
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
determine	O
whether	O
histologic	B-T169
evaluation	O
of	O
non-neoplastic	O
kidney	O
could	O
enable	O
early	B-T061
identification	I-T061
of	O
unrecognized	O
kidney	B-T047
disease	I-T047
and	O
could	O
be	O
of	O
prognostic	B-T170
value	O
in	O
predicting	O
postoperative	B-T079
renal	O
outcomes	B-T080
.	O
	
we	O
retrospectively	B-T062
analyzed	I-T062
51	O
patients	O
with	O
upper	O
urinary	O
tract	O
malignancies	O
who	O
received	O
uninephrectomy	B-T061
or	O
uninephroureterectomy	B-T061
.	O
	
a	O
thorough	O
pathologic	B-T169
evaluation	O
of	O
non-neoplastic	O
kidney	O
including	O
special	B-T061
stains	I-T061
,	O
immunofluorescence	O
,	O
and	O
electron	O
microscopic	O
studies	O
was	O
performed	O
.	O
	
the	O
degree	B-T081
of	O
parenchymal	O
changes	B-T169
was	O
graded	O
from	O
0	O
to	O
15	O
.	O
	
of	O
51	O
patients	O
,	O
only	O
13	O
showed	O
normal	O
kidney	O
pathology	O
.	O
	
fifteen	O
patients	O
showed	O
glomerular	B-T047
abnormalities	I-T047
,	O
14	O
showed	O
diabetic	B-T047
nephropathy	I-T047
,	O
and	O
11	O
showed	O
vascular	O
nephropathy	B-T061
.	O
	
there	O
was	O
one	O
case	O
each	O
of	O
reflux	B-T047
nephropathy	I-T047
and	O
chronic	B-T047
pyelonephritis	I-T047
.	O
	
the	O
median	O
histologic	B-T081
score	I-T081
was	O
5	O
points	O
.	O
	
only	O
25.4	O
of	O
patients	O
had	O
3	O
points	O
.	O
	
score	B-T081
more	O
than	O
5	O
was	O
observed	O
in	O
47.1	O
of	O
patients	O
.	O
	
postoperative	B-T079
estimated	O
glomerular	O
filtration	O
rate	O
egfr	O
at	O
3	O
to	O
36	O
months	B-T079
were	O
obtained	O
from	O
90.2	O
of	O
patients	O
,	O
and	O
of	O
those	O
,	O
34.8	O
had	O
de	O
novo	O
ckd	B-T047
.	O
	
since	O
no	O
one	O
had	O
ckd	B-T047
in	O
partial	O
nephrectomized	O
patients	O
,	O
we	O
determined	O
risk	B-T033
factors	I-T033
for	O
ckd	B-T047
in	O
radical	O
nephrectomized	O
patients	O
.	O
	
cox	B-T170
regression	I-T170
analysis	I-T170
revealed	O
that	O
postoperative	B-T079
aki	O
,	O
preoperative	B-T079
egfr	O
,	O
and	O
histologic	B-T169
score	O
of	O
non-neoplastic	O
kidney	O
were	O
the	O
independent	O
predictors	B-T078
for	O
ckd	B-T047
.	O
	
we	O
conclude	O
that	O
routine	O
pathologic	B-T169
evaluation	O
of	O
non-neoplastic	O
kidney	O
provides	O
valuable	O
diagnostic	B-T169
and	O
prognostic	B-T170
concordant	O
but	O
varied	O
phenotypes	O
among	O
duchenne	B-T047
muscular	I-T047
dystrophy	I-T047
patient	O
-specific	O
myoblasts	O
derived	O
using	O
a	O
human	O
ipsc	O
-based	O
model	O
duchenne	B-T047
muscular	I-T047
dystrophy	I-T047
dmd	B-T047
remains	O
an	O
intractable	O
genetic	B-T047
disease	I-T047
.	O
	
althogh	O
there	O
are	O
several	O
animal	O
models	O
of	O
dmd	B-T047
,	O
there	O
is	O
no	O
human	O
cell	O
model	O
that	O
carries	O
patient	O
-specific	O
dystrophin	O
mutations	O
.	O
	
here	O
,	O
we	O
present	O
a	O
human	O
dmd	B-T047
model	O
using	O
human	O
induced	O
pluripotent	O
stem	O
cells	O
hipscs	O
.	O
	
our	O
model	O
reveals	O
concordant	O
disease	B-T047
-	O
related	B-T169
phenotypes	O
with	O
patient	O
-	O
dependent	B-T080
variation	B-T080
,	O
which	O
are	O
partially	O
reversed	O
by	O
genetic	B-T169
and	O
pharmacological	B-T169
approaches	O
.	O
	
our	O
""""	O
chemical-compound	O
"-based"""	O
strategy	B-T062
successfully	O
directs	O
hipscs	O
into	O
expandable	O
myoblasts	O
,	O
which	O
exhibit	O
a	O
myogenic	O
transcriptional	O
program	B-T169
,	O
forming	O
striated	B-T080
contractile	O
myofibers	O
and	O
participating	O
in	O
muscle	B-T033
regeneration	I-T033
in	B-T082
vivo	I-T082
.	O
	
dmd	B-T047
-	O
hipsc	O
-derived	O
myoblasts	O
show	O
disease	B-T047
-	O
related	B-T169
phenotypes	O
with	O
patient	O
-to-	O
patient	O
variability	O
,	O
including	O
aberrant	B-T080
expression	O
of	O
inflammation	O
or	O
immune-response	O
genes	O
and	O
collagens	B-T116
,	O
increased	O
bmp	O
/	O
tgfβ	O
signaling	O
,	O
and	O
reduced	O
fusion	O
competence	O
.	O
	
furthermore	O
,	O
by	O
genetic	B-T169
correction	B-T169
and	O
pharmacological	B-T169
"""dual-"	O
smad	B-T116
""""	O
inhibition	O
,	O
the	O
dmd	B-T047
-	O
hipsc	O
-derived	O
myoblasts	O
and	O
genetically	B-T169
corrected	O
isogenic	B-T080
myoblasts	O
form	O
"""rescued"""	O
multi	B-T081
-	O
nucleated	B-T080
myotubes	O
.	O
	
in	O
conclusion	O
,	O
our	O
findings	O
demonstrate	O
the	O
feasibility	O
of	O
establishing	O
a	O
human	O
""""	O
dmd	B-T047
"-in-a-dish"""	O
model	O
using	O
hipsc	O
-based	O
disease	O
modeling	O
.	O
	
snai1	B-T116
promotes	B-T052
the	O
development	B-T169
of	O
hcc	O
through	O
the	O
enhancement	B-T052
of	O
proliferation	B-T169
and	O
inhibition	O
of	O
apoptosis	O
snai1	B-T116
,	O
a	O
zinc-finger	B-T116
transcription	I-T116
factor	I-T116
,	O
plays	O
an	O
important	O
role	O
in	O
the	O
induction	B-T169
of	O
epithelial-mesenchymal	O
transition	O
emt	O
in	O
various	O
cancers	O
.	O
	
however	O
,	O
the	O
possible	O
functions	O
of	O
snai1	B-T116
in	O
the	O
proliferation	B-T169
and	O
apoptosis	O
of	O
hepatocellular	O
carcinoma	O
have	O
not	O
been	O
clearly	O
identified	O
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
investigated	O
the	O
effects	B-T080
and	O
mechanisms	B-T169
of	O
snai1	B-T116
in	O
the	O
proliferation	B-T169
and	O
apoptosis	O
of	O
hepatocellular	O
carcinoma	O
using	O
clinical	B-T080
samples	O
and	O
cell	O
lines	O
.	O
	
we	O
found	O
that	O
snai1	B-T116
is	O
highly	O
expressed	O
in	O
the	O
tissues	O
of	O
liver	O
cancer	O
compared	O
with	O
adjacent	O
nontumor	O
tissues	O
.	O
	
snai1	B-T116
is	O
also	O
highly	O
expressed	O
in	O
the	O
hepatoma	O
cell	O
lines	O
hepg2	O
,	O
smmc-7721	O
,	O
and	O
bel-7402	O
compared	O
with	O
the	O
human	O
normal	O
liver	O
cell	O
line	O
l02	O
.	O
	
we	O
also	O
observed	O
that	O
snai1	B-T116
expression	O
was	O
correlated	O
with	O
distal	O
metastasis	O
,	O
incomplete	O
tumor	O
capsule	O
formation	O
,	O
and	O
histological	O
differentiation	O
in	O
hepatocellular	O
carcinoma	O
hcc	O
.	O
	
moreover	O
,	O
we	O
demonstrated	O
that	O
knockdown	O
of	O
snai1	O
via	O
lentiviral	O
vectors	O
of	O
rnai	O
against	O
snai	B-T116
inhibited	O
cell	B-T169
proliferation	I-T169
by	O
inducing	O
g1	O
arrest	O
,	O
which	O
was	O
accompanied	O
by	O
the	O
downregulation	O
of	O
cyclin	B-T116
d1	I-T116
but	O
not	O
that	O
of	O
cyclin	B-T116
a	I-T116
.	O
	
in	O
addition	O
,	O
knockdown	O
of	O
snai1	O
promoted	B-T052
apoptosis	O
by	O
decreasing	O
the	O
expression	O
of	O
bcl-2	B-T116
.	O
	
in	O
conclusion	O
,	O
our	O
findings	O
revealed	O
that	O
snai1	B-T116
is	O
involved	O
in	O
the	O
development	B-T169
of	O
hepatocellular	O
carcinoma	O
via	O
regulating	O
the	O
growth	O
and	O
apoptosis	O
of	O
tumor	O
cells	O
.	O
	
quantitative	B-T081
assessment	I-T081
of	O
fluorescent	B-T116
proteins	I-T116
the	O
advent	O
of	O
fluorescent	B-T116
proteins	I-T116
fps	B-T116
for	O
genetic	O
labeling	O
of	O
molecules	O
and	O
cells	O
has	O
revolutionized	O
fluorescence	O
microscopy	O
.	O
	
genetic	O
manipulations	O
have	O
created	O
a	O
vast	O
array	O
of	O
bright	O
and	O
stable	O
fps	B-T116
spanning	O
blue	B-T082
to	I-T082
red	I-T082
spectral	I-T082
regions	I-T082
.	O
	
common	O
to	O
autofluorescent	O
fps	B-T116
is	O
their	O
tight	O
β-barrel	O
structure	O
,	O
which	O
provides	O
the	O
rigidity	B-T080
and	O
chemical	O
environment	B-T082
needed	O
for	O
effectual	O
fluorescence	O
.	O
	
despite	O
the	O
common	O
structure	O
,	O
each	O
fp	B-T116
has	O
unique	O
properties	B-T080
.	O
	
thus	O
,	O
there	O
is	O
no	O
single	O
'best'	O
fp	B-T116
for	O
every	O
circumstance	O
,	O
and	O
each	O
fp	B-T116
has	O
advantages	O
and	O
disadvantages	O
.	O
	
to	O
guide	O
decisions	O
about	O
which	O
fp	B-T116
is	O
right	O
for	O
a	O
given	O
application	O
,	O
we	O
have	O
quantitatively	B-T081
characterized	O
the	O
brightness	O
,	O
photostability	B-T033
,	O
ph	B-T081
stability	B-T080
and	O
monomeric	O
properties	B-T080
of	O
more	O
than	O
40	O
fps	B-T116
to	O
enable	O
straightforward	B-T080
and	O
direct	O
comparison	B-T052
between	O
them	O
.	O
	
we	O
focus	O
on	O
popular	O
and/or	O
top-performing	O
fps	B-T116
in	O
each	O
spectral	B-T082
region	I-T082
.	O
	
consumption	O
of	O
fruits	O
and	O
vegetables	O
associated	B-T080
with	I-T080
other	O
risk	O
behaviors	O
among	O
adolescents	O
in	O
northeast	O
brazil	O
to	O
determine	O
the	O
prevalence	B-T081
of	O
consumption	O
of	O
fruits	O
and	O
vegetables	O
and	O
identify	O
the	O
association	B-T080
with	I-T080
low	B-T080
level	B-T080
of	O
physical	O
activity	O
,	O
exposure	B-T080
to	I-T080
sedentary	B-T033
behavior	I-T033
,	O
consumption	B-T052
of	O
soft	O
drinks	O
and	O
overweight	O
/	O
obesity	B-T047
in	O
adolescents	O
.	O
	
this	O
is	O
a	O
cross-sectional	B-T062
school-based	I-T062
study	I-T062
with	O
a	O
representative	O
sample	O
of	O
3992	O
students	B-T098
aged	O
14-19	O
years	B-T079
from	O
the	O
state	O
of	O
sergipe	O
,	O
brazil	O
.	O
	
the	O
outcome	B-T169
was	O
low	B-T080
consumption	O
of	O
fruits	O
and	O
vegetables	O
<5	O
servings/day	B-T079
.	O
	
independent	B-T169
variables	I-T169
were	O
level	B-T080
of	O
physical	O
activity	O
,	O
sedentary	B-T033
behavior	I-T033
,	O
consumption	B-T052
of	O
soft	O
drinks	O
,	O
and	O
overweight	O
/	O
obesity	B-T047
.	O
	
global	B-T170
student	I-T170
health	I-T170
survey	I-T170
questionnaire	I-T170
and	O
body	O
mass	O
and	O
height	O
measurements	O
were	O
used	O
,	O
as	O
well	O
as	O
chi-square	B-T170
test	I-T170
and	O
crude	B-T062
and	I-T062
adjusted	I-T062
binary	I-T062
logistic	I-T062
regression	I-T062
.	O
	
the	O
significance	B-T062
level	I-T062
adopted	O
was	O
5%	O
.	O
	
the	O
prevalence	B-T081
of	O
inadequate	B-T080
consumption	O
of	O
fruits	O
and	O
vegetables	O
was	O
high	B-T080
-	O
88.6	O
95%	O
ci	B-T081
=87	O
.	O
	
higher	B-T080
likelihood	O
of	O
low	B-T080
consumption	O
of	O
fruits	O
and	O
vegetables	O
was	O
verified	O
among	O
boys	O
who	O
were	O
exposed	B-T080
to	I-T080
sedentary	B-T033
behavior	I-T033
or	B-T081
=1	O
95%	O
ci	B-T081
=1	O
,	O
who	O
consumed	B-T052
soft	O
drinks	O
or	B-T081
=3	O
95%	O
ci	B-T081
=2	O
,	O
with	O
insufficiently	B-T080
physical	O
activity	O
or	B-T081
=1	O
95%	O
ci	B-T081
=1	O
and	O
girls	O
who	O
consumed	B-T052
soft	O
drinks	O
or	B-T081
=1	O
95%	O
ci	B-T081
=1	O
and	O
those	O
with	O
overweight	O
/	O
obesity	B-T047
or	B-T081
=1	O
95%	O
ci	B-T081
=1	O
.	O
	
there	O
is	O
a	O
need	O
of	O
public	O
policies	O
aimed	O
at	O
encouraging	O
the	O
consumption	B-T052
of	I-T052
healthy	I-T052
foods	I-T052
among	O
cobalamin	O
protection	B-T033
against	O
oxidative	O
stress	O
in	O
the	O
acidophilic	B-T169
iron-oxidizing	O
bacterium	O
leptospirillum	O
group	O
ii	O
cf-1	O
members	O
of	O
the	O
genus	O
leptospirillum	O
are	O
aerobic	B-T080
iron-oxidizing	O
bacteria	O
belonging	O
to	O
the	O
phylum	O
nitrospira	O
.	O
	
they	O
are	O
important	O
members	O
of	O
microbial	O
communities	O
that	O
catalyze	O
the	O
biomining	O
of	O
sulfidic	O
ores	O
,	O
thereby	O
solubilizing	O
metal	O
ions	O
.	O
	
these	O
microorganisms	O
live	O
under	O
extremely	O
acidic	O
and	O
metal	O
-loaded	O
environments	B-T082
and	O
thus	O
must	O
tolerate	O
high	O
concentrations	B-T081
of	O
reactive	O
oxygen	O
species	O
ros	O
.	O
	
cobalamin	O
vitamin	B-T109
b12	I-T109
is	O
a	O
cobalt	O
-containing	O
tetrapyrrole	B-T109
cofactor	O
involved	O
in	O
intramolecular	O
rearrangement	O
reactions	O
and	O
has	O
recently	O
been	O
suggested	O
to	O
be	O
an	O
intracellular	B-T082
antioxidant	O
.	O
	
in	O
this	O
work	O
,	O
we	O
investigated	B-T169
the	O
effect	B-T080
of	O
the	O
exogenous	B-T169
addition	O
of	O
cobalamin	O
on	O
oxidative	O
stress	O
parameters	O
in	O
leptospirillum	O
group	O
ii	O
strain	O
cf-1	O
.	O
	
our	O
results	O
revealed	B-T080
that	O
the	O
external	O
supplementation	O
of	O
cobalamin	O
reduces	O
the	O
levels	O
of	O
intracellular	B-T082
ross	O
and	O
the	O
damage	B-T169
to	O
biomolecules	O
,	O
and	O
also	O
stimulates	O
the	O
growth	O
and	O
survival	O
of	O
cells	O
exposed	O
to	O
oxidative	O
stress	O
exerted	O
by	O
ferric	O
ion	O
,	O
hydrogen	O
peroxide	O
,	O
chromate	O
and	O
diamide	B-T109
.	O
	
furthermore	O
,	O
exposure	O
of	O
strain	O
cf-1	O
to	O
oxidative	O
stress	O
elicitors	O
resulted	O
in	O
the	O
transcriptional	O
activation	O
of	O
the	O
cbia	O
gene	O
encoding	O
cbia	B-T116
of	O
the	O
cobalamin	O
biosynthetic	O
pathway	O
.	O
	
altogether	O
,	O
these	O
data	B-T078
suggest	O
that	O
cobalamin	O
plays	O
an	O
important	O
role	O
in	O
redox	O
protection	B-T033
of	O
leptospirillum	O
strain	O
cf-1	O
,	O
supporting	O
survival	O
of	O
this	O
microorganism	O
under	O
extremely	O
oxidative	B-T169
environmental	B-T080
conditions	I-T080
.	O
	
understanding	O
the	O
mechanisms	B-T169
underlying	O
the	O
protective	B-T033
effect	B-T080
of	O
cobalamin	O
against	O
oxidative	O
stress	O
may	O
help	O
to	O
develop	O
strategies	O
to	O
make	O
biomining	O
processes	O
more	O
a	O
longitudinal	B-T062
study	I-T062
assessing	O
childcare	O
services'	O
adoption	O
of	O
obesity	B-T047
prevention	O
policies	O
and	O
practices	O
despite	O
ongoing	O
investments	O
to	O
improve	O
the	O
obesogenic	B-T047
environments	B-T082
of	O
childcare	O
settings	O
,	O
little	O
is	O
known	O
regarding	O
how	O
these	O
services	O
have	O
changed	O
their	O
physical	O
activity	O
and	O
nutrition-promoting	B-T062
practices	I-T062
.	O
	
this	O
study	O
aims	O
to	O
describe	O
changes	O
in	O
the	O
proportion	O
of	O
australian	B-T098
childcare	O
services	O
that	O
have	O
adopted	O
best-practice	O
healthy	B-T061
eating	I-T061
and	O
physical	O
activity	O
practices	O
between	O
2006	O
and	O
2013	O
and	O
to	O
assess	O
whether	O
adoption	O
varied	O
by	O
socio-economic	B-T080
status	I-T080
and	O
locality	B-T082
.	O
	
a	O
randomly	B-T062
selected	I-T062
sample	I-T062
of	O
nominated	O
supervisors	O
n	O
=	O
358	O
from	O
childcare	O
services	O
located	O
in	O
new	O
south	O
wales	O
,	O
australia	O
,	O
participated	O
in	O
a	O
telephone	B-T062
survey	I-T062
in	O
2006	O
,	O
2009	O
,	O
2010	O
and	O
2013	O
.	O
	
supervisors	O
reported	O
on	O
their	O
service's	O
adoption	O
of	O
six	O
practices	O
i	O
having	O
written	O
nutrition	B-T062
and	O
physical	O
activity	O
policies	B-T170
ii	O
staff	O
trained	O
in	O
physical	O
activity	O
and	O
nutrition	B-T062
in	O
the	O
past	O
year	O
iii	O
scheduled	O
time	B-T079
for	O
fundamental	O
movement	O
skills	O
and	O
iv	O
outdoor	O
play	O
v	O
weekly	B-T079
or	O
less	O
screen	B-T033
time	I-T033
opportunitie	I-T033
s	O
and	O
vi	O
serving	O
only	O
non-sweetened	O
beverages	O
.	O
	
a	O
significant	O
increase	O
in	O
the	O
prevalence	B-T081
of	O
services	O
adopting	O
all	O
but	O
one	O
practice	O
,	O
between	O
2006	O
and	O
2013	O
was	O
identified	O
.	O
	
ninety	O
one	O
percent	O
of	O
services	O
adopted	O
four	O
or	O
more	O
practices	O
,	O
a	O
significant	O
increase	O
from	O
38%	O
in	O
2006	O
.	O
	
there	O
were	O
no	O
differences	O
in	O
the	O
proportion	O
of	O
services	O
adopting	O
each	O
practice	O
by	O
locality	B-T082
and	O
socio-economic	B-T080
status	I-T080
.	O
	
government	O
investment	B-T081
in	O
obesity	B-T047
prevention	O
programmes	O
can	O
equitably	O
improve	O
childcare	O
service's	O
adoption	O
of	O
healthy	B-T061
eating	I-T061
and	O
physical	O
activity	O
promoting	O
practices	O
on	O
a	O
jurisdiction	B-T170
-wide	O
basis	O
.	O
	
the	O
establishment	O
of	O
a	O
routine	O
system	O
to	O
monitor	O
adoption	O
of	O
a	O
broader	O
range	O
of	O
practices	O
by	O
childcare	O
services	O
isolation	B-T169
and	O
characterization	B-T052
of	O
burkholderia	O
sp	O
.	O
	
strain	O
cca53	O
exhibiting	O
ligninolytic	O
potential	B-T080
microbial	O
degradation	O
of	O
lignin	B-T109
releases	O
fermentable	B-T109
sugars	I-T109
,	O
effective	B-T080
utilization	B-T169
of	O
which	O
could	O
support	O
biofuel	B-T109
production	O
from	O
lignocellulosic	B-T109
biomass	B-T081
.	O
	
in	O
the	O
present	O
study	B-T062
,	O
a	O
lignin-degrading	O
bacterium	O
was	O
isolated	B-T169
from	O
leaf	O
soil	O
and	O
identified	O
as	O
burkholderia	O
sp	O
.	O
	
based	O
on	O
16s	O
rrna	O
gene	O
sequencing	O
.	O
	
this	O
strain	B-T080
was	O
named	O
cca53	O
,	O
and	O
its	O
lignin-degrading	O
capability	B-T080
was	O
assessed	B-T052
by	O
observing	O
its	O
growth	O
on	O
medium	O
containing	O
alkali	B-T109
lignin	I-T109
or	O
lignin	B-T109
-associated	O
aromatic	O
monomers	O
as	O
the	O
sole	O
carbon	O
source	B-T033
.	O
	
alkali	B-T109
lignin	I-T109
and	O
at	O
least	O
eight	O
lignin	B-T109
-associated	O
aromatic	O
monomers	O
supported	O
growth	O
of	O
this	O
strain	B-T080
,	O
and	O
the	O
most	O
effective	B-T080
utilization	B-T169
was	O
observed	O
for	O
p-hydroxybenzene	O
monomers	O
.	O
	
these	O
findings	B-T033
indicate	O
that	O
burkholderia	O
sp	O
.	O
	
strain	O
cca53	O
has	O
fragmentary	B-T052
activity	I-T052
for	O
lignin	O
degradation	O
.	O
	
diagnostic	B-T169
utility	B-T169
of	O
additional	O
conventional	B-T081
techniques	O
after	O
endobronchial	O
ultrasonography	O
guidance	O
during	O
transbronchial	O
biopsy	O
endobronchial	O
ultrasonography	O
with	O
a	O
guide	O
sheath	O
transbronchial	O
biopsy	O
ebus	O
-	O
gs	O
tbb	O
has	O
been	O
used	O
to	O
diagnose	B-T033
peripheral	B-T033
pulmonary	I-T033
lesions	I-T033
ppls	B-T033
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
evaluated	O
the	O
diagnostic	B-T169
utility	B-T169
of	O
conventional	B-T081
tbb	O
after	O
ebus	O
-	O
gs	O
tbb	O
.	O
	
a	O
retrospective	B-T062
analysis	I-T062
of	O
patients	O
who	O
underwent	O
conventional	B-T081
tbb	O
after	O
ebus	O
-	O
gs	O
tbb	O
for	O
ppl	B-T033
between	O
august	O
1	O
,	O
2012	O
and	O
december	O
31	O
,	O
2014	O
.	O
	
we	O
performed	O
multivariate	B-T081
analysis	I-T081
to	O
examine	O
the	O
association	B-T080
of	O
various	O
clinical	B-T080
factors	B-T169
,	O
including	O
ebus	O
probe	O
distance	B-T081
and	O
sample	B-T081
size	I-T081
area	B-T082
,	O
with	O
diagnostic	B-T080
yield	I-T080
.	O
	
of	O
88	O
eligible	O
patients	O
,	O
57	O
65%	O
were	O
successfully	O
diagnosed	B-T033
by	O
ebus	O
-	O
gs	O
tbb	O
.	O
	
in	O
31	O
patients	O
not	O
diagnosed	B-T033
by	O
ebus	O
-	O
gs	O
tbb	O
,	O
15	O
48%	O
were	O
successfully	O
diagnosed	B-T033
by	O
additional	O
conventional	B-T081
tbb	O
.	O
	
ground	B-T033
glass	I-T033
opacity	I-T033
ggo	B-T033
was	O
a	O
significant	B-T078
factor	B-T169
associated	O
with	O
the	O
diagnostic	B-T080
yield	I-T080
of	O
additional	O
conventional	B-T081
tbb	O
following	O
ebus	O
-	O
gs	O
tbb	O
.	O
	
multivariate	B-T081
analysis	I-T081
and	O
receiver	B-T081
operator	I-T081
curves	I-T081
revealed	O
that	O
distance	B-T081
between	O
the	O
ppl	B-T033
and	O
the	O
ebus	O
probe	O
of	O
less	O
than	O
2.55	O
mm	O
favored	O
the	O
utility	B-T169
of	O
conventional	B-T081
tbb	O
.	O
	
additional	O
conventional	B-T081
tbb	O
after	O
ebus	O
-	O
gs	O
tbb	O
could	O
be	O
a	O
useful	O
procedure	O
for	O
the	O
diagnosis	B-T033
of	O
ground	B-T033
glass	I-T033
opacity	I-T033
ppls	B-T033
and	O
in	O
cases	B-T169
of	O
a	O
distance	B-T081
of	O
less	O
than	O
2.55	O
mm	O
between	O
the	O
ebus	O
probe	O
and	O
the	O
active	B-T169
diffusion	O
and	O
microtubule-based	O
transport	O
oppose	O
myosin	B-T116
forces	O
to	O
position	B-T082
organelles	O
in	O
cells	O
even	O
distribution	B-T169
of	O
peroxisomes	O
pos	O
and	O
lipid	O
droplets	O
lds	O
is	O
critical	O
to	O
their	O
role	O
in	O
lipid	B-T109
and	O
reactive	O
oxygen	O
species	O
homeostasis	O
.	O
	
how	O
even	O
distribution	B-T169
is	O
achieved	O
remains	O
elusive	O
,	O
but	O
diffusive	O
motion	O
and	O
directed	O
motility	O
may	O
play	O
a	O
role	O
.	O
	
here	O
we	O
show	O
that	O
in	O
the	O
fungus	O
ustilago	O
maydis	O
95%	O
of	O
pos	O
and	O
lds	O
undergo	O
diffusive	O
motions	O
.	O
	
these	O
movements	O
require	O
atp	O
and	O
involve	O
bidirectional	B-T080
early	O
endosome	O
motility	O
,	O
indicating	O
that	O
microtubule	O
-	O
associated	B-T080
membrane	O
trafficking	O
enhances	B-T052
diffusion	O
of	O
organelles	O
.	O
	
when	O
early	O
endosome	O
transport	O
is	O
abolished	O
,	O
pos	O
and	O
lds	O
drift	O
slowly	O
towards	O
the	O
growing	O
cell	O
end	O
.	O
	
this	O
pole-ward	O
drift	O
is	O
facilitated	O
by	O
anterograde	O
delivery	O
of	O
secretory	B-T116
cargo	I-T116
to	O
the	O
cell	O
tip	O
by	O
myosin-5	B-T116
.	O
	
modelling	B-T062
reveals	O
that	O
microtubule-based	O
directed	O
transport	O
and	O
active	B-T169
diffusion	O
support	O
distribution	B-T169
,	O
mobility	O
and	O
mixing	O
of	O
pos	O
.	O
	
in	O
mammalian	O
cos-7	O
cells	O
,	O
microtubules	O
and	O
f-actin	B-T116
also	O
counteract	O
each	O
other	O
to	O
distribute	B-T169
pos	O
.	O
	
this	O
highlights	O
the	O
importance	O
of	O
opposing	O
cytoskeletal	O
forces	O
in	O
organelle	O
positioning	B-T082
in	O
the	O
role	O
of	O
catheter	B-T061
ablation	I-T061
in	O
the	O
management	O
of	O
atrial	B-T047
fibrillation	I-T047
atrial	B-T047
fibrillation	I-T047
is	O
driven	O
by	O
spontaneous	O
electrical	O
activation	O
emerging	O
from	O
the	O
pulmonary	O
veins	O
.	O
	
catheter	B-T061
ablation	I-T061
using	O
either	O
radiofrequency	B-T061
or	O
cryothermal	B-T061
energy	I-T061
electrically	B-T169
isolates	B-T169
these	O
veins	O
from	O
the	O
left	O
atrium	O
,	O
both	O
reducing	B-T080
the	O
burden	B-T078
of	O
atrial	B-T047
fibrillation	I-T047
episodes	B-T079
and	O
improving	O
the	O
patient's	O
symptoms	O
.	O
	
catheter	B-T061
ablation	I-T061
is	O
superior	O
to	O
antiarryhthmic	O
drugs	O
when	O
patients	O
are	O
carefully	O
selected	O
.	O
	
underlying	O
medical	O
problems	O
-	O
including	O
obesity	B-T047
,	O
hypertension	B-T047
and	O
obstructive	B-T047
sleep	I-T047
apnoea	I-T047
-	O
should	O
be	O
optimally	O
treated	B-T169
before	O
considering	O
ablation	B-T061
.	O
	
although	O
this	O
treatment	B-T061
has	O
the	O
potential	B-T080
to	O
cure	O
patients	O
of	O
their	O
symptoms	O
,	O
they	O
should	O
be	O
aware	O
of	O
the	O
important	O
associated	O
procedural	B-T033
complications	I-T033
.	O
	
the	O
chinese	B-T080
herbal	I-T080
mixture	O
tien-hsien	B-T109
liquid	I-T109
augments	B-T081
the	O
anticancer	B-T080
immunity	O
in	O
tumor	O
cell	O
-	O
vaccinated	B-T033
mice	O
background	O
the	O
chinese	B-T080
herbal	I-T080
mixture	O
,	O
tien-hsien	B-T109
liquid	I-T109
thl	B-T109
,	O
has	O
been	O
used	O
as	O
an	O
anticancer	B-T080
dietary	O
supplement	O
for	O
more	O
than	O
20	O
years	B-T079
.	O
	
our	O
previous	B-T079
studies	B-T062
have	O
shown	O
that	O
thl	B-T109
can	O
modulate	B-T082
immune	O
response	O
and	O
inhibit	B-T052
tumor	O
growth	O
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
further	O
evaluated	O
the	O
effect	B-T080
of	O
thl	B-T109
on	O
anticancer	B-T080
immune	O
response	O
in	O
mice	O
vaccinated	B-T033
with	O
γ-ray	O
-	O
irradiated	O
tumor	O
cells	O
.	O
	
methods	O
the	O
antitumor	B-T080
effect	B-T080
of	O
thl	B-T109
was	O
determined	B-T080
in	O
mice	O
vaccinated	B-T033
with	O
low-tumorigenic	O
ct-26-low	O
colon	O
cancer	O
cells	O
or	O
γ-ray-irradiated	B-T061
high-tumorigenic	O
ct-26-high	O
colon	O
cancer	O
cells	O
.	O
	
the	O
number	B-T081
of	O
natural	O
killer	O
nk	O
cells	O
and	O
t	O
lymphocytes	O
in	O
the	O
spleen	O
was	O
analyzed	B-T062
by	O
flow	O
cytometry	O
.	O
	
the	O
tumor	O
-	O
killing	O
activities	B-T052
of	O
nk	O
cells	O
and	O
cytotoxic	O
t	O
lymphocytes	O
ctls	O
were	O
analyzed	B-T062
by	O
flow	O
cytometry	O
using	O
yac-1	O
and	O
ct-26-high	O
cells	O
,	O
respectively	O
,	O
as	O
target	B-T169
cells	O
.	O
	
the	O
levels	B-T080
of	O
ifn-γ	B-T116
,	O
il-2	B-T116
,	O
and	O
tnf-α	B-T116
were	O
determined	B-T080
by	I-T080
elisa	O
.	O
	
results	O
thl	B-T109
suppressed	B-T169
the	O
growth	O
of	O
ct-26-high	O
tumor	O
in	O
mice	O
previously	O
vaccinated	B-T033
with	O
low-tumorigenic	O
ct-26-low	O
cells	O
or	O
γ-irradiated	B-T061
ct-26-high	O
cells	O
.	O
	
thl	B-T109
increased	B-T081
the	O
populations	O
of	O
nk	O
cells	O
and	O
cd4+	O
t	O
lymphocytes	O
in	O
the	O
spleen	O
and	O
enhanced	B-T052
the	O
tumor	O
-	O
killing	O
activities	B-T052
of	O
nk	O
cells	O
and	O
ctl	O
in	O
mice	O
vaccinated	B-T033
with	O
γ-irradiated	B-T061
ct-26-high	O
cells	O
.	O
	
thl	B-T109
increased	B-T081
the	O
production	B-T169
of	O
ifn-γ	B-T116
,	O
il-2	B-T116
,	O
and	O
tnf-α	B-T116
in	O
mice	O
vaccinated	B-T033
with	O
γ-irradiated	B-T061
ct-26-high	O
cells	O
.	O
	
conclusion	O
thl	B-T109
can	O
enhance	B-T052
the	O
antitumor	B-T080
immune	O
responses	O
in	O
mice	O
vaccinated	B-T033
with	O
killed	B-T169
tumor	O
cells	O
.	O
	
these	O
results	B-T169
suggest	O
that	O
thl	B-T109
may	O
be	O
used	O
as	O
a	O
complementary	O
medicine	O
for	O
cancer	O
patients	O
previously	B-T079
treated	B-T169
with	O
killed	B-T116
tumor	I-T116
cell	I-T116
vaccines	I-T116
,	O
radiotherapy	B-T061
,	O
or	O
timing	B-T079
of	O
false	O
ring	O
formation	O
in	O
pinus	O
halepensis	O
and	O
arbutus	O
unedo	O
in	O
southern	B-T082
italy	O
outlook	O
from	O
an	O
analysis	B-T062
of	O
xylogenesis	O
and	O
tree-ring	O
chronologies	B-T170
mediterranean	O
tree	O
rings	O
are	O
characterized	B-T052
by	O
intra-annual	B-T079
density	I-T079
fluctuations	I-T079
iadfs	B-T079
due	O
to	O
partly	O
climate-driven	O
cambial	O
activity	O
.	O
	
iadfs	B-T079
are	O
used	O
as	O
structural	B-T082
signals	B-T078
to	O
gain	O
information	B-T078
on	O
relations	B-T080
between	B-T082
environmental	B-T082
conditions	B-T080
and	O
eco-physiological	O
processes	O
during	B-T079
xylogenesis	O
,	O
with	O
intra-annual	B-T079
resolution	O
.	O
	
to	O
reach	O
an	O
unbiased	B-T062
synchronization	B-T079
of	O
the	O
iadf	B-T079
position	B-T082
within	O
tree	O
rings	B-T082
and	O
seasonal	B-T079
fluctuations	O
in	O
environmental	B-T082
conditions	B-T080
,	O
it	O
is	O
necessary	O
to	O
know	O
the	O
timing	B-T079
of	O
cambial	O
activity	O
and	O
wood	O
formation	B-T169
,	O
which	O
are	O
species-	B-T080
and	O
site-specific	B-T080
processes	O
.	O
	
we	O
applied	B-T169
the	O
microcoring	B-T169
technique	I-T169
to	O
analyze	B-T062
xylogenesis	O
in	O
pinus	O
halepensis	O
and	O
arbutus	O
unedo	O
.	O
	
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
attempt	O
to	O
study	B-T062
xylogenesis	O
in	O
a	O
hardwood	O
species	O
forming	O
frequent	B-T079
iadfs	B-T079
.	O
	
both	O
species	O
co-occur	B-T052
at	O
a	O
site	B-T082
in	O
southern	B-T082
italy	O
characterized	B-T052
by	O
a	O
mediterranean	O
climate	O
.	O
	
to	O
facilitate	O
tree-ring	B-T062
dating	I-T062
and	O
identification	B-T080
of	O
iadfs	B-T079
,	O
we	O
performed	B-T169
traditional	B-T169
dendroecological	B-T080
analysis	B-T062
.	O
	
we	O
analyzed	B-T062
xylogenesis	O
during	B-T079
summer	B-T079
,	O
which	O
is	O
considered	B-T078
a	O
constraint	B-T169
for	O
xylogenesis	O
and	O
a	O
trigger	O
for	O
iadf	B-T079
formation	B-T169
.	O
	
we	O
followed	O
the	O
different	B-T080
phases	B-T079
of	O
cell	O
development	O
in	O
the	O
current	B-T079
wood	O
increment	B-T081
with	O
the	O
aim	O
of	O
evaluating	O
whether	O
and	O
which	O
type	O
of	O
iadfs	B-T079
were	O
formed	B-T169
.	O
	
we	O
additionally	O
analyzed	B-T062
the	O
same	O
phases	B-T079
again	O
in	O
september	B-T079
and	O
in	O
winter	B-T079
to	O
verify	B-T169
the	O
possible	B-T033
formation	B-T169
of	O
iadfs	B-T079
in	O
fall	B-T079
and	O
whether	O
cell	O
production	O
and	O
differentiation	O
was	O
completed	B-T080
by	O
the	O
end	O
of	O
the	O
calendar	B-T079
year	I-T079
.	O
	
both	O
species	O
formed	B-T169
the	O
same	O
type	O
of	O
iadfs	B-T079
earlywood	O
-like	O
cells	O
within	O
latewood	O
,	O
due	O
to	O
temporary	B-T079
growth	O
restoration	B-T033
triggered	B-T080
by	I-T080
rain	O
events	O
during	B-T079
the	O
period	B-T079
of	O
summer	B-T079
drought	O
.	O
	
at	O
the	O
end	O
of	O
the	O
calendar	B-T079
year	I-T079
,	O
no	O
cells	O
in	O
the	O
phases	B-T079
of	O
enlargement	B-T080
and	O
secondary	O
cell	O
wall	O
deposition	B-T169
occurred	B-T052
.	O
	
a	O
.	O
	
unedo	O
was	O
more	O
sensitive	B-T169
than	O
p	O
.	O
	
halepensis	O
because	O
iadf	B-T079
s	O
were	O
formed	B-T169
earlier	B-T079
in	O
the	O
season	B-T079
and	O
were	O
more	O
frequent	B-T079
in	O
the	O
tree-ring	O
series	O
.	O
	
the	O
dendro-anatomical	B-T080
approach	O
,	O
combining	O
analysis	B-T062
of	O
tree-ring	O
series	O
and	O
of	O
xylogenesis	O
,	O
helped	O
to	O
detect	B-T033
the	O
period	B-T079
of	O
iadf	B-T079
formation	B-T169
in	O
the	O
two	O
species	O
.	O
	
results	B-T169
are	O
discussed	O
in	O
functional	B-T169
terms	B-T078
,	O
highlighting	O
the	O
environmental	B-T082
conditions	B-T080
triggering	B-T080
iadfs	B-T079
,	O
and	O
also	O
in	O
methodological	O
terms	B-T078
,	O
evaluating	O
the	O
applicability	B-T169
of	O
xylogenesis	O
analysis	B-T062
in	O
mediterranean	O
woods	O
,	O
especially	O
when	O
the	O
formation	B-T169
of	O
iadfs	B-T079
is	O
not	O
uniform	B-T080
around	O
the	O
emergence	B-T080
of	O
family	O
medicine	O
in	O
ethiopia	O
corrected	O
an	O
international	B-T078
collaborative	O
education	B-T170
model	I-T170
family	O
medicine	O
fm	O
is	O
a	O
new	O
specialty	O
in	O
ethiopia	O
.	O
	
the	O
first	O
seven	O
family	O
physicians	O
graduated	B-T098
in	O
february	B-T080
2016	O
from	O
the	O
inaugural	O
residency	O
programme	B-T170
at	O
addis	O
ababa	O
university	O
.	O
	
cooperation	O
amongst	O
ethiopian	B-T098
and	O
expatriate	B-T033
decision-makers	O
and	O
physicians	O
was	O
needed	O
to	O
begin	B-T079
the	O
programme	B-T170
.	O
	
intentional	B-T078
replacement	B-T169
of	O
expatriates	B-T033
with	O
ethiopian	B-T098
family	O
physicians	O
has	O
begun	B-T079
.	O
	
barriers	B-T080
include	O
lack	B-T080
of	I-T080
understanding	O
of	O
fm	O
and	O
the	O
human	B-T169
and	O
financial	B-T033
resources	I-T033
needed	O
for	O
scaling	B-T081
up	I-T081
the	O
programme	B-T170
.	O
	
regular	B-T080
programme	B-T170
review	B-T080
with	O
resident	O
physician	O
involvement	O
has	O
allowed	O
the	O
fm	O
training	O
programme	O
to	O
adapt	B-T080
and	O
fit	B-T052
the	O
ethiopian	B-T098
context	B-T078
.	O
	
further	O
successes	O
will	O
result	B-T169
from	O
ongoing	O
support	O
and	O
advocacy	O
from	O
the	O
federal	O
ministry	O
of	O
health	O
and	O
other	O
ethiopian	B-T098
,	O
african	B-T098
,	O
and	O
international	B-T078
primary	O
care	O
organisations	O
the	O
experience	O
of	O
women	B-T098
veterans	B-T098
coming	O
back	O
from	O
war	B-T052
issues	O
surrounding	O
mental	O
health	O
are	O
common	O
for	O
women	B-T098
veterans	B-T098
who	O
have	O
served	O
in	O
iraq	O
and	O
afghanistan	O
wars	B-T052
.	O
	
the	O
goal	O
of	O
this	O
phenomenological	B-T078
study	B-T062
was	O
to	O
document	B-T170
themes	O
in	O
the	O
stories	B-T170
gathered	O
from	O
eight	O
women	B-T098
veterans	B-T098
who	O
had	O
come	O
back	O
from	O
war	B-T052
.	O
	
themes	O
in	O
the	O
stories	B-T170
were	O
arriving	O
with	O
mixed	O
sentiments	O
evolving	O
to	O
a	O
changed	B-T169
view	O
of	O
self	O
permeating	B-T033
aggravation	I-T033
confounding	O
broken	O
relationships	O
,	O
frequent	B-T033
deployments	I-T033
,	O
and	O
change	B-T033
in	I-T033
military	I-T033
status	I-T033
remembering	O
war	B-T052
experiences	O
and	O
seeking	B-T033
opportunity	I-T033
for	I-T033
what	I-T033
is	I-T033
possible	I-T033
.	O
	
mental	O
health	O
issues	O
can	O
be	O
observed	O
in	O
the	O
themes	O
.	O
	
including	O
story	B-T170
as	O
part	O
of	O
the	O
mental	O
health	O
visit	O
with	O
veterans	B-T098
may	O
be	O
beneficial	O
to	O
veterans	B-T098
as	O
they	O
deal	O
with	O
the	O
transition	B-T052
of	I-T052
coming	I-T052
back	I-T052
.	O
	
trajectories	B-T082
of	O
health	B-T078
and	O
behavioral	O
health	O
services	O
use	B-T169
among	O
community	O
corrections	B-T169
-involved	O
rural	B-T033
adults	O
this	O
article	O
seeks	O
to	O
establish	O
time-based	O
trajectories	B-T082
of	O
health	B-T078
and	O
behavioral	O
health	O
services	O
utilization	B-T169
for	O
community	B-T078
corrections-involved	I-T078
cci	B-T078
adults	O
and	O
to	O
examine	O
demographic	B-T078
and	O
clinical	B-T080
correlates	O
associated	O
with	O
these	O
trajectories	B-T082
.	O
	
to	O
accomplish	O
this	O
aim	O
,	O
the	O
authors	O
applied	O
a	O
latent	B-T062
class	I-T062
growth	I-T062
analysis	I-T062
lcga	B-T062
to	O
services	O
use	O
data	O
from	O
a	O
sample	O
of	O
rural	B-T033
cci	B-T078
adults	O
who	O
reported	O
their	O
medical	B-T169
,	O
mental	O
health	O
,	O
and	O
substance	B-T078
use	I-T078
treatment	O
utilization	O
behavior	O
every	O
60	O
days	B-T079
for	O
1.5	O
years	B-T079
.	O
	
lcga	B-T062
established	O
1.5	B-T079
trajectories	B-T082
and	O
demographic	B-T078
correlates	O
of	O
health	O
services	O
among	O
rural	B-T033
cci	B-T078
adults	O
.	O
	
for	O
medical	O
services	O
,	O
three	O
classes	O
emerged	O
stable-low	O
users	B-T098
,	O
13%	O
stable-intermediate	O
users	B-T098
,	O
40%	O
and	O
stable-high	O
users	B-T098
,	O
47%	O
.	O
	
for	O
mental	O
health	O
and	O
substance	B-T078
use	I-T078
services	O
,	O
three	O
classes	O
emerged	O
stable-low	O
,	O
69%	O
and	O
61%	O
,	O
respectively	O
low-baseline-increase	O
,	O
10%	O
and	O
12%	O
,	O
respectively	O
high-baseline	O
decline	O
,	O
21%	O
and	O
28%	O
,	O
respectively	O
.	O
	
employment	B-T080
,	O
gender	O
,	O
medication	B-T033
usage	I-T033
,	O
and	O
depression	O
severity	B-T080
predicted	O
membership	O
across	O
all	O
services	O
.	O
	
results	O
underscore	O
the	O
importance	O
of	O
social	O
workers	O
and	O
other	O
community	O
services	O
providers	O
aligning	O
health	O
services	O
access	O
with	O
the	O
needs	O
of	O
the	O
cci	B-T078
population	O
,	O
and	O
highlight	O
cci	B-T078
adults	O
as	O
being	O
at	O
risk	B-T078
of	O
underservice	O
in	O
critical	O
prevention	B-T061
and	O
intervention	B-T061
domains	I-T061
.	O
	
data	B-T170
set	I-T170
of	O
interactomes	O
and	O
metabolic	B-T169
pathways	I-T169
of	O
proteins	B-T116
differentially	O
expressed	O
in	O
brains	O
with	O
alzheimer	B-T047
disease	I-T047
alzheimer	B-T047
disease	I-T047
is	O
one	O
of	O
the	O
main	O
causes	O
of	O
dementia	O
in	O
the	O
elderly	B-T098
and	O
its	O
frequency	B-T079
is	O
on	O
the	O
rise	O
worldwide	B-T098
.	O
	
it	O
is	O
considered	O
the	O
result	O
of	O
complex	B-T080
interactions	B-T169
between	O
genetic	B-T080
and	O
environmental	B-T080
factors	I-T080
,	O
being	O
many	O
of	O
them	O
unknown	O
.	O
	
therefore	O
,	O
there	O
is	O
a	O
dire	O
necessity	O
for	O
the	O
identification	O
of	O
novel	O
molecular	B-T116
players	I-T116
for	O
the	O
understanding	O
of	O
this	O
disease	B-T047
.	O
	
in	O
this	O
data	B-T078
article	B-T170
we	O
determined	O
the	O
protein	O
expression	O
profiles	O
of	O
whole	O
protein	B-T116
extracts	O
from	O
cortex	O
regions	O
of	O
brains	O
from	O
patients	O
with	O
alzheimer	B-T047
disease	I-T047
in	O
comparison	O
to	O
a	O
normal	O
brain	O
.	O
	
we	O
identified	B-T080
721	O
itraq-labeled	O
polypeptides	B-T116
with	O
more	O
than	O
95%	O
in	O
confidence	O
.	O
	
we	O
analyzed	B-T062
all	O
proteins	B-T116
that	O
changed	O
in	O
their	O
expression	B-T081
level	I-T081
and	O
located	O
them	O
in	O
the	O
kegg	B-T170
metabolic	I-T170
pathways	I-T170
,	O
as	O
well	O
as	O
in	O
the	O
mitochondrial	O
complexes	O
of	O
the	O
electron	O
transport	O
chain	O
and	O
atp	B-T116
synthase	I-T116
.	O
	
in	O
addition	O
,	O
we	O
analyzed	B-T062
the	O
over-	B-T116
and	I-T116
sub-expressed	I-T116
polypeptides	I-T116
through	O
ipa	O
software	O
,	O
specifically	O
core	B-T170
i	I-T170
and	I-T170
biomarkers	I-T170
i	I-T170
modules	I-T170
.	O
	
data	B-T078
in	O
this	O
article	B-T170
is	O
related	O
to	O
the	O
research	B-T062
article	B-T170
"""identification"	O
of	O
proteins	B-T116
that	O
are	O
differentially	O
expressed	O
in	O
brains	O
with	O
alzheimer's	B-T047
disease	I-T047
using	O
itraq	O
labeling	O
and	O
tandem	O
mass	O
spectrometry	O
emergency	B-T061
general	I-T061
surgery	I-T061
specific	B-T170
frailty	I-T170
index	I-T170
a	O
validation	B-T062
study	I-T062
assessment	O
of	O
operative	B-T078
risk	I-T078
in	O
geriatric	O
patients	O
undergoing	O
emergency	B-T061
general	I-T061
surgery	I-T061
egs	B-T061
is	O
challenging	O
.	O
	
frailty	B-T033
is	O
an	O
established	O
measure	B-T081
for	O
risk	O
assessment	O
in	O
surgical	O
cases	O
.	O
	
the	O
aim	O
of	O
our	O
study	B-T062
was	O
to	O
validate	B-T062
a	O
modified	O
15	O
variable	B-T080
emergency	O
general	O
surgery	O
specific	O
frailty	O
index	O
egsfi	O
.	O
	
we	O
prospectively	O
collected	B-T078
geriatric	B-T080
age	O
>	O
65	O
emergency	B-T061
general	I-T061
surgery	I-T061
patients	O
for	O
1-	O
year	B-T079
.	O
	
post-operative	O
complications	O
were	O
collected	B-T078
.	O
	
frailty	B-T170
index	I-T170
was	O
calculated	O
for	O
200	O
patients	O
based	O
on	O
their	O
pre-admission	B-T079
condition	B-T080
using	O
50-	O
variable	B-T080
modified	O
rockwood	B-T170
frailty	I-T170
index	I-T170
fi	B-T170
.	O
	
egsfi	O
was	O
developed	O
based	O
on	O
the	O
regression	B-T170
model	I-T170
for	O
complications	O
and	O
the	O
most	O
significant	O
factors	O
in	O
the	O
fi	B-T170
.	O
	
roc	B-T081
curve	I-T081
analysis	I-T081
was	O
performed	O
to	O
determine	O
cutoff	B-T169
for	O
frail	B-T033
status	B-T080
.	O
	
we	O
validated	B-T062
our	O
results	B-T169
using	O
60	O
patients	O
for	O
predicting	B-T078
complications	O
.	O
	
a	O
total	O
of	O
260	O
patients	O
200	O
developing	O
,	O
60	O
validation	B-T062
were	O
enrolled	O
in	O
this	O
study	B-T062
.	O
	
mean	O
age	O
was	O
71	O
11	O
years	B-T079
,	O
and	O
33%	O
developed	O
complications	O
.	O
	
most	O
common	B-T081
complications	O
were	O
pneumonia	B-T047
12%	O
,	O
uti	B-T047
9%	O
,	O
and	O
wound	O
infection	O
7%	O
.	O
	
univariate	B-T062
analysis	I-T062
identified	O
15	O
variables	B-T080
significantly	O
associated	B-T080
with	I-T080
complications	O
that	O
were	O
used	O
to	O
develop	O
the	O
egsfi	O
.	O
	
a	O
cutoff	B-T169
frailty	B-T033
score	I-T033
of	O
0.325	O
was	O
identified	O
using	O
roc	B-T081
curve	I-T081
analysis	I-T081
for	O
frail	B-T033
status	B-T080
sixty-	O
patients	O
frail	B-T033
18	O
,	O
non-frail	B-T033
42	O
were	O
enrolled	O
in	O
the	O
validation	B-T062
cohort	B-T098
.	O
	
frail	B-T033
patients	O
were	O
more	O
likely	O
to	O
have	O
post-operative	O
complications	O
47%	O
vs	O
.	O
	
20%	O
,	O
p	O
<	O
0.001	O
compared	O
to	O
nonfrail	O
patients	O
.	O
	
frail	B-T033
status	B-T080
based	O
on	O
egsfi	O
was	O
a	O
significant	B-T078
predictor	I-T078
of	O
post-operative	O
complications	O
or	B-T081
=7	O
,	O
95%	O
ci	B-T081
=	O
1.7	O
-	O
19.8	O
p=0	O
.	O
	
age	O
was	O
not	O
associated	B-T080
with	I-T080
postoperative	O
complications	O
or	B-T081
=0	O
,	O
95%	O
ci	B-T081
=	O
0.92	O
-1	O
p=0	O
.	O
	
the	O
15-	O
variable	B-T080
validated	B-T062
egsfi	O
is	O
a	O
simple	O
and	O
reliable	O
bedside	O
tool	O
to	O
determine	O
the	O
frailty	B-T033
status	I-T033
of	O
patients	O
undergoing	O
emergency	B-T061
general	I-T061
surgery	I-T061
.	O
	
frail	B-T033
status	B-T080
as	O
determined	O
by	O
abstract	O
the	O
egsfi	O
is	O
an	O
independent	B-T078
predictor	I-T078
of	O
post-operative	O
complications	O
and	O
mortality	B-T081
in	O
geriatric	B-T080
emergency	B-T061
general	I-T061
surgery	I-T061
patients	O
.	O
	
level	O
ii	O
,	O
prognostic	B-T062
studies	I-T062
-	O
investigating	B-T169
the	O
effect	B-T080
of	O
a	O
patient	O
characteristic	O
on	O
the	O
outcome	B-T033
of	I-T033
disease	I-T033
.	O
	
comparative	O
epidemiologic	B-T169
characteristics	B-T080
of	O
pertussis	B-T047
in	O
10	O
central	O
and	O
eastern	O
european	O
countries	O
,	O
2000-2013	O
we	O
undertook	O
an	O
epidemiological	B-T062
survey	I-T062
of	O
the	O
annual	B-T079
incidence	B-T081
of	O
pertussis	B-T047
reported	O
from	O
2000	O
to	O
2013	O
in	O
ten	O
central	O
and	O
eastern	O
european	O
countries	O
to	O
ascertain	O
whether	O
increased	O
pertussis	B-T047
reports	B-T170
in	O
some	O
countries	O
share	O
common	O
underlying	O
drivers	O
or	O
whether	O
there	O
are	O
specific	O
features	B-T080
in	O
each	O
country	O
.	O
	
the	O
annual	B-T079
incidence	B-T081
of	O
pertussis	B-T047
in	O
the	O
participating	O
countries	O
was	O
obtained	O
from	O
relevant	O
government	O
institutions	O
and/or	O
national	O
surveillance	O
systems	O
.	O
	
we	O
reviewed	B-T080
the	O
changes	B-T169
in	O
the	O
pertussis	B-T047
incidence	B-T081
rates	I-T081
in	O
each	O
country	O
to	O
explore	O
differences	B-T080
and/or	O
similarities	B-T080
between	O
countries	O
in	O
relation	O
to	O
pertussis	B-T047
surveillance	B-T169
case	B-T170
definitions	I-T170
for	O
detection	B-T033
and	O
confirmation	B-T080
of	O
pertussis	B-T047
incidence	B-T081
and	O
number	B-T081
of	I-T081
cases	I-T081
of	O
pertussis	B-T047
by	O
year	B-T079
,	O
overall	O
and	O
by	O
age	O
group	O
population	B-T098
by	O
year	B-T079
,	O
overall	O
and	O
by	O
age	O
group	O
pertussis	B-T047
immunization	B-T061
schedule	I-T061
and	O
coverage	B-T169
,	O
and	O
switch	O
from	O
whole-cell	O
pertussis	O
vaccines	O
wp	O
to	O
acellular	O
pertussis	O
vaccines	O
ap	O
.	O
	
there	O
was	O
heterogeneity	B-T080
in	O
the	O
reported	O
annual	B-T079
incidence	B-T081
rates	I-T081
and	O
trends	O
observed	O
across	O
countries	O
.	O
	
reported	O
pertussis	B-T047
incidence	B-T081
rates	I-T081
varied	O
considerably	O
,	O
ranging	O
from	O
0.01	O
to	O
96	O
per	O
100	O
population	B-T098
,	O
with	O
the	O
highest	B-T080
rates	B-T081
generally	O
reported	O
in	O
estonia	O
and	O
the	O
lowest	B-T080
in	O
hungary	O
and	O
serbia	O
.	O
	
the	O
greatest	O
burden	B-T078
appears	O
for	O
the	O
most	O
part	O
in	O
infants	O
<1	O
year	B-T079
in	O
bulgaria	O
,	O
hungary	O
,	O
latvia	O
,	O
romania	O
,	O
and	O
serbia	O
,	O
but	O
not	O
in	O
the	O
other	O
participating	O
countries	O
where	O
the	O
burden	B-T078
may	O
have	O
shifted	O
to	O
older	O
children	O
,	O
though	O
surveillance	B-T169
of	O
adults	O
may	O
be	O
inappropriate	O
.	O
	
there	O
was	O
no	O
consistent	O
pattern	O
associated	B-T080
with	I-T080
the	O
switch	O
from	O
wp	O
to	O
ap	O
vaccines	O
on	O
reported	O
pertussis	B-T047
incidence	B-T081
rates	I-T081
.	O
	
the	O
heterogeneity	B-T080
in	O
reported	O
data	B-T078
may	O
be	O
related	O
to	O
a	O
number	O
of	O
factors	B-T169
including	O
surveillance	B-T169
system	B-T169
characteristics	B-T080
or	O
capabilities	B-T080
,	O
different	O
case	B-T170
definitions	I-T170
,	O
type	B-T080
of	O
pertussis	B-T047
confirmation	O
tests	O
used	O
,	O
public	O
awareness	B-T033
of	O
the	O
disease	B-T047
,	O
as	O
well	O
as	O
real	O
differences	B-T081
in	O
the	O
magnitude	B-T081
of	O
the	O
disease	B-T047
,	O
or	O
a	O
combination	O
of	O
these	O
factors	B-T169
.	O
	
our	O
study	O
highlights	O
the	O
need	O
to	O
standardize	O
pertussis	B-T047
detection	B-T033
and	O
confirmation	B-T080
in	O
surveillance	B-T062
programs	I-T062
across	O
europe	O
,	O
complemented	O
with	O
carefully-designed	O
seroprevalence	B-T062
studies	I-T062
using	O
the	O
same	O
protocols	B-T170
and	O
identification	B-T080
and	O
characterization	B-T052
of	O
dichelobacter	O
nodosus	O
serogroup	B-T170
h	I-T170
from	O
ovine	O
footrot	B-T047
in	O
india	O
a	O
total	O
of	O
56	O
foot	O
swabs	O
were	O
collected	O
from	O
inter	O
digital	O
spaces	O
of	O
sheep	O
with	O
footrot	B-T047
lesions	B-T033
were	O
screened	O
for	O
16	O
rrna	O
of	O
dichelobacter	O
nodosus	O
by	O
pcr	O
.	O
	
out	O
of	O
the	O
56	O
samples	O
,	O
38	O
were	O
found	O
to	O
be	O
positive	B-T033
.	O
	
all	O
the	O
positive	B-T033
samples	O
were	O
subjected	O
to	O
multiplex	O
pcr	O
targeting	O
fima	O
gene	O
for	O
identification	B-T080
of	O
serogroups	B-T170
of	O
d	O
.	O
	
nodosus	O
.	O
	
serogroup	B-T170
h	I-T170
was	O
found	O
along	O
with	O
serogroup	B-T170
b	I-T170
in	O
12	O
55.26	O
samples	O
and	O
with	O
serogroup	B-T170
i	I-T170
in	O
8	O
22.2	O
samples	O
.	O
	
the	O
serogroup	B-T170
h	I-T170
was	O
identified	B-T080
for	O
the	O
first	O
time	O
from	O
the	O
indian	O
subcontinent	O
.	O
	
the	O
phylogenetic	B-T062
analysis	I-T062
of	O
the	O
present	O
sequence	O
with	O
the	O
available	O
serogroup	B-T170
h	I-T170
sequences	O
of	O
genbank	B-T170
revealed	O
to	O
be	O
in	O
close	O
association	O
with	O
the	O
serotype	B-T170
h1	I-T170
.	O
	
conservation	O
education	O
and	O
habitat	B-T082
restoration	B-T169
for	O
the	O
endangered	B-T098
sagalla	O
caecilian	O
boulengerula	O
niedeni	O
in	O
sagalla	O
hill	O
,	O
kenya	O
the	O
sagalla	O
caecilian	O
boulengerula	O
niedeni	O
is	O
an	O
endangered	B-T098
amphibian	O
endemic	O
to	O
sagalla	O
hill	O
in	O
the	O
taita	O
hills	O
.	O
	
this	O
burrowing	O
worm	O
-like	O
species	O
prefers	O
soft	B-T080
soil	O
with	O
high	B-T080
moisture	O
and	O
organic	O
matter	O
.	O
	
the	O
major	B-T080
threats	B-T078
to	O
the	O
sagalla	O
caecilian	O
are	O
soil	O
erosion	O
caused	B-T169
by	O
steep	B-T082
slopes	I-T082
,	O
bare	O
ground	O
and	O
water	O
siphoning	O
/	O
soil	O
hardening	O
from	O
exotic	O
eucalyptus	O
trees	O
.	O
	
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
get	O
a	O
better	B-T080
understanding	O
of	O
the	O
local	B-T082
people's	B-T098
attitude	O
towards	O
this	O
species	O
and	O
how	O
they	O
can	O
contribute	B-T052
to	O
its	O
continued	B-T078
conservation	B-T080
through	O
restoration	B-T169
of	O
its	O
remaining	B-T080
habitat	B-T082
.	O
	
in	O
this	O
study	B-T062
,	O
it	O
was	O
found	B-T033
that	O
96%	O
of	O
sagalla	O
people	B-T098
are	O
aware	O
of	O
the	O
species	O
,	O
its	O
habits	O
and	O
its	O
association	O
with	O
soils	O
high	B-T080
in	O
organic	O
matter	O
.	O
	
it	O
was	O
also	O
found	B-T033
that	O
96%	O
of	O
sagalla	O
people	B-T098
use	O
organic	B-T080
manure	O
from	O
cow	O
dung	O
in	O
their	O
farms	B-T082
.	O
	
habitat	B-T082
restoration	B-T169
through	O
planting	B-T052
of	O
indigenous	B-T082
plants	O
was	O
found	B-T033
to	O
be	O
ongoing	B-T078
,	O
especially	B-T080
on	O
compounds	O
of	O
public	O
institutions	O
as	O
well	O
as	O
on	O
private	O
lands	O
.	O
	
although	O
drought	O
was	O
found	B-T033
to	O
be	O
a	O
challenge	O
for	O
seedlings	O
development	B-T169
especially	O
on	O
the	O
low	B-T080
elevation	B-T082
sites	B-T082
,	O
destruction	B-T052
by	O
livestock	O
especially	O
during	B-T079
the	O
dry	B-T080
season	B-T079
is	O
also	O
a	O
major	B-T080
threat	B-T078
.	O
	
in	O
this	O
study	B-T062
,	O
it	O
was	O
recommended	B-T078
that	O
any	O
future	B-T079
habitat	B-T082
restoration	B-T169
initiative	O
should	O
include	B-T169
strong	B-T080
chain-link	O
fencing	B-T052
to	O
protect	O
the	O
seedlings	O
from	O
livestock	O
activity	B-T052
.	O
	
recognizing	O
that	O
the	O
preferred	B-T078
habitats	B-T082
for	O
the	O
species	O
are	O
in	O
the	O
valleys	B-T082
,	O
systematic	B-T169
planting	B-T052
of	O
keystone	O
plant	O
species	O
such	O
as	O
fig	O
trees	O
ficus	O
creates	B-T052
the	O
best	O
microhabitats	B-T082
.	O
	
these	O
are	O
better	B-T080
than	O
general	B-T082
woodlots	B-T082
of	O
indigenous	B-T082
trees	O
.	O
	
the	O
clinical	B-T080
and	O
economic	B-T169
burden	B-T078
of	O
significant	B-T078
bleeding	O
during	B-T079
lung	B-T061
resection	I-T061
surgery	I-T061
a	O
retrospective	B-T062
matched	I-T062
cohort	I-T062
analysis	I-T062
of	O
real	B-T080
-	O
world	B-T098
data	B-T078
the	O
objective	B-T080
of	O
this	O
retrospective	B-T062
study	I-T062
was	O
to	O
quantify	B-T081
the	O
clinical	B-T080
and	O
economic	B-T169
burden	B-T078
of	O
significant	B-T078
bleeding	O
in	O
lung	B-T061
resection	I-T061
surgery	I-T061
in	O
the	O
us	O
.	O
	
this	O
study	B-T062
utilized	B-T169
2009-2012	O
data	B-T078
from	O
the	O
premier	B-T170
perspective	I-T170
database	I-T170
.	O
	
adult	O
patients	O
with	O
primary	B-T061
pulmonary	I-T061
lobectomy	I-T061
or	O
segmentectomy	B-T061
procedures	I-T061
were	O
categorized	B-T052
by	O
the	O
surgical	B-T169
approach	I-T169
vats	B-T061
vs	O
open	B-T061
and	O
primary	B-T080
diagnosis	I-T080
primary	O
or	O
metastatic	O
lung	O
cancer	O
vs	O
non-lung	O
cancer	O
.	O
	
patients	O
requiring	O
3	O
units	B-T081
of	O
blood	O
products	O
with	O
at	B-T080
least	I-T080
1	O
unit	B-T081
of	O
prbcs	B-T116
""""	O
significant	B-T078
bleeding	O
""""	O
cohort	B-T098
those	O
requiring	O
<3	O
units	B-T081
""""	O
non-significant	B-T033
bleeding	O
""""	O
cohort	B-T098
and	O
those	O
not	O
requiring	O
blood	O
products	O
""""	O
no	B-T169
bleeding	O
""""	O
cohort	B-T098
.	O
	
a	O
matched	O
cohort	B-T062
analysis	I-T062
was	O
performed	B-T169
between	O
the	O
""""	O
significant	B-T078
bleeding	O
""""	O
and	O
the	O
""""	O
no	B-T169
bleeding	O
cohort	B-T098
""""	O
using	O
matching	O
variables	O
hospital	O
,	O
lung	O
cancer	O
diagnosis	O
,	O
year	B-T079
of	I-T079
surgery	I-T079
,	O
apr-drg	B-T081
severity	I-T081
score	I-T081
,	O
procedure	O
type	O
and	O
approach	B-T169
,	O
age	O
,	O
and	O
gender	O
.	O
	
the	O
""""	O
all	B-T081
-	O
patient	O
""""	O
cohort	B-T098
comprised	O
21	O
patients	O
213	O
""""	O
significant	B-T078
bleeding	O
""""	O
2	O
""""	O
non-significant	B-T033
bleeding	O
""""	O
and	O
18	O
""""	O
no	B-T169
bleeding	O
""""	O
.	O
	
overall	B-T080
incidence	B-T081
of	O
significant	B-T078
chest	O
bleeding	O
was	O
0.99	O
.	O
	
patients	O
from	O
""""	O
significant	B-T078
bleeding	O
""""	O
cohort	B-T098
and	O
""""	O
non-significant	B-T033
bleeding	O
""""	O
cohort	B-T098
had	O
2.5	O
days	B-T079
and	O
2	O
days	B-T079
p	O
<	O
0.0001	O
longer	B-T080
length	B-T079
of	I-T079
stay	I-T079
in	O
the	O
hospital	O
compared	B-T052
to	O
those	O
in	O
the	O
""""	O
no	B-T169
bleeding	O
""""	O
cohort	B-T098
,	O
respectively	O
.	O
	
overall	B-T080
,	O
hospital	B-T081
costs	I-T081
for	O
""""	O
significant	B-T078
bleeding	O
""""	O
cohort	B-T098
were	O
higher	B-T080
than	O
""""	O
no	B-T169
bleeding	O
""""	O
cohort	B-T098
for	O
those	O
who	O
were	O
covered	B-T169
under	O
medicare	O
59	O
vs	O
23	O
,	O
were	O
76	O
years	B-T079
of	I-T079
age	I-T079
64	O
vs	O
24	O
,	O
had	O
greater	B-T081
severity	B-T080
of	I-T080
illness	I-T080
97	O
vs	O
51	O
and	O
underwent	O
open	O
segmentectomy	B-T061
74	O
vs	O
21	O
.	O
	
hospital	B-T081
costs	I-T081
for	O
""""	O
significant	B-T078
bleeding	O
""""	O
cohort	B-T098
and	O
""""	O
non-significant	B-T033
bleeding	O
""""	O
were	O
significantly	B-T078
higher	B-T080
11	O
and	O
5	O
,	O
respectively	O
,	O
p	O
<	O
0.0001	O
than	O
no	B-T169
bleeding	O
cohort	B-T098
.	O
	
although	O
significant	B-T078
bleeding	O
during	B-T079
lung	B-T061
resection	I-T061
surgery	I-T061
is	O
rare	B-T080
,	O
patients	O
with	O
such	O
complication	O
could	O
stay	B-T079
longer	B-T080
at	O
the	O
hospital	O
and	O
cost	B-T081
laceration	O
of	O
a	O
branch	B-T082
of	I-T082
the	O
profunda	O
femoris	O
artery	O
caused	B-T169
by	O
a	O
spike	B-T033
of	O
the	O
displaced	B-T082
lesser	O
trochanter	O
in	O
an	O
inter-trochanteric	O
femoral	O
fracture	O
.	O
	
a	O
case	B-T170
report	I-T170
injury	O
of	O
femoral	O
vessels	O
is	O
an	O
extremely	B-T080
rare	B-T080
complication	O
in	O
intertrochanteric	O
femoral	O
fractures	O
.	O
	
in	O
most	O
cases	B-T169
reported	O
,	O
the	O
vascular	B-T047
lesion	I-T047
involves	B-T169
the	O
superficial	O
femoral	O
artery	O
,	O
whereas	O
in	O
very	O
few	O
cases	B-T169
does	O
it	O
involve	B-T169
the	O
profunda	O
femoris	O
artery	O
.	O
	
we	O
report	B-T170
a	O
case	B-T169
of	O
acute	O
bleeding	O
due	O
to	O
laceration	O
of	O
a	O
perforating	B-T033
branch	B-T082
of	I-T082
the	O
profunda	O
femoris	O
artery	O
caused	B-T169
by	O
a	O
sharp	B-T033
fragment	B-T169
of	I-T169
the	O
displaced	B-T082
lesser	O
trochanter	O
in	O
an	O
intertrochanteric	O
femoral	O
fracture	O
the	O
lesion	B-T033
was	O
treated	B-T169
by	O
transcatheter	B-T061
embolization	I-T061
.	O
	
the	O
arterial	O
injury	O
may	O
be	O
iatrogenic	B-T080
,	O
occurring	B-T052
during	O
intramedullary	B-T082
internal	B-T061
fixation	I-T061
,	O
or	O
less	O
frequently	B-T079
,	O
the	O
injury	O
may	O
be	O
due	O
to	O
the	O
fracture	O
itself	O
,	O
caused	B-T169
by	O
a	O
sharp	B-T033
bone	O
fragment	O
that	O
damages	B-T169
the	O
profunda	O
femoris	O
artery	O
or	O
one	O
of	O
its	O
perforating	B-T033
branches	B-T082
.	O
	
we	O
believe	O
that	O
intertrochanteric	O
femoral	O
fractures	O
with	O
avulsed	O
lesser	O
trochanter	O
are	O
at	B-T080
risk	I-T080
for	O
femoral	O
vessel	O
injuries	O
caused	B-T169
by	O
the	O
displaced	B-T082
bone	O
spike	B-T033
,	O
and	O
we	O
advise	O
meticulous	B-T080
clinical	B-T080
and	O
laboratory	O
monitoring	O
pre-	B-T079
and	O
post-operatively	B-T079
to	O
prevent	B-T061
serious	I-T061
complications	I-T061
.	O
	
direct	O
contact	O
with	O
perivascular	O
tumor	O
cells	O
enhances	O
integrin	B-T116
αvβ3	I-T116
signaling	O
and	O
migration	O
of	O
endothelial	O
cells	O
the	O
secretion	O
of	O
soluble	O
pro-angiogenic	O
factors	O
by	O
tumor	O
cells	O
and	O
stromal	O
cells	O
in	O
the	O
perivascular	O
niche	O
promotes	O
the	O
aggressive	O
angiogenesis	O
that	O
is	O
typical	O
of	O
glioblastoma	O
gbm	O
.	O
	
here	O
,	O
we	O
show	O
that	O
angiogenesis	O
also	O
can	O
be	O
promoted	O
by	O
a	O
direct	O
interaction	O
between	O
brain	O
tumor	O
cells	O
,	O
including	O
tumor	O
cells	O
with	O
cancer	O
stem	O
-like	O
properties	O
cscs	O
,	O
and	O
endothelial	O
cells	O
ecs	O
.	O
	
as	O
shown	O
in	B-T080
vitro	I-T080
,	O
this	O
direct	O
interaction	O
is	O
mediated	O
by	O
binding	O
of	O
integrin	B-T116
αvβ3	I-T116
expressed	O
on	O
ecs	O
to	O
the	O
rgd-peptide	B-T116
in	O
l1cam	B-T116
expressed	O
on	O
cscs	O
.	O
	
it	O
promotes	O
both	O
ec	O
network	O
formation	O
and	O
enhances	O
directed	O
migration	O
toward	O
basic	O
fibroblast	B-T116
growth	I-T116
factor	I-T116
.	O
	
activation	B-T052
of	O
αvβ3	B-T116
and	O
bone	B-T116
marrow	I-T116
tyrosine	I-T116
kinase	I-T116
on	I-T116
chromosome	I-T116
x	I-T116
bmx	B-T116
is	O
required	O
for	O
migration	O
stimulated	O
by	O
direct	O
binding	O
but	O
not	O
for	O
migration	O
stimulated	O
by	O
soluble	O
factors	O
.	O
	
rgd-peptide	B-T116
treatment	B-T169
of	O
mice	O
with	O
established	O
intracerebral	B-T082
gbm	O
xenografts	O
significantly	O
reduced	O
the	O
percentage	O
of	O
sox2	B-T116
-positive	O
tumor	O
cells	O
and	O
cscs	O
in	O
close	O
proximity	O
to	O
ecs	O
,	O
decreased	O
integrin	B-T116
αvβ3	I-T116
and	O
bmx	B-T116
activation	O
and	O
p130cas	B-T116
phosphorylation	O
in	O
the	O
ecs	O
,	O
and	O
reduced	O
the	O
vessel	O
surface	B-T082
area	I-T082
.	O
	
these	O
results	O
reveal	O
a	O
previously	O
unrecognized	O
aspect	O
of	O
the	O
regulation	O
of	O
angiogenesis	O
in	O
gbm	O
that	O
can	O
impact	O
therapeutic	B-T169
anti-angiogenic	O
the	O
use	O
of	O
ocimum	O
americanum	O
essential	B-T109
oil	I-T109
against	O
the	O
pathogens	O
aeromonas	O
hydrophila	O
and	O
gyrodactylus	O
sp	O
.	O
	
in	O
silver	O
catfish	O
rhamdia	O
quelen	O
the	O
bactericidal	O
activity	O
mic-test	O
of	O
ocimum	O
americanum	O
inflorescences	O
essential	B-T109
oil	I-T109
oaeo	B-T109
against	O
aeromonas	O
hydrophila	O
was	O
determined	O
in	O
this	O
study	O
.	O
	
it	O
was	O
also	O
investigated	O
the	O
potential	O
of	O
oaeo	B-T109
and	O
the	O
main	O
compound	B-T080
found	O
in	O
the	O
oil	B-T109
linalool	B-T109
at	O
subinhibitory	O
concentrations	O
to	O
be	O
inhibitors	O
of	O
hemolysis	O
caused	O
by	O
aer	O
.	O
	
hydrophila	O
in	O
fish	O
erythrocytes	O
.	O
	
an	O
in	B-T062
vivo	I-T062
experiment	I-T062
was	O
conducted	O
to	O
evaluate	O
survival	B-T052
of	O
fish	O
rhamdia	O
quelen	O
experimentally	B-T062
infected	B-T033
with	O
aer	O
.	O
	
hydrophila	O
and	O
exposed	B-T080
to	O
oaeo	B-T109
.	O
	
a	O
second	O
experiment	B-T062
was	O
conducted	O
to	O
evaluate	O
the	O
in	B-T062
vitro	I-T062
and	O
in	B-T062
vivo	I-T062
activity	O
of	O
oaeo	B-T109
mix	O
from	O
inflorescences	O
and	O
leaves	O
against	O
the	O
parasite	O
gyrodactylus	O
sp	O
.	O
	
the	O
oaeo	B-T109
showed	O
weak	B-T080
in	B-T062
vitro	I-T062
activity	O
against	O
aer	O
.	O
	
hydrophila	O
6400	O
μg	O
ml	O
.	O
	
at	O
subinhibitory	O
concentrations	O
oaeo	B-T109
100	O
μg	O
ml	O
inhibited	B-T052
hemolysis	O
90%	O
caused	O
by	O
aer	O
.	O
	
hydrophila	O
in	O
fish	O
erythrocytes	O
,	O
however	O
,	O
linalool	B-T109
did	O
not	B-T169
present	I-T169
hemolysis	O
inhibition	B-T052
activity	I-T052
.	O
	
at	O
low	O
concentrations	O
10	O
and	O
20	O
mg	O
l	O
added	O
to	O
the	O
water	O
oaeo	B-T109
promoted	B-T052
survival	B-T052
of	O
experimentally	O
infected	B-T033
fish	O
with	O
aer	O
.	O
	
hydrophila	O
.	O
	
lastly	O
,	O
oaeo	B-T109
-mix	O
50	O
mg	O
l	O
was	O
effective	B-T080
against	O
gyrodactylus	O
sp	O
.	O
	
significantly	B-T081
reducing	I-T081
60%	O
the	O
number	O
of	O
parasites	O
in	O
the	O
fish	O
.	O
	
interleukin-1β	B-T116
induced	O
stress	O
granules	O
sequester	B-T169
cox-2	B-T116
mrna	O
and	O
regulates	O
its	O
stability	B-T080
and	O
translation	O
in	O
human	O
oa	B-T047
chondrocytes	O
enhanced	B-T052
and	O
immediate	O
expression	O
of	O
cyclooxygenase-2	O
cox-2	O
mrna	O
is	O
observed	O
in	O
il-1β	B-T116
-	O
stimulated	B-T061
oa	B-T047
chondrocytes	O
but	O
the	O
synthesis	O
of	O
protein	O
found	O
significantly	O
delayed	B-T079
.	O
	
here	O
we	O
investigated	O
the	O
role	O
of	O
stress	O
granules	O
sgs	O
,	O
ribonucleoprotein	O
complexes	O
that	O
regulate	O
mrna	O
translation	O
,	O
in	O
the	O
delayed	B-T079
translation	O
of	O
cox-2	O
mrnas	O
in	O
il-1β	B-T116
-	O
stimulated	B-T061
oa	B-T047
chondrocytes	O
.	O
	
stimulation	B-T061
of	O
human	O
chondrocytes	O
with	O
il-1β	B-T116
activated	O
the	O
stress	O
response	O
genes	O
and	O
the	O
phosphorylation	O
of	O
eif2α	B-T116
that	O
triggered	B-T080
the	O
assembly	O
of	O
sgs	O
.	O
	
using	O
combined	O
immunofluorescence	O
staining	O
of	O
sgs	O
markers	O
and	O
cox-2	B-T116
protein	I-T116
,	O
rna	O
fluorescence	O
in	O
situ	O
hybridization	O
and	O
rna	O
immunoprecipitation	O
,	O
the	O
cox-2	O
mrnas	O
were	O
found	O
sequestered	B-T169
in	O
sgs	O
in	O
il-1β	B-T116
-	O
stimulated	B-T061
oa	B-T047
chondrocytes	O
.	O
	
no	B-T033
increase	B-T169
in	O
cox-2	B-T116
protein	O
expression	O
was	O
observed	O
during	O
the	O
persistence	B-T079
of	O
sgs	O
but	O
enhanced	B-T052
expression	O
of	O
cox-2	B-T116
protein	I-T116
was	O
noted	O
upon	O
clearance	B-T080
of	O
the	O
sgs	O
.	O
	
inhibition	B-T052
of	O
sgs	O
clearance	B-T080
blocked	B-T169
cox-2	O
mrna	O
translation	O
whereas	O
blocking	B-T169
the	O
assembly	O
of	O
sgs	O
by	O
tia-1	B-T116
depletion	B-T169
resulted	O
in	O
rapid	O
and	O
increased	B-T081
production	B-T169
of	O
cox-2	B-T116
and	O
pge2	B-T109
.	O
	
our	O
findings	O
show	O
for	O
the	O
first	O
time	O
assembly	O
of	O
sgs	O
and	O
sequestration	B-T169
of	O
cox-2	O
mrnas	O
in	O
human	O
oa	B-T047
chondrocytes	O
under	O
pathological	O
conditions	O
.	O
	
post-transcriptional	O
regulation	O
of	O
cox-2	O
mrnas	O
translation	O
by	O
sgs	O
indicates	O
a	O
role	O
in	O
il-1β	B-T116
-mediated	O
catabolic	B-T169
response	O
that	O
could	O
be	O
therapeutically	B-T061
targeted	O
in	O
spatio-temporal	B-T169
distribution	I-T169
of	O
bark	O
and	O
ambrosia	O
beetles	O
in	O
a	O
brazilian	O
tropical	O
dry	O
forest	O
bark	O
and	O
the	O
ambrosia	O
beetles	O
dig	O
into	O
host	O
plants	O
and	O
live	O
most	O
of	O
their	O
lives	O
in	O
concealed	O
tunnels	B-T082
.	O
	
we	O
assessed	B-T052
beetle	O
community	O
dynamics	O
in	O
tropical	O
dry	O
forest	O
sites	B-T082
in	O
early	B-T079
,	O
intermediate	B-T079
,	O
and	O
late	B-T079
successional	B-T079
stages	I-T079
,	O
evaluating	O
the	O
influence	O
of	O
resource	B-T078
availability	B-T169
and	O
seasonal	B-T079
variations	I-T079
in	O
guild	B-T080
structure	I-T080
.	O
	
we	O
collected	B-T078
a	O
total	O
of	O
763	O
beetles	O
from	O
23	O
species	O
,	O
including	O
14	O
bark	O
beetle	O
species	O
,	O
and	O
9	O
ambrosia	O
beetle	O
species	O
.	O
	
local	B-T082
richness	B-T080
of	O
bark	O
and	O
ambrosia	O
beetles	O
was	O
estimated	O
at	O
31	O
species	O
.	O
	
bark	O
and	O
ambrosia	O
composition	B-T078
was	O
similar	O
over	O
the	O
successional	B-T079
stages	I-T079
gradient	B-T081
,	O
and	O
beta	B-T080
diversity	I-T080
among	O
sites	B-T082
was	O
primarily	O
determined	O
by	O
species	O
turnover	O
,	O
mainly	O
in	O
the	O
bark	O
beetle	O
community	O
.	O
	
bark	O
beetle	O
richness	B-T080
and	O
abundance	B-T080
were	O
higher	O
at	O
intermediate	B-T079
stages	I-T079
availability	B-T169
of	I-T169
wood	O
was	O
the	O
main	O
spatial	B-T169
mechanism	I-T169
.	O
	
climate	O
factors	B-T169
were	O
effectively	O
non-seasonal	B-T080
.	O
	
ambrosia	O
beetles	O
were	O
not	O
influenced	O
by	O
successional	B-T079
stages	I-T079
,	O
however	O
the	O
increase	B-T169
in	O
wood	O
resulted	O
in	O
increased	B-T081
abundance	B-T080
.	O
	
we	O
found	O
higher	O
richness	B-T080
at	O
the	O
end	O
of	O
the	O
dry	B-T079
and	O
wet	B-T079
seasons	I-T079
,	O
and	O
abundance	B-T080
increased	B-T081
with	O
air	O
moisture	O
and	O
decreased	O
with	O
higher	O
temperatures	B-T081
and	O
greater	O
rainfall	O
.	O
	
in	O
summary	O
,	O
bark	O
beetle	O
species	O
accumulation	B-T169
was	O
higher	O
at	O
sites	B-T082
with	O
better	O
wood	O
production	B-T052
,	O
while	O
the	O
needs	O
of	O
fungi	O
host	O
and	O
air	O
moisture	O
,	O
resulted	O
in	O
a	O
favorable	O
conditions	B-T080
for	O
species	O
accumulation	B-T169
of	O
ambrosia	O
.	O
	
the	O
overall	O
biological	B-T080
pattern	B-T080
among	O
guilds	O
differed	O
from	O
tropical	O
rain	O
forests	O
,	O
showing	O
patterns	O
similar	O
to	O
dry	O
forest	O
areas	O
.	O
	
detection	B-T061
and	O
characterization	O
of	O
flat	B-T047
aberrant	I-T047
crypt	I-T047
foci	I-T047
flat	I-T047
acf	I-T047
in	O
the	O
novel	O
a/j	O
min/+	O
mouse	O
flat	B-T047
aberrant	I-T047
crypt	I-T047
foci	I-T047
flat	B-T047
acf	I-T047
and	O
mucin-depleted	B-T047
foci	I-T047
mdf	B-T047
have	O
previously	O
been	O
described	O
as	O
preneoplastic	B-T047
colonic	I-T047
lesions	I-T047
.	O
	
we	O
used	O
the	O
novel	O
a/j	O
min/+	O
mouse	O
model	O
,	O
that	O
demonstrates	O
extensive	O
spontaneous	O
colon	O
carcinogenesis	O
to	O
refine	O
the	O
method	O
of	O
detection	B-T061
of	O
flat	B-T047
acf	I-T047
and	O
further	O
characterize	O
and	O
define	O
them	O
as	O
early	O
lesions	B-T033
by	O
histological	O
examination	O
and	O
comparison	O
with	O
mdf	B-T047
.	O
	
colons	O
were	O
stained	O
with	O
methylene	O
blue	O
mb	B-T109
for	O
flat	B-T047
acf	I-T047
detection	B-T061
and	O
restained	O
with	O
high-iron	B-T109
diamine-alcian	I-T109
blue	I-T109
hid-ab	B-T109
for	O
mdf	B-T047
detection	B-T061
.	O
	
optimal	O
flat	B-T047
acf	I-T047
recognition	O
required	O
at	O
least	O
24	O
h	O
of	O
storage	O
post-	O
mb	O
staining	O
and	O
adherence	O
to	O
a	O
set	O
of	O
characteristics	O
.	O
	
the	O
fraction	B-T081
of	I-T081
flat	B-T047
acf	I-T047
corresponding	O
with	O
mdf	B-T047
was	O
93%	O
.	O
	
flat	B-T047
acf	I-T047
/	O
mdf	B-T047
displayed	O
the	O
same	O
picture	O
of	O
severe	O
dysplasia	O
,	O
lack	B-T080
of	I-T080
mucus	O
and	O
goblet	O
cells	O
and	O
accumulation	B-T033
of	O
cytoplasmic	O
β-catenin	B-T116
.	O
	
the	O
easily	O
detectable	O
flat	B-T047
acf	I-T047
are	O
reliable	O
surface	O
biomarkers	O
of	O
apc	O
-driven	O
colon	O
carcinogenesis	O
.	O
	
transcriptional	O
enhancement	O
of	O
smn	O
levels	O
in	O
motoneurons	O
is	O
crucial	O
for	O
proper	O
axon	O
morphology	B-T080
in	O
zebrafish	O
an	O
unresolved	O
mystery	O
in	O
the	O
field	O
of	O
spinal	B-T047
muscular	I-T047
atrophy	I-T047
sma	B-T047
is	O
why	O
a	O
reduction	O
of	O
the	O
ubiquitously	O
expressed	O
smn	B-T116
protein	I-T116
causes	O
defects	B-T033
mostly	O
in	O
motoneurons	O
.	O
	
we	O
addressed	O
the	O
possibility	O
that	O
this	O
restricted	O
vulnerability	O
stems	O
from	O
elevated	O
smn	O
expression	O
in	O
motoneurons	O
.	O
	
to	O
explore	O
this	O
,	O
we	O
established	O
an	O
ex	O
vivo	O
zebrafish	O
culture	O
system	O
of	O
gfp	O
-	O
marked	O
motoneurons	O
to	O
quantitatively	O
measure	O
smn	O
protein	O
and	O
smn	O
mrna	O
levels	O
as	O
well	O
as	O
promoter	O
activity	O
in	O
motoneurons	O
versus	O
other	O
cell	O
types	O
.	O
	
importantly	O
,	O
we	O
uncovered	O
that	O
smn	O
levels	O
are	O
elevated	O
in	O
motoneurons	O
by	O
means	O
of	O
transcriptional	O
activation	O
.	O
	
in	O
addition	O
,	O
we	O
identified	O
the	O
ets	O
family	O
transcription	O
factor	O
etv5b	O
to	O
be	O
responsible	O
for	O
increased	O
smn	O
transcription	O
in	O
motoneurons	O
.	O
	
moreover	O
,	O
we	O
established	O
that	O
the	O
additional	O
supply	O
of	O
smn	O
protein	O
in	O
motoneurons	O
is	O
necessary	O
for	O
proper	O
axonogenesis	O
in	O
a	O
cell-autonomous	O
manner	O
.	O
	
these	O
findings	O
demonstrate	O
the	O
reliance	O
of	O
motoneurons	O
on	O
more	O
smn	O
,	O
thereby	O
adding	O
a	O
novel	O
piece	O
of	O
evidence	O
for	O
their	O
increased	O
vulnerability	O
under	O
sma	O
conditions	I-T047
evaluation	O
of	O
response	O
from	O
axitinib	B-T109
per	O
response	B-T170
evaluation	I-T170
criteria	I-T170
in	I-T170
solid	I-T170
tumors	I-T170
versus	O
choi	B-T170
criteria	I-T170
in	O
previously	O
treated	B-T033
patients	O
with	O
metastatic	O
renal	O
cell	O
carcinoma	O
axitinib	B-T109
,	O
a	O
selective	O
and	O
potent	O
tyrosine	O
kinase	O
inhibitor	O
of	O
vascular	B-T116
endothelial	I-T116
growth	I-T116
factor	I-T116
receptors	I-T116
,	O
was	O
available	O
to	O
patients	O
from	O
canada	O
and	O
australia	O
,	O
prior	O
to	O
regulatory	O
approval	B-T170
of	O
axitinib	B-T109
in	O
these	O
countries	O
,	O
for	O
treatment	B-T061
of	O
clear-cell	O
metastatic	O
renal	O
cell	O
carcinoma	O
mrcc	O
after	O
failure	O
of	O
one	O
prior	O
systemic	O
regimen	B-T061
.	O
	
this	O
single-arm	B-T062
,	O
open-label	B-T062
study	I-T062
of	O
axitinib	B-T109
evaluated	O
the	O
efficacy	B-T062
,	O
safety	B-T062
,	O
and	O
quality	B-T078
of	I-T078
life	I-T078
qol	B-T078
in	O
patients	O
with	O
mrcc	O
whose	O
disease	B-T047
progressed	O
after	O
one	O
prior	O
systemic	O
first-line	B-T061
regimen	I-T061
.	O
	
primary	O
objective	O
was	O
objective	O
response	B-T079
rate	I-T079
evaluated	O
per	O
response	B-T170
evaluation	I-T170
criteria	I-T170
in	I-T170
solid	I-T170
tumors	I-T170
recist	B-T170
and	O
choi	B-T170
criteria	I-T170
.	O
	
progression-free	B-T081
survival	I-T081
,	O
overall	B-T081
survival	I-T081
,	O
safety	B-T062
,	O
and	O
qol	B-T078
were	O
secondary	O
end	O
points	O
.	O
	
due	O
to	O
the	O
small	O
study	B-T062
size	O
,	O
analyses	O
comprised	O
of	O
descriptive	O
statistics	B-T062
.	O
	
fifteen	O
patients	O
were	O
recruited	O
,	O
five	O
from	O
canada	O
and	O
ten	O
from	O
australia	O
,	O
over	O
a	O
limited	O
recruitment	O
period	O
.	O
	
thirteen	O
patients	O
received	O
sunitinib	B-T109
as	O
prior	O
therapy	B-T061
.	O
	
all	O
patients	O
had	O
clear-cell	O
carcinoma	O
,	O
eleven	O
had	O
prior	O
nephrectomy	B-T061
.	O
	
liver	O
,	O
lung	O
,	O
and	O
lymph	O
nodes	O
were	O
the	O
most	O
frequent	O
sites	O
of	O
metastases	O
one	O
patient	O
had	O
brain	O
metastasis	O
.	O
	
median	B-T081
time	O
on	O
axitinib	B-T109
was	O
118.0	O
days	B-T079
range	B-T081
3.5	O
days	B-T079
estimated	O
survival	B-T052
probability	O
at	O
12	O
months	B-T079
was	O
57.8	O
.	O
	
two	O
13.3	O
patients	O
had	O
objective	O
responses	O
per	O
recist	B-T170
versus	O
nine	O
60.0	O
per	O
choi	B-T170
criteria	I-T170
.	O
	
six	O
patients	O
had	O
progressive	O
disease	B-T047
based	O
on	O
recist	B-T170
versus	O
three	O
per	O
choi	B-T170
criteria	I-T170
.	O
	
nine	O
60.0	O
events	O
of	O
progression	O
or	O
death	O
occurred	O
by	O
the	O
end	O
of	O
study	B-T062
,	O
and	O
three	O
patients	O
continued	O
to	O
receive	O
the	O
study	B-T062
drug	O
.	O
	
fatigue	O
33%	O
and	O
diarrhea	O
20%	O
were	O
the	O
most	O
common	O
grade	O
3	O
all-causality	O
,	O
treatment	B-T061
-emergent	O
adverse	O
events	O
.	O
	
the	O
mean	B-T081
change	O
in	O
european	O
quality	B-T078
of	I-T078
life	I-T078
-	O
5	O
dimensions	O
score	B-T081
from	O
baseline	B-T081
to	O
end	O
of	O
treatment	B-T061
was	O
-0	O
.	O
	
the	O
small	O
number	O
of	O
patients	O
and	O
lack	O
of	O
a	O
comparator	O
arm	O
limit	O
the	O
ability	O
to	O
draw	O
definitive	B-T079
conclusions	B-T078
however	O
,	O
safety	B-T062
and	O
efficacy	B-T062
profiles	O
of	O
axitinib	B-T109
were	O
consistent	O
with	O
reports	O
from	O
previous	O
studies	B-T062
in	O
patients	O
with	O
mrcc	O
,	O
and	O
patients	O
generally	O
maintained	O
qol	B-T078
.	O
	
the	O
sizeable	O
difference	O
observed	O
in	O
objective	O
response	B-T079
rate	I-T079
by	O
recist	B-T170
versus	O
choi	B-T170
criteria	I-T170
merits	O
further	O
biochemical	B-T169
characteristics	B-T080
of	O
atfar2	B-T116
,	O
a	O
fatty	B-T116
acid	I-T116
reductase	I-T116
from	O
arabidopsis	O
thaliana	O
that	O
reduces	O
fatty	O
acyl-coa	O
and	O
-	O
acp	B-T116
substrates	I-T116
into	O
fatty	B-T109
alcohols	I-T109
fatty	B-T109
alcohols	I-T109
and	O
derivatives	O
are	O
important	B-T080
for	O
proper	O
deposition	B-T169
of	O
a	O
functional	B-T169
pollen	O
wall	O
.	O
	
mutations	O
in	O
specific	O
genes	O
encoding	O
fatty	B-T116
acid	I-T116
reductases	I-T116
far	B-T116
responsible	O
for	O
fatty	B-T109
alcohol	I-T109
production	B-T169
cause	O
abnormal	B-T033
development	B-T169
of	O
pollen	O
.	O
	
a	O
disrupted	B-T080
atfar2	O
ms2	O
gene	O
in	O
arabidopsis	O
thaliana	O
results	B-T169
in	O
pollen	O
developing	B-T169
an	O
abnormal	B-T033
exine	O
layer	O
and	O
a	O
reduced	B-T033
fertility	I-T033
phenotype	O
.	O
	
atfar2	B-T116
has	O
been	O
shown	O
to	O
be	O
targeted	B-T169
to	O
chloroplasts	O
and	O
in	O
a	O
purified	B-T080
form	I-T080
to	O
be	O
specific	B-T080
for	O
acyl-acp	B-T116
substrates	I-T116
.	O
	
here	O
,	O
we	O
present	O
data	B-T078
on	O
the	O
in	B-T080
vitro	I-T080
and	O
in	O
planta	O
characterizations	B-T052
of	O
atfar2	B-T116
from	O
a	O
.	O
	
thaliana	O
and	O
show	O
that	O
this	O
enzyme	B-T116
has	O
the	O
ability	O
to	O
use	O
both	O
,	O
c16	B-T116
and	O
c16	O
,	O
as	O
substrates	O
to	O
produce	O
c16	B-T109
.	O
	
our	O
results	O
further	O
show	O
that	O
atfar2	B-T116
is	O
highly	O
similar	O
in	O
properties	B-T080
and	O
substrate	O
specificity	B-T081
to	O
atfar6	B-T116
for	O
which	O
in	B-T080
vitro	I-T080
data	B-T078
has	O
been	O
published	O
,	O
and	O
which	O
is	O
also	O
a	O
chloroplast	O
localized	B-T082
enzyme	B-T116
.	O
	
this	O
suggests	O
that	O
although	O
atfar2	B-T116
is	O
the	O
major	O
enzyme	B-T116
responsible	O
for	O
exine	O
layer	O
functionality	B-T169
,	O
atfar6	B-T116
might	O
provide	O
functional	B-T169
redundancy	B-T169
to	O
comparing	B-T052
time	O
perception	O
among	O
morphine	B-T109
-	O
derived	B-T080
drugs	O
addicts	O
and	O
controls	O
the	O
aim	B-T078
of	O
the	O
present	O
study	B-T062
is	O
to	O
compare	B-T052
time	O
perception	O
among	O
drug	B-T033
addicts	I-T033
and	O
controls	O
.	O
	
30	O
drug	B-T033
addicts	I-T033
were	O
selected	B-T052
,	O
and	O
30	O
non-addict	B-T098
individuals	I-T098
were	O
selected	B-T052
as	O
the	O
control	O
group	O
.	O
	
the	O
two	O
groups	B-T078
performed	O
three	O
tests	B-T170
of	O
time	B-T079
reproduction	O
,	O
time	B-T079
estimation	I-T079
,	O
and	O
time	B-T079
discrimination	O
.	O
	
there	O
was	O
a	O
significant	B-T078
difference	B-T080
between	O
the	O
addicts	O
group	B-T078
and	O
the	O
control	O
group	O
regarding	O
the	O
error	B-T080
of	O
time	B-T079
reproduction	O
and	O
time	B-T079
estimation	I-T079
.	O
	
the	O
addict	O
group	B-T078
in	O
comparison	B-T052
to	O
the	O
control	O
group	O
had	O
a	O
lower	B-T052
under-	O
reproduction	O
and	O
a	O
higher	B-T080
over-	O
reproduction	O
error	B-T080
,	O
and	O
also	O
a	O
lower	B-T052
under-	O
estimation	O
and	O
higher	B-T080
over-	O
estimation	O
error	B-T080
.	O
	
however	O
,	O
regarding	O
time	B-T079
discrimination	O
,	O
no	O
significant	B-T078
difference	B-T080
was	O
observed	O
between	O
the	O
errors	B-T080
committed	O
by	O
both	O
groups	B-T078
.	O
	
on	O
the	O
other	O
hand	O
,	O
when	O
showing	O
images	B-T170
of	O
drug	O
consumption	O
tools	O
and	O
normal	B-T080
images	B-T170
with	O
same	O
durations	B-T079
,	O
the	O
normal	B-T080
group	B-T078
believed	O
that	O
the	O
images	B-T170
related	O
to	O
drug	O
consumption	O
tools	O
were	O
shown	O
for	O
a	O
shorter	B-T081
period	B-T079
of	O
time	B-T079
.	O
	
time	O
perception	O
is	O
different	B-T080
between	O
morphine	B-T109
-	O
derived	B-T080
drugs	O
addicts	O
and	O
co-delivery	B-T169
of	O
pemetrexed	B-T109
and	O
mir-21	O
antisense	O
oligonucleotide	O
by	O
lipid	B-T109
-	O
polymer	O
hybrid	O
nanoparticles	O
and	O
effects	B-T080
on	O
glioblastoma	O
cells	O
combination	B-T061
therapy	I-T061
using	O
anticancer	B-T109
drugs	I-T109
and	O
nucleic	O
acid	O
is	O
a	O
more	O
promising	O
strategy	O
to	O
overcome	O
multidrug	O
resistance	O
in	O
cancer	O
and	O
to	O
enhance	O
apoptosis	O
.	O
	
in	O
this	O
study	B-T062
,	O
lipid	B-T109
-	O
polymer	O
hybrid	O
nanoparticles	O
lpns	O
,	O
which	O
contain	O
both	O
pemetrexed	B-T109
and	O
mir-21	O
antisense	O
oligonucleotide	O
anti-mir-21	O
,	O
have	O
been	O
developed	O
for	O
treatment	B-T169
of	O
glioblastoma	O
,	O
the	O
most	O
aggressive	O
type	O
of	O
brain	O
tumor	O
.	O
	
prepared	O
lpns	O
have	O
been	O
well	O
characterized	O
by	O
particle	B-T081
size	I-T081
distribution	B-T169
and	O
zeta	O
potential	O
measurements	B-T169
,	O
determination	O
of	O
encapsulation	O
efficiency	B-T081
,	O
and	O
in	B-T080
vitro	I-T080
release	B-T062
experiments	I-T062
.	O
	
morphology	B-T080
of	O
lpns	O
was	O
determined	O
by	O
transmission	O
electron	O
microscopy	O
.	O
	
lpns	O
had	O
a	O
hydrodynamic	O
size	B-T082
below	O
100	O
nm	O
and	O
exhibited	O
sustained	B-T169
release	I-T169
of	O
pemetrexed	B-T109
up	O
to	O
10	O
h	O
.	O
	
encapsulation	O
of	O
pemetrexed	B-T109
in	O
lpns	O
increased	O
cellular	O
uptake	O
from	O
6%	O
to	O
78%	O
.	O
	
results	O
of	O
confocal	O
microscopy	O
analysis	O
have	O
shown	O
that	O
co-delivery	B-T169
of	O
anti-mir-21	O
significantly	O
improved	O
accumulation	B-T033
of	O
lpns	O
in	O
the	O
nucleus	O
of	O
u87mg	O
cells	O
.	O
	
nevertheless	O
,	O
more	O
effective	O
cytotoxicity	O
results	B-T169
could	O
not	O
be	O
obtained	O
due	O
to	O
low	O
concentration	O
of	O
anti-mir-21	O
,	O
loaded	O
in	O
lpns	O
.	O
	
we	O
expect	O
that	O
the	O
effective	O
drug	O
delivery	O
systems	O
can	O
be	O
obtained	O
with	O
higher	O
concentration	O
of	O
anti-mir-21	O
for	O
the	O
treatment	B-T061
of	O
expert	O
position	B-T170
paper	I-T170
on	O
prolonged	B-T079
dual	B-T061
antiplatelet	I-T061
therapy	I-T061
in	O
secondary	B-T061
prevention	I-T061
following	O
myocardial	B-T047
infarction	I-T047
the	O
protective	B-T080
effect	I-T080
of	O
dual	B-T061
antiplatelet	I-T061
therapy	I-T061
dapt	B-T061
following	O
acute	B-T047
coronary	I-T047
syndrome	I-T047
is	O
undisputed	O
,	O
but	O
its	O
duration	B-T079
is	O
subject	O
of	O
debate	B-T052
.	O
	
several	O
studies	B-T062
show	O
that	O
prolonged	B-T079
therapy	B-T061
provides	O
a	O
clinical	B-T080
benefit	B-T081
in	O
patients	O
following	O
acute	B-T047
coronary	I-T047
syndrome	I-T047
.	O
	
the	O
aim	O
of	O
this	O
position	B-T170
paper	I-T170
authored	O
by	O
austrian	B-T098
experts	O
is	O
to	O
outline	O
the	O
current	B-T079
evidence	B-T078
and	O
provide	O
an	O
overview	O
of	O
recent	O
studies	B-T062
.	O
	
it	O
is	O
also	O
intended	O
to	O
serve	O
as	O
a	O
practical	B-T170
guide	I-T170
to	O
identify	O
those	O
patients	O
who	O
may	O
benefit	B-T081
from	O
prolonged	B-T079
dapt	B-T061
.	O
	
medulloblastoma	O
molecular	O
pathways	O
and	O
histopathological	B-T169
classification	O
malignant	O
brain	O
tumors	O
are	O
the	O
leading	B-T169
cause	B-T169
of	O
cancer	O
death	B-T033
among	O
pediatric	B-T080
patients	O
,	O
and	O
medulloblastoma	O
constitutes	O
20%	O
of	O
them	O
.	O
	
currently	O
,	O
the	O
treatment	B-T061
is	O
risk-adapted	O
.	O
	
maximum	O
surgical	B-T061
resection	I-T061
is	O
recommended	B-T078
,	O
always	O
followed	O
by	O
chemotherapy	B-T061
and	O
neuroaxis	O
radiotherapy	B-T061
.	O
	
in	O
spite	O
of	O
the	O
improving	B-T080
survival	B-T081
rate	I-T081
,	O
survivors	O
succumb	O
to	O
treatment	B-T061
-	O
induced	B-T169
side	O
effects	O
.	O
	
to	O
reduce	B-T080
toxic	O
effects	O
,	O
molecular-targeted	B-T061
treatment	I-T061
is	O
proposed	O
.	O
	
medulloblastoma	O
research	B-T062
is	O
very	O
robust	B-T080
,	O
and	O
new	O
articles	B-T170
on	O
the	O
subject	O
are	O
published	O
daily	O
.	O
	
in	O
the	O
current	O
review	B-T170
we	O
have	O
tried	O
to	O
bring	O
together	O
molecular	B-T080
pathophysiology	B-T169
of	O
the	O
neoplasm	O
and	O
current	O
pathological	B-T169
classification	O
,	O
thus	O
making	O
an	O
effort	O
to	O
relate	O
tumor	B-T062
biology	I-T062
and	O
the	O
histological	O
picture	O
.	O
	
spatio-temporal	B-T062
history	I-T062
of	O
hiv-1	O
crf35_ad	O
in	O
afghanistan	O
and	O
iran	O
hiv-1	O
circulating	O
recombinant	O
form	O
35_ad	O
crf35_ad	O
has	O
an	O
important	O
position	O
in	O
the	O
epidemiological	O
profile	B-T169
of	O
afghanistan	O
and	O
iran	O
.	O
	
despite	O
the	O
presence	O
of	O
this	O
clade	O
in	O
afghanistan	O
and	O
iran	O
for	O
over	O
a	O
decade	O
,	O
our	O
understanding	O
of	O
its	O
origin	O
and	O
dissemination	B-T080
patterns	O
is	O
limited	O
.	O
	
in	O
this	O
study	O
,	O
we	O
performed	O
a	O
bayesian	B-T081
phylogeographic	I-T081
analysis	I-T081
to	O
reconstruct	O
the	O
spatio-temporal	B-T080
dispersion	I-T080
pattern	I-T080
of	O
this	O
clade	O
using	O
eligible	O
crf35_ad	O
gag	O
and	O
pol	O
sequences	O
available	O
in	O
the	O
los	O
alamos	O
hiv	B-T170
database	I-T170
432	O
sequences	O
available	O
from	O
iran	O
,	O
16	O
sequences	O
available	O
from	O
afghanistan	O
,	O
and	O
a	O
single	O
crf35_ad	O
-like	O
pol	O
sequence	O
available	O
from	O
usa	O
.	O
	
bayesian	B-T170
markov	I-T170
chain	I-T170
monte	I-T170
carlo	I-T170
algorithm	I-T170
was	O
implemented	O
in	O
beast	O
v1.8	O
.	O
	
between-country	O
dispersion	O
rates	O
were	O
tested	O
with	O
bayesian	B-T170
stochastic	I-T170
search	I-T170
variable	I-T170
selection	I-T170
method	I-T170
and	O
were	O
considered	O
significant	O
where	O
bayes	B-T081
factor	I-T081
values	I-T081
were	O
greater	O
than	O
three	O
.	O
	
the	O
findings	O
suggested	O
that	O
crf35_ad	O
sequences	O
were	O
genetically	O
similar	O
to	O
parental	O
sequences	O
from	O
kenya	O
and	O
uganda	O
,	O
and	O
to	O
a	O
set	O
of	O
subtype	O
a1	O
sequences	O
available	O
from	O
afghan	O
refugees	B-T098
living	O
in	O
pakistan	O
.	O
	
our	O
results	O
also	O
showed	O
that	O
across	O
all	O
phylogenies	B-T078
,	O
afghan	O
and	O
iranian	O
crf35_ad	O
sequences	O
formed	O
a	O
monophyletic	B-T081
cluster	I-T081
posterior	O
clade	O
credibility>	O
0.7	O
.	O
	
the	O
divergence	O
date	O
of	O
this	O
cluster	B-T081
was	O
estimated	O
to	O
be	O
between	O
1990	O
and	O
1992	O
.	O
	
within	O
this	O
cluster	B-T081
,	O
a	O
bidirectional	B-T080
dispersion	B-T080
of	O
the	O
virus	O
was	O
observed	O
across	O
afghanistan	O
and	O
iran	O
.	O
	
we	O
could	O
not	O
clearly	O
identify	O
if	O
afghanistan	O
or	O
iran	O
first	O
established	O
or	O
received	O
this	O
epidemic	B-T047
,	O
as	O
the	O
root	O
location	O
of	O
this	O
cluster	B-T081
could	O
not	O
be	O
robustly	O
estimated	O
.	O
	
three	O
crf35_ad	O
sequences	O
from	O
afghan	O
refugees	B-T098
living	B-T082
in	I-T082
pakistan	O
nested	O
among	O
afghan	O
and	O
iranian	O
crf35_ad	O
branches	O
.	O
	
however	O
,	O
the	O
crf35_ad	O
-like	O
sequence	O
available	O
from	O
usa	O
diverged	O
independently	O
from	O
kenyan	O
subtype	O
a1	O
sequences	O
,	O
suggesting	O
it	O
not	O
to	O
be	O
a	O
true	O
crf35_ad	O
lineage	O
.	O
	
potential	B-T080
factors	B-T169
contributing	O
to	O
viral	O
exchange	O
between	O
afghanistan	O
and	O
iran	O
could	O
be	O
injection	O
drug	O
networks	O
and	O
mass	O
migration	O
of	O
afghan	O
refugees	B-T098
and	O
labours	O
to	O
iran	O
,	O
which	O
calls	O
for	O
extensive	B-T080
preventive	B-T080
the	O
benefits	B-T081
of	O
combination	B-T061
therapy	I-T061
with	O
esomeprazole	B-T109
and	O
rebamipide	B-T109
in	O
symptom	O
improvement	O
in	O
reflux	B-T047
esophagitis	I-T047
an	O
international	B-T078
multicenter	B-T062
study	I-T062
to	O
investigate	B-T169
the	O
effects	B-T080
of	O
esomeprazole	B-T109
and	O
rebamipide	B-T109
combination	B-T061
therapy	I-T061
on	O
symptomatic	O
improvement	O
in	O
patients	O
with	O
reflux	B-T047
esophagitis	I-T047
.	O
	
a	O
total	O
of	O
501	O
patients	O
with	O
reflux	B-T047
esophagitis	I-T047
were	O
randomized	B-T062
into	O
one	O
of	O
the	O
following	O
two	O
treatment	B-T061
regimens	I-T061
40	O
mg	O
esomeprazole	B-T109
plus	O
300	O
mg	O
rebamipide	B-T109
daily	B-T079
combination	B-T061
therapy	I-T061
group	B-T078
or	O
40	O
mg	O
esomeprazole	B-T109
daily	B-T079
monotherapy	B-T061
group	B-T078
.	O
	
we	O
used	O
a	O
symptom	O
questionnaire	B-T170
that	O
evaluated	B-T169
heartburn	O
,	O
acid	O
regurgitation	O
,	O
and	O
four	O
upper	B-T047
gastrointestinal	I-T047
symptoms	I-T047
.	O
	
the	O
primary	O
efficacy	B-T080
end	O
point	O
was	O
the	O
mean	O
decrease	B-T081
in	O
the	O
total	O
symptom	B-T033
score	I-T033
.	O
	
the	O
mean	O
decreases	B-T081
in	O
the	O
total	O
symptom	B-T033
score	I-T033
at	O
4	O
weeks	B-T079
were	O
estimated	O
to	O
be	O
-18	O
in	O
the	O
combination	B-T061
therapy	I-T061
group	B-T078
and	O
-15	O
in	O
the	O
monotherapy	B-T061
group	B-T078
p=0	O
.	O
	
changes	O
in	O
reflux	B-T047
symptom	O
s	O
from	O
baseline	B-T081
after	O
4	O
weeks	B-T079
of	O
treatment	B-T061
were	O
-8	O
in	O
the	O
combination	B-T061
therapy	I-T061
group	B-T078
and	O
-6	O
in	O
the	O
monotherapy	B-T061
group	B-T078
p=0	O
.	O
	
over	O
a	O
4-	O
week	B-T079
treatment	B-T061
course	O
,	O
esomeprazole	B-T109
and	O
rebamipide	B-T109
combination	B-T061
therapy	I-T061
was	O
more	O
effective	B-T080
in	O
decreasing	B-T033
the	O
symptoms	O
of	O
reflux	B-T047
esophagitis	I-T047
than	O
esomeprazole	B-T109
monotherapy	B-T061
.	O
	
integrating	B-T080
palliative	O
care	O
in	O
pediatric	O
oncology	O
evidence	O
for	O
an	O
evolving	B-T169
paradigm	B-T062
for	O
comprehensive	O
cancer	B-T061
care	I-T061
the	O
demonstrated	O
benefit	O
of	O
integrating	B-T080
palliative	O
care	O
pc	O
into	O
cancer	B-T061
treatment	I-T061
has	O
triggered	O
an	O
increased	B-T081
need	O
for	O
pc	O
services	O
.	O
	
the	O
trajectory	O
of	O
integrating	B-T080
pc	O
in	O
comprehensive	O
cancer	O
centers	O
,	O
particularly	O
pediatric	O
centers	O
,	O
is	O
unknown	O
.	O
	
we	O
describe	O
our	O
8-	O
year	B-T079
experience	O
of	O
initiating	O
and	O
establishing	B-T080
pc	O
with	O
the	O
quality	O
of	O
life	O
service	O
qols	O
at	O
st	O
.	O
	
jude	O
children's	O
research	O
hospital	O
.	O
	
we	O
retrospectively	O
reviewed	O
records	B-T170
of	I-T170
patients	I-T170
seen	O
by	O
the	O
qols	O
n=615	O
from	O
march	B-T079
2007	O
to	O
december	B-T080
2014	O
.	O
	
variables	B-T081
analyzed	O
for	O
each	O
year	B-T079
,	O
using	O
descriptive	O
statistics	B-T081
,	O
included	O
diagnostic	B-T170
groups	I-T170
,	O
qols	O
encounters	O
,	O
goals	O
of	O
care	O
,	O
duration	O
of	O
survival	O
,	O
and	O
location	B-T082
of	I-T082
death	I-T082
.	O
	
total	O
qols	O
patient	O
encounters	O
increased	B-T081
from	O
58	O
2007	O
to	O
1	O
2014	O
,	O
new	O
consults	O
increased	B-T081
from	O
17	O
2007	O
to	O
115	O
2014	O
,	O
and	O
mean	O
encounters	O
per	O
patient	O
increased	B-T081
from	O
5.06	O
2007	O
to	O
16.11	O
2014	O
.	O
	
goal	O
of	O
care	O
at	O
initial	O
consultation	O
shifted	O
from	O
primarily	O
comfort	O
to	O
an	O
increasing	B-T169
goal	B-T170
of	I-T170
cure	I-T170
.	O
	
the	O
median	O
number	O
of	O
days	O
from	O
initial	O
consult	O
to	O
death	B-T033
increased	B-T081
from	O
52	O
days	O
2008	O
to	O
223	O
days	O
2014	O
.	O
	
a	O
trend	O
toward	O
increased	B-T081
outpatient	O
location	B-T082
of	I-T082
death	I-T082
was	O
noted	O
with	O
42%	O
outpatient	O
deaths	B-T033
in	O
2007	O
,	O
increasing	B-T169
to	O
a	O
majority	B-T080
in	O
each	O
subsequent	O
year	B-T079
range	O
,	O
51%-74%	O
.	O
	
hospital-wide	B-T080
,	O
patients	O
receiving	O
pc	O
services	O
before	O
death	B-T033
increased	B-T081
from	O
approximately	B-T080
50%	O
to	O
nearly	O
100%	O
.	O
	
since	O
its	O
inception	O
,	O
the	O
qols	O
experienced	O
a	O
dramatic	O
increase	B-T081
in	O
referrals	O
and	O
encounters	O
per	O
patient	O
,	O
increased	B-T081
use	O
by	O
all	O
clinical	O
services	O
,	O
a	O
trend	O
toward	O
earlier	B-T079
consultation	O
and	O
longer	B-T079
term	I-T079
follow-up	O
,	O
increasing	B-T169
outpatient	O
location	B-T082
of	I-T082
death	I-T082
,	O
and	O
near-	O
universal	B-T080
pc	O
involvement	O
at	O
the	O
end-of-life	O
.	O
	
the	O
successful	O
integration	B-T080
of	O
pc	O
in	O
a	O
comprehensive	O
cancer	O
center	O
,	O
and	O
the	O
resulting	O
potential	O
for	O
improved	O
care	O
provision	O
over	O
time	B-T079
,	O
can	O
serve	O
as	O
a	O
model	B-T170
for	O
other	O
programs	O
protective	B-T080
effects	I-T080
of	I-T080
dipeptidyl	O
peptidase-4	O
inhibitors	O
on	O
progression	O
of	O
diabetic	B-T047
retinopathy	I-T047
in	O
patients	O
with	O
type	B-T047
2	I-T047
diabetes	I-T047
to	O
investigate	B-T169
the	O
effects	B-T080
of	I-T080
dipeptidyl	O
peptidase-4	O
inhibitors	O
dpp4	O
on	O
the	O
progression	O
of	O
diabetic	B-T047
retinopathy	I-T047
dr	B-T047
in	O
patients	O
with	O
type	B-T047
2	I-T047
diabetes	I-T047
based	O
on	O
the	O
dr	B-T047
severity	B-T081
scale	I-T081
.	O
	
the	O
medical	B-T170
records	I-T170
of	O
82	O
patients	O
with	O
type	B-T047
2	I-T047
diabetes	I-T047
enrolled	O
from	O
2005	O
to	O
2015	O
were	O
retrospectively	B-T080
reviewed	B-T080
.	O
	
fundus	O
photographs	O
were	O
graded	O
using	O
early	B-T170
treatment	I-T170
diabetic	I-T170
retinopathy	I-T170
study	I-T170
methods	I-T170
.	O
	
the	O
associations	B-T080
between	O
baseline	B-T081
risk	B-T033
factors	I-T033
and	O
progression	O
of	O
dr	B-T047
were	O
investigated	B-T169
.	O
	
seven	O
of	O
28	O
patients	O
treated	B-T169
with	O
dpp4	O
inhibitors	O
and	O
26	O
of	O
54	O
treated	B-T169
with	O
other	O
hypoglycemic	O
agents	O
showed	O
progression	O
of	O
retinopathy	B-T047
,	O
defined	O
as	O
one	O
or	O
more	O
steps	O
on	O
the	O
early	B-T081
treatment	I-T081
diabetic	I-T081
retinopathy	I-T081
study	I-T081
scale	I-T081
p	O
=	O
0.043	O
.	O
	
only	O
treatment	B-T169
with	O
dpp4	O
inhibitors	O
significantly	O
reduced	B-T080
the	O
progression	O
of	O
dr	B-T047
in	O
patients	O
after	O
propensity	B-T081
score	I-T081
matching	O
p	O
=	O
0.009	O
.	O
	
treatment	B-T169
with	O
dpp4	O
inhibitors	O
was	O
associated	B-T080
with	I-T080
a	O
lower	B-T052
risk	B-T078
of	O
dr	B-T047
progression	O
p	O
=	O
0.011	O
.	O
	
treatment	B-T169
with	O
dpp4	O
inhibitors	O
was	O
the	O
independent	B-T078
protective	B-T169
factor	I-T169
against	O
the	O
progression	O
of	O
dr	B-T047
,	O
aside	O
from	O
improving	B-T033
glycemic	I-T033
control	I-T033
.	O
	
this	O
is	O
the	O
first	O
study	O
to	O
show	O
the	O
benefits	B-T081
of	O
dpp4	O
inhibitors	O
in	O
reducing	B-T080
dr	B-T047
progression	O
,	O
and	O
provides	O
encouraging	O
preliminary	B-T079
data	B-T078
for	O
further	O
evaluation	O
of	O
dpp4	O
inhibitors	O
in	O
the	O
progression	O
of	O
dr	B-T047
in	O
a	O
randomized	B-T062
,	O
double-blind	B-T062
,	O
placebo-controlled	B-T062
trial	I-T062
.	O
	
production	O
of	O
laccase	B-T116
by	O
cochliobolus	O
sp	O
.	O
	
isolated	B-T169
from	O
plastic	O
dumped	O
soils	O
and	O
their	O
ability	O
to	O
degrade	O
low	B-T109
molecular	I-T109
weight	I-T109
pvc	I-T109
one	O
of	O
the	O
utmost	O
man-made	O
problems	O
faced	O
today	O
has	O
been	O
the	O
ever	B-T079
-	O
increasing	B-T169
plastic	O
waste	O
filling	B-T052
the	O
world	O
.	O
	
it	O
accounts	O
for	O
an	O
estimated	O
20-30%	O
by	O
volume	O
of	O
municipal	O
solid	O
waste	O
in	O
landfill	O
sites	O
worldwide	O
.	O
	
research	O
on	O
plastic	O
biodegradation	O
has	O
been	O
steadily	O
growing	O
over	O
the	O
past	O
four	O
decades	O
.	O
	
several	O
fungi	O
have	O
been	O
identified	O
that	O
produce	O
enzymes	B-T116
capable	O
of	O
plastic	O
degradation	O
in	O
various	O
laboratory	B-T080
conditions	I-T080
.	O
	
this	O
paper	O
presents	O
a	O
study	O
that	O
determined	O
the	O
ability	O
of	O
fungi	O
to	O
degrade	O
low	B-T109
molecular	I-T109
weight	I-T109
polyvinyl	I-T109
chloride	I-T109
pvc	B-T109
by	O
the	O
enzyme	B-T116
laccase	I-T116
.	O
	
we	O
have	O
isolated	B-T169
a	O
fungal	O
species	O
,	O
cochliobolus	O
sp	O
,	O
from	O
plastic	O
dumped	O
soils	O
and	O
they	O
were	O
cultured	O
on	O
czapek	O
dox	O
agar	O
slants	O
at	O
30	O
.	O
	
the	O
effectiveness	B-T080
of	O
this	O
fungal	O
species	O
on	O
the	O
degradation	O
of	O
commercial	O
low	B-T109
molecular	I-T109
weight	I-T109
polyvinyl	I-T109
chloride	I-T109
pvc	B-T109
was	O
studied	O
under	O
laboratory	B-T080
conditions	I-T080
.	O
	
significant	O
differences	O
were	O
observed	O
from	O
the	O
ftir	B-T062
,	O
gc-ms	O
,	O
and	O
sem	O
results	O
in	O
between	O
control	O
and	O
cochliobolus	O
sp	O
.	O
	
treated	O
effects	B-T080
of	I-T080
cerium	O
and	O
titanium	O
oxide	O
nanoparticles	O
in	O
soil	O
on	O
the	O
nutrient	O
composition	O
of	O
barley	O
hordeum	O
vulgare	O
l	O
kernels	O
the	O
implications	B-T169
of	O
metal	O
nanoparticles	O
menps	O
are	O
still	O
unknown	B-T080
for	O
many	B-T081
food	O
crops	O
.	O
	
the	O
purpose	B-T169
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
effects	B-T080
of	I-T080
cerium	O
oxide	O
nceo₂	O
and	O
titanium	O
oxide	O
ntio₂	O
nanoparticles	O
in	O
soil	O
at	O
0	O
,	O
500	O
and	O
1000	O
mg	O
on	O
the	O
nutritional	B-T080
parameters	I-T080
of	O
barley	O
hordeum	O
vulgare	O
l	O
kernels	O
.	O
	
mineral	O
nutrients	O
,	O
amylose	B-T109
,	O
β-glucans	B-T109
,	O
amino	B-T116
acid	I-T116
and	O
crude	B-T116
protein	I-T116
cp	B-T116
concentrations	B-T081
were	I-T081
measured	I-T081
in	O
kernels	O
.	O
	
whole	B-T081
flour	O
samples	O
were	O
analyzed	O
by	O
icp-aes/ms	O
,	O
hplc	O
and	O
elemental	O
chns	O
analyzer	O
.	O
	
results	O
showed	O
that	O
ce	B-T109
and	O
ti	O
accumulation	B-T033
under	O
menps	O
treatments	B-T169
did	O
not	O
differ	O
from	O
the	O
control	B-T169
treatment	I-T169
.	O
	
however	O
,	O
nceo₂	O
and	O
ntio₂	O
had	O
an	O
impact	B-T080
on	O
composition	O
and	O
nutritional	B-T080
quality	I-T080
of	O
barley	O
kernels	O
in	O
contrasting	B-T080
ways	I-T080
.	O
	
both	O
menps	O
left	O
β-glucans	B-T109
unaffected	O
but	O
reduced	O
amylose	B-T109
content	O
by	O
approximately	O
21%	O
.	O
	
most	O
amino	B-T116
acids	I-T116
and	O
cp	B-T116
increased	B-T081
.	O
	
among	O
amino	B-T116
acids	I-T116
,	O
lysine	B-T116
followed	O
by	O
proline	B-T116
saw	O
the	O
largest	B-T169
increase	I-T169
51%	O
and	O
37%	O
,	O
respectively	O
.	O
	
potassium	O
and	O
s	O
were	O
both	O
negatively	B-T080
impacted	I-T080
by	O
menps	O
,	O
while	O
b	O
was	O
only	O
affected	B-T169
by	O
500	O
mg	O
nceo₂	O
kg	O
.	O
	
on	O
the	O
contrary	O
zn	O
and	O
mn	O
concentrations	O
were	O
improved	O
by	O
500	O
mg	O
ntio₂	O
kg	O
,	O
and	O
ca	O
by	O
both	O
ntio₂	O
treatments	B-T169
.	O
	
generally	O
,	O
our	O
findings	O
demonstrated	B-T052
that	O
kernels	O
are	O
negatively	B-T033
affected	I-T033
by	O
nceo₂	O
while	O
ntio₂	O
can	O
potentially	O
have	O
beneficial	B-T080
effects	I-T080
.	O
	
however	O
,	O
both	O
menps	O
have	O
the	O
potential	O
to	O
negatively	B-T080
impact	I-T080
malt	O
and	O
feed	O
production	O
.	O
	
quantifying	B-T081
nonlinear	O
contributions	B-T052
to	O
cortical	O
responses	O
evoked	O
by	O
continuous	B-T061
wrist	I-T061
manipulation	I-T061
cortical	O
responses	O
to	O
continuous	O
stimuli	O
as	O
recorded	O
using	O
either	O
magneto-	O
or	O
electroencephalography	O
eeg	O
have	O
shown	O
power	O
at	O
harmonics	O
of	O
the	O
stimulated	B-T079
frequency	I-T079
,	O
indicating	O
nonlinear	O
behavior	O
.	O
	
even	O
though	O
the	O
selection	O
of	O
analysis	B-T062
techniques	B-T169
depends	O
on	O
the	O
linearity	B-T082
of	O
the	O
system	O
under	O
study	O
,	O
the	O
importance	O
of	O
nonlinear	O
contributions	B-T052
to	O
cortical	O
responses	O
has	O
not	O
been	O
formally	O
addressed	O
.	O
	
the	O
goal	B-T170
of	I-T170
this	I-T170
paper	I-T170
is	O
to	O
quantify	B-T081
the	O
nonlinear	O
contributions	B-T052
to	O
the	O
cortical	O
response	O
obtained	O
from	O
continuous	B-T078
sensory	B-T061
stimulation	I-T061
.	O
	
eeg	O
was	O
used	O
to	O
record	O
the	O
cortical	O
response	O
evoked	O
by	O
continuous	B-T033
movement	I-T033
of	I-T033
the	I-T033
wrist	I-T033
joint	I-T033
of	O
healthy	O
subjects	O
applied	O
with	O
a	O
robotic	O
manipulator	O
.	O
	
multisine	O
stimulus	O
signals	O
i.e	O
,	O
the	O
sum	O
of	O
several	B-T081
sinusoids	O
elicit	O
a	O
periodic	B-T079
cortical	O
response	O
and	O
allow	O
to	O
assess	B-T052
the	O
nonlinear	O
contributions	B-T052
to	O
the	O
response	O
.	O
	
wrist	B-T061
dynamics	I-T061
relation	O
between	O
joint	O
angle	O
and	O
torque	O
were	O
successfully	O
linearized	B-T082
,	O
explaining	O
99%	O
of	O
the	O
response	O
.	O
	
in	O
contrast	O
,	O
the	O
cortical	O
response	O
revealed	O
a	O
highly	O
nonlinear	O
relation	O
where	O
most	O
power	O
80	O
%	O
occurred	O
at	O
non-stimulated	O
frequencies	O
.	O
	
moreover	O
,	O
only	O
10%	O
of	O
the	O
response	O
could	O
be	O
explained	O
using	O
a	O
nonparametric	B-T081
linear	I-T081
model	I-T081
.	O
	
these	O
results	B-T033
indicate	O
that	O
the	O
recorded	O
evoked	O
cortical	O
responses	O
are	O
governed	O
by	O
nonlinearities	O
and	O
that	O
linear	B-T082
methods	O
do	O
not	O
suffice	O
when	O
describing	O
the	O
relation	O
between	O
mechanical	O
stimulus	O
and	O
cortical	B-T033
response	I-T033
.	O
	
using	B-T169
melanopsin	B-T116
to	O
study	B-T062
g	O
protein	O
signaling	O
in	O
cortical	O
neurons	O
our	O
understanding	O
of	O
g	B-T116
protein-coupled	I-T116
receptors	I-T116
gpcrs	B-T116
in	O
the	O
central	O
nervous	O
system	O
cns	O
has	O
been	O
hampered	O
by	O
the	O
limited	O
availability	O
of	O
tools	O
allowing	O
for	O
the	O
study	B-T062
of	O
their	O
signaling	O
with	O
precise	B-T079
temporal	I-T079
control	B-T169
.	O
	
to	O
overcome	B-T052
this	O
,	O
we	O
tested	B-T169
the	O
utility	O
of	O
the	O
bistable	B-T080
mammalian	O
opsin	B-T116
melanopsin	B-T116
to	O
examine	O
g	O
protein	O
signaling	O
in	O
cns	O
neurons	O
.	O
	
specifically	O
,	O
we	O
used	B-T169
biolistic	O
gene	O
gun	O
approaches	O
to	O
transfect	B-T116
melanopsin	I-T116
into	O
cortical	O
pyramidal	O
cells	O
maintained	B-T169
in	O
organotypic	O
slice	O
culture	O
.	O
	
whole	B-T062
cell	I-T062
recordings	I-T062
from	O
transfected	O
neurons	O
indicated	O
that	O
application	O
of	O
blue	O
light	O
effectively	B-T080
activated	B-T169
the	O
transfected	B-T116
melanopsin	I-T116
to	O
elicit	B-T080
the	O
canonical	O
biphasic	B-T079
modulation	O
of	O
membrane	O
excitability	O
previously	O
associated	B-T080
with	I-T080
the	O
activation	B-T169
of	O
gpcrs	B-T116
coupling	B-T169
to	O
gαq-11	B-T116
remarkably	O
,	O
full	O
mimicry	O
of	O
exogenous	B-T169
agonist	O
concentration	B-T081
could	O
be	O
obtained	B-T169
with	O
pulses	O
as	O
short	O
as	O
a	O
few	B-T081
milliseconds	B-T079
,	O
suggesting	O
that	O
their	O
triggering	B-T080
required	O
a	O
single	B-T081
melanopsin	B-T116
activation-deactivation	B-T079
cycle	I-T079
.	O
	
the	O
resulting	B-T169
temporal	B-T169
control	I-T169
over	O
melanopsin	B-T116
activation	B-T169
allowed	O
us	O
to	O
compare	B-T052
the	O
activation	B-T169
kinetics	O
of	O
different	O
components	O
of	O
the	O
electrophysiological	O
response	O
.	O
	
we	O
also	O
replaced	O
the	O
intracellular	B-T082
loops	B-T082
of	O
melanopsin	B-T116
with	O
those	O
of	O
the	O
5-ht2a	B-T116
receptor	I-T116
to	O
create	O
a	O
light-activated	O
gpcr	B-T116
capable	O
of	O
interacting	B-T169
with	O
the	O
5-ht2a	B-T116
receptor	I-T116
interacting	B-T169
proteins	B-T116
.	O
	
the	O
resulting	B-T169
chimera	B-T116
expressed	B-T169
weak	B-T080
activity	B-T052
but	O
validated	B-T062
the	O
potential	B-T080
usefulness	B-T080
of	O
melanopsin	B-T116
as	O
a	O
tool	O
for	O
the	O
study	B-T062
of	O
g	O
protein	O
signaling	O
in	O
cns	O
neurons	O
.	O
	
maternal	O
vitamin	B-T109
d	I-T109
levels	B-T080
and	O
the	O
risk	B-T078
of	O
perinatal	O
death	O
to	O
determine	O
the	O
association	B-T080
between	O
maternal	O
vitamin	B-T109
d	I-T109
levels	B-T080
and	O
perinatal	O
death	O
.	O
	
a	O
retrospective	B-T080
cross-sectional	B-T062
study	I-T062
of	O
all	O
non-anomalous	O
,	O
singleton	O
births	O
24	O
weeks	B-T079
with	O
perinatal	O
death	O
compared	O
to	O
a	O
matched	O
control	O
group	O
.	O
	
only	O
pregnancies	O
with	O
a	O
recorded	O
vitamin	B-T109
d	I-T109
level	B-T080
at	O
booking	O
8-19	O
weeks	B-T079
gestation	O
were	O
included	O
for	O
analysis	B-T062
.	O
	
maternal	O
vitamin	B-T109
d	I-T109
levels	B-T080
were	O
categorized	O
into	O
normal	B-T080
,	O
deficient	B-T169
and	O
insufficient	B-T080
cohorts	B-T098
and	O
variables	B-T080
compared	O
between	O
the	O
three	O
groups	B-T098
.	O
	
there	O
were	O
31	O
perinatal	O
deaths	O
which	O
were	O
compared	O
to	O
111	O
controls	O
.	O
	
median	O
vitamin	B-T109
d	I-T109
levels	B-T080
were	O
lower	O
in	O
the	O
perinatal	O
death	O
cohort	B-T098
compared	O
to	O
the	O
control	O
group	O
55	O
nmol/l	O
versus	O
64	O
nmol/l	O
,	O
p	O
=	O
0.43	O
.	O
	
there	O
was	O
no	O
significant	O
increase	O
in	O
deaths	O
between	O
the	O
normal	B-T080
and	O
deficient	B-T169
p	O
=	O
0.33	O
or	O
insufficient	B-T080
p	O
=	O
0.09	O
groups	B-T098
.	O
	
low	O
maternal	O
vitamin	B-T109
d	I-T109
levels	B-T080
at	O
booking	O
were	O
not	O
associated	B-T080
with	I-T080
an	O
increased	O
risk	B-T078
of	O
perinatal	O
demise	O
.	O
	
effect	B-T080
of	O
constitutive	O
inactivation	O
of	O
the	O
myostatin	O
gene	O
on	O
the	O
gain	B-T081
in	O
muscle	O
strength	O
during	O
postnatal	O
growth	O
in	O
two	O
murine	O
models	O
the	O
effect	B-T080
of	O
constitutive	O
inactivation	O
of	O
the	O
gene	O
encoding	O
myostatin	O
on	O
the	O
gain	B-T081
in	O
muscle	O
performance	O
during	O
postnatal	O
growth	O
has	O
not	O
been	O
well	O
characterized	O
.	O
	
we	O
analyzed	O
2	O
murine	O
myostatin	O
knockout	O
ko	O
models	O
,	O
i	O
the	O
lee	O
model	O
ko	O
and	O
ii	O
the	O
grobet	O
model	O
ko	O
,	O
and	O
measured	B-T080
the	O
contraction	O
of	O
tibialis	O
anterior	O
muscle	O
in	B-T082
situ	I-T082
.	O
	
absolute	O
maximal	O
isometric	O
force	O
was	O
increased	B-T081
in	O
6-month-old	O
ko	O
and	O
ko	O
mice	O
,	O
as	O
compared	B-T052
to	O
wild-type	O
mice	O
.	O
	
similarly	O
,	O
absolute	O
maximal	O
power	O
was	O
increased	B-T081
in	O
6-month-old	O
ko	O
mice	O
.	O
	
in	O
contrast	O
,	O
specific	B-T080
maximal	O
force	O
relative	B-T080
maximal	O
force	O
per	O
unit	O
of	O
muscle	O
mass	B-T033
was	O
decreased	B-T081
in	O
all	O
6-month-old	O
male	O
and	O
female	O
ko	O
mice	O
,	O
except	B-T169
in	O
6-month	B-T079
-old	O
female	O
ko	O
mice	O
,	O
whereas	O
specific	B-T080
maximal	O
power	O
was	O
reduced	B-T080
only	O
in	O
male	O
ko	O
mice	O
.	O
	
genetic	O
inactivation	O
of	O
myostatin	O
increases	B-T169
maximal	O
force	O
and	O
power	O
,	O
but	O
in	O
return	B-T080
it	O
reduces	B-T080
muscle	O
quality	B-T080
,	O
particularly	O
in	O
male	O
mice	O
.	O
	
methylation	O
status	B-T080
of	O
the	O
promoter	O
region	O
of	O
the	O
human	O
frizzled	O
9	O
gene	O
in	O
acute	O
myeloid	O
leukemia	O
the	O
fzd9	O
gene	O
is	O
located	O
at	O
chromosome	O
7q11.23	O
,	O
and	O
has	O
been	O
indicated	O
to	O
be	O
a	O
tumor	O
suppressor	O
gene	O
.	O
	
the	O
present	O
study	B-T062
examined	B-T033
the	O
involvement	B-T169
of	O
fzd9	O
promoter	O
methylation	O
in	O
the	O
downregulation	O
of	O
fzd9	O
expression	O
in	O
leukemia	O
cells	O
.	O
	
the	O
expression	O
of	O
the	O
fzd9	O
gene	O
was	O
absent	B-T169
in	O
various	O
leukemic	O
cell	O
lines	O
,	O
while	O
it	O
was	O
restored	O
following	O
treatment	B-T169
with	O
dna	B-T109
demethylating	I-T109
agent	I-T109
5-aza-2'-deoxycytidine	B-T109
.	O
	
bisulfite	O
sequencing	O
analysis	O
of	O
the	O
fzd9	O
promoter	O
region	O
showed	O
that	O
it	O
was	O
partially	O
methylated	O
in	O
cell	O
lines	O
in	O
which	O
fzd9	O
gene	O
was	O
not	O
expressed	O
.	O
	
thus	O
,	O
dna	O
methylation	O
in	O
the	O
promoter	O
region	O
may	O
lead	O
to	O
inactivation	B-T169
of	O
the	O
fzd9	O
gene	O
,	O
which	O
may	O
represent	O
and	O
aberration	O
associated	B-T080
with	I-T080
leukemia	O
,	O
since	O
dna	O
was	O
not	O
methylated	O
in	O
normal	O
peripheral	O
blood	O
mononuclear	O
cells	O
.	O
	
methylation	O
-specific	O
polymerase	O
chain	O
reaction	O
analysis	O
revealed	O
that	O
the	O
promoter	O
region	O
of	O
the	O
fzd9	O
gene	O
was	O
frequently	B-T079
methylated	O
in	O
primary	B-T080
or	O
relapse	O
acute	O
myeloid	O
leukemia	O
52.9	O
excluding	O
acute	O
promyelocytic	O
leukemia	O
however	O
,	O
methylation	O
was	O
infrequent	O
in	O
b-cell	O
acute	O
lymphocytic	O
leukemia	O
5.6	O
.	O
	
in	O
conclusion	O
,	O
the	O
present	O
study	B-T062
indicated	O
that	O
the	O
methylation	O
profile	O
of	O
the	O
fzd9	O
gene	O
corresponded	O
to	O
that	O
of	O
a	O
candidate	O
tumor-suppressor	O
gene	O
in	O
acute	O
myeloid	O
leukemia	O
.	O
	
identification	B-T080
of	O
a	O
group	B-T078
of	O
xths	B-T116
genes	O
responding	O
to	O
heavy	O
metal	O
mercury	O
,	O
salinity	O
and	O
drought	O
stresses	O
in	O
medicago	O
truncatula	O
xyloglucan	B-T116
endotransglucosylase/hydrolases	I-T116
xth	B-T116
are	O
one	O
of	O
the	O
key	O
enzymes	B-T116
regulating	O
cell	O
wall	O
construction	O
,	O
extension	B-T169
and	O
metabolism	O
.	O
	
in	O
the	O
study	B-T062
,	O
44	O
xth	B-T116
protein	I-T116
genes	O
from	O
medicago	O
truncatula	O
genome	O
were	O
identified	O
using	O
bioinformatics	O
,	O
microarray	O
and	O
rt-pcr	O
.	O
	
each	O
xth	B-T116
was	O
showed	O
to	O
possess	O
a	O
highly	O
conserved	O
domain	O
d/n	O
,	O
and	O
most	O
of	O
xths	B-T116
possess	O
four	O
cys	B-T116
in	O
the	O
c	O
terminal	O
region	O
,	O
which	O
suggests	O
the	O
potential	B-T080
for	O
generating	O
disulfide	O
bonds	O
.	O
	
based	O
on	O
the	O
xth	B-T116
protein	O
sequences	O
,	O
these	O
xths	B-T116
can	O
be	O
classified	O
into	O
three	O
major	O
families	B-T116
and	O
each	O
family	B-T116
can	O
be	O
subdivided	O
into	O
more	O
groups	B-T078
.	O
	
examination	O
of	O
the	O
genomic	B-T082
location	I-T082
of	O
xth	O
genes	O
on	O
m	O
.	O
	
truncatula	O
chromosomes	O
showed	O
that	O
the	O
evolutional	O
expansion	O
of	O
the	O
genes	O
was	O
possibly	O
attributed	O
to	O
localized	B-T082
gene	O
duplications	O
.	O
	
to	O
investigate	O
the	O
possible	O
involvement	B-T169
of	O
the	O
xths	B-T116
responding	O
to	O
heavy	O
metals	O
and	O
other	O
abiotic	O
stresses	O
,	O
the	O
xth	O
genes	O
were	O
exposed	O
to	O
heavy	O
metal	O
hg	O
or	O
cu	O
,	O
salt	O
and	O
drought	O
stresses	O
.	O
	
there	O
were	O
28	O
,	O
21	O
and	O
21	O
mtxth	O
genes	O
found	O
to	O
respond	O
to	O
hgcl2	O
,	O
salt	O
and	O
drought	O
stresses	O
,	O
respectively	O
,	O
but	O
their	O
expression	O
were	O
different	O
under	O
the	O
stresses	O
.	O
	
some	O
of	O
the	O
xth	O
genes	O
were	O
well	O
confirmed	O
by	O
quantitative	B-T081
rt-pcr	O
qrt-pcr	O
.	O
	
we	O
further	O
specified	B-T080
expression	O
of	O
a	O
xth	O
gene	O
medtr4g128580	O
mtxth3	O
under	O
different	O
environmental	O
stresses	O
,	O
and	O
showed	O
that	O
mtxth3	O
was	O
induced	O
by	O
hg	O
exposure	B-T080
.	O
	
these	O
results	B-T169
indicated	O
that	O
a	O
group	B-T078
of	O
mtxths	O
could	O
be	O
differentially	O
expressed	O
under	O
the	O
environmental	O
stresses	O
.	O
	
vestibular	B-T047
disorders	I-T047
and	O
nausea	O
during	O
head	O
and	O
neck	O
intensity-modulated	B-T061
radiation	I-T061
therapy	I-T061
we	O
studied	O
whether	O
there	O
is	O
a	O
relationship	B-T080
between	O
nausea	O
and	O
vestibular	B-T047
disorders	I-T047
in	O
patients	O
treated	B-T061
with	I-T061
intensity	B-T061
modulated	I-T061
radiation	I-T061
therapy	I-T061
imrt	B-T061
for	O
head	O
and	O
neck	O
cancer	O
.	O
	
we	O
performed	O
a	O
prospective	B-T062
single-centre	I-T062
study	I-T062
that	O
enrolled	O
31	O
patients	O
.	O
	
a	O
videonystagmography	B-T061
was	O
carried	O
out	O
before	O
and	O
within	O
15	O
days	O
after	O
radiation	B-T061
therapy	I-T061
for	O
each	O
patient	O
.	O
	
nausea	O
was	O
assessed	O
at	O
baseline	B-T081
,	O
every	O
week	O
,	O
and	O
at	O
the	O
post-radiotherapy	B-T061
videonystagmography	B-T061
visit	O
.	O
	
twenty-six	O
patients	O
had	O
benefited	O
from	O
a	O
complete	O
interpretable	O
videonystagmography	B-T061
.	O
	
for	O
14	O
of	O
these	O
patients	O
vestibular	B-T033
damage	I-T033
was	O
diagnosed	B-T033
post-radiotherapy	B-T061
.	O
	
during	O
irradiation	O
,	O
six	O
patients	O
felt	O
nauseous	O
,	O
but	O
without	O
dizziness	O
.	O
	
in	O
univariate	B-T062
analysis	I-T062
,	O
we	O
found	O
a	O
relationship	B-T080
statistically	B-T081
significant	I-T081
between	O
the	O
average	O
dose	B-T081
received	O
by	O
the	O
vestibules	O
and	O
vestibular	B-T047
disorder	I-T047
videonystagmography	B-T061
p=0	O
,	O
odds	B-T081
ratio	I-T081
or	B-T081
1.08	O
1.025	O
,	O
but	O
there	O
was	O
no	B-T033
relationship	B-T080
between	O
vestibular	B-T047
disorder	I-T047
videonystagmography	B-T061
and	O
nausea	O
p=0	O
.	O
	
irradiation	O
of	O
the	O
vestibular	O
system	O
during	O
imrt	B-T061
does	O
not	O
seem	O
to	O
explain	O
the	O
preventing	O
youth	O
internalizing	O
symptoms	O
through	O
the	O
familias	O
unidas	O
intervention	O
examining	O
variation	B-T081
in	O
response	O
prevention	B-T170
programs	I-T170
that	O
strengthen	O
parenting	O
and	O
family	O
functioning	O
have	O
been	O
found	O
to	O
reduce	B-T061
poor	O
behavioral	O
outcomes	O
in	O
adolescents	O
,	O
including	O
substance	O
use	O
,	O
hiv	B-T033
risk	I-T033
,	O
externalizing	O
and	O
internalizing	O
problems	O
.	O
	
however	O
,	O
there	O
is	O
evidence	O
that	O
not	O
all	O
youth	O
benefit	O
similarly	O
from	O
these	O
programs	B-T170
.	O
	
familias	O
unidas	O
is	O
a	O
family-focused	O
intervention	O
designed	O
to	O
prevent	O
substance	O
use	O
and	O
sexual	B-T033
risk	I-T033
among	O
hispanic	B-T098
youth	O
and	O
has	O
recently	O
demonstrated	O
unanticipated	O
reductions	B-T061
in	O
internalizing	O
symptoms	O
for	O
some	O
youth	O
.	O
	
this	O
paper	O
examines	O
variation	O
in	O
intervention	O
response	O
for	O
internalizing	O
symptoms	O
using	O
individual-level	O
data	O
pooled	O
across	O
four	O
distinct	O
familias	O
unidas	O
trials	B-T062
1	O
266	O
eighth	B-T033
grade	I-T033
students	B-T098
recruited	O
from	O
the	O
general	O
school	B-T098
population	I-T098
2	O
160	O
ninth	B-T033
grade	I-T033
students	B-T098
from	O
the	O
general	O
school	B-T098
population	I-T098
3	O
213	O
adolescents	O
with	O
conduct	O
,	O
aggression	O
,	O
and/or	O
attention	B-T033
problems	I-T033
and	O
4	O
242	O
adolescents	O
with	O
a	O
delinquency	O
history	O
.	O
	
causal	O
inference	O
growth	O
mixture	O
modeling	O
suggests	O
a	O
three-	O
class	O
model	B-T170
.	O
	
the	O
two	O
largest	O
classes	O
represent	O
youth	O
with	O
low	B-T080
60	O
%	O
and	O
medium	B-T081
27	O
%	O
internalizing	O
symptoms	O
at	O
baseline	B-T081
,	O
and	O
both	O
intervention	O
and	O
control	O
participants	B-T098
show	O
reductions	B-T061
in	O
internalizing	O
symptoms	O
.	O
	
the	O
third	O
class	O
13	O
%	O
represents	O
youth	O
with	O
high	B-T080
levels	B-T080
of	O
baseline	B-T081
internalizing	O
symptoms	O
who	O
remain	O
at	O
steady	B-T080
levels	B-T080
of	O
internalizing	O
symptoms	O
when	O
exposed	B-T080
to	I-T080
the	O
intervention	O
,	O
but	O
who	O
experience	O
an	O
increase	O
in	O
symptoms	O
under	O
the	O
control	B-T080
condition	I-T080
.	O
	
female	O
gender	O
,	O
low	B-T080
baseline	B-T081
levels	B-T080
of	O
parent	O
-	O
adolescent	O
communication	O
,	O
and	O
older	B-T098
age	I-T098
were	O
associated	O
with	O
membership	O
in	O
the	O
high-risk	B-T033
class	O
.	O
	
these	O
synthesis	O
analyses	O
involving	O
a	O
large	O
sample	O
of	O
youth	O
with	O
varying	O
initial	B-T080
risk	I-T080
levels	I-T080
represent	O
a	O
further	O
step	O
toward	O
strengthening	O
our	O
knowledge	O
of	O
preventive	O
intervention	O
response	O
and	O
improving	O
preventive	O
interventions	O
.	O
	
acute	O
kidney	O
injury	O
severity	B-T080
and	O
long-term	B-T079
readmission	O
and	O
mortality	B-T081
after	O
cardiac	B-T061
surgery	I-T061
acute	O
kidney	O
injury	O
aki	O
is	O
a	O
common	O
complication	O
after	O
cardiac	B-T061
surgery	I-T061
.	O
	
while	O
aki	O
severity	B-T080
is	O
known	O
to	O
be	O
associated	B-T080
with	I-T080
increased	O
risk	B-T078
of	O
short-term	B-T079
outcomes	O
,	O
its	O
long-term	B-T079
impact	O
is	O
less	O
well	O
understood	O
.	O
	
adult	O
patients	O
undergoing	O
isolated	O
coronary	B-T061
artery	I-T061
bypass	I-T061
graft	I-T061
surgery	I-T061
at	O
eight	O
centers	O
were	O
enrolled	O
into	O
the	O
northern	B-T170
new	I-T170
england	I-T170
biomarker	I-T170
registry	I-T170
n	O
=	O
1	O
.	O
	
patients	O
were	O
excluded	O
if	O
they	O
had	O
renal	B-T047
failure	I-T047
n	O
=	O
15	O
or	O
died	B-T033
during	O
index	O
admission	O
n	O
=	O
38	O
.	O
	
severity	B-T080
of	O
aki	O
was	O
defined	O
using	O
the	O
acute	O
kidney	O
injury	O
network	O
akin	O
.	O
	
we	O
linked	O
our	O
cohort	B-T081
to	O
national	O
medicare	O
and	O
state	B-T170
all-payer	I-T170
claims	I-T170
to	O
ascertain	O
readmissions	O
and	O
to	O
the	O
national	B-T170
death	I-T170
index	I-T170
to	O
ascertain	O
survival	B-T169
.	O
	
kaplan-meier	B-T081
and	O
multivariate	B-T081
cox	I-T081
proportional	I-T081
hazards	I-T081
modeling	I-T081
was	O
conducted	O
for	O
time	O
to	O
readmission	O
and	O
death	B-T033
over	O
5	O
years	O
.	O
	
within	O
5	O
years	O
,	O
513	O
patients	O
33.8	O
had	O
aki	O
with	O
akin	O
stage	O
1	O
29.9	O
and	O
stage	O
2	O
to	O
3	O
3.9	O
.	O
	
there	O
were	O
620	O
readmissions	O
39.9	O
and	O
370	O
deaths	B-T033
23.8	O
.	O
	
after	O
adjustment	O
,	O
stage	O
1	O
aki	O
patients	O
had	O
a	O
31%	O
increased	O
risk	B-T078
of	O
readmission	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
1.10	O
to	O
1.57	O
,	O
whereas	O
stage	O
2	O
or	O
3	O
patients	O
had	O
a	O
98%	O
increased	O
risk	B-T078
95%	O
ci	B-T081
1.41	O
to	O
2.78	O
compared	O
with	O
patients	O
having	O
no	B-T033
aki	O
.	O
	
relative	O
to	O
patients	O
without	O
aki	O
,	O
stage	O
1	O
patients	O
had	O
a	O
56%	O
increased	O
risk	B-T078
of	O
mortality	B-T081
95%	O
ci	B-T081
1.14	O
to	O
2.13	O
,	O
whereas	O
stage	O
2	O
or	O
3	O
patients	O
had	O
a	O
3.5	O
times	O
higher	O
risk	B-T078
95%	O
ci	B-T081
2.16	O
to	O
5.60	O
.	O
	
severity	B-T080
of	O
aki	O
using	O
the	O
akin	O
stage	O
criteria	O
is	O
associated	B-T080
with	I-T080
a	O
significantly	O
increased	O
risk	B-T078
of	O
5-year	O
readmission	O
and	O
mortality	B-T081
.	O
	
our	O
findings	O
suggest	O
that	O
efforts	O
to	O
reduce	O
aki	O
in	O
the	O
perioperative	B-T079
period	I-T079
may	O
have	O
a	O
significant	O
long-term	B-T079
impact	O
on	O
patients	O
and	O
payers	O
in	O
reducing	O
mortality	B-T081
and	O
health	O
care	O
utilization	O
.	O
	
association	B-T080
of	O
abdominal	O
fat	O
with	O
serum	O
amylase	B-T116
in	O
an	O
older	B-T098
cohort	B-T098
the	O
baltimore	O
longitudinal	B-T062
study	I-T062
of	O
aging	O
abdominal	O
fat	O
is	O
a	O
major	O
determinant	B-T169
of	O
metabolic	B-T047
diseases	I-T047
in	O
older	B-T098
individuals	B-T098
.	O
	
obesity	B-T047
and	O
diabetes	B-T047
are	O
associated	B-T080
with	I-T080
low	B-T080
serum	B-T033
amylase	I-T033
sa	I-T033
levels	I-T033
,	O
but	O
the	O
association	B-T080
between	O
sa	B-T033
and	O
metabolic	B-T047
disease	I-T047
is	O
poorly	O
understood	O
.	O
	
we	O
investigated	B-T169
the	O
association	B-T080
of	O
low	B-T080
sa	B-T033
with	O
diabetes	B-T047
and	O
sex	O
-	O
specific	B-T080
associations	B-T080
of	O
serum	O
amylase	B-T116
with	O
abdominal	O
fat	O
in	O
older	O
adults	O
.	O
	
in	O
community-dwelling	O
volunteers	B-T098
from	O
the	O
baltimore	O
longitudinal	B-T062
study	I-T062
of	O
aging	O
778	O
participants	B-T098
,	O
age	O
66.8	O
years	B-T079
,	O
we	O
assessed	B-T052
abdominal	O
fat	O
by	O
computed	O
tomography	O
and	O
diabetes	B-T033
status	I-T033
using	O
the	O
american	O
diabetes	O
association	O
criteria	B-T078
.	O
	
linear	B-T081
regression	I-T081
analyses	I-T081
assessed	B-T052
the	O
cross-sectional	B-T080
associations	I-T080
between	O
abdominal	O
fat	O
and	O
sa	B-T033
,	O
and	O
logistic	B-T062
regression	I-T062
assessed	B-T052
the	O
odds	B-T081
of	O
diabetes	B-T047
,	O
given	O
low	B-T080
sa	B-T033
.	O
	
in	O
unadjusted	B-T062
analyses	I-T062
,	O
individuals	B-T098
in	O
the	O
lowest	B-T080
sa	B-T033
quartile	B-T080
<48μ/l	O
had	O
1.97	O
greater	O
odds	B-T081
of	O
diabetes	B-T047
,	O
95%	O
ci	B-T081
,	O
1.01	O
than	O
those	O
in	O
the	O
highest	O
quartile	B-T080
80μ/l	O
.	O
	
this	O
association	B-T080
was	O
no	O
longer	O
significant	B-T078
after	O
adjusting	O
for	O
visceral	O
adipose	O
tissue	O
area	O
vat	O
,	O
dm	O
,	O
abdominal	O
subcutaneous	O
adipose	O
tissue	O
sat	O
,	O
dm	O
or	O
bmi	O
.	O
	
in	O
adjusted	B-T062
analyses	I-T062
,	O
vat	O
and	O
sat	O
were	O
significantly	B-T078
associated	B-T080
with	I-T080
sa	B-T033
in	O
both	O
sexes	O
.	O
	
among	O
women	B-T098
,	O
sa	B-T033
was	O
more	O
strongly	O
associated	B-T080
with	I-T080
vat	O
than	O
with	O
sat	O
or	O
bmi	O
vat	O
β=-0	O
,	O
p<0	O
,	O
sat	O
β=-0	O
,	O
p=0	O
and	O
bmi	O
β=-0	O
,	O
p=0	O
.	O
	
the	O
association	B-T080
between	O
sa	B-T116
and	O
diabetes	B-T047
was	O
explained	O
mainly	O
by	O
abdominal	O
visceral	O
fat	O
.	O
	
in	O
women	B-T098
,	O
sa	B-T116
was	O
more	O
strongly	O
associated	B-T080
with	I-T080
vat	O
than	O
with	O
bmi	O
or	O
sat	O
.	O
	
these	O
findings	O
provide	O
motivation	O
for	O
future	O
mechanistic	O
studies	O
on	O
sa's	B-T116
role	O
in	O
metabolic	B-T047
diseases	I-T047
.	O
	
efficacy	B-T080
of	O
intravenous	B-T082
chlorothiazide	B-T109
for	O
refractory	B-T169
acute	B-T047
decompensated	I-T047
heart	I-T047
failure	I-T047
unresponsive	B-T169
to	O
adjunct	B-T169
metolazone	B-T109
to	O
assess	O
the	O
efficacy	B-T080
of	O
intravenous	B-T082
chlorothiazide	B-T109
in	O
patients	O
with	O
acute	B-T047
decompensated	I-T047
heart	I-T047
failure	I-T047
adhf	B-T047
who	O
were	O
determined	O
to	O
be	O
loop	O
diuretic	O
resistant	B-T169
and	O
refractory	B-T169
to	O
metolazone	B-T109
.	O
	
retrospective	B-T062
cohort	I-T062
study	I-T062
with	O
patients	O
serving	O
as	O
their	O
own	O
controls	O
.	O
	
large	B-T081
,	O
academic	O
,	O
tertiary	O
care	O
hospital	O
.	O
	
forty-five	O
patients	O
with	O
adhf	B-T047
who	O
had	O
an	O
inadequate	B-T080
response	O
to	O
high-dose	B-T081
loop	O
diuretics	O
and	O
then	O
received	O
at	O
least	O
one	O
dose	B-T081
of	O
oral	B-T082
metolazone	B-T109
5	O
mg	O
or	O
greater	B-T081
metolazone	B-T109
index	B-T081
dose	I-T081
followed	O
by	O
at	O
least	O
one	O
dose	B-T081
of	O
intravenous	B-T082
chlorothiazide	B-T109
500	O
mg	O
chlorothiazide	B-T109
index	B-T081
dose	I-T081
if	O
the	O
response	O
to	O
metolazone	B-T109
was	O
considered	O
inadequate	B-T080
,	O
according	O
to	O
the	O
institutional	B-T170
protocol	I-T170
,	O
between	O
february	O
4	O
,	O
2013	O
,	O
and	O
february	O
28	O
,	O
2015	O
,	O
were	O
included	O
.	O
	
if	O
multiple	O
doses	B-T081
of	O
metolazone	B-T109
were	O
administered	O
,	O
the	O
last	O
dose	B-T081
given	O
before	O
the	O
chlorothiazide	B-T109
index	B-T081
dose	I-T081
was	O
considered	O
the	O
index	B-T081
dose	I-T081
the	O
metolazone	B-T109
index	B-T081
dose	I-T081
had	O
to	O
have	O
been	O
administered	O
more	O
than	O
2	O
hours	B-T079
before	O
the	O
chlorothiazide	B-T109
index	B-T081
dose	I-T081
.	O
	
data	B-T078
for	O
a	O
total	O
of	O
90	O
diuretic	O
doses	B-T081
45	O
metolazone	B-T109
,	O
45	O
chlorothiazide	B-T109
were	O
included	O
in	O
the	O
analysis	B-T062
.	O
	
the	O
median	O
dose	B-T081
of	O
loop	O
diuretic	O
in	O
intravenous	B-T082
furosemide	B-T109
equivalents	O
given	O
over	O
the	O
24-	O
hour	B-T079
period	B-T079
before	O
the	O
metolazone	B-T109
index	B-T081
dose	I-T081
was	O
400	O
mg	O
.	O
	
the	O
average	O
length	O
of	O
stay	B-T079
was	O
34.7	O
days	B-T079
,	O
and	O
in-hospital	B-T080
mortality	I-T080
was	O
35.6	O
16/45	O
patients	O
.	O
	
the	O
primary	O
end	B-T080
point	I-T080
of	O
a	O
net-negative	B-T033
urine	O
output	O
of	O
500	O
ml	O
or	O
greater	O
during	O
the	O
12	O
hours	B-T079
after	O
the	O
index	B-T081
dose	I-T081
occurred	O
in	O
42.2	O
19/45	O
patients	O
and	O
35.5	O
16/45	O
patients	O
for	O
the	O
chlorothiazide	B-T109
and	O
metolazone	B-T109
doses	B-T081
,	O
respectively	O
p=0	O
.	O
	
the	O
median	O
12-	O
hour	B-T079
urine	O
output	O
following	O
administration	B-T081
of	O
metolazone	B-T109
was	O
810	O
ml	O
interquartile	B-T081
range	I-T081
iqr	B-T081
866	O
ml	O
versus	O
1075	O
ml	O
iqr	B-T081
940	O
ml	O
following	O
administration	B-T081
of	O
chlorothiazide	B-T109
p=0	O
.	O
	
compared	B-T052
with	O
metolazone	B-T109
,	O
the	O
chlorothiazide	B-T109
doses	B-T081
did	O
not	O
result	O
in	O
an	O
increase	B-T169
in	O
urine	O
output	O
of	O
at	O
least	O
500	O
ml	O
during	O
the	O
12	O
hours	B-T079
following	O
the	O
dose	B-T081
relative	O
to	O
the	O
12	O
hours	B-T079
before	O
the	O
dose	B-T081
31.1	O
vs	O
22.2	O
,	O
p=0	O
.	O
	
no	O
significant	O
difference	O
in	O
achievement	O
of	O
net-negative	B-T033
urine	O
output	O
of	O
500	O
ml	O
or	O
greater	O
during	O
the	O
12	O
hours	B-T079
following	O
the	O
chlorothiazide	B-T109
or	O
metolazone	B-T109
dose	B-T081
was	O
noted	O
42.2	O
for	O
chlorothiazide	B-T109
vs	O
35.5	O
for	O
metolazone	B-T109
,	O
p=0	O
.	O
	
the	O
addition	O
of	O
intravenous	B-T082
chlorothiazide	B-T109
did	O
not	O
result	O
in	O
improved	B-T033
diuresis	O
in	O
patients	O
with	O
adhf	B-T047
determined	O
to	O
be	O
refractory	B-T169
to	O
loop	O
diuretic	O
s	O
and	O
adjunctive	B-T169
oral	B-T082
metolazone	B-T109
.	O
	
comparisons	B-T052
of	O
safety	O
and	O
clinical	B-T080
outcomes	B-T169
between	O
multiple-level	B-T061
and	O
single-level	B-T061
cervical	I-T061
disk	I-T061
replacement	I-T061
for	O
cervical	B-T047
spondylosis	I-T047
a	O
systematic	B-T170
review	I-T170
and	O
meta-analysis	B-T170
this	O
is	O
a	O
systematic	B-T170
review	I-T170
and	O
meta-analysis	B-T170
.	O
	
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	B-T169
the	O
efficacy	B-T080
and	O
safety	O
of	O
multiple-level	B-T061
cervical	I-T061
disk	I-T061
replacement	I-T061
cdr	B-T061
over	O
single-level	B-T061
cdr	I-T061
for	O
the	O
treatment	B-T061
of	O
cervical	B-T047
spondylosis	I-T047
.	O
	
some	O
authors	O
advocate	O
for	O
the	O
multiple-level	B-T061
cdr	I-T061
instead	O
of	O
anterior	B-T082
decompression	B-T061
and	O
fusion	B-T061
in	O
cervical	B-T047
multiple-level	I-T047
spondylosis	I-T047
.	O
	
however	O
,	O
whether	O
the	O
efficacy	B-T080
and	O
safety	O
of	O
multi-level	B-T061
cdr	I-T061
are	O
as	O
favorable	O
as	O
that	O
of	O
single-level	B-T061
cdr	I-T061
remains	O
controversial	O
.	O
	
medline	B-T170
,	O
embase	B-T170
,	O
and	O
cochrane	B-T170
library	I-T170
databases	I-T170
were	O
searched	O
up	O
to	O
november	O
2015	O
for	O
controlled	B-T062
studies	I-T062
that	O
compared	B-T052
the	O
clinical	B-T080
outcomes	B-T169
of	O
single-level	B-T061
and	O
multiple-level	B-T061
cdr	I-T061
for	O
the	O
treatment	B-T061
of	O
cervical	B-T047
spondylosis	I-T047
.	O
	
the	O
following	O
outcomes	B-T169
were	O
extracted	O
and	O
analyzed	B-T062
prevalence	B-T081
of	O
heterotopic	O
ossification	O
and	O
reoperation	B-T061
,	O
preoperative	B-T079
and	O
postoperative	B-T079
neck	B-T033
disability	I-T033
index	I-T033
scores	I-T033
,	O
preoperative	B-T079
and	O
postoperative	B-T079
visual	O
analog	O
scale	O
scores	O
,	O
and	O
success	B-T080
rate	B-T081
using	O
the	O
odom	O
grading	O
system	O
.	O
	
ten	O
studies	B-T062
involving	O
1402	O
patients	O
were	O
included	O
including	O
3	O
randomized	B-T062
controlled	I-T062
trials	I-T062
,	O
5	O
prospective	B-T062
studies	I-T062
,	O
and	O
3	O
retrospective	B-T062
studies	I-T062
.	O
	
no	O
significant	O
differences	O
between	O
single-level	B-T061
and	O
multiple-level	B-T061
groups	O
were	O
found	O
in	O
terms	O
of	O
the	O
prevalence	B-T081
of	O
heterotopic	O
ossification	O
and	O
reoperation	B-T061
rate	B-T081
,	O
neck	B-T033
disability	I-T033
index	I-T033
score	I-T033
,	O
visual	O
analog	O
scale	O
score	O
,	O
and	O
success	B-T080
rate	B-T081
using	O
the	O
odom	O
grading	O
system	O
.	O
	
on	O
the	O
basis	O
of	O
this	O
meta-analysis	B-T170
,	O
clinical	B-T080
outcomes	B-T169
of	O
multiple-level	B-T061
cdr	I-T061
are	O
similar	O
to	O
those	O
of	O
single-level	B-T061
cdr	I-T061
for	O
cervical	B-T047
spondylosis	I-T047
,	O
which	O
suggests	O
the	O
multiple-level	B-T061
cdr	I-T061
is	O
as	O
effective	B-T080
and	O
safe	O
as	O
the	O
single-level	B-T061
cdr	I-T061
.	O
	
nonetheless	O
,	O
more	O
well-designed	O
studies	B-T062
are	O
needed	O
for	O
further	O
evaluation	O
of	O
the	O
effects	B-T080
of	I-T080
intravenous	B-T082
and	O
percutaneous	B-T082
low	B-T061
level	I-T061
laser	I-T061
therapy	I-T061
in	O
the	O
management	B-T061
of	O
shoulder	O
myofascial	B-T047
pain	I-T047
syndrome	I-T047
myofascial	B-T047
pain	I-T047
syndrome	I-T047
mps	B-T047
treatment	B-T061
is	O
challenging	O
with	O
a	O
high	O
recurrence	O
rate	O
and	O
still	O
lacks	O
a	O
clear	O
treatment	B-T061
frame	I-T061
.	O
	
therefore	O
research	O
on	O
new	O
,	O
more	O
efficient	B-T080
and	O
long	O
lasting	O
effect	O
treatment	B-T061
modalities	B-T078
is	O
necessary	O
.	O
	
this	O
study	O
looked	O
at	O
the	O
effects	B-T080
of	I-T080
intravenous	B-T082
laser	B-T061
therapy	I-T061
ivl	B-T061
and	O
percutaneous	B-T082
low	B-T061
level	I-T061
laser	I-T061
plll	B-T061
in	O
the	O
management	B-T061
of	O
shoulder	O
mps	B-T047
.	O
	
in	O
this	O
randomized	B-T062
controlled	I-T062
trial	I-T062
,	O
30	O
patients	O
fulfilling	O
inclusion	B-T080
criteria	I-T080
were	O
randomly	O
equally	O
allocated	O
to	O
3	O
groups	O
,	O
control	O
,	O
ivl	B-T098
and	O
plll	B-T098
.	O
	
control	O
group	O
received	O
12	O
sessions	O
of	O
placebo	B-T062
low	B-T061
level	I-T061
laser	I-T061
,	O
ivl	B-T098
group	I-T098
received	O
12	O
sessions	O
of	O
ivl	B-T061
therapy	I-T061
,	O
and	O
plll	B-T098
group	I-T098
received	O
12	O
sessions	O
of	O
plll	B-T061
therapy	I-T061
.	O
	
all	O
patients	O
were	O
trained	O
for	O
better	B-T080
body	O
posture	O
,	O
body	O
mechanics	O
,	O
gentle	B-T061
massage	I-T061
of	O
trigger	O
points	O
,	O
stretching	B-T061
exercises	I-T061
of	O
affected	B-T169
muscle	O
trapezius	O
,	O
and	O
received	O
10	O
mg	O
of	O
oral	B-T082
nortriptyline	B-T109
regimen	B-T061
every	O
night	O
for	O
3	O
months	O
.	O
	
outcomes	O
included	O
pain	B-T080
severity	I-T080
,	O
functional	B-T033
disability	I-T033
,	O
and	O
quality	B-T078
of	I-T078
life	I-T078
.	O
	
patients	O
were	O
assessed	O
using	O
numeric	B-T170
rating	I-T170
scale	I-T170
nrs	B-T170
,	O
pain	B-T170
disability	I-T170
index	I-T170
pdi	B-T170
,	O
and	O
short	B-T170
form	I-T170
health	I-T170
survey	I-T170
sf-12	B-T170
.	O
	
data	B-T033
collected	I-T033
were	O
analyzed	B-T062
using	O
analysis	B-T081
of	I-T081
variance	I-T081
anova	B-T081
,	O
mann-whitney	B-T170
and	O
t	B-T170
tests	I-T170
.	O
	
the	O
mean	O
of	O
pdi	B-T170
and	O
maximum	O
pain	O
intensity	O
during	O
day	O
and	O
night	O
significantly	O
reduced	B-T080
in	O
both	O
plll	B-T098
and	O
ivl	B-T098
groups	I-T098
compared	O
to	O
control	O
group	O
.	O
	
although	O
pain	O
severity	O
and	O
pdi	B-T170
reduction	O
was	O
more	O
pronounced	O
in	O
ivl	B-T098
group	I-T098
compared	O
to	O
plll	B-T098
group	I-T098
,	O
the	O
differences	O
were	O
not	O
statistically	B-T081
significant	I-T081
.	O
	
also	O
,	O
quality	B-T078
of	I-T078
life	I-T078
statistically	B-T081
significantly	I-T081
improved	O
in	O
both	O
ivl	B-T098
and	O
plll	B-T098
groups	I-T098
compared	O
to	O
control	O
group	O
was	O
more	O
,	O
and	O
although	O
higher	O
in	O
ivl	B-T098
group	I-T098
,	O
the	O
difference	O
was	O
not	O
statistically	B-T081
significant	I-T081
when	O
compared	O
to	O
plll	B-T098
group	I-T098
.	O
	
no	B-T033
side	I-T033
effects	I-T033
were	O
observed	O
in	O
the	O
intervention	B-T098
groups	I-T098
.	O
	
intravenous	B-T082
laser	B-T061
and	O
plll	B-T061
therapy	I-T061
had	O
a	O
positive	O
effect	B-T080
on	O
pain	B-T080
severity	I-T080
and	O
pdi	B-T170
reduction	O
,	O
and	O
quality	B-T078
of	I-T078
life	I-T078
in	O
this	O
study	O
.	O
	
also	O
no	B-T033
adverse	I-T033
event	I-T033
was	O
recorded	O
.	O
	
thus	O
,	O
intravenous	B-T082
lasers	B-T061
and	O
plll	B-T061
therapy	I-T061
seem	O
to	O
be	O
effective	B-T080
complementary	O
modalities	B-T078
in	O
managing	B-T061
patients	O
with	O
shoulder	O
mps	B-T047
.	O
	
structural	B-T082
insights	O
into	O
5-ht1a	B-T116
/	O
d4	B-T116
selectivity	O
of	O
way-100635	B-T109
analogues	O
molecular	B-T062
modeling	I-T062
,	O
synthesis	B-T052
,	O
and	O
in	B-T080
vitro	I-T080
binding	O
the	O
resurgence	O
of	O
interest	O
in	O
5-ht1a	B-T116
receptors	I-T116
as	O
a	O
therapeutic	B-T169
target	B-T169
requires	O
the	O
existence	O
of	O
highly	O
selective	B-T080
5-ht1a	B-T116
ligands	O
.	O
	
to	O
date	O
,	O
way-100635	B-T109
has	O
been	O
the	O
prototypical	O
antagonist	O
of	O
these	O
receptors	B-T116
.	O
	
however	O
,	O
this	O
compound	B-T080
also	O
has	O
significant	O
affinity	O
for	O
and	O
activity	O
at	O
d4	B-T116
dopamine	I-T116
receptors	I-T116
.	O
	
in	O
this	O
context	O
,	O
this	O
work	O
was	O
aimed	O
at	O
better	O
understanding	O
the	O
5-ht1a	B-T116
/	O
d4	B-T116
selectivity	O
of	O
way-100635	B-T109
and	O
analogues	O
from	O
a	O
structural	B-T082
point	O
of	O
view	O
.	O
	
in	O
silico	O
investigations	B-T169
revealed	O
two	O
key	O
interactions	B-T169
for	O
the	O
5-ht1a	B-T116
/	O
d4	B-T116
selectivity	O
of	O
way-100635	B-T109
and	O
analogues	O
.	O
	
first	O
,	O
a	O
hydrogen	O
bond	O
only	O
found	O
with	O
the	O
ser	B-T116
7.36	I-T116
of	O
d4	B-T116
receptor	I-T116
appeared	O
to	O
be	O
the	O
key	O
for	O
a	O
higher	O
d4	B-T116
affinity	O
for	O
newly	O
synthesized	B-T052
aza	B-T109
analogues	O
.	O
	
the	O
role	O
of	O
ser	B-T116
7.36	I-T116
was	O
confirmed	O
as	O
the	O
affinity	O
of	O
aza	B-T109
analogues	O
for	O
the	O
mutant	O
d4	B-T116
receptor	I-T116
s7.36a	I-T116
was	O
reduced	O
.	O
	
then	O
,	O
the	O
formation	O
of	O
another	O
hydrogen	O
bond	O
with	O
the	O
conserved	O
ser	B-T116
5.42	I-T116
residue	I-T116
appeared	O
to	O
be	O
also	O
critical	O
for	O
d4	B-T116
binding	O
.	O
	
genomic	O
analysis	O
of	O
nontypeable	O
pneumococci	O
causing	O
invasive	B-T047
pneumococcal	I-T047
disease	I-T047
in	O
south	O
africa	O
,	O
2003-2013	O
the	O
capsular	B-T109
polysaccharide	I-T109
is	O
the	O
principal	O
virulence	B-T109
factor	I-T109
of	O
streptococcus	O
pneumoniae	O
and	O
a	O
target	B-T169
for	O
current	O
pneumococcal	O
vaccines	O
.	O
	
however	O
,	O
some	O
pathogenic	B-T033
pneumococci	O
are	O
serologically	B-T170
nontypeable	I-T170
nontypeable	O
pneumococci	O
ntpn	O
.	O
	
due	O
to	O
their	O
relative	O
rarity	B-T080
,	O
ntpn	O
are	O
poorly	O
characterized	B-T052
,	O
and	O
,	O
as	O
such	O
,	O
limited	O
data	B-T078
exist	O
which	O
describe	O
these	O
organisms	O
.	O
	
we	O
aimed	O
to	O
describe	O
disease	B-T047
and	O
genotypically	O
characterize	B-T052
ntpn	O
causing	O
invasive	B-T047
pneumococcal	I-T047
disease	I-T047
in	O
south	O
africa	O
.	O
	
isolates	O
were	O
detected	O
through	O
national	O
,	O
laboratory	O
-	O
based	B-T078
surveillance	B-T169
for	O
invasive	B-T047
pneumococcal	I-T047
disease	I-T047
in	O
south	O
africa	O
and	O
characterized	B-T052
by	O
whole	O
genome	O
analysis	O
.	O
	
we	O
predicted	O
ancestral	B-T169
serotypes	B-T170
serotypes	B-T170
from	O
which	O
ntpn	O
may	O
have	O
originated	O
for	O
group	B-T078
i	I-T078
ntpn	O
using	O
multilocus	B-T062
sequence	I-T062
typing	I-T062
and	O
capsular	B-T082
region	I-T082
sequence	O
analyses	O
.	O
	
antimicrobial	O
resistance	O
patterns	B-T082
and	O
mutations	O
potentially	B-T080
causing	O
nontypeability	B-T170
were	O
identified	B-T080
.	O
	
from	O
2003-2013	O
,	O
39	O
0.1	O
%	O
,	O
39/32	O
ntpn	O
were	O
reported	O
.	O
	
twenty-two	B-T081
56	O
%	O
had	O
partial	B-T081
capsular	O
genes	O
group	B-T078
i	I-T078
and	O
17	O
44	O
%	O
had	O
complete	B-T080
capsular	O
deletion	O
of	O
which	O
15	O
had	O
replacement	B-T169
by	O
other	O
genes	O
group	B-T078
ii	I-T078
.	O
	
seventy-nine	B-T081
percent	B-T081
31/39	O
of	O
our	O
ntpn	O
isolates	O
were	O
derived	O
from	O
encapsulated	B-T080
s	O
.	O
	
pneumoniae	O
.	O
	
ancestral	O
serotypes	B-T170
1	O
27	O
%	O
,	O
6/22	O
and	O
8	O
14	O
%	O
,	O
3/22	O
were	O
most	O
prevalent	O
,	O
and	O
59	O
%	O
13/22	O
of	O
ancestral	B-T169
serotypes	B-T170
were	O
serotypes	B-T170
included	O
in	O
the	O
13-valent	O
pneumococcal	O
conjugate	O
vaccine	O
.	O
	
we	O
identified	O
a	O
variety	O
of	O
mutations	O
within	O
the	O
capsular	B-T082
region	I-T082
of	O
group	B-T078
i	I-T078
ntpn	O
,	O
some	O
of	O
which	O
may	O
be	O
responsible	O
for	O
the	O
nontypeable	B-T170
phenotype	O
.	O
	
nonsusceptibility	O
to	O
tetracycline	B-T109
and	O
erythromycin	B-T109
was	O
higher	O
in	O
ntpn	O
than	O
encapsulated	B-T080
s	O
.	O
	
pneumoniae	O
.	O
	
ntpn	O
are	O
currently	O
a	O
rare	O
cause	O
of	O
invasive	B-T047
pneumococcal	I-T047
disease	I-T047
in	O
south	O
africa	O
pre-hypertension	B-T047
,	O
pre-diabetes	B-T047
or	O
both	O
which	O
is	O
best	O
at	O
predicting	B-T078
cardiovascular	B-T033
events	I-T033
in	O
the	O
long	B-T079
term	I-T079
the	O
present	O
study	B-T062
aimed	O
to	O
assess	O
the	O
value	O
of	O
pre-diabetes	B-T047
and	O
pre-hypertension	B-T047
in	O
predicting	B-T078
cardiovascular	B-T033
events	I-T033
.	O
	
a	O
population	B-T081
-based	O
,	O
cross-sectional	B-T062
survey	I-T062
was	O
conducted	O
,	O
representing	O
a	O
large	O
sample	O
of	O
the	O
general	O
iranian	B-T098
population	B-T098
aged	O
35	O
years	B-T079
and	O
older	O
from	O
the	O
isfahan	O
province	O
and	O
determined	O
using	O
a	O
random	B-T062
,	O
multistage	I-T062
cluster-sampling	I-T062
10-year	O
cohort	B-T098
.	O
	
the	O
five	O
end	O
points	O
considered	O
as	O
study	B-T169
outcome	I-T169
were	O
unstable	B-T047
angina	I-T047
ua	B-T047
,	O
acute	B-T079
occurrence	B-T079
of	O
myocardial	B-T047
infarction	I-T047
mi	B-T047
,	O
sudden	O
cardiac	O
death	O
scd	O
,	O
brain	B-T047
stroke	I-T047
and	O
cardiovascular	B-T047
disease	I-T047
cvd	B-T047
.	O
	
of	O
the	O
6323	O
subjects	O
scheduled	O
for	O
assessment	O
of	O
diabetes	B-T047
state	I-T047
617	O
were	O
diabetics	B-T033
and	O
712	O
were	O
pre-diabetic	B-T033
.	O
	
in	O
addition	O
,	O
of	O
these	O
subjects	O
,	O
1754	O
had	O
hypertension	B-T047
and	O
2500	O
had	O
pre-hypertension	B-T047
.	O
	
analysing	O
only	O
pre-hypertension	B-T047
,	O
pre-diabetes	B-T047
and	O
its	O
combination	O
and	O
adjusted	O
for	O
gender	O
and	O
age	O
variables	O
,	O
pre-hypertension	B-T047
and	O
pre-diabetes	B-T047
status	O
together	O
,	O
could	O
only	O
effectively	O
predict	O
occurrence	B-T079
of	O
mi	B-T047
hazard	B-T081
ratio	I-T081
hr	B-T081
,	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
1.06	O
,	O
p=0	O
.	O
	
in	O
the	O
same	O
cox	B-T170
regression	I-T170
models	I-T170
,	O
pre-hypertension	B-T047
status	O
could	O
predict	O
ua	B-T047
and	O
cvd	B-T047
occurrence	B-T079
hr	B-T081
=2	O
,	O
95%	O
ci	B-T081
1.68	O
,	O
p<0	O
and	O
hr	B-T081
=1	O
,	O
95%	O
ci	B-T081
1.23	O
,	O
p=0	O
,	O
respectively	O
.	O
	
however	O
,	O
pre-diabetes	B-T047
status	O
could	O
not	O
predict	O
any	O
of	O
these	O
events	O
after	O
adjustment	O
for	O
gender	O
and	O
age	O
.	O
	
our	O
data	B-T078
provide	O
valuable	O
evidence	B-T078
of	O
the	O
triggering	O
role	O
of	O
pre-hypertension	B-T047
and	O
pre-diabetes	B-T047
together	O
,	O
on	O
appearance	B-T080
and	O
progression	O
of	O
mi	B-T047
even	O
in	O
healthy	B-T098
individuals	I-T098
and	O
the	O
significant	O
predicting	B-T078
value	O
of	O
pre-hypertension	B-T047
on	O
the	O
occurrence	B-T079
of	O
ua	B-T047
and	O
cvd	B-T047
.	O
	
in	O
this	O
regard	O
,	O
the	O
value	O
of	O
pre-hypertension	B-T047
and	O
pre-diabetes	B-T047
together	O
,	O
and	O
the	O
pre-hypertension	B-T047
state	O
alone	O
,	O
are	O
clearly	O
superior	O
to	O
pre-diabetes	B-T047
state	O
alone	O
in	O
predicting	B-T078
cardiovascular	B-T033
events	I-T033
.	O
	
strategies	O
for	O
successful	B-T080
clinical	B-T080
teaching	O
this	O
article	B-T170
is	O
one	O
in	O
a	O
series	O
on	O
the	O
roles	O
of	O
adjunct	O
clinical	O
faculty	O
and	O
preceptors	O
,	O
who	O
teach	O
nursing	O
students	O
and	O
new	B-T080
graduates	B-T098
to	O
apply	B-T169
knowledge	B-T170
in	O
clinical	B-T082
settings	I-T082
.	O
	
this	O
article	B-T170
describes	O
teaching	O
strategies	O
as	O
well	O
as	O
the	O
importance	O
of	O
the	O
learning	B-T082
environment	I-T082
.	O
	
learned	O
helplessness	O
at	O
fifty	O
insights	O
from	O
neuroscience	O
learned	O
helplessness	O
,	O
the	O
failure	B-T169
to	O
escape	O
shock	O
induced	B-T169
by	O
uncontrollable	O
aversive	B-T169
events	I-T169
,	O
was	O
discovered	O
half	O
a	O
century	O
ago	O
.	O
	
seligman	O
and	O
maier	O
1967	O
theorized	B-T078
that	O
animals	O
learned	O
that	O
outcomes	B-T169
were	O
independent	B-T169
of	I-T169
their	O
responses	O
-that	O
nothing	O
they	O
did	O
mattered-and	O
that	O
this	O
learning	O
undermined	O
trying	O
to	O
escape	O
.	O
	
the	O
mechanism	O
of	O
learned	O
helplessness	O
is	O
now	O
very	O
well-charted	B-T080
biologically	I-T080
,	O
and	O
the	O
original	O
theory	B-T078
got	O
it	O
backward	O
.	O
	
passivity	O
in	O
response	O
to	O
shock	O
is	O
not	O
learned	O
.	O
	
it	O
is	O
the	O
default	O
,	O
unlearned	O
response	O
to	O
prolonged	B-T079
aversive	B-T169
events	I-T169
and	O
it	O
is	O
mediated	O
by	O
the	O
serotonergic	O
activity	O
of	O
the	O
dorsal	O
raphe	O
nucleus	O
,	O
which	O
in	O
turn	O
inhibits	B-T052
escape	O
.	O
	
this	O
passivity	O
can	O
be	O
overcome	O
by	O
learning	O
control	B-T080
,	O
with	O
the	O
activity	O
of	O
the	O
medial	O
prefrontal	O
cortex	O
,	O
which	O
subserves	O
the	O
detection	B-T033
of	O
control	B-T080
leading	O
to	O
the	O
automatic	B-T169
inhibition	B-T052
of	O
the	O
dorsal	O
raphe	O
nucleus	O
.	O
	
so	O
animals	O
learn	O
that	O
they	O
can	O
control	B-T080
aversive	B-T169
events	I-T169
,	O
but	O
the	O
passive	B-T080
failure	B-T169
to	O
learn	O
to	O
escape	O
is	O
an	O
unlearned	O
reaction	B-T169
to	O
prolonged	B-T079
aversive	B-T061
stimulation	I-T061
.	O
	
in	O
addition	O
,	O
alterations	B-T078
of	O
the	O
ventromedial	O
prefrontal	O
cortex	O
-	O
dorsal	O
raphe	O
pathway	O
can	O
come	O
to	O
subserve	O
the	O
expectation	B-T078
of	O
control	B-T080
.	O
	
we	O
speculate	O
that	O
default	O
passivity	O
and	O
the	O
compensating	B-T080
detection	B-T033
and	O
expectation	B-T078
of	O
control	B-T080
may	O
have	O
substantial	O
implications	O
for	O
how	O
to	O
treat	B-T169
depression	O
.	O
	
a	O
peptide	B-T116
from	O
human	B-T116
β	I-T116
thymosin	I-T116
as	O
a	O
platform	O
for	O
the	O
development	O
of	O
new	O
anti-biofilm	O
agents	O
for	O
staphylococcus	O
spp	O
.	O
	
and	O
pseudomonas	O
aeruginosa	O
conventional	O
antibiotics	O
might	O
fail	O
in	O
the	O
treatment	O
of	O
biofilm	O
-associated	O
infections	O
causing	O
infection	O
recurrence	O
and	O
chronicity	O
.	O
	
the	O
search	O
for	O
antimicrobial	O
peptides	O
has	O
been	O
performed	O
with	O
the	O
aim	O
to	O
discover	O
novel	O
anti-infective	O
agents	O
active	O
on	O
pathogens	O
in	O
both	O
planktonic	O
and	O
biofilm	O
associated	O
forms	O
.	O
	
the	O
fragment	O
9-19	O
of	O
human	O
thymosin	O
β4	O
was	O
studied	O
through	O
1	O
μs	O
md	O
simulation	O
.	O
	
two	O
main	O
conformations	O
of	O
the	O
peptide	O
were	O
detected	O
,	O
both	O
constituted	O
by	O
a	O
central	O
hydrophobic	O
core	O
and	O
by	O
the	O
presence	O
of	O
peripheral	O
charged	O
residues	O
suggesting	O
a	O
possible	O
mechanism	O
of	O
interaction	O
with	O
two	O
models	O
of	O
biological	O
membranes	O
,	O
related	O
to	O
eukaryotic	O
or	O
bacterial	O
membrane	O
respectively	O
.	O
	
in	O
addition	O
,	O
the	O
peptide	O
was	O
chemically	O
synthesized	O
and	O
its	O
antimicrobial	O
activity	O
was	O
tested	O
in	O
vitro	O
against	O
planktonic	O
and	O
biofilm	O
form	O
of	O
a	O
group	O
of	O
reference	O
strains	O
of	O
staphylococcus	O
spp	O
.	O
	
and	O
one	O
p	O
.	O
	
aeruginosa	O
strain	O
.	O
	
the	O
human	O
thymosin	O
β4	O
fragment	O
eiekfdksklk	O
showed	O
antibacterial	O
activity	O
against	O
staphylococcal	O
strains	O
and	O
pseudomonas	O
aeruginosa	O
atcc	O
15442	O
at	O
concentrations	O
from	O
12.5	O
to	O
6.2	O
mg/ml	O
and	O
inhibited	O
biofilm	O
formation	O
at	O
sub-inhibitory	O
concentrations	O
3.1	O
mg/ml	O
.	O
	
the	O
activity	O
of	O
the	O
fragment	O
in	O
inhibiting	O
biofilm	O
formation	O
,	O
could	O
be	O
due	O
to	O
the	O
conformations	O
highlighted	O
by	O
the	O
md	O
simulations	O
,	O
suggesting	O
its	O
interaction	O
with	O
the	O
bacterial	O
membrane	O
.	O
	
human	O
thymosin	O
β4	O
fragment	O
can	O
be	O
considered	O
a	O
promising	O
lead	O
compound	O
to	O
develop	O
novel	O
synthetic	O
or	O
recombinant	O
derivatives	O
with	O
improved	O
pharmaceutical	O
structural	B-T082
basis	B-T169
for	O
simvastatin	B-T109
competitive	O
antagonism	O
of	O
complement	B-T116
receptor	I-T116
3	I-T116
the	O
complement	B-T116
system	I-T116
is	O
an	O
important	O
part	O
of	O
the	O
innate	O
immune	O
response	O
to	O
infection	B-T047
but	O
may	O
also	O
cause	O
severe	B-T033
complications	I-T033
during	O
inflammation	O
.	O
	
small	B-T109
molecule	I-T109
antagonists	O
to	O
complement	B-T116
receptor	I-T116
3	I-T116
cr3	B-T116
have	O
been	O
widely	O
sought	O
,	O
but	O
a	O
structural	B-T082
basis	B-T169
for	O
their	O
mode	B-T169
of	I-T169
action	I-T169
is	O
not	O
available	O
.	O
	
we	O
report	B-T170
here	O
on	O
the	O
structure	B-T082
of	O
the	O
human	O
cr3	B-T116
ligand-binding	O
i	O
domain	O
in	O
complex	O
with	O
simvastatin	B-T109
.	O
	
simvastatin	B-T109
targets	B-T169
the	O
metal	O
ion-dependent	B-T080
adhesion	B-T082
site	I-T082
of	O
the	O
open	O
,	O
ligand-binding	O
conformation	B-T082
of	O
the	O
cr3	B-T116
i	O
domain	O
by	O
direct	O
contact	B-T169
with	I-T169
the	O
chelated	B-T109
mg	I-T109
ion	I-T109
.	O
	
simvastatin	B-T109
antagonizes	B-T033
i	O
domain	O
binding	O
to	O
the	O
complement	B-T116
fragments	I-T116
ic3b	B-T116
and	O
c3d	B-T116
but	O
not	O
to	O
intercellular	B-T116
adhesion	I-T116
molecule-1	I-T116
.	O
	
by	O
virtue	B-T078
of	O
the	O
i	O
domain's	O
wide	O
distribution	B-T082
in	O
binding	O
kinetics	O
to	O
ligands	O
,	O
it	O
was	O
possible	B-T033
to	O
identify	O
ligand	O
binding	O
kinetics	O
as	O
discriminator	O
for	O
simvastatin	B-T109
antagonism	O
.	O
	
in	O
static	B-T080
cellular	O
experiments	B-T062
,	O
15-25	O
μm	O
simvastatin	B-T109
reduced	B-T080
adhesion	O
by	O
k562	O
cells	O
expressing	O
recombinant	O
cr3	B-T116
and	O
by	O
primary	B-T080
human	O
monocytes	O
,	O
with	O
an	O
endogenous	B-T169
expression	O
of	O
this	O
receptor	B-T116
.	O
	
application	O
of	O
force	O
to	O
adhering	O
monocytes	O
potentiated	O
the	O
effects	B-T080
of	I-T080
simvastatin	B-T109
where	O
only	O
a	O
50-100	O
nm	O
concentration	B-T081
of	O
the	O
drug	O
reduced	B-T080
the	O
adhesion	O
by	O
20-40%	O
compared	B-T052
with	O
untreated	B-T080
cells	O
.	O
	
the	O
ability	O
of	O
simvastatin	B-T109
to	O
target	B-T169
cr3	B-T116
in	O
its	O
ligand	O
binding	O
-	O
activated	B-T052
conformation	B-T082
is	O
a	O
novel	B-T080
mechanism	O
to	O
explain	O
the	O
known	O
anti-inflammatory	B-T080
effects	I-T080
of	O
this	O
compound	O
,	O
in	O
particular	O
because	O
this	O
cr3	B-T116
conformation	B-T082
is	O
found	O
in	O
pro-inflammatory	B-T080
environments	B-T082
.	O
	
our	O
report	B-T170
points	O
to	O
new	O
designs	O
of	O
cr3	B-T116
antagonists	O
and	O
opens	O
new	O
perspectives	O
and	O
identifies	B-T033
druggable	B-T080
receptors	B-T116
from	O
characterization	B-T052
of	O
the	O
ligand	O
binding	O
kinetics	O
in	O
the	O
presence	B-T080
of	O
common	B-T081
laboratory	O
parameters	B-T033
for	O
differentiating	B-T169
between	O
community-acquired	B-T047
and	O
healthcare-associated	B-T047
pneumonia	I-T047
the	O
correct	B-T080
diagnosis	B-T033
of	O
healthcare-associated	B-T047
pneumonia	I-T047
hcap	B-T047
as	O
opposed	O
to	O
community-acquired	B-T047
pneumonia	I-T047
is	O
essential	B-T080
for	O
the	O
selection	B-T052
of	O
a	O
correct	B-T080
empirical	B-T080
antimicrobial	O
approach	O
,	O
reserving	O
the	O
broad-spectrum	O
or	O
highly	B-T080
potent	I-T080
antimicrobial	B-T061
therapies	I-T061
for	O
resistant	B-T169
strains	O
most	O
commonly	O
present	O
in	O
hcap	B-T047
,	O
whereas	O
treating	B-T169
the	O
less	O
resistant	B-T169
strains	O
,	O
most	O
commonly	O
associated	B-T080
with	I-T080
community	O
and	O
long-term	O
care	O
facility	O
-	O
acquired	O
infections	O
,	O
with	O
a	O
more	O
targeted	B-T169
empirical	B-T062
approach	I-T062
.	O
	
the	O
standard	B-T080
approach	I-T080
today	B-T079
is	O
to	O
differentiate	B-T169
between	O
the	O
two	O
based	O
on	O
the	O
medical	B-T033
history	I-T033
of	O
the	O
past	B-T079
90	O
days	B-T079
prior	O
to	O
admission	O
.	O
	
measurable	B-T169
,	O
quantitative	B-T081
assessment	O
may	O
be	O
able	O
to	O
assist	B-T080
in	O
this	O
decision	O
.	O
	
the	O
objective	O
of	O
this	O
study	O
is	O
to	O
find	O
a	O
measurable	B-T169
method	B-T170
of	O
differentiating	B-T169
between	O
community-acquired	B-T047
and	O
healthcare-associated	B-T047
pneumonias	I-T047
.	O
	
the	O
records	B-T170
of	O
126	O
patients	O
admitted	O
with	O
a	O
diagnosis	B-T033
of	O
pneumonia	B-T047
were	O
divided	O
into	O
two	O
groups	B-T078
based	O
on	O
the	O
probable	O
cause	O
of	O
their	O
disease	O
,	O
in	O
accordance	O
with	O
common	O
practice	O
.	O
	
the	O
routine	B-T080
laboratory	O
work	O
taken	O
upon	O
admittance	O
was	O
analyzed	B-T062
using	O
logistical	B-T062
regression	I-T062
and	O
student's	B-T081
t-test	I-T081
.	O
	
we	O
have	O
found	O
that	O
the	O
red	O
blood	O
cell	O
distribution	O
width	O
and	O
the	O
neutrophil	O
-to-	O
lymphocyte	O
ratio	O
,	O
both	O
routine	O
parameters	O
obtained	O
in	O
a	O
simple	O
blood	O
count	O
,	O
can	O
each	O
assist	O
in	O
differentiating	O
between	O
community-acquired	O
and	O
healthcare-associated	O
pneumonias	O
.	O
	
we	O
have	O
found	O
two	O
statistically	O
significant	O
parameters	O
that	O
may	O
be	O
used	O
as	O
adjuncts	O
to	O
the	O
medical	O
history	O
,	O
chest	O
radiography	O
and	O
other	O
parameters	O
in	O
forming	O
an	O
immediate	O
clinical	O
impression	O
of	O
a	O
patient	O
presenting	O
with	O
pneumonia	B-T047
a	O
quasi-experimental	B-T062
study	I-T062
of	O
a	O
reminiscence	B-T061
program	I-T061
focused	O
on	O
autobiographical	O
memory	O
in	O
institutionalized	O
older	B-T098
adults	I-T098
with	O
cognitive	O
impairment	O
working	O
with	O
past	O
memories	O
through	O
reminiscence	B-T061
interventions	I-T061
has	O
been	O
practiced	O
for	O
several	B-T081
decades	I-T081
with	O
successful	O
outcomes	B-T169
on	O
mental	O
health	O
in	O
older	B-T098
adults	I-T098
.	O
	
few	O
studies	B-T062
however	O
have	O
focused	O
on	O
autobiographical	O
memory	O
recall	O
in	O
older	B-T098
individuals	I-T098
with	O
cognitive	O
impairment	O
.	O
	
this	O
study	B-T062
aims	O
to	O
analyze	O
the	O
impact	O
of	O
an	O
individual	B-T098
reminiscence	B-T061
program	I-T061
in	O
a	O
group	O
of	O
older	B-T098
persons	I-T098
with	O
cognitive	O
decline	O
living	O
in	O
nursing	O
homes	O
on	O
the	O
dimensions	O
of	O
cognition	O
,	O
autobiographical	O
memory	O
,	O
mood	O
,	O
behavior	O
and	O
anxiety	O
.	O
	
a	O
two-group	O
pre-test	B-T170
and	I-T170
post-test	I-T170
design	I-T170
with	O
single	O
blinded	O
assessment	O
was	O
conducted	O
.	O
	
forty-one	O
participants	B-T098
were	O
randomized	O
to	O
an	O
experimental	B-T098
group	I-T098
n=20	O
and	O
a	O
control	O
group	O
n=21	O
.	O
	
the	O
first	O
group	O
attended	O
five	O
weekly	O
individual	B-T098
reminiscence	O
sessions	O
.	O
	
changes	O
in	O
the	O
outcome	B-T081
measures	I-T081
were	O
examined	B-T033
for	O
cognition	O
montreal	B-T170
cognitive	I-T170
assessment	I-T170
autobiographical	B-T170
memory	I-T170
test	I-T170
,	O
behavior	O
alzheimer	B-T170
disease	I-T170
assessment	I-T170
subscale	I-T170
non-cog	I-T170
and	O
emotional	B-T033
status	I-T033
cornell	B-T170
scale	I-T170
for	I-T170
depression	I-T170
in	O
dementia	O
geriatric	B-T170
depression	I-T170
scale	I-T170
,	O
and	O
geriatric	B-T170
anxiety	I-T170
inventory	I-T170
.	O
	
participants	B-T098
attending	O
reminiscence	O
sessions	O
exhibited	O
better	O
outcomes	B-T169
compared	O
to	O
the	O
control	O
group	O
in	O
cognition	O
,	O
anxiety	O
and	O
depression	O
p<0	O
,	O
and	O
presented	O
a	O
higher	O
number	O
of	O
retrieved	O
autobiographical	O
events	O
,	O
specificity	O
of	O
evoked	O
memories	O
and	O
positive	O
valence	O
of	O
events	O
p<0	O
,	O
and	O
also	O
presented	O
lower	O
latency	O
time	O
for	O
recalling	O
events	O
,	O
and	O
lower	O
negative	O
recalled	O
events	O
p<0	O
.	O
	
this	O
study	O
supports	O
the	O
potential	O
value	O
of	O
reminiscence	B-T061
therapy	I-T061
in	O
improving	O
the	O
recall	O
of	O
autobiographical	O
memory	O
.	O
	
reminiscence	B-T061
therapy	I-T061
can	O
be	O
helpful	O
to	O
maintain	O
or	O
improve	O
cognitive	O
function	O
,	O
decrease	O
anxiety	O
and	O
manage	O
depressive	O
symptoms	O
and	O
altered	O
behavior	O
,	O
economic	B-T081
burden	I-T081
of	O
illness	O
among	O
patients	O
with	O
severe	B-T033
asthma	I-T033
in	O
a	O
managed	O
care	O
setting	O
despite	O
intensive	O
pharmacotherapy	B-T061
,	O
a	O
considerable	O
number	B-T081
of	O
patients	O
with	O
severe	B-T033
asthma	I-T033
have	O
inadequate	B-T080
disease	B-T047
control	B-T080
.	O
	
patients	O
with	O
severe	B-T033
asthma	I-T033
who	O
experience	O
exacerbations	B-T033
consume	O
significant	O
health	B-T081
care	I-T081
resources	I-T081
.	O
	
to	O
assess	B-T052
health	B-T081
care	I-T081
resource	I-T081
utilization	B-T169
and	O
associated	O
costs	B-T081
among	O
patients	O
with	O
persistent	B-T079
severe	B-T033
asthma	I-T033
who	O
experienced	O
exacerbations	B-T033
compared	O
with	O
patients	O
with	O
persistent	B-T079
but	O
nonsevere	O
asthma	B-T047
.	O
	
this	O
retrospective	B-T080
analysis	B-T062
of	O
a	O
national	B-T170
administrative	I-T170
claims	I-T170
database	I-T170
identified	B-T080
patients	O
aged	O
12	O
years	B-T079
who	O
had	O
at	O
least	O
1	O
medical	O
claim	O
with	O
an	O
asthma	B-T047
diagnosis	B-T033
in	O
2012	O
and	O
had	O
continuous	O
medical	B-T033
and	O
pharmacy	B-T033
coverage	I-T033
under	O
a	O
commercial	B-T170
or	O
medicare	O
advantage	O
plan	O
from	O
january	O
1	O
,	O
2012	O
,	O
to	O
december	O
31	O
,	O
2013	O
.	O
	
patients	O
were	O
assigned	B-T169
to	O
1	O
of	O
2	O
mutually	O
exclusive	O
cohorts	B-T098
-	O
persistent	B-T047
asthma	I-T047
pa	B-T047
or	O
severe	B-T033
asthma	I-T033
sa	B-T033
to	O
an	O
established	O
algorithm	B-T170
based	O
on	O
asthma	B-T047
-related	O
health	B-T081
care	I-T081
resource	I-T081
use	B-T169
and	O
pharmacy	B-T033
claims	I-T033
for	O
controller	O
medication	O
.	O
	
sa	B-T033
patients	O
were	O
required	O
to	O
meet	O
pa	B-T047
criteria	B-T078
and	O
also	O
have	O
evidence	B-T078
of	O
2	O
asthma	B-T033
exacerbations	I-T033
in	O
2012	O
.	O
	
asthma	B-T047
-related	O
health	B-T081
care	I-T081
resource	I-T081
utilization	B-T169
and	O
costs	B-T081
were	O
computed	B-T052
from	O
asthma	B-T047
medication	O
use	B-T169
rescue	B-T169
and	O
controller	B-T169
therapy	I-T169
and	O
medical	O
claims	O
with	O
an	O
asthma	B-T047
diagnosis	B-T033
in	O
the	O
primary	B-T082
position	I-T082
in	O
2012	O
and	O
2013	O
.	O
	
adherence	B-T169
to	O
controller	B-T169
therapy	I-T169
was	O
assessed	B-T052
over	O
365	O
days	B-T079
by	O
using	O
the	O
proportion	B-T079
of	I-T079
days	I-T079
covered	I-T079
pdc	B-T079
,	O
starting	O
with	O
the	O
first	O
claim	O
for	O
controller	B-T169
therapy	I-T169
in	O
2012	O
.	O
	
differences	B-T080
between	O
the	O
pa	B-T047
and	O
sa	B-T033
cohorts	B-T098
were	O
analyzed	B-T062
by	O
t-test	B-T170
for	O
continuous	B-T080
variables	I-T080
and	O
chi-square	B-T170
test	I-T170
for	O
categorical	B-T080
variables	I-T080
.	O
	
asthma	B-T047
-related	O
costs	B-T081
in	O
2013	O
were	O
also	O
analyzed	B-T062
using	O
a	O
generalized	O
linear	B-T081
model	I-T081
with	O
a	O
gamma	B-T081
distribution	I-T081
and	O
log	B-T081
link	I-T081
,	O
adjusted	B-T169
for	O
patient	O
demographics	O
age	O
,	O
gender	O
,	O
region	O
,	O
and	O
insurance	B-T170
type	I-T170
and	O
quan-charlson	B-T081
comorbidity	I-T081
score	I-T081
.	O
	
a	O
total	O
of	O
65	O
patients	O
were	O
included	O
63	O
97.3	O
pa	B-T047
patients	O
and	O
1	O
sa	B-T033
patients	O
2.7	O
.	O
	
compared	B-T052
with	O
the	O
pa	B-T047
cohort	B-T098
,	O
the	O
sa	B-T033
cohort	B-T098
was	O
older	B-T098
mean	O
age	O
=	O
50.8	O
years	B-T079
vs	O
.	O
	
46.5	O
years	B-T079
,	O
p	O
<	O
0.001	O
and	O
had	O
higher	O
mean	O
comorbidity	B-T081
score	I-T081
1.47	O
vs	O
.	O
	
1.31	O
,	O
p<	O
0.001	O
.	O
	
the	O
mean	O
count	O
of	O
all	O
asthma	B-T047
medications	O
fills	O
was	O
2.2	O
2012	O
and	O
2.1	O
2013	O
higher	O
in	O
the	O
sa	B-T033
cohort	B-T098
,	O
compared	B-T052
with	O
the	O
pa	B-T047
cohort	B-T098
p<	O
0.001	O
.	O
	
mean	O
pdc	B-T079
for	O
all	O
oral	O
and	O
inhaled	O
controller	B-T061
therapy	I-T061
was	O
also	O
higher	O
in	O
the	O
sa	B-T033
cohort	B-T098
compared	B-T052
with	O
the	O
pa	B-T047
cohort	B-T098
0.80	O
vs	O
.	O
	
0.65	O
,	O
p<	O
0.001	O
.	O
	
sa	B-T033
patients	O
had	O
a	O
significantly	O
greater	B-T081
mean	I-T081
count	I-T081
of	O
asthma	B-T047
-related	O
hospitalizations	O
,	O
emergency	O
room	O
visits	O
,	O
and	O
ambulatory	B-T033
visits	I-T033
in	O
2012	O
and	O
2013	O
p<	O
0.001	O
.	O
	
unadjusted	O
mean	O
annual	O
asthma	B-T047
-related	O
costs	B-T081
in	O
the	O
sa	B-T033
versus	O
pa	B-T047
cohorts	B-T098
were	O
6	O
versus	O
2	O
p	O
<	O
0.001	O
in	O
2012	O
and	O
5	O
versus	O
1	O
p<	O
0.001	O
in	O
2013	O
.	O
	
higher	O
asthma	B-T047
-related	O
costs	B-T081
were	O
driven	O
by	O
greater	O
mean	O
annual	O
asthma	B-T047
medication	O
costs	B-T081
in	O
2012	O
4	O
vs	O
.	O
	
1	O
,	O
p<	O
0.001	O
and	O
2013	O
4	O
vs	O
.	O
	
1	O
,	O
p<	O
0.001	O
.	O
	
adjusted	B-T169
mean	O
annual	O
asthma	B-T047
-related	O
costs	B-T081
in	O
2013	O
were	O
3	O
greater	O
cost	B-T081
ratio	I-T081
=2	O
,	O
p<	O
0.001	O
in	O
the	O
sa	B-T033
cohort	B-T098
,	O
and	O
adjusted	B-T169
mean	O
annual	O
asthma	B-T047
medication	O
costs	B-T081
were	O
2	O
higher	O
cost	O
ratio=2	O
,	O
p<	O
0.001	O
in	O
the	O
sa	B-T033
cohort	B-T098
.	O
	
patients	O
with	O
sa	B-T033
who	O
experienced	O
2	O
or	O
more	O
exacerbations	B-T033
had	O
2.1	O
greater	O
use	B-T169
of	O
controller	B-T061
medications	I-T061
across	O
both	O
study	O
years	B-T079
and	O
were	O
more	O
adherent	B-T169
to	O
controller	B-T169
therapy	I-T169
than	O
patients	O
with	O
pa	B-T047
.	O
	
despite	O
more	O
intensive	O
pharmacotherapy	B-T061
,	O
sa	B-T033
patients	O
incurred	O
2.9	O
higher	O
adjusted	B-T169
asthma	B-T047
-related	O
costs	B-T081
and	O
3-fold	O
higher	O
adjusted	B-T169
asthma	B-T047
medication	O
costs	B-T081
than	O
pa	B-T047
patients	O
.	O
	
patients	O
with	O
sa	B-T033
consistently	B-T078
demonstrated	O
a	O
higher	O
rate	O
of	O
health	O
care	O
utilization	B-T169
.	O
	
funding	B-T081
for	O
this	O
study	B-T062
ho-14-14443	O
was	O
provided	O
by	O
glaxosmithkline	O
gsk	O
.	O
	
all	O
listed	O
authors	O
meet	O
the	O
criteria	B-T078
for	O
authorship	O
set	O
forth	O
by	O
the	O
international	O
committee	O
for	O
medical	O
journal	O
editors	O
.	O
	
albers	B-T170
,	O
forshag	B-T170
,	O
and	O
yancey	B-T170
are	O
employees	O
of	O
gsk	O
and	O
hold	O
stock	O
in	O
gsk	O
.	O
	
dalal	B-T170
,	O
nagar	B-T170
,	O
and	O
ortega	B-T170
were	O
employees	O
of	O
gsk	O
at	O
the	O
time	B-T079
this	O
research	B-T062
was	O
conducted	O
.	O
	
chastek	B-T170
and	O
korrer	B-T170
are	O
employees	O
of	O
optum	O
,	O
which	O
received	O
consulting	B-T081
fees	I-T081
from	O
gsk	O
for	O
research	B-T062
related	O
to	O
this	O
study	B-T062
.	O
	
study	B-T078
concept	I-T078
and	O
design	B-T052
were	O
contributed	B-T052
by	O
chastek	B-T170
,	O
nagar	B-T170
,	O
and	O
dalal	B-T170
.	O
	
korrer	B-T170
took	O
the	O
lead	O
in	O
data	B-T062
collection	I-T062
,	O
along	O
with	O
chastek	B-T170
,	O
and	O
data	B-T081
interpretation	I-T081
was	O
performed	O
by	O
chastek	B-T170
,	O
ortega	B-T170
,	O
forshag	B-T170
,	O
and	O
dalal	B-T170
.	O
	
the	O
manuscript	O
was	O
written	O
by	O
chastek	B-T170
and	O
dalal	B-T170
and	O
revised	B-T169
by	O
albers	B-T170
and	O
yancy	B-T170
,	O
assisted	B-T080
by	O
the	O
other	O
differential	O
regulation	O
of	O
spontaneous	B-T169
and	O
evoked	B-T080
inhibitory	O
synaptic	O
transmission	O
in	O
somatosensory	O
cortex	O
by	O
retinoic	B-T109
acid	I-T109
retinoic	B-T109
acid	I-T109
ra	B-T109
,	O
a	O
developmental	B-T080
morphogen	O
,	O
has	O
emerged	O
in	O
recent	O
studies	O
as	O
a	O
novel	B-T080
synaptic	O
signaling	O
molecule	O
that	O
acts	O
in	O
mature	B-T079
hippocampal	O
neurons	O
to	O
modulate	O
excitatory	O
and	O
inhibitory	O
synaptic	O
transmission	O
in	O
the	O
context	O
of	O
homeostatic	O
synaptic	O
plasticity	O
.	O
	
however	O
,	O
it	O
is	O
unclear	O
whether	O
ra	B-T109
is	O
capable	O
of	O
modulating	O
neural	O
circuits	O
outside	B-T082
of	O
the	O
hippocampus	O
,	O
and	O
if	O
so	O
,	O
whether	O
the	O
mode	B-T169
of	I-T169
ra's	I-T169
action	I-T169
at	O
synapses	O
is	O
similar	B-T080
to	O
that	O
within	B-T082
the	O
hippocampal	O
network	O
.	O
	
here	O
we	O
explore	O
for	O
the	O
first	O
time	O
ra	B-T109
's	O
synaptic	O
function	O
outside	B-T082
the	O
hippocampus	O
and	O
uncover	O
a	O
novel	B-T080
function	B-T169
of	O
all-trans	B-T109
retinoic	I-T109
acid	I-T109
at	O
inhibitory	O
synapses	O
.	O
	
acute	B-T079
ra	B-T109
treatment	B-T169
increases	B-T169
spontaneous	B-T169
inhibitory	O
synaptic	O
transmission	O
in	O
l2/3	O
pyramidal	O
neurons	O
of	O
the	O
somatosensory	O
cortex	O
,	O
and	O
this	O
effect	B-T080
requires	O
expression	O
of	O
ra's	B-T116
receptor	I-T116
rarα	B-T116
both	O
pre-	O
and	O
post-synaptically	O
.	O
	
intriguingly	O
,	O
ra	B-T109
does	O
not	O
seem	O
to	O
affect	O
evoked	B-T080
inhibitory	O
transmission	O
assayed	O
with	O
either	O
extracellular	O
stimulation	O
or	O
direct	O
activation	O
of	O
action	O
potentials	O
in	O
presynaptic	O
interneurons	O
at	O
connected	O
pairs	O
of	O
interneurons	O
and	O
pyramidal	O
neurons	O
.	O
	
taken	O
together	O
,	O
these	O
results	B-T033
suggest	O
that	O
ra's	B-T109
action	B-T052
at	O
synapses	O
is	O
not	O
monotonous	O
,	O
but	O
is	O
diverse	B-T080
depending	O
on	O
the	O
type	O
of	O
synaptic	O
connection	O
excitatory	O
versus	O
inhibitory	O
and	O
circuit	O
hippocampal	O
versus	O
cortical	O
.	O
	
thus	O
,	O
synaptic	O
signaling	O
of	O
ra	B-T109
may	O
mediate	O
multi-faceted	O
regulation	O
of	O
synaptic	O
plasticity	O
.	O
	
in	O
addition	O
to	O
its	O
classic	O
roles	O
in	O
brain	O
development	O
,	O
retinoic	B-T109
acid	I-T109
ra	B-T109
has	O
recently	O
been	O
shown	O
to	O
regulate	O
excitatory	O
and	O
inhibitory	O
transmission	O
in	O
the	O
adult	O
brain	O
.	O
	
here	O
,	O
the	O
authors	O
show	O
that	O
in	O
layer	O
2/3	O
l2/3	O
of	O
the	O
somatosensory	O
cortex	O
s1	O
,	O
acute	B-T079
ra	B-T109
induces	B-T169
increases	B-T169
in	O
spontaneous	B-T169
but	O
not	O
action-potential	O
evoked	B-T080
transmission	O
,	O
and	O
that	O
this	O
requires	O
retinoic	B-T116
acid	I-T116
receptor	I-T116
rarα	B-T116
both	O
in	O
presynaptic	O
pv	B-T116
-positive	O
interneurons	O
and	O
postsynaptic	O
pyramidal	O
pn	O
neurons	O
.	O
	
utilization	B-T081
pattern	B-T082
and	O
drug	O
use	O
of	O
traditional	O
chinese	O
medicine	O
,	O
western	O
medicine	O
,	O
and	O
integrated	O
chinese-western	O
medicine	O
treatments	O
for	O
allergic	O
rhinitis	O
under	O
the	O
national	O
health	O
insurance	O
program	O
in	O
taiwan	O
patients	O
in	O
taiwan	O
with	O
allergic	O
rhinitis	O
seek	O
not	O
only	O
western	O
medicine	O
treatment	O
but	O
also	O
traditional	O
chinese	O
medicine	O
treatment	O
or	O
integrated	O
chinese-western	O
medicine	O
treatment	O
.	O
	
various	O
studies	O
have	O
conducted	O
pairwise	O
comparison	O
on	O
traditional	O
chinese	O
medicine	O
,	O
western	O
medicine	O
,	O
and	O
integrated	O
chinese-western	O
medicine	O
treatments	O
.	O
	
however	O
,	O
none	O
conducted	O
simultaneous	O
analysis	O
of	O
the	O
three	O
treatments	O
.	O
	
this	O
study	O
analyzed	O
patients	O
with	O
allergic	O
rhinitis	O
receiving	O
the	O
three	O
treatments	O
to	O
identify	O
differences	O
in	O
demographic	O
characteristic	O
and	O
medical	O
use	O
and	O
thereby	O
to	O
determine	O
drug	O
use	O
patterns	O
of	O
different	O
treatments	O
.	O
	
the	O
national	O
health	O
insurance	O
research	O
database	O
was	O
the	O
data	O
source	O
,	O
and	O
included	O
patients	O
were	O
those	O
diagnosed	O
with	O
allergic	O
rhinitis	O
international	O
classification	O
of	O
diseases	O
,	O
ninth	O
revision	O
,	O
clinical	O
modification	O
codes	O
470-478	O
.	O
	
chi-square	O
test	O
and	O
tukey	O
studentized	O
range	O
honest	O
significant	O
difference	O
test	O
were	O
conducted	O
to	O
investigate	O
the	O
differences	O
among	O
the	O
three	O
treatments	O
.	O
	
visit	O
frequency	O
for	O
allergic	O
rhinitis	O
treatment	O
was	O
higher	O
in	O
female	O
than	O
male	O
patients	O
,	O
regardless	O
of	O
treatment	O
with	O
traditional	O
chinese	O
medicine	O
,	O
western	O
medicine	O
,	O
or	O
integrated	O
chinese-western	O
medicine	O
.	O
	
persons	O
aged	O
0-19	O
years	O
ranked	O
the	O
highest	O
in	O
proportion	O
of	O
visits	O
for	O
allergic	O
rhinitis	O
.	O
	
traditional	O
chinese	O
medicine	O
treatment	O
had	O
more	O
medical	O
items	O
per	O
person-time	O
and	O
daily	O
drug	O
cost	O
per	O
person-time	O
and	O
had	O
the	O
lowest	O
total	O
expenditure	O
per	O
person-time	O
.	O
	
in	O
contrast	O
,	O
western	O
medicine	O
had	O
the	O
lowest	O
daily	O
drug	O
cost	O
per	O
person-time	O
and	O
the	O
highest	O
total	O
expenditure	O
per	O
person-time	O
.	O
	
the	O
total	O
expenditure	O
per	O
person-time	O
,	O
daily	O
drug	O
cost	O
per	O
person-time	O
,	O
and	O
medical	O
items	O
per	O
person-time	O
of	O
integrated	O
chinese-western	O
medicine	O
treatment	O
lay	O
between	O
those	O
seen	O
with	O
traditional	O
chinese	O
medicine	O
and	O
western	O
medicine	O
treatments	O
.	O
	
although	O
only	O
6.82	O
%	O
of	O
patients	O
with	O
allergic	O
rhinitis	O
chose	O
integrated	O
chinese-western	O
medicine	O
treatment	O
,	O
the	O
visit	O
frequency	O
per	O
person-year	O
of	O
integrated	O
chinese-western	O
medicine	O
ranked	O
highest	O
.	O
	
in	O
addition	O
,	O
multiple-composition	O
medicines	O
were	O
used	O
more	O
frequently	O
than	O
single-composition	O
medicines	O
,	O
and	O
mar	O
huang	O
ephedra	O
sinica	O
stapf	O
was	O
seldom	O
used	O
to	O
decrease	O
the	O
risk	O
of	O
combining	O
medications	O
tlr9	O
deficiency	B-T169
leads	O
to	O
accelerated	B-T169
renal	B-T047
disease	I-T047
and	O
myeloid	O
lineage	O
abnormalities	B-T033
in	O
pristane	B-T109
-induced	O
murine	O
lupus	B-T047
systemic	B-T047
lupus	I-T047
erythematosus	I-T047
sle	B-T047
is	O
a	O
chronic	B-T079
,	O
life-threatening	B-T033
autoimmune	B-T047
disorder	I-T047
,	O
leading	O
to	O
multiple	O
organ	O
pathologies	O
and	O
kidney	O
destruction	B-T052
.	O
	
analyses	O
of	O
numerous	O
murine	O
models	O
of	O
spontaneous	O
sle	B-T047
have	O
revealed	O
a	O
critical	O
role	O
for	O
endosomal	O
tlrs	B-T116
in	O
the	O
production	O
of	O
autoantibodies	B-T116
and	O
development	O
of	O
other	O
clinical	B-T080
disease	B-T047
manifestations	B-T169
.	O
	
nevertheless	O
,	O
the	O
corresponding	O
tlr9	O
-	O
deficient	B-T169
autoimmune	O
-prone	O
strains	O
consistently	O
develop	O
more	O
severe	O
disease	B-T047
pathology	O
.	O
	
injection	B-T061
of	O
balb/c	O
mice	O
with	O
2	B-T109
tmpd	B-T109
,	O
commonly	O
known	O
as	O
pristane	B-T109
,	O
also	O
results	O
in	O
the	O
development	O
of	O
sle-like	B-T047
disease	I-T047
.	O
	
we	O
now	O
show	O
that	O
tlr9	O
balb/c	O
mice	O
injected	B-T061
i.p	I-T061
.	O
	
with	O
tmpd	B-T109
develop	O
more	O
severe	O
autoimmunity	O
than	O
do	O
their	O
tlr	B-T116
-sufficient	O
cohorts	O
.	O
	
early	O
indications	O
include	O
an	O
increased	O
accumulation	B-T033
of	O
tlr7	O
-	O
expressing	O
ly6c	O
inflammatory	B-T169
monocytes	O
at	O
the	O
site	B-T082
of	I-T082
injection	I-T082
,	O
upregulation	O
of	O
ifn	B-T116
-regulated	O
gene	O
expression	O
in	O
the	O
peritoneal	O
cavity	O
,	O
and	O
an	O
increased	O
production	O
of	O
myeloid	O
lineage	O
precursors	O
common	O
myeloid	O
progenitors	O
and	O
granulocyte	O
myeloid	O
precursors	O
in	O
the	O
bone	O
marrow	O
.	O
	
tmpd	B-T109
-	O
injected	B-T061
tlr9	O
balb/c	O
mice	O
develop	O
higher	O
autoantibody	B-T116
titers	O
against	O
rna	O
,	O
neutrophil	O
cytoplasmic	O
ags	O
,	O
and	O
myeloperoxidase	B-T116
than	O
do	O
tmpd	B-T109
-	O
injected	B-T061
wild-type	O
balb/c	O
mice	O
.	O
	
the	O
tmp	B-T109
-	O
injected	B-T061
tlr9	O
mice	O
,	O
and	O
not	O
the	O
wild-type	O
mice	O
,	O
also	O
develop	O
a	O
marked	O
increase	O
in	O
glomerular	B-T116
igg	I-T116
deposition	B-T169
and	O
infiltrating	O
granulocytes	O
,	O
much	O
more	O
severe	O
glomerulonephritis	B-T047
,	O
and	O
a	O
reduced	B-T080
lifespan	O
.	O
	
collectively	O
,	O
the	O
data	O
point	O
to	O
a	O
major	O
role	O
for	O
tlr7	O
in	O
the	O
response	O
to	O
self-antigens	O
in	O
this	O
model	O
of	O
experimental	O
autoimmunity	O
.	O
	
therefore	O
,	O
the	O
balb/c	O
pristane	B-T109
model	O
recapitulates	O
other	O
tlr7	O
-driven	O
spontaneous	O
models	O
of	O
sle	B-T047
and	O
is	O
negatively	B-T033
regulated	O
by	O
effect	B-T080
of	O
xenotransplantation	B-T061
site	B-T082
on	O
microrna	O
expression	O
of	O
human	O
colon	O
cancer	O
stem	O
cells	O
cancer	O
stem	O
cells	O
cscs	O
have	O
a	O
high	B-T080
tumorigenic	O
ability	O
to	O
form	O
patient-derived	O
tumor	O
xenografts	O
pdxs	O
.	O
	
pdxs	O
are	O
an	O
attractive	B-T080
pre-clinical	B-T170
model	I-T170
,	O
but	O
gene	O
expression	O
and	O
biological	O
behavior	O
of	O
cancer	O
cells	O
in	O
the	O
tumor	O
will	O
change	B-T169
during	O
establishment	B-T080
and	O
passage	O
of	O
pdxs	O
.	O
	
human	O
colon	O
cancer	O
pdx	O
was	O
established	B-T080
and	O
passaged	O
either	O
subcutaneously	B-T082
or	O
orthotopically	B-T082
into	O
the	O
murine	O
intestine	O
.	O
	
histology	O
and	O
flow	O
cytometric	O
profile	O
of	O
the	O
surgical	B-T061
specimen	O
and	O
the	O
pdx	O
were	O
analyzed	B-T062
.	O
	
cscs	O
were	O
then	O
isolated	B-T169
from	O
the	O
tumors	O
and	O
their	O
microrna	O
mirna	O
expression	O
was	O
analyzed	B-T062
by	O
semi-quantitative	O
polymerase	O
chain	O
reaction	O
.	O
	
the	O
surgical	B-T061
specimens	O
and	O
pdxs	O
were	O
histologically	O
similar	B-T080
.	O
	
the	O
size	B-T082
of	O
csc	O
population	B-T098
increased	B-T081
and	O
expression	O
of	O
mirna	O
s	O
in	O
cscs	O
changed	B-T169
in	O
the	O
passaged	O
pdxs	O
.	O
	
expression	O
of	O
oncogenic	O
mirnas	O
was	O
highly	B-T080
up-regulated	O
in	O
the	O
cscs	O
of	O
the	O
orthotopically	B-T082
passaged	O
pdxs	O
.	O
	
the	O
xenotransplantation	B-T061
site	B-T082
and	O
the	O
number	B-T081
of	O
tumor	O
passages	O
affect	O
the	O
mirna	O
expression	O
of	O
human	O
colon	O
cscs	O
.	O
	
chemosensitivity	B-T033
,	O
cardiovascular	B-T033
risk	I-T033
,	O
and	O
the	O
ventilatory	O
response	O
to	O
exercise	O
in	O
copd	B-T047
copd	B-T047
is	O
associated	O
with	O
elevated	B-T080
cardiovascular	B-T033
risk	I-T033
and	O
a	O
potentiated	B-T080
ventilatory	O
response	O
to	O
exercise	O
.	O
	
enhanced	O
carotid	O
chemoreceptor	O
cc	O
activity	O
/	O
sensitivity	O
is	O
present	O
in	O
other	O
clinical	O
conditions	O
,	O
has	O
been	O
shown	O
to	O
contribute	O
to	O
sympathetic	O
vasoconstrictor	O
outflow	O
,	O
and	O
is	O
predictive	O
of	O
mortality	O
.	O
	
cc	O
activity	O
/	O
sensitivity	O
,	O
and	O
the	O
resulting	O
functional	O
significance	O
,	O
has	O
not	O
been	O
well	O
examined	O
in	O
copd	O
.	O
	
we	O
hypothesized	O
that	O
cc	O
activity	O
/	O
sensitivity	O
would	O
be	O
elevated	O
in	O
copd	O
,	O
and	O
related	O
to	O
increased	O
pulse	O
wave	O
velocity	O
a	O
marker	O
of	O
cv	O
risk	O
and	O
the	O
ventilatory	O
response	O
to	O
exercise	O
.	O
	
30	O
copd	O
patients	O
and	O
10	O
healthy	O
age-matched	O
controls	O
were	O
examined	O
.	O
	
participants	O
performed	O
baseline	O
cardiopulmonary	O
exercise	O
and	O
pulmonary	O
function	O
testing	O
.	O
	
cc	O
activity	O
was	O
later	O
evaluated	O
by	O
the	O
drop	O
in	O
ventilation	O
with	O
breathing	O
100%	O
o2	O
,	O
and	O
cc	O
sensitivity	O
was	O
then	O
assessed	O
by	O
the	O
ventilatory	O
response	O
to	O
hypoxia	O
δve/δs	O
po2	O
.	O
	
peripheral	O
arterial	O
stiffness	O
was	O
subsequently	O
evaluated	O
by	O
measurement	O
of	O
pulse	O
wave	O
velocity	O
pwv	O
using	O
applanation	O
tonometry	O
while	O
the	O
subjects	O
were	O
breathing	O
room	O
air	O
,	O
and	O
then	O
following	O
chemoreceptor	O
inhibition	O
by	O
breathing	O
100%	O
o2	O
for	O
2	O
minutes	O
.	O
	
cc	O
activity	O
,	O
cc	O
sensitivity	O
,	O
pwv	O
and	O
the	O
ventilatory	O
response	O
to	O
exercise	O
were	O
all	O
increased	O
in	O
copd	O
relative	O
to	O
controls	O
.	O
	
cc	O
sensitivity	O
was	O
related	O
to	O
pwv	O
however	O
,	O
neither	O
cc	O
activity	O
nor	O
cc	O
sensitivity	O
was	O
related	O
to	O
the	O
ventilatory	O
response	O
to	O
exercise	O
in	O
copd	O
.	O
	
cc	O
inhibition	O
by	O
breathing	O
100%	O
o2	O
normalized	O
pwv	O
in	O
copd	O
,	O
while	O
no	O
effect	O
was	O
observed	O
in	O
controls	O
.	O
	
cc	O
activity	O
and	O
sensitivity	O
are	O
elevated	O
in	O
copd	O
,	O
and	O
appear	O
related	O
to	O
cardiovascular	O
risk	O
however	O
,	O
cc	O
activity	O
/	O
sensitivity	O
does	O
not	O
contribute	O
to	O
the	O
potentiated	O
ventilatory	O
response	O
to	O
exercise	O
isolation	O
of	O
cells	O
specialized	O
in	O
anticancer	B-T109
alkaloid	O
metabolism	O
by	O
fluorescence-activated	O
cell	O
sorting	O
plant	O
specialized	O
metabolism	O
often	O
presents	O
a	O
complex	B-T080
cell	O
-	O
specific	B-T080
compartmentation	O
essential	O
to	O
accomplish	O
the	O
biosynthesis	B-T169
of	O
valuable	O
plant	O
natural	O
products	O
.	O
	
hence	O
,	O
the	O
disclosure	O
and	O
potential	O
manipulation	B-T169
of	O
such	O
pathways	O
may	O
depend	O
on	O
the	O
capacity	O
to	O
isolate	O
and	O
characterize	B-T052
specific	B-T080
cell	B-T170
types	I-T170
.	O
	
catharanthus	O
roseus	O
is	O
the	O
source	O
of	O
several	O
medicinal	O
terpenoid	B-T109
indole	I-T109
alkaloids	I-T109
,	O
including	O
the	O
low-level	O
anticancer	B-T109
vinblastine	B-T109
and	O
vincristine	B-T109
,	O
for	O
which	O
the	O
late	O
biosynthetic	B-T169
steps	I-T169
occur	O
in	O
specialized	O
mesophyll	O
cells	O
called	O
idioblasts	O
.	O
	
here	O
,	O
the	O
optical	O
,	O
fluorescence	O
,	O
and	O
alkaloid	B-T109
-	O
accumulating	B-T033
properties	O
of	O
c	O
.	O
	
roseus	O
leaf	O
idioblasts	O
are	O
characterized	B-T052
,	O
and	O
a	O
methodology	B-T078
for	O
the	O
isolation	O
of	O
idioblast	O
protoplasts	O
by	O
fluorescence-activated	O
cell	O
sorting	O
is	O
established	O
,	O
taking	O
advantage	O
of	O
the	O
distinctive	O
autofluorescence	O
of	O
these	O
cells	O
.	O
	
this	O
achievement	O
represents	O
a	O
crucial	O
step	O
for	O
the	O
development	O
of	O
differential	O
omic	B-T062
strategies	I-T062
leading	O
to	O
the	O
identification	B-T080
of	O
candidate	O
genes	O
putatively	O
involved	O
in	O
the	O
biosynthesis	B-T169
,	O
pathway	O
regulation	O
,	O
and	O
transmembrane	O
transport	O
leading	O
to	O
the	O
anticancer	B-T033
alkaloids	B-T109
from	O
c	O
.	O
	
roseus	O
.	O
	
interaction	B-T169
of	O
the	O
antimicrobial	B-T116
peptides	I-T116
rhesus	B-T116
θ-defensin	I-T116
and	O
porcine	O
protegrin-1	B-T116
with	O
anionic	B-T109
phospholipid	I-T109
monolayers	I-T109
a	O
combination	O
of	O
langmuir	B-T170
isotherm	I-T170
,	O
brewster	O
angle	O
microscopy	O
bam	O
,	O
and	O
neutron	B-T062
reflectivity	I-T062
studies	I-T062
have	O
been	O
performed	O
to	O
gain	O
insight	O
into	O
the	O
effects	O
on	O
model	B-T170
bacterial	O
cell	O
membranes	O
of	O
the	O
antimicrobial	B-T116
peptides	I-T116
,	O
rhesus	B-T116
θ-defensin	I-T116
1	I-T116
rtd-1	B-T116
,	O
and	O
porcine	O
protegrin	B-T116
1	I-T116
pg-1	B-T116
.	O
	
the	O
peptides	B-T116
were	O
interacted	B-T169
with	O
monolayers	B-T109
spread	O
at	O
the	O
air	O
-	O
water	O
interface	O
and	O
prepared	O
from	O
a	O
3	O
molar	O
mixture	O
of	O
phosphatidylethanolamine	B-T109
and	O
phosphatidylglycerol	B-T109
used	O
to	O
approximate	B-T080
the	O
cell	O
membranes	O
of	O
gram	O
positive	O
bacteria	O
.	O
	
the	O
langmuir	O
film	O
balance	O
measurements	B-T169
show	O
that	O
both	O
peptides	B-T116
perturb	B-T169
the	O
lipid	B-T109
monolayers	I-T109
causing	O
an	O
increase	O
in	O
surface	O
pressure	O
,	O
and	O
the	O
bam	O
studies	O
show	O
that	O
each	O
results	O
in	O
the	O
formation	O
of	O
small	O
domains	O
within	O
the	O
lipid	B-T170
films	I-T170
,	O
around	O
5	O
μm	O
diameter	O
.	O
	
the	O
overall	O
change	O
in	O
monolayer	B-T109
surface	O
pressure	O
caused	O
by	O
pg-1	B-T116
,	O
however	O
,	O
is	O
a	O
little	O
more	O
pronounced	O
than	O
that	O
due	O
to	O
rtd-1	B-T116
+8	O
mn	O
vs	O
+5	O
mn	O
,	O
and	O
the	O
rate	O
of	O
its	O
initial	O
interaction	B-T169
with	O
the	O
monolayer	B-T109
is	O
a	O
little	O
more	O
rapid	O
than	O
that	O
for	O
rtd-1	B-T116
.	O
	
the	O
neutron	O
reflectivity	O
studies	O
also	O
show	O
differences	O
for	O
pg-1	B-T116
and	O
rtd-1	B-T116
,	O
with	O
the	O
model	B-T170
fits	O
to	O
these	O
data	O
showing	O
that	O
the	O
more	O
amphiphilic	O
pg-1	B-T116
becomes	O
fully	O
embedded	O
within	O
the	O
lipid	B-T170
film	I-T170
-causing	O
an	O
extension	O
of	O
the	O
lipid	O
acyl	O
chains	O
but	O
leaving	O
the	O
thickness	B-T080
of	O
the	O
lipid	O
headgroup	O
layer	O
unaffected-while	O
rtd-1	B-T116
is	O
seen	O
to	O
insert	O
less	O
deeply-causing	O
the	O
same	O
extension	O
of	O
the	O
lipid	O
acyl	O
chains	O
as	O
pg-1	B-T116
but	O
also	O
causing	O
a	O
significant	O
increase	O
in	O
thickness	B-T080
of	O
the	O
lipid	O
headgroup	O
layer	O
.	O
	
the	O
various	O
differing	O
effects	O
of	O
the	O
two	O
peptides	B-T116
on	O
anionic	B-T109
lipid	I-T109
monolayers	I-T109
are	O
discussed	O
in	O
the	O
context	O
of	O
their	O
differing	O
hemolytic	O
activities	O
,	O
and	O
their	O
proposed	O
differing	B-T081
propensities	I-T081
to	O
form	O
transmembrane	O
pores	O
.	O
	
development	O
of	O
chrysin	B-T109
loaded	O
poloxamer	B-T109
micelles	O
and	O
toxicity	B-T080
evaluation	O
in	O
fish	O
embryos	O
poloxamer	B-T109
micelles	B-T109
promise	O
safety	O
and	O
efficacy	O
for	O
many	O
water	O
insoluble	O
drugs	O
.	O
	
chrysin	O
has	O
been	O
reported	O
to	O
have	O
anticancer	O
,	O
anti-inflammatory	O
,	O
antioxidant	O
,	O
and	O
anti-aromatase	O
activities	O
but	O
its	O
water	O
insoluble	O
properties	O
limit	O
its	O
pharmaceutical	O
application	O
.	O
	
in	O
the	O
present	O
study	O
,	O
chrysin	O
loaded	O
poloxamer	O
micelles	B-T109
were	O
developed	O
.	O
	
two	O
types	O
of	O
poloxamers	O
,	O
pluronic	O
f-68	O
and	O
pluronic	O
f-127	O
were	O
compared	O
.	O
	
it	O
was	O
found	O
that	O
chrysin	O
loaded	O
pluronic	O
f-68	O
micelles	O
cs-p68	O
and	O
chrysin	O
loaded	O
pluronic	O
f-127	O
micelles	O
cs-p127	O
obviously	O
increase	O
the	O
aqueous	O
solubility	O
of	O
chrysin	O
.	O
	
the	O
results	O
also	O
indicated	O
that	O
the	O
type	O
of	O
polymer	O
and	O
ratio	O
of	O
drug	O
to	O
polymer	O
affected	O
size	O
and	O
desirable	O
characteristics	O
of	O
the	O
micelles	O
.	O
	
the	O
micelle	O
system	O
of	O
cs-p68	O
and	O
cs-p127	O
formed	O
at	O
drug	O
to	O
polymer	O
ratios	O
of	O
1	O
and	O
1	O
,	O
respectively	O
,	O
was	O
found	O
to	O
be	O
the	O
most	O
suitable	O
monodispersed	O
system	O
with	O
a	O
nanosize-range	O
diameter	O
.	O
	
the	O
in	O
vivo	O
study	O
in	O
zebrafish	O
eggs	O
indicates	O
that	O
the	O
toxicity	O
of	O
cs-p68	O
and	O
cs-p127	O
is	O
a	O
dose	O
response	O
.	O
	
cs-p68	O
and	O
cs-p127	O
at	O
a	O
drug	O
dose	O
of	O
10	O
ng/ml	O
or	O
less	O
is	O
safe	O
for	O
zebrafish	O
embryo	O
growth	O
.	O
	
the	O
results	O
of	O
this	O
study	O
indicate	O
enhanced	O
water	O
solubility	O
of	O
chrysin	O
.	O
	
chrysin	O
loaded	O
poloxamer	O
micelles	O
are	O
promising	O
for	O
further	O
use	O
in	O
in	O
vivo	O
studies	O
in	O
mammalian	O
animals	O
and	O
humans	O
adenoviral	O
delivery	B-T061
of	O
tumor	B-T116
necrosis	I-T116
factor-α	I-T116
and	O
interleukin-2	B-T116
enables	O
successful	O
adoptive	B-T061
cell	I-T061
therapy	I-T061
of	O
immunosuppressive	O
melanoma	O
adoptive	B-T061
t-cell	I-T061
transfer	I-T061
is	O
a	O
promising	O
treatment	O
approach	O
for	O
metastatic	O
cancer	O
,	O
but	O
efficacy	B-T080
in	O
solid	O
tumors	O
has	O
only	O
been	O
achieved	O
with	O
toxic	B-T080
pre-	O
and	O
postconditioning	O
regimens	O
.	O
	
thus	O
,	O
adoptive	B-T061
t-cell	I-T061
therapies	I-T061
would	O
benefit	B-T081
from	O
complementary	O
modalities	B-T078
that	O
enable	O
their	O
full	B-T080
potential	B-T080
without	O
excessive	B-T080
toxicity	B-T080
.	O
	
we	O
aimed	B-T078
to	O
improve	B-T080
the	O
efficacy	B-T080
and	O
safety	B-T080
of	O
adoptive	B-T061
t-cell	I-T061
transfer	I-T061
by	O
using	O
adenoviral	O
vectors	O
for	O
direct	O
delivery	B-T169
of	O
immunomodulatory	B-T061
murine	O
cytokines	B-T116
into	O
b16.ova	O
melanoma	O
tumors	O
with	O
concomitant	O
t-cell	O
receptor	O
transgenic	O
ot-i	O
t-cell	O
transfer	O
.	O
	
armed	O
adenoviruses	O
expressed	O
high	O
local	O
and	O
low	O
systemic	O
levels	O
of	O
cytokine	O
when	O
injected	O
into	O
b16.ova	O
tumors	O
,	O
suggesting	O
safety	O
of	O
virus-mediated	O
cytokine	O
delivery	O
.	O
	
antitumor	O
efficacy	O
was	O
significantly	O
enhanced	O
with	O
adenoviruses	O
coding	O
for	O
murine	O
interleukin-2	O
mil-2	O
and	O
tumor	O
necrosis	O
factor-α	O
mtnfα	O
when	O
compared	O
with	O
t-cell	O
transfer	O
alone	O
or	O
viruses	O
alone	O
.	O
	
further	O
improvement	O
in	O
efficacy	O
was	O
achieved	O
with	O
a	O
triple	O
combination	O
of	O
mil-2	O
,	O
mtnfα	O
,	O
and	O
ot-i	O
t-cells	O
.	O
	
mechanistic	O
studies	O
suggest	O
that	O
mil-2	O
has	O
an	O
important	O
role	O
in	O
activating	O
t-cells	O
at	O
the	O
tumor	O
,	O
while	O
mtnfα	O
induces	O
chemokine	O
expression	O
.	O
	
furthermore	O
,	O
adenovirus	O
treatments	O
enhanced	O
tumor	O
-	O
infiltration	O
of	O
ot-i	O
t-cells	O
as	O
demonstrated	O
by	O
spect/ct	O
imaging	O
of	O
111	O
cells	O
.	O
	
our	O
results	O
suggest	O
the	O
utility	O
of	O
cytokine-coding	O
adenoviruses	O
for	O
improving	O
the	O
efficacy	O
of	O
adoptive	O
t-cell	O
therapies	I-T061
the	O
maternal	B-T033
legacy	B-T081
female	O
identity	O
predicts	O
offspring	O
sex	B-T081
ratio	I-T081
in	O
the	O
loggerhead	O
sea	O
turtle	O
in	O
organisms	O
with	O
temperature-dependent	B-T081
sex	O
determination	O
,	O
the	O
incubation	B-T082
environment	I-T082
plays	O
a	O
key	O
role	O
in	O
determining	O
offspring	O
sex	B-T081
ratios	I-T081
.	O
	
given	O
that	O
global	B-T080
temperatures	B-T081
have	O
warmed	O
approximately	O
0.6	O
c	O
in	O
the	O
last	O
century	O
,	O
it	O
is	O
necessary	O
to	O
consider	O
how	O
organisms	O
will	O
adjust	B-T033
to	O
climate	O
change	O
.	O
	
to	O
better	O
understand	O
the	O
degree	B-T080
to	O
which	O
mothers	O
influence	O
the	O
sex	B-T081
ratios	I-T081
of	O
their	O
offspring	O
,	O
we	O
use	O
24	O
years	B-T079
of	O
nesting	B-T078
data	I-T078
for	O
individual	B-T098
female	O
loggerhead	O
sea	O
turtles	O
caretta	O
caretta	O
observed	O
on	O
bald	O
head	O
island	O
,	O
north	O
carolina	O
.	O
	
we	O
find	O
that	O
maternal	B-T033
identity	O
is	O
the	O
best	O
predictor	O
of	O
nest	B-T082
sex	B-T081
ratio	I-T081
in	O
univariate	B-T062
and	O
multivariate	B-T062
predictive	I-T062
models	I-T062
.	O
	
we	O
find	O
significant	O
variability	O
in	O
estimated	O
nest	B-T082
sex	B-T081
ratios	I-T081
among	O
mothers	O
,	O
but	O
a	O
high	O
degree	O
of	O
consistency	B-T080
within	O
mothers	O
,	O
despite	O
substantial	O
spatial	B-T082
and	O
temporal	B-T079
thermal	O
variation	O
.	O
	
our	O
results	O
suggest	O
that	O
individual	B-T098
differences	O
in	O
nesting	O
preferences	O
are	O
the	O
main	O
driver	O
behind	O
divergences	B-T082
in	O
nest	B-T082
sex	B-T081
ratios	I-T081
.	O
	
as	O
such	O
,	O
a	O
female's	O
ability	O
to	O
plastically	O
adjust	O
her	O
nest	B-T082
sex	B-T081
ratios	I-T081
in	O
response	O
to	O
environmental	B-T082
conditions	B-T080
is	O
constrained	O
,	O
potentially	O
limiting	O
how	O
individuals	B-T098
behaviorally	O
mitigate	O
the	O
effects	O
of	O
environmental	B-T033
change	I-T033
.	O
	
given	O
that	O
many	O
loggerhead	O
populations	B-T098
already	O
show	O
female-biased	B-T078
offspring	O
sex	B-T081
ratios	I-T081
,	O
understanding	O
maternal	O
behavioral	O
responses	O
is	O
critical	B-T080
for	O
predicting	O
the	O
future	O
of	O
long-lived	O
species	O
vulnerable	B-T169
to	O
increased	O
rhoa	B-T116
activity	O
predicts	O
worse	B-T033
overall	B-T081
survival	I-T081
in	O
patients	O
undergoing	O
surgical	B-T061
resection	I-T061
for	O
lauren	O
diffuse-type	O
gastric	O
adenocarcinoma	O
several	O
studies	O
have	O
reported	O
a	O
high	O
rate	O
of	O
rhoa	O
mutations	O
in	O
the	O
lauren	O
diffuse-type	O
gastric	O
adenocarcinoma	O
ga	O
but	O
not	O
in	O
intestinal-type	O
ga	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
if	O
rhoa	B-T116
activity	O
is	O
prognostic	O
for	O
overall	B-T081
survival	I-T081
os	B-T081
in	O
patients	O
with	O
resectable	O
ga	O
.	O
	
retrospective	B-T062
review	I-T062
was	O
performed	O
on	O
a	O
prospective	O
database	O
of	O
ga	O
patients	O
who	O
underwent	O
potentially	O
curative	B-T061
resection	I-T061
between	O
2003	O
and	O
2012	O
at	O
a	O
single	O
institution	O
.	O
	
tissue	O
microarrays	O
were	O
constructed	O
from	O
surgical	O
specimens	O
and	O
analyzed	O
for	O
phosphorylated	B-T116
rhoa	B-T116
,	O
a	O
marker	O
of	O
inactive	O
rhoa	B-T116
signaling	O
.	O
	
os	B-T081
was	O
estimated	O
by	O
the	O
kaplan-meier	B-T062
method	I-T062
,	O
and	O
multivariate	B-T081
analysis	I-T081
was	O
performed	O
by	O
cox	B-T081
proportional	I-T081
hazards	I-T081
regression	I-T081
modeling	I-T081
.	O
	
one	O
hundred	O
thirty-six	O
patients	O
with	O
diffuse-type	O
ga	O
and	O
129	O
patients	O
with	O
intestinal-type	O
ga	O
were	O
examined	O
.	O
	
compared	O
to	O
intestinal-type	O
ga	O
,	O
diffuse-type	O
ga	O
tumors	O
were	O
significantly	O
associated	B-T080
with	I-T080
increased	O
tumor	B-T082
size	I-T082
and	O
advanced	O
tumor	O
,	O
node	O
,	O
metastasis	O
tnm	O
classification	O
system	O
stage	O
.	O
	
in	O
patients	O
with	O
diffuse-type	O
ga	O
,	O
high	O
rhoa	B-T116
activity	O
was	O
associated	B-T080
with	I-T080
significantly	O
worse	B-T033
os	B-T081
when	O
compared	O
to	O
low	O
rhoa	B-T116
activity	O
5-year	O
os	B-T081
52.5	O
vs	O
.	O
	
81.0	O
%	O
,	O
p	O
=	O
0.017	O
.	O
	
this	O
difference	O
in	O
os	B-T081
was	O
not	O
observed	O
in	O
patients	O
with	O
intestinal-type	O
ga	O
5-year	O
os	B-T081
83.9	O
vs	O
.	O
	
81.6	O
%	O
,	O
p	O
=	O
0.766	O
.	O
	
on	O
multivariate	B-T081
analysis	I-T081
of	O
diffuse-type	O
ga	O
patients	O
,	O
high	O
rhoa	B-T116
activity	O
was	O
an	O
independent	O
negative	O
prognostic	O
factor	O
for	O
os	B-T081
hazard	B-T081
ratio	I-T081
2.38	O
,	O
95	O
%	O
confidence	B-T081
interval	I-T081
1.07	O
.	O
	
increased	O
rhoa	B-T116
activity	O
is	O
predictive	O
of	O
worse	B-T033
os	B-T081
in	O
patients	O
with	O
diffuse-type	O
ga	O
who	O
undergo	O
potentially	O
curative	B-T061
surgical	I-T061
resection	I-T061
.	O
	
along	O
with	O
findings	O
from	O
genomic	O
studies	O
,	O
these	O
results	O
suggest	O
rhoa	B-T116
may	O
be	O
a	O
novel	O
therapeutic	B-T061
target	B-T169
in	O
diffuse-type	O
ga	O
.	O
	
doxifluridine	O
-	O
conjugated	B-T082
2-5a	O
analog	O
shows	O
strong	B-T080
rnase	B-T116
l	I-T116
activation	O
ability	B-T080
and	O
tumor	O
suppressive	O
effect	B-T080
rnase	B-T116
l	I-T116
is	O
activated	O
by	O
2'	O
2-5a	O
at	O
subnanomolar	B-T081
levels	B-T080
to	O
cleave	B-T082
single-stranded	O
rna	O
.	O
	
we	O
previously	O
reported	B-T170
the	O
hypothesis	B-T078
that	O
the	O
introduction	B-T169
of	O
an	O
8-methyladenosine	O
residue	O
at	O
the	O
2'-	O
terminus	B-T082
of	O
the	O
2-5a	O
tetramer	O
shifts	B-T169
the	O
2-5a	O
binding	O
site	O
of	O
rnase	B-T116
l	I-T116
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
synthesized	B-T052
various	O
5'-	O
modified	B-T169
2-5a	O
analog	O
s	O
with	O
8-methyladenosine	O
at	O
the	O
2'-	O
terminus	B-T082
.	O
	
the	O
doxifluridine	O
-	O
conjugated	B-T082
8-methyladenosine	O
-	O
substituted	B-T052
2-5a	O
analog	O
was	O
significantly	B-T081
more	I-T081
effective	B-T080
as	O
an	O
activator	B-T052
of	O
rnase	B-T116
l	I-T116
than	O
the	O
parent	O
5'-	O
monophophorylated	O
2-5a	O
tetramer	O
and	O
showed	O
a	O
tumor	O
suppressive	O
effect	B-T080
against	B-T080
human	O
cervical	O
cancer	O
cells	O
.	O
	
does	O
video	O
laryngoscopy	O
offer	O
advantages	B-T080
over	O
direct	O
laryngoscopy	O
during	B-T079
cardiopulmonary	B-T061
resuscitation	I-T061
interruption	B-T079
of	O
chest	O
compressions	O
should	O
be	O
minimized	B-T080
because	O
of	O
its	O
negative	B-T033
effects	B-T080
on	O
survival	B-T081
.	O
	
this	O
randomized	B-T062
,	O
controlled	B-T169
,	O
cross-over	B-T062
study	I-T062
aimed	B-T078
to	O
analyze	B-T062
the	O
effectiveness	B-T080
of	O
macintosh	O
,	O
miller	O
,	O
mccoy	O
and	O
mcgrath	O
laryngoscopes	O
during	B-T079
with	O
or	O
without	O
chest	O
compressions	O
in	O
the	O
scope	O
of	O
a	O
simulated	O
cardiopulmonary	B-T061
resuscitation	I-T061
scenario	B-T169
.	O
	
the	O
time	B-T079
required	B-T169
for	O
successful	B-T080
tracheal	B-T061
intubation	I-T061
,	O
number	O
of	O
attempts	O
,	O
dental	O
trauma	O
severity	B-T080
and	O
the	O
need	B-T080
for	O
optimization	B-T052
manoeuvres	B-T052
were	O
recorded	B-T033
during	B-T079
cardiopulmonary	B-T061
resuscitation	I-T061
with	O
and	O
without	O
chest	O
compressions	O
.	O
	
the	O
experience	O
with	O
computer	O
games	O
during	B-T079
the	O
last	O
10	O
years	B-T079
were	O
asked	O
to	O
the	O
participants	B-T098
and	O
recorded	B-T033
.	O
	
mccoy	O
laryngoscope	O
yielded	O
the	O
shortest	B-T079
time	I-T079
for	O
successful	B-T080
tracheal	B-T061
intubation	I-T061
both	O
in	O
the	O
presence	B-T033
of	O
and	O
without	O
chest	O
compressions	O
.	O
	
during	B-T079
the	O
use	B-T169
of	O
mccoy	O
laryngoscopes	O
,	O
fewer	B-T081
tracheal	B-T061
intubation	I-T061
attempts	O
,	O
lower	B-T081
incidence	I-T081
of	O
dental	O
trauma	O
and	O
lower	B-T052
visual	O
analogue	O
scale	O
scores	O
on	O
the	O
ease	O
of	O
intubation	B-T061
were	O
recorded	B-T033
.	O
	
participants	B-T098
who	O
are	O
experienced	O
computer	O
game	O
players	B-T098
using	O
macintosh	O
,	O
mccoy	O
and	O
mcgrath	O
achieved	B-T033
successful	B-T080
tracheal	B-T061
intubation	I-T061
in	O
a	O
significantly	B-T078
shorter	B-T079
time	I-T079
during	B-T079
resuscitation	B-T061
without	O
chest	O
compressions	O
.	O
	
dental	O
trauma	O
incidence	B-T081
and	O
number	B-T081
of	O
tracheal	B-T061
intubation	I-T061
attempts	O
did	O
not	O
show	O
any	O
significant	B-T078
difference	B-T080
between	O
the	O
four	B-T081
laryngoscopes	O
being	O
related	O
to	O
the	O
rate	B-T081
of	O
playing	B-T052
computer	O
games	O
.	O
	
mcgrath	O
video	O
laryngoscopes	O
do	O
not	O
appear	O
to	O
have	O
advantages	B-T080
over	O
direct	O
laryngoscopes	O
for	O
securing	O
a	O
smooth	B-T080
and	O
successful	B-T080
tracheal	B-T061
intubation	I-T061
during	B-T079
rhythmic	O
chest	O
compressions	O
.	O
	
we	O
believe	O
that	O
as	O
mccoy	O
laryngoscope	O
provided	B-T052
tracheal	B-T061
intubation	I-T061
in	O
a	O
shorter	B-T079
time	I-T079
and	O
with	O
fewer	B-T081
attempts	O
,	O
this	O
laryngoscope	O
may	O
increase	B-T169
the	O
success	B-T081
rate	I-T081
of	O
the	O
nurse-patient	O
communication	O
voices	O
from	O
nursing	O
students	O
effective	O
communication	O
skills	O
have	O
been	O
found	O
to	O
be	O
one	O
of	O
the	O
pivotal	B-T169
factors	I-T169
in	O
building	O
positive	O
interpersonal	O
relationships	O
.	O
	
little	O
is	O
known	O
about	O
nursing	O
undergraduates	O
'	O
perspectives	O
on	O
communicating	B-T169
with	O
patients	O
.	O
	
this	O
study	B-T062
aimed	O
to	O
explore	O
nursing	O
students'	O
perspectives	O
and	O
experiences	O
of	O
nurse-patient	O
communication	O
in	O
their	O
clinical	B-T080
placement	B-T080
.	O
	
the	O
participants	B-T098
included	O
21	O
second-year	B-T098
undergraduates	I-T098
and	O
21	O
first-year	B-T098
master's	I-T098
students	I-T098
.	O
	
interviews	B-T052
were	O
conducted	O
in	O
cantonese	O
and	O
then	O
transcribed	O
in	O
chinese	O
and	O
translated	O
into	O
english	O
.	O
	
a	O
content	B-T062
analysis	I-T062
approach	B-T082
was	O
adopted	O
to	O
analyze	O
the	O
data	B-T078
.	O
	
five	O
themes	O
emerged	O
from	O
the	O
interview	B-T078
data	I-T078
.	O
	
'the	O
necessity	O
of	O
nurse-patient	O
communication	O
'	O
reveals	B-T080
why	O
the	O
students	B-T098
valued	O
nurse-patient	O
communication	O
.	O
	
'the	O
conversation	B-T033
contents	I-T033
'	O
describes	O
the	O
content	B-T033
of	I-T033
the	I-T033
conversations	I-T033
that	O
students	B-T098
typically	O
had	O
with	O
patients	O
.	O
	
the	O
third	O
theme	O
is	O
'	O
self-reflection	B-T033
on	O
the	O
nurse-patient	O
communication	O
'	O
.	O
	
the	O
last	O
two	O
themes	O
,	O
'the	O
communication	B-T033
pattern	I-T033
in	I-T033
different	I-T033
hospital	O
settings	O
'	O
and	O
'the	O
obstacles	O
impeding	O
nurse-patient	O
communication	O
'	O
,	O
are	O
about	O
the	O
students'	B-T098
communication	B-T080
styles	I-T080
in	O
different	O
hospitals	O
and	O
the	O
barriers	O
they	O
encounter	O
.	O
	
to	O
improve	B-T033
students'	B-T098
communication	O
skills	O
,	O
educators	O
and	O
clinical	O
staff	O
should	O
listen	O
to	O
students	B-T098
,	O
enhance	B-T052
students'	B-T098
reflective	O
skills	O
and	O
strengthen	O
their	O
confidence	O
.	O
	
through	O
understanding	O
students'	B-T098
difficulties	B-T080
in	O
the	O
nurse-patient	O
communication	O
experience	O
and	O
the	O
skills	O
that	O
they	O
lack	O
,	O
educators	O
can	O
provide	O
them	O
with	O
helpful	O
recommendations	B-T078
to	O
improve	B-T033
their	O
communication	O
skills	O
in	O
clinical	O
practice	O
.	O
	
the	O
results	O
of	O
this	O
study	B-T062
reveal	B-T080
that	O
students'	B-T098
nurse-patient	O
communication	O
skills	O
need	O
to	O
be	O
early	O
hippocampal	O
volume	B-T033
loss	I-T033
as	O
a	O
marker	O
of	O
eventual	O
memory	O
deficits	O
caused	O
by	O
repeated	B-T033
stress	I-T033
exposure	B-T080
to	I-T080
severe	B-T080
and	O
prolonged	B-T079
stress	B-T033
has	O
detrimental	B-T033
effects	I-T033
on	O
the	O
hippocampus	O
.	O
	
however	O
,	O
relatively	B-T080
little	B-T081
is	O
known	B-T080
about	O
the	O
gradual	B-T080
changes	B-T169
in	O
hippocampal	O
structure	O
,	O
and	O
its	O
behavioral	O
consequences	B-T169
,	O
over	O
the	O
course	O
of	O
repeated	B-T033
stress	I-T033
.	O
	
behavioral	O
analyses	O
during	O
10	O
days	O
of	O
chronic	O
stress	O
pointed	O
to	O
a	O
delayed	O
decline	B-T081
in	O
spatial	O
memory	O
,	O
the	O
full	O
impact	B-T080
of	O
which	O
is	O
evident	O
only	O
after	O
the	O
end	O
of	O
stress	B-T033
.	O
	
in	O
contrast	O
,	O
concurrent	B-T079
volumetric	B-T081
measurements	I-T081
in	O
the	O
same	O
animals	O
revealed	O
significant	O
reduction	B-T080
in	O
hippocampal	O
volumes	B-T081
in	O
stressed	B-T033
animals	O
relative	O
to	O
their	O
unstressed	B-T033
counterparts	I-T033
,	O
as	O
early	O
as	O
the	O
third	O
day	O
of	O
stress	B-T033
.	O
	
notably	O
,	O
animals	O
that	O
were	O
behaviorally	O
the	O
worst	B-T080
affected	B-T169
at	O
the	O
end	O
of	O
chronic	O
stress	O
suffered	O
the	O
most	O
pronounced	O
early	B-T033
loss	I-T033
in	I-T033
hippocampal	I-T033
volume	I-T033
.	O
	
together	O
,	O
these	O
findings	O
support	O
the	O
view	O
that	O
not	O
only	O
is	O
smaller	O
hippocampal	O
volume	B-T081
linked	O
to	O
stress	B-T033
-	O
induced	B-T169
memory	O
deficits	O
,	O
but	O
it	O
may	O
also	O
act	O
as	O
an	O
early	O
risk	B-T033
factor	I-T033
for	O
the	O
eventual	O
development	O
of	O
cognitive	O
impairments	O
seen	O
in	O
stress-related	O
psychiatric	O
disorders	O
.	O
	
the	O
association	B-T080
between	O
c9orf72	O
repeats	O
and	O
risk	B-T078
of	O
alzheimer's	B-T047
disease	I-T047
and	O
amyotrophic	B-T047
lateral	I-T047
sclerosis	I-T047
a	O
meta-analysis	B-T062
c9orf72	O
is	O
the	O
most	O
common	O
genetic	B-T169
cause	B-T169
of	O
amyotrophic	B-T047
lateral	I-T047
sclerosis	I-T047
als	B-T047
and	O
frontotemporal	B-T047
dementia	I-T047
ftd	B-T047
in	O
caucasian	B-T098
populations	I-T098
.	O
	
however	O
,	O
the	O
relationship	B-T080
between	O
c9orf72	O
repeats	O
and	O
alzheimer's	B-T047
disease	I-T047
ad	B-T047
was	O
not	B-T033
clear	I-T033
.	O
	
additionally	O
,	O
there	O
were	O
few	O
articles	B-T170
assessing	B-T052
c9orf72	O
in	O
other	O
ethnicities	B-T080
with	O
als	B-T047
.	O
	
in	O
this	O
meta-analysis	B-T062
,	O
we	O
aimed	O
to	O
investigate	B-T169
the	O
relationship	B-T080
between	O
c9orf72	O
repeat	O
expansions	O
30	O
repeats	O
and	O
intermediate	B-T082
repeat	O
copies	O
20-29	O
repeats	O
and	O
ad	B-T047
or	O
als	B-T047
.	O
	
the	O
results	B-T169
suggested	O
positive	B-T033
correlations	B-T080
between	O
c9orf72	O
repeat	O
expansions	O
and	O
the	O
risk	B-T078
of	O
alzheimer's	B-T047
disease	I-T047
or	B-T081
=	O
6.36	O
,	O
95%	O
ci	B-T081
=	O
3.13	O
,	O
and	O
p	B-T081
<	O
0.00001	O
,	O
while	O
intermediate	B-T082
repeat	O
copies	O
of	O
c9orf72	O
gene	O
were	O
not	O
associated	B-T080
with	I-T080
the	O
risk	B-T078
of	O
the	O
disease	B-T047
.	O
	
c9orf72	O
repeat	O
expansions	O
were	O
positively	B-T033
correlated	B-T080
with	O
the	O
risk	B-T078
of	O
familial	B-T047
and	O
sporadic	B-T047
als	I-T047
or	B-T081
=	O
293.25	O
,	O
95%	O
ci	B-T081
=	O
148.17	O
,	O
and	O
p	B-T081
<	O
0.00001	O
or	B-T081
=	O
35.57	O
,	O
95%	O
ci	B-T081
=	O
19.61	O
,	O
and	O
p	B-T081
<	O
0.00001	O
.	O
	
there	O
was	O
a	O
positive	B-T033
correlation	B-T080
between	O
the	O
gene	O
variations	O
and	O
als	B-T047
risk	B-T078
among	O
caucasians	B-T098
and	O
asians	B-T098
or	B-T081
=	O
57.56	O
,	O
95%	O
ci	B-T081
=	O
36.73	O
,	O
and	O
p	B-T081
<	O
0.00001	O
or	B-T081
=	O
6.35	O
,	O
95%	O
ci	B-T081
=	O
1.39	O
,	O
and	O
p	B-T081
demonstration	O
and	O
validation	B-T062
of	O
a	O
new	O
pressure	O
-based	O
mri	O
-safe	O
pain	B-T033
tolerance	I-T033
device	O
one	O
of	O
the	O
barriers	O
to	O
studying	O
the	O
behavioral	O
and	O
emotional	O
effects	B-T080
of	O
pain	O
using	O
functional	O
magnetic	O
resonance	O
imaging	O
fmri	O
is	O
the	O
absence	O
of	O
a	O
commercially	O
available	O
,	O
mri	O
-	O
compatible	B-T080
,	O
pressure	O
-based	O
algometer	O
to	O
elicit	B-T080
pain	O
.	O
	
the	O
present	O
study	O
sought	O
to	O
address	O
this	O
barrier	O
through	O
creation	O
and	O
validation	O
of	O
a	O
novel	O
mri	O
-safe	O
apparatus	O
capable	O
of	O
delivering	O
incremental	B-T081
,	O
measurable	B-T169
amounts	O
of	O
pressure	O
inside	O
a	O
scanning	O
bore	O
.	O
	
we	O
introduced	O
an	O
mr-safe	O
device	O
used	O
to	O
administer	O
pressure	O
-based	O
pain	O
.	O
	
to	O
test	O
against	O
a	O
commercially	O
available	O
,	O
mri	O
-	O
incompatible	B-T080
algometer	O
algomed	O
,	O
199	O
participants	O
reported	O
their	O
pain	B-T033
tolerance	I-T033
for	O
both	O
devices	O
.	O
	
a	O
second	O
experiment	O
tested	O
the	O
validity	O
of	O
pressure	O
-based	O
pain	O
in	O
an	O
mri	O
environment	B-T082
by	O
comparing	O
brain	O
activation	B-T052
with	O
established	O
neural	O
networks	O
for	O
pain	O
.	O
	
10	O
participants	O
performed	O
an	O
identical	O
procedure	O
to	O
test	O
for	O
pain	O
tolerance	O
while	O
being	O
scanned	O
in	O
a	O
7t	O
mri	O
scanner	O
.	O
	
results	O
support	O
the	O
validity	B-T080
and	I-T080
reliability	I-T080
of	O
our	O
novel	O
device	O
.	O
	
in	O
study	O
1	O
,	O
pain	B-T033
tolerance	I-T033
with	O
this	O
device	O
was	O
strongly	O
correlated	O
with	O
pain	B-T033
tolerance	I-T033
as	O
measured	O
by	O
a	O
commercially	O
available	O
algometer	O
r=0	O
.	O
	
in	O
study	O
2	O
,	O
this	O
device	O
yielded	O
bold	O
activation	O
within	O
the	O
insula	O
ba	O
13	O
and	O
anterior	O
cingulate	O
gyrus	O
ba	O
24	O
as	O
pressure	O
increased	B-T081
,	O
activation	O
in	O
these	O
areas	O
parametrically	O
increased	B-T081
.	O
	
these	O
findings	O
correspond	O
to	O
other	O
studies	O
using	O
thermal	B-T061
,	O
electrical	B-T061
,	O
or	O
mechanical	B-T061
pain	O
applications	O
.	O
	
behavioral	O
and	O
functional	B-T169
data	B-T078
demonstrate	O
that	O
this	O
new	O
device	O
is	O
a	O
valid	O
method	O
of	O
administering	B-T061
pressure	O
-related	O
pain	O
in	O
mri	O
environments	B-T082
.	O
	
our	O
novel	O
mri	O
-safe	O
device	O
is	O
a	O
valid	O
instrument	O
to	O
measure	B-T169
and	O
administer	B-T169
pressure	O
-based	O
anti-inflammatory	B-T080
properties	I-T080
of	O
menthol	B-T109
and	O
menthone	B-T109
in	O
schistosoma	B-T047
mansoni	I-T047
infection	I-T047
schistosomiasis	B-T047
is	O
a	O
parasitic	B-T047
disease	I-T047
caused	O
by	O
several	O
species	O
of	O
trematode	O
worms	O
and	O
it	O
is	O
believed	O
that	O
more	O
than	O
261	O
million	O
people	B-T098
are	O
affected	B-T169
worldwide	O
.	O
	
new	O
drug	O
development	O
has	O
become	O
essential	B-T080
because	O
there	O
is	O
a	O
risk	O
of	O
the	O
parasite	O
becoming	O
resistant	O
to	O
praziquantel	B-T109
,	O
the	O
only	O
drug	O
available	O
for	O
this	O
infection	O
.	O
	
this	O
study	B-T062
evaluated	O
parasitological	B-T080
,	O
immunological	B-T169
and	O
histological	B-T169
parameters	B-T033
in	O
mice	O
infected	B-T033
with	O
schistosoma	O
mansoni	O
and	O
treated	B-T061
with	I-T061
an	O
herbal	O
commercial	O
medicine	O
.	O
	
this	O
drug	O
consists	O
of	O
menthol	B-T109
30-55%	O
and	O
menthone	B-T109
14-32%	O
.	O
	
a	O
60	O
day	O
treatment	B-T061
regimen	I-T061
with	O
the	O
herbal	O
medicine	O
decreased	B-T081
the	O
number	O
of	O
s	O
.	O
	
mansoni	O
eggs	O
in	O
the	O
feces	O
,	O
liver	O
,	O
and	O
intestine	O
and	O
reduced	B-T080
the	O
number	O
of	O
hepatic	B-T047
granulomas	I-T047
.	O
	
we	O
observed	B-T169
a	O
reduction	B-T061
of	O
84%	O
in	O
blood	B-T047
eosinophilia	I-T047
and	O
a	O
decrease	B-T081
in	O
the	O
il-4	B-T116
and	O
il-10	B-T116
blood	O
levels	O
after	O
treatment	B-T061
.	O
	
therefore	O
,	O
we	O
propose	O
that	O
schistosomiasis	B-T047
treatment	B-T061
with	O
this	O
herbal	O
medicine	O
for	O
60	O
days	O
has	O
an	O
immunomodulatory	B-T080
and	O
anti-inflammatory	B-T080
action	I-T080
in	O
this	O
animal	O
model	O
for	O
schistosomiasis	B-T047
thus	O
contributing	B-T052
to	O
the	O
decrease	B-T081
in	O
physio	O
pathological	B-T169
effects	B-T080
caused	O
by	O
s	B-T047
.	O
	
mansoni	I-T047
infection	I-T047
.	O
	
catastrophic	B-T047
health	B-T081
expenditure	I-T081
a	O
comparative	B-T062
analysis	I-T062
of	O
empty-nest	B-T078
and	O
non-empty-nest	B-T078
households	O
with	O
seniors	B-T098
in	O
shandong	O
,	O
china	O
the	O
aim	B-T078
of	O
this	O
study	B-T062
was	O
to	O
compare	B-T052
the	O
catastrophic	B-T047
health	B-T081
expenditure	I-T081
che	B-T081
prevalence	B-T081
and	O
its	O
determinants	B-T169
between	O
empty-nest	B-T078
and	O
non-empty-nest	B-T078
elderly	B-T098
households	O
.	O
	
shandong	O
province	O
of	O
china	O
.	O
	
a	O
total	B-T080
of	O
2761	O
elderly	B-T098
households	O
are	O
included	B-T169
in	O
the	O
analysis	B-T062
.	O
	
che	B-T081
incidence	B-T081
among	O
elderly	B-T098
households	O
was	O
44.9	O
.	O
	
the	O
che	B-T081
incidence	B-T081
of	O
empty-nest	B-T078
singles	B-T033
59.3	O
,	O
p=0	O
,	O
or=3	O
and	O
empty-nest	B-T078
couples	O
52.9	O
,	O
p=0	O
,	O
or=2	O
are	O
both	O
statistically	B-T081
higher	B-T080
than	O
that	O
of	O
non-empty-nest	B-T078
elderly	B-T098
households	O
31.4	O
.	O
	
an	O
inverse	O
association	O
was	O
observed	B-T169
between	O
che	B-T081
incidence	B-T081
and	O
income	B-T080
level	I-T080
in	O
all	O
elderly	B-T098
household	O
types	B-T080
.	O
	
factors	B-T169
including	B-T169
1	O
or	O
more	O
household	O
elderly	B-T098
members	I-T098
with	O
non-communicable	B-T047
chronic	I-T047
diseases	I-T047
in	O
the	O
past	O
6	O
months	O
,	O
1	O
or	O
more	O
elderly	B-T098
household	O
members	O
being	O
hospitalised	B-T033
in	O
the	O
past	B-T079
year	I-T079
and	O
lower	B-T052
household	O
income	B-T081
,	O
are	O
significant	B-T078
risk	B-T033
factors	I-T033
for	O
che	B-T081
in	O
all	O
3	O
household	O
types	B-T080
p<0	O
.	O
	
health	O
insurance	O
status	B-T080
was	O
found	O
to	O
be	O
a	O
significant	B-T078
determinant	B-T169
of	O
che	B-T081
among	O
empty-nest	B-T078
singles	B-T033
and	O
non-empty-nest	B-T078
households	O
p<0	O
.	O
	
che	B-T081
incidence	B-T081
among	O
elderly	B-T098
households	O
is	O
high	B-T080
in	O
china	O
.	O
	
empty-nest	B-T078
households	O
are	O
at	O
higher	B-T080
risk	B-T078
for	O
che	B-T081
than	O
non-empty-nest	B-T078
households	O
.	O
	
based	O
on	O
these	O
findings	B-T033
,	O
we	O
suggest	B-T078
that	O
special	B-T080
insurance	O
be	O
developed	O
to	O
broaden	B-T082
the	O
coverage	B-T078
of	O
health	O
services	O
and	O
heighten	B-T080
the	O
reimbursement	O
rate	O
for	O
empty-nest	B-T078
elderly	B-T098
in	O
the	O
existing	O
health	O
insurance	O
schemes	B-T170
.	O
	
financial	B-T080
and	O
social	O
protection	O
interventions	O
are	O
also	O
essential	B-T080
for	O
identifie	B-T080
d	O
at-risk	B-T080
subgroups	O
among	O
different	O
types	O
of	O
elderly	B-T098
households	O
.	O
	
role	O
of	O
agonistic	B-T116
autoantibodies	I-T116
against	O
type-1	B-T116
angiotensin	I-T116
ii	I-T116
receptor	I-T116
in	O
the	O
pathogenesis	O
of	O
retinopathy	B-T047
in	O
preeclampsia	O
to	O
investigate	B-T169
the	O
mechanism	B-T169
underlying	O
at1-aa	O
-induced	O
retinopathy	B-T047
in	O
severe	O
preeclampsia	O
by	O
measuring	O
the	O
positive	B-T081
rate	I-T081
and	O
titer	B-T081
of	O
at1-aa	O
in	O
plasma	O
from	O
women	B-T098
with	O
severe	O
preeclampsia	O
and	O
normal	O
pregnant	B-T098
women	I-T098
to	O
see	O
whether	O
at1-aa	O
titer	B-T081
was	O
correlated	B-T080
with	O
the	O
grade	O
of	O
retinopathy	B-T047
.	O
	
a	O
preeclampsia	O
rat	O
model	O
was	O
also	O
established	O
by	O
intravenous	B-T169
injection	I-T169
of	O
at1-aa	O
extracted	O
from	O
the	O
plasma	O
of	O
patient	O
suffering	O
from	O
severe	O
preeclampsia	O
.	O
	
the	O
results	O
showed	O
that	O
the	O
plasma	O
titer	B-T081
and	O
positive	B-T081
rate	I-T081
of	O
at1-aa	O
were	O
significantly	O
higher	O
in	O
women	B-T098
with	O
severe	O
preeclampsia	O
than	O
normal	O
pregnant	B-T098
women	I-T098
.	O
	
the	O
antibody	B-T116
titer	B-T081
in	O
cases	O
of	O
severe	O
preeclampsia	O
was	O
associated	O
with	O
the	O
grade	O
of	O
retinopathy	B-T047
,	O
and	O
positively	O
correlated	B-T080
with	O
the	O
level	O
of	O
tnf-α	B-T116
and	O
vegf	B-T116
.	O
	
the	O
animal	B-T062
experiment	I-T062
results	B-T169
showed	O
that	O
the	O
modeled	O
rats	O
presented	O
symptoms	O
very	O
similar	O
to	O
symptoms	O
of	O
human	O
preeclampsia	O
,	O
including	O
retinopathy	B-T047
.	O
	
ocular	O
fundus	O
examination	O
showed	O
retinal	B-T033
microvascular	I-T033
abnormalities	I-T033
,	O
hemorrhaging	O
and	O
leakage	B-T033
in	O
the	O
severe	O
preeclampsia	O
.	O
	
morphological	B-T082
changes	I-T082
included	O
edema	O
,	O
thickening	B-T033
of	O
the	O
inl	O
and	O
onl	O
,	O
and	O
pigment	B-T033
atrophy	I-T033
.	O
	
tnf-α	B-T116
and	O
vegf	B-T116
levels	O
were	O
increased	O
in	O
the	O
vitreous	O
humor	O
and	O
retina	O
of	O
the	O
model	O
rats	O
.	O
	
our	O
studies	B-T062
results	B-T169
suggest	O
that	O
abnormal	O
expression	O
of	O
at1-aa	O
could	O
induce	O
damage	B-T169
to	O
retinal	O
capillary	O
endothelial	O
cells	O
and	O
increase	O
vascular	O
permeability	O
,	O
resulting	B-T169
in	I-T169
retinopathy	B-T047
.	O
	
characterizing	B-T052
sexual	O
function	O
in	O
patients	O
with	O
generalized	O
anxiety	O
disorder	O
a	O
pooled	B-T062
analysis	I-T062
of	O
three	O
vilazodone	B-T109
studies	B-T062
vilazodone	B-T109
has	O
been	O
shown	O
to	O
reduce	B-T080
core	O
symptoms	O
of	O
generalized	O
anxiety	O
disorder	O
gad	O
in	O
three	O
randomized	B-T062
,	O
double-blind	B-T062
,	O
placebo-controlled	B-T062
trials	I-T062
.	O
	
since	O
sexual	B-T047
dysfunction	I-T047
sd	B-T047
is	O
not	O
well	O
characterized	O
in	O
gad	O
,	O
a	O
post	B-T062
hoc	I-T062
analysis	I-T062
of	O
these	O
trials	B-T062
was	O
conducted	O
to	O
evaluate	O
the	O
effects	B-T080
of	I-T080
vilazodone	B-T109
on	O
sexual	O
functioning	O
in	O
gad	O
patients	O
.	O
	
data	B-T078
were	O
pooled	B-T169
from	O
one	O
fixed-dose	B-T062
trial	I-T062
of	O
vilazodone	B-T109
20	O
and	O
40	O
mg/day	B-T081
nct01629966	B-T170
and	O
two	O
flexible-dose	B-T062
studies	I-T062
of	O
vilazodone	B-T109
20-40	O
mg/day	B-T081
nct01766401	B-T170
,	O
nct01844115	B-T170
in	O
adults	O
with	O
gad	O
.	O
	
sexual	O
functioning	O
was	O
assessed	B-T052
using	O
the	O
changes	B-T170
in	I-T170
sexual	I-T170
functioning	I-T170
questionnaire	I-T170
csfq	B-T170
.	O
	
outcomes	B-T062
included	O
mean	B-T081
change	I-T081
from	I-T081
baseline	I-T081
to	I-T081
end	I-T081
of	I-T081
treatment	I-T081
eot	B-T080
in	O
csfq	B-T033
total	I-T033
score	I-T033
and	O
percentage	B-T081
of	O
patients	O
shifting	B-T169
from	O
sd	B-T047
at	O
baseline	B-T081
csfq	B-T033
total	I-T033
score	I-T033
47	O
for	O
males	B-T098
,	O
41	O
for	O
females	B-T098
to	O
normal	B-T033
functioning	I-T033
at	O
eot	B-T080
.	O
	
treatment-emergent	O
adverse	O
events	O
related	O
to	O
sexual	O
functioning	O
were	O
also	O
analyzed	B-T062
.	O
	
a	O
total	B-T080
of	O
1	O
patients	O
were	O
included	O
in	O
the	O
analyses	B-T062
.	O
	
sd	B-T047
at	O
baseline	B-T081
was	O
more	O
common	O
in	O
females	B-T098
placebo	O
,	O
46.4	O
vilazodone	B-T109
,	O
49%	O
than	O
in	O
males	B-T098
placebo	O
,	O
35.1	O
vilazodone	B-T109
,	O
40.9	O
.	O
	
csfq	B-T033
total	I-T033
score	I-T033
improvement	O
was	O
found	O
in	O
both	O
females	B-T098
placebo	O
,	O
+1	O
vilazodone	B-T109
,	O
+1	O
and	O
males	B-T098
placebo	O
,	O
+2	O
vilazodone	B-T109
,	O
+1	O
,	O
with	O
no	B-T033
statistically	I-T033
significant	I-T033
differences	I-T033
between	O
treatment	B-T169
groups	B-T078
.	O
	
the	O
percentage	B-T081
of	O
patients	O
who	O
shifted	B-T169
from	O
sd	B-T047
at	O
baseline	B-T081
to	O
normal	B-T080
sexual	O
functioning	O
at	O
eot	B-T080
was	O
higher	O
in	O
males	B-T098
placebo	O
,	O
40.6	O
vilazodone	B-T109
,	O
35.7	O
than	O
in	O
females	B-T098
placebo	O
,	O
24.9	O
vilazodone	B-T109
,	O
34.9	O
no	B-T033
statistical	I-T033
testing	I-T033
was	O
performed	O
.	O
	
except	O
for	O
erectile	B-T047
dysfunction	I-T047
and	O
delayed	O
ejaculation	O
in	O
vilazodone	B-T109
-	O
treated	B-T169
males	B-T098
2.4	O
and	O
2.1	O
,	O
respectively	O
,	O
no	B-T033
treatment-emergent	I-T033
adverse	I-T033
events	I-T033
related	O
to	O
sexual	O
functioning	O
occurred	B-T052
in	O
2%	O
of	O
patients	O
in	O
either	O
treatment	B-T169
group	B-T078
.	O
	
approximately	B-T080
35%-50%	O
of	O
patients	O
in	O
the	O
vilazodone	B-T109
gad	O
studies	B-T062
had	O
sd	B-T047
at	O
baseline	B-T081
.	O
	
vilazodone	B-T109
and	O
placebo	O
had	O
similar	O
effects	B-T080
on	O
csfq	B-T170
outcomes	B-T062
in	O
both	O
females	B-T098
and	O
males	B-T098
,	O
indicating	O
a	O
limited	B-T169
adverse	O
impact	O
on	O
sexual	O
functioning	O
with	O
biogeochemical	B-T169
controls	B-T080
of	O
uranium	O
bioavailability	B-T081
from	O
the	O
dissolved	B-T080
phase	I-T080
in	O
natural	B-T169
freshwaters	O
to	O
gain	O
insights	O
into	O
the	O
risks	B-T078
associated	B-T080
with	I-T080
uranium	O
u	O
mining	O
and	O
processing	B-T052
,	O
we	O
investigated	B-T169
the	O
biogeochemical	B-T169
controls	B-T080
of	O
u	O
bioavailability	B-T081
in	O
the	O
model	O
freshwater	O
species	O
lymnaea	O
stagnalis	O
gastropoda	O
.	O
	
bioavailability	B-T081
of	O
dissolved	O
u	O
was	O
characterized	B-T052
in	O
controlled	B-T169
laboratory	O
experiments	B-T062
over	O
a	O
range	O
of	O
water	O
hardness	B-T080
,	O
ph	B-T081
,	O
and	O
in	O
the	O
presence	B-T033
of	O
complexing	O
ligands	O
in	O
the	O
form	O
of	O
dissolved	O
natural	O
organic	O
matter	O
dom	O
.	O
	
results	O
show	O
that	O
dissolved	O
u	O
is	O
bioavailable	B-T080
under	O
all	O
the	O
geochemical	O
conditions	O
tested	B-T169
.	O
	
uranium	O
uptake	O
rates	B-T081
follow	O
first	O
order	O
kinetics	O
over	O
a	O
range	O
encompassing	O
most	O
environmental	B-T082
concentrations	B-T081
.	O
	
uranium	O
uptake	O
rates	B-T081
in	O
l	O
.	O
	
stagnalis	O
ultimately	O
demonstrate	O
saturation	O
uptake	O
kinetics	O
when	O
exposure	B-T080
concentrations	B-T081
exceed	O
100	O
nm	O
,	O
suggesting	B-T078
uptake	O
via	O
a	O
finite	O
number	O
of	O
carriers	O
or	O
ion	B-T116
channels	I-T116
.	O
	
the	O
lack	O
of	O
a	O
relationship	O
between	O
u	O
uptake	O
rate	O
constants	B-T081
and	O
ca	O
uptake	O
rates	B-T081
suggest	B-T078
that	O
u	O
does	O
not	O
exclusively	O
use	O
ca	O
membrane	B-T116
transporters	I-T116
.	O
	
in	O
general	O
,	O
u	O
bioavailability	B-T081
decreases	B-T033
with	O
increasing	B-T169
ph	B-T081
,	O
increasing	B-T169
ca	O
and	O
mg	O
concentrations	B-T081
,	O
and	O
when	O
dom	O
is	O
present	B-T033
.	O
	
competing	O
ions	O
did	O
not	O
affect	O
u	O
uptake	O
rates	B-T081
.	O
	
speciation	B-T062
modeling	I-T062
that	O
includes	O
formation	B-T169
constants	B-T081
for	O
u	O
ternary	O
complexes	O
reveals	B-T080
that	O
the	O
aqueous	B-T080
concentration	B-T081
of	O
dicarbonato	O
u	O
species	O
uo2	O
best	O
predicts	O
u	O
bioavailability	B-T081
to	O
l	O
.	O
	
stagnalis	O
,	O
challenging	O
the	O
free-ion	B-T052
activity	I-T052
interleukin-21	B-T116
plays	O
a	O
critical	O
role	O
in	O
the	O
pathogenesis	O
and	O
severity	O
of	O
type	B-T047
i	I-T047
autoimmune	I-T047
hepatitis	I-T047
recently	O
,	O
the	O
number	O
of	O
follicular	O
helper	O
t	O
tfh	O
cells	O
expressing	O
interleukin	B-T116
il	I-T116
was	O
found	O
to	O
increase	O
in	O
peripheral	O
blood	O
of	O
human	O
and	O
murine	O
models	O
of	O
autoimmune	B-T047
hepatitis	I-T047
aih	B-T047
.	O
	
il-21	B-T116
,	O
the	O
most	O
recently	O
discovered	O
member	O
of	O
the	O
type-i	B-T116
cytokine	I-T116
family	I-T116
,	O
exerts	O
various	O
effects	O
on	O
the	O
immune	O
system	O
,	O
including	O
b	O
cell	O
activation	O
,	O
plasma	O
cell	O
differentiation	O
,	O
and	O
immunoglobulin	O
production	O
.	O
	
we	O
aimed	O
to	O
assess	O
the	O
relationship	O
of	O
serum	O
il-21	B-T116
levels	B-T080
in	O
patients	O
with	O
type	B-T047
i	I-T047
aih	I-T047
with	O
clinical	B-T080
and	O
laboratory	O
parameters	O
and	O
histology	O
.	O
	
ninety-two	O
japanese	B-T098
patients	O
with	O
liver	B-T047
disease	I-T047
22	O
aih	B-T047
,	O
20	O
primary	B-T047
biliary	I-T047
cholangitis	I-T047
,	O
19	O
drug-induced	B-T047
liver	I-T047
injury	I-T047
,	O
8	O
acute	B-T047
hepatitis	I-T047
b	I-T047
,	O
8	O
chronic	B-T047
hepatitis	I-T047
c	I-T047
,	O
10	O
non-alcoholic	B-T047
steatohepatitis	I-T047
,	O
5	O
viral	B-T047
hepatitis	I-T047
and	O
10	O
healthy	B-T098
volunteers	I-T098
were	O
recruited	O
.	O
	
serum	O
il-21	B-T116
levels	B-T080
were	O
detected	O
by	O
enzyme-linked	O
immunosorbent	O
assay	O
.	O
	
real-time	O
polymerase	O
chain	O
reaction	O
measured	O
mrna	O
levels	B-T080
of	O
bcl-6	O
,	O
il-21	O
,	O
and	O
cxcr5	O
tfh-related	B-T116
factors	I-T116
in	O
peripheral	B-T082
mononuclear	O
cells	O
.	O
	
mean	O
age	O
at	O
diagnosis	B-T033
of	O
aih	B-T047
was	O
58.6	O
years	O
,	O
male-to-female	B-T033
ratio	I-T033
was	O
4	O
,	O
18.2	O
%	O
of	O
participants	O
had	O
cirrhosis	B-T047
,	O
and	O
22.7	O
%	O
had	O
severe	B-T080
disease	B-T047
.	O
	
il-21	B-T116
levels	B-T080
were	O
significantly	O
increased	B-T081
in	O
the	O
serum	O
of	O
patients	O
with	O
aih	B-T047
compared	O
to	O
those	O
with	O
other	O
liver	O
diseases	O
and	O
controls	O
p	O
<	O
0.0001	O
.	O
	
particularly	O
,	O
serum	O
il-21	B-T116
levels	B-T080
were	O
significantly	O
increased	B-T081
in	O
severe	B-T080
aih	B-T047
cases	O
compared	O
to	O
non-severe	O
cases	O
p	O
<	O
0.05	O
.	O
	
serum	O
il-21	B-T116
levels	B-T080
correlated	O
positively	O
with	O
total	O
serum	O
bilirubin	O
levels	O
r	O
=	O
0.46	O
,	O
p	O
<	O
0.05	O
,	O
grading	B-T033
of	I-T033
necroinflammatory	I-T033
activity	I-T033
r	O
=	O
0.68	O
,	O
p	O
<	O
0.005	O
and	O
negatively	O
with	O
serum	O
albumin	O
levels	O
in	O
patients	O
with	O
aih	B-T047
r	O
=	O
-0	O
,	O
p	O
<	O
0.05	O
.	O
	
in	O
patients	O
with	O
biochemical	B-T169
remission	B-T033
of	O
aih	B-T047
,	O
serum	O
il-21	B-T116
levels	B-T080
remained	O
elevated	B-T080
and	O
correlated	B-T080
positively	B-T033
with	O
serum	O
igg	O
levels	O
r	O
=	O
0.84	O
,	O
p	O
<	O
0.01	O
.	O
	
expression	O
of	O
tfh-related	B-T116
factors	I-T116
,	O
such	O
as	O
bcl-6	B-T116
and	O
il-21	B-T116
,	O
in	O
peripheral	O
blood	O
mononuclear	O
cells	O
of	O
patients	O
with	O
aih	B-T047
was	O
significantly	O
higher	B-T080
than	O
that	O
in	O
healthy	B-T098
volunteers	I-T098
.	O
	
il-21	B-T116
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
and	O
severity	O
of	O
aih	B-T047
,	O
and	O
may	O
present	O
a	O
promising	O
target	O
for	O
aih	B-T047
therapy	B-T169
.	O
	
resistance	B-T169
exercise	O
in	O
pregnancy	O
and	O
outcome	B-T033
as	O
the	O
health	B-T081
benefits	I-T081
of	O
exercise	O
are	O
increasingly	O
recognized	O
,	O
the	O
traditional	O
advice	O
to	O
rest	O
during	O
pregnancy	O
has	O
changed	B-T169
toward	O
a	O
more	O
healthy	B-T080
and	O
active	B-T169
pregnancy	O
,	O
therefore	O
different	O
forms	O
of	O
exercise	O
have	O
been	O
integrated	O
into	O
the	O
life	B-T078
of	O
the	O
pregnant	B-T098
woman	I-T098
.	O
	
although	O
the	O
benefits	B-T081
of	O
using	O
a	O
combination	B-T080
of	O
resistance	B-T169
and	O
aerobic	B-T061
exercises	I-T061
are	O
not	O
yet	O
determined	O
,	O
studies	B-T062
about	O
resistance	B-T169
and	O
strengthen	O
training	O
programs	O
are	O
few	O
although	O
no	O
adverse	O
outcomes	B-T033
custom	O
ocular	O
prosthesis	O
in	O
rehabilitation	B-T061
of	O
a	O
child	O
operated	O
for	O
retinoblastoma	O
a	O
maxillofacial	B-T061
prosthodontist	I-T061
forms	O
an	O
important	B-T080
link	O
in	O
the	O
interdisciplinary	O
management	O
of	O
a	O
patient	O
with	O
anopthalmosis	O
.	O
	
prosthetic	B-T061
management	I-T061
of	O
an	O
anopthalmic	O
defect	O
aims	O
to	O
deliver	O
a	O
well-fitting	O
ocular	O
prosthesis	O
that	O
can	O
mimic	O
the	O
original	O
eye	O
as	O
closely	O
as	O
possible	O
,	O
and	O
thus	O
restoring	O
the	O
patient's	O
self-confidence	O
and	O
thereby	O
rehabilitating	B-T169
them	O
in	O
the	O
society	O
.	O
	
the	O
fabrication	B-T061
of	O
a	O
custom	O
ocular	O
prosthesis	O
is	O
a	O
demanding	O
art	O
.	O
	
this	O
case	B-T170
report	I-T170
presents	O
a	O
simplified	O
technique	B-T169
for	O
the	O
fabrication	B-T061
of	O
a	O
custom	O
ocular	O
prosthesis	O
for	O
a	O
child	O
who	O
had	O
lost	B-T169
his	O
eye	O
to	O
enucleation	B-T061
following	O
retinoblastoma	O
.	O
	
early	O
and	O
effective	O
rehabilitation	B-T061
of	O
the	O
defect	O
goes	O
a	O
long	O
way	O
in	O
restoring	O
the	O
self-image	O
of	O
a	O
child	O
pulmonary	O
function	O
and	O
health-related	B-T078
quality	I-T078
of	I-T078
life	I-T078
1-	O
year	B-T079
follow	O
up	O
after	O
cardiac	B-T061
surgery	I-T061
pulmonary	O
function	O
is	O
severely	B-T080
reduced	B-T080
in	O
the	O
early	B-T079
period	B-T079
after	O
cardiac	B-T061
surgery	I-T061
,	O
and	O
impairments	O
have	O
been	O
described	O
up	O
to	O
4-6	O
months	B-T079
after	B-T079
surgery	I-T079
.	O
	
evaluation	O
of	O
pulmonary	O
function	O
in	O
a	O
longer	O
perspective	O
is	O
lacking	B-T080
.	O
	
in	O
this	O
prospective	B-T062
study	I-T062
pulmonary	O
function	O
and	O
health-related	B-T078
quality	I-T078
of	I-T078
life	I-T078
were	O
investigated	B-T169
1	O
year	B-T079
after	O
cardiac	B-T061
surgery	I-T061
.	O
	
pulmonary	O
function	O
measurements	B-T169
,	O
health-related	B-T078
quality	I-T078
of	I-T078
life	I-T078
sf-36	B-T170
,	O
dyspnoea	O
,	O
subjective	B-T080
breathing	O
and	O
coughing	O
ability	O
and	O
pain	O
were	O
evaluated	O
before	B-T079
and	O
1	O
year	B-T079
after	B-T079
surgery	I-T079
in	O
150	O
patients	O
undergoing	O
coronary	B-T061
artery	I-T061
bypass	I-T061
grafting	I-T061
,	O
valve	B-T061
surgery	I-T061
or	O
combined	O
surgery	B-T061
.	O
	
one	O
year	B-T079
after	B-T079
surgery	I-T079
the	O
forced	O
vital	O
capacity	O
and	O
forced	O
expiratory	O
volume	O
in	O
1	O
s	O
were	O
significantly	O
decreased	B-T081
by	O
4-5	O
%	O
compared	B-T052
to	O
preoperative	B-T079
values	B-T081
p	O
<	O
0.05	O
.	O
	
saturation	O
of	O
peripheral	O
oxygen	O
was	O
unchanged	B-T033
1	O
year	B-T079
postoperatively	B-T079
compared	B-T052
to	O
baseline	B-T081
.	O
	
a	O
significantly	O
improved	B-T033
health-related	B-T078
quality	I-T078
of	I-T078
life	I-T078
was	O
found	O
1	O
year	B-T079
after	B-T079
surgery	I-T079
,	O
with	O
improvements	O
in	O
all	O
eight	O
aspects	B-T080
of	O
sf-36	B-T170
p	O
<	O
0.001	O
.	O
	
sternotomy	B-T061
-related	O
pain	O
was	O
low	B-T080
1	O
year	B-T079
postoperatively	B-T079
at	B-T169
rest	I-T169
median	O
0	O
min-max	O
0-7	O
,	O
while	O
taking	O
a	O
deep	O
breath	O
0	O
0-4	O
and	O
while	O
coughing	O
0	O
0-8	O
.	O
	
a	O
more	O
pronounced	O
decrease	O
in	O
pulmonary	O
function	O
was	O
associated	B-T080
with	I-T080
dyspnoea	O
limitations	B-T169
and	O
impaired	O
subjective	B-T080
breathing	O
and	O
coughing	O
ability	O
.	O
	
one	O
year	B-T079
after	O
cardiac	B-T061
surgery	I-T061
static	B-T080
and	O
dynamic	B-T169
lung	O
function	O
measurements	O
were	O
slightly	O
decreased	B-T081
,	O
while	O
health-related	B-T078
quality	I-T078
of	I-T078
life	I-T078
was	O
improved	B-T033
in	O
comparison	B-T052
to	O
preoperative	B-T079
values	B-T081
.	O
	
measured	B-T080
levels	B-T080
of	O
pain	O
were	O
low	B-T080
and	O
saturation	O
of	O
peripheral	O
oxygen	O
was	O
same	B-T080
as	O
impact	B-T080
of	O
soil	O
salinity	B-T081
on	O
the	O
structure	B-T082
of	O
the	O
bacterial	O
endophytic	O
community	O
identified	B-T080
from	O
the	O
roots	O
of	O
caliph	O
medic	O
medicago	O
truncatula	O
in	O
addition	O
to	O
being	O
a	O
forage	O
crop	O
,	O
caliph	O
medic	O
medicago	O
truncatula	O
is	O
also	O
a	O
model	B-T062
legume	I-T062
plant	I-T062
and	O
is	O
used	O
for	O
research	O
focusing	O
on	O
the	O
molecular	B-T052
characterization	I-T052
of	O
the	O
interaction	B-T169
between	O
rhizobia	O
and	O
plants	O
.	O
	
however	O
,	O
the	O
endophytic	O
microbiome	O
in	O
this	O
plant	O
is	O
poorly	O
defined	O
.	O
	
endophytic	O
bacteria	O
play	O
a	O
role	O
in	O
supplying	O
plants	O
with	O
the	O
basic	O
requirements	B-T169
necessary	O
for	O
growth	O
and	O
development	O
.	O
	
moreover	O
,	O
these	O
bacteria	O
also	O
play	O
a	O
role	O
in	O
the	O
mechanism	B-T169
of	O
salinity	O
stress	O
adaptation	O
in	O
plants	O
.	O
	
as	O
a	O
prelude	O
to	O
the	O
isolation	O
and	O
utilization	B-T169
of	O
these	O
bacteria	O
in	O
caliph	O
medic	O
farming	B-T082
,	O
41	O
bacterial	O
otus	O
were	O
identified	B-T080
in	O
this	O
project	O
from	O
within	O
the	O
interior	B-T082
of	O
the	O
roots	O
of	O
this	O
plant	O
by	O
pyrosequencing	O
of	O
the	O
small	O
ribosomal	O
subunit	O
gene	O
16s	O
rdna	O
using	O
a	O
cultivation-independent	O
approach	O
.	O
	
in	O
addition	O
,	O
the	O
differential	B-T080
abundance	B-T080
of	O
these	O
bacteria	O
was	O
studied	O
following	O
exposure	O
of	O
the	O
plants	O
to	O
salinity	O
stress	O
.	O
	
about	O
29	O
high-quality	B-T081
reads	I-T081
were	O
obtained	O
from	O
the	O
sequencing	O
of	O
six	O
libraries	O
prepared	O
from	O
control	O
and	O
salinity-treated	O
tissues	O
.	O
	
statistical	B-T062
analysis	I-T062
revealed	O
that	O
the	O
abundance	B-T080
of	O
70%	O
of	O
the	O
otus	O
was	O
significantly	O
p	O
0.05	O
altered	O
in	O
roots	O
that	O
were	O
exposed	B-T080
to	I-T080
salinity	O
stress	O
.	O
	
sequence	O
analysis	O
showed	O
a	O
similarity	O
between	O
some	O
of	O
the	O
identified	B-T080
species	O
and	O
other	O
,	O
known	O
,	O
growth-promoting	O
bacteria	O
,	O
marine	O
and	O
salt-stressed	O
soil-borne	O
bacteria	O
,	O
and	O
nitrogen-fixing	O
bacterial	O
isolates	O
.	O
	
determination	O
of	O
the	O
amendments	O
to	O
the	O
bacteria	O
l	O
community	O
due	O
to	O
salinity	O
stress	O
in	O
caliph	O
medic	O
provides	O
a	O
crucial	O
step	O
toward	O
developing	O
an	O
understanding	O
of	O
the	O
association	B-T080
of	O
these	O
endophytes	O
,	O
under	O
salt	O
stress	O
conditions	O
,	O
in	O
this	O
model	B-T062
plant	I-T062
.	O
	
to	O
provide	O
direct	O
evidence	B-T078
regarding	O
their	O
growth	B-T052
promoting	I-T052
activity	I-T052
,	O
a	O
group	B-T078
of	O
endophytic	O
bacteria	O
were	O
isolated	B-T169
from	O
inside	O
of	O
plant	O
roots	O
using	O
a	O
cultivation-dependent	O
approach	O
.	O
	
several	O
of	O
these	O
isolates	O
were	O
able	O
to	O
produce	O
acc-deaminase	B-T116
,	O
ammonia	O
and	O
iaa	B-T109
and	O
to	O
solubilize	B-T169
zn+2	O
and	O
po4-3	O
.	O
	
this	O
data	B-T078
is	O
consistent	O
with	O
the	O
predicted	O
occurrence	B-T079
based	O
on	O
cultivation-independent	O
techniques	O
of	O
these	O
bacteria	O
and	O
provides	O
some	O
insight	O
into	O
the	O
importance	O
of	O
the	O
endophytic	O
bacteria	O
in	O
caliph	O
medic	O
when	O
grown	O
under	O
normal	B-T080
and	O
saline	O
conditions	B-T080
.	O
	
eliminating	O
cancer	O
stem	O
cells	O
in	O
cml	O
with	O
combination	O
transcriptional	O
therapy	B-T061
leukemia	O
stem	O
cells	O
lscs	O
are	O
resistant	O
to	O
current	O
therapies	B-T061
used	O
to	O
treat	O
chronic	O
myeloid	O
leukemia	O
cml	O
.	O
	
abraham	O
et	O
al	O
.	O
	
2016	O
have	O
identified	O
a	O
molecular	O
network	O
critical	B-T169
for	O
cml	O
lsc	O
survival	O
and	O
propose	O
that	O
simultaneously	O
targeting	O
two	O
of	O
their	O
major	O
transcriptional	B-T116
regulators	I-T116
,	O
p53	O
and	O
c-myc	B-T116
,	O
may	O
facilitate	O
their	O
crocetin	B-T109
improves	B-T033
the	O
quality	B-T080
of	O
in	B-T080
vitro	I-T080
-	O
produced	B-T169
bovine	O
embryos	O
implications	O
for	O
blastocyst	O
development	O
,	O
cryotolerance	B-T080
,	O
and	O
apoptosis	O
the	O
aim	O
of	O
this	O
work	O
was	O
to	O
assess	O
the	O
effect	B-T080
of	O
supplementation	B-T061
of	O
bovine	O
culture	O
medium	O
with	O
the	O
natural	O
antioxidant	O
crocetin	B-T109
on	O
in	B-T080
vitro	I-T080
blastocyst	O
development	O
and	O
quality	B-T080
.	O
	
this	O
was	O
evaluated	O
as	O
cryotolerance	B-T080
,	O
apoptosis	B-T170
index	I-T170
,	O
and	O
total	O
cells	O
number	O
and	O
allocation	B-T052
.	O
	
abattoir	O
-derived	O
oocytes	O
were	O
matured	B-T079
and	O
fertilized	B-T169
in	B-T080
vitro	I-T080
according	O
to	O
standard	O
procedure	O
.	O
	
twenty	O
hours	B-T079
after	O
ivf	B-T061
,	O
presumptive	B-T080
zygotes	O
were	O
cultured	O
in	O
synthetic	O
oviduct	O
fluid	O
medium	O
,	O
supplemented	O
with	O
0	O
,	O
1	O
,	O
2.5	O
,	O
and	O
5	O
μm	O
crocetin	B-T109
experiment	O
1	O
at	O
39	O
c	O
under	O
humidified	B-T061
air	I-T061
with	O
5%	O
co2	O
,	O
7%	O
o2	O
,	O
and	O
88%	O
n2	O
.	O
	
on	O
day	B-T079
7	O
,	O
embryo	B-T081
yields	I-T081
were	O
assessed	B-T052
and	O
the	O
blastocysts	O
were	O
vitrified	O
by	O
cryotop	B-T170
method	I-T170
in	O
16.5	O
ethylene	B-T109
glycol	I-T109
,	O
16.5	O
dmso	B-T109
,	O
and	O
0.5	O
m	O
sucrose	B-T109
.	O
	
finally	O
,	O
blastocysts	O
produced	O
on	O
day	B-T079
8	O
in	O
the	O
absence	B-T169
control	O
and	O
presence	B-T033
of	O
1	O
μm	O
crocetin	B-T109
were	O
used	O
for	O
terminal	O
deoxynucleotidyl	O
transferase-mediated	O
dutp	O
nick	O
end	O
labelling	O
and	O
differential	O
staining	O
to	O
evaluate	O
,	O
respectively	O
,	O
the	O
apoptotic	B-T081
rate	I-T081
and	O
the	O
allocation	B-T052
of	O
cells	O
into	O
inner	O
cell	O
mass	O
icm	O
and	O
trophectoderm	O
te	O
lineages	O
experiment	O
2	O
.	O
	
embryo	O
development	O
was	O
higher	O
in	O
the	O
1	O
μm	O
crocetin	B-T078
group	I-T078
compared	O
to	O
the	O
control	O
,	O
both	O
in	O
terms	O
of	O
total	B-T080
embryo	O
output	B-T033
37.7	O
4.2	O
,	O
52.9	O
6.3	O
,	O
40.9	O
7.6	O
,	O
and	O
42.4	O
8.7	O
,	O
respectively	O
,	O
with	O
0	O
,	O
1	O
,	O
2.5	O
,	O
and	O
5	O
μm	O
p	O
<	O
0.01	O
and	O
grade	O
1	O
and	O
2	O
blastocysts	O
33.6	O
4.9	O
,	O
46.1	O
7.3	O
,	O
37.8	O
7.9	O
,	O
and	O
39.4	O
7.9	O
,	O
respectively	O
,	O
with	O
0	O
,	O
1	O
,	O
2.5	O
,	O
and	O
5	O
μm	O
p	O
<	O
0.05	O
.	O
	
moreover	O
,	O
the	O
percentage	B-T078
of	O
fast-developing	O
embryos	O
increased	B-T081
in	O
1	O
μm	O
crocetin	B-T078
group	I-T078
compared	O
to	O
the	O
control	O
23.4	O
4.7	O
,	O
32.7	O
6.6	O
,	O
27.2	O
6.6	O
,	O
and	O
30.1	O
7.2	O
,	O
respectively	O
,	O
with	O
0	O
,	O
1	O
,	O
2.5	O
,	O
and	O
5	O
μm	O
p	O
<	O
0.05	O
.	O
	
in	O
addition	O
,	O
the	O
enrichment	O
of	O
culture	O
medium	O
with	O
1	O
μm	O
crocetin	B-T109
improved	B-T033
embryo	O
cryotolerance	B-T080
compared	O
to	O
the	O
control	O
,	O
as	O
indicated	O
by	O
higher	O
hatching	O
rates	B-T081
recorded	O
after	O
48	O
hours	B-T079
postwarming	O
culture	O
46.5	O
vs	O
.	O
	
60.4	O
p	O
<	O
0.05	O
.	O
	
furthermore	O
,	O
1	O
μm	O
crocetin	B-T109
decreased	B-T081
both	O
the	O
average	O
number	O
9.9	O
0.4	O
vs	O
.	O
	
7.1	O
0.3	O
and	O
the	O
percentage	B-T078
of	O
apoptotic	B-T080
cells	O
7.1	O
0.4	O
vs	O
.	O
	
4.2	O
0.2	O
in	O
blastocysts	O
compared	O
to	O
the	O
control	O
p	O
<	O
0.01	O
.	O
	
however	O
,	O
no	O
differences	O
were	O
recorded	O
in	O
the	O
average	O
number	O
of	O
icm	O
,	O
te	O
,	O
and	O
total	B-T080
cells	O
between	O
1	O
μm	O
crocetin	O
and	O
control	O
groups	O
.	O
	
in	O
conclusion	O
,	O
the	O
enrichment	O
of	O
bovine	O
culture	O
medium	O
with	O
1	O
μm	O
crocetin	O
increased	O
both	O
blastocyst	O
yield	O
and	O
quality	O
,	O
as	O
indicated	O
by	O
the	O
improved	O
chronology	O
of	O
embryo	O
development	O
,	O
increased	O
resistance	O
to	O
cryopreservation	O
,	O
and	O
reduced	O
incidence	O
of	O
apoptosis	O
matrix	O
solid-phase	O
dispersion	O
combined	O
to	O
liquid	O
chromatography-tandem	O
mass	O
spectrometry	O
for	O
the	O
determination	O
of	O
paraben	B-T109
preservatives	O
in	O
mollusks	O
a	O
method	B-T170
for	I-T170
the	I-T170
extraction	I-T170
and	O
determination	O
of	O
seven	O
parabens	B-T109
,	O
esters	B-T109
of	O
4-hydroxybenzoic	B-T109
acid	I-T109
,	O
widely	O
used	O
as	O
preservatives	O
in	O
personal	O
care	O
products	O
,	O
pharmaceuticals	O
,	O
etc	O
,	O
and	O
two	O
chlorinated	B-T109
derivatives	I-T109
mono-	B-T109
and	O
di-chloro	B-T109
methyl	I-T109
paraben	I-T109
from	O
mollusk	O
samples	O
was	O
developed	O
by	O
combining	O
matrix	O
solid-phase	O
dispersion	O
mspd	O
and	O
liquid	O
chromatography-tandem	O
mass	O
spectrometry	O
.	O
	
mspd	B-T170
parameters	I-T170
,	O
such	O
as	O
solvent	O
,	O
solid	O
support	O
and	O
clean-up	O
sorbent	O
,	O
were	O
optimized	B-T052
.	O
	
besides	O
,	O
since	O
blank	O
problems	O
were	O
observed	O
for	O
some	O
parabens	B-T109
,	O
these	O
were	O
investigated	B-T169
and	O
blanks	O
were	O
tackled	O
by	O
precleaning	B-T052
all	O
sorbents	O
prior	O
to	O
use	O
.	O
	
under	O
final	O
conditions	O
,	O
0.5g	O
of	O
freeze-dried	O
mollusk	O
were	O
dispersed	B-T082
with	O
1.2g	O
of	O
silica	O
and	O
packed	B-T052
into	O
a	O
cartridge	B-T170
containing	O
3g	O
of	O
c18	B-T109
,	O
as	O
on-line	O
clean-up	O
sorbent	O
.	O
	
this	O
cartridge	B-T170
was	O
eluted	O
with	O
10ml	O
of	O
acetonitrile	B-T109
,	O
evaporated	O
and	O
reconstituted	B-T052
in	O
methanol	B-T109
for	O
analysis	B-T062
.	O
	
in	O
the	O
validation	B-T062
stage	O
,	O
successful	O
linearity	O
r	O
,	O
recoveries	B-T052
between	O
71	O
and	O
117%	O
for	O
most	O
analytes	O
,	O
precision	B-T080
rsd	O
lower	O
than	O
21%	O
and	O
limits	B-T081
of	I-T081
detection	I-T081
and	O
quantification	B-T081
lod	B-T081
and	O
loq	B-T062
,	O
lower	O
than	O
0.4	O
and	O
1.4ngg	O
dry	B-T081
weight	I-T081
respectively	O
levels	B-T080
were	O
achieved	O
.	O
	
finally	O
,	O
the	O
new	O
methodology	B-T170
was	O
applied	O
to	O
mussel	O
,	O
clam	O
and	O
cockle	O
samples	O
.	O
	
methyl	B-T109
paraben	I-T109
was	O
above	O
the	O
loq	B-T081
in	O
five	O
of	O
the	O
six	O
samples	O
not	O
found	O
in	O
one	O
clam	O
sample	O
at	O
concentrations	B-T081
up	O
to	O
7ngg	O
dry	B-T081
weight	I-T081
.	O
	
ethyl	B-T109
paraben	I-T109
was	O
found	O
above	O
the	O
loq	B-T081
in	O
mussel	O
and	O
cockle	O
samples	O
at	O
a	O
concentration	B-T081
level	I-T081
around	O
0.3ngg	O
.	O
	
n-propyl	B-T109
paraben	I-T109
was	O
only	O
above	O
the	O
loq	B-T081
in	O
one	O
mussel	O
sample	O
.	O
	
two-stage	O
reconstructive	B-T061
overlapping	O
stent	O
leo+	O
and	O
silk	O
for	O
treatment	B-T061
of	O
intracranial	O
circumferential	B-T082
fusiform	O
aneurysms	O
in	O
the	O
posterior	B-T082
circulation	O
intracranial	O
circumferential	B-T082
fusiform	O
aneurysms	O
of	O
the	O
posterior	B-T082
circulation	O
involving	O
arterial	O
branches	O
or	O
perforating	B-T033
vessels	O
are	O
difficult	O
to	O
treat	O
.	O
	
this	O
article	O
shows	O
an	O
endovascular	O
reconstruction	O
technique	O
not	O
yet	O
described	O
,	O
using	O
a	O
telescoping	O
self-expandable	O
stent	O
leo+	O
and	O
flow-diverter	O
device	O
silk	O
at	O
different	O
surgical	O
times	O
.	O
	
two	O
patients	O
with	O
circumferential	O
fusiform	O
aneurysm	O
,	O
one	O
being	O
an	O
aneurysm	O
of	O
the	O
segments	O
p2	O
and	O
p3	O
of	O
the	O
posterior	O
cerebral	O
artery	O
,	O
diagnosed	O
after	O
a	O
headache	O
,	O
and	O
the	O
other	O
a	O
partially	O
thrombosed	O
aneurysm	O
of	O
the	O
lower	O
basilar	O
artery	O
,	O
diagnosed	O
following	O
ischemia	O
of	O
the	O
brain	O
stem	O
.	O
	
endovascular	O
treatment	O
was	O
performed	O
by	O
means	O
of	O
a	O
vascular	O
reconstruction	O
technique	O
that	O
used	O
at	O
different	O
surgical	O
times	O
overlapping	O
a	O
telescoped	O
self-expandable	O
stent	O
,	O
leo+	O
and	O
a	O
flow-diverter	O
device	O
,	O
silk	O
.	O
	
angiographic	O
control	O
was	O
carried	O
out	O
at	O
6	O
and	O
12	O
months	O
,	O
to	O
evaluate	O
arterial	O
patency	O
,	O
flow	O
maintenance	O
in	O
the	O
arterial	O
branches	O
and	O
perforating	O
vessels	O
,	O
and	O
thrombosis	O
of	O
the	O
aneurysm	O
.	O
	
the	O
combined	O
use	O
at	O
different	O
surgical	O
times	O
of	O
the	O
self-expandable	O
stent	O
and	O
flow-diverter	O
device	O
was	O
technically	O
successful	O
in	O
both	O
patients	O
.	O
	
there	O
were	O
no	O
complications	O
during	O
the	O
procedure	O
,	O
nor	O
in	O
the	O
long-term	O
follow-up	O
with	O
full	O
arterial	O
vascular	O
reconstruction	O
,	O
maintenance	O
of	O
cerebral	O
perfusion	O
and	O
complete	O
aneurysm	O
occlusion	O
at	O
the	O
6-	O
and	O
12-	O
month	O
angiographic	O
follow-up	O
.	O
	
there	O
was	O
no	O
aneurysm	O
recanalization	O
nor	O
intra-stent	O
stenosis	O
.	O
	
circumferential	O
fusiform	O
aneurysm	O
of	O
the	O
posterior	O
circulation	O
involving	O
arterial	O
branches	O
or	O
perforating	O
vessels	O
to	O
the	O
brain	O
stem	O
may	O
be	O
treated	O
with	O
this	O
arterial	O
reconstruction	O
technique	O
at	O
different	O
surgical	O
times	O
,	O
using	O
the	O
self-expandable	O
stent	O
called	O
leo+	O
and	O
the	O
flow-diverter	O
device	O
silk	O
,	O
minimizing	O
the	O
risk	O
of	O
complications	O
and	O
failure	O
of	O
the	O
endovascular	O
technique	O
,	O
with	O
the	O
potential	O
for	O
arterial	O
reconstruction	O
with	O
thrombosis	O
of	O
the	O
aneurysmatic	O
sac	O
,	O
as	O
well	O
as	O
flow	O
maintenance	O
in	O
the	O
eloquent	O
arteries	O
,	O
in	O
this	O
type	O
of	O
cerebral	O
aneurysm	O
polysaccharide	B-T109
-	O
specific	B-T080
memory	O
b	O
cells	O
predict	O
protection	B-T033
against	O
experimental	B-T080
human	O
pneumococcal	O
carriage	B-T033
we	O
have	O
previously	B-T079
demonstrated	O
that	O
experimental	B-T080
pneumococcal	O
carriage	B-T033
enhances	B-T052
immunity	O
and	O
protects	B-T033
healthy	B-T080
adults	O
against	B-T080
carriage	B-T033
reacquisition	B-T052
after	O
rechallenge	B-T061
with	O
a	O
homologous	O
strain	O
.	O
	
to	O
investigate	O
the	O
role	O
of	O
naturally	B-T169
acquired	B-T080
pneumococcal	B-T116
protein	I-T116
and	O
polysaccharide	B-T109
ps	B-T109
specific	B-T080
immunity	O
in	O
protection	B-T033
against	B-T080
carriage	B-T033
acquisition	B-T052
using	O
a	O
heterologous	O
challenge	O
model	O
.	O
	
we	O
identified	O
healthy	B-T098
volunteers	I-T098
that	O
were	O
naturally	B-T169
colonized	O
with	O
pneumococcus	O
and	O
,	O
after	O
clearance	B-T080
of	O
their	O
natural	B-T169
carriage	B-T033
episode	B-T079
,	O
challenged	O
them	O
with	O
a	O
heterologous	O
6b	O
strain	O
.	O
	
in	O
another	O
cohort	B-T098
of	O
volunteers	B-T098
we	O
assessed	O
6bps	B-T109
-	O
specific	B-T080
,	O
pspa	B-T116
-	O
specific	B-T080
,	O
and	O
pspc	B-T116
-	O
specific	B-T080
igg	B-T116
and	O
iga	B-T116
plasma	O
and	O
memory	O
b-cell	O
populations	O
before	B-T079
and	O
7	O
,	O
14	O
,	O
and	O
35	O
days	O
after	B-T079
experimental	B-T080
pneumococcal	O
inoculation	B-T061
.	O
	
heterologous	O
challenge	O
with	O
6b	O
resulted	O
in	O
50%	O
carriage	B-T033
among	O
volunteers	B-T098
with	O
previous	B-T079
natural	B-T169
pneumococcal	O
carriage	B-T033
.	O
	
protection	B-T033
from	O
carriage	B-T033
was	O
associated	B-T080
with	I-T080
a	O
high	B-T080
number	O
of	O
circulating	B-T169
6bps	B-T109
igg	B-T116
-	O
secreting	O
memory	O
b	O
cells	O
at	O
baseline	B-T081
.	O
	
there	O
were	O
no	O
associations	B-T080
between	O
protection	B-T033
from	O
carriage	B-T033
and	O
baseline	B-T081
levels	B-T080
of	O
6bps	B-T109
igg	B-T116
in	O
serum	O
or	O
nasal	O
wash	O
,	O
pspa	B-T116
-	O
specific	B-T080
,	O
or	O
pspc	B-T116
-	O
specific	B-T080
memory	O
b	O
cells	O
or	O
plasma	O
cells	O
.	O
	
in	O
volunteers	B-T098
who	O
did	O
not	B-T033
develop	I-T033
carriage	B-T033
,	O
the	O
number	O
of	O
circulating	B-T169
6bps	B-T109
memory	O
b	O
cells	O
decreased	B-T081
and	O
the	O
number	O
of	O
6bps	B-T109
plasma	O
cells	O
increased	B-T081
postinoculation	B-T033
.	O
	
our	O
data	O
indicate	O
that	O
naturally	B-T169
acquired	B-T080
ps	B-T109
-	O
specific	B-T080
memory	O
b	O
cells	O
,	O
but	O
not	B-T033
levels	I-T033
of	O
circulating	B-T169
igg	B-T116
at	O
time	O
of	O
pneumococcal	O
exposure	B-T080
,	O
are	O
associated	B-T080
with	I-T080
protection	B-T033
against	B-T080
carriage	B-T033
acquisition	B-T052
.	O
	
hounsfield	B-T081
unit	I-T081
recovery	B-T052
in	O
clinical	B-T080
cone	O
beam	O
ct	O
images	B-T078
of	O
the	O
thorax	O
acquired	O
for	O
image	B-T061
guided	I-T061
radiation	I-T061
therapy	I-T061
a	O
comprehensive	B-T080
artefact	O
correction	B-T169
method	B-T170
for	O
clinical	B-T080
cone	O
beam	O
ct	O
cbct	O
images	B-T078
acquired	O
for	O
image	B-T061
guided	I-T061
radiation	I-T061
therapy	I-T061
igrt	B-T061
on	O
a	O
commercial	O
system	O
is	O
presented	O
.	O
	
the	O
method	B-T170
is	O
demonstrated	O
to	O
reduce	B-T080
artefacts	O
and	O
recover	B-T052
ct	O
-like	O
hounsfield	B-T081
units	I-T081
hu	B-T081
in	O
reconstructed	O
cbct	O
images	B-T078
of	O
five	O
lung	O
cancer	O
patients	O
.	O
	
projection	B-T078
image	I-T078
based	O
artefact	O
corrections	B-T169
of	O
image	O
lag	O
,	O
detector	O
scatter	O
,	O
body	O
scatter	O
and	O
beam	B-T033
hardening	I-T033
are	O
described	O
and	O
applied	O
to	O
cbct	O
images	B-T078
of	O
five	O
lung	O
cancer	O
patients	O
.	O
	
image	B-T080
quality	I-T080
is	O
evaluated	O
through	O
visual	B-T169
appearance	B-T080
of	O
the	O
reconstructed	O
images	B-T078
,	O
hu	B-T081
-correspondence	O
with	O
the	O
planning	O
ct	O
images	B-T078
,	O
and	O
total	B-T081
volume	I-T081
hu	B-T081
error	B-T080
.	O
	
artefacts	O
are	O
reduced	B-T080
and	O
ct	O
-like	O
hus	B-T081
are	O
recovered	B-T052
in	O
the	O
artefact	O
corrected	B-T080
cbct	O
images	B-T078
.	O
	
visual	O
inspection	O
confirms	B-T033
that	O
artefacts	O
are	O
indeed	O
suppressed	B-T169
by	O
the	O
proposed	O
method	B-T170
,	O
and	O
the	O
hu	B-T081
root	B-T081
mean	I-T081
square	I-T081
difference	B-T081
between	O
reconstructed	O
cbcts	O
and	O
the	O
reference	O
ct	O
images	B-T078
are	O
reduced	B-T080
by	O
31%	O
when	O
using	O
the	O
artefact	O
corrections	B-T169
compared	B-T052
to	O
the	O
standard	B-T080
clinical	B-T080
cbct	O
reconstruction	O
.	O
	
a	O
versatile	O
artefact	O
correction	B-T169
method	B-T170
for	O
clinical	B-T080
cbct	O
images	B-T078
acquired	O
for	O
igrt	B-T061
has	O
been	O
developed	O
.	O
	
hu	B-T081
values	B-T081
are	O
recovered	B-T052
in	O
the	O
corrected	B-T080
cbct	O
images	B-T078
.	O
	
the	O
proposed	O
method	B-T170
relies	O
on	O
post	B-T170
processing	I-T170
of	O
clinical	B-T080
projection	B-T078
images	I-T078
,	O
and	O
does	O
not	O
require	O
patient	O
specific	B-T080
optimisation	B-T052
.	O
	
it	O
is	O
thus	O
a	O
powerful	O
tool	B-T170
for	O
image	B-T078
quality	B-T080
improvement	O
of	O
large	B-T081
numbers	B-T081
of	O
cbct	O
images	B-T078
.	O
	
risk	B-T033
factors	I-T033
for	O
infection	O
after	O
knee	O
arthroscopy	O
analysis	B-T062
of	O
595	O
cases	B-T169
from	O
3	O
united	O
states	O
databases	B-T170
to	O
identify	B-T080
and	O
quantify	B-T081
patient-	B-T033
and	O
procedure-related	B-T033
risk	I-T033
factors	I-T033
for	O
post-arthroscopic	B-T079
knee	B-T047
infections	I-T047
using	O
a	O
large	O
dataset	B-T170
.	O
	
an	O
administrative	B-T170
health	I-T170
care	I-T170
database	I-T170
including	O
8	O
years	B-T079
of	O
records	O
from	O
2	O
large	O
commercial	O
insurers	O
and	O
medicare	O
a	O
5%	O
random	B-T062
sample	I-T062
was	O
queried	O
to	O
identify	O
all	O
knee	O
arthroscopies	O
performed	B-T169
on	O
patients	O
aged	O
at	O
least	O
15	O
years	B-T079
using	O
current	B-T170
procedural	I-T170
terminology	I-T170
cpt	I-T170
codes	I-T170
.	O
	
each	O
cpt	B-T170
code	I-T170
was	O
designated	O
as	O
a	O
high-	O
or	O
low-complexity	O
procedure	O
,	O
with	O
the	O
former	O
typically	O
requiring	O
accessory	O
incisions	B-T061
or	O
increased	O
operative	B-T079
time	I-T079
.	O
	
deep	O
infections	O
were	O
identified	O
by	O
a	O
cpt	B-T170
code	I-T170
for	O
incision	B-T061
and	O
drainage	B-T061
within	O
90	O
days	B-T079
of	O
surgery	B-T169
.	O
	
superficial	O
infections	O
were	O
identified	O
by	O
international	B-T170
classification	I-T170
of	I-T170
diseases	I-T170
,	O
ninth	I-T170
revision	I-T170
infection	I-T170
codes	I-T170
without	O
any	O
record	B-T170
of	O
incision	B-T061
and	O
drainage	B-T061
.	O
	
patients	O
were	O
compared	O
based	O
on	O
age	O
,	O
sex	O
,	O
body	O
mass	O
index	O
,	O
tobacco	O
use	O
,	O
presence	B-T080
of	O
diabetes	B-T047
,	O
and	O
charlson	B-T081
comorbidity	I-T081
index	I-T081
.	O
	
a	O
total	O
of	O
526	O
patients	O
underwent	O
595	O
arthroscopic	O
knee	O
procedures	O
.	O
	
deep	O
postoperative	O
infections	O
occurred	O
at	O
a	O
rate	O
of	O
0.22	O
.	O
	
superficial	O
infections	O
occurred	O
at	O
a	O
rate	O
of	O
0.29	O
.	O
	
tobacco	O
use	O
and	O
morbid	B-T047
obesity	I-T047
were	O
the	O
largest	O
risk	B-T033
factors	I-T033
for	O
deep	O
and	O
superficial	O
infections	O
,	O
respectively	O
p	O
<	O
001	O
relative	B-T081
risk	I-T081
of	O
1.90	O
and	O
2.19	O
,	O
respectively	O
.	O
	
there	O
were	O
also	O
higher	O
infection	O
rates	O
among	O
patients	O
undergoing	O
relatively	O
high-complexity	O
arthroscopies	O
,	O
men	B-T098
,	O
obese	B-T047
patients	O
,	O
diabetic	B-T047
patients	O
,	O
and	O
younger	B-T079
patients	O
in	O
order	O
of	O
decreasing	O
relative	B-T081
risk	I-T081
.	O
	
increased	O
charlson	B-T081
comorbidity	I-T081
index	I-T081
was	O
associated	B-T080
with	I-T080
superficial	O
and	O
total	O
infections	O
p	O
<	O
001	O
.	O
	
post-arthroscopic	B-T079
knee	B-T047
infections	I-T047
were	O
more	O
frequent	O
among	O
morbidly	B-T047
obese	I-T047
patients	O
,	O
tobacco	B-T033
users	I-T033
,	O
patients	O
undergoing	O
relatively	O
complex	O
procedures	O
,	O
men	B-T098
,	O
obese	O
patients	O
,	O
diabetic	O
patients	O
,	O
relatively	O
young	O
patients	O
,	O
and	O
patients	O
with	O
increased	O
comorbidity	B-T078
burdens	O
in	O
this	O
study	O
population	B-T081
.	O
	
this	O
knowledge	O
may	O
allow	O
more	O
informed	O
preoperative	O
counseling	O
,	O
aid	O
surgeons	O
in	O
patient	B-T062
selection	I-T062
,	O
and	O
facilitate	O
infection	B-T061
prevention	I-T061
by	O
targeting	O
individuals	B-T098
with	O
higher	O
inherent	B-T078
risk	I-T078
.	O
	
level	O
iv	O
,	O
cross-sectional	B-T062
study	I-T062
.	O
	
association	B-T080
of	O
prenatal	O
and	O
early	O
life	O
exposure	B-T080
to	I-T080
tetrachloroethylene	B-T109
pce	B-T109
with	O
polycystic	B-T047
ovary	I-T047
syndrome	I-T047
and	O
other	O
reproductive	B-T047
disorders	I-T047
in	O
the	O
cape	O
cod	O
health	B-T062
study	I-T062
a	O
retrospective	B-T062
cohort	I-T062
study	I-T062
tetrachloroethylene	B-T109
pce	B-T109
is	O
an	O
organic	B-T080
lipophilic	B-T081
solvent	O
with	O
possible	O
neuroendocrine	O
toxicity	B-T080
.	O
	
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
determine	O
the	O
association	B-T080
of	O
prenatal	O
and	O
early	B-T079
childhood	I-T079
exposure	B-T080
to	I-T080
pce	B-T109
-	O
contaminated	B-T169
drinking	O
water	O
and	O
development	O
of	O
adult-onset	B-T033
polycystic	B-T047
ovary	I-T047
syndrome	I-T047
pcos	B-T047
,	O
endometriosis	B-T047
,	O
difficulty	B-T033
conceiving	I-T033
and	O
miscarriage	O
.	O
	
five-hundred	O
exposed	B-T080
and	O
331	O
unexposed	B-T098
female	O
participants	B-T098
born	O
between	O
1969	O
and	O
1983	O
completed	B-T080
questionnaires	B-T170
on	O
demographic	B-T078
and	O
lifestyle	O
characteristics	B-T080
,	O
and	O
reproductive	B-T047
disorders	I-T047
.	O
	
residential	B-T082
locations	I-T082
from	O
the	O
prenatal	O
period	B-T079
through	O
five	O
years	O
of	O
age	O
were	O
used	O
to	O
estimate	B-T081
early	O
life	O
pce	B-T109
exposure	B-T080
with	O
water	O
modeling	O
software	O
.	O
	
for	O
any	O
early	O
life	O
exposure	B-T080
to	I-T080
pce	B-T109
,	O
the	O
adjusted	B-T081
risk	I-T081
ratio	I-T081
for	O
pcos	B-T047
was	O
0.9	O
95%	O
ci	B-T081
0.5	O
.	O
	
no	O
statistically	B-T081
significan	I-T081
t	O
associations	B-T080
were	O
observed	B-T169
for	O
increasing	B-T169
levels	B-T080
of	O
exposure	B-T080
with	O
pcos	B-T047
or	O
the	O
other	O
reproductive	B-T047
disorders	I-T047
.	O
	
no	O
meaningful	O
associations	B-T080
were	O
found	B-T033
among	O
adult	O
women	B-T098
with	O
early	O
life	O
exposure	B-T080
to	I-T080
pce	B-T109
-	O
contaminated	B-T169
drinking	O
water	O
and	O
adult-onset	B-T033
reproductive	B-T047
disorders	I-T047
.	O
	
host	O
plant	O
affects	O
the	O
sexual	O
attractiveness	O
of	O
the	O
female	O
white-spotted	O
longicorn	O
beetle	O
,	O
anoplophora	O
malasiaca	O
anoplophora	O
malasiaca	O
coleoptera	O
cerambycidae	O
is	O
a	O
serious	O
pest	O
that	O
destroys	O
various	O
landscape	B-T082
and	O
crop	O
trees	O
in	O
japan	O
.	O
	
we	O
evaluated	O
the	O
precopulatory	B-T080
responses	O
of	O
three	O
different	O
a	O
.	O
	
malasiaca	O
populations	B-T098
collected	O
from	O
mandarin	O
orange	O
,	O
willow	O
and	O
blueberry	O
trees	O
.	O
	
most	O
of	O
the	O
males	O
accepted	O
mates	O
from	O
within	O
the	O
same	O
host	O
plant	O
population	B-T098
as	O
well	O
as	O
females	O
from	O
the	O
willow	O
and	O
blueberry	O
populations	B-T081
.	O
	
however	O
,	O
significant	O
number	O
of	O
males	O
from	O
the	O
blueberry	O
and	O
willow	O
populations	B-T098
rejected	O
females	O
from	O
the	O
mandarin	O
orange	O
population	B-T081
immediately	O
after	O
touching	O
them	O
with	O
their	O
antennae	O
.	O
	
because	O
all	O
three	O
of	O
the	O
female	O
populations	B-T098
produced	O
contact	O
sex	O
pheromones	O
on	O
their	O
elytra	O
,	O
the	O
females	O
of	O
the	O
mandarin	O
orange	O
population	B-T081
were	O
predicted	O
to	O
possess	O
extra	O
chemicals	O
that	O
repelled	O
the	O
males	O
of	O
the	O
other	O
two	O
populations	B-T081
.	O
	
β-elemene	B-T109
was	O
identified	O
as	O
a	O
key	O
component	O
that	O
was	O
only	O
found	O
in	O
mandarin	O
orange	O
-fed	O
females	O
and	O
induced	O
a	O
rejection	B-T080
response	O
in	O
willow	O
-fed	O
males	O
.	O
	
our	O
results	O
represent	O
the	O
first	O
example	O
of	O
a	O
female	O
-acquired	O
repellent	O
against	O
conspecific	O
males	O
of	O
different	O
host	O
plant	O
populations	B-T081
,	O
indicating	O
that	O
the	O
host	O
plant	O
greatly	O
affects	O
the	O
female's	O
sexual	O
attractiveness	O
.	O
	
molecular	B-T080
detection	B-T061
of	O
infection	O
homogeneity	B-T080
and	O
impact	B-T080
of	O
miltefosine	B-T109
treatment	B-T169
in	O
a	O
syrian	O
golden	O
hamster	O
model	O
of	O
leishmania	O
donovani	O
and	O
l	O
.	O
	
infantum	O
visceral	B-T047
leishmaniasis	I-T047
control	B-T169
of	O
visceral	B-T047
leishmaniasis	I-T047
caused	O
by	O
leishmania	O
infantum	O
and	O
leishmania	O
donovani	O
primarily	O
relies	O
on	O
chemotherapy	B-T061
using	O
an	O
increasingly	O
compromised	B-T033
repertoire	O
of	O
antileishmanial	O
compounds	O
.	O
	
for	O
evaluation	O
of	O
novel	B-T080
drugs	O
,	O
the	O
syrian	O
golden	O
hamster	O
is	O
considered	O
as	O
a	O
clinically	B-T080
relevant	B-T080
laboratory	B-T170
model	I-T170
.	O
	
in	O
this	O
study	B-T062
,	O
two	O
molecular	O
parasite	O
detection	O
assays	O
were	O
developed	O
targeting	B-T169
cathepsin-like	B-T116
cysteine	I-T116
protease	I-T116
b	I-T116
cpb	B-T116
dna	O
and	O
18s	O
rrna	O
to	O
achieve	O
absolute	B-T080
amastigote	O
quantification	B-T081
in	O
the	O
major	O
target	B-T169
organs	O
liver	O
and	O
spleen	O
.	O
	
both	O
quantitative	O
pcr	O
qpcr	O
techniques	O
showed	O
excellent	O
agreement	O
with	O
a	O
strong	O
correlation	B-T080
with	O
the	O
conventional	O
microscopic	O
reading	O
of	O
giemsa-stained	O
tissue	O
smears	O
.	O
	
using	O
multiple	B-T081
single	B-T081
tissue	O
pieces	O
and	O
all	O
three	O
detection	B-T033
methods	B-T170
,	O
we	O
confirmed	O
homogeneity	B-T080
of	O
infection	O
in	O
liver	O
and	O
spleen	O
and	O
the	O
robustness	B-T080
of	O
extrapolating	O
whole	B-T081
organ	I-T081
burdens	I-T081
from	O
a	O
small	B-T081
single	B-T081
tissue	O
piece	O
.	O
	
comparison	B-T052
of	O
pre	B-T079
-	O
and	O
post-treatment	B-T079
burdens	B-T078
in	O
infected	B-T033
hamsters	O
using	O
the	O
three	O
detection	B-T033
methods	B-T170
consistently	O
revealed	B-T080
a	O
stronger	O
parasite	O
reduction	B-T080
in	O
the	O
spleen	O
compared	B-T052
to	O
the	O
liver	O
,	O
indicating	O
an	O
organ	O
-	O
dependent	B-T080
clearance	B-T080
efficacy	B-T080
for	O
miltefosine	B-T109
.	O
	
in	O
conclusion	B-T078
,	O
this	O
study	B-T062
in	O
the	O
hamster	O
demonstrated	O
high	B-T080
homogeneity	B-T080
of	O
infection	O
in	O
liver	O
and	O
spleen	O
and	O
advocates	O
the	O
use	O
of	O
molecular	B-T080
detection	B-T061
methods	B-T170
for	O
assessment	O
of	O
low	B-T080
post-treatment	B-T079
tissue	O
burdens	B-T078
.	O
	
approximate	B-T080
bayesian	B-T081
computation	I-T081
for	O
estimating	B-T081
number	B-T081
concentrations	I-T081
of	O
monodisperse	B-T080
nanoparticles	O
in	O
suspension	O
by	O
optical	O
microscopy	O
we	O
present	B-T078
an	O
approximate	B-T080
bayesian	B-T081
computation	I-T081
scheme	B-T170
for	O
estimating	B-T081
number	B-T081
concentrations	I-T081
of	O
monodisperse	B-T080
diffusing	O
nanoparticles	O
in	O
suspension	O
by	O
optical	O
particle	O
tracking	O
microscopy	O
.	O
	
the	O
method	B-T169
is	O
based	B-T078
on	O
the	O
probability	B-T081
distribution	I-T081
of	O
the	O
time	B-T079
spent	B-T081
by	O
a	O
particle	O
inside	B-T082
a	O
detection	B-T061
region	B-T082
.	O
	
we	O
validate	O
the	O
method	B-T169
on	O
suspensions	O
of	O
well-controlled	B-T169
reference	O
particles	O
.	O
	
we	O
illustrate	O
its	O
usefulness	B-T080
with	O
an	O
application	B-T169
in	O
gene	B-T061
therapy	I-T061
,	O
applying	B-T169
the	O
method	B-T169
to	O
estimate	B-T081
number	B-T081
concentrations	I-T081
of	O
plasmid	O
dna	O
molecules	O
and	O
the	O
average	B-T081
number	I-T081
of	O
dna	O
molecules	O
complexed	O
with	O
liposomal	B-T109
drug	O
delivery	O
particles	O
.	O
	
gestational	O
age	O
specific	O
stillbirth	B-T033
risk	B-T078
among	O
indigenous	O
and	O
non	B-T169
-	O
indigenous	O
women	B-T098
in	O
queensland	O
,	O
australia	O
a	O
population	B-T062
based	I-T062
study	I-T062
in	O
australia	O
,	O
significant	O
disparity	O
persists	O
in	O
stillbirth	B-T033
rates	B-T081
between	O
aboriginal	B-T098
and	O
torres	B-T098
strait	I-T098
islander	I-T098
indigenous	B-T098
australian	I-T098
and	O
non	B-T169
-	O
indigenous	O
women	B-T098
.	O
	
diabetes	B-T047
,	O
hypertension	B-T047
,	O
antepartum	O
haemorrhage	O
and	O
small-for-gestational	O
age	O
sga	O
have	O
been	O
identified	B-T080
as	O
important	B-T080
contributors	O
to	O
higher	O
rates	B-T081
among	O
indigenous	O
women	B-T098
.	O
	
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
examine	O
gestational	O
age	O
specific	O
risk	B-T078
of	O
stillbirth	B-T033
associated	B-T080
with	I-T080
these	O
conditions	B-T080
among	O
indigenous	O
and	O
non	B-T169
-	O
indigenous	O
women	B-T098
.	O
	
retrospective	B-T080
population-based	B-T062
study	I-T062
of	O
all	O
singleton	O
births	B-T081
of	O
at	O
least	O
20	O
weeks	B-T079
gestation	O
or	O
at	O
least	O
400	O
grams	B-T081
birthweight	O
in	O
queensland	O
between	O
july	B-T080
2005	O
and	O
december	B-T080
2011	O
using	O
data	B-T078
from	O
the	O
queensland	O
perinatal	B-T079
data	B-T062
collection	I-T062
,	O
which	O
is	O
a	O
routinely-maintained	B-T170
database	I-T170
that	O
collects	O
data	B-T078
on	O
all	O
births	B-T081
in	O
queensland	O
.	O
	
multivariate	B-T062
logistic	I-T062
regression	I-T062
was	O
used	O
to	O
calculate	O
adjusted	B-T081
odds	I-T081
ratios	I-T081
aor	B-T081
and	O
95	O
%	O
confidence	B-T081
intervals	I-T081
,	O
adjusting	O
for	O
maternal	B-T033
demographic	B-T078
and	O
pregnancy	B-T033
factors	I-T033
.	O
	
of	O
360987	O
births	B-T081
analysed	B-T062
,	O
20273	O
5.6	O
%	O
were	O
to	O
indigenous	O
women	B-T098
and	O
340714	O
94.4	O
%	O
were	O
to	O
non	B-T169
-	O
indigenous	O
women	B-T098
.	O
	
stillbirth	B-T033
rates	B-T081
were	O
7.9	O
95	O
%	O
ci	B-T081
6.8	O
and	O
4.1	O
95	O
%	O
ci	B-T081
3.9	O
per	O
1000	O
births	B-T081
,	O
respectively	O
.	O
	
for	O
both	O
indigenous	O
and	O
non	B-T169
-	O
indigenous	O
women	B-T098
across	O
most	O
gestational	B-T079
age	O
groups	O
,	O
antepartum	O
haemorrhage	O
,	O
sga	O
,	O
pre-existing	B-T033
diabetes	I-T033
and	O
pre-existing	B-T033
hypertension	I-T033
were	O
associated	B-T080
with	I-T080
increased	B-T081
risk	B-T078
of	O
stillbirth	B-T033
.	O
	
there	O
were	O
mixed	O
results	O
for	O
pre-eclampsia	O
and	O
eclampsia	B-T047
and	O
a	O
consistently	O
raised	O
risk	B-T078
of	O
stillbirth	B-T033
was	O
not	O
seen	O
for	O
gestational	B-T047
diabetes	I-T047
.	O
	
this	O
study	B-T062
highlights	O
gestational	O
age	O
specific	O
stillbirth	B-T033
risk	B-T078
for	O
indigenous	O
and	O
non	B-T169
-	O
indigenous	O
women	B-T098
and	O
disparity	O
in	O
risk	B-T078
at	O
term	O
gestations	O
.	O
	
improving	O
access	O
to	O
and	O
utilisation	O
of	O
appropriate	B-T080
and	O
responsive	B-T169
healthcare	O
may	O
help	O
to	O
address	O
disparities	O
in	O
stillbirth	B-T033
risk	B-T078
for	O
indigenous	O
women	B-T098
.	O
	
defining	O
,	O
describing	B-T170
,	O
and	O
categorizing	B-T052
public	O
health	O
infrastructure	O
priorities	B-T079
for	O
tropical	O
cyclone	O
,	O
flood	O
,	O
storm	O
,	O
tornado	O
,	O
and	O
tsunami-related	O
disasters	O
the	O
study	B-T062
aim	O
was	O
to	O
undertake	O
a	O
qualitative	O
research	O
literature	B-T170
review	I-T170
to	O
analyze	O
available	O
databases	B-T170
to	O
define	O
,	O
describe	B-T170
,	O
and	O
categorize	B-T052
public	O
health	O
infrastructure	O
phi	O
priorities	B-T079
for	O
tropical	O
cyclone	O
,	O
flood	O
,	O
storm	O
,	O
tornado	O
,	O
and	O
tsunami-related	O
disasters	O
.	O
	
five	O
electronic	O
publication	B-T170
databases	I-T170
were	O
searched	O
to	O
define	O
,	O
describe	B-T170
,	O
or	O
categorize	B-T052
phi	O
and	O
discuss	O
tropical	O
cyclone	O
,	O
flood	O
,	O
storm	O
,	O
tornado	O
,	O
and	O
tsunami-related	O
disasters	O
and	O
their	O
impact	B-T080
on	O
phi	O
.	O
	
the	O
data	B-T078
were	O
analyzed	O
through	O
aggregation	B-T169
of	O
individual	O
articles	B-T170
to	O
create	O
an	O
overall	O
data	B-T078
description	O
.	O
	
the	O
data	O
were	O
grouped	B-T169
into	O
phi	O
themes	O
,	O
which	O
were	O
then	O
prioritized	B-T079
on	O
the	O
basis	O
of	O
degree	O
of	O
interdependency	O
.	O
	
sixty-seven	O
relevant	O
articles	B-T170
were	O
identified	O
.	O
	
phi	O
was	O
categorized	B-T052
into	O
13	O
themes	O
with	O
a	O
total	O
of	O
158	O
descriptors	B-T170
.	O
	
the	O
highest	O
priority	B-T079
phi	O
identified	O
was	O
workforce	B-T169
.	O
	
this	O
was	O
followed	O
by	O
water	O
,	O
sanitation	O
,	O
equipment	O
,	O
communication	O
,	O
physical	O
structure	O
,	O
power	O
,	O
governance	O
,	O
prevention	B-T080
,	O
supplies	B-T169
,	O
service	O
,	O
transport	O
,	O
and	O
surveillance	B-T169
.	O
	
this	O
review	B-T170
identified	O
workforce	B-T169
as	O
the	O
most	O
important	O
of	O
the	O
13	O
thematic	O
areas	O
related	O
to	O
phi	O
and	O
disasters	O
.	O
	
if	O
its	O
functionality	O
fails	O
,	O
workforce	B-T169
has	O
the	O
greatest	O
impact	O
on	O
the	O
performance	O
of	O
health	O
services	O
.	O
	
if	O
addressed	O
post-disaster	B-T079
,	O
the	O
remaining	O
forms	O
of	O
phi	O
will	O
then	O
be	O
progressively	O
addressed	O
.	O
	
these	O
findings	O
are	O
a	O
step	O
toward	O
providing	O
an	O
evidence	O
base	O
to	O
inform	O
phi	O
priorities	B-T079
in	O
the	O
disaster	O
fragment	B-T116
-based	O
discovery	B-T052
of	O
5-arylisatin	B-T109
-based	O
inhibitors	O
of	O
matrix	B-T116
metalloproteinases	I-T116
2	I-T116
and	O
13	B-T116
matrix	B-T116
metalloproteinases	I-T116
mmps	B-T116
are	O
well-established	O
targets	O
for	O
several	O
pathologies	O
.	O
	
in	O
particular	O
,	O
mmp-2	B-T116
and	O
mmp-13	B-T116
play	O
a	O
prominent	O
role	O
in	O
cancer	O
progression	O
.	O
	
in	O
this	O
study	B-T062
,	O
a	O
structure-based	O
screening	O
campaign	O
was	O
applied	O
to	O
prioritize	O
metalloproteinase	B-T116
-oriented	O
fragments	B-T116
.	O
	
this	O
computational	O
model	O
was	O
applied	O
to	O
a	O
representative	O
fragment	B-T116
set	O
from	O
the	O
publically	O
available	O
edasa	B-T170
scientific	I-T170
compound	I-T170
library	I-T170
.	O
	
these	O
fragments	B-T116
were	O
prioritized	O
,	O
and	O
the	O
top-ranking	O
hits	O
were	O
tested	O
in	O
a	O
biological	O
assay	O
to	O
validate	B-T062
the	O
model	O
.	O
	
two	O
scaffolds	B-T116
showed	O
consistent	O
activity	B-T052
in	O
the	O
assay	O
,	O
and	O
the	O
isatin-based	B-T109
compounds	I-T109
were	O
the	O
most	O
interesting	O
.	O
	
these	O
latter	O
fragments	B-T116
have	O
significant	O
potential	O
as	O
tools	O
for	O
the	O
design	B-T052
and	O
realization	O
of	O
novel	O
mmp	O
inhibitors	O
.	O
	
in	O
addition	O
to	O
their	O
micromolar	B-T052
activity	I-T052
,	O
the	O
chemical	O
synthesis	O
affords	O
flexible	B-T080
and	O
creative	B-T082
access	I-T082
to	O
their	O
incidence	B-T081
of	O
environmental	B-T080
and	O
genetic	B-T080
factors	I-T080
causing	O
congenital	O
cataract	O
in	O
children	O
of	O
lahore	O
to	O
check	O
the	O
incidence	B-T081
of	O
environmental	B-T080
and	O
genetic	B-T080
factors	I-T080
causing	O
congenital	O
cataract	O
in	O
infants	O
.	O
	
the	O
descriptive	B-T062
study	I-T062
was	O
conducted	O
at	O
layton	O
rahmatullah	O
benevolent	O
trust	O
,	O
lahore	O
,	O
pakistan	O
,	O
from	O
october	O
2013	O
to	O
april	O
2014	O
,	O
and	O
comprised	O
children	O
under	O
15	O
years	B-T079
of	O
age	O
who	O
had	O
rubella	B-T047
syndrome	I-T047
,	O
herpes	B-T047
simplex	I-T047
,	O
birth	B-T033
trauma	I-T033
,	O
trisomy	O
21	O
,	O
nance-horan	B-T047
syndrome	I-T047
or	O
lowe's	B-T047
syndrome	I-T047
.	O
	
of	O
the	O
38	O
cases	B-T081
examined	O
,	O
120	O
patients	O
were	O
diagnosed	B-T033
with	O
congenital	O
cataract	O
.	O
	
of	O
them	O
,	O
52	O
aged	O
between	O
2	O
and	O
5	O
years	B-T079
22	O
<11	O
years	B-T079
and	O
10	O
15	O
years	B-T079
.	O
	
bilateral	B-T047
congenital	I-T047
cataract	I-T047
was	O
observed	O
in	O
91	O
patients	O
and	O
unilateral	B-T047
congenital	I-T047
cataract	I-T047
in	O
29	O
.	O
	
environmental	B-T080
factors	I-T080
caused	O
72	O
cases	B-T081
and	O
genetic	B-T080
factors	I-T080
caused	O
44	O
.	O
	
congenital	O
cataract	O
predominated	B-T080
in	O
boys	O
compared	O
to	O
girls	O
.	O
	
early	O
diagnosis	B-T033
and	O
adequate	O
therapy	B-T061
requires	O
specific	O
technology	O
,	O
as	O
well	O
as	O
long-term	B-T079
and	O
permanent	B-T079
care	B-T052
transcriptome	O
and	O
metabolome	O
analyses	B-T062
of	O
glucosinolates	B-T109
in	O
two	O
broccoli	O
cultivars	O
following	O
jasmonate	B-T109
treatment	B-T169
for	O
the	O
induction	B-T169
of	O
glucosinolate	B-T109
defense	O
to	O
trichoplusia	O
ni	O
hübner	B-T170
lepidopteran	O
larvae	O
growth	O
is	O
influenced	O
by	O
host	O
plant	O
glucosinolate	B-T109
gs	B-T109
concentrations	B-T081
,	O
which	O
are	O
,	O
in	O
turn	O
,	O
influenced	O
by	O
the	O
phytohormone	B-T116
jasmonate	B-T109
ja	B-T109
.	O
	
in	O
order	O
to	O
elucidate	O
insect	O
resistance	B-T169
biomarkers	O
to	O
lepidopteran	O
pests	O
,	O
transcriptome	O
and	O
metabolome	O
analyses	B-T062
following	O
ja	B-T109
treatments	B-T169
were	O
conducted	O
with	O
two	O
broccoli	O
cultivars	O
,	O
green	O
magic	O
and	O
vi-158	O
,	O
which	O
have	O
differentially	O
induced	B-T169
indole	B-T109
gss	I-T109
,	O
neoglucobrassicin	B-T109
and	O
glucobrassicin	B-T109
,	O
respectively	O
.	O
	
to	O
test	B-T169
these	O
two	O
inducible	B-T169
gss	B-T109
on	O
growth	O
of	O
cabbage	O
looper	O
trichoplusia	O
ni	O
,	O
eight	O
neonate	O
cabbage	O
looper	O
larvae	O
were	O
placed	O
onto	O
each	O
of	O
three	O
plants	O
per	O
ja	B-T109
treatments	B-T169
0	O
,	O
100	O
,	O
200	O
,	O
400	O
µm	O
three	O
days	B-T079
after	O
treatment	B-T169
.	O
	
after	O
five	O
days	B-T079
of	O
feeding	B-T052
,	O
weight	B-T081
of	O
larvae	O
and	O
their	O
survival	B-T081
rate	I-T081
was	O
found	O
to	O
decrease	B-T081
with	O
increasing	B-T169
ja	B-T109
concentrations	B-T081
in	O
both	O
broccoli	O
cultivars	O
.	O
	
ja	B-T109
-	O
inducible	B-T169
gss	B-T109
were	O
measured	B-T080
by	O
high	O
performance	O
liquid	O
chromatography	O
.	O
	
neoglucobrassicin	B-T109
in	O
green	O
magic	O
and	O
glucobrassicin	B-T109
in	O
vi-158	O
leaves	O
were	O
increased	B-T081
in	O
a	O
dose-dependent	B-T081
manner	O
.	O
	
one	O
or	O
both	O
of	O
these	O
glucosinolates	B-T109
and/or	O
their	O
hydrolysis	O
products	O
showed	O
significant	O
inverse	B-T080
correlations	B-T080
with	O
larval	O
weight	B-T081
and	O
survival	B-T052
five	O
days	B-T079
after	O
treatment	B-T169
while	O
being	O
positively	B-T033
correlated	B-T080
with	O
the	O
number	O
of	O
days	B-T079
to	O
pupation	O
.	O
	
this	O
implies	O
that	O
these	O
two	O
ja	B-T109
-	O
inducible	B-T169
glucosinolates	B-T109
can	O
influence	O
the	O
growth	O
and	O
survival	B-T052
of	O
cabbage	O
looper	O
larvae	O
.	O
	
transcriptome	O
profiling	O
supported	O
the	O
observed	O
changes	B-T169
in	O
glucosinolate	B-T109
and	O
their	O
hydrolysis	O
product	O
concentrations	B-T081
following	O
ja	B-T109
treatments	B-T169
.	O
	
several	O
genes	O
related	O
to	O
gs	B-T109
metabolism	O
differentiate	B-T169
the	O
two	O
broccoli	O
cultivars	O
in	O
their	O
pattern	B-T082
of	O
transcriptional	O
response	O
to	O
ja	B-T109
treatments	B-T169
.	O
	
indicative	O
of	O
the	O
corresponding	O
change	B-T169
in	O
indole	B-T109
gs	I-T109
concentrations	B-T081
,	O
transcripts	O
of	O
the	O
transcription	B-T116
factor	I-T116
myb122	B-T116
,	O
core	O
structure	O
biosynthesis	B-T169
genes	O
cyp79b2	O
,	O
ugt74b1	O
,	O
sur1	O
,	O
sot16	O
,	O
sot17	O
,	O
and	O
sot18	O
,	O
an	O
indole	O
glucosinolate	O
side	O
chain	O
modification	B-T033
gene	O
igmt1	O
,	O
and	O
several	O
glucosinolate	B-T109
hydrolysis	O
genes	O
tgg1	O
,	O
tgg2	O
,	O
and	O
esm1	O
were	O
significantly	O
increased	B-T081
in	O
green	O
magic	O
statistically	O
significant	O
in	O
most	O
cases	O
at	O
400	O
µm	O
while	O
ugt74b1	O
and	O
myb122	O
were	O
significantly	O
increased	B-T081
in	O
vi-158	O
.	O
	
therefore	O
,	O
these	O
metabolite	O
and	O
transcript	O
biomarker	O
results	O
indicate	O
that	O
transcriptome	O
profiling	O
can	O
identify	B-T080
genes	O
associated	O
with	O
the	O
formation	B-T169
of	O
two	O
different	O
indole	B-T109
gs	I-T109
and	O
their	O
hydrolysis	O
products	O
.	O
	
therefore	O
,	O
these	O
metabolite	O
and	O
transcript	O
biomarkers	O
could	O
be	O
useful	O
in	O
an	O
effective	B-T080
marker	O
-	O
assisted	B-T080
breeding	O
strategy	O
for	O
resistance	B-T169
to	O
generalist	O
lepidopteran	O
pests	O
in	O
broccoli	O
and	O
potentially	O
other	O
brassica	O
vegetables	O
.	O
	
the	O
clinical	B-T033
prognosis	I-T033
of	O
implants	O
that	O
are	O
placed	O
against	O
super-erupted	B-T047
opposing	O
dentition	O
if	O
teeth	O
are	O
missing	O
,	O
super-eruption	B-T047
of	I-T047
teeth	I-T047
in	O
the	O
opposing	B-T082
arch	I-T082
can	O
occur	O
in	O
the	O
area	B-T082
and	O
can	O
change	O
the	O
occlusal	O
plane	O
.	O
	
when	O
missing	O
teeth	O
are	O
replaced	O
with	O
implants	O
,	O
the	O
oral	O
surgeon	O
must	O
determine	O
whether	O
or	O
not	O
the	O
super-erupted	O
teeth	O
need	O
to	O
be	O
treated	B-T169
in	O
order	O
to	O
normalize	B-T062
the	O
occlusal	O
plane	O
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
evaluated	O
the	O
clinical	B-T033
prognosis	I-T033
of	O
dentition	O
after	O
implant	B-T061
placement	I-T061
and	O
prosthetic	B-T061
treatment	I-T061
were	O
completed	B-T080
in	O
an	O
occlusal	O
plane	O
altered	O
by	O
super-erupted	O
teeth	O
in	O
the	O
opposing	B-T082
arch	I-T082
without	O
additional	O
treatment	B-T169
of	O
the	O
super-erupted	O
teeth	O
.	O
	
twenty-two	O
patients	O
9	O
males	O
,	O
13	O
females	O
were	O
treated	B-T169
with	O
implants	O
and	O
prosthetics	O
without	O
addressing	O
the	O
super-erupted	B-T047
opposing	O
dentition	O
from	O
april	O
2004	O
to	O
august	O
2012	O
at	O
seoul	O
national	O
university	O
bundang	O
hospital	O
.	O
	
a	O
total	O
of	O
33	O
implants	O
were	O
placed	O
.	O
	
values	O
of	O
crestal	B-T047
bone	I-T047
loss	I-T047
,	O
survival	B-T081
rates	I-T081
,	O
and	O
surgical	O
and	O
prosthetic	O
complications	O
for	O
an	O
average	O
of	O
29.6	O
months	B-T079
after	O
prosthetic	B-T061
loading	I-T061
were	O
recorded	O
.	O
	
in	O
one	O
case	O
,	O
the	O
cover	O
screw	O
was	O
exposed	O
after	O
implant	B-T061
surgery	I-T061
.	O
	
the	O
mean	O
crestal	B-T047
bone	I-T047
loss	I-T047
was	O
0.09	O
mm	O
.	O
	
of	O
the	O
33	O
implants	O
,	O
31	O
survived	O
,	O
a	O
survival	B-T081
rate	I-T081
of	O
93.94	O
.	O
	
a	O
prosthetic	O
complication	O
occurred	O
in	O
one	O
case	O
but	O
functioned	O
well	O
after	O
correction	O
.	O
	
favorable	O
clinical	O
results	O
from	O
prosthetic	O
complications	O
,	O
crestal	B-T047
bone	I-T047
loss	I-T047
,	O
and	O
implant	O
survival	B-T081
rates	I-T081
were	O
exhibited	O
in	O
implants	O
next	O
to	O
a	O
super-erupted	O
opposing	O
tooth	O
.	O
	
evaluation	B-T080
of	O
mathisen's	B-T169
technique	I-T169
for	O
ureteral	B-T061
reimplantation	I-T061
in	O
children	O
with	O
primary	B-T080
vesicoureteral	B-T047
reflux	I-T047
although	O
cross-trigonal	B-T061
ureteral	I-T061
reimplantation	I-T061
cohen	I-T061
is	O
a	O
commonly	O
used	O
technique	B-T169
in	O
children	O
,	O
it	O
represents	O
a	O
non-physiological	O
transfer	O
of	O
the	O
ureteral	O
orifices	O
and	O
may	O
prove	O
challenging	O
with	O
regard	O
to	O
endoscopic	B-T061
ureteral	I-T061
operations	I-T061
in	O
later	B-T079
life	B-T078
.	O
	
in	O
1964	O
,	O
mathisen	O
described	B-T078
an	O
alternative	O
method	B-T169
of	O
ureteral	B-T061
reimplantation	I-T061
with	O
lateralization	B-T169
of	O
the	O
neohiatus	B-T082
,	O
creating	O
an	O
orthotopic	B-T082
course	B-T079
of	O
the	O
submucosal	O
ureter	O
.	O
	
we	O
have	O
evaluated	B-T052
success	B-T080
and	O
complication	B-T078
rates	B-T081
of	O
both	O
techniques	B-T169
that	O
were	O
applied	B-T169
sequentially	B-T169
at	O
our	O
departments	O
.	O
	
forty-eight	O
consecutive	B-T080
patients	O
83	O
ureters	B-T098
,	O
24	O
males	B-T098
/24	O
females	B-T098
following	O
mathisen	B-T061
reimplantation	I-T061
were	O
compared	B-T052
with	O
53	O
consecutive	B-T080
patients	O
98	O
ureters	B-T098
,	O
30	O
males	B-T098
/23	O
females	B-T098
following	O
cohen	B-T061
reimplantation	I-T061
.	O
	
inclusion	B-T080
criteria	B-T078
were	O
primary	B-T080
vesicoureteral	B-T047
reflux	I-T047
vur	B-T047
and	O
no	O
previous	B-T079
intervention	B-T061
.	O
	
reflux	B-T047
grades	O
mathisen	O
58	O
ureters	B-T098
/69	O
vur	B-T033
iii	I-T033
cohen	O
66	O
ureters	B-T098
/66	O
vur	B-T033
iii	I-T033
and	O
the	O
occurence	O
of	O
other	O
complicating	B-T169
factors	B-T169
ureteroceles	O
,	O
megaureters	O
,	O
posterior	O
urethral	O
valves	O
in	O
both	O
groups	B-T078
were	O
comparable	B-T052
.	O
	
after	O
cohen's	B-T061
reimplantation	I-T061
there	O
were	O
no	O
immediate	B-T079
complications	O
requiring	O
intervention	B-T061
during	B-T079
follow-up	O
mean	B-T081
28.2	O
months	B-T079
three	O
patients	O
5.6	O
suffered	O
febrile	B-T047
urinary	I-T047
tract	I-T047
infections	I-T047
utis	B-T047
,	O
of	O
which	O
one	O
1.8	O
was	O
diagnosed	B-T033
with	O
a	O
persisting	B-T078
vur	B-T047
.	O
	
persistent	B-T078
hydronephroses	B-T047
ii	O
sfu	B-T047
were	O
recorded	O
in	O
six	O
patients	O
13.2	O
.	O
	
after	O
reimplantation	B-T061
using	O
mathisen's	B-T169
technique	I-T169
,	O
two	O
patients	O
4.1	O
suffered	O
significant	B-T078
intravesical	B-T047
bleeding	I-T047
during	O
follow-up	O
mean	B-T081
23.06	O
months	B-T079
four	O
patients	O
8.3	O
suffered	O
febrile	B-T047
utis	I-T047
,	O
and	O
seven	O
patients	O
14.5	O
were	O
diagnosed	B-T033
with	O
persisting	B-T078
vur	B-T047
after	O
a	O
mean	B-T081
follow-up	O
of	O
10.8	O
months	B-T079
.	O
	
the	O
patients	O
with	O
persistent	B-T078
vur	B-T047
had	O
more	O
commonly	O
high-grade	B-T080
iv	O
and	O
v	O
vur	B-T047
initially	O
,	O
compared	B-T052
to	O
the	O
whole	B-T078
group	I-T078
.	O
	
two	O
patients	O
4.1	O
had	O
persistent	B-T078
hydronephroses	B-T047
ii	O
sfu	B-T047
.	O
	
mathisen's	B-T169
technique	I-T169
for	O
ureteral	B-T061
reimplantation	I-T061
yielded	O
a	O
significantly	B-T078
p	O
=	O
0.0256	O
patients	O
,	O
p	O
=	O
0.006	O
ureterorenal	B-T081
units	I-T081
lower	B-T082
success	B-T080
rate	B-T081
85.5	O
patients	O
,	O
89.2	O
ureterorenal	B-T081
units	I-T081
in	O
comparison	B-T052
with	O
cohen's	B-T169
technique	I-T169
98.2	O
patients	O
,	O
99%	O
ureterorenal	B-T081
units	I-T081
.	O
	
although	O
there	O
was	O
no	O
intervention	B-T061
for	O
obstruction	O
,	O
persistent	B-T078
hydronephrosis	B-T047
was	O
more	O
common	O
in	O
the	O
cohen	B-T078
group	I-T078
13.2	O
vs	O
.	O
	
4.1	O
,	O
n.s	O
.	O
	
despite	O
the	O
advantages	O
of	O
an	O
orthotopic	B-T082
ureteral	O
orifice	O
close	O
to	O
the	O
bladder	O
neck	O
,	O
as	O
achieved	O
by	O
mathisen's	B-T061
reimplantation	I-T061
,	O
cross-trigonal	B-T061
ureteral	I-T061
reimplantation	I-T061
proved	O
more	O
reliable	B-T170
for	O
vur	B-T047
correction	B-T169
.	O
	
as	O
regards	O
optimizing	O
the	O
results	O
,	O
patient	B-T062
selection	I-T062
for	O
either	O
technique	B-T169
could	O
prove	B-T080
essential	I-T080
.	O
	
nevertheless	O
,	O
as	O
regards	O
the	O
difficulties	B-T080
with	O
ectopic	B-T082
ureteral	O
orifices	O
in	O
the	O
cohen	B-T169
technique	I-T169
in	O
the	O
long-term	B-T079
follow-up	O
,	O
the	O
concept	B-T078
of	O
anatomic	B-T080
,	O
orthotopic	B-T082
ureteral	B-T061
reimplantation	I-T061
should	O
be	O
pursued	O
and	O
the	O
technique	B-T169
the	O
use	B-T169
of	I-T169
neonatal	B-T079
extracorporeal	B-T061
life	I-T061
support	I-T061
in	O
pediatric	B-T080
cardiac	O
intensive	O
care	O
unit	O
the	O
aim	O
of	O
the	O
study	O
is	O
to	O
evaluate	O
extracorporeal	B-T061
life	I-T061
support	I-T061
system	I-T061
ecls	B-T061
employed	O
in	O
neonates	O
in	O
pediatric	B-T080
cardiac	O
intensive	O
care	O
unit	O
.	O
	
twenty-five	O
neonates	O
that	O
required	O
ecls	B-T061
in	O
between	O
november	O
2010	O
and	O
november	O
2015	O
were	O
evaluated	O
.	O
	
the	O
median	B-T081
age	O
was	O
12	O
days	B-T079
range	B-T081
3-28	O
days	B-T079
and	O
the	O
median	B-T081
body	O
weight	O
was	O
3	O
kg	O
range	B-T081
2.5	O
kg	O
.	O
	
venoarterial	B-T082
ecls	B-T061
was	O
performed	B-T169
in	O
all	O
of	O
the	O
cases	O
.	O
	
ascendan	O
aorta	O
-	O
right	O
atrial	O
cannulation	B-T061
in	O
22	O
patients	O
and	O
neck	O
cannulation	B-T061
in	O
three	O
patients	O
were	O
performed	B-T169
.	O
	
the	O
reason	O
for	O
ecls	B-T061
was	O
e-cpr	B-T061
in	O
two	O
patients	O
,	O
inability	B-T033
to	I-T033
wean	I-T033
from	O
cardiopulmonary	B-T061
bypass	I-T061
cpb	B-T061
in	O
seven	O
patients	O
,	O
respiratory	O
insufficiency	O
and	O
hypoxia	O
in	O
nine	O
patients	O
,	O
low	O
cardiac	O
output	O
lcos	O
in	O
seven	O
patients	O
.	O
	
median	B-T081
duration	B-T079
of	O
ecls	B-T061
was	O
four	O
days	B-T079
range	B-T081
1-15	O
.	O
	
hemorrhagic	B-T080
complications	O
developed	O
in	O
15	O
,	O
renal	O
complications	O
in	O
13	O
,	O
pulmonary	O
complications	O
in	O
12	O
,	O
infectious	B-T047
complications	O
in	O
11	O
,	O
neurologic	O
complications	O
in	O
three	O
and	O
mechanical	O
complications	O
in	O
two	O
of	O
the	O
patients	O
.	O
	
weaning	B-T033
was	O
successful	B-T080
in	O
15	O
of	O
the	O
patients	O
.	O
	
eleven	O
patients	O
were	O
successfully	B-T080
discharged	O
.	O
	
ecls	B-T061
is	O
an	O
important	B-T080
treatment	B-T061
option	I-T061
that	O
is	O
performed	B-T169
successfully	B-T080
in	O
many	O
centers	O
around	O
the	O
world	B-T098
to	O
maintain	B-T052
life	B-T061
support	I-T061
in	O
patients	O
unresponsive	B-T169
to	I-T169
medical	I-T169
treatment	I-T169
.	O
	
the	O
utilization	B-T169
of	O
this	O
modality	B-T078
especially	O
in	O
newborns	O
with	O
congenital	O
heart	O
disease	O
medicare	O
claims	B-T170
indicators	B-T169
of	O
healthcare	O
utilization	B-T169
differences	B-T080
after	O
hospitalization	O
for	O
ischemic	B-T047
stroke	I-T047
race	B-T098
,	O
gender	O
,	O
and	O
caregiving	B-T052
effects	B-T080
background	O
differences	B-T080
in	O
healthcare	O
utilization	B-T169
after	O
stroke	B-T047
may	O
partly	O
explain	O
race	B-T098
or	O
gender	O
differences	B-T080
in	O
stroke	B-T047
outcomes	O
and	O
identify	O
factors	B-T169
that	O
might	O
reduce	B-T080
post	B-T079
-	O
acute	B-T047
stroke	I-T047
care	B-T081
costs	I-T081
.	O
	
aim	O
to	O
examine	O
systematic	B-T169
differences	B-T080
in	O
medicare	O
claims	B-T170
for	O
healthcare	O
utilization	B-T169
after	O
hospitalization	O
for	O
ischemic	B-T047
stroke	I-T047
in	O
a	O
us	O
population	B-T098
-based	O
sample	O
.	O
	
methods	O
claims	B-T170
were	O
examined	B-T033
over	O
a	O
six-month	B-T079
period	B-T079
after	O
hospitalization	O
for	O
279	O
ischemic	B-T047
stroke	I-T047
survivors	O
65	O
years	B-T079
or	O
older	B-T098
from	O
the	O
reasons	B-T078
for	O
geographic	B-T078
and	O
racial	B-T033
differences	I-T033
in	O
stroke	B-T047
regards	B-T047
study	O
.	O
	
statistical	B-T062
analyses	I-T062
examined	B-T033
differences	B-T080
in	O
post	B-T079
-	O
acute	O
healthcare	O
utilization	B-T169
,	O
adjusted	O
for	O
pre	B-T079
-	O
stroke	B-T047
utilization	B-T169
,	O
as	O
a	O
function	B-T169
of	O
race	B-T098
african-american	B-T098
vs	O
.	O
	
white	B-T098
,	O
gender	O
,	O
age	O
,	O
stroke	O
belt	O
residence	B-T082
,	O
income	B-T081
,	O
medicaid	O
dual-eligibility	O
,	O
charlson	B-T170
comorbidity	I-T170
index	I-T170
,	O
and	O
whether	O
the	O
person	B-T098
lived	B-T052
with	O
an	O
available	B-T169
caregiver	O
.	O
	
results	O
after	O
adjusting	O
for	O
covariates	O
,	O
women	B-T098
were	O
more	O
likely	O
than	O
men	B-T098
to	O
receive	B-T080
home	O
health	O
care	O
and	O
to	O
use	O
emergency	O
department	O
services	O
during	O
the	O
post	B-T079
-	O
acute	O
care	O
period	B-T079
.	O
	
these	O
effects	B-T080
were	O
maintained	B-T169
even	O
after	O
further	B-T082
adjustment	B-T169
for	O
acute	B-T047
stroke	I-T047
severity	B-T080
.	O
	
african-americans	B-T098
had	O
more	O
home	O
health	O
care	O
visits	O
than	O
whites	B-T098
among	O
patients	O
who	O
received	B-T080
some	O
home	O
health	O
care	O
.	O
	
having	O
a	O
co-residing	B-T052
caregiver	O
was	O
associated	B-T080
with	I-T080
reduced	B-T080
acute	O
hospitalization	O
length	B-T079
of	I-T079
stay	I-T079
and	O
fewer	O
post	B-T079
-	O
acute	O
emergency	O
department	O
and	O
primary	O
care	O
physician	O
visits	O
.	O
	
conclusions	O
underutilization	O
of	O
healthcare	O
after	O
stroke	B-T047
does	O
not	O
appear	O
to	O
explain	O
poorer	O
long-term	B-T079
stroke	B-T047
outcomes	O
for	O
women	B-T098
and	O
african-americans	B-T098
in	O
this	O
epidemiologically	B-T169
-derived	O
sample	O
.	O
	
caregiver	O
availability	B-T169
may	O
contribute	B-T052
to	O
reduced	B-T080
formal	B-T052
care	I-T052
and	O
cost	B-T081
during	O
the	O
post	B-T079
-	O
acute	O
period	B-T079
.	O
	
do	O
dynamic	B-T170
global	I-T170
vegetation	I-T170
models	I-T170
capture	O
the	O
seasonality	B-T079
of	O
carbon	O
fluxes	O
in	O
the	O
amazon	O
basin	O
a	O
data	B-T078
-	O
model	B-T170
intercomparison	O
to	O
predict	O
forest	O
response	O
to	O
long-term	B-T079
climate	O
change	O
with	O
high	O
confidence	O
requires	O
that	O
dynamic	B-T170
global	I-T170
vegetation	I-T170
models	I-T170
dgvms	B-T170
be	O
successfully	O
tested	O
against	O
ecosystem	O
response	O
to	O
short-term	B-T079
variations	B-T079
in	O
environmental	B-T082
drivers	I-T082
,	O
including	O
regular	O
seasonal	B-T079
patterns	I-T079
.	O
	
here	O
,	O
we	O
used	O
an	O
integrated	O
dataset	B-T170
from	O
four	O
forests	O
in	O
the	O
brasil	B-T170
flux	I-T170
network	I-T170
,	O
spanning	O
a	O
range	O
of	O
dry-season	B-T079
intensities	B-T080
and	O
lengths	B-T081
,	O
to	O
determine	O
how	O
well	O
four	O
state-of-the-art	O
models	B-T170
ibis	B-T170
,	O
ed2	B-T170
,	O
jules	B-T170
,	O
and	O
clm3.5	B-T170
simulated	O
the	O
seasonality	B-T079
of	O
carbon	O
exchanges	O
in	O
amazonian	O
tropical	O
forests	O
.	O
	
we	O
found	O
that	O
most	O
dgvms	B-T170
poorly	O
represented	O
the	O
annual	O
cycle	O
of	O
gross	B-T081
primary	I-T081
productivity	I-T081
gpp	B-T081
,	O
of	O
photosynthetic	B-T081
capacity	I-T081
pc	B-T081
,	O
and	O
of	O
other	O
fluxes	O
and	O
pools	O
.	O
	
models	B-T170
simulated	O
consistent	O
dry-season	B-T079
declines	B-T081
in	O
gpp	B-T081
in	O
the	O
equatorial	O
amazon	O
manaus	O
k34	O
,	O
santarem	O
k67	O
,	O
and	O
caxiuanã	O
cax	O
a	O
contrast	O
to	O
observed	O
gpp	B-T081
increases	O
.	O
	
model	B-T170
simulated	O
dry-season	B-T079
gpp	B-T081
reductions	B-T080
were	O
driven	O
by	O
an	O
external	O
environmental	B-T082
factor	B-T169
,	O
'	O
soil	B-T033
water	I-T033
stress	I-T033
'	O
and	O
consequently	O
by	O
a	O
constant	O
or	O
decreasing	O
photosynthetic	O
infrastructure	O
pc	B-T081
,	O
while	O
observed	O
dry-season	B-T079
gpp	B-T081
resulted	O
from	O
a	O
combination	O
of	O
internal	O
biological	B-T080
leaf	O
-flush	O
and	O
abscission	O
and	O
increased	O
pc	B-T081
and	O
environmental	B-T082
incoming	O
radiation	O
causes	O
.	O
	
moreover	O
,	O
we	O
found	O
models	B-T170
generally	O
overestimated	O
observed	O
seasonal	O
net	B-T081
ecosystem	I-T081
exchange	I-T081
nee	B-T081
and	O
respiration	O
re	O
at	O
equatorial	O
locations	O
.	O
	
in	O
contrast	O
,	O
a	O
southern	O
amazon	O
forest	O
jarú	O
rja	O
exhibited	O
dry-season	B-T079
declines	B-T081
in	O
gpp	B-T081
and	O
re	O
consistent	O
with	O
most	O
dgvms	B-T170
simulations	B-T062
.	O
	
while	O
water	O
limitation	O
was	O
represented	O
in	O
models	B-T170
and	O
the	O
primary	O
driver	O
of	O
seasonal	O
photosynthesis	O
in	O
southern	O
amazonia	O
,	O
changes	O
in	O
internal	O
biophysical	O
processes	O
,	O
light-harvesting	O
adaptations	O
e.g	O
,	O
variations	O
in	O
leaf	B-T170
area	I-T170
index	I-T170
lai	B-T170
and	O
increasing	O
leaf	O
-level	O
assimilation	O
rate	B-T081
related	O
to	O
leaf	O
demography	O
,	O
and	O
allocation	O
lags	O
between	O
leaf	O
and	O
wood	O
,	O
dominated	O
equatorial	O
amazon	O
carbon	O
flux	O
dynamics	O
and	O
were	O
deficient	O
or	O
absent	O
from	O
current	O
model	B-T170
formulations	O
.	O
	
correctly	O
simulating	O
flux	O
seasonality	B-T079
at	O
tropical	O
forests	O
requires	O
a	O
greater	O
understanding	O
and	O
the	O
incorporation	O
of	O
internal	O
biophysical	O
mechanisms	O
in	O
future	O
model	B-T170
developments	I-T170
.	O
	
blood	O
pressure	O
and	O
all-cause	B-T033
mortality	I-T033
by	O
level	B-T080
of	O
cognitive	O
function	O
in	O
the	O
elderly	B-T098
results	B-T033
from	O
a	O
population-based	B-T062
study	I-T062
in	O
rural	O
greece	O
this	O
study	B-T062
aimed	B-T078
to	O
investigate	B-T169
whether	O
the	O
effect	B-T080
of	O
blood	O
pressure	O
bp	O
on	O
mortality	B-T033
differs	O
by	O
levels	B-T080
of	O
cognitive	O
function	O
.	O
	
the	O
associations	B-T080
of	O
brachial	B-T082
systolic	O
bp	O
,	O
diastolic	O
bp	O
,	O
mean	B-T033
arterial	I-T033
pressure	I-T033
map	B-T033
,	O
and	O
pulse	O
pressure	O
with	O
all-cause	B-T033
mortality	I-T033
were	O
prospectively	B-T033
explored	I-T033
follow-up	O
7.0	O
years	B-T079
in	O
660	O
community-dwelling	O
individuals	B-T098
60	B-T033
years	I-T033
using	O
adjusted	B-T081
cox	I-T081
models	I-T081
,	O
stratified	B-T080
by	O
cognitive	O
impairment	O
mini-mental	O
state	O
examination	O
mmse	O
<24	O
.	O
	
no	B-T080
association	I-T080
between	O
brachial	B-T082
bp	O
variables	B-T080
and	O
mortality	B-T033
was	O
shown	O
for	O
the	O
total	B-T080
sample	O
in	O
quartiles	B-T062
analysis	I-T062
however	O
,	O
map	B-T033
in	O
the	O
highest	B-T080
quartile	I-T080
,	O
compared	B-T052
with	O
the	O
second	B-T081
,	O
was	O
associated	B-T080
with	I-T080
mortality	B-T033
hazard	B-T081
ratio	I-T081
,	O
1.85	O
95%	O
confidence	B-T081
intervals	I-T081
,	O
1.09	O
among	O
cognitively	O
impaired	O
individuals	B-T098
.	O
	
the	O
fractional-polynomials	B-T062
approach	I-T062
for	O
bp	O
confirmed	B-T033
this	O
finding	B-T033
and	O
further	B-T082
showed	O
,	O
solely	B-T081
in	O
the	O
mmse	O
<24	O
subcohort	B-T081
,	O
u-shaped	B-T079
trends	I-T079
of	O
map	B-T033
and	O
systolic	O
bp	O
,	O
with	O
increased	B-T081
mortality	B-T078
risk	I-T078
in	O
extremely	B-T080
low	B-T080
or	I-T080
high	I-T080
values	I-T080
no	O
such	O
pattern	B-T082
was	O
evident	B-T078
for	O
patients	O
with	O
mmse	O
24	O
.	O
	
elderly	B-T098
individuals	B-T098
with	O
cognitive	O
impairment	O
might	O
be	O
more	B-T081
susceptible	B-T169
to	O
the	O
detrimental	O
effects	O
of	O
low	B-T080
and	O
elevated	B-T080
map	B-T033
and	O
systolic	O
bp	O
.	O
	
hypovitaminosis	B-T047
d	I-T047
and	O
associated	O
cardiometabolic	B-T078
risk	I-T078
in	O
women	B-T098
with	O
pcos	B-T047
women	B-T098
with	O
polycystic	B-T047
ovary	I-T047
syndrome	I-T047
pcos	B-T047
frequently	O
suffer	O
from	O
metabolic	B-T047
disturbances	I-T047
like	O
insulin	O
resistance	O
,	O
hypertension	B-T047
and	O
atherogenic	B-T047
dyslipidemia	I-T047
.	O
	
accumulating	B-T033
evidences	O
suggest	O
that	O
vitamin	B-T047
d	I-T047
deficiency	I-T047
is	O
common	O
in	O
pcos	B-T047
and	O
may	O
be	O
associated	B-T080
with	I-T080
metabolic	B-T047
and	O
endocrinal	B-T047
dysfunctions	I-T047
in	O
pcos	B-T047
.	O
	
thus	O
women	B-T098
with	O
pcos	B-T047
may	O
be	O
at	O
elevated	O
risk	B-T078
of	O
cardiovascular	B-T047
disease	I-T047
.	O
	
present	O
study	B-T062
aims	O
to	O
evaluate	O
vitamin	B-T109
d	I-T109
status	O
and	O
to	O
assess	O
its	O
association	O
with	O
metabolic	B-T047
and	O
endocrinal	B-T047
dysregulations	I-T047
in	O
women	B-T098
with	O
pcos	B-T047
,	O
which	O
might	O
help	O
in	O
early	B-T061
identification	I-T061
and	O
prevention	B-T061
of	O
future	O
symptomatic	B-T169
cardiac	B-T047
disease	I-T047
.	O
	
a	O
total	O
of	O
44	O
women	B-T098
with	O
pcos	B-T047
,	O
diagnosed	O
by	O
rotterdam	B-T170
criteria	I-T170
and	O
45	O
healthy	B-T080
control	I-T080
without	O
pcos	B-T047
,	O
were	O
evaluated	O
for	O
vitamin	B-T109
d	I-T109
and	O
cardiometabolic	B-T033
risk	I-T033
factors	I-T033
,	O
including	O
fasting	O
plasma	O
glucose	O
,	O
insulin	O
resistance	O
,	O
dyslipidemia	B-T047
,	O
hs-crp	B-T033
.	O
	
that	O
apart	O
,	O
several	O
endocrinal	B-T169
parameters	O
of	O
hyperandrogenism	B-T047
were	O
also	O
examined	O
.	O
	
several	O
correlation	B-T062
studies	I-T062
were	O
determined	O
to	O
establish	O
the	O
role	O
of	O
vitamin	B-T109
d	I-T109
as	O
a	O
cardiometabolic	B-T033
risk	I-T033
factor	I-T033
in	O
pcos	B-T047
.	O
	
results	O
were	O
expressed	O
as	O
mean	O
and	O
were	O
statistically	B-T062
analysed	I-T062
using	O
spss	O
software	O
version	O
16	O
,	O
unpaired	B-T170
student's	I-T170
t-test	I-T170
and	O
pearson's	B-T081
correlation	I-T081
coefficient	I-T081
.	O
	
we	O
found	O
lower	O
levels	O
of	O
vitamin	B-T109
d	I-T109
,	O
which	O
was	O
statistically	O
significant	O
as	O
compared	O
to	O
healthy	B-T080
controls	I-T080
.	O
	
hyperinsulinemia	B-T047
,	O
rise	O
in	O
insulin	O
resistance	O
and	O
marked	O
dyslipidemia	B-T047
was	O
observed	O
in	O
the	O
present	O
study	B-T062
.	O
	
another	O
relevant	O
finding	O
was	O
significant	O
correlation	O
of	O
vitamin	B-T109
d	I-T109
with	O
insulin	B-T116
and	O
homeostatic	O
model	O
of	O
assessment-	O
insulin	O
resistance	O
index	O
homa-ir	O
.	O
	
hypovitaminosis	B-T047
d	I-T047
was	O
prevalent	O
in	O
pcos	B-T047
.	O
	
this	O
was	O
related	O
to	O
metabolic	B-T047
and	O
hormonal	B-T033
disorders	I-T033
in	O
pcos	B-T047
.	O
	
possibly	O
this	O
combined	O
with	O
impaired	B-T033
fasting	I-T033
glucose	I-T033
,	O
ir	O
and	O
dyslipidemia	B-T047
,	O
could	O
account	O
for	O
cardio	B-T078
vascular	I-T078
risks	I-T078
in	O
pcos	B-T047
.	O
	
further	O
prospective	O
observational	B-T170
studies	I-T170
and	O
randomized	B-T062
control	I-T062
trials	I-T062
are	O
required	O
to	O
explore	O
the	O
above	O
family	O
close	B-T033
but	O
friends	B-T098
closer	B-T033
exploring	O
social	O
support	O
and	O
resilience	O
in	O
older	B-T098
spousal	O
dementia	O
carers	O
spousal	O
dementia	O
carers	O
have	O
unique	O
support	O
needs	B-T080
they	O
are	O
likely	O
to	O
disengage	B-T080
from	O
their	O
existing	O
social	B-T098
networks	I-T098
as	O
they	O
need	O
to	O
devote	O
more	O
time	B-T079
to	O
caring	O
as	O
the	O
disease	O
progresses	O
.	O
	
previously	O
we	O
showed	O
that	O
support	O
resources	B-T078
can	O
facilitate	O
resilience	O
in	O
carers	O
,	O
but	O
the	O
relationship	B-T080
is	O
complex	B-T080
and	O
varies	O
by	O
relationship	B-T169
type	I-T169
.	O
	
the	O
current	O
paper	O
aims	O
to	O
explore	O
social	O
support	O
as	O
a	O
key	O
component	O
of	O
resilience	O
to	O
identify	O
the	O
availability	B-T169
,	O
function	B-T169
and	O
perceived	B-T169
functional	I-T169
aspects	I-T169
of	O
support	O
provided	O
to	O
older	B-T098
spousal	O
dementia	O
carers	O
.	O
	
we	O
conducted	O
23	O
in-depth	B-T052
qualitative	I-T052
interviews	I-T052
with	O
spousal	O
carers	O
from	O
two	O
carer	O
support	O
groups	O
and	O
a	O
care	O
home	O
in	O
north	O
west	O
england	O
.	O
	
family	O
and	O
friends	B-T098
served	O
a	O
wide	O
range	O
of	O
functions	B-T169
but	O
were	O
equally	O
available	O
to	O
resilient	B-T098
and	O
non-resilient	B-T098
participants	I-T098
.	O
	
family	B-T061
support	I-T061
was	O
perceived	O
as	O
unhelpful	O
if	O
it	O
created	B-T052
feelings	O
of	O
over-dependence	B-T080
.	O
	
participants	B-T098
were	O
less	O
likely	O
to	O
resist	B-T169
involvement	I-T169
of	O
grandchildren	O
due	O
to	O
their	O
relatively	O
narrow	O
and	O
low-level	O
support	O
functions	O
.	O
	
friend	B-T098
support	O
was	O
perceived	O
as	O
most	O
helpful	B-T080
when	O
it	O
derived	O
from	O
those	O
in	O
similar	O
circumstances	B-T080
.	O
	
neighbours	B-T098
played	O
a	O
functionally	O
unique	O
role	O
of	O
crisis	B-T061
management	I-T061
.	O
	
these	O
perceptions	O
may	O
moderate	B-T080
the	O
effect	B-T080
of	O
support	O
on	O
resilience	O
.	O
	
family	B-T061
and	O
friend	B-T098
support	O
is	O
not	O
always	O
sufficient	B-T080
to	O
facilitate	O
resilience	O
.	O
	
support	O
functions	O
facilitate	O
resilience	O
only	O
if	O
they	O
are	O
perceived	O
to	O
match	O
need	B-T080
.	O
	
implications	B-T033
of	O
these	O
findings	B-T169
measure	O
up	O
pressure	O
down	O
provider	O
toolkit	O
to	O
improve	O
hypertension	B-T047
control	O
hypertension	B-T047
is	O
one	O
of	O
the	O
most	O
important	O
risk	B-T033
factors	I-T033
for	O
heart	B-T047
disease	I-T047
,	O
stroke	B-T047
,	O
kidney	B-T047
failure	I-T047
,	O
and	O
diabetes	B-T047
complications	I-T047
.	O
	
nearly	O
one	O
in	O
three	O
americans	B-T098
adults	O
has	O
high	B-T047
blood	I-T047
pressure	I-T047
,	O
and	O
the	O
cost	B-T081
associated	B-T080
with	I-T080
treating	B-T061
this	O
condition	B-T047
is	O
staggering	O
.	O
	
the	O
measure	O
up	O
pressure	O
down	O
provider	O
toolkit	O
to	O
improve	O
hypertension	B-T047
control	O
is	O
a	O
resource	B-T078
developed	B-T169
by	O
the	O
american	O
medical	O
group	O
foundation	O
in	O
partnership	O
with	O
the	O
american	O
medical	O
group	O
association	O
.	O
	
the	O
goal	B-T170
of	O
this	O
toolkit	B-T170
is	O
to	O
mobilize	O
health	O
care	O
practitioners	O
to	O
work	O
together	B-T080
through	O
team	O
-based	O
approaches	O
to	O
achieve	O
an	O
80%	O
control	O
rate	B-T081
of	O
high	B-T047
blood	I-T047
pressure	I-T047
among	O
their	O
patient	O
population	O
.	O
	
the	O
toolkit	B-T170
can	O
be	O
used	O
by	O
health	O
educators	O
,	O
clinic	O
administrators	O
,	O
physicians	O
,	O
students	B-T098
,	O
and	O
other	O
clinic	O
staff	O
as	O
a	O
step-by-step	O
resource	B-T078
for	O
developing	B-T169
the	O
infrastructure	B-T062
needed	O
to	O
better	O
identify	O
and	O
treat	B-T061
individuals	B-T098
with	O
high	B-T047
blood	I-T047
pressure	I-T047
or	O
other	O
chronic	B-T047
conditions	I-T047
.	O
	
potentiation	B-T061
of	O
lps	B-T109
-	O
induced	O
apoptotic	O
cell	O
death	O
in	O
human	O
hepatoma	O
hepg2	O
cells	O
by	O
aspirin	B-T109
via	O
ros	O
and	O
mitochondrial	B-T033
dysfunction	I-T033
protection	B-T033
by	O
n-acetyl	B-T116
cysteine	I-T116
cytotoxicity	O
and	O
inflammation	O
-	O
associated	O
toxic	B-T080
responses	O
have	O
been	O
observed	B-T169
to	O
be	O
induced	B-T169
by	O
bacterial	B-T080
lipopolysaccharides	B-T109
lps	B-T109
in	B-T080
vitro	I-T080
and	O
in	B-T082
vivo	I-T082
respectively	O
.	O
	
use	O
of	O
nonsteroidal	O
anti-inflammatory	O
drugs	O
nsaids	O
,	O
such	O
as	O
aspirin	B-T109
,	O
has	O
been	O
reported	O
to	O
be	O
beneficial	O
in	O
inflammation	O
-	O
associated	O
diseases	O
like	O
cancer	O
,	O
diabetes	B-T047
and	O
cardiovascular	B-T047
disorders	I-T047
.	O
	
their	O
precise	O
molecular	B-T080
mechanisms	B-T169
,	O
however	O
,	O
are	O
not	O
clearly	O
understood	O
.	O
	
our	O
previous	O
studies	B-T062
on	O
aspirin	B-T109
treated	B-T061
hepg2	O
cells	O
strongly	O
suggest	O
cell	O
cycle	O
arrest	O
and	O
induction	B-T169
of	O
apoptosis	O
associated	B-T080
with	I-T080
mitochondrial	B-T033
dysfunction	I-T033
.	O
	
in	O
the	O
present	O
study	B-T062
,	O
we	O
have	O
further	O
demonstrated	O
that	O
hepg2	O
cells	O
treated	B-T061
with	I-T061
lps	B-T109
alone	O
or	O
in	O
combination	B-T080
with	O
aspirin	B-T109
induces	B-T169
subcellular	O
toxic	O
responses	O
which	O
are	O
accompanied	O
by	O
increase	B-T169
in	O
reactive	O
oxygen	O
species	O
ros	O
production	O
,	O
oxidative	O
stress	O
,	O
mitochondrial	B-T033
respiratory	I-T033
dysfunction	I-T033
and	O
apoptosis	O
.	O
	
the	O
lps	B-T109
/	O
aspirin	B-T109
induced	B-T169
toxicity	O
was	O
attenuated	B-T052
by	O
pre-treatment	B-T079
of	O
cells	O
with	O
n-acetyl	B-T116
cysteine	I-T116
nac	B-T116
.	O
	
alterations	O
in	O
oxidative	O
stress	O
and	O
glutathione	B-T116
-	O
dependent	B-T080
redox-homeostasis	O
were	O
more	O
pronounced	O
in	O
mitochondria	O
compared	B-T052
to	O
extra	B-T082
-	O
mitochondrial	O
cellular	O
compartments	O
.	O
	
pre-treatment	B-T079
of	O
hepg2	O
cells	O
with	O
nac	B-T116
exhibited	O
a	O
selective	O
protection	B-T033
in	O
redox	O
homeostasis	O
and	O
mitochondrial	B-T033
dysfunction	I-T033
.	O
	
our	O
results	B-T033
suggest	O
that	O
the	O
altered	B-T169
redox	O
metabolism	O
,	O
oxidative	O
stress	O
and	O
mitochondrial	O
function	B-T169
in	O
hepg2	O
cells	O
play	O
a	O
critical	O
role	O
in	O
lps	B-T109
/	O
aspirin	B-T109
-	O
induced	B-T169
cytotoxicity	O
.	O
	
these	O
results	B-T033
may	O
help	O
in	O
better	O
understanding	O
the	O
pharmacological	B-T169
,	O
toxicological	B-T169
and	O
therapeutic	B-T169
properties	I-T169
of	O
nsaids	O
in	O
cancer	O
cells	O
exposed	B-T080
to	O
bacterial	B-T109
endotoxins	I-T109
.	O
	
placental	O
pathologic	B-T169
associations	B-T080
with	O
morbidly	O
adherent	O
placenta	O
potential	O
insights	O
into	O
pathogenesis	O
the	O
pathology	B-T169
that	O
underlies	O
morbidly	O
adherent	O
placenta	O
map	O
is	O
poorly	O
understood	O
.	O
	
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
describe	O
the	O
placental	O
pathology	B-T169
,	O
especially	O
implantation	B-T082
site	I-T082
pathology	B-T169
,	O
associated	B-T080
with	I-T080
map	O
.	O
	
this	O
was	O
a	O
single	B-T081
institution	O
,	O
retrospective	B-T062
case-control	I-T062
study	I-T062
design	O
examining	O
placentas	O
of	O
patients	O
who	O
delivered	B-T033
between	O
january	O
2008	O
and	O
september	O
2013	O
.	O
	
map	O
cases	O
were	O
defined	O
by	O
the	O
need	O
for	O
clinical	B-T080
intervention	O
at	O
delivery	B-T061
beyond	O
spontaneous	B-T169
placental	B-T061
delivery	I-T061
or	O
simple	O
manual	B-T061
extraction	I-T061
of	O
the	O
placenta	O
.	O
	
controls	O
consisted	O
of	O
patients	O
with	O
placentas	O
sent	O
for	O
examination	O
due	O
to	O
a	O
history	B-T033
of	O
maternal	O
malignancy	O
with	O
no	B-T033
clinical	B-T080
suspicion	B-T078
of	O
accreta	O
.	O
	
placental	O
pathologic	B-T033
findings	I-T033
of	O
maternal	B-T047
vascular	I-T047
underperfusion	I-T047
mvu	B-T047
,	O
acute	B-T033
inflammation	I-T033
,	O
chronic	O
inflammation	O
,	O
fetal	O
vascular	B-T047
obstruction	I-T047
and	O
hemorrhage	O
were	O
recorded	O
and	O
compared	O
using	O
bivariable	O
and	O
multivariable	O
analyses	O
.	O
	
three	O
categories	B-T170
of	O
pathologic	B-T169
changes	B-T169
were	O
seen	O
more	O
commonly	O
in	O
map	O
placentas	O
n=101	O
than	O
control	O
placentas	O
n=110	O
chronic	O
basal	O
inflammation	O
,	O
villous	O
changes	B-T169
of	O
mvu	B-T047
and	O
retromembranous	O
and	O
retromembranous	O
/	O
intervillous	O
hemorrhage	O
.	O
	
in	O
multivariable	B-T081
analyses	I-T081
adjusted	O
for	O
confounders	B-T169
,	O
chronic	B-T047
basal	I-T047
villitis	I-T047
aor	B-T081
5.6	O
,	O
1.73	O
,	O
plasma	B-T033
cell	I-T033
deciduitis	I-T033
aor	B-T081
2.63	O
,	O
1.08	O
,	O
increased	B-T033
syncytial	I-T033
knots	I-T033
aor	B-T081
3.92	O
,	O
1.57	O
,	O
villous	O
agglutination	O
aor	B-T081
24.85	O
,	O
2.78	O
,	O
increased	B-T033
perivillous	I-T033
fibrin	I-T033
aor	B-T081
5.08	O
,	O
1.49	O
,	O
and	O
the	O
presence	O
of	O
subchorionic	O
/	O
intervillous	B-T033
thrombi	I-T033
aor	B-T081
4.01	O
,	O
1.63	O
remained	O
associated	B-T080
with	I-T080
map	O
.	O
	
map	O
is	O
highly	O
associated	B-T080
with	I-T080
evidence	O
of	O
intraparenchymal	O
placental	O
hemorrhage	O
villous	B-T080
changes	B-T169
of	O
mvu	B-T047
,	O
and	O
a	O
lymphoplasmacytic	B-T033
infiltrate	I-T033
at	O
the	O
implantation	B-T082
site	I-T082
.	O
	
the	O
contribution	O
of	O
this	O
basal	B-T033
chronic	I-T033
inflammatory	I-T033
infiltrate	I-T033
to	O
map	O
an	O
ion-gating	O
multinanochannel	O
system	O
based	O
on	O
a	O
copper	O
-	O
responsive	B-T169
self	B-T078
-	O
cleaving	B-T082
dnazyme	O
we	O
developed	O
an	O
ion-gating	O
nanochannel	O
composite	O
system	O
by	O
immobilizing	B-T169
a	O
cu	O
-	O
responsive	B-T169
self	B-T078
-	O
cleaving	B-T082
dnazyme	O
into	O
pet	B-T109
conical	O
multinanochannels	O
,	O
which	O
could	O
control	B-T169
the	O
ion	O
transport	O
by	O
regulating	O
the	O
surface	B-T082
charge	O
density	B-T081
of	O
the	O
high-intensity	O
intermittent	O
training	O
positively	B-T033
affects	B-T080
aerobic	B-T061
and	O
anaerobic	O
performance	O
in	O
judo	O
athletes	O
independently	O
of	O
exercise	O
mode	O
the	O
present	O
study	O
investigated	O
the	O
effects	B-T080
of	O
high-intensity	O
intermittent	O
training	O
hiit	O
on	O
lower	O
-	O
and	O
upper-body	O
graded	O
exercise	O
and	O
high-intensity	O
intermittent	O
exercise	O
hiie	O
,	O
four	O
wingate	O
bouts	O
performance	B-T052
,	O
and	O
on	O
physiological	B-T169
and	O
muscle	O
damage	O
markers	B-T033
responses	I-T033
in	O
judo	O
athletes	O
.	O
	
thirty-five	O
subjects	B-T098
were	O
randomly	B-T062
allocated	I-T062
to	O
a	O
control	O
group	O
n	O
=	O
8	O
or	O
to	O
one	O
of	O
the	O
following	O
hiit	O
groups	B-T078
n	O
=	O
9	O
for	O
each	O
and	O
tested	B-T170
pre-	I-T170
and	I-T170
post	I-T170
-four	O
weeks	O
2	O
training	O
d	O
1	O
lower-body	O
cycle-ergometer	B-T061
2	O
upper-body	O
cycle-ergometer	B-T061
3	O
uchi-komi	B-T169
judo	B-T169
technique	I-T169
entrance	I-T169
.	O
	
all	O
hiit	O
were	O
constituted	O
by	O
two	O
blocks	O
of	O
10	O
sets	O
of	O
20	O
s	O
of	O
all	O
out	O
effort	O
interspersed	O
by	O
10	O
s	O
set	O
intervals	O
and	O
5-min	O
between	O
blocks	O
.	O
	
for	O
the	O
upper-body	O
group	B-T078
there	O
was	O
an	O
increase	B-T169
in	O
maximal	O
aerobic	O
power	O
in	O
graded	O
upper-body	O
exercise	B-T033
test	I-T033
12.3	O
.	O
	
the	O
lower-body	O
group	B-T078
increased	B-T169
power	O
at	O
onset	B-T109
blood	I-T109
lactate	I-T109
in	O
graded	O
upper-body	O
exercise	B-T033
test	I-T033
22.1	O
.	O
	
the	O
uchi-komi	B-T078
group	I-T078
increased	B-T169
peak	O
power	O
in	O
upper	O
-	O
16.7	O
and	O
lower-body	O
8.5	O
,	O
while	O
the	O
lower-body	O
group	O
increased	B-T169
lower-body	O
mean	O
power	O
14.2	O
during	O
the	O
hiie	O
.	O
	
there	O
was	O
a	O
decrease	B-T081
in	O
the	O
delta	B-T109
blood	I-T109
lactate	I-T109
for	O
the	O
uchi-komi	O
training	O
group	B-T078
and	O
in	O
the	O
third	O
and	O
fourth	O
bouts	O
for	O
the	O
upper-body	O
training	O
group	B-T078
.	O
	
training	O
induced	O
testosterone-cortisol	B-T081
ratio	B-T081
increased	B-T169
in	O
the	O
lower-body	O
hiie	O
for	O
the	O
lower-body	O
14.9	O
and	O
uchi-komi	O
61.4	O
training	O
groups	B-T078
.	O
	
thus	O
,	O
short-duration	B-T080
low-volume	O
hiit	O
added	O
to	O
regular	O
judo	O
training	O
was	O
able	O
to	O
increase	B-T169
upper-body	O
aerobic	O
power	O
,	O
lower	O
-	O
and	O
upper-body	O
hiie	O
performance	B-T052
.	O
	
microbiomes	O
of	O
muricea	O
californica	O
and	O
m	O
.	O
	
fruticosa	O
comparative	B-T062
analyses	I-T062
of	O
two	O
co-occurring	O
eastern	O
pacific	O
octocorals	O
octocorals	O
are	O
sources	O
of	O
novel	O
but	O
understudied	B-T062
microbial	O
diversity	B-T080
.	O
	
conversely	O
,	O
scleractinian	O
or	O
reef-building	O
coral	O
microbiomes	O
have	O
been	O
heavily	O
examined	B-T033
in	O
light	O
of	O
the	O
threats	B-T078
of	O
climate	O
change	O
.	O
	
muricea	O
californica	O
and	O
muricea	O
fruticosa	O
are	O
two	O
co-occurring	O
species	O
of	O
gorgonian	O
octocoral	O
abundantly	B-T033
found	I-T033
in	O
the	O
kelp	O
forests	O
of	O
southern	O
california	O
,	O
and	O
thus	O
provide	O
an	O
excellent	B-T169
basis	I-T169
to	O
determine	O
if	O
octocoral	O
microbiomes	O
are	O
host	O
specific	B-T080
.	O
	
using	O
illumina	B-T170
miseq	I-T170
amplicon	I-T170
sequencing	I-T170
and	O
replicate	B-T169
samples	I-T169
,	O
we	O
evaluated	O
the	O
microbiomes	O
collected	O
from	O
multiple	B-T081
colonies	I-T081
of	O
both	O
species	O
of	O
muricea	O
to	O
measure	B-T081
both	O
inter-	O
and	O
intra-colony	O
microbiome	O
variabilities	O
.	O
	
in	O
addition	O
,	O
microbiomes	O
from	O
overlying	O
sea	O
water	O
and	O
nearby	O
zoanthids	O
another	O
benthic	O
invertebrate	O
were	O
also	O
included	O
in	O
the	O
analysis	B-T062
to	O
evaluate	O
whether	O
bacterial	B-T170
taxa	I-T170
specifically	O
associate	B-T080
with	I-T080
octocorals	O
.	O
	
this	O
is	O
also	O
the	O
first	B-T170
report	I-T170
of	O
microbiomes	O
from	O
these	O
species	O
of	O
muricea	O
.	O
	
we	O
show	O
that	O
microbiomes	O
isolated	B-T169
from	O
each	O
sample	B-T080
type	I-T080
are	O
distinct	B-T080
,	O
and	O
specifically	O
,	O
that	O
octocoral	O
species	O
type	B-T080
had	O
the	O
greatest	O
effect	O
on	O
predicting	B-T078
the	O
composition	O
of	O
the	O
muricea	O
microbiome	O
.	O
	
bacterial	B-T170
taxa	I-T170
contributing	O
to	O
compositional	B-T081
differences	I-T081
include	O
distinct	B-T080
strains	O
of	O
mycoplasma	O
associated	B-T080
with	I-T080
either	O
m	O
.	O
	
californica	O
or	O
m	O
.	O
	
fruticosa	O
,	O
an	O
abundance	B-T080
of	O
spirochaetes	O
observed	B-T169
on	O
m	O
.	O
	
californica	O
,	O
and	O
a	O
greater	B-T081
diversity	B-T080
of	O
γ-proteobacteria	O
associated	B-T080
with	I-T080
m	O
.	O
	
fruticosa	O
.	O
	
many	O
of	O
the	O
bacterial	B-T170
taxa	I-T170
contributing	O
to	O
these	O
differences	B-T081
are	O
known	O
for	O
their	O
presence	B-T033
in	O
photosymbiont-containing	O
invertebrate	O
microbiomes	O
.	O
	
2	O
nephropathy	B-T047
identified	O
as	O
cause	B-T169
of	O
end-stage	B-T047
renal	I-T047
disease	I-T047
after	O
renal	B-T061
transplant	I-T061
adenine	B-T116
phosphoribosyltransferase	I-T116
deficiency	O
is	O
a	O
rare	O
autosomal	O
recessive	O
disorder	O
of	O
uric	O
acid	O
metabolism	O
that	O
leads	O
to	O
formation	O
and	O
excretion	O
of	O
2	O
into	O
urine	O
.	O
	
the	O
low	O
solubility	O
of	O
2	O
results	O
in	O
precipitation	O
and	O
formation	O
of	O
urinary	O
crystals	O
and	O
renal	O
stones	O
.	O
	
patients	O
with	O
this	O
disorder	O
usually	O
have	O
recurrent	O
nephrolithiasis	O
and	O
can	O
develop	O
nephropathy	O
secondary	O
to	O
crystal	O
precipitation	O
in	O
the	O
renal	O
parenchyma	O
.	O
	
the	O
disease	O
is	O
most	O
often	O
underdiagnosed	O
and	O
can	O
recur	O
in	O
renal	O
transplant	O
,	O
causing	O
graft	O
failure	O
.	O
	
lack	O
of	O
specific	O
clinical	O
manifestations	O
,	O
chemical	O
and	O
radiologic	O
features	O
identical	O
to	O
those	O
shown	O
with	O
uric	O
acid	O
stones	O
,	O
and	O
lack	O
of	O
awareness	O
among	O
clinicians	O
are	O
among	O
the	O
causes	O
for	O
the	O
underdiagnoses	O
of	O
this	O
treatable	O
disease	O
.	O
	
allopurinol	O
,	O
a	O
xanthine	O
dehydrogenase	O
inhibitor	O
,	O
is	O
the	O
mainstay	O
of	O
treatment	O
,	O
supported	O
by	O
high	O
fluid	O
intake	O
and	O
dietary	O
modifications	O
.	O
	
the	O
possibility	O
of	O
adenine	O
phosphoribosyl	O
transferase	O
deficiency	O
should	O
be	O
considered	O
in	O
all	O
cases	O
of	O
urolithiasis	O
in	O
children	O
,	O
patients	O
with	O
recurrent	O
urolithiasis	O
,	O
and	O
patients	O
with	O
urolithiasis	O
associated	O
with	O
renal	O
failure	O
of	O
unknown	O
cause	O
,	O
including	O
patients	O
with	O
end-stage	O
renal	O
disease	O
and	O
renal	O
transplant	O
recipients	O
.	O
	
here	O
,	O
we	O
report	O
a	O
case	O
of	O
a	O
41-year-old	O
female	O
patient	O
who	O
had	O
a	O
late	O
diagnosis	O
of	O
2	O
nephropathy	O
-induced	O
end-stage	O
renal	O
disease	O
,	O
made	O
on	O
the	O
native	O
nephrectomy	O
that	O
accompanied	O
the	O
renal	O
transplant	O
,	O
and	O
who	O
had	O
a	O
timely	O
intervention	O
that	O
prevented	O
recurrence	O
in	O
the	O
graft	O
social	B-T169
capital	I-T169
and	O
healthy	B-T080
ageing	O
in	O
indonesia	O
a	O
large	B-T081
international	B-T078
literature	B-T170
has	O
found	O
a	O
positive	B-T033
association	B-T080
between	O
social	B-T169
capital	I-T169
and	O
measures	B-T081
of	O
physical	B-T033
and	O
mental	O
health	O
.	O
	
however	O
,	O
there	O
is	O
a	O
paucity	O
of	O
research	B-T062
on	O
the	O
links	B-T080
between	O
social	B-T169
capital	I-T169
and	O
healthy	B-T080
ageing	O
in	O
a	O
developing	B-T080
country	I-T080
environment	B-T082
,	O
where	O
universal	O
social	O
security	O
coverage	O
is	O
absent	B-T169
and	O
health	B-T078
infrastructure	I-T078
is	O
poor	B-T080
.	O
	
in	O
this	O
paper	O
,	O
we	O
develop	O
and	O
empirically	O
test	B-T169
a	O
model	B-T170
of	O
the	O
linkages	O
between	O
social	B-T169
capital	I-T169
and	O
the	O
health	B-T170
outcomes	I-T170
for	O
older	B-T098
adults	I-T098
in	O
indonesia	O
,	O
using	O
data	B-T078
from	O
the	O
indonesian	B-T170
family	I-T170
life	I-T170
survey-east	I-T170
ifls-east	B-T170
,	O
conducted	O
in	O
2012	O
.	O
	
using	O
multivariate	B-T170
regression	I-T170
analysis	I-T170
,	O
we	O
examine	O
whether	O
social	B-T169
capital	I-T169
plays	O
a	O
role	O
in	O
mitigating	B-T080
poor	B-T033
health	I-T033
among	O
older	B-T098
individuals	B-T098
aged	O
50	O
years	B-T079
and	O
above	O
in	O
indonesia	O
's	O
most	O
vulnerable	O
provinces	O
.	O
	
we	O
test	B-T169
the	O
robustness	B-T080
of	O
these	O
social	B-T169
capital	I-T169
variables	B-T080
across	O
different	O
health	B-T078
measures	B-T081
self-assessed	B-T052
health	B-T078
,	O
activities	O
of	O
daily	O
living	O
adl	O
,	O
measures	B-T081
of	O
chronic	B-T047
illness	I-T047
and	O
mental	O
health	O
measures	B-T081
,	O
as	O
well	O
as	O
across	O
different	O
demographic	O
groups	B-T078
,	O
after	O
controlling	B-T169
for	O
an	O
array	B-T082
of	O
socio-economic	B-T080
,	O
demographic	O
and	O
geographic	B-T082
characteristics	B-T080
.	O
	
our	O
findings	B-T033
show	O
that	O
access	B-T082
to	O
better	O
social	B-T169
capital	I-T169
using	O
measures	B-T081
of	O
neighbourhood	B-T098
trust	O
and	O
community	O
participation	O
is	O
associated	B-T080
with	I-T080
a	O
higher	B-T080
degree	B-T081
of	O
physical	O
mobility	O
,	O
independence	B-T078
,	O
and	O
mental	O
well-being	O
among	O
older	B-T098
individuals	B-T098
but	O
has	O
no	O
influence	O
on	O
chronic	B-T047
illnesses	I-T047
.	O
	
these	O
results	B-T169
are	O
consistent	B-T078
when	O
we	O
estimate	B-T081
samples	O
disaggregated	O
by	O
gender	O
,	O
rural	B-T033
/	O
urban	B-T080
residence	B-T082
,	O
and	O
by	O
age	O
categories	B-T170
.	O
	
from	O
a	O
policy	B-T170
perspective	O
these	O
results	B-T169
point	O
to	O
the	O
importance	O
of	O
social	B-T169
capital	I-T169
measures	B-T169
in	O
moderating	B-T080
the	O
influence	O
of	O
poor	B-T033
health	I-T033
,	O
particularly	O
in	O
the	O
activities	O
of	O
daily	O
living	O
.	O
	
modulation	B-T082
of	O
interleukins	B-T116
in	O
sepsis	B-T047
-	O
associated	B-T080
clotting	B-T047
disorders	I-T047
interplay	O
with	O
hemostatic	B-T047
derangement	I-T047
interleukins	B-T116
play	O
a	O
central	B-T082
role	O
in	O
the	O
immune	O
system	O
and	O
are	O
involved	B-T169
in	O
a	O
variety	O
of	O
immunological	B-T047
,	O
inflammatory	B-T047
,	O
and	O
infectious	B-T047
disease	I-T047
states	B-T169
including	O
sepsis	B-T047
syndrome	I-T047
.	O
	
levels	B-T080
of	O
interleukins	B-T116
may	O
correlate	B-T080
with	O
overall	B-T081
survival	I-T081
and	O
may	O
directly	B-T080
or	O
indirectly	B-T080
affect	O
some	O
of	O
the	O
regulators	O
of	O
coagulation	O
and	O
fibrinolysis	O
,	O
thereby	O
disrupting	O
hemostasis	O
and	O
thrombosis	O
.	O
	
our	O
hypothesis	B-T078
is	O
that	O
in	O
sepsis-associated	B-T047
coagulopathies	I-T047
sacs	B-T047
,	O
interleukins	B-T116
may	O
be	O
upregulated	O
,	O
leading	O
to	O
hemostatic	B-T047
imbalance	I-T047
by	O
generating	O
thrombogenic	O
mediators	O
.	O
	
we	O
profiled	B-T169
the	O
levels	B-T080
of	O
interleukins	B-T116
il-1α	B-T116
,	O
il-1β	B-T116
,	O
il-2	B-T116
,	O
il-4	B-T116
,	O
il-6	B-T116
,	O
il-8	B-T116
,	O
and	O
il-10	B-T116
in	B-T169
addition	I-T169
to	I-T169
d-dimer	B-T116
dd	B-T116
in	O
patients	O
with	O
sac	B-T047
and	O
in	O
normal	B-T080
donors	B-T098
.	O
	
we	O
observed	B-T169
the	O
highest	B-T080
increase	B-T169
in	O
interleukins	B-T116
il-6	B-T116
322-fold	B-T081
,	O
il-8	B-T116
48-fold	B-T081
,	O
il-10	B-T116
72-fold	B-T081
,	O
and	O
dd	B-T116
18-fold	B-T081
.	O
	
this	O
suggests	B-T078
that	O
interleukins	B-T116
such	O
as	O
il-6	B-T116
and	O
il-10	B-T116
have	O
a	O
close	O
association	B-T080
with	I-T080
coagulopathy	B-T047
and	O
fibrinolytic	O
dysregulation	O
in	O
sepsis	B-T047
and	O
can	O
be	O
considered	B-T078
as	O
candidates	B-T116
for	O
potential	B-T080
therapeutic	B-T169
targets	B-T169
in	O
thymosin	B-T116
β4	I-T116
roles	O
in	O
development	B-T169
,	O
repair	O
,	O
and	O
engineering	B-T169
of	O
the	O
cardiovascular	O
system	O
the	O
burden	O
of	O
cardiovascular	B-T047
disease	I-T047
is	O
a	O
growing	O
worldwide	O
issue	O
that	O
demands	O
attention	O
.	O
	
while	O
many	O
clinical	B-T062
trials	I-T062
are	O
ongoing	O
to	O
test	B-T169
therapies	B-T061
for	O
treating	B-T169
the	O
heart	O
after	O
myocardial	B-T047
infarction	I-T047
mi	B-T047
and	O
heart	B-T047
failure	I-T047
,	O
there	O
are	O
few	O
options	O
doctors	O
able	O
to	O
currently	O
give	O
patients	O
to	O
repair	B-T061
the	I-T061
heart	I-T061
.	O
	
this	O
eventually	O
leads	O
to	O
decreased	O
ventricular	O
contractility	O
and	O
increased	O
systemic	B-T047
disease	I-T047
,	O
including	O
vascular	B-T047
disorders	I-T047
that	O
could	O
result	O
in	O
stroke	B-T047
.	O
	
small	O
peptides	B-T116
such	O
as	O
thymosin	B-T116
β4	I-T116
tβ4	B-T116
are	O
upregulated	O
in	O
the	O
cardiovascular	O
niche	O
during	O
fetal	O
development	O
and	O
after	O
injuries	O
such	O
as	O
mi	B-T047
,	O
providing	O
increased	O
neovasculogenesis	O
and	O
paracrine	O
signals	O
for	O
endogenous	B-T169
stem	O
cell	O
recruitment	O
to	O
aid	O
in	O
wound	O
repair	O
.	O
	
new	O
research	O
is	O
looking	O
into	O
the	O
effects	O
of	O
in	O
vivo	O
administration	O
of	O
tβ4	O
through	O
injections	O
and	O
coatings	O
on	O
implants	O
,	O
as	O
well	O
as	O
its	O
effect	O
on	O
cell	O
differentiation	O
.	O
	
results	O
so	O
far	O
demonstrate	O
tβ4	O
administration	O
leads	O
to	O
robust	O
increases	O
in	O
angiogenesis	O
and	O
wound	O
healing	O
in	O
the	O
heart	O
after	O
mi	O
and	O
the	O
brain	O
after	O
stroke	O
,	O
and	O
can	O
differentiate	O
adult	O
stem	O
cells	O
toward	O
the	O
cardiac	O
lineage	O
for	O
implantation	O
to	O
the	O
heart	O
to	O
increase	O
contractility	O
and	O
survival	O
.	O
	
future	O
work	O
,	O
some	O
of	O
which	O
is	O
currently	O
in	O
clinical	O
trials	O
,	O
will	O
demonstrate	O
the	O
in	O
vivo	O
effect	O
of	O
these	O
therapies	O
on	O
human	O
patients	O
,	O
with	O
the	O
goal	O
of	O
helping	O
the	O
millions	O
of	O
people	O
worldwide	O
affected	O
by	O
cardiovascular	O
disease	I-T047
yersinia	O
ruckeri	O
isolates	O
recovered	B-T080
from	I-T080
diseased	B-T047
atlantic	O
salmon	O
salmo	O
salar	O
in	O
scotland	O
are	O
more	O
diverse	O
than	O
those	O
from	O
rainbow	O
trout	O
oncorhynchus	O
mykiss	O
and	O
represent	B-T052
distinct	O
subpopulations	B-T098
yersinia	O
ruckeri	O
is	O
the	O
etiological	B-T169
agent	I-T169
of	O
enteric	B-T047
redmouth	I-T047
erm	B-T047
disease	B-T047
of	O
farmed	O
salmonids	O
.	O
	
enteric	B-T047
redmouth	I-T047
disease	I-T047
is	O
traditionally	O
associated	B-T080
with	I-T080
rainbow	O
trout	O
oncorhynchus	O
mykiss	O
,	O
walbaum	O
,	O
but	O
its	O
incidence	B-T081
in	O
atlantic	O
salmon	O
salmo	O
salar	O
is	O
increasing	B-T169
.	O
	
yersinia	O
ruckeri	O
isolates	O
recovered	B-T080
from	I-T080
diseased	B-T047
atlantic	O
salmon	O
have	O
been	O
poorly	B-T052
characterized	I-T052
,	O
and	O
very	O
little	O
is	O
known	O
about	O
the	O
relationship	B-T080
of	O
the	O
isolates	O
associated	B-T080
with	I-T080
these	O
two	O
species	O
.	O
	
phenotypic	O
approaches	O
were	O
used	O
to	O
characterize	O
109	O
y	O
.	O
	
ruckeri	O
isolates	O
recovered	O
over	O
a	O
14-year	O
period	O
from	O
infected	B-T033
atlantic	O
salmon	O
in	O
scotland	O
26	O
isolates	O
from	O
infected	B-T033
rainbow	O
trout	O
were	O
also	O
characterized	B-T052
.	O
	
biotyping	O
,	O
serotyping	O
,	O
and	O
comparison	B-T052
of	O
outer	O
membrane	O
protein	O
profiles	O
identified	O
19	O
y	O
.	O
	
ruckeri	O
clones	O
associated	B-T080
with	I-T080
atlantic	O
salmon	O
but	O
only	O
five	O
associated	B-T080
with	I-T080
rainbow	O
trout	O
none	O
of	O
the	O
atlantic	O
salmon	O
clones	O
occurred	O
in	O
rainbow	O
trout	O
and	O
vice	O
versa	O
these	O
findings	B-T033
suggest	O
that	O
distinct	O
subpopulations	B-T098
of	O
y	O
.	O
	
ruckeri	O
are	O
associated	B-T080
with	I-T080
each	O
species	O
.	O
	
a	O
new	O
o	B-T170
serotype	I-T170
designated	O
o8	O
was	O
identified	O
in	O
56	B-T170
biotype	I-T170
1	I-T170
atlantic	O
salmon	O
isolates	O
and	O
was	O
the	O
most	O
common	O
serotype	B-T170
identified	O
from	O
2006	O
to	O
2011	O
and	O
in	O
2014	O
,	O
suggesting	O
an	O
increased	B-T081
prevalence	I-T081
during	O
the	O
time	O
period	O
sampled	O
.	O
	
rainbow	O
trout	O
isolates	O
were	O
represented	B-T052
almost	O
exclusively	O
by	O
the	O
same	O
biotype	B-T170
2	I-T170
,	O
serotype	B-T170
o1	I-T170
clone	O
that	O
has	O
been	O
responsible	O
for	O
the	O
majority	O
of	O
erm	B-T047
outbreaks	O
in	O
this	O
species	O
within	O
the	O
united	O
kingdom	O
since	O
the	O
1980s	O
.	O
	
however	O
,	O
the	O
identification	O
of	O
two	O
biotype	B-T170
2	I-T170
,	O
serotype	B-T170
o8	I-T170
isolates	O
in	O
rainbow	O
trout	O
suggests	O
that	O
vaccines	O
containing	O
serotypes	B-T170
o1	I-T170
and	I-T170
o8	I-T170
should	O
be	O
evaluated	O
in	O
both	O
rainbow	O
trout	O
and	O
atlantic	O
salmon	O
for	O
application	O
in	O
scotland	O
.	O
	
vaccination	B-T061
plays	O
an	O
important	O
role	O
in	O
protecting	O
atlantic	O
salmon	O
against	O
the	O
bacterial	O
pathogen	O
yersinia	O
ruckeri	O
,	O
but	O
,	O
in	O
recent	O
years	O
,	O
there	O
has	O
been	O
an	O
increasing	B-T169
incidence	B-T081
of	O
vaccine	O
breakdown	O
in	O
salmon	O
.	O
	
this	O
is	O
largely	O
because	O
current	O
vaccines	O
are	O
aimed	O
at	O
rainbow	O
trout	O
and	O
are	O
based	O
on	O
serotypes	B-T170
specific	O
for	O
this	O
species	O
.	O
	
a	O
wider	O
range	O
of	O
serotypes	B-T170
is	O
responsible	O
for	O
infection	O
in	O
atlantic	O
salmon	O
,	O
but	O
very	O
little	O
is	O
known	O
about	O
the	O
diversity	O
of	O
these	O
strains	O
and	O
their	O
relationships	B-T080
to	O
those	O
recovered	B-T080
from	I-T080
rainbow	O
trout	O
.	O
	
in	O
the	O
present	O
study	O
,	O
we	O
demonstrate	O
that	O
y	O
.	O
	
ruckeri	O
isolates	O
recovered	B-T080
from	I-T080
diseased	B-T047
atlantic	O
salmon	O
in	O
scotland	O
are	O
more	O
diverse	O
than	O
those	O
from	O
rainbow	O
trout	O
furthermore	O
,	O
isolates	O
from	O
the	O
two	O
species	O
represent	B-T052
distinct	O
subpopulations	B-T098
.	O
	
in	O
addition	O
,	O
a	O
new	O
o	B-T170
serotype	I-T170
was	O
identified	O
that	O
is	O
responsible	O
for	O
a	O
significant	B-T078
proportion	B-T081
of	O
the	O
disease	B-T047
in	O
atlantic	O
salmon	O
.	O
	
our	O
findings	B-T033
are	O
likely	O
to	O
have	O
important	O
implications	O
for	O
the	O
development	B-T062
of	I-T062
improved	I-T062
vaccines	I-T062
against	O
y	O
.	O
	
ruckeri	O
.	O
	
cd84	B-T116
mediates	O
cll	O
-	O
microenvironment	O
interactions	O
chronic	O
lymphocytic	O
leukemia	O
cll	O
is	O
a	O
malignant	B-T047
disease	I-T047
of	O
small	O
mature	O
lymphocytes	O
.	O
	
signals	O
from	O
the	O
cll	O
microenvironment	O
promote	B-T052
progression	O
of	O
the	O
disease	O
and	O
induce	B-T169
drug	O
resistance	O
.	O
	
this	O
phenomenon	O
is	O
largely	O
dependent	B-T080
on	O
direct	O
contact	O
between	O
the	O
malignant	O
b	O
cells	O
and	O
stromal	O
cells	O
.	O
	
cd84	B-T116
belongs	O
to	O
the	O
signaling	B-T116
lymphocyte	I-T116
activation	I-T116
molecule	I-T116
family	I-T116
of	O
immunoreceptors	B-T116
,	O
which	O
self-associates	O
,	O
forming	O
an	O
orthogonal	O
homophilic	O
dimer	O
.	O
	
we	O
therefore	O
hypothesized	O
that	O
cd84	B-T116
may	O
bridge	O
between	O
cll	O
cells	O
and	O
their	O
microenvironment	O
,	O
promoting	B-T052
cell	O
survival	O
.	O
	
our	O
in	B-T080
vitro	I-T080
results	B-T169
show	O
that	O
cd84	O
expressed	O
on	O
cll	O
cells	O
interact	B-T169
with	O
cd84	O
expressed	O
on	O
cells	O
in	O
their	O
microenvironment	O
,	O
inducing	B-T169
cell	O
survival	O
in	O
both	O
sides	O
.	O
	
blocking	B-T169
cd84	B-T116
in	B-T080
vitro	I-T080
and	O
in	B-T082
vivo	I-T082
disrupt	B-T080
the	O
interaction	B-T169
of	O
cll	O
cells	O
with	O
their	O
microenvironment	O
,	O
resulting	B-T169
in	I-T169
induced	B-T169
cell	O
death	O
.	O
	
thus	O
,	O
our	O
findings	B-T033
suggest	O
novel	B-T080
therapeutic	B-T169
strategies	O
based	O
on	O
the	O
blockade	O
of	O
this	O
cd84	B-T116
-	O
dependent	B-T080
survival	O
pathway	O
.	O
	
aurantimonas	O
endophytica	O
sp	O
.	O
	
nov	O
,	O
a	O
novel	O
endophytic	O
bacterium	O
isolated	O
from	O
roots	O
of	O
anabasis	O
elatior	O
c	O
.	O
	
a	O
.	O
	
mey	O
schischk	O
an	O
orange-coloured	B-T080
,	O
aerobic	B-T080
,	O
motile	B-T033
and	O
short-rods	O
bacterial	O
strain	O
,	O
designated	O
egi	O
6500337t	O
,	O
was	O
isolated	O
from	O
the	O
surface-sterilized	O
root	O
of	O
a	O
halophyte	O
anabasis	O
elatior	O
c	O
.	O
	
a	O
.	O
	
mey	O
schischk	O
collected	O
from	O
urumqi	O
,	O
xinjiang	O
province	O
,	O
north-west	O
china	O
.	O
	
growth	O
occurred	O
at	O
5-35	O
c	O
optimum	O
30	O
c	O
,	O
at	O
ph	B-T081
6.0	O
optimum	O
ph	B-T081
7.0	O
,	O
and	O
in	O
the	O
presence	O
of	O
0-6	O
%	O
nacl	O
w/v	O
optimum	O
0-1	O
%	O
.	O
	
phylogenetic	B-T080
tree	I-T080
based	O
on	O
16s	O
rrna	O
gene	O
sequences	O
indicated	O
that	O
strain	O
egi	O
6500337t	O
formed	O
a	O
distinct	O
lineage	O
in	O
the	O
cluster	O
that	O
comprised	O
the	O
genera	O
aurantimonas	O
and	O
aureimonas	O
in	O
the	O
family	O
aurantimonadaceae	O
.	O
	
the	O
16s	O
rrna	O
gene	O
sequence	O
of	O
strain	O
egi	O
6500337t	O
shared	O
the	O
highest	O
similarities	O
to	O
those	O
of	O
aurantimonas	O
coralicida	O
dsm	O
14790t	O
97.15	O
%	O
and	O
aurantimonas	O
manganoxydans	O
dsm	O
21871t	O
97.15	O
%	O
.	O
	
strain	O
egi	O
6500337t	O
contained	O
q-10	B-T109
as	O
the	O
dominant	O
isoprenoid	B-T109
quinone	I-T109
.	O
	
the	O
major	O
cellular	O
fatty	B-T109
acids	I-T109
were	O
c18	B-T109
7c	I-T109
66.4	O
%	O
and	O
c19	B-T109
8c	I-T109
cyclo	I-T109
23.3	O
%	O
.	O
	
the	O
polar	O
lipid	B-T109
profile	I-T109
of	O
strain	O
egi	O
6500337t	O
contained	O
diphosphatidylglycerol	B-T109
,	O
phosphatidylglycerol	B-T109
,	O
phosphatidylcholine	B-T109
,	O
phosphatidylethanolamine	B-T109
as	O
major	O
components	O
,	O
similarly	O
to	O
the	O
members	O
of	O
the	O
genus	O
aurantimonas	O
.	O
	
the	O
dna	O
g+c	B-T081
content	I-T081
of	O
strain	O
egi	O
6500337t	O
was	O
66.8	O
mol%	O
.	O
	
the	O
dna	O
-	O
dna	O
relatedness	O
between	O
strain	O
egi	O
6500337t	O
and	O
aurantimonas	O
coralicida	O
dsm	O
14790t	O
was	O
24.7	O
2.9	O
%	O
.	O
	
on	O
the	O
basis	O
of	O
the	O
phylogenetic	B-T062
analysis	I-T062
,	O
chemotaxonomic	B-T078
data	I-T078
and	O
phenotypic	O
characteristics	O
,	O
strain	O
egi	O
6500337t	O
represents	O
a	O
novel	O
species	O
of	O
the	O
genus	O
aurantimonas	O
,	O
for	O
which	O
the	O
name	O
aurantimonas	O
endophytica	O
sp	O
.	O
	
nov	O
.	O
	
is	O
proposed	O
.	O
	
the	O
type	O
strain	O
is	O
egi	O
6500337t	O
=	O
kctc	O
52296t	O
=	O
cpcc	O
100904t	O
.	O
	
assessment	O
and	O
classification	O
of	O
protocol	B-T033
deviations	I-T033
deviations	B-T033
from	O
the	O
approved	O
trial	B-T170
protocol	I-T170
are	O
common	O
during	O
clinical	B-T062
trials	I-T062
.	O
	
they	O
have	O
been	O
conventionally	O
classified	O
as	O
deviations	B-T033
or	O
violations	B-T062
,	O
depending	O
on	O
their	O
impact	B-T080
on	O
the	O
trial	B-T062
.	O
	
a	O
new	O
method	O
has	O
been	O
proposed	O
by	O
which	O
deviations	B-T033
are	O
classified	O
in	O
five	O
grades	O
from	O
1	O
to	O
5	O
.	O
	
a	O
deviation	B-T033
of	O
grade	B-T033
1	I-T033
has	O
no	B-T033
impact	B-T080
on	O
the	O
subjects'	B-T098
well-being	B-T033
or	O
on	O
the	O
quality	B-T080
of	I-T080
data	I-T080
.	O
	
at	O
the	O
maximum	O
,	O
a	O
deviation	B-T033
grade	O
5	O
leads	O
to	O
the	O
death	B-T033
of	O
the	O
subject	B-T098
.	O
	
this	O
method	O
of	O
classification	O
was	O
applied	O
to	O
deviations	B-T033
noted	O
in	O
the	O
center	O
over	O
the	O
last	O
3	O
years	O
.	O
	
it	O
was	O
observed	O
that	O
most	O
deviations	B-T033
were	O
of	O
grades	O
1	O
and	O
2	O
,	O
with	O
fewer	O
falling	O
in	O
grades	O
3	O
and	O
4	O
.	O
	
there	O
were	O
no	O
deviations	B-T033
that	O
led	O
to	O
the	O
death	B-T033
of	I-T033
the	I-T033
subject	I-T033
grade	O
5	O
.	O
	
this	O
method	O
of	O
classification	O
would	O
help	O
trial	B-T062
managers	O
decide	O
on	O
the	O
action	O
to	O
be	O
taken	O
on	O
the	O
occurrence	B-T079
of	O
deviations	B-T033
,	O
which	O
would	O
be	O
based	O
on	O
their	O
fabrication	O
and	O
modelling	B-T062
of	O
fractal	B-T082
,	O
biomimetic	B-T082
,	O
micro	B-T082
and	O
nano-topographical	B-T082
surfaces	I-T082
natural	B-T169
surface	O
topographies	O
are	O
often	O
self-similar	O
with	O
hierarchical	B-T080
features	I-T080
at	O
the	O
micro	O
and	O
nanoscale	O
,	O
which	O
may	O
be	O
mimicked	O
to	O
overcome	O
modern	B-T079
tissue	B-T061
engineering	I-T061
and	O
biomaterial	O
design	B-T052
limitations	B-T169
.	O
	
specifically	O
,	O
a	O
cell's	O
microenvironment	O
within	O
the	O
human	O
body	O
contains	O
highly	O
optimised	O
,	O
fractal	O
topographical	O
cues	O
,	O
which	O
directs	O
precise	O
cell	O
behaviour	O
.	O
	
however	O
,	O
recreating	B-T169
biomimetic	B-T082
,	O
fractal	B-T082
topographies	I-T082
in	B-T080
vitro	I-T080
is	O
not	O
a	O
trivial	O
process	O
and	O
a	O
number	O
of	O
fabrication	O
methods	O
have	O
been	O
proposed	O
but	O
often	O
fail	B-T169
to	O
precisely	O
control	B-T080
the	O
spatial	B-T082
resolution	I-T082
of	O
features	B-T080
at	O
different	B-T080
lengths	B-T081
scales	O
and	O
hence	O
,	O
to	O
provide	O
true	O
biomimetic	B-T080
properties	I-T080
.	O
	
here	O
,	O
we	O
propose	O
a	O
method	B-T170
of	O
accurately	B-T080
reproducing	B-T169
the	O
self-similar	O
,	O
micro	B-T082
and	O
nanoscale	B-T082
topography	I-T082
of	O
a	O
human	O
biological	O
tissue	O
into	O
a	O
synthetic	B-T109
polymer	I-T109
through	O
an	O
innovative	O
fabrication	O
process	O
.	O
	
the	O
biological	O
tissue	O
surface	B-T082
was	O
characterised	B-T052
using	O
atomic	O
force	O
microscopy	O
afm	O
to	O
obtain	O
spatial	B-T082
data	B-T078
in	O
x	O
,	O
y	O
and	O
z	O
,	O
which	O
was	O
converted	O
into	O
a	O
grayscale	O
'digital	O
photomask'	O
.	O
	
as	O
a	O
result	O
of	O
maskless	O
grayscale	O
optical	O
lithography	O
followed	O
by	O
modified	O
deep	O
reactive	O
ion	O
etching	O
and	O
replica	O
molding	O
,	O
we	O
were	O
able	O
to	O
accurately	B-T080
reproduce	O
the	O
fractal	B-T082
topography	I-T082
of	O
acellular	O
dermal	O
matrix	O
adm	O
into	O
polydimethylsiloxane	B-T109
pdms	B-T109
.	O
	
characterisation	B-T052
using	O
afm	O
at	O
three	O
different	B-T080
length	B-T081
scales	O
revealed	O
that	O
the	O
nano	B-T082
and	O
micro-topographical	B-T082
features	B-T080
,	O
in	O
addition	O
to	O
the	O
fractal	B-T081
dimension	I-T081
,	O
of	O
native	B-T169
adm	O
were	O
reproduced	B-T169
in	O
pdms	B-T109
.	O
	
in	O
conclusion	O
,	O
it	O
has	O
been	O
shown	O
that	O
the	O
fractal	B-T082
topography	I-T082
of	O
biological	B-T082
surfaces	I-T082
can	O
be	O
mimicked	O
in	O
synthetic	O
materials	O
using	O
the	O
novel	B-T080
fabrication	O
process	O
outlined	O
,	O
which	O
may	O
be	O
applied	O
to	O
significantly	O
enhance	O
medical	O
device	O
biocompatibility	O
and	O
investigating	B-T169
effects	B-T080
of	I-T080
acidic	B-T081
ph	I-T081
on	O
proliferation	O
,	O
invasion	O
and	O
drug	O
-	O
induced	B-T169
apoptosis	O
in	O
lymphoblastic	O
leukemia	O
some	O
studies	O
have	O
shown	O
that	O
extracellular	O
ph	B-T081
in	O
tumors	O
,	O
which	O
results	O
in	O
tumor	O
progression	O
,	O
is	O
less	O
than	O
that	O
in	O
normal	B-T080
tissues	O
.	O
	
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	B-T169
the	O
effects	B-T080
of	I-T080
extracellular	O
acidic	B-T081
ph	I-T081
on	O
proliferation	O
,	O
invasion	O
,	O
and	O
drug	O
-	O
induced	B-T169
apoptosis	O
in	O
acute	O
lymphoblastic	O
cells	O
.	O
	
the	O
cells	O
were	O
cultured	O
in	O
different	B-T080
ph	B-T081
ph	B-T081
6.6	O
and	O
ph	B-T081
7.4	O
for	O
12	O
days	B-T079
.	O
	
cell	O
proliferation	O
was	O
assessed	B-T052
by	O
mtt	B-T062
assay	I-T062
and	O
cell	O
invasion	O
was	O
assayed	O
by	O
invasion	O
assay	O
and	O
gene	O
expression	O
analysis	O
of	O
mmp-9	B-T116
.	O
	
drug	O
-	O
induced	B-T169
apoptosis	O
was	O
evaluated	O
after	O
exposure	B-T080
to	I-T080
doxorubicin	B-T109
for	O
24	O
hours	O
by	O
annexin	B-T116
v	I-T116
/	O
pi	B-T109
staining	O
and	O
gene	O
expression	O
analysis	O
of	O
bax	B-T116
pro-apoptotic	I-T116
protein	I-T116
.	O
	
the	O
results	O
indicated	O
the	O
enhanced	O
growth	O
and	O
invasion	O
of	O
leukemic	O
cells	O
at	O
ph	B-T081
6.6	O
p	O
0.05	O
.	O
	
furthermore	O
,	O
the	O
cells	O
at	O
ph	B-T081
6.6	O
were	O
resistant	B-T169
to	O
apoptosis	O
by	O
doxorubicin	B-T109
p	O
0.05	O
.	O
	
it	O
can	O
be	O
concluded	O
that	O
acidic	B-T081
ph	I-T081
increases	B-T169
the	O
proliferation	O
,	O
invasion	O
and	O
reduces	B-T080
the	O
drug	O
-	O
induced	B-T169
apoptosis	O
in	O
acute	O
lymphoblastic	O
leukemia	O
.	O
	
extracellular	O
acidity	B-T081
can	O
influence	O
the	O
behavior	O
of	O
leukemic	O
cells	O
and	O
therefore	O
,	O
the	O
manipulation	B-T169
of	O
extracellular	O
liquid	O
can	O
be	O
selected	O
as	O
a	O
therapeutic	B-T061
strategy	I-T061
for	O
leukemia	O
,	O
especially	O
for	O
acute	O
lymphoblastic	O
leukemia	O
.	O
	
gold	O
-	O
nanosponge	O
-based	O
multistimuli-responsive	O
drug	O
vehicles	O
for	O
targeted	B-T169
chemo-photothermal	B-T061
therapy	I-T061
gold	O
-	O
nanosponge	O
-based	O
multistimuli-responsive	O
drug	O
vehicles	O
are	O
constructed	O
for	O
combined	O
chemo-photothermal	B-T061
therapy	I-T061
with	O
pinpointed	O
drug	O
delivery	B-T169
and	O
release	B-T169
capabilities	O
and	O
minimized	O
nonspecific	B-T078
systemic	B-T169
spread	B-T080
of	O
drugs	O
,	O
remarkably	O
enhancing	B-T052
the	O
therapeutic	B-T080
efficiency	I-T080
while	O
minimizing	O
acute	B-T079
side	O
effects	O
.	O
	
hemodynamic	O
correlates	O
of	O
transient	O
cognitive	O
impairment	O
after	O
transient	B-T047
ischemic	I-T047
attack	I-T047
and	O
minor	B-T047
stroke	I-T047
a	O
transcranial	O
doppler	O
study	O
transient	O
cognitive	O
impairment	O
tci	O
on	O
the	O
mini	O
mental	O
state	O
evaluation	O
score	B-T081
is	O
common	O
after	O
transient	B-T047
ischemic	I-T047
attack	I-T047
/	O
minor	B-T047
stroke	I-T047
and	O
might	O
identify	B-T080
patients	O
at	O
increased	O
risk	B-T078
of	O
dementia	O
.	O
	
we	O
aimed	B-T078
to	O
replicate	B-T080
tci	O
using	O
the	O
montreal	B-T170
cognitive	I-T170
assessment	I-T170
moca	B-T170
,	O
compare	B-T052
it	O
with	O
persistent	O
mild	O
cognitive	O
impairment	O
pmci	O
,	O
and	O
to	O
determine	O
whether	O
global	B-T080
cerebral	O
hemodynamic	O
changes	B-T169
could	O
explain	O
transient	B-T079
impairment	B-T169
.	O
	
consecutive	O
patients	O
with	O
transient	B-T047
ischemic	I-T047
attack	I-T047
/	O
minor	B-T047
stroke	I-T047
nihss	O
3	O
were	O
assessed	B-T052
with	O
the	O
moca	B-T170
and	O
transcranial	O
doppler	O
ultrasound	O
acutely	B-T079
and	O
at	O
1	O
month	O
.	O
	
we	O
compared	B-T052
patients	O
with	O
tci	O
baseline	B-T081
moca	B-T170
<	O
26	O
with	O
2	O
points	B-T081
increase	B-T169
at	O
1	O
month	O
,	O
pmci	O
moca	B-T170
<	O
26	O
with	O
<	O
2	O
points	B-T081
increase	B-T169
,	O
and	O
no	B-T033
cognitive	I-T033
impairment	I-T033
nci	B-T033
moca	B-T170
26	O
.	O
	
of	O
326	O
patients	O
,	O
46	O
14.1	O
had	O
pmci	O
,	O
98	O
30.1	O
tci	O
,	O
and	O
182	O
55.8	O
nci	B-T033
.	O
	
at	O
baseline	B-T081
,	O
tci	O
patients	O
had	O
higher	B-T033
systolic	I-T033
blood	I-T033
pressure	I-T033
150.95	O
21.52	O
vs	O
144.86	O
22.44	O
mmhg	O
,	O
p	O
=	O
0.02	O
and	O
lower	B-T080
cerebral	B-T081
blood	I-T081
flow	I-T081
velocities	I-T081
,	O
particularly	O
end-diastolic	B-T081
velocity	I-T081
30.16	O
9.63	O
vs	O
35.02	O
9.01	O
cm/s	O
,	O
p	O
<	O
0.001	O
and	O
mean	B-T033
flow	I-T033
velocity	I-T033
48.95	O
12.72	O
vs	O
54	O
12.46	O
cm/s	O
,	O
p	O
=	O
0.001	O
than	O
those	O
with	O
nci	B-T033
,	O
but	O
similar	O
clinical	B-T080
and	O
hemodynamic	O
profiles	O
to	O
those	O
with	O
pmci	O
.	O
	
systolic	B-T033
bp	I-T033
fell	I-T033
between	O
baseline	B-T081
and	O
1	O
month	O
mean	B-T081
reduction	B-T061
=	O
14.01	O
21.26	O
mmhg	O
and	O
end-diastolic	B-T081
velocity	I-T081
and	O
mean	B-T033
flow	I-T033
velocity	I-T033
increased	B-T169
mean	B-T081
increase	B-T169
=	O
+	O
2.42	O
6.41	O
and	O
1.89	O
8.77	O
cm/s	O
,	O
respectively	O
,	O
but	O
these	O
changes	B-T169
did	O
not	B-T033
differ	I-T033
between	O
patients	O
with	O
tci	O
,	O
pmci	O
,	O
and	O
nci	B-T033
.	O
	
tci	O
is	O
detectable	O
with	O
the	O
moca	B-T170
after	O
transient	B-T047
ischemic	I-T047
attack	I-T047
and	O
minor	B-T047
stroke	I-T047
and	O
has	O
similar	O
clinical	B-T080
and	O
hemodynamic	O
profile	O
to	O
pmci	O
.	O
	
however	O
,	O
tci	O
does	O
not	B-T169
appear	I-T169
to	O
be	O
due	O
to	O
exaggerated	B-T080
acute	B-T079
reversible	B-T169
global	B-T080
hemodynamic	O
changes	B-T169
.	O
	
apixaban	B-T109
5	O
mg	O
twice	B-T081
daily	B-T079
and	O
clinical	B-T080
outcomes	B-T169
in	O
patients	O
with	O
atrial	B-T047
fibrillation	I-T047
and	O
advanced	B-T080
age	O
,	O
low	B-T080
body	O
weight	O
,	O
or	O
high	B-T080
creatinine	B-T109
a	O
secondary	O
analysis	O
of	O
a	O
randomized	B-T062
clinical	I-T062
trial	I-T062
in	O
the	O
apixaban	B-T109
for	O
reduction	B-T080
of	O
stroke	B-T047
and	O
other	O
thromboembolic	O
complications	O
in	O
atrial	B-T047
fibrillation	I-T047
aristotle	B-T062
trial	B-T062
,	O
the	O
standard	O
dose	B-T081
of	O
apixaban	B-T109
was	O
5	O
mg	O
twice	B-T081
daily	B-T079
patients	O
with	O
at	O
least	O
2	O
dose	B-T081
-	O
reduction	B-T080
criteria-80	O
years	B-T079
or	O
older	O
,	O
weight	O
60	O
kg	O
or	O
less	O
,	O
and	O
creatinine	B-T033
level	I-T033
1.5	O
mg/dl	O
or	O
higher-received	O
a	O
reduced	O
dose	O
of	O
apixaban	O
of	O
2.5	O
mg	O
twice	O
daily	O
.	O
	
little	O
is	O
known	O
about	O
patients	O
with	O
1	O
dose	O
-	O
reduction	O
criterion	O
who	O
received	O
the	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
apixaban	O
.	O
	
to	O
determine	O
the	O
frequency	O
of	O
1	O
dose	O
-	O
reduction	O
criterion	O
and	O
whether	O
the	O
effects	O
of	O
the	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
apixaban	O
on	O
stroke	O
or	O
systemic	O
embolism	O
and	O
bleeding	O
varied	O
among	O
patients	O
with	O
1	O
or	O
no	O
dose	O
-	O
reduction	O
criteria	O
.	O
	
among	O
18	O
201	O
patients	O
in	O
the	O
aristotle	O
trial	O
,	O
17	O
322	O
were	O
included	O
in	O
this	O
analysis	O
.	O
	
annualized	O
event	O
rates	O
of	O
stroke	O
or	O
systemic	O
embolism	O
and	O
major	O
bleeding	O
and	O
hazard	O
ratios	O
hrs	O
and	O
95%	O
cis	O
were	O
evaluated	O
.	O
	
interactions	O
between	O
the	O
effects	O
of	O
apixaban	O
vs	O
warfarin	O
and	O
the	O
presence	O
of	O
1	O
or	O
no	O
dose	O
-	O
reduction	O
criteria	O
were	O
assessed	O
.	O
	
the	O
first	O
patient	O
was	O
enrolled	O
in	O
the	O
aristotle	O
trial	O
on	O
december	O
19	O
,	O
2006	O
,	O
and	O
follow-up	O
was	O
completed	O
on	O
january	O
30	O
,	O
2011	O
.	O
	
data	O
were	O
analyzed	O
from	O
january	O
2015	O
to	O
may	O
30	O
,	O
2016	O
.	O
	
analysis	O
of	O
major	O
bleeding	O
included	O
events	O
during	O
study	O
drug	O
treatment	O
.	O
	
analysis	O
of	O
stroke	O
or	O
systemic	O
embolism	O
was	O
based	O
on	O
intention	O
to	O
treat	O
.	O
	
of	O
the	O
patients	O
with	O
1	O
or	O
no	O
dose	O
-	O
reduction	O
criteria	O
assigned	O
to	O
receive	O
the	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
apixaban	O
or	O
warfarin	O
,	O
3966	O
had	O
1	O
dose	O
-	O
reduction	O
criterion	O
these	O
patients	O
had	O
higher	O
rates	O
of	O
stroke	O
or	O
systemic	O
embolism	O
hr	O
,	O
1.47	O
95%	O
ci	O
,	O
1.20	O
and	O
major	O
bleeding	O
hr	O
,	O
1.89	O
95%	O
ci	O
,	O
1.62	O
compared	O
with	O
those	O
with	O
no	O
dose	O
-	O
reduction	O
criteria	O
n	O
=	O
13	O
356	O
.	O
	
the	O
benefit	O
of	O
the	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
apixaban	O
n	O
=	O
8665	O
compared	O
with	O
warfarin	O
n	O
=	O
8657	O
on	O
stroke	O
or	O
systemic	O
embolism	O
in	O
patients	O
with	O
1	O
dose	O
-	O
reduction	O
criterion	O
hr	O
,	O
0.94	O
95%	O
ci	O
,	O
0.66	O
and	O
no	O
dose	O
-	O
reduction	O
criterion	O
hr	O
,	O
0.77	O
95%	O
ci	O
,	O
0.62	O
were	O
similar	O
p	O
for	O
interaction	O
=	O
36	O
.	O
	
similarly	O
,	O
the	O
benefit	O
of	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
apixaban	O
compared	O
with	O
warfarin	O
on	O
major	O
bleeding	O
in	O
patients	O
with	O
1	O
dose	O
-	O
reduction	O
criterion	O
hr	O
,	O
0.68	O
95%	O
ci	O
,	O
0.53	O
and	O
no	O
dose	O
-	O
reduction	O
criterion	O
hr	O
,	O
0.72	O
95%	O
ci	O
,	O
0.60	O
were	O
similar	O
p	O
for	O
interaction	O
=	O
71	O
.	O
	
similar	O
patterns	O
were	O
seen	O
for	O
each	O
dose	O
-	O
reduction	O
criterion	O
and	O
across	O
the	O
spectrum	O
of	O
age	O
,	O
body	O
weight	O
,	O
creatinine	O
level	B-T080
,	O
and	O
creatinine	O
clearance	O
.	O
	
patients	O
with	O
atrial	O
fibrillation	O
and	O
isolated	O
advanced	O
age	O
,	O
low	O
body	O
weight	O
,	O
or	O
renal	O
dysfunction	O
have	O
a	O
higher	O
risk	O
of	O
stroke	O
or	O
systemic	O
embolism	O
and	O
major	O
bleeding	O
but	O
show	O
consistent	O
benefits	O
with	O
the	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
apixaban	O
vs	O
warfarin	O
compared	O
with	O
patients	O
without	O
these	O
characteristics	O
.	O
	
the	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
apixaban	O
is	O
safe	O
,	O
efficacious	O
,	O
and	O
appropriate	O
for	O
patients	O
with	O
only	O
1	O
dose	O
-	O
reduction	O
criterion	O
.	O
	
clinicaltrials.gov	O
identifier	O
transition	B-T052
from	O
hospital	O
to	O
home	B-T082
in	O
preterm	O
infants	O
and	O
their	O
families	O
when	O
the	O
day	B-T079
of	O
discharge	O
from	O
a	O
neonatal	O
intensive	O
care	O
unit	O
nicu	O
comes	O
for	O
the	O
parents	O
of	O
newborn	O
infants	O
,	O
they	O
are	O
filled	O
with	O
long-awaited	O
joy	O
and	O
happiness	O
.	O
	
they	O
go	O
home	B-T082
feeling	O
as	O
parents	O
,	O
away	O
from	O
scheduled	B-T080
routines	I-T080
of	O
the	O
hospital	O
,	O
monitor	B-T033
alarms	I-T033
,	O
clinical	B-T033
rounds	I-T033
,	O
numerous	B-T081
tests	O
,	O
and	O
so	O
on	O
.	O
	
what	O
do	O
we	O
know	O
about	O
what	O
happens	B-T052
after	O
these	O
little	O
patients	O
and	O
their	O
families	O
leave	B-T052
the	O
nicu	O
what	O
happens	B-T052
from	O
the	O
point	O
of	O
leaving	B-T052
the	O
hospital	O
until	O
when	O
things	O
get	O
settled	O
and	O
life	B-T078
becomes	O
perceived	O
as	O
normal	B-T080
this	O
article	B-T170
presents	O
a	O
short	O
summary	B-T170
of	O
research	B-T062
conducted	O
with	O
the	O
vulnerable	B-T098
population	I-T098
of	O
high-risk	B-T033
and	O
preterm	O
infants	O
and	O
their	O
families	O
postdischarge	O
.	O
	
available	O
evidence	B-T078
suggests	O
that	O
transition	B-T052
to	O
home	B-T082
after	O
hospital	O
discharge	O
,	O
a	O
phenomenon	O
that	O
many	O
families	O
experience	O
,	O
is	O
challenging	B-T080
and	O
requires	O
attention	O
from	O
clinicians	O
and	O
researchers	O
if	O
we	O
are	O
to	O
provide	O
effective	B-T080
,	O
efficient	B-T080
,	O
and	O
high-quality	O
care	O
.	O
	
visual	O
analytics	O
for	O
pattern	O
discovery	O
in	O
home	O
care	O
.	O
	
clinical	B-T080
relevance	I-T080
for	O
quality	O
improvement	O
visualization	O
can	O
reduce	O
the	O
cognitive	B-T081
load	I-T081
of	I-T081
information	I-T081
,	O
allowing	O
users	O
to	O
easily	O
interpret	B-T169
and	O
assess	O
large	O
amounts	O
of	O
data	O
.	O
	
the	O
purpose	O
of	O
our	O
study	O
was	O
to	O
examine	O
home	B-T170
health	I-T170
data	I-T170
using	O
visual	O
analysis	O
techniques	O
to	O
discover	O
clinically	B-T080
salient	I-T080
associations	B-T078
between	O
patient	O
characteristics	O
with	O
problem-oriented	B-T170
health	I-T170
outcomes	I-T170
of	O
older	O
adult	O
home	O
health	O
patients	O
during	O
the	O
home	O
health	O
service	O
period	O
.	O
	
knowledge	B-T170
,	O
behavior	O
and	O
status	B-T081
ratings	I-T081
at	O
discharge	O
as	O
well	O
as	O
change	O
from	O
admission	O
to	O
discharge	O
that	O
was	O
coded	O
using	O
the	O
omaha	B-T170
system	I-T170
was	O
collected	O
from	O
a	O
dataset	B-T170
on	O
988	O
de-identified	O
patient	B-T170
data	I-T170
from	O
15	O
home	O
health	O
agencies	O
.	O
	
spss	B-T170
visualization	I-T170
designer	I-T170
v1.0	I-T170
was	O
used	O
to	O
visually	O
analyze	O
patterns	O
between	O
independent	O
and	O
outcome	O
variables	O
using	O
heat	B-T078
maps	I-T078
and	O
histograms	O
.	O
	
visualizations	O
suggesting	O
clinical	B-T033
salience	I-T033
were	O
tested	B-T169
for	O
significance	O
using	O
correlation	B-T062
analysis	I-T062
.	O
	
the	O
mean	O
age	O
of	O
the	O
patients	O
was	O
80	O
years	O
,	O
with	O
the	O
majority	O
female	O
66%	O
.	O
	
of	O
the	O
150	O
visualizations	O
,	O
69	O
potentially	O
meaningful	B-T078
patterns	I-T078
were	O
statistically	O
evaluated	O
through	O
bivariate	O
associations	O
,	O
revealing	O
21	O
significant	O
associations	B-T078
.	O
	
further	O
,	O
14	O
associations	B-T078
between	O
episode	O
length	O
and	O
charlson	B-T170
co-morbidity	I-T170
index	I-T170
mainly	O
with	O
urinary	B-T080
related	O
diagnoses	B-T047
and	I-T047
problems	I-T047
remained	O
significant	O
after	O
adjustment	O
analyses	O
.	O
	
through	O
visual	O
analysis	O
,	O
the	O
adverse	O
association	B-T078
of	O
the	O
longer	O
home	O
health	O
episode	O
length	O
and	O
higher	O
charlson	B-T170
co-morbidity	I-T170
index	I-T170
with	O
behavior	B-T033
or	I-T033
status	I-T033
outcomes	I-T033
for	O
patients	O
with	O
impaired	B-T047
urinary	I-T047
function	I-T047
was	O
revealed	O
.	O
	
we	O
have	O
demonstrated	O
the	O
use	O
of	O
visual	O
analysis	O
to	O
discover	O
novel	O
patterns	O
that	O
described	O
high-needs	O
subgroups	O
among	O
the	O
older	B-T081
home	I-T081
health	I-T081
patient	I-T081
population	I-T081
.	O
	
the	O
effective	O
presentation	O
of	O
these	O
data	B-T078
patterns	I-T078
can	O
allow	O
clinicians	O
to	O
identify	O
areas	O
of	O
patient	O
improvement	O
,	O
and	O
time	O
periods	O
that	O
are	O
most	O
effective	O
for	O
implementing	O
home	O
health	O
interventions	O
to	O
improve	O
patient	O
outcomes	O
.	O
	
transforming	B-T116
growth	I-T116
factor	I-T116
beta	I-T116
1	I-T116
tgf-β1	B-T116
in	O
thyroid	O
cancer	O
patients	O
a	O
view	O
from	O
the	O
peripheral	O
blood	O
transforming	B-T116
growth	I-T116
factor	I-T116
beta	I-T116
tgf-β	B-T116
plays	O
an	O
important	O
role	O
in	O
many	O
pathophysiological	B-T169
conditions	B-T080
,	O
including	O
cancer	O
.	O
	
the	O
level	B-T080
of	O
tgf-β	B-T116
in	O
patients	O
with	O
differentiated	O
thyroid	O
cancer	O
dtc	O
has	O
not	O
been	O
examined	B-T033
so	O
far	O
.	O
	
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
measure	O
tgf-β	B-T116
concentration	B-T081
in	O
serum	O
samples	O
and	O
in	O
pha	B-T116
-	O
stimulated	O
whole	O
blood	O
culture	O
in	B-T080
vitro	I-T080
and	O
to	O
analyze	B-T062
possible	O
associations	O
of	O
tgf-β1	B-T116
levels	B-T080
with	O
leukocyte	O
,	O
lymphocyte	O
and	O
platelets	O
counts	O
,	O
the	O
histological	B-T169
type	O
of	O
thyroid	O
cancer	O
,	O
and	O
stage	O
of	O
disease	O
.	O
	
tgf-β1	B-T116
was	O
measured	O
in	O
22	O
dtc	O
patients	O
and	O
20	O
healthy	B-T080
controls	O
using	O
the	O
duoset	O
elisa	O
development	O
kit	O
for	O
human	B-T116
tgf-β1	I-T116
.	O
	
the	O
concentration	B-T081
of	O
tgf-β1	B-T116
in	O
serum	O
samples	O
from	O
both	O
groups	B-T098
correlated	O
positively	O
with	O
the	O
platelet	O
counts	O
.	O
	
there	O
was	O
no	O
statistically	B-T081
significant	I-T081
difference	O
in	O
the	O
serum	B-T081
concentrations	I-T081
of	O
tgf-β1	B-T116
between	O
dtc	O
patients	O
and	O
control	O
subjects	O
,	O
but	O
pha	B-T116
stimulated	O
whole	O
blood	O
cultures	O
of	O
dtc	O
patients	O
produced	O
less	O
tgf-β1	B-T116
than	O
those	O
from	O
controls	O
.	O
	
additional	O
studies	B-T062
are	O
needed	O
to	O
determine	O
the	O
significance	B-T078
of	O
these	O
in	B-T080
vitro	I-T080
findings	B-T033
.	O
	
p-glycoprotein	B-T116
traffics	B-T169
from	O
the	O
nucleus	O
to	O
the	O
plasma	O
membrane	O
in	O
rat	O
brain	O
endothelium	O
during	O
inflammatory	O
pain	O
p-glycoprotein	B-T116
pgp	B-T116
,	O
a	O
drug	O
efflux	O
pump	O
in	O
blood-brain	O
barrier	O
endothelial	O
cells	O
,	O
is	O
a	O
major	O
clinical	B-T080
obstacle	B-T080
for	O
effective	O
central	O
nervous	O
system	O
drug	B-T061
delivery	I-T061
.	O
	
identifying	O
pgp	B-T116
regulatory	B-T169
pathways	I-T169
that	O
can	O
be	O
exploited	O
clinically	O
is	O
critical	O
for	O
improving	O
central	O
nervous	O
system	O
drug	B-T061
delivery	I-T061
.	O
	
we	O
previously	O
found	O
that	O
pgp	O
activity	O
increases	B-T169
in	O
rat	O
brain	O
microvessels	O
concomitant	B-T079
with	O
decreased	B-T081
central	O
nervous	O
system	O
drug	B-T061
delivery	I-T061
in	O
response	O
to	O
acute	B-T079
peripheral	B-T082
inflammatory	O
pain	O
.	O
	
in	O
the	O
current	O
study	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
pgp	B-T116
traffics	B-T169
to	O
the	O
luminal	B-T082
plasma	O
membrane	O
of	O
the	O
microvessel	O
endothelial	O
cells	O
from	O
intracellular	B-T082
stores	B-T169
during	O
peripheral	B-T082
inflammatory	O
pain	O
.	O
	
using	O
immunofluorescence	O
microscopy	O
,	O
we	O
detected	B-T033
pgp	B-T116
in	O
endothelial	O
cell	O
nuclei	O
and	O
in	O
the	O
luminal	B-T082
plasma	O
membrane	O
in	O
control	O
animals	O
.	O
	
following	O
peripheral	B-T082
inflammatory	O
pain	O
,	O
luminal	B-T082
pgp	B-T116
staining	O
increased	B-T081
while	O
staining	O
in	O
the	O
nucleus	O
decreased	B-T081
.	O
	
biochemical	O
analysis	O
of	O
nuclear	O
pgp	B-T116
content	O
confirmed	O
our	O
visual	B-T169
observations	I-T169
.	O
	
peripheral	B-T082
inflammatory	O
pain	O
also	O
increased	B-T081
endothelial	O
cell	O
luminal	B-T082
staining	O
of	O
polymerase	O
1	O
and	O
transcript	O
release	O
factor	O
/	O
cavin1	O
and	O
serum	O
deprivation	O
response	O
protein	O
/	O
cavin2	O
,	O
two	O
caveolar	B-T116
scaffold	I-T116
proteins	I-T116
,	O
without	O
changing	O
caveolin1	B-T116
or	O
protein	O
kinase	O
c	O
delta	O
binding	O
protein	O
/	O
cavin3	O
location	B-T082
.	O
	
our	O
data	B-T078
a	O
indicate	O
that	O
pgp	B-T116
traffics	B-T169
from	O
stores	B-T169
in	O
the	O
nucleus	O
to	O
the	O
endothelial	O
cell	O
luminal	O
membrane	O
in	O
response	O
to	O
peripheral	B-T082
inflammatory	O
pain	O
b	O
provide	O
an	O
explanation	O
for	O
our	O
previous	O
observation	B-T062
that	O
peripheral	B-T082
inflammatory	O
pain	O
inhibits	B-T052
central	O
nervous	O
system	O
drug	O
uptake	O
and	O
c	O
suggest	O
a	O
novel	B-T080
regulatory	B-T033
mechanism	I-T033
for	O
pgp	O
activity	O
in	O
rat	O
brain	O
.	O
	
functional	B-T169
impairment	B-T169
in	O
children	O
with	O
externalizing	O
behavior	O
disorders	O
psychometric	O
properties	B-T080
of	O
the	O
weiss	B-T170
functional	I-T170
impairment	I-T170
rating	I-T170
scale-parent	I-T170
report	I-T170
in	O
a	O
german	O
clinical	O
sample	O
to	O
examine	O
the	O
psychometric	O
properties	B-T080
of	O
a	O
german	O
adaptation	O
of	O
the	O
weiss	B-T170
functional	I-T170
impairment	I-T170
rating	I-T170
scale-parent	I-T170
report	I-T170
wfirs-p	B-T170
in	O
a	O
clinical	O
sample	O
of	O
children	O
4-12	O
years	B-T079
with	O
externalizing	O
behavior	O
disorders	O
.	O
	
data	B-T078
were	O
collected	B-T169
within	O
two	O
clinical	B-T062
trials	I-T062
n	O
=	O
264	O
.	O
	
factorial	B-T080
validity	I-T080
,	O
reliability	B-T081
,	O
and	O
divergent	B-T081
validity	I-T081
from	O
symptoms	O
of	O
adhd	O
and	O
oppositional	O
defiant	O
disorder	O
odd	O
were	O
assessed	B-T052
.	O
	
confirmatory	B-T080
factor	I-T080
analyses	I-T080
revealed	B-T080
that	O
a	O
bifactor	B-T170
model	I-T170
consistent	B-T078
with	I-T078
the	O
theoretical	B-T078
assumption	I-T078
of	O
a	O
general	O
construct	O
of	O
impairment	B-T169
total	O
scale	O
and	O
additional	B-T169
specific	B-T169
factors	I-T169
subscales	O
provided	O
satisfactory	B-T080
data	B-T078
fit	I-T078
.	O
	
model	B-T170
-based	O
reliability	B-T081
estimates	B-T081
showed	O
that	O
both	O
the	O
general	O
construct	O
and	O
specific	B-T169
factors	I-T169
accounted	O
for	O
item	O
variance	B-T080
.	O
	
internal	O
consistencies	B-T080
were	O
>	O
,	O
part-whole	O
corrected	O
item-scale	O
correlations	B-T080
mostly	O
>	O
.	O
	
correlations	B-T080
between	O
the	O
wfirs-p	B-T170
scales	I-T170
and	O
adhd	O
and	O
odd	O
symptoms	O
were	O
low	B-T080
to	O
moderate	B-T080
.	O
	
the	O
results	B-T169
support	O
the	O
factorial	B-T080
validity	I-T080
,	O
reliability	B-T081
,	O
and	O
divergent	B-T081
validity	I-T081
of	O
the	O
what	O
can	O
the	O
canadians	B-T098
and	O
americans	B-T098
learn	O
from	O
each	O
other's	O
health	O
care	O
systems	O
numerous	O
papers	B-T170
have	O
been	O
written	O
comparing	B-T052
the	O
canadian	B-T098
and	O
us	O
healthcare	O
systems	O
,	O
and	O
a	O
number	O
of	O
health	O
policy	O
experts	O
have	O
recommended	B-T078
that	O
the	O
americans	B-T098
implement	B-T052
their	O
single-payer	O
system	O
to	O
save	O
12-20%	O
of	O
its	O
healthcare	B-T081
expenditures	I-T081
.	O
	
this	O
paper	B-T170
is	O
different	O
in	O
that	O
it	O
assumes	O
that	O
neither	O
country	O
will	O
undertake	O
a	O
significant	B-T078
philosophic	B-T080
or	O
structural	B-T082
change	B-T169
in	O
their	O
healthcare	O
system	O
,	O
but	O
there	O
are	O
lessons	O
to	O
be	O
learned	O
that	O
are	O
inherent	O
in	O
one	O
that	O
could	O
be	O
a	O
major	O
breakthrough	B-T080
for	O
the	O
other	O
.	O
	
following	O
the	O
model	O
in	O
canada	O
and	O
in	O
western	O
europe	O
,	O
the	O
usa	O
could	O
implement	B-T052
universal	B-T080
health	O
insurance	O
so	O
that	O
the	O
32.0	O
million	O
2015	O
americans	B-T098
still	O
uninsured	B-T098
would	O
have	O
at	O
least	O
minimal	B-T080
coverage	B-T078
when	O
incurring	O
medical	B-T081
expenditures	I-T081
.	O
	
also	O
,	O
the	O
usa	O
could	O
use	O
smart	O
cards	O
to	O
evaluate	O
eligibility	O
and	O
to	O
process	O
health	O
insurance	O
claims	O
these	O
changes	O
resulting	B-T169
in	I-T169
an	O
estimated	B-T081
15%	O
reduction	B-T080
in	O
us	O
health	B-T081
expenditures	I-T081
without	O
adversely	O
effecting	B-T080
access	B-T080
or	O
quality	O
of	O
care	O
.	O
	
such	O
a	O
strategy	O
would	O
result	B-T169
in	O
the	O
eventual	O
loss	B-T081
of	O
2.5	O
million	O
white-collar	O
jobs	O
at	O
hospitals	O
,	O
physician	O
offices	O
and	O
insurance	B-T078
companies	I-T078
,	O
a	O
long-term	B-T079
economic	B-T169
gain	B-T081
.	O
	
only	O
a	O
few	O
would	O
agree	O
with	O
the	O
statement	O
that	O
canada	O
already	O
functions	B-T169
with	O
a	O
multi-payer	O
reimbursement	B-T170
system	I-T170
as	O
evidenced	O
by	O
1	O
a	O
federal	O
-	O
provincial	O
,	O
tax	B-T081
-	O
supported	O
plan	O
,	O
administered	O
by	O
each	O
of	O
the	O
provinces	O
,	O
providing	O
universal	B-T078
coverage	I-T078
for	O
hospital	O
and	O
physician	O
services	O
and	O
2	O
roughly	O
60%	O
of	O
its	O
residents	B-T098
receiving	O
employer-paid	B-T081
health	O
insurance	O
benefits	B-T081
,	O
underwritten	O
primarily	O
by	O
investor-owned	O
plans	O
,	O
that	O
are	O
less	O
than	O
effective	B-T080
to	O
reimburse	B-T080
for	O
pharmaceuticals	O
,	O
dental	O
and	O
other	O
healthcare	O
services	O
.	O
	
what	O
could	O
be	O
learned	O
from	O
the	O
usa	O
and	O
particularly	O
from	O
western	O
european	O
countries	O
is	O
possibly	O
implementing	B-T052
an	O
approach	O
,	O
whereby	O
at	O
least	O
upper-income	B-T080
canadians	B-T098
could	O
opt	O
out	O
of	O
their	O
federal	O
-	O
provincial	O
plan	O
and	O
purchase	O
private	O
insurance	B-T078
coverage	I-T078
-	O
being	O
eligible	O
for	O
far	O
more	O
comprehensive	O
"""private"""	O
benefits	O
for	O
hospital	O
,	O
physician	O
,	O
pharmaceutical	O
,	O
dental	O
and	O
other	O
healthcare	O
services	O
.	O
	
aside	O
from	O
generating	O
billions	O
of	O
additional	O
needed	O
revenues	B-T081
from	O
the	O
private	B-T098
sector	I-T098
,	O
it	O
could	O
1	O
help	O
eliminate	B-T052
long	O
waits	O
for	O
non-emergent	O
physicians'	O
care	O
by	O
appointing	O
newly	O
minted	O
specialists	O
to	O
their	O
medical	O
staffs	O
2	O
offer	O
prompt	B-T169
admissions	O
for	O
elective	B-T033
cases	I-T033
to	O
""""	O
private	O
""""	O
wings	O
of	O
hospitals	O
3	O
increase	B-T081
available	O
funding	B-T081
for	O
what	O
is	O
currently	B-T079
an	O
undercapitalized	B-T033
system	B-T169
4	O
enhance	B-T052
the	O
system's	O
sluggish	B-T033
operations	B-T052
and	O
5	O
encourage	O
more	O
competition	O
among	O
various	O
providers	O
.	O
	
although	O
such	O
a	O
two-tier	B-T170
approach	I-T170
,	O
such	O
as	O
available	O
in	O
the	O
usa	O
and	O
elsewhere	O
,	O
is	O
politically	O
dead	O
on	O
arrival	O
in	O
canada	O
today	O
,	O
private	O
insurance	O
being	O
already	O
legal	B-T169
and	O
commonly	O
available	O
there	O
.	O
	
interestingly	O
,	O
this	O
recommended	B-T078
solution	O
is	O
utilized	O
in	O
most	O
western	O
european	O
countries	O
where	O
there	O
is	O
a	O
higher	O
percentagea	B-T081
than	O
in	O
canada	O
of	O
public	O
versus	O
private	O
funding	B-T081
of	O
their	O
total	O
health	B-T081
expenditures	I-T081
.	O
	
because	O
of	O
various	O
vested	O
interests	O
,	O
attempts	O
to	O
implement	B-T052
any	O
of	O
the	O
aforementioned	O
proposals	O
will	O
undoubtedly	O
result	B-T169
in	O
considerable	O
political	O
rancor	O
.	O
	
there	O
is	O
greater	O
likelihood	O
,	O
however	O
,	O
that	O
the	O
canadians	B-T098
because	O
their	O
need	O
to	O
be	O
more	O
effective	B-T080
and	O
efficient	B-T080
in	O
their	O
delivery	O
of	O
care	O
,	O
and	O
their	O
overall	O
long-term	B-T079
fiscal	O
outlook	O
will	O
agree	B-T033
to	O
the	O
further	O
privatization	O
of	O
their	O
healthcare	O
system	O
before	O
the	O
americans	B-T098
will	O
mandate	O
universal	O
access	O
,	O
use	O
the	O
smart	O
card	O
to	O
process	O
insurance	O
eligibility	O
and	O
claims	O
or	O
will	O
impose	O
price	O
controls	B-T169
on	O
high-tech	O
services	O
and	O
on	O
pharmaceuticals	O
.	O
	
optimal	B-T080
duration	B-T079
of	O
coronary	B-T061
ligation	I-T061
and	O
reperfusion	B-T061
for	O
reperfusion	O
injury	O
study	B-T062
in	O
a	O
rat	O
model	O
reperfusion	O
injury	O
ri	O
has	O
an	O
important	B-T080
impact	B-T080
on	O
the	O
clinical	B-T080
prognosis	O
for	O
patients	O
with	O
acute	O
myocardial	O
injury	O
who	O
had	O
their	O
coronary	B-T082
blood	O
flow	O
reestablished	B-T080
.	O
	
however	O
,	O
no	O
studies	B-T062
to	O
date	O
have	O
investigated	B-T169
the	O
timeframe	B-T079
of	O
coronary	B-T047
occlusion	I-T047
and	O
reperfusion	B-T061
effects	B-T080
on	O
ri	O
.	O
	
a	O
total	O
of	O
100	O
rats	O
were	O
divided	O
into	O
4	O
groups	B-T078
based	O
on	O
the	O
coronary	B-T061
ligation	I-T061
period	B-T079
30	O
,	O
60	O
,	O
120	O
,	O
and	O
180	O
min	O
,	O
and	O
each	O
group	B-T078
was	O
further	O
divided	O
into	O
5	O
subgroups	B-T078
with	O
different	B-T080
reperfusion	B-T061
periods	B-T079
0	O
,	O
30	O
,	O
60	O
,	O
120	O
,	O
and	O
180	O
min	O
.	O
	
r0	O
was	O
the	O
baseline	B-T081
of	O
each	O
subgroup	B-T078
.	O
	
all	O
animals	O
received	O
the	O
same	O
protocols	B-T170
for	O
designed	B-T052
ligation	B-T061
and	O
reperfusion	B-T061
periods	B-T079
.	O
	
evans	B-T109
blue	I-T109
and	O
2	B-T109
chloride	I-T109
were	O
used	O
to	O
distinguish	O
different	B-T080
myocardial	O
injury	O
areas	B-T082
area	B-T082
at	B-T080
risk	I-T080
aar	B-T082
and	O
myocardial	B-T047
necrosis	I-T047
.	O
	
the	O
differences	B-T080
of	O
the	O
ratios	B-T081
of	O
the	O
necrotic	O
area	B-T082
to	O
aar	B-T082
between	O
each	O
subgroup	B-T078
and	O
baseline	B-T081
were	O
further	O
averaged	B-T081
to	O
calculate	B-T052
an	O
overall	B-T080
value	B-T081
of	O
each	O
heart	O
.	O
	
the	O
relative	O
ri	O
percentages	B-T081
showed	O
significant	B-T078
differences	B-T080
0.8	O
2.3	O
,	O
4.9	O
3.3	O
,	O
10.8	O
3.1	O
,	O
and	O
20.3	O
3.6	O
respectively	O
,	O
p	O
<	O
0.001	O
at	O
different	B-T080
time	B-T079
points	I-T079
of	O
reperfusion	B-T061
but	O
not	O
at	O
different	B-T080
time	B-T079
points	I-T079
of	O
ligation	B-T061
p	O
=	O
0.593	O
.	O
	
the	O
effects	B-T080
of	O
different	B-T080
time	B-T079
courses	I-T079
in	O
ri	O
showed	O
that	O
the	O
l120r180	O
group	B-T078
43.4	O
2.3	O
had	O
the	O
highest	B-T080
ri	O
difference	B-T080
with	O
the	O
baseline	B-T081
group	B-T078
.	O
	
maximal	B-T080
ri	O
occurred	O
at	O
the	O
timeframe	B-T079
of	O
l120r180	O
in	O
our	O
animal	O
model	O
.	O
	
this	O
result	B-T169
may	O
be	O
utilized	O
to	O
assess	B-T052
the	O
substantial	O
benefits	B-T081
of	O
ri	B-T061
therapies	I-T061
in	O
an	O
experimental	O
rat	O
model	O
derivation	B-T080
of	O
a	O
predictive	B-T080
score	B-T081
for	O
hemorrhagic	O
progression	B-T169
of	O
cerebral	O
contusions	O
in	O
moderate	O
and	O
severe	O
traumatic	O
brain	O
injury	O
after	O
traumatic	O
brain	O
injury	O
tbi	O
,	O
hemorrhagic	O
progression	B-T169
of	O
contusions	O
hpcs	O
occurs	O
frequently	B-T079
.	O
	
however	O
,	O
there	O
is	O
no	O
established	B-T080
predictive	B-T080
score	B-T081
to	O
identify	O
high-risk	B-T033
patients	O
for	O
hpc	O
.	O
	
consecutive	B-T080
patients	O
who	O
were	O
hospitalized	B-T033
2008-2013	O
with	O
non-penetrating	O
moderate	O
or	O
severe	O
tbi	O
were	O
studied	O
.	O
	
the	O
primary	B-T080
outcome	I-T080
was	O
hpc	O
,	O
defined	O
by	O
both	O
a	O
relative	O
increase	B-T169
in	O
contusion	O
volume	B-T081
by	O
30	O
%	O
and	O
an	O
absolute	B-T080
increase	B-T169
by	O
10	O
ml	O
on	O
serial	O
imaging	O
.	O
	
logistic	B-T081
regression	I-T081
models	I-T081
were	O
created	B-T052
to	O
identify	O
independent	O
risk	B-T033
factors	I-T033
for	O
hpc	O
.	O
	
the	O
hpc	O
score	B-T081
was	O
then	O
derived	B-T080
based	O
on	O
the	O
final	B-T170
model	I-T170
.	O
	
among	O
a	O
total	O
of	O
286	O
eligible	O
patients	O
,	O
61	O
21	O
%	O
patients	O
developed	O
hpc	O
.	O
	
on	O
univariate	B-T062
analyses	I-T062
,	O
hpc	O
was	O
associated	B-T080
with	I-T080
older	O
age	O
,	O
higher	B-T033
initial	I-T033
blood	I-T033
pressure	I-T033
,	O
antiplatelet	O
medications	O
,	O
anticoagulants	O
,	O
subarachnoid	B-T047
hemorrhage	I-T047
sah	B-T047
subdural	O
hematoma	O
sdh	O
,	O
skull	O
fracture	O
,	O
frontal	O
contusion	O
,	O
larger	B-T081
contusion	O
volume	B-T081
,	O
and	O
shorter	B-T079
interval	I-T079
from	O
injury	O
to	O
initial	O
ct	O
.	O
	
in	O
the	O
final	B-T170
model	I-T170
,	O
sah	B-T047
or	B-T081
6.33	O
,	O
95	O
%	O
ci	B-T081
,	O
1.80	O
,	O
sdh	O
or	B-T081
3.46	O
,	O
95	O
%	O
ci	B-T081
,	O
1.39	O
,	O
and	O
skull	O
fracture	O
or	B-T081
2.67	O
,	O
95	O
%	O
ci	B-T081
,	O
1.28	O
were	O
associated	B-T080
with	I-T080
hpc	O
.	O
	
based	O
on	O
these	O
factors	B-T169
,	O
the	O
hpc	O
score	B-T081
was	O
derived	B-T080
sah	B-T047
=	O
2	O
points	O
,	O
sdh	O
=	O
1	O
point	O
,	O
and	O
skull	O
fracture	O
=	O
1	O
point	O
.	O
	
this	O
score	B-T081
had	O
an	O
area	O
under	O
the	O
receiver	B-T081
operating	I-T081
curve	I-T081
of	O
0.77	O
.	O
	
patients	O
with	O
a	O
score	B-T081
of	O
0-2	O
had	O
a	O
4.0	O
%	O
incidence	B-T081
of	O
hpc	O
,	O
while	O
patients	O
with	O
a	O
score	B-T081
of	O
3-4	O
had	O
a	O
34.6	O
%	O
incidence	B-T081
of	O
hpc	O
.	O
	
a	O
simple	O
hpc	O
score	B-T081
was	O
developed	O
for	O
early	O
risk	B-T078
stratification	B-T169
of	O
hpc	O
in	O
patients	O
with	O
moderate	O
or	O
severe	O
tbi	O
.	O
	
expressing	O
sexuality	O
in	O
nursing	O
homes	O
.	O
	
the	O
experience	O
of	O
older	B-T098
women	I-T098
a	O
qualitative	B-T062
study	I-T062
in	O
nursing	O
homes	O
,	O
a	O
number	O
of	O
barriers	B-T080
to	O
the	O
expression	O
of	O
sexuality	O
exist	O
,	O
such	O
as	O
the	O
lack	B-T033
of	I-T033
privacy	I-T033
,	O
certain	O
attitudes	O
on	O
behalf	O
of	O
the	O
staff	O
and	O
the	O
family	O
,	O
the	O
lack	O
of	O
a	O
sexual	B-T098
partner	I-T098
,	O
and	O
physical	B-T033
limitations	I-T033
.	O
	
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
describe	O
the	O
lived	O
experience	O
of	O
sexuality	O
in	O
elderly	B-T098
spanish	I-T098
women	I-T098
residing	O
in	O
nursing	O
homes	O
.	O
	
a	O
qualitative	B-T062
phenomenological	I-T062
approach	I-T062
was	O
followed	O
.	O
	
data	B-T078
were	O
collected	B-T062
over	O
an	O
18-	O
month	B-T079
period	I-T079
between	O
2013	O
and	O
2015	O
.	O
	
purposeful	O
sampling	B-T078
was	O
conducted	O
with	O
spanish	B-T098
residents	I-T098
in	O
nursing	O
homes	O
in	O
madrid	O
.	O
	
data	B-T078
were	O
collected	O
using	O
unstructured	B-T052
and	I-T052
semi-structured	I-T052
interviews	I-T052
.	O
	
the	O
data	B-T078
were	O
analyzed	B-T062
using	O
thematic	B-T062
analysis	I-T062
.	O
	
twenty	O
female	O
residents	B-T098
participated	O
.	O
	
three	O
main	O
themes	O
emerged	O
from	O
the	O
data	B-T078
a	O
expressing	O
sexuality	O
,	O
b	O
sexuality	O
as	O
a	O
duty	O
and	O
c	O
respecting	O
vows	B-T079
.	O
	
female	O
residents	B-T098
reported	O
key	O
elements	O
influencing	O
how	O
they	O
manage	O
their	O
sexuality	O
in	O
nursing	O
homes	O
.	O
	
these	O
results	O
serve	O
to	O
improve	O
our	O
understanding	O
regarding	O
the	O
expression	O
of	O
sexuality	O
in	O
older	O
female	O
nursing	O
home	O
residents	B-T098
.	O
	
xylan-based	B-T109
temperature	B-T081
/	O
ph	B-T081
sensitive	B-T169
hydrogels	O
for	O
drug	O
controlled	O
release	O
xylan-based	B-T109
temperature	B-T081
/	O
ph	B-T081
sensitive	B-T169
hydrogels	O
were	O
prepared	O
by	O
the	O
crosslinking	O
copolymerization	O
of	O
xylan	B-T109
with	O
n-isopropylacrylamide	B-T109
nipam	B-T109
and	O
acrylic	B-T109
acid	I-T109
aa	B-T109
using	O
n	B-T109
mba	B-T109
as	O
a	O
cross-linker	O
and	O
2	B-T109
as	O
a	O
photoinitiator	B-T109
via	O
ultraviolet	O
irradiation	O
.	O
	
the	O
influence	O
of	O
the	O
nipam	B-T109
,	O
aa	B-T109
and	O
mba	B-T109
amount	O
on	O
properties	O
of	O
xylan-based	B-T109
hydrogels	O
was	O
discussed	O
.	O
	
the	O
morphology	B-T080
and	O
interactions	B-T169
of	O
hydrogels	O
were	O
characterized	B-T052
by	O
sem	O
and	O
ftir	B-T062
.	O
	
the	O
lower	B-T081
critical	I-T081
solution	I-T081
temperature	I-T081
lcst	B-T081
of	O
hydrogels	O
was	O
investigated	B-T169
by	O
dsc	O
.	O
	
the	O
results	B-T033
indicated	O
that	O
the	O
lcst	B-T081
of	O
hydrogels	O
emerged	O
at	O
around	O
34	O
and	O
increased	O
with	O
increasing	O
the	O
aa	B-T109
content	O
.	O
	
the	O
drug	O
encapsulation	O
efficiency	B-T081
of	O
as-prepared	O
hydrogels	O
reached	O
to	O
97.60	O
and	O
the	O
cumulative	B-T080
release	O
rate	B-T081
of	O
acetylsalicylic	B-T109
acid	I-T109
was	O
90.12	O
and	O
26.35	O
in	O
the	O
intestinal	O
and	O
gastric	O
fluid	O
,	O
respectively	O
.	O
	
xylan-based	B-T109
hydrogels	O
were	O
proved	O
to	O
be	O
biocompatible	B-T080
with	O
nih3t3	O
cell	O
by	O
mtt	B-T062
assay	I-T062
and	O
showed	O
the	O
promising	O
application	O
as	O
drug	O
carriers	O
for	O
the	O
intestinal	O
-	O
targeted	B-T169
oral	B-T061
drug	I-T061
delivery	I-T061
.	O
	
isolation	O
and	O
prebiotic	B-T109
activity	B-T169
of	O
water-soluble	O
polysaccharides	B-T109
fractions	B-T081
from	O
the	O
bamboo	O
shoots	O
phyllostachys	O
praecox	O
the	O
water-soluble	O
polysaccharides	B-T109
from	O
bamboo	O
shoots	O
phyllostachys	O
praecox	O
wbp	B-T109
were	O
isolated	B-T169
,	O
and	O
the	O
characterizations	O
as	O
well	O
as	O
prebiotic	B-T109
activities	B-T169
were	O
investigated	B-T169
.	O
	
the	O
yield	B-T081
of	O
wbp	B-T109
was	O
7.58	O
under	O
optimal	O
hot-water	O
extraction	O
conditions	O
.	O
	
two	O
fractions	B-T081
,	O
i.e	O
,	O
wbp-1	B-T109
and	O
wbp-2	B-T109
with	O
molecular	B-T081
weight	I-T081
of	O
83.50kda	O
and	O
80.08kda	O
,	O
respectively	O
,	O
were	O
purified	O
by	O
chromatography	O
.	O
	
both	O
the	O
polysaccharides	B-T109
fractions	B-T081
were	O
identified	O
as	O
heteropolysaccharides-protein	O
complexes	O
composed	O
of	O
15	O
kinds	O
of	O
common	O
amino	B-T116
acids	I-T116
in	O
protein	B-T116
part	O
and	O
rhamnose	B-T109
,	O
arabinose	B-T109
,	O
xylose	B-T109
,	O
mannose	B-T109
,	O
glucose	B-T109
and	O
galactose	B-T109
in	O
different	O
molar	B-T081
ratios	I-T081
in	O
polysaccharide	B-T109
part	O
.	O
	
the	O
existence	O
of	O
α-	B-T078
and	O
β-glycosidic	B-T078
linkages	I-T078
between	O
the	O
sugar	B-T109
units	O
was	O
confirmed	O
by	O
ftir	B-T062
and	O
nmr	O
spectra	O
.	O
	
compared	O
with	O
the	O
blank	O
control	O
and	O
the	O
reference	O
of	O
fos	O
,	O
wbp-1	B-T109
and	O
wbp-2	B-T109
significantly	O
increased	O
the	O
numbers	O
of	O
bifidobacterium	O
adolescentis	O
and	O
bifidobacterium	O
bifidum	O
p<0	O
,	O
which	O
contributed	O
to	O
the	O
production	B-T169
of	O
organic	B-T109
acids	I-T109
,	O
suggesting	O
that	O
the	O
polysaccharides	B-T109
have	O
potential	B-T080
prebiotic	B-T109
properties	B-T080
.	O
	
evaluation	O
of	O
nutraceutical	B-T033
and	O
antinutritional	B-T033
properties	I-T033
in	O
barnyard	O
and	O
finger	O
millet	O
varieties	O
grown	O
in	O
himalayan	O
region	O
five	O
elite	O
varieties	O
of	O
barnyard	O
echinochloa	O
frumentacea	O
and	O
finger	O
eleusine	O
coracana	O
growing	O
at	O
northwestern	O
himalaya	O
were	O
investigated	B-T169
for	O
nutraceutical	B-T033
and	O
antinutritional	B-T033
properties	I-T033
.	O
	
barnyard	O
millet	O
contained	O
higher	O
amount	B-T081
of	O
crude	B-T109
fiber	I-T109
,	O
total	O
dietary	O
fiber	O
,	O
tryptophan	B-T116
content	O
,	O
total	B-T109
carotenoids	I-T109
,	O
α-tocopherol	B-T109
compared	O
to	O
the	O
finger	O
millet	O
whereas	O
the	O
finger	O
millet	O
contains	O
higher	O
amount	B-T081
of	O
methionine	B-T116
and	O
ascorbic	B-T109
acid	I-T109
as	O
compared	O
to	O
the	O
barnyard	O
millet	O
.	O
	
the	O
secondary	O
metabolites	O
of	O
biological	O
functions	O
were	O
analyzed	O
and	O
found	O
that	O
barnyard	O
millet	O
contained	O
the	O
higher	O
amount	B-T081
of	O
polyphenols	B-T109
,	O
tannins	B-T109
and	O
ortho-dihydroxy	B-T109
phenol	I-T109
content	O
compared	O
to	O
finger	O
millet	O
.	O
	
among	O
antinutitional	B-T109
compounds	I-T109
barnyard	O
millet	O
contained	O
lower	O
phytic	B-T109
acid	I-T109
content	O
compare	O
to	O
finger	O
millet	O
whereas	O
no	B-T033
significant	I-T033
difference	I-T033
in	O
trypsin	O
inhibition	O
activity	O
of	O
barnyard	O
millet	O
and	O
finger	O
millet	O
varieties	O
were	O
found	O
.	O
	
barnyard	O
millet	O
contained	O
higher	O
acid	B-T116
phosphatase	I-T116
,	O
α-galactosidase	B-T116
and	O
α-amylase	O
inhibitor	O
activity	O
compared	O
to	O
finger	O
millet	O
.	O
	
finger	O
millet	O
seeds	O
contained	O
about	O
10-13	O
folds	O
higher	O
calcium	O
content	O
and	O
double	O
amount	B-T081
of	O
manganese	O
content	O
in	O
comparison	O
to	O
barnyard	O
millet	O
seeds	O
.	O
	
present	O
study	O
suggests	O
that	O
barnyard	O
millet	O
varieties	O
studied	O
under	O
present	O
investigation	O
were	O
found	O
nutritionally	O
superior	O
compared	O
to	O
finger	O
millet	O
varieties	O
.	O
	
polymorphisms	O
in	O
inflammatory	B-T169
mediator	O
genes	O
and	O
risk	B-T078
of	O
preeclampsia	O
in	O
taiyuan	O
,	O
china	O
excessive	B-T080
maternal	B-T033
inflammatory	O
response	O
is	O
involved	O
in	O
the	O
pathogenesis	O
of	O
preeclampsia	O
.	O
	
few	O
epidemiologic	B-T062
studies	I-T062
have	O
investigated	B-T169
the	O
associations	B-T080
between	O
genetic	O
variations	O
in	O
the	O
inflammatory	B-T169
mediator	O
genes	O
and	O
preeclampsia	O
risk	B-T078
,	O
and	O
these	O
studies	B-T062
have	O
reached	O
inconsistent	O
results	O
.	O
	
we	O
examined	O
31	O
single-nucleotide	O
polymorphisms	O
in	O
il-1a	O
,	O
il-1b	O
,	O
il-1r1	B-T116
,	O
il-2ra	B-T116
,	O
il-5ra	B-T116
,	O
il-6	O
,	O
il-6r	B-T116
,	O
tnfsf11	O
,	O
tnfrsf11a	O
,	O
il-28ra	O
,	O
irak4	O
,	O
and	O
kit	O
genes	O
and	O
the	O
risk	B-T078
of	O
preeclampsia	O
and	O
its	O
clinical	B-T080
subtypes	O
in	O
a	O
nested	B-T062
case-control	I-T062
study	I-T062
including	O
203	O
preeclampsia	O
cases	O
and	O
233	O
controls	O
.	O
	
we	O
found	O
that	O
il-1r1	B-T116
,	O
il-5ra	B-T116
,	O
il-6r	B-T116
,	O
and	O
tnfsf11	O
were	O
associated	B-T080
with	I-T080
the	O
risk	B-T078
of	O
preeclampsia	O
.	O
	
although	O
the	O
significant	B-T078
associations	B-T080
observed	O
for	O
preeclampsia	O
overall	B-T080
were	O
mainly	O
seen	O
for	O
late-onset	B-T079
preeclampsia	O
and	O
severe	B-T080
preeclampsia	O
,	O
il-6r	B-T116
rs2229238	B-T170
and	O
tnfsf11	O
rs9525643	B-T170
polymorphisms	O
were	O
associated	B-T080
with	I-T080
the	O
risk	B-T078
of	O
early-onset	O
preeclampsia	O
.	O
	
tnfsf11	O
rs2200287	B-T170
and	O
rs2148072	B-T170
polymorphisms	O
were	O
associated	B-T080
with	I-T080
risk	B-T078
of	O
mild	O
preeclampsia	O
.	O
	
our	O
study	B-T062
provided	O
the	O
first	O
evidence	B-T078
that	O
genetic	O
variations	O
in	O
inflammatory	B-T169
mediator	O
genes	O
il-1r1	B-T116
,	O
il-6r	B-T116
,	O
tnfsf11	O
,	O
and	O
il-5ra	B-T116
were	O
associated	B-T080
with	I-T080
preeclampsia	O
risk	B-T078
,	O
and	O
the	O
risk	B-T078
varied	O
by	O
preeclampsia	O
subtypes	O
.	O
	
a	O
closer	O
look	O
at	O
school	O
bonding	O
among	O
african	B-T098
american	I-T098
adolescents	O
in	O
low-income	B-T098
communities	I-T098
a	O
latent	B-T062
class	I-T062
analysis	I-T062
positive	B-T033
school	O
bonding	O
is	O
a	O
significant	B-T078
precursor	B-T078
to	O
students	B-T098
'	O
school	O
success	O
.	O
	
however	O
,	O
african	B-T098
american	I-T098
youth	O
report	O
lower	B-T080
school	O
success	O
compared	O
with	O
their	O
white	B-T098
counterparts	I-T098
.	O
	
this	O
study	B-T062
examined	O
correlates	B-T080
of	O
school	O
bonding	O
among	O
633	O
african	B-T098
american	I-T098
youth	O
who	O
were	O
recruited	B-T052
from	O
community	O
settings	O
in	O
chicago	O
.	O
	
major	B-T080
findings	B-T033
indicated	O
that	O
negative	B-T033
peer	I-T033
norms	I-T033
,	O
exposure	B-T080
to	I-T080
community	B-T033
violence	I-T033
,	O
and	O
poor	B-T080
mental	O
health	O
were	O
negatively	B-T033
correlated	B-T080
with	O
school	O
bonding	O
,	O
while	O
parental	O
monitoring	O
,	O
positive	B-T033
self-regard	I-T033
,	O
and	O
future	B-T079
orientation	O
were	O
correlated	B-T080
with	O
higher	B-T080
school	O
motivation	O
.	O
	
students	B-T098
classified	O
as	O
having	O
high	B-T080
or	O
moderate	B-T080
school	O
bonding	O
were	O
more	O
likely	O
to	O
live	B-T052
with	O
both	O
parents	O
,	O
experience	O
higher	B-T080
levels	B-T080
of	O
parental	O
monitoring	O
,	O
and	O
exhibit	B-T033
positive	I-T033
self-regard	I-T033
.	O
	
implications	O
are	O
discussed	O
in	O
view	O
of	O
these	O
depression	O
,	O
anxiety	O
,	O
stress	O
,	O
and	O
their	O
associated	B-T080
factors	B-T169
among	O
corps	B-T098
members	I-T098
serving	O
in	O
kebbi	O
state	O
depression	O
,	O
anxiety	O
and	O
stress	O
,	O
are	O
not	O
only	O
health	B-T033
problems	I-T033
by	O
themselves	O
,	O
but	O
also	O
associated	B-T080
with	I-T080
other	O
negative	B-T033
health	B-T078
consequences	B-T169
.	O
	
the	O
national	O
youth	O
service	O
is	O
usually	O
characterized	B-T052
by	O
a	O
number	O
of	O
new	O
challenges	O
and	O
experiences	O
which	O
may	O
require	O
life	O
style	O
adjustments	O
by	O
the	O
corps	B-T098
member	I-T098
.	O
	
however	O
,	O
no	O
previous	O
study	O
on	O
psychological	O
factors	O
has	O
been	O
conducted	O
among	O
corps	B-T098
members	I-T098
.	O
	
this	O
study	B-T062
was	O
conducted	O
to	O
determine	O
the	O
prevalence	B-T081
of	O
depression	O
,	O
anxiety	O
and	O
,	O
stress	O
and	O
their	O
associated	B-T080
factors	B-T169
among	O
corps	B-T098
members	I-T098
serving	O
in	O
kebbi	O
state	O
.	O
	
a	O
cross-sectional	B-T062
study	I-T062
was	O
conducted	O
among	O
264	O
corps	B-T098
members	I-T098
from	O
four	O
local	O
government	O
areas	O
of	O
the	O
state	O
.	O
	
selection	O
of	O
the	O
local	O
government	O
areas	O
and	O
the	O
individual	O
participants	B-T098
was	O
by	O
simple	B-T062
random	I-T062
sampling	I-T062
.	O
	
data	B-T078
was	O
collected	O
from	O
may	B-T079
to	O
june	B-T079
2014	O
using	O
a	O
self-administered	B-T170
questionnaire	I-T170
.	O
	
data	O
analysis	O
used	O
chi-square	B-T170
test	I-T170
to	O
identify	O
the	O
relationship	B-T080
between	O
categorical	B-T080
variables	I-T080
and	O
multivariate	B-T062
logistic	I-T062
regression	I-T062
to	O
identify	O
the	O
independent	O
factors	B-T169
for	O
depression	O
,	O
anxiety	O
and	O
stress	O
each	O
.	O
	
the	O
response	B-T079
rate	I-T079
was	O
97%	O
.	O
	
most	O
of	O
the	O
respondents	B-T098
were	O
males	O
63.6	O
,	O
single	B-T098
85.5	O
,	O
and	O
above	O
20	O
years	B-T079
of	O
age	O
71.6	O
.	O
	
the	O
overall	O
prevalences	B-T081
of	O
depression	O
,	O
anxiety	O
and	O
stress	O
among	O
the	O
respondents	B-T098
were	O
36.4	O
,	O
54.5	O
and	O
18.2	O
respectively	O
.	O
	
the	O
independent	O
factors	B-T169
for	O
depression	O
were	O
being	O
from	O
the	O
north	O
central	O
or	B-T081
=	O
5.99	O
95%	O
ci	B-T081
2.194	O
or	O
south-south	O
and	O
the	O
perception	O
of	O
earning	B-T081
enough	O
income	B-T081
or	B-T081
=	O
2.987	O
95%	O
ci	B-T081
1.062	O
.	O
	
for	O
anxiety	O
,	O
male	O
gender	O
or	O
=	O
0.411	O
95%	O
ci	B-T081
0.169	O
and	O
being	O
from	O
the	O
north	O
central	O
were	O
significant	O
risk	O
factors	O
or	O
=	O
3.731	O
95%	O
ci	O
1.450	O
.	O
	
being	O
above	O
26	O
years	O
of	O
age	O
was	O
an	O
independent	O
risk	O
factor	O
for	O
stress	O
or	O
=	O
0.083	O
95%	O
ci	O
0.018	O
.	O
	
also	O
,	O
those	O
who	O
had	O
ever	O
schooled	O
outside	O
their	O
towns	O
of	O
residence	O
were	O
less	O
likely	O
to	O
be	O
stressed	O
compared	O
to	O
those	O
who	O
had	O
never	O
or	O
=	O
0.30	O
95%	O
ci	O
0.110	O
.	O
	
all	O
other	O
factors	O
did	O
not	O
show	O
any	O
significant	O
association	O
with	O
any	O
of	O
the	O
outcome	O
variables	O
in	O
multivariate	O
analysis	O
.	O
	
in	O
conclusion	O
,	O
the	O
prevalences	O
of	O
depression	O
,	O
anxiety	O
and	O
stress	O
are	O
high	O
among	O
corps	O
members	O
serving	O
in	O
kebbi	O
state	O
.	O
	
there	O
is	O
need	O
to	O
expand	O
the	O
scope	O
of	O
this	O
study	O
to	O
a	O
national	O
level	O
so	O
as	O
to	O
get	O
a	O
bigger	O
picture	O
of	O
the	O
problem	B-T033
trans-oral	B-T082
fine	O
needle	O
aspiration	O
cytology	O
in	O
cervical	O
c1	O
and	O
c2	O
vertebral	O
lesions	B-T033
a	O
novel	O
diagnostic	O
approach	O
fine	O
needle	O
aspiration	O
fna	O
cytology	O
is	O
a	O
relatively	O
non-invasive	B-T169
method	O
for	O
diagnosing	B-T033
both	O
superficial	B-T033
and	O
deep-seated	O
neoplastic	O
and	O
non-neoplastic	B-T033
lesions	I-T033
.	O
	
in	O
this	O
study	O
,	O
we	O
evaluated	O
the	O
diagnostic	B-T169
utility	I-T169
of	O
trans-oral	B-T082
fna	O
in	O
cervical	O
c1	O
and	O
c2	O
vertebral	O
and	O
paravertebral	O
lesions	B-T033
.	O
	
eighteen	O
fna	O
cases	O
of	O
cervical	O
vertebral	O
and	O
paravertebral	O
lesions	B-T033
performed	O
by	O
a	O
trans-oral	B-T082
route	I-T082
without	O
any	O
image-guidance	O
between	O
1995	O
and	O
2014	O
were	O
retrieved	O
from	O
the	O
archives	O
of	O
the	O
cytology	O
department	O
at	O
pgimer	O
,	O
chandigarh	O
and	O
reviewed	O
.	O
	
out	O
of	O
18	O
cases	O
,	O
a	O
definite	O
diagnosis	B-T033
was	O
given	O
in	O
15	O
cases	O
83.3	O
.	O
	
the	O
commonest	O
diagnosis	B-T033
seen	O
was	O
granulomatous	O
inflammation	O
consistent	O
with	O
tuberculosis	B-T047
33.3	O
.	O
	
trans-oral	B-T082
fna	O
is	O
a	O
quick	O
,	O
inexpensive	O
and	O
relatively	O
safe	O
outpatient	B-T061
procedure	I-T061
for	O
sampling	O
c1	O
and	O
c2	O
vertebral	O
and	O
paravertebral	O
lesions	B-T033
,	O
which	O
are	O
clinically	O
and	O
radiologically	O
difficult	O
to	O
approach	O
.	O
	
it	O
helps	O
in	O
the	O
early	O
diagnosis	O
and	O
management	O
of	O
these	O
patients	O
.	O
	
neonatal	B-T047
infections	I-T047
case	B-T170
definition	I-T170
and	O
guidelines	B-T170
for	O
data	B-T062
collection	I-T062
,	O
analysis	B-T062
,	O
and	O
presentation	B-T078
of	O
immunisation	B-T061
safety	B-T078
data	I-T078
maternal	B-T033
vaccination	B-T061
is	O
an	O
important	O
area	O
of	O
research	B-T062
and	O
requires	O
appropriate	O
and	O
internationally	O
comparable	O
definitions	B-T170
and	O
safety	B-T170
standards	I-T170
.	O
	
the	O
gaia	O
group	O
,	O
part	O
of	O
the	O
brighton	O
collaboration	O
was	O
created	O
with	O
the	O
mandate	O
of	O
proposing	O
standardised	O
definitions	B-T170
applicable	O
to	O
maternal	B-T033
vaccine	O
research	B-T062
.	O
	
this	O
study	B-T062
proposes	O
international	O
definitions	B-T170
for	O
neonatal	B-T047
infections	I-T047
.	O
	
the	O
neonatal	B-T047
infections	I-T047
gaia	O
working	B-T098
group	I-T098
performed	O
a	O
literature	B-T170
review	B-T169
using	O
medline	B-T170
,	O
embase	B-T170
and	O
the	O
cochrane	B-T169
collaboration	I-T169
and	O
collected	O
definitions	B-T170
in	O
use	O
in	O
neonatal	B-T169
and	O
public	B-T169
health	I-T169
networks	I-T169
.	O
	
the	O
common	O
criteria	B-T078
derived	B-T080
from	O
the	O
extensive	O
search	O
formed	O
the	O
basis	O
for	O
a	O
consensus	O
process	O
that	O
resulted	O
in	O
three	O
separate	O
definitions	B-T170
for	O
neonatal	O
blood	O
stream	O
infections	O
bsi	O
,	O
meningitis	B-T047
and	O
lower	B-T047
respiratory	I-T047
tract	I-T047
infections	I-T047
lrti	B-T047
.	O
	
for	O
each	O
definition	B-T170
three	O
levels	O
of	O
evidence	O
are	O
proposed	O
to	O
ensure	O
the	O
applicability	O
of	O
the	O
definitions	B-T170
to	O
different	O
settings	O
.	O
	
recommendations	O
about	O
data	B-T062
collection	I-T062
,	O
analysis	B-T062
and	O
presentation	B-T078
are	O
presented	O
and	O
harmonized	B-T062
with	O
the	O
brighton	O
collaboration	O
and	O
gaia	O
format	B-T170
and	O
other	O
existing	O
international	B-T170
standards	I-T170
for	O
study	B-T062
reporting	B-T062
.	O
	
beneficial	B-T081
effects	B-T080
of	O
dark	O
chocolate	O
on	O
exercise	O
capacity	B-T081
in	O
sedentary	B-T080
subjects	B-T098
underlying	O
mechanisms	B-T169
.	O
	
a	O
double	B-T062
blind	I-T062
,	O
randomized	B-T062
,	O
placebo	B-T062
controlled	I-T062
trial	B-T062
in	O
heart	B-T047
failure	I-T047
patients	O
the	O
consumption	O
of	O
-	O
-	O
cocoa	O
can	O
restore	O
skeletal	O
muscle	O
skm	O
mitochondrial	O
structure	B-T082
and	O
decrease	B-T081
biomarkers	O
of	O
oxidative	O
stress	O
.	O
	
however	O
,	O
nothing	O
is	O
known	O
about	O
its	O
effects	B-T080
on	O
exercise	O
capacity	B-T081
and	O
underlying	O
mechanisms	B-T169
in	O
normal	B-T080
,	O
sedentary	B-T080
subjects	B-T098
.	O
	
twenty	O
normal	B-T080
,	O
sedentary	B-T080
subjects	B-T098
50	O
years	O
old	O
were	O
randomized	B-T062
to	O
placebo	B-T061
or	O
dark	O
chocolate	O
dc	O
groups	B-T078
and	O
consumed	B-T052
20	O
g	O
of	O
the	O
products	O
for	O
3	O
months	B-T079
.	O
	
subjects	B-T098
underwent	O
before	O
and	O
after	O
treatment	B-T061
,	O
bicycle	O
ergometry	O
to	O
assess	O
vo2	B-T033
max	I-T033
and	O
work	O
,	O
skm	O
biopsy	O
to	O
assess	O
changes	O
in	O
mitochondrial	O
density	B-T081
,	O
function	B-T169
and	O
oxidative	O
stress	O
and	O
blood	O
sampling	O
to	O
assess	O
metabolic	B-T169
endpoints	B-T080
.	O
	
seventeen	O
subjects	B-T098
completed	O
the	O
trial	B-T062
.	O
	
in	O
the	O
dc	O
group	O
n	O
=	O
9	O
,	O
vo2	B-T033
max	I-T033
increased	B-T169
17%	O
increase	B-T169
,	O
p	O
=	O
0.056	O
as	O
well	O
as	O
maximum	O
work	O
watts	B-T081
achieved	O
p	O
=	O
0.026	O
with	O
no	O
changes	O
with	O
placebo	B-T061
n	O
=	O
8	O
.	O
	
the	O
dc	O
group	O
evidenced	O
increases	B-T169
in	O
hdl	B-T116
levels	O
p	O
=	O
0.005	O
and	O
decreased	B-T081
triglycerides	B-T109
p	O
=	O
0.07	O
.	O
	
with	O
dc	O
,	O
skm	O
evidenced	O
significant	B-T078
increases	B-T169
in	O
protein	B-T116
levels	O
for	O
lkb1	B-T116
,	O
ampk	B-T116
and	O
pgc1α	B-T116
and	O
in	O
their	O
active	B-T169
forms	O
phosphorylated	O
ampk	B-T116
and	O
lkb1	B-T116
as	O
well	O
as	O
in	O
citrate	O
synthase	O
activity	O
while	O
no	O
changes	O
were	O
observed	O
in	O
mitochondrial	O
density	B-T081
.	O
	
with	O
dc	O
,	O
significant	B-T078
increases	B-T169
in	O
skm	O
reduced	O
glutathione	B-T116
levels	O
and	O
decreases	B-T081
in	O
protein	O
carbonylation	O
were	O
observed	O
.	O
	
improvements	O
in	O
maximum	O
work	O
achieved	O
and	O
vo2	B-T033
max	I-T033
may	O
be	O
due	O
to	O
dc	O
activation	B-T052
of	O
upstream	O
control	O
systems	O
and	O
enhancement	O
of	O
skm	O
mitochondria	O
efficiency	B-T081
.	O
	
larger	O
clinical	B-T062
studies	I-T062
are	O
warranted	O
to	O
confirm	O
these	O
reduction	B-T080
in	O
hospital-wide	O
clinical	O
laboratory	O
specimen	O
identification	O
errors	B-T080
following	O
process	O
interventions	O
a	O
10-	O
year	B-T079
retrospective	B-T062
observational	I-T062
study	I-T062
accurate	B-T080
patient	O
identification	O
and	O
specimen	O
labeling	O
at	O
the	O
time	O
of	O
collection	O
are	O
crucial	O
steps	O
in	O
the	O
prevention	B-T062
of	O
medical	B-T080
errors	I-T080
,	O
thereby	O
improving	B-T080
patient	O
safety	O
.	O
	
all	O
patient	O
specimen	O
identification	B-T080
errors	B-T080
that	O
occurred	B-T052
in	O
the	O
outpatient	B-T082
department	I-T082
opd	B-T082
,	O
emergency	O
department	O
ed	O
,	O
and	O
inpatient	B-T082
department	I-T082
ipd	B-T082
of	O
a	O
3	O
bed	O
academic	O
medical	O
center	O
in	O
taiwan	O
were	O
documented	O
and	O
analyzed	O
retrospectively	O
from	O
2005	O
to	O
2014	O
.	O
	
to	O
reduce	B-T080
such	O
errors	B-T080
,	O
the	O
following	O
series	B-T081
of	O
strategies	B-T170
were	O
implemented	O
a	O
restrictive	O
specimen	O
acceptance	O
policy	O
for	O
the	O
ed	O
and	O
ipd	B-T082
in	O
2006	O
a	O
computer-assisted	O
barcode	B-T170
positive	O
patient	O
identification	O
system	O
for	O
the	O
ed	O
and	O
ipd	B-T082
in	O
2007	O
and	O
2010	O
,	O
and	O
automated	B-T169
sample	O
labeling	O
combined	B-T080
with	O
electronic	O
identification	O
systems	O
introduced	B-T169
to	O
the	O
opd	B-T082
in	O
2009	O
.	O
	
of	O
the	O
2000345	O
specimens	O
collected	B-T169
in	O
2005	O
,	O
1023	O
0.0511	O
were	O
identified	B-T033
as	O
having	O
patient	O
identification	O
errors	B-T080
,	O
compared	O
with	O
58	O
errors	B-T080
0.0015	O
among	O
3761238	O
specimens	O
collected	B-T169
in	O
2014	O
,	O
after	O
serial	O
interventions	O
this	O
represents	O
a	O
97%	O
relative	B-T080
reduction	B-T080
.	O
	
the	O
total	B-T081
number	I-T081
rate	B-T081
of	O
institutional	O
identification	O
errors	B-T080
contributed	O
from	O
the	O
ed	O
,	O
ipd	B-T082
,	O
and	O
opd	B-T082
over	O
a	O
10-	O
year	B-T079
period	B-T079
were	O
423	O
0.1058	O
,	O
556	O
0.0587	O
,	O
and	O
44	O
0.0067	O
errors	B-T080
before	B-T079
the	O
interventions	O
,	O
and	O
3	O
0.0007	O
,	O
52	O
0.0045	O
and	O
3	O
0.0001	O
after	B-T079
interventions	O
,	O
representing	O
relative	B-T080
99%	O
,	O
92%	O
and	O
98%	O
reductions	B-T080
,	O
respectively	O
.	O
	
accurate	B-T080
patient	O
identification	O
is	O
a	O
challenge	O
of	O
patient	O
safety	O
in	O
different	O
health	B-T078
settings	B-T081
.	O
	
the	O
data	B-T033
collected	I-T033
in	O
our	O
study	B-T062
indicate	O
that	O
a	O
restrictive	O
specimen	O
acceptance	O
policy	O
,	O
computer-generated	O
positive	O
identification	O
systems	O
,	O
and	O
interdisciplinary	O
cooperation	O
can	O
significantly	O
reduce	B-T080
patient	O
identification	O
errors	B-T080
.	O
	
management	O
of	O
skin	B-T047
and	I-T047
soft-tissue	I-T047
infections	I-T047
at	O
a	O
community	O
teaching	O
hospital	O
using	O
a	O
severity-of-illness	B-T169
tool	I-T169
skin	B-T047
and	I-T047
soft-tissue	I-T047
infections	I-T047
sstis	B-T047
encompass	O
a	O
diverse	B-T080
range	B-T081
of	O
infections	O
of	O
varying	O
severity	B-T080
.	O
	
the	O
clinical	B-T170
resource	I-T170
efficiency	I-T170
support	I-T170
team	I-T170
crest	I-T170
scoring	I-T170
system	I-T170
stratifies	O
patients	O
into	O
four	O
classes	O
i	O
=	O
least	O
severe	B-T080
to	O
iv	O
=	O
most	O
severe	B-T080
based	O
on	O
the	O
standardized	B-T170
early	I-T170
warning	I-T170
score	I-T170
sews	B-T170
.	O
	
the	O
objective	B-T078
of	O
this	O
study	B-T062
was	O
to	O
apply	O
crest	B-T170
to	O
hospitalized	O
patients	O
with	O
sstis	B-T047
in	O
order	O
to	O
quantify	O
disease	B-T080
severity	I-T080
and	O
evaluate	O
appropriateness	O
of	O
antibiotic	O
management	O
.	O
	
this	O
was	O
a	O
retrospective	B-T062
,	O
hypothesis	B-T078
-generating	O
,	O
single-centre	O
evaluation	O
of	O
hospitalized	O
patients	O
with	O
sstis	B-T047
admitted	O
in	O
2011	O
.	O
	
based	O
on	O
crest	B-T170
classification	O
,	O
the	O
empirical	B-T080
antimicrobial	O
choices	O
were	O
categorized	B-T052
as	O
appropriate	O
,	O
over-treatment	O
or	O
under-treatment	B-T061
.	O
	
a	O
total	O
of	O
369	O
patients	O
were	O
screened	O
and	O
200	O
met	O
the	O
inclusion	B-T080
criteria	I-T080
.	O
	
the	O
majority	O
of	O
patients	O
were	O
classified	O
as	O
either	O
crest	B-T170
class	O
i	O
n	O
=	O
68	O
or	O
class	O
i	O
i	O
n	O
=	O
102	O
.	O
	
over-treatment	O
was	O
more	O
common	O
in	O
the	O
less	O
severe	B-T080
classes	O
88%	O
and	O
32%	O
in	O
class	O
i	O
and	O
class	O
ii	O
,	O
respectively	O
p	O
<	O
0.05	O
.	O
	
sixty-three	O
percent	B-T081
of	O
class	O
i	O
n	O
=	O
43	O
were	O
over-treated	O
due	O
to	O
both	O
the	O
use	O
of	O
intravenous	B-T169
antibiotic	O
s	O
when	O
oral	B-T061
therapy	I-T061
was	O
sufficient	O
and	O
use	O
of	O
unnecessarily	O
broad-spectrum	O
antibiotics	O
.	O
	
in	O
contrast	O
,	O
25%	O
n	O
=	O
26	O
of	O
class	O
ii	O
were	O
over-treated	O
due	O
to	O
use	O
of	O
unnecessarily	O
broad-spectrum	O
antibiotics	O
.	O
	
overall	O
clinical	B-T033
failure	I-T033
rates	O
remained	O
low	O
with	O
only	O
1%	O
,	O
4%	O
and	O
17%	O
of	O
patients	O
unable	O
to	O
achieve	O
initial	O
response	O
in	O
class	O
ii	O
,	O
class	O
iii	O
and	O
class	O
iv	O
.	O
	
retrospective	B-T080
application	O
of	O
crest	B-T170
identified	O
opportunities	O
to	O
improve	O
the	O
management	O
of	O
sstis	B-T047
.	O
	
crest	B-T170
can	O
be	O
of	O
great	O
value	O
in	O
discriminating	O
less-	O
severe	B-T080
sstis	B-T047
,	O
which	O
can	O
be	O
treated	B-T061
on	O
an	O
outpatient	O
breakthrough	B-T080
viridans	B-T047
streptococcal	I-T047
bacteremia	I-T047
in	O
allogeneic	B-T061
hematopoietic	I-T061
stem	I-T061
cell	I-T061
transplant	I-T061
recipients	O
receiving	B-T080
levofloxacin	B-T109
prophylaxis	B-T061
in	O
a	O
japanese	O
hospital	O
breakthrough	B-T080
viridans	B-T047
streptococcal	I-T047
bacteremia	I-T047
vsb	B-T047
in	O
patients	O
with	O
hematological	O
malignancy	O
receiving	B-T080
levofloxacin	B-T109
prophylaxis	B-T061
is	O
a	O
major	B-T080
blood	B-T047
stream	I-T047
infection	I-T047
bsi	B-T047
occurring	B-T052
during	B-T079
febrile	B-T047
neutropenia	I-T047
.	O
	
however	O
,	O
clinical	B-T170
data	I-T170
focused	B-T169
on	O
vsb	B-T047
in	O
allogeneic	B-T061
hematopoietic	I-T061
stem	I-T061
cell	I-T061
transplant	I-T061
allo-hsct	B-T061
recipients	O
are	O
lacking	B-T080
.	O
	
the	O
medical	B-T170
records	I-T170
of	O
allo-hsct	B-T061
recipients	O
who	O
received	B-T080
oral	B-T169
levofloxacin	B-T109
prophylaxis	B-T061
between	O
january	O
2011	O
and	O
august	O
2013	O
at	O
toranomon	O
hospital	O
were	O
reviewed	B-T080
to	O
evaluate	O
breakthrough	B-T080
vsb	B-T047
.	O
	
stored	O
viridans	O
streptococcal	O
vgs	O
species	O
were	O
identified	B-T080
by	O
using	B-T169
soda	O
gene	O
sequencing	O
,	O
and	O
were	O
assessed	B-T052
for	O
drug	O
susceptibility	O
.	O
	
among	O
the	O
184	O
allo-hsct	B-T061
recipients	O
on	O
levofloxacin	B-T109
prophylaxis	B-T061
,	O
28	O
15.2	O
%	O
experienced	O
breakthrough	B-T080
vsb	B-T047
.	O
	
all	O
of	O
the	O
28	O
recipients	O
with	O
vsb	B-T047
were	O
treated	B-T169
with	O
a	O
cefepime	B-T109
-	O
based	B-T169
or	O
piperacillin/tazobactam	O
-	O
based	B-T169
regimen	B-T061
.	O
	
the	O
susceptibility	O
rates	B-T081
of	O
the	O
vgs	O
strains	O
for	O
levofloxacin	B-T109
,	O
cefepime	B-T109
,	O
piperacillin/tazobactam	O
,	O
meropenem	B-T109
,	O
and	O
vancomycin	B-T116
were	O
0	O
%	O
,	O
95	O
%	O
,	O
100	O
%	O
,	O
100	O
%	O
,	O
and	O
100	O
%	O
,	O
respectively	O
.	O
	
both	O
the	O
mic50	O
minimum	O
inhibitory	O
concentration	O
and	O
the	O
mic90	O
of	O
ceftazidim	B-T109
0.5	O
μg/ml	O
and	O
2	O
μg/ml	O
,	O
respectively	O
were	O
higher	B-T080
than	O
the	O
mic90	O
of	O
all	O
the	O
other	O
anti-pseudomonal	O
beta-lactams	O
apbls	O
.	O
	
only	O
1	O
vgs	O
strain	O
had	O
a	O
penicillin	B-T109
mic	O
2	O
μg/ml	O
by	O
the	O
etest	O
3.6	O
%	O
.	O
	
there	O
were	O
no	B-T169
cases	B-T169
with	O
acute	B-T033
respiratory	I-T033
distress	I-T033
syndrome	I-T033
ards	B-T033
that	O
was	O
associated	B-T080
with	I-T080
vsb	B-T047
,	O
although	O
the	O
rate	B-T081
of	O
viridans	B-T047
group	I-T047
streptococcal	I-T047
shock	I-T047
syndrome	I-T047
was	O
high	B-T080
26	O
%	O
.	O
	
the	O
crude	O
30-day	B-T079
mortality	B-T081
rate	I-T081
in	O
the	O
vsb	B-T047
group	O
10.7	O
%	O
did	O
not	B-T169
differ	B-T080
significantly	B-T078
from	O
that	O
in	O
the	O
bsi	B-T047
without	B-T080
vsb	B-T047
group	O
9.3	O
%	O
or	O
non	B-T169
-	O
bsi	B-T047
group	O
7.0	O
%	O
p	O
=	O
0.77	O
.	O
	
also	O
,	O
vsb	B-T047
was	O
not	B-T169
a	O
risk	B-T033
factor	I-T033
for	O
all-cause	O
mortality	B-T081
up	O
to	O
60	B-T079
days	I-T079
following	B-T079
allo-hsct	B-T061
p	O
=	O
0.43	O
.	O
	
apbl	O
with	O
increased	B-T081
anti-vgs	B-T033
activity	I-T033
apbl-va	B-T033
monotherapy	B-T061
would	O
typically	O
be	O
optimal	B-T080
for	O
treating	B-T169
the	O
vgs	O
strains	O
in	O
this	O
setting	O
.	O
	
indication	O
of	O
adding	O
an	O
empiric	O
anti-gram-positive	O
agent	O
to	O
apbl-va	B-T033
for	O
treating	B-T169
vsb	B-T047
should	O
depend	O
on	O
local	B-T082
factors	B-T169
,	O
such	O
as	O
the	O
susceptibility	O
results	B-T169
.	O
	
in	O
addition	O
,	O
breakthrough	B-T080
vsb	B-T047
is	O
probably	O
not	B-T169
a	O
major	B-T080
cause	B-T033
of	I-T033
death	I-T033
in	O
allo-hsct	B-T061
settings	O
,	O
where	O
beta-lactam	B-T109
non-susceptible	O
vgs	O
and	O
the	O
ards	B-T033
are	O
the	O
lost	O
art	O
of	O
the	O
splenorrhaphy	B-T061
in	O
the	O
case	O
of	O
the	O
hemodynamically	B-T047
unstable	I-T047
child	O
,	O
splenorrhaphy	B-T061
is	O
preferred	O
to	O
splenectomy	B-T061
to	O
avert	O
postsplenectomy	O
sepsis	B-T047
.	O
	
however	O
,	O
successful	O
splenorrhaphy	B-T061
requires	O
familiarity	O
with	O
the	O
procedure	B-T061
.	O
	
we	O
sought	O
to	O
determine	O
how	O
many	O
splenectomies	B-T061
or	O
splenorrhaphies	B-T061
for	O
trauma	O
the	O
average	O
pediatric	O
surgeon	O
can	O
be	O
expected	O
to	O
perform	B-T169
during	O
their	O
career	O
.	O
	
the	O
pediatric	B-T170
health	I-T170
information	I-T170
system	I-T170
phis	I-T170
database	I-T170
was	O
queried	O
for	O
patients	O
18	O
years	B-T079
coded	O
with	O
an	O
international	B-T170
classification	I-T170
of	I-T170
diseases	I-T170
9th	I-T170
edition	I-T170
diagnosis	B-T170
code	I-T170
of	O
a	O
splenic	O
injury	O
from	O
2004	O
to	O
2013	O
.	O
	
age	O
,	O
gender	O
,	O
grade	O
of	O
splenic	O
injury	O
,	O
and	O
operations	B-T061
performed	B-T169
were	O
extracted	B-T078
.	O
	
numbers	O
of	O
pediatric	O
surgeons	O
per	O
hospital	O
were	O
obtained	O
.	O
	
9567	O
children	O
were	O
identified	B-T080
.	O
	
2.1	O
underwent	O
a	O
splenectomy	B-T061
and	O
0.8	O
underwent	O
a	O
splenorrhaphy	B-T061
.	O
	
the	O
average	O
surgeon	O
performed	B-T169
0.6	O
sd=0	O
splenectomies	B-T061
and	O
0.2	O
sd=0	O
splenorrhaphies	B-T061
for	O
trauma	O
.	O
	
if	O
these	O
rates	B-T081
remain	O
constant	B-T080
over	O
time	O
,	O
the	O
average	O
surgeon	O
would	O
perform	B-T169
1.8	O
sd	O
=1	O
splenectomies	B-T061
and	O
0.6	O
sd	O
=1	O
splenorrhaphies	B-T061
for	O
trauma	O
over	O
a	O
30-	O
year	B-T079
surgical	O
career	O
.	O
	
nonoperative	B-T061
management	I-T061
is	O
associated	O
with	O
a	O
host	O
of	O
benefits	O
,	O
but	O
has	O
resulted	O
in	O
a	O
decrease	O
in	O
the	O
experience	B-T080
level	I-T080
of	O
the	O
pediatric	O
surgeons	O
expected	O
to	O
perform	B-T169
an	O
emergency	O
splenectomy	B-T061
or	O
splenorrhaphy	B-T061
vestibular	O
-dependent	O
inter-stimulus	B-T079
interval	I-T079
effects	B-T080
on	O
sound	O
evoked	O
potentials	O
of	O
central	B-T082
origin	B-T079
todd	O
et	O
al	O
.	O
	
2014ab	O
have	O
recently	O
demonstrated	O
the	O
presence	B-T033
of	O
vestibular	O
-dependent	O
contributions	B-T052
to	O
auditory	O
evoked	O
potentials	O
aeps	O
when	O
passing	O
through	O
the	O
vestibular	O
threshold	B-T081
as	O
determined	O
by	O
vestibular	O
evoked	O
myogenic	O
potentials	O
vemps	O
,	O
including	O
a	O
particular	O
deflection	B-T082
labeled	B-T080
as	O
an	O
n42/p52	O
prior	B-T079
to	O
the	O
long	B-T080
-	O
latency	B-T079
aeps	O
n1	O
and	O
p2	O
.	O
	
in	O
this	O
paper	O
we	O
report	O
the	O
results	B-T033
of	O
an	O
experiment	B-T062
to	O
determine	O
the	O
effect	B-T080
of	I-T080
inter-stimulus	B-T079
interval	I-T079
isi	B-T079
and	O
regularity	B-T080
on	O
potentials	O
recorded	O
above	B-T082
and	O
below	B-T082
vemp	O
threshold	B-T081
.	O
	
five	O
healthy	B-T080
,	O
right-handed	O
subjects	B-T098
were	O
recruited	O
and	O
evoked	O
potentials	O
were	O
recorded	O
to	O
binaurally	O
presented	O
sound	B-T061
stimulation	I-T061
,	O
above	B-T082
and	O
below	B-T082
vestibular	O
threshold	B-T081
,	O
at	O
seven	O
stimulus	O
rates	B-T081
with	O
isis	B-T079
of	O
212	O
,	O
300	O
,	O
424	O
,	O
600	O
,	O
848	O
,	O
1200	O
and	O
1696	O
ms	O
.	O
	
the	O
inner	O
five	O
intervals	B-T079
,	O
i.e	O
.	O
	
300	O
,	O
424	O
,	O
600	O
,	O
848	O
,	O
1200	O
ms	O
,	O
were	O
presented	B-T078
twice	O
in	O
both	O
regular	B-T080
and	O
irregular	B-T080
conditions	O
.	O
	
anova	B-T081
on	O
the	O
global	B-T081
field	I-T081
power	I-T081
gfp	B-T081
were	O
conducted	O
for	O
each	O
of	O
four	O
waves	O
,	O
n42	O
,	O
p52	O
,	O
n1	O
and	O
p2	O
with	O
factors	O
of	O
intensity	B-T081
,	O
isi	B-T079
and	O
regularity	B-T080
.	O
	
both	O
n42	O
and	O
p52	O
waves	O
showed	O
significant	B-T078
anova	B-T081
effects	B-T080
of	I-T080
intensity	B-T081
but	O
no	O
other	O
main	O
effects	B-T080
or	O
interactions	B-T169
.	O
	
in	O
contrast	O
both	O
n1	O
and	O
p2	O
showed	O
additional	B-T169
effects	B-T080
of	I-T080
isi	B-T079
,	O
as	O
well	O
as	O
intensity	B-T081
,	O
and	O
evidence	B-T169
of	I-T169
non	B-T169
-	O
linear	B-T082
interactions	B-T169
between	O
isi	B-T079
and	O
intensity	B-T081
.	O
	
a	O
source	B-T062
analysis	I-T062
was	O
carried	O
out	O
consistent	B-T078
with	I-T078
prior	B-T079
work	O
suggesting	O
that	O
when	O
above	B-T082
vestibular	O
threshold	B-T081
,	O
in	B-T169
addition	I-T169
to	I-T169
bilateral	B-T082
superior	B-T082
temporal	O
cortex	O
,	O
ocular	O
,	O
cerebellar	O
and	O
cingulate	O
sources	B-T033
are	O
recruited	O
.	O
	
further	O
statistical	B-T062
analysis	I-T062
of	O
the	O
source	B-T033
currents	O
indicated	O
that	O
the	O
origin	O
of	O
the	O
interactions	B-T169
with	O
intensity	B-T081
may	O
be	O
the	O
isi	B-T079
sensitivity	B-T081
of	O
the	O
vestibular	O
-dependent	O
sources	B-T033
.	O
	
this	O
in	O
turn	O
may	O
reflect	O
a	O
specific	B-T080
vestibular	O
preference	B-T078
for	O
stimulus	O
rates	B-T081
associated	B-T080
with	I-T080
locomotion	O
,	O
i.e	O
.	O
	
rates	B-T081
close	O
to	O
2	O
hz	O
,	O
or	O
isis	B-T079
close	O
to	O
500	O
ms	O
,	O
where	O
saccular	B-T082
afferents	B-T082
show	O
increased	B-T081
gain	B-T081
and	O
the	O
corresponding	O
reflexes	O
are	O
most	O
a	O
systematic	B-T170
review	I-T170
of	O
the	O
diagnostic	B-T169
and	O
prognostic	B-T080
value	I-T080
of	O
urinary	B-T080
protein	B-T116
biomarkers	O
in	O
urothelial	O
bladder	O
cancer	O
for	O
over	O
80	O
years	O
,	O
cystoscopy	O
has	O
remained	O
the	O
gold-standard	B-T080
for	O
detecting	B-T033
tumours	O
of	O
the	O
urinary	O
bladder	O
.	O
	
since	O
bladder	O
tumours	O
have	O
a	O
tendency	O
to	O
recur	O
and	O
progress	O
,	O
many	O
patients	O
are	O
subjected	O
to	O
repeated	O
cystoscopies	O
during	O
long-term	B-T079
surveillance	O
,	O
with	O
the	O
procedure	B-T061
being	O
both	O
unpleasant	O
for	O
the	O
patient	O
and	O
expensive	O
for	O
healthcare	O
providers	O
.	O
	
the	O
identification	B-T080
and	O
validation	B-T062
of	O
bladder	O
tumour	O
specific	O
molecular	O
markers	O
in	O
urine	O
could	O
enable	O
tumour	O
detection	B-T033
and	O
reduce	O
reliance	O
on	O
cystoscopy	O
,	O
and	O
numerous	O
classes	O
of	O
biomarkers	O
have	O
been	O
studied	O
.	O
	
proteins	B-T116
represent	O
the	O
most	O
intensively	O
studied	O
class	O
of	O
biomolecule	O
in	O
this	O
setting	O
.	O
	
as	O
an	O
aid	O
to	O
researchers	O
searching	O
for	O
better	O
urinary	B-T080
biomarkers	O
,	O
we	O
report	O
a	O
comprehensive	B-T170
systematic	I-T170
review	I-T170
of	O
the	O
literature	B-T170
and	O
a	O
searchable	O
database	B-T170
of	O
proteins	B-T116
that	O
have	O
been	O
investigated	O
to	O
date	O
.	O
	
our	O
objective	O
was	O
to	O
classify	O
these	O
proteins	B-T116
as	O
1	O
those	O
with	O
robustly	O
characterised	O
sensitivity	B-T081
and	I-T081
specificity	I-T081
for	O
bladder	O
cancer	O
detection	B-T033
2	O
those	O
that	O
show	O
potential	O
but	O
further	O
investigation	O
is	O
required	O
3	O
those	O
unlikely	O
to	O
warrant	O
further	O
investigation	O
and	O
4	O
those	O
investigated	O
as	O
prognostic	B-T080
markers	I-T080
.	O
	
this	O
work	O
should	O
help	O
to	O
prioritise	O
certain	O
biomarkers	O
for	O
rigorous	B-T062
validation	I-T062
,	O
whilst	O
preventing	B-T169
wasted	O
effort	O
on	O
proteins	B-T116
that	O
have	O
shown	O
no	O
association	O
whatsoever	O
with	O
the	O
disease	B-T047
,	O
or	O
only	O
modest	O
biomarker	O
performance	O
despite	O
large-scale	O
efforts	O
at	O
well	O
,	O
i	O
wouldn't	O
be	O
any	O
worse	O
off	O
,	O
would	O
i	O
,	O
than	O
i	O
am	O
now	O
a	O
qualitative	B-T062
study	I-T062
of	O
decision-making	O
,	O
hopes	O
,	O
and	O
realities	B-T078
of	O
adults	O
with	O
type	B-T047
1	I-T047
diabetes	I-T047
undergoing	O
islet	B-T061
cell	I-T061
transplantation	I-T061
for	O
selected	O
individuals	B-T098
with	O
type	B-T047
1	I-T047
diabetes	I-T047
,	O
pancreatic	B-T061
islet	I-T061
transplantation	I-T061
it	B-T061
prevents	O
recurrent	O
severe	O
hypoglycemia	B-T047
and	O
optimizes	B-T061
glycemia	I-T061
,	O
although	O
ongoing	O
systemic	B-T061
immunosuppression	I-T061
is	O
needed	O
.	O
	
our	O
aim	O
was	O
to	O
explore	O
candidates	B-T098
and	O
recipients	O
'	O
expectations	O
of	O
transplantation	B-T061
,	O
their	O
experience	O
of	O
being	O
on	O
the	O
waiting	B-T033
list	I-T033
,	O
and	O
for	O
recipients	O
the	O
procedure	O
and	O
life	O
posttransplant	B-T079
.	O
	
cross-sectional	O
qualitative	B-T080
research	B-T062
design	I-T062
using	O
semistructured	O
interviews	O
with	O
16	O
adults	O
8	O
pretransplant	B-T079
,	O
8	O
posttransplant	B-T079
from	O
4	O
uk	O
centers	O
n	O
=	O
13	O
and	O
1	O
canadian	O
center	O
n	O
=	O
3	O
.	O
	
interviews	O
were	O
audio-recorded	O
,	O
transcribed	O
,	O
and	O
underwent	O
inductive	B-T062
thematic	I-T062
analysis	I-T062
.	O
	
interviewees	B-T098
were	O
aged	O
mean	O
sd	O
52	O
10	O
years	B-T079
range	O
,	O
30-64	O
duration	B-T079
of	O
diabetes	B-T047
,	O
36	O
9	O
years	B-T079
range	O
,	O
21-56	O
12	O
75%	O
were	O
women	B-T098
.	O
	
narrative	O
accounts	O
centered	O
on	O
expectations	B-T078
,	O
hopes	O
,	O
and	O
realities	B-T078
decision-making	O
waiting	O
and	O
uncertainty	O
the	O
procedure	O
,	O
hospital	B-T079
stay	I-T079
,	O
and	O
follow-up	O
.	O
	
expected	O
benefits	O
included	O
fewer	O
severe	O
hypoglycemic	B-T047
episodes	I-T047
,	O
reduced	B-T080
need	O
for	O
insulin	B-T116
,	O
preventing	O
onset/progression	O
of	O
complications	O
and	O
improved	O
psychological	B-T033
well-being	I-T033
.	O
	
these	O
were	O
realized	O
for	O
most	O
,	O
at	O
least	O
in	O
the	O
short	O
term	O
.	O
	
most	O
interviewees	B-T098
described	O
well-informed	O
,	O
shared	O
decision-making	O
with	O
clinicians	O
and	O
family	O
,	O
and	O
managing	O
their	O
expectations	O
.	O
	
although	O
life	O
"""on"	O
the	O
"list"""	O
could	O
be	O
stressful	B-T169
,	O
and	O
immunosuppressant	O
side	O
effects	O
were	O
severe	B-T080
,	O
interviewees	B-T098
reported	O
""""	O
no	B-T033
regrets	O
""""	O
posttransplant	B-T079
,	O
interviewees	B-T098
experienced	O
increased	O
confidence	O
,	O
through	O
freedom	B-T033
from	I-T033
hypoglycemia	I-T033
and	O
regained	O
glycemic	B-T061
control	I-T061
,	O
which	O
tempered	O
any	O
disappointment	O
about	O
continued	O
reliance	O
on	O
insulin	B-T116
.	O
	
most	O
viewed	O
their	O
transplant	B-T061
as	O
a	O
success	O
,	O
though	O
several	O
reflected	O
upon	O
setbacks	O
and	O
hidden	O
hopes	O
for	O
becoming	O
""""	O
insulin-free	B-T033
""""	O
independently	O
undertaken	O
interviews	O
demonstrated	O
realistic	O
and	O
balanced	O
expectations	O
of	O
it	B-T061
and	O
indicate	O
how	O
to	O
optimize	O
the	O
process	O
and	O
support	O
for	O
future	O
it	B-T061
candidates	B-T098
.	O
	
the	O
nanocomposite	B-T080
nature	O
of	O
bone	O
drives	O
its	O
strength	B-T081
and	O
damage	B-T169
resistance	B-T169
in	O
human	O
bone	O
,	O
an	O
amorphous	B-T080
mineral	O
serves	O
as	O
a	O
precursor	B-T078
to	O
the	O
formation	B-T169
of	O
a	O
highly	O
substituted	O
nanocrystalline	O
apatite	O
.	O
	
however	O
,	O
the	O
precise	O
role	O
of	O
this	O
amorphous	B-T080
mineral	O
remains	O
unknown	O
.	O
	
here	O
,	O
we	O
show	O
by	O
using	O
transmission	O
electron	O
microscopy	O
that	O
100-300	O
nm	O
amorphous	B-T080
calcium	O
phosphate	O
regions	O
are	O
present	O
in	O
the	O
disordered	B-T082
phase	I-T082
of	O
trabecular	O
bone	O
.	O
	
nanomechanical	B-T062
experiments	I-T062
on	O
cylindrical	B-T082
samples	O
,	O
with	O
diameters	B-T081
between	O
250	O
nm	O
and	O
3	O
nm	O
,	O
of	O
the	O
bone's	O
ordered	B-T082
and	O
disordered	B-T082
phases	I-T082
revealed	O
a	O
transition	B-T052
from	O
plastic	O
deformation	B-T033
to	O
brittle	B-T033
failure	O
and	O
at	O
least	O
a	O
factor-of-2	O
higher	O
strength	B-T081
in	O
the	O
smaller	B-T080
samples	O
.	O
	
we	O
postulate	O
that	O
this	O
transition	B-T052
in	O
failure	B-T169
mechanism	B-T169
is	O
caused	O
by	O
the	O
suppression	B-T169
of	O
extrafibrillar	O
shearing	B-T061
in	O
the	O
smaller	O
samples	O
,	O
and	O
that	O
the	O
emergent	O
smaller	B-T080
-is-	O
stronger	B-T080
size	B-T081
effect	I-T081
is	O
related	O
to	O
the	O
sample-size	B-T081
scaling	B-T052
of	O
the	O
distribution	O
of	O
flaws	O
.	O
	
our	O
findings	B-T033
should	O
help	O
in	O
the	O
understanding	O
of	O
the	O
multi-scale	B-T078
nature	I-T078
of	O
bone	O
and	O
provide	O
insights	O
into	O
the	O
biomineralization	O
process	O
.	O
	
assessing	B-T052
the	O
physiological	B-T169
relevance	B-T080
of	O
alternate	O
architectures	B-T082
of	O
the	O
p7	B-T116
protein	I-T116
of	O
hepatitis	O
c	O
virus	O
in	O
different	O
environments	B-T082
the	O
viroporin	O
p7	B-T116
of	O
the	O
hepatitis	O
c	O
virus	O
forms	O
multimeric	B-T116
channels	I-T116
eligible	O
for	O
ion	O
transport	O
across	O
the	O
endoplasmic	O
reticulum	O
membrane	O
.	O
	
currently	O
the	O
subject	B-T078
of	O
many	O
studies	B-T062
and	O
discussion	O
,	O
the	O
molecular	O
assembly	O
of	O
the	O
ion	B-T116
channel	I-T116
and	O
the	O
structural	B-T082
characteristics	B-T080
of	O
the	O
p7	B-T116
monomer	O
are	O
not	O
yet	O
fully	O
understood	O
.	O
	
structural	B-T082
investigation	B-T169
of	O
p7	B-T116
has	O
been	O
carried	O
out	O
only	O
in	O
detergent	O
environments	B-T082
,	O
making	O
the	O
interpretation	O
of	O
the	O
experimental	O
results	O
somewhat	O
questionable	O
.	O
	
here	O
,	O
we	O
analyze	B-T062
by	O
means	O
of	O
molecular	O
dynamics	O
simulations	O
the	O
structure	B-T082
of	O
the	O
p7	B-T116
monomer	O
as	O
a	O
function	O
of	O
its	O
sequence	O
,	O
initial	O
conformation	B-T082
and	O
environment	B-T082
.	O
	
we	O
investigate	O
the	O
conductance	O
properties	O
of	O
three	O
models	O
of	O
a	O
hexameric	O
p7	B-T116
ion	B-T116
channel	I-T116
by	O
examining	O
ion	O
translocation	O
in	O
a	O
pure	O
lipid	O
bilayer	O
.	O
	
it	O
is	O
noteworthy	O
that	O
although	O
none	O
of	O
the	O
models	O
reflects	O
the	O
experimentally	O
observed	O
trend	O
to	O
conduct	O
preferentially	O
cations	O
,	O
we	O
were	O
able	O
to	O
identify	O
the	O
position	B-T082
and	O
orientation	B-T082
of	O
titratable	O
acidic	O
or	O
basic	O
residues	O
playing	O
a	O
crucial	O
role	O
in	O
ion	O
selectivity	B-T052
and	O
in	O
the	O
overall	O
conductance	O
of	O
the	O
channel	B-T116
.	O
	
in	O
addition	O
,	O
too	O
compact	O
a	O
packing	O
of	O
the	O
monomers	O
leads	O
to	O
channel	B-T116
collapse	O
rather	O
than	O
formation	O
of	O
a	O
reasonable	O
pore	O
,	O
amenable	O
to	O
ion	O
translocation	O
.	O
	
the	O
present	O
findings	O
are	O
envisioned	O
to	O
help	O
assess	O
the	O
physiological	B-T169
relevance	B-T080
of	O
p7	B-T116
ion	B-T116
channel	I-T116
models	O
consisting	O
of	O
multimeric	B-T082
structures	I-T082
obtained	O
in	O
non-native	O
the	O
genome	O
-scale	O
dna-binding	O
profile	O
of	O
barr	B-T116
,	O
a	O
β-alanine	B-T116
responsive	B-T169
transcription	B-T116
factor	I-T116
in	O
the	O
archaeon	O
sulfolobus	O
acidocaldarius	O
the	O
leucine-responsive	B-T116
regulatory	I-T116
protein	I-T116
lrp	B-T116
family	B-T116
is	O
a	O
widespread	O
family	B-T116
of	O
regulatory	B-T116
transcription	I-T116
factors	I-T116
in	O
prokaryotes	O
.	O
	
barr	B-T116
is	O
an	O
lrp	B-T116
-like	O
transcription	B-T116
factor	I-T116
in	O
the	O
model	O
archaeon	O
sulfolobus	O
acidocaldarius	O
that	O
activates	B-T052
the	O
expression	O
of	O
a	O
β-alanine	O
aminotransferase	O
gene	O
,	O
which	O
is	O
involved	O
in	O
β-alanine	O
degradation	O
.	O
	
in	O
contrast	O
to	O
classical	O
lrp	B-T116
-like	O
transcription	B-T116
factors	I-T116
,	O
barr	B-T116
is	O
not	B-T033
responsive	I-T033
to	O
any	O
of	O
the	O
α-amino	B-T116
acids	I-T116
but	O
interacts	O
specifically	O
with	O
β-alanine	B-T116
.	O
	
besides	O
the	O
juxtaposed	O
β-alanine	O
aminotransferase	O
gene	O
,	O
other	O
regulatory	O
targets	O
of	O
barr	B-T116
have	O
not	O
yet	O
been	O
identified	O
although	O
β-alanine	B-T116
is	O
the	O
precursor	B-T116
of	O
coenzyme	O
a	O
and	O
thus	O
an	O
important	O
central	O
metabolite	O
.	O
	
the	O
aim	B-T078
of	O
this	O
study	B-T062
is	O
to	O
extend	O
the	O
knowledge	O
of	O
the	O
dna-binding	O
characteristics	B-T080
of	O
barr	B-T116
and	O
of	O
its	O
corresponding	O
regulon	O
from	O
a	O
local	B-T082
to	O
a	O
genome	O
-wide	O
perspective	O
.	O
	
we	O
characterized	O
the	O
genome-wide	O
binding	O
profile	O
of	O
barr	B-T116
using	O
chromatin	O
immunoprecipation	O
combined	O
with	O
high-throughput	O
sequencing	O
chip-seq	O
.	O
	
this	O
revealed	O
21	O
genomic	O
binding	O
loci	B-T082
.	O
	
high-enrichment	O
binding	O
regions	O
were	O
validated	O
to	O
interact	O
with	O
purified	O
barr	B-T116
protein	I-T116
in	B-T080
vitro	I-T080
using	O
electrophoretic	O
mobility	O
shift	O
assays	O
and	O
almost	O
all	O
targets	O
were	O
also	O
shown	O
to	O
harbour	O
a	O
conserved	O
semi-palindromic	O
binding	O
motif	O
.	O
	
only	O
a	O
small	O
subset	O
of	O
enriched	O
genomic	O
sites	O
are	O
located	O
in	O
intergenic	O
regions	O
at	O
a	O
relative	O
short	O
distance	O
to	O
a	O
promoter	O
,	O
and	O
qrt-pcr	O
analysis	O
demonstrated	O
that	O
only	O
one	O
additional	O
operon	O
is	O
under	O
activation	O
of	O
barr	B-T116
,	O
namely	O
the	O
glutamine	O
synthase	O
operon	O
.	O
	
the	O
latter	O
is	O
also	O
a	O
target	O
of	O
other	O
lrp	B-T116
-like	O
transcription	B-T116
factors	I-T116
.	O
	
detailed	O
inspection	O
of	O
the	O
barr	B-T116
chip-seq	O
profile	O
at	O
the	O
β-alanine	O
aminotransferase	O
promoter	O
region	O
in	O
combination	B-T080
with	O
binding	O
motif	O
predictions	O
indicate	O
that	O
the	O
operator	O
structure	O
is	O
more	O
complicated	B-T169
than	O
previously	O
anticipated	O
,	O
consisting	O
of	O
multiple	O
major	O
and	O
auxiliary	O
operators	O
.	O
	
barr	B-T116
has	O
a	O
limited	B-T169
regulon	O
,	O
and	O
includes	O
also	O
glutamine	O
synthase	O
genes	O
besides	O
the	O
previously	O
characterized	O
β-alanine	O
aminotransferase	O
.	O
	
regulation	O
of	O
glutamine	B-T116
synthase	I-T116
is	O
suggestive	O
of	O
a	O
link	O
between	O
β-alanine	O
and	O
α-amino	O
acid	O
metabolism	O
in	O
s	O
.	O
	
acidocaldarius	O
.	O
	
furthermore	O
,	O
this	O
work	O
reveals	O
that	O
the	O
barr	B-T116
regulon	O
overlaps	O
with	O
that	O
of	O
other	O
lrp	B-T116
-like	O
gh32	B-T116
family	I-T116
activity	O
a	O
topological	B-T082
approach	O
through	O
protein	B-T169
contact	I-T169
networks	I-T169
the	O
application	O
of	O
protein	B-T169
contact	I-T169
networks	I-T169
methodology	I-T169
allowed	O
to	O
highlight	O
a	O
novel	O
response	O
of	O
border	B-T082
region	I-T082
between	O
the	O
two	O
domains	O
to	O
substrate	O
binding	O
.	O
	
glycoside	B-T116
hydrolases	I-T116
gh	B-T116
are	O
enzymes	B-T116
that	O
mainly	O
hydrolyze	O
the	O
glycosidic	O
bond	O
between	O
two	O
carbohydrates	B-T109
or	O
a	O
carbohydrate	B-T109
and	O
a	O
non-carbohydrate	O
moiety	O
.	O
	
these	O
enzymes	B-T116
are	O
involved	O
in	O
many	O
fundamental	O
and	O
diverse	O
biological	O
processes	O
in	O
plants	O
.	O
	
we	O
have	O
focused	O
on	O
the	O
gh32	B-T116
family	I-T116
,	O
including	O
enzymes	B-T116
very	O
similar	O
in	O
both	O
sequence	O
and	O
structure	B-T116
,	O
each	O
having	O
however	O
clear	O
specificities	O
of	O
substrate	O
preferences	B-T078
and	O
kinetic	B-T169
properties	I-T169
.	O
	
structural	B-T116
and	O
topological	B-T082
differences	O
among	O
proteins	B-T116
of	O
the	O
gh32	B-T116
family	I-T116
have	O
been	O
here	O
identified	O
by	O
means	O
of	O
an	O
emerging	O
approach	O
protein	B-T169
contact	I-T169
network	I-T169
,	O
pcn	B-T169
based	O
on	O
the	O
formalization	O
of	O
3d	B-T082
structures	I-T082
as	O
contact	B-T169
networks	I-T169
among	O
amino-acid	O
residues	O
.	O
	
the	O
pcn	B-T169
approach	O
proved	O
successful	O
in	O
both	O
reconstructing	O
the	O
already	O
known	O
functional	B-T169
domains	O
and	O
in	O
identifying	O
the	O
structural	B-T116
counterpart	O
of	O
the	O
properties	O
of	O
gh32	B-T116
enzymes	I-T116
,	O
which	O
remain	O
uncertain	O
,	O
like	O
their	O
allosteric	B-T169
character	O
.	O
	
the	O
main	O
outcome	O
of	O
the	O
study	O
was	O
the	O
discovery	O
of	O
the	O
activation	O
upon	O
binding	O
of	O
the	O
border	O
cleft	O
region	O
between	O
the	O
two	O
domains	O
.	O
	
this	O
reveals	O
the	O
allosteric	B-T169
nature	O
of	O
the	O
enzymatic	O
activity	O
for	O
all	O
the	O
analyzed	O
forms	O
in	O
the	O
gh32	B-T116
family	I-T116
,	O
a	O
character	O
yet	O
to	O
be	O
highlighted	O
in	O
biochemical	O
studies	O
.	O
	
furthermore	O
,	O
we	O
have	O
been	O
able	O
to	O
recognize	O
a	O
topological	B-T082
signature	I-T082
graph	O
energy	O
of	O
the	O
different	O
affinity	O
of	O
the	O
enzymes	B-T116
towards	O
small	O
and	O
large	O
grasping	O
at	O
the	O
moon	O
enhancing	B-T052
access	B-T082
to	O
careers	O
in	O
the	O
health	O
professions	O
a	O
former	B-T078
hhs	O
secretary	O
reflects	O
on	O
what's	O
needed	O
to	O
enable	O
more	O
minorities	B-T098
to	O
become	O
doctors	O
and	O
other	O
health	O
professionals	O
.	O
	
multivariate	B-T081
imaging	O
genetics	B-T062
study	I-T062
of	O
mri	O
gray	O
matter	O
volume	B-T081
and	O
snps	O
reveals	O
biological	B-T080
pathways	O
correlated	B-T080
with	O
brain	O
structural	B-T082
differences	B-T081
in	O
attention	O
deficit	O
hyperactivity	O
disorder	O
attention	O
deficit	O
hyperactivity	O
disorder	O
adhd	O
is	O
a	O
prevalent	B-T081
neurodevelopmental	O
disorder	O
affecting	B-T169
children	O
,	O
adolescents	O
,	O
and	O
adults	O
.	O
	
its	O
etiology	B-T169
is	O
not	O
well	O
understood	O
,	O
but	O
it	O
is	O
increasingly	O
believed	O
to	O
result	B-T169
from	O
diverse	B-T080
pathophysiologies	O
that	O
affect	B-T169
the	O
structure	B-T082
and	O
function	B-T169
of	O
specific	B-T080
brain	O
circuits	O
.	O
	
although	O
one	O
of	O
the	O
best-studied	O
neurobiological	B-T047
abnormalities	I-T047
in	O
adhd	O
is	O
reduced	B-T080
fronto-striatal-cerebellar	O
gray	O
matter	O
gm	O
volume	B-T081
,	O
its	O
specific	O
genetic	B-T169
correlates	B-T080
are	O
largely	O
unknown	B-T080
.	O
	
in	O
this	O
study	B-T062
,	O
t1-weighted	O
mr	O
images	O
of	O
brain	O
structure	O
were	O
collected	O
from	O
198	O
adolescents	O
63	O
adhd	O
-	O
diagnosed	B-T033
.	O
	
a	O
multivariate	B-T081
parallel	I-T081
independent	I-T081
component	I-T081
analysis	I-T081
para-ica	B-T081
technique	B-T169
-identified	O
imaging	O
genetic	B-T169
relationships	B-T080
between	O
regional	B-T082
gm	O
volume	B-T081
and	O
single	O
nucleotide	O
polymorphism	O
data	B-T078
.	O
	
para-ica	B-T081
analyses	I-T081
extracted	O
14	O
components	O
from	O
genetic	B-T170
data	I-T170
and	O
9	O
from	O
mr	O
data	B-T078
.	O
	
an	O
iterative	B-T062
cross-validation	I-T062
using	O
randomly	O
chosen	O
subsamples	O
indicated	O
acceptable	O
stability	B-T080
of	O
these	O
ica	B-T081
solutions	O
.	O
	
a	O
series	O
of	O
partial	O
correlation	O
analyses	O
controlling	O
for	O
age	O
,	O
sex	O
,	O
and	O
ethnicity	B-T080
revealed	O
two	O
genotype-phenotype	O
component	O
pairs	B-T080
significantly	O
differed	O
between	O
adhd	O
and	O
non-adhd	B-T033
groups	B-T078
,	O
after	O
a	O
bonferroni	B-T081
correction	I-T081
for	O
multiple	B-T081
comparisons	B-T052
.	O
	
the	O
brain	O
phenotype	O
component	O
not	O
only	O
included	O
structures	B-T082
frequently	O
found	O
to	O
have	O
abnormally	B-T080
low	I-T080
volume	B-T081
in	O
previous	O
adhd	O
studies	B-T062
but	O
was	O
also	O
significantly	O
associated	B-T080
with	I-T080
adhd	O
differences	O
in	O
symptom	B-T033
severity	I-T033
and	O
performance	B-T052
on	O
cognitive	B-T170
tests	I-T170
frequently	O
found	O
to	O
be	O
impaired	O
in	O
patients	O
diagnosed	B-T033
with	O
the	O
disorder	B-T047
.	O
	
pathway	B-T170
analysis	I-T170
of	O
the	O
genotype	O
component	O
identified	O
several	O
different	O
biological	B-T080
pathways	O
linked	O
to	O
these	O
structural	B-T082
abnormalities	B-T033
in	O
adhd	O
.	O
	
some	O
of	O
these	O
pathways	O
implicate	O
well-known	O
dopaminergic	O
neurotransmission	O
and	O
neurodevelopment	O
hypothesized	B-T078
to	O
be	O
abnormal	B-T033
in	O
adhd	O
.	O
	
other	O
more	O
recently	O
implicated	O
pathways	O
included	O
glutamatergic	O
and	O
gaba-eric	O
physiological	O
systems	O
others	O
might	O
reflect	O
sources	O
of	O
shared	O
liability	O
to	O
disturbances	O
commonly	O
found	O
in	O
adhd	O
,	O
such	O
as	O
sleep	O
abnormalities	O
.	O
	
clinicopathological	O
and	O
immunohistochemical	O
characteristics	O
of	O
verruciform	B-T047
xanthoma	I-T047
of	O
the	O
lower	O
gingiva	O
a	O
case	B-T170
report	I-T170
verruciform	B-T047
xanthoma	I-T047
vx	B-T047
is	O
a	O
rare	O
benign	O
lesion	O
and	O
mainly	O
effects	O
the	O
oral	O
mucosa	O
.	O
	
this	O
slow-growing	B-T033
asymptomatic	B-T033
lesion	O
typically	O
develops	O
along	O
the	O
gingival	O
margin	O
of	O
the	O
masticatory	B-T169
mucosa	O
,	O
followed	O
by	O
the	O
hard	O
palate	O
,	O
tongue	O
,	O
buccal	O
mucosa	O
,	O
floor	O
of	O
the	O
mouth	O
,	O
alveolar	O
mucosa	O
,	O
soft	O
palate	O
and	O
junction	B-T082
between	O
the	O
hard	O
and	O
soft	O
palate	O
.	O
	
moreover	O
,	O
this	O
lesion	O
can	O
also	O
affect	O
the	O
skin	O
and	O
genital	O
organs	O
.	O
	
clinically	B-T080
,	O
vx	B-T047
generally	O
presents	O
a	O
sessile	B-T033
or	O
pedunculated	B-T033
appearance	I-T033
,	O
forming	O
a	O
papule	B-T033
or	O
single	B-T033
plaque	I-T033
with	O
verrucous	O
or	O
papillomatous	O
mucosal	O
growth	O
.	O
	
the	O
colour	B-T080
white	B-T080
,	O
pink	B-T080
,	O
grey	B-T080
,	O
or	O
yellow	B-T080
depends	O
on	O
the	O
thickness	B-T080
of	O
the	O
overlying	O
epidermis	O
.	O
	
in	O
fact	O
,	O
the	O
clinical	B-T080
findings	B-T033
of	O
vx	B-T047
are	O
similar	O
to	O
those	O
of	O
verrucous	O
carcinoma	O
and	O
other	O
benign	O
tumours	O
,	O
such	O
as	O
squamous	O
papilloma	O
,	O
verruca	B-T047
vulgaris	I-T047
and	O
mucosal	O
fibroma	O
.	O
	
for	O
this	O
reason	O
,	O
clinical	B-T080
and	O
histopathological	B-T169
examinations	O
are	O
essential	O
for	O
accurate	O
differential	O
diagnosis	O
.	O
	
histologically	B-T169
,	O
vx	B-T047
is	O
characterized	O
by	O
parakeratosis	B-T047
,	O
rete	O
ridges	O
of	O
uniform	O
depth	O
and	O
the	O
accumulation	B-T033
of	O
foam	O
cells	O
,	O
which	O
are	O
also	O
called	O
""""	O
xanthoma	O
cells	O
""""	O
.	O
	
here	O
,	O
we	O
describe	O
the	O
clinicopathological	O
and	O
immunohistochemical	O
findings	B-T033
of	O
a	O
vx	B-T047
located	O
on	O
the	O
lower	O
gingiva	O
of	O
a	O
64-year-old	O
male	O
patient	O
.	O
	
microrna	O
101b	O
is	O
downregulated	O
in	O
the	O
prefrontal	O
cortex	O
of	O
a	O
genetic	B-T170
model	I-T170
of	O
depression	O
and	O
targets	B-T169
the	O
glutamate	B-T116
transporter	I-T116
slc1a1	B-T116
eaat3	B-T116
in	B-T080
vitro	I-T080
micrornas	O
mirnas	O
are	O
small	B-T081
regulatory	O
molecules	O
that	O
cause	O
translational	O
repression	O
by	O
base	O
pairing	O
with	O
target	O
mrnas	O
.	O
	
cumulative	B-T080
evidence	B-T078
suggests	O
that	O
changes	B-T169
in	O
mirna	O
expression	O
may	O
in	O
part	O
underlie	O
the	O
pathophysiology	B-T169
and	O
treatment	B-T061
of	O
neuropsychiatric	B-T047
disorders	I-T047
,	O
including	O
major	O
depressive	O
disorder	O
mdd	O
.	O
	
a	O
mirna	O
expression	O
assay	O
that	O
can	O
simultaneously	B-T079
detect	O
423	O
rat	O
mirnas	O
mirbase	O
v.17	O
was	O
used	O
to	O
profile	O
the	O
prefrontal	O
cortex	O
pfc	O
of	O
a	O
genetic	B-T170
rat	I-T170
model	I-T170
of	O
mdd	O
the	O
flinders	B-T170
sensitive	I-T170
line	I-T170
fsl	B-T170
and	O
the	O
controls	O
,	O
the	O
flinders	B-T170
resistant	I-T170
line	I-T170
frl	B-T170
.	O
	
gene	O
expression	O
data	B-T078
from	O
the	O
pfc	O
of	O
fsl	B-T170
/	O
frl	B-T170
animals	O
geo	O
accession	O
no	O
.	O
	
gse20388	O
were	O
used	O
to	O
guide	O
mrna	O
target	B-T169
selection	B-T052
.	O
	
luciferase	O
reporter	O
assays	O
were	O
used	O
to	O
verify	B-T169
mirna	O
targets	B-T169
in	B-T080
vitro	I-T080
.	O
	
we	O
identified	B-T080
23	O
mirnas	O
that	O
were	O
downregulated	O
in	O
the	O
pfc	O
of	O
the	O
fsl	B-T170
model	I-T170
compared	B-T052
with	O
controls	O
.	O
	
interestingly	O
,	O
one	O
of	O
the	O
identified	B-T080
mirnas	O
mir-101b	O
is	O
highly	O
conserved	B-T080
between	O
rat	O
and	O
human	O
and	O
was	O
recently	O
found	O
to	O
be	O
downregulated	O
in	O
the	O
pfc	O
of	O
depressed	O
suicide	B-T033
subjects	O
.	O
	
using	O
a	O
combination	B-T080
of	O
in	O
silico	O
and	O
in	B-T080
vitro	I-T080
analyses	B-T062
,	O
we	O
found	O
that	O
mir-101b	O
targets	B-T169
the	O
neuronal	O
glutamate	B-T116
transporter	I-T116
slc1a1	B-T116
also	O
known	O
as	O
eaac1	B-T116
or	O
eaat3	B-T116
.	O
	
accordingly	O
,	O
both	O
mrna	O
and	O
protein	O
levels	O
of	O
slc1a1	B-T116
were	O
found	O
to	O
be	O
upregulated	O
in	O
the	O
pfc	O
of	O
the	O
fsl	B-T170
model	I-T170
.	O
	
besides	O
providing	O
a	O
list	O
of	O
novel	O
mirnas	O
associated	B-T080
with	I-T080
depression-like	B-T033
states	I-T033
,	O
this	O
preclinical	B-T062
study	I-T062
replicated	B-T169
the	O
human	O
association	B-T080
of	O
mir-101	O
with	O
depression	O
.	O
	
in	O
addition	O
,	O
since	O
one	O
of	O
the	O
targets	B-T169
of	O
mir-101b	O
appears	O
to	O
be	O
a	O
glutamate	B-T116
transporter	I-T116
,	O
our	O
preclinical	B-T080
data	B-T078
support	O
the	O
hypothesis	B-T078
of	O
a	O
glutamatergic	O
dysregulation	B-T033
being	O
implicated	O
in	O
the	O
etiology	B-T169
of	O
a	O
practical	O
guide	O
to	O
forensic	O
nursing	O
incorporating	B-T169
forensic	O
principles	B-T081
into	O
nursing	O
practice	O
amar	O
angela	O
f	O
and	O
sekula	O
l	O
kathleen	O
a	O
practical	O
guide	O
to	O
forensic	O
nursing	O
incorporating	O
forensic	O
principles	B-T081
into	O
nursing	O
practice	O
392pp	O
us	O
sigma	O
theta	O
tau	O
international	O
honor	O
society	O
of	O
nursing	O
9781940446349	O
1940446341	O
formula	O
see	O
text	O
george	O
bernard	O
shaw	O
described	O
britons	B-T098
and	O
americans	B-T098
as	O
'	O
divided	B-T169
by	O
a	O
common	O
language	O
'	O
,	O
and	O
that	O
is	O
made	O
very	O
clear	O
in	O
this	O
fascinating	O
publication	O
that	O
describes	O
in	O
depth	O
the	O
roles	B-T170
and	I-T170
responsibilities	I-T170
of	O
forensic	O
nurses	O
in	O
the	O
incidence	B-T081
of	O
diabetes	B-T047
mellitus	I-T047
and	O
obesity	B-T047
and	O
the	O
overlap	B-T079
of	O
comorbidities	B-T078
in	O
hiv+	O
hispanics	B-T098
initiating	B-T169
antiretroviral	B-T061
therapy	I-T061
cardiovascular	B-T047
disease	I-T047
cvd	B-T047
is	O
a	O
leading	O
health	B-T078
threat	B-T078
for	O
hiv+	O
patients	O
on	O
antiretroviral	B-T061
therapy	I-T061
art	B-T061
cardiometabolic	B-T047
comorbidities	B-T078
are	O
key	O
predictors	B-T033
of	I-T033
risk	I-T033
.	O
	
data	B-T078
are	O
limited	O
on	O
incidence	B-T081
of	O
metabolic	B-T169
comorbidities	B-T078
in	O
hiv+	O
individuals	B-T098
initiating	B-T169
art	B-T061
in	O
low	B-T080
and	O
middle	B-T080
income	I-T080
countries	O
lmics	O
,	O
particularly	B-T080
for	O
hispanics	B-T098
.	O
	
we	O
examined	B-T033
incidence	B-T081
of	O
diabetes	B-T047
and	O
obesity	B-T047
in	O
a	O
prospective	B-T098
cohort	I-T098
of	O
those	O
initiating	B-T169
art	B-T061
in	O
the	O
dominican	O
republic	O
.	O
	
participants	B-T098
18	O
years	B-T079
,	O
initiating	B-T169
art	B-T061
<90	O
days	B-T079
prior	O
to	O
study	B-T062
enrollment	O
,	O
were	O
examined	B-T033
for	O
incidence	B-T081
of	O
impaired	B-T033
fasting	I-T033
glucose	I-T033
ifg	B-T033
,	O
diabetes	B-T047
mellitus	I-T047
dm	B-T047
,	O
overweight	B-T047
,	O
and	I-T047
obesity	I-T047
.	O
	
fasting	O
plasma	O
glucose	O
fpg	O
100-125mg/dl	O
defined	O
ifg	B-T033
fpg	O
126	O
mg/dl	O
,	O
diagnosis	B-T062
per	O
medical	B-T170
record	I-T170
,	O
or	O
use	O
of	O
hypoglycemic	O
medication	O
defined	O
dm	B-T047
.	O
	
overweight	B-T047
and	I-T047
obesity	I-T047
were	O
bmi	O
25-30	O
and	O
30kg/m2	O
,	O
respectively	O
.	O
	
dyslipidemia	B-T047
was	O
total	B-T109
cholesterol	I-T109
240mg/dl	O
or	O
use	B-T169
of	I-T169
lipid-lowering	O
medication	O
.	O
	
framingham	B-T170
risk	I-T170
equation	I-T170
was	O
used	B-T033
to	O
determine	B-T080
ten-year	B-T079
cvd	B-T047
risk	O
at	O
the	O
end	B-T062
of	I-T062
observation	I-T062
.	O
	
of	O
153	O
initiating	B-T169
art	B-T061
,	O
8	O
6%	O
had	O
dm	B-T047
and	O
23	O
16%	O
had	O
ifg	B-T033
at	O
baseline	B-T081
,	O
6	O
developed	O
dm	B-T047
28/1000	O
person	B-T098
-	O
years	B-T079
follow	O
up	O
pyfu	O
and	O
46	O
developed	O
ifg	B-T033
329/1000	O
pyfu	O
.	O
	
at	O
baseline	B-T081
,	O
24	O
18%	O
were	O
obese	B-T047
and	O
36	O
27%	O
were	O
overweight	O
,	O
15	O
became	O
obese	B-T047
69/1000	O
pyfu	O
and	O
22	O
became	O
overweight	O
163/1000	O
pyfu	O
.	O
	
median	B-T082
observation	O
periods	B-T079
for	O
the	O
diabetes	B-T047
and	O
obesity	B-T047
analyses	B-T062
were	O
23.5	O
months	B-T079
and	O
24.3	O
months	B-T079
,	O
respectively	O
.	O
	
increased	B-T081
cvd	B-T047
risk	O
10%	O
10-year	B-T033
framingham	I-T033
risk	I-T033
score	I-T033
was	O
present	B-T033
for	O
13%	O
of	O
the	O
cohort	B-T098
79%	O
of	O
the	O
cohort	B-T098
had	O
1	O
cardiometabolic	B-T078
comorbidity	I-T078
,	O
48%	O
had	O
2	O
,	O
and	O
13%	O
had	O
all	O
three	O
.	O
	
in	O
this	O
hispanic	B-T098
cohort	B-T098
in	O
an	O
lmic	O
,	O
incidences	B-T081
of	O
ifg	B-T033
/	O
dm	B-T047
and	O
overweight	O
/	O
obesity	B-T047
were	O
similar	B-T080
to	O
or	O
higher	B-T080
than	I-T080
that	O
found	B-T033
in	O
high	B-T033
income	I-T033
countries	O
,	O
and	O
cardiometabolic	B-T047
disorders	I-T047
affected	B-T169
three-quarters	O
of	O
those	O
initiating	B-T169
art	B-T061
.	O
	
care	B-T170
models	I-T170
incorporating	O
cardiovascular	B-T047
risk	I-T047
reduction	B-T061
into	O
hiv	B-T047
treatment	O
programs	O
are	O
needed	B-T080
to	O
prevent	B-T169
cvd	B-T047
-	O
associated	B-T080
mortality	B-T081
in	O
this	O
vulnerable	B-T098
population	I-T098
.	O
	
laparoscopic	O
approach	O
for	O
thermoablation	B-T061
microwave	I-T061
in	O
the	O
treatment	B-T061
of	O
hepatocellular	O
carcinoma	O
a	O
single	O
center	O
experience	O
the	O
surgical	B-T061
therapy	I-T061
of	O
choice	O
for	O
hepatocellular	O
carcinoma	O
hcc	O
is	O
liver	B-T061
transplantation	I-T061
lt	B-T061
or	O
hepatic	B-T061
resection	I-T061
,	O
although	O
only	O
a	O
small	B-T081
percentage	B-T081
of	O
patients	O
can	O
undergo	O
these	O
procedures	B-T169
.	O
	
microwave	B-T061
thermal	I-T061
ablation	I-T061
mwta	B-T061
can	O
be	O
an	O
effective	B-T080
alternative	O
treatment	B-T061
for	O
hcc	O
that	O
complicates	B-T169
a	O
cirrhotic	B-T047
liver	I-T047
disease	I-T047
,	O
either	O
as	O
a	O
final	B-T079
procedure	B-T169
or	O
for	O
downstaging	O
patients	O
on	O
the	O
waiting	O
list	O
for	O
lt	B-T061
,	O
or	O
in	O
combination	B-T080
with	O
resective	B-T061
surgery	B-T061
to	O
achieve	O
oncological	O
radicality	B-T080
.	O
	
the	O
purpose	O
of	O
this	O
retrospective	B-T062
study	I-T062
was	O
to	O
evaluate	O
experience	O
with	O
the	O
laparoscopic	O
approach	O
of	O
mwta	B-T061
at	O
our	O
center	O
.	O
	
in	O
a	O
cohort	B-T098
of	O
35	O
consecutive	B-T080
patients	O
undergoing	O
mwta	B-T061
with	O
laparoscopic	O
approach	O
between	O
january	O
,	O
2013	O
and	O
may	O
,	O
2016	O
,	O
we	O
reviewed	O
the	O
demographic	B-T062
data	I-T062
,	O
the	O
barcelona	O
clinic	O
liver	O
cancer	O
stage	O
,	O
the	O
severity	B-T080
of	O
cirrhotic	B-T047
liver	I-T047
disease	I-T047
,	O
the	O
size	B-T082
of	O
the	O
ablated	B-T061
lesion	B-T033
,	O
the	O
duration	B-T079
of	O
the	O
procedure	B-T169
,	O
and	O
complications	B-T169
occurring	O
within	O
90	O
days	B-T079
of	O
surgery	B-T061
.	O
	
mwta	B-T061
was	O
performed	O
by	O
applying	O
one	O
to	O
three	O
hepatic	O
parenchymal	O
insertions	O
mean	B-T081
1.8	O
per	O
patient	O
.	O
	
the	O
mean	B-T081
duration	B-T079
of	O
surgery	B-T061
was	O
163	O
18	O
minutes	B-T079
.	O
	
there	O
was	O
no	O
blood	B-T033
loss	I-T033
in	O
any	O
of	O
the	O
procedures	B-T169
.	O
	
complete	O
necrosis	O
on	O
ct	O
scan	O
was	O
achieved	O
in	O
26/35	O
patients	O
75%	O
.	O
	
the	O
mean	B-T081
hospital	B-T079
stay	I-T079
was	O
4.6	O
range	O
2-7	O
days	B-T079
major	O
complications	B-T169
were	O
postablation	B-T079
syndrome	B-T047
in	O
2/35	O
5.7	O
,	O
peritoneal	O
fluid	O
in	O
4/35	O
11.4	O
,	O
and	O
transient	B-T079
jaundice	B-T047
in	O
1/35	O
2.8	O
patients	O
.	O
	
there	O
was	O
no	B-T033
mortality	I-T033
.	O
	
laparoscopic	O
mwta	B-T061
is	O
a	O
safe	O
and	O
effective	B-T080
treatment	B-T061
for	O
unresectable	O
hcc	O
and	O
when	O
a	O
percutaneous	B-T082
procedure	B-T169
structured	B-T082
instruction	B-T170
with	O
modified	B-T169
storybooks	O
to	O
teach	O
morphosyntax	O
and	O
vocabulary	B-T170
to	O
preschoolers	O
who	O
are	O
deaf	O
/	O
hard	O
of	O
hearing	O
children	O
who	O
are	O
deaf	O
/	O
hard	O
of	O
hearing	O
d	O
/	O
hh	O
are	O
at	B-T080
risk	I-T080
for	O
diminished	B-T081
morphosyntactical	O
and	O
vocabulary	B-T170
development	B-T169
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
effects	B-T080
of	I-T080
repeated	B-T169
reading	O
combined	B-T080
with	O
structured	B-T082
instruction	B-T170
.	O
	
targets	B-T169
were	O
a	O
morphosyntactical	O
form	O
and	O
novel	O
vocabulary	B-T170
words	I-T170
.	O
	
participants	B-T098
were	O
3	O
preschoolers	O
who	O
are	O
d	O
/	O
hh	O
who	O
were	O
receiving	B-T080
instruction	B-T170
with	O
an	O
oral	B-T082
approach	O
.	O
	
data	B-T078
from	O
a	O
multiple	B-T081
baseline	B-T062
design	I-T062
indicated	O
that	O
all	O
children	O
acquired	B-T052
the	O
targeted	B-T169
skills	O
and	O
demonstrated	O
high	O
levels	O
of	O
generalization	O
of	O
these	O
skills	O
to	O
untrained	B-T033
context	B-T078
.	O
	
implications	B-T080
for	O
teaching	O
young	B-T079
children	O
who	O
are	O
d	O
/	O
hh	O
using	B-T169
repeated	B-T169
storybook	O
reading	O
application	O
of	O
braf	B-T033
v600e	I-T033
mutation	O
-	O
specific	B-T080
immunohistochemistry	O
in	O
diagnosis	B-T033
of	O
gastrointestinal	O
stromal	O
tumors	O
to	O
evaluate	O
the	O
utility	O
of	O
braf	B-T033
v600e	I-T033
allele	O
-	O
specific	B-T080
antibody	B-T116
in	O
the	O
diagnosis	B-T033
of	O
gastrointestinal	O
stromal	O
tumors	O
gists	O
.	O
	
braf	B-T033
v600e	I-T033
mutation	O
-	O
specific	B-T080
immunohistochemistry	O
and	O
braf	O
sequencing	B-T169
were	O
performed	O
in	O
24	O
consecutive	B-T080
gists	O
,	O
including	O
14	O
cases	B-T169
of	O
kit	O
or	O
pdgfra	O
mutations	O
and	O
10	O
cases	B-T169
of	O
kit	O
/	O
pdgfra	O
wild	O
gists	O
.	O
	
gists	O
of	O
11	O
men	B-T098
and	O
13	O
women	B-T098
with	O
a	O
mean	B-T081
age	O
54	O
years	O
29-75	O
years	O
were	O
included	O
with	O
tumors	O
arising	O
from	O
stomach	O
16	O
cases	B-T169
,	O
small	O
bowel	O
7	O
cases	B-T169
,	O
and	O
peritoneal	O
cavity	O
1	O
case	B-T169
.	O
	
strong	B-T080
and	O
diffuse	B-T082
cytoplasmic	O
braf	B-T116
staining	B-T033
was	O
noted	B-T080
in	O
4	O
of	O
24	O
cases	B-T169
17%	O
,	O
while	O
1	O
of	O
24	O
cases	B-T169
4%	O
showed	O
weak	B-T080
staining	B-T033
,	O
and	O
19	O
of	O
24	O
cases	B-T169
79%	O
had	O
no	B-T169
staining	B-T033
.	O
	
the	O
four	O
cases	B-T169
with	O
strong	B-T080
braf	B-T116
immunostain	O
were	O
confirmed	B-T080
to	O
have	O
braf	O
mutations	O
,	O
including	O
3	O
cases	B-T169
in	O
the	O
stomach	O
and	O
1	O
case	B-T169
in	O
the	O
small	O
intestine	O
.	O
	
all	O
tumors	O
showed	O
spindle	O
cell	O
morphology	B-T080
.	O
	
only	O
one	O
case	B-T169
had	O
progressive	B-T047
disease	I-T047
.	O
	
no	B-T169
braf	O
mutations	O
were	O
detected	B-T033
in	O
cases	B-T169
with	O
weak	B-T080
or	O
negative	B-T033
braf	B-T116
immunostain	O
.	O
	
braf	B-T033
v600e	I-T033
mutation	O
-	O
specific	B-T080
immunohistochemistry	O
is	O
a	O
highly	B-T080
sensitive	I-T080
and	O
specific	B-T080
marker	O
for	O
detecting	B-T033
braf-mutated	O
gists	O
.	O
	
efficacy	O
of	O
pegylated	B-T109
liposomal	I-T109
etoposide	I-T109
nanoparticles	I-T109
on	O
breast	O
cancer	O
cell	O
lines	O
this	O
study	O
aimed	O
to	O
investigate	O
the	O
efficacy	B-T080
of	I-T080
pegylated	B-T109
liposomal	I-T109
etoposide	I-T109
nanoparticles	I-T109
nps	O
against	O
t-47d	O
and	O
mcf-7	O
breast	O
cancer	O
cell	O
lines	O
.	O
	
pegylated	B-T109
liposomal	I-T109
etoposide	I-T109
nps	I-T109
were	O
prepared	O
by	O
reverse	O
phase	O
evaporation	O
method	O
.	O
	
the	O
size	B-T082
,	O
size	B-T082
distribution	I-T082
,	O
and	O
zeta	O
potential	O
of	O
the	O
nps	B-T109
was	O
measured	O
by	O
a	O
zetasizer	O
instrument	O
.	O
	
the	O
cytotoxicity	O
of	O
nps	B-T109
was	O
inspected	O
by	O
methyl	B-T062
thiazol	I-T062
tetrazolium	I-T062
assay	I-T062
.	O
	
the	O
release	O
pattern	O
of	O
the	O
drug	O
from	O
the	O
vesicles	O
was	O
studied	O
by	O
the	O
dialysis	B-T061
method	I-T061
.	O
	
drug	O
loading	O
and	O
encapsulation	O
efficiency	O
ee	O
were	O
also	O
measured	O
.	O
	
the	O
mean	B-T082
size	I-T082
,	O
size	B-T082
distribution	I-T082
,	O
and	O
zeta	O
potential	O
of	O
pegylated	B-T109
liposomal	I-T109
etoposide	I-T109
nps	I-T109
were	O
491	O
15.5	O
nm	O
,	O
0.504	O
0.14	O
,	O
and	O
-35	O
2.5	O
mv	O
,	O
respectively	O
.	O
	
drug	O
loading	O
and	O
ee	O
were	O
10.3	O
1.6	O
and	O
99.1	O
2.8	O
,	O
respectively	O
.	O
	
the	O
etoposide	O
release	O
in	O
the	O
formulation	O
was	O
estimated	O
at	O
about	O
3.48	O
after	O
48	O
h	O
.	O
	
the	O
cytotoxicity	O
effect	O
of	O
etoposide	B-T109
nps	I-T109
on	O
t-47d	O
and	O
mcf-7	O
cell	O
lines	O
of	O
breast	O
cancer	O
showed	O
higher	O
antitumor	B-T080
activity	I-T080
as	O
compared	O
with	O
those	O
of	O
the	O
free	B-T081
drug	I-T081
.	O
	
liposome-based	B-T109
nps	I-T109
may	O
hold	O
great	O
potential	O
as	O
a	O
drug	O
delivery	O
system	O
.	O
	
the	O
bindex	O
ultrasound	O
device	O
reliability	B-T081
of	O
cortical	O
bone	O
thickness	B-T080
measures	B-T081
and	O
their	O
relationship	B-T080
to	O
regional	B-T082
bone	O
mineral	O
density	O
the	O
bindex	O
quantitative	O
ultrasound	O
qus	O
device	O
is	O
currently	O
available	O
and	O
this	O
study	B-T062
analyzed	B-T062
i	O
its	O
relative	B-T080
and	O
absolute	B-T080
intra-	B-T081
and	I-T081
inter-session	I-T081
reliability	I-T081
and	O
ii	O
the	O
relationship	B-T080
between	O
the	O
data	B-T078
provided	O
by	O
bindex	O
and	O
the	O
bone	O
mineral	O
density	O
bmd	O
measured	B-T080
by	O
dual-energy	O
x-ray	O
absorptiometry	O
at	O
corresponding	O
skeletal	B-T082
sites	I-T082
in	O
young	B-T098
and	O
healthy	B-T098
subjects	I-T098
age	O
25.0	O
3.6	O
years	B-T079
.	O
	
bindex	O
calculates	B-T052
a	O
density	O
index	O
on	O
the	O
basis	O
of	O
the	O
thickness	B-T080
of	O
cortical	O
bone	O
measured	B-T080
at	O
the	O
distal	O
radius	O
and	O
the	O
distal	O
plus	O
proximal	O
tibia	O
.	O
	
the	O
data	B-T078
show	O
a	O
very	O
good	O
relative	B-T080
and	O
absolute	B-T080
intra-	B-T081
icc	B-T081
=	O
0.977	O
,	O
cv	B-T081
=	O
1.5	O
and	O
inter-session	B-T081
reliability	I-T081
icc	B-T081
=	O
0.978	O
,	O
cv	B-T081
=	O
1.4	O
for	O
the	O
density	O
index	O
.	O
	
the	O
highest	B-T080
positive	B-T033
correlations	B-T080
were	O
found	O
between	O
cortical	O
thickness	B-T080
and	O
bmd	O
for	O
the	O
distal	O
radius	O
and	O
distal	O
tibia	O
r	O
0.71	O
,	O
p	O
<	O
0.001	O
.	O
	
the	O
data	B-T078
indicate	O
that	O
the	O
bindex	O
parameters	B-T033
are	O
repeatable	O
within	O
and	O
between	O
measurement	B-T169
sessions	O
.	O
	
furthermore	O
,	O
the	O
measurements	B-T169
reflect	O
the	O
bmd	O
at	O
specific	B-T080
skeletal	B-T082
sites	I-T082
.	O
	
bindex	O
might	O
be	O
a	O
useful	O
tool	O
for	O
the	O
measurement	B-T169
of	O
skeletal	O
adaptations	O
.	O
	
botulinum	B-T116
toxin	I-T116
use	O
in	O
refractory	O
pain	O
and	O
other	O
symptoms	O
in	O
parkinsonism	B-T047
parkinson's	B-T047
disease	I-T047
pd	B-T047
and	O
other	O
parkinsonian	B-T047
syndromes	I-T047
are	O
chronic	B-T079
,	O
progressive	B-T169
neurodegenerative	B-T047
diseases	I-T047
.	O
	
with	O
advancing	O
disease	B-T047
,	O
both	O
motor	O
and	O
non-motor	O
symptoms	O
represent	O
a	O
considerable	O
burden	B-T078
and	O
symptom	O
relief	B-T033
and	O
quality	B-T078
of	I-T078
life	I-T078
improvement	O
become	O
the	O
main	O
goal	B-T170
of	O
treatment	B-T061
.	O
	
botulinum	B-T116
toxins	I-T116
btx	B-T116
are	O
an	O
effective	B-T080
treatment	B-T061
modality	B-T078
for	O
many	O
neurological	B-T047
conditions	I-T047
.	O
	
to	O
understand	O
the	O
potential	B-T080
usefulness	B-T080
of	O
btx	B-T116
in	O
this	O
population	B-T098
,	O
we	O
performed	B-T169
a	O
retrospective	B-T080
chart	O
review	O
of	O
all	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
idiopathic	B-T047
pd	I-T047
and	O
atypical	B-T047
parkinsonism	I-T047
who	O
received	O
treatment	B-T169
with	O
btx	B-T061
injections	I-T061
in	O
our	O
center	O
from	O
1995	O
to	O
2014	O
for	O
a	O
variety	O
of	O
symptoms	O
.	O
	
response	O
to	O
btx	B-T116
was	O
assessed	B-T052
using	O
a	O
subjective	B-T170
clinical	I-T170
global	I-T170
impression	I-T170
.	O
	
records	B-T170
of	O
160	O
patients	O
were	O
reviewed	B-T080
.	O
	
probable	O
idiopathic	B-T047
pd	I-T047
was	O
the	O
diagnosis	B-T033
in	O
117	O
patients	O
73.1	O
.	O
	
the	O
main	O
indication	B-T078
for	O
btx	B-T116
treatment	B-T061
was	O
pain	O
50.6	O
of	O
cases	O
.	O
	
other	O
indications	B-T078
were	O
the	O
treatment	B-T061
of	O
functional	B-T033
impairment	I-T033
resulting	B-T169
from	O
dystonia	O
26.25	O
,	O
sialorrhea	B-T047
18.75	O
,	O
freezing	O
of	O
gait	O
,	O
and	O
camptocormia	O
.	O
	
considering	O
pain	O
as	O
indication	B-T078
,	O
81%	O
of	O
all	O
patients	O
with	O
pd	B-T047
reported	O
benefits	B-T081
after	O
the	O
first	O
btx	B-T061
injections	I-T061
.	O
	
this	O
benefit	B-T081
was	O
maintained	B-T169
after	O
the	O
last	O
recorded	O
visit	O
without	O
significant	O
difference	B-T080
in	O
outcome	B-T169
compared	B-T052
with	O
the	O
first	O
injection	B-T061
p=0	O
.	O
	
similar	O
results	B-T169
were	O
observed	O
in	O
patients	O
with	O
atypical	B-T047
parkinsonism	I-T047
.	O
	
our	O
results	B-T169
confirm	O
the	O
safety	O
and	O
efficacy	B-T080
of	O
different	B-T080
uses	B-T169
of	O
btx	B-T116
in	O
the	O
symptomatic	B-T169
treatment	B-T169
of	O
patients	O
with	O
parkinsonism	B-T047
even	O
in	O
advanced	B-T080
stages	B-T079
of	O
the	O
disease	B-T047
,	O
and	O
suggest	B-T078
btx	B-T116
treatment	B-T061
could	O
have	O
a	O
safe	O
and	O
useful	O
role	O
in	O
the	O
treatment	B-T169
of	O
pain	O
in	O
this	O
chronic	B-T033
exposure	I-T033
to	I-T033
haloperidol	B-T109
and	O
olanzapine	B-T109
leads	O
to	O
common	O
and	O
divergent	O
shape	B-T033
changes	I-T033
in	O
the	O
rat	O
hippocampus	O
in	O
the	O
absence	O
of	O
grey-matter	O
volume	B-T169
loss	I-T169
one	O
of	O
the	O
most	O
consistently	O
reported	O
brain	O
abnormalities	O
in	O
schizophrenia	O
scz	O
is	O
decreased	O
volume	B-T033
and	I-T033
shape	I-T033
deformation	I-T033
of	O
the	O
hippocampus	O
.	O
	
however	O
,	O
the	O
potential	O
contribution	O
of	O
chronic	O
antipsychotic	O
medication	O
exposure	B-T033
to	O
these	O
phenomena	O
remains	O
unclear	O
.	O
	
we	O
examined	O
the	O
effect	O
of	O
chronic	B-T033
exposure	I-T033
8	O
weeks	O
to	O
clinically	O
relevant	B-T081
doses	I-T081
of	O
either	O
haloperidol	B-T109
hal	B-T109
or	O
olanzapine	B-T109
olz	B-T109
on	O
adult	O
rat	O
hippocampal	O
volume	B-T033
and	I-T033
shape	I-T033
using	O
ex	B-T169
vivo	I-T169
structural	O
mri	O
with	O
the	O
brain	O
retained	O
inside	O
the	O
cranium	O
to	O
prevent	O
distortions	O
due	O
to	O
dissection	B-T061
,	O
followed	O
by	O
tensor-based	O
morphometry	O
tbm	O
and	O
elastic	B-T062
surface-based	I-T062
shape	I-T062
deformation	I-T062
analysis	I-T062
.	O
	
the	O
volume	O
of	O
the	O
hippocampus	O
was	O
also	O
measured	O
post-mortem	O
from	O
brain	O
tissue	O
sections	O
in	O
each	O
group	O
.	O
	
chronic	B-T033
exposure	I-T033
to	O
either	O
hal	B-T109
or	O
olz	B-T109
had	O
no	O
effect	O
on	O
the	O
volume	O
of	O
the	O
hippocampus	O
,	O
even	O
at	O
exploratory	O
thresholds	O
,	O
which	O
was	O
confirmed	O
post-mortem	O
.	O
	
in	O
contrast	O
,	O
shape	B-T062
deformation	I-T062
analysis	I-T062
revealed	O
that	O
chronic	O
hal	B-T109
and	O
olz	B-T109
exposure	B-T033
lead	O
to	O
both	O
common	O
and	O
divergent	B-T033
shape	I-T033
deformations	I-T033
q	O
=	O
0.05	O
,	O
fdr-corrected	O
in	O
the	O
rat	O
hippocampus	O
.	O
	
in	O
particular	O
,	O
in	O
the	O
dorsal	O
hippocampus	O
,	O
hal	B-T109
exposure	B-T033
led	O
to	O
inward	B-T033
shape	I-T033
deformation	I-T033
,	O
whereas	O
olz	B-T109
exposure	B-T033
led	O
to	O
outward	B-T033
shape	I-T033
deformation	I-T033
.	O
	
interestingly	O
,	O
outward	B-T033
shape	I-T033
deformations	I-T033
that	O
were	O
common	O
to	O
both	O
drugs	O
occurred	O
in	O
the	O
ventral	O
hippocampus	O
.	O
	
these	O
effects	O
remained	O
significant	O
after	O
controlling	O
for	O
hippocampal	O
volume	O
suggesting	O
true	O
shape	B-T033
changes	I-T033
.	O
	
chronic	B-T033
exposure	I-T033
to	O
either	O
hal	B-T109
or	O
olz	B-T109
leads	O
to	O
both	O
common	O
and	O
divergent	O
effects	O
on	O
rat	O
hippocampal	O
shape	O
shear	O
and	O
extensional	O
properties	O
of	O
kefiran	B-T109
kefiran	B-T109
is	O
a	O
neutral	B-T109
polysaccharide	I-T109
constituted	O
by	O
glucose	B-T109
and	O
galactose	B-T109
produced	O
by	O
lactobacillus	O
kefiranofaciens	O
.	O
	
it	O
is	O
included	O
into	O
kefir	O
grains	O
and	O
has	O
several	O
health	O
promoting	O
properties	O
.	O
	
in	O
the	O
present	O
work	O
,	O
shear	O
and	O
extensional	O
properties	O
of	O
different	B-T080
kefiran	B-T109
aqueous	O
dispersions	O
0.5	O
,	O
1	O
and	O
2%	O
wt	O
were	O
assessed	B-T052
and	O
compared	B-T052
to	O
other	O
neutral	B-T109
gums	I-T109
commonly	O
used	O
in	O
food	O
,	O
cosmetic	O
and	O
pharmaceutics	O
industries	O
methylcellulose	B-T109
,	O
locust	O
bean	O
gum	O
and	O
guar	B-T109
gum	I-T109
.	O
	
kefiran	B-T109
showed	O
shear	O
flow	O
characteristics	O
similar	O
to	O
that	O
displayed	O
by	O
other	O
representative	O
neutral	B-T109
gums	I-T109
,	O
although	O
it	O
always	O
yielded	O
lower	B-T080
viscosities	O
at	O
a	O
given	O
concentration	B-T081
.	O
	
for	O
each	O
gum	B-T109
system	B-T169
it	O
was	O
possible	O
to	O
find	O
a	O
correlation	B-T080
between	O
dynamic	O
and	O
steady	O
shear	O
properties	O
by	O
a	O
master	B-T082
curve	I-T082
including	O
both	O
the	O
apparent	B-T078
and	O
complex	B-T080
viscosities	O
.	O
	
when	O
studying	O
extensional	O
properties	O
of	O
selected	O
gums	B-T109
at	O
2%	O
wt	O
.	O
	
by	O
means	O
of	O
a	O
capillary	O
break-up	O
rheometer	O
,	O
kefiran	B-T109
solutions	O
did	O
not	O
show	O
important	O
extensional	O
properties	O
,	O
displaying	O
a	O
behaviour	B-T080
close	O
the	O
air	O
tamponade	B-T169
of	O
the	O
heart	O
pneumopericardium	B-T047
is	O
a	O
rare	B-T047
disease	I-T047
defined	O
as	O
the	O
presence	B-T033
of	O
air	O
or	O
gas	O
in	O
the	O
pericardial	O
sac	O
.	O
	
among	O
the	O
etiological	B-T169
factors	I-T169
,	O
the	O
following	O
stand	O
out	O
chest	O
trauma	O
,	O
barotrauma	O
,	O
air	O
-containing	O
fistulas	O
between	O
the	O
pericardium	O
and	O
the	O
surrounding	B-T082
structures	B-T082
,	O
secondary	B-T169
gas	I-T169
production	I-T169
by	O
microorganisms	O
growing	O
in	O
the	O
pericardial	O
sac	O
,	O
and	O
iatrogenic	B-T080
factors	B-T169
.	O
	
until	O
now	O
,	O
spontaneous	B-T169
pneumopericardium	B-T047
has	O
been	O
considered	B-T078
a	O
harmless	B-T080
and	O
temporary	B-T079
state	B-T169
,	O
but	O
a	O
review	B-T169
of	I-T169
clinical	O
cases	O
indicates	O
that	O
the	O
presence	B-T033
of	O
air	O
in	O
the	O
pericardium	O
can	O
lead	O
to	O
cardiac	B-T047
tamponade	I-T047
and	O
life-threatening	B-T033
hemodynamic	O
disturbances	B-T080
.	O
	
we	O
present	B-T033
the	O
case	O
of	O
an	O
80-	O
year-old	B-T079
patient	O
with	O
a	O
chronic	B-T079
bronchopericardial	O
fistula	O
,	O
who	O
suffered	O
from	O
a	O
cardiac	B-T047
arrest	I-T047
due	O
to	O
air	O
tamponade	B-T169
of	O
the	O
the	O
complete	B-T080
chloroplast	O
genome	O
sequence	O
of	O
the	O
medicinal	O
plant	O
swertia	O
mussotii	O
using	O
the	O
pacbio	O
rs	O
ii	O
platform	O
swertia	O
mussotii	O
is	O
an	O
important	O
medicinal	O
plant	O
that	O
has	O
great	B-T081
economic	B-T081
and	O
medicinal	O
value	O
and	O
is	O
found	O
on	O
the	O
qinghai	O
tibetan	O
plateau	O
.	O
	
the	O
complete	B-T080
chloroplast	O
cp	O
genome	O
of	O
s	O
.	O
	
mussotii	O
is	O
153	O
bp	O
in	O
size	B-T081
,	O
with	O
a	O
pair	B-T080
of	O
inverted	O
repeat	O
ir	O
regions	O
of	O
25	O
bp	O
each	O
that	O
separate	B-T080
an	O
large	O
single-copy	O
lsc	O
region	O
of	O
83	O
bp	O
and	O
an	O
a	O
small	O
single-copy	O
ssc	O
region	O
of	O
18	O
bp	O
.	O
	
the	O
s	O
.	O
	
mussotii	O
cp	O
genome	O
encodes	B-T052
84	O
protein-coding	O
genes	O
,	O
37	O
transfer	O
rna	O
trna	O
genes	O
,	O
and	O
eight	O
ribosomal	O
rna	O
rrna	O
genes	O
.	O
	
the	O
identity	O
,	O
number	O
,	O
and	O
gc	B-T081
content	I-T081
of	O
s	O
.	O
	
mussotii	O
cp	O
genes	O
were	O
similar	O
to	O
those	O
in	O
the	O
genomes	O
of	O
other	O
gentianales	O
species	O
.	O
	
via	O
analysis	B-T062
of	O
the	O
repeat	O
structure	O
,	O
11	O
forward	O
repeats	O
,	O
eight	O
palindromic	O
repeats	O
,	O
and	O
one	O
reverse	O
repeat	O
were	O
detected	B-T033
in	O
the	O
s	O
.	O
	
mussotii	O
cp	O
genome	O
.	O
	
there	O
are	O
45	O
ssrs	O
in	O
the	O
s	O
.	O
	
mussotii	O
cp	O
genome	O
,	O
the	O
majority	B-T080
of	O
which	O
are	O
mononucleotides	O
found	O
in	O
all	O
other	O
gentianales	O
species	O
.	O
	
an	O
entire	B-T081
cp	O
genome	O
comparison	B-T062
study	I-T062
of	O
s	O
.	O
	
mussotii	O
and	O
two	O
other	O
species	O
in	O
gentianaceae	O
was	O
conducted	O
.	O
	
the	O
complete	B-T080
cp	O
genome	O
sequence	O
provides	O
intragenic	O
information	B-T078
for	O
the	O
cp	O
genetic	O
engineering	O
of	O
this	O
medicinal	O
plant	O
.	O
	
meta-analysis	B-T062
of	O
29	O
experiments	B-T062
evaluating	O
the	O
effects	B-T080
of	I-T080
rapamycin	B-T109
on	O
life	O
span	O
in	O
the	O
laboratory	O
mouse	O
rapamycin	B-T109
has	O
favorable	O
effects	B-T080
on	O
aging	O
in	O
mice	O
and	O
may	O
eventually	O
be	O
applied	B-T169
to	O
encourage	O
""""	O
healthy	B-T080
aging	O
""""	O
in	O
humans	O
.	O
	
this	O
study	B-T062
analyzed	B-T062
raw	B-T080
data	B-T078
from	O
29	O
survival	B-T062
studies	I-T062
of	O
rapamycin	B-T109
-	O
and	O
control	O
-	O
treated	B-T169
mice	O
,	O
with	O
the	O
goals	B-T170
of	O
estimating	B-T081
summary	B-T170
statistics	B-T170
and	O
identifying	B-T080
factors	B-T169
associated	B-T080
with	I-T080
effect	B-T081
size	I-T081
heterogeneity	B-T080
.	O
	
meta-analysis	B-T062
demonstrated	B-T080
significant	B-T078
heterogeneity	B-T080
across	O
studies	O
,	O
with	O
hazard	B-T081
ratio	I-T081
hr	B-T081
estimates	B-T081
ranging	B-T081
from	O
0.22	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
0.06	O
to	O
0.92	O
95%	O
ci	B-T081
0.65	O
.	O
	
sex	O
was	O
the	O
major	B-T080
factor	B-T169
accounting	B-T169
for	O
effect	B-T081
size	I-T081
variation	B-T080
,	O
and	O
mortality	B-T081
was	O
decreased	B-T081
more	B-T081
in	O
females	O
hr	B-T081
=	O
0.41	O
95%	O
ci	B-T081
0.35	O
as	O
compared	B-T052
with	O
males	O
hr	B-T081
=	O
0.63	O
95%	O
ci	B-T081
0.55	O
.	O
	
rapamycin	B-T109
effects	B-T080
were	O
also	O
genotype	O
dependent	B-T080
,	O
however	O
,	O
with	O
stronger	B-T080
survivorship	B-T079
increases	B-T169
in	O
hybrid	O
mice	O
14.4	O
95%	O
ci	B-T081
12.5	O
relative	B-T080
to	O
pure	O
inbred	O
strains	O
8.8	O
95%	O
ci	B-T081
6.2	O
.	O
	
number	B-T081
needed	B-T169
to	O
treat	B-T169
was	O
applied	B-T169
as	O
an	O
effect	B-T081
size	I-T081
metric	B-T081
,	O
which	O
consistently	O
identified	B-T080
early	O
senescence	B-T033
as	O
the	O
age	O
of	O
peak	B-T080
treatment	B-T169
benefit	B-T081
.	O
	
these	O
results	B-T169
provide	B-T052
synthesis	B-T052
of	O
existing	O
data	B-T078
to	O
support	O
the	O
potential	O
translation	B-T062
of	O
findings	B-T033
from	O
mouse	O
to	O
primate	O
species	O
.	O
	
because	O
rapamycin's	B-T109
effect	B-T080
on	O
survival	B-T052
depends	B-T080
on	O
sex	O
and	O
genotype	O
,	O
further	O
work	O
is	O
justified	O
to	O
understand	O
how	O
these	O
factors	B-T169
shape	O
treatment	B-T169
response	O
.	O
	
transfusion	O
medicine	O
in	O
medical	O
education	O
an	O
analysis	B-T062
of	O
curricular	O
grids	O
in	O
brazil	O
and	O
a	O
review	B-T078
of	O
the	O
current	B-T170
literature	I-T170
blood	B-T061
transfusions	I-T061
are	O
one	O
of	O
the	O
most	O
performed	O
medical	O
procedures	O
in	O
the	O
world	B-T098
.	O
	
thus	O
,	O
as	O
education	O
in	O
transfusion	O
medicine	O
is	O
vital	B-T080
to	O
medical	B-T033
care	I-T033
,	O
it	O
should	O
aim	O
to	O
promote	B-T052
a	O
responsible	O
practice	O
with	O
the	O
rational	O
use	O
of	O
blood	O
by	O
doctors	O
.	O
	
this	O
study	O
aims	O
to	O
investigate	B-T169
the	O
situation	O
of	O
the	O
teaching	O
of	O
transfusion	O
medicine	O
in	O
medical	O
schools	O
in	O
brazil	O
.	O
	
the	O
websites	B-T170
of	O
the	O
249	O
brazilian	B-T098
medical	O
schools	O
in	O
operation	B-T052
in	O
june	O
2015	O
were	O
visited	O
and	O
the	O
curricula	B-T170
of	O
the	O
medical	O
courses	O
were	O
investigated	B-T169
in	O
respect	O
to	O
the	O
presence	O
or	O
absence	O
of	O
a	O
transfusion	O
medicine	O
discipline	O
.	O
	
when	O
available	O
,	O
the	O
subject	O
grids	O
were	O
analyzed	B-T062
to	O
verify	O
whether	O
a	O
description	B-T170
of	I-T170
content	I-T170
regarding	O
transfusion	O
medicine	O
was	O
given	O
within	O
other	O
disciplines	O
.	O
	
of	O
the	O
249	O
medical	O
school	O
sites	O
visited	O
,	O
information	B-T078
on	O
the	O
curriculum	B-T170
was	O
obtained	O
from	O
178	O
.	O
	
of	O
the	O
medical	O
schools	O
that	O
published	O
their	O
curriculum	B-T170
,	O
132	O
74.1	O
did	O
not	O
have	O
disciplines	O
of	O
transfusion	O
medicine	O
or	O
hematology	O
and	O
only	O
seven	O
3.9	O
had	O
a	O
discipline	O
of	O
transfusion	O
medicine	O
in	O
the	O
curricular	O
grid	O
.	O
	
education	O
on	O
transfusion	O
medicine	O
is	O
of	O
fundamental	B-T080
importance	I-T080
for	O
safe	B-T061
and	I-T061
efficient	I-T061
transfusion	I-T061
practices	I-T061
.	O
	
deficiencies	B-T169
in	O
medical	B-T169
knowledge	B-T170
of	O
this	O
subject	O
have	O
been	O
found	O
worldwide	O
.	O
	
the	O
results	O
of	O
this	O
study	O
indicate	O
a	O
possible	O
deficiency	B-T169
in	O
teaching	O
the	O
basics	B-T169
of	O
this	O
specialty	O
.	O
	
thus	O
,	O
additional	O
prospective	B-T062
studies	I-T062
to	O
assess	O
the	O
knowledge	B-T170
and	O
practice	O
of	O
transfusion	O
medicine	O
in	O
brazilian	B-T098
medical	O
schools	O
are	O
warranted	O
,	O
which	O
could	O
prompt	O
a	O
discussion	O
on	O
the	O
importance	B-T080
of	O
offering	O
training	O
in	O
transfusion	O
medicine	O
to	O
medical	O
students	O
.	O
	
advanced	B-T080
interlocking	O
systems	O
to	O
improve	B-T033
heavy	B-T080
-	O
load-bearing	O
characteristics	B-T080
of	O
flexible	B-T080
intramedullary	B-T061
nailing	I-T061
flexible	B-T080
intramedullary	B-T061
nailing	I-T061
fin	B-T061
is	O
a	O
minimally	B-T061
invasive	I-T061
and	O
widespread	B-T082
standard	B-T080
method	B-T061
for	O
osteosynthesis	B-T061
of	O
pediatric	B-T080
long	B-T033
bone	I-T033
fractures	I-T033
.	O
	
in	O
the	O
case	O
of	O
unstable	O
fractures	O
of	O
the	O
lower	O
extremity	O
,	O
interlocking	O
systems	O
need	O
to	O
be	O
used	O
to	O
prevent	O
axial	B-T082
shortening	B-T061
and	O
subsequent	B-T079
perforation	O
of	O
the	O
nail	O
at	O
its	O
insertion	B-T082
site	I-T082
.	O
	
in	O
the	O
present	O
study	B-T062
,	O
four	O
different	O
screw	O
-fixed	O
interlocking	O
systems	O
for	O
fins	B-T061
hofer	O
twinplug	O
with	O
two	O
3-mm	O
titanium	O
interlocking	O
screws	O
,	O
hofer	O
fixplug	O
with	O
3-mm	O
titanium	O
interlocking	O
screw	O
,	O
hofer	O
plug	O
with	O
3.5	O
titanium	O
interlocking	O
screw	O
,	O
and	O
hofer	O
plug	O
with	O
3-mm	O
titanium	O
interlocking	O
screw	O
in	O
comparison	B-T052
with	O
the	O
commonly	O
used	O
ender	O
stainless	O
steel	O
nails	O
locked	O
with	O
3.5	O
screw	O
were	O
experimentally	B-T169
investigated	I-T169
in	O
cadaveric	O
lamb	O
tibiae	O
,	O
regarding	O
their	O
load	B-T052
characteristics	B-T080
and	O
failure	O
modes	B-T169
in	O
the	O
case	O
of	O
heavy	B-T080
loading	B-T052
.	O
	
the	O
specimens	O
were	O
subjected	O
to	O
sequential	B-T080
axial	B-T082
cyclic	B-T079
loading	B-T052
of	O
5000	O
cycles	B-T079
with	O
stepwise	B-T169
increase	I-T169
of	O
the	O
load	B-T052
amplitude	B-T082
until	O
failure	O
.	O
	
migration	O
of	O
locking	O
screws	O
and	O
internal	B-T082
damage	O
of	O
bone	O
tissue	O
was	O
quantified	O
by	O
micro-computed	O
tomography	O
ct	O
imaging	O
.	O
	
ender	O
nails	O
failed	B-T169
on	O
average	B-T081
at	O
a	O
peak	B-T080
load	B-T052
of	O
800	O
n	O
,	O
twinplugs	O
at	O
1367	O
n	O
,	O
fixplugs	O
at	O
1222	O
n	O
,	O
plugs	O
3.5mm	O
at	O
1225	O
n	O
and	O
plugs	O
3.0mm	O
at	O
971	O
n	O
.	O
	
twinplugs	O
,	O
fixplugs	O
,	O
and	O
plugs	O
3.5mm	O
failed	B-T169
in	O
a	O
slow	O
manner	O
over	O
several	O
hundred	O
loading	B-T052
cycles	B-T079
,	O
whereas	O
ender	O
nails	O
and	O
plugs	O
3.0mm	O
exhibited	O
abrupt	B-T080
failure	O
without	O
any	O
prior	B-T079
indication	B-T078
.	O
	
our	O
results	O
confirm	O
that	O
axial	B-T082
stability	B-T080
of	O
fin	B-T061
can	O
be	O
further	O
improved	B-T033
by	O
screw	O
-fixed	O
plugs	O
by	O
simultaneously	B-T079
avoiding	O
shortcomings	O
of	O
an	O
eye-locked	O
system	O
,	O
which	O
the	O
ender	O
nails	O
are	O
.	O
	
considering	O
biomechanical	O
results	B-T033
,	O
plug	O
interlocking	O
systems	O
with	O
3.5	O
screws	O
should	O
be	O
favored	O
over	O
conventional	B-T080
ender	O
nails	O
and	O
plugs	O
with	O
3-mm	O
surgical	B-T061
guidance	B-T061
via	O
multiplexed	O
molecular	O
imaging	O
of	O
fresh	O
tissues	O
labeled	O
with	O
sers	O
-coded	O
nanoparticles	O
the	O
imaging	O
of	O
dysregulated	O
cell-surface	B-T116
receptors	I-T116
or	O
biomarkers	O
is	O
a	O
potential	O
means	O
of	O
identifying	O
the	O
presence	B-T033
of	O
cancer	O
with	O
high	O
sensitivity	B-T169
and	O
specificity	B-T081
.	O
	
however	O
,	O
due	O
to	O
heterogeneities	B-T080
in	O
the	O
expression	O
of	O
protein	O
biomarkers	O
in	O
tumors	O
,	O
molecular	O
imaging	O
technologies	O
should	O
ideally	O
be	O
capable	O
of	O
visualizing	O
a	O
multiplexed	O
panel	O
of	O
cancer	O
biomarkers	O
.	O
	
recently	O
,	O
surface-enhanced	O
raman-scattering	O
sers	O
nanoparticles	O
nps	O
have	O
attracted	O
wide	O
interest	O
due	O
to	O
their	O
potential	O
for	O
sensitive	B-T169
and	O
multiplexed	O
biomarker	O
detection	B-T061
.	O
	
in	O
this	O
review	B-T170
,	O
we	O
focus	O
on	O
the	O
most	O
recent	O
advances	O
in	O
tumor	O
imaging	O
using	O
sers	O
-coded	O
nps	O
.	O
	
a	O
brief	O
introduction	O
of	O
the	O
structure	B-T082
and	O
optical	O
properties	O
of	O
sers	O
nps	O
is	O
provided	O
,	O
followed	O
by	O
a	O
detailed	O
discussion	O
of	O
key	O
imaging	O
issues	O
such	O
as	O
the	O
administration	B-T169
of	O
nps	O
in	O
tissue	O
topical	B-T082
versus	O
systemic	B-T169
,	O
the	O
optical	O
configuration	O
and	O
imaging	O
approach	O
of	O
raman	O
imaging	O
systems	O
,	O
spectral	O
demultiplexing	O
methods	O
for	O
quantifying	B-T081
np	O
concentrations	B-T081
,	O
and	O
the	O
disambiguation	B-T080
of	O
specific	B-T080
vs	O
.	O
	
nonspecific	B-T078
sources	O
of	O
contrast	O
through	O
ratiometric	O
imaging	O
of	O
targeted	B-T169
and	O
untargeted	O
control	O
np	O
expression	O
and	O
methylation	O
in	O
posttraumatic	O
stress	O
disorder	O
and	O
resilience	O
evidence	B-T078
of	O
a	O
role	O
for	O
odorant	B-T116
receptors	I-T116
post-traumatic	O
stress	O
disorder	O
ptsd	O
is	O
a	O
common	O
and	O
potentially	B-T080
disabling	B-T047
disorder	I-T047
that	O
develops	O
in	O
1/5	O
to	O
1/3	O
of	O
people	B-T098
exposed	B-T080
to	I-T080
severe	B-T080
trauma	O
.	O
	
twin	B-T170
studies	I-T170
indicate	O
that	O
genetic	B-T169
factors	B-T169
account	O
for	O
at	O
least	O
one	O
third	O
of	O
the	O
variance	B-T080
in	O
the	O
risk	O
for	O
developing	O
ptsd	O
,	O
however	O
,	O
the	O
specific	B-T080
role	O
for	O
genetic	B-T169
factors	B-T169
in	O
the	O
pathogenesis	O
of	O
ptsd	O
is	O
not	O
well	O
understood	O
.	O
	
we	O
studied	O
genome-wide	O
gene	O
expression	O
and	O
dna	O
methylation	O
profiles	B-T081
in	O
12	O
participants	B-T098
with	O
ptsd	O
and	O
12	O
participants	B-T098
who	O
were	O
resilient	O
to	O
similar	O
severity	B-T080
trauma	O
exposure	B-T080
.	O
	
close	O
to	O
4000	O
genes	O
were	O
differentially	B-T080
expressed	O
with	O
adjusted	B-T169
p<0	O
,	O
fold-change	B-T081
>2	O
,	O
with	O
all	O
but	O
3	O
upregulated	O
with	O
ptsd	O
.	O
	
eight	O
odorant/olfactory	B-T116
receptor	I-T116
related	O
genes	O
were	O
up-regulated	O
with	O
ptsd	O
as	O
well	O
as	O
genes	O
related	O
to	O
immune	O
activation	O
,	O
the	O
gamma-aminobutyric	B-T116
acid	I-T116
a	I-T116
gabaa	I-T116
receptor	I-T116
,	O
and	O
vitamin	O
d	O
synthesis	O
.	O
	
no	O
differences	O
with	O
adjusted	B-T169
significance	B-T078
for	O
dna	O
methylation	O
were	O
found	O
.	O
	
we	O
conclude	O
that	O
increased	B-T081
gene	O
expression	O
may	O
play	O
an	O
important	B-T080
role	O
in	O
ptsd	O
and	O
this	O
expression	O
may	O
not	O
be	O
a	O
consequence	B-T169
of	I-T169
dna	O
methylation	O
.	O
	
the	O
role	O
of	O
odorant	B-T116
receptor	I-T116
expression	O
warrants	O
independent	B-T169
replication	O
.	O
	
absorption	B-T169
characteristics	I-T169
of	O
vertebrate	O
non	B-T169
-	O
visual	B-T169
opsin	B-T116
,	O
opn3	I-T116
most	O
animals	O
possess	B-T078
multiple	B-T081
opsins	B-T116
which	O
sense	O
light	O
for	O
visual	B-T169
and	O
non	B-T169
-	O
visual	O
functions	O
.	O
	
here	O
,	O
we	O
show	O
spectral	B-T081
characteristics	B-T080
of	O
non	B-T169
-	O
visual	B-T169
opsins	B-T116
,	O
vertebrate	O
opn3s	B-T116
,	O
which	O
are	O
widely	O
distributed	B-T169
among	O
vertebrates	O
.	O
	
we	O
successfully	B-T080
expressed	O
zebrafish	O
opn3	B-T116
in	O
mammalian	O
cultured	O
cells	O
and	O
measured	B-T080
its	O
absorption	O
spectrum	O
spectroscopically	O
.	O
	
when	O
incubated	O
with	O
11-cis	B-T109
retinal	I-T109
,	O
zebrafish	O
opn3	B-T116
formed	O
a	O
blue-sensitive	B-T109
photopigment	I-T109
with	O
an	O
absorption	O
maximum	B-T081
around	O
465	O
nm	O
.	O
	
the	O
opn3	B-T116
converts	B-T169
to	O
an	O
all-trans	B-T109
retinal-bearing	I-T109
photoproduct	O
with	O
an	O
absorption	O
spectrum	O
similar	B-T080
to	O
the	O
dark	O
state	O
following	O
brief	B-T079
blue-light	O
irradiation	O
.	O
	
the	O
photoproduct	O
experienced	O
a	O
remarkable	O
blue-shift	B-T081
,	O
with	O
changes	O
in	B-T082
position	I-T082
of	O
the	O
isosbestic	B-T081
point	I-T081
,	O
during	O
further	O
irradiation	O
.	O
	
we	O
then	O
used	O
a	O
camp	O
-	O
dependent	B-T169
luciferase	B-T116
reporter	O
assay	O
to	O
investigate	B-T169
light	O
-	O
dependent	B-T169
camp	O
responses	O
in	O
cultured	O
cells	O
expressing	O
zebrafish	O
,	O
pufferfish	O
,	O
anole	O
and	O
chicken	O
opn3	B-T116
.	O
	
the	O
wild	O
type	O
opsins	B-T116
did	O
not	O
produce	O
responses	O
,	O
but	O
cells	O
expressing	O
chimera	O
mutants	B-T116
wt	B-T116
opn3s	I-T116
in	O
which	O
the	O
third	B-T082
intracellular	I-T082
loops	O
were	O
replaced	B-T169
with	O
the	O
third	B-T082
intracellular	I-T082
loop	O
of	O
a	O
gs-coupled	B-T116
jellyfish	O
opsin	B-T116
displayed	B-T169
light	O
-	O
dependent	B-T169
changes	B-T081
in	O
camp	O
.	O
	
the	O
results	O
suggest	O
that	O
opn3	B-T116
is	O
capable	O
of	O
activating	O
g	B-T116
protein	I-T116
in	O
a	O
light	O
-	O
dependent	B-T169
manner	O
.	O
	
finally	O
,	O
we	O
used	O
this	O
assay	O
to	O
measure	B-T081
the	O
relative	B-T080
wavelength	B-T081
-	O
dependent	B-T169
response	O
of	O
cells	O
expressing	O
opn3	B-T116
chimeras	O
to	O
multiple	B-T081
quantally	B-T170
-	O
matched	B-T080
stimuli	O
.	O
	
the	O
inferred	B-T078
spectral	O
sensitivity	O
curve	B-T082
of	O
zebrafish	O
opn3	B-T116
accurately	B-T080
matched	B-T080
the	O
measured	B-T080
absorption	O
spectrum	O
.	O
	
we	O
were	O
unable	O
to	O
estimate	O
the	O
spectral	O
sensitivity	O
curve	B-T082
of	O
mouse	O
or	O
anole	O
opn3	B-T116
,	O
but	O
,	O
like	O
zebrafish	O
opn3	B-T116
,	O
the	O
chicken	O
and	O
pufferfish	O
opn3-jil3	B-T116
chimeras	O
also	O
formed	O
blue-sensitive	B-T116
pigments	I-T116
.	O
	
these	O
findings	O
suggest	O
that	O
vertebrate	O
opn3s	B-T116
may	O
form	O
blue-sensitive	B-T116
g	I-T116
protein-coupled	I-T116
pigments	I-T116
.	O
	
further	O
,	O
we	O
suggest	O
that	O
the	O
method	O
described	O
here	O
,	O
combining	O
a	O
camp	O
-	O
dependent	B-T169
luciferase	B-T116
reporter	O
assay	O
with	O
chimeric	O
opsins	B-T116
possessing	O
the	O
third	B-T082
intracellular	I-T082
loop	O
of	O
jellyfish	O
opsin	B-T116
,	O
is	O
a	O
versatile	O
approach	O
for	O
estimating	B-T081
absorption	O
spectra	O
of	O
opsins	B-T116
with	O
unknown	O
signaling	O
cascades	O
or	O
for	O
which	O
absorption	O
spectra	O
are	O
difficult	B-T080
effectiveness	B-T080
of	O
offloading	B-T061
methods	B-T061
in	O
preventing	B-T061
primary	B-T080
diabetic	B-T047
foot	I-T047
ulcers	I-T047
in	O
adults	O
with	O
diabetes	B-T047
a	O
systematic	B-T170
review	I-T170
the	O
incidence	B-T081
of	O
foot	B-T047
ulceration	I-T047
related	O
to	O
diabetes	B-T047
is	O
increasing	B-T169
.	O
	
many	O
foot	B-T061
care	I-T061
professionals	O
recommend	O
offloading	B-T061
measures	O
as	O
part	O
of	O
management	O
strategies	O
for	O
modulating	O
excess	B-T080
pressure	B-T081
to	O
prevent	B-T061
development	O
of	O
diabetic	B-T047
foot	I-T047
ulcers	I-T047
dfus	B-T047
.	O
	
these	O
measures	B-T081
may	O
include	O
padding	B-T061
,	O
insoles	O
/	O
orthotic	O
devices	O
and	O
footwear	O
.	O
	
there	O
is	O
a	O
lack	O
of	O
evidence	B-T078
-based	O
guidance	O
on	O
the	O
effectiveness	B-T080
of	O
the	O
different	O
offloading	B-T061
options	O
for	O
preventing	B-T061
primary	B-T080
ulceration	B-T047
in	O
those	O
with	O
diabetes	B-T047
.	O
	
to	O
identify	O
,	O
critically	O
appraise	O
and	O
synthesize	O
the	O
best	O
available	O
evidence	B-T078
on	O
methods	B-T061
of	O
offloading	B-T061
to	O
prevent	B-T061
the	O
development	B-T169
,	O
and	O
reduce	B-T080
the	O
risk	B-T078
,	O
of	O
primary	B-T080
foot	B-T047
ulceration	I-T047
in	O
adults	O
with	O
diabetes	B-T047
the	O
question	B-T078
addressed	B-T170
by	O
the	O
review	B-T170
was	O
what	O
is	O
the	O
effectiveness	B-T080
of	O
methods	B-T061
of	O
offloading	B-T061
in	O
preventing	B-T061
primary	B-T080
dfus	B-T047
in	O
adults	O
with	O
diabetes	B-T047
adults	O
18	O
years	B-T079
and	O
older	O
with	O
diabetes	B-T047
mellitus	I-T047
,	O
regardless	O
of	O
age	O
,	O
gender	O
,	O
ethnicity	B-T080
,	O
duration	B-T079
or	O
type	B-T080
of	O
diabetes	B-T047
,	O
with	O
no	O
history	B-T033
of	O
dfus	B-T047
and	O
in	O
any	O
clinical	B-T082
setting	I-T082
will	O
be	O
included	O
.	O
	
interventions	B-T061
will	O
include	O
all	O
external	O
methods	B-T061
of	O
offloading	B-T061
.	O
	
all	O
comparators	O
will	O
be	O
considered	O
.	O
	
studies	B-T062
that	O
utilize	O
interventions	B-T061
not	O
considered	O
usual	B-T080
practice	B-T061
in	O
the	O
prevention	B-T061
of	O
dfus	B-T047
will	O
be	O
excluded	B-T078
.	O
	
the	O
primary	B-T080
outcome	B-T169
will	O
be	O
primary	B-T080
foot	B-T047
ulceration	I-T047
.	O
	
the	O
secondary	B-T081
outcome	B-T169
will	O
be	O
indications	O
of	O
changes	O
in	O
plantar	O
pressure	B-T081
.	O
	
this	O
review	B-T170
will	O
consider	O
all	O
quantitative	B-T081
study	B-T062
designs	I-T062
.	O
	
a	O
three-step	O
strategy	O
for	O
published	O
and	O
unpublished	O
literature	B-T170
will	O
be	O
used	O
.	O
	
fourteen	O
databases	B-T170
will	O
be	O
searched	O
for	O
studies	B-T062
in	O
english	O
up	O
to	O
november	O
2013	O
.	O
	
the	O
jbi-mastari	B-T170
extraction	I-T170
tool	I-T170
was	O
used	O
to	O
extract	O
relevant	O
data	B-T078
.	O
	
results	B-T169
were	O
summarized	B-T170
using	O
narrative	O
and	O
tables	B-T170
.	O
	
three	O
studies	B-T062
which	O
examined	O
the	O
effectiveness	B-T080
of	O
four	O
different	O
offloading	B-T061
interventions	B-T061
met	O
the	O
inclusion	B-T080
criteria	I-T080
.	O
	
there	O
is	O
limited	O
evidence	B-T078
that	O
use	O
of	O
a	O
footwear	O
system	O
prototype	O
shoe	O
plus	O
polyurethane	O
or	O
cork	O
insole	O
may	O
prevent	B-T061
a	O
break	O
in	O
the	O
skin	O
use	O
of	O
customized	O
rigid	O
orthotic	O
devices	O
may	O
contribute	O
to	O
a	O
reduction	B-T080
in	O
the	O
grade	B-T080
and	O
number	B-T081
of	O
calluses	O
and	O
a	O
manufactured	O
shoe	O
plus	O
customized	O
insole	O
may	O
reduce	O
plantar	O
pressure	B-T081
and	O
therefore	O
reduce	O
the	O
potential	O
risk	B-T078
of	O
skin	B-T047
ulceration	I-T047
.	O
	
there	O
is	O
limited	O
and	O
low-quality	O
evidence	B-T078
that	O
in	O
a	O
population	B-T098
of	O
adults	O
with	O
diabetes	B-T047
with	O
no	O
history	B-T033
of	O
dfu	B-T047
,	O
the	O
use	O
of	O
footwear	O
with	O
customized	O
or	O
prefabricated	O
orthotic	O
devices	O
may	O
provide	O
some	O
reduction	O
in	O
plantar	O
pressure	B-T081
and	O
therefore	O
help	O
to	O
prevent	B-T061
a	O
primary	B-T080
dfu	B-T047
.	O
	
there	O
is	O
a	O
lack	O
of	O
evidence	B-T078
on	O
the	O
relative	O
effectiveness	B-T080
of	O
different	O
offloading	B-T061
punch	O
injury	O
self-harm	O
in	O
young	O
people	O
punch	O
injuries	O
are	O
a	O
form	B-T080
of	O
self-harm	O
characterised	B-T052
by	O
the	O
intentional	B-T080
act	B-T052
of	I-T052
striking	I-T052
an	O
object	O
with	O
a	O
closed	B-T169
fist	O
.	O
	
we	O
aimed	B-T078
to	O
describe	O
the	O
characteristics	B-T080
and	O
trends	B-T079
in	O
young	O
people	O
presenting	B-T078
with	O
injuries	O
sustained	B-T169
via	O
the	O
punch	O
mechanism	B-T169
.	O
	
a	O
comprehensive	B-T080
retrospective	B-T062
review	I-T062
of	O
medical	B-T170
records	I-T170
was	O
completed	B-T080
of	O
all	O
young	O
people	O
aged	O
10-18	O
years	B-T079
presenting	B-T078
to	O
our	O
central	O
london	O
emergency	O
department	O
over	O
a	O
12-month	B-T079
period	I-T079
.	O
	
a	O
subset	O
of	O
the	O
total	O
group	O
was	O
identified	B-T080
as	O
the	O
punch	O
injury	O
subgroup	O
.	O
	
a	O
total	O
of	O
78	O
punch	O
injury	O
presentations	B-T078
were	O
identified	B-T080
.	O
	
in	O
this	O
subgroup	O
,	O
the	O
male	O
female	O
ratio	B-T081
is	O
4.57	O
37.18	O
of	O
presentations	B-T078
were	O
associated	B-T080
with	I-T080
a	O
fracture	O
n	O
=	O
29	O
and	O
35.90	O
n	O
=	O
28	O
of	O
patients	O
re-presented	B-T078
following	O
another	O
punch	O
injury	O
,	O
as	O
a	O
victim	B-T033
of	I-T033
violence	I-T033
,	O
or	O
by	O
other	O
psychiatric	B-T169
presentation	B-T078
.	O
	
in	O
conclusion	B-T078
,	O
a	O
male	B-T033
preponderance	I-T033
was	O
observed	B-T169
,	O
with	O
frequent	B-T079
re-presentations	B-T078
,	O
often	O
in	O
high-risk	B-T033
circumstances	B-T169
.	O
	
an	O
opportunity	O
for	O
screening	O
,	O
including	O
mental	O
health	O
,	O
social	B-T169
and	O
substance	B-T033
misuse	I-T033
,	O
was	O
identified	B-T080
.	O
	
further	O
research	B-T062
is	O
needed	B-T080
to	O
enable	O
targeted	B-T169
effective	B-T080
interventions	O
in	O
this	O
delayed	B-T079
recognition	O
of	O
deterioration	B-T033
of	O
patients	O
in	O
general	O
wards	O
is	O
mostly	O
caused	O
by	O
human	O
related	O
monitoring	O
failures	B-T169
a	O
root	B-T080
cause	I-T080
analysis	I-T080
of	O
unplanned	O
icu	O
admissions	O
an	O
unplanned	O
icu	O
admission	O
of	O
an	O
inpatient	O
is	O
a	O
serious	B-T033
adverse	I-T033
event	I-T033
sae	B-T033
.	O
	
so	O
far	O
,	O
no	O
in	O
depth-study	O
has	O
been	O
performed	O
to	O
systematically	O
analyse	O
the	O
root	B-T080
causes	I-T080
of	O
unplanned	O
icu-admissions	O
.	O
	
the	O
primary	O
aim	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
healthcare	O
worker	O
-	O
,	O
organisational	B-T080
-	O
,	O
technical	O
-	O
disease	B-T047
-	O
and	O
patient	O
-	O
related	O
causes	O
that	O
contribute	O
to	O
acute	O
unplanned	O
icu	O
admissions	O
from	O
general	O
wards	O
using	O
a	O
root-cause	B-T080
analysis	I-T080
tool	I-T080
called	O
prisma-medical	O
.	O
	
although	O
a	O
track	O
and	O
trigger	O
system	O
mews	O
was	O
introduced	O
in	O
our	O
hospital	O
a	O
few	O
years	O
ago	O
,	O
it	O
was	O
implemented	O
without	O
a	O
clear	O
protocol	B-T061
.	O
	
therefore	O
,	O
the	O
secondary	O
aim	O
was	O
to	O
assess	O
the	O
adherence	O
to	O
a	O
track	O
and	O
trigger	O
system	O
to	O
identify	O
deterioration	B-T033
on	O
general	O
hospital	O
wards	O
in	O
patients	O
eventually	O
transferred	O
to	O
the	O
icu	O
.	O
	
retrospective	B-T062
observational	I-T062
study	I-T062
in	O
49	O
consecutive	O
adult	O
patients	O
acutely	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
from	O
a	O
general	O
nursing	O
ward	O
.	O
	
1	O
.	O
	
prisma-analysis	B-T062
on	O
root	B-T080
causes	I-T080
of	O
unplanned	O
icu	O
admissions	O
2	O
.	O
	
assessment	O
of	O
protocol	B-T061
adherence	O
to	O
the	O
early	B-T033
warning	I-T033
score	I-T033
system	I-T033
.	O
	
out	O
of	O
49	O
cases	O
,	O
156	O
root	B-T080
causes	I-T080
were	O
identified	O
.	O
	
the	O
most	O
frequent	O
root	B-T080
causes	I-T080
were	O
healthcare	O
worker	O
related	O
46%	O
,	O
which	O
were	O
mainly	O
failures	B-T169
in	O
monitoring	O
the	O
patient	O
.	O
	
they	O
were	O
followed	O
by	O
disease	B-T047
-related	O
45%	O
,	O
patient	O
-related	O
causes	O
7	O
,	O
5%	O
,	O
and	O
organisational	B-T080
root	B-T080
causes	I-T080
3%	O
.	O
	
in	O
only	O
40%	O
of	O
the	O
patients	O
vital	O
parameters	O
were	O
monitored	O
as	O
was	O
instructed	O
by	O
the	O
doctor	O
.	O
	
477	O
vital	O
parameter	O
sets	O
were	O
found	O
in	O
the	O
48	O
hours	O
before	O
icu	O
admission	O
,	O
in	O
only	O
1%	O
a	O
correct	O
mews	O
was	O
explicitly	O
documented	O
in	O
the	O
record	O
.	O
	
this	O
in-depth	B-T062
analysis	I-T062
demonstrates	O
that	O
almost	O
half	O
of	O
the	O
unplanned	O
icu	O
admissions	O
from	O
the	O
general	O
ward	O
had	O
healthcare	O
worker	O
related	O
root	B-T080
causes	I-T080
,	O
mostly	O
due	O
to	O
monitoring	O
failures	B-T169
in	O
clinically	B-T033
deteriorating	I-T033
patients	O
.	O
	
in	O
order	O
to	O
reduce	O
unplanned	O
icu	O
admissions	O
,	O
improving	O
the	O
monitoring	O
of	O
patients	O
effects	O
of	O
a	O
novel	O
phosphodiesterase	O
10a	O
inhibitor	O
in	O
non-human	O
primates	O
a	O
therapeutic	B-T169
approach	I-T169
for	O
schizophrenia	O
with	O
improved	O
side	O
effect	O
profile	O
schizophrenia	O
symptoms	O
are	O
associated	B-T080
with	I-T080
alterations	B-T047
in	I-T047
basal	I-T047
ganglia-cortical	I-T047
networks	I-T047
that	O
include	O
the	O
cyclic	O
nucleotides	O
camp	O
/	O
cgmp	O
signaling	O
pathways	O
.	O
	
phosphodiesterase	O
10a	O
pde10a	O
inhibitors	O
have	O
been	O
considered	O
as	O
therapeutic	O
agents	O
for	O
schizophrenia	O
because	O
the	O
regulation	O
of	O
camp	O
and	O
cgmp	O
in	O
the	O
striatum	O
by	O
pde10a	B-T116
plays	O
an	O
important	O
role	O
in	O
the	O
signaling	O
mechanisms	O
of	O
the	O
striatal-cortical	O
network	O
,	O
and	O
thereby	O
in	O
cognitive	O
function	O
.	O
	
in	O
the	O
present	O
study	O
we	O
assessed	O
in	O
non-human	O
primates	O
nhps	O
the	O
effects	O
of	O
a	O
novel	O
pde10a	O
inhibitor	O
frm-6308	O
that	O
has	O
demonstrated	O
high	O
potency	O
and	O
selectivity	O
for	O
human	B-T116
recombinant	I-T116
pde10a	I-T116
in	B-T062
vitro	I-T062
.	O
	
the	O
behavioral	B-T033
effects	I-T033
of	O
frm-6308	O
in	O
a	O
dose	B-T081
range	I-T081
were	O
determined	O
in	O
rhesus	O
monkeys	O
using	O
a	O
standardized	B-T033
motor	I-T033
disability	I-T033
scale	I-T033
for	O
primates	O
,	O
motor	B-T061
tasks	I-T061
,	O
and	O
the	O
""""	O
drug	O
effects	O
on	O
the	O
nervous	O
"system"""	O
dens	O
scale	O
.	O
	
the	O
neuronal	O
metabolic	O
effects	O
of	O
frm-6308	O
were	O
determined	O
with	O
18	O
pet	O
imaging	O
.	O
	
results	O
showed	O
that	O
frm-6308	O
did	O
not	O
have	O
any	O
specific	O
effects	O
on	O
the	O
motor	O
system	O
at	O
s.c	B-T169
.	O
	
doses	I-T169
up	O
to	O
0.32	O
mg/kg	O
in	O
nhps	O
,	O
which	O
induced	O
a	O
significant	O
increase	O
in	O
the	O
fdg	B-T109
-	O
suv	B-T081
in	O
striatum	O
f	O
16.069	O
,	O
p	O
<	O
0.05	O
and	O
cortical	O
f	O
15.181	O
,	O
p	O
<	O
0.05	O
regions	O
.	O
	
higher	B-T081
doses	I-T081
induced	O
sedation	B-T033
and	O
occasional	O
involuntary	O
movements	O
with	O
clear	O
development	O
of	O
tolerance	B-T033
after	I-T033
repeated	I-T033
exposures	I-T033
.	O
	
these	O
findings	O
suggest	O
that	O
frm-6308	O
has	O
the	O
adequate	B-T061
pharmacological	I-T061
profile	I-T061
to	O
advance	O
testing	O
in	O
clinical	B-T062
trials	I-T062
and	O
demonstrate	O
antipsychotic	O
efficacy	O
of	O
pde10a	B-T116
inhibition	B-T052
for	O
the	O
treatment	B-T169
of	O
schizophrenia	O
patients	O
.	O
	
agglomeration	B-T081
of	O
luminescent	O
porous	B-T082
silicon	O
nanoparticles	O
in	O
colloidal	O
solutions	O
we	O
have	O
prepared	B-T033
colloidal	O
solutions	O
of	O
clusters	B-T081
composed	O
from	O
porous	B-T082
silicon	O
nanoparticles	O
in	O
methanol	B-T109
,	O
water	O
and	O
phosphate-buffered	O
saline	O
pbs	O
.	O
	
even	O
if	O
the	O
size	B-T082
of	O
the	O
nanoclusters	B-T081
is	O
between	O
60	O
and	O
500	O
nm	O
,	O
due	O
to	O
their	O
highly	B-T080
porous	B-T082
"""cauliflower""-like"	B-T082
structure	I-T082
,	O
the	O
porous	B-T082
silicon	O
nanoparticles	O
are	O
composed	O
of	O
interconnected	B-T082
nanocrystals	O
having	O
around	O
2.5	O
nm	O
in	O
size	B-T082
and	O
showing	O
strong	B-T080
visible	B-T080
luminescence	O
in	O
the	O
orange	B-T080
-	O
red	B-T080
spectral	O
region	B-T082
centred	O
at	O
600-700	O
nm	O
.	O
	
hydrophilic	B-T080
behaviour	I-T080
and	O
good	B-T080
solubility	B-T080
of	O
the	O
nanoclusters	B-T081
in	O
water	O
and	O
water	O
-	O
based	B-T078
solutions	O
were	O
obtained	B-T169
by	O
adding	O
hydrogen	O
peroxide	O
into	O
the	O
etching	O
solution	O
during	O
preparation	B-T052
and	O
16	O
min	O
long	O
after-bath	B-T169
in	O
hydrogen	O
peroxide	O
.	O
	
by	O
simple	B-T080
filtration	O
of	O
the	O
solutions	O
with	O
syringe	O
filters	O
,	O
we	O
have	O
extracted	B-T080
smaller	B-T081
nanoclusters	B-T081
with	O
sizes	B-T082
of	O
approx	B-T080
.	O
	
60-70	O
nm	O
however	O
,	O
these	O
nanoclusters	B-T081
in	O
water	O
and	O
pbs	O
solution	O
ph	B-T080
neutral	I-T080
are	O
prone	B-T169
to	O
agglomeration	B-T081
,	O
as	O
was	O
confirmed	B-T033
by	O
zeta	O
potential	O
measurements	B-T169
.	O
	
when	O
the	O
samples	O
were	O
left	O
at	O
ambient	B-T080
conditions	I-T080
for	O
several	B-T081
weeks	O
,	O
the	O
typical	B-T080
nanocluster	B-T081
size	B-T082
increased	B-T081
to	O
approx	B-T080
.	O
	
330-400	O
nm	O
and	O
then	O
remained	O
stable	B-T080
.	O
	
however	O
,	O
both	O
freshly	B-T080
filtered	O
and	O
aged	B-T079
samples	O
with	O
agglomerated	B-T081
porous	B-T082
silicon	O
nanoparticles	O
of	O
porous	B-T082
silicon	O
in	O
water	O
and	O
pbs	O
solutions	O
can	O
be	O
further	O
used	O
for	O
biological	B-T080
studies	B-T062
or	O
as	O
luminescent	O
markers	O
in	O
living	O
cells	O
.	O
	
development	B-T169
of	O
a	O
liquid	O
chromatography-tandem	O
mass	O
spectrometry	O
method	B-T169
for	O
quantitative	O
analysis	O
of	O
trace	B-T081
d-amino	B-T116
acids	I-T116
d-amino	B-T116
acids	I-T116
have	O
recently	B-T079
attracted	O
much	O
attention	O
in	O
various	O
research	B-T062
fields	I-T062
including	B-T169
medical	B-T169
,	O
clinical	B-T080
and	O
food	O
industry	O
due	O
to	O
their	O
important	B-T080
biological	O
functions	O
that	O
differ	O
from	O
l-amino	B-T116
acid	I-T116
.	O
	
most	O
chiral	O
amino	B-T116
acid	I-T116
separation	O
techniques	B-T169
require	B-T169
complicated	B-T169
derivatization	O
procedures	B-T169
in	O
order	O
to	O
achieve	O
the	O
desirable	B-T080
chromatographic	B-T080
behavior	O
and	O
detectability	B-T033
.	O
	
thus	O
,	O
the	O
aim	B-T078
of	O
this	O
research	B-T062
is	O
to	O
develop	B-T169
a	O
highly	B-T080
sensitive	I-T080
analytical	B-T170
method	I-T170
for	O
the	O
enantioseparation	O
of	O
chiral	O
amino	B-T116
acids	I-T116
without	O
any	O
derivatization	O
process	O
using	O
liquid	O
chromatography-tandem	O
mass	O
spectrometry	O
lc-ms/ms	O
.	O
	
by	O
optimizing	B-T052
ms/ms	O
parameters	O
,	O
we	O
established	B-T080
a	O
quantification	B-T081
method	B-T169
that	O
allowed	O
the	O
simultaneous	B-T079
analysis	B-T062
of	O
18	O
d-amino	B-T116
acids	I-T116
with	O
high	O
sensitivity	O
and	O
reproducibility	B-T080
.	O
	
additionally	O
,	O
we	O
applied	B-T169
the	O
method	B-T169
to	O
food	O
sample	O
vinegar	B-T109
for	O
the	O
validation	B-T062
,	O
and	O
successfully	O
quantified	B-T081
trace	B-T081
levels	I-T081
of	O
d-amino	B-T116
acids	I-T116
in	O
samples	O
.	O
	
these	O
results	O
demonstrated	O
the	O
applicability	B-T080
and	O
feasibility	B-T080
of	O
the	O
lc-ms/ms	O
method	B-T169
as	O
a	O
novel	B-T080
,	O
effective	B-T080
tool	O
for	O
d-amino	B-T116
acid	I-T116
measurement	B-T169
in	O
various	O
biological	O
samples	O
.	O
	
the	O
multi-center	B-T170
evaluation	I-T170
of	I-T170
the	I-T170
accuracy	I-T170
of	I-T170
the	I-T170
contrast	I-T170
medium	I-T170
induced	I-T170
pd/pa	I-T170
ratio	I-T170
in	O
predicting	O
ffr	O
memento	B-T170
-	O
ffr	O
study	B-T062
adenosine	O
administration	B-T061
is	O
needed	O
for	O
the	O
achievement	O
of	O
maximal	B-T080
hyperaemia	B-T047
fractional	O
flow	O
reserve	O
ffr	O
assessment	O
.	O
	
the	O
objective	O
was	O
to	O
test	O
the	O
accuracy	B-T080
of	O
pd	O
/	O
pa	O
ratio	B-T081
registered	O
during	O
submaximal	B-T080
hyperaemia	B-T047
induced	O
by	O
non-ionic	O
contrast	O
medium	O
contrast	O
ffr	O
cffr	O
in	O
predicting	O
ffr	O
and	O
comparing	O
it	O
to	O
the	O
performance	O
of	O
resting	B-T033
pd	O
/	O
pa	O
in	O
a	O
collaborative	B-T062
registry	O
of	O
926	O
patients	O
enrolled	O
in	O
10	O
hospitals	O
from	O
four	B-T081
european	O
countries	O
italy	O
,	O
spain	O
,	O
france	O
and	O
portugal	O
.	O
	
resting	B-T033
pd	O
/	O
pa	O
,	O
cffr	O
and	O
ffr	O
were	O
measured	O
in	O
1	O
coronary	B-T047
stenoses	I-T047
functionally	B-T169
evaluated	O
using	O
commercially	O
available	O
pressure	O
wires	O
.	O
	
cffr	O
was	O
obtained	O
after	O
intracoronary	B-T169
injection	I-T169
of	O
contrast	O
medium	O
,	O
while	O
ffr	O
was	O
measured	O
after	O
administration	B-T061
of	O
adenosine	O
.	O
	
resting	B-T033
pd	O
/	O
pa	O
and	O
cffr	O
were	O
significantly	O
higher	B-T080
than	O
ffr	O
0.93	O
vs	O
.	O
	
0.87	O
vs	O
.	O
	
0.84	O
,	O
p<0	O
.	O
	
a	O
strong	O
correlation	B-T080
and	O
a	O
close	O
agreement	O
at	O
bland-altman	B-T170
analysis	I-T170
between	O
cffr	O
and	O
ffr	O
were	O
observed	O
r=0	O
,	O
p<0	O
and	O
95%	O
ci	B-T081
of	O
disagreement	O
from	O
-0	O
to	O
0.11	O
.	O
	
roc	B-T081
curve	I-T081
analysis	B-T062
showed	O
an	O
excellent	O
accuracy	B-T080
89%	O
of	O
the	O
cffr	O
cut-off	O
of	O
0.85	O
in	O
predicting	O
an	O
ffr	O
value	O
0.80	O
auc	O
0.95	O
95%	O
ci	B-T081
0.94	O
,	O
significantly	O
better	O
than	O
that	O
observed	O
using	O
resting	B-T033
pd	O
/	O
pa	O
auc	O
0.90	O
,	O
95%	O
ci	B-T081
0.88	O
p<0	O
.	O
	
a	O
cffr	O
/	O
ffr	O
hybrid	B-T170
approach	I-T170
showed	O
a	O
significantly	O
lower	B-T080
number	O
of	O
lesions	B-T033
requiring	O
adenosine	O
than	O
a	O
resting	B-T033
pd	O
/	O
pa	O
/	O
ffr	O
hybrid	B-T170
approach	I-T170
22%	O
vs	O
.	O
	
44%	O
,	O
p<0	O
.	O
	
cffr	O
is	O
accurate	B-T080
in	O
predicting	O
the	O
functional	B-T169
significance	O
of	O
coronary	B-T047
stenosis	I-T047
.	O
	
this	O
could	O
allow	O
limiting	O
the	O
use	O
of	O
adenosine	O
to	O
obtain	O
ffr	O
to	O
a	O
minority	O
of	O
stenoses	O
with	O
considerable	O
savings	O
of	O
time	B-T079
and	O
transfemoral	B-T061
aortic	I-T061
valve	I-T061
implantation	I-T061
with	O
the	O
repositionable	O
lotus	O
valve	O
for	O
treatment	B-T061
of	O
patients	O
with	O
symptomatic	B-T169
severe	B-T080
aortic	B-T047
stenosis	I-T047
results	B-T169
from	O
a	O
single-centre	O
experience	O
the	O
aim	O
of	O
the	O
study	B-T062
was	O
to	O
evaluate	O
the	O
procedural	O
and	O
30-	O
day	B-T079
results	B-T169
for	O
the	O
repositionable	O
lotus	O
valve	O
in	O
patients	O
undergoing	O
transfemoral	B-T061
aortic	I-T061
valve	I-T061
implantation	I-T061
in	O
a	O
single-centre	O
experience	O
.	O
	
we	O
prospectively	O
enrolled	O
110	O
patients	O
with	O
severe	B-T080
symptomatic	B-T169
aortic	B-T047
stenosis	I-T047
nct02162069	B-T170
.	O
	
all	O
procedures	B-T169
were	O
performed	O
without	O
general	B-T061
anaesthesia	I-T061
by	O
the	O
transfemoral	B-T061
approach	I-T061
.	O
	
patients	O
were	O
followed	O
for	O
30	O
days	B-T079
.	O
	
patients	O
received	B-T080
the	O
23	O
mm	O
n=20	O
,	O
25	O
mm	O
n=43	O
or	O
27	O
mm	O
n=47	O
lotus	O
device	O
.	O
	
mean	B-T081
oversizing	I-T081
in	O
relation	O
to	O
annulus	O
or	O
left	O
ventricular	O
outflow	O
tract	O
lvot	O
did	O
not	O
differ	O
among	O
groups	B-T078
.	O
	
there	O
was	O
no	O
residual	O
moderate	B-T080
or	O
severe	B-T080
aortic	B-T047
regurgitation	I-T047
.	O
	
the	O
rate	B-T081
of	I-T081
mild	I-T081
aortic	I-T081
regurgitation	I-T081
was	O
low	O
at	O
9.1	O
.	O
	
there	O
was	O
no	O
valve	O
embolisation	O
,	O
no	O
need	O
for	O
a	O
second	O
valve	O
and	O
no	O
conversion	O
to	O
surgery	O
.	O
	
the	O
need	O
for	O
a	O
new	O
pacemaker	O
implantation	O
due	O
to	O
complete	O
third	O
degree	O
or	O
type	O
ii	O
mobitz	O
second	O
degree	O
atrioventricular	O
block	O
was	O
24.1	O
,	O
excluding	O
patients	O
with	O
previously	O
implanted	O
devices	O
.	O
	
within	O
30	O
days	O
the	O
rates	O
of	O
all-cause	O
mortalit	O
y	O
and	O
stroke	O
were	O
low	O
.	O
	
in	O
patients	O
with	O
severe	O
aortic	B-T047
stenosis	O
,	O
transfemoral	O
tavi	O
with	O
the	O
repositionable	O
lotus	O
valve	O
was	O
associated	O
with	O
a	O
high	O
rate	O
of	O
device	O
success	O
,	O
no	O
moderate	O
or	O
severe	O
residual	O
aortic	O
regurgitation	I-T047
,	O
low	O
rates	O
of	O
major	O
vascular	O
complications	O
and	O
mortality	O
within	O
30	O
days	B-T079
a	O
comparison	B-T052
between	O
measured	B-T080
concentration	B-T081
of	O
3h	O
in	O
kalpakkam	O
environment	O
with	O
predicted	O
atmospheric	O
dispersion	O
model	O
the	O
field	B-T082
measurements	B-T169
of	O
3h	O
in	O
the	O
form	O
of	O
hto	O
present	O
in	O
air	O
moisture	O
carried	O
out	O
around	O
madras	O
atomic	O
power	O
station	O
were	O
compared	B-T052
with	O
predicted	O
values	O
using	O
atmospheric	O
dispersion	O
modeling	O
.	O
	
air	O
3h	O
samples	O
were	O
collected	B-T078
from	O
different	O
sectors	O
at	O
the	O
site	B-T082
boundary	O
of	O
the	O
operating	B-T052
reactors	O
for	O
the	O
period	B-T079
of	O
2	O
y	B-T079
and	O
compared	B-T052
with	O
gaussian	O
plume	O
model	O
.	O
	
the	O
predictions	B-T078
were	O
comparable	O
with	O
the	O
measured	B-T080
value	B-T081
.	O
	
the	O
slight	B-T080
variation	B-T080
observed	B-T169
between	O
the	O
two	O
methods	B-T170
is	O
attributed	O
to	O
the	O
uncertainty	B-T033
involved	O
in	O
the	O
measurement	B-T169
of	O
air	O
3h	O
concentration	B-T081
and	O
in	O
the	O
measurement	B-T169
of	O
site-specific	B-T082
meteorological	O
parameters	O
.	O
	
the	O
radiation	B-T081
dose	I-T081
imparted	B-T169
to	O
members	O
of	O
public	O
due	O
to	O
the	O
levels	B-T080
observed	B-T169
is	O
well	O
within	O
station	O
technical	B-T169
specification	I-T169
limit	I-T169
for	O
the	O
four-component	O
aureocin	B-T116
a70	I-T116
as	O
a	O
promising	O
agent	O
for	O
food	O
biopreservation	O
aureocin	B-T116
a70	I-T116
is	O
the	O
only	O
four-component	O
bacteriocin	B-T116
described	O
to	O
date	O
.	O
	
as	O
it	O
inhibits	O
the	O
growth	O
of	O
a	O
wide	O
range	O
of	O
gram-positive	O
bacteria	O
,	O
including	O
listeria	O
monocytogenes	O
strains	O
isolated	O
from	O
food	O
,	O
its	O
potential	O
for	O
improving	O
food	O
safety	O
was	O
investigated	O
in	O
this	O
study	O
.	O
	
aureocin	B-T116
a70	I-T116
10	O
proved	O
to	O
be	O
bactericidal	O
,	O
but	O
not	O
extensively	O
lytic	B-T080
,	O
against	O
listerial	O
strains	O
.	O
	
the	O
antibacterial	B-T052
activity	I-T052
of	O
aureocin	B-T116
a70	I-T116
16au/ml	O
was	O
then	O
tested	O
in	O
uht-treated	B-T061
skimmed	O
milk	O
inoculated	O
with	O
the	O
food	O
-associated	O
l	O
.	O
	
monocytogenes	O
l12	O
strain	O
4-log	O
cfu/ml	O
during	O
storage	B-T169
at	O
4	O
for	O
one	O
week	O
.	O
	
aureocin	B-T116
a70	I-T116
caused	O
a	O
time-dependent	O
reduction	O
in	O
the	O
listerial	O
viable	O
cell	O
counts	O
5.51	O
units	O
up	O
to	O
7days	O
of	O
incubation	O
.	O
	
aureocin	B-T116
a70	I-T116
was	O
neither	O
toxic	B-T080
to	O
the	O
vero	O
and	O
the	O
l-929	O
cell	O
lines	O
nor	O
exhibited	O
a	O
hemolytic	O
activity	O
against	O
sheep	O
red	O
blood	O
cells	O
.	O
	
aureocin	B-T116
a70	I-T116
proved	O
to	O
be	O
completely	O
stable	O
for	O
one	O
month	O
at	O
25	O
,	O
16weeks	O
at	O
4	O
and	O
20weeks	O
at	O
-20	O
.	O
	
aureocin	B-T116
a70	I-T116
exhibited	O
a	O
time-dependent	O
susceptibility	B-T081
to	O
simulated	O
gastric	O
juice	O
and	O
bile	B-T109
salts	I-T109
mimicking	O
gastrointestinal	B-T033
conditions	I-T033
.	O
	
the	O
entrapment	O
of	O
aureocin	B-T116
a70	I-T116
in	O
an	O
alginate	B-T109
/	O
gelatin	B-T116
matrix	I-T116
revealed	O
that	O
this	O
bacteriocin	B-T116
can	O
be	O
released	O
from	O
this	O
matrix	O
.	O
	
moreover	O
,	O
it	O
remained	O
adsorbed	O
to	O
and	O
active	O
on	O
a	O
low-density	B-T109
polyethylene	I-T109
plastic	I-T109
surface	O
suggesting	O
that	O
aureocin	B-T116
a70	I-T116
may	O
be	O
employed	O
in	O
bioactive	O
packaging	B-T052
to	O
control	O
the	O
growth	O
of	O
undesirable	O
bacteria	O
.	O
	
taken	O
together	O
these	O
results	O
suggest	O
that	O
aureocin	B-T116
a70	I-T116
is	O
a	O
promising	O
alternative	O
to	O
be	O
used	O
in	O
food	O
applications	O
.	O
	
folate	B-T109
-	O
conjugated	B-T082
gene	O
-	O
carrying	O
microbubbles	O
with	O
focused	B-T061
ultrasound	I-T061
for	O
concurrent	B-T079
blood-brain	O
barrier	O
opening	B-T082
and	O
local	B-T082
gene	O
delivery	O
previous	B-T079
studies	B-T062
have	O
demonstrated	O
that	O
circulating	B-T169
dna	O
-	O
encapsulated	B-T080
microbubbles	O
mbs	O
combined	B-T080
with	O
focused	B-T061
ultrasound	I-T061
fus	B-T061
can	O
be	O
used	B-T169
for	O
local	B-T082
blood-brain	O
barrier	O
bbb	O
opening	B-T082
and	O
gene	O
delivery	O
.	O
	
however	O
,	O
few	O
studies	B-T062
focused	B-T169
on	O
how	O
to	O
increase	B-T169
the	O
efficiency	B-T081
of	O
gene	O
delivery	O
to	O
brain	O
tumors	O
after	O
the	O
released	B-T169
gene	O
penetrating	B-T169
the	O
bbb	O
.	O
	
here	O
,	O
we	O
proposed	O
the	O
use	B-T169
of	I-T169
folate	B-T109
-	O
conjugated	O
dna	O
-	O
loaded	O
cationic	O
mbs	O
fcmbs	O
.	O
	
when	O
combined	B-T080
with	O
fus	B-T061
as	O
a	O
trigger	B-T080
for	O
bbb	O
opening	O
,	O
fcmbs	O
were	O
converted	O
into	O
nanometer	B-T081
-	O
sized	B-T082
vesicles	O
that	O
were	O
transported	O
to	O
the	O
brain	O
parenchyma	O
.	O
	
the	O
fcmbs	O
can	O
selectively	O
aggregate	B-T080
around	O
tumor	O
cells	O
that	O
overexpressed	O
the	O
folate	B-T116
receptor	I-T116
,	O
thus	O
enhancing	B-T052
gene	O
delivery	O
via	O
folate	B-T116
-	O
stimulated	O
endocytosis	O
.	O
	
our	O
results	B-T169
confirmed	B-T080
that	O
fcmbs	O
can	O
carry	O
dna	O
on	O
the	O
surface	B-T082
of	O
the	O
mb	O
shell	B-T080
and	O
have	O
good	B-T080
targeting	B-T169
ability	B-T081
on	O
c6	O
glioma	O
cells	O
.	O
	
in	O
addition	O
,	O
the	O
optimized	O
fus	B-T061
parameters	O
for	O
fcmbs	O
-	O
enhanced	B-T052
gene	O
delivery	O
were	O
confirmed	B-T080
by	I-T080
cell	O
experiments	B-T062
center	B-T081
frequency	I-T081
=	O
1	O
mhz	O
acoustic	B-T081
pressure	I-T081
=	O
700	O
kpa	O
pulse	O
repetition	B-T169
frequency	B-T081
=	O
5	O
hz	O
cycle	B-T079
number	B-T081
=	O
10000	O
exposure	B-T080
time	B-T079
=	O
1	O
min	O
fcmbs	O
concentration	B-T081
=	O
4	O
10	O
mb/ml	O
.	O
	
in	B-T082
vivo	I-T082
data	B-T078
also	O
indicated	B-T033
that	O
fcmbs	O
show	O
better	B-T080
gene	O
transfection	O
efficiency	B-T081
than	O
mbs	O
without	B-T080
folate	B-T116
conjugation	O
and	O
the	O
traditional	B-T169
approach	B-T082
of	O
directly	B-T080
injecting	B-T061
the	O
gene	O
.	O
	
this	O
study	B-T062
described	O
our	O
novel	B-T080
development	B-T169
of	O
multifunctional	B-T169
mbs	O
for	O
fus	B-T061
-	O
triggered	B-T080
gene	O
delivery	O
/	O
modulation	B-T082
of	O
il-6	B-T116
induced	B-T169
rankl	B-T116
expression	O
in	O
arthritic	B-T047
synovium	O
by	O
a	O
transcription	B-T116
factor	I-T116
sox5	I-T116
receptor	B-T116
activator	I-T116
of	I-T116
nuclear	I-T116
factor	I-T116
κb	I-T116
ligand	I-T116
rankl	B-T116
is	O
critically	B-T080
involved	O
in	O
bone	O
erosion	O
of	O
rheumatoid	B-T047
arthritis	I-T047
ra	B-T047
.	O
	
we	O
previously	B-T079
reported	O
association	O
between	O
younger	O
age	O
at	O
onset	O
of	O
ra	B-T047
and	O
a	O
rankl	B-T116
promoter	O
snp	O
that	O
conferred	O
an	O
elevated	B-T080
promoter	O
activity	O
via	O
binding	B-T052
to	O
a	O
transcription	B-T116
factor	I-T116
sox5	I-T116
.	O
	
here	O
we	O
study	B-T062
the	O
regulation	O
of	O
sox5	B-T116
levels	O
in	O
relation	O
to	O
rankl	B-T116
expression	O
in	O
ra	B-T047
synovial	O
fibroblasts	O
sf	O
and	O
the	O
development	B-T169
of	O
bone	O
erosion	O
in	O
the	O
collagen-induced	O
arthritis	O
cia	O
mouse	O
.	O
	
our	O
data	B-T170
indicated	B-T033
sox5	B-T116
levels	O
were	O
higher	O
in	O
synovium	O
and	O
synovial	O
fluid	O
from	O
ra	B-T047
compared	B-T052
to	O
osteoarthritis	B-T047
patients	O
.	O
	
pro-inflammatory	B-T169
cytokines	B-T116
upregulated	O
sox5	B-T116
and	O
rankl	B-T116
expression	O
in	O
both	O
primary	O
ra	B-T047
sf	O
and	O
the	O
rheumatoid	O
synovial	O
fibroblast	O
cell	O
line	O
,	O
mh7a	O
.	O
	
overexpression	O
of	O
sox5	B-T116
resulted	B-T169
in	O
significantly	B-T081
increased	I-T081
rankl	B-T116
levels	O
,	O
while	O
knockdown	O
of	O
sox5	O
resulted	B-T169
in	O
diminished	B-T081
il-6	B-T116
mediated	O
rankl	B-T116
upregulation	O
in	O
mh7a	O
cells	O
.	O
	
chromatin	O
immunoprecipitation	O
chip	O
showed	O
approximately	B-T080
3-fold	O
enrichment	O
of	O
rankl-specific	O
dna	O
in	O
anti-sox5	O
immunoprecipitate	O
in	O
il-6	B-T116
treated	B-T169
mh7a	O
cells	O
as	O
compared	B-T052
to	O
untreated	B-T033
cells	I-T033
.	O
	
locally	O
silencing	O
sox5	O
gene	O
significantly	B-T081
diminished	I-T081
rankl	B-T116
positive	B-T033
cells	O
and	O
bone	O
erosion	O
in	O
cia	O
mice	O
.	O
	
these	O
findings	B-T033
suggest	B-T078
sox5	B-T116
is	O
an	O
important	O
regulator	O
of	O
il-6	B-T116
-	O
induced	B-T169
rankl	B-T116
expression	O
in	O
ra	B-T047
sf	O
.	O
	
intracameral	B-T082
cefuroxime	B-T109
in	O
the	O
prevention	B-T061
of	O
postoperative	B-T047
endophthalmitis	I-T047
an	O
experience	O
from	O
hong	O
kong	O
the	O
purpose	O
was	O
to	O
study	B-T062
the	O
effect	B-T080
of	O
introducing	B-T169
intracameral	B-T082
cefuroxime	B-T109
,	O
which	O
was	O
compounded	O
by	O
a	O
hospital	O
pharmacy	O
,	O
on	O
postoperative	B-T047
endophthalmitis	I-T047
in	O
a	O
tertiary	O
eye	O
centre	O
in	O
hong	O
kong	O
.	O
	
all	O
cases	O
that	O
underwent	O
cataract	B-T061
surgeries	I-T061
over	O
a	O
12-year	O
period	O
january	O
2004	O
to	O
december	O
2015	O
were	O
included	O
.	O
	
the	O
routine	B-T080
use	B-T169
of	O
intracameral	B-T082
cefuroxime	B-T109
at	O
the	O
end	O
of	O
cataract	B-T061
surgery	I-T061
was	O
introduced	O
at	O
our	O
centre	O
after	O
april	O
2010	O
.	O
	
all	O
cefuroxime	B-T109
aliquots	B-T081
were	O
prepared	O
by	O
the	O
hospital	O
pharmacy	O
using	O
an	O
aseptic	B-T080
compounding	O
technique	O
.	O
	
the	O
rates	O
of	O
postoperative	O
endophthalmitis	O
before	O
april	O
2010	O
group	O
1	O
,	O
no	O
intracameral	O
cefuroxime	O
and	O
after	O
april	O
2010	O
group	O
2	O
,	O
routine	O
use	O
of	O
intracameral	O
cefuroxime	O
were	O
compared	O
.	O
	
a	O
total	O
of	O
30	O
eyes	O
7	O
in	O
group	O
1	O
and	O
23	O
in	O
group	O
2	O
were	O
studied	O
.	O
	
eight	O
cases	O
developed	O
postoperative	O
endophthalmitis	O
1.09	O
in	O
1000	O
0.11	O
%	O
in	O
group	O
1	O
whereas	O
no	O
cases	O
developed	O
endophthalmitis	O
0	O
%	O
in	O
group	O
2	O
.	O
	
the	O
rate	O
of	O
reduction	O
was	O
statistically	O
significant	O
p	O
<	O
0.0001	O
.	O
	
seven	O
out	O
of	O
eight	O
cases	O
of	O
endophthalmitis	O
were	O
confirmed	O
by	O
positive	O
culture	O
.	O
	
organisms	O
identified	O
were	O
group	O
g	O
streptococcus	O
two	O
cases	O
,	O
group	O
b	O
streptococcus	O
,	O
staphylococcus	O
aureus	O
,	O
serratia	O
marcescens	O
,	O
and	O
coagulase-negative	O
staphylococcus	O
two	O
cases	O
.	O
	
antibiotic	O
susceptibility	O
testing	O
results	O
were	O
available	O
in	O
six	O
cases	O
.	O
	
four	O
out	O
of	O
six	O
organisms	O
were	O
susceptible	O
to	O
the	O
penicillin	O
group	O
.	O
	
no	O
adverse	O
events	O
related	O
to	O
the	O
use	O
of	O
intracameral	O
cefuroxime	O
were	O
encountered	O
.	O
	
the	O
use	O
of	O
intracameral	O
cefuroxime	O
could	O
significantly	O
reduce	O
the	O
rate	O
of	O
postoperative	O
endophthalmitis	O
in	O
a	O
tertiary	O
centre	O
in	O
hong	O
kong	O
.	O
	
the	O
use	O
of	O
aseptic	O
compounding	O
to	O
prepare	O
cefuroxime	O
aliquots	O
by	O
hospital	O
pharmacy	O
appeared	O
to	O
be	O
safe	O
and	O
a	O
standardized	O
approach	O
for	O
the	O
assessment	O
and	O
treatment	B-T061
of	O
internationally	B-T078
adopted	O
children	O
with	O
a	O
previously	O
repaired	O
anorectal	O
malformation	O
arm	O
a	O
significant	O
number	O
of	O
internationally	B-T078
adopted	O
children	O
have	O
congenital	O
birth	O
defects	O
.	O
	
as	O
a	O
specialist	O
center	O
for	O
colorectal	B-T082
diagnoses	O
,	O
we	O
evaluate	O
such	O
children	O
with	O
an	O
anorectal	O
malformation	O
arm	O
and	O
have	O
found	O
that	O
a	O
significant	O
number	O
need	O
a	O
reoperation	B-T061
.	O
	
knowledge	B-T033
of	O
the	O
common	O
complications	O
following	O
arm	O
surgery	B-T061
has	O
led	O
us	O
to	O
develop	O
treatment	B-T061
algorithms	B-T170
for	O
patients	O
with	O
unknown	O
past	B-T033
medical	I-T033
and	O
surgical	B-T033
history	I-T033
,	O
a	O
situation	O
typically	O
encountered	O
in	O
the	O
adopted	B-T033
population	B-T098
.	O
	
the	O
results	O
of	O
investigations	O
,	O
indications	B-T078
,	O
and	O
rate	B-T081
of	O
reoperation	B-T061
were	O
assessed	O
for	O
adopted	O
children	O
with	O
an	O
arm	O
evaluated	O
between	O
2014	O
and	O
2016	O
.	O
	
56	O
patients	O
28	O
males	O
were	O
identified	O
.	O
	
76.8	O
required	O
reoperative	B-T061
surgery	I-T061
.	O
	
mislocation	O
of	O
the	O
anus	O
outside	B-T082
the	O
sphincter	O
complex	O
was	O
seen	O
in	O
50%	O
of	O
males	O
and	O
39.3	O
of	O
females	O
.	O
	
anal	O
stricture	O
,	O
rectal	B-T047
prolapse	I-T047
,	O
retained	B-T169
vaginal	O
septum	O
,	O
and	O
a	O
strictured	O
vaginal	O
introitus	O
were	O
also	O
common	O
.	O
	
the	O
reoperative	B-T061
surgery	I-T061
rate	B-T081
in	O
the	O
internationally	B-T078
adopted	O
child	O
with	O
an	O
arm	O
is	O
high	O
.	O
	
complete	O
,	O
systematic	O
evaluation	O
of	O
these	O
children	O
is	O
required	O
to	O
identify	O
complications	O
following	O
initial	O
repair	O
.	O
	
development	O
of	O
mechanisms	O
to	O
improve	O
the	O
primary	O
surgical	O
care	O
these	O
children	O
highly	O
fluorescent	O
gold	O
nanoclusters	O
stabilized	O
by	O
food	B-T116
proteins	I-T116
from	O
preparation	O
to	O
application	O
in	O
detection	B-T061
of	O
food	O
contaminants	O
and	O
bioactive	O
nutrients	O
applications	O
of	O
nanotechnology	O
in	O
food	O
have	O
rapidly	O
increased	O
in	O
the	O
past	O
decades	O
.	O
	
ultra-small	O
gold	O
nanoclusters	O
au	O
ncs	O
,	O
composed	O
of	O
several	O
to	O
roughly	O
a	O
hundred	O
atoms	O
,	O
represent	O
a	O
kind	O
of	O
novel	O
nanomaterials	O
.	O
	
the	O
au	O
ncs	O
directed	O
by	O
food	B-T116
proteins	I-T116
have	O
drawn	O
considerable	O
research	O
attention	O
due	O
to	O
their	O
environmentally	O
friendly	O
preparation	O
,	O
strong	O
fluorescence	O
,	O
excellent	O
photo-stability	B-T080
and	O
favorable	O
biocompatibility	O
.	O
	
these	O
interesting	O
protein-au	O
hybrids	O
have	O
opened	O
up	O
a	O
new	O
area	O
at	O
the	O
nano-bio-food	O
interface	O
,	O
not	O
only	O
did	O
they	O
provide	O
the	O
missing	O
link	O
between	O
single	O
metal	O
atoms	O
and	O
plasmonic	B-T062
metal	O
nanoparticles	O
,	O
but	O
also	O
developed	O
the	O
hybrid	O
system	O
between	O
biomacromolecule	O
and	O
inorganic	O
ions	O
.	O
	
in	O
this	O
review	O
,	O
we	O
highlighted	O
the	O
synthesis	B-T052
strategies	O
and	O
optical	B-T080
properties	I-T080
of	O
the	O
au	O
ncs	O
stabilized	O
by	O
typical	O
food	B-T116
proteins	I-T116
as	O
well	O
as	O
their	O
applications	O
in	O
detection	B-T061
of	O
food	O
contaminants	O
or	O
bioactive	O
nutrients	O
.	O
	
in	O
addition	O
,	O
we	O
discussed	O
current	O
challenges	O
and	O
future	O
development	O
in	O
food	B-T116
proteins	I-T116
directed	O
gold	O
nanoclusters	O
for	O
size-controlled	O
synthesis	B-T052
sub-lethal	B-T033
effects	I-T033
of	O
dietary	O
neonicotinoid	O
insecticide	O
exposure	B-T080
on	O
honey	O
bee	O
queen	O
fecundity	O
and	O
colony	O
development	O
many	O
factors	B-T169
can	O
negatively	B-T033
affect	O
honey	O
bee	O
apis	O
mellifera	O
l	O
health	B-T078
including	O
the	O
pervasive	B-T082
use	O
of	O
systemic	B-T169
neonicotinoid	O
insecticides	O
.	O
	
through	O
direct	O
consumption	O
of	O
contaminated	B-T169
nectar	O
and	O
pollen	O
from	O
treated	B-T169
plants	O
,	O
neonicotinoids	O
can	O
affect	O
foraging	O
,	O
learning	O
,	O
and	O
memory	O
in	O
worker	O
bees	O
.	O
	
less	O
well	O
studied	O
are	O
the	O
potential	O
effects	O
of	O
neonicotinoids	O
on	O
queen	O
bees	O
,	O
which	O
may	O
be	O
exposed	O
indirectly	O
through	O
trophallaxis	O
,	O
or	O
food	O
-	O
sharing	O
.	O
	
to	O
assess	O
effects	O
on	O
queen	O
productivity	B-T081
,	O
small	B-T081
colonies	O
of	O
different	O
sizes	B-T082
1500	O
,	O
3000	O
,	O
and	O
7000	O
bees	O
were	O
fed	B-T052
imidacloprid	B-T109
0	O
,	O
10	O
,	O
20	O
,	O
50	O
,	O
and	O
100	O
ppb	O
in	O
syrup	O
for	O
three	O
weeks	B-T079
.	O
	
we	O
found	O
adverse	O
effects	O
of	O
imidacloprid	B-T109
on	O
queens	O
egg-laying	O
and	O
locomotor	O
activity	O
,	O
worker	O
bees	O
foraging	O
and	O
hygienic	O
activities	B-T052
,	O
and	O
colony	O
development	O
brood	O
production	O
and	O
pollen	O
stores	O
in	O
all	O
treated	B-T169
colonies	O
.	O
	
some	O
effects	O
were	O
less	B-T080
evident	O
as	O
colony	O
size	B-T082
increased	B-T081
,	O
suggesting	O
that	O
larger	B-T081
colony	O
populations	B-T098
may	O
act	O
as	O
a	O
buffer	O
to	O
pesticide	B-T033
exposure	I-T033
.	O
	
this	O
study	B-T062
is	O
the	O
first	O
to	O
show	O
adverse	O
effects	O
of	O
imidacloprid	B-T109
on	O
queen	O
bee	O
fecundity	O
and	O
behavior	O
and	O
improves	B-T080
our	O
understanding	O
of	O
how	O
neonicotinoids	O
may	O
impair	B-T169
short-term	O
colony	O
functioning	B-T169
.	O
	
these	O
data	B-T078
indicate	O
that	O
risk-mitigation	B-T170
efforts	I-T170
should	O
focus	O
on	O
reducing	B-T080
neonicotinoid	O
exposure	B-T080
in	O
the	O
early	B-T079
spring	I-T079
when	O
colonies	O
are	O
smallest	B-T081
and	O
queens	O
are	O
most	O
vulnerable	B-T169
to	O
therapeutic	B-T169
applications	I-T169
of	O
crispr	O
rna-guided	O
genome	O
editing	O
the	O
rapid	O
development	O
of	O
programmable	B-T116
nuclease	I-T116
-based	O
genome	O
editing	O
technologies	O
has	O
enabled	O
targeted	B-T169
gene	O
disruption	B-T169
and	O
correction	B-T061
both	O
in	B-T080
vitro	I-T080
and	O
in	B-T082
vivo	I-T082
this	O
revolution	O
opens	O
up	O
the	O
possibility	O
of	O
precise	O
genome	O
editing	O
at	O
target	B-T169
genomic	B-T082
sites	I-T082
to	O
modulate	O
gene	O
function	O
in	O
animals	O
and	O
plants	O
.	O
	
among	O
several	O
programmable	B-T116
nucleases	I-T116
,	O
the	O
type	O
ii	O
clustered	O
regularly	O
interspaced	O
short	O
palindromic	O
repeats	O
crispr	O
crispr-associated	O
nuclease	O
9	O
cas9	O
system	O
has	O
progressed	O
remarkably	O
in	O
recent	O
years	O
,	O
leading	O
to	O
its	O
widespread	O
use	O
in	O
research	B-T062
,	O
medicine	O
and	O
biotechnology	O
.	O
	
in	O
particular	O
,	O
crispr-cas9	O
shows	O
highly	O
efficient	O
gene	O
editing	O
activity	O
for	O
therapeutic	B-T169
purposes	I-T169
in	O
systems	O
ranging	O
from	O
patient	O
stem	O
cells	O
to	O
animal	O
models	O
.	O
	
however	O
,	O
the	O
development	O
of	O
therapeutic	B-T169
approaches	I-T169
and	O
delivery	B-T061
methods	I-T061
remains	O
a	O
great	O
challenge	O
for	O
biomedical	O
applications	B-T169
.	O
	
herein	O
,	O
we	O
review	O
therapeutic	B-T169
applications	I-T169
that	O
use	O
the	O
crispr-cas9	O
system	O
design	B-T052
and	O
characteristics	B-T080
of	O
cytotoxic	B-T169
fibroblast	B-T116
growth	I-T116
factor	I-T116
1	I-T116
conjugate	O
for	O
fibroblast	B-T116
growth	I-T116
factor	I-T116
receptor	I-T116
-	O
targeted	B-T061
cancer	I-T061
therapy	I-T061
fibroblast	B-T116
growth	I-T116
factor	I-T116
receptors	I-T116
fgfrs	B-T116
are	O
attractive	O
candidate	O
cancer	B-T061
therapy	I-T061
targets	B-T169
as	O
they	O
are	O
overexpressed	O
in	O
multiple	B-T081
types	O
of	O
tumors	O
,	O
such	O
as	O
breast	O
,	O
prostate	O
,	O
bladder	O
,	O
and	O
lung	O
cancer	O
.	O
	
in	O
this	O
study	O
,	O
a	O
natural	O
ligand	O
of	O
fgfr	B-T116
,	O
an	O
engineered	B-T116
variant	I-T116
of	O
fibroblast	B-T116
growth	I-T116
factor	I-T116
1	I-T116
fgf1v	B-T116
,	O
was	O
conjugated	B-T082
to	O
a	O
potent	O
cytotoxic	O
drug	O
,	O
monomethyl	B-T116
auristatin	I-T116
e	I-T116
mmae	B-T116
,	O
and	O
used	O
as	O
a	O
targeting	O
agent	O
for	O
cancer	O
cells	O
overexpressing	O
fgfrs	B-T116
,	O
similar	O
to	O
antibodies	B-T116
in	O
antibody-drug	B-T061
conjugates	I-T061
.	O
	
the	O
fgf1v-valine-citrulline-mmae	O
conjugate	O
showed	O
a	O
favorable	O
stability	O
profile	O
,	O
bound	O
fgfrs	B-T116
on	O
the	O
cell	O
surface	O
specifically	B-T080
,	O
and	O
efficiently	B-T080
released	B-T169
the	O
drug	B-T116
mmae	I-T116
upon	O
cleavage	O
by	O
the	O
lysosomal	B-T116
protease	I-T116
cathepsin	I-T116
b	I-T116
.	O
	
importantly	O
,	O
the	O
conjugate	O
showed	O
a	O
prominent	B-T080
cytotoxic	O
effect	O
toward	O
cell	O
lines	O
expressing	O
fgfr	B-T116
.	O
	
fgf1v-vcmmae	O
was	O
highly	O
cytotoxic	B-T169
at	O
concentrations	B-T081
even	O
an	O
order	O
of	O
magnitude	O
lower	B-T052
than	O
those	O
found	O
for	O
free	O
mmae	B-T116
.	O
	
this	O
effect	O
was	O
fgfr	B-T116
-specific	O
as	O
cells	O
lacking	B-T080
fgfr	B-T116
did	B-T033
not	I-T033
show	I-T033
any	O
increased	B-T081
mortality	O
.	O
	
effects	O
of	O
morphology	B-T080
and	O
surface	O
hydroxyl	O
on	O
the	O
toxicity	O
of	O
biocl	O
in	O
human	O
hacat	O
cells	O
recently	O
,	O
bismuth	O
oxychloride	O
nanomaterials	O
biocls	O
are	O
showing	O
great	O
promise	O
in	O
pollutant	O
removal	B-T052
.	O
	
residues	O
from	O
these	O
environmental	O
remediations	O
are	O
potential	O
hazardous	O
materials	O
.	O
	
unfortunately	O
,	O
human	O
health	O
risks	O
of	O
biocls	O
are	O
still	O
unexplored	O
widely	O
.	O
	
in	O
the	O
present	O
study	B-T062
,	O
we	O
focused	O
on	O
the	O
influence	O
of	O
physicochemical	B-T080
properties	I-T080
on	O
the	O
cytotoxicity	O
of	O
biocls	O
toward	O
a	O
human	O
skin	O
derived	O
cell	O
line	O
hacat	O
.	O
	
results	O
showed	O
that	O
morphology	B-T080
and	O
surface	O
hydroxyl	O
both	O
had	O
a	O
profound	O
effect	O
on	O
the	O
toxicity	O
of	O
biocls	O
.	O
	
microsphere-shaped	B-T082
biocl	O
caused	O
less	O
toxicity	O
than	O
nanosheet-shaped	B-T082
biocl	O
because	O
of	O
weaker	O
particle-membrane	O
interactions	O
,	O
while	O
the	O
presence	O
of	O
surface	O
hydroxyl	O
on	O
microsphere-shaped	B-T082
biocl	O
significantly	O
raised	O
the	O
toxicity	O
owing	O
to	O
the	O
increased	O
interaction	O
with	O
cell	O
membrane	O
.	O
	
both	O
microsphere-shaped	B-T082
biocl	O
with	O
surface	O
hydroxyl	O
and	O
nanosheet-shaped	B-T082
biocl	O
caused	O
significant	O
cell	O
membrane	O
damage	O
pi	B-T109
uptake	O
and	O
ldh	O
release	O
,	O
however	O
,	O
based	O
on	O
the	O
different	O
mechanism	O
.	O
	
the	O
former	O
may	O
be	O
a	O
predominant	O
"""chemical"""	O
mechanism	O
involved	O
an	O
oxidative	O
stress	O
paradigm	O
,	O
as	O
manifested	O
by	O
elevated	O
ros	O
and	O
depleted	O
gsh	O
,	O
while	O
the	O
latter	O
is	O
mainly	O
due	O
to	O
a	O
direct	O
""""	O
physical	O
""""	O
damage	O
to	O
cell	O
membrane	O
.	O
	
both	O
""""	O
physical	O
""""	O
and	O
"""chemical"""	O
response	O
led	O
to	O
cell	O
death	O
.	O
	
furthermore	O
,	O
a	O
set	O
of	O
experiments	O
including	O
mmp	O
collapse	O
,	O
cell	O
cycle	O
arrest	O
,	O
and	O
apoptosis	O
/	O
necrosis	O
were	O
conducted	O
to	O
propose	O
a	O
scenario	O
for	O
toxicological	O
aspects	O
of	O
biocls	O
.	O
	
data	O
presented	O
here	O
would	O
help	O
to	O
enable	O
the	O
rational	O
design	O
of	O
biocls	O
for	O
either	O
reducing	O
their	O
unintended	O
consequences	O
or	O
increasing	O
their	O
application	O
potentials	I-T080
reduced	B-T080
haemodynamic	O
coupling	O
and	O
exercise	O
are	O
associated	B-T080
with	I-T080
vascular	O
stiffening	O
in	O
pulmonary	B-T047
arterial	I-T047
hypertension	I-T047
inadequate	B-T080
right	O
ventricular	O
rv	O
and	O
pulmonary	O
arterial	O
pa	O
functional	B-T169
responses	B-T169
to	O
exercise	O
are	O
important	O
yet	O
poorly	O
understood	O
features	O
of	O
pulmonary	B-T047
arterial	I-T047
hypertension	I-T047
pah	B-T047
.	O
	
this	O
study	B-T062
combined	O
invasive	B-T061
catheterisation	B-T061
with	O
echocardiography	O
to	O
assess	B-T052
rv	O
afterload	O
,	O
rv	O
function	O
and	O
ventricular	O
-	O
vascular	O
coupling	O
in	O
subjects	B-T098
with	O
pah	B-T047
.	O
	
twenty-six	O
subjects	B-T098
with	O
pah	B-T047
were	O
prospectively	O
recruited	O
to	O
undergo	O
right	O
heart	O
catheterisation	B-T061
and	O
doppler	O
echocardiography	O
at	O
rest	O
and	O
during	O
incremental	B-T081
exercise	O
,	O
and	O
cardiac	O
mri	O
at	O
rest	O
.	O
	
measurements	B-T169
at	O
rest	O
included	O
basic	O
haemodynamics	O
,	O
rv	O
function	O
and	O
coupling	B-T081
efficiency	I-T081
η	B-T081
.	O
	
measurements	B-T169
during	O
incremental	B-T081
exercise	O
included	O
pulmonary	B-T033
vascular	I-T033
resistance	I-T033
z0	B-T033
,	O
characteristic	O
impedance	O
zc	O
,	O
a	O
measure	B-T169
of	O
proximal	B-T082
pa	O
stiffness	O
and	O
proximal	B-T082
and	O
distal	B-T082
pa	O
compliance	O
cpa	O
.	O
	
in	O
patients	O
with	O
pah	B-T047
,	O
the	O
proximal	B-T082
pas	O
were	O
significantly	B-T078
stiffer	B-T033
at	O
maximum	B-T081
exercise	O
zc	O
=2	O
vs	O
1.33	O
wu	O
at	O
rest	O
p=0	O
and	O
pa	O
compliance	O
was	O
decreased	B-T081
cpa	O
=0	O
vs	O
1.32	O
ml/mm	O
hg/m	O
at	O
rest	O
p=0	O
.	O
	
z0	B-T033
did	O
not	O
change	O
with	O
exercise	O
.	O
	
as	O
a	O
result	O
,	O
the	O
resistance-compliance	B-T081
rc	I-T081
time	I-T081
decreased	B-T081
with	O
exercise	O
0.67	O
vs	O
1.00	O
s	O
at	O
rest	O
p<10	O
.	O
	
when	O
patients	O
were	O
grouped	O
according	O
to	O
resting	O
coupling	B-T081
efficiency	I-T081
,	O
those	O
with	O
poorer	O
η	B-T081
exhibited	O
stiffer	B-T033
proximal	B-T082
pas	O
at	O
rest	O
,	O
a	O
lower	O
maximum	B-T081
exercise	O
level	B-T080
,	O
and	O
more	O
limited	O
cpa	O
reduction	B-T080
at	O
maximum	B-T081
exercise	O
.	O
	
in	O
pah	B-T047
,	O
exercise	O
causes	O
proximal	B-T082
and	O
distal	B-T082
pa	O
stiffening	O
,	O
which	O
combined	O
with	O
preserved	O
z0	B-T033
results	O
in	O
decreased	B-T081
rc	B-T081
time	I-T081
with	O
exercise	O
.	O
	
stiff	O
pas	O
at	O
rest	O
may	O
also	O
contribute	O
to	O
poor	O
haemodynamic	O
coupling	O
,	O
reflecting	O
reduced	B-T080
pulmonary	O
vascular	O
reserve	O
that	O
contributes	B-T052
to	O
limit	O
the	O
maximum	B-T081
exercise	O
level	B-T080
altered	B-T081
ph	I-T081
gradient	I-T081
at	O
the	O
plasma	O
membrane	O
of	O
osteosarcoma	O
cells	O
is	O
a	O
key	O
mechanism	B-T169
of	O
drug	O
resistance	O
current	O
therapy	B-T061
of	O
osteosarcoma	O
os	O
,	O
the	O
most	O
common	O
primary	O
bone	O
malignancy	O
,	O
is	O
based	O
on	O
a	O
combination	B-T061
of	I-T061
surgery	I-T061
and	I-T061
chemotherapy	I-T061
.	O
	
multidrug	O
resistance	O
mediated	O
by	O
p-glycoprotein	B-T116
p-gp	B-T116
overexpression	O
has	O
been	O
previously	O
associated	O
with	O
treatment	B-T033
failure	I-T033
and	O
progression	O
of	O
os	O
,	O
although	O
other	O
mechanisms	B-T169
may	O
also	O
play	O
a	O
role	O
.	O
	
we	O
considered	O
the	O
typical	O
acidic	B-T081
extracellular	I-T081
ph	I-T081
phe	B-T081
of	O
sarcomas	O
,	O
and	O
found	O
that	O
doxorubicin	B-T109
dxr	B-T109
cytotoxicity	O
is	O
reduced	B-T080
in	O
p-gp	O
negative	O
os	O
cells	O
cultured	O
at	O
phe	B-T081
6.5	O
compared	O
to	O
standard	O
7.4	O
.	O
	
short-time	B-T079
24-48	O
hours	O
exposure	B-T080
to	I-T080
low	O
phe	B-T081
significantly	B-T081
increased	I-T081
the	O
number	O
and	O
acidity	O
of	O
lysosomes	O
,	O
and	O
the	O
combination	B-T080
of	O
dxr	B-T109
with	O
omeprazole	B-T109
,	O
a	O
proton	O
pump	O
inhibitor	O
targeting	O
lysosomal	O
acidity	O
,	O
significantly	B-T081
enhanced	I-T081
dxr	B-T109
cytotoxicity	O
.	O
	
in	O
os	O
xenografts	O
,	O
the	O
combination	B-T061
treatment	I-T061
of	O
dxr	B-T109
and	O
omeprazole	B-T109
significantly	O
reduced	O
tumor	B-T081
volume	I-T081
and	O
body	B-T033
weight	I-T033
loss	I-T033
.	O
	
the	O
impaired	O
toxicity	O
of	O
dxr	B-T109
at	O
low	O
phe	B-T081
was	O
not	O
associated	O
with	O
increased	B-T081
autophagy	O
or	O
lysosomal	O
acidification	O
,	O
but	O
rather	O
,	O
as	O
shown	O
by	O
snarf	O
staining	O
,	O
with	O
a	O
reversal	B-T169
of	O
the	O
ph	B-T081
gradient	I-T081
at	O
the	O
plasma	O
membrane	O
δphcm	B-T081
,	O
eventually	O
leading	O
to	O
a	O
reduced	B-T080
dxr	B-T109
intracellular	B-T082
accumulation	B-T033
.	O
	
finally	O
,	O
the	O
reversal	B-T169
of	O
δphcm	B-T081
in	O
os	O
cells	O
promoted	O
resistance	B-T169
not	O
only	O
to	O
dxr	B-T109
,	O
but	O
also	O
to	O
cisplatin	O
and	O
methotrexate	B-T109
,	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
to	O
vincristine	B-T109
.	O
	
altogether	O
,	O
our	O
findings	O
show	O
that	O
,	O
in	O
os	O
cells	O
,	O
short-term	B-T079
acidosis	O
induces	O
resistance	B-T169
to	O
different	O
chemotherapeutic	B-T109
drugs	I-T109
by	O
a	O
reversal	B-T169
of	O
δphcm	B-T081
,	O
suggesting	O
that	O
buffer	O
therapies	B-T061
or	O
regimens	B-T170
including	O
proton	O
pump	O
inhibitors	O
in	O
combination	B-T080
to	O
low	O
concentrations	B-T081
of	O
conventional	O
anticancer	B-T109
agents	I-T109
may	O
offer	O
novel	B-T080
solutions	O
to	O
overcome	B-T052
drug	O
resistance	O
.	O
	
boston	O
keratoprosthesis	O
type	O
1	O
a	O
randomized	B-T062
controlled	I-T062
trial	I-T062
of	O
fresh	B-T080
versus	O
frozen	B-T080
corneal	O
donor	O
carriers	O
with	O
long-term	B-T079
follow-up	O
to	O
compare	B-T052
the	O
long-term	B-T079
clinical	B-T169
outcomes	I-T169
of	O
fresh	B-T080
versus	O
frozen	B-T080
corneal	O
graft	O
carriers	O
for	O
the	O
boston	O
keratoprosthesis	O
type	O
1	O
b-kpro	O
.	O
	
prospective	O
,	O
single-center	O
,	O
nonblinded	O
,	O
randomized	B-T062
controlled	I-T062
trial	I-T062
.	O
	
all	O
participants	B-T098
were	O
followed	O
through	O
the	O
initial	B-T079
study	B-T170
protocol	I-T170
of	O
24	O
months	B-T079
and	O
were	O
approached	O
to	O
enter	O
an	O
extension	B-T169
phase	B-T079
,	O
with	O
continuing	O
follow-up	O
visits	O
to	O
60	O
months	B-T079
.	O
	
all	O
patients	O
undergoing	O
b-kpro	B-T061
surgery	I-T061
between	O
october	O
2008	O
and	O
december	O
2009	O
by	O
a	O
single	O
experienced	O
surgeon	O
at	O
the	O
centre	O
hospitalier	O
de	O
l'université	O
de	O
montréal	O
using	O
an	O
allograft	O
carrier	O
were	O
considered	O
.	O
	
patients	O
were	O
excluded	B-T052
if	O
they	O
had	O
previously	B-T079
undergone	O
b-kpro	O
implantation	B-T061
.	O
	
participants	B-T098
were	O
randomized	B-T033
individually	O
to	O
receive	B-T080
a	O
b-kpro	O
using	O
a	O
frozen	B-T080
or	O
a	O
fresh	B-T080
corneal	O
graft	O
carrier	O
on	O
the	O
basis	O
of	O
tissue	O
availability	B-T169
on	O
the	O
day	B-T079
of	O
surgery	B-T061
,	O
as	O
determined	O
by	O
the	O
local	O
eye	O
bank	O
.	O
	
the	O
primary	O
outcome	B-T081
measure	I-T081
was	O
device	B-T033
retention	I-T033
at	O
24	O
and	O
60	O
months	B-T079
.	O
	
secondary	O
outcome	O
measures	O
included	O
surgical	B-T033
feasibility	I-T033
,	O
visual	O
acuity	O
va	O
,	O
and	O
complications	O
.	O
	
thirty-seven	O
eyes	O
of	O
37	O
patients	O
were	O
enrolled	O
in	O
the	O
initial	B-T079
study	B-T170
protocol	I-T170
,	O
with	O
19	O
eyes	O
randomized	B-T062
to	O
fresh	B-T080
and	O
18	O
to	O
frozen	B-T080
carrier	O
grafts	O
.	O
	
thirty-six	O
eyes	O
were	O
followed	O
through	O
to	O
24	O
months	B-T079
,	O
with	O
1	O
lost	O
to	O
follow-up	O
.	O
	
of	O
these	O
,	O
26	O
were	O
enrolled	O
in	O
the	O
extension	B-T169
11	O
eyes	O
with	O
a	O
frozen	B-T080
and	O
15	O
eyes	O
with	O
a	O
fresh	B-T080
carrier	O
graft	O
.	O
	
there	O
were	O
no	B-T033
differences	I-T033
in	O
the	O
baseline	B-T081
characteristics	B-T080
of	O
patients	O
enrolled	O
in	O
the	O
extension	B-T169
phase	B-T079
versus	O
those	O
who	O
were	O
not	O
.	O
	
at	O
60	O
months	B-T079
,	O
median	O
corrected	O
distance	O
va	O
in	O
the	O
fresh	B-T078
group	I-T078
had	O
improved	B-T033
to	O
20/150	O
from	O
a	O
baseline	B-T081
of	O
counting	O
fingers	O
,	O
whereas	O
the	O
frozen	B-T078
group	I-T078
improved	B-T033
to	O
20/400	O
from	O
a	O
baseline	B-T081
of	O
hand	O
motions	O
.	O
	
device	B-T033
retention	I-T033
was	O
100%	O
at	O
24	O
months	B-T079
and	O
96%	O
at	O
60	O
months	B-T079
.	O
	
there	O
were	O
no	O
significant	O
differences	B-T080
in	O
the	O
rate	B-T081
of	O
complications	O
between	O
groups	B-T078
.	O
	
fresh	B-T080
and	O
frozen	B-T080
corneal	B-T098
donors	I-T098
offer	O
similar	O
clinical	B-T169
outcomes	I-T169
when	O
used	O
as	O
carriers	O
for	O
the	O
b-kpro	O
,	O
with	O
no	O
significant	O
differences	B-T080
in	O
device	B-T033
retention	I-T033
,	O
visual	B-T033
rehabilitation	I-T033
,	O
or	O
rates	B-T081
of	O
complications	O
at	O
24	O
or	O
60	O
impact	B-T080
of	O
an	O
educational	B-T061
intervention	I-T061
to	O
improve	B-T033
antibiotic	O
prescribing	O
for	O
nurse	O
practitioners	O
in	O
a	O
pediatric	O
urgent	O
care	O
center	O
up	O
to	O
21%	O
of	O
pediatric	O
visits	O
result	O
in	O
an	O
antibiotic	O
prescription	O
,	O
and	O
a	O
large	O
portion	O
of	O
these	O
are	O
unnecessary	O
.	O
	
to	O
determine	O
if	O
educational	O
sessions	O
would	O
reduce	B-T080
inappropriate	B-T080
antibiotic	O
use	B-T169
.	O
	
intervention	B-T170
study	I-T170
evaluating	O
antibiotic	O
prescribing	O
following	O
educational	O
sessions	O
for	O
urinary	B-T047
tract	I-T047
infection	I-T047
,	O
skin	B-T047
and	O
soft	B-T047
tissue	I-T047
infection	I-T047
,	O
pharyngitis	B-T047
,	O
upper	B-T047
respiratory	I-T047
tract	I-T047
infection	I-T047
,	O
acute	B-T047
otitis	I-T047
media	I-T047
,	O
and	O
acute	B-T047
bacterial	I-T047
sinusitis	I-T047
.	O
	
a	O
total	O
of	O
26	O
out	O
of	O
43	O
60%	O
nurse	O
practitioners	O
in	O
4	O
urgent	O
care	O
centers	O
were	O
enrolled	O
in	O
the	O
study	B-T062
.	O
	
the	O
rate	B-T081
of	O
inappropriate	B-T080
antibiotic	O
use	B-T169
among	O
all	O
conditions	O
was	O
10%	O
before	O
and	O
8%	O
after	O
the	O
intervention	B-T061
p	O
=	O
02	O
.	O
	
a	O
decrease	B-T081
in	O
inappropriate	B-T080
antibiotic	O
prescribing	O
was	O
seen	O
after	O
the	O
educational	O
session	O
p	O
<	O
01	O
.	O
	
the	O
most	O
common	O
reasons	O
for	O
inappropriate	B-T080
antibiotic	O
prescribing	O
were	O
too	O
broad	O
41%	O
,	O
wrong	B-T033
dosage	I-T033
22%	O
,	O
and	O
not	B-T033
indicated	I-T033
17%	O
.	O
	
educational	O
sessions	O
led	O
to	O
improvement	O
in	O
overall	O
inappropriate	B-T080
antibiotic	O
use	B-T169
.	O
	
additional	O
stewardship	B-T170
interventions	B-T061
are	O
needed	O
to	O
further	O
reduce	B-T080
unnecessary	O
antibiotic	O
use	B-T169
.	O
	
zika	O
virus	O
disrupts	B-T080
phospho-tbk1	B-T116
localization	O
and	O
mitosis	O
in	O
human	O
neuroepithelial	B-T080
stem	O
cells	O
and	O
radial	O
glia	O
the	O
mechanisms	B-T169
underlying	O
zika	O
virus	O
zikv	O
microcephaly	O
and	O
other	O
neurodevelopment	O
defects	B-T169
remain	O
poorly	B-T080
understood	O
.	O
	
here	O
,	O
we	O
describe	O
the	O
derivation	B-T080
and	O
characterization	B-T052
,	O
including	O
single-cell	O
rna-seq	O
,	O
of	O
neocortical	O
and	O
spinal	O
cord	O
neuroepithelial	B-T080
stem	O
nes	O
cells	O
to	O
model	O
early	B-T079
human	O
neurodevelopment	O
and	O
zikv	O
-related	O
neuropathogenesis	B-T047
.	O
	
by	O
analyzing	O
human	O
nes	O
cells	O
,	O
organotypic	B-T080
fetal	O
brain	O
slices	O
,	O
and	O
a	O
zikv	O
-	O
infected	B-T033
micrencephalic	O
brain	O
,	O
we	O
show	O
that	O
zikv	O
infects	B-T033
both	O
neocortical	O
and	O
spinal	O
nes	O
cells	O
as	O
well	O
as	O
their	O
fetal	O
homolog	O
,	O
radial	O
glial	O
cells	O
rgcs	O
,	O
causing	O
disrupted	B-T080
mitoses	O
,	O
supernumerary	B-T081
centrosomes	O
,	O
structural	B-T082
disorganization	B-T033
,	O
and	O
cell	O
death	O
.	O
	
zikv	B-T047
infection	I-T047
of	O
nes	O
cells	O
and	O
rgcs	O
causes	O
centrosomal	O
depletion	B-T169
and	O
mitochondrial	O
sequestration	B-T169
of	O
phospho-tbk1	B-T116
during	O
mitosis	O
.	O
	
we	O
also	O
found	O
that	O
nucleoside	O
analogs	O
inhibit	B-T052
zikv	O
replication	O
in	O
nes	O
cells	O
,	O
protecting	O
them	O
from	O
zikv	O
-	O
induced	B-T169
ptbk1	B-T116
relocalization	O
and	O
cell	O
death	O
.	O
	
we	O
established	B-T080
a	O
model	B-T170
system	I-T170
of	O
human	O
neural	O
stem	O
cells	O
to	O
reveal	O
cellular	O
and	O
molecular	B-T080
mechanisms	B-T169
underlying	O
neurodevelopmental	O
defects	B-T169
associated	B-T080
with	I-T080
zikv	B-T047
infection	I-T047
and	O
its	O
potential	B-T080
treatment	B-T061
.	O
	
prevalence	B-T081
of	O
hpv	O
genotypes	O
in	O
cervical	O
adenocarcinoma	O
a	O
study	B-T062
in	O
greek	B-T098
women	B-T098
to	O
study	B-T062
the	O
prevalence	B-T081
of	O
human	O
papillomavirus	O
hpv	O
genotypes	O
among	O
cervical	O
adenocarcinomas	O
in	O
greek	B-T098
women	B-T098
.	O
	
the	O
study	O
group	O
comprised	O
78	O
adenocarcinoma	O
cases	O
20	O
in	O
situ	O
and	O
58	O
invasive	O
.	O
	
hpv	O
dna	O
was	O
amplified	O
using	O
polymerase	O
chain	O
reaction	O
pcr	O
and	O
hpv	O
genotypes	O
were	O
identified	B-T080
by	O
reverse	O
hybridization	O
.	O
	
there	O
was	O
a	O
high	B-T081
prevalence	I-T081
of	O
hpv	B-T047
infection	I-T047
both	O
for	O
in	O
situ	O
95%	O
or	O
invasive	O
94.83	O
adenocarcinomas	O
,	O
comprising	O
also	O
cancers	O
of	O
unusual	B-T080
morphology	I-T080
.	O
	
hpv	O
16	O
was	O
the	O
commonest	B-T081
strain	O
n=57	O
,	O
73.08	O
followed	O
by	O
hpv	O
18	O
n=28	O
,	O
35.90	O
.	O
	
interestingly	O
,	O
13	O
cases	O
16.67	O
were	O
also	O
hpv	O
52	O
positive	O
as	O
co-infection	B-T047
with	O
hpv	O
16	O
or	O
18	O
.	O
	
all	O
other	O
strains	O
with	O
the	O
exception	O
of	O
hpv	O
66	O
were	O
found	O
only	O
as	O
co-infections	B-T047
.	O
	
no	O
significant	O
age	O
difference	O
was	O
noted	O
in	O
terms	O
of	O
any	O
hpv	O
strain	O
positivity	B-T033
.	O
	
hpv	O
dna	O
was	O
found	O
in	O
the	O
large	O
majority	O
of	O
cervical	O
adenocarcinomas	O
.	O
	
as	O
opposed	O
to	O
other	O
studies	B-T062
,	O
hpv	O
52	O
was	O
the	O
third	O
most	O
commonly	B-T081
encountered	O
strain	O
after	O
hpv	O
16	O
and	O
hpv	O
18	O
.	O
	
the	O
above	O
findings	O
would	O
probably	O
be	O
of	O
help	B-T080
in	O
decision	O
making	O
concerning	O
vaccination	B-T061
policy	B-T170
for	O
the	O
prevention	B-T080
of	O
hpv	B-T047
infection	I-T047
in	O
glucose	O
metabolism	O
-	O
weighted	O
imaging	O
with	O
chemical	O
exchange-sensitive	O
mri	O
of	O
2-deoxyglucose	B-T109
2dg	B-T109
in	O
brain	O
sensitivity	B-T081
and	O
biological	B-T080
sources	B-T033
recent	B-T062
proof-of-principle	I-T062
studies	I-T062
have	O
demonstrated	O
the	O
feasibility	O
of	O
measuring	O
the	O
uptake	O
and	O
metabolism	O
of	O
non-labeled	O
2-deoxy-d-glucose	B-T109
2dg	B-T109
by	O
a	O
chemical	O
exchange-sensitive	O
spin-lock	O
cesl	O
mri	O
approach	O
.	O
	
in	O
order	O
to	O
gain	O
better	O
understanding	O
of	O
this	O
new	O
approach	O
,	O
we	O
performed	O
dynamic	B-T169
in	B-T082
vivo	I-T082
cesl	O
mri	O
on	O
healthy	B-T080
rat	O
brains	O
with	O
an	O
intravenous	B-T169
injection	I-T169
of	O
2dg	B-T109
under	O
various	O
conditions	O
at	O
9.4t	O
.	O
	
for	O
three	O
2dg	B-T109
doses	B-T081
of	O
0.25	O
,	O
0.5	O
and	O
1g/kg	O
,	O
we	O
found	O
that	O
2dg	B-T109
-	O
cesl	O
signals	O
increased	B-T081
linearly	O
with	O
injection	B-T061
dose	B-T081
at	O
the	O
initial	O
<20min	O
but	O
not	O
the	O
later	O
period	O
>40min	O
suggesting	O
time-dependent	O
differential	O
weightings	O
of	O
2dg	B-T109
transport	O
and	O
metabolism	O
.	O
	
remaining	O
2dg	B-T109
-	O
cesl	O
studies	O
were	O
performed	O
with	O
0.25g	O
2dg	B-T109
.	O
	
since	O
a	O
higher	B-T080
isoflurane	B-T109
level	B-T080
reduces	B-T080
glucose	O
metabolism	O
and	O
increases	B-T169
blood	O
flow	O
,	O
2dg	B-T109
-	O
cesl	O
was	O
measured	B-T080
under	O
0.5	O
,	O
1.5	O
and	O
2.2	O
isoflurane	B-T109
.	O
	
the	O
2dg	B-T109
-	O
cesl	O
signal	O
was	O
reduced	B-T080
at	O
higher	B-T080
isoflurane	B-T109
levels	O
correlating	O
well	O
with	O
the	O
2dg	B-T109
phosphorylation	O
in	O
the	O
intracellular	O
space	O
.	O
	
to	O
detect	O
regional	O
heterogeneities	O
of	O
glucose	O
metabolism	O
,	O
2dg	B-T109
-	O
cesl	O
with	O
0.33	O
resolution	O
was	O
obtained	O
,	O
which	O
indeed	O
showed	O
a	O
higher	B-T080
response	O
in	O
the	O
cortex	O
compared	O
to	O
the	O
corpus	O
callosum	O
.	O
	
lastly	O
,	O
unlike	O
cesl	O
mri	O
with	O
the	O
injection	B-T061
of	O
non-transportable	B-T109
mannitol	I-T109
,	O
the	O
2dg	B-T109
-	O
cesl	O
response	O
decreased	B-T081
with	O
an	O
increased	B-T081
spin-lock	B-T081
pulse	I-T081
power	I-T081
confirming	O
that	O
2dg	B-T109
-	O
cesl	O
is	O
dominated	O
by	O
chemical	O
exchange	O
processes	O
in	O
the	O
extravascular	B-T082
space	I-T082
.	O
	
taken	O
together	O
,	O
our	O
results	O
showed	O
that	O
2dg	B-T109
-	O
cesl	O
mri	O
signals	O
mainly	O
indicate	O
glucose	O
transport	O
and	O
metabolism	O
and	O
may	O
be	O
a	O
useful	O
biomarker	O
for	O
metabolic	B-T169
studies	B-T062
of	O
normal	O
and	O
diseased	B-T047
brains	O
.	O
	
parental	O
perceptions	O
of	O
children	O
agency	O
parental	O
warmth	O
,	O
school	O
achievement	O
and	O
adjustment	O
the	O
present	O
study	B-T062
examined	O
swedish	B-T098
mothers'	O
and	O
fathers'	O
warmth	O
towards	O
their	O
children	O
in	O
relation	O
to	O
their	O
children	O
agency	O
.	O
	
it	O
also	O
examined	O
the	O
longitudinal	O
relation	O
between	O
agency	O
and	O
children's	O
externalizing	O
,	O
internalizing	O
,	O
and	O
school	O
achievement	O
.	O
	
swedish	B-T098
children's	O
mothers	O
and	O
fathers	O
n	O
=	O
103	O
were	O
interviewed	B-T052
at	O
three	O
time	B-T079
points	I-T079
when	O
children	O
were	O
8	O
,	O
9	O
,	O
and	O
10	O
years	B-T079
old	O
about	O
their	O
warmth	O
towards	O
their	O
children	O
,	O
children's	O
agency	O
,	O
and	O
children's	O
externalizing	O
and	O
internalizing	O
behaviors	O
and	O
school	O
achievement	O
.	O
	
parental	O
warmth	O
at	O
time	B-T079
1	O
was	O
significantly	O
correlated	B-T080
with	O
child	O
agency	O
at	O
time	B-T079
2	O
,	O
which	O
was	O
significantly	O
correlated	B-T080
with	O
child	O
externalizing	O
and	O
internalizing	O
behaviors	O
and	O
academic	O
achievement	O
at	O
time	B-T079
3	O
.	O
	
there	O
were	O
no	O
differences	O
between	O
girls	O
and	O
boys	O
.	O
	
results	O
from	O
this	O
study	B-T062
indicate	O
that	O
swedish	B-T098
parents'	O
warmth	O
is	O
directly	O
related	O
to	O
subsequent	O
perceptions	O
of	O
children's	O
agency	O
,	O
which	O
in	O
turn	O
are	O
related	O
to	O
subsequently	O
lower	O
child	O
externalizing	O
and	O
internalizing	O
problems	B-T033
and	O
higher	O
academic	O
achievement	O
.	O
	
these	O
findings	B-T033
held	O
in	O
the	O
context	O
of	O
a	O
three-	O
year	B-T079
longitudinal	B-T062
study	I-T062
and	O
for	O
both	O
boys	O
and	O
girls	O
,	O
suggesting	O
the	O
importance	O
of	O
child	O
agency	O
in	O
the	O
link	O
between	O
parental	O
warmth	O
and	O
children's	O
adjustment	O
.	O
	
vasopressin	B-T116
regulates	O
the	O
growth	O
of	O
the	O
biliary	O
epithelium	O
in	O
polycystic	O
liver	O
disease	O
the	O
neurohypophysial	B-T116
hormone	I-T116
arginine	B-T116
vasopressin	I-T116
avp	B-T116
acts	O
by	O
three	O
distinct	O
receptor	B-T116
subtypes	O
v1a	B-T116
,	O
v1b	B-T116
,	O
and	O
v2	B-T116
.	O
	
in	O
the	O
liver	O
,	O
avp	B-T116
is	O
involved	B-T169
in	O
ureogenesis	O
,	O
glycogenolysis	O
,	O
neoglucogenesis	O
and	O
regeneration	O
.	O
	
no	O
data	O
exist	O
about	O
the	O
presence	B-T033
of	O
avp	B-T116
in	O
the	O
biliary	O
epithelium	O
.	O
	
cholangiocytes	O
are	O
the	O
target	O
cells	O
in	O
a	O
number	O
of	O
animal	O
models	O
of	O
cholestasis	B-T047
,	O
including	O
bile	O
duct	O
ligation	B-T061
bdl	B-T061
,	O
and	O
in	O
several	O
human	O
pathologies	O
,	O
such	O
as	O
polycystic	O
liver	O
disease	O
characterized	B-T052
by	O
the	O
presence	B-T033
of	O
cysts	B-T047
that	O
bud	O
from	O
the	O
biliary	O
epithelium	O
.	O
	
in	B-T082
vivo	I-T082
,	O
liver	O
fragments	O
from	O
normal	O
and	O
bdl	B-T061
mice	O
and	O
rats	O
as	O
well	O
as	O
liver	O
samples	O
from	O
normal	O
and	O
adpkd	O
patients	O
were	O
collected	O
to	O
evaluate	O
i	O
intrahepatic	B-T082
bile	O
duct	O
mass	B-T033
by	O
immunohistochemistry	O
for	O
cytokeratin-19	B-T116
and	O
ii	O
expression	O
of	O
v1a	B-T116
,	O
v1b	B-T116
and	O
v2	B-T116
by	O
immunohistochemistry	O
,	O
immunofluorescence	O
and	O
real-time	O
pcr	O
.	O
	
in	B-T080
vitro	I-T080
,	O
small	O
and	O
large	O
mouse	O
cholangiocytes	O
,	O
h69	O
non-malignant	B-T080
human	O
cholangiocytes	O
and	O
lcde	O
human	O
cholangiocytes	O
from	O
the	O
cystic	O
epithelium	O
were	O
stimulated	O
with	O
vasopressin	B-T116
in	O
the	O
absence/	O
presence	B-T033
of	O
avp	B-T116
antagonists	I-T116
such	O
as	O
opc-31260	B-T109
and	O
tolvaptan	B-T109
,	O
before	O
assessing	O
cellular	O
growth	O
by	O
mtt	O
assay	O
and	O
camp	O
levels	O
.	O
	
cholangiocytes	O
express	O
v2	B-T116
receptor	I-T116
that	O
was	O
upregulated	O
following	O
bdl	B-T061
and	O
in	O
adpkd	O
liver	O
samples	O
.	O
	
administration	B-T061
of	O
avp	B-T116
increased	B-T081
proliferation	O
and	O
camp	O
levels	O
of	O
small	O
cholangiocytes	O
and	O
lcde	O
cells	O
.	O
	
we	O
found	O
no	B-T080
effect	I-T080
in	O
the	O
proliferation	O
of	O
large	O
mouse	O
cholangiocytes	O
and	O
h69	O
cells	O
.	O
	
increases	B-T169
were	O
blocked	B-T169
by	O
preincubation	O
with	O
the	O
avp	B-T116
antagonists	I-T116
.	O
	
these	O
results	B-T169
showed	O
that	O
avp	B-T116
and	O
its	O
receptors	B-T116
may	O
be	O
important	O
in	O
the	O
modulation	O
of	O
the	O
proliferation	O
rate	O
of	O
the	O
biliary	O
epithelium	O
.	O
	
central	O
corneal	O
thickness	O
reproducibility	B-T081
among	O
ten	O
different	O
instruments	O
to	O
assess	O
agreement	O
between	O
one	O
ultrasonic	O
us	O
and	O
nine	O
optical	O
instruments	O
for	O
the	O
measurement	B-T169
of	O
central	O
corneal	O
thickness	O
cct	O
,	O
and	O
to	O
evaluate	O
intra-	B-T081
and	I-T081
inter-operator	I-T081
reproducibility	I-T081
.	O
	
in	O
this	O
observational	O
cross-sectional	B-T062
study	I-T062
,	O
two	O
masked	O
operators	O
measured	O
cct	O
thickness	O
twice	O
in	O
28	O
healthy	B-T080
eyes	O
.	O
	
we	O
used	O
seven	O
spectral-domain	O
optical	O
coherence	O
tomography	O
sd-oct	O
devices	O
,	O
one	O
time-domain	O
oct	O
,	O
one	O
scheimpflug	O
camera	O
,	O
and	O
one	O
us-based	O
instrument	O
.	O
	
inter-	B-T080
and	I-T080
intra-operator	I-T080
reproducibility	I-T080
was	O
evaluated	O
by	O
intraclass	B-T081
correlation	I-T081
coefficient	I-T081
icc	B-T081
,	O
coefficient	B-T081
of	I-T081
variation	I-T081
cv	B-T081
,	O
and	O
bland-altman	B-T170
test	I-T170
analysis	B-T062
.	O
	
instrument	O
-to-	O
instrument	O
reproducibility	B-T081
was	O
determined	O
by	O
anova	B-T081
for	O
repeated	O
measurements	O
.	O
	
we	O
also	O
tested	B-T169
how	O
the	O
devices	O
disagreed	O
regarding	O
systemic	B-T169
bias	B-T078
and	O
random	B-T080
error	B-T080
using	O
a	O
structural	B-T062
equation	I-T062
model	I-T062
.	O
	
mean	O
cct	O
of	O
all	O
instruments	O
ranged	O
from	O
536	O
42	O
μm	O
to	O
577	O
40	O
μm	O
.	O
	
an	O
instrument	O
-to-	O
instrument	O
correlation	B-T170
test	I-T170
showed	O
high	B-T080
values	B-T080
among	O
the	O
10	O
investigated	B-T169
devices	O
correlation	B-T081
coefficient	I-T081
range	B-T081
0.852	O
p	B-T081
values	I-T081
<0	O
in	O
all	O
cases	O
.	O
	
the	O
highest	O
correlation	O
coefficient	O
values	O
were	O
registered	O
between	O
3d	O
oct-2000	O
topcon-spectral	O
oct/slo	O
opko	O
0.995	O
and	O
cirrus	O
hd-oct	O
zeiss-rs-3000	O
nidek	O
0.995	O
,	O
whereas	O
the	O
lowest	O
were	O
seen	O
between	O
ss-1000	O
casia	O
and	O
spectral	O
oct/slo	O
opko	O
0.852	O
.	O
	
icc	B-T081
and	O
cv	B-T081
showed	O
excellent	O
inter-	B-T080
and	I-T080
intra-operator	I-T080
reproducibility	I-T080
for	O
all	O
optic	O
-based	O
devices	O
,	O
except	O
for	O
the	O
us	O
-based	O
device	O
.	O
	
bland-altman	B-T170
analysis	B-T062
demonstrated	O
low	O
mean	O
biases	B-T078
between	O
operators	O
.	O
	
despite	O
highlighting	O
good	O
intra-	B-T080
and	I-T080
inter-operator	I-T080
reproducibility	I-T080
,	O
we	O
found	O
that	O
a	O
scale	B-T170
bias	B-T078
between	O
instruments	O
might	O
interfere	B-T169
with	I-T169
thorough	O
cct	O
monitoring	O
.	O
	
we	O
suggest	O
that	O
optimal	B-T080
monitoring	O
is	O
achieved	O
with	O
the	O
same	O
operator	O
and	O
the	O
same	O
predictors	B-T078
of	O
neurologic	O
and	O
nonneurologic	B-T033
death	I-T033
in	O
patients	O
with	O
brain	O
metastasis	O
initially	O
treated	B-T169
with	O
upfront	B-T061
stereotactic	I-T061
radiosurgery	I-T061
without	O
whole-brain	B-T061
radiation	I-T061
therapy	I-T061
in	O
this	O
study	B-T062
we	O
attempted	O
to	O
discern	O
the	O
factors	B-T169
predictive	B-T080
of	O
neurologic	O
death	O
in	O
patients	O
with	O
brain	O
metastasis	O
treated	B-T169
with	O
upfront	B-T061
stereotactic	I-T061
radiosurgery	I-T061
srs	B-T061
without	O
whole	B-T061
brain	I-T061
radiation	I-T061
therapy	I-T061
wbrt	B-T061
while	O
accounting	O
for	O
the	O
competing	B-T078
risk	I-T078
of	O
nonneurologic	B-T033
death	I-T033
.	O
	
we	O
performed	O
a	O
retrospective	B-T080
single-institution	O
analysis	B-T062
of	O
patients	O
with	O
brain	O
metastasis	O
treated	B-T169
with	O
upfront	O
srs	B-T061
without	O
wbrt	B-T061
.	O
	
competing	B-T080
risks	I-T080
analysis	I-T080
was	O
performed	O
to	O
estimate	O
the	O
subdistribution	O
hazard	B-T081
ratios	I-T081
hrs	B-T081
for	O
neurologic	O
and	O
nonneurologic	B-T033
death	I-T033
for	O
predictor	B-T078
variables	O
of	O
interest	O
.	O
	
of	O
738	O
patients	O
treated	B-T169
with	O
upfront	B-T061
srs	I-T061
alone	O
,	O
neurologic	O
death	O
occurred	O
in	O
226	O
30.6	O
,	O
while	O
nonneurologic	B-T033
death	I-T033
occurred	O
in	O
309	O
41.9	O
.	O
	
multivariate	B-T081
competing	I-T081
risks	I-T081
analysis	I-T081
identified	O
an	O
increased	B-T081
hazard	B-T081
of	O
neurologic	O
death	O
associated	O
with	O
diagnosis-specific	B-T170
graded	I-T170
prognostic	I-T170
assessment	I-T170
ds-gpa	B-T170
2	O
p	O
=	O
005	O
,	O
melanoma	O
histology	O
p	O
=	O
009	O
,	O
and	O
increased	B-T081
number	O
of	O
brain	O
metastases	O
p<	O
,	O
while	O
there	O
was	O
a	O
decreased	B-T081
hazard	B-T081
associated	O
with	O
higher	O
srs	B-T061
dose	B-T081
p	O
=	O
004	O
.	O
	
targeted	O
agents	O
were	O
associated	O
with	O
a	O
decreased	B-T081
hr	B-T081
of	O
neurologic	O
death	O
in	O
the	O
first	O
1.5	O
years	B-T079
p	O
=	O
04	O
but	O
not	O
afterwards	O
.	O
	
an	O
increased	B-T081
hazard	B-T081
of	O
nonneurologic	B-T033
death	I-T033
was	O
seen	O
with	O
increasing	O
age	O
p	O
=	O
,	O
nonmelanoma	O
histology	O
p<	O
,	O
presence	O
of	O
extracranial	B-T047
disease	I-T047
p<	O
,	O
and	O
progressive	B-T169
systemic	B-T047
disease	I-T047
p	O
=	O
.	O
	
melanoma	O
,	O
ds-gpa	B-T170
,	O
number	B-T081
of	O
brain	O
metastases	O
,	O
and	O
srs	B-T061
dose	B-T081
are	O
predictive	B-T080
of	O
neurologic	O
death	O
,	O
while	O
age	O
,	O
nonmelanoma	O
histology	O
,	O
and	O
more	O
advanced	O
systemic	B-T047
disease	I-T047
are	O
predictive	B-T080
of	O
nonneurologic	B-T033
death	I-T033
.	O
	
targeted	O
agents	O
appear	O
to	O
delay	B-T079
neurologic	O
death	O
.	O
	
pharmacological	O
actions	O
of	O
glucagon-like	B-T116
peptide-1	I-T116
,	O
gastric	B-T116
inhibitory	I-T116
polypeptide	I-T116
,	O
and	O
glucagon	B-T116
glucagon	B-T116
family	I-T116
of	O
peptide	B-T116
hormones	I-T116
is	O
a	O
group	O
of	O
structurally	O
related	O
brain-gut	B-T116
peptides	I-T116
that	O
exert	O
their	O
pleiotropic	O
actions	O
through	O
interactions	O
with	O
unique	O
members	O
of	O
class	O
b1	O
g	B-T116
protein-coupled	I-T116
receptors	I-T116
gpcrs	B-T116
.	O
	
they	O
are	O
key	O
regulators	O
of	O
hormonal	B-T080
homeostasis	O
and	O
are	O
important	O
drug	O
targets	O
for	O
metabolic	B-T047
disorders	I-T047
such	O
as	O
type-2	B-T047
diabetes	I-T047
mellitus	I-T047
t2dm	B-T047
,	O
obesity	B-T047
,	O
and	O
dysregulations	B-T047
of	I-T047
the	I-T047
nervous	I-T047
systems	I-T047
such	O
as	O
migraine	B-T047
,	O
anxiety	O
,	O
depression	O
,	O
neurodegeneration	O
,	O
psychiatric	O
disorders	O
,	O
and	O
cardiovascular	B-T047
diseases	I-T047
.	O
	
the	O
current	O
review	O
aims	O
to	O
provide	O
a	O
detailed	O
overview	B-T170
of	O
the	O
current	O
understanding	O
of	O
the	O
pharmacological	O
actions	O
and	O
therapeutic	B-T061
advances	I-T061
of	O
three	O
members	O
within	O
this	O
family	O
including	O
glucagon-like	B-T116
peptide-1	I-T116
glp-1	B-T116
,	O
gastric	B-T116
inhibitory	I-T116
polypeptide	I-T116
gip	B-T116
,	O
and	O
endemic	B-T082
hydrothermal	O
vent	O
species	O
identified	B-T080
in	O
the	O
open	O
ocean	B-T170
seed	O
bank	O
hydrothermal	O
vent	O
systems	B-T169
host	O
microbial	O
communities	O
among	O
which	O
several	B-T081
microorganisms	O
have	O
been	O
considered	B-T078
endemic	B-T082
to	O
this	O
type	O
of	O
habitat	B-T082
.	O
	
it	O
is	O
still	O
unclear	B-T033
how	O
these	O
organisms	O
colonize	B-T033
geographically	O
distant	B-T082
hydrothermal	B-T080
environments	B-T082
.	O
	
based	O
on	O
16s	O
rrna	O
gene	O
sequences	O
,	O
we	O
compare	B-T052
the	O
bacterial	B-T080
communities	O
of	O
sixteen	O
atlantic	O
hydrothermal	O
vent	O
samples	O
with	O
our	O
own	O
and	O
publicly	O
available	B-T169
global	B-T080
open	O
ocean	B-T170
samples	O
.	O
	
analysing	B-T062
sequences	O
obtained	B-T169
from	O
63	O
million	O
16s	O
rrna	O
genes	O
,	O
the	O
genera	O
we	O
could	O
identify	O
in	O
the	O
open	O
ocean	B-T170
waters	I-T170
contained	B-T169
99.9	O
of	O
the	O
vent	O
reads	O
.	O
	
this	O
suggests	B-T078
that	O
previously	B-T079
observed	B-T169
vent	O
exclusiveness	B-T033
is	O
,	O
in	O
most	O
cases	B-T169
,	O
probably	B-T078
an	O
artefact	B-T033
of	O
lower	B-T052
sequencing	O
depth	B-T080
.	O
	
these	O
findings	B-T033
are	O
a	O
further	O
step	O
towards	O
elucidating	O
the	O
role	B-T170
of	O
the	O
open	O
ocean	B-T170
as	O
a	O
seed	O
bank	O
.	O
	
they	O
can	O
explain	O
the	O
predicament	B-T033
of	O
how	O
species	O
expected	B-T170
to	O
be	O
endemic	B-T082
to	O
vent	O
systems	B-T169
are	O
able	B-T033
to	O
colonize	B-T033
geographically	O
distant	B-T082
hydrothermal	B-T080
habitats	B-T082
and	O
contribute	B-T052
to	O
our	O
understanding	O
cerebral	B-T047
toxoplasmosis	I-T047
in	O
patients	O
with	O
acquired	B-T047
immune	I-T047
deficiency	I-T047
syndrome	I-T047
in	O
the	O
neurological	O
emergency	O
department	O
of	O
a	O
tertiary	O
hospital	O
cerebral	B-T047
toxoplasmosis	I-T047
is	O
the	O
most	O
common	O
cause	B-T169
of	O
space	B-T082
occupying	O
brain	B-T047
lesion	I-T047
in	O
patients	O
with	O
hiv/aids	B-T047
in	O
brazil	O
.	O
	
in	O
the	O
post-haart	B-T079
era	I-T079
,	O
it	O
is	O
responsible	O
for	O
high	B-T080
rates	B-T081
of	O
morbidity	B-T081
and	O
mortality	B-T081
worldwide	O
.	O
	
this	O
study	B-T062
consists	O
of	O
a	O
case	B-T062
series	I-T062
of	O
56	O
patients	O
diagnosed	B-T033
with	O
cerebral	B-T047
toxoplasmosis	I-T047
whose	O
clinical	B-T080
features	B-T080
,	O
brain	O
imaging	O
and	O
cerebrospinal	O
fluid	O
aspects	B-T080
were	O
analyzed	B-T062
.	O
	
cerebral	B-T047
toxoplasmosis	I-T047
led	O
to	O
the	O
diagnosis	B-T033
of	O
infection	O
by	O
the	O
human	O
immunodeficiency	O
virus	O
hiv	O
in	O
27	O
48.2	O
of	O
the	O
patients	O
,	O
while	O
29	O
51.2	O
others	O
already	O
knew	O
to	O
be	O
hiv	O
seropositive	O
.	O
	
however	O
,	O
at	O
the	O
time	B-T079
of	O
diagnosis	B-T033
of	O
cerebral	B-T047
toxoplasmosis	I-T047
,	O
only	O
9	O
16.6	O
reported	O
being	O
under	O
antiretroviral	B-T061
therapy	I-T061
and	O
5	O
8.9	O
were	O
receiving	B-T080
primary	B-T080
prophylaxis	B-T061
for	O
toxoplasmosis	B-T047
.	O
	
headache	O
,	O
strength	O
deficit	O
and	O
fever	O
were	O
the	O
most	O
frequent	O
signs	O
and	O
symptoms	O
throughout	O
the	O
study	B-T062
.	O
	
fifty-three	O
patients	O
showed	O
changes	B-T169
consistent	B-T078
with	I-T078
toxoplasmosis	B-T047
in	O
ct	O
or	O
mri	O
.	O
	
thirty-four	O
60.7	O
csf	O
samples	O
were	O
positive	B-T033
in	O
the	O
indirect	O
haemagglutination	O
test	O
and	O
for	O
the	O
reaction	B-T169
of	O
toxoplasma	B-T116
gondii	I-T116
igg	I-T116
elisa	O
,	O
while	O
31	O
55.4	O
were	O
positive	B-T033
in	O
the	O
direct	O
haemagglutination	O
test	O
.	O
	
fifty	O
89.3	O
patients	O
underwent	O
first-line	B-T061
treatment	I-T061
for	O
toxoplasmosis	B-T047
.	O
	
cerebral	B-T047
toxoplasmosis	I-T047
is	O
still	O
a	O
very	O
relevant	B-T080
neurological	B-T047
disease	I-T047
in	O
individuals	B-T098
with	O
aids	B-T047
admitted	O
to	O
neurology	O
emergency	O
departments	O
.	O
	
early	O
diagnosis	O
and	O
initiation	B-T169
of	O
empiric	B-T033
treatment	I-T033
and	O
antiretroviral	B-T061
therapy	I-T061
are	O
important	O
for	O
good	O
maf1	O
-mediated	O
regulation	O
of	O
yeast	O
rna	B-T116
polymerase	I-T116
iii	I-T116
is	O
correlated	B-T080
with	O
cca	O
addition	O
at	O
the	O
3'	O
end	O
of	O
trna	O
precursors	O
in	O
eukaryotic	O
cells	O
trna	O
synthesis	O
is	O
negatively	O
regulated	O
by	O
the	O
protein	O
maf1	O
,	O
conserved	O
from	O
yeast	O
to	O
humans	O
.	O
	
maf1	O
from	O
yeast	O
saccharomyces	O
cerevisiae	O
mediates	O
repression	O
of	O
trna	O
transcription	O
when	O
cells	O
are	O
transferred	O
from	O
medium	O
with	O
glucose	O
to	O
medium	O
with	O
glycerol	O
,	O
a	O
non-fermentable	O
carbon	O
source	O
.	O
	
the	O
strain	O
with	O
deleted	O
gene	O
encoding	O
maf1	O
maf1δ	O
is	O
viable	O
but	O
accumulates	O
trna	O
precursors	O
.	O
	
in	O
this	O
study	O
trna	O
precursors	O
were	O
analysed	O
by	O
rna-seq	O
and	O
northern	O
hybridization	O
in	O
wild	O
type	O
strain	O
and	O
maf1δ	O
mutant	O
grown	O
in	O
glucose	O
medium	O
or	O
upon	O
shift	O
to	O
repressive	O
conditions	O
.	O
	
a	O
negative	O
effect	O
of	O
maf1δ	O
mutant	O
on	O
the	O
addition	O
of	O
the	O
auxiliary	O
cca	O
nucleotides	O
to	O
the	O
3'	O
end	O
of	O
pre-trnas	O
was	O
observed	O
in	O
cells	O
shifted	O
to	O
unfavourable	O
growth	O
conditions	O
.	O
	
this	O
effect	O
was	O
reduced	O
by	O
overexpression	O
of	O
the	O
yeast	O
cca1	O
gene	O
encoding	O
atp	O
nucleotidyltransferase	O
.	O
	
the	O
cca	O
sequence	O
at	O
the	O
3'	O
end	O
is	O
important	O
for	O
export	O
of	O
trna	O
precursors	O
from	O
the	O
nucleus	O
and	O
essential	O
for	O
trna	O
charging	O
with	O
amino	O
acids	O
.	O
	
data	O
presented	O
here	O
indicate	O
that	O
cca-addition	O
to	O
intron	O
-containing	O
end-processed	O
trna	O
precursors	O
is	O
a	O
limiting	O
step	O
in	O
trna	O
maturation	O
when	O
there	O
is	O
no	O
maf1	O
mediated	O
rna	O
polymerase	O
iii	O
pol	O
iii	O
repression	O
.	O
	
the	O
correlation	O
between	O
cca	O
synthesis	O
and	O
pol	O
iii	O
regulation	O
by	O
maf1	O
could	O
be	O
important	O
in	O
coordination	O
of	O
trna	O
transcription	O
,	O
processing	O
and	O
regulation	O
of	O
translation	O
pre-existing	B-T080
renal	O
lesions	B-T033
revealed	O
after	O
renal	O
trauma	O
,	O
difficulties	O
in	O
diagnosis	B-T062
and	O
accountability	B-T078
about	O
14	O
cases	O
pre-existing	B-T080
renal	O
lesions	B-T033
perl	B-T033
may	O
interfere	O
with	O
the	O
patho-physiology	B-T169
of	O
trauma	O
,	O
alter	O
the	O
radiographic	O
imaging	O
and	O
influence	O
the	O
therapeutic	B-T061
approach	O
.	O
	
the	O
aims	B-T078
of	O
this	O
study	B-T062
were	O
to	O
record	O
the	O
perl	B-T033
found	O
incidentally	O
during	O
blunt	B-T080
renal	O
trauma	O
,	O
to	O
specify	O
the	O
place	O
for	O
effective	O
conservative	B-T061
management	I-T061
and	O
to	O
determin	O
the	O
estimated	O
partial	B-T033
permanent	I-T033
disability	I-T033
ppd	B-T033
.	O
	
the	O
medical	B-T170
records	I-T170
of	O
14	O
patients	O
with	O
perl	B-T033
and	O
blunt	B-T080
renal	O
trauma	O
were	O
reviewed	O
.	O
	
in	O
each	O
patient	O
,	O
pre-existing	B-T080
renal	O
abnormalities	O
,	O
clinical	B-T080
symptoms	O
,	O
ct	O
scan	O
study	B-T062
findings	B-T033
,	O
associated	O
injuries	O
,	O
therapeutic	B-T061
approach	O
,	O
the	O
accountability	B-T078
criteria	O
and	O
the	O
estimated	O
ppd	B-T033
were	O
recorded	O
.	O
	
there	O
were	O
11	O
men	B-T098
and	O
3	O
women	B-T098
with	O
a	O
mean	B-T081
age	O
of	O
35	O
years	B-T079
range	O
19-66	O
years	B-T079
.	O
	
renal	O
trauma	O
was	O
due	O
to	O
a	O
traffic	O
accident	O
in	O
8	O
patients	O
.	O
	
renal	O
damage	O
appeared	O
to	O
be	O
disproportionate	O
to	O
the	O
severity	B-T080
of	O
the	O
trauma	O
minor	O
trauma	O
.	O
	
they	O
had	O
a	O
lower	O
rate	O
of	O
associated	O
trauma	O
to	O
other	O
abdominal	O
organs	O
four	O
patients	O
only	O
.	O
	
urinary	O
stones	O
were	O
present	O
in	O
5	O
patients	O
,	O
pelvi-ureteric	O
junction	O
obstruction	O
in	O
3	O
,	O
horseshoe	O
kidny	O
in	O
3	O
,	O
ectopic	O
kidney	O
in	O
2	O
and	O
upper	O
urinary	O
tract	O
carcinoma	O
in	O
one	O
case	O
.	O
	
early	O
nephrectomy	B-T061
was	O
required	O
in	O
three	O
cases	O
for	O
hemodynamic	B-T047
instability	I-T047
.	O
	
ureteral	O
stenting	O
was	O
indicated	O
in	O
3	O
cases	O
.	O
	
six	O
patients	O
were	O
operated	B-T061
later	O
because	O
of	O
their	O
underlying	O
renal	O
pathology	O
.	O
	
a	O
conservative	B-T061
treatment	I-T061
was	O
possible	O
only	O
in	O
7	O
of	O
cases	O
.	O
	
the	O
ppd	B-T033
related	O
to	O
renal	O
trauma	O
varide	O
from	O
0	O
to	O
13%	O
in	O
all	O
cases	O
.	O
	
perl	B-T033
may	O
complicate	O
a	O
negligible	O
renal	O
trauma	O
while	O
in	O
some	O
cases	O
they	O
may	O
be	O
of	O
vital	O
importance	O
for	O
the	O
patient's	O
final	O
outcome	O
.	O
	
the	O
imaging	O
findings	B-T033
are	O
crucial	O
but	O
may	O
be	O
confusing	O
.	O
	
the	O
therapeutic	B-T061
approach	O
is	O
,	O
to	O
a	O
large	O
extent	O
,	O
dependent	O
on	O
the	O
type	O
of	O
perl	B-T033
and	O
the	O
severity	B-T080
of	O
damage	B-T169
,	O
and	O
is	O
often	O
conservative	O
in	O
the	O
hemo-dynamically	B-T033
stable	I-T033
patient	O
.	O
	
accountability	B-T078
link	O
may	O
be	O
difficult	O
to	O
establish	O
and	O
the	O
ppd	B-T033
depends	O
on	O
the	O
perl	B-T033
and	O
the	O
renal	O
injuries	O
severity	B-T080
.	O
	
polymeric	O
nanostructure	O
compiled	O
with	O
multifunctional	O
components	O
to	O
exert	O
tumor	O
-	O
targeted	O
delivery	O
of	O
antiangiogenic	O
gene	O
for	O
tumor	O
growth	O
suppression	B-T080
nucleic	O
acid-based	O
therapy	B-T061
has	O
emerged	O
as	O
a	O
revolutionary	B-T078
methodology	I-T078
for	O
treatment	B-T169
of	O
the	O
diseases	B-T047
related	O
to	O
protein	B-T116
dysfunction	O
however	O
,	O
lack	B-T080
of	I-T080
systemically	B-T169
applicable	B-T080
synthetic	O
delivery	O
systems	O
limits	O
its	O
current	O
usage	O
in	O
local	O
applications	O
,	O
particularly	O
for	O
dna-based	O
therapy	B-T061
with	O
regard	O
to	O
the	O
poor	B-T081
bioavailability	I-T081
in	O
the	O
systemic	O
administrations	O
.	O
	
to	O
overcome	O
this	O
obstacle	O
,	O
we	O
compiled	O
multiple	B-T081
chemistry-based	O
strategies	O
into	O
the	O
manufacture	O
of	O
the	O
gene	O
delivery	O
formulations	O
to	O
pursue	O
improved	B-T033
tolerability	B-T080
of	O
dna	O
to	O
the	O
enzymatic	O
degradation	O
in	O
the	O
biological	B-T080
milieu	B-T082
and	O
prolonged	O
retention	O
in	O
the	O
systemic	O
circulation	O
.	O
	
here	O
,	O
we	O
constructed	O
a	O
distinctive	B-T080
multilayered	I-T080
functional	B-T169
architecture	B-T082
plasmid	O
dna	O
pdna	O
was	O
electrostatically	O
complexed	O
with	O
cationic	O
poly	B-T116
polyplex	O
as	O
the	O
interior	B-T082
pdna	O
reservoir	B-T082
,	O
which	O
was	O
further	O
cross-linked	O
by	O
redox	O
-	O
responsive	B-T169
disulfide	O
cross-linking	B-T169
to	O
minimize	O
the	O
occurrence	B-T079
of	O
polyplex	O
disassembly	B-T052
through	O
exchange	O
reaction	O
with	O
the	O
biological	B-T080
charged	O
components	O
.	O
	
still	O
,	O
the	O
pdna	O
reservoir	B-T082
was	O
spatially	O
protected	O
by	O
a	O
sequential	B-T080
thermoresponsive	B-T169
poly	B-T109
palisade	B-T033
as	O
the	O
intermediate	B-T033
barrier	I-T033
and	O
a	O
biocompatible	O
hydrophilic	B-T080
poly	B-T109
glycol	I-T109
peg	B-T109
shell	B-T080
with	O
the	O
aim	O
of	O
preventing	O
the	O
accessibility	B-T080
of	O
the	O
biological	B-T080
species	O
,	O
particularly	O
the	O
nuclease	B-T116
degradation	B-T169
to	O
the	O
pdna	O
payload	O
.	O
	
subsequent	O
investigations	O
validated	O
the	O
utilities	O
of	O
these	O
strategies	O
in	O
accomplishing	O
prolonged	O
blood	O
retention	O
.	O
	
in	O
an	O
attempt	O
to	O
apply	O
this	O
method	B-T170
for	O
tumor	O
therapy	B-T061
,	O
ligand	B-T116
cyclic	I-T116
arg-gly-asp	I-T116
peptide	I-T116
was	O
attached	O
at	O
the	O
distal	O
end	O
of	O
peg	B-T109
,	O
validating	O
prompted	O
tumor	O
-	O
targeted	B-T169
delivery	O
and	O
gene	O
expression	O
of	O
the	O
loaded	O
antiangiogenic	O
gene	O
at	O
the	O
targeted	B-T169
tumor	O
cells	O
and	O
accordingly	O
exerting	O
antiangiogenesis	O
of	O
the	O
tumors	O
for	O
abrogation	B-T079
of	O
tumor	O
growth	O
.	O
	
together	O
with	O
its	O
excellent	O
safe	O
profile	O
,	O
the	O
proposed	O
formulation	O
suggests	O
potential	B-T080
utility	O
as	O
a	O
practical	O
gene	O
delivery	O
system	O
for	O
treatment	B-T169
of	O
intractable	B-T169
diseases	B-T047
.	O
	
evaluation	O
of	O
the	O
vidas	O
anti-hcv	O
assay	O
for	O
detection	B-T061
of	O
hepatitis	B-T047
c	I-T047
virus	I-T047
infection	I-T047
anti-hepatitis	B-T116
c	I-T116
virus	I-T116
antibody	I-T116
anti-hcv	B-T116
assays	O
are	O
recommended	O
for	O
screening	O
hcv	O
-infected	O
persons	O
.	O
	
the	O
vidas	O
anti-hcv	O
assay	O
biomérieux	O
,	O
france	O
,	O
based	O
on	O
the	O
enzyme-linked	O
fluorescence	O
test	O
principle	O
,	O
was	O
recently	O
introduced	O
in	O
korea	O
.	O
	
we	O
evaluated	O
the	O
clinical	O
performance	O
of	O
the	O
vidas	O
assay	O
.	O
	
one	O
hundred	O
hcv-positive	O
and	O
1	O
hcv-negative	O
blood	O
samples	O
confirmed	O
by	O
architect	O
anti-hcv	O
abbott	O
laboratories	O
,	O
usa	O
and	O
cobas	O
taqman	O
hcv	B-T098
real-time	O
pcr	O
roche	O
diagnostics	O
,	O
usa	O
or	O
the	O
procleix	O
ultrio	O
plus	O
assay	O
gen-probe	O
incorporated	O
,	O
usa	O
were	O
obtained	O
from	O
the	O
human	O
serum	O
bank	O
hsb	O
and	O
tested	O
by	O
vidas	O
.	O
	
in	O
case	O
of	O
discrepant	O
results	O
,	O
we	O
conducted	O
a	O
recombinant	O
immunoblot	O
assay	O
riba	O
.	O
	
the	O
agreement	O
rates	O
for	O
known	O
hcv-positive	O
and	O
hcv-negative	O
samples	O
between	O
the	O
vidas	O
assay	O
and	O
the	O
hsb	O
testing	O
were	O
100%	O
95%	O
confidence	O
interval	O
ci	O
96.4	O
and	O
99.5	O
95%	O
ci	O
98.8	O
,	O
respectively	O
.	O
	
one	O
of	O
the	O
five	O
discrepant	O
samples	O
was	O
positive	O
for	O
core	O
2+	O
and	O
ns3-2	O
2+	O
reactivity	O
,	O
two	O
samples	O
were	O
negative	O
,	O
and	O
the	O
other	O
two	O
were	O
indeterminate	O
regarding	O
ns4	O
2+	O
reactivity	O
in	O
riba	O
.	O
	
we	O
observed	O
a	O
significant	O
but	O
weak	O
positive	O
correlation	O
between	O
the	O
titers	O
of	O
vidas	O
and	O
architect	O
assays	O
r=0	O
,	O
p<0	O
.	O
	
the	O
vidas	O
anti-hcv	O
assay	O
,	O
developed	O
on	O
the	O
vidas	O
automated	O
immunoassay	O
platform	O
based	O
on	O
the	O
ready-to-use	O
,	O
single-sample	O
test	O
concept	O
may	O
be	O
useful	O
in	O
small-to-medium-sized	O
laboratories	O
.	O
	
it	O
showed	O
good	O
agreement	O
with	O
architect	O
anti-hcv	O
and	O
cobas	O
pcr	O
assays	O
and	O
is	O
therefore	O
useful	O
for	O
detection	O
of	O
hcv	O
infection	O
.	O
	
weakly	O
test-positive	O
ambiguous	O
samples	O
require	O
additional	O
testing	O
by	O
another	O
anti-hcv	O
,	O
riba	O
,	O
or	O
hcv	O
rna	O
assay	O
reassembly	O
of	O
excitable	O
domains	O
after	O
cns	O
axon	O
regeneration	O
action	O
potential	O
initiation	O
and	O
propagation	O
in	O
myelinated	O
axons	O
require	O
ion	O
channel	O
clustering	O
at	O
axon	O
initial	O
segments	O
ais	O
and	O
nodes	O
of	O
ranvier	O
.	O
	
disruption	B-T169
of	O
these	O
domains	O
after	O
injury	O
impairs	B-T169
nervous	O
system	O
function	O
.	O
	
traditionally	O
,	O
injured	B-T169
cns	O
axons	O
are	O
considered	O
refractory	O
to	O
regeneration	O
,	O
but	O
some	O
recent	O
approaches	O
challenge	O
this	O
view	O
by	O
showing	O
robust	B-T080
long-distance	B-T081
regeneration	O
.	O
	
however	O
,	O
whether	O
these	O
approaches	O
allow	O
remyelination	O
and	O
promote	O
the	O
reestablishment	O
of	O
ais	O
and	O
nodes	O
of	O
ranvier	O
is	O
unknown	B-T080
.	O
	
using	O
mouse	O
optic	O
nerve	O
crush	O
as	O
a	O
model	O
for	O
cns	O
traumatic	O
injury	O
,	O
we	O
performed	O
a	O
detailed	O
analysis	B-T062
of	O
ais	O
and	O
node	O
disruption	B-T169
after	O
nerve	O
crush	O
.	O
	
we	O
found	O
significant	O
disruption	B-T169
of	O
ais	O
and	O
loss	B-T081
of	O
nodes	O
within	O
days	O
of	O
the	O
crush	O
,	O
and	O
complete	O
loss	B-T081
of	O
nodes	O
1	O
week	O
after	O
injury	O
.	O
	
genetic	O
deletion	O
of	O
the	O
tumor	O
suppressor	O
phosphatase	O
and	O
tensin	O
homolog	O
pten	O
in	O
retinal	O
ganglion	O
cells	O
rgcs	O
,	O
coupled	O
with	O
stimulation	O
of	O
rgcs	O
by	O
inflammation	O
and	O
camp	O
,	O
dramatically	O
enhanced	O
regeneration	O
.	O
	
with	O
this	O
treatmen	B-T062
t	O
,	O
we	O
found	O
significant	O
reestablishment	O
of	O
rgc	O
ais	O
,	O
remyelination	O
,	O
and	O
even	O
reassembly	O
of	O
nodes	O
in	O
regions	B-T082
proximal	I-T082
,	O
within	B-T082
,	O
and	O
distal	B-T082
to	O
the	O
crush	O
site	O
.	O
	
remyelination	O
began	O
near	O
the	O
retina	O
,	O
progressed	B-T169
distally	B-T082
,	O
and	O
was	O
confirmed	O
by	O
electron	O
microscopy	O
.	O
	
although	O
axons	O
grew	O
rapidly	B-T080
,	O
remyelination	O
and	O
nodal	O
ion	O
channel	O
clustering	O
was	O
much	O
slower	B-T080
.	O
	
finally	O
,	O
genetic	O
deletion	O
of	O
ankyring	B-T116
from	O
rgcs	O
to	O
block	B-T169
ais	O
reassembly	O
did	O
not	O
affect	O
axon	O
regeneration	O
,	O
indicating	O
that	O
preservation	O
of	O
neuronal	B-T082
polarity	I-T082
is	O
not	B-T033
required	I-T033
for	O
axon	O
regeneration	O
.	O
	
together	O
,	O
our	O
results	O
demonstrate	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
regenerating	O
cns	O
axons	O
can	O
be	O
remyelinated	O
and	O
reassemble	O
new	O
ais	O
and	O
nodes	O
of	O
ranvier	O
.	O
	
we	O
show	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
regenerated	O
cns	O
axons	O
have	O
the	O
capacity	B-T081
to	O
both	O
remyelinate	O
and	O
reassemble	O
the	O
axon	O
initial	O
segments	O
and	O
nodes	O
of	O
ranvier	O
necessary	O
for	O
rapid	B-T080
and	O
efficient	B-T080
action	O
potential	O
propagation	O
.	O
	
clinicopathological	O
relevance	O
of	O
kinesin	B-T116
family	I-T116
member	I-T116
18a	I-T116
expression	O
in	O
invasive	O
breast	O
cancer	O
recently	O
,	O
kinesin	B-T116
motor	B-T116
proteins	I-T116
have	O
been	O
focused	O
on	O
as	O
targets	B-T169
for	O
cancer	B-T061
therapy	I-T061
.	O
	
kinesins	B-T116
are	O
microtubule	B-T116
-based	O
motor	B-T116
proteins	I-T116
that	O
mediate	O
diverse	B-T169
functions	I-T169
within	O
the	O
cell	O
,	O
including	O
the	O
transport	O
of	O
vesicles	O
,	O
organelles	O
,	O
chromosomes	O
and	O
protein	B-T116
complexes	I-T116
,	O
as	O
well	O
as	O
the	O
movement	O
of	O
microtubules	O
.	O
	
in	O
the	O
current	O
study	O
,	O
the	O
expression	O
of	O
kinesin	B-T116
family	I-T116
member	I-T116
18a	I-T116
kif18a	B-T116
,	O
a	O
member	B-T116
of	I-T116
kinesin	I-T116
superfamily	I-T116
,	O
was	O
investigated	B-T169
in	O
breast	O
cancer	O
using	O
immunohistochemistry	O
,	O
and	O
its	O
effect	O
on	O
breast	O
cancer	O
prognosis	O
was	O
examined	O
.	O
	
kif18a	B-T116
expression	B-T081
level	I-T081
was	O
significantly	O
associated	B-T080
with	I-T080
lymph	O
node	O
metastasis	O
p=0	O
.	O
	
in	O
patients	O
with	O
high	O
levels	O
of	O
kif18a	B-T116
expression	O
,	O
survival	B-T052
was	O
significantly	O
poorer	O
compared	O
to	O
patients	O
with	O
low	O
levels	O
of	O
kif18a	B-T116
expression	O
disease-free	B-T081
survival	I-T081
,	O
p=0	O
.	O
	
multivariate	B-T081
analysis	I-T081
revealed	O
that	O
venous	B-T033
invasion	I-T033
hazard	B-T081
ratio	I-T081
,	O
9.22	O
95%	O
confidence	B-T081
interval	I-T081
,	O
3.90	O
p<0	O
and	O
kif18a	B-T116
expression	O
hazard	B-T081
ratio	I-T081
,	O
3.20	O
95%	O
confidence	B-T081
interval	I-T081
,	O
1.34	O
p=0	O
were	O
independent	O
predictive	B-T170
factors	I-T170
for	O
lymph	O
node	O
metastasis	O
.	O
	
kif18a	B-T116
may	O
be	O
a	O
useful	O
predictive	B-T170
marker	O
for	O
lymph	O
node	O
metastasis	O
in	O
breast	O
cancer	O
,	O
which	O
could	O
facilitate	O
curative	B-T033
adjuvant	I-T033
treatment	B-T061
.	O
	
the	O
underlying	O
inflammatory	B-T047
chronic	I-T047
disease	I-T047
influences	O
infliximab	B-T116
pharmacokinetics	B-T169
infliximab	B-T116
is	O
an	O
anti-tumor	O
necrosis	O
factor	O
monoclonal	B-T116
antibody	I-T116
approved	O
in	O
chronic	B-T047
inflammatory	I-T047
diseases	I-T047
such	O
as	O
rheumatoid	B-T047
arthritis	I-T047
ra	B-T047
,	O
psoriatic	B-T047
arthritis	I-T047
psa	B-T047
,	O
ankylosing	B-T047
spondylitis	I-T047
as	B-T047
,	O
crohn's	B-T047
disease	I-T047
cd	B-T047
and	O
ulcerative	B-T047
colitis	I-T047
uc	B-T047
.	O
	
infliximab	B-T116
pharmacokinetics	B-T169
is	O
variable	O
between	O
patients	O
,	O
but	O
influence	O
of	O
the	O
underlying	B-T047
disease	I-T047
was	O
never	O
assessed	B-T052
.	O
	
this	O
study	O
aimed	O
at	O
assessing	O
this	O
influence	O
using	O
a	O
cohort	B-T098
of	O
patients	O
monitored	O
in	O
a	O
single	O
center	O
and	O
with	O
the	O
same	O
assay	O
.	O
	
infliximab	B-T116
trough	O
concentrations	B-T081
were	O
determined	B-T080
on	O
samples	O
collected	O
between	O
weeks	O
0	O
and	O
22	O
after	O
treatment	B-T169
initiation	B-T169
in	O
218	O
patients	O
treated	B-T169
for	O
ra	B-T047
,	O
psa	B-T047
,	O
as	B-T047
,	O
cd	B-T047
or	O
uc	B-T047
.	O
	
infliximab	B-T116
pharmacokinetics	B-T169
was	O
analyzed	B-T062
by	O
a	O
one-compartment	O
population	B-T098
model	O
with	O
first-order	O
elimination	B-T033
rate	B-T081
constant	I-T081
.	O
	
in	O
as	B-T047
patients	O
,	O
volume	B-T081
of	I-T081
distribution	I-T081
v	B-T081
and	O
elimination	B-T033
clearance	B-T080
cl	B-T080
were	O
5.4	O
l	O
and	O
0.24	O
l/day	O
,	O
respectively	O
.	O
	
in	O
cd	B-T047
and	O
uc	B-T047
patients	O
,	O
v	O
was	O
49%	O
and	O
52%	O
higher	O
than	O
in	O
as	B-T047
,	O
respectively	O
,	O
and	O
cl	B-T080
was	O
47%	O
and	O
60%	O
higher	O
than	O
in	O
as	B-T047
,	O
respectively	O
.	O
	
in	O
ra	B-T047
patients	O
,	O
cl	B-T080
was	O
49%	O
higher	O
than	O
in	O
as	B-T047
patients	O
.	O
	
simulations	B-T062
showed	O
that	O
without	O
methotrexate	B-T109
,	O
a	O
3	O
mg/kg	O
dosing	B-T081
regimen	B-T061
would	O
lead	O
only	O
16%	O
of	O
ra	B-T047
patients	O
to	O
reach	O
the	O
target	B-T169
concentration	B-T081
2.5	O
mg/l	O
at	O
week	O
22	O
,	O
whereas	O
target	B-T169
concentrations	B-T081
would	O
be	O
reached	O
in	O
approximately	B-T080
half	O
of	O
ra	B-T047
patients	O
cotreated	B-T169
with	O
methotrexate	B-T109
,	O
as	O
well	O
as	O
half	O
of	O
cd	B-T047
3.5	O
mg/l	O
and	O
uc	B-T047
3.7	O
mg/l	O
patients	O
.	O
	
the	O
suboptimality	O
of	O
approved	O
dosing	B-T081
regimens	B-T061
supports	O
the	O
development	B-T169
of	O
dosing	B-T081
optimization	B-T052
based	O
on	O
concentration	B-T081
measurements	I-T081
.	O
	
international	B-T078
validation	B-T062
of	O
a	O
urinary	O
biomarker	O
panel	O
for	O
identification	O
of	O
active	B-T169
lupus	B-T047
nephritis	I-T047
in	O
children	O
conventional	O
markers	O
of	O
juvenile-onset	B-T047
systemic	I-T047
lupus	I-T047
erythematosus	I-T047
jsle	B-T047
disease	O
activity	O
fail	O
to	O
adequately	O
identify	O
lupus	B-T047
nephritis	I-T047
ln	B-T047
.	O
	
while	O
individual	O
novel	B-T080
urine	O
biomarkers	O
are	O
good	O
at	O
detecting	B-T061
ln	B-T047
flares	O
,	O
biomarker	O
panels	O
may	O
improve	O
diagnostic	B-T080
accuracy	I-T080
.	O
	
the	O
aim	B-T078
of	O
this	O
study	B-T062
was	O
to	O
assess	B-T052
the	O
performance	O
of	O
a	O
biomarker	O
panel	O
to	O
identify	O
active	B-T169
ln	B-T047
in	O
two	O
international	B-T078
jsle	B-T047
cohorts	B-T098
.	O
	
novel	O
urinary	O
biomarkers	O
,	O
namely	O
vascular	B-T116
cell	I-T116
adhesion	I-T116
molecule-1	I-T116
vcam-1	B-T116
,	O
monocyte	B-T116
chemoattractant	I-T116
protein	I-T116
1	I-T116
mcp-1	B-T116
,	O
lipocalin-like	B-T116
prostaglandin	I-T116
d	I-T116
synthase	I-T116
lpgds	B-T116
,	O
transferrin	B-T116
tf	B-T116
,	O
ceruloplasmin	B-T116
,	O
alpha-1-acid	B-T116
glycoprotein	I-T116
agp	B-T116
and	O
neutrophil	B-T116
gelatinase-associated	I-T116
lipocalin	I-T116
ngal	B-T116
,	O
were	O
quantified	B-T081
in	O
a	O
cross-sectional	B-T062
study	I-T062
that	O
included	O
participants	B-T098
of	O
the	O
uk	O
jsle	B-T047
cohort	B-T081
study	I-T081
cohort	B-T098
1	I-T098
and	O
validated	O
within	O
the	O
einstein	O
lupus	O
cohort	B-T098
cohort	B-T098
2	I-T098
.	O
	
binary	B-T080
logistic	B-T062
regression	I-T062
modelling	I-T062
and	O
receiver	B-T081
operating	I-T081
characteristic	I-T081
curve	B-T081
analysis	I-T081
area	B-T081
under	I-T081
the	I-T081
curve	I-T081
auc	B-T081
were	O
used	O
to	O
identify	O
and	O
assess	B-T052
combinations	B-T080
of	O
biomarkers	O
for	O
diagnostic	B-T080
accuracy	I-T080
.	O
	
a	O
total	O
of	O
91	O
jsle	B-T047
patients	O
were	O
recruited	O
across	O
both	O
cohorts	B-T098
,	O
of	O
whom	O
31	O
34	O
%	O
had	O
active	B-T169
ln	B-T047
and	O
60	O
66	O
%	O
had	O
no	O
ln	B-T047
.	O
	
urinary	O
agp	B-T116
,	O
ceruloplasmin	B-T116
,	O
vcam-1	B-T116
,	O
mcp-1	B-T116
and	O
lpgds	B-T116
levels	B-T080
were	O
significantly	B-T081
higher	I-T081
in	O
those	O
patients	O
with	O
active	B-T169
ln	B-T047
than	O
in	O
non	B-T169
-	O
ln	B-T047
patients	O
all	O
corrected	O
p	O
values	O
p	O
c	O
<	O
0.05	O
across	O
both	O
cohorts	B-T098
.	O
	
urinary	O
tf	B-T116
also	O
differed	O
between	O
patient	O
groups	O
in	O
cohort	B-T098
2	I-T098
p	O
c	O
=	O
0.001	O
.	O
	
within	O
cohort	B-T098
1	I-T098
,	O
the	O
optimal	B-T080
biomarker	O
panel	O
included	O
agp	B-T116
,	O
ceruloplasmin	B-T116
,	O
lpgds	B-T116
and	O
tf	B-T116
auc	B-T081
0.920	O
for	O
active	B-T169
ln	B-T047
identification	O
.	O
	
these	O
results	O
were	O
validated	O
in	O
cohort	B-T098
2	I-T098
,	O
with	O
the	O
same	O
markers	O
resulting	O
in	O
the	O
optimal	B-T080
urine	O
biomarker	O
panel	O
auc	B-T081
0.991	O
.	O
	
in	O
two	O
international	B-T078
jsle	B-T047
cohorts	B-T098
,	O
urinary	O
agp	B-T116
,	O
ceruloplasmin	B-T116
,	O
lpgds	B-T116
and	O
tf	B-T116
demonstrate	O
an	O
'excellent'	O
ability	O
for	O
accurately	O
identifying	O
active	B-T169
ln	B-T047
in	O
fine	O
structure	O
of	O
interleukin	B-T116
18	I-T116
il-18	I-T116
receptor	I-T116
-	O
immunoreactive	O
neurons	O
in	O
the	O
retrosplenial	O
cortex	O
and	O
its	O
changes	O
in	O
il18	O
knockout	O
mice	O
interleukin	B-T116
18	I-T116
il-18	B-T116
participates	O
in	O
the	O
inflammatory	B-T169
immune	O
response	O
of	O
lymphocytes	O
.	O
	
delay	O
in	O
learning	O
or	O
memory	O
are	O
common	O
in	O
the	O
il-18	O
knockout	O
mouse	O
.	O
	
many	O
il-18	O
-	O
immunoreactive	O
neurons	O
are	O
found	O
in	O
the	O
retrosplenial	O
cortex	O
rsc	O
and	O
the	O
subiculum	O
.	O
	
these	O
neurons	O
also	O
contain	O
the	O
il-18	O
receptor	O
.	O
	
we	O
determined	O
the	O
location	O
and	O
the	O
ultrastructure	O
of	O
the	O
il-18	O
receptor	O
-	O
immunoreactive	O
neurons	O
in	O
the	O
rsc	O
and	O
observed	O
changes	O
in	O
the	O
il-18	O
receptor	O
-	O
immunoreactive	O
neurons	O
of	O
the	O
il-18	O
knockout	O
mouse	O
.	O
	
the	O
il-18	O
receptor	O
-	O
immunoreactive	O
neurons	O
were	O
found	O
specifically	O
in	O
layer	O
v	O
of	O
the	O
granular	O
rsc	O
.	O
	
they	O
were	O
medium-sized	O
neurons	O
with	O
a	O
light	O
oval	O
nucleus	O
and	O
had	O
little	O
cytoplasm	O
with	O
many	O
free	O
ribosomes	O
,	O
rough	O
endoplasmic	O
reticulum	O
and	O
many	O
mitochondria	O
,	O
but	O
no	O
nissl	O
bodies	O
.	O
	
the	O
number	O
of	O
axosomatic	O
terminals	O
was	O
about	O
six	O
per	O
section	O
.	O
	
the	O
il-18	O
receptor	O
-	O
immunoreactive	O
neurons	O
were	O
not	O
found	O
in	O
the	O
rsc	O
in	O
the	O
il-18	O
knockout	O
mouse	O
at	O
5	O
or	O
9	O
weeks	O
of	O
age	O
.	O
	
however	O
,	O
many	O
small	O
electron-dense	O
neurons	O
were	O
found	O
in	O
layer	O
v	O
.	O
	
both	O
the	O
nucleus	O
and	O
cytoplasm	O
were	O
electron-dense	O
,	O
but	O
not	O
necrotic	O
.	O
	
the	O
mitochondria	O
and	O
rough	O
endoplasmic	O
reticulum	O
were	O
swollen	O
.	O
	
the	O
il-18	O
receptor	O
-	O
immunoreactive	O
neurons	O
were	O
presumed	O
to	O
be	O
degenerating	O
.	O
	
the	O
degeneration	O
of	O
the	O
il18-receptor	O
-	O
immunoreactive	O
neurons	O
in	O
the	O
rsc	O
may	O
cause	O
the	O
abnormal	O
behaviors	O
of	O
the	O
il-18	O
knockout	O
mice	O
exploring	O
the	O
genetic	B-T169
variability	O
in	O
water	O
use	B-T169
efficiency	B-T081
evaluation	O
of	O
inter	B-T079
and	O
intra	O
cultivar	O
genetic	O
diversity	O
in	O
grapevines	O
genetic	B-T169
improvement	O
of	O
crop	O
water	O
use	B-T169
efficiency	B-T081
wue	B-T081
is	O
a	O
general	O
goal	B-T078
because	O
the	O
increasing	B-T169
water	O
scarcity	B-T169
and	O
the	O
trend	O
to	O
a	O
more	O
sustainable	B-T169
agriculture	O
.	O
	
for	O
grapevines	O
,	O
this	O
subject	B-T078
is	O
relevant	B-T080
and	O
need	O
an	O
urgent	O
response	O
because	O
their	O
wide	O
distribution	B-T169
in	O
semi-arid	O
areas	B-T082
.	O
	
new	O
cultivars	O
are	O
difficult	B-T080
to	O
introduce	B-T169
in	O
viticulture	O
due	O
to	O
the	O
narrow	O
dependency	O
of	O
consumer	B-T098
appreciation	O
often	O
linked	O
to	O
a	O
certain	O
particular	O
wine	O
taste	B-T081
.	O
	
clones	O
of	O
reputed	O
cultivars	O
would	O
presumably	O
be	O
more	O
accepted	B-T080
but	O
little	O
is	O
known	O
on	O
the	O
intra-cultivar	O
genetic	B-T169
variability	O
of	O
the	O
wue	B-T081
.	O
	
the	O
present	O
work	O
compares	B-T052
,	O
on	O
the	O
basis	O
of	O
two	O
field	O
assays	O
,	O
the	O
variability	O
of	O
intrinsic	O
water	O
use	B-T169
efficiency	B-T081
wuei	B-T081
in	O
a	O
large	O
collection	B-T169
of	O
cultivars	O
in	O
contrast	B-T080
with	O
a	O
collection	B-T169
of	O
clones	O
of	O
tempranillo	O
cultivar	O
.	O
	
the	O
results	B-T169
show	O
that	O
clonal	B-T080
variability	O
of	O
wuei	B-T081
was	O
around	B-T078
80%	O
of	O
the	O
inter-cultivar	O
,	O
thus	O
providing	O
a	O
first	O
assessment	B-T052
on	O
the	O
opportunity	O
for	O
clonal	B-T080
selection	B-T052
by	O
wue	B-T081
.	O
	
plotting	O
the	O
wuei	B-T081
data	B-T078
against	O
stem	O
water	O
potential	B-T080
or	O
stomatal	O
conductance	O
it	O
was	O
possible	B-T033
to	O
identify	B-T080
cultivars	O
and	O
clones	O
out	O
of	O
the	O
confidence	B-T081
intervals	I-T081
of	O
this	O
linear	B-T081
regression	I-T081
thus	O
with	O
significantly	B-T081
higher	I-T081
and	O
lower	B-T081
wuei	B-T081
values	B-T081
.	O
	
the	O
present	O
results	B-T169
contribute	B-T052
to	O
open	O
the	O
expectative	O
for	O
a	O
genetic	B-T169
improvement	O
of	O
grapevine	O
wue	B-T081
.	O
	
comparison	O
of	O
methods	O
for	O
isolating	O
primary	B-T080
hepatocytes	O
from	O
mini	O
pigs	O
successful	O
porcine	O
hepatocyte	O
isolation	O
is	O
crucial	O
for	O
the	O
development	B-T169
of	O
bioartificial	O
liver	O
devices	O
and	O
hepatocyte	B-T061
transplantation	I-T061
.	O
	
serva	B-T116
collagenase	I-T116
nb	I-T116
grades	I-T116
are	O
formulated	O
collagenases	B-T116
that	O
are	O
suitable	O
for	O
various	O
tissue	O
isolation	O
applications	O
.	O
	
n-acetylcysteine	B-T116
nac	B-T116
can	O
improve	O
the	O
viability	B-T080
of	O
human	O
hepatocytes	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effectiveness	B-T080
of	O
two	O
collagenases	B-T116
and	O
effect	B-T080
of	I-T080
nac	B-T116
on	O
hepatocyte	O
isolation	O
from	O
porcine	O
liver	O
tissue	O
.	O
	
porcine	O
hepatocytes	O
were	O
isolated	O
using	O
the	O
perfusion	B-T061
method	I-T061
from	O
bama	O
mini	O
pigs	O
assigned	O
to	O
the	O
serva	B-T116
nb	I-T116
4	I-T116
group	B-T078
n=6	O
,	O
the	O
serva	B-T116
nb	I-T116
8	I-T116
group	B-T078
n=6	O
,	O
or	O
the	O
nb	B-T116
8	I-T116
+	O
nac	B-T116
group	B-T078
n=6	O
.	O
	
viability	B-T080
and	O
yield	O
were	O
defined	O
as	O
fresh	O
hepatocytes	O
and	O
their	O
spheroids	B-T033
formation	I-T033
after	O
24-hour	O
rocker	O
culture	O
in	O
serum-free	O
medium	O
.	O
	
metabolic	O
function	O
was	O
assessed	O
by	O
gene	O
expression	O
,	O
albumin	B-T116
,	O
and	O
urea	B-T109
synthesis	O
.	O
	
all	O
procedures	O
resulted	O
in	O
successful	O
hepatocyte	O
isolation	O
.	O
	
cells	O
from	O
the	O
nb	B-T116
8	I-T116
+	O
nac	B-T116
group	B-T078
had	O
97.8	O
viability	B-T080
,	O
which	O
was	O
higher	O
than	O
the	O
nb	B-T116
8	I-T116
group	B-T078
with	O
94.4	O
and	O
the	O
nb	B-T116
4	I-T116
group	B-T078
with	O
94.5	O
p<	O
.	O
	
the	O
final	O
cell	O
yield	O
reached	O
11.8	O
cells	O
in	O
the	O
nb	B-T116
8	I-T116
+	O
nac	B-T116
group	B-T078
,	O
compared	O
to	O
9.5	O
cells	O
in	O
the	O
nb	B-T116
8	I-T116
group	B-T078
p<	O
and	O
9.1	O
10	O
cells	O
in	O
the	O
nb	B-T116
4	I-T116
group	B-T078
p<	O
.	O
	
the	O
secretion	O
of	O
albumin	B-T116
was	O
superior	O
in	O
the	O
nb	B-T116
8	I-T116
+	O
nac	B-T116
group	B-T078
at	O
a	O
concentration	O
of	O
425.8	O
ng/ml	O
compared	O
to	O
the	O
nb	B-T116
8	I-T116
group	B-T078
339.1	O
ng/ml	O
p	O
<	O
and	O
nb	B-T116
4	I-T116
group	B-T078
293.6	O
ng/ml	O
p	O
<	O
.	O
	
the	O
injury	O
of	O
hepatocytes	O
also	O
decreased	O
in	O
the	O
nb	B-T116
8	I-T116
+	O
nac	B-T116
group	B-T078
p<	O
.	O
	
the	O
data	O
are	O
presented	O
as	O
means	B-T081
sd	I-T081
.	O
	
formulated	O
collagenase	B-T116
serva	I-T116
nb	I-T116
8	I-T116
and	O
nac	B-T116
could	O
improve	O
the	O
porcine	O
hepatocyte	O
isolation	O
,	O
resulting	O
in	O
higher	O
yields	O
of	O
viable	O
cells	O
.	O
	
endothermal	B-T061
venous	I-T061
ablation	I-T061
of	O
the	O
saphenous	O
vein	O
on	O
patients	O
who	O
are	O
on	O
anticoagulation	B-T061
therapy	I-T061
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
risks	B-T078
of	O
bleeding	O
,	O
deep	B-T047
venous	I-T047
thrombosis	I-T047
dvt	B-T047
,	O
endovenous	O
heat	O
induced	O
thrombosis	O
ehit	O
and	O
failure	B-T169
of	O
ablation	B-T061
on	O
patients	O
who	O
undergo	O
ablation	B-T061
while	O
on	O
oral	B-T061
anticoagulation	I-T061
.	O
	
we	O
compared	B-T052
378	O
3.4	O
out	O
of	O
11252	O
patients	O
group	O
a	O
who	O
had	O
undergone	O
724	O
endovenous	B-T061
ablation	I-T061
of	O
the	O
saphenous	O
veins	O
from	O
january	O
1	O
,	O
2011	O
to	O
september	O
30	O
,	O
2014	O
while	O
on	O
oral	B-T061
anticoagulation	I-T061
to	O
a	O
randomly	O
selected	O
375	O
patients	O
group	O
b	O
who	O
underwent	O
641	O
endovenous	B-T061
ablation	I-T061
in	O
the	O
same	O
time	B-T079
period	I-T079
but	O
were	O
not	O
on	O
anticoagulation	B-T061
.	O
	
the	O
demographic	B-T081
data	I-T081
,	O
history	B-T033
of	I-T033
dvt	B-T047
,	O
the	O
clinical	B-T080
,	O
etiologic	B-T080
,	O
anatomic	B-T080
,	O
pathologic	B-T169
ceap	B-T080
classification	O
and	O
the	O
vcss	B-T081
venous	B-T081
clinical	I-T081
severity	I-T081
score	I-T081
scores	O
were	O
analyzed	O
.	O
	
the	O
indications	B-T078
for	O
anticoagulation	B-T061
,	O
the	O
anticoagulants	O
used	O
were	O
recorded	O
.	O
	
the	O
primary	O
endpoints	O
were	O
bleeding	O
,	O
development	O
of	O
dvt	B-T047
or	O
ehit	O
,	O
and	O
failure	B-T169
of	O
ablation	B-T061
.	O
	
patients	O
in	O
group	O
a	O
were	O
older	B-T098
,	O
had	O
more	O
men	B-T098
,	O
more	O
history	O
of	O
dvt	B-T047
and	O
pe	B-T047
,	O
had	O
higher	O
ceap	B-T080
and	O
vcss	B-T081
scores	O
compared	O
to	O
group	O
b	O
.	O
	
the	O
type	O
of	O
anticoagulation	B-T061
used	O
was	O
warfarin	B-T109
in	O
77.2	O
direct	O
oral	O
inhibitors	O
dois	O
in	O
22.8	O
.	O
	
the	O
rate	B-T081
of	O
failure	B-T169
of	O
ablation	B-T061
at	O
3	O
days	B-T079
was	O
39	O
5.6	O
for	O
group	O
a	O
and	O
3	O
0.5	O
for	O
group	O
b	O
p<0	O
and	O
at	O
one	B-T079
month	I-T079
it	O
was	O
46	O
10.1	O
vs	O
.	O
	
27	O
6.7	O
p=0	O
.	O
	
the	O
number	O
of	O
ehit	O
cases	B-T169
in	O
group	O
a	O
at	O
3	O
days	B-T079
was	O
2	O
0.3	O
,	O
compared	O
to	O
6	O
0.9	O
in	O
group	O
b	O
p=0	O
and	O
at	O
1	B-T079
month	I-T079
it	O
was	O
0	O
compared	O
to	O
4	O
1.0	O
p=0	O
.	O
	
the	O
dvt	B-T047
,	O
svt	B-T047
,	O
hematoma	O
and	O
wound	O
infection	O
rates	B-T081
were	O
similar	O
in	O
the	O
two	O
groups	B-T078
.	O
	
ablation	B-T061
of	O
the	O
saphenous	O
veins	O
in	O
patients	O
who	O
are	O
on	O
oral	B-T061
anticoagulation	I-T061
is	O
safe	O
and	O
does	O
not	O
increase	O
the	O
risk	B-T078
of	O
bleeding	O
or	O
hematoma	O
,	O
but	O
it	O
may	O
slightly	O
lower	O
the	O
incidence	B-T081
of	O
ehit	O
and	O
increase	O
the	O
incidence	B-T081
of	O
failure	B-T169
of	O
variation	B-T062
analysis	I-T062
of	O
prim1	O
gene	O
in	O
chinese	B-T098
patients	O
with	O
primary	B-T047
ovarian	I-T047
insufficiency	I-T047
insights	O
into	O
common	O
genetic	O
susceptibility	O
between	O
primary	B-T047
ovarian	I-T047
insufficiency	I-T047
poi	B-T047
and	O
natural	O
or	O
early	B-T047
menopause	I-T047
have	O
delivered	B-T169
an	O
innovative	O
way	O
of	O
assessing	O
the	O
genetic	B-T169
mechanisms	I-T169
involved	O
in	O
poi	B-T047
.	O
	
prim1	O
plays	O
a	O
crucial	O
role	O
in	O
dna	O
replication	O
by	O
synthesizing	B-T052
rna	O
primers	O
for	O
okazaki	O
fragments	O
.	O
	
it	O
is	O
closely	O
associated	B-T080
with	I-T080
age	O
at	O
natural	O
menopause	O
,	O
early	B-T047
menopause	I-T047
and	O
poi	B-T047
in	O
european	B-T098
women	B-T098
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
aimed	O
to	O
investigate	B-T169
whether	O
mutations	O
in	O
prim1	O
contribute	O
to	O
poi	B-T047
in	O
chinese	B-T098
women	B-T098
.	O
	
all	O
exons	O
and	O
exon-intron	O
boundaries	O
of	O
prim1	O
gene	O
were	O
sequenced	O
in	O
192	O
han	O
chinese	O
women	B-T098
with	O
non-syndromic	O
poi	B-T047
.	O
	
no	O
plausible	O
mutations	O
were	O
identified	B-T080
.	O
	
the	O
results	O
suggest	O
that	O
the	O
perturbations	B-T169
in	O
prim1	O
gene	O
are	O
not	O
a	O
common	O
explanation	O
for	O
poi	B-T047
in	O
chinese	B-T098
women	B-T098
.	O
	
selection	B-T052
of	O
a	O
marker	O
gene	O
to	O
construct	O
a	O
reference	O
library	O
for	O
wetland	O
plants	O
,	O
and	O
the	O
application	O
of	O
metabarcoding	B-T062
to	O
analyze	B-T062
the	O
diet	O
of	O
wintering	B-T079
herbivorous	O
waterbirds	O
food	O
availability	B-T169
and	O
diet	O
selection	B-T052
are	O
important	O
factors	B-T169
influencing	O
the	O
abundance	B-T080
and	O
distribution	B-T169
of	O
wild	B-T170
waterbirds	O
.	O
	
in	O
order	O
to	O
better	O
understand	O
changes	B-T169
in	O
waterbird	O
population	B-T081
,	O
it	O
is	O
essential	O
to	O
figure	O
out	O
what	O
they	O
feed	B-T052
on	I-T052
.	O
	
however	O
,	O
analyzing	B-T062
their	O
diet	O
could	O
be	O
difficult	B-T080
and	O
inefficient	B-T169
using	O
traditional	O
methods	B-T169
such	O
as	O
microhistologic	O
observation	O
.	O
	
here	O
,	O
we	O
addressed	O
this	O
gap	O
of	O
knowledge	O
by	O
investigating	O
the	O
diet	O
of	O
greater	O
white-fronted	O
goose	O
anser	O
albifrons	O
and	O
bean	O
goose	O
anser	O
fabalis	O
,	O
which	O
are	O
obligate	O
herbivores	O
wintering	B-T079
in	O
china	O
,	O
mostly	O
in	O
the	O
middle	O
and	O
lower	O
yangtze	O
river	O
floodplain	O
.	O
	
first	O
,	O
we	O
selected	B-T052
a	O
suitable	B-T080
and	O
high-resolution	O
marker	O
gene	O
for	O
wetland	O
plants	O
that	O
these	O
geese	O
would	O
consume	O
during	O
the	O
wintering	B-T079
period	I-T079
.	O
	
eight	O
candidate	O
genes	O
were	O
included	O
rbcl	O
,	O
rpoc1	O
,	O
rpob	O
,	O
matk	O
,	O
trnh-psba	O
,	O
trnl	O
uaa	O
,	O
atpf-atph	O
,	O
and	O
psbk-psbi	O
.	O
	
the	O
selection	B-T052
was	O
performed	O
via	O
analysis	B-T062
of	O
representative	B-T052
sequences	O
from	O
ncbi	O
and	O
comparison	B-T052
of	O
amplification	O
efficiency	B-T081
and	O
resolution	O
power	O
of	O
plant	O
samples	O
collected	O
from	O
the	O
wintering	O
area	O
.	O
	
the	O
trnl	O
gene	O
was	O
chosen	O
at	O
last	O
with	O
c/h	O
primers	O
,	O
and	O
a	O
local	B-T082
plant	O
reference	O
library	O
was	O
constructed	O
with	O
this	O
gene	O
.	O
	
then	O
,	O
utilizing	O
dna	B-T062
metabarcoding	I-T062
,	O
we	O
discovered	B-T052
15	O
food	O
items	O
in	O
total	O
from	O
the	O
feces	O
of	O
these	O
birds	O
.	O
	
of	O
the	O
15	O
unique	O
dietary	O
sequences	O
,	O
10	O
could	O
be	O
identified	O
at	O
specie	O
level	B-T080
.	O
	
as	O
for	O
greater	O
white-fronted	O
goose	O
,	O
73%	O
of	O
sequences	O
belonged	O
to	O
poaceae	O
spp	O
,	O
and	O
26%	O
belonged	O
to	O
carex	O
spp	O
.	O
	
in	O
contrast	O
,	O
almost	O
all	O
sequences	O
of	O
bean	O
goose	O
belonged	O
to	O
carex	O
spp	O
.	O
	
99%	O
.	O
	
using	O
the	O
same	O
samples	O
,	O
microhistology	O
provided	O
consistent	B-T078
food	O
composition	O
with	O
metabarcoding	B-T062
results	B-T169
for	O
greater	O
white-fronted	O
goose	O
,	O
while	O
13%	O
of	O
poaceae	O
was	O
recovered	O
for	O
bean	O
goose	O
.	O
	
in	O
addition	O
,	O
two	O
other	O
taxa	O
were	O
discovered	B-T052
only	O
through	O
microhistologic	O
analysis	O
.	O
	
although	O
most	O
of	O
the	O
identified	O
taxa	O
matched	B-T080
relatively	O
well	O
between	O
the	O
two	O
methods	B-T169
,	O
dna	B-T062
metabarcoding	I-T062
gave	O
taxonomically	B-T169
more	O
detailed	B-T078
information	I-T078
.	O
	
discrepancies	B-T033
were	O
likely	O
due	O
to	O
biased	B-T078
pcr	O
amplification	O
in	O
metabarcoding	B-T062
,	O
low	O
discriminating	O
power	B-T081
of	O
current	O
marker	O
genes	O
for	O
monocots	O
,	O
and	O
biases	B-T078
in	O
microhistologic	O
analysis	O
.	O
	
the	O
diet	O
differences	B-T080
between	O
two	O
geese	O
species	O
might	O
indicate	O
deeper	O
ecological	O
significance	B-T078
beyond	O
the	O
scope	O
of	O
this	O
study	B-T062
.	O
	
we	O
concluded	O
that	O
dna	B-T062
metabarcoding	I-T062
provides	O
new	O
perspectives	B-T170
for	O
studies	B-T062
of	O
herbivorous	O
waterbird	O
diets	O
and	O
inter-specific	B-T169
interactions	I-T169
,	O
as	O
well	O
as	O
new	O
possibilities	O
to	O
investigate	B-T169
interactions	B-T169
between	O
herbivores	O
and	O
plants	O
.	O
	
in	O
addition	O
,	O
microhistologic	O
analysis	O
should	O
be	O
used	O
together	O
with	O
metabarcoding	B-T062
methods	I-T062
to	O
integrate	O
this	O
expressions	O
of	O
cd8	O
+	O
tils	O
,	O
pd-l1	B-T116
and	O
foxp3	B-T116
+	O
tils	O
in	O
stage	O
i	O
nsclc	O
guiding	O
adjuvant	B-T061
chemotherapy	I-T061
decisions	O
currently	O
,	O
adjuvant	B-T061
chemotherapy	I-T061
is	O
recommended	B-T078
for	O
patients	O
with	O
high	B-T033
risk	I-T033
stage	O
i	O
non-small	O
cell	O
lung	O
cancer	O
nsclc	O
.	O
	
however	O
,	O
identifying	B-T080
high	B-T033
risk	I-T033
patients	O
remains	O
a	O
challenge	O
.	O
	
this	O
study	B-T062
aims	B-T078
to	O
identify	B-T080
the	O
patient	O
cohorts	B-T098
more	O
likely	O
to	O
benefit	O
from	O
adjuvant	B-T061
chemotherapy	I-T061
based	O
on	O
the	O
tumor	O
micro-immune	B-T169
environment	B-T082
.	O
	
cd8	O
+	O
tils	O
significantly	B-T080
associated	I-T080
with	I-T080
disease-free	B-T081
survival	I-T081
dfs	B-T081
and	O
overall	B-T081
survial	I-T081
os	B-T081
p=0	O
0.040	O
.	O
	
patients	O
with	O
high	B-T033
risk	I-T033
factors	I-T033
may	O
also	O
predict	O
shorter	O
dfs	B-T081
p=0	O
.	O
	
when	O
compared	B-T052
together	O
,	O
patients	O
with	O
high	B-T080
-	O
cd8	O
+	O
tils	O
showed	O
better	O
dfs	B-T081
than	O
patients	O
with	O
low	B-T080
-	O
cd8	O
+	O
tils	O
,	O
no	O
matter	O
their	O
risk	B-T033
factors	I-T033
status	O
.	O
	
there's	O
no	B-T033
correlation	I-T033
between	O
pd-l1	B-T116
expressions	O
and	O
survival	B-T169
.	O
	
pd-l1	B-T116
was	O
highly	B-T080
expressed	O
in	O
men	B-T098
,	O
squamous	B-T080
and	O
well	B-T080
differentiated	I-T080
carcinoma	O
.	O
	
in	O
addition	O
,	O
foxp3	B-T116
+	O
tils	O
alone	O
didn't	O
show	O
any	O
prognostic	O
effects	O
,	O
but	O
low	B-T080
-	O
foxp3	B-T116
/	O
high	B-T080
-	O
cd8	O
+	O
tils	O
were	O
associated	B-T080
with	I-T080
prolonged	B-T079
dfs	B-T081
p=0	O
.	O
	
a	O
total	O
of	O
126	O
patients	O
with	O
surgically	B-T080
resected	I-T080
stage	O
i	O
nsclc	O
were	O
included	B-T169
to	O
perform	O
immunohistochemistry	O
of	O
cd8	O
+	O
tumor	O
infiltrating	O
lymphocytes	O
tils	O
,	O
programmed	B-T116
death	I-T116
ligand-1	I-T116
pd-l1	B-T116
and	O
forkhead	B-T116
box	I-T116
p3	I-T116
foxp3	B-T116
tils	O
.	O
	
cd8	O
+	O
tils	O
are	O
effective	B-T080
prognostic	O
predictors	O
.	O
	
patients	O
with	O
surgically	B-T080
resected	I-T080
stage	O
i	O
nsclc	O
showing	O
low	O
cd8	O
+	O
tils	O
could	O
be	O
considered	O
for	O
adjuvant	B-T061
chemotherapy	I-T061
,	O
even	O
if	O
they	O
have	O
no	O
high	B-T033
risk	I-T033
unaffected	O
twins	O
discordant	O
for	O
affective	O
disorders	O
show	O
changes	O
in	O
anterior	O
callosal	O
white	O
matter	O
microstructure	B-T082
the	O
neurobiological	O
mechanisms	B-T169
mediating	O
an	O
increased	O
risk	B-T078
to	O
develop	O
affective	O
disorders	O
remain	O
poorly	O
understood	O
.	O
	
in	O
a	O
group	B-T098
of	I-T098
individuals	I-T098
with	O
a	O
family	B-T033
history	I-T033
of	O
major	O
depressive	O
mdd	O
or	O
bipolar	O
disorder	O
bd	O
,	O
we	O
investigated	O
the	O
microstructural	O
properties	O
of	O
white	O
matter	O
fiber	O
tracts	O
,	O
that	O
is	O
,	O
cingulum	O
bundle	O
,	O
uncinate	O
fasciculus	O
,	O
anterior	O
limb	O
of	O
the	O
internal	O
capsule	O
,	O
and	O
corpus	O
callosum	O
,	O
that	O
facilitate	O
the	O
communication	O
between	O
brain	O
regions	O
implicated	O
in	O
affective	O
disorders	O
.	O
	
eighty-nine	O
healthy	O
mono	O
-	O
or	O
dizygotic	O
twins	O
with	O
a	O
co-twin	O
diagnosed	B-T033
with	O
mdd	O
or	O
bd	O
high-risk	B-T098
and	O
57	O
healthy	B-T080
twins	O
with	O
a	O
co-twin	O
with	O
no	B-T033
familial	I-T033
history	I-T033
of	I-T033
affective	O
disorders	O
low-risk	O
were	O
included	O
in	O
a	O
diffusion	O
tensor	O
imaging	O
study	O
.	O
	
the	O
high-risk	B-T098
group	I-T098
showed	O
decreased	O
fractional	O
anisotropy	O
fa	O
,	O
a	O
measure	O
of	O
water	O
diffusion	O
directionality	B-T169
,	O
and	O
increased	O
radial	O
diffusivity	O
in	O
the	O
anterior	O
region	O
of	O
corpus	O
callosum	O
compared	O
to	O
the	O
low-risk	B-T098
group	I-T098
.	O
	
this	O
abnormality	B-T033
was	O
not	O
associated	O
with	O
zygosity	B-T169
or	O
type	O
of	O
depressive	O
disorder	O
of	O
co-twin	O
.	O
	
the	O
observed	O
decreased	O
anterior	O
callosal	O
fiber	O
fa	O
in	O
the	O
high-risk	B-T098
group	I-T098
may	O
be	O
indicative	O
of	O
a	O
compromised	O
interhemispheric	O
communication	O
between	O
left	O
and	O
right	O
frontal	O
regions	O
critically	O
involved	O
in	O
mood	O
regulation	O
.	O
	
reduced	O
anterior	O
callosal	O
fa	O
may	O
act	O
as	O
a	O
vulnerability	O
marker	O
for	O
affective	O
disorders	O
in	O
individuals	B-T098
at	O
familial	B-T078
risk	I-T078
.	O
	
a	O
window	O
on	O
the	O
study	B-T061
of	I-T061
aversive	I-T061
instrumental	O
learning	O
strains	O
,	O
performance	B-T052
,	O
neuroendocrine	O
,	O
and	O
immunologic	O
systems	O
the	O
avoidance	O
response	O
is	O
present	O
in	O
pathological	B-T169
anxiety	B-T033
and	O
interferes	O
with	O
normal	B-T169
daily	I-T169
functions	I-T169
.	O
	
the	O
aim	O
of	O
this	O
article	O
is	O
to	O
shed	O
light	O
on	O
performance	B-T052
markers	O
of	O
active	O
avoidance	O
aa	O
using	O
two	O
different	O
rat	O
strains	O
,	O
sprague-dawley	O
sd	O
and	O
wistar	O
.	O
	
specifically	O
,	O
good	O
and	O
poor	O
performers	B-T169
were	O
evaluated	O
regarding	O
anxiety	B-T033
traits	O
exhibited	O
in	O
the	O
elevated	O
plus	O
maze	O
epm	O
and	O
corticosterone	O
levels	O
and	O
motor	O
activity	O
in	O
the	O
open	O
field	O
test	O
.	O
	
in	O
addition	O
,	O
the	O
plasma	O
levels	O
of	O
interleukin-6	B-T116
il-6	B-T116
,	O
interleukin-1beta	B-T116
il-1beta	B-T116
,	O
nerve	B-T116
growth	I-T116
factor	I-T116
beta	I-T116
ngf-beta	B-T116
,	O
tumor	B-T116
necrosis	I-T116
factor-alpha	I-T116
tnf-alpha	B-T116
and	O
cytokine-induced	B-T116
neutrophil	I-T116
chemoattractant	I-T116
1	I-T116
cinc-1	B-T116
were	O
compared	O
in	O
the	O
good	O
and	O
poor	O
performers	B-T169
to	O
better	O
understand	O
the	O
role	O
of	O
the	O
immunologic	O
system	O
in	O
aversive	B-T061
learning	I-T061
.	O
	
behavioral	B-T170
criteria	I-T170
were	O
employed	O
to	O
identify	O
subpopulations	B-T098
of	O
sd	O
and	O
wistar	O
rats	O
based	O
on	O
their	O
behavioral	B-T170
scores	I-T170
during	O
a	O
two-way	O
aa	O
test	B-T170
.	O
	
the	O
animals	O
were	O
tested	B-T170
for	O
anxiety	B-T033
-like	O
behavior	O
in	O
the	O
epm	O
and	O
motor	O
activity	O
in	O
the	O
open-field	O
test	O
.	O
	
plasma	O
corticosterone	O
levels	O
were	O
measured	B-T080
at	O
the	O
end	O
of	O
the	O
avoidance	O
test	B-T170
.	O
	
cytokine	O
levels	O
of	O
il-6	B-T116
,	O
il-1beta	B-T116
,	O
ngf-beta	B-T116
,	O
tnf-alpha	B-T116
,	O
and	O
cinc-1	B-T116
were	O
measured	B-T080
in	O
the	O
plasma	O
of	O
the	O
wistar	O
rats	O
.	O
	
sixty-six	O
percent	O
of	O
the	O
wistar	O
rats	O
and	O
35%	O
of	O
the	O
sd	O
rats	O
exhibited	O
a	O
poor	O
performance	B-T052
.	O
	
this	O
feature	O
was	O
associated	B-T080
with	I-T080
a	O
decrease	O
in	O
anxiety	B-T033
-like	O
behavior	O
in	O
the	O
epm	O
.	O
	
the	O
poor	O
and	O
good	O
performers	B-T169
exhibited	O
lower	O
levels	O
of	O
corticosterone	O
compared	O
with	O
the	O
control	O
animals	O
,	O
which	O
suggests	O
that	O
training	O
alters	O
corticosterone	O
levels	O
,	O
thereby	O
leading	O
to	O
hypocortisolism	B-T047
,	O
independent	O
of	O
the	O
performance	B-T052
.	O
	
the	O
cinc-1	B-T116
levels	B-T080
were	O
increased	O
in	O
the	O
poor	O
performers	B-T169
,	O
which	O
reinforces	O
the	O
role	O
of	O
immunologic	O
system	O
activation	B-T052
in	O
learning	O
deficits	O
.	O
	
our	O
study	O
provides	O
a	O
better	O
understanding	O
of	O
the	O
complex	B-T080
interactions	B-T169
that	O
underlie	O
neuroimmune	O
consequences	B-T169
and	O
their	O
implications	O
for	O
costing	B-T169
'	O
healthy'	O
food	O
baskets	O
in	O
australia	O
-	O
a	O
systematic	B-T170
review	I-T170
of	O
food	O
price	B-T081
and	O
affordability	B-T081
monitoring	B-T170
tools	I-T170
,	O
protocols	B-T170
and	O
methods	B-T170
to	O
undertake	O
a	O
systematic	B-T170
review	I-T170
to	O
determine	O
similarities	B-T080
and	O
differences	B-T080
in	O
metrics	B-T081
and	O
results	B-T169
between	O
recently	B-T079
and/or	O
currently	B-T079
used	O
tools	B-T170
,	O
protocols	B-T170
and	O
methods	B-T170
for	O
monitoring	O
australian	O
healthy	O
food	O
prices	B-T081
and	O
affordability	B-T081
.	O
	
electronic	B-T170
databases	I-T170
of	O
peer-reviewed	B-T170
literature	I-T170
and	O
online	B-T170
grey	I-T170
literature	I-T170
were	O
systematically	B-T169
searched	B-T052
using	O
the	O
prisma	B-T062
approach	O
for	O
articles	B-T170
and	O
reports	B-T170
relating	O
to	O
healthy	O
food	O
and	O
diet	B-T170
price	I-T170
assessment	I-T170
tools	I-T170
,	O
protocols	B-T170
,	O
methods	B-T170
and	O
results	B-T169
that	O
utilised	O
retail	B-T081
pricing	I-T081
.	O
	
national	O
,	O
state	O
,	O
regional	B-T082
and	O
local	O
areas	O
of	O
australia	O
from	O
1995	O
to	O
2015	O
.	O
	
assessment	B-T170
tools	I-T170
,	O
protocols	B-T170
and	O
methods	B-T170
to	O
measure	B-T081
the	O
price	B-T081
of	O
'healthy'	O
foods	O
and	O
diets	O
.	O
	
the	O
search	O
identified	B-T080
fifty-nine	O
discrete	O
surveys	B-T170
of	O
'	O
healthy'	O
food	O
pricing	B-T081
incorporating	O
six	O
major	O
food	B-T170
pricing	I-T170
tools	I-T170
those	O
used	O
in	O
multiple	B-T082
areas	I-T082
and	O
time	B-T079
periods	I-T079
and	O
five	O
minor	B-T080
food	B-T170
pricing	I-T170
tools	I-T170
those	O
used	O
in	O
a	O
single	B-T082
survey	I-T082
area	I-T082
or	O
time	B-T079
period	I-T079
.	O
	
analysis	B-T062
demonstrated	O
methodological	B-T078
differences	B-T080
regarding	O
included	B-T169
foods	O
reference	O
households	O
use	O
of	O
availability	B-T169
and/or	O
quality	B-T170
measures	I-T170
household	B-T033
income	I-T033
sources	B-T033
store	O
sampling	B-T170
methods	I-T170
data	B-T062
collection	I-T062
protocols	B-T170
analysis	B-T062
methods	I-T062
and	O
results	B-T169
.	O
	
'	O
healthy'	O
food	O
price	B-T081
assessment	B-T052
methods	B-T170
used	O
in	O
australia	O
lack	B-T080
comparability	B-T052
across	O
all	O
metrics	B-T081
and	O
most	O
do	O
not	O
fully	O
align	O
with	O
a	O
'	O
healthy'	O
diet	O
as	O
recommended	B-T078
by	O
the	O
current	O
australian	B-T170
dietary	I-T170
guidelines	I-T170
.	O
	
none	O
have	O
been	O
applied	O
nationally	O
.	O
	
assessment	B-T052
of	O
the	O
price	B-T081
,	O
price	B-T078
differential	I-T078
and	O
affordability	B-T081
of	O
healthy	B-T061
recommended	B-T078
and	O
current	B-T079
unhealthy	O
diets	O
would	O
provide	B-T052
more	O
robust	B-T080
and	O
meaningful	O
data	B-T078
to	O
inform	O
health	O
and	O
fiscal	O
policy	O
in	O
australia	O
.	O
	
the	O
informas	B-T170
'	O
optimal	B-T080
'	O
approach	O
provides	O
a	O
potential	B-T080
framework	O
for	O
development	B-T169
of	O
these	O
consecutive	B-T080
endovascular	B-T061
treatment	I-T061
of	O
20	O
ruptured	B-T169
very	O
small	B-T081
<3	O
mm	O
anterior	B-T047
communicating	I-T047
artery	I-T047
aneurysms	I-T047
small	B-T081
aneurysms	B-T047
located	O
at	O
the	O
anterior	O
communicating	O
artery	O
carry	O
significant	O
procedural	O
challenges	O
due	O
to	O
a	O
complex	O
anatomy	O
.	O
	
recent	O
advances	O
in	O
endovascular	B-T061
technologies	I-T061
have	O
expanded	O
the	O
use	O
of	O
coil	B-T061
embolization	I-T061
for	O
small	B-T081
aneurysm	B-T047
treatment	B-T169
.	O
	
however	O
,	O
limited	O
reports	O
describe	O
their	O
safety	O
and	O
efficacy	B-T080
profiles	O
in	O
very	O
small	B-T081
anterior	B-T047
communicating	I-T047
artery	I-T047
aneurysms	I-T047
.	O
	
we	O
sought	O
to	O
review	O
and	O
report	O
the	O
immediate	O
and	O
long-term	B-T080
clinical	I-T080
as	O
well	O
as	O
radiographic	B-T080
outcomes	I-T080
of	O
consecutive	B-T080
patients	O
with	O
ruptured	B-T169
very	O
small	B-T081
anterior	B-T047
communicating	I-T047
artery	I-T047
aneurysms	I-T047
treated	O
with	O
current	O
endovascular	B-T061
coil	I-T061
embolization	I-T061
techniques	I-T061
.	O
	
a	O
prospectively	O
maintained	O
single-institution	O
neuroendovascular	B-T170
database	I-T170
was	O
accessed	O
to	O
identify	O
consecutive	O
cases	O
of	O
very	O
small	B-T081
<3	O
mm	O
ruptured	B-T169
anterior	B-T047
communicating	I-T047
artery	I-T047
aneurysms	I-T047
treated	O
endovascularly	O
between	O
2006	O
and	O
2013	O
.	O
	
a	O
total	O
of	O
20	O
patients	O
with	O
ruptured	B-T169
very	O
small	B-T081
<3	O
mm	O
anterior	B-T047
communicating	I-T047
artery	I-T047
aneurysms	I-T047
were	O
consecutively	B-T080
treated	O
with	O
coil	B-T061
embolization	I-T061
.	O
	
the	O
average	O
maximum	O
diameter	B-T081
was	O
2.66	O
0.41	O
mm	O
.	O
	
complete	O
aneurysm	B-T061
occlusion	I-T061
was	O
achieved	O
for	O
17	O
85%	O
aneurysms	B-T047
and	O
near-complete	O
aneurysm	B-T061
occlusion	I-T061
for	O
3	O
15%	O
aneurysms	B-T047
.	O
	
intraoperative	B-T079
perforation	B-T033
was	O
seen	O
in	O
2	O
10%	O
patients	O
without	O
any	O
clinical	B-T078
worsening	I-T078
or	O
need	O
for	O
an	O
external	B-T061
ventricular	I-T061
drain	I-T061
.	O
	
a	O
thromboembolic	O
event	O
occurred	O
in	O
1	O
5	O
%	O
patient	O
without	O
clinical	B-T078
worsening	I-T078
or	O
radiologic	O
infarct	O
.	O
	
median	O
clinical	O
follow-up	O
was	O
12	O
14.1	O
months	B-T079
and	O
median	O
imaging	O
follow-up	O
was	O
12	O
18.4	O
months	B-T079
.	O
	
this	O
report	O
describes	O
the	O
largest	O
series	O
of	O
consecutive	B-T080
endovascular	B-T061
treatments	I-T061
of	O
ruptured	B-T169
very	O
small	B-T081
anterior	B-T047
communicating	I-T047
artery	I-T047
aneurysms	I-T047
.	O
	
these	O
findings	O
suggest	O
that	O
coil	B-T061
embolization	I-T061
of	O
very	O
small	B-T081
aneurysms	B-T047
in	O
this	O
location	B-T082
can	O
be	O
performed	O
with	O
acceptable	O
rates	O
of	O
complications	O
and	O
factors	B-T169
affecting	B-T169
the	O
formation	B-T169
of	O
nitrogenous	B-T061
disinfection	I-T061
by-products	O
during	O
chlorination	O
of	O
aspartic	B-T116
acid	I-T116
in	O
drinking	O
water	O
the	O
formation	B-T169
of	O
emerging	O
nitrogenous	B-T061
disinfection	I-T061
by-products	O
n-dbps	O
from	O
the	O
chlorination	O
of	O
aspartic	B-T116
acid	I-T116
asp	B-T116
was	O
investigated	B-T169
.	O
	
the	O
yield	O
of	O
dichloroacetonitrile	B-T109
dcan	B-T109
was	O
higher	O
than	O
other	O
n-dbps	O
,	O
such	O
as	O
dichloroacetamide	B-T109
dcacam	B-T109
and	O
chloropicrin	B-T109
tcnm	B-T109
during	O
the	O
chlorination	O
of	O
asp	B-T116
.	O
	
the	O
formation	B-T169
of	O
dcan	B-T109
,	O
dcacam	B-T109
,	O
and	O
tcnm	B-T109
all	O
showed	O
a	O
trend	O
of	O
first	O
increasing	B-T169
and	O
then	O
decreasing	B-T033
during	O
the	O
chlorination	O
of	O
asp	B-T116
with	O
increasing	B-T169
contact	B-T079
time	I-T079
.	O
	
the	O
dosage	B-T081
of	O
chlorine	O
had	O
an	O
impact	O
on	O
the	O
formation	B-T169
of	O
dcan	B-T109
,	O
dcacam	B-T109
,	O
and	O
tcnm	B-T109
.	O
	
the	O
highest	O
yields	B-T081
of	O
dcan	B-T109
and	O
dcacam	B-T109
appeared	O
when	O
the	O
cl2	O
/	O
asp	B-T116
molar	B-T081
ratio	I-T081
was	O
about	O
20	O
,	O
the	O
yield	B-T081
of	O
tcnm	B-T109
increased	B-T081
with	O
increasing	B-T169
the	O
cl2	O
/	O
asp	B-T116
molar	B-T081
ratio	I-T081
from	O
5	O
to	O
30	O
and	O
tcnm	B-T109
was	O
not	O
produced	O
when	O
the	O
ratio	B-T081
was	O
less	O
than	O
5	O
.	O
	
cyanogen	B-T109
chloride	I-T109
cncl	B-T109
was	O
detected	O
when	O
the	O
cl2	O
/	O
asp	B-T116
molar	B-T081
ratio	I-T081
was	O
lower	O
than	O
5	O
.	O
	
n-dbps	O
formation	B-T169
was	O
influenced	O
by	O
ph	B-T081
.	O
	
dcan	B-T109
formation	B-T169
increased	B-T081
with	O
increasing	B-T169
ph	B-T081
from	O
5	O
to	O
6	O
and	O
then	O
decreased	B-T081
with	O
increasing	B-T169
ph	B-T081
from	O
6	O
to	O
9	O
,	O
but	O
dcacam	B-T109
and	O
tcnm	B-T109
increased	B-T081
with	O
increasing	B-T169
ph	B-T081
from	O
5	O
to	O
8	O
and	O
then	O
decreased	B-T081
.	O
	
higher	O
temperatures	B-T081
reduced	B-T080
the	O
formation	B-T169
of	O
dcan	B-T109
and	O
dcacam	B-T109
,	O
but	O
increased	B-T081
tcnm	B-T109
formation	B-T169
.	O
	
dcan	B-T109
and	O
dcacam	B-T109
formation	B-T169
decreased	B-T081
,	O
and	O
relatively	O
stable	B-T080
tcnm	B-T109
formation	B-T169
increased	B-T081
,	O
with	O
increasing	B-T169
free	O
chlorine	O
contact	B-T079
time	I-T079
during	O
chloramination	O
.	O
	
n-nitrosodimethylamine	B-T109
ndma	B-T109
was	O
produced	O
during	O
chloramination	O
of	O
asp	B-T116
and	O
increased	B-T081
with	O
prolonged	B-T079
chloramination	O
contact	B-T079
time	I-T079
.	O
	
the	O
presence	O
of	O
bromide	O
ions	O
enhanced	B-T052
the	O
yields	B-T081
of	O
haloacetonitriles	B-T109
and	O
shifted	O
n-dbps	O
to	O
more	O
brominated	B-T109
species	I-T109
.	O
	
midodrine	B-T109
and	O
tolvaptan	B-T109
in	O
patients	O
with	O
cirrhosis	B-T047
and	O
refractory	B-T033
or	O
recurrent	O
ascites	O
a	O
randomised	B-T062
pilot	B-T062
study	I-T062
splanchnic	O
arterial	O
vasodilatation	O
and	O
subsequent	O
sodium	B-T047
and	O
water	B-T033
retention	I-T033
play	O
an	O
important	O
role	O
in	O
cirrhotic	B-T047
ascites	I-T047
.	O
	
midodrine	B-T109
and	O
tolvaptan	B-T109
have	O
been	O
used	O
separately	O
in	O
these	O
patients	O
.	O
	
however	O
,	O
there	O
are	O
no	O
reports	O
on	O
the	O
use	O
of	O
combination	B-T061
of	O
midodrine	B-T109
and	O
tolvaptan	B-T109
in	O
the	O
control	O
of	O
ascites	B-T047
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
safety	O
and	O
efficacy	B-T080
of	O
midodrine	B-T109
,	O
tolvaptan	B-T109
and	O
their	O
combination	B-T061
in	O
control	O
of	O
refractory	B-T033
or	O
recurrent	O
ascites	O
in	O
cirrhotics	B-T047
.	O
	
fifty	O
cirrhotic	B-T080
patients	O
with	O
refractory	B-T033
or	O
recurrent	O
ascites	O
were	O
randomised	B-T062
to	O
receive	O
midodrine	B-T109
n=13	O
,	O
tolvaptan	B-T109
n=12	O
or	O
both	O
n=13	O
plus	O
standard	O
medical	B-T061
therapy	I-T061
smt	B-T061
or	O
smt	B-T061
alone	O
n=12	O
.	O
	
a	O
significant	B-T033
increase	I-T033
in	I-T033
urinary	I-T033
volume	I-T033
and	O
urinary	B-T047
sodium	I-T047
at	O
1	O
and	O
3	O
months	B-T079
p<	O
was	O
observed	O
in	O
all	O
groups	B-T098
except	O
smt	B-T061
.	O
	
there	O
was	O
no	O
worsening	B-T080
of	O
renal	B-T033
or	O
hepatic	O
function	O
in	O
any	O
group	B-T098
.	O
	
there	O
was	O
deterioration	O
of	O
model	O
for	O
end-stage	O
liver	O
disease	O
meld	O
in	O
smt	O
.	O
	
midodrine	B-T109
as	O
well	O
as	O
combination	B-T061
of	O
midodrine	B-T109
and	O
tolvaptan	B-T109
but	O
not	O
tolvaptan	B-T109
alone	O
was	O
superior	O
to	O
smt	B-T061
in	O
control	O
of	O
ascites	B-T047
at	O
3	O
months	B-T079
p<	O
.	O
	
the	O
combination	B-T061
therapy	I-T061
was	O
also	O
superior	O
to	O
midodrine	B-T109
in	O
the	O
control	O
of	O
ascites	B-T047
at	O
1	O
month	B-T079
.	O
	
the	O
morbidity	B-T081
and	O
mortality	B-T081
were	O
similar	O
in	O
all	O
the	O
groups	B-T098
except	O
smt	B-T061
.	O
	
the	O
results	O
of	O
this	O
pilot	B-T062
study	I-T062
suggest	O
that	O
midodrine	B-T109
and	O
combination	B-T061
with	O
tolvaptan	B-T109
better	O
controls	O
ascites	B-T047
without	O
any	O
renal	B-T047
or	O
hepatic	O
dysfunction	O
.	O
	
the	O
combination	B-T061
therapy	I-T061
rapidly	O
controls	O
ascites	B-T047
as	O
compared	O
to	O
midodrine	B-T109
or	O
tolvaptan	B-T109
acute	B-T047
complicated	I-T047
sinusitis	I-T047
ten	O
years	B-T079
experience	O
from	O
the	O
university	O
hospital	O
of	O
the	O
west	O
indies	O
complicated	B-T047
sinusitis	I-T047
is	O
rare	B-T047
.	O
	
it	O
might	O
not	O
be	O
identified	O
early	O
and	O
might	O
expose	O
the	O
patient	O
to	O
an	O
unfavourable	B-T169
outcome	I-T169
.	O
	
there	O
is	O
a	O
paucity	O
of	O
data	B-T078
regarding	O
this	O
condition	B-T047
in	O
the	O
caribbean	O
.	O
	
this	O
study	B-T062
was	O
undertaken	O
to	O
describe	O
the	O
clinical	O
characteristics	O
and	O
treatment	B-T080
outcomes	I-T080
of	O
patients	O
admitted	O
with	O
this	O
condition	B-T047
.	O
	
a	O
retrospective	B-T080
chart	O
review	O
was	O
performed	O
on	O
patients	O
admitted	O
to	O
the	O
university	O
hospital	O
of	O
the	O
west	O
indies	O
uhwi	O
with	O
complicated	B-T047
sinusitis	I-T047
between	O
1999	O
to	O
2011	O
.	O
	
the	O
data	B-T078
was	O
analysed	B-T062
using	O
spss	B-T170
statistics	I-T170
22	I-T170
software	I-T170
.	O
	
there	O
were	O
30	O
patients	O
23	O
males	O
and	O
7	O
females	O
.	O
	
the	O
mean	B-T081
sd	B-T081
age	O
was	O
19	O
13.96	O
years	B-T079
.	O
	
twenty-two	O
had	O
orbital	O
complications	O
,	O
two	O
had	O
intracranial	O
complications	O
and	O
one	O
had	O
both	O
.	O
	
the	O
most	O
common	B-T081
organisms	O
isolated	B-T169
were	O
streptococcus	O
and	O
the	O
most	O
common	B-T081
sensitivity	O
was	O
to	O
amoxicillin	B-T109
and	O
clavulinic	B-T109
acid	I-T109
.	O
	
sixteen	O
patients	O
who	O
had	O
an	O
external	B-T082
surgical	B-T169
approach	I-T169
had	O
a	O
mean	B-T081
sd	B-T081
hospital	B-T079
stay	I-T079
of	O
8.8	O
3.71	O
days	B-T079
compared	O
to	O
three	O
patients	O
who	O
had	O
a	O
purely	O
endoscopic	B-T082
approach	I-T082
who	O
had	O
a	O
mean	B-T081
sd	B-T081
hospital	B-T079
stay	I-T079
of	O
7.67	O
0.577	O
days	B-T079
.	O
	
there	O
was	O
no	B-T033
statistical	B-T081
difference	I-T081
in	O
mean	B-T081
hospital	B-T079
stay	I-T079
between	O
these	O
two	O
groups	B-T078
95%	O
ci	O
p	O
=	O
0.609	O
.	O
	
the	O
mean	B-T081
duration	B-T079
of	O
hospital	B-T079
stay	I-T079
for	O
those	O
treated	O
medically	O
was	O
six	O
days	B-T079
versus	O
ten	O
days	B-T079
for	O
the	O
surgical	B-T169
group	B-T078
.	O
	
the	O
mean	B-T081
difference	B-T081
was	O
three	O
days	B-T079
95%	O
ci	O
,	O
0.193	O
p	O
=	O
0.039	O
.	O
	
acute	B-T047
complicated	I-T047
sinusitis	I-T047
is	O
seen	O
more	O
commonly	B-T081
in	O
adolescent	O
males	O
.	O
	
the	O
most	O
common	B-T081
complication	O
was	O
orbital	O
.	O
	
surgical	B-T061
treatment	I-T061
is	O
indicated	O
for	O
those	O
patients	O
who	O
fail	B-T169
medical	B-T169
management	O
and	O
should	O
consist	O
of	O
an	O
endoscopic	B-T082
approach	I-T082
comparative	O
proteomic	O
analysis	O
reveals	O
alterations	B-T078
in	O
development	O
and	O
photosynthesis	O
-related	O
proteins	B-T116
in	O
diploid	O
and	O
triploid	O
rice	O
polyploidy	O
has	O
pivotal	O
influences	O
on	O
rice	O
oryza	O
sativa	O
l	O
morphology	B-T080
and	O
physiology	O
,	O
and	O
is	O
very	O
important	O
for	O
understanding	O
rice	O
domestication	B-T078
and	O
improving	O
agricultural	O
traits	O
.	O
	
diploid	O
dp	O
and	O
triploid	O
tp	O
rice	O
shows	O
differences	B-T080
in	O
morphological	B-T080
parameters	B-T033
,	O
such	O
as	O
plant	O
height	O
,	O
leaf	O
length	B-T081
,	O
leaf	O
width	B-T081
and	O
the	O
physiological	B-T169
index	B-T170
of	O
chlorophyll	B-T109
content	O
.	O
	
however	O
,	O
the	O
underlying	O
mechanisms	B-T169
determining	O
these	O
morphological	B-T080
differences	B-T080
are	O
remain	O
to	O
be	O
defined	O
.	O
	
to	O
better	O
understand	O
the	O
proteomic	B-T116
changes	B-T169
between	O
dp	O
and	O
tp	O
,	O
tandem	O
mass	O
tags	O
tmt	O
mass	O
spectrometry	O
ms	O
/	O
ms	O
was	O
used	O
to	O
detect	O
the	O
significant	O
changes	B-T169
to	O
protein	O
expression	O
between	O
dp	O
and	O
tp	O
.	O
	
results	O
indicated	O
that	O
both	O
photosynthesis	O
and	O
metabolic	B-T169
pathways	I-T169
were	O
highly	O
significantly	O
associated	B-T080
with	I-T080
proteomic	O
alteration	O
between	O
dp	O
and	O
tp	O
based	O
on	O
biological	O
process	O
and	O
pathway	O
enrichment	O
analysis	O
,	O
and	O
13	O
higher	O
abundance	B-T080
chloroplast	B-T116
proteins	I-T116
involving	O
in	O
these	O
two	O
pathways	O
were	O
identified	B-T080
in	O
tp	O
.	O
	
quantitative	O
real-time	O
pcr	O
analysis	O
demonstrated	O
that	O
5	O
of	O
the	O
13	O
chloroplast	B-T116
proteins	I-T116
atpf	B-T116
,	O
psaa	B-T116
,	O
psab	B-T116
,	O
psbb	B-T116
and	O
rbl	B-T116
in	O
tp	O
were	O
higher	O
abundance	B-T080
compared	O
with	O
those	O
in	O
dp	O
.	O
	
this	O
study	B-T062
integrates	O
morphology	B-T080
,	O
physiology	O
and	O
proteomic	O
profiling	O
alteration	B-T078
of	O
dp	O
and	O
tp	O
to	O
address	O
their	O
underlying	O
different	O
molecular	O
mechanisms	O
.	O
	
our	O
finding	O
revealed	O
that	O
atpf	B-T116
,	O
psaa	B-T116
,	O
psab	B-T116
,	O
psbb	B-T116
and	O
rbl	B-T116
can	O
induce	O
considerable	O
expression	O
changes	B-T169
in	O
tp	O
and	O
may	O
affect	O
the	O
development	O
and	O
growth	O
of	O
rice	O
through	O
photosynthesis	O
and	O
metabolic	B-T169
pathways	I-T169
.	O
	
correlation	B-T080
of	O
cardiopulmonary	O
exercise	O
testing	O
parameters	O
with	O
quality	B-T078
of	I-T078
life	I-T078
in	O
stable	B-T033
copd	B-T047
patients	O
the	O
precise	O
head	O
to	O
head	O
relationships	B-T080
between	O
cardio-pulmonary	O
exercise	O
testing	O
cpet	O
parameters	O
and	O
patients	O
'	O
daily	B-T033
symptoms	I-T033
/	O
activities	O
and	O
the	O
disease	B-T047
social	B-T080
/	O
emotional	O
impact	O
are	O
less	O
well	O
defined	O
.	O
	
in	O
this	O
study	O
,	O
the	O
correlation	B-T080
of	O
copd	B-T047
daily	B-T033
symptoms	I-T033
and	O
quality	B-T078
of	I-T078
life	I-T078
assessed	O
by	O
st	B-T170
.	O
	
george's	I-T170
respiratory	I-T170
questionnaire	I-T170
sgrq	B-T170
and	O
copd	B-T047
severity	B-T170
index	I-T170
bode-index	B-T170
with	O
cpet	O
parameters	O
were	O
investigated	O
.	O
	
symptom	O
-limited	O
cpet	O
was	O
performed	O
in	O
37	O
consecutive	B-T080
copd	B-T047
gold	O
i-iii	O
subjects	O
during	O
non-	O
exacerbation	B-T047
phase	B-T079
.	O
	
the	O
sgrq	B-T170
was	O
also	O
completed	O
by	O
each	O
patient	O
.	O
	
sgrq-score	O
correlated	B-T080
negatively	B-T033
with	O
fev1	O
r=-0	O
,	O
p<0	O
,	O
predicted	B-T078
maximal	B-T033
work-rate	I-T033
%wr-max	B-T033
r=-0	O
,	O
p<0	O
,	O
v'o2	B-T033
/	O
wr	O
r=-0	O
,	O
p<0	O
and	O
breathing	B-T081
reserve	I-T081
r=-0	O
,	O
p<0	O
.	O
	
however	O
it	O
did	B-T033
not	I-T033
correlate	I-T033
with	O
peak-v'o2	B-T033
%	O
predicted	O
r=-0	O
,	O
p=0	O
.	O
	
in	O
20	O
54.1	O
subjects	O
in	O
which	O
leg	B-T033
fatigue	I-T033
was	I-T033
the	I-T033
main	I-T033
cause	I-T033
for	I-T033
stopping	I-T033
the	I-T033
test	I-T033
,	O
peak-v'o2	B-T033
,	O
%wr-max	B-T033
,	O
hr-reserve	B-T081
and	O
breathing	B-T081
reserve	I-T081
were	O
higher	O
p=0	O
,	O
<0	O
,	O
0.04	O
and	O
<0	O
respectively	O
than	O
the	O
others	O
.	O
	
there	O
was	O
also	O
a	O
significant	B-T081
correlation	B-T080
between	O
bode-index	B-T170
and	O
vo2	B-T033
/	O
wr	O
r=-0	O
,	O
p<0	O
and	O
breathing-reserve	B-T081
r=-0	O
,	O
p=0	O
.	O
	
the	O
observed	O
relationships	B-T080
between	O
cpet	O
parameter	O
and	O
daily	B-T079
subjective	O
complaints	O
in	O
copd	B-T047
were	O
not	O
strong	O
.	O
	
those	O
who	O
discontinued	O
the	O
cpet	O
because	B-T033
of	I-T033
leg	I-T033
fatigue	I-T033
were	O
in	O
the	O
earlier	B-T079
stages	I-T079
of	O
copd	B-T047
.	O
	
significant	O
negative	B-T033
correlation	B-T080
between	O
vo2	B-T033
/	O
wr	O
and	O
bode-index	B-T170
suggests	O
that	O
along	O
with	O
copd	B-T047
progression	O
,	O
regardless	O
of	O
negative	B-T033
past	I-T033
history	I-T033
,	O
other	O
comorbidities	B-T078
such	O
as	O
cardiac	B-T033
/	O
musculoskeletal	B-T033
problems	I-T033
intrapartum	B-T079
cervical	O
laceration	O
and	O
subsequent	O
pregnancy	B-T033
outcomes	I-T033
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
describe	O
pregnancy	B-T033
outcomes	I-T033
,	O
including	O
cervical	B-T047
insufficiency	I-T047
and	O
preterm	B-T033
birth	I-T033
,	O
in	O
the	O
subsequent	O
pregnancy	O
following	B-T079
an	O
intrapartum	B-T079
cervical	O
laceration	O
.	O
	
retrospective	O
cohort	B-T098
of	O
women	B-T098
with	O
their	O
first	O
two	O
consecutive	B-T080
singleton	O
pregnancies	O
carried	O
to	O
20	O
weeks	B-T079
'	O
gestation	O
within	O
a	O
tertiary	O
health	O
care	O
system	O
from	O
2002	O
to	O
2012	O
.	O
	
cervical	O
laceration	O
cases	O
were	O
identified	B-T080
by	O
icd9	B-T170
codes	I-T170
and	O
included	B-T169
if	O
suture	B-T061
repair	I-T061
was	O
required	B-T169
.	O
	
in	O
this	O
study	B-T062
,	O
55	O
women	B-T098
were	O
confirmed	B-T033
to	O
have	O
a	O
cervical	O
laceration	O
in	O
the	O
first	O
delivery	O
43	O
lacerations	O
after	O
vaginal	B-T061
delivery	I-T061
vd	B-T061
and	O
12	O
after	O
cesarean	B-T061
delivery	I-T061
cd	B-T061
.	O
	
the	O
median	B-T081
gestational	O
age	O
of	O
the	O
first	O
delivery	O
was	O
40	O
weeks	B-T079
and	O
the	O
median	B-T081
birth	O
weight	O
3	O
g	O
these	O
did	O
not	O
differ	B-T080
between	O
vd	B-T061
and	O
cd	B-T061
.	O
	
in	O
the	O
second	O
pregnancy	O
,	O
2	O
of	O
55	O
women	B-T098
4.6	O
had	O
a	O
prophylactic	B-T169
cerclage	B-T061
placed	O
1	O
carried	B-T052
to	O
term	O
and	O
the	O
other	O
delivered	B-T033
at	O
35	O
weeks	B-T079
.	O
	
in	O
total	B-T080
,	O
four	O
women	B-T098
9.3	O
delivered	B-T033
the	O
second	O
pregnancy	O
<	O
37	O
weeks	B-T079
three	O
had	O
a	O
prior	B-T079
term	O
vd	B-T061
and	O
one	O
had	O
a	O
prior	B-T079
34	O
weeks	B-T079
vd	B-T061
.	O
	
there	O
was	O
only	O
one	O
case	O
of	O
recurrent	B-T079
cervical	O
laceration	O
,	O
occurring	B-T052
in	O
the	O
setting	B-T169
of	O
vaginal	B-T061
deliveries	I-T061
.	O
	
obstetric	B-T169
cervical	O
lacerations	O
are	O
uncommon	B-T080
.	O
	
complications	O
in	O
the	O
following	B-T079
pregnancy	O
were	O
low	B-T080
,	O
despite	O
lack	B-T080
of	O
additional	O
prophylactic	B-T169
cerclage	B-T061
a	O
wnt	O
pathway	O
activator	B-T109
induces	O
apoptosis	O
and	O
cell	O
death	O
in	O
mouse	O
monocytic	O
leukemia	O
cells	O
a	O
wnt	B-T109
agonist	I-T109
,	O
2-amino-4-	B-T109
pyrimidine	I-T109
,	O
is	O
a	O
cell-permeable	O
pyrimidine	B-T109
compound	I-T109
that	O
has	O
been	O
shown	O
to	O
mimic	O
the	O
effect	O
of	O
wnt	B-T116
.	O
	
in	O
this	O
study	O
,	O
leukemic	O
mouse	O
cell	O
lines	O
,	O
raw	O
264.7	O
and	O
j774.1	O
,	O
were	O
incubated	O
with	O
the	O
wnt	B-T109
agonist	I-T109
.	O
	
the	O
wnt	B-T109
agonist	I-T109
showed	O
cell	O
death	O
in	O
the	O
concentration	O
of	O
1-10	O
μm	O
.	O
	
the	O
wnt	B-T109
agonist	I-T109
did	O
not	O
show	O
inhibition	B-T052
of	O
gsk-3β	B-T116
activity	O
but	O
induced	B-T169
β-catenin	O
accumulation	O
in	O
the	O
nucleus	O
.	O
	
the	O
wnt	B-T109
agonist	I-T109
showed	O
caspase-independent	O
cell	O
death	O
,	O
but	O
no	O
further	O
involvement	O
in	O
cell	O
death	O
er	O
stress	O
signaling	O
.	O
	
here	O
we	O
discuss	O
the	O
possible	O
mechanism	O
of	O
wnt	B-T109
agonist	I-T109
-	O
induced	O
apoptotic	O
cell	O
death	O
in	O
raw	O
264.7	O
cells	O
.	O
	
extracorporeal	B-T061
membrane	I-T061
oxygenation	I-T061
outcomes	B-T169
in	O
children	O
with	O
hemophagocytic	B-T047
lymphohistiocytosis	I-T047
pediatric	B-T080
patients	O
with	O
hemophagocytic	B-T047
lymphohistiocytosis	I-T047
hlh	B-T047
may	O
develop	O
refractory	B-T169
respiratory	B-T047
or	O
cardiac	B-T047
failure	I-T047
that	O
warrants	O
consideration	B-T033
for	O
extracorporeal	B-T061
membrane	I-T061
oxygenation	I-T061
ecmo	B-T061
support	O
.	O
	
the	O
purposes	B-T169
of	O
this	O
study	B-T062
were	O
to	O
describe	O
the	O
use	B-T169
and	O
outcomes	B-T080
of	O
ecmo	B-T061
in	O
pediatric	B-T080
hlh	B-T047
patients	O
,	O
to	O
identify	B-T080
risk	B-T033
factors	I-T033
for	O
hospital	B-T080
mortality	I-T080
and	O
to	O
compare	B-T052
their	O
ecmo	B-T061
use	B-T169
and	O
outcomes	B-T080
to	O
the	O
ecmo	B-T061
population	B-T098
as	O
a	O
whole	O
.	O
	
pediatric	B-T080
patients	O
18	O
years	B-T079
with	O
a	O
diagnosis	B-T033
of	O
hlh	B-T047
in	O
the	O
extracorporeal	O
life	O
support	O
organization	O
elso	O
registry	B-T170
were	O
included	B-T169
.	O
	
between	O
1983	O
and	O
2014	O
,	O
data	B-T078
for	O
30	O
children	O
with	O
hlh	B-T047
were	O
available	O
in	O
the	O
elso	O
registry	B-T170
and	O
all	O
were	O
included	B-T169
in	O
this	O
study	B-T062
.	O
	
all	O
cases	O
occurred	B-T052
in	O
the	O
last	B-T079
decade	B-T081
.	O
	
of	O
the	O
30	O
hlh	B-T047
patients	O
,	O
24	O
80%	O
had	O
a	O
respiratory	B-T047
indication	B-T078
for	O
ecmo	B-T061
and	O
six	O
20%	O
had	O
a	O
cardiac	B-T047
indication	B-T078
of	O
which	O
4	O
were	O
e	B-T082
-	O
cpr	B-T061
and	O
2	O
cardiac	B-T047
failure	I-T047
.	O
	
of	O
the	O
24	O
respiratory	B-T047
ecmo	B-T061
patients	O
,	O
63%	O
were	O
placed	O
on	O
va	B-T061
ecmo	I-T061
.	O
	
compared	B-T052
with	O
all	O
pediatric	B-T080
patients	O
in	O
the	O
elso	O
registry	B-T170
during	O
the	O
study	B-T079
period	I-T079
n=17	O
,	O
hlh	B-T047
patients	O
had	O
worse	O
hospital	B-T169
survival	I-T169
non-hlh	O
59%	O
vs	O
hlh	B-T047
30%	O
,	O
p	B-T081
=0	O
.	O
	
in	O
pediatric	B-T080
hlh	B-T047
patients	O
,	O
no	O
pre-	O
ecmo	B-T061
risk	B-T033
factors	I-T033
for	O
mortality	B-T081
were	O
identified	B-T080
.	O
	
the	O
development	B-T169
of	O
a	O
hemorrhagic	B-T080
complication	O
on	O
ecmo	B-T061
was	O
associated	B-T080
with	I-T080
decreased	B-T081
mortality	B-T081
p	B-T081
=0	O
.	O
	
comparing	B-T052
hlh	B-T047
patients	O
with	O
respiratory	B-T047
failure	I-T047
to	O
patients	O
with	O
other	O
immune	O
compromised	O
conditions	O
,	O
the	O
overall	O
survival	B-T081
rate	I-T081
is	O
similar	O
hlh	B-T047
38%	O
vs	O
.	O
	
non-hlh	O
immune	O
compromised	O
31%	O
,	O
p	B-T081
=0	O
.	O
	
hlh	B-T047
is	O
an	O
uncommon	B-T080
indication	B-T078
for	O
ecmo	B-T061
and	O
these	O
patients	O
have	O
increased	B-T081
mortality	B-T081
compared	B-T052
to	O
the	O
overall	O
pediatric	B-T080
ecmo	B-T061
population	B-T098
.	O
	
these	O
data	B-T078
should	O
be	O
factored	O
into	O
decision-making	O
when	O
considering	O
ecmo	B-T061
for	O
pediatric	B-T080
hlh	B-T047
patients	O
.	O
	
gut	O
microbiome	O
alterations	B-T078
in	O
patients	O
with	O
stage	B-T080
4	I-T080
hepatitis	B-T047
c	I-T047
hepatitis	O
c	O
virus	O
hcv	O
causes	O
debilitating	O
liver	B-T047
diseases	I-T047
,	O
which	O
may	O
progress	O
to	O
cirrhosis	B-T047
and	O
cancer	O
,	O
and	O
claims	O
500	O
annual	O
lives	O
worldwide	B-T078
.	O
	
while	O
hcv	O
epidemiology	B-T062
,	O
pathophysiology	O
,	O
and	O
therapy	B-T169
are	O
being	O
deeply	O
studied	O
,	O
rare	O
attention	O
is	O
given	O
to	O
reciprocal	O
interactions	O
between	O
hcv	B-T047
infection	I-T047
,	O
hcv	O
-induced	O
chronic	B-T047
liver	I-T047
diseases	I-T047
,	O
and	O
the	O
human	O
gut	O
microbiome	O
.	O
	
as	O
egypt	O
has	O
the	O
world's	B-T098
highest	B-T081
prevalence	I-T081
of	O
hcv	B-T047
infections	I-T047
,	O
we	O
launched	O
this	O
study	B-T062
to	O
monitor	O
differences	O
in	O
the	O
gut	O
microbial	O
community	O
composition	O
of	O
egyptian	B-T098
hcv	O
patients	O
that	O
may	O
affect	O
,	O
or	O
result	O
from	O
,	O
the	O
patients	O
'	O
liver	O
state	B-T169
.	O
	
to	O
this	O
end	O
,	O
we	O
analyzed	O
stool	O
samples	O
from	O
six	O
stage	B-T080
4	I-T080
-	O
hcv	O
patients	O
and	O
eight	O
healthy	B-T098
individuals	I-T098
by	O
high-throughput	O
16s	O
rrna	O
gene	O
sequencing	O
using	O
illumina	O
miseq	O
.	O
	
overall	O
,	O
the	O
alpha-diversity	B-T080
of	O
the	O
healthy	B-T098
persons'	I-T098
gut	O
microbiomes	O
was	O
higher	B-T080
than	O
those	O
of	O
the	O
hcv	O
patients	O
.	O
	
whereas	O
members	O
of	O
phylum	O
bacteroidetes	O
were	O
more	O
abundant	O
in	O
hcv	O
patients	O
,	O
healthy	B-T098
individuals	I-T098
had	O
higher	B-T080
abundance	B-T080
of	O
firmicutes	O
,	O
proteobacteria	O
,	O
and	O
actinobacteria	O
.	O
	
genus	O
-level	O
analysis	B-T062
showed	O
differential	O
abundance	B-T080
of	O
prevotella	O
and	O
faecalibacterium	O
higher	B-T080
in	O
hcv	O
patients	O
vs	O
.	O
	
ruminococcus	O
and	O
clostridium	O
healthy	B-T078
group	I-T078
,	O
indicating	O
that	O
the	O
higher	B-T080
abundance	B-T080
of	O
bacteroidetes	O
in	O
hcv	O
patients	O
is	O
most	O
likely	O
due	O
to	O
prevotella	O
overabundance	B-T080
.	O
	
the	O
probiotic	O
genus	O
,	O
bifidobacterium	O
,	O
was	O
only	O
observed	O
in	O
the	O
microbiotas	O
of	O
healthy	B-T098
individuals	I-T098
.	O
	
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
study	B-T062
provides	O
a	O
first	O
overview	O
of	O
major	O
phyla	O
and	O
genera	O
differentiating	O
stage	B-T080
4	I-T080
-	O
hcv	O
patients	O
from	O
healthy	B-T098
individuals	I-T098
and	O
suggests	O
possible	O
microbiome	O
remodeling	O
in	O
chronic	B-T047
hepatitis	I-T047
c	I-T047
,	O
possibly	O
shaped	O
by	O
bacterial	O
translocation	O
as	O
well	O
as	O
the	O
liver's	O
impaired	B-T033
role	I-T033
in	O
digestion	O
and	O
protein	O
synthesis	O
.	O
	
future	O
studies	O
will	O
investigate	O
the	O
microbiome	O
composition	O
and	O
functional	O
capabilities	B-T080
in	O
more	O
patients	O
while	O
tracing	O
some	O
potential	O
biomarker	O
taxa	O
e.g	O
,	O
prevotella	O
,	O
faecalibacterium	O
vs	O
.	O
	
peptide	B-T116
-mediated	O
interference	O
of	O
pb2	B-T116
-	O
eif4g1	B-T116
interaction	O
inhibits	B-T052
influenza	O
a	O
viruses	O
'	O
replication	O
in	B-T062
vitro	I-T062
and	O
in	B-T062
vivo	I-T062
influenza	O
viruses	O
are	O
obligate	O
parasites	O
that	O
hijack	O
the	O
host	O
cellular	O
system	O
.	O
	
previous	O
results	O
have	O
shown	O
that	O
the	O
influenza	B-T116
virus	I-T116
pb2	I-T116
subunit	O
confers	O
a	O
dependence	O
of	O
host	B-T116
eukaryotic	I-T116
translation	I-T116
initiation	I-T116
factor	I-T116
4-γ	I-T116
1	I-T116
eif4g1	B-T116
for	O
viral	O
mrna	O
translation	O
.	O
	
here	O
,	O
we	O
demonstrated	O
that	O
peptide	B-T116
-mediated	O
interference	O
of	O
the	O
pb2	B-T116
-	O
eif4g1	B-T116
interaction	O
inhibited	B-T052
virus	O
replication	O
in	B-T062
vitro	I-T062
and	O
in	B-T062
vivo	I-T062
.	O
	
remarkably	O
,	O
intranasal	B-T061
administration	I-T061
of	O
the	O
peptide	B-T116
provided	O
100%	O
protection	B-T033
against	O
lethal	B-T033
challenges	O
of	O
influenza	O
a	O
viruses	O
in	O
balb/c	O
mice	O
,	O
including	O
h1n1	O
,	O
h5n1	O
,	O
and	O
h7n9	O
influenza	O
virus	O
subtypes	O
.	O
	
mapping	O
of	O
the	O
pb2	B-T116
protein	I-T116
indicated	O
that	O
the	O
eif4g1	B-T116
binding	O
sites	O
resided	O
within	O
the	O
pb2	B-T116
cap	I-T116
-	O
binding	O
domain	O
.	O
	
virtual	B-T170
docking	I-T170
analysis	I-T170
suggested	O
that	O
the	O
inhibitory	B-T052
peptide	B-T116
associated	B-T080
with	I-T080
the	O
conserved	O
amino	B-T116
acid	I-T116
residues	I-T116
that	O
were	O
essential	O
to	O
pb2	B-T116
cap-binding	O
activity	O
.	O
	
overall	O
,	O
our	O
results	O
identified	O
the	O
pb2	B-T116
-	O
eif4g1	B-T116
interactive	O
site	O
as	O
a	O
druggable	O
target	O
for	O
influenza	B-T047
therapeutics	B-T061
.	O
	
drg1	O
is	O
a	O
potential	O
oncogene	O
in	O
lung	O
adenocarcinoma	O
and	O
promotes	B-T052
tumor	O
progression	O
via	O
spindle	O
checkpoint	O
signaling	O
regulation	O
developmentally	O
regulated	O
gtp	B-T116
binding	I-T116
protein	I-T116
1	I-T116
drg1	B-T116
,	O
a	O
member	O
of	O
the	O
drg	B-T116
family	I-T116
,	O
plays	O
important	O
roles	O
in	O
regulating	O
cell	O
growth	O
.	O
	
however	O
,	O
the	O
molecular	B-T078
basis	I-T078
of	O
drg1	B-T116
in	O
cell	O
proliferation	O
regulation	O
and	O
the	O
relationship	O
between	O
drg1	B-T116
and	O
tumor	O
progression	O
remain	O
poorly	O
understood	O
.	O
	
here	O
,	O
we	O
demonstrate	O
that	O
drg1	B-T116
is	O
elevated	O
in	O
lung	O
adenocarcinomas	O
while	O
weakly	O
expressed	O
in	O
adjacent	O
lung	O
tissues	O
.	O
	
drg1	O
knockdown	O
causes	O
growth	O
inhibition	O
of	O
tumor	O
cells	O
by	O
significantly	O
increasing	O
the	O
proportion	O
of	O
cells	O
in	O
m	O
phase	O
.	O
	
overexpression	O
of	O
drg1	B-T116
leads	O
to	O
chromosome	O
missegregation	O
which	O
is	O
an	O
important	O
index	O
for	O
tumorigenesis	O
.	O
	
interestingly	O
,	O
ectopic	O
of	O
drg1	O
reduces	O
taxol	B-T109
induced	B-T169
apoptosis	O
of	O
lung	O
adenocarcinoma	O
cells	O
.	O
	
mechanistic	O
analyses	B-T062
confirm	O
that	O
drg1	B-T116
localizes	B-T082
at	O
mitotic	O
spindles	O
in	O
dividing	O
cells	O
and	O
binds	O
to	O
spindle	O
checkpoint	O
signaling	O
proteins	B-T116
in	B-T082
vivo	I-T082
.	O
	
these	O
studies	B-T062
highlight	O
the	O
expanding	O
role	O
of	O
drg1	O
in	O
tumorigenesis	O
and	O
reveal	O
a	O
mechanism	B-T169
of	O
drg1	O
in	O
taxol	B-T109
gelsolin	B-T116
in	O
onychophora	O
and	O
tardigrada	O
with	O
notes	O
on	O
its	O
variability	O
in	O
the	O
ecdysozoa	O
rearrangements	O
of	O
the	O
filamentous	B-T116
actin	I-T116
network	I-T116
involve	O
a	O
broad	O
range	B-T081
of	O
actin	B-T116
binding	I-T116
proteins	I-T116
.	O
	
among	O
these	O
,	O
the	O
gelsolin	B-T116
proteins	I-T116
sever	O
actin	O
filaments	O
,	O
cap	O
their	O
fast	B-T033
growing	I-T033
end	O
and	O
nucleate	O
actin	O
assembly	O
in	O
a	O
calcium	O
-	O
dependent	B-T080
manner	O
.	O
	
here	O
,	O
we	O
focus	O
on	O
the	O
gelsolin	B-T116
of	O
the	O
onychophoran	O
peripatoides	O
novaezealandiae	O
and	O
the	O
eutardigrade	O
hypsibius	O
dujardini	O
.	O
	
from	O
the	O
cdna	O
of	O
p	O
.	O
	
novaezealandiae	O
we	O
obtained	B-T169
the	O
complete	O
coding	O
sequence	O
with	O
an	O
open	O
reading	O
frame	O
of	O
2178	O
bp	O
.	O
	
it	O
encodes	B-T052
a	O
protein	B-T116
of	O
726	O
amino	B-T116
acids	I-T116
with	O
a	O
calculated	B-T052
molecular	B-T081
mass	I-T081
of	O
82	O
and	O
a	O
pi	O
of	O
5.57	O
.	O
	
this	O
sequence	O
is	O
comprised	B-T052
of	O
six	O
segments	B-T082
s1-s6	O
.	O
	
however	O
,	O
analysis	B-T062
of	O
data	B-T078
from	O
tardibase	B-T170
reveals	B-T080
that	O
the	O
gelsolin	B-T116
of	O
the	O
eutardigrade	O
hypsibius	O
dujardini	O
has	O
only	O
three	O
segments	B-T082
s1-s3	O
.	O
	
the	O
coding	O
sequence	O
consist	O
of	O
1119	O
bp	O
for	O
373	O
amino	B-T116
acids	I-T116
with	O
a	O
calculated	B-T052
molecular	B-T081
mass	I-T081
of	O
42	O
and	O
a	O
pi	O
of	O
6.17	O
.	O
	
the	O
peripatoides	O
and	O
hypsibius	O
gelsolin	B-T116
revealed	B-T080
both	O
conserved	O
binding	B-T116
motifs	I-T116
for	O
g-actin	B-T116
,	O
f-actin	B-T116
and	O
phosphatidylinositol	B-T109
4	I-T109
pip2	B-T109
,	O
along	O
with	O
a	O
full	O
set	O
of	O
type-1	O
and	O
type-2	O
ca	O
-	O
binding	O
sites	O
which	O
could	O
result	B-T169
in	O
the	O
binding	O
of	O
eight	O
and	O
four	O
calcium	O
ions	O
,	O
respectively	O
.	O
	
both	O
gelsolin	B-T116
proteins	I-T116
lack	B-T080
a	O
c-terminal	O
latch-helix	B-T082
indicating	O
a	O
more	O
rapid	B-T080
activation	B-T052
in	O
the	O
submicromolar	O
ca	O
range	O
.	O
	
we	O
suggest	O
that	O
a	O
gelsolin	B-T116
with	O
three	O
segments	B-T082
was	O
present	B-T033
in	O
the	O
last	O
common	O
ancestor	O
of	O
the	O
ecdysozoan	O
clade	O
panarthropoda	O
onychophora	O
,	O
tardigrada	O
,	O
arthropoda	O
,	O
primarily	B-T080
because	O
the	O
gelsolin	B-T116
of	O
all	O
non-ecdysozoa	O
studied	B-T062
so	O
far	O
except	O
chordata	O
reveals	B-T080
this	O
number	O
of	O
segments	B-T082
.	O
	
mapping	O
of	O
our	O
molecular	B-T170
data	I-T170
onto	O
a	O
well-established	B-T080
phylogeny	B-T078
revealed	B-T080
that	O
the	O
number	O
of	O
gelsolin	B-T116
segments	B-T082
does	O
not	O
correlate	B-T080
with	O
the	O
phylogenetic	B-T078
lineage	O
but	O
rather	O
with	O
particular	O
functional	B-T169
demands	O
to	O
alter	B-T169
the	O
kinetics	O
of	O
actin	O
polymerization	O
.	O
	
mir-424-5p	O
participates	B-T169
in	O
esophageal	O
squamous	O
cell	O
carcinoma	O
invasion	O
and	O
metastasis	O
via	O
smad7	O
pathway	O
mediated	O
emt	O
escc	O
is	O
a	O
life-threatening	B-T033
disease	B-T047
due	O
to	O
invasion	O
and	O
metastasis	O
in	O
the	O
early	B-T079
stage	I-T079
.	O
	
great	O
efforts	O
had	O
been	O
made	O
to	O
detect	B-T033
the	O
molecular	B-T080
mechanisms	B-T169
which	O
led	O
to	O
the	O
invasion	O
and	O
metastasis	O
in	O
escc	O
.	O
	
recent	O
evidence	B-T078
had	O
suggested	O
that	O
deregulation	B-T052
of	O
mir-424-5p	O
took	O
an	O
important	O
role	O
in	O
cancers	O
.	O
	
however	O
,	O
its	O
role	O
and	O
functional	B-T169
mechanism	B-T169
in	O
escc	O
had	O
seldom	B-T080
been	O
elucidated	O
.	O
	
the	O
expression	B-T081
levels	I-T081
of	O
mir-424-5p	O
were	O
detected	B-T033
in	O
escc	O
tissues	O
and	O
cell	O
lines	O
by	O
real-time	O
pcr	O
methods	O
.	O
	
then	O
,	O
the	O
invasion	O
,	O
metastasis	O
and	O
proliferation	O
ability	O
of	O
escc	O
cell	O
lines	O
transfected	O
with	O
mir-424-5p	O
mimics	O
were	O
analyzed	B-T062
separately	O
by	O
transwell	O
invasion	O
assay	O
,	O
wound	O
healing	O
assay	O
and	O
cell	B-T062
proliferation	I-T062
assay	I-T062
.	O
	
finally	O
,	O
the	O
target	O
gene	O
of	O
mir-424-5p	O
was	O
studied	O
and	O
verified	B-T169
by	O
luciferase	O
activity	O
assay	O
.	O
	
and	O
the	O
role	O
of	O
mir-424-5p	O
in	O
emt	O
was	O
also	O
investigated	B-T169
by	O
real-time	O
pcr	O
and	O
western	O
blot	O
assay	O
.	O
	
we	O
showed	O
that	O
the	O
expression	B-T081
levels	I-T081
of	O
mir-424-5p	O
were	O
decreased	B-T081
both	O
in	O
escc	O
tissues	O
and	O
cell	O
lines	O
.	O
	
furthermore	O
,	O
the	O
expression	B-T081
levels	I-T081
of	O
mir-424-5p	O
were	O
negatively	O
linked	O
to	O
lymph	O
node	O
metastasis	O
in	O
escc	O
tissues	O
.	O
	
restoration	O
of	O
mir-424-5p	O
in	O
ec-1	O
cells	O
by	O
using	O
mir-424-5p	O
mimics	O
could	O
decrease	B-T081
the	O
invasion	O
,	O
metastasis	O
and	O
proliferation	O
of	O
ec-1	O
cells	O
,	O
indicating	O
its	O
role	O
in	O
inhibition	B-T052
on	O
the	O
invasion	O
and	O
metastasis	O
ability	O
of	O
escc	O
cells	O
and	O
tissues	O
.	O
	
in	O
addition	O
,	O
we	O
demonstrated	O
that	O
smad7	O
was	O
a	O
specific	O
target	O
gene	O
for	O
mir-424-5p	O
by	O
luciferase	O
activity	O
assay	O
and	O
mir-424-5p	O
could	O
not	O
only	O
negatively	B-T033
regulate	O
smad7	O
expression	O
but	O
also	O
participate	O
in	O
emt	O
via	O
smad7	O
,	O
because	O
overexpression	O
of	O
smad7	O
could	O
partly	O
enhance	B-T052
the	O
mir-424-5p	O
anti-emt	B-T033
function	B-T169
.	O
	
our	O
results	B-T169
described	O
that	O
mir-424-5p	O
-	O
smad7	O
pathway	O
contributed	O
to	O
escc	O
invasion	O
and	O
metastasis	O
and	O
up-regulation	O
of	O
mir-424-5p	O
perhaps	O
provided	O
a	O
strategy	O
for	O
preventing	B-T169
tumor	B-T033
invasion	I-T033
,	O
metastasis	O
.	O
	
double-network	B-T109
hydrogel	I-T109
with	O
tunable	B-T080
mechanical	B-T052
performance	I-T052
and	O
biocompatibility	O
for	O
the	O
fabrication	B-T170
of	O
stem	O
cells	O
-	O
encapsulated	B-T109
fibers	I-T109
and	O
3d	B-T082
assemble	I-T082
fabrication	B-T170
of	O
cell	O
-	O
encapsulated	B-T109
fibers	I-T109
could	O
greatly	O
contribute	B-T052
to	O
tissue	B-T061
engineering	I-T061
and	O
regenerative	O
medicine	O
.	O
	
however	O
,	O
existing	B-T080
methods	B-T169
suffered	O
from	O
not	O
only	O
unavoidability	B-T080
of	O
cell	O
damaging	O
conditions	B-T080
and/or	O
sophisticated	O
equipment	O
,	O
but	O
also	O
unavailability	B-T080
of	O
proper	O
materials	O
to	O
satisfy	O
both	O
mechanical	B-T169
and	O
biological	B-T080
expectations	B-T078
.	O
	
in	O
this	O
work	O
,	O
a	O
simple	B-T080
method	B-T169
is	O
proposed	B-T080
to	O
prepare	B-T052
cell	O
-	O
encapsulated	B-T109
fibers	I-T109
with	O
tunable	B-T080
mechanical	B-T081
strength	I-T081
and	O
stretching	B-T080
behavior	I-T080
as	O
well	O
as	O
diameter	B-T081
and	O
microstructure	O
.	O
	
the	O
hydrogel	B-T109
fibers	B-T109
are	O
made	O
from	O
optimal	B-T080
combination	B-T080
of	O
alginate	B-T109
and	O
poly	O
glycol	O
,	O
characteristics	O
of	O
double-network	B-T109
hydrogel	I-T109
,	O
with	O
enough	O
stiffness	O
and	O
flexibility	B-T080
to	O
create	B-T052
a	O
variety	O
of	O
three	B-T082
dimensional	I-T082
structures	I-T082
like	O
parallel	B-T082
helical	I-T082
and	O
different	B-T080
knots	B-T082
without	I-T082
crack	I-T082
.	O
	
furthermore	O
,	O
such	O
hydrogel	B-T109
fibers	B-T109
exhibit	O
better	B-T080
compatibility	O
as	O
indicated	B-T033
by	O
the	O
viability	B-T080
,	O
proliferation	B-T169
and	O
expression	B-T169
of	O
pluripotency	B-T169
markers	O
of	O
embryonic	O
stem	O
cells	O
encapsulated	B-T080
after	O
4-day	B-T033
culture	O
.	O
	
the	O
double-network	B-T109
hydrogel	I-T109
possesses	O
specific	B-T080
quick	B-T080
responses	O
to	O
either	O
of	O
alginate	B-T116
lyase	I-T116
,	O
edta	B-T109
or	O
lower	O
environmental	B-T081
temperature	I-T081
which	O
facilitate	O
the	O
optional	O
degradation	B-T169
of	O
fibers	B-T109
or	O
fibrous	B-T082
assemblies	I-T082
to	O
release	O
the	O
cells	O
encapsulated	B-T080
for	O
subsequent	B-T079
assay	O
or	O
synchronous	B-T079
vitellogenin	B-T116
expression	O
and	O
sexual	O
maturation	O
during	O
migration	O
are	O
negatively	B-T033
correlated	B-T080
with	O
juvenile	O
hormone	O
levels	B-T080
in	O
mythimna	O
separata	O
annual	O
migration	O
of	O
pests	O
between	O
different	B-T080
seasonal	B-T079
habitats	B-T082
can	O
lead	B-T169
to	O
serious	O
crop	O
damage	B-T169
.	O
	
reproductive	O
immaturity	B-T080
is	O
generally	O
associated	O
with	O
the	O
migratory	O
process	O
oogenesis	O
-	O
flight	B-T047
syndrome	I-T047
,	O
but	O
the	O
mechanism	B-T169
of	O
reproductive	O
development	O
during	O
migration	O
varies	O
unpredictably	O
.	O
	
here	O
,	O
the	O
vitellogenin	O
gene	O
msvg	O
and	O
three	O
key	O
regulatory	O
enzyme	O
genes	O
msjhamt	O
,	O
msjheh	O
and	O
msjhe	O
related	O
to	O
juvenile	O
hormone	O
jh	O
synthesis	O
and	O
degradation	O
were	O
identified	O
and	O
characterized	O
in	O
mythimna	O
separata	O
.	O
	
the	O
relative	O
expression	O
of	O
msvg	O
varied	O
significantly	O
in	O
response	O
to	O
seasonal	O
changes	O
and	O
was	O
significantly	O
correlated	O
with	O
stages	O
of	O
ovarian	O
development	O
.	O
	
the	O
relatively	O
low	O
levels	O
of	O
jh	O
titer	O
did	O
not	O
differ	O
significantly	O
in	O
male	O
moths	O
but	O
slightly	O
increased	O
in	O
female	O
adults	O
during	O
the	O
migratory	O
season	O
,	O
which	O
was	O
consistent	O
with	O
changes	O
in	O
mrna	O
levels	O
for	O
msjhamt	O
,	O
msjheh	O
and	O
msjhe	O
.	O
	
jh	O
titer	O
was	O
negatively	O
associated	O
with	O
relative	O
seasonal	O
levels	O
of	O
vitellogenin	O
mrna	O
transcripts	O
and	O
with	O
ovarian	O
development	O
in	O
migrating	O
m	O
.	O
	
separata	O
.	O
	
the	O
synchrony	O
of	O
msvg	O
expression	O
with	O
sexual	O
maturation	O
highlighted	O
the	O
potential	O
of	O
msvg	O
transcript	O
levels	O
to	O
serve	O
as	O
an	O
index	O
to	O
monitor	O
the	O
adult	O
reproductive	O
status	O
.	O
	
in	O
addition	O
,	O
the	O
level	O
of	O
jh	O
and	O
sexual	O
maturity	O
were	O
correlated	O
with	O
the	O
extent	O
of	O
jh	O
in	O
regulating	O
the	O
msvg	O
expression	O
and	O
reproduction	O
during	O
seasonal	O
northern	O
and	O
southern	O
migration	O
functional	B-T169
result	I-T169
after	O
cochlear	B-T061
implantation	I-T061
in	O
children	O
and	O
adults	O
with	O
single-sided	B-T047
deafness	I-T047
patients	O
with	O
single-sided	B-T047
deafness	I-T047
ssd	B-T047
suffer	O
from	O
reduced	B-T080
binaural	O
hearing	O
i.e	O
,	O
sound	O
localization	O
and	O
speech	O
in	O
noise	O
discrimination	O
.	O
	
cochlear	B-T061
implantation	I-T061
has	O
recently	O
been	O
introduced	O
for	O
patients	O
with	O
ssd	B-T047
,	O
as	O
an	O
alternative	O
to	O
hearing	O
devices	O
that	O
employ	O
contralateral	B-T082
routing	O
of	O
the	O
signal	O
.	O
	
application	O
to	O
children	O
has	O
also	O
been	O
started	O
.	O
	
we	O
retrospectively	B-T062
analyze	O
a	O
case	O
series	O
of	O
4	O
children	O
and	O
17	O
adults	O
with	O
ssd	B-T047
,	O
treated	B-T061
with	I-T061
cochlear	B-T061
implantation	I-T061
.	O
	
the	O
outcome	B-T169
of	O
adult	O
patients	O
was	O
compared	O
with	O
a	O
control	O
group	O
of	O
27	O
patients	O
with	O
bilateral	B-T047
profound	I-T047
hearing	I-T047
loss	I-T047
using	O
a	O
cochlear	O
implant	O
.	O
	
during	O
12	O
months	O
,	O
the	O
mean	B-T033
speech	O
recognition	O
score	B-T081
increased	O
from	O
30	O
to	O
41%	O
for	O
monosyllabic	B-T170
words	O
in	O
adults	O
,	O
and	O
from	O
58	O
to	O
89%	O
for	O
multisyllabic	O
numbers	O
.	O
	
the	O
cochlear	O
implant	O
ci	O
improved	O
hearing	O
in	O
noise	O
in	O
all	O
ssd	O
patients	O
,	O
as	O
was	O
demonstrated	O
by	O
a	O
significant	O
improvement	O
of	O
the	O
speech	O
reception	O
threshold	O
in	O
different	O
speech	O
and	O
noise	O
configurations	O
.	O
	
sound	O
localization	O
-correlated	O
angle	O
detection	O
error	O
improved	O
with	O
ci	O
use	O
at	O
every	O
time	O
point	O
.	O
	
the	O
maximum	O
word	O
recognition	O
score	O
for	O
monosyllabic	B-T170
words	I-T170
in	O
quiet	O
correlated	O
with	O
the	O
logarithm	O
of	O
the	O
duration	O
of	O
deafness	O
improvement	O
of	O
the	O
speech	O
reception	O
threshold	O
and	O
rms	O
angle	O
detection	O
error	O
by	O
the	O
ci	O
did	O
not	O
.	O
	
all	O
ssd	O
patients	O
benefitted	O
from	O
the	O
ci	O
in	O
different	O
hearing	O
situations	O
.	O
	
patients	O
with	O
ssd	O
for	O
a	O
long	O
period	O
can	O
improve	O
after	O
cochlear	O
implantation	I-T061
choroidal	B-T081
vascularity	I-T081
index	I-T081
a	O
novel	O
optical	O
coherence	O
tomography	O
based	O
parameter	O
in	O
patients	O
with	O
exudative	B-T047
age-related	I-T047
macular	I-T047
degeneration	I-T047
to	O
evaluate	O
choroidal	O
structural	B-T082
changes	O
in	O
exudative	B-T047
age-related	I-T047
macular	I-T047
degeneration	I-T047
amd	B-T047
using	O
choroidal	B-T081
vascularity	I-T081
index	I-T081
computed	B-T052
from	O
image	O
binarization	O
on	O
spectral	O
domain	O
optical	O
coherence	O
tomography	O
with	O
enhanced	O
depth	O
imaging	O
.	O
	
this	O
prospective	O
case	B-T062
series	I-T062
included	O
42	O
consecutive	B-T080
patients	O
with	O
unilateral	B-T082
exudative	B-T047
amd	I-T047
.	O
	
choroidal	O
images	O
were	O
segmented	O
into	O
luminal	B-T082
area	B-T082
and	O
stromal	O
area	O
.	O
	
choroidal	B-T081
vascularity	I-T081
index	I-T081
was	O
defined	O
as	O
the	O
ratio	B-T081
of	O
luminal	B-T082
area	B-T082
to	O
total	O
choroid	O
area	B-T082
.	O
	
mean	B-T081
choroidal	B-T081
vascularity	I-T081
index	I-T081
and	O
mean	B-T081
choroidal	B-T081
thickness	I-T081
between	O
study	B-T062
and	O
fellow	O
eyes	O
of	O
the	O
same	O
patient	O
with	O
dry	O
amd	B-T047
were	O
compared	O
using	O
student's	B-T081
t-test	I-T081
.	O
	
there	O
was	O
a	O
significantly	B-T081
lower	I-T081
choroidal	B-T081
vascularity	I-T081
index	I-T081
in	O
eyes	O
with	O
exudative	B-T047
amd	I-T047
60.14	O
4.55	O
vs	O
.	O
	
62.75	O
4.82	O
,	O
p	O
<	O
0.01	O
.	O
	
luminal	B-T082
area	I-T082
p	O
<	O
0.01	O
was	O
decreased	B-T081
in	O
eyes	O
with	O
exudative	B-T047
amd	I-T047
but	O
there	O
was	O
no	B-T033
significant	I-T033
difference	I-T033
in	O
total	O
choroid	O
area	B-T082
p	O
=	O
0.05	O
and	O
choroidal	O
thickness	O
p	O
=	O
0.93	O
between	O
study	B-T062
and	O
fellow	O
eyes	O
.	O
	
eyes	O
with	O
exudative	B-T047
amd	I-T047
demonstrated	O
reduced	B-T080
choroidal	B-T081
vascularity	I-T081
index	I-T081
but	O
insignificant	O
differences	B-T080
in	O
choroidal	O
thickness	O
compared	O
with	O
their	O
fellow	O
eyes	O
.	O
	
choroidal	B-T081
vascularity	I-T081
index	I-T081
may	O
be	O
a	O
potential	B-T080
noninvasive	B-T033
tool	I-T033
for	O
studying	B-T062
structural	B-T082
changes	O
in	O
choroid	O
and	O
monitoring	O
choroidal	B-T047
disease	I-T047
in	O
exudative	B-T047
amd	I-T047
.	O
	
comparison	B-T052
of	O
esophageal	O
,	O
rectal	B-T033
,	O
and	O
gastrointestinal	O
temperatures	B-T081
during	O
passive	O
rest	O
after	O
exercise	O
in	O
the	O
heat	O
the	O
influence	O
of	O
hydration	B-T033
it	O
is	O
unknown	O
how	O
valid	O
esophageal	O
,	O
rectal	B-T033
,	O
and	O
gastrointestinal	O
temperatures	B-T081
tes	O
,	O
tre	B-T033
,	O
and	O
tgi	B-T081
compare	O
after	O
exercise-induced	O
hyperthermia	O
in	O
various	O
hydration	B-T033
states	I-T033
.	O
	
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
examine	O
the	O
differences	O
between	O
tes	O
,	O
tre	B-T033
,	O
and	O
tgi	B-T081
during	O
passive	O
rest	O
following	O
exercise-induced	O
hyperthermia	O
under	O
two	O
different	O
hydration	B-T033
states	I-T033
euhydrated	B-T033
eu	B-T033
and	O
hypohydrated	B-T047
hy	B-T047
.	O
	
randomized-crossover	B-T062
design	I-T062
.	O
	
controlled	O
laboratory	O
setting	O
.	O
	
nine	O
recreationally	O
active	B-T169
male	O
participants	B-T098
mean	O
sd	B-T081
age	O
,	O
24	O
height	O
,	O
177.3	O
body	O
mass	O
,	O
76.7	O
body	O
fat	O
,	O
14.7	O
.	O
	
participants	B-T098
completed	O
two	O
trials	B-T062
eu	B-T033
and	O
hy	B-T047
consisting	O
of	O
a	O
bout	B-T079
of	O
treadmill	O
exercise	O
a	O
10	O
minute	O
walk	O
ranging	B-T081
4.8	O
at	O
a	O
5%	O
grade	O
followed	O
by	O
a	O
20	O
minute	B-T079
jog	O
ranging	B-T081
8.0	O
at	O
a	O
1%	O
grade	O
in	O
a	O
hot	O
environment	O
ambient	O
temperature	O
,	O
39.3	O
relative	B-T081
humidity	I-T081
,	O
37.6	O
wet	B-T169
bulb	I-T169
globe	I-T169
temperature	I-T169
,	O
31.3	O
followed	O
by	O
passive	O
rest	O
.	O
	
root	B-T081
mean	I-T081
squared	I-T081
difference	I-T081
rmsd	B-T081
was	O
used	O
to	O
compare	O
the	O
variance	B-T080
of	O
temperature	O
readings	O
at	O
corresponding	O
time	B-T079
points	I-T079
for	O
tre	B-T033
vs	O
tgi	B-T081
,	O
tre	B-T033
vs	O
tes	O
,	O
and	O
tgi	B-T081
vs	O
tes	O
in	O
eu	B-T033
and	O
hy	B-T047
.	O
	
rmsd	B-T081
values	O
were	O
compared	O
using	O
three-way	B-T081
repeated	I-T081
measures	I-T081
anova	I-T081
.	O
	
post	O
hoc	O
analysis	B-T062
of	O
significant	O
main	O
effects	B-T080
was	O
done	O
using	O
tukey's	B-T170
hsd	I-T170
with	O
significance	O
set	O
at	O
p<0	O
.	O
	
rmsd	B-T081
values	I-T081
c	O
for	O
all	O
device	O
comparisons	B-T052
were	O
significantly	B-T081
different	O
in	O
eu	B-T033
tre	B-T033
-	O
tgi	B-T081
,	O
0.11	O
tre	B-T033
-	O
tes	O
,	O
1.58	O
tgi	B-T081
-	O
tes	O
,	O
2.04	O
than	O
hy	B-T047
tre	B-T033
-	O
tgi	B-T081
,	O
0.22	O
tre	B-T033
-	O
tes	O
,	O
1.27	O
tgi	B-T081
-	O
tes	O
,	O
1.16	O
p<0	O
.	O
	
across	O
the	O
45-	O
minute	B-T079
bout	B-T079
of	O
passive	O
rest	O
,	O
there	O
were	O
no	O
differences	O
in	O
tre	B-T033
,	O
tgi	B-T081
and	O
tes	O
between	O
eu	B-T033
and	O
hy	B-T047
trials	B-T062
p=0	O
.	O
	
during	O
passive	O
rest	O
after	O
exercise	O
in	O
the	O
heat	O
,	O
tre	B-T033
and	O
tgi	B-T081
were	O
in	O
good	O
agreement	O
when	O
tracking	O
body	O
temperature	O
,	O
with	O
a	O
better	O
agreement	O
appearing	O
in	O
those	O
maintaining	O
a	O
state	O
of	O
euhydration	B-T033
versus	O
those	O
who	O
became	O
hypohydrated	B-T047
during	O
exercise	O
however	O
,	O
this	O
small	O
difference	O
does	O
not	O
appear	O
to	O
be	O
of	O
clinical	B-T033
significance	I-T033
.	O
	
annexin	B-T116
a1	I-T116
restores	O
aβ1-42	B-T116
-induced	O
blood-brain	B-T061
barrier	I-T061
disruption	I-T061
through	O
the	O
inhibition	O
of	O
rhoa-rock	O
signaling	O
pathway	O
the	O
blood-brain	O
barrier	O
bbb	O
is	O
composed	O
of	O
brain	O
capillary	O
endothelial	O
cells	O
and	O
has	O
an	O
important	O
role	O
in	O
maintaining	O
homeostasis	O
of	O
the	O
brain	O
separating	O
the	O
blood	O
from	O
the	O
parenchyma	O
of	O
the	O
central	O
nervous	O
system	O
cns	O
.	O
	
it	O
is	O
widely	O
known	O
that	O
disruption	B-T061
of	I-T061
the	I-T061
bbb	I-T061
occurs	O
in	O
various	O
neurodegenerative	B-T047
diseases	I-T047
,	O
including	O
alzheimer's	B-T047
disease	I-T047
ad	B-T047
.	O
	
annexin	B-T116
a1	I-T116
anxa1	B-T116
,	O
an	O
anti-inflammatory	B-T116
messenger	I-T116
,	O
is	O
expressed	O
in	O
brain	O
endothelial	O
cells	O
and	O
regulates	O
the	O
bbb	O
integrity	O
.	O
	
however	O
,	O
its	O
role	O
and	O
mechanism	O
for	O
protecting	O
bbb	O
in	O
ad	B-T047
have	O
not	O
been	O
identified	O
.	O
	
we	O
found	O
that	O
β-amyloid	B-T116
1-42	I-T116
aβ42	B-T116
bbb	B-T061
disruption	I-T061
was	O
rescued	O
by	O
human	B-T116
recombinant	I-T116
anxa1	I-T116
hranxa1	B-T116
in	O
the	O
murine	B-T109
brain	O
endothelial	O
cell	O
line	O
bend.3	O
.	O
	
also	O
,	O
anxa1	B-T116
was	O
decreased	O
in	O
the	O
bend.3	O
cells	O
,	O
the	O
capillaries	O
of	O
5xfad	O
mice	O
,	O
and	O
the	O
human	O
serum	O
of	O
patients	O
with	O
ad	B-T047
.	O
	
to	O
find	O
out	O
the	O
mechanism	O
by	O
which	O
anxa1	B-T116
recovers	O
the	O
bbb	O
integrity	O
in	O
ad	B-T047
,	O
the	O
rhoa-rock	O
signaling	O
pathway	O
was	O
examined	O
in	O
both	O
aβ42	B-T116
-treated	O
bend.3	O
cells	O
and	O
the	O
capillaries	O
of	O
5xfad	O
mice	O
as	O
rhoa	B-T116
was	O
activated	O
in	O
both	O
cases	O
.	O
	
rhoa	B-T080
inhibitors	I-T080
alleviated	O
aβ42	B-T116
-induced	O
bbb	B-T061
disruption	I-T061
and	O
constitutively	O
overexpressed	O
rhoa-gtp	B-T116
active	O
form	O
of	O
rhoa	B-T116
attenuated	O
the	O
protective	O
effect	O
of	O
anxa1	B-T116
.	O
	
when	O
pericytes	O
were	O
cocultured	O
with	O
bend.3	O
cells	O
,	O
aβ42	B-T116
-induced	O
rhoa	O
activation	O
of	O
bend.3	O
cells	O
was	O
inhibited	B-T080
by	O
the	O
secretion	O
of	O
anxa1	B-T116
from	O
pericytes	O
.	O
	
taken	O
together	O
,	O
our	O
results	O
suggest	O
that	O
anxa1	B-T116
restores	O
aβ42	B-T116
-induced	O
bbb	B-T061
disruption	I-T061
through	O
inhibition	O
of	O
rhoa-rock	O
signaling	O
pathway	O
and	O
we	O
propose	O
anxa1	B-T116
as	O
a	O
therapeutic	O
reagent	O
,	O
protecting	O
against	O
the	O
breakdown	B-T061
of	I-T061
the	I-T061
bbb	I-T061
in	O
association	B-T080
of	O
kidney	B-T047
disease	I-T047
with	O
obstructive	B-T047
sleep	I-T047
apnea	I-T047
in	O
a	O
population	B-T062
study	I-T062
of	O
men	B-T098
to	O
determine	O
the	O
relationship	B-T080
between	O
obstructive	B-T047
sleep	I-T047
apnea	I-T047
osa	B-T047
and	O
chronic	B-T047
kidney	I-T047
disease	I-T047
ckd	B-T047
.	O
	
previous	O
population	B-T062
studies	I-T062
of	O
the	O
association	B-T080
are	O
sparse	B-T079
,	O
conflicting	B-T033
and	O
confined	B-T169
largely	O
to	O
studies	B-T062
of	O
administrative	B-T033
data	B-T078
.	O
	
cross-sectional	B-T062
analysis	I-T062
in	O
unselected	O
participants	B-T098
of	O
the	O
men	B-T081
androgens	I-T081
inflammation	I-T081
lifestyle	I-T081
environment	I-T081
and	I-T081
stress	I-T081
mailes	I-T081
study	I-T081
,	O
aged	O
>40	O
y	O
.	O
	
renal	O
data	B-T078
were	O
available	O
on	O
812	O
men	B-T098
without	O
a	O
prior	B-T079
osa	B-T047
diagnosis	B-T033
who	O
underwent	O
full	O
in-home	B-T082
polysomnography	O
embletta	O
x100	O
in	O
2010-2011	O
.	O
	
ckd	B-T047
was	O
defined	O
as	O
an	O
estimated	O
glomerular	O
filtration	O
rate	O
egfr	O
<60	O
ml/min/1	O
or	O
egfr	O
60	O
and	O
albuminuria	B-T033
albumin	O
creatinine	O
ratio	O
3.0	O
mg/mmol	O
.	O
	
ckd	B-T047
10.5	O
,	O
n=85	O
stage	B-T079
1-3	O
,	O
9.7	O
stage	B-T079
4-5	O
,	O
0.7	O
of	O
predominantly	B-T080
mild	B-T033
severity	I-T033
showed	O
significant	B-T078
association	B-T080
s	O
with	O
osa	B-T047
ahi	O
odds	B-T081
ratio	I-T081
or	B-T081
,	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
,	O
severe	B-T080
osa	B-T047
ahi	O
30/h	O
or	B-T081
=2	O
,	O
95%	O
ci	O
,	O
and	O
respiratory	B-T169
related	O
arousal	O
index	B-T170
7.6	O
or	B-T081
=2	O
,	O
95%ci	O
1.1	O
,	O
but	O
not	O
measures	B-T081
of	O
hypoxemia	B-T033
after	O
adjustment	B-T169
for	O
age	O
,	O
hypertension	B-T047
,	O
diabetes	B-T047
,	O
smoking	O
,	O
obesity	B-T047
,	O
and	O
nsaid	O
use	B-T169
.	O
	
there	O
was	O
no	O
association	B-T080
of	O
ckd	B-T047
with	O
daytime	B-T033
sleepiness	I-T033
.	O
	
in	O
men	B-T098
with	O
ckd	B-T047
,	O
those	O
with	O
osa	B-T047
were	O
not	B-T033
significantly	I-T033
more	B-T081
likely	B-T081
to	O
report	O
symptoms	O
sleepiness	B-T033
,	O
snoring	O
,	O
apneas	O
or	O
be	O
identified	B-T080
with	O
the	O
stop	B-T062
osa	I-T062
screening	I-T062
questionnaire	I-T062
,	O
compared	O
to	O
men	B-T098
without	O
osa	B-T047
.	O
	
predominantly	B-T080
mild	B-T080
ckd	B-T047
is	O
associated	B-T080
with	I-T080
severe	B-T080
osa	B-T047
and	O
arousals	O
.	O
	
further	O
population	B-T062
studies	I-T062
examining	B-T033
the	O
longitudinal	B-T082
relationship	B-T080
between	O
ckd	B-T047
and	O
osa	B-T047
are	O
warranted	B-T169
.	O
	
better	O
methods	B-T170
are	O
needed	B-T080
to	O
identify	O
osa	B-T047
in	O
ckd	B-T047
which	O
may	O
have	O
few	B-T081
symptoms	O
.	O
	
evidence	O
that	O
vitronectin	B-T116
is	O
a	O
potent	O
migration-enhancing	O
factor	O
for	O
cancer	O
cells	O
chaperoned	B-T116
by	O
fibrinogen	B-T116
a	O
novel	O
view	O
of	O
the	O
metastasis	O
of	O
cancer	O
cells	O
to	O
low-	O
fibrinogen	B-T116
lymphatics	O
and	O
body	O
cavities	O
diluted	B-T169
1%	O
plasma	O
induces	O
migration	O
of	O
malignant	O
cell	O
lines	O
much	O
more	O
strongly	O
than	O
potent	O
pro-metastatic	B-T169
factors	I-T169
.	O
	
to	O
characterize	O
the	O
factor	B-T169
present	O
in	O
diluted	B-T169
plasma	O
responsible	O
for	O
this	O
phenomenon	O
we	O
performed	O
i	O
heat	O
inactivation	B-T169
,	O
ii	O
dialysis	O
,	O
iii	O
proteinase	B-T116
k	I-T116
treatment	B-T169
,	O
and	O
iv	O
molecular	O
size	O
filtration	O
studies	O
.	O
	
we	O
found	O
that	O
this	O
remarkable	O
pro-migratory	B-T052
activity	I-T052
of	O
diluted	B-T169
normal	O
plasma	O
is	O
associated	O
with	O
a	O
50-100-kd	O
protein	B-T116
that	O
interacts	O
with	O
gαi	B-T116
protein-coupled	I-T116
receptors	I-T116
and	O
activates	O
p42/44	B-T116
mapk	I-T116
and	O
akt	O
signaling	O
in	O
target	O
cells	O
.	O
	
since	O
this	O
pro-migratory	B-T052
activity	I-T052
of	O
1%	O
plasma	O
decreases	O
at	O
higher	O
plasma	B-T081
concentrations	I-T081
>	O
20%	O
,	O
but	O
is	O
retained	O
in	O
serum	O
,	O
we	O
hypothesized	O
that	O
fibrinogen	B-T116
may	O
be	O
involved	O
as	O
a	O
chaperone	B-T116
of	O
the	O
protein	B-T116
.	O
	
to	O
identify	O
the	O
pro-migratory	B-T116
protein	I-T116
present	O
in	O
diluted	B-T169
plasma	O
and	O
fibrinogen	B-T116
-depleted	O
serum	O
,	O
we	O
performed	O
gel	O
filtration	O
and	O
hydrophobic	O
interaction	O
chromatography	O
followed	O
by	O
mass	O
spectrometry	O
analysis	O
.	O
	
we	O
identified	O
several	O
putative	O
protein	B-T116
candidates	O
that	O
were	O
further	O
tested	O
in	B-T080
in	O
vitro	I-T080
experiments	B-T062
.	O
	
we	O
found	O
that	O
this	O
pro-migratory	O
factor	O
chaperoned	B-T116
by	O
fibrinogen	B-T116
is	O
vitronectin	B-T116
,	O
which	O
activates	O
upar	O
,	O
and	O
that	O
this	O
effect	O
can	O
be	O
inhibited	O
by	O
fibrinogen	B-T116
.	O
	
these	O
results	O
provide	O
a	O
novel	O
mechanism	O
for	O
the	O
metastasis	O
of	O
cancer	O
cells	O
to	O
lymphatics	O
and	O
body	O
cavities	O
,	O
in	O
which	O
the	O
concentration	B-T081
of	O
fibrinogen	B-T116
is	O
low	O
,	O
and	O
thus	O
suggests	O
that	O
free	O
vitronectin	B-T116
stimulates	O
migration	O
of	O
tumor	O
cells	O
.	O
	
development	B-T169
and	O
initial	B-T079
validation	B-T062
of	O
the	O
respirator	O
comfort	O
,	O
wearing	O
experience	O
,	O
and	O
function	B-T169
instrument	O
r-comfi	O
filtering	O
face-piece	O
respirators	O
ffrs	O
are	O
worn	O
to	O
protect	B-T033
health	O
care	O
personnel	O
from	O
airborne	O
particles	O
however	O
,	O
clinical	B-T062
studies	I-T062
have	O
demonstrated	O
that	O
ffr	O
adherence	B-T169
is	O
relatively	O
low	B-T080
in	O
some	O
settings	O
,	O
in	O
part	B-T082
,	O
due	O
to	O
discomfort	O
and	O
intolerance	O
.	O
	
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
develop	O
and	O
initially	B-T079
evaluate	B-T052
the	O
psychometric	B-T080
properties	I-T080
of	O
an	O
instrument	O
designed	O
to	O
measure	B-T081
the	O
comfort	O
and	O
tolerability	B-T080
of	O
ffrs	O
.	O
	
instrument	O
items	O
were	O
developed	O
through	O
literature	B-T170
reviews	I-T170
,	O
focus	O
groups	O
,	O
and	O
several	B-T081
iterations	B-T033
of	O
ranking	B-T170
and	O
refining	O
by	O
experts	O
.	O
	
psychometric	O
evaluation	O
of	O
the	O
instrument	O
was	O
conducted	O
using	O
rasch	B-T170
partial	I-T170
credit	I-T170
model	I-T170
pcm	B-T170
analysis	B-T062
.	O
	
pivot	B-T170
anchoring	I-T170
was	O
used	O
to	O
specify	O
the	O
threshold	B-T080
defining	O
item	O
difficulty	B-T080
in	O
our	O
analyses	B-T062
,	O
this	O
was	O
the	O
point	B-T081
that	O
participants	B-T098
moved	O
from	O
possessing	B-T078
none	O
of	O
the	O
trait	O
to	O
some	O
of	O
the	O
trait	O
.	O
	
the	O
final	B-T079
instrument	O
was	O
completed	B-T080
by	O
165	O
health	O
care	O
personnel	O
from	O
3	O
veterans	B-T098
health	O
administration	O
facilities	O
,	O
and	O
data	B-T078
were	O
analyzed	B-T062
using	O
rasch	B-T170
pcm	I-T170
.	O
	
seven	O
items	O
were	O
removed	B-T080
because	O
they	O
1	O
violated	B-T080
the	I-T080
assumption	I-T080
of	I-T080
independence	I-T080
2	O
were	O
mis-fitting	B-T080
and/or	O
3	O
were	O
deemed	O
not	B-T080
relevant	I-T080
.	O
	
category	B-T170
function	B-T169
analysis	B-T062
demonstrated	O
that	O
all	O
categories	B-T170
progressed	B-T169
monotonically	B-T080
.	O
	
principal	B-T081
components	I-T081
analysis	I-T081
demonstrated	O
the	O
existence	B-T081
of	O
three	O
subscales	B-T081
discomfort	O
,	O
general	O
wearing	O
experience	O
,	O
and	O
function	B-T169
.	O
	
final	B-T079
reliability	B-T081
analyses	B-T062
showed	O
that	O
the	O
scale	B-T081
had	O
moderate	B-T080
to	O
high	B-T081
person	I-T081
reliability	I-T081
and	O
high	O
item	O
reliability	B-T081
.	O
	
the	O
final	O
instrument	O
contained	B-T169
21	O
items	O
.	O
	
until	O
now	O
,	O
to	O
our	O
knowledge	O
no	O
instrument	O
with	O
evidence	B-T078
supporting	O
its	O
reliability	B-T080
and	I-T080
validity	I-T080
to	O
assess	B-T052
discomfort	O
and	O
tolerance	B-T080
of	O
ffrs	O
among	O
health	O
care	O
personnel	O
has	O
been	O
published	O
.	O
	
a	O
21-item	O
psychometrically	B-T081
sound	I-T081
measure	I-T081
of	O
comfort	O
and	O
tolerability	B-T080
of	O
ffrs	O
,	O
respirator	O
comfort	O
,	O
wearing	O
experience	O
,	O
and	O
function	B-T169
instrument	O
r-comfi	O
,	O
was	O
developed	O
.	O
	
the	O
significance	B-T078
of	O
developing	O
such	O
an	O
instrument	O
is	O
that	O
it	O
will	O
help	O
identify	O
respirators	O
that	O
are	O
likely	O
to	O
have	O
better	O
adherence	B-T169
in	O
practice	O
settings	O
.	O
	
the	O
r-comfi	O
may	O
be	O
used	O
within	B-T082
and	O
beyond	O
the	O
va	O
healthcare	O
system	O
as	O
a	O
psychometrically	O
sound	O
instrument	O
to	O
evaluate	B-T052
the	O
comfort	O
and	O
tolerability	B-T080
of	O
respirators	O
,	O
including	O
developmental	B-T080
kidney	B-T033
transplant	I-T033
recipients	I-T033
after	O
nonrenal	B-T061
solid	I-T061
organ	I-T061
transplantation	I-T061
show	O
low	O
alloreactivity	O
but	O
an	O
increased	O
risk	B-T078
of	O
infection	O
the	O
number	O
of	O
kidney	B-T033
transplant	I-T033
recipients	I-T033
ktrs	B-T033
after	O
nonrenal	B-T061
solid	I-T061
organ	I-T061
transplantation	I-T061
sot	B-T061
has	O
increased	O
to	O
almost	O
5%	O
.	O
	
knowledge	O
on	O
patient	O
and	O
allograft	B-T061
outcomes	B-T080
,	O
infections	O
,	O
and	O
alloreactivity	O
,	O
however	O
,	O
remains	O
scarce	O
.	O
	
we	O
studied	B-T062
40	O
ktrs	B-T033
after	O
nonrenal	B-T061
sot	I-T061
.	O
	
seven	O
hundred	O
and	O
twenty	O
primary	O
ktrs	B-T033
and	O
119	O
repeat	O
ktrs	B-T033
were	O
used	O
for	O
comparison	O
.	O
	
samples	O
were	O
collected	O
pretransplantation	B-T079
,	O
at	O
+1	O
,	O
+2	O
,	O
and	O
+3	O
months	O
post-transplantation	B-T079
.	O
	
alloreactive	O
and	O
cmv-specific	O
t	O
cells	O
were	O
measured	O
by	O
interferon-γ	O
elispot	O
assay	O
.	O
	
patient	O
survival	B-T052
in	O
ktrs	B-T033
after	O
sot	B-T061
,	O
primary	O
and	O
repeat	O
ktrs	B-T033
was	O
comparable	O
.	O
	
while	O
death	O
-censored	O
allograft	B-T061
survival	B-T052
was	O
comparable	O
between	O
ktrs	B-T033
after	O
sot	B-T061
and	O
primary	O
ktrs	B-T033
,	O
ktrs	B-T033
after	O
sot	B-T061
showed	O
superior	O
5-year	B-T079
death	O
-censored	O
allograft	B-T061
survival	B-T052
of	O
92.5	O
compared	O
to	O
81.2	O
in	O
repeat	O
ktrs	B-T033
.	O
	
interestingly	O
,	O
ktrs	B-T033
after	O
sot	B-T061
show	O
less	O
preformed	O
panel-reactive	O
antibodies	O
,	O
frequencies	B-T079
of	O
alloreactive	O
t	O
cells	O
,	O
and	O
acute	B-T033
rejections	I-T033
compared	O
to	O
repeat	O
ktrs	B-T033
.	O
	
ktrs	B-T033
after	O
sot	B-T061
,	O
however	O
,	O
show	O
higher	O
incidences	B-T081
of	O
ebv	B-T047
viremia	I-T047
and	O
ptld	O
,	O
sepsis	B-T047
,	O
and	O
death	O
from	O
sepsis	B-T047
.	O
	
impaired	O
cmv-specific	O
cellular	O
immunity	O
was	O
associated	B-T080
with	I-T080
more	O
cmv	O
replication	O
compared	O
to	O
repeat	O
ktrs	B-T033
.	O
	
our	O
results	O
suggest	O
comparable	O
patient	O
and	O
allograft	B-T061
outcomes	B-T080
in	O
ktrs	B-T033
after	O
sot	B-T061
and	O
primary	O
ktrs	B-T033
.	O
	
the	O
observed	O
low	O
alloreactivity	O
may	O
contribute	O
to	O
excellent	O
allograft	B-T061
outcomes	B-T080
.	O
	
caution	O
should	O
be	O
taken	O
in	O
ktrs	B-T033
after	O
sot	B-T061
regarding	O
infectious	B-T047
complications	I-T047
due	O
to	O
improved	B-T033
protocol	B-T170
for	O
the	O
isolation	O
of	O
naïve	O
follicular	O
dendritic	O
cells	O
follicular	O
dendritic	O
cells	O
fdcs	O
in	O
lymphoid	O
organs	O
play	O
an	O
important	O
role	O
in	O
the	O
humoral	O
immune	O
response	O
.	O
	
however	O
,	O
because	O
the	O
isolation	B-T061
of	O
fdcs	O
is	O
difficult	B-T080
due	O
to	O
their	O
very	O
small	B-T081
population	B-T081
size	I-T081
and	O
fragility	O
under	O
mechanical	O
and	O
chemical	O
stresses	O
,	O
the	O
genetic	B-T169
and	O
biochemical	B-T169
characteristics	B-T080
of	O
fdcs	O
remain	O
unclear	B-T033
.	O
	
previously	O
,	O
we	O
identified	O
fdcs	O
as	O
icam-1	B-T116
cells	O
in	O
the	O
cd45	B-T116
-	B-T033
non-hematopoietic	O
cell	O
fraction	O
from	O
naïve	O
mouse	O
spleen	O
after	O
cell	O
separation	O
by	O
means	O
of	O
digestion	O
with	O
a	O
combination	B-T080
of	O
enzymes	B-T116
.	O
	
in	O
the	O
present	O
study	O
,	O
using	O
a	O
new	B-T080
combination	B-T080
of	O
enzymes	B-T116
,	O
we	O
found	O
that	O
fdcs	O
are	O
highly	O
enriched	O
in	O
the	O
cd45	B-T116
-	B-T033
icam-1	B-T116
cd21	B-T116
/	O
35	B-T116
cell	O
fraction	O
.	O
	
cd45	B-T116
-	B-T033
icam-1	B-T116
cd21	B-T116
/	O
35	B-T116
cells	O
in	O
the	O
mouse	O
spleen	O
retained	O
an	O
antigen	O
administered	O
in	B-T082
vivo	I-T082
for	O
more	O
than	O
7	O
days	B-T079
.	O
	
moreover	O
,	O
cd45	B-T116
-	B-T033
icam-1	B-T116
cd21	B-T116
/	O
35	B-T116
cells	O
isolated	B-T169
from	O
the	O
spleen	O
of	O
mice	O
administered	O
with	O
a	O
cognate	O
antigen	O
enhanced	B-T052
the	O
survival	O
and	O
proliferation	B-T169
of	O
antigen-specific	O
b	O
cells	O
in	B-T080
vitro	I-T080
.	O
	
our	O
improved	B-T033
protocol	B-T170
for	O
the	O
isolation	O
of	O
naïve	O
fdcs	O
will	O
be	O
useful	O
for	O
the	O
analysis	B-T062
of	O
fdcs	O
in	B-T080
vitro	I-T080
and	O
in	B-T082
vivo	I-T082
.	O
	
dental	B-T080
enamel	B-T033
defects	I-T033
in	O
german	B-T098
medieval	B-T079
and	O
early-modern-age	B-T079
populations	B-T098
aim	B-T078
of	O
this	O
study	B-T062
was	O
to	O
investigate	B-T169
the	O
frequency	B-T079
and	O
type	B-T080
of	O
developmental	B-T033
defects	I-T033
of	I-T033
enamel	I-T033
dde	B-T033
in	O
a	O
medieval	B-T079
and	O
an	O
early-modern-age	B-T079
population	B-T098
from	O
thuringia	O
,	O
germany	O
.	O
	
sixty-six	O
skeletons	O
subdivided	B-T169
into	O
31	O
single	B-T081
burials	B-T052
12	O
c	O
and	O
35	O
individuals	B-T098
buried	B-T052
in	O
groups	B-T078
15	O
c	O
were	O
examined	B-T033
.	O
	
dde	B-T033
were	O
classified	O
on	O
1	O
teeth	O
according	O
to	O
the	O
dde	B-T033
index	B-T170
.	O
	
molar-incisor-hypomineralisation	B-T047
mih	B-T047
,	O
a	O
special	O
type	B-T080
of	O
dde	B-T033
,	O
was	O
recorded	B-T170
according	O
to	O
the	O
european	O
academy	O
of	O
paediatric	O
dentistry	O
eapd	O
criteria	B-T078
.	O
	
dde	B-T033
was	O
found	O
in	O
89.4	O
of	O
the	O
individuals	B-T098
single	B-T081
burials	B-T052
90.3	O
and	O
group	B-T078
burials	B-T052
88.6	O
.	O
	
hypoplastic	B-T169
pits	B-T033
were	O
the	O
most	O
frequent	B-T079
defect	B-T169
in	O
primary	O
teeth	O
and	O
linear	B-T047
enamel	I-T047
hypoplasia	I-T047
leh	B-T047
in	O
permanent	O
teeth	O
.	O
	
13	O
individuals	B-T098
24.1	O
showed	O
at	O
least	O
one	O
hypomineralised	B-T047
permanent	O
tooth	O
,	O
12.2	O
had	O
mih	B-T047
on	O
at	O
least	O
one	O
first	O
permanent	O
molar	O
and	O
10.0	O
in	O
permanent	O
incisors	O
.	O
	
second	O
primary	O
molars	O
were	O
affected	B-T169
in	O
8.0	O
of	O
the	O
children	O
and	O
juveniles	O
.	O
	
no	O
individual	B-T098
suffered	O
from	O
affected	B-T169
molars	O
and	O
incisors	O
in	O
combination	B-T080
.	O
	
endogenous	B-T169
factors	B-T169
like	O
nutritional	B-T047
deficiencies	I-T047
and	O
health	B-T033
problems	I-T033
in	O
early	B-T079
childhood	B-T079
could	O
have	O
been	O
aetiological	B-T169
reasons	B-T078
of	O
dde	B-T033
and	O
mih	B-T047
.	O
	
the	O
frequency	B-T079
of	O
dde	B-T033
and	O
mih	B-T047
might	O
have	O
been	O
masked	B-T062
by	O
extended	B-T082
carious	B-T047
lesions	I-T047
,	O
dental	O
wear	O
and	O
ante-mortem	B-T033
tooth	O
loss	O
.	O
	
breast	O
cancer	O
detection	B-T081
rate	I-T081
,	O
incidence	B-T081
,	O
prevalence	B-T081
and	O
interval	B-T079
cancer	O
-related	O
mammography	B-T061
screening	I-T061
times	B-T079
among	O
thai	B-T098
women	B-T098
a	O
recent	O
guideline	B-T170
by	O
the	O
american	O
cancer	O
society	O
recommended	O
that	O
mammography	O
mmg	O
should	O
be	O
done	O
for	O
women	B-T098
starting	O
in	O
their	O
mid-40s	O
.	O
	
in	O
thailand	O
,	O
information	O
on	O
opportunistic	O
mammography	O
screening	O
is	O
limited	B-T169
and	O
data	B-T078
on	O
the	O
total	O
incidence	B-T081
of	O
breast	O
cancer	O
are	O
also	O
lacking	O
.	O
	
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
estimate	B-T081
the	O
breast	O
cancer	O
detection	O
,	O
incident	O
and	O
prevalence	B-T081
rates	I-T081
among	O
thai	B-T098
women	B-T098
.	O
	
we	O
retrospectively	O
reviewed	O
the	O
opportunistic	O
mammography	O
screening	O
of	O
normal	O
women	B-T098
between	O
30	O
and	O
80	O
years	B-T079
who	O
underwent	O
the	O
procedure	O
between	O
2001	O
and	O
2010	O
.	O
	
all	O
cases	O
were	O
followed	O
until	O
2012	O
.	O
	
the	O
detection	B-T081
rate	I-T081
was	O
calculated	O
for	O
the	O
whole	O
period	O
of	O
observation	B-T062
using	O
'	O
number	B-T081
of	O
women	B-T098
with	O
positive	B-T033
findings	I-T033
'	O
divided	O
by	O
'	O
total	B-T081
number	I-T081
of	O
women	B-T098
screened	O
'	O
.	O
	
the	O
incidence	B-T081
rate	I-T081
was	O
calculated	B-T169
only	O
at	O
the	O
first	O
mmg	O
while	O
the	O
subsequence	O
rate	O
was	O
calculated	O
based	O
on	O
all	O
new	O
cases	O
detected	B-T033
at	O
each	O
subsequent	O
mmg	O
.	O
	
among	O
the	O
47	O
women	B-T098
,	O
there	O
were	O
152	O
mmgs	O
or	O
approximately	O
3.2	O
occasions	O
per	O
person	B-T098
range	O
,	O
1-10	O
.	O
	
the	O
average	O
duration	B-T079
of	O
the	O
interval	B-T079
between	O
each	O
subsequence	O
visit	O
was	O
1.8	O
years	B-T079
.	O
	
overall	O
,	O
breast	O
cancer	O
was	O
detected	B-T033
in	O
543	O
women	B-T098
,	O
with	O
a	O
detection	B-T081
rate	I-T081
of	O
10.3	O
per	O
1	O
persons	B-T098
.	O
	
the	O
prevalence	B-T081
rate	I-T081
of	O
breast	O
cancer	O
at	O
the	O
first	O
visit	O
was	O
5.78	O
per	O
1	O
person	B-T098
s	O
.	O
	
the	O
incidence	B-T081
or	O
new	O
cases	O
detected	B-T033
at	O
any	O
follow-up	O
visit	O
was	O
10.4	O
per	O
1	O
person	B-T098
s	O
.	O
	
the	O
overall	O
interval	B-T079
cancer	O
was	O
0.91	O
per	O
1	O
women	B-T098
,	O
mainly	O
detected	B-T033
before	O
their	O
second	O
and	O
third	O
mmg	O
,	O
with	O
a	O
rate	O
of	O
0.0	O
and	O
0.76	O
per	O
1	O
women	B-T098
.	O
	
opportunistic	O
mammography	O
screening	O
in	O
thailand	O
detected	B-T033
10	O
cases	O
of	O
breast	O
cancer	O
from	O
each	O
1	O
women	B-T098
.	O
	
this	O
paper	O
indicated	O
a	O
high	O
rate	O
of	O
cancer	O
detection	O
during	O
a	O
two	O
year	O
interval	B-T079
,	O
hence	O
,	O
a	O
screening	B-T061
mammogram	I-T061
assessment	O
of	O
groundwater	B-T082
vulnerability	B-T080
in	O
the	O
daule	O
aquifer	O
,	O
ecuador	O
,	O
using	O
the	O
susceptibility	O
index	O
method	O
the	O
guayas	O
region	O
in	O
ecuador	O
is	O
economically	O
very	O
important	O
,	O
producing	O
68%	O
of	O
the	O
national	O
crops	O
.	O
	
the	O
main	O
agricultural	O
activities	O
threaten	O
the	O
groundwater	B-T082
therein	O
with	O
nitrate	O
contamination	B-T078
given	O
the	O
large	O
fertiliser	O
and	O
water	O
needs	B-T080
.	O
	
the	O
present	O
work	O
tests	O
the	O
applicability	O
of	O
the	O
susceptibility	O
index	O
assessment	O
method	O
in	O
evaluating	O
the	O
impact	O
of	O
agricultural	O
activities	O
on	O
groundwater	B-T082
quality	B-T080
,	O
using	O
as	O
a	O
case	O
study	O
an	O
aquifer	O
of	O
the	O
guayas	O
river	B-T082
basin	I-T082
in	O
ecuador	O
.	O
	
the	O
index	O
adapts	O
four	O
parameters	O
of	O
the	O
drastic	O
method	O
and	O
incorporated	O
a	O
new	O
land	O
use	O
parameter	O
.	O
	
results	O
show	O
that	O
the	O
areas	B-T082
highly	B-T080
vulnerable	B-T080
to	O
contamination	B-T078
are	O
located	O
in	O
irrigation	O
perimeters	B-T082
of	O
dominant	O
paddy	B-T082
fields	I-T082
associated	O
with	O
the	O
high	O
recharge	O
rates	O
in	O
the	O
alluvial	O
deposits	O
.	O
	
respectively	O
,	O
moderately	B-T080
vulnerable	B-T080
and	O
low	B-T080
-	O
vulnerability	B-T080
areas	B-T082
correspond	O
to	O
aquatic	O
environments	O
and	O
forests	O
,	O
semi-natural	B-T082
zones	I-T082
and	O
water	O
bodies	O
.	O
	
one	O
of	O
the	O
main	O
contributions	O
of	O
the	O
daule	O
aquifer	O
vulnerability	B-T080
is	O
likely	O
its	O
wide	B-T082
,	O
flat	B-T082
topography	I-T082
.	O
	
a	O
great	O
part	O
of	O
the	O
aquifer	O
is	O
at	O
high	B-T033
risk	I-T033
of	I-T033
contamination	I-T033
by	O
nitrates	O
if	O
a	O
code	O
of	O
good	B-T080
agricultural	O
practices	O
is	O
not	O
applied	O
.	O
	
therefore	O
the	O
implementation	O
of	O
a	O
monitoring	B-T033
network	I-T033
to	I-T033
control	I-T033
the	O
nitrates	O
concentrations	B-T081
is	O
the	O
first	O
step	O
to	O
assure	O
groundwater	B-T082
quality	B-T080
for	O
drinking	O
purposes	B-T169
.	O
	
heterogeneous	B-T080
depression	O
trajectories	B-T079
in	O
multiple	B-T047
sclerosis	I-T047
patients	O
trajectories	B-T079
of	O
depression	O
over	O
time	O
may	O
be	O
heterogeneous	B-T080
in	O
multiple	B-T047
sclerosis	I-T047
ms	B-T047
patients	O
.	O
	
describing	O
these	O
trajectories	B-T079
will	O
help	O
clinicians	O
understand	O
better	O
the	O
progression	B-T169
of	O
depression	O
in	O
ms	B-T047
patients	O
to	O
aid	O
in	O
patient	O
care	O
decisions	O
.	O
	
latent	B-T062
class	I-T062
growth	I-T062
analysis	I-T062
lcga	B-T062
was	O
applied	O
to	O
3507	O
ms	B-T047
patients	O
using	O
an	O
electronic	B-T170
health	I-T170
records	I-T170
ehr	I-T170
data	I-T170
base	I-T170
to	O
identify	O
subgroups	B-T098
of	O
ms	B-T047
patients	O
based	O
on	O
self-reported	O
depression	B-T061
screening	I-T061
phq-9	B-T170
.	O
	
latent	B-T080
trajectory	B-T079
classes	O
were	O
used	O
for	O
group	B-T098
comparisons	O
based	O
on	O
baseline	B-T081
clinical	O
characteristics	O
.	O
	
three	O
subgroups	B-T098
were	O
found	O
characterized	O
by	O
high	B-T080
10.0	O
of	O
participants	B-T098
,	O
wavering	O
above	O
and	O
below	O
moderate	B-T080
26.2	O
and	O
low	B-T080
and	O
variable	B-T080
63.8	O
depression	B-T033
level	I-T033
trajectories	B-T079
.	O
	
the	O
subpopulation	B-T098
trajectories	B-T079
,	O
respectively	O
,	O
were	O
also	O
characterized	O
by	O
high	B-T080
,	O
moderate	B-T080
and	O
low	B-T080
ms	B-T047
disability	B-T033
at	O
baseline	B-T081
.	O
	
in	O
contrast	O
,	O
the	O
overall	O
average	O
trajectory	B-T079
was	O
slightly	O
declining	O
and	O
below	O
the	O
moderate	B-T080
depression	O
threshold	B-T080
.	O
	
the	O
lcga	B-T062
approach	O
described	O
in	O
this	O
paper	O
and	O
applied	O
to	O
ms	B-T047
patients	O
provides	O
a	O
template	B-T078
for	O
improved	O
use	O
of	O
an	O
ehr	B-T170
data	I-T170
base	I-T170
for	O
understanding	O
heterogeneous	B-T080
depression	B-T061
screening	I-T061
trajectories	B-T079
.	O
	
clinicians	O
may	O
use	O
such	O
information	B-T078
to	O
more	O
closely	O
monitor	O
patients	O
that	O
are	O
expected	O
to	O
maintain	O
high	B-T080
or	O
unstable	B-T033
depression	B-T033
levels	I-T033
.	O
	
the	O
pla2	O
gene	O
mediates	O
the	O
humoral	O
immune	O
responses	O
in	O
bactrocera	O
dorsalis	O
hendel	O
the	O
phospholipase	O
a2	O
pla2	O
gene	O
encodes	B-T052
the	O
enzyme	B-T116
that	O
catalyzes	B-T169
the	O
hydrolysis	O
of	O
phospholipids	B-T109
pls	B-T109
from	O
the	O
sn-2	B-T082
position	I-T082
.	O
	
however	O
,	O
little	O
is	O
known	O
about	O
its	O
role	B-T170
in	O
humoral	O
immune	O
responses	O
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
investigated	B-T169
the	O
expression	B-T081
profile	I-T081
of	O
pla2	O
in	O
different	B-T080
tissues	O
and	O
developmental	B-T079
stages	I-T079
in	O
bactrocera	O
dorsalis	O
hendel	O
,	O
and	O
the	O
results	O
showed	O
that	O
the	O
transcriptional	O
level	B-T080
of	O
pla2	O
was	O
high	B-T080
in	O
the	O
egg	O
and	O
mature	O
stage	O
and	O
in	O
the	O
testis	O
tissue	O
.	O
	
bacterial	B-T047
infection	I-T047
increased	O
the	O
expression	O
of	O
pla2	O
,	O
and	O
the	O
highest	O
degree	O
of	O
up-regulation	O
appeared	O
in	O
the	O
fat	O
body	O
.	O
	
silencing	O
pla2	O
influenced	O
the	O
expression	O
of	O
immune-related	O
genes	O
,	O
including	O
myd88	O
and	O
defensin	B-T116
in	O
the	O
toll	O
pathway	O
and	O
relish	B-T116
and	O
diptericin	B-T116
in	O
the	O
imd	O
pathway	O
.	O
	
moreover	O
,	O
the	O
expression	O
of	O
myd88	O
and	O
defensin	B-T116
was	O
down-regulated	O
significantly	O
in	O
the	O
ds-pla2	O
group	B-T078
compared	O
with	O
those	O
in	O
the	O
ds-egfp	B-T116
group	B-T078
when	O
b	O
.	O
	
dorsalis	O
was	O
infected	B-T033
with	O
l	O
.	O
	
monocytogenes	O
and	O
s	O
.	O
	
aureus	O
,	O
indicating	O
that	O
pla2	O
was	O
involved	O
in	O
the	O
activation	O
of	O
the	O
toll	O
pathway	O
.	O
	
meanwhile	O
,	O
infection	O
with	O
l	O
.	O
	
monocytogenes	O
and	O
e	O
.	O
	
coli	O
,	O
which	O
activate	B-T169
the	O
imd	O
pathway	O
,	O
does	O
not	O
increase	B-T169
the	O
mrna	O
levels	B-T080
of	O
relish	B-T116
and	O
diptericin	B-T116
in	O
the	O
ds-pla2	O
group	B-T078
as	O
severely	O
as	O
it	O
increases	B-T169
those	O
in	O
the	O
ds-egfp	B-T116
group	B-T078
,	O
indicating	O
that	O
the	O
imd	O
pathway	O
was	O
also	O
repressed	B-T169
after	O
silencing	O
pla2	O
.	O
	
notably	O
,	O
the	O
development	B-T169
of	O
lipid	O
droplets	O
in	O
fat	O
body	O
cells	O
was	O
influenced	O
by	O
silencing	O
pla2	O
,	O
implying	O
that	O
pla2	O
affects	O
the	O
function	B-T169
of	O
fat	O
body	O
tissue	O
.	O
	
these	O
results	O
suggest	O
that	O
the	O
pla2	O
gene	O
may	O
mediate	O
humoral	O
immune	O
responses	O
by	O
reducing	O
lipid	O
storage	O
in	O
fat	O
body	O
cells	O
in	O
b	O
.	O
	
dorsalis	O
gambling	O
disorders	O
,	O
gambling	O
type	O
preferences	O
,	O
and	O
psychiatric	B-T169
comorbidity	B-T078
among	O
the	O
thai	B-T098
general	I-T098
population	I-T098
results	O
of	O
the	O
2013	O
national	B-T170
mental	I-T170
health	I-T170
survey	I-T170
background	O
and	O
aims	O
to	O
estimate	O
the	O
prevalence	B-T081
of	O
problem	O
and	O
pathological	O
gambling	O
,	O
gender	O
and	O
age-group	O
differences	O
in	O
gambling	O
types	O
,	O
and	O
comorbidities	B-T078
with	O
other	O
psychiatric	O
disorders	O
among	O
the	O
thai	B-T098
general	I-T098
population	I-T098
.	O
	
methods	O
analysis	O
was	O
conducted	O
on	O
4	O
participants	B-T098
of	O
thailand's	O
2013	O
national	B-T170
mental	I-T170
health	I-T170
survey	I-T170
,	O
a	O
multistage	B-T170
stratified	I-T170
cluster	I-T170
survey	I-T170
,	O
using	O
the	O
composite	B-T170
international	I-T170
diagnostic	I-T170
interview	I-T170
.	O
	
diagnoses	B-T033
of	O
problem	O
and	O
pathological	O
gambling	O
and	O
other	O
psychiatric	O
disorders	O
were	O
based	O
on	O
the	O
dsm-iv-tr	B-T170
criteria	I-T170
with	O
the	O
following	O
additional	O
criteria	B-T078
for	O
gamblers	O
more	O
than	O
10	O
lifetime	B-T079
gambling	O
episodes	O
and	O
a	O
single	B-T081
year	I-T081
loss	I-T081
of	O
at	O
least	O
365	O
usd	B-T081
from	O
gambling	O
.	O
	
results	O
the	O
estimated	O
lifetime	B-T079
prevalence	B-T081
rates	I-T081
of	O
pathological	O
and	O
problem	O
gambling	O
were	O
0.90	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
0.51	O
and	O
1.14	O
95%	O
ci	B-T081
0.58	O
,	O
respectively	O
.	O
	
the	O
most	O
popular	O
type	O
of	O
gambling	O
was	O
playing	O
lotteries	O
69.5	O
,	O
standard	B-T081
error	I-T081
se	B-T081
=	O
1.9	O
,	O
the	O
prevalence	B-T081
of	O
which	O
was	O
significantly	O
higher	O
among	O
females	O
and	O
older	B-T098
age	I-T098
groups	I-T098
.	O
	
the	O
most	O
common	O
psychiatric	O
disorders	O
seen	O
among	O
pathological	O
gamblers	O
were	O
alcohol	O
abuse	O
57.4	O
,	O
nicotine	O
dependence	O
49.5	O
,	O
and	O
any	O
drug	O
use	O
disorder	O
16.2	O
.	O
	
pathological	O
gambling	O
was	O
highly	O
prevalent	O
among	O
those	O
who	O
ever	O
experienced	O
major	O
depressive	O
episodes	O
5.5	O
,	O
any	O
drug	O
dependence	O
5.1	O
,	O
and	O
intermittent	O
explosive	O
disorder	O
4.8	O
.	O
	
the	O
association	O
between	O
pathological	O
gambling	O
was	O
strongest	O
with	O
a	O
history	O
of	O
major	O
depressive	O
episode	O
adjusted	B-T081
odds	I-T081
ratio	I-T081
aor	B-T081
=	O
10.4	O
,	O
95%	O
ci	B-T081
2.80	O
.	O
	
conclusion	O
the	O
study	O
confirms	O
the	O
recognition	O
of	O
gambling	O
disorders	O
as	O
a	O
public	B-T170
health	I-T170
concern	O
in	O
thailand	O
and	O
suggests	O
a	O
need	O
for	O
culturally	B-T169
specific	O
preventive	B-T080
measures	O
for	O
pathological	O
gamblers	O
and	O
those	O
with	O
a	O
history	O
of	O
substance	O
use	O
disorders	O
or	O
major	O
depression	O
.	O
	
synovial	O
sarcoma	O
of	O
the	O
hypopharynx	O
in	O
a	O
pediatric	B-T080
patient	O
case	B-T170
report	I-T170
synovial	O
sarcoma	O
ss	O
is	O
uncommon	O
high	O
grade	O
soft	O
tissue	O
sarcoma	O
,	O
accounting	O
for	O
less	O
than	O
10%	O
of	O
all	O
head	O
and	O
neck	O
sarcomas	O
.	O
	
also	O
,	O
about	O
10%	O
of	O
ss	O
occur	O
within	O
the	O
head	O
neck	O
.	O
	
in	O
the	O
pediatric	B-T080
population	B-T098
,	O
ss	O
is	O
an	O
extremely	O
rare	B-T080
head	O
neck	O
malignancy	O
.	O
	
we	O
present	O
a	O
case	O
of	O
sixteen	O
years	O
old	O
boy	O
diagnosed	B-T033
with	O
ss	O
situated	O
of	O
the	O
hypopharynx	O
treated	B-T061
by	I-T061
surgical	B-T061
excision	I-T061
and	O
post	B-T033
operative	I-T033
radio	B-T061
-	O
chemotherapy	B-T061
.	O
	
this	O
anatomical	O
location	O
brings	O
additional	O
functional	B-T169
challenges	O
swallowing	O
,	O
phonation	O
,	O
respiration	O
,	O
especially	O
in	O
the	O
pediatric	B-T080
population	B-T098
.	O
	
pre-operative	B-T079
and	O
even	O
post-operative	B-T033
histopathological	B-T169
diagnosis	B-T033
of	O
ss	O
remains	O
difficult	O
.	O
	
optimal	B-T080
treatment	B-T061
of	O
head	O
neck	O
ss	O
has	O
to	O
balance	O
functional	B-T169
and	O
oncologic	O
aspects	B-T080
.	O
	
ss	O
is	O
an	O
extremely	O
rare	B-T080
head	O
neck	O
malignancy	O
in	O
pediatric	B-T080
population	B-T098
.	O
	
it	O
has	O
multifaceted	B-T082
challenges	O
including	O
pre	O
and	O
post-operative	B-T033
histopathological	B-T169
diagnosis	B-T033
and	O
optimal	B-T080
modality	B-T078
of	O
treatment	B-T061
.	O
	
clinical	B-T170
judgment	I-T170
,	O
especially	O
in	O
the	O
pediatric	B-T080
population	B-T098
,	O
needs	O
to	O
balance	O
tumor	O
free	O
margins	O
and	O
organ	B-T061
preservation	I-T061
in	O
head	O
and	O
neck	O
region	O
.	O
	
ocular	B-T047
hypotensive	I-T047
effect	B-T080
of	O
the	O
novel	O
ep3	B-T116
/	O
fp	B-T116
agonist	O
ono-9054	B-T109
versus	O
xalatan	B-T109
results	O
of	O
a	O
28-	O
day	B-T079
,	O
double-masked	B-T062
,	O
randomised	B-T080
study	B-T062
ono-9054	B-T109
is	O
being	O
developed	O
for	O
the	O
reduction	B-T080
of	O
intraocular	O
pressure	O
iop	O
in	O
patients	O
with	O
ocular	B-T047
hypertension	I-T047
oht	B-T047
and	O
open-angle	B-T047
glaucoma	I-T047
oag	B-T047
.	O
	
this	O
study	B-T062
compared	O
the	O
novel	O
dual	O
ep3	B-T116
/	O
fp	B-T116
agonist	O
ono-9054	B-T109
with	O
the	O
fp	B-T116
agonist	O
xalatan	B-T109
.	O
	
adults	O
n=123	O
with	O
bilateral	O
mild/moderate	O
oag	B-T047
or	O
oht	B-T047
,	O
with	O
unmedicated	O
iop	O
of	O
24	O
mm	O
hg	O
at	O
8	O
hours	O
,	O
21	O
mm	O
hg	O
at	O
10	O
hours	O
and	O
36	O
mm	O
hg	O
,	O
were	O
randomised	O
1	O
to	O
receive	O
ono-9054	B-T109
0.003	O
,	O
30	O
μg/ml	O
or	O
xalatan	B-T109
0.005	O
,	O
50	O
μg/ml	O
once	O
daily	B-T079
for	O
28	O
days	B-T079
.	O
	
day	B-T079
29	O
mean	O
diurnal	O
iop	O
was	O
-7	O
mm	O
hg	O
for	O
ono-9054	B-T109
vs	O
-6	O
mm	O
hg	O
for	O
xalatan	B-T109
.	O
	
at	O
08	O
hours	O
,	O
the	O
iops	O
were	O
comparable	O
,	O
and	O
at	O
all	O
later	O
time	O
points	O
the	O
decrease	B-T081
in	O
iop	O
was	O
greater	O
for	O
ono-9054	B-T109
.	O
	
on	O
day	B-T079
29	O
,	O
the	O
odds	O
of	O
a	O
mean	O
iop	O
reduction	B-T080
of	O
-25%	O
,	O
-30%	O
and	O
-35%	O
for	O
ono-9054	B-T109
were	O
2.39	O
,	O
2.37	O
and	O
4.85	O
times	O
more	O
,	O
respectively	O
,	O
than	O
the	O
odds	O
for	O
xalatan	B-T109
p<0	O
,	O
post	B-T062
hoc	I-T062
analyses	I-T062
.	O
	
the	O
percentage	O
of	O
subjects	O
achieving	O
target	O
iops	O
on	O
day	B-T079
29	O
17	O
,	O
16	O
and	O
15	O
mm	O
hg	O
was	O
greater	O
for	O
ono-9054	B-T109
than	O
for	O
xalatan	B-T109
the	O
odds	O
of	O
achieving	O
an	O
iop	O
15	O
mm	O
hg	O
for	O
ono-9054	B-T109
were	O
2.4	O
times	O
more	O
than	O
the	O
odds	O
for	O
xalatan	B-T109
p<0	O
,	O
post	B-T062
hoc	I-T062
analysis	I-T062
.	O
	
subjects	O
randomised	O
to	O
receive	O
ono-9054	B-T109
were	O
more	O
likely	O
to	O
achieve	O
a	O
greater	O
per	O
cent	O
reduction	O
in	O
iop	O
and	O
were	O
more	O
likely	O
to	O
achieve	O
target	O
iops	O
than	O
those	O
receiving	O
xalatan	B-T109
.	O
	
the	O
effects	O
of	O
ono-9054	B-T109
in	O
reducing	O
iop	O
appear	O
to	O
persist	O
longer	O
than	O
those	O
of	O
xalatan	B-T109
.	O
	
whole-body	B-T061
strength	I-T061
training	I-T061
with	O
huber	O
motion	O
lab	O
and	O
traditional	B-T061
strength	I-T061
training	I-T061
in	O
cardiac	B-T061
rehabilitation	I-T061
a	O
randomized	B-T062
controlled	I-T062
study	I-T062
isometric	B-T061
strengthening	I-T061
has	O
been	O
rarely	O
studied	O
in	O
patients	O
with	O
coronary	B-T047
heart	I-T047
disease	I-T047
chd	B-T047
,	O
mainly	O
because	O
of	O
possible	O
potential	O
side	O
effects	O
and	O
lack	B-T080
of	O
appropriate	B-T080
and	O
reliable	B-T170
devices	O
.	O
	
we	O
aimed	O
to	O
compare	O
2	O
different	O
modes	B-T169
of	O
resistance	B-T061
training	I-T061
,	O
an	O
isometric	O
mode	B-T169
with	O
the	O
huber	O
motion	O
lab	O
hml	O
and	O
traditional	B-T061
strength	I-T061
training	I-T061
tst	B-T061
,	O
in	O
chd	B-T047
patients	O
undergoing	O
a	O
cardiac	B-T061
rehabilitation	I-T061
program	O
.	O
	
we	O
randomly	O
assigned	O
50	O
patients	O
to	O
hml	O
or	O
tst	B-T061
.	O
	
patients	O
underwent	O
complete	O
blinded	B-T062
evaluation	O
before	O
and	O
after	O
the	O
rehabilitation	B-T061
program	I-T061
,	O
including	O
testing	O
for	O
cardiopulmonary	O
exercise	O
,	O
maximal	O
isometric	O
voluntary	O
contraction	O
,	O
endothelial	O
function	O
and	O
body	O
composition	O
.	O
	
after	O
4	O
weeks	B-T079
of	O
training	O
16	O
sessions	O
,	O
the	O
groups	B-T078
did	O
not	O
differ	O
in	O
body	O
composition	O
,	O
anthropometric	B-T062
characteristics	B-T080
,	O
or	O
endothelial	O
function	O
.	O
	
with	O
hml	O
,	O
peak	B-T080
power	O
output	O
p=0	O
,	O
maximal	B-T080
heart	O
rate	O
p<0	O
and	O
gain	B-T081
of	O
force	O
measured	B-T080
in	O
the	O
chest	O
press	O
position	O
p<0	O
were	O
greater	B-T081
after	O
versus	O
before	O
training	O
.	O
	
both	O
protocols	B-T170
appeared	O
to	O
be	O
well	O
tolerated	O
,	O
safe	O
and	O
feasible	O
for	O
these	O
chd	B-T047
patients	O
.	O
	
a	O
training	B-T170
protocol	I-T170
involving	O
6s	O
phases	O
of	O
isometric	O
contractions	O
with	O
10s	O
of	O
passive	B-T080
recovery	O
on	O
an	O
hml	O
device	O
could	O
be	O
safely	O
implemented	O
in	O
rehabilitation	B-T061
programs	I-T061
for	O
patients	O
with	O
chd	B-T047
and	O
improve	O
functional	B-T080
outcomes	I-T080
.	O
	
percutaneous	B-T061
coronary	I-T061
intervention	I-T061
and	O
heart	B-T061
surgery	I-T061
learning	O
needs	B-T169
of	I-T169
patients	I-T169
in	O
jordan	O
this	O
study	O
aimed	O
to	O
identify	O
and	O
prioritize	B-T079
the	O
perceived	O
learning	O
needs	B-T169
of	I-T169
patients	I-T169
who	O
underwent	O
percutaneous	B-T061
coronary	I-T061
intervention	I-T061
or	O
open-heart	B-T061
surgery	I-T061
.	O
	
identifying	O
learning	O
needs	O
for	O
post-cardiac	B-T061
intervention	I-T061
patients	O
is	O
essential	O
to	O
establish	O
successful	O
health	O
education	O
programmes	O
based	O
on	O
patient	O
central	O
care	O
.	O
	
a	O
descriptive	O
comparative	O
design	B-T052
was	O
employed	O
on	O
a	O
convenience	B-T080
sample	B-T098
of	O
260	O
patients	O
who	O
underwent	O
a	O
percutaneous	B-T061
coronary	I-T061
intervention	I-T061
and	O
105	O
patients	O
who	O
underwent	O
open-heart	B-T061
surgery	I-T061
patients	O
.	O
	
participants	B-T098
had	O
completed	O
the	O
patient	O
learning	B-T170
needs	I-T170
scale	I-T170
.	O
	
data	B-T078
were	O
collected	O
between	O
1	O
october	O
2014	O
and	O
31	O
june	O
2015	O
.	O
	
patients	O
from	O
the	O
two	O
groups	B-T078
highly	O
requesting	O
health	O
and	O
recovery	O
related	O
information	O
.	O
	
they	O
scored	O
all	O
learning	O
need	O
topics	B-T170
as	O
important	O
or	O
highly	O
important	O
for	O
them	O
.	O
	
the	O
top	O
priority	B-T079
learning	O
need	O
for	O
both	O
patient	O
groups	O
was	O
'	O
information	B-T078
about	O
wound	B-T061
care	I-T061
'	O
,	O
and	O
the	O
lowest	O
priority	B-T079
learning	O
need	O
topic	B-T170
was	O
'	O
physical	O
activity	O
'	O
.	O
	
the	O
learning	O
needs	B-T080
of	O
both	O
groups	B-T078
were	O
very	O
close	O
,	O
which	O
indicated	O
that	O
educational	B-T170
secondary	I-T170
prevention	I-T170
programmes	I-T170
'	O
content	O
can	O
be	O
prepared	O
in	O
a	O
unified	O
structure	O
for	O
those	O
patients	O
.	O
	
although	O
,	O
specific	O
headings	B-T170
can	O
be	O
used	O
to	O
address	O
the	O
unique	O
needs	B-T080
that	O
emerge	O
from	O
having	O
a	O
specific	O
cardiac	O
interventional	B-T061
procedure	I-T061
.	O
	
the	O
fact	O
that	O
wound	B-T061
care	I-T061
and	O
medications	O
are	O
areas	O
of	O
highest	O
learning	O
needs	B-T080
for	O
patients	O
requires	O
health	O
policy	O
decision	O
makers	O
to	O
address	O
these	O
topics	B-T170
at	O
the	O
time	B-T079
of	O
hospital	O
discharge	O
.	O
	
in	O
addition	O
,	O
a	O
policy	O
focus	O
on	O
considering	O
patients	O
'	O
actual	O
learning	O
needs	B-T080
requires	O
establishment	O
and	O
managerial	O
support	O
.	O
	
as	O
patients	O
'	O
learning	O
needs	B-T080
might	O
change	O
later	O
after	O
discharge	O
,	O
the	O
health	O
services	O
should	O
be	O
proactive	O
and	O
focus	O
on	O
continuous	O
support	O
for	O
patients	O
after	O
hospital	O
discharge	O
.	O
	
secondary	B-T170
prevention	I-T170
programmes	I-T170
should	O
incorporate	O
health	O
education	O
topics	B-T170
based	O
on	O
patients	O
'	O
own	O
views	O
.	O
	
this	O
can	O
be	O
done	O
by	O
giving	O
higher	O
priority	B-T079
to	O
understand	O
patients'	B-T169
needs	I-T169
,	O
put	O
much	O
more	O
effort	O
into	O
how	O
to	O
meet	O
patients	O
'	O
information	B-T078
needs	B-T080
and	O
to	O
create	O
a	O
more	O
engaging	O
learning	O
environment	B-T082
for	O
patients	O
and	O
their	O
complications	O
and	O
near-miss	O
events	O
after	O
hepatectomy	B-T061
for	O
living-related	B-T061
liver	I-T061
donation	I-T061
an	O
italian	O
single	O
center	O
report	B-T170
of	O
one	O
hundred	O
cases	B-T169
background	O
in	O
healthy	B-T080
individuals	B-T098
,	O
such	O
as	O
liver	B-T098
living	I-T098
donors	I-T098
,	O
potential	O
complications	O
may	O
occur	O
during	O
surgery	B-T061
.	O
	
reporting	O
such	O
complications	O
and	O
near-miss	O
events	O
is	O
mandatory	O
to	O
improve	O
living	B-T098
donor	I-T098
management	O
and	O
safety	O
.	O
	
material	O
and	O
methods	O
this	O
retrospective	B-T062
study	I-T062
was	O
performed	O
on	O
a	O
prospective	O
database	B-T170
with	O
the	O
aim	O
of	O
providing	O
a	O
brief	O
analysis	B-T062
of	O
the	O
perioperative	B-T079
,	O
medium-term	B-T079
,	O
and	O
long-term	B-T079
complications	O
,	O
and	O
the	O
near-miss	O
events	O
in	O
a	O
single	O
center	O
series	O
of	O
100	O
consecutive	O
liver	B-T061
resections	I-T061
for	O
adult	O
-to-	O
adult	O
living-donor	B-T098
liver	B-T061
transplantation	I-T061
.	O
	
results	O
only	O
23.3	O
of	O
potential	O
living	B-T098
donors	I-T098
underwent	O
surgery	B-T061
.	O
	
no	B-T033
living	B-T098
donor	I-T098
mortality	B-T081
was	O
reported	O
29	O
patients	O
29%	O
experienced	O
at	O
least	O
one	O
complication	O
.	O
	
five	O
patients	O
developed	O
mild	B-T080
long-term	B-T079
dysfunction	O
two	O
aborted	O
hepatectomies	B-T061
,	O
and	O
there	O
were	O
two	O
near-miss	O
events	O
reported	O
.	O
	
conclusions	O
a	O
strategy	O
for	O
an	O
accurate	O
assessment	O
of	O
living	B-T098
donor	I-T098
complications	O
and	O
strict	O
selection	B-T052
criterion	O
cannot	O
be	O
overemphasized	O
,	O
as	O
well	O
as	O
the	O
need	O
to	O
continuously	O
update	O
center	O
patient	B-T078
outcome	I-T078
reports	B-T170
.	O
	
tooth	O
wear	O
as	O
a	O
means	O
to	O
quantify	B-T081
intra-specific	B-T080
variations	B-T080
in	O
diet	O
and	O
chewing	O
movements	O
in	O
mammals	O
,	O
tooth	O
function	B-T169
,	O
and	O
its	O
efficiency	B-T081
,	O
depends	O
both	O
on	O
the	O
mechanical	O
properties	B-T080
of	O
the	O
food	O
and	O
on	O
chewing	O
dynamics	B-T169
.	O
	
these	O
aspects	B-T080
have	O
rarely	O
been	O
studied	B-T062
in	O
combination	O
and/or	O
at	O
the	O
intra-specific	B-T080
level	O
.	O
	
here	O
we	O
applied	O
3d	B-T082
dental	O
surface	B-T082
texture	B-T080
analysis	B-T062
to	O
a	O
sample	O
of	O
field	O
voles	O
microtus	O
agrestis	O
trapped	O
from	O
finnish	O
lapland	O
at	O
different	O
seasons	B-T079
and	O
localities	O
to	O
test	B-T169
for	O
inter-population	B-T098
variations	B-T080
.	O
	
we	O
also	O
explored	O
intra-individual	B-T098
variation	B-T080
in	O
chewing	O
dynamics	B-T169
by	O
analysing	B-T062
two	O
facets	B-T082
on	O
the	O
second	O
upper	O
molars	O
.	O
	
our	O
results	B-T033
confirm	O
that	O
the	O
two	O
localities	O
have	O
similar	O
environments	B-T082
and	O
that	O
the	O
voles	O
feed	B-T052
on	O
the	O
same	O
items	O
there	O
.	O
	
on	O
the	O
other	O
hand	O
,	O
the	O
texture	B-T080
data	B-T078
suggest	O
that	O
diets	O
are	O
seasonally	O
variable	B-T080
,	O
probably	O
due	O
to	O
varying	O
concentrations	B-T081
of	O
abrasives	O
.	O
	
lastly	O
,	O
the	O
textures	B-T080
on	O
the	O
buccal	O
facets	O
are	O
more	O
isotropic	O
and	O
their	O
direction	B-T082
deviates	B-T082
more	O
from	O
the	O
mesial	O
chewing	O
direction	B-T082
than	O
the	O
lingual	O
facets	B-T082
.	O
	
we	O
interpret	B-T169
these	O
results	B-T033
as	O
reflecting	O
food	O
,	O
rather	O
than	O
chewing	O
,	O
movements	O
,	O
where	O
food	O
particles	O
are	O
more	O
guided	O
on	O
the	O
lingual	O
side	O
of	O
the	O
molars	O
.	O
	
this	O
has	O
implications	O
for	O
the	O
application	O
of	O
dental	O
microwear	O
analysis	B-T062
to	O
fossils	O
only	O
homologous	O
facets	B-T082
can	O
be	O
compared	O
,	O
even	O
when	O
the	O
molar	O
row	O
seems	O
to	O
constitute	O
a	O
functional	B-T169
unit	I-T169
.	O
	
human	B-T116
cathelicidin	I-T116
ll-37	I-T116
enhance	O
the	O
antibiofilm	B-T033
effect	I-T033
of	O
egcg	B-T109
on	O
streptococcus	O
mutans	O
streptococcus	O
mutans	O
forms	O
biofilms	O
as	O
a	O
resistance	B-T169
mechanism	B-T169
against	O
antimicrobial	O
agents	O
in	O
the	O
human	O
oral	O
cavity	O
.	O
	
we	O
recently	O
showed	O
that	O
human	B-T116
cathelicidin	I-T116
ll-37	I-T116
exhibits	O
inhibitory	B-T080
effects	I-T080
on	O
biofilm	O
formation	O
of	O
s	O
.	O
	
mutans	O
through	O
interaction	B-T169
with	O
lipoteichoic	B-T109
acid	I-T109
lta	B-T109
,	O
but	O
without	O
antibacterial	B-T033
or	O
biofilm	O
dispersal	B-T082
abilities	I-T082
.	O
	
-	B-T109
gallate	I-T109
egcg	B-T109
is	O
the	O
most	O
abundant	O
constituent	O
of	O
tea	O
catechins	B-T109
that	O
has	O
the	O
greatest	O
anti-infective	B-T033
potential	I-T033
to	O
inhibit	O
the	O
growth	O
of	O
various	O
microorganisms	O
and	O
biofilm	O
formation	O
.	O
	
therefore	O
,	O
in	O
this	O
study	O
,	O
we	O
evaluated	O
whether	O
ll-37	B-T116
interacts	O
with	O
egcg	B-T109
to	O
enhance	O
the	O
antibiofilm	B-T033
effect	I-T033
of	O
egcg	B-T109
on	O
s	O
.	O
	
mutans	O
biofilm	O
formation	O
.	O
	
clinical	O
s	O
.	O
	
mutans	O
strains	O
n	O
=	O
10	O
isolated	O
from	O
children's	O
saliva	O
were	O
tested	B-T169
in	O
a	O
biofilm	O
formation	O
assay	O
.	O
	
the	O
antibiofilm	B-T033
effect	I-T033
of	O
egcg	B-T109
with	O
and	O
without	O
ll-37	B-T116
was	O
analyzed	B-T062
by	O
the	O
minimum	O
biofilm	O
eradication	B-T080
concentration	B-T081
assay	O
and	O
confirmed	O
using	O
field	O
emission-scanning	O
electron	O
microscopy	O
.	O
	
in	O
addition	O
,	O
the	O
interaction	B-T169
among	O
egcg	B-T109
,	O
ll-37	B-T116
,	O
and	O
lta	B-T109
of	O
s	O
.	O
	
mutans	O
was	O
determined	O
using	O
quartz	B-T062
crystal	I-T062
microbalance	I-T062
analysis	I-T062
.	O
	
egcg	B-T109
killed	O
100	O
%	O
of	O
planktonic	O
s	O
.	O
	
mutans	O
within	O
5	O
h	O
,	O
inhibited	O
biofilm	O
formation	O
within	O
24	O
h	O
,	O
and	O
reduced	O
bacteria	O
cells	O
in	O
preformed	O
biofilms	O
within	O
3	O
h	O
at	O
a	O
concentration	B-T081
of	O
0.2	O
mg/ml	O
.	O
	
however	O
,	O
egcg	B-T109
did	O
not	O
appear	O
to	O
interact	O
with	O
lta	B-T109
.	O
	
ll-37	B-T116
effectively	O
enhanced	O
the	O
bactericidal	O
activity	O
of	O
egcg	B-T109
against	O
biofilm	O
formation	O
and	O
preformed	O
biofilms	O
as	O
determined	O
by	O
quantitative	B-T081
crystal	B-T109
violet	I-T109
staining	O
and	O
field	O
emission-scanning	O
electron	O
microscopy	O
.	O
	
in	O
addition	O
,	O
quartz	B-T062
crystal	I-T062
microbalance	I-T062
analysis	I-T062
revealed	O
that	O
ll-37	B-T116
interacted	B-T169
with	O
egcg	B-T109
and	O
promoted	O
binding	O
between	O
egcg	B-T109
and	O
lta	B-T109
of	O
s	O
.	O
	
mutans	O
.	O
	
we	O
show	O
that	O
ll-37	B-T116
enhances	O
the	O
antibiofilm	B-T033
effect	I-T033
of	O
egcg	B-T109
on	O
s	O
.	O
	
mutans	O
.	O
	
this	O
finding	O
provides	O
new	O
knowledge	O
for	O
dental	B-T061
treatment	I-T061
by	O
using	O
ll-37	B-T116
as	O
a	O
potential	O
antibiofilm	O
compound	O
.	O
	
discovery	B-T052
of	O
orally	O
efficacious	B-T080
phosphoinositide-3-kinase	B-T116
delta	I-T116
inhibitors	O
with	O
improved	B-T033
metabolic	B-T169
stability	B-T080
aberrant	O
signaling	O
of	O
phosphoinositide-3-kinase	B-T116
delta	I-T116
pi3k-delta	B-T116
has	O
been	O
implicated	O
in	O
numerous	O
pathologies	O
including	O
hematological	O
malignancies	O
and	O
rheumatoid	B-T047
arthritis	I-T047
.	O
	
described	O
in	O
this	O
manuscript	O
is	O
the	O
discovery	B-T052
,	O
optimization	B-T052
and	O
in	B-T082
vivo	I-T082
evaluation	O
of	O
a	O
novel	O
series	O
of	O
pyridine-containing	B-T109
pi3k-delta	B-T116
inhibitors	O
.	O
	
this	O
work	O
led	O
to	O
the	O
discovery	B-T052
of	O
35	O
,	O
a	O
highly	O
selective	O
inhibitor	O
of	O
pi3k-delta	B-T116
which	O
displays	O
an	O
excellent	O
pharmacokinetic	B-T169
profile	I-T169
and	O
is	O
efficacious	B-T080
in	O
a	O
rodent	O
model	O
of	O
rheumatoid	B-T047
arthritis	I-T047
.	O
	
mobile	O
phone	O
use	B-T169
,	O
behavioural	O
problems	O
and	O
concentration	O
capacity	B-T081
in	O
adolescents	O
a	O
prospective	B-T062
study	I-T062
the	O
aim	O
of	O
this	O
study	B-T062
is	O
to	O
prospectively	O
investigate	B-T169
whether	O
exposure	B-T080
to	I-T080
radiofrequency	O
electromagnetic	O
fields	O
rf-emf	O
emitted	O
by	O
mobile	O
phones	O
and	O
other	O
wireless	O
communication	O
devices	O
is	O
related	O
to	O
behavioural	O
problems	O
or	O
concentration	O
capacity	B-T081
in	O
adolescents	O
.	O
	
the	O
hermes	B-T062
health	B-T078
effects	B-T080
related	B-T080
to	O
mobile	O
phone	O
use	O
in	O
adolescents	O
study	O
sample	O
consisted	O
of	O
439	O
swiss	B-T098
adolescents	O
aged	O
12-17	O
years	B-T079
.	O
	
behavioural	O
problems	O
were	O
assessed	B-T052
using	O
the	O
strengths	B-T170
and	I-T170
difficulties	I-T170
questionnaire	I-T170
sdq	B-T170
,	O
concentration	O
capacity	B-T081
of	O
the	O
adolescents	O
was	O
measured	B-T080
by	O
means	O
of	O
a	O
standardized	B-T170
computerized	I-T170
cognitive	I-T170
test	I-T170
named	O
fakt	B-T170
.	O
	
cross-sectional	B-T062
and	O
longitudinal	B-T062
1year	B-T079
of	O
follow-up	B-T033
analyses	B-T062
were	O
performed	B-T169
to	O
investigate	B-T169
possible	O
associations	B-T080
between	O
behavioural	O
problems	O
and	O
concentration	O
capacity	B-T081
and	O
different	B-T080
exposure	B-T080
measures	B-T081
self-reported	B-T062
and	O
operator	O
-recorded	O
wireless	O
communication	O
device	O
use	O
,	O
cumulative	B-T080
rf-emf	O
brain	O
and	O
whole	O
body	O
dose	O
and	O
measured	B-T080
personal	O
rf-emf	O
exposure	B-T080
.	O
	
in	O
the	O
cross-sectional	B-T062
analyses	I-T062
behavioural	O
problems	O
were	O
associated	B-T080
with	I-T080
several	O
self-reported	B-T170
wireless	O
device	O
use	B-T169
measures	B-T081
but	O
not	O
operator	O
-recorded	O
mobile	O
phone	O
use	B-T169
measures	B-T081
,	O
concentration	O
capacity	B-T081
was	O
associated	B-T080
with	I-T080
several	O
self-reported	B-T062
and	O
operator	O
-recorded	O
exposures	B-T080
.	O
	
the	O
longitudinal	B-T062
analyses	I-T062
point	O
towards	O
absence	B-T169
of	O
associations	B-T080
.	O
	
the	O
lack	B-T080
of	O
consistent	B-T078
exposure	B-T080
-response	O
patterns	B-T082
in	O
the	O
longitudinal	B-T062
analyses	I-T062
suggests	O
that	O
behavioural	O
problems	O
and	O
concentration	O
capacity	B-T081
are	O
not	O
affected	B-T169
by	O
the	O
use	O
of	O
wireless	O
communication	O
devices	O
or	O
rf-emf	O
exposure	B-T080
.	O
	
information	B-T078
bias	B-T078
and	O
reverse	O
causality	O
are	O
likely	O
explanations	B-T170
for	O
the	O
observed	O
cross-sectional	B-T062
findings	I-T062
.	O
	
twisting	B-T169
method	I-T169
for	O
reducing	B-T080
friction	O
during	O
insertion	B-T061
of	O
a	O
sheath	O
introducer	O
and	O
a	O
sheathless	O
guiding	O
catheter	O
a	O
sheathless	B-T169
system	I-T169
that	O
inserts	O
a	O
catheter	O
directly	B-T080
into	O
the	O
artery	O
can	O
reduce	B-T080
puncture	O
site	B-T082
-related	O
complications	O
through	O
a	O
2-fr	B-T080
reduction	I-T080
of	O
the	O
outer	B-T082
diameter	I-T082
.	O
	
however	O
,	O
the	O
gap	B-T082
between	O
the	O
dilator	O
and	O
the	O
guiding	O
catheter	O
of	O
the	O
sheathless	B-T169
system	I-T169
is	O
larger	B-T081
than	O
the	O
gap	B-T082
between	O
the	O
dilator	O
and	O
sheath	O
of	O
the	O
introducer	O
system	O
,	O
resulting	O
in	O
stronger	O
insertion	B-T061
resistance	O
.	O
	
a	O
twisting	B-T169
method	I-T169
with	O
rapid	B-T080
alternating	B-T169
rotation	B-T169
of	O
a	O
device	O
to	O
the	O
left	O
and	O
right	O
during	O
insertion	B-T061
can	O
reduce	O
the	O
insertion	B-T061
resistance	O
.	O
	
this	O
method	O
can	O
be	O
effective	O
with	O
the	O
sheathless	O
system	O
which	O
has	O
a	O
larger	O
gap	O
.	O
	
to	O
examine	O
the	O
effect	O
of	O
size	O
reduction	O
on	O
the	O
sheathless	O
system	O
and	O
the	O
effect	O
of	O
insertion	O
resistance	O
reduction	O
using	O
the	O
twisting	O
method	O
,	O
we	O
developed	O
an	O
insertion	O
simulator	O
and	O
compared	O
insertion	O
resistance	O
to	O
a	O
5-fr	O
sheath	O
introducer	O
and	O
a	O
5-fr	O
sheathless	O
system	O
,	O
with	O
and	O
without	O
the	O
twisting	O
method	O
.	O
	
the	O
insertion	O
simulator	O
pushed	O
a	O
sheath	O
introducer	O
or	O
a	O
sheathless	O
system	O
toward	O
a	O
mock	O
artery	O
consisted	O
with	O
a	O
5-mm	O
urethane	O
and	O
a	O
1-mm	O
rubber	O
sheet	O
by	O
an	O
electrical	O
motor	O
with	O
or	O
without	O
twisting	O
motion	O
generated	O
by	O
a	O
crank	O
shaft	O
.	O
	
insertion	O
resistance	O
during	O
the	O
penetration	O
was	O
measured	O
by	O
a	O
tension	O
meter	O
.	O
	
the	O
insertion	O
resistance	O
was	O
less	O
with	O
the	O
5-fr	O
sheathless	O
system	O
than	O
with	O
the	O
5-fr	O
sheath	O
introducer	O
.	O
	
the	O
resistance	O
reduced	O
further	O
with	O
use	O
of	O
twisting	O
for	O
both	O
the	O
sheathed	O
and	O
sheathless	O
catheters	O
.	O
	
in	O
conclusion	O
,	O
the	O
experiment	O
suggests	O
the	O
benefits	O
of	O
twisting	O
insertion	O
of	O
a	O
sheathless	O
guiding	O
catheter	O
for	O
reduction	O
of	O
puncture	O
site	O
-related	O
complications	O
unconventional	B-T080
protein	O
secretion	O
in	O
plants	O
unconventional	B-T080
protein	O
secretion	O
ups	O
describes	B-T078
secretion	O
pathways	O
that	O
bypass	O
one	O
or	O
several	B-T081
of	O
the	O
canonical	B-T081
secretion	O
pit-stops	O
on	O
the	O
way	O
to	O
the	O
plasma	O
membrane	O
,	O
and/or	O
involve	B-T169
the	O
secretion	O
of	O
leaderless	O
proteins	B-T116
.	O
	
so	O
far	O
,	O
alternatives	O
to	O
conventional	B-T080
secretion	O
were	O
primarily	B-T080
observed	B-T169
and	O
studied	B-T062
in	O
yeast	O
and	O
animal	O
cells	O
.	O
	
the	O
sessile	B-T080
lifestyle	O
of	O
plants	O
brings	O
with	O
it	O
unique	B-T080
restraints	O
on	O
how	O
they	O
adapt	O
to	O
adverse	O
conditions	O
and	O
environmental	B-T082
challenges	I-T082
.	O
	
recently	O
,	O
attention	O
towards	O
unconventional	B-T080
secretion	O
pathways	O
in	O
plant	O
cells	O
has	O
substantially	O
increased	O
,	O
with	O
the	O
large	O
number	O
of	O
leaderless	O
proteins	B-T116
identified	B-T080
through	O
proteomic	O
studies	O
.	O
	
while	O
ups	O
pathways	O
in	O
plants	O
are	O
certainly	O
not	O
yet	O
exhaustively	O
researched	O
,	O
an	O
emerging	O
notion	O
is	O
that	O
induction	B-T169
of	O
ups	O
pathways	O
is	O
correlated	B-T080
with	O
pathogenesis	O
and	O
stress	O
responses	O
.	O
	
given	O
the	O
multitude	O
ups	O
events	O
observed	O
,	O
comprehensively	B-T080
organizing	B-T169
the	O
routes	O
proteins	B-T116
take	O
to	O
the	O
apoplast	O
in	O
defined	O
ups	O
categories	O
is	O
challenging	O
.	O
	
with	O
the	O
establishment	B-T080
of	O
a	O
larger	O
collection	B-T169
of	O
studied	O
plant	B-T116
proteins	I-T116
taking	O
these	O
ups	O
pathways	O
,	O
a	O
clearer	O
picture	O
of	O
endomembrane	O
trafficking	O
as	O
a	O
whole	O
will	O
emerge	O
.	O
	
there	O
are	O
several	B-T081
novel	B-T080
enabling	O
technologies	O
,	O
such	O
as	O
vesicle	O
proteomics	O
and	O
chemical	O
genomics	O
,	O
with	O
great	O
potential	B-T080
for	O
dissecting	B-T169
secretion	O
pathways	O
,	O
providing	B-T052
information	B-T078
about	O
the	O
cargo	O
that	O
travels	O
along	O
them	O
and	O
the	O
conditions	O
that	O
induce	B-T169
neospora	O
caninum	O
in	O
axis	O
deer	O
axis	O
axis	O
and	O
fallow	O
deer	O
dama	O
dama	O
in	O
northern	B-T082
mexico	O
serum	O
samples	O
from	O
18	O
axis	O
deer	O
axis	O
axis	O
and	O
19	O
fallow	O
deer	O
dama	O
dama	O
were	O
analyzed	O
with	O
an	O
enzyme-linked	O
immunosorbent	O
assay	O
for	O
neospora	B-T116
caninum	I-T116
antibodies	I-T116
.	O
	
two	O
axis	O
11%	O
and	O
two	O
fallow	O
deer	O
11%	O
were	O
positive	B-T033
for	O
n	B-T116
.	O
	
caninum	I-T116
antibodies	I-T116
.	O
	
the	O
abba	B-T062
study	I-T062
-	O
approach	O
bias	O
modification	O
in	O
bulimia	O
nervosa	O
and	O
binge	O
eating	O
disorder	O
study	O
protocol	O
for	O
a	O
randomised	B-T062
controlled	I-T062
trial	I-T062
the	O
core	O
symptoms	O
of	O
bulimia	O
nervosa	O
bn	O
and	O
binge	O
eating	O
disorder	O
bed	O
are	O
recurrent	B-T033
episodes	I-T033
of	I-T033
binge	I-T033
eating	I-T033
.	O
	
despite	O
negative	O
psychological	O
and	O
physical	B-T033
consequences	I-T033
,	O
bn/bed	O
patients	O
show	O
uncontrollable	O
approach	O
tendencies	O
towards	O
food	O
.	O
	
this	O
cognitive	B-T078
bias	I-T078
occurs	O
at	O
an	O
early	O
stage	O
of	O
information	O
processing	O
.	O
	
cognitive	B-T061
bias	I-T061
modification	I-T061
cbm	B-T061
directly	O
targets	O
such	O
biases	B-T078
and	O
has	O
been	O
shown	O
to	O
be	O
effective	O
in	O
treating	B-T061
several	O
mental	O
disorders	O
.	O
	
in	O
alcohol	O
addiction	O
,	O
automatic	O
action	O
tendencies	O
towards	O
alcohol	O
cues	O
and	O
relapse	O
rates	B-T081
were	O
successfully	O
reduced	O
by	O
a	O
specific	O
form	O
of	O
cbm	B-T061
,	O
termed	O
approach	O
bias	B-T169
modification	I-T169
.	O
	
based	O
on	O
these	O
findings	O
and	O
data	B-T078
from	O
a	O
proof-of-concept	B-T062
study	I-T062
in	O
people	B-T098
with	O
high	O
levels	O
of	O
food	O
craving	O
,	O
cbm	B-T169
is	O
considered	O
a	O
promising	O
new	O
treatment	O
approach	O
for	O
bn/bed	O
.	O
	
given	O
the	O
similarities	O
between	O
bn/bed	O
and	O
addictive	O
disorders	O
,	O
the	O
rationale	B-T078
for	O
using	O
approach	O
bias	B-T169
modification	I-T169
appears	O
to	O
be	O
particularly	O
strong	O
.	O
	
the	O
aim	O
of	O
the	O
present	O
study	O
is	O
to	O
examine	O
whether	O
,	O
compared	O
to	O
a	O
sham	B-T062
training	I-T062
,	O
computerised	O
approach	O
bias	B-T169
modification	I-T169
10	O
sessions	O
can	O
reduce	O
binge-eating	B-T033
episodes	I-T033
in	O
bn/bed	O
patients	O
from	O
pre-treatment	B-T079
to	O
follow-up	O
.	O
	
additionally	O
,	O
we	O
will	O
investigate	O
whether	O
this	O
cbm	B-T061
programme	O
also	O
reduces	O
global	B-T080
eating	O
disorder	O
psychopathology	O
,	O
trait	O
and	O
cue-elicited	O
food	O
craving	O
,	O
food	O
intake	O
as	O
well	O
as	O
approach	O
and	O
attentional	O
bias	O
towards	O
visual	B-T078
food	I-T078
cues	I-T078
.	O
	
treatment	B-T061
acceptance	I-T061
will	O
be	O
determined	O
by	O
attrition	O
rates	O
and	O
responses	B-T170
on	O
a	O
feedback	O
form	O
.	O
	
this	O
is	O
a	O
double-blind	B-T062
,	O
randomised	B-T062
,	O
placebo-controlled	B-T062
,	O
parallel-group	B-T078
superiority	I-T078
trial	I-T078
with	O
two	O
parallel	O
arms	O
.	O
	
a	O
total	O
of	O
54	O
bn/bed	O
patients	O
will	O
be	O
recruited	O
.	O
	
approach	O
bias	B-T078
towards	I-T078
food	I-T078
will	O
be	O
retrained	O
by	O
a	O
computer	O
task	O
adopting	O
an	O
implicit	B-T062
learning	I-T062
paradigm	I-T062
.	O
	
patients	O
in	O
the	O
control	O
condition	O
sham	B-T062
will	O
conduct	O
a	O
similar	O
task	O
but	O
will	O
not	O
be	O
trained	O
to	O
avoid	O
food	B-T078
cues	I-T078
.	O
	
methods	O
against	O
bias	B-T078
include	O
public	B-T170
registration	I-T170
,	O
randomisation	B-T062
by	O
a	O
central	O
study	O
office	O
,	O
standardisation	B-T062
of	I-T062
the	I-T062
treatments	I-T062
and	O
blinding	B-T062
of	I-T062
assessors	I-T062
.	O
	
furthermore	O
,	O
the	O
session	O
number	O
and	O
duration	O
will	O
be	O
equivalent	O
in	O
the	O
two	O
conditions	O
.	O
	
this	O
is	O
the	O
first	O
registered	O
randomised	B-T062
controlled	I-T062
trial	I-T062
of	O
approach	O
bias	B-T169
modification	I-T169
in	O
a	O
clinical	B-T062
bn/bed	I-T062
sample	I-T062
.	O
	
results	O
from	O
this	O
study	O
will	O
provide	O
an	O
indication	O
of	O
the	O
efficacy	O
of	O
approach	O
bias	B-T169
modification	I-T169
training	O
for	O
bn/bed	O
and	O
the	O
potential	O
mechanisms	O
of	O
action	O
underlying	O
this	O
treatment	B-T061
.	O
	
protein	B-T116
design	B-T052
for	O
nanostructural	O
engineering	O
concluding	O
remarks	B-T170
and	O
future	O
directions	O
this	O
final	O
chapter	B-T170
aims	O
to	O
summarize	O
the	O
main	O
conclusions	B-T170
of	O
the	O
book	B-T170
and	O
to	O
point	O
to	O
possible	O
directions	O
for	O
further	O
research	B-T062
in	O
the	O
field	O
of	O
protein	B-T116
design	B-T052
for	O
nanostructural	O
engineering	O
.	O
	
even	O
though	O
this	O
research	O
field	O
is	O
still	O
at	O
its	O
infancy	O
,	O
multidisciplinary	B-T080
research	B-T062
efforts	I-T062
in	O
the	O
design	B-T052
of	O
synthetic	B-T116
protein	I-T116
-based	O
nanostructures	O
and	O
functional	B-T169
materials	O
have	O
resulted	O
in	O
significant	O
progress	B-T169
.	O
	
the	O
chapters	B-T170
in	O
this	O
book	B-T170
cover	O
several	O
selected	O
examples	O
of	O
the	O
most	O
recent	O
advances	B-T079
concerning	O
the	O
use	B-T169
of	I-T169
proteins	B-T116
and	O
peptides	B-T116
as	O
building	O
blocks	O
for	O
the	O
fabrication	O
of	O
architectures	O
and	O
functional	B-T169
nanostructures	O
,	O
assemblies	B-T052
,	O
and	O
materials	O
.	O
	
here	O
,	O
we	O
provide	O
a	O
general	O
overview	O
of	O
the	O
strategies	B-T169
that	O
can	O
be	O
employed	O
to	O
prepare	B-T052
functional	B-T169
protein	B-T116
-based	O
nanostructures	O
,	O
and	O
nanostructured	O
materials	O
and	O
devices	O
.	O
	
finally	O
,	O
we	O
highlight	O
some	O
of	O
the	O
main	O
aspects	B-T080
to	O
be	O
considered	O
by	O
the	O
research	B-T062
community	O
to	O
set	O
the	O
path	O
for	O
the	O
near	O
future	O
synthesis	B-T052
,	O
characterization	B-T052
and	O
drug	O
loading	B-T052
property	B-T080
of	O
monomethoxy-poly	O
glycol	O
mpeg-pcla	O
copolymers	O
amphiphilic	O
block	O
copolymers	O
have	O
attracted	O
a	O
great	O
deal	O
of	O
attention	O
in	O
drug	O
delivery	O
systems	O
.	O
	
in	O
this	O
work	O
,	O
a	O
series	O
of	O
monomethoxy-poly	O
ethylene	O
glycol	O
ε-caprolactone-co-d	O
mpeg-pcla	O
copolymers	O
with	O
variable	O
composition	O
of	O
poly	B-T109
ε-caprolactone	I-T109
pcl	B-T109
and	O
poly	O
d	O
pdlla	O
were	O
prepared	O
via	O
ring-opening	O
copolymerization	O
of	O
ε-cl	B-T109
and	O
d	B-T109
in	O
the	O
presence	O
of	O
mpeg	B-T109
and	O
stannous	B-T109
octoate	I-T109
.	O
	
the	O
structure	B-T082
and	O
molecular	B-T081
weight	I-T081
were	O
characterized	B-T052
by	O
nuclear	O
magnetic	O
resonance	O
nmr	O
and	O
gel	O
permeation	O
chromatography	O
gpc	O
.	O
	
the	O
crystallinity	O
,	O
hydrophilicity	B-T080
,	O
thermal	O
stability	B-T080
and	O
hydrolytic	O
degradation	B-T169
behavior	I-T169
were	O
investigated	O
in	O
detail	O
,	O
respectively	O
.	O
	
the	O
results	O
showed	O
that	O
the	O
prepared	O
amphiphilic	O
mpeg-pcla	O
copolymers	O
have	O
adjustable	O
properties	B-T080
by	O
altering	O
the	O
composition	O
of	O
pcla	B-T109
,	O
which	O
make	O
it	O
convenient	O
for	O
clinical	O
applications	O
.	O
	
besides	O
,	O
the	O
drug	O
loading	B-T052
properties	B-T080
were	O
also	O
studied	O
.	O
	
docetaxel	B-T109
dtx	B-T109
could	O
be	O
entrapped	O
in	O
mpeg-pcla	O
micelles	B-T109
with	O
high	B-T080
loading	B-T052
capacity	B-T081
and	O
encapsulation	O
efficiency	B-T081
.	O
	
and	O
all	O
lyophilized	B-T080
dtx	B-T109
-loaded	O
mpeg-pcla	O
micelles	B-T109
except	O
mpeg-pcl	O
micelles	B-T109
were	O
readily	O
re-dissolved	B-T169
in	O
normal	O
saline	O
at	O
25	O
c	O
.	O
	
in	O
addition	O
,	O
dtx	B-T109
-loaded	O
mpeg-pcla	O
micelles	B-T109
showed	O
a	O
slightly	O
enhanced	B-T052
antitumor	B-T080
activity	B-T052
compared	O
with	O
free	O
dtx	B-T109
.	O
	
furthermore	O
,	O
dtx	B-T109
micelles	B-T109
exhibited	O
a	O
slower	B-T080
and	O
sustained	B-T169
release	B-T169
behavior	B-T080
in	B-T080
vitro	I-T080
,	O
and	O
higher	B-T080
dtx	B-T109
concentration	B-T081
and	O
longer	O
retention	B-T081
time	I-T081
in	B-T082
vivo	I-T082
.	O
	
the	O
results	O
suggested	O
that	O
the	O
mpeg-pcla	O
copolymer	O
with	O
the	O
adjustable	O
ratio	B-T081
of	O
pcl	B-T109
to	O
pdlla	O
may	O
be	O
a	O
promising	O
drug	O
delivery	O
carrier	O
for	O
thyroid	O
cancer	O
burden	B-T081
in	O
central	O
and	O
south	O
america	O
incidence	B-T081
of	O
thyroid	O
cancer	O
tc	O
is	O
rapidly	B-T080
increasing	B-T169
worldwide	B-T078
,	O
but	O
little	O
is	O
known	O
about	O
the	O
tc	O
burden	B-T081
in	O
central	O
and	O
south	O
america	O
csa	O
.	O
	
we	O
describe	O
the	O
geographic	B-T082
patterns	I-T082
and	O
trends	B-T079
of	O
tc	O
by	O
sex	O
in	O
csa	O
.	O
	
we	O
obtained	O
regional	O
-	O
and	O
national-level	B-T082
incidence	B-T081
data	B-T078
from	O
48	O
population-based	B-T170
cancer	I-T170
registries	I-T170
in	O
13	O
countries	O
and	O
nationwide	O
cancer	B-T081
deaths	I-T081
from	O
the	O
who	O
mortality	B-T081
database	B-T170
for	O
18	O
countries	O
.	O
	
we	O
estimated	O
world	B-T098
population	O
age-standardized	B-T081
incidence	I-T081
rates	I-T081
asrs	B-T081
and	O
age-standardized	B-T081
mortality	I-T081
rates	I-T081
asmrs	B-T081
per	O
100	O
person	B-T098
-	O
years	B-T079
.	O
	
we	O
calculated	O
asrs	B-T081
by	O
histological	O
subtype	O
.	O
	
we	O
estimated	B-T081
the	I-T081
annual	I-T081
percentage	I-T081
change	I-T081
eapc	B-T081
to	O
describe	O
time	B-T079
trends	I-T079
.	O
	
between	O
csa	O
countries	O
,	O
tc	O
incidence	B-T081
and	O
mortality	B-T081
rates	I-T081
varied	O
from	O
8-fold	O
to	O
12-fold	O
and	O
from	O
2-fold	O
to	O
5-fold	O
,	O
respectively	O
.	O
	
in	O
2003-2007	O
,	O
the	O
highest	B-T080
tc	O
asrs	B-T081
in	O
females	O
and	O
males	O
were	O
in	O
ecuador	O
16.0	O
and	O
3.5	O
,	O
respectively	O
,	O
brazil	O
14.4	O
and	O
3.4	O
,	O
costa	O
rica	O
12.6	O
and	O
2.1	O
and	O
colombia	O
10.7	O
and	O
2.5	O
.	O
	
the	O
highest	B-T080
asmrs	B-T081
were	O
in	O
ecuador	O
,	O
colombia	O
,	O
mexico	O
,	O
peru	O
and	O
panama	O
0.68	O
in	O
females	O
and	O
0.41	O
in	O
males	O
.	O
	
papillary	O
tc	O
was	O
the	O
most	O
commonly	O
diagnosed	B-T033
histological	O
subtype	O
,	O
following	O
the	O
same	O
incidence	B-T081
pattern	I-T081
as	O
overall	O
tc	O
.	O
	
in	O
argentinean	B-T098
,	O
brazilian	B-T033
,	O
chilean	B-T098
and	O
costa	B-T098
rican	I-T098
females	O
tc	O
incidence	B-T081
increased	B-T081
by	O
2.2	O
annually	B-T079
,	O
and	O
papillary	O
tc	O
increased	B-T081
by	O
9.1	O
annually	B-T079
,	O
while	O
mortality	B-T081
remained	O
stable	B-T080
between	O
1997	O
and	O
2008	O
.	O
	
in	O
males	O
,	O
trends	B-T079
in	O
tc	O
were	O
stable	B-T080
.	O
	
tc	O
occurred	B-T052
more	O
frequently	B-T079
in	O
females	O
than	O
in	O
males	O
.	O
	
the	O
overall	B-T080
high	B-T080
incidence	B-T081
and	O
low	B-T080
mortality	B-T081
of	O
tc	O
suggest	B-T078
identification	O
of	O
subclinical	B-T047
disease	I-T047
due	O
to	O
improved	B-T080
detection	B-T170
methods	I-T170
.	O
	
histopathological	B-T169
evaluation	O
of	O
the	O
effectiveness	B-T080
of	O
glycyrrhizic	B-T109
acid	I-T109
as	O
a	O
radioprotector	B-T061
against	O
the	O
development	B-T169
of	O
radiation-induced	B-T047
lung	I-T047
fibrosis	I-T047
radiotherapy	B-T061
of	O
the	O
thorax	O
often	O
causes	O
lung	B-T047
inflammation	I-T047
leading	O
to	O
fibrosis	B-T047
.	O
	
the	O
aim	B-T078
of	O
this	O
study	B-T062
was	O
to	O
investigate	B-T169
whether	O
the	O
use	O
of	O
glycyrrhizic	B-T109
acid	I-T109
gla	B-T109
could	O
improve	O
the	O
development	B-T169
of	O
lung	B-T047
fibrosis	I-T047
in	O
irradiated	B-T061
animals	O
.	O
	
wistar	O
rats	O
were	O
divided	O
into	O
four	O
groups	B-T078
.	O
	
group	B-T078
a	I-T078
rats	O
received	O
thoracic	B-T061
irradiation	I-T061
.	O
	
rats	O
in	O
group	B-T078
b	I-T078
received	O
gla	B-T109
and	O
irradiation	B-T061
.	O
	
group	B-T078
c	I-T078
received	O
gla	B-T109
and	O
no	O
irradiation	B-T061
.	O
	
group	B-T078
d	I-T078
received	O
no	O
gla	B-T109
and	O
irradiation	B-T061
.	O
	
gla	B-T109
was	O
administered	B-T169
at	O
a	O
dose	B-T081
of	O
4	O
mg/kg	O
body	O
weight	O
using	O
an	O
intraperitoneal	B-T061
injection	I-T061
one	O
hour	O
before	O
thoracic	B-T061
irradiation	I-T061
.	O
	
radiation	B-T061
therapy	I-T061
was	O
delivered	O
on	O
a	O
cobalt-60	O
unit	O
using	O
a	O
single	O
fraction	O
of	O
16	O
gy	O
.	O
	
the	O
animals	O
were	O
sacrificed	O
at	O
32	O
weeks	O
following	O
thoracic	B-T061
irradiation	I-T061
.	O
	
the	O
lungs	O
were	O
dissected	B-T169
and	O
blind	O
histopathological	B-T169
evaluation	O
was	O
performed	O
.	O
	
histopathologically	B-T169
,	O
a	O
decrease	B-T081
statistically	O
not	O
significant	O
in	O
the	O
thickening	B-T033
of	O
alveolar	O
or	O
bronchial	O
wall	O
,	O
formation	O
of	O
fibrous	O
bands	O
,	O
and	O
superimposed	O
collagen	B-T116
were	O
noted	O
in	O
the	O
animals	O
in	O
group	B-T078
b	I-T078
as	O
compared	O
to	O
the	O
animals	O
in	O
group	B-T078
a	I-T078
.	O
	
in	O
this	O
experimental	B-T062
study	I-T062
,	O
administration	B-T081
of	O
gla	B-T109
one	O
hour	O
before	O
thoracic	B-T061
irradiation	I-T061
may	O
be	O
a	O
protective	O
agent	O
against	O
radiation-induced	B-T047
fibrosis	I-T047
in	O
animals	O
and	O
this	O
model	O
avulsions	O
of	O
triceps	O
brachii	O
associated	O
injuries	O
and	O
surgical	B-T061
treatment	I-T061
a	O
case	O
series	O
this	O
study	B-T062
reports	O
the	O
clinical	B-T170
presentations	I-T170
,	O
intra	B-T079
-operative	I-T079
findings	B-T033
,	O
type	O
of	O
the	O
treatments	B-T061
,	O
outcome	B-T169
of	O
the	O
treatment	B-T061
and	O
specially	O
associated	O
injuries	O
in	O
patients	O
with	O
the	O
avulsion	O
of	O
the	O
distal	B-T082
end	I-T082
of	O
the	O
triceps	O
brachii	O
tb	O
tendon	O
.	O
	
we	O
studied	O
6	O
patients	O
with	O
rupture	O
or	O
avulsion	O
of	O
the	O
distal	B-T082
end	I-T082
of	O
the	O
tb	O
tendon	O
.	O
	
the	O
medical	B-T170
records	I-T170
,	O
imaging	B-T170
files	I-T170
,	O
clinical	B-T080
outcomes	B-T169
at	O
the	O
final	O
follow	O
up	O
visit	O
were	O
reviewed	O
.	O
	
the	O
clinical	B-T080
outcomes	B-T169
were	O
assessed	O
by	O
mayo	B-T170
elbow	I-T170
score	I-T170
at	O
the	O
final	O
follow-up	O
visit	O
.	O
	
all	O
patients	O
were	O
male	O
,	O
4	O
of	O
them	O
having	O
injury	O
in	O
the	O
left	O
hand	O
as	O
the	O
non-dominant	O
hand	O
.	O
	
mean	O
age	O
of	O
them	O
was	O
34.5	O
years	B-T079
.	O
	
all	O
cases	O
had	O
small	O
bony	B-T169
fleck	O
in	O
the	O
posterior	O
of	O
elbow	O
in	O
lateral	O
radiograph	O
.	O
	
three	O
patients	O
had	O
associated	O
injuries	O
-including	O
intra-articular	B-T082
fractures	O
and	O
medial	O
collateral	O
ligament	O
rupture	O
.	O
	
in	O
one	O
case	O
v-y	B-T061
plasty	I-T061
of	O
the	O
distal	B-T082
tb	O
was	O
done	O
.	O
	
in	O
4	O
patients	O
the	O
results	O
of	O
surgery	B-T061
were	O
excellent	O
,	O
one	O
was	O
good	O
and	O
one	O
was	O
fair	O
.	O
	
although	O
tb	O
tendon	O
rupture	O
is	O
rare	O
,	O
it	O
should	O
be	O
-considered	O
in	O
differential	O
diagnosis	B-T062
of	O
the	O
upper	O
-extremity	O
trauma	O
and	O
its	O
associated	O
injuries	O
prolyl-4-hydroxylase	B-T116
2	I-T116
and	O
3	B-T116
coregulate	O
murine	B-T109
erythropoietin	B-T116
in	O
brain	O
pericytes	O
a	O
classic	O
response	B-T033
to	O
systemic	B-T169
hypoxia	O
is	O
the	O
increased	B-T081
production	O
of	O
red	O
blood	O
cells	O
due	O
to	O
hypoxia-inducible	B-T116
factor	I-T116
hif	B-T116
induction	B-T169
of	O
erythropoietin	B-T116
epo	B-T116
.	O
	
epo	B-T116
is	O
a	O
glycoprotein	B-T109
hormone	I-T109
that	O
is	O
essential	O
for	O
normal	O
erythropoiesis	O
and	O
is	O
predominantly	O
synthesized	O
by	O
peritubular	B-T082
renal	O
interstitial	O
fibroblast-like	O
cells	O
,	O
which	O
express	O
cellular	O
markers	O
characteristic	O
of	O
neuronal	O
cells	O
and	O
pericytes	O
.	O
	
to	O
investigate	B-T169
whether	O
the	O
ability	O
to	O
synthesize	O
epo	B-T116
is	O
a	O
general	O
functional	B-T169
feature	B-T080
of	O
pericytes	O
,	O
we	O
used	O
conditional	O
gene	O
targeting	O
to	O
examine	O
the	O
von	B-T047
hippel-lindau	I-T047
/	O
prolyl-4-hydroxylase	B-T116
domain	I-T116
phd	I-T116
axis	O
in	O
cell	O
-	O
expressing	O
neural	B-T116
glial	I-T116
antigen	I-T116
2	I-T116
,	O
a	O
known	O
molecular	O
marker	O
of	O
pericytes	O
in	O
multiple	O
organs	O
.	O
	
we	O
found	O
that	O
pericytes	O
in	O
the	O
brain	O
synthesized	O
epo	B-T116
in	O
mice	O
with	O
genetic	B-T169
hif	B-T116
activation	B-T052
and	O
were	O
capable	O
of	O
responding	O
to	O
systemic	B-T169
hypoxia	O
with	O
the	O
induction	B-T169
of	O
epo	B-T116
.	O
	
using	O
high-resolution	O
multiplex	O
in	O
situ	O
hybridization	O
,	O
we	O
determined	O
that	O
brain	O
pericytes	O
represent	O
an	O
important	O
cellular	O
source	O
of	O
epo	B-T116
in	O
the	O
hypoxic	O
brain	O
up	O
to	O
70%	O
of	O
all	O
epo	B-T116
-	O
expressing	O
cells	O
.	O
	
we	O
furthermore	O
determined	O
that	O
epo	B-T116
transcription	O
in	O
brain	O
pericytes	O
was	O
hif-2	B-T116
dependent	O
and	O
cocontrolled	O
by	O
phd2	B-T116
and	O
phd3	B-T116
,	O
oxygen	O
-	O
and	O
2-oxoglutarate	B-T109
-dependent	O
prolyl-4-hydroxylases	B-T116
that	O
regulate	O
hif	B-T116
activity	O
.	O
	
in	O
summary	O
,	O
our	O
studies	O
provide	O
experimental	B-T080
evidence	B-T078
that	O
pericytes	O
in	O
the	O
brain	O
have	O
the	O
ability	O
to	O
function	O
as	O
oxygen	O
sensors	O
and	O
respond	O
to	O
hypoxia	O
with	O
epo	B-T116
synthesis	O
.	O
	
our	O
findings	B-T169
furthermore	O
suggest	O
that	O
the	O
ability	O
to	O
synthesize	O
epo	B-T116
may	O
represent	O
a	O
functional	B-T169
feature	B-T080
of	O
pericytes	O
in	O
the	O
brain	O
and	O
patient	B-T080
satisfaction	I-T080
with	O
pharmacist	O
-led	O
collaborative	O
follow-up	O
care	O
in	O
an	O
ambulatory	B-T078
rheumatology	O
clinic	O
patient	B-T080
satisfaction	I-T080
is	O
known	O
to	O
increase	O
with	O
pharmacist	O
intervention	B-T061
in	O
general	O
outpatient	O
clinics	O
and	O
with	O
nurse-led	O
care	O
in	O
rheumatology	O
clinics	O
.	O
	
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
describe	O
and	O
compare	O
patient	B-T080
satisfaction	I-T080
with	O
two	O
different	O
types	O
of	O
care	O
a	O
pharmacist	O
physician	O
collaborative	B-T170
model	I-T170
and	O
a	O
traditional	B-T170
physician	I-T170
model	I-T170
in	O
a	O
rheumatology	O
clinic	O
setting	O
.	O
	
a	O
cross-sectional	B-T062
survey	I-T062
of	O
inflammatory	B-T047
arthritis	I-T047
patients	O
seen	O
during	O
a	O
follow-up	O
visit	O
in	O
edmonton	O
,	O
alberta	O
,	O
canada	O
,	O
was	O
conducted	O
over	O
a	O
ten-week	B-T062
period	I-T062
.	O
	
patient	B-T080
satisfaction	I-T080
was	O
measured	O
using	O
a	O
modified	O
version	O
of	O
the	O
validated	O
leeds	O
satisfaction	O
questionnaire	O
,	O
which	O
uses	O
a	O
five-point	O
likert	B-T170
scale	I-T170
to	O
measure	O
six	B-T082
dimensions	I-T082
of	O
satisfaction	B-T080
,	O
and	O
compared	O
between	O
the	O
collaborative	O
care	O
and	O
traditional	B-T170
physician	I-T170
models	I-T170
.	O
	
a	O
total	O
of	O
62	O
patients	O
completed	O
the	O
questionnaire	B-T170
21	O
collaborative	O
care	O
and	O
41	O
traditional	B-T170
physician	I-T170
model	I-T170
.	O
	
the	O
average	O
age	O
of	O
respondents	B-T098
was	O
52	O
years	O
and	O
the	O
majority	O
were	O
female	O
.	O
	
the	O
mean	B-T170
score	I-T170
for	I-T170
satisfaction	I-T170
across	O
the	O
six	B-T082
dimensions	I-T082
was	O
4.56	O
in	O
the	O
collaborative	O
care	O
group	O
and	O
4.30	O
in	O
the	O
traditional	O
physician	O
group	O
p	O
=	O
0.02	O
.	O
	
patient	B-T080
satisfaction	I-T080
in	O
the	O
collaborative	O
care	O
group	O
was	O
consistently	O
higher	O
across	O
all	O
dimensions	O
.	O
	
no	B-T033
difference	I-T033
was	O
noted	O
between	O
participants	B-T098
seen	O
for	O
the	O
first	O
time	O
compared	O
with	O
those	O
seen	O
two	O
or	O
more	O
times	O
by	O
the	O
pharmacist	O
.	O
	
a	O
collaborative	B-T170
care	I-T170
model	I-T170
can	O
exceed	O
the	O
already	O
high	B-T078
expectations	I-T078
for	O
care	O
of	O
patients	O
with	O
inflammatory	B-T047
arthritis	I-T047
.	O
	
our	O
findings	O
support	O
the	O
role	O
of	O
pharmacists	O
using	O
a	O
collaborative	O
care	O
approach	O
to	O
care	O
for	O
patients	O
in	O
rheumatology	O
clinics	O
.	O
	
ontology	O
-based	O
high	B-T080
-	O
level	B-T080
context	B-T078
inference	O
for	O
human	O
behavior	O
identification	B-T080
recent	O
years	O
have	O
witnessed	O
a	O
huge	O
progress	B-T169
in	O
the	O
automatic	B-T169
identification	B-T080
of	O
individual	B-T098
primitives	B-T170
of	O
human	O
behavior	O
,	O
such	O
as	O
activities	O
or	O
locations	B-T082
.	O
	
however	O
,	O
the	O
complex	B-T080
nature	B-T169
of	O
human	O
behavior	O
demands	O
more	O
abstract	O
contextual	B-T078
information	B-T078
for	O
its	O
analysis	O
.	O
	
this	O
work	O
presents	O
an	O
ontology	O
-based	O
method	B-T170
that	O
combines	O
low	B-T080
-	O
level	B-T080
primitives	B-T170
of	O
behavior	O
,	O
namely	O
activity	O
,	O
locations	B-T082
and	O
emotions	O
,	O
unprecedented	B-T080
to	O
date	B-T079
,	O
to	O
intelligently	O
derive	O
more	O
meaningful	O
high	B-T080
-	O
level	B-T080
context	B-T078
information	B-T078
.	O
	
the	O
paper	O
contributes	B-T052
with	O
a	O
new	O
open	O
ontology	O
describing	O
both	O
low	B-T080
-	O
level	B-T080
and	O
high	B-T080
-	O
level	B-T080
context	B-T078
information	B-T078
,	O
as	O
well	O
as	O
their	O
relationships	B-T080
.	O
	
furthermore	O
,	O
a	O
framework	O
building	O
on	O
the	O
developed	O
ontology	O
and	O
reasoning	O
models	B-T170
is	O
presented	O
and	O
evaluated	O
.	O
	
the	O
proposed	O
method	O
proves	O
to	O
be	O
robust	O
while	O
identifying	O
high	B-T080
-	O
level	B-T080
contexts	B-T078
even	O
in	O
the	O
event	O
of	O
erroneously	B-T080
-	O
detected	B-T033
low	B-T080
-l	O
evel	B-T080
context	B-T078
s	O
.	O
	
despite	O
reasonable	O
inference	O
times	O
being	O
obtained	O
for	O
a	O
relevant	B-T080
set	O
of	O
users	B-T098
and	O
instances	B-T078
,	O
additional	O
work	O
is	O
required	O
to	O
scale	O
to	O
long-term	O
scenarios	B-T169
with	O
a	O
large	O
number	O
of	O
characterization	B-T052
of	O
exposure	O
in	O
epidemiological	B-T062
studies	I-T062
on	O
air	O
pollution	O
from	O
biodegradable	B-T080
wastes	O
misclassification	O
and	O
comparison	B-T052
of	O
exposure	O
assessment	O
strategies	B-T062
the	O
assignment	O
of	O
exposure	O
is	O
one	O
of	O
the	O
main	O
challenges	O
faced	O
by	O
environmental	B-T082
epidemiologists	O
.	O
	
however	O
,	O
misclassification	O
of	O
exposures	O
has	O
not	O
been	O
explored	O
in	O
population	B-T098
epidemiological	B-T062
studies	I-T062
on	O
air	O
pollution	O
from	O
biodegradable	B-T080
wastes	O
.	O
	
the	O
objective	B-T078
of	O
this	O
study	B-T062
was	O
to	O
investigate	B-T169
the	O
use	O
of	O
different	O
approaches	O
for	O
assessing	O
exposure	O
to	O
air	O
pollution	O
from	O
biodegradable	B-T080
wastes	O
by	O
analyzing	B-T062
1	O
the	O
misclassification	O
of	O
exposure	O
that	O
is	O
committed	O
by	O
using	O
these	O
surrogates	O
,	O
2	O
the	O
existence	O
of	O
differentia	B-T080
l	O
misclassification	O
3	O
the	O
effects	B-T080
that	O
misclassification	O
may	O
have	O
on	O
health	B-T078
effect	B-T080
estimates	B-T081
and	O
the	O
interpretation	B-T169
of	O
epidemiological	B-T062
results	B-T033
,	O
and	O
4	O
the	O
ability	O
of	O
the	O
exposure	O
measures	O
to	O
predict	O
health	B-T170
outcomes	I-T170
using	O
10-fold	O
cross	B-T062
validation	I-T062
.	O
	
four	O
different	O
exposure	O
assessment	O
approaches	O
were	O
studied	B-T062
ammonia	O
concentrations	B-T081
at	O
the	O
residence	B-T082
metric	B-T081
i	I-T081
,	O
distance	B-T081
to	O
the	O
closest	O
source	B-T033
metric	B-T081
ii	I-T081
,	O
number	O
of	O
sources	B-T033
within	O
certain	O
distances	B-T081
from	O
the	O
residence	B-T082
metric	B-T081
iiia	I-T081
,	O
b	B-T081
and	O
location	B-T082
in	O
a	O
specific	O
region	O
metric	B-T081
iv	I-T081
.	O
	
exposure-response	B-T170
models	I-T170
based	O
on	O
metric	B-T081
i	I-T081
provided	O
the	O
highest	O
predictive	O
ability	O
72.3	O
and	O
goodness-of-fit	B-T080
,	O
followed	O
by	O
iv	B-T081
,	O
iii	B-T081
and	O
ii	B-T081
.	O
	
when	O
compared	O
to	O
metric	B-T081
i	I-T081
,	O
metric	B-T081
iv	I-T081
yielded	O
the	O
best	O
results	B-T033
for	O
exposure	O
misclassification	O
analysis	B-T062
and	O
interpretation	B-T169
of	O
health	B-T078
effect	B-T080
estimates	B-T081
,	O
followed	O
by	O
metric	B-T081
iiib	I-T081
,	O
iiia	B-T081
and	O
ii	B-T081
.	O
	
the	O
study	B-T062
showed	O
that	O
modelled	O
nh3	O
concentrations	B-T081
provide	O
more	O
accurate	O
estimations	B-T081
of	O
true	O
exposure	O
than	O
distances-based	O
surrogates	O
,	O
and	O
that	O
distance-based	O
surrogates	O
especially	O
those	O
based	O
on	O
distance	B-T081
to	O
the	O
closest	O
point	O
source	B-T033
are	O
imprecise	O
methods	O
to	O
identify	O
exposed	O
populations	B-T098
,	O
although	O
they	O
may	O
be	O
useful	O
for	O
initial	O
de	O
ritis	O
ratio	O
ast/alt	O
as	O
a	O
significant	O
prognostic	O
factor	O
in	O
patients	O
with	O
upper	O
tract	O
urothelial	O
cancer	O
treated	B-T169
with	O
surgery	B-T169
we	O
investigated	B-T169
the	O
clinical	B-T170
prognostic	I-T170
value	I-T170
of	O
preoperative	B-T079
de	O
ritis	O
ratio	O
aspartate	O
aminotransferase	O
ast	O
aminotransferase	O
alt	O
on	O
postsurgical	B-T033
survival	B-T052
outcomes	B-T169
in	O
patients	O
with	O
upper	O
tract	O
urothelial	O
cancer	O
utuc	O
.	O
	
we	O
retrospectively	B-T062
analyzed	I-T062
the	O
data	B-T078
of	O
623	O
patients	O
who	O
underwent	O
radical	B-T061
nephrouretectomy	I-T061
for	O
utuc	O
.	O
	
multivariate	B-T080
regression	I-T080
tests	B-T170
were	O
performed	O
to	O
identify	O
possible	B-T080
associations	I-T080
between	O
adverse	O
pathologic	O
events	O
and	O
ast/alt	O
.	O
	
the	O
risk	O
of	O
postoperative	B-T079
progression	B-T169
and	O
survival	B-T052
were	O
tested	B-T169
using	O
kaplan-meier	B-T081
analyses	I-T081
and	O
cox	B-T081
proportional	I-T081
hazards	I-T081
models	I-T081
.	O
	
according	O
to	O
the	O
receiver	B-T081
operator	I-T081
characteristic	I-T081
curve	I-T081
of	O
ast/alt	O
for	O
cancer-specific	B-T081
mortality	I-T081
,	O
patients	O
with	O
ast/alt	O
value	O
1.5	O
were	O
regarded	O
as	O
the	O
high	O
ast/alt	O
group	O
,	O
and	O
the	O
remaining	O
patients	O
formed	O
the	O
low	O
ast/alt	O
group	O
.	O
	
in	O
kaplan-meier	B-T081
analyses	I-T081
,	O
the	O
high	O
ast/alt	O
group	O
showed	O
worse	O
progression-free	B-T081
survival	I-T081
pfs	B-T081
,	O
cancer-specific	B-T081
survival	I-T081
css	B-T081
,	O
and	O
overall	B-T081
survival	I-T081
all	O
p	O
<	O
001	O
.	O
	
elevated	O
ast/alt	O
was	O
associated	B-T080
with	I-T080
higher	O
t	O
stage	O
hazard	B-T081
ratio	I-T081
hr	B-T081
,	O
1.577	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
,	O
1.077	O
p	O
=	O
033	O
and	O
higher	O
cellular	O
grade	O
hr	B-T081
,	O
1.538	O
95%	O
ci	B-T081
,	O
1.034	O
p	O
=	O
041	O
in	O
multivariate	B-T080
regression	I-T080
tests	B-T170
.	O
	
in	O
multivariate	B-T081
cox	I-T081
analyses	I-T081
,	O
high	O
ast/alt	O
was	O
revealed	O
as	O
an	O
independent	B-T078
predictor	I-T078
of	O
pfs	B-T081
hr	B-T081
,	O
2.335	O
95%	O
ci	B-T081
,	O
1.633	O
p	O
<	O
001	O
,	O
css	B-T081
hr	B-T081
,	O
2.550	O
1.689	O
p	O
<	O
001	O
,	O
and	O
overall	B-T081
survival	I-T081
hr	B-T081
,	O
2.069	O
95%	O
ci	B-T081
,	O
1.409	O
p	O
<	O
001	O
.	O
	
elevated	O
preoperative	B-T079
ast/alt	O
was	O
a	O
significant	B-T078
predictor	I-T078
of	O
worse	B-T033
postoperative	B-T079
survival	B-T052
in	O
patients	O
surgically	B-T061
treated	I-T061
for	O
utuc	O
.	O
	
further	O
large	O
prospective	B-T062
studies	I-T062
are	O
needed	O
for	O
better	O
understanding	O
of	O
the	O
prognostic	B-T170
value	I-T170
of	O
preoperative	B-T079
ast/alt	O
.	O
	
molecular	O
simulation	O
study	B-T062
on	O
concentration	B-T081
effects	B-T080
of	I-T080
rofecoxib	B-T109
with	O
popc	B-T109
bilayer	O
the	O
interactions	O
between	O
rofecoxib	B-T109
and	O
popc	B-T109
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine	B-T109
bilayer	O
were	O
studied	B-T062
using	B-T169
all-atom	O
molecular	O
dynamics	O
simulation	O
method	B-T170
.	O
	
four	O
popc	B-T109
bilayer	O
systems	B-T169
with	O
different	B-T080
number	B-T081
of	O
rofecoxib	B-T109
molecules	O
were	O
constructed	B-T169
to	O
simulate	B-T080
different	B-T080
drug	O
concentration	B-T081
.	O
	
the	O
free	O
energy	O
of	O
rofecoxib	B-T109
passing	O
across	O
pure	B-T080
popc	B-T109
bilayer	O
has	O
two	O
minima	B-T080
at	O
z	O
1.2nm	O
or	O
1.6nm	O
.	O
	
as	O
for	O
the	O
high	B-T080
concentration	B-T081
model	B-T170
,	O
the	O
minimum	B-T080
of	O
the	O
free	O
energy	O
profile	O
slightly	O
shifts	O
to	O
the	O
bilayer	O
center	B-T082
.	O
	
moreover	O
,	O
the	O
energy	O
change	O
from	O
bulk	O
water	O
to	O
popc	B-T109
bilayer	O
increases	B-T169
while	O
the	O
central	B-T082
barrier	O
to	O
cross	O
the	O
hydrophobic	O
core	O
of	O
bilayer	O
slightly	B-T080
decreases	B-T081
,	O
suggesting	B-T078
that	O
increasing	B-T169
drug	O
concentration	B-T081
makes	O
it	O
favorable	B-T033
for	O
rofecoxib	B-T109
to	O
partition	B-T169
into	O
the	O
bilayer	O
and	O
easier	O
to	O
pass	O
across	O
bialyer	O
center	B-T082
.	O
	
energy	B-T081
analysis	B-T062
show	O
that	O
the	O
stabilization	B-T080
between	O
the	O
selected	B-T052
rofecoxib	B-T109
and	O
other	O
pre-inserted	B-T169
rofecoxib	B-T109
molecule	O
is	O
mainly	O
due	O
to	O
van	O
der	O
waals	O
interaction	O
energy	B-T081
.	O
	
the	O
predicted	B-T078
permeability	O
of	O
rofecoxib	B-T109
in	O
high	B-T080
concentration	B-T081
model	B-T170
slightly	O
weakens	B-T080
as	O
compared	B-T052
with	O
low	B-T080
concentration	B-T081
model	B-T170
.	O
	
short-term	O
variability	O
of	O
vitamin	B-T109
d	I-T109
-related	O
biomarkers	O
quantifying	B-T081
the	O
variability	O
of	O
biomarkers	O
is	O
important	B-T080
,	O
as	O
high	O
within-person	O
variability	O
can	O
lead	O
to	O
misclassification	O
of	O
individuals	B-T098
.	O
	
short-term	O
variability	O
of	O
important	B-T080
markers	O
of	O
vitamin	O
d	O
metabolism	O
is	O
relatively	O
unknown	O
.	O
	
a	O
repeatability	B-T062
study	I-T062
was	O
conducted	O
in	O
160	O
atherosclerosis	B-T047
risk	B-T078
in	O
communities	B-T098
study	I-T098
participants	I-T098
60%	O
female	O
,	O
28%	O
black	B-T098
,	O
mean	O
age	O
76	O
years	O
.	O
	
fasting	B-T033
serum	O
was	O
drawn	O
at	O
2	O
time	O
points	O
,	O
a	O
median	O
of	O
6	O
range	O
3-13	O
weeks	B-T079
apart	O
.	O
	
vitamin	B-T116
d	I-T116
binding	I-T116
protein	I-T116
vdbp	B-T116
and	O
25-hydroxyvitamin	B-T109
d	I-T109
25	B-T109
were	O
measured	B-T080
by	O
lc-ms	O
,	O
fibroblast	B-T116
growth	I-T116
factor	I-T116
fgf23	B-T116
and	O
parathyroid	B-T116
hormone	I-T116
pth	B-T116
by	O
enzyme-linked	O
immunoassay	O
,	O
and	O
calcium	O
and	O
phosphorus	O
by	O
roche	O
cobas	O
6000	O
.	O
	
free	B-T080
and	O
bioavailable	B-T080
25	B-T109
were	O
calculated	B-T052
.	O
	
we	O
calculated	B-T052
the	O
within-person	B-T081
cv	I-T081
cvw	B-T081
,	O
intraclass	B-T081
correlation	I-T081
coefficient	I-T081
icc	B-T081
,	O
spearman	B-T081
rank	I-T081
correlation	I-T081
coefficient	I-T081
r	B-T081
,	O
and	O
percent	B-T081
reclassified	B-T080
.	O
	
the	O
cvw	B-T081
was	O
lowest	B-T080
for	O
calcium	O
2.0	O
,	O
albumin	B-T116
3.6	O
,	O
25	B-T109
6.9	O
,	O
vdbp	B-T116
7.0	O
and	O
phosphorus	O
7.6	O
intermediate	O
for	O
free	B-T080
25	B-T109
9.0	O
and	O
bioavailable	B-T080
25	B-T109
9.9	O
and	O
highest	B-T080
for	O
pth	B-T116
16.7	O
and	O
fgf23	B-T116
17.8	O
.	O
	
reclassification	O
was	O
highest	B-T080
for	O
pth	B-T116
,	O
vdbp	B-T116
,	O
and	O
phosphorus	O
all	O
7.5	O
.	O
	
the	O
icc	B-T081
and	O
r	B-T081
were	O
highest	B-T080
0.80	O
for	O
25	B-T109
,	O
free	B-T080
25	B-T109
,	O
bioavailable	B-T080
25	B-T109
and	O
pth	B-T116
,	O
but	O
somewhat	O
lower	B-T080
approximately	B-T080
0.60	O
for	O
the	O
other	O
biomarkers	O
.	O
	
six-	O
week	B-T079
short-term	O
variability	O
,	O
as	O
assessed	B-T052
by	O
cvw	B-T081
,	O
was	O
quite	B-T080
low	I-T080
for	O
vdbp	B-T116
,	O
calcium	O
and	O
phosphorus	O
,	O
but	O
fairly	B-T080
high	I-T080
for	O
fgf23	B-T116
and	O
pth	B-T116
.	O
	
as	O
such	O
,	O
multiple	B-T169
measurements	I-T169
of	O
fgf23	B-T116
and	O
pth	B-T116
may	O
be	O
needed	O
to	O
minimize	B-T080
misclassification	O
.	O
	
these	O
results	B-T169
provide	O
insight	O
into	O
the	O
extent	O
of	O
potential	B-T080
misclassification	O
of	O
vitamin	B-T109
d	I-T109
markers	O
in	O
research	B-T062
and	O
clinical	B-T169
settings	I-T169
.	O
	
fabrication	O
of	O
gelatin	B-T109
methacrylate	I-T109
/	O
nanohydroxyapatite	O
microgel	O
arrays	B-T082
for	O
periodontal	B-T061
tissue	I-T061
regeneration	I-T061
periodontitis	B-T047
is	O
a	O
chronic	B-T047
infectious	I-T047
disease	I-T047
and	O
is	O
the	O
major	B-T033
cause	I-T033
of	O
tooth	O
loss	O
and	O
other	O
oral	O
health	O
issues	B-T033
around	O
the	O
world	B-T098
.	O
	
periodontal	B-T061
tissue	I-T061
regeneration	I-T061
has	O
therefore	O
always	O
been	O
the	O
ultimate	B-T170
goal	I-T170
of	O
dentists	O
and	O
researchers	O
.	O
	
existing	O
fabrication	O
methods	B-T170
mainly	O
focused	B-T169
on	O
a	O
top-down	B-T061
tissue	I-T061
engineering	I-T061
strategy	O
in	O
which	O
several	O
drawbacks	B-T080
remain	B-T033
,	O
including	O
low	B-T080
throughput	I-T080
and	O
limited	O
diffusion	O
properties	B-T080
resulting	B-T169
from	O
a	O
large	B-T081
sample	I-T081
size	I-T081
.	O
	
gelatin	B-T109
methacrylate	I-T109
gelma	B-T109
is	O
a	O
kind	O
of	O
photocrosslinkable	O
and	O
biocompatible	O
hydrogel	B-T109
,	O
with	O
the	O
capacities	B-T081
of	O
enabling	O
cell	O
encapsulation	O
and	O
regeneration	O
of	O
functional	O
tissues	O
.	O
	
here	O
,	O
we	O
developed	O
a	O
novel	B-T080
method	B-T169
to	O
fabricate	O
gelma	B-T109
/	O
nanohydroxylapatite	O
nha	O
microgel	O
arrays	B-T082
using	O
a	O
photocrosslinkable	O
strategy	O
.	O
	
the	O
viability	O
,	O
proliferation	O
,	O
and	O
osteogenic	O
differentiation	O
and	O
in	B-T082
vivo	I-T082
osteogenesis	O
of	O
human	O
periodontal	O
ligament	O
stem	O
cells	O
hpdlscs	O
encapsulated	B-T080
in	O
microgels	O
were	O
evaluated	O
.	O
	
the	O
results	B-T169
suggested	B-T078
that	O
such	O
microgels	O
provide	B-T052
great	O
potential	B-T080
for	O
periodontal	B-T061
tissue	I-T061
repair	I-T061
and	I-T061
regeneration	I-T061
.	O
	
microgel	O
arrays	B-T082
were	O
fabricated	O
by	O
blending	O
different	B-T080
weight	B-T081
ratios	I-T081
of	O
gelma	B-T109
and	O
nha	O
.	O
	
hpdlscs	O
were	O
encapsulated	B-T080
in	O
gelma	B-T109
/	O
nha	O
microgels	O
of	O
various	O
ratios	B-T081
for	O
a	O
systematic	B-T169
evaluation	O
of	O
cell	O
viability	O
,	O
proliferation	O
,	O
and	O
osteogenic	O
differentiation	O
.	O
	
in	B-T082
vivo	I-T082
osteogenesis	O
in	O
nude	O
mice	O
was	O
also	O
studied	O
.	O
	
the	O
gelma	B-T109
/	O
nha	O
microgels	O
exhibited	O
appropriate	B-T080
microarchitecture	B-T080
,	O
mechanical	B-T078
strength	I-T078
,	O
and	O
surface	B-T082
roughness	B-T080
,	O
thus	O
enabling	O
cell	O
adhesion	O
and	O
proliferation	O
.	O
	
additionally	O
,	O
the	O
gelma	B-T109
/	O
nha	O
microgels	O
10%/2%	O
w/v	O
enhanced	B-T052
the	O
osteogenic	O
differentiation	O
of	O
hpdlscs	O
by	O
elevating	B-T080
the	O
expression	B-T081
levels	I-T081
of	O
osteogenic	O
biomarker	O
genes	O
,	O
such	O
as	O
alp	O
,	O
bsp	O
,	O
ocn	O
,	O
and	O
runx2	O
.	O
	
in	B-T082
vivo	I-T082
ectopic	B-T082
transplantation	B-T061
results	B-T169
showed	O
that	O
gelma	B-T109
/	O
nha	O
microgels	O
10%/2%	O
w/v	O
increased	B-T081
mineralized	O
tissue	O
formation	B-T169
with	O
abundant	B-T080
vascularization	B-T169
,	O
compared	B-T052
with	O
the	O
1%	O
,	O
3%	O
,	O
and	O
the	O
pure	O
gelma	B-T109
group	I-T109
.	O
	
the	O
gelma	B-T109
/	O
nha	O
microgels	O
10%/2%	O
w/v	O
facilitated	O
hpdlscs	O
viability	O
,	O
proliferation	O
,	O
and	O
osteogenic	O
differentiation	O
in	B-T080
vitro	I-T080
and	O
further	B-T082
promoted	B-T052
new	B-T080
bone	O
formation	O
in	B-T082
vivo	I-T082
,	O
suggesting	O
that	O
the	O
gelma	B-T109
/	O
nha	O
microgels	O
10%/2%	O
w/v	O
provide	B-T052
great	O
potential	B-T080
for	O
periodontal	B-T061
tissue	I-T061
regeneration	I-T061
.	O
	
esomeprazole	B-T109
-	O
or	O
rabeprazole	B-T109
-based	O
triple	B-T081
therapy	B-T061
eradicated	O
helicobacter	O
pylori	O
comparably	O
regardless	B-T080
of	O
clarithromycin	B-T109
susceptibility	B-T169
and	O
cyp2c19	O
genotypes	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
assess	B-T052
the	O
efficacy	B-T080
of	O
esomeprazole	B-T109
-based	O
triple	B-T081
therapy	B-T061
compared	B-T052
with	O
rabeprazole	B-T109
-based	O
triple	B-T081
therapy	B-T061
according	O
to	O
cyp2c19	O
genotype	O
and	O
clarithromycin	B-T109
susceptibility	B-T169
status	B-T080
for	O
first-line	O
eradication	B-T061
therapy	I-T061
of	I-T061
helicobacter	I-T061
pylori	I-T061
h	O
.	O
	
pylori	O
in	O
japan	O
.	O
	
we	O
enrolled	O
219	O
h	O
.	O
	
pylori	O
-	O
infected	O
patients	O
,	O
and	O
randomly	B-T080
allocated	B-T052
patients	O
to	O
the	O
eac	O
group	O
esomeprazole	B-T109
20	O
mg	O
,	O
clarithromycin	B-T109
200	O
mg	O
,	O
amoxicillin	B-T109
750	O
mg	O
for	O
one	O
week	B-T079
,	O
with	O
all	O
drugs	O
given	B-T169
twice	B-T079
daily	I-T079
or	O
rac	O
group	O
rabeprazole	B-T109
10	O
mg	O
,	O
clarithromycin	B-T109
200	O
mg	O
,	O
amoxicillin	B-T109
750	O
mg	O
for	O
one	O
week	B-T079
,	O
with	O
all	O
drugs	O
given	B-T169
twice	B-T079
daily	I-T079
.	O
	
the	O
h	O
.	O
	
pylori	O
eradication	B-T081
rate	I-T081
according	O
to	O
the	O
pp	B-T062
analyses	I-T062
was	O
75.0	O
95%	O
ci	B-T081
65.2	O
in	O
the	O
eac	O
group	O
and	O
71.4	O
95%	O
ci	B-T081
61.4	O
in	O
the	O
rac	O
group	O
.	O
	
there	O
were	O
no	O
statistically	O
significant	O
differences	B-T080
.	O
	
the	O
eradication	B-T081
rates	I-T081
of	O
the	O
clarithromycin	B-T109
-resistant	O
/-	O
sensitive	O
strains	O
were	O
,	O
respectively	O
,	O
45.0	O
95%	O
ci	O
30.7	O
95%	O
ci	O
88.7	O
in	O
the	O
eac	O
group	O
and	O
39.5	O
95%	O
ci	O
25.6	O
95%	O
ci	O
81.9	O
in	O
the	O
rac	O
group	O
.	O
	
the	O
eradication	O
rate	O
of	O
the	O
clarithromycin	O
-	O
sensitive	O
strains	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
resistant	O
strains	O
in	O
both	O
groups	O
.	O
	
in	O
conclusion	O
,	O
eac	O
and	O
rac	O
therapies	O
show	O
a	O
comparable	O
efficacy	O
regardless	O
of	O
the	O
cyp2c19	O
genotype	O
and	O
clarithromycin	O
susceptibility	O
status	O
in	O
japan	O
optimization	O
of	O
early	B-T079
response	O
monitoring	O
and	O
prediction	O
of	O
cancer	O
antiangiogenesis	B-T061
therapy	I-T061
via	O
noninvasive	O
pet	O
molecular	O
imaging	O
strategies	O
of	O
multifactorial	B-T033
bioparameters	O
objective	O
antiangiogenesis	B-T061
therapy	I-T061
aat	B-T061
has	O
provided	O
substantial	O
benefits	O
regarding	O
improved	O
outcomes	O
and	O
survival	B-T052
for	O
suitable	O
patients	O
in	O
clinical	B-T082
settings	I-T082
.	O
	
therefore	O
,	O
the	O
early	B-T079
definition	O
of	O
therapeutic	O
effects	O
is	O
urgently	O
needed	O
to	O
guide	O
cancer	O
aat	B-T061
.	O
	
we	O
aimed	O
to	O
optimize	O
the	O
early	B-T079
response	O
monitoring	O
and	O
prediction	O
of	O
aat	B-T061
efficacy	B-T080
,	O
as	O
indicated	O
by	O
the	O
multi-targeted	O
anti-angiogenic	O
drug	O
sunitinib	B-T109
in	O
u87mg	O
tumors	O
,	O
using	O
noninvasive	O
positron	O
emission	O
computed	O
tomography	O
pet	O
molecular	O
imaging	O
strategies	O
of	O
multifactorial	B-T033
bioparameters	O
.	O
	
methods	O
u87mg	O
tumor	O
mice	O
were	O
treated	O
via	O
intragastric	B-T082
injections	B-T061
of	O
sunitinib	B-T109
80	O
mg/kg	O
or	O
vehicle	O
for	O
7	O
consecutive	O
days	O
.	O
	
longitudinal	B-T082
micropet/ct	O
scans	O
with	O
18	B-T109
,	O
18	B-T109
,	O
18	B-T109
and	O
18	B-T116
ii	I-T116
were	O
acquired	O
to	O
quantitatively	O
measure	O
metabolism	O
,	O
hypoxia	O
,	O
apoptosis	O
and	O
angiogenesis	O
on	O
days	O
0	O
,	O
1	O
,	O
3	O
,	O
7	O
and	O
13	O
following	O
therapy	B-T061
initiation	O
.	O
	
tumor	O
tissues	O
from	O
a	O
dedicated	O
group	O
of	O
mice	O
were	O
collected	O
for	O
immunohistochemical	O
ihc	O
analysis	O
of	O
key	O
biomarkers	O
glut-1	B-T116
,	O
ca-ix	B-T116
,	O
tunel	O
,	O
ανβ3	B-T116
and	O
cd31	B-T116
at	O
the	O
time	O
points	O
of	O
pet	O
imaging	O
.	O
	
the	O
tumor	B-T082
sizes	I-T082
and	O
mouse	O
weights	O
were	O
measured	O
throughout	O
the	O
study	O
.	O
	
the	O
tumor	O
uptake	O
id%/gmax	O
,	O
the	O
ratios	O
of	O
the	O
tumor	O
/	O
muscle	O
t	O
/	O
m	O
for	O
each	O
probe	O
,	O
and	O
the	O
tumor	O
growth	O
ratios	B-T081
tgr	B-T081
were	O
calculated	O
and	O
used	O
for	O
statistical	B-T062
analyses	I-T062
of	O
the	O
differences	O
and	O
correlations	O
.	O
	
results	O
sunitinib	B-T109
successfully	O
inhibited	O
u87mg	O
tumor	O
growth	O
with	O
significant	O
differences	O
in	O
the	O
tumor	B-T082
size	I-T082
from	O
day	O
9	O
after	O
sunitinib	B-T109
treatment	B-T061
compared	O
with	O
the	O
control	O
group	O
p	O
<	O
0.01	O
.	O
	
the	O
uptakes	O
of	O
18	B-T109
reduced	O
hypoxia	O
,	O
18	B-T109
increased	O
apoptosis	O
and	O
18	B-T116
ii	I-T116
decreased	O
angiogenesis	O
in	O
the	O
tumor	O
lesions	B-T033
significantly	O
changed	O
during	O
the	O
early	B-T079
stage	O
days	O
1	O
to	O
3	O
of	O
sunitinib	O
treatment	O
however	O
,	O
the	O
uptake	O
of	O
18	O
increased	O
glucose	O
metabolism	O
was	O
significantly	O
different	O
during	O
the	O
late	O
stage	O
.	O
	
the	O
pet	O
imaging	O
data	O
of	O
each	O
probe	O
were	O
all	O
confirmed	O
via	O
ex	O
vivo	O
ihc	O
of	O
the	O
relevant	O
biomarkers	O
.	O
	
notably	O
,	O
the	O
pet	O
imaging	O
of	O
18	O
ii	O
and	O
18	O
was	O
significantly	O
correlated	O
all	O
p	O
<	O
0.05	O
with	O
tgr	O
,	O
whereas	O
the	O
imaging	O
of	O
18	O
and	O
18	O
was	O
not	O
significantly	O
correlated	O
with	O
tgr	O
.	O
	
conclusion	O
based	O
on	O
the	O
tumor	O
uptake	O
of	O
the	O
pet	O
probes	O
and	O
their	O
correlations	O
with	O
mvd	O
and	O
tgr	O
,	O
18	O
ii	O
pet	O
may	O
not	O
only	O
monitor	O
the	O
early	B-T079
response	O
but	O
also	O
precisely	O
predict	O
the	O
therapeutic	O
efficacy	O
of	O
the	O
multi-targeted	O
,	O
anti-angiogenic	O
drug	O
sunitinib	O
in	O
u87mg	O
tumors	O
.	O
	
in	O
conclusion	O
,	O
it	O
is	O
feasible	O
to	O
optimize	O
the	O
early	O
response	O
monitoring	O
and	O
efficacy	O
prediction	O
of	O
cancer	O
aat	O
using	O
noninvasive	O
pet	O
molecular	O
imaging	O
strategies	O
of	O
multifactorial	O
bioparameters	O
,	O
such	O
as	O
angiogenesis	O
imaging	O
with	O
18	O
ii	O
,	O
which	O
represents	O
an	O
rgd	O
-based	O
identifying	O
research	B-T062
priorities	I-T062
with	O
nurses	O
at	O
a	O
tertiary	O
children's	O
hospital	O
in	O
the	O
united	O
kingdom	O
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
undertake	O
a	O
research	B-T062
priority	I-T062
setting	O
exercise	O
with	O
the	O
aim	O
of	O
maximizing	O
efficiency	B-T081
and	O
impact	B-T080
in	O
research	B-T062
activity	I-T062
undertaken	O
by	O
nurses	O
at	O
one	O
children's	O
tertiary	O
healthcare	O
institution	O
by	O
ensuring	O
the	O
clinical	O
staff	O
directly	O
shaped	O
a	O
coherent	B-T033
,	O
transparent	B-T080
and	O
consensus	O
driven	O
nurse-led	B-T062
research	I-T062
agenda	I-T062
.	O
	
in	O
round	O
1	O
,	O
the	O
research	O
topics	O
of	O
147	O
nurses	O
were	O
elicited	O
using	O
a	O
modified	B-T062
nominal	I-T062
group	I-T062
technique	I-T062
as	O
the	O
consensus	B-T170
method	I-T170
.	O
	
the	O
number	O
of	O
participants	B-T098
in	O
the	O
24	O
separate	O
discussions	O
ranged	O
from	O
3	O
to	O
21	O
,	O
generating	O
lists	O
of	O
between	O
6	O
and	O
23	O
topics	O
.	O
	
in	O
round	O
2	O
,	O
nurses	O
from	O
the	O
clinical	B-T078
areas	I-T078
ranked	B-T170
topics	O
of	O
importance	O
resulting	O
in	O
a	O
set	O
of	O
four	O
to	O
five	O
priorities	B-T062
.	O
	
in	O
round	O
3	O
,	O
the	O
divisional	O
heads	O
of	O
nursing	O
consulted	O
with	O
staff	O
in	O
all	O
of	O
their	O
clinical	B-T078
areas	I-T078
to	O
each	O
finalize	O
their	O
five	O
divisional	B-T062
priorities	I-T062
.	O
	
the	O
nursing	O
research	O
working	O
group	O
discussed	O
and	O
refined	O
the	O
divisions'	B-T062
priorities	I-T062
and	O
voted	O
on	O
the	O
final	O
list	O
to	O
agree	O
the	O
top	O
five	O
research	B-T062
priorities	I-T062
for	O
the	O
organization	O
.	O
	
a	O
total	O
of	O
269	O
research	O
topics	O
were	O
initially	O
generated	O
.	O
	
following	O
three	O
rounds	O
of	O
ranking	B-T170
and	O
prioritizing	O
,	O
five	O
priorities	B-T062
were	O
agreed	O
at	O
divisional	O
level	O
,	O
and	O
from	O
these	O
,	O
the	O
five	O
top	O
organizational	B-T062
priorities	I-T062
were	O
selected	O
.	O
	
these	O
were	O
i	O
understanding	O
and	O
improving	O
all	O
aspects	O
of	O
the	O
patient	O
journey	O
through	O
the	O
hospital	O
system	O
ii	O
play	O
iii	O
staff	B-T078
wellbeing	I-T078
,	O
patient	O
care	O
and	O
productivity	B-T081
iv	O
team	O
work	O
-	O
linking	O
to	O
a	O
more	O
efficient	O
service	O
and	O
v	O
supporting	O
parents	O
/	O
parent	O
pathway	O
.	O
	
divisional	O
priorities	B-T062
have	O
been	O
disseminated	O
widely	O
to	O
clinical	O
teams	O
to	O
inform	O
a	O
patient-specific	B-T062
nurse-led	I-T062
research	I-T062
agenda	I-T062
.	O
	
organizational	B-T062
priorities	I-T062
agreed	O
upon	O
have	O
been	O
disseminated	O
through	O
management	O
structures	O
and	O
processes	O
to	O
ensure	O
engagement	O
at	O
all	O
levels	O
.	O
	
a	O
subgroup	O
of	O
the	O
nursing	O
research	O
working	O
group	O
has	O
been	O
delegated	O
to	O
take	O
this	O
work	O
forward	O
so	O
that	O
the	O
agreed	O
priorities	B-T062
continue	O
to	O
contribute	O
towards	O
shaping	O
nurse-led	B-T062
research	I-T062
activity	I-T062
,	O
thereby	O
going	O
some	O
way	O
to	O
inform	O
and	O
embed	O
an	O
evidence-based	O
culture	O
of	O
accurate	B-T080
lungs	O
segmentation	O
on	O
ct	O
chest	O
images	B-T170
by	O
adaptive	B-T062
appearance-guided	I-T062
shape	I-T062
modeling	I-T062
to	O
accurately	B-T080
segment	O
pathological	B-T169
and	O
healthy	B-T080
lungs	O
for	O
reliable	B-T080
computer-aided	O
disease	O
diagnostics	O
,	O
a	O
stack	B-T082
of	O
chest	O
ct	O
scans	O
is	O
modeled	B-T062
as	O
a	O
sample	O
of	O
a	O
spatially	B-T082
inhomogeneous	I-T082
joint	B-T080
3d	I-T080
markov-gibbs	I-T080
random	I-T080
field	I-T080
mgrf	B-T080
of	O
voxel-wise	O
lung	O
and	O
chest	O
ct	O
image	B-T170
signals	O
intensities	B-T081
.	O
	
the	O
proposed	B-T080
learnable	O
mgrf	B-T080
integrates	O
two	O
visual	B-T169
appearance	B-T080
sub-models	O
with	O
an	O
adaptive	O
lung	O
shape	O
submodel	O
.	O
	
the	O
first-order	O
appearance	B-T080
submodel	O
accounts	O
for	O
both	O
the	O
original	B-T078
ct	O
image	B-T170
and	O
its	O
gaussian	B-T080
scale	I-T080
space	I-T080
gss	I-T080
filtered	I-T080
version	I-T080
to	O
specify	O
local	O
and	O
global	O
signal	O
properties	O
,	O
respectively	O
.	O
	
each	O
empirical	B-T080
marginal	B-T080
probability	B-T081
distribution	I-T081
of	O
signals	O
is	O
closely	O
approximated	O
with	O
a	O
linear	B-T080
combination	I-T080
of	I-T080
discrete	I-T080
gaussians	I-T080
lcdg	B-T080
,	O
containing	O
two	O
positive	B-T080
dominant	I-T080
and	I-T080
multiple	I-T080
sign-alternate	I-T080
subordinate	I-T080
dgs	I-T080
.	O
	
the	O
approximation	O
is	O
separated	O
into	O
two	O
lcdgs	B-T080
to	O
describe	O
individually	O
the	O
lungs	O
and	O
their	O
background	O
,	O
i.e	O
,	O
all	O
other	O
chest	O
tissues	O
.	O
	
the	O
second-order	O
appearance	B-T080
submodel	O
quantifies	B-T081
conditional	B-T080
pairwise	B-T081
intensity	B-T081
dependencies	B-T170
in	O
the	O
nearest	O
voxel	O
26-neighborhood	O
in	O
both	O
the	O
original	B-T078
and	O
gss-filtered	B-T080
images	B-T170
.	O
	
the	O
shape	O
submodel	O
is	O
built	O
for	O
a	O
set	O
of	O
training	B-T078
data	I-T078
and	O
is	O
adapted	O
during	O
segmentation	O
using	O
both	O
the	O
lung	O
and	O
chest	O
appearances	B-T080
.	O
	
the	O
accuracy	B-T080
of	O
the	O
proposed	B-T080
segmentation	O
framework	O
is	O
quantitatively	B-T081
assessed	B-T052
using	O
two	O
public	O
databases	B-T170
isbi	B-T170
vessel12	I-T170
challenge	I-T170
and	O
miccai	B-T170
lola11	I-T170
challenge	I-T170
and	O
our	O
own	O
database	B-T170
with	O
,	O
respectively	O
,	O
20	O
,	O
55	O
,	O
and	O
30	O
ct	O
images	B-T170
of	O
various	O
lung	O
pathologies	B-T169
acquired	O
with	O
different	O
scanners	O
and	O
protocols	B-T061
.	O
	
quantitative	B-T081
assessment	B-T052
of	O
our	O
framework	O
in	O
terms	O
of	O
dice	B-T081
similarity	I-T081
coefficients	I-T081
,	O
95-percentile	B-T081
bidirectional	I-T081
hausdorff	I-T081
distances	I-T081
,	O
and	O
percentage	B-T081
volume	I-T081
differences	I-T081
confirms	O
the	O
high	O
accuracy	B-T080
of	O
our	O
model	O
on	O
both	O
our	O
database	B-T170
98.4	O
,	O
2.2	O
mm	O
,	O
0.42	O
and	O
the	O
vessel12	B-T170
database	I-T170
99.0	O
,	O
2.1	O
mm	O
,	O
0.39	O
,	O
respectively	O
.	O
	
similarly	O
,	O
the	O
accuracy	B-T080
of	O
our	O
approach	O
is	O
further	O
verified	O
via	O
a	O
blind	O
evaluation	O
by	O
the	O
organizers	O
of	O
the	O
lola11	O
competition	O
,	O
where	O
an	O
average	O
overlap	O
of	O
98.0	O
with	O
the	O
expert's	O
segmentation	O
is	O
yielded	O
on	O
all	O
55	O
subjects	O
with	O
our	O
framework	O
being	O
ranked	O
first	O
among	O
all	O
the	O
state-of-the-art	O
techniques	O
compared	B-T052
influence	O
of	O
different	B-T080
levels	B-T079
of	O
lipoic	O
acid	O
synthase	O
gene	O
expression	O
on	O
diabetic	B-T047
nephropathy	I-T047
oxidative	O
stress	O
is	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
diabetic	B-T047
nephropathy	I-T047
dn	B-T047
but	O
outcomes	B-T169
of	O
many	O
clinical	B-T062
trials	I-T062
are	O
controversial	O
.	O
	
to	O
define	O
the	O
role	O
of	O
antioxidants	O
in	O
kidney	O
protection	O
during	B-T079
the	O
development	B-T169
of	O
diabetic	B-T047
nephropathy	I-T047
,	O
we	O
have	O
generated	B-T052
a	O
novel	B-T080
genetic	O
antioxidant	O
mouse	O
model	O
with	O
over-	O
or	O
under-expression	O
of	O
lipoic	O
acid	O
synthase	O
gene	O
lias	O
.	O
	
these	O
models	O
have	O
been	O
mated	O
with	O
ins2akita/+	O
mice	O
,	O
a	O
type	B-T047
i	I-T047
diabetic	I-T047
mouse	O
model	O
.	O
	
we	O
compare	B-T052
the	O
major	B-T080
pathologic	O
changes	O
and	O
oxidative	O
stress	O
status	B-T080
in	O
two	O
new	O
strains	O
of	O
the	O
mice	O
with	O
controls	O
.	O
	
our	O
results	B-T169
show	O
that	O
ins2akita/+	O
mice	O
with	O
under-expressed	O
lias	O
gene	O
,	O
exhibit	O
higher	B-T080
oxidative	O
stress	O
and	O
more	B-T081
severe	B-T080
dn	B-T047
features	B-T080
albuminuria	B-T033
,	O
glomerular	B-T033
basement	I-T033
membrane	I-T033
thickening	I-T033
and	O
mesangial	B-T033
matrix	I-T033
expansion	I-T033
.	O
	
in	O
contrast	O
,	O
ins2akita/+	O
mice	O
with	O
highly	B-T080
-	O
expressed	O
lias	O
gene	O
display	B-T169
lower	B-T080
oxidative	O
stress	O
and	O
less	B-T080
dn	B-T047
pathologic	O
changes	O
.	O
	
our	O
study	B-T062
demonstrates	B-T052
that	O
strengthening	O
endogenous	B-T169
antioxidant	O
capacity	B-T081
could	O
be	O
an	O
effective	O
strategy	O
for	O
prevention	O
and	O
treatment	B-T169
of	O
assessment	B-T052
of	O
genetic	B-T169
relationship	B-T080
among	O
rhododendron	O
cultivars	O
using	O
amplified	O
fragment	O
length	O
polymorphism	O
and	O
inter-simple	O
sequence	O
repeat	O
markers	O
genetic	B-T169
relationships	B-T080
of	O
17	O
rhododendron	O
cultivars	O
,	O
china	O
,	O
were	O
assessed	B-T052
using	O
inter-simple	O
sequence	O
repeat	O
issr	O
and	O
amplified	O
fragment	O
length	O
polymorphism	O
aflp	O
markers	O
.	O
	
a	O
total	O
of	O
133	O
bands	O
were	O
obtained	O
using	O
nine	O
selected	O
issr	O
primers	O
,	O
129	O
96.99	O
of	O
which	O
were	O
polymorphic	B-T080
267	O
bands	O
were	O
amplified	O
by	O
four	O
aflp	O
primer	O
pairs	O
,	O
251	O
94.01	O
of	O
which	O
exhibited	O
polymorphism	B-T080
.	O
	
based	O
on	O
these	O
polymorphic	B-T080
products	O
,	O
a	O
cluster	B-T062
analysis	I-T062
revealed	O
similarities	B-T080
between	O
the	O
results	B-T169
of	O
the	O
issr	O
and	O
aflp	O
.	O
	
all	O
of	O
the	O
cultivars	O
were	O
clustered	B-T169
into	O
two	O
major	O
branches	B-T078
one	O
branch	B-T078
contained	O
the	O
same	O
four	O
cultivars	O
,	O
and	O
the	O
other	O
cultivars	O
were	O
separated	O
into	O
different	O
groups	B-T078
in	O
the	O
other	O
branch	B-T078
.	O
	
the	O
cluster	B-T081
results	B-T169
showed	O
that	O
the	O
genetic	B-T169
relationships	B-T080
of	O
the	O
17	O
cultivars	O
were	O
partly	O
related	B-T080
to	O
their	O
morphological	B-T082
characteristics	B-T080
,	O
particularly	O
the	O
flowering	O
phase	B-T079
.	O
	
therefore	O
,	O
the	O
results	B-T169
of	O
this	O
study	B-T062
support	O
the	O
classification	O
of	O
rhododendron	O
cultivars	O
according	O
to	O
flowering	O
phase	B-T079
.	O
	
in	O
addition	O
,	O
the	O
cluster	B-T081
results	B-T169
can	O
be	O
used	O
to	O
select	B-T052
suitable	O
parents	O
for	O
spontaneous	O
activity	O
is	O
correlated	B-T080
with	O
coding	B-T052
density	B-T081
in	O
primary	O
auditory	O
cortex	O
sensory	O
neurons	O
across	O
sensory	O
modalities	O
and	O
specific	O
processing	B-T052
areas	O
have	O
diverse	O
levels	O
of	O
spontaneous	O
firing	O
rates	O
sfrs	O
in	O
the	O
absence	O
of	O
sensory	O
stimuli	O
.	O
	
however	O
,	O
the	O
functional	B-T169
significance	B-T078
of	O
this	O
spontaneous	O
activity	O
is	O
not	O
well-understood	O
.	O
	
previous	O
studies	B-T062
in	O
the	O
auditory	O
system	O
have	O
demonstrated	O
that	O
different	O
levels	O
of	O
spontaneous	O
activity	O
are	O
correlated	B-T080
with	O
a	O
variety	O
of	O
physiological	B-T169
and	O
anatomic	B-T080
properties	O
,	O
suggesting	O
that	O
neurons	O
with	O
differing	O
sfrs	O
make	O
unique	O
contributions	O
to	O
the	O
encoding	B-T052
of	O
auditory	O
stimuli	O
.	O
	
additionally	O
,	O
altered	O
sfrs	O
are	O
a	O
correlate	O
of	O
tinnitus	B-T033
,	O
arising	O
in	O
several	O
auditory	O
areas	O
after	O
exposure	O
to	O
ototoxic	O
substances	O
and	O
noise	O
trauma	O
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
recorded	O
single-unit	O
activity	O
from	O
primary	O
auditory	O
cortex	O
of	O
awake	O
marmoset	O
monkeys	O
while	O
delivering	O
wide-band	O
random-spectrum	O
stimuli	O
and	O
white	B-T170
gaussian	I-T170
noise	I-T170
wgn	B-T170
to	O
examine	O
any	O
divergences	B-T082
in	O
stimulus	O
encoding	B-T052
properties	O
across	O
sfr	O
classes	O
.	O
	
we	O
found	O
that	O
higher	O
levels	O
of	O
spontaneous	O
activity	O
were	O
associated	O
with	O
both	O
higher	O
levels	O
of	O
activation	B-T052
relative	O
to	O
suppression	B-T169
across	O
a	O
variety	O
of	O
wide-band	O
stimuli	O
and	O
higher	O
driven	O
rates	O
in	O
response	O
to	O
wgn	B-T170
.	O
	
moreover	O
,	O
response	B-T079
latencies	I-T079
to	O
wgn	B-T170
were	O
negatively	O
correlated	B-T080
with	O
the	O
level	O
of	O
activation	B-T052
in	O
response	O
to	O
both	O
stimulus	O
types	O
.	O
	
these	O
findings	O
are	O
consistent	O
with	O
a	O
novel	O
view	O
of	O
the	O
role	O
spontaneous	O
spiking	O
may	O
play	O
during	O
normal	O
stimulus	O
processing	B-T052
in	O
primary	O
auditory	O
cortex	O
and	O
how	O
it	O
may	O
malfunction	B-T169
in	O
cases	O
of	O
systematic	B-T062
mapping	I-T062
of	O
functional	B-T169
enhancer	O
-	O
promoter	O
connections	B-T169
with	O
crispr	O
interference	O
gene	O
expression	O
in	O
mammals	O
is	O
regulated	O
by	O
noncoding	O
elements	O
that	O
can	O
affect	O
physiology	O
and	O
disease	O
,	O
yet	O
the	O
functions	O
and	O
target	O
genes	O
of	O
most	O
noncoding	O
elements	O
remain	O
unknown	O
.	O
	
we	O
present	O
a	O
high-throughput	O
approach	O
that	O
uses	O
clustered	O
regularly	O
interspaced	O
short	O
palindromic	O
repeats	O
crispr	O
interference	O
crispri	O
to	O
discover	O
regulatory	O
elements	O
and	O
identify	O
their	O
target	O
genes	O
.	O
	
we	O
assess	O
>1	O
megabase	O
of	O
sequence	O
in	O
the	O
vicinity	O
of	O
two	O
essential	O
transcription	O
factors	O
,	O
myc	O
and	O
gata1	O
,	O
and	O
identify	O
nine	O
distal	O
enhancers	O
that	O
control	O
gene	O
expression	O
and	O
cellular	O
proliferation	O
.	O
	
quantitative	O
features	O
of	O
chromatin	O
state	O
and	O
chromosome	O
conformation	O
distinguish	O
the	O
seven	O
enhancers	O
that	O
regulate	O
myc	O
from	O
other	O
elements	O
that	O
do	O
not	O
,	O
suggesting	O
a	O
strategy	O
for	O
predicting	O
enhancer	O
-	O
promoter	O
connectivity	O
.	O
	
this	O
crispri	O
-based	O
approach	O
can	O
be	O
applied	O
to	O
dissect	O
transcriptional	O
networks	O
and	O
interpret	O
the	O
contributions	O
of	O
noncoding	O
genetic	O
variation	O
to	O
human	O
disease	B-T047
proliferation	O
-enhancing	O
effects	B-T080
of	I-T080
gastrodin	B-T109
on	O
rsc96	O
schwann	O
cells	O
by	O
regulating	O
erk1	B-T116
/	O
2	B-T116
and	O
pi3k	B-T116
signaling	O
pathways	O
the	O
proliferation	O
and	O
migration	O
of	O
schwann	O
cells	O
scs	O
are	O
essential	O
in	O
the	O
process	O
of	O
peripheral	B-T061
nerve	I-T061
repair	I-T061
.	O
	
a	O
large	O
amount	O
of	O
studies	O
focused	O
on	O
the	O
promotion	B-T052
of	O
the	O
growth	O
of	O
scs	O
for	O
cell	B-T061
based	I-T061
therapy	I-T061
.	O
	
gastrodin	B-T109
gas	B-T109
,	O
the	O
main	O
constituent	O
of	O
a	O
chinese	O
traditional	O
herbal	O
medicine	O
named	O
gastrodia	O
elata	O
blume	O
,	O
has	O
been	O
reported	O
to	O
be	O
associated	B-T080
with	I-T080
neuroprotective	O
properties	O
.	O
	
besides	O
,	O
gas	B-T109
activated	B-T052
mapk	B-T116
and	O
pi3k	B-T116
signaling	O
pathways	O
which	O
are	O
often	O
involved	O
in	O
growth	O
of	O
nerve	O
cells	O
were	O
also	O
reported	O
.	O
	
based	O
on	O
the	O
hypothesis	B-T078
that	O
gas	B-T109
may	O
have	O
an	O
effect	O
on	O
scs	O
growth	O
,	O
we	O
studied	O
the	O
effect	B-T080
of	I-T080
gas	B-T109
on	O
rat	O
rsc96	O
schwann	O
cells	O
scs	O
and	O
further	O
explored	O
the	O
underlying	O
mechanism	B-T169
.	O
	
various	O
concentration	B-T081
of	O
gas	B-T109
0μm	O
,	O
50μm	O
,	O
100μm	O
,	O
and	O
200μm	O
was	O
used	O
for	O
treatment	B-T061
of	O
rsc96	O
scs	O
,	O
with	O
the	O
cell	O
proliferation	O
and	O
gene	O
expression	O
of	O
several	O
neurotrophic	B-T116
factors	I-T116
to	O
be	O
detected	O
.	O
	
regulation	O
of	O
mapk	B-T116
and	O
pi3k	B-T116
signaling	O
pathways	O
were	O
assayed	O
by	O
detecting	O
phosphorylation	O
of	O
erk1	B-T116
/	O
2	B-T116
and	O
akt	B-T116
.	O
	
the	O
results	O
showed	O
that	O
gas	B-T109
could	O
effectively	O
promote	B-T052
proliferation	O
of	O
rsc96	O
scs	O
in	O
a	O
dose	B-T081
-	O
and	O
time	B-T079
-dependent	O
manner	O
.	O
	
the	O
best	O
performance	O
was	O
obtained	O
at	O
the	O
concentration	B-T081
of	O
200μm	O
.	O
	
exploration	B-T061
of	O
the	O
underlying	O
mechanism	B-T169
showed	O
that	O
gas	B-T109
probably	O
affects	O
scs	O
metabolism	O
through	O
inhibiting	B-T052
erk1	B-T116
/	O
2	B-T116
phosphorylation	O
and	O
activating	B-T052
akt	B-T116
phosphorylation	O
in	O
rsc96	O
scs	O
.	O
	
this	O
study	O
may	O
provide	O
reference	O
for	O
its	O
application	O
in	O
treatment	B-T061
of	O
peripheral	O
nerve	O
injuries	O
.	O
	
an	O
influenza	O
a	O
virus	O
h7n9	O
anti-neuraminidase	B-T033
monoclonal	B-T116
antibody	I-T116
with	O
prophylactic	B-T061
and	I-T061
therapeutic	I-T061
activity	I-T061
in	B-T082
vivo	I-T082
zoonotic	B-T047
a	O
avian	O
influenza	O
viruses	O
emerged	O
in	O
china	O
in	O
2013	O
and	O
continue	O
to	O
be	O
a	O
threat	B-T078
to	O
human	O
public	O
health	O
,	O
having	O
infected	B-T033
over	O
800	O
individuals	B-T098
with	O
a	O
mortality	B-T081
rate	I-T081
approaching	O
40%	O
.	O
	
treatment	B-T061
options	I-T061
for	O
people	O
infected	B-T033
with	O
a	O
include	O
the	O
use	O
of	O
neuraminidase	O
na	O
inhibitors	O
.	O
	
however	O
,	O
like	O
other	O
influenza	O
viruses	O
,	O
a	O
can	O
become	O
resistant	B-T169
to	O
these	O
drugs	O
.	O
	
the	O
use	O
of	O
monoclonal	B-T116
antibodies	I-T116
is	O
a	O
rapidly	O
developing	O
strategy	O
for	O
controlling	O
influenza	O
virus	O
infection	O
.	O
	
here	O
we	O
generated	O
a	O
murine	O
monoclonal	B-T116
antibody	I-T116
3c10-3	O
directed	O
against	O
the	O
na	B-T116
of	O
a	O
and	O
show	O
that	O
prophylactic	B-T169
systemic	O
administration	O
of	O
3c10-3	O
fully	O
protected	O
mice	O
from	O
lethal	O
challenge	O
with	O
wild-type	O
a/anhui/1/2013	O
h7n9	O
.	O
	
further	O
,	O
post-	O
infection	O
treatment	B-T061
with	O
a	O
single	O
systemic	B-T169
dose	B-T081
of	O
3c10-3	O
at	O
either	O
24	O
,	O
48	O
or	O
72	O
h	O
post	O
a	O
challenge	O
resulted	O
in	O
both	O
dose	B-T081
-	O
and	O
time	B-T079
-	O
dependent	B-T169
protection	B-T033
of	O
up	O
to	O
100%	O
of	O
mice	O
,	O
demonstrating	O
therapeutic	B-T169
potential	B-T080
for	O
3c10-3	O
.	O
	
epitope	O
mapping	O
revealed	O
that	O
3c10-3	O
binds	O
near	O
the	O
enzyme	B-T116
active	B-T169
site	I-T169
of	O
na	B-T116
,	O
and	O
functional	B-T169
characterization	O
showed	O
that	O
3c10-3	O
inhibits	O
the	O
enzyme	O
activity	O
of	O
na	B-T116
and	O
restricts	O
the	O
cell	O
-to-	O
cell	O
spread	B-T080
of	O
the	O
virus	O
in	O
cultured	O
cells	O
.	O
	
affinity	O
analysis	B-T062
also	O
revealed	O
that	O
3c10-3	O
binds	O
equally	O
well	O
to	O
recombinant	B-T116
na	B-T116
of	O
wild-type	O
a/anhui/1/2013	O
and	O
to	O
a	O
variant	B-T080
na	B-T116
carrying	O
a	O
r289k	O
mutation	O
known	O
to	O
infer	O
nai	O
resistance	B-T169
.	O
	
these	O
results	O
suggest	O
that	O
3c10-3	O
has	O
the	O
potential	B-T080
to	O
be	O
used	O
as	O
a	O
therapeutic	B-T169
to	O
treat	O
a	O
infections	O
either	O
as	O
an	O
alternative	O
to	O
,	O
or	O
in	O
combination	B-T080
with	O
,	O
current	O
na	B-T116
antiviral	O
inhibitors	O
.	O
	
mechanisms	B-T169
of	O
ear	O
trauma	O
and	O
reconstructive	B-T061
techniques	B-T169
in	O
105	O
consecutive	B-T080
patients	O
acquired	B-T080
auricular	O
deformities	O
may	O
diminish	B-T081
facial	O
esthetics	O
and	O
cause	O
psychological	O
distress	O
.	O
	
the	O
aim	O
of	O
this	O
article	O
is	O
to	O
provide	O
an	O
overview	O
of	O
the	O
type	O
of	O
injuries	O
and	O
applied	B-T061
reconstructive	I-T061
techniques	B-T169
in	O
a	O
large	O
academic	O
hospital	O
in	O
the	O
netherlands	O
.	O
	
a	O
retrospective	B-T080
chart	O
review	O
was	O
conducted	O
for	O
the	O
last	O
105	O
patients	O
who	O
underwent	O
auricular	O
reconstruction	B-T061
for	O
an	O
acquired	O
deformity	O
.	O
	
data	B-T078
concerning	O
gender	O
,	O
affected	B-T033
side	I-T033
,	O
cause	B-T033
of	I-T033
injury	I-T033
,	O
anatomical	O
region	O
,	O
the	O
previous	O
and	O
further	O
surgeries	B-T061
,	O
type	O
of	O
cartilage	O
,	O
and	O
skin	O
cover	O
used	O
were	O
collected	O
and	O
analyzed	B-T062
.	O
	
105	O
patients	O
were	O
included	O
.	O
	
acquired	B-T080
auricular	O
deformities	O
were	O
mainly	O
caused	O
by	O
bite	O
injuries	O
22	O
%	O
,	O
traffic	O
accidents	O
17	O
%	O
,	O
burns	O
9.5	O
%	O
,	O
and	O
post-otoplasty	B-T061
complications	O
9.5	O
%	O
.	O
	
the	O
upper	O
third	O
of	O
the	O
auricle	O
was	O
most	O
often	O
injured	B-T169
41	O
%	O
,	O
followed	O
by	O
the	O
entire	O
auricle	O
19	O
%	O
.	O
	
70	O
%	O
of	O
cases	B-T169
required	O
reconstruction	B-T061
with	O
costal	O
cartilage	O
.	O
	
the	O
most	O
common	O
form	O
of	O
cutaneous	B-T082
cover	I-T082
was	O
a	O
postauricular	B-T061
skin	I-T061
flap	I-T061
40	O
%	O
of	O
cases	B-T169
.	O
	
this	O
study	B-T062
gives	O
a	O
complete	O
overview	O
of	O
causes	O
and	O
treatment	B-T169
of	O
acquired	B-T080
auricular	O
deformities	O
.	O
	
the	O
results	B-T169
are	O
comparable	O
with	O
the	O
results	O
of	O
similar	O
studies	B-T062
found	O
in	O
literature	B-T170
.	O
	
bite	O
wounds	O
are	O
the	O
leading	O
cause	O
of	O
acquired	B-T080
auricular	O
injuries	O
.	O
	
the	O
upper	O
third	O
is	O
most	O
commonly	O
affected	O
.	O
	
in	O
the	O
largest	O
percentage	O
of	O
reconstructions	B-T061
,	O
costal	O
cartilage	O
and	O
a	O
postauricular	O
flap	O
were	O
used	O
to	O
correct	O
the	O
anatomic	B-T080
assessment	O
of	O
the	O
left	B-T082
main	I-T082
bifurcation	I-T082
and	O
dynamic	B-T082
bifurcation	I-T082
angles	I-T082
using	O
computed	O
tomography	O
angiography	O
an	O
understanding	O
of	O
the	O
left	O
main	O
coronary	O
artery	O
lmca	O
anatomy	O
is	O
important	O
for	O
accurate	O
diagnosis	B-T080
and	O
therapeutic	B-T061
.	O
	
we	O
aimed	O
to	O
investigate	B-T169
lmca	O
anatomy	O
via	O
128-multisliced	O
coronary	O
computed-tomography-angiography	O
ccta	O
in	O
patients	O
with	O
normal	O
lmca	O
.	O
	
a	O
total	O
of	O
201	O
ccta	O
studies	B-T062
were	O
included	O
in	O
this	O
study	B-T062
.	O
	
anatomical	O
features	O
of	O
lmca	O
including	O
cross-sectional	B-T082
areas	I-T082
of	O
the	O
lmca	O
ostial	O
,	O
lmca	O
distal	B-T082
,	O
lad	O
ostial	O
and	O
lcx	O
ostial	O
,	O
and	O
degree	O
of	O
tapering	O
and	O
lmca	O
bifurcation	B-T082
angles	I-T082
ba	B-T082
in	O
the	O
form	O
of	O
lmca	O
-	O
lcx	O
ba	B-T082
,	O
lmca	O
-	O
lad	O
ba	B-T082
,	O
lad	O
-	O
lcx	O
ba	B-T082
at	O
end-diastole	B-T079
and	O
end-systole	B-T079
.	O
	
the	O
mean	O
age	O
was	O
55	O
11	O
with	O
55.7	O
males	O
.	O
	
rca	O
was	O
dominant	B-T169
in	O
173	O
86.1	O
patients	O
.	O
	
mean	O
lmca	O
length	B-T081
was	O
10.0	O
mm	O
.	O
	
the	O
mean	O
values	O
of	O
lmca	O
ostial	O
,	O
lmca	O
distal	B-T082
,	O
lad	O
ostial	O
and	O
lcx	O
ostial	O
areas	B-T082
were	O
18.2	O
mm²	O
,	O
13.2	O
,	O
9.0	O
mm²	O
and	O
7.6	O
mm²	O
,	O
respectively	O
.	O
	
lmca	O
ostial	O
-	O
distal	B-T082
area	B-T082
,	O
lmca	O
distal	B-T082
-	O
lad	O
ostial	O
area	B-T082
and	O
lmca	O
distal	B-T082
-	O
lcx	O
ostial	O
area	B-T081
ratios	I-T081
were	O
1.44	O
-	O
<1	O
in	O
47	O
23.4	O
,	O
53	O
26.4	O
,	O
47	O
23.4	O
patients	O
,	O
respectively	O
,	O
and	O
were	O
1.69	O
in	O
19	O
9.5	O
,	O
24	O
,	O
40	O
patients	O
respectively	O
.	O
	
systolic	O
motion	O
modifies	O
lmca	O
bas	B-T082
systolic	O
motion	O
begets	O
an	O
increment	O
of	O
lmca	O
-	O
lad	O
angle	O
in	O
72.6	O
of	O
patients	O
and	O
decrement	O
of	O
lad	O
-	O
lcx	O
angle	O
in	O
75.6	O
of	O
the	O
patients	O
.	O
	
patients	O
with	O
t-shaped	O
lad	O
-	O
lcx	O
ba	B-T082
was	O
shown	O
to	O
have	O
significantly	O
longer	O
lmca	O
,	O
larger	O
lad	O
ostial	O
area	B-T082
,	O
larger	O
lcx	O
ostial	O
area	B-T082
and	O
higher	O
diastolic-to-systolic	B-T081
range	I-T081
dsr	B-T081
of	O
lad	O
-	O
lcx	O
ba	B-T082
compared	O
to	O
patients	O
with	O
y-shaped	O
lad	O
-	O
lcx	O
ba	B-T082
.	O
	
lmca	O
with	O
t-shaped	B-T082
distal	I-T082
ba	B-T082
was	O
found	O
to	O
have	O
significantly	O
longer	O
lmca	O
,	O
larger	O
lad	O
ostial	O
area	B-T082
,	O
larger	O
lcx	O
ostial	O
area	B-T082
and	O
higher	O
dsr	B-T081
of	O
distal	B-T082
ba	B-T082
compared	O
to	O
patients	O
with	O
y-shaped	B-T082
distal	I-T082
ba	B-T082
.	O
	
these	O
findings	B-T033
may	O
provide	O
useful	O
information	O
for	O
lmca	O
bifurcation	B-T061
stenting	I-T061
or	O
designing	O
dedicated	O
stents	O
for	O
a	O
three	B-T081
perspective	B-T062
study	I-T062
of	O
the	O
sense	O
of	O
home	B-T082
of	O
nursing	B-T098
home	I-T098
residents	I-T098
the	O
views	O
of	O
residents	B-T098
,	O
care	O
professionals	O
and	O
relatives	O
the	O
sense	O
of	O
home	B-T082
of	O
nursing	B-T098
home	I-T098
residents	I-T098
is	O
a	O
multifactorial	B-T033
phenomenon	O
which	O
is	O
important	B-T080
for	O
the	O
quality	B-T080
of	O
living	B-T078
.	O
	
the	O
purpose	B-T169
of	O
this	O
study	B-T062
is	O
to	O
investigate	B-T169
the	O
factors	B-T169
influencing	O
the	O
sense	O
of	O
home	B-T082
of	O
older	B-T098
adults	I-T098
residing	B-T052
in	O
the	O
nursing	O
home	O
from	O
the	O
perspective	O
of	O
residents	B-T098
,	O
relatives	O
and	O
care	O
professionals	O
.	O
	
a	O
total	O
of	O
78	O
participants	B-T098
n	O
=	O
24	O
residents	B-T098
,	O
n	O
=	O
18	O
relatives	O
and	O
n	O
=	O
26	O
care	O
professionals	O
from	O
4	O
nursing	O
homes	O
in	O
the	O
netherlands	O
engaged	O
in	O
a	O
qualitative	B-T062
study	I-T062
,	O
in	O
which	O
photography	O
was	O
as	O
a	O
supportive	O
tool	O
for	O
subsequent	B-T079
interviews	B-T052
and	O
focus	O
groups	O
.	O
	
the	O
data	B-T078
were	O
analyzed	O
based	O
on	O
open	B-T080
ended	I-T080
coding	I-T080
,	O
axial	B-T080
coding	I-T080
and	O
selective	B-T080
coding	I-T080
.	O
	
the	O
sense	O
of	O
home	B-T082
of	O
nursing	B-T098
home	I-T098
residents	I-T098
is	O
influenced	O
by	O
a	O
number	O
of	O
jointly	O
identified	O
factors	B-T169
,	O
including	O
the	O
building	O
and	O
interior	O
design	O
eating	O
and	O
drinking	O
autonomy	B-T078
and	O
control	B-T169
involvement	B-T169
of	O
relatives	O
engagement	O
with	O
others	O
and	O
activities	B-T052
quality	O
of	O
care	O
are	O
shared	O
themes	O
.	O
	
residents	B-T098
and	O
relatives	O
stressed	O
the	O
importance	B-T080
of	O
having	O
a	O
connection	O
with	O
nature	B-T078
and	O
the	O
outdoors	O
,	O
as	O
well	O
as	O
coping	O
strategies	O
.	O
	
relatives	O
and	O
care	O
professionals	O
emphasized	O
the	O
role	O
the	O
organization	O
of	O
facilitation	O
of	O
care	B-T052
played	O
,	O
as	O
well	O
as	O
making	O
residents	B-T098
feel	O
like	O
they	O
still	O
matter	O
.	O
	
the	O
sense	O
of	O
home	B-T082
of	O
nursing	B-T098
home	I-T098
residents	I-T098
is	O
influenced	O
by	O
a	O
multitude	B-T081
of	O
factors	B-T169
related	O
to	O
the	O
psychology	B-T169
of	O
the	O
residents	B-T098
,	O
and	O
the	O
social	B-T078
and	I-T078
built	I-T078
environmental	I-T078
contexts	I-T078
.	O
	
a	O
holistic	B-T078
understanding	O
of	O
which	O
factors	B-T169
influence	O
the	O
sense	O
of	O
home	B-T082
of	O
residents	B-T098
can	O
lead	O
to	O
strategies	O
to	O
optimize	B-T052
this	O
sense	O
of	O
home	B-T082
.	O
	
this	O
study	B-T062
also	O
indicated	O
that	O
the	O
nursing	O
home	O
has	O
a	O
dual	O
nature	B-T078
as	O
a	O
place	O
of	O
residence	B-T082
and	O
a	O
place	B-T082
where	O
people	B-T098
are	O
supported	O
through	O
numerous	B-T081
integrating	O
one	O
health	O
in	O
national	B-T170
health	I-T170
policies	I-T170
of	O
developing	B-T080
countries	I-T080
india's	O
lost	O
opportunities	O
globally	B-T080
,	O
the	O
threat	B-T078
of	O
infectious	B-T047
diseases	I-T047
,	O
particularly	O
emerging	B-T047
infectious	I-T047
diseases	I-T047
,	O
originating	B-T079
at	O
the	O
human	O
-	O
animal	O
-	O
environment	B-T082
interface	B-T169
,	O
has	O
caught	O
health	O
systems	O
off	O
guard	O
.	O
	
with	O
forecasts	O
that	O
future	O
pathogen	O
emergence	B-T047
will	O
be	O
centred	O
in	O
hotspots	O
in	O
asia	O
,	O
africa	O
,	O
and	O
latin	O
america	O
,	O
the	O
need	O
to	O
prepare	O
policy	B-T170
frameworks	I-T170
that	O
can	O
combat	O
this	O
threat	B-T078
is	O
urgent	B-T079
.	O
	
emergence	B-T047
of	I-T047
diseases	I-T047
such	O
as	O
avian	B-T047
influenza	I-T047
and	O
ebola	B-T047
virus	I-T047
disease	I-T047
,	O
which	O
threatened	B-T078
social	B-T169
disruption	B-T169
,	O
have	O
established	B-T080
the	O
need	O
for	O
intersectoral	O
coordination/collaboration	O
.	O
	
these	O
events	O
led	O
to	O
the	O
initiation	B-T169
of	O
establishing	B-T080
institutionalised	B-T033
collaborative	O
frameworks	O
in	O
india	O
to	O
adopt	O
a	O
one	O
health	O
approach	O
to	O
disease	O
prevention	O
and	O
control	O
.	O
	
however	O
,	O
the	O
gains	B-T081
made	O
in	O
influenza	B-T047
control	O
could	O
not	O
be	O
adapted	O
to	O
other	O
infectious	B-T047
diseases	I-T047
.	O
	
intersectoral	O
coordination	O
was	O
briefly	O
carried	O
out	O
,	O
more	O
as	O
a	O
reactive	B-T080
response	O
to	O
threats	B-T078
.	O
	
the	O
systemic	B-T169
failure	B-T169
to	O
sustain	B-T169
such	O
efforts	O
have	O
therefore	O
,	O
only	O
undermined	O
a	O
coordinated	B-T169
response	B-T169
.	O
	
the	O
recent	O
draft	B-T170
national	B-T170
health	I-T170
policy	I-T170
,	O
2015	O
,	O
has	O
also	O
failed	B-T169
to	O
establish	B-T080
the	O
need	O
for	O
intersectoral	O
coordination	O
in	O
disease	O
control	O
approaches	O
.	O
	
neglecting	O
the	O
need	O
to	O
endorse	O
linkages	O
between	O
human	O
health	B-T078
,	O
animal	O
health	B-T078
and	O
husbandry	O
,	O
agriculture	O
,	O
and	O
environmental	B-T082
sectors	O
,	O
has	O
led	O
to	O
duplicative	B-T169
and	O
weak	B-T033
response	I-T033
systems	I-T033
.	O
	
the	O
absence	B-T169
of	O
health	O
impact	O
assessment	O
with	O
respect	O
to	O
the	O
development	B-T169
agenda	B-T170
in	O
policies	B-T170
,	O
has	O
cast	O
negative	B-T033
effects	B-T080
on	O
the	O
health	B-T078
and	O
wellbeing	B-T170
of	I-T170
man	I-T170
,	O
animal	O
,	O
and	O
the	O
environment	B-T082
.	O
	
lack	B-T033
of	I-T033
attention	I-T033
to	O
building	O
core	O
capacity	B-T081
in	O
these	O
critical	B-T080
sectors	O
has	O
further	O
raised	B-T080
challenges	O
in	O
designing	O
and	O
deploying	B-T052
mitigation	O
strategies	O
.	O
	
with	O
developing	B-T080
countries	I-T080
like	O
india	O
being	O
home	O
to	O
a	O
major	O
portion	B-T082
of	O
the	O
world's	B-T098
poorest	B-T080
livestock	O
farmers	O
,	O
the	O
absence	B-T169
of	O
a	O
policy	B-T170
discourse	O
that	O
endorses	O
the	O
one	O
health	O
approach	O
in	O
development	B-T169
and	O
health	O
policies	O
is	O
a	O
major	O
hurdle	O
in	O
eliminating	B-T052
poverty	O
and	O
poverty	O
-	O
related	B-T080
diseases	B-T047
.	O
	
the	O
adoption	B-T080
of	O
one	O
health	O
approaches	O
in	O
health	B-T078
and	O
related	O
sectoral	B-T082
policies	B-T170
is	O
a	O
critical	B-T080
policy	B-T170
requirement	O
for	O
india	O
and	O
other	O
developing	B-T080
countries	I-T080
.	O
	
the	O
goal	O
should	O
be	O
to	O
not	O
just	O
establish	B-T080
preparedness	B-T033
plans	O
,	O
but	O
also	O
to	O
encourage	B-T169
a	O
policy	O
environment	O
where	O
assessment	O
and	O
mitigation	O
of	O
downstream	B-T082
impacts	B-T080
of	O
different	O
agenda	B-T170
are	O
assessment	O
of	O
demographic	B-T078
and	O
pathoanatomic	B-T033
risk	I-T033
factors	I-T033
in	O
recurrent	B-T079
patellofemoral	O
instability	B-T033
the	O
warps/staid	O
classification	O
employs	O
clinical	B-T080
assessment	O
of	O
presenting	O
features	B-T080
and	O
anatomic	B-T080
characteristics	B-T080
to	O
identify	O
two	O
distinct	O
subsets	O
of	O
patients	O
within	O
the	O
patellofemoral	B-T033
instability	I-T033
population	O
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
further	O
define	O
the	O
specific	O
demographics	O
and	O
the	O
prevalence	B-T081
of	O
risky	B-T080
pathoanatomies	B-T080
in	O
patients	O
classified	O
as	O
either	O
warps	O
or	O
staid	O
presenting	O
with	O
recurrent	B-T079
patellofemoral	O
instability	B-T033
.	O
	
a	O
secondary	O
purpose	O
was	O
to	O
further	O
validate	O
the	O
warps/staid	O
classification	O
with	O
the	O
banff	B-T170
patella	I-T170
instability	I-T170
instrument	I-T170
bpii	B-T170
,	O
the	O
marx	B-T170
activity	I-T170
scale	I-T170
and	O
the	O
patellar	O
instability	B-T170
severity	I-T170
score	I-T170
iss	B-T170
.	O
	
a	O
convenience	O
sample	O
of	O
50	O
patients	O
with	O
recurrent	B-T079
patellofemoral	O
instability	B-T033
,	O
including	O
25	O
warps	O
and	O
25	O
staid	O
subtype	O
patients	O
,	O
were	O
assessed	B-T052
.	O
	
clinical	B-T170
data	I-T170
were	O
collected	O
including	O
assessment	O
of	O
demographic	B-T078
risk	B-T033
factors	I-T033
sex	O
,	O
bmi	O
,	O
bilaterality	B-T082
of	O
symptoms	O
,	O
affected	B-T082
limb	O
side	O
and	O
age	O
at	O
first	O
dislocation	O
and	O
pathoanatomic	B-T033
risk	I-T033
factors	I-T033
tt-tg	B-T081
distance	I-T081
,	O
patella	O
height	O
,	O
patellar	O
tilt	O
,	O
grade	O
of	O
trochlear	B-T047
dysplasia	I-T047
,	O
beighton	B-T033
score	I-T033
and	O
rotational	B-T033
abnormalities	I-T033
of	O
the	O
tibia	O
or	O
femur	O
.	O
	
patients	O
completed	O
the	O
bpii	B-T170
and	O
the	O
marx	B-T170
activity	I-T170
scale	I-T170
.	O
	
the	O
iss	B-T170
was	O
calculated	O
from	O
the	O
clinical	B-T170
assessment	I-T170
data	I-T170
.	O
	
patients	O
were	O
stratified	O
into	O
the	O
warps	O
or	O
staid	O
subtypes	O
for	O
comparative	B-T062
analysis	I-T062
.	O
	
an	O
independent	O
t	B-T170
test	I-T170
was	O
used	O
to	O
compare	O
demographics	O
,	O
the	O
pathoanatomic	B-T033
risk	I-T033
factors	I-T033
and	O
subjective	O
measures	O
between	O
the	O
groups	O
.	O
	
convergent	B-T080
validity	I-T080
was	O
tested	O
with	O
a	O
pearson	B-T081
r	I-T081
correlation	I-T081
coefficient	I-T081
between	O
the	O
warps/staid	B-T081
and	O
iss	B-T170
scores	I-T170
.	O
	
demographic	B-T078
risk	I-T078
factors	I-T078
statistically	O
associated	B-T080
with	I-T080
a	O
warps	O
subtype	O
included	O
female	O
sex	O
,	O
age	O
at	O
first	O
dislocation	O
and	O
bilaterality	B-T082
.	O
	
pathoanatomic	B-T033
risk	I-T033
factors	I-T033
statistically	O
associated	B-T080
with	I-T080
a	O
warps	O
subtype	O
included	O
trochlear	B-T047
dysplasia	I-T047
,	O
tt-tg	B-T081
distance	I-T081
,	O
generalized	O
ligamentous	O
laxity	O
,	O
patellar	O
tilt	O
and	O
rotational	B-T033
abnormalities	I-T033
.	O
	
the	O
independent	O
t	B-T170
test	I-T170
revealed	O
a	O
significant	O
difference	O
between	O
the	O
iss	B-T170
scores	O
warps	O
subtype	O
m	O
=	O
4.4	O
,	O
sd	O
=	O
1.1	O
and	O
staid	O
subtype	O
m	O
=	O
2.5	O
,	O
sd	O
=	O
1.5	O
t	O
=	O
5.2	O
,	O
p	O
<	O
0.001	O
.	O
	
the	O
relationship	B-T080
between	O
the	O
warps/staid	B-T081
and	O
the	O
iss	B-T170
scores	I-T170
,	O
measured	O
using	O
a	O
pearson	B-T081
r	I-T081
correlation	I-T081
coefficient	I-T081
,	O
demonstrated	O
a	O
strong	O
relationship	B-T080
r	O
=	O
-0	O
,	O
n	O
=	O
50	O
,	O
p	O
<	O
0.001	O
.	O
	
this	O
study	B-T062
has	O
demonstrated	O
statistically	B-T081
significant	I-T081
evidence	B-T078
that	O
certain	O
demographics	O
and	O
pathoanatomies	B-T080
are	O
more	O
prevalent	O
in	O
each	O
of	O
the	O
warps	O
and	O
staid	O
patellofemoral	O
instability	B-T033
subtypes	O
.	O
	
there	O
was	O
no	O
difference	O
in	O
quality-of-life	B-T078
or	O
activity	B-T033
level	I-T033
between	O
the	O
subtypes	O
.	O
	
the	O
warps/staid	B-T081
score	I-T081
demonstrated	O
convergent	B-T080
validity	I-T080
to	O
the	O
iss	B-T170
and	O
divergent	B-T081
validity	I-T081
to	O
the	O
bpii	B-T170
score	I-T170
and	O
the	O
marx	B-T170
activity	I-T170
scale	I-T170
.	O
	
this	O
study	B-T062
has	O
further	O
validated	O
both	O
the	O
warps/staid	O
classification	O
and	O
the	O
iss	B-T170
of	O
patients	O
that	O
present	O
with	O
recurrent	B-T079
patellofemoral	O
instability	B-T033
.	O
	
expression	O
of	O
caspase	B-T116
3	I-T116
in	O
ovarian	O
follicle	O
cells	O
of	O
the	O
lizard	O
podarcis	O
sicula	O
in	O
this	O
study	O
,	O
our	O
aim	O
was	O
to	O
determine	O
whether	O
caspase	B-T116
3	I-T116
plays	O
a	O
role	O
,	O
during	O
previtellogenesis	O
,	O
in	O
the	O
ovarian	O
follicular	O
epithelium	O
of	O
the	O
lizard	O
podarcis	O
sicula	O
.	O
	
we	O
investigated	O
the	O
presence	O
and	O
localization	B-T169
of	O
proform	O
and	O
active	O
caspase	B-T116
3	I-T116
by	O
enzyme	O
assay	O
,	O
western	O
blotting	O
and	O
immunocytochemistry	O
.	O
	
in	O
parallel	O
,	O
a	O
fragment	B-T080
of	O
caspase	O
3	O
was	O
cloned	O
for	O
the	O
first	O
time	O
in	O
this	O
species	O
,	O
sequenced	B-T169
and	O
used	O
for	O
in	O
situ	O
hybridization	O
to	O
localize	B-T082
messengers	O
and	O
analysed	O
by	O
a	O
phylogenetic	B-T062
survey	I-T062
to	O
shed	O
light	O
on	O
its	O
homology	B-T080
with	O
reptilian	O
caspases	B-T116
.	O
	
results	O
demonstrated	O
that	O
1	O
the	O
follicle	O
cells	O
expressed	O
a	O
caspase	B-T116
of	O
the	O
3/7	O
group	O
and	O
the	O
mrna	O
for	O
caspase	B-T116
3	I-T116
was	O
transcribed	O
in	O
the	O
stem	B-T079
phase	I-T079
and	O
was	O
completely	O
translated	O
during	O
cell	O
differentiation	O
2	O
the	O
proform	B-T116
protein	I-T116
was	O
stored	O
during	O
the	O
differentiated	B-T080
nurse	I-T080
stage	I-T080
and	O
activated	O
at	O
the	O
end	O
of	O
previtellogenesis	O
provoking	O
the	O
degeneration	O
of	O
cells	O
3	O
the	O
predicted	O
protein	O
sequence	O
,	O
although	O
partial	O
,	O
had	O
a	O
strong	O
similarity	O
with	O
the	O
known	O
reptilian	O
caspases	B-T116
3	I-T116
.	O
	
the	O
epithelial	O
cells	O
of	O
the	O
ovarian	O
follicle	O
,	O
therefore	O
,	O
do	O
not	O
employ	O
caspase	B-T116
3	I-T116
during	O
the	O
nurse	B-T080
stage	I-T080
but	O
,	O
instead	O
,	O
prepare	O
for	O
apoptosis	O
increased	B-T081
acute	B-T079
mortality	B-T081
with	O
chemoradiotherapy	B-T061
for	O
locally	O
advanced	O
head	O
and	O
neck	O
cancer	O
in	O
patients	O
70	O
years	B-T079
concurrent	B-T061
chemoradiotherapy	I-T061
crt	B-T061
is	O
the	O
standard	B-T061
of	I-T061
care	I-T061
for	O
many	O
sites	B-T082
of	O
locally	O
advanced	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinomas	O
lahnc	O
.	O
	
however	O
,	O
on	O
meta-analysis	B-T062
,	O
the	O
addition	O
of	O
chemotherapy	B-T061
did	O
not	O
improve	O
survival	B-T169
for	O
patients	O
>70	O
years	B-T079
.	O
	
we	O
hypothesized	O
that	O
elderly	B-T098
patients	O
treated	B-T169
with	O
crt	B-T061
would	O
have	O
increased	B-T081
toxicity	O
without	O
similar	O
improvements	O
in	O
survival	B-T169
.	O
	
a	O
single-institution	O
,	O
irb-approved	B-T170
retrospective	B-T062
study	I-T062
took	O
place	O
from	O
2005	O
to	O
2012	O
including	O
369	O
patients	O
treated	B-T169
with	O
crt	B-T061
for	O
lahnc	O
.	O
	
multivariate	B-T081
models	I-T081
for	O
death	B-T033
at	O
3	O
months	B-T079
and	O
death	B-T033
over	O
time	B-T079
were	O
developed	O
using	O
logistic	B-T062
regression	I-T062
and	O
cox	B-T062
modeling	I-T062
,	O
respectively	O
.	O
	
patients	O
70	O
years	B-T079
were	O
treated	B-T169
less	O
often	O
with	O
concurrent	B-T079
cisplatin	O
dosed	O
every	O
3	O
weeks	B-T079
25.5	O
vs	O
.	O
	
71.4	O
,	O
respectively	O
and	O
more	O
often	O
with	O
weekly	B-T079
carboplatin	B-T109
31.9	O
vs	O
.	O
	
3.4	O
than	O
patients	O
<70	O
years	B-T079
n=322	O
p<0	O
.	O
	
patients	O
70	O
years	B-T079
experienced	O
increased	B-T081
toxicity	O
during	O
treatment	B-T061
with	O
more	O
frequently	O
hospitalizations	O
36.2	O
vs	O
.	O
	
21.1	O
p=0	O
and	O
a	O
lower	O
rate	O
of	O
peg	B-T061
removal	I-T061
at	O
last	O
follow-up	O
or	O
death	B-T033
77.1	O
vs	O
.	O
	
92.9	O
p=0	O
.	O
	
a	O
higher	O
proportion	B-T081
of	O
patients	O
70	O
years	B-T079
died	O
within	O
3	O
months	B-T079
12.8	O
vs	O
.	O
	
2.8	O
p=0	O
following	O
crt	B-T061
.	O
	
patients	O
70	O
had	O
an	O
increased	B-T081
risk	B-T078
of	O
death	B-T033
at	O
3	O
months	B-T079
following	O
crt	B-T061
odds	B-T081
ratio	I-T081
5.19	O
,	O
95%	O
ci	B-T081
1.64	O
p=0	O
and	O
worse	O
survival	B-T169
over	O
time	B-T079
hazard	B-T081
ratio	I-T081
2.30	O
,	O
95%	O
ci	B-T081
1.34	O
p=0	O
.	O
	
patients	O
70	O
years	B-T079
were	O
more	O
often	O
treated	B-T169
with	O
less	O
toxic	B-T080
chemotherapy	B-T061
,	O
yet	O
experienced	O
higher	O
rates	B-T081
of	O
hospitalization	O
during	O
treatment	B-T061
and	O
increased	B-T081
rates	B-T081
of	O
acute	B-T079
mortality	B-T081
following	O
crt	B-T061
.	O
	
the	O
efficacy	B-T080
of	O
chemoradiotherapy	B-T061
for	O
elderly	B-T098
patients	O
should	O
be	O
evaluated	O
in	O
a	O
prospective	B-T080
setting	I-T080
.	O
	
food	B-T080
security	I-T080
and	O
the	O
nutritional	B-T033
status	I-T033
of	O
children	O
in	O
foster	O
care	O
new	O
horizons	O
in	O
the	O
protection	O
of	O
a	O
fragile	O
population	O
the	O
nutritional	B-T033
status	I-T033
of	O
foster	O
children	O
,	O
the	O
quality	B-T080
of	O
daily	O
menus	O
in	O
group	O
homes	O
and	O
the	O
food	B-T080
security	I-T080
inside	O
these	O
organizations	O
have	O
been	O
poorly	O
studied	O
and	O
this	O
study	B-T062
means	O
to	O
investigate	O
them	O
.	O
	
a	O
sample	O
of	O
125	O
children	O
,	O
ranging	O
in	O
age	O
from	O
0-17	O
years	O
,	O
among	O
seven	O
group	O
homes	O
group	O
a	O
was	O
compared	O
with	O
121	O
children	O
of	O
the	O
general	B-T098
population	I-T098
we	O
group	O
b	O
.	O
	
to	O
evaluate	O
nutritional	B-T033
status	I-T033
,	O
bmi	B-T033
percentiles	I-T033
were	O
used	O
.	O
	
mean	B-T081
percentiles	B-T081
of	O
both	O
groups	O
were	O
compared	O
through	O
statistical	B-T062
analysis	I-T062
.	O
	
both	O
nutritional	B-T033
and	O
caloric	B-T033
daily	I-T033
distributions	I-T033
in	O
each	O
organization	O
were	O
obtained	O
using	O
the	O
24-hour	O
recall	B-T170
method	I-T170
.	O
	
a	O
specific	O
questionnaire	B-T170
was	O
administered	O
to	O
evaluate	O
food	B-T080
security	I-T080
.	O
	
from	O
the	O
analysis	B-T062
of	O
mean	B-T081
bmi	O
-for-	O
age	O
or	O
height-for-length	O
percentiles	B-T081
,	O
did	O
not	O
observe	O
statistically	O
significant	O
differences	B-T033
between	O
group	O
a	O
and	O
group	O
b	O
.	O
	
the	O
average	B-T081
daily	B-T079
nutrient	B-T033
and	O
calorie	B-T033
distribution	I-T033
in	O
group	O
homes	O
proves	O
to	O
be	O
nearly	B-T033
optimal	I-T033
with	O
the	O
exception	O
of	O
a	O
slight	O
excess	B-T080
in	O
proteins	O
and	O
a	O
slight	O
deficiency	B-T169
in	O
pufas	B-T109
.	O
	
moreover	O
,	O
a	O
low	B-T033
intake	I-T033
of	O
iron	B-T033
and	O
calcium	O
was	O
revealed	O
.	O
	
all	O
organizations	O
obtained	O
a	O
""""	O
high	B-T080
food	I-T080
security	I-T080
""""	O
profile	O
.	O
	
nutritional	B-T033
conditions	I-T033
of	O
foster	O
children	O
are	O
no	O
worse	O
than	O
that	O
of	O
children	O
of	O
the	O
general	B-T098
population	I-T098
.	O
	
foster	O
care	O
provides	O
the	O
necessary	B-T080
conditions	I-T080
to	O
support	O
their	O
incontinence	B-T047
-associated	O
dermatitis	B-T047
reducing	B-T080
adverse	O
events	O
incontinence	B-T047
-associated	O
dermatitis	B-T047
iad	B-T047
is	O
a	O
common	O
problem	B-T033
in	O
patients	O
with	O
faecal	B-T047
and/or	O
urinary	O
incontinence	O
.	O
	
urine	O
alters	O
the	O
normal	O
skin	O
flora	B-T033
and	O
increases	O
permeability	O
of	O
the	O
stratum	O
corneum	O
and	O
faecal	O
enzymes	B-T116
on	O
the	O
skin	O
contribute	O
to	O
skin	O
damage	O
.	O
	
faecal	O
bacteria	O
can	O
then	O
penetrate	B-T169
the	O
skin	O
,	O
increasing	O
the	O
risk	B-T078
of	O
secondary	B-T047
infection	I-T047
.	O
	
however	O
,	O
iad	B-T047
can	O
be	O
prevented	B-T061
and	O
healed	B-T169
with	O
timely	O
and	O
appropriate	B-T080
skin	B-T061
cleansing	I-T061
and	O
skin	O
protection	O
.	O
	
this	O
includes	O
appropriate	B-T080
use	O
of	O
containment	O
devices	O
.	O
	
this	O
article	O
also	O
looks	O
at	O
hartmann	O
incontinence	O
pads	O
that	O
have	O
been	O
developed	O
to	O
absorb	O
the	O
fluids	O
that	O
cause	O
iad	B-T047
and	O
maintain	O
the	O
skin's	O
acidic	B-T081
ph	I-T081
.	O
	
the	O
acidic	B-T081
ph	I-T081
of	O
the	O
skin	O
contributes	O
to	O
its	O
barrier	O
function	O
and	O
defence	O
against	O
infection	O
.	O
	
therefore	O
,	O
maintaining	O
an	O
acidic	B-T081
ph	I-T081
will	O
help	O
protect	O
the	O
skin	O
from	O
feasibility	B-T062
of	O
a	O
transition	B-T052
intervention	B-T061
aimed	B-T078
at	O
adolescents	O
with	O
chronic	B-T047
illness	I-T047
international	B-T078
guidelines	B-T170
recommend	O
planned	O
and	O
structured	O
transition	B-T052
programmes	O
for	O
adolescents	O
with	O
chronic	B-T047
illness	I-T047
because	O
inadequate	B-T080
transition	B-T052
may	O
lead	O
to	O
poor	B-T033
disease	I-T033
control	I-T033
and	O
risk	B-T078
of	O
lacking	B-T080
outpatient	O
follow-up	O
.	O
	
to	O
investigate	B-T169
the	O
feasibility	B-T062
of	O
a	O
transition	B-T052
intervention	B-T061
aimed	B-T078
at	O
adolescents	O
with	O
chronic	B-T047
illness	I-T047
focusing	O
on	O
declines	O
,	O
drop-outs	B-T098
,	O
no-shows	B-T081
and	O
advantages	B-T078
and	O
disadvantages	B-T078
of	O
participating	B-T169
.	O
	
we	O
invited	O
236	O
adolescents	O
12-20	O
years	O
with	O
juvenile	B-T047
idiopathic	I-T047
arthritis	I-T047
jia	B-T047
to	O
participate	B-T169
in	O
a	O
randomised	B-T062
controlled	I-T062
trial	I-T062
rct	B-T062
transition	B-T052
intervention	B-T061
.	O
	
reasons	B-T078
for	O
decline	O
and	O
drop-outs	B-T098
were	O
calculated	B-T169
.	O
	
adolescents	O
'	O
experiences	O
of	O
advantages	B-T078
and	O
disadvantages	B-T078
of	O
participating	B-T169
and	O
reasons	B-T078
for	O
no-shows	B-T081
were	O
investigated	B-T169
through	O
focus	O
groups	O
and	O
telephone	B-T062
interviews	I-T062
,	O
which	O
were	O
analysed	B-T062
using	O
thematic	B-T062
analysis	B-T062
.	O
	
one	O
hundred	O
and	O
twenty	O
of	O
the	O
236	O
eligible	O
patients	O
declined	O
to	O
participate	O
in	O
the	O
intervention	B-T061
and	O
20%	O
dropped	B-T098
out	I-T098
during	O
the	O
intervention	B-T061
.	O
	
unspecified	B-T080
declines	O
and	O
practical	B-T033
issues	I-T033
were	O
the	O
most	O
common	B-T081
reason	B-T078
to	O
decline	O
,	O
and	O
'	O
do	O
not	O
wish	O
to	O
continue	O
'	O
was	O
the	O
most	O
common	B-T081
reason	B-T078
to	O
drop-out	B-T098
.	O
	
reasons	B-T078
for	O
no-shows	B-T081
were	O
forgetting	O
and	O
being	O
too	O
busy	O
.	O
	
advantages	B-T078
of	O
participating	B-T169
were	O
stated	O
as	O
'	O
participating	B-T169
without	B-T080
parents	O
'	O
,	O
'	O
trust	O
and	O
confidentiality	B-T078
'	O
,	O
'being	O
able	O
to	O
set	O
the	O
agenda	B-T170
'	O
and	O
'	O
responsiveness	B-T169
'	O
.	O
	
disadvantages	B-T078
were	O
'	O
unclear	B-T033
aim	B-T078
of	O
the	O
study	B-T062
'	O
,	O
'meeting	O
others	O
with	O
jia	B-T047
'	O
,	O
'too	O
few	O
conversations	O
'	O
and	O
'	O
transport	O
issues	B-T033
'	O
.	O
	
many	O
adolescents	O
had	O
difficulties	B-T033
understanding	O
the	O
aim	B-T078
of	O
the	O
intervention	B-T061
.	O
	
however	O
,	O
most	O
participants	O
appreciated	O
the	O
conversations	O
about	O
identity	O
as	O
well	O
as	O
the	O
trust	O
and	O
confidentiality	B-T078
in	O
the	O
communication	O
.	O
	
in	O
the	O
future	O
,	O
adolescents	O
should	O
be	O
offered	O
more	O
individually	O
organised	O
programmes	O
according	O
to	O
their	O
preferences	B-T078
and	O
needs	O
in	O
cooperation	O
with	O
parents	O
and	O
health	O
care	O
providers	O
.	O
	
high-throughput	O
analysis	O
of	O
the	O
igg	B-T116
n-glycome	I-T116
by	O
uplc	O
-	O
flr	O
as	O
biological	B-T080
and	O
clinical	B-T080
relevance	B-T080
of	O
glycosylation	O
is	O
becoming	O
more	O
apparent	B-T078
,	O
interest	O
in	O
large	B-T062
scale	I-T062
studies	I-T062
of	O
the	O
glycome	B-T109
is	O
growing	O
.	O
	
glycans	B-T109
attached	O
to	O
immunoglobulin	B-T116
g	I-T116
igg	B-T116
were	O
shown	O
to	O
be	O
essential	B-T080
for	O
its	O
function	O
and	O
igg	B-T116
glycosylation	O
was	O
shown	O
to	O
change	B-T169
with	O
various	O
processes	O
,	O
making	O
igg	B-T116
one	O
of	O
the	O
most	O
studied	O
glycoproteins	B-T116
.	O
	
many	O
approaches	B-T082
including	O
liquid	O
chromatography	O
,	O
capillary	O
gel	O
electrophoresis	O
,	O
and	O
mass	O
spectrometry	O
were	O
developed	O
to	O
study	B-T062
igg	B-T116
glycosylation	O
.	O
	
generation	B-T052
of	O
high-quality	B-T080
glycomics	O
data	B-T078
in	O
a	O
high-throughput	B-T170
fashion	O
requires	O
reproducible	B-T081
and	O
robust	B-T080
sample	O
preparation	O
and	O
accurate	B-T080
and	O
reliable	O
quantitative	O
analysis	O
.	O
	
this	O
chapter	B-T078
presents	O
a	O
protocol	B-T170
for	O
an	O
optimized	O
and	O
high-throughput	B-T170
igg	B-T116
n-glycan	I-T116
release	B-T169
,	O
fluorescent	O
labeling	O
and	O
cleanup	B-T169
,	O
and	O
analysis	B-T062
of	O
fluorescently	B-T080
labeled	I-T080
igg	B-T116
n-glycans	I-T116
by	O
hydrophilic	O
interaction	O
liquid	O
chromatography	O
hilic	O
on	O
an	O
ultra	O
performance	O
liquid	O
chromatography	O
uplc	O
system	O
with	O
fluorescence	O
flr	O
detection	B-T061
.	O
	
biomimetic	O
whitlockite	O
inorganic	O
nanoparticles	O
-mediated	O
in	B-T082
situ	I-T082
remodeling	O
and	O
rapid	O
bone	O
regeneration	O
bone	O
remodeling	O
process	O
relies	O
on	O
complex	B-T080
signaling	O
pathway	O
between	O
osteoblasts	O
and	O
osteoclasts	O
and	O
control	O
mechanisms	B-T169
to	O
achieve	O
homeostasis	O
of	O
their	O
growth	O
and	O
differentiation	O
.	O
	
despite	O
previous	O
achievements	O
in	O
understanding	O
complicated	O
signaling	O
pathways	O
between	O
cells	O
and	O
bone	O
extracellular	O
matrices	O
during	O
bone	O
remodeling	O
process	O
,	O
a	O
role	O
of	O
local	O
ionic	O
concentration	B-T081
remains	O
to	O
be	O
elucidated	B-T052
.	O
	
here	O
,	O
we	O
demonstrate	O
that	O
synthetic	B-T052
whitlockite	O
wh	O
ca18mg2	O
nanoparticles	O
can	O
recapitulate	B-T169
early-stage	O
of	O
bone	O
regeneration	O
through	O
stimulating	O
osteogenic	O
differentiation	O
,	O
prohibiting	B-T169
osteoclastic	O
activity	B-T052
,	O
and	O
transforming	O
into	O
mechanically	O
enhanced	O
hydroxyapatite	O
hap	O
neo	O
bone	O
tissues	O
by	O
continuous	O
supply	O
of	O
po4	O
and	O
mg	O
under	O
physiological	B-T169
conditions	B-T080
.	O
	
in	O
addition	O
,	O
based	O
on	O
their	O
structural	B-T062
analysis	I-T062
,	O
the	O
dynamic	O
phase	B-T079
transformation	O
from	O
wh	O
into	O
hap	O
contributed	O
as	O
a	O
key	O
factor	B-T169
for	O
rapid	O
bone	O
regeneration	O
with	O
denser	B-T080
hierarchical	B-T169
neo-bone	O
structure	B-T082
.	O
	
our	O
findings	B-T033
suggest	O
a	O
groundbreaking	O
concept	O
of	O
'	O
living	B-T078
bone	O
minerals	O
'	O
that	O
actively	B-T169
communicate	O
with	O
the	O
surrounding	O
system	O
to	O
induce	B-T169
self-healing	O
,	O
while	O
previous	O
notions	O
about	O
bone	O
minerals	O
have	O
been	O
limited	O
to	O
passive	B-T080
products	O
of	O
cellular	O
mineralization	O
.	O
	
is	O
the	O
inactivation	B-T169
of	O
dentin	O
proteases	B-T116
by	O
crosslinkers	O
reversible	B-T169
inactivation	B-T169
of	O
dentin	O
proteases	B-T116
by	O
crosslinkers	O
has	O
been	O
suggested	B-T078
as	O
a	O
way	O
to	O
prevent	B-T080
the	O
degradation	O
of	O
dentin	O
collagen	B-T116
in	O
the	O
hybrid	B-T116
layer	B-T082
.	O
	
however	O
,	O
it	O
is	O
not	B-T080
known	I-T080
if	O
the	O
inhibition	B-T052
is	O
reversible	B-T169
.	O
	
the	O
aim	B-T078
of	O
this	O
study	B-T062
was	O
to	O
evaluate	B-T052
the	O
inactivation	B-T169
effect	B-T080
of	O
various	O
crosslinkers	O
on	O
dentin	O
protease	B-T116
activity	O
over	O
a	O
period	B-T079
of	O
6	O
months	O
.	O
	
demineralized	O
dentin	O
beams	O
1	O
,	O
n=10/group	O
were	O
treated	B-T169
with	I-T169
1	O
1%	O
glutaraldehyde	B-T109
ga1	B-T109
,	O
2	O
5%	O
glutaraldehyde	B-T109
ga5	B-T109
,	O
3	O
1%	O
grape	B-T109
seed	I-T109
extract	I-T109
gs1	B-T109
,	O
4	O
5%	O
grape	B-T109
seed	I-T109
extract	I-T109
gs5	B-T109
,	O
5	O
10%	O
sumac	O
berry	O
extract	O
s	O
,	O
6	O
20μm	B-T109
curcumin	I-T109
cr20	B-T109
,	O
and	O
7	O
200μm	O
curcumin	B-T109
cr200	B-T109
for	O
5min	O
.	O
	
untreated	B-T033
beams	O
served	O
as	O
control	O
.	O
	
the	O
beams	O
were	O
incubated	O
up	O
to	O
6	O
months	O
and	O
incubation	O
media	O
were	O
used	O
to	O
analyze	B-T062
solubilized	B-T080
telopeptide	B-T116
ictp	B-T116
and	O
ctx	B-T116
fragments	B-T116
as	O
indicators	B-T169
of	O
mmp	B-T116
-	O
and	O
cathepsin	B-T116
k	I-T116
-mediated	O
degradation	O
after	O
1	O
,	O
3	O
and	O
6	O
months	O
of	O
incubation	O
.	O
	
the	O
relative	B-T080
mmp	B-T116
activity	O
of	O
dentin	O
beams	O
was	O
tested	O
using	O
a	O
generic	O
mmp	B-T116
assay	O
.	O
	
data	B-T078
were	O
analyzed	B-T062
using	O
repeated-measures	B-T062
anova	B-T081
,	O
α=0	O
.	O
	
all	O
treated	B-T169
groups	B-T078
showed	O
significant	B-T078
decrease	B-T081
in	O
ctx	B-T116
release	O
32.2	O
dentin	O
and	O
ictp	B-T116
1.8	O
dentin	O
fragments	B-T116
during	O
the	O
first	O
month	O
of	O
incubation	O
compared	B-T052
to	O
control	O
1159pg/mg	O
and	O
72.9ng	O
dentin	O
,	O
respectively	O
.	O
	
ga5	B-T109
,	O
gs5	B-T109
and	O
cr200	B-T109
maintained	B-T169
their	O
inhibitory	B-T052
effect	B-T080
during	O
6-month	O
incubation	O
.	O
	
the	O
results	O
were	O
confirmed	O
by	O
dry	O
mass	O
loss	O
and	O
relative	B-T080
mmp	B-T116
activity	O
following	O
6	O
months	O
.	O
	
the	O
results	B-T033
of	O
this	O
study	B-T062
indicate	O
that	O
the	O
long-term	O
effect	O
is	O
both	O
crosslinker	O
and	O
dose	B-T081
dependent	I-T081
.	O
	
inhibition	O
of	O
step61	B-T116
ameliorates	B-T080
deficits	B-T080
in	O
mouse	O
and	O
hipsc	O
-based	O
schizophrenia	O
models	O
the	O
brain	O
-	O
specific	B-T080
tyrosine	B-T116
phosphatase	I-T116
,	O
step	B-T116
striatal-enriched	B-T116
protein	I-T116
tyrosine	I-T116
phosphatase	I-T116
is	O
an	O
important	O
regulator	O
of	O
synaptic	O
function	O
.	O
	
step	B-T116
normally	O
opposes	O
synaptic	O
strengthening	B-T080
by	O
increasing	B-T081
n-methyl	B-T116
d-aspartate	I-T116
glutamate	I-T116
receptor	I-T116
nmdar	B-T116
internalization	O
through	O
dephosphorylation	O
of	O
glun2b	B-T116
and	O
inactivation	O
of	O
the	O
kinases	B-T116
extracellular	B-T116
signal-regulated	I-T116
kinase	I-T116
1	I-T116
/	O
2	B-T116
and	O
fyn	B-T116
.	O
	
here	O
we	O
show	O
that	O
step61	B-T116
is	O
elevated	B-T080
in	O
the	O
cortex	O
in	O
the	O
nrg1	O
knockout	O
mouse	O
model	O
of	O
schizophrenia	O
sz	O
.	O
	
genetic	B-T169
reduction	B-T061
or	O
pharmacological	B-T169
inhibition	B-T052
of	O
step	B-T116
prevents	B-T169
the	O
loss	O
of	O
nmdars	B-T116
from	O
synaptic	O
membranes	O
and	O
reverses	O
behavioral	O
deficits	O
in	O
nrg1	O
mice	O
.	O
	
step61	B-T116
protein	I-T116
is	O
also	O
increased	B-T081
in	O
cortical	O
lysates	O
from	O
the	O
central	O
nervous	O
system	O
-	O
specific	B-T080
erbb2	B-T116
/	O
4	B-T116
mouse	O
model	O
of	O
sz	O
,	O
as	O
well	O
as	O
in	O
human	O
induced	O
pluripotent	O
stem	O
cell	O
hipsc	O
forebrain	O
neurons	O
and	O
ngn2	O
-	O
induced	B-T169
excitatory	O
neurons	O
,	O
from	O
two	O
independent	B-T169
sz	O
patient	O
cohorts	B-T098
.	O
	
in	O
these	O
selected	B-T052
sz	O
models	O
,	O
increased	B-T081
step61	B-T116
protein	O
levels	O
likely	O
reflect	O
reduced	B-T080
ubiquitination	O
and	O
degradation	O
.	O
	
these	O
convergent	B-T080
findings	B-T033
from	O
mouse	O
and	O
hipsc	O
sz	O
models	O
provide	B-T052
evidence	B-T078
for	O
step61	B-T116
dysfunction	O
in	O
sz	O
incident	O
fracture	O
associated	B-T080
with	I-T080
increased	B-T081
risk	B-T078
of	O
mortality	B-T081
even	O
after	O
adjusting	O
for	O
frailty	B-T033
status	B-T080
in	O
elderly	B-T098
japanese	B-T098
men	B-T098
the	O
fujiwara-kyo	B-T081
osteoporosis	I-T081
risk	I-T081
in	I-T081
men	I-T081
formen	I-T081
cohort	I-T081
study	I-T081
frail	B-T033
elderly	B-T098
individuals	B-T098
have	O
elevated	B-T080
risks	B-T078
of	O
both	O
fracture	O
and	O
mortality	B-T081
.	O
	
we	O
found	O
that	O
incident	O
fractures	O
were	O
associated	B-T080
with	I-T080
an	O
increased	B-T081
risk	B-T078
of	O
death	B-T033
even	O
after	O
adjusting	O
for	O
pre-fracture	O
frailty	B-T033
status	B-T080
as	O
represented	O
by	O
physical	O
performance	O
tests	O
and	O
laboratory	O
tests	O
for	O
common	O
geriatric	B-T080
diseases	B-T047
in	O
community-dwelling	O
elderly	B-T098
japanese	B-T098
men	B-T098
.	O
	
while	O
fractures	O
reportedly	O
increase	B-T169
the	O
risk	B-T078
of	O
mortality	B-T081
,	O
frailty	B-T033
may	O
complicate	B-T169
this	O
association	B-T080
,	O
generating	O
a	O
false-positive	B-T033
result	I-T033
.	O
	
we	O
evaluated	O
this	O
association	B-T080
after	O
adjusting	O
for	O
pre-fracture	O
levels	B-T080
of	O
frailty	B-T033
.	O
	
we	O
examined	B-T033
1998	O
community-dwelling	O
ambulatory	B-T169
men	B-T098
aged	O
65	O
years	B-T079
at	O
baseline	B-T081
in	O
the	O
fujiwara-kyo	B-T081
osteoporosis	I-T081
risk	I-T081
in	I-T081
men	I-T081
study	I-T081
for	O
frailty	B-T033
status	B-T080
as	O
represented	O
by	O
activities	O
of	O
daily	O
living	O
adl	O
,	O
physical	O
performance	O
tests	O
grip	B-T081
strength	I-T081
,	O
one-foot	B-T033
standing	I-T033
balance	I-T033
with	I-T033
eyes	I-T033
open	I-T033
,	O
timed	O
10-m	O
walk	O
,	O
and	O
laboratory	O
sera	O
tests	O
.	O
	
participants	O
were	O
then	O
followed	O
for	O
5	O
years	O
for	O
incident	O
clinical	O
fractures	O
and	O
death	O
.	O
	
effects	O
of	O
incident	O
fracture	O
on	O
death	O
were	O
determined	O
by	O
cox	O
proportional	O
hazards	O
model	O
with	O
the	O
first	O
fracture	O
during	O
follow-up	O
as	O
a	O
time-dependent	O
predictor	O
and	O
with	O
frailty	O
status	O
indices	O
as	O
covariates	O
.	O
	
we	O
identified	O
111	O
fractures	O
in	O
99	O
men	O
and	O
138	O
deaths	O
during	O
the	O
follow-up	O
period	O
median	O
follow-up	O
,	O
4.5	O
years	O
.	O
	
participants	O
with	O
incident	O
fractures	O
did	O
not	O
have	O
significantly	O
worse	O
frailty	O
statuses	O
,	O
but	O
did	O
show	O
a	O
significantly	O
higher	O
cumulative	O
mortality	O
rate	O
than	O
those	O
without	O
fractures	O
p	O
=	O
0.0047	O
.	O
	
age-adjusted	O
hazard	O
ratio	O
hr	O
of	O
death	O
for	O
incident	O
fracture	O
was	O
3.57	O
95	O
%	O
confidence	O
interval	O
2.05	O
,	O
6.24	O
.	O
	
when	O
adjusted	O
for	O
physical	O
performance	O
,	O
this	O
decreased	O
to	O
2.77	O
1.51	O
,	O
5.06	O
,	O
but	O
remained	O
significant	O
.	O
	
the	O
hr	O
showed	O
no	O
significant	O
change	O
when	O
adjusted	O
for	O
laboratory	O
test	O
results	O
3.96	O
2.26	O
,	O
6.94	O
.	O
	
exclusion	O
of	O
deaths	O
within	O
the	O
first	O
24	O
months	O
of	O
follow-up	O
did	O
not	O
alter	O
these	O
results	O
.	O
	
incident	O
clinical	O
fracture	O
was	O
associated	O
with	O
an	O
elevated	O
risk	O
of	O
death	O
independently	O
of	O
pre-fracture	O
levels	O
of	O
frailty	O
in	O
community-dwelling	O
elderly	O
men	B-T098
total	B-T033
energy	I-T033
expenditure	I-T033
in	O
obese	B-T047
kuwaiti	O
primary	O
school	O
children	O
assessed	B-T052
by	O
the	O
doubly-labeled	B-T169
water	I-T169
technique	I-T169
the	O
aim	O
of	O
this	O
pilot	B-T062
study	I-T062
was	O
to	O
assess	B-T052
body	O
composition	O
and	O
total	B-T033
energy	I-T033
expenditure	I-T033
tee	B-T033
in	O
35	O
obese	B-T047
7-9	O
years	B-T079
old	O
kuwaiti	B-T098
children	O
18	O
girls	O
and	O
17	O
boys	O
.	O
	
total	B-T033
body	I-T033
water	I-T033
tbw	B-T033
and	O
tee	B-T033
were	O
assessed	B-T052
by	O
doubly-labeled	B-T169
water	I-T169
technique	I-T169
.	O
	
tbw	B-T033
was	O
derived	O
from	O
the	O
intercept	B-T081
of	O
the	O
elimination	B-T033
rate	I-T033
of	O
deuterium	O
and	O
tee	B-T033
from	O
the	O
difference	B-T081
in	O
elimination	B-T033
rates	I-T033
of	O
18	O
and	O
deuterium	O
.	O
	
tbw	B-T033
was	O
used	O
to	O
estimate	B-T081
fat-free	B-T033
mass	I-T033
ffm	B-T033
,	O
using	O
hydration	O
factors	B-T169
for	O
different	O
ages	O
and	O
gender	O
.	O
	
fat	O
mass	O
fm	O
was	O
calculated	B-T052
as	O
the	O
difference	B-T081
between	O
body	O
weight	O
and	O
ffm	B-T033
.	O
	
body	O
weight	O
was	O
not	O
statistically	B-T081
different	I-T081
but	O
tbw	B-T033
was	O
significantly	B-T080
higher	I-T080
p	O
=	O
0.018	O
in	O
boys	O
44.9	O
3.3	O
than	O
girls	O
42.4	O
3.0	O
,	O
while	O
girls	O
had	O
significantly	B-T080
higher	I-T080
estimated	B-T081
fm	O
45.2	O
3.9	O
weight	O
%	O
versus	O
41.6	O
4.3	O
p	O
=	O
0.014	O
.	O
	
tee	B-T033
was	O
significantly	B-T080
higher	I-T080
in	O
boys	O
2395	O
349	O
kcal/day	O
compared	O
with	O
girls	O
1978	O
169	O
kcal/day	O
p	O
=	O
0.001	O
.	O
	
estimated	B-T081
physical	B-T033
activity	I-T033
level	I-T033
pal	B-T033
was	O
significantly	B-T080
higher	I-T080
in	O
boys	O
1.61	O
0.167	O
versus	O
1.51	O
0.870	O
p	O
=	O
0.034	O
.	O
	
our	O
results	B-T169
provide	O
the	O
first	O
dataset	B-T170
of	O
tee	B-T033
in	O
7-9	O
years	B-T079
old	O
obese	B-T047
kuwaiti	B-T098
children	O
and	O
highlight	O
important	O
gender	O
differences	O
to	O
be	O
considered	O
during	O
the	O
development	O
of	O
school	O
based	O
interventions	O
targeted	O
to	O
combat	O
childhood	B-T047
obesity	I-T047
.	O
	
mesenchymal	O
stromal	O
cells	O
in	O
clinical	B-T080
kidney	B-T061
transplantation	I-T061
how	O
tolerant	B-T169
can	O
it	O
be	O
progress	B-T169
in	O
the	O
improvement	O
of	O
short-term	B-T079
and	O
long-term	B-T079
outcomes	B-T080
of	O
kidney	B-T061
transplantation	I-T061
seems	O
to	O
have	O
reached	O
a	O
plateau	B-T081
,	O
partially	O
due	O
to	O
consequences	B-T169
of	I-T169
very	O
efficient	B-T080
,	O
but	O
nonspecific	B-T078
immunosuppressive	O
drugs	O
.	O
	
in	O
recent	O
years	O
,	O
various	O
forms	O
of	O
cell	B-T061
therapy	I-T061
,	O
including	O
the	O
use	O
of	O
mesenchymal	O
stromal	O
cells	O
,	O
have	O
been	O
put	O
forward	O
as	O
an	O
alternative	O
strategy	B-T170
for	O
more	O
defined	O
therapy	B-T061
.	O
	
it	O
is	O
thought	O
that	O
these	O
therapies	B-T061
will	O
not	O
only	O
allow	O
controlled	B-T169
tapering	O
of	O
immunosuppressive	O
medication	O
,	O
but	O
might	O
bring	O
us	O
also	O
closer	O
to	O
the	O
ambition	O
of	O
generating	B-T052
donor	B-T098
-specific	O
immune	O
regulation	O
and	O
tolerance	O
.	O
	
different	O
forms	O
of	O
alloimmunity	O
,	O
including	O
direct	B-T080
,	O
indirect	B-T080
and	O
semi-direct	B-T080
alloantigen	O
presentation	O
have	O
to	O
be	O
controlled	O
before	O
donor	B-T098
-specific	O
immune	O
regulation	O
can	O
be	O
reached	O
.	O
	
several	O
mechanisms	B-T169
have	O
been	O
described	O
how	O
mesenchymal	O
stromal	O
cells	O
can	O
affect	O
alloimmunity	O
.	O
	
especially	O
,	O
the	O
interaction	O
with	O
professional	O
antigen	O
presenting	O
cells	O
,	O
like	O
dendritic	O
cells	O
,	O
is	O
of	O
critical	B-T080
importance	B-T080
.	O
	
this	O
review	O
will	O
discuss	O
the	O
current	B-T079
status	B-T080
of	O
ongoing	O
clinical	B-T062
trials	I-T062
with	O
mesenchymal	O
stromal	O
cells	O
in	O
kidney	B-T061
transplantation	I-T061
and	O
specifically	O
concentrate	O
on	O
the	O
possibilities	O
and	O
impossibilities	O
of	O
how	O
these	O
therapeutic	B-T061
strategies	I-T061
can	O
contribute	B-T052
to	O
control	B-T080
of	O
the	O
different	O
forms	O
of	O
alloreactivity	O
operation	O
in	O
organ	B-T061
transplantation	I-T061
.	O
	
facilitating	B-T169
factors	I-T169
and	O
barriers	B-T080
to	O
malaria	B-T047
research	B-T062
utilization	B-T169
for	O
policy	O
development	O
in	O
malawi	O
research	B-T062
on	O
various	O
determinants	B-T169
of	O
health	B-T078
is	O
key	O
in	O
providing	B-T052
evidence	B-T078
for	O
policy	O
development	O
,	O
thereby	O
leading	O
to	O
successful	B-T080
interventions	O
.	O
	
utilization	B-T169
of	O
research	B-T062
is	O
an	O
intricate	B-T080
process	O
requiring	O
an	O
understanding	O
of	O
contextual	O
factors	O
.	O
	
the	O
study	O
was	O
conducted	O
to	O
assess	O
enhancing	B-T052
factors	B-T169
and	O
barriers	B-T080
of	O
research	B-T062
utilization	B-T169
for	O
malaria	B-T047
policy	O
development	O
in	O
malawi	O
.	O
	
qualitative	B-T080
research	B-T062
approach	O
was	O
used	O
through	O
in-depth	O
interviews	B-T052
with	O
39	O
key	O
informants	B-T098
that	O
included	O
malaria	B-T047
researchers	O
,	O
policy	O
makers	O
,	O
programme	O
managers	O
,	O
and	O
key	B-T098
stakeholders	I-T098
.	O
	
purposive	B-T062
sampling	I-T062
and	O
snowballing	B-T062
techniques	I-T062
were	O
used	O
in	O
identifying	B-T080
key	O
informants	B-T098
.	O
	
interview	B-T052
transcripts	B-T170
were	O
entered	B-T080
in	O
qsr	O
nvivo	O
11	O
software	O
for	O
coding	O
and	O
analysis	B-T062
.	O
	
respondents	B-T098
identified	B-T080
global	B-T080
efforts	B-T052
as	O
key	O
in	O
advancing	O
knowledge	B-T062
translation	I-T062
,	O
while	O
local	B-T082
political	O
will	O
has	O
been	O
conducive	B-T080
for	O
research	B-T062
utilization	B-T169
.	O
	
other	O
factors	B-T169
were	O
availability	B-T169
of	I-T169
research	B-T062
,	O
availability	B-T169
of	I-T169
diverse	O
local	B-T082
researchers	O
and	O
stakeholders	B-T098
supporting	O
knowledge	B-T062
translation	I-T062
.	O
	
while	O
barriers	B-T080
included	O
lack	B-T080
of	O
platforms	O
for	O
researcher	O
-	O
public	O
engagement	B-T033
,	O
politics	O
,	O
researchers'	O
lack	B-T080
of	O
communication	O
skills	O
,	O
lack	B-T080
of	O
research	B-T062
collaborations	O
,	O
funder	B-T062
driven	I-T062
research	I-T062
,	O
unknown	B-T080
world	O
health	O
organization	O
policy	B-T170
position	O
,	O
and	O
the	O
lack	B-T080
of	O
a	O
malaria	B-T047
research	B-T062
repository	O
.	O
	
overall	O
,	O
the	O
study	O
identified	B-T080
facilitating	B-T169
factors	I-T169
to	O
malaria	B-T047
research	B-T062
utilization	B-T169
for	O
policy	O
development	O
in	O
malawi	O
.	O
	
these	O
factors	B-T169
need	O
to	O
be	O
systematically	B-T169
coordinated	B-T169
to	O
address	O
the	O
identified	B-T080
barriers	B-T080
and	O
improve	B-T033
on	O
malaria	B-T047
research	B-T062
utilization	B-T169
in	O
policy	O
development	O
.	O
	
malaria	B-T047
research	B-T062
can	O
be	O
key	O
in	O
the	O
implementation	B-T052
of	O
evidence-based	B-T078
interventions	O
to	O
reduce	B-T080
the	O
malaria	B-T047
burden	B-T078
and	O
assist	O
in	O
the	O
paradigm	B-T062
shift	I-T062
from	O
malaria	B-T047
control	B-T169
to	O
elimination	B-T052
in	O
altered	B-T169
interregional	O
correlations	B-T080
between	O
serotonin	B-T116
transporter	I-T116
availability	B-T169
and	O
cerebral	B-T109
glucose	I-T109
metabolism	O
in	O
schizophrenia	O
a	O
high-resolution	O
pet	O
study	O
using	O
11	O
and	O
18	O
the	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
patterns	O
of	O
interregional	O
correlations	O
of	O
serotonin	O
transporter	O
sert	O
availability	O
with	O
glucose	O
metabolism	O
using	O
7-tesla	O
magnetic	O
resonance	O
imaging	O
mri	O
and	O
high-resolution	O
positron	O
emission	O
tomography	O
pet	O
with	O
11	O
11	O
and	O
18	O
18	O
in	O
antipsychotic-free	O
patients	O
with	O
schizophrenia	O
in	O
order	O
to	O
shed	O
new	O
light	O
on	O
the	O
disrupted	O
functional	O
connectivity	O
in	O
schizophrenia	O
.	O
	
nineteen	O
patients	O
with	O
schizophrenia	O
and	O
18	O
healthy	O
controls	O
underwent	O
high-resolution	O
pet	O
and	O
mri	O
.	O
	
the	O
binding	O
potential	O
bpnd	O
of	O
11	B-T109
and	O
standardized	O
uptake	O
value	O
ratio	O
suvr	O
of	O
18	B-T109
were	O
obtained	O
.	O
	
in	O
sert	O
availability	O
,	O
the	O
region	O
of	O
interest	O
roi	O
analyses	O
showed	O
no	O
significant	O
group	O
differences	O
in	O
any	O
region	O
,	O
except	O
for	O
the	O
anterior	O
hippocampus	O
where	O
the	O
sert	O
availability	O
was	O
lower	O
in	O
patients	O
with	O
schizophrenia	O
than	O
in	O
controls	O
.	O
	
the	O
roi	O
-	O
and	O
voxel	O
-based	O
analyses	O
revealed	O
that	O
the	O
18	O
suvr	O
values	O
were	O
significantly	O
lower	O
in	O
patients	O
than	O
in	O
controls	O
in	O
the	O
right	O
superior	O
frontal	O
gyrus	O
and	O
medial	O
part	O
of	O
the	O
left	O
superior	O
frontal	O
gyrus	O
.	O
	
regarding	O
the	O
interregional	O
correlations	B-T080
of	O
11	O
bpnd	O
with	O
18	O
suvr	O
,	O
more	O
widespread	O
positive	O
correlations	O
across	O
the	O
brain	O
regions	O
were	O
observed	O
in	O
control	O
subjects	O
than	O
in	O
patients	O
with	O
schizophrenia	O
.	O
	
notably	O
,	O
the	O
patients	O
and	O
control	O
subjects	O
showed	O
statistically	O
significant	O
differences	O
in	O
correlations	O
between	O
the	O
sert	O
availability	O
in	O
the	O
parietal	O
and	O
temporal	O
cortices	O
and	O
the	O
glucose	O
metabolism	O
in	O
the	O
posterior	O
cingulate	O
cortex	O
.	O
	
these	O
results	O
suggest	O
abnormal	O
functional	O
connectivity	O
between	O
the	O
higher-order	O
cortical	O
regions	O
in	O
schizophrenia	O
and	O
a	O
possible	O
important	O
role	O
of	O
the	O
posterior	O
cingulate	O
gyrus	O
and	O
its	O
related	O
circuitry	O
in	O
the	O
pathophysiology	O
of	O
schizophrenia	O
urticarial	B-T047
exanthema	O
due	O
to	O
hepatitis	B-T047
b	I-T047
in	O
a	O
pregnant	B-T098
woman	I-T098
,	O
mimicking	O
a	O
polymorphic	B-T047
eruption	I-T047
of	O
pregnancy	O
hepatitis	B-T047
b	I-T047
virus	I-T047
hbv	I-T047
infection	I-T047
in	I-T047
pregnant	I-T047
women	I-T047
is	O
very	O
rare	O
in	O
western	O
countries	O
,	O
thus	O
,	O
cutaneous	B-T082
manifestation	B-T080
of	I-T080
hbv	B-T047
infection	I-T047
may	O
be	O
confused	O
with	O
a	O
dermatosis	B-T047
specific	O
of	O
pregnancy	O
.	O
	
we	O
report	O
a	O
39-year-old	O
woman	B-T098
who	O
presented	O
in	O
her	O
20th	O
week	O
of	O
pregnancy	O
with	O
a	O
pruritic	B-T047
rash	I-T047
,	O
which	O
consisted	O
of	O
generalized	O
erythematous	B-T033
plaques	I-T033
,	O
some	O
of	O
them	O
with	O
a	O
purple	B-T033
centre	I-T033
.	O
	
serology	O
testing	O
showed	O
acute	B-T047
hbv	I-T047
infection	I-T047
,	O
and	O
a	O
biopsy	O
revealed	O
a	O
superficial	B-T082
and	O
interstitial	B-T033
perivascular	I-T033
inflammatory	I-T033
infiltrate	I-T033
of	O
lymphocytes	O
and	O
eosinophils	O
.	O
	
a	O
diagnosis	B-T033
of	O
exanthema	O
due	O
to	O
acute	B-T047
hepatitis	I-T047
b	I-T047
infection	I-T047
was	O
established	O
.	O
	
the	O
patient	O
delivered	B-T033
a	O
clinically	B-T033
healthy	I-T033
boy	I-T033
,	O
who	O
was	O
given	O
the	O
first	B-T081
dose	I-T081
of	O
the	O
hbv	B-T061
vaccine	I-T061
and	O
intravenous	B-T116
specific	I-T116
immunoglobulin	I-T116
,	O
followed	O
by	O
the	O
second	B-T081
dose	I-T081
2	O
months	O
later	O
,	O
and	O
did	O
not	O
get	O
infected	B-T033
with	O
hbv	O
.	O
	
to	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
case	O
describing	O
hbv	B-T047
exanthema	O
in	O
a	O
pregnant	B-T098
woman	I-T098
,	O
which	O
led	O
to	O
early	O
action	O
for	O
the	O
newborn	O
,	O
avoiding	O
vertical	O
transmission	O
and	O
its	O
high	O
prevalence	O
of	O
cirrhosis	B-T047
and	O
hepatocellular	O
carcinoma	O
.	O
	
determination	O
of	O
the	O
mutant	B-T061
prevention	I-T061
concentration	I-T061
and	O
the	O
mutant	B-T081
selection	I-T081
window	I-T081
of	O
topical	O
antimicrobial	O
agents	O
against	O
propionibacterium	O
acnes	O
determination	O
of	O
the	O
mutant	B-T061
prevention	I-T061
concentration	I-T061
mpc	B-T061
and	O
the	O
mutant	B-T081
selection	I-T081
window	I-T081
msw	B-T081
of	O
antimicrobial	O
agents	O
used	O
to	O
treat	O
pathogenic	O
bacteria	O
is	O
important	O
in	O
order	O
to	O
apply	O
effective	O
antimicrobial	O
therapies	B-T061
.	O
	
here	O
,	O
we	O
determined	O
the	O
mpcs	B-T061
of	O
the	O
major	O
topical	O
antimicrobial	O
agents	O
against	O
propionibacterium	O
acnes	O
and	O
staphylococcus	O
aureus	O
which	O
cause	O
skin	B-T047
infections	I-T047
and	O
compared	O
their	O
msws	B-T081
.	O
	
among	O
the	O
mpcs	B-T061
of	O
nadifloxacin	B-T109
and	O
clindamycin	B-T109
,	O
the	O
clindamycin	B-T109
mpc	B-T061
was	O
determined	O
to	O
be	O
the	O
lowest	B-T080
against	O
p	O
.	O
	
acnes	O
.	O
	
in	O
contrast	O
,	O
the	O
nadifloxacin	B-T109
mpc	B-T061
was	O
the	O
lowest	B-T080
against	O
s	O
.	O
	
aureus	O
.	O
	
calculations	O
based	O
on	O
the	O
minimum	O
inhibitory	O
concentrations	O
and	O
mpcs	B-T061
showed	O
that	O
clindamycin	B-T109
has	O
the	O
lowest	B-T080
msw	B-T081
against	O
both	O
p	O
.	O
	
acnes	O
and	O
s	O
.	O
	
aureus	O
.	O
	
nadifloxacin	B-T109
msws	B-T081
were	O
4-fold	O
higher	B-T080
against	O
p	O
.	O
	
acnes	O
than	O
against	O
s	O
.	O
	
aureus	O
.	O
	
it	O
is	O
more	O
likely	O
for	O
p	O
.	O
	
acnes	O
to	O
acquire	O
resistance	O
to	O
fluoroquinolones	B-T109
than	O
s	O
.	O
	
aureus	O
.	O
	
therefore	O
,	O
topical	B-T061
application	I-T061
of	O
clindamycin	B-T109
contributes	O
very	O
little	O
to	O
the	O
emergence	O
of	O
resistant	O
p	O
.	O
	
acnes	O
and	O
s	O
.	O
	
aureus	O
total	O
colectomy	B-T061
for	O
colon	O
perforation	O
after	O
kayexalate	B-T109
administration	B-T061
a	O
case	O
report	O
and	O
literature	B-T170
review	I-T170
of	O
a	O
rare	B-T080
complication	O
kayexalate	B-T109
is	O
an	O
ion	O
exchange	O
resin	O
that	O
is	O
commonly	O
used	O
to	O
acutely	O
treat	B-T061
patients	O
with	O
hyperkalemia	B-T033
.	O
	
bowel	B-T047
ulceration	I-T047
and	O
necrosis	O
is	O
a	O
rare	B-T080
and	O
uncommonly	O
recognized	O
complication	O
of	O
kayexalate	B-T109
administration	B-T061
.	O
	
more	O
often	O
,	O
concomitant	B-T079
administration	B-T061
with	O
sorbitol	B-T109
is	O
reported	O
to	O
damage	B-T169
the	O
bowel	O
however	O
,	O
there	O
are	O
reports	O
of	O
kayexalate	B-T109
administration	B-T061
causing	O
bowel	B-T047
necrosis	I-T047
without	O
sorbitol	B-T109
.	O
	
we	O
present	O
a	O
case	O
of	O
a	O
critically	B-T047
ill	I-T047
patient	O
who	O
underwent	O
total	O
colectomy	B-T061
for	O
colonic	B-T047
necrosis	I-T047
secondary	O
to	O
oral	B-T082
kayexalate	B-T109
administration	B-T061
that	O
was	O
not	O
recognized	O
until	O
late	O
in	O
the	O
pathologic	O
process	O
.	O
	
we	O
also	O
review	B-T170
the	I-T170
literature	I-T170
to	O
further	O
investigate	O
this	O
total	B-T080
arsenic	O
,	O
cadmium	O
,	O
and	O
lead	O
determination	O
in	O
brazilian	O
rice	O
samples	O
using	O
icp-ms	O
this	O
study	B-T062
is	O
aimed	O
at	O
investigating	B-T169
a	O
suitable	O
method	B-T170
for	O
rice	O
sample	O
preparation	B-T052
as	O
well	O
as	O
validating	B-T062
and	O
applying	B-T169
the	O
method	B-T170
for	O
monitoring	B-T169
the	O
concentration	B-T081
of	O
total	B-T080
arsenic	O
,	O
cadmium	O
,	O
and	O
lead	O
in	O
rice	O
by	O
using	O
inductively	O
coupled	O
plasma	O
mass	O
spectrometry	O
icp-ms	O
.	O
	
various	O
rice	O
sample	O
preparation	B-T052
procedures	B-T169
were	O
evaluated	O
.	O
	
the	O
analytical	B-T170
method	I-T170
was	O
validated	B-T062
by	O
measuring	B-T169
several	O
parameters	B-T033
including	O
limit	B-T081
of	I-T081
detection	I-T081
lod	B-T081
,	O
limit	B-T081
of	I-T081
quantification	I-T081
loq	B-T081
,	O
linearity	B-T081
,	O
relative	B-T078
bias	I-T078
,	O
and	O
repeatability	B-T080
.	O
	
regarding	O
the	O
sample	O
preparation	B-T052
,	O
recoveries	B-T033
of	O
spiked	O
samples	O
were	O
within	O
the	O
acceptable	B-T081
range	I-T081
from	O
89.3	O
to	O
98.2	O
for	O
muffle	O
furnace	O
,	O
94.2	O
to	O
103.3	O
for	O
heating	O
block	O
,	O
81.0	O
to	O
115.0	O
for	O
hot	O
plate	O
,	O
and	O
92.8	O
to	O
108.2	O
for	O
microwave	O
.	O
	
validation	B-T062
parameters	B-T033
showed	O
that	O
the	O
method	B-T170
fits	O
for	O
its	O
purpose	O
,	O
being	O
the	O
total	B-T080
arsenic	O
,	O
cadmium	O
,	O
and	O
lead	O
within	O
the	O
brazilian	O
legislation	O
limits	O
.	O
	
the	O
method	B-T170
was	O
applied	O
for	O
analyzing	B-T062
37	O
rice	O
samples	O
including	O
polished	O
,	O
brown	O
,	O
and	O
parboiled	O
,	O
consumed	O
by	O
the	O
brazilian	B-T081
population	I-T081
.	O
	
the	O
total	B-T080
arsenic	O
,	O
cadmium	O
,	O
and	O
lead	O
contents	O
were	O
lower	O
than	O
the	O
established	O
legislative	B-T170
values	B-T080
,	O
except	O
for	O
total	B-T080
arsenic	O
in	O
one	O
brown	O
rice	O
sample	O
.	O
	
this	O
study	B-T062
indicated	O
the	O
need	O
to	O
establish	O
monitoring	B-T169
programs	B-T169
for	O
emphasizing	O
the	O
study	B-T062
on	O
this	O
type	B-T080
of	O
cereal	O
,	O
aiming	O
at	O
promoting	O
the	O
public	B-T170
health	I-T170
.	O
	
safety	O
precautions	O
and	O
operating	B-T170
procedures	I-T170
in	O
an	O
a	O
bsl-4	B-T170
laboratory	O
1	O
.	O
	
biosafety	B-T170
level	I-T170
4	I-T170
suit	O
laboratory	O
suite	B-T170
entry	I-T170
and	I-T170
exit	I-T170
procedures	I-T170
biosafety	B-T170
level	I-T170
4	I-T170
bsl-4	B-T170
suit	O
laboratories	O
are	O
specifically	O
designed	B-T052
to	O
study	B-T062
high-consequence	O
pathogens	O
for	O
which	O
neither	O
infection	O
prophylaxes	B-T061
nor	O
treatment	B-T061
options	O
exist	O
.	O
	
the	O
hallmarks	O
of	O
these	O
laboratories	O
are	O
custom-designed	B-T052
airtight	O
doors	O
,	O
dedicated	O
supply	B-T169
and	O
exhaust	O
airflow	O
systems	O
,	O
a	O
negative-pressure	O
environment	O
,	O
and	O
mandatory	O
use	O
of	O
positive-pressure	O
"""space"""	O
suits	O
.	O
	
the	O
risk	O
for	O
laboratory	O
specialists	O
working	O
with	O
highly	O
pathogenic	O
agents	O
is	O
minimized	O
through	O
rigorous	O
training	O
and	O
adherence	O
to	O
stringent	O
safety	B-T170
protocols	I-T170
and	O
standard	B-T170
operating	I-T170
procedures	I-T170
.	O
	
researchers	O
perform	O
the	O
majority	B-T080
of	O
their	O
work	O
in	O
bsl-2	B-T170
laboratories	O
and	O
switch	O
to	O
bsl-4	B-T170
suit	O
laboratories	O
when	O
work	O
with	O
a	O
high-consequence	O
pathogen	O
is	O
required	O
.	O
	
collaborators	O
and	O
scientists	O
considering	O
bsl-4	B-T170
projects	B-T062
should	O
be	O
aware	O
of	O
the	O
challenges	B-T033
associated	B-T080
with	I-T080
bsl-4	B-T170
research	B-T062
both	O
in	O
terms	O
of	O
experimental	B-T080
technical	B-T169
limitations	B-T169
in	O
bsl-4	B-T170
laboratory	O
space	B-T082
and	O
the	O
increased	B-T081
duration	B-T079
of	O
such	O
experiments	B-T062
.	O
	
tasks	O
such	O
as	O
entering	B-T169
and	O
exiting	B-T169
the	O
bsl-4	B-T170
suit	O
laboratories	O
are	O
considerably	O
more	O
complex	B-T080
and	O
time-consuming	B-T080
compared	B-T052
to	O
bsl-2	B-T170
and	O
bsl-3	B-T170
laboratories	O
.	O
	
the	O
focus	O
of	O
this	O
particular	O
article	B-T170
is	O
to	O
address	B-T170
basic	O
biosafety	O
concerns	B-T078
and	O
describe	O
the	O
entrance	B-T170
and	I-T170
exit	I-T170
procedures	I-T170
for	O
the	O
bsl-4	B-T170
laboratory	O
at	O
the	O
nih	O
/	O
niaid	O
integrated	O
research	O
facility	O
at	O
fort	O
detrick	O
.	O
	
such	O
procedures	B-T170
include	O
checking	O
external	O
systems	O
that	O
support	O
the	O
bsl-4	B-T170
laboratory	O
,	O
and	O
inspecting	O
and	O
donning	O
positive-pressure	O
suits	O
,	O
entering	O
the	O
laboratory	O
,	O
moving	O
through	O
air	O
pressure	O
-	O
resistant	B-T169
doors	O
,	O
and	O
connecting	O
to	O
air-supply	O
hoses	O
.	O
	
we	O
will	O
also	O
discuss	O
moving	O
within	O
and	O
exiting	B-T169
the	O
bsl-4	B-T170
suit	O
laboratories	O
,	O
including	O
using	O
the	O
chemical	O
shower	O
and	O
removing	B-T052
and	O
storing	B-T169
positive-pressure	O
suits	O
.	O
	
masters	O
athletes	O
exemplars	O
of	O
successful	O
aging	O
global	B-T098
population	I-T098
aging	O
has	O
raised	B-T033
academic	I-T033
interest	I-T033
in	O
successful	O
aging	O
to	O
a	O
public	O
policy	O
priority	O
.	O
	
currently	O
there	O
is	O
no	O
consensus	O
regarding	O
the	O
definition	O
of	O
successful	O
aging	O
.	O
	
however	O
,	O
a	O
synthesis	O
of	O
research	O
shows	O
successful	O
aging	O
can	O
be	O
defined	O
as	O
a	O
late-life	O
process	O
of	O
change	O
characterized	O
by	O
high	B-T033
physical	I-T033
,	O
psychological	O
,	O
cognitive	O
,	O
and	O
social	O
functioning	O
.	O
	
masters	O
athletes	O
systematically	B-T080
train	I-T080
for	O
,	O
and	O
compete	O
in	O
,	O
organized	O
forms	O
of	O
team	O
and	O
individual	O
sport	O
specifically	O
designed	O
for	O
older	B-T098
adults	I-T098
.	O
	
masters	O
athletes	O
are	O
often	O
proposed	O
as	O
exemplars	O
of	O
successful	O
aging	O
.	O
	
however	O
,	O
their	O
aging	B-T033
status	I-T033
has	O
never	O
been	O
examined	O
using	O
a	O
comprehensive	B-T080
multidimensional	B-T082
successful	O
aging	O
definition	O
.	O
	
here	O
,	O
we	O
examine	O
the	O
successful	B-T170
aging	I-T170
literature	I-T170
,	O
propose	O
a	O
successful	O
aging	O
definition	O
based	O
on	O
this	O
literature	B-T170
,	O
present	O
evidence	O
which	O
suggests	O
masters	O
athletes	O
could	O
be	O
considered	O
exemplars	O
of	O
successful	O
aging	O
according	O
to	O
the	O
proposed	O
definition	O
,	O
and	O
list	O
future	O
experimental	B-T062
research	I-T062
non-specific	O
transient	O
mutualism	O
between	O
the	O
plant	O
parasitic	O
nematode	O
,	O
bursaphelenchus	O
xylophilus	O
,	O
and	O
the	O
opportunistic	O
bacterium	O
serratia	O
quinivorans	O
bxf1	O
,	O
a	O
plant-growth	O
promoting	O
pine	O
endophyte	O
with	O
antagonistic	O
effects	B-T080
the	O
aim	O
of	O
this	O
study	B-T062
is	O
to	O
understand	O
the	O
biological	O
role	O
of	O
serratia	O
quinivorans	O
bxf1	O
,	O
a	O
bacterium	O
commonly	O
found	O
associated	O
with	O
bursaphelenchus	O
xylophilus	O
,	O
the	O
plant	O
parasitic	O
nematode	O
responsible	O
for	O
pine	O
wilt	B-T047
disease	I-T047
.	O
	
therefore	O
,	O
we	O
studied	O
strain	O
bxf1	O
effect	O
in	O
pine	O
wilt	B-T047
disease	I-T047
.	O
	
we	O
found	O
that	O
strain	O
bxf1	O
promoted	O
in	B-T080
vitro	I-T080
nematode	O
reproduction	O
.	O
	
moreover	O
,	O
the	O
presence	O
of	O
bacteria	O
led	O
to	O
the	O
absence	O
of	O
nematode	O
chitinase	O
gene	O
bxcht-1	O
expression	O
,	O
suggesting	O
an	O
effect	O
for	O
bacterial	O
chitinase	B-T116
in	O
nematode	O
reproduction	O
.	O
	
nevertheless	O
,	O
strain	O
bxf1	O
was	O
unable	O
to	O
colonize	B-T033
the	O
nematode	O
interior	O
,	O
bind	O
to	O
its	O
cuticle	O
with	O
high	O
affinity	O
or	O
protect	O
the	O
nematode	O
from	O
xenobiotic	O
stress	O
.	O
	
interestingly	O
,	O
strain	O
bxf1	O
was	O
able	O
to	O
promote	O
tomato	O
and	O
pine	O
plant-growth	O
,	O
as	O
well	O
as	O
to	O
colonize	B-T033
its	O
interior	O
,	O
thus	O
,	O
acting	O
like	O
a	O
plant-growth	O
promoting	O
endophyte	O
.	O
	
consequently	O
,	O
strain	O
bxf1	O
failed	O
to	O
induce	O
wilting	O
symptoms	O
when	O
inoculated	O
in	O
pine	O
shoot	O
artificial	B-T169
incisions	I-T169
.	O
	
this	O
bacterium	O
also	O
presented	O
strong	O
antagonistic	O
activities	B-T052
against	O
fungi	O
and	O
bacteria	O
isolated	O
from	O
pinus	O
pinaster	O
.	O
	
our	O
results	O
suggest	O
that	O
b	O
.	O
	
xylophilus	O
does	O
not	O
possess	O
a	O
strict	O
symbiotic	O
community	O
capable	O
of	O
inducing	O
pine	O
wilt	B-T047
disease	I-T047
symptoms	O
as	O
previously	O
hypothesized	O
.	O
	
we	O
show	O
that	O
bacteria	O
like	O
bxf1	O
,	O
which	O
possess	O
plant-growth	O
promoting	O
and	O
antagonistic	O
effects	B-T080
,	O
may	O
be	O
opportunistically	O
associated	O
with	O
b	O
.	O
	
xylophilus	O
,	O
possibly	O
acquired	O
from	O
the	O
bacterial	O
endophytic	O
community	O
of	O
the	O
host	O
pine	O
.	O
	
habitual	O
physical	O
activity	O
is	O
associated	B-T080
with	I-T080
improved	O
anthropometric	B-T081
and	O
androgenic	O
profile	O
in	O
pcos	B-T047
a	O
cross-sectional	B-T062
study	I-T062
to	O
examine	O
the	O
effect	B-T080
of	O
habitual	O
physical	O
activity	O
pa	O
on	O
the	O
metabolic	O
and	O
hormonal	O
profiles	O
of	O
women	B-T098
with	O
polycystic	B-T047
ovary	I-T047
syndrome	I-T047
.	O
	
anthropometric	B-T081
,	O
metabolic	O
and	O
hormonal	O
assessment	O
and	O
determination	O
of	O
habitual	O
pa	O
levels	O
with	O
a	O
digital	O
pedometer	O
were	O
evaluated	O
in	O
84	O
women	B-T098
with	O
pcos	B-T047
and	O
67	O
age-	O
and	O
body	O
mass	O
index	O
bmi	O
controls	O
.	O
	
pa	O
status	O
was	O
defined	O
according	O
to	O
number	B-T081
of	I-T081
steps	I-T081
7500	O
steps	O
,	O
active	O
,	O
or	O
<7500	O
steps	O
,	O
sedentary	B-T080
.	O
	
bmi	O
was	O
lower	O
in	O
active	O
women	B-T098
from	O
both	O
groups	O
.	O
	
active	O
pcos	B-T047
women	B-T098
presented	O
lower	O
waist	O
circumference	O
wc	O
and	O
lipid	B-T081
accumulation	I-T081
product	I-T081
lap	B-T081
values	O
versus	O
sedentary	B-T080
pcos	B-T047
women	B-T098
.	O
	
in	O
the	O
control	O
group	O
,	O
active	O
women	B-T098
also	O
had	O
lower	O
wc	O
,	O
lower	O
values	O
for	O
fasting	O
and	O
120-min	O
insulin	B-T116
,	O
and	O
lower	O
lap	B-T081
than	O
sedentary	O
controls	O
.	O
	
in	O
the	O
pcos	B-T047
group	O
,	O
androgen	O
levels	O
were	O
lower	O
in	O
active	O
versus	O
sedentary	B-T098
women	I-T098
p	O
=	O
0.001	O
.	O
	
in	O
the	O
control	O
group	O
,	O
free	O
androgen	O
index	O
fai	O
was	O
also	O
lower	O
in	O
active	O
versus	O
sedentary	B-T098
women	I-T098
p	O
=	O
0.018	O
.	O
	
homeostasis	O
model	O
assessment	O
of	O
insulin	O
resistance	O
and	O
2000	O
daily	O
step	O
increments	O
were	O
independent	O
predictors	B-T078
of	O
fai	O
.	O
	
each	O
2000	O
daily	O
step	O
increment	O
was	O
associated	B-T080
with	I-T080
a	O
decrease	O
of	O
1.07	O
in	O
fai	O
.	O
	
habitual	O
pa	O
was	O
associated	B-T080
with	I-T080
a	O
better	O
anthropometric	B-T081
and	O
androgenic	O
profile	O
in	O
geolocalization	O
of	O
influenza	B-T047
outbreak	O
within	O
an	O
acute	O
care	O
population	B-T098
a	O
layered-surveillance	B-T169
approach	B-T082
we	O
seek	O
to	O
use	O
a	O
novel	O
layered-surveillance	B-T169
approach	B-T082
to	O
localize	B-T082
influenza	B-T047
clusters	B-T081
within	O
an	O
acute	O
care	O
population	B-T098
.	O
	
the	O
first	O
layer	O
of	O
this	O
system	B-T169
is	O
a	O
syndromic	B-T047
surveillance	O
screen	O
to	O
guide	O
rapid	O
polymerase	O
chain	O
reaction	O
testing	O
.	O
	
the	O
second	B-T081
layer	O
is	O
geolocalization	O
and	O
cluster	B-T062
analysis	I-T062
of	O
these	O
patients	O
.	O
	
we	O
posit	O
that	O
any	O
identified	B-T080
clusters	B-T081
could	O
represent	O
at-risk	B-T098
populations	I-T098
who	O
could	O
serve	O
as	O
high-yield	B-T081
targets	B-T169
for	O
preventive	B-T061
medical	I-T061
interventions	I-T061
.	O
	
this	O
was	O
a	O
prospective	B-T062
observational	I-T062
surveillance	I-T062
study	I-T062
.	O
	
patients	O
were	O
screened	O
with	O
a	O
previously	O
derived	O
clinical	B-T170
decision	I-T170
guideline	I-T170
that	O
has	O
a	O
90%	O
sensitivity	B-T081
and	O
30%	O
specificity	B-T081
for	O
influenza	B-T047
.	O
	
patients	O
received	O
points	B-T081
for	O
the	O
following	O
signs	O
and	O
symptoms	O
within	O
the	O
past	B-T079
7	O
days	B-T079
cough	O
2	O
points	O
,	O
headache	O
1	O
point	O
,	O
subjective	O
fever	O
1	O
point	O
,	O
and	O
documented	O
fever	O
at	O
triage	B-T061
temperature	B-T081
>38	O
100.4	O
1	O
point	O
.	O
	
patients	O
scoring	B-T081
3	O
points	O
or	O
higher	O
were	O
indicated	B-T033
for	O
influenza	B-T047
testing	B-T169
.	O
	
patients	O
were	O
tested	B-T169
with	O
xpert	O
flu	O
cepheid	O
,	O
sunnyvale	O
,	O
ca	O
,	O
a	O
rapid	O
polymerase	O
chain	O
reaction	O
test	O
.	O
	
positive	B-T033
results	B-T169
were	O
mapped	B-T170
with	O
arcgis	B-T170
esri	O
,	O
redlands	O
,	O
ca	O
and	O
analyzed	B-T062
with	O
kernel	B-T062
density	I-T062
estimation	I-T062
to	O
create	O
heat	O
maps	O
.	O
	
there	O
were	O
1	O
patients	O
tested	B-T169
with	O
xpert	O
flu	O
with	O
retrievable	B-T080
addresses	B-T170
within	O
the	O
greater	O
phoenix	O
metro	O
area	O
.	O
	
one	O
hundred	O
sixty-seven	O
12%	O
of	O
them	O
tested	B-T169
positive	O
for	O
influenza	O
a	O
and	O
23	O
2%	O
tested	B-T169
positive	O
for	O
influenza	O
b	O
.	O
	
the	O
influenza	O
a	O
virus	O
exhibited	O
a	O
clear	B-T081
cluster	I-T081
pattern	B-T082
within	O
this	O
patient	O
population	B-T098
.	O
	
the	O
densest	B-T081
cluster	I-T081
was	O
located	B-T082
in	O
an	O
approximately	O
1-	O
square-mile	B-T081
region	O
southeast	B-T082
of	O
our	O
hospital	O
.	O
	
our	O
layered-surveillance	B-T169
approach	B-T082
was	O
effective	B-T080
in	O
localizing	B-T082
a	O
cluster	B-T081
of	O
influenza	B-T047
a	I-T047
outbreak	O
.	O
	
this	O
region	O
may	O
house	O
a	O
high-yield	B-T081
target	B-T169
population	B-T098
for	O
public	O
health	O
intervention	O
.	O
	
further	O
collaborative	O
efforts	O
will	O
be	O
made	O
between	O
our	O
hospital	O
and	O
the	O
maricopa	O
county	O
department	O
of	O
public	O
health	O
to	O
perform	B-T169
a	O
series	O
of	O
community	O
vaccination	B-T061
events	O
before	O
the	O
next	O
influenza	B-T047
season	B-T079
.	O
	
we	O
hope	O
these	O
efforts	O
will	O
ultimately	O
serve	O
to	O
reduce	B-T080
the	O
burden	B-T078
of	O
this	O
disease	B-T047
on	O
our	O
patient	O
population	B-T098
,	O
and	O
that	O
this	O
system	B-T169
will	O
serve	O
as	O
a	O
framework	O
for	O
future	B-T079
investigations	O
locating	O
at-risk	B-T098
populations	I-T098
.	O
	
heart	O
rate	O
variability	O
pre-deployment	B-T079
predictor	B-T078
of	O
post-deployment	B-T079
ptsd	O
symptoms	O
heart	O
rate	O
variability	O
is	O
a	O
physiological	O
measure	O
associated	O
with	O
autonomic	O
nervous	O
system	O
activity	B-T052
.	O
	
this	O
study	B-T062
hypothesized	O
that	O
lower	O
pre-deployment	B-T079
hrv	O
would	O
be	O
associated	O
with	O
higher	O
post-deployment	B-T079
post-traumatic	O
stress	O
disorder	O
ptsd	O
symptoms	O
.	O
	
three-hundred-forty-three	O
army	O
national	O
guard	O
soldiers	O
enrolled	O
in	O
the	O
warriors	B-T062
achieving	I-T062
resilience	I-T062
war	I-T062
study	I-T062
were	O
analyzed	O
.	O
	
the	O
primary	O
outcome	B-T169
was	O
ptsd	O
symptom	O
severity	B-T080
using	O
the	O
ptsd	O
checklist	B-T170
-	O
military	O
version	B-T170
pcl	B-T170
measured	O
at	O
baseline	B-T081
,	O
3-	O
and	O
12-	O
month	B-T079
post-deployment	B-T079
.	O
	
heart	O
rate	O
variability	O
predictor	B-T078
variables	B-T080
included	O
high	B-T081
frequency	I-T081
power	I-T081
hf	B-T081
and	O
standard	B-T081
deviation	I-T081
of	O
the	O
normal	O
cardiac	O
inter-beat	O
interval	B-T079
sdnn	B-T079
.	O
	
generalized	O
linear	B-T170
mixed	I-T170
models	I-T170
revealed	O
that	O
the	O
pre-deployment	B-T079
pcl	B-T170
*	O
ln	B-T081
interaction	I-T081
term	O
was	O
significant	O
p<0	O
.	O
	
pre-deployment	B-T079
sdnn	B-T079
was	O
not	O
a	O
significant	O
predictor	B-T078
of	O
post-deployment	B-T079
pcl	B-T170
.	O
	
covariates	B-T080
included	O
age	O
,	O
pre-deployment	B-T079
pcl	B-T170
,	O
race	B-T098
/	O
ethnicity	B-T098
,	O
marital	O
status	O
,	O
tobacco	O
use	O
,	O
childhood	O
abuse	O
,	O
pre-deployment	B-T079
traumatic	O
brain	O
injury	O
,	O
and	O
previous	O
combat	B-T082
zone	I-T082
deployment	B-T052
.	O
	
pre-deployment	B-T079
heart	O
rate	O
variability	O
predicts	O
post-deployment	B-T079
ptsd	O
symptoms	O
in	O
the	O
context	O
of	O
higher	O
pre-deployment	B-T079
pcl	B-T170
scores	B-T081
.	O
	
a	O
neuronal	O
pi	B-T109
-dependent	O
program	B-T169
of	O
oligodendrocyte	O
precursor	B-T078
recruitment	B-T052
and	O
myelination	O
the	O
molecular	O
trigger	O
of	O
cns	O
myelination	O
is	O
unknown	B-T080
.	O
	
by	O
targeting	B-T169
pten	B-T116
in	O
cerebellar	O
granule	O
cells	O
and	O
activating	B-T052
the	O
akt1	B-T116
-	O
mtor	B-T116
pathway	O
,	O
we	O
increased	B-T081
the	O
caliber	O
of	O
normally	B-T080
unmyelinated	O
axons	O
and	O
the	O
expression	O
of	O
numerous	B-T081
genes	O
encoding	B-T052
regulatory	B-T116
proteins	I-T116
.	O
	
this	O
led	O
to	O
the	O
expansion	O
of	O
genetically	O
wild-type	O
oligodendrocyte	O
progenitor	O
cells	O
,	O
oligodendrocyte	O
differentiation	O
and	O
de	B-T078
novo	I-T078
myelination	O
of	O
parallel	O
fibers	O
.	O
	
thus	O
,	O
a	O
neuronal	O
program	B-T169
dependent	O
on	O
the	O
phosphoinositide	B-T109
pi	B-T109
is	O
sufficient	O
to	O
trigger	O
all	O
steps	O
of	O
atypical	O
microglial	O
response	O
to	O
biodiesel	B-T109
exhaust	I-T109
in	O
healthy	B-T080
and	O
hypertensive	B-T047
rats	O
accumulating	O
evidence	B-T078
suggests	B-T078
a	O
deleterious	B-T169
role	O
for	O
urban	O
air	O
pollution	O
in	O
central	B-T047
nervous	I-T047
system	I-T047
cns	I-T047
diseases	I-T047
and	O
neurodevelopmental	O
disorders	O
.	O
	
microglia	O
,	O
the	O
resident	O
innate	O
immune	O
cells	O
and	O
sentinels	B-T109
in	O
the	O
brain	O
,	O
are	O
a	O
common	B-T081
source	B-T033
of	O
neuroinflammation	O
and	O
are	O
implicated	O
in	O
air	O
pollution	O
-	O
induced	B-T169
cns	B-T047
effects	I-T047
.	O
	
while	O
renewable	B-T169
energy	I-T169
,	O
such	O
as	O
soy-based	B-T109
biofuel	I-T109
,	O
is	O
of	O
increasing	B-T169
public	B-T098
interest	O
,	O
there	O
is	O
little	B-T081
information	B-T078
on	O
how	O
soy	B-T109
biofuel	I-T109
may	O
affect	B-T080
the	O
brain	O
,	O
especially	O
in	O
people	B-T098
with	O
preexisting	B-T033
disease	I-T033
conditions	I-T033
.	O
	
to	O
address	O
this	O
,	O
male	O
spontaneously	O
hypertensive	O
rats	O
shr	O
and	O
normotensive	B-T033
wistar	O
kyoto	O
wky	O
rats	O
were	O
exposed	B-T080
to	I-T080
100%	B-T109
soy-based	I-T109
biodiesel	I-T109
exhaust	I-T109
100sbde	B-T109
0	O
,	O
50	O
,	O
150	O
and	O
500μg/m	O
by	O
inhalation	O
,	O
4h/	O
day	B-T079
for	O
4	O
weeks	B-T079
5	O
days	B-T079
/	O
week	B-T079
.	O
	
ionized	B-T116
calcium-binding	I-T116
adapter	I-T116
molecule-1	I-T116
iba-1	B-T116
staining	O
of	O
microglia	O
in	O
the	O
substantia	O
nigra	O
revealed	B-T080
significant	B-T078
changes	B-T169
in	O
morphology	B-T080
with	O
100sbde	B-T109
exposure	B-T080
in	O
rats	O
from	O
both	B-T080
genotypes	O
,	O
where	O
shr	O
were	O
less	B-T081
sensitive	B-T169
.	O
	
aconitase	O
activity	O
was	O
inhibited	B-T080
in	O
the	O
frontal	O
cortex	O
and	O
cerebellum	O
of	O
wky	O
rats	O
exposed	B-T080
to	I-T080
100sbde	B-T109
.	O
	
no	B-T169
consistent	B-T080
changes	B-T169
occurred	B-T079
in	O
pro-inflammatory	B-T169
cytokine	B-T116
expression	O
,	O
nitrated	B-T116
protein	I-T116
,	O
or	O
arginase1	B-T116
expression	O
in	O
brain	O
regions	O
from	O
either	O
rat	O
strain	O
exposed	B-T080
to	I-T080
100sbde	B-T109
.	O
	
however	O
,	O
while	O
iba-1	B-T116
mrna	O
expression	O
was	O
not	B-T169
modified	B-T169
,	O
cx3cr1	B-T116
mrna	O
expression	O
was	O
lower	B-T080
in	O
the	O
striatum	O
of	O
100sbde	B-T109
exposed	O
rats	O
regardless	B-T080
of	O
genotype	O
,	O
suggesting	B-T078
a	O
downregulation	O
of	O
the	O
fractalkine	B-T116
receptor	I-T116
on	O
microglia	O
in	O
this	O
brain	O
region	O
.	O
	
together	O
,	O
these	O
data	B-T078
indicate	B-T078
that	O
while	O
microglia	O
are	O
detecting	B-T033
and	O
responding	O
to	O
100sbde	B-T109
exposure	B-T080
with	O
changes	B-T169
in	O
morphology	B-T080
,	O
there	O
is	O
reduced	B-T080
expression	O
of	O
cx3cr1	B-T116
regardless	B-T080
of	O
genetic	O
background	O
and	O
the	O
activation	O
response	O
is	O
atypical	B-T080
without	O
traditional	B-T169
inflammatory	O
markers	O
of	O
m1	O
or	O
m2	O
activation	O
in	O
the	O
pre-activation	B-T033
negativity	I-T033
pran	B-T033
in	O
brain	O
potentials	B-T080
to	O
unfolding	O
words	O
we	O
describe	O
an	O
event-related	O
potential	O
erp	O
effect	B-T080
termed	O
the	O
""""	O
pre-activation	B-T033
negativity	I-T033
""""	O
pran	B-T033
,	O
which	O
is	O
proposed	O
to	O
index	B-T170
the	O
degree	B-T081
of	I-T081
pre-activation	I-T081
of	O
upcoming	O
word	B-T078
-	O
internal	B-T082
morphemes	B-T170
in	O
speech	O
processing	B-T052
.	O
	
using	O
lexical	O
competition	O
measures	B-T081
based	O
on	O
word-initial	O
speech	O
fragments	O
wifs	O
,	O
as	O
well	O
as	O
statistical	B-T062
analyses	I-T062
of	O
erp	O
data	B-T078
from	O
three	O
experiments	B-T062
,	O
it	O
is	O
shown	O
that	O
the	O
pran	B-T033
is	O
sensitive	O
to	O
lexical	O
competition	O
and	O
that	O
it	O
reflects	O
the	O
degree	B-T081
of	O
predictive	B-T080
certainty	B-T080
the	O
negativity	B-T033
is	O
larger	B-T081
when	O
there	O
are	O
fewer	B-T081
upcoming	O
lexical	B-T078
competitors	B-T098
.	O
	
angiotensin-converting	B-T033
enzyme	I-T033
insertion/deletion	I-T033
polymorphism	I-T033
association	B-T080
with	I-T080
obesity	B-T047
and	O
some	O
related	O
disorders	B-T047
in	O
egyptian	B-T098
females	O
a	O
case-control	B-T062
observational	I-T062
study	I-T062
according	O
to	O
the	O
who	O
report	B-T170
in	O
2015	O
,	O
obesity	B-T047
is	O
the	O
fifth	O
leading	O
cause	B-T033
of	I-T033
death	I-T033
worldwide	B-T079
,	O
and	O
the	O
prevalence	B-T081
of	O
egyptian	B-T098
female	B-T098
obesity	B-T047
is	O
37.5	O
%	O
.	O
	
since	O
obesity	B-T047
is	O
highly	O
influenced	O
by	O
genetics	B-T169
,	O
and	O
adipose	O
tissue	O
renin-angiotensin	O
system	O
is	O
over-activated	B-T169
in	O
obesity	B-T047
,	O
the	O
effect	B-T080
of	I-T080
angiotensin-converting	B-T033
enzyme	I-T033
ace	I-T033
insertion/deletion	I-T033
i/d	I-T033
polymorphism	I-T033
on	O
obesity	B-T047
and	O
related	O
disorders	B-T047
was	O
studied	O
in	O
several	O
populations	B-T098
,	O
because	O
of	O
its	O
effect	B-T080
on	O
ace	O
activity	O
.	O
	
our	O
objective	B-T170
was	O
to	O
study	B-T062
the	O
association	B-T080
of	O
ace	B-T033
i/d	I-T033
polymorphism	I-T033
with	O
obesity	B-T047
and	O
certain	O
related	O
disorders	B-T047
,	O
namely	O
hypertension	B-T047
,	O
insulin	O
resistance	O
and	O
metabolic	B-T047
syndrome	I-T047
,	O
in	O
egyptian	B-T098
females	O
.	O
	
eighty	B-T081
female	B-T098
volunteers	B-T098
were	O
recruited	O
,	O
blood	O
pressure	O
and	O
body	O
measurements	O
were	O
recorded	B-T169
and	O
a	O
fasting	B-T033
blood	O
sample	O
was	O
obtained	O
for	O
the	O
quantitation	B-T081
of	O
glucose	B-T109
,	O
lipid	O
profile	O
,	O
insulin	B-T116
,	O
leptin	B-T116
and	O
identification	B-T080
of	O
ace	B-T033
i/d	I-T033
polymorphs	I-T033
.	O
	
subjects	B-T098
were	O
grouped	O
based	O
on	O
hypertension	B-T047
and	O
obesity	B-T033
states	I-T033
.	O
	
comparisons	B-T052
of	O
continuous	B-T078
parameters	B-T033
were	O
made	O
with	O
independent	B-T078
sample	B-T170
t-test	I-T170
between	O
two	O
groups	B-T078
.	O
	
the	O
frequencies	B-T081
of	O
ace	B-T116
genotypes	O
and	O
alleles	O
,	O
and	O
the	O
association	B-T080
between	O
gene	O
polymorphism	O
and	O
metabolic	B-T169
parameters	B-T033
were	O
assessed	B-T052
using	O
chi-square	B-T170
or	O
fisher's	B-T170
exact	I-T170
test	I-T170
.	O
	
genotype	O
frequencies	B-T081
were	O
in	O
hardy-weinberg	B-T081
equilibrium	I-T081
for	O
all	O
groups	B-T078
.	O
	
genotype	O
distribution	B-T169
did	O
not	O
differ	O
significantly	O
between	O
controls	O
and	O
cases	O
of	O
all	O
the	O
studied	O
disorders	B-T047
.	O
	
although	O
dd	B-T033
carriers	I-T033
had	O
apparently	O
higher	B-T080
parameters	B-T033
of	O
blood	O
pressure	O
,	O
lipid	O
profile	O
and	O
insulin	O
resistance	O
,	O
only	O
diastolic	O
blood	O
pressure	O
was	O
almost	O
significant	B-T078
p	O
=	O
0.057	O
.	O
	
i-carriers	B-T033
were	O
significantly	O
less	O
susceptible	B-T169
to	O
hypertension	B-T047
than	O
dd	B-T033
carriers	I-T033
having	O
normal	B-T080
waist/hip	O
ratio	O
p	O
=	O
0.007	O
,	O
or	B-T081
=	O
17.29	O
,	O
ci	B-T081
=	O
1.81	O
and	O
normal	B-T080
conicity	O
index	O
p	O
=	O
0.024	O
,	O
or	B-T081
=	O
7.00	O
,	O
ci	B-T081
=	O
1.36	O
.	O
	
in	O
dd	B-T033
genotype	I-T033
carriers	I-T033
,	O
a	O
significant	B-T078
association	B-T080
was	O
found	O
between	O
insulin	O
resistance	O
and	O
high	B-T033
body	I-T033
mass	I-T033
index	I-T033
p	O
=	O
0.004	O
,	O
or	B-T081
=	O
8.89	O
,	O
ci	B-T081
=	O
1.94	O
,	O
waist	O
circumference	O
p	O
=	O
0.003	O
,	O
or	B-T081
=	O
9.63	O
,	O
ci	B-T081
=	O
2.14	O
and	O
waist/height	B-T033
ratio	I-T033
p	O
=	O
0.034	O
,	O
or	B-T081
=	O
6.86	O
,	O
ci	B-T081
=	O
1.25	O
,	O
although	O
the	O
variations	O
in	O
percentages	B-T081
between	O
dd	B-T033
and	O
i-carriers	B-T033
were	O
not	O
high	O
enough	O
to	O
conclude	O
an	O
effect	B-T080
of	I-T080
ace	B-T033
i/d	I-T033
on	O
such	O
an	O
association	B-T080
.	O
	
in	O
this	O
sample	O
of	O
egyptian	B-T098
females	O
,	O
ace	B-T033
i/d	I-T033
polymorphism	I-T033
was	O
not	B-T033
significantly	I-T033
associated	B-T080
with	I-T080
obesity	B-T047
nor	O
with	O
any	O
of	O
its	O
related	O
disorders	B-T047
studied	O
.	O
	
the	O
i	O
allele	O
seemed	O
protective	O
against	O
hypertension	B-T047
in	O
subjects	B-T098
with	O
normal	B-T080
,	O
not	O
high	O
,	O
waist/hip	O
ratio	O
and	O
conicity	O
index	O
compared	O
to	O
dd	B-T033
genotype	I-T033
carriers	I-T033
.	O
	
expressed	O
microrna	O
associated	B-T080
with	I-T080
high	B-T080
rate	B-T081
of	O
egg	O
production	O
in	O
chicken	O
ovarian	O
follicles	O
microrna	O
mirna	O
is	O
a	O
highly	O
conserved	O
class	O
of	O
small	O
noncoding	O
rna	O
about	O
19-24	O
nucleotides	O
in	O
length	B-T081
that	O
function	B-T169
in	O
a	O
specific	O
manner	O
to	O
post-transcriptionally	O
regulate	O
gene	O
expression	O
in	O
organisms	O
.	O
	
tissue	O
mirna	O
expression	O
studies	B-T062
have	O
discovered	O
a	O
myriad	O
of	O
functions	B-T169
for	O
mirnas	O
in	O
various	O
aspects	O
,	O
but	O
a	O
role	O
for	O
mirnas	O
in	O
chicken	O
ovarian	O
tissue	O
at	O
300	O
days	B-T079
of	O
age	O
has	O
not	O
hitherto	O
been	O
reported	O
.	O
	
in	O
this	O
study	O
,	O
we	O
performed	O
the	O
first	O
mirna	O
analysis	B-T062
of	O
ovarian	O
tissues	O
in	O
chickens	O
with	O
low	B-T080
and	O
high	B-T080
rates	B-T081
of	O
egg	O
production	O
using	O
high-throughput	O
sequencing	O
.	O
	
by	O
comparing	O
low	B-T080
rate	B-T081
of	O
egg	O
production	O
chickens	O
with	O
high	B-T080
rate	B-T081
of	O
egg	O
production	O
chickens	O
,	O
17	O
significantly	O
differentially	O
expressed	O
mirnas	O
were	O
found	O
p	O
<	O
0.05	O
,	O
including	O
11	O
known	O
and	O
six	O
novel	O
mirnas	O
.	O
	
we	O
found	O
that	O
all	O
11	O
known	O
mirnas	O
were	O
involved	O
mainly	O
in	O
pathways	O
of	O
reproduction	O
regulation	O
,	O
such	O
as	O
steroid	O
hormone	O
biosynthesis	O
and	O
dopaminergic	O
synapse	O
.	O
	
additionally	O
,	O
expression	O
profiling	O
of	O
six	O
randomly	O
selected	O
differentially	O
regulated	O
mirnas	O
were	O
validated	O
by	O
quantitative	O
real-time	O
polymerase	O
chain	O
reaction	O
rt-qpcr	O
.	O
	
some	O
mirnas	O
,	O
such	O
as	O
gga-mir-34b	O
,	O
gga-mir-34c	O
and	O
gga-mir-216b	O
,	O
were	O
reported	O
to	O
regulate	O
processes	O
such	O
as	O
proliferation	O
,	O
cell	O
cycle	O
,	O
apoptosis	O
and	O
metastasis	O
and	O
were	O
expressed	O
differentially	O
in	O
ovaries	O
of	O
chickens	O
with	O
high	B-T080
rates	B-T081
of	O
egg	O
production	O
,	O
suggesting	O
that	O
these	O
mirnas	O
have	O
an	O
important	O
role	O
in	O
ovary	O
development	O
and	O
reproductive	O
management	O
of	O
chicken	O
.	O
	
furthermore	O
,	O
we	O
uncovered	O
that	O
a	O
significantly	O
up-regulated	O
mirna	O
-	O
gga-mir-200a-3p	O
-is	O
ubiquitous	O
in	O
reproduction	O
-	O
regulation	O
-related	O
pathways	O
.	O
	
this	O
mirna	O
may	O
play	O
a	O
special	O
central	O
role	O
in	O
the	O
reproductive	O
management	O
of	O
chicken	O
,	O
air	O
pollution	O
,	O
neighbourhood	B-T082
and	O
maternal	B-T033
-	O
level	B-T080
factors	B-T169
modify	B-T169
the	O
effect	B-T080
of	O
smoking	O
on	O
birth	O
weight	O
a	O
multilevel	B-T062
analysis	I-T062
in	O
british	O
columbia	O
,	O
canada	O
maternal	B-T033
smoking	O
during	O
pregnancy	O
negatively	B-T033
impacts	B-T080
fetal	O
growth	O
,	O
but	O
the	O
effect	B-T080
is	O
not	O
homogenous	B-T082
across	O
the	O
population	B-T081
.	O
	
we	O
sought	O
to	O
determine	O
how	O
the	O
relationship	B-T080
between	O
cigarette	O
use	O
and	O
fetal	O
growth	O
is	O
modified	B-T033
by	O
the	O
social	B-T078
and	O
physical	B-T082
environment	I-T082
.	O
	
birth	O
records	O
with	O
covariates	O
were	O
obtained	O
from	O
the	O
bc	B-T170
perinatal	I-T170
database	I-T170
registry	I-T170
n	O
=	O
232	O
.	O
	
maternal	B-T033
smoking	O
status	O
was	O
self-reported	B-T062
as	O
the	O
number	B-T081
of	O
cigarettes	O
smoked	O
per	B-T079
day	I-T079
usually	O
at	O
the	O
first	B-T061
prenatal	I-T061
care	I-T061
visit	I-T061
.	O
	
census	B-T081
dissemination	B-T082
areas	O
das	O
were	O
used	O
as	O
neighbourhood	B-T082
-	O
level	B-T080
units	B-T081
and	O
linked	O
to	O
individual	B-T098
births	O
using	O
residential	B-T078
postal	I-T078
codes	I-T078
to	O
assign	B-T169
exposure	B-T080
to	I-T080
particulate	O
air	O
pollution	O
pm2.5	O
and	O
neighbourhood	B-T082
-	O
level	B-T080
attributes	B-T078
such	O
as	O
socioeconomic	B-T080
status	I-T080
ses	B-T080
,	O
proportion	B-T081
of	O
post-secondary	B-T170
education	I-T170
,	O
immigrant	B-T098
density	B-T081
and	O
living	O
in	O
a	O
rural	B-T082
place	I-T082
.	O
	
random	B-T080
coefficient	B-T081
models	B-T170
were	O
used	O
with	O
cigarettes	O
/day	B-T079
modeled	B-T170
with	O
a	O
random	B-T080
slope	B-T081
to	O
estimate	B-T081
its	O
between-	O
da	O
variability	O
and	O
test	B-T169
cross-level	B-T080
interactions	B-T169
with	O
the	O
neighbourhood	B-T082
-	O
level	B-T080
variables	B-T080
on	O
continuous	B-T078
birth	O
weight	O
.	O
	
a	O
significant	B-T078
negative	B-T033
and	O
non-linear	O
association	B-T080
was	O
found	O
between	O
maternal	B-T033
smoking	O
and	O
birth	O
weight	O
.	O
	
there	O
was	O
significant	B-T078
between-	O
da	O
intercept	B-T081
variability	O
in	O
birth	O
weight	O
as	O
well	O
as	O
between-	O
da	O
slope	B-T081
variability	O
of	O
maternal	B-T033
smoking	O
on	O
birth	O
weight	O
of	O
which	O
68	O
and	O
30	O
%	O
respectively	O
was	O
explained	O
with	O
the	O
inclusion	B-T080
of	O
da	O
-	O
level	B-T080
variables	B-T080
and	O
their	O
cross-level	B-T080
interactions	B-T169
.	O
	
high	B-T080
da	O
-	O
level	B-T080
ses	B-T080
had	O
a	O
strong	B-T080
positive	B-T033
association	B-T080
with	O
birth	O
weight	O
but	O
the	O
effect	B-T080
was	O
moderated	B-T080
with	O
increased	B-T169
cigarettes	O
/day	B-T079
.	O
	
conversely	O
,	O
heavy	B-T033
smokers	I-T033
showed	O
the	O
largest	B-T081
increases	B-T169
in	O
birth	O
weight	O
with	O
rising	B-T169
neighbourhood	B-T082
education	B-T033
levels	I-T033
.	O
	
increased	B-T169
levels	B-T080
of	O
pm2.5	O
and	O
immigrant	B-T098
density	B-T081
were	O
negatively	B-T033
associated	B-T080
with	I-T080
birth	O
weight	O
,	O
but	O
showed	O
positive	B-T033
interactions	B-T169
with	O
increased	B-T169
levels	B-T080
of	O
smoking	O
.	O
	
older	O
maternal	B-T079
age	I-T079
and	O
suspected	B-T078
drug	O
or	O
alcohol	O
use	O
both	O
had	O
negative	B-T033
interactions	B-T169
with	O
increased	B-T169
levels	B-T080
of	O
maternal	B-T033
smoking	O
.	O
	
maternal	B-T033
smoking	O
had	O
a	O
negative	B-T033
and	O
non-linear	O
dose-response	O
association	O
with	O
birth	O
weight	O
which	O
was	O
highly	B-T080
variable	B-T080
between	O
neighbourhood	B-T082
s	O
and	O
evidence	B-T078
of	O
effect	B-T080
modification	B-T033
with	O
neighbourhood	B-T082
-	O
level	B-T080
factors	B-T169
.	O
	
these	O
results	B-T169
suggest	B-T078
that	O
focusing	O
exclusively	O
on	O
individual	B-T098
behaviours	O
may	O
have	O
limited	B-T169
success	O
in	O
improving	B-T080
outcomes	B-T169
without	B-T080
addressing	O
the	O
contextual	O
influences	O
at	O
the	O
neighbourhood	B-T082
-	O
level	B-T080
.	O
	
further	O
studies	B-T062
are	O
needed	O
to	O
corroborate	B-T080
our	O
findings	B-T033
and	O
to	O
understand	O
how	O
neighbourhood	B-T082
-	O
level	B-T080
attributes	B-T078
interact	B-T169
with	O
smoking	O
to	O
affect	O
birth	O
outcomes	O
.	O
	
individual	B-T098
leg	O
muscle	O
contributions	B-T052
to	O
the	O
cost	O
of	O
walking	O
effects	B-T080
of	O
age	O
and	O
walking	O
speed	O
this	O
study	B-T062
examined	B-T033
the	O
contributions	B-T052
of	O
individual	B-T098
muscles	O
to	O
changes	O
in	O
energetic	O
cost	B-T169
of	I-T169
transport	I-T169
cot	B-T169
over	O
seven	O
walking	O
speeds	O
,	O
and	O
compared	O
results	O
between	O
healthy	O
young	O
and	O
elderly	B-T098
subjects	I-T098
.	O
	
twenty	O
six	O
participants	B-T098
13	O
young	O
aged	O
18-30	O
13	O
old	B-T098
aged	I-T098
70-80	O
were	O
recruited	O
.	O
	
cot	B-T169
o2/kg	O
body	O
mass/km	O
was	O
calculated	O
by	O
standardizing	O
the	O
mean	O
oxygen	O
consumption	O
recorded	O
during	O
steady	O
state	O
walking	O
.	O
	
electromyography	O
signals	O
from	O
10	O
leg	O
muscles	O
were	O
used	O
to	O
calculate	O
the	O
cumulative	O
activity	O
required	O
to	O
traverse	O
a	O
unit	O
of	O
distance	O
cmapd	O
for	O
each	O
muscle	O
at	O
each	O
speed	B-T081
.	O
	
in	O
the	O
old	B-T098
group	I-T098
cmapd	O
was	O
correlated	B-T080
with	O
cot	B-T169
,	O
presented	O
higher	O
and	O
more	O
variable	O
values	O
,	O
and	O
showed	O
greater	O
increases	O
around	O
optimal	B-T081
speed	I-T081
for	O
all	O
studied	O
muscles	O
.	O
	
soleus	O
cmapd	O
was	O
independent	O
of	O
speed	B-T081
in	O
the	O
young	O
group	O
,	O
but	O
this	O
was	O
not	O
evident	O
with	O
aging	O
.	O
	
greater	B-T169
energy	I-T169
cost	I-T169
of	O
walking	O
in	O
older	B-T098
individuals	B-T098
seems	O
to	O
be	O
attributable	O
to	O
increased	O
energy	B-T169
cost	I-T169
of	O
all	O
lower	O
limb	O
muscles	O
.	O
	
glycated	B-T116
hemoglobin	I-T116
hba1c	B-T116
correlation	B-T080
with	O
severity	B-T080
of	O
coronary	B-T047
artery	I-T047
disease	I-T047
in	O
non-diabetic	B-T033
patients	O
-	O
a	O
hospital	O
based	O
study	B-T062
from	O
north-eastern	O
india	O
glycated	O
hemoglobin	O
hba1c	O
levels	O
are	O
predictive	B-T080
of	O
cardiovascular	B-T047
disease	I-T047
and	O
mortality	B-T081
in	O
patients	O
with	O
diabetes	B-T047
mellitus	I-T047
,	O
however	O
,	O
association	O
of	O
hba1c	B-T116
with	O
coronary	B-T047
artery	I-T047
disease	I-T047
cad	B-T047
in	O
non-diabetics	B-T033
is	O
inconsistent	B-T080
.	O
	
to	O
evaluate	O
the	O
correlation	B-T080
between	O
hba1c	O
level	O
and	O
severity	B-T080
of	O
cad	B-T047
in	O
non-diabetic	O
patients	O
using	O
syntax	B-T081
score	I-T081
in	O
a	O
cohort	B-T098
of	O
proven	O
cad	B-T047
on	O
angiography	O
at	O
gauhati	O
medical	O
college	O
,	O
guwahati	O
,	O
assam	O
,	O
india	O
,	O
which	O
is	O
a	O
major	O
tertiary	O
care	O
hospital	O
of	O
north-eastern	O
india	O
.	O
	
we	O
prospectively	O
collected	O
data	B-T078
of	O
non-diabetic	O
patients	O
with	O
proven	O
cad	B-T047
on	O
angiography	O
from	O
june	O
2014	O
to	O
june	O
2015	O
.	O
	
patients	O
were	O
divided	O
into	O
four	O
groups	B-T078
interquartiles	B-T080
according	O
to	O
hba1c	O
levels	O
,	O
less	O
than	O
4.8	O
,	O
4.8	O
to	O
5.1	O
,	O
5.1	O
to	O
5.6	O
,	O
and	O
5.6	O
to	O
6.5	O
.	O
	
severity	B-T080
of	O
cad	B-T047
was	O
assessed	B-T052
using	O
syntax	B-T081
score	I-T081
and	O
the	O
number	B-T081
of	I-T081
coronary	I-T081
vessels	I-T081
diseased	I-T081
.	O
	
we	O
compared	O
different	O
quartiles	B-T080
of	O
hba1c	B-T116
with	O
regard	O
to	O
syntax	B-T081
score	I-T081
and	O
number	O
of	O
diseased	B-T081
vessels	I-T081
.	O
	
a	O
total	O
of	O
346	O
patients	O
were	O
included	O
in	O
the	O
study	B-T062
.	O
	
mean	O
age	O
was	O
58.1	O
years	O
.	O
	
of	O
the	O
total	O
91.9	O
318	O
were	O
males	O
,	O
44.8	O
155	O
were	O
hypertensives	B-T033
,	O
29.2	O
101	O
were	O
smokers	B-T033
and	O
34.7	O
120	O
were	O
dyslipidemic	B-T033
.	O
	
we	O
found	O
that	O
cad	B-T047
severity	B-T080
by	O
syntax	B-T081
score	I-T081
as	O
well	O
as	O
number	O
of	O
vessels	O
involved	O
was	O
significantly	O
different	O
among	O
quartiles	B-T080
p-values	B-T081
<0	O
and	O
<0	O
respectively	O
.	O
	
increase	B-T169
in	O
hba1c	O
level	O
was	O
strongly	O
correlated	B-T080
with	O
disease	B-T080
severity	I-T080
and	O
higher	O
syntax	B-T081
score	I-T081
.	O
	
a	O
significant	O
increase	B-T169
was	O
noted	O
in	O
the	O
mean	O
number	O
of	O
diseased	B-T081
vessels	I-T081
p-value	B-T081
<0	O
as	O
hba1c	O
level	O
increases	B-T169
.	O
	
age	O
,	O
gender	O
,	O
hypertension	B-T047
and	O
dyslipidemia	B-T047
did	O
not	O
show	O
significant	O
difference	O
among	O
quartiles	B-T080
however	O
smoking	O
was	O
found	O
to	O
be	O
an	O
independent	O
predictor	B-T078
of	O
severity	B-T080
of	O
cad	B-T047
by	O
syntax	B-T081
score	I-T081
p	O
<0	O
.	O
	
from	O
this	O
clinical	B-T062
study	I-T062
,	O
we	O
can	O
conclude	O
that	O
a	O
significant	O
correlation	B-T080
exists	O
between	O
hba1c	B-T116
and	O
severity	B-T080
of	O
cad	B-T047
by	O
syntax	B-T081
score	I-T081
as	O
well	O
as	O
number	O
of	O
vessels	O
involved	O
in	O
non-	B-T033
diabetes	I-T033
.	O
	
on	O
the	O
relation	B-T080
between	O
face	O
and	O
object	O
recognition	O
in	O
developmental	O
prosopagnosia	O
no	O
dissociation	O
but	O
a	O
systematic	B-T169
association	B-T080
there	O
is	O
an	O
ongoing	O
debate	B-T052
about	O
whether	O
face	O
recognition	O
and	O
object	O
recognition	O
constitute	O
separate	B-T080
domains	B-T169
.	O
	
clarification	B-T052
of	O
this	O
issue	B-T033
can	O
have	O
important	B-T080
theoretical	B-T078
implications	B-T080
as	O
face	O
recognition	O
is	O
often	O
used	O
as	O
a	O
prime	O
example	O
of	O
domain	B-T169
-	O
specificity	B-T081
in	O
mind	B-T078
and	O
brain	O
.	O
	
an	O
important	B-T080
source	B-T033
of	O
input	O
to	O
this	O
debate	B-T052
comes	O
from	O
studies	O
of	O
individuals	B-T098
with	O
developmental	O
prosopagnosia	O
,	O
suggesting	B-T078
that	O
face	O
recognition	O
can	O
be	O
selectively	B-T169
impaired	I-T169
.	O
	
we	O
put	O
the	O
selectivity	B-T080
hypothesis	B-T078
to	O
test	B-T169
by	O
assessing	O
the	O
performance	B-T052
of	O
10	O
individuals	B-T098
with	O
developmental	O
prosopagnosia	O
on	O
demanding	O
tests	O
of	O
visual	O
object	O
processing	O
involving	B-T169
both	O
regular	B-T080
and	O
degraded	B-T033
drawings	B-T170
.	O
	
none	O
of	O
the	O
individuals	B-T098
exhibited	O
a	O
clear	O
dissociation	O
between	O
face	O
and	O
object	O
recognition	O
,	O
and	O
as	O
a	O
group	O
they	O
were	O
significantly	B-T078
more	O
affected	B-T169
by	O
degradation	B-T033
of	O
objects	O
than	O
control	O
participants	B-T098
.	O
	
importantly	O
,	O
we	O
also	O
find	O
positive	B-T033
correlations	B-T080
between	O
the	O
severity	B-T080
of	O
the	O
face	O
recognition	O
impairment	B-T169
and	O
the	O
degree	B-T081
of	O
impaired	B-T169
performance	B-T052
with	O
degraded	B-T033
objects	O
.	O
	
this	O
suggests	O
that	O
the	O
face	O
and	O
object	O
deficits	B-T080
are	O
systematically	O
related	B-T080
rather	O
than	O
coincidental	B-T079
.	O
	
we	O
conclude	O
that	O
at	O
present	O
,	O
there	O
is	O
no	O
strong	O
evidence	B-T078
in	O
the	O
literature	B-T170
on	O
developmental	O
prosopagnosia	O
supporting	O
domain	B-T169
-	O
specific	B-T080
accounts	O
of	O
face	O
recognition	O
.	O
	
reduced	B-T033
chest	I-T033
and	O
abdominal	O
wall	O
mobility	B-T080
and	O
their	O
relationship	B-T080
to	O
lung	O
function	O
,	O
respiratory	B-T169
muscle	O
strength	O
,	O
and	O
exercise	O
tolerance	O
in	O
subjects	O
with	O
copd	B-T047
advanced	O
air-flow	O
limitation	B-T169
in	O
patients	O
with	O
copd	B-T047
leads	O
to	O
a	O
reduction	B-T080
in	O
vital	O
capacity	O
,	O
respiratory	B-T169
muscle	O
strength	O
,	O
and	O
exercise	O
capacity	O
.	O
	
however	O
,	O
its	O
impact	O
on	O
chest	O
and	O
abdominal	O
wall	O
mobility	B-T080
is	O
unknown	B-T080
.	O
	
this	O
study	O
aimed	O
to	O
ascertain	O
the	O
prevalence	B-T081
of	O
patients	O
with	O
copd	B-T047
with	O
reduced	B-T033
chest	I-T033
and	O
abdominal	O
wall	O
mobility	B-T080
and	O
to	O
investigate	B-T169
the	O
effect	B-T080
of	O
reduced	B-T033
chest	I-T033
and	O
abdominal	O
wall	O
mobility	B-T080
on	O
pulmonary	O
function	O
,	O
respiratory	B-T169
muscle	O
strength	O
,	O
and	O
exercise	O
capacity	O
.	O
	
in	O
51	O
elderly	B-T098
male	O
subjects	O
with	O
copd	B-T047
,	O
chest	O
and	O
abdominal	O
wall	O
mobility	B-T080
,	O
fvc	O
,	O
fev1	O
,	O
fev1/fvc	O
,	O
maximal	O
inspiratory	O
pressure	O
pimax	O
,	O
maximal	O
expiratory	O
pressure	O
pemax	O
,	O
and	O
the	O
6-min	O
walk	O
distance	O
6mwd	O
were	O
assessed	B-T052
.	O
	
chest	O
and	O
abdominal	O
wall	O
mobility	B-T080
were	O
measured	B-T080
using	O
the	O
breathing	O
movement	O
scale	O
0-8	O
at	O
the	O
3	O
regions	O
upper	O
chest	O
,	O
lower	O
chest	O
,	O
and	O
abdomen	O
.	O
	
reduced	B-T033
mobility	I-T033
was	O
defined	O
as	O
a	O
value	B-T081
lower	B-T052
than	O
the	O
lower	B-T081
limit	I-T081
of	I-T081
the	I-T081
normal	I-T081
scale	I-T081
.	O
	
the	O
unpaired	B-T170
t	I-T170
test	I-T170
,	O
mann-whitney	B-T170
test	I-T170
,	O
and	O
multiple	B-T080
regression	I-T080
analysis	I-T080
were	O
performed	B-T169
.	O
	
the	O
percentages	B-T081
of	O
subjects	O
with	O
reduced	B-T033
mobility	I-T033
were	O
78%	O
for	O
the	O
upper	O
chest	O
,	O
76%	O
for	O
the	O
lower	O
chest	O
,	O
and	O
53%	O
for	O
the	O
abdomen	O
.	O
	
the	O
subjects	O
with	O
reduced	B-T033
mobility	I-T033
had	O
significantly	B-T081
low	I-T081
fvc	O
,	O
fev1	O
,	O
and	O
6mwd	O
in	O
each	O
region	O
and	O
significantly	B-T081
low	I-T081
fev1/fvc	O
,	O
pimax	O
,	O
and	O
pemax	O
in	O
the	O
abdominal	O
region	O
compared	B-T052
with	O
those	O
with	O
nonreduced	O
mobility	B-T080
.	O
	
fvc	O
and	O
6mwd	O
were	O
independently	O
associated	B-T080
with	I-T080
the	O
scale	B-T080
values	I-T080
in	O
each	O
region	O
and	O
with	O
the	O
abdominal	O
scale	B-T080
value	I-T080
,	O
respectively	O
.	O
	
the	O
majority	O
of	O
subjects	O
with	O
copd	B-T047
had	O
reduced	B-T033
chest	I-T033
and	O
abdominal	O
wall	O
mobility	B-T080
,	O
which	O
was	O
independently	O
associated	B-T080
with	I-T080
fvc	O
.	O
	
even	O
though	O
abdominal	O
wall	O
mobility	B-T080
was	O
relatively	O
preserved	O
compared	B-T052
with	O
chest	O
wall	O
mobility	B-T080
,	O
it	O
was	O
also	O
independently	O
associated	B-T080
with	I-T080
6mwd	O
.	O
	
fgf21	B-T116
is	O
a	O
biomarker	O
for	O
mitochondrial	O
translation	O
and	O
mtdna	O
maintenance	B-T052
disorders	B-T047
to	O
validate	O
new	O
mitochondrial	O
myopathy	O
serum	O
biomarkers	O
for	O
diagnostic	O
use	O
.	O
	
we	O
analyzed	B-T062
serum	O
fgf21	B-T116
s-fgf21	B-T116
and	O
gdf15	B-T116
from	O
patients	O
with	O
1	O
mitochondrial	B-T047
diseases	I-T047
and	O
2	O
nonmitochondrial	B-T047
disorders	I-T047
partially	B-T081
overlapping	B-T079
with	O
mitochondrial	B-T047
disorder	I-T047
phenotypes	O
.	O
	
we	O
3	O
did	O
a	O
meta-analysis	B-T062
of	O
s-fgf21	B-T116
in	O
mitochondrial	B-T047
disease	I-T047
and	O
4	O
analyzed	B-T062
s-fgf21	B-T116
and	O
skeletal	O
muscle	O
fgf21	B-T116
expression	O
in	O
6	O
mouse	O
models	O
with	O
different	B-T080
muscle	O
-	O
manifesting	B-T169
mitochondrial	B-T033
dysfunctions	I-T033
.	O
	
we	O
report	O
that	O
s-fgf21	B-T116
consistently	O
increases	B-T169
in	O
primary	B-T080
mitochondrial	O
myopathy	O
,	O
especially	O
in	O
patients	O
with	O
mitochondrial	O
translation	O
defects	O
or	O
mitochondrial	B-T033
dna	I-T033
mtdna	I-T033
deletions	I-T033
675	O
and	O
347	O
pg/ml	O
,	O
respectively	O
controls	O
66	O
pg/ml	O
,	O
p	O
<	O
0.0001	O
for	O
both	O
.	O
	
this	O
is	O
corroborated	O
in	O
mice	O
mtdna	B-T033
deletions	I-T033
1	O
vs	O
379	O
pg/ml	O
,	O
p	O
<	O
0.0001	O
.	O
	
however	O
,	O
patients	O
and	O
mice	O
with	O
structural	O
respiratory	O
chain	O
subunit	O
or	O
assembly	O
factor	O
defects	O
showed	O
low	B-T080
induction	B-T169
human	O
335	O
pg/ml	O
,	O
p	O
<	O
0.05	O
mice	O
335	O
pg/ml	O
,	O
not	B-T033
significant	I-T033
.	O
	
overall	B-T080
specificities	B-T081
of	O
fgf21	B-T116
and	O
gdf15	B-T116
to	O
find	O
patients	O
with	O
mitochondrial	O
myopathy	O
were	O
89.3	O
vs	O
86.4	O
,	O
and	O
sensitivities	B-T081
67.3	O
and	O
76.0	O
,	O
respectively	O
.	O
	
however	O
,	O
gdf15	B-T116
was	O
increased	B-T081
also	O
in	O
a	O
wide	O
range	O
of	O
nonmitochondrial	B-T080
conditions	I-T080
.	O
	
s-fgf21	B-T116
is	O
a	O
specific	B-T080
biomarker	O
for	O
muscle	O
-	O
manifesting	B-T169
defects	O
of	O
mitochondrial	O
translation	O
,	O
including	O
mitochondrial	O
transfer-rna	O
mutations	O
and	O
primary	B-T080
and	O
secondary	B-T080
mtdna	B-T033
deletions	I-T033
,	O
the	O
most	O
common	O
causes	B-T169
of	O
mitochondrial	B-T047
disease	I-T047
.	O
	
however	O
,	O
normal	B-T080
s-fgf21	B-T116
does	O
not	B-T033
exclude	B-T169
structural	O
respiratory	O
chain	O
complex	O
or	O
assembly	O
factor	O
defects	O
,	O
important	O
to	O
acknowledge	O
in	O
diagnostics	O
.	O
	
this	O
study	B-T062
provides	O
class	B-T170
iii	I-T170
evidence	B-T078
that	O
elevated	B-T080
s-fgf21	B-T116
accurately	O
distinguishes	O
patients	O
with	O
mitochondrial	O
myopathies	O
from	O
patients	O
with	O
other	O
conditions	B-T080
,	O
and	O
fgf21	B-T116
and	O
gdf15	B-T116
mitochondrial	O
myopathy	O
from	O
other	O
the	O
effects	B-T080
of	I-T080
captopril	B-T116
on	O
lipopolysaccharide	B-T109
induced	B-T169
learning	O
and	O
memory	O
impairments	O
and	O
the	O
brain	O
cytokine	B-T116
levels	B-T080
and	O
oxidative	B-T169
damage	O
in	O
rats	O
renin-angiotensin	O
system	O
has	O
a	O
role	O
in	O
inflammation	O
and	O
also	O
involves	O
in	O
learning	O
and	O
memory	O
.	O
	
in	O
the	O
present	O
study	O
,	O
the	O
effects	B-T080
of	I-T080
captopril	B-T116
on	O
lipopolysaccharide	B-T109
lps	B-T109
induced	B-T169
learning	O
and	O
memory	O
impairments	O
,	O
hippocampal	O
cytokine	B-T116
levels	B-T080
and	O
brain	O
tissues	O
oxidative	B-T169
damage	O
was	O
investigated	B-T169
.	O
	
the	O
rats	O
were	O
divided	O
and	O
treated	O
1	O
saline	O
control	O
,	O
2	O
lps	B-T109
1mg/kg	O
,	O
3-5	O
10	O
,	O
50	O
or	O
100mg/kg	O
captopril	B-T116
30min	O
before	O
lps	B-T109
.	O
	
the	O
treatment	B-T061
was	O
started	O
since	O
six	O
days	B-T079
before	O
the	O
behavioral	O
experiments	O
and	O
continued	O
during	O
the	O
behavioral	O
tests	O
lps	B-T109
injection	B-T061
two	O
h	O
before	O
each	O
behavioral	O
experiment	O
.	O
	
administration	B-T061
of	O
lps	B-T109
prolonged	B-T079
the	O
escape	O
latency	B-T080
and	O
traveled	O
path	O
to	O
find	O
the	O
platform	O
in	O
morris	O
water	O
maze	O
mwm	O
test	O
p<0	O
while	O
,	O
shortened	O
the	O
latency	B-T080
to	O
enter	O
the	O
dark	O
compartment	O
in	O
passive	O
avoidance	O
pa	O
test	O
p<0	O
.	O
	
pretreatment	B-T052
by	O
all	O
doses	B-T081
of	O
captopril	B-T116
improved	B-T080
performances	B-T052
of	O
the	O
rats	O
in	O
mwm	O
p<0	O
and	O
also	O
prolonged	B-T079
the	O
latency	B-T080
to	O
enter	O
the	O
dark	O
in	O
pa	O
test	O
p<0	O
.	O
	
lps	B-T109
also	O
increased	B-T081
il-6	B-T116
,	O
tnf-α	B-T116
,	O
malondialdehyde	B-T109
mda	B-T109
and	O
nitric	O
oxide	O
no	O
metabolites	O
in	O
the	O
hippocampal	O
tissues	O
p<0	O
which	O
were	O
prevented	B-T061
by	O
captopril	B-T116
p<0	O
.	O
	
the	O
thiol	O
,	O
superoxide	B-T116
dismutase	I-T116
sod	B-T116
and	O
catalase	B-T116
cat	B-T116
in	O
the	O
hippocampus	O
of	O
lps	B-T109
group	B-T078
were	O
lower	O
than	O
the	O
control	O
p<0	O
while	O
,	O
they	O
were	O
enhanced	B-T052
when	O
the	O
aniamls	O
were	O
pretreated	B-T052
by	O
captopril	B-T116
p<0	O
.	O
	
the	O
results	O
of	O
present	O
study	O
showed	O
that	O
captopril	B-T116
improved	B-T080
the	O
lps	B-T109
-	O
induced	B-T169
learning	O
and	O
memory	O
impairments	O
in	O
rats	O
which	O
were	O
accompanied	O
with	O
attenuating	B-T052
hippocampal	O
cytokine	B-T116
levels	B-T080
and	O
improving	B-T080
the	O
brain	O
tissues	O
oxidative	B-T169
damage	O
criteria	B-T078
.	O
	
targeted	B-T061
therapy	I-T061
in	O
gastric	O
cancer	O
gastric	O
cancer	O
is	O
the	O
fourth	O
most	O
common	O
cancer	O
worldwide	O
.	O
	
surgery	B-T061
in	O
combination	O
with	O
multimodal	B-T061
therapy	I-T061
provides	O
the	O
only	O
curative	B-T033
therapy	I-T033
until	O
now	O
.	O
	
the	O
importance	O
of	O
targeted	B-T061
therapy	I-T061
became	O
clear	O
over	O
the	O
last	O
few	O
years	B-T079
.	O
	
due	O
to	O
the	O
implication	B-T169
of	O
her2	O
and	O
angiogenesis	O
-directed	O
targeted	B-T061
therapies	I-T061
major	O
advances	O
in	O
the	O
treatment	B-T061
of	O
gastric	O
cancer	O
could	O
be	O
reached	O
.	O
	
nevertheless	O
,	O
benefits	O
in	O
survival	O
remain	O
unsatisfactory	O
and	O
the	O
development	O
of	O
resistance	B-T169
to	O
monoclonal	B-T116
antibodies	I-T116
is	O
arising	O
.	O
	
a	O
comprehensive	B-T080
and	O
comparative	B-T062
literature	B-T170
research	B-T062
was	O
performed	O
to	O
evaluate	O
the	O
status	O
of	O
her2	O
and	O
angiogenesis	O
-directed	O
targeted	B-T061
therapy	I-T061
in	O
gastric	O
cancer	O
.	O
	
up	O
to	O
now	O
,	O
trastuzumab	B-T116
and	O
ramucirumab	B-T116
are	O
the	O
only	O
agents	B-T109
showing	O
remarkable	O
benefits	O
in	O
the	O
therapy	B-T061
for	O
the	O
patients	O
suffering	O
from	O
gastric	O
cancer	O
.	O
	
the	O
limitations	O
of	O
targeted	B-T061
therapies	I-T061
in	O
gastric	O
cancer	O
are	O
mainly	O
associated	O
with	O
the	O
development	O
of	O
secondary	O
resistance	B-T169
.	O
	
addition	O
of	O
targeted	B-T061
therapy	I-T061
in	O
second-line	B-T061
treatment	I-T061
is	O
beneficial	O
when	O
compared	O
with	O
chemotherapy	B-T061
alone	O
.	O
	
nevertheless	O
,	O
results	B-T033
in	O
first-line	B-T061
treatment	I-T061
remain	O
modest	O
.	O
	
therefore	O
,	O
new	O
therapeutic	O
agents	O
and	O
combinations	O
in	O
the	O
first-line	B-T061
treatment	I-T061
of	O
gastric	O
cancer	O
are	O
urgently	O
needed	O
and	O
remain	O
to	O
be	O
validated	O
in	O
clinical	B-T062
trials	I-T062
.	O
	
serum	O
c-reactive	O
protein	O
in	O
children	O
with	O
liver	B-T047
disease	I-T047
and	O
ascites	B-T033
the	O
diagnosis	B-T062
of	O
peritonitis	O
as	O
a	O
complication	O
of	O
cirrhosis	B-T047
is	O
an	O
important	O
clinical	O
problem	O
.	O
	
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
serum	O
c-reactive	O
protein	O
levels	O
as	O
a	O
diagnostic	O
factor	O
for	O
spontaneous	B-T047
bacterial	I-T047
peritonitis	I-T047
sbp	B-T047
in	O
child	O
patients	O
with	O
liver	B-T047
disease	I-T047
.	O
	
in	O
this	O
study	B-T062
,	O
150	O
children	O
diagnosed	B-T062
with	O
liver	B-T047
disease	I-T047
and	O
ascites	B-T033
upon	O
admission	O
to	O
nemazee	O
teaching	O
hospital	O
shiraz	O
,	O
iran	O
were	O
examined	B-T033
.	O
	
patients	O
were	O
divided	O
into	O
spontaneous	B-T047
bacterial	I-T047
peritonitis	I-T047
and	O
sterile	O
ascetic	O
fluid	O
groups	O
according	O
to	O
the	O
pmn	O
count	O
250/mm	O
in	O
the	O
ascetic	O
fluids	O
.	O
	
routine	O
laboratory	O
tests	O
were	O
conducted	O
and	O
quantitative	O
c-reactive	O
protein	O
crp	O
levels	O
were	O
measured	O
for	O
all	O
of	O
the	O
patients	O
.	O
	
accuracy	B-T080
,	O
sensitivity	B-T081
,	O
and	I-T081
specificity	I-T081
of	O
crp	O
was	O
evaluated	O
for	O
diagnosis	B-T062
of	O
sbp	B-T047
.	O
	
of	O
150	O
cirrhotic	B-T047
patients	O
,	O
109	O
patients	O
presented	O
without	O
sbp	B-T047
52.29	O
male	B-T098
,	O
mean	O
age	O
5.02	O
4.49	O
years	B-T079
and	O
41	O
patients	O
presented	O
with	O
sbp	B-T047
51.21	O
male	B-T098
,	O
mean	O
age	O
4.71	O
years	B-T079
.	O
	
cell	O
counts	O
,	O
protein	O
levels	O
,	O
albumin	O
levels	O
,	O
and	O
lactate	O
dehydrogenize	O
ldh	O
levels	O
of	O
the	O
ascetic	O
fluid	O
and	O
serum	O
samples	O
in	O
the	O
sbp	B-T047
group	O
were	O
higher	O
than	O
the	O
rates	O
for	O
those	O
without	O
sbp	B-T047
p	O
<	O
0.05	O
.	O
	
the	O
mean	O
sd	O
of	O
crp	O
in	O
the	O
sbp	B-T047
group	O
36.89	O
23.43	O
increased	O
significantly	O
compared	O
to	O
the	O
rate	O
among	O
those	O
without	O
sbp	B-T047
21.59	O
15.43	O
,	O
p	O
=	O
0.001	O
.	O
	
the	O
percentages	O
for	O
sensitivity	B-T081
and	I-T081
specificity	I-T081
of	O
crp	O
,	O
the	O
diagnosis	B-T062
of	O
sbp	B-T047
based	O
on	O
the	O
pmn	O
count	O
250/mm	O
,	O
and	O
cultured	B-T033
ascites	I-T033
were	O
69.23	O
,	O
90.25	O
,	O
88.43	O
,	O
and	O
84.32	O
,	O
respectively	O
.	O
	
the	O
areas	O
under	O
the	O
curve	O
of	O
crp	O
for	O
sbp	B-T047
based	O
on	O
the	O
pmn	O
count	O
250/mm	O
and	O
cultured	B-T033
ascites	I-T033
was	O
0.94	O
ci	O
95%	O
0.90	O
to	O
0.96	O
and	O
0.85	O
ci	O
95%	O
0.84	O
to	O
0.92	O
,	O
respectively	O
p	O
<	O
0.001	O
.	O
	
our	O
study	B-T062
showed	O
that	O
crp	O
is	O
a	O
marker	O
with	O
high	O
sensitivity	B-T081
and	I-T081
specificity	I-T081
for	O
the	O
diagnosis	B-T062
of	O
sbp	B-T047
in	O
cirrhotic	B-T047
children	O
.	O
	
structure	O
of	O
the	O
bacterial	B-T080
plant	O
-	O
ferredoxin	B-T116
receptor	B-T116
fusa	B-T116
iron	O
is	O
a	O
limiting	O
nutrient	O
in	O
bacterial	B-T047
infection	I-T047
putting	O
it	O
at	O
the	O
centre	O
of	O
an	O
evolutionary	O
arms	O
race	O
between	O
host	O
and	O
pathogen	O
.	O
	
gram-negative	O
bacteria	O
utilize	O
tonb	B-T116
-dependent	O
outer	O
membrane	O
receptors	B-T116
to	O
obtain	O
iron	O
during	O
infection	O
.	O
	
these	O
receptors	B-T116
acquire	O
iron	O
either	O
in	O
concert	O
with	O
soluble	O
iron-scavenging	B-T109
siderophores	I-T109
or	O
through	O
direct	B-T169
interaction	I-T169
and	O
extraction	B-T061
from	O
host	O
proteins	B-T116
.	O
	
characterization	B-T052
of	O
these	O
receptors	B-T116
provides	O
invaluable	O
insight	O
into	O
pathogenesis	O
.	O
	
however	O
,	O
only	O
a	O
subset	O
of	O
virulence	O
-related	O
tonb	B-T116
-dependent	O
receptors	B-T116
have	O
been	O
currently	O
described	O
.	O
	
here	O
we	O
report	O
the	O
discovery	B-T052
of	O
fusa	B-T116
,	O
a	O
new	O
class	O
of	O
tonb	B-T116
-dependent	O
receptor	B-T116
,	O
which	O
is	O
utilized	O
by	O
phytopathogenic	O
pectobacterium	O
spp	O
.	O
	
to	O
obtain	O
iron	O
from	O
plant	O
ferredoxin	B-T116
.	O
	
through	O
the	O
crystal	O
structure	O
of	O
fusa	B-T116
we	O
show	O
that	O
binding	O
of	O
ferredoxin	B-T116
occurs	O
through	O
specialized	O
extracellular	O
loops	O
that	O
form	O
extensive	B-T080
interactions	B-T169
with	O
ferredoxin	B-T116
.	O
	
the	O
function	B-T169
of	O
fusa	B-T116
and	O
the	O
presence	O
of	O
homologues	O
in	O
clinically	B-T080
important	I-T080
pathogens	O
suggests	O
that	O
small	O
iron-containing	B-T116
proteins	I-T116
represent	O
an	O
iron	O
source	B-T033
for	O
bacterial	B-T080
pathogens	O
.	O
	
antigen	O
masking	O
during	O
fixation	O
and	O
embedding	O
,	O
dissected	B-T169
antigen	O
masking	O
in	O
routinely	O
processed	O
tissue	O
is	O
a	O
poorly	O
understood	O
process	O
caused	O
by	O
multiple	B-T081
factors	B-T169
.	O
	
we	O
sought	O
to	O
dissect	B-T169
the	O
effect	O
on	O
antigenicity	O
of	O
each	O
step	O
of	O
processing	B-T052
by	O
using	O
frozen	O
sections	O
as	O
proxies	O
of	O
the	O
whole	O
tissue	O
.	O
	
an	O
equivalent	O
extent	O
of	O
antigen	O
masking	O
occurs	O
across	O
variable	O
fixation	O
times	B-T079
at	O
room	B-T080
temperature	I-T080
.	O
	
most	O
antigens	O
benefit	O
from	O
longer	O
fixation	O
times	B-T079
>24	O
hr	O
for	O
optimal	O
detection	B-T033
after	O
antigen	O
retrieval	O
ar	O
for	O
example	O
,	O
ki-67	B-T116
,	O
bcl-2	O
,	O
er	B-T116
.	O
	
the	O
transfer	B-T169
to	O
a	O
graded	B-T109
alcohol	I-T109
series	B-T081
results	O
in	O
an	O
enhanced	O
staining	B-T033
effect	I-T033
,	O
reproduced	O
by	O
treating	B-T169
the	O
sections	O
with	O
detergents	O
,	O
possibly	O
because	O
of	O
a	O
better	O
access	O
of	O
the	O
polymeric	O
immunohistochemical	O
detection	B-T033
system	B-T169
to	O
tissue	O
structures	B-T082
.	O
	
a	O
second	O
round	O
of	O
masking	O
occurs	O
upon	O
entering	O
the	O
clearing	O
agent	O
,	O
mostly	O
at	O
the	O
paraffin	B-T109
embedding	O
step	O
.	O
	
this	O
may	O
depend	O
on	O
the	O
non-freezable	B-T080
water	O
removal	B-T052
.	O
	
ar	O
fully	O
reverses	O
the	O
masking	O
due	O
both	O
to	O
the	O
fixation	O
time	B-T079
and	O
the	O
paraffin	B-T109
embedding	O
.	O
	
ar	O
itself	O
destroys	B-T052
some	O
epitopes	O
which	O
do	O
not	O
survive	O
routine	B-T080
processing	B-T052
.	O
	
processed	O
frozen	O
sections	O
are	O
a	O
tool	O
to	O
investigate	B-T169
fixation	O
and	O
processing	B-T052
requirements	B-T169
for	O
antigens	O
in	O
routine	B-T080
specimens	O
.	O
	
synthesis	B-T052
of	O
1	B-T109
as	O
thermochemiluminescent	O
labels	O
for	O
ultrasensitive	O
bioassays	O
rational	B-T078
prediction	I-T078
of	O
olefin	B-T109
photooxygenation	O
outcome	B-T169
by	O
using	O
a	O
chemometric	O
approach	O
great	O
interest	O
in	O
new	O
thermochemiluminescent	O
tcl	O
molecules	O
,	O
for	O
example	O
,	O
in	O
bioanalytical	O
assays	O
,	O
has	O
prompted	O
the	O
design	B-T052
and	O
synthesis	B-T052
of	O
a	O
small	O
library	O
of	O
more	O
than	O
30	O
olefins	B-T109
to	O
be	O
subjected	O
to	O
photooxygenation	O
,	O
with	O
the	O
aim	O
of	O
obtaining	O
new	O
1	B-T109
tcl	O
labels	O
with	O
optimized	B-T080
properties	I-T080
.	O
	
fluorine	O
atoms	O
on	O
the	O
acridan	B-T109
system	O
remarkably	O
stabilize	O
1	B-T109
when	O
they	O
are	O
located	O
in	O
the	O
3-	B-T082
and/or	I-T082
6-position	I-T082
4	O
h	O
and	O
4	O
i	O
.	O
	
on	O
the	O
other	O
hand	O
,	O
2	B-T109
acridan	I-T109
dioxetane	I-T109
4	O
j	O
showed	O
a	O
significantly	O
enhanced	O
fluorescence	B-T081
quantum	I-T081
yield	I-T081
with	O
respect	O
to	O
the	O
unsubstituted	B-T109
dioxetane	I-T109
4	O
a	O
.	O
	
some	O
of	O
the	O
synthesized	B-T052
olefins	B-T109
did	O
not	O
undergo	O
singlet	O
oxygen	O
addition	O
and	O
a	O
rationale	B-T078
was	O
sought	O
to	O
ease	O
the	O
photooxygenation	O
step	O
,	O
leading	O
to	O
the	O
tcl	B-T109
dioxetanes	I-T109
.	O
	
a	O
chemometric	O
approach	O
has	O
been	O
adopted	O
to	O
exploit	O
principal	B-T062
component	I-T062
analysis	I-T062
and	O
linear	B-T062
discriminant	I-T062
analysis	I-T062
of	O
the	O
structural	B-T082
and	O
electronic	B-T170
molecular	I-T170
descriptors	I-T170
obtained	O
by	O
dft	B-T052
optimizations	I-T052
of	O
olefins	B-T109
3	O
.	O
	
this	O
approach	B-T082
allows	O
the	O
steric	O
and	O
electronic	O
parameters	O
that	O
govern	O
dioxetane	B-T109
formation	B-T169
to	O
be	O
prostate	B-T061
external	I-T061
beam	I-T061
radiotherapy	I-T061
combined	B-T080
with	O
high-dose-rate	B-T061
brachytherapy	I-T061
dose	B-T081
-	O
volume	B-T081
parameters	B-T033
from	O
deformably-registered	B-T170
plans	I-T170
correlate	B-T080
with	O
late	B-T079
gastrointestinal	O
complications	O
derivation	B-T080
of	O
dose	B-T081
-	O
volume	B-T081
correlated	B-T080
with	O
toxicity	B-T080
for	O
multi-modal	B-T061
treatments	I-T061
can	O
be	O
difficult	B-T080
due	O
to	O
the	O
perceived	O
need	O
for	O
voxel-by-voxel	O
dose	O
accumulation	O
.	O
	
with	O
data	B-T078
available	O
for	O
a	O
single	B-T081
-	O
institution	O
cohort	B-T098
with	O
long	B-T080
follow-up	O
,	O
an	O
investigation	B-T169
was	O
undertaken	O
into	O
rectal	B-T082
dose	B-T081
-	O
volume	B-T081
effects	B-T080
for	O
gastrointestinal	B-T033
toxicities	I-T033
after	O
deformably-registering	O
each	O
phase	B-T079
of	O
a	O
combined	B-T080
external	B-T061
beam	I-T061
radiotherapy	I-T061
ebrt	B-T061
high-dose-rate	B-T061
hdr	I-T061
brachytherapy	I-T061
prostate	B-T061
treatment	I-T061
.	O
	
one	O
hundred	O
and	O
eighteen	O
patients	O
received	O
ebrt	B-T061
in	O
23	O
fractions	B-T081
of	O
2	O
gy	B-T081
and	O
hdr	B-T061
tg43	B-T170
algorithm	I-T170
in	O
3	O
fractions	B-T081
of	O
6.5	O
gy	B-T081
.	O
	
results	B-T033
for	O
the	O
late	B-T170
effects	I-T170
of	I-T170
normal	I-T170
tissues	I-T170
-	I-T170
subjective	I-T170
,	O
objective	I-T170
,	O
management	I-T170
and	I-T170
analytic	I-T170
toxicity	I-T170
assessments	I-T170
were	O
available	O
with	O
a	O
median	B-T081
follow-up	O
of	O
72	O
months	B-T079
.	O
	
the	O
hdr	B-T061
ct	O
was	O
deformably-registered	O
to	O
the	O
ebrt	B-T061
ct	O
.	O
	
doses	B-T081
were	O
corrected	B-T080
for	O
dose	B-T061
fractionation	I-T061
.	O
	
rectum	O
dose-volume	B-T170
histogram	I-T170
dvh	B-T170
parameters	B-T033
were	O
calculated	B-T052
in	O
two	O
ways	O
.	O
	
1	O
distribution-adding	B-T170
parameters	B-T033
were	O
calculated	B-T052
after	O
the	O
ebrt	B-T061
dose	B-T081
distribution	B-T169
was	O
3d-summed	O
with	O
the	O
registered	O
hdr	B-T061
dose	B-T081
distribution	B-T169
.	O
	
2	O
parameter-adding	B-T170
the	O
ebrt	B-T061
dvh	B-T170
parameters	B-T033
were	O
added	B-T169
to	O
hdr	B-T061
dvh	B-T170
parameters	B-T033
.	O
	
logistic	B-T062
regressions	I-T062
and	O
mann-whitney	B-T081
u-tests	I-T081
were	O
used	O
to	O
correlate	B-T080
parameters	B-T033
with	O
late	B-T079
peak	B-T080
toxicity	B-T080
dichotomised	B-T169
at	O
grade	O
1	O
or	O
2	O
.	O
	
the	O
48-80	O
,	O
40-63	O
and	O
49-55	O
gy	B-T081
dose	B-T081
regions	B-T082
from	O
distribution-adding	B-T170
were	O
significantly	B-T078
correlated	B-T080
with	O
rectal	O
bleeding	O
,	O
urgency	B-T047
/	O
tenesmus	O
and	O
stool	B-T033
frequency	I-T033
respectively	O
.	O
	
additionally	B-T169
,	O
urgency	B-T047
/	O
tenesmus	O
and	O
anorectal	O
pain	O
were	O
associated	B-T080
with	I-T080
the	O
25-26	O
gy	B-T081
and	O
44-48	O
gy	B-T081
dose	B-T081
regions	B-T082
from	O
distribution-adding	B-T170
respectively	O
.	O
	
parameter-adding	B-T170
also	O
indicated	O
the	O
low	B-T080
-	O
mid	B-T082
dose	B-T081
region	B-T082
was	O
significantly	B-T078
correlated	B-T080
with	O
stool	B-T033
frequency	I-T033
and	O
proctitis	B-T047
.	O
	
this	O
study	B-T062
confirms	B-T033
significant	B-T078
dose-histogram	B-T170
effects	B-T080
for	O
gastrointestinal	B-T033
toxicities	I-T033
after	O
including	B-T169
deformable	B-T170
registration	I-T170
to	O
combine	B-T080
phases	B-T079
of	O
ebrt	B-T061
/	O
hdr	B-T061
prostate	O
cancer	O
treatment	B-T061
.	O
	
the	O
findings	B-T033
from	O
distribution-adding	B-T170
were	O
in	O
most	O
cases	B-T169
consistent	B-T078
with	I-T078
those	O
from	O
parameter-adding	B-T170
.	O
	
the	O
mid	B-T082
-	O
high	B-T080
dose	B-T081
range	B-T081
and	O
near	B-T080
maximum	B-T081
doses	B-T081
were	O
important	B-T080
for	O
rectal	O
bleeding	O
.	O
	
the	O
distribution-adding	B-T170
mid	B-T082
-	O
high	B-T080
dose	B-T081
range	B-T081
was	O
also	O
important	B-T080
for	O
stool	B-T033
frequency	I-T033
and	O
urgency	B-T047
/	O
tenesmus	O
.	O
	
we	O
encourage	O
additional	B-T169
studies	B-T062
in	O
a	O
variety	O
of	O
institutions	B-T078
using	O
a	O
variety	O
of	O
dose	O
accumulation	O
methods	O
with	O
appropriate	O
inter-fraction	O
motion	O
management	O
.	O
	
prescription	B-T170
of	O
opioids	B-T109
for	O
breathlessness	O
in	O
end-stage	B-T080
copd	B-T047
a	O
national	O
population-based	B-T062
study	I-T062
low-dose	B-T081
opioids	B-T109
can	O
relieve	B-T169
breathlessness	O
but	O
may	O
be	O
underused	O
in	O
late-stage	B-T079
copd	B-T047
due	O
to	O
fear	O
of	O
complications	O
,	O
contributing	O
to	O
poor	O
symptom	B-T061
control	I-T061
.	O
	
we	O
aimed	O
to	O
study	B-T062
the	O
period	B-T079
prevalence	O
and	O
indications	B-T078
of	O
opioids	B-T109
actually	O
prescribed	O
in	O
people	B-T098
with	O
end-stage	B-T080
copd	B-T047
.	O
	
the	O
study	B-T062
was	O
a	O
longitudinal	B-T062
,	O
population-based	B-T062
study	I-T062
of	O
patients	O
starting	O
long-term	B-T061
oxygen	I-T061
therapy	I-T061
ltot	B-T061
for	O
copd	B-T047
between	O
october	O
1	O
,	O
2005	O
and	O
june	O
30	O
,	O
2009	O
in	O
sweden	O
.	O
	
a	O
random	O
sample	O
n=2	O
of	O
their	O
dispensed	O
opioid	B-T109
prescriptions	B-T170
was	O
obtained	O
from	O
the	O
national	B-T170
prescribed	I-T170
drugs	I-T170
register	I-T170
from	O
91	O
days	B-T079
before	O
starting	O
ltot	B-T061
until	O
the	O
first	O
of	O
ltot	B-T061
withdrawal	B-T052
,	O
death	O
,	O
or	O
study	B-T079
end	I-T079
december	O
31	O
,	O
2009	O
.	O
	
we	O
analyzed	O
medication	O
type	O
,	O
dispensed	B-T081
quantity	I-T081
,	O
date	B-T033
of	I-T033
dispensing	I-T033
,	O
and	O
indications	B-T078
categorized	O
as	O
pain	O
,	O
breathlessness	O
,	O
other	O
,	O
or	O
unknown	O
.	O
	
in	O
total	O
,	O
2	O
copd	B-T047
patients	O
59%	O
women	B-T098
were	O
included	O
.	O
	
during	O
a	O
median	O
follow-up	O
of	O
1.1	O
interquartile	B-T081
range	I-T081
0.6	O
years	B-T079
,	O
1	O
patients	O
46%	O
were	O
dispensed	O
1	O
opioid	B-T109
prescription	O
n=13	O
prescriptions	O
.	O
	
the	O
most	O
frequently	O
prescribed	O
opioids	B-T109
were	O
tramadol	B-T109
23%	O
,	O
oxycodone	B-T109
23%	O
,	O
morphine	B-T109
16%	O
,	O
and	O
codeine	B-T109
16%	O
.	O
	
average	O
dispensed	B-T081
quantity	I-T081
was	O
9.3	O
interquartile	B-T081
range	I-T081
3.7	O
defined	O
daily	B-T081
doses	I-T081
per	O
prescription	O
.	O
	
in	O
the	O
random	O
sample	O
,	O
the	O
most	O
commonly	O
stated	O
indication	B-T078
was	O
pain	O
97%	O
,	O
with	O
only	O
2%	O
for	O
breathlessness	O
and	O
1%	O
for	O
other	O
reasons	O
.	O
	
despite	O
evidence	O
that	O
supported	O
the	O
use	O
of	O
opioids	B-T109
for	O
the	O
relief	B-T169
of	O
breathlessness	O
predating	O
this	O
study	B-T062
,	O
opioids	B-T109
are	O
rarely	O
prescribed	O
to	O
relieve	B-T169
breathlessness	O
in	O
oxygen-dependent	O
copd	B-T047
,	O
potentially	O
contributing	O
to	O
less-than-optimal	O
symptom	B-T061
control	I-T061
.	O
	
this	O
study	B-T062
creates	O
a	O
baseline	B-T081
against	O
which	O
to	O
compare	O
future	O
changes	O
in	O
morphine	B-T109
in	B-T082
vivo	I-T082
3-dimensional	B-T082
strain	B-T052
mapping	I-T052
confirms	B-T080
large	B-T081
optic	O
nerve	O
head	O
deformations	O
following	B-T079
horizontal	O
eye	O
movements	O
to	O
measure	B-T081
lamina	O
cribrosa	O
lc	O
strains	O
deformations	O
following	B-T079
abduction	O
and	O
adduction	B-T169
in	O
healthy	B-T098
subjects	I-T098
and	O
to	O
compare	B-T052
them	O
with	O
those	O
resulting	B-T169
from	O
a	O
relatively	B-T080
high	B-T080
acute	B-T079
intraocular	O
pressure	O
iop	O
elevation	B-T082
.	O
	
a	O
total	B-T080
of	O
16	O
eyes	O
from	O
8	O
healthy	B-T098
subjects	I-T098
were	O
included	B-T052
.	O
	
among	O
the	O
16	O
eyes	O
,	O
11	O
had	O
peripapillary	B-T033
atrophy	I-T033
ppa	B-T033
.	O
	
for	O
each	B-T081
subject	O
,	O
both	O
optic	O
nerve	O
heads	O
onhs	O
were	O
imaged	B-T170
using	O
optical	O
coherence	O
tomography	O
oct	O
at	O
baseline	B-T081
twice	B-T081
,	O
in	O
different	B-T080
gaze	O
positions	B-T082
adduction	B-T169
and	O
abduction	O
of	O
20	O
and	O
following	B-T079
an	O
acute	B-T079
iop	O
elevation	B-T082
of	O
approximately	B-T080
20	O
mm	O
hg	O
from	O
baseline	B-T081
via	O
ophthalmodynamometry	O
.	O
	
strains	O
of	O
lc	O
for	O
all	O
loading	B-T169
scenarios	I-T169
were	O
mapped	B-T170
using	O
a	O
three-dimensional	B-T082
tracking	B-T082
algorithm	B-T170
.	O
	
in	O
all	O
16	O
eyes	O
,	O
lc	O
strains	O
induced	B-T169
by	O
adduction	B-T169
and	O
abduction	O
were	O
5.83	O
3.78	O
and	O
3.93	O
2.57	O
,	O
respectively	O
,	O
and	O
both	O
significantly	B-T081
higher	I-T081
than	O
the	O
control	O
strains	O
measured	B-T080
from	O
the	O
repeated	B-T169
baseline	B-T081
acquisitions	B-T052
p	O
<	O
0.01	O
.	O
	
strains	O
of	O
lc	O
in	O
adduction	B-T169
were	O
on	O
average	B-T081
higher	B-T080
than	O
those	O
in	O
abduction	O
,	O
but	O
the	O
difference	B-T080
was	O
not	O
statistically	B-T081
significant	I-T081
p	O
=	O
0.07	O
.	O
	
strains	O
of	O
lc	O
induced	B-T169
by	O
iop	O
elevations	B-T082
on	O
average	B-T081
21.13	O
7.61	O
mm	O
hg	O
were	O
6.41	O
3.21	O
and	O
significantly	B-T081
higher	I-T081
than	O
the	O
control	O
strains	O
p	O
<	O
0.0005	O
.	O
	
gaze	O
-	O
induced	B-T169
lc	O
strains	O
in	O
the	O
ppa	B-T033
group	O
were	O
on	O
average	B-T081
larger	B-T081
than	O
those	O
in	O
the	O
non-ppa	O
group	O
however	O
,	O
the	O
relationship	B-T080
was	O
not	O
statistically	B-T081
significant	I-T081
.	O
	
our	O
results	B-T033
confirm	B-T080
that	O
horizontal	O
eye	O
movements	O
generate	B-T080
significant	B-T078
onh	O
strains	O
,	O
which	O
is	O
consistent	B-T078
with	I-T078
our	O
previous	B-T079
estimations	O
using	O
finite	B-T170
element	I-T170
analysis	I-T170
.	O
	
further	B-T062
studies	I-T062
are	O
needed	O
to	O
explore	O
a	O
possible	B-T033
link	O
between	O
onh	O
strains	O
induced	B-T169
by	O
eye	O
movements	O
and	O
axonal	B-T033
loss	I-T033
in	O
optic	B-T047
neuropathies	I-T047
.	O
	
simultaneously	B-T079
targeting	B-T169
myofibroblast	O
contractility	O
and	O
extracellular	O
matrix	O
cross-linking	B-T169
as	O
a	O
therapeutic	B-T169
concept	I-T169
in	O
airway	O
fibrosis	O
fibrosis	O
after	O
solid	B-T061
organ	I-T061
transplantation	I-T061
is	O
considered	O
an	O
irreversible	B-T079
process	O
and	O
remains	O
the	O
major	B-T080
cause	O
of	O
graft	O
dysfunction	O
and	O
death	O
with	O
limited	B-T169
therapies	B-T061
.	O
	
this	O
remodeling	O
is	O
characterized	B-T052
by	O
aberrant	B-T080
accumulation	B-T033
of	O
contractile	O
myofibroblasts	O
that	O
deposit	B-T169
excessive	B-T080
extracellular	O
matrix	O
ecm	O
and	O
increase	B-T169
tissue	O
stiffness	O
.	O
	
studies	B-T062
demonstrate	O
,	O
however	O
,	O
that	O
a	O
stiff	O
ecm	O
itself	O
promotes	B-T052
fibroblast	O
-to-	O
myofibroblast	O
differentiation	O
,	O
stimulating	B-T052
further	O
ecm	O
production	B-T052
.	O
	
this	O
creates	O
a	O
positive	O
feedback	O
loop	O
that	O
perpetuates	B-T080
fibrosis	O
.	O
	
we	O
hypothesized	B-T078
that	O
simultaneously	B-T079
targeting	B-T169
myofibroblast	O
contractility	O
with	O
relaxin	B-T116
and	O
ecm	O
stiffness	O
with	O
lysyl	B-T116
oxidase	I-T116
inhibitors	O
could	O
break	O
the	O
feedback	O
loop	O
,	O
reversing	B-T169
established	B-T080
fibrosis	O
.	O
	
to	O
test	B-T169
this	O
,	O
we	O
used	O
the	O
orthotopic	B-T061
tracheal	I-T061
transplantation	I-T061
ott	B-T061
mouse	O
model	O
,	O
which	O
develops	O
robust	B-T080
fibrotic	B-T169
airway	O
remodeling	O
.	O
	
mice	O
with	O
established	B-T080
fibrosis	O
were	O
treated	B-T169
with	O
saline	O
,	O
mono-	B-T061
,	O
or	O
combination	B-T061
therapies	I-T061
.	O
	
although	O
monotherapies	B-T061
had	O
no	B-T080
effect	I-T080
,	O
combining	O
these	O
agents	O
decreased	B-T081
collagen	B-T116
deposition	B-T169
and	O
promoted	B-T052
re-epithelialization	O
of	O
remodeled	B-T033
airways	I-T033
.	O
	
relaxin	B-T116
inhibited	B-T080
myofibroblast	O
differentiation	O
and	O
contraction	O
in	O
a	O
matrix	O
-	O
stiffness	O
-	O
dependent	B-T169
manner	O
through	O
prostaglandin	B-T109
e2	I-T109
pge2	B-T109
.	O
	
furthermore	O
,	O
the	O
effect	B-T080
of	O
combination	B-T061
therapy	I-T061
was	O
lost	O
in	O
pge2	B-T116
receptor	I-T116
knockout	O
and	O
pge2	B-T109
-	O
inhibited	B-T080
ott	B-T061
mice	O
.	O
	
this	O
study	B-T062
revealed	B-T080
the	O
important	O
synergistic	B-T080
roles	O
of	O
cellular	O
contractility	O
and	O
tissue	O
stiffness	O
in	O
the	O
maintenance	B-T052
of	O
fibrotic	B-T169
tissue	O
and	O
suggests	O
a	O
new	O
therapeutic	B-T169
principle	O
for	O
systemic	B-T116
matrix	I-T116
metalloproteinase-8	I-T116
response	O
in	O
chronic	B-T047
tonsillitis	I-T047
the	O
development	B-T169
of	O
several	O
life-long	O
diseases	B-T047
,	O
such	O
as	O
coronary	B-T047
heart	I-T047
disease	I-T047
,	O
is	O
affected	O
by	O
low-grade	B-T080
systemic	B-T169
inflammation	O
.	O
	
data	B-T078
on	O
the	O
potential	B-T080
long-term	B-T079
health	B-T078
effects	B-T080
of	O
chronic	B-T047
tonsillitis	I-T047
are	O
limited	O
.	O
	
many	O
inflammatory	O
conditions	B-T080
present	O
with	O
enhanced	O
systemic	B-T116
matrix	I-T116
metalloproteinase	I-T116
mmp	B-T116
response	O
.	O
	
in	O
head	O
and	O
neck	O
cancer	O
,	O
high	B-T080
plasma	O
level	B-T080
of	O
tissue	B-T116
inhibitor	I-T116
of	I-T116
metalloproteinase	I-T116
timp	B-T116
predicts	B-T078
poor	B-T033
prognosis	I-T033
.	O
	
we	O
analyzed	O
s-mmp-8	B-T116
with	O
immunofluorometric	O
assay	O
and	O
s-timp-1	B-T116
with	O
an	O
immunosorbent	O
assay	O
in	O
175	O
consecutive	B-T080
patients	O
undergoing	O
tonsillectomy	B-T061
for	O
benign	O
tonsillar	O
disease	O
,	O
and	O
in	O
33	O
control	O
patients	O
with	O
tonsillar	O
squamous	O
cell	O
carcinoma	O
.	O
	
tonsillar	O
human	O
papillomavirus	O
hpv	O
status	O
was	O
determined	O
by	O
pcr	O
.	O
	
in	O
patients	O
with	O
benign	O
tonsillar	O
disease	O
,	O
chronic	B-T047
tonsillitis	I-T047
without	O
hypertrophy	O
was	O
associated	B-T080
with	I-T080
enhanced	O
systemic	B-T116
mmp-8	I-T116
response	O
.	O
	
compared	O
to	O
patients	O
with	O
benign	O
tonsillar	O
disease	O
,	O
patients	O
with	O
tonsillar	O
squamous	O
cell	O
carcinoma	O
had	O
significantly	B-T081
higher	I-T081
concentrations	B-T081
of	O
s-mmp-8	B-T116
and	O
s-timp-1	B-T116
.	O
	
neither	O
s-mmp-8	B-T116
nor	O
s-timp-1	B-T116
correlated	O
with	O
tonsillar	O
hpv	O
positivity	B-T033
.	O
	
addressing	B-T170
holistic	B-T078
health	I-T078
and	O
work	O
empowerment	O
through	B-T169
a	O
body-mind-spirit	O
intervention	O
program	O
among	O
helping	O
professionals	O
in	O
continuous	B-T078
education	O
a	O
pilot	B-T062
study	I-T062
to	O
examine	O
the	O
effectiveness	B-T080
of	O
a	O
body-mind-spirit	O
bms	O
intervention	O
program	O
in	O
improving	B-T080
the	O
holistic	B-T078
well-being	I-T078
and	O
work	O
empowerment	O
among	O
helping	O
professionals	O
in	O
continuous	B-T078
education	O
.	O
	
forty-four	O
helping	O
professionals	O
,	O
who	O
were	O
in	O
their	O
first-year	O
part-time	O
postgraduate	O
study	O
,	O
participated	O
in	O
the	O
present	O
study	O
.	O
	
all	O
participants	B-T098
attended	B-T169
a	O
3-day	O
bms	O
intervention	O
program	O
which	O
emphasized	O
a	O
holistic	B-T078
approach	I-T078
to	O
health	B-T078
and	O
well-being	B-T078
.	O
	
ratings	O
on	O
their	O
levels	B-T080
of	O
physical	B-T033
distress	I-T033
,	O
daily	O
functioning	O
,	O
affect	O
,	O
spirituality	B-T078
,	O
and	O
psychologica	B-T169
l	O
empowerment	O
at	O
work	O
were	O
compared	O
before	O
and	O
immediately	O
after	O
the	O
intervention	O
.	O
	
participants	B-T098
reported	O
significantly	O
lower	O
levels	B-T080
of	O
negative	B-T033
affect	I-T033
and	O
physical	B-T033
distress	I-T033
,	O
and	O
were	O
less	O
spiritually	B-T033
disoriented	I-T033
after	O
the	O
intervention	O
.	O
	
enhanced	B-T052
levels	B-T080
of	O
daily	O
functioning	O
,	O
positive	O
affect	O
,	O
spiritual	O
resilience	O
,	O
and	O
tranquility	O
were	O
also	O
reported	O
.	O
	
results	O
also	O
suggested	O
that	O
participants	B-T098
were	O
empowered	O
at	O
work	O
,	O
and	O
specifically	O
felt	O
more	O
able	O
to	O
make	O
an	O
impact	O
on	O
work	O
outcomes	O
.	O
	
the	O
3-day	O
bms	O
intervention	O
program	O
produced	O
a	O
positive	B-T033
and	O
measurable	B-T169
effec	B-T080
t	O
on	O
participants	B-T098
'	O
holistic	B-T078
well-being	I-T078
and	O
empowerment	O
at	O
work	O
.	O
	
educators	O
in	O
related	O
fields	O
could	O
incorporate	O
holistic	B-T078
practices	O
into	O
the	O
curriculum	B-T170
to	O
better	O
prepare	O
the	O
future	O
practitioners	O
,	O
leading	O
to	O
better	O
outcomes	O
both	O
to	O
the	O
professionals	O
themselves	O
and	O
their	O
clients	O
or	O
successful	B-T061
restoration	I-T061
of	O
severely	O
mutilated	O
primary	O
incisors	O
using	O
a	O
novel	O
method	O
to	O
retain	O
zirconia	O
crowns	O
-	O
two	B-T079
year	I-T079
results	B-T169
this	O
manuscript	O
describes	O
a	O
simple	O
reliable	B-T169
technique	I-T169
for	O
restoring	B-T061
severely	O
mutilated	O
primary	O
anterior	O
teeth	O
.	O
	
a	O
rigid	O
glass	O
ionomer	O
post	O
is	O
created	O
over	O
which	O
zirconia	O
crowns	O
can	O
be	O
fitted	O
to	O
achieve	O
a	O
long-term	B-T079
stable	O
esthetic	B-T061
restoration	B-T061
for	O
primary	O
anterior	O
teeth	O
.	O
	
children	O
aged	O
2-5	O
years	B-T079
with	O
two	O
up	O
to	O
six	O
extensively	O
decayed	B-T047
upper	O
primary	O
incisors	O
were	O
included	O
.	O
	
fuji	O
ix	O
was	O
condensed	O
into	O
an	O
intracanal	B-T061
space	I-T061
created	O
to	O
a	O
depth	B-T082
of	O
3mm	O
,	O
to	O
provide	O
a	O
core	B-T082
which	O
also	O
extended	O
3mm	O
supragingivally	B-T061
.	O
	
crown	B-T061
preparations	I-T061
were	O
completed	O
upon	O
these	O
cores	B-T082
.	O
	
zirconia	O
crowns	O
nusmile	B-T170
,	O
houston	O
texas	O
usa	O
were	O
fitted	O
and	O
cemented	O
over	O
the	O
prepared	O
cores	B-T082
.	O
	
all	O
patients	O
were	O
recalled	B-T061
at	O
regular	B-T079
intervals	I-T079
.	O
	
twenty-three	O
healthy	O
children	O
with	O
86	O
restorations	B-T061
participated	O
in	O
the	O
study	B-T062
.	O
	
the	O
overall	B-T081
survival	I-T081
of	O
the	O
restorations	B-T061
was	O
95.3	O
after	O
12	O
months	B-T079
and	O
80.2	O
after	O
24	O
months	B-T079
.	O
	
according	O
to	O
kaplan-meier	B-T062
survival	I-T062
analysis	I-T062
,	O
the	O
median	B-T079
survival	I-T079
time	I-T079
was	O
not	O
reached	O
while	O
the	O
estimated	O
mean	B-T081
survival	I-T081
time	I-T081
was	O
22.9	O
months	B-T079
.	O
	
this	O
newly	O
described	O
clinical	O
technique	O
is	O
simple	O
and	O
reliable	B-T170
to	O
use	O
for	O
restoration	B-T061
of	O
extensively	O
decayed	B-T047
primary	O
incisors	O
.	O
	
use	O
of	O
zirconia	O
crowns	O
retained	O
using	O
this	O
technique	B-T169
offers	O
superior	B-T080
esthetic	I-T080
,	O
durable	O
restorations	B-T061
with	O
remarkable	O
gingival	B-T033
response	I-T033
up	O
to	O
24	O
reimbursement	B-T170
based	O
on	O
value	O
in	O
knee	B-T061
surgery	I-T061
what	O
you	O
need	O
to	O
know	O
about	O
the	O
medicare	O
access	O
and	O
children's	O
health	O
insurance	O
program	O
reauthorization	O
act	O
of	O
2015	O
health	B-T081
care	I-T081
cost	I-T081
is	O
consuming	O
a	O
large	O
portion	O
of	O
the	O
nation's	O
gross	B-T081
domestic	I-T081
product	I-T081
while	O
placing	O
added	O
economic	B-T081
burdens	I-T081
on	O
physicians	O
and	O
their	O
patients	O
.	O
	
with	O
total	B-T061
joint	I-T061
replacement	I-T061
being	O
one	O
of	O
the	O
early-targeted	O
procedures	B-T061
in	O
the	O
evolving	O
health	O
care	O
environment	O
,	O
knee	O
surgeons	O
will	O
benefit	O
from	O
developing	O
a	O
critical	O
knowledge	O
on	O
health	O
care	O
reforms	O
and	O
their	O
financial	O
implications	O
.	O
	
the	O
medicare	O
access	O
and	O
children's	O
health	O
insurance	O
program	O
reauthorization	O
act	O
represents	O
a	O
cohesive	O
movement	O
toward	O
value-based	O
payment	O
reform	O
and	O
contains	O
several	O
unchartered	O
rulings	O
that	O
require	O
detailed	O
attention	O
by	O
knee	O
surgeons	O
.	O
	
in	O
this	O
article	O
,	O
we	O
provide	O
a	O
contextual	B-T078
framework	I-T078
of	O
health	O
care	O
legislation	O
that	O
has	O
led	O
to	O
the	O
formation	O
of	O
the	O
current	O
health	O
policy	O
,	O
and	O
present	O
a	O
comprehensive	B-T080
summary	B-T170
and	O
update	O
on	O
the	O
merit-based	B-T170
incentive	I-T170
payment	I-T170
systems	I-T170
and	O
alternative	B-T170
payment	I-T170
models	I-T170
reimbursement	I-T170
models	I-T170
.	O
	
empty	B-T080
capsids	O
and	O
macrophage	O
inhibition	B-T052
/	O
depletion	B-T169
increase	B-T169
raav	O
transgene	O
expression	O
in	O
joints	O
of	O
both	O
healthy	B-T080
and	O
arthritic	B-T047
mice	O
gene	B-T061
therapy	I-T061
has	O
potential	B-T080
to	O
treat	B-T061
rheumatic	B-T047
diseases	I-T047
however	O
,	O
the	O
presence	B-T033
of	O
macrophages	O
in	O
the	O
joint	O
might	O
hamper	O
adeno-associated	O
viral	O
vector	O
-mediated	O
gene	O
delivery	O
.	O
	
here	O
we	O
demonstrate	O
that	O
in	O
arthritic	B-T047
,	O
but	O
also	O
in	O
healthy	B-T080
,	O
mice	O
administration	O
of	O
agents	O
that	O
influence	O
macrophage	O
activity	B-T052
/	O
number	B-T081
and/or	O
addition	B-T169
of	O
empty	B-T080
decoy	O
capsids	O
substantially	O
improve	B-T033
the	O
efficacy	B-T080
of	O
recombinant	O
adeno-associated	O
viral	O
vector	O
5	O
transgene	O
expression	O
in	O
the	O
joint	O
.	O
	
pretreatment	B-T052
with	O
triamcinolone	B-T109
or	O
clodronate	B-T109
liposomes	B-T109
improved	B-T033
luciferase	B-T116
expression	O
over	O
a	O
period	B-T079
of	O
4	O
weeks	B-T079
.	O
	
similar	B-T080
results	B-T033
were	O
seen	O
when	O
empty	B-T080
decoy	O
capsids	O
were	O
added	B-T169
to	O
full	B-T080
genome	O
containing	O
capsids	O
in	O
a	O
5	O
ratio	B-T081
.	O
	
in	O
a	O
study	B-T062
to	O
assess	B-T052
the	O
duration	B-T079
of	O
expression	O
as	O
well	O
as	O
to	O
investigate	B-T169
the	O
combination	B-T080
of	O
these	O
two	O
approaches	B-T169
,	O
we	O
observed	B-T169
a	O
synergistic	B-T080
enhancement	B-T052
of	O
gene	O
expression	O
,	O
sustained	B-T169
for	O
at	O
least	O
12	O
weeks	B-T079
.	O
	
the	O
enhancement	B-T052
of	O
gene	O
expression	O
was	O
independent	O
of	O
the	O
route	B-T169
of	I-T169
administration	I-T169
of	O
triamcinolone	B-T109
intra-articular	B-T082
or	O
intramuscular	B-T082
.	O
	
in	O
healthy	B-T080
mice	O
it	O
was	O
demonstrated	O
that	O
the	O
combination	B-T080
improved	B-T033
expression	O
of	O
the	O
transgene	O
significantly	O
,	O
in	O
a	O
serotype	B-T170
independent	O
manner	O
.	O
	
these	O
data	B-T078
have	O
implications	O
for	O
future	O
applications	O
of	O
gene	B-T061
therapy	I-T061
to	O
the	O
joint	O
and	O
for	O
other	O
tissues	O
with	O
an	O
abundance	B-T080
of	O
an	O
inhibitory	B-T052
septum	O
to	O
lateral	O
hypothalamus	O
circuit	O
that	O
suppresses	B-T169
feeding	O
feeding	O
behavior	O
is	O
orchestrated	B-T169
by	O
neural	O
circuits	O
primarily	O
residing	O
in	O
the	O
hypothalamus	O
and	O
hindbrain	O
.	O
	
however	O
,	O
the	O
relative	B-T080
influence	O
of	O
cognitive	B-T169
and	O
emotional	O
brain	O
circuits	O
to	O
the	O
feeding	O
circuitry	O
in	O
the	O
hypothalamus	O
and	O
hindbrain	O
remains	O
unclear	B-T033
.	O
	
here	O
,	O
using	B-T169
the	O
cell-type	B-T170
selectivity	O
of	O
genetic	B-T062
methods	I-T062
,	O
circuit	O
mapping	O
,	O
and	O
behavior	O
assays	O
,	O
we	O
sought	O
to	O
decipher	O
neural	O
circuits	O
emanating	O
from	O
the	O
septal	O
nucleus	O
to	O
the	O
lateral	O
hypothalamus	O
lh	O
that	O
contribute	O
to	O
neural	O
regulation	O
of	O
food	O
intake	O
in	O
mice	O
.	O
	
we	O
found	O
that	O
chemogenetic	B-T169
and	O
optogenetic	B-T169
activation	B-T052
of	O
septal	B-T082
vesicular	B-T116
gaba	I-T116
transporter	I-T116
vgat	B-T116
containing	B-T169
neurons	O
or	O
their	O
projections	O
in	O
the	O
lh	O
reduced	B-T080
food	O
intake	O
in	O
mice	O
.	O
	
consistently	O
,	O
chemogenetic	B-T169
inhibition	B-T052
of	O
septal	B-T082
vgat	B-T116
neurons	O
increased	B-T081
food	O
intake	O
.	O
	
furthermore	O
,	O
we	O
investigated	B-T169
a	O
previously	O
unknown	B-T080
neural	O
circuit	O
originating	B-T079
from	O
septal	B-T082
vgat	B-T116
neurons	O
to	O
a	O
subset	O
of	O
vgat	B-T116
neurons	O
in	O
the	O
lh	O
,	O
an	O
area	B-T082
involved	B-T169
in	O
homeostatic	O
and	O
hedonic	O
control	B-T080
of	O
energy	B-T033
states	I-T033
.	O
	
collectively	O
,	O
our	O
data	B-T078
reveal	B-T080
an	O
inhibitory	B-T052
septohypothalamic	O
feeding	O
circuit	O
that	O
might	O
serve	O
as	O
a	O
therapeutic	B-T169
target	B-T169
for	O
the	O
treatment	B-T169
of	O
eating	O
disorders	O
such	O
as	O
anorexia	O
nervosa	O
.	O
	
our	O
results	O
demonstrate	O
that	O
top-down	O
projections	O
from	O
the	O
septum	O
to	O
the	O
hypothalamus	O
control	B-T080
food	O
intake	O
negatively	B-T033
.	O
	
given	O
the	O
known	O
role	O
for	O
both	O
of	O
these	O
brain	O
regions	O
in	O
the	O
control	B-T080
of	O
feeding	O
and	O
emotion	O
-	O
related	B-T169
behaviors	O
,	O
these	O
findings	B-T033
reveal	B-T080
previously	O
unknown	B-T080
neural	O
circuitry	O
that	O
is	O
likely	O
implicated	O
in	O
emotional	B-T078
aspects	I-T078
of	O
food	O
intake	O
and	O
provide	B-T052
new	O
insights	O
into	O
the	O
development	B-T169
of	O
therapeutic	B-T169
targets	B-T169
for	O
the	O
treatment	B-T169
of	O
eating	O
disorders	O
.	O
	
human	O
umbilical	O
cord	O
blood	O
-	O
derived	B-T078
neural	O
stem	O
cell	O
line	O
as	O
a	O
screening	O
model	O
for	O
toxicity	O
the	O
aim	B-T078
was	O
to	O
investigate	B-T169
whether	O
a	O
human	O
neural	O
stem	O
cell	O
nsc	O
line	O
derived	B-T078
from	O
human	O
umbilical	O
cord	O
blood	O
hucb	O
can	O
be	O
used	O
for	O
toxicity	O
study	B-T062
.	O
	
toxicity	O
of	O
both	O
neurotoxic	O
environmental	B-T082
xenobiotics	O
,	O
methyl	B-T109
mercury	I-T109
chloride	I-T109
ch3hgcl	B-T109
,	O
lead	O
acetate	O
ch3coopb	O
,	O
and	O
chlorpyrifos	B-T109
cp	B-T109
,	O
and	O
non-neurotoxic	B-T033
insecticide	O
,	O
dichlorvos	B-T109
,	O
as	O
well	O
as	O
non-neurotoxic	B-T033
drugs	O
,	O
theophylline	B-T109
and	O
acetaminophen	B-T109
were	O
assessed	B-T052
.	O
	
additionally	O
,	O
differentiation	B-T169
of	O
neuronal	O
and	O
glial	O
cell	O
lines	O
derived	B-T078
from	O
hucb	O
was	O
elucidated	O
.	O
	
it	O
was	O
observed	B-T169
that	O
ch3hgcl	B-T109
was	O
more	O
toxic	B-T080
to	O
human	O
nscs	O
in	O
comparison	B-T052
to	O
ch3coopb	O
and	O
cp	B-T109
.	O
	
the	O
minimum	O
inhibitory	O
concentration	O
mic	O
value	O
against	O
nscs	O
was	O
3	O
,	O
10	O
,	O
and	O
300	O
mg/l	O
,	O
in	O
each	O
staining	O
process	O
,	O
acridine	B-T109
orange	I-T109
/	O
ethidium	B-T109
bromide	I-T109
ao	B-T109
/	O
eb	B-T109
staining	O
,	O
3-	B-T109
tetrazolium	I-T109
bromide	I-T109
mtt	B-T109
assay	O
,	O
and	O
hoechst	O
staining	O
,	O
for	O
ch3hgcl	B-T109
,	O
cp	B-T109
,	O
and	O
ch3coopb	O
,	O
respectively	O
.	O
	
ch3hgcl	B-T109
had	O
the	O
lc25	B-T081
value	B-T080
as	O
10.0	O
,	O
14.4	O
,	O
and	O
12.7	O
mg/l	O
,	O
by	O
staining	O
method	O
mentioned	O
in	O
succession	O
.	O
	
cp	B-T109
had	O
the	O
lc25	B-T081
value	B-T080
as	O
21.9	O
,	O
23.7	O
,	O
and	O
18.4	O
mg/l	O
similarly	O
,	O
ch3coopb	O
had	O
lc25	B-T081
values	B-T080
,	O
successively	O
as	O
616.9	O
,	O
719.2	O
,	O
and	O
890.3	O
mg/l	O
.	O
	
lc50	B-T081
values	B-T080
ranged	B-T081
from	O
18.2	O
to	O
21.7	O
mg/l	O
for	O
ch3hgcl	B-T109
,	O
56.4	O
to	O
60.2	O
mg/l	O
for	O
cp	B-T109
,	O
and	O
1000	O
to	O
1460.1	O
for	O
ch3coopb	O
.	O
	
theophylline	B-T109
,	O
acetaminophen	B-T109
,	O
and	O
dichlorvos	B-T109
had	O
no	O
impact	B-T080
on	O
the	O
viability	B-T080
of	O
nscs	O
.	O
	
this	O
work	O
justified	O
that	O
hucb	O
-	O
nsc	O
model	O
can	O
be	O
used	O
for	O
toxicity	O
study	B-T062
.	O
	
mir	O
221	O
/	O
222	O
as	O
new	O
players	O
in	O
tamoxifen	B-T109
resistance	O
breast	O
cancer	O
is	O
the	O
most	O
frequent	O
cancer	O
in	O
women	B-T098
.	O
	
despite	O
advances	O
in	O
early	O
detection	O
and	O
treatment	B-T061
,	O
it	O
has	O
the	O
second	O
highest	O
mortality	B-T081
rate	I-T081
after	O
lung	O
cancer	O
.	O
	
around	O
85%	O
of	O
breast	O
carcinomas	O
are	O
er+	B-T033
thus	O
,	O
antiestrogens	O
like	O
tamoxifen	B-T109
are	O
beneficial	O
.	O
	
although	O
,	O
tamoxifen	B-T109
is	O
useful	O
for	O
many	O
patients	O
,	O
plenty	O
of	O
patients	O
respond	B-T033
poorly	I-T033
to	O
initial	O
therapy	B-T061
or	O
recurrence	O
occurs	O
in	O
about	O
30%	O
of	O
cases	O
,	O
because	O
tamoxifen	B-T109
resistance	O
happens	O
.	O
	
drug	O
resistance	O
remains	O
a	O
major	O
clinical	B-T080
obstacle	O
to	O
successful	O
treatment	O
of	O
breast	O
cancer	O
and	O
more	O
than	O
90%	O
of	O
unsuccessful	B-T033
treatments	I-T033
are	O
because	O
of	O
acquired	B-T080
resistance	O
and	O
multidrug	O
resistance	O
mdr	O
is	O
a	O
major	O
contributor	O
.	O
	
micrornas	O
are	O
members	O
of	O
a	O
novel	O
class	O
of	O
short	O
noncoding	O
rnas	O
.	O
	
besides	O
to	O
their	O
various	O
roles	O
in	O
gene	O
expression	O
,	O
mirnas	O
are	O
considered	O
as	O
important	O
cancer	O
therapeutic	O
targets	O
and	O
biomarkers	O
.	O
	
since	O
2005	O
,	O
when	O
mirna	O
deregulation	B-T052
was	O
first	O
reported	O
in	O
breast	O
cancer	O
,	O
more	O
than	O
1000	O
reports	B-T170
have	O
been	O
published	O
about	O
mirnas	O
.	O
	
increasing	O
number	O
of	O
studies	B-T062
showed	O
the	O
importance	O
of	O
mirnas	O
in	O
antiestrogen	B-T061
therapy	I-T061
,	O
especially	O
on	O
tamoxifen	B-T109
thus	O
,	O
it	O
is	O
not	O
surprising	O
that	O
these	O
tiny	O
molecules	O
are	O
involved	O
in	O
drug	O
resistance	O
.	O
	
due	O
to	O
the	O
pivotal	O
role	O
of	O
these	O
known	O
rna	O
molecules	O
,	O
in	O
this	O
review	O
,	O
we	O
tried	O
to	O
illustrate	O
the	O
importance	O
of	O
the	O
mirnas	O
as	O
a	O
new	O
player	O
in	O
breast	O
cancer	O
pathogenesis	O
.	O
	
we	O
have	O
also	O
focused	O
on	O
cancer	O
drug	O
resistance	O
mechanisms	B-T169
highlighting	O
the	O
role	O
of	O
important	O
oncomirs	O
,	O
mir	O
221	O
/	O
222	O
,	O
involved	O
in	O
cell	O
cycle	O
deregulation	O
in	O
breast	O
cancer	O
.	O
	
the	O
relationship	O
between	O
these	O
oncomirs	O
with	O
resistance	O
to	O
tamoxifen	B-T109
is	O
also	O
ultra-low	B-T052
activities	I-T052
of	O
a	O
common	O
radioisotope	O
for	O
permission	B-T080
-free	O
tracking	B-T082
of	O
a	O
drosophilid	O
fly	O
in	O
its	O
natural	B-T082
habitat	I-T082
knowledge	O
of	O
a	O
species	O
'	O
ecology	O
,	O
including	O
its	O
movement	O
in	O
time	B-T079
and	O
space	B-T082
,	O
is	O
key	O
for	O
many	O
questions	O
in	O
biology	O
and	O
conservation	B-T080
.	O
	
while	O
numerous	O
tools	O
for	O
tracking	B-T082
larger	O
animals	O
are	O
available	O
,	O
millimetre-sized	O
insects	O
are	O
averse	O
to	O
standard	O
tracking	B-T082
and	O
labelling	B-T062
procedures	I-T062
.	O
	
here	O
,	O
we	O
evaluated	O
the	O
applicability	O
of	O
ultra-low	B-T052
,	O
permission	B-T080
-	O
exempt	B-T052
activities	I-T052
of	O
the	O
metastable	O
isomer	O
of	O
the	O
radionuclide	O
technetium-99	O
for	O
labelling	B-T062
and	O
field	B-T033
detection	I-T033
of	O
the	O
mountain	O
fly	O
drosophila	O
nigrosparsa	O
.	O
	
we	O
demonstrate	O
that	O
an	O
activity	B-T052
of	O
less	O
than	O
10	O
mbq	O
is	O
sufficient	O
to	O
label	B-T062
dozens	O
of	O
flies	O
and	O
detect	B-T033
single	I-T033
individuals	I-T033
using	O
standard	O
radiation	B-T061
protection	I-T061
monitors	O
.	O
	
the	O
methodology	B-T078
presented	O
here	O
is	O
applicable	O
to	O
many	O
small-sized	B-T033
,	O
low-mobility	B-T033
animals	O
as	O
well	O
as	O
independent	O
from	O
light	O
and	O
weather	O
conditions	B-T080
and	O
visual	B-T033
contact	I-T033
with	O
the	O
target	B-T169
organism	O
.	O
	
injury	O
surveillance	O
of	O
female	O
adult	O
zumba	O
dancers	O
we	O
sought	O
to	O
describe	O
the	O
patterns	B-T082
of	O
injury	O
and	O
to	O
establish	O
the	O
injury	O
incidence	B-T081
rates	I-T081
associated	B-T080
with	O
zumba	O
zumba	O
dancers	O
were	O
invited	O
to	O
complete	O
an	O
anonymous	O
web-based	O
survey	B-T170
containing	O
13	O
demographic	B-T078
background	O
and	O
14	O
1	O
yr	B-T079
retrospective	B-T080
injury	O
history	B-T169
questions	B-T170
.	O
	
inclusion	B-T080
criteria	B-T078
stated	O
that	O
the	O
respondents	B-T098
had	O
to	O
be	O
aged	O
18	O
-	O
64	O
yr	B-T079
and	O
currently	O
involved	O
in	O
group	B-T098
-based	O
classes	B-T170
of	O
zumba	O
either	O
as	O
a	O
registered	O
instructor	O
or	O
class	B-T170
participant	B-T098
.	O
	
binomial	O
logistic	O
regression	O
analysis	O
was	O
used	O
to	O
predict	O
the	O
odds	B-T081
of	O
injury	O
during	O
zumba	O
and	O
mann-whitney	B-T170
tests	I-T170
were	O
employed	O
to	O
ascertain	O
differences	O
between	O
groups	B-T098
.	O
	
the	O
survey	B-T170
response	B-T081
rate	I-T081
was	O
74%	O
.	O
	
the	O
final	O
sample	O
of	O
respondents	B-T098
n	O
=	O
138	O
female	O
=	O
100%	O
included	O
19	O
registered	O
instructors	O
and	O
119	O
class	B-T170
participants	B-T098
,	O
of	O
which	O
58%	O
and	O
16%	O
,	O
respectively	O
,	O
sustained	B-T169
1	O
injury	O
during	O
zumba	O
in	O
the	O
past	O
year	B-T079
.	O
	
the	O
odds	B-T081
of	O
injury	O
was	O
7	O
95%	O
ci	B-T081
2	O
-	O
19	O
times	O
greater	B-T081
p	O
<	O
0.01	O
for	O
registered	O
instructors	O
than	O
for	O
class	B-T170
participants	B-T098
.	O
	
zumba	O
dancers	O
had	O
a	O
17	O
95%	O
ci	B-T081
7	O
-	O
28	O
%	O
greater	B-T081
p	O
<	O
0.01	O
odds	B-T081
of	O
injury	O
for	O
every	O
1	O
h	B-T079
of	O
non-	O
zumba	O
-	O
related	O
moderate	O
to	O
vigorous	O
physical	O
activity	O
mvpa	O
engagement	O
per	O
week	B-T079
.	O
	
the	O
injury	O
incidence	B-T081
rate	I-T081
for	O
registered	O
instructors	O
and	O
class	B-T170
participants	B-T098
was	O
5.7	O
95%	O
ci	B-T081
3.1	O
-	O
8.2	O
and	O
3.9	O
95%	O
ci	B-T081
2.5	O
-	O
5.3	O
injuries	O
per	O
1000	O
h	B-T079
of	O
exposure	B-T080
,	O
respectively	O
.	O
	
zumba	O
presents	O
a	O
low	B-T081
risk	I-T081
of	O
injury	O
for	O
registered	O
instructors	O
,	O
the	O
increased	B-T080
risk	I-T080
of	O
injury	O
is	O
likely	O
due	O
to	O
the	O
high	O
total	O
volume	O
of	O
mvpa	O
participated	B-T169
in	O
clinical	B-T080
features	B-T080
of	O
smokers	B-T033
with	O
radiological	O
emphysema	B-T047
but	O
without	O
airway	O
limitation	B-T169
the	O
clinical	O
characteristics	O
of	O
patients	O
with	O
emphysema	B-T047
but	O
without	O
airway	O
limitations	B-T169
remain	O
unknown	B-T080
.	O
	
the	O
goal	B-T170
of	O
this	O
study	B-T062
was	O
to	O
compare	B-T052
the	O
clinical	B-T080
features	B-T080
of	O
current	B-T033
and	O
former	B-T033
smokers	I-T033
without	O
airflow	O
limitation	B-T169
who	O
have	O
radiologic	O
emphysema	B-T047
on	O
chest	O
ct	O
scans	O
vs	O
a	O
control	O
group	O
of	O
current	B-T033
and	O
ex-smokers	B-T033
without	O
emphysema	B-T047
.	O
	
subjects	O
enrolled	O
had	O
anthropometric	O
characteristics	O
recorded	O
,	O
provided	B-T052
a	O
medical	B-T033
history	I-T033
,	O
and	O
underwent	O
low-dose	B-T081
chest	O
ct	O
scanning	O
.	O
	
the	O
following	O
parameters	B-T033
were	O
also	O
evaluated	O
pulmonary	O
function	O
tests	O
including	O
diffusion	O
capacity	O
for	O
carbon	O
monoxide	O
dlco	O
,	O
the	O
modified	O
medical	B-T170
research	I-T170
council	I-T170
dyspnea	I-T170
score	I-T170
,	O
copd	B-T170
assessment	I-T170
test	I-T170
cat	B-T170
,	O
and	O
6-min	O
walk	O
test	O
6mwt	O
.	O
	
a	O
comparison	B-T052
was	O
conducted	O
between	O
those	O
with	O
and	O
without	O
ct	O
-	O
confirmed	B-T033
emphysema	B-T047
.	O
	
of	O
the	O
203	O
subjects	O
,	O
154	O
had	O
emphysema	B-T047
,	O
and	O
49	O
did	O
not	O
.	O
	
adjusted	O
group	B-T098
comparisons	B-T052
revealed	B-T080
that	O
a	O
higher	O
proportion	B-T081
of	O
patients	O
with	O
emphysema	B-T047
according	O
to	O
low-dose	B-T081
chest	O
ct	O
scanning	O
had	O
an	O
abnormal	B-T033
dlco	I-T033
value	B-T081
<	O
80%	O
46%	O
vs	O
19%	O
p	O
=	O
02	O
,	O
a	O
decrease	B-T081
in	O
percentage	B-T081
of	O
oxygen	O
saturation	O
>	O
4%	O
during	O
the	O
6mwt	O
8.5	O
vs	O
0	O
p	O
=	O
04	O
,	O
and	O
an	O
altered	B-T169
quality	B-T078
of	I-T078
life	I-T078
cat	B-T170
score	B-T081
10	O
32%	O
vs	O
14%	O
p	O
=	O
01	O
.	O
	
a	O
detailed	O
analysis	B-T062
of	O
the	O
cat	B-T170
questionnaire	I-T170
items	O
revealed	B-T080
that	O
more	O
patients	O
with	O
emphysema	B-T047
had	O
a	O
score	B-T081
1	O
in	O
the	O
""""	O
chest	O
tightness	O
""""	O
p	O
=	O
05	O
and	O
""""	O
limitation	B-T169
when	O
doing	O
activities	B-T052
at	O
home	B-T082
""""	O
p	O
<	O
01	O
items	O
compared	B-T052
with	O
those	O
with	O
no	B-T033
emphysema	I-T033
.	O
	
they	O
also	O
experienced	O
significantly	O
more	O
exacerbations	B-T033
in	O
the	O
previous	O
year	B-T079
0.19	O
vs	O
0.04	O
p	O
=	O
02	O
.	O
	
a	O
significant	B-T078
proportion	B-T081
of	O
smokers	B-T033
with	O
emphysema	B-T047
according	O
to	O
low-dose	B-T081
chest	O
ct	O
scanning	O
but	O
without	O
airway	O
limitation	B-T169
had	O
alterations	B-T078
in	O
their	O
quality	B-T078
of	I-T078
life	I-T078
,	O
number	O
of	O
exacerbations	B-T033
,	O
dlco	O
values	B-T081
,	O
and	O
oxygen	O
saturation	O
during	O
the	O
6mwt	O
test	O
.	O
	
anti-tumor	O
activity	O
of	O
sl4	B-T109
against	O
breast	O
cancer	O
cells	O
induction	B-T169
of	O
g2/m	O
arrest	O
through	O
modulation	O
of	O
the	O
mapk	B-T116
-dependent	O
p21	B-T116
signaling	O
pathway	O
sl4	B-T109
,	O
a	O
chalcone	B-T109
-based	O
compound	O
,	O
has	O
been	O
shown	O
to	O
retard	B-T080
tumor	B-T033
invasion	I-T033
and	O
angiogenesis	O
by	O
suppressing	B-T169
hif1	B-T116
activity	B-T052
and	O
to	O
induce	B-T169
apoptosis	O
by	O
promoting	B-T052
ros	O
release	B-T169
.	O
	
here	O
,	O
we	O
report	B-T170
that	O
sl4	B-T109
is	O
able	O
to	O
inhibit	B-T052
the	O
proliferation	O
of	O
different	B-T080
types	B-T080
of	O
breast	O
cancer	O
cell	O
in	B-T080
vitro	I-T080
and	O
in	B-T082
vivo	I-T082
by	O
inducing	B-T169
g2/m	O
cell	O
cycle	O
arrest	O
.	O
	
our	O
results	B-T033
showed	O
that	O
sl4	B-T109
exhibited	B-T169
strong	B-T080
anti-proliferative	B-T109
activity	B-T052
in	O
several	O
human	O
breast	O
cancer	O
cell	O
lines	O
,	O
with	O
ic50	B-T081
values	I-T081
lower	B-T052
than	O
1.3	O
μm	O
.	O
	
further	O
studies	B-T062
indicated	B-T033
that	O
sl4	B-T109
induced	B-T169
g2/m	O
arrest	O
in	O
these	O
cell	O
lines	O
.	O
	
mechanistically	O
,	O
sl4	B-T109
reduces	B-T080
the	O
expression	O
of	O
cyclin	B-T116
a2	I-T116
and	O
cdc25c	B-T116
and	O
decreases	B-T081
the	O
activity	O
of	O
the	O
cdc2	B-T116
/	O
cyclin	B-T116
b1	I-T116
complex	O
.	O
	
notably	O
,	O
sl4	B-T109
treatment	B-T061
resulted	B-T169
in	I-T169
an	O
obvious	O
increase	B-T169
in	O
p21	O
mrna	O
and	O
protein	B-T116
levels	B-T080
through	O
activation	O
of	O
mapk	O
signaling	O
pathways	O
,	O
but	O
not	O
the	O
tgf-β	O
pathway	O
.	O
	
sp600125	B-T109
and	O
pd98059	B-T109
,	O
specific	O
inhibitors	O
of	O
jnk	B-T116
kinase	I-T116
and	O
erk	B-T116
kinase	I-T116
,	O
significantly	B-T078
blocked	B-T169
the	O
sl4	B-T109
-	O
induced	B-T169
g2/m	O
phase	O
arrest	O
and	O
upregulation	O
of	O
p21	B-T116
.	O
	
furthermore	O
,	O
sl4	B-T109
suppressed	B-T169
the	O
growth	O
of	O
established	B-T080
breast	O
tumors	O
in	O
nude	O
mice	O
through	O
upregulation	O
of	O
p21	B-T116
and	O
downregulation	O
of	O
cdc25c	B-T116
,	O
and	O
displayed	B-T169
a	O
good	O
safety	O
profile	B-T169
.	O
	
taken	O
together	O
,	O
these	O
findings	B-T033
demonstrate	B-T080
the	O
potential	B-T080
value	B-T080
of	O
sl4	B-T109
as	O
a	O
novel	O
multi-target	B-T109
anti-tumor	I-T109
drug	I-T109
candidate	I-T109
.	O
	
identification	B-T080
of	O
in-chain-functionalized	O
compounds	O
and	O
methyl-branched	B-T109
alkanes	I-T109
in	O
cuticular	O
waxes	O
of	O
triticum	O
aestivum	O
cv	O
.	O
	
bethlehem	O
in	O
this	O
work	O
,	O
cuticular	O
waxes	O
from	O
flag	O
leaf	O
blades	O
and	O
peduncles	O
of	O
triticum	O
aestivum	O
cv	O
.	O
	
bethlehem	O
were	O
investigated	B-T169
in	O
search	O
for	O
novel	B-T080
wax	O
compounds	O
.	O
	
seven	O
wax	O
compound	O
classes	O
were	O
detected	B-T033
that	O
had	O
previously	O
not	O
been	O
reported	O
,	O
and	O
their	O
structures	B-T170
were	O
elucidated	O
using	O
gas	O
chromatography-mass	O
spectrometry	O
of	O
various	O
derivatives	O
.	O
	
six	O
of	O
the	O
classes	O
were	O
identified	O
as	O
series	B-T081
of	I-T081
homologs	I-T081
differing	B-T080
by	O
two	O
methylene	O
units	O
,	O
while	O
the	O
seventh	O
was	O
a	O
homologous	B-T081
series	I-T081
with	O
homologs	O
with	O
single	O
methylene	O
unit	O
differences	O
.	O
	
in	O
the	O
waxes	O
of	O
flag	O
leaf	O
blades	O
,	O
secondary	O
alcohols	O
predominantly	B-T080
c27	O
and	O
c33	O
,	O
primary	B-T109
/	O
secondary	B-T109
diols	I-T109
predominantly	B-T080
c28	B-T109
and	O
esters	B-T109
of	I-T109
primary	I-T109
/	O
secondary	B-T109
diols	I-T109
predominantly	B-T080
c50	B-T109
,	O
combining	O
c28	B-T109
diol	I-T109
with	O
c22	B-T109
acid	I-T109
were	O
found	O
,	O
all	O
sharing	O
similar	O
secondary	O
hydroxyl	O
group	O
positions	O
at	O
and	O
around	O
c-12	O
or	O
ω-12	O
.	O
	
7-	B-T109
and	O
8-hydroxy-2-alkanol	B-T109
esters	I-T109
predominantly	B-T080
c35	B-T109
,	O
7-	B-T109
and	O
8-oxo-2-alkanol	B-T109
esters	I-T109
predominantly	B-T080
c35	B-T109
,	O
and	O
4-alkylbutan-4-olides	B-T109
predominantly	B-T080
c28	B-T109
were	O
found	O
both	O
in	O
flag	O
leaf	O
and	O
peduncle	O
wax	O
mixtures	O
.	O
	
finally	O
,	O
a	O
series	B-T081
of	O
even	O
-	O
and	O
odd-numbered	O
alkane	O
homologs	O
was	O
identified	O
in	O
both	O
leaf	O
and	O
peduncle	O
waxes	O
,	O
with	O
an	O
internal	O
methyl	O
branch	O
preferentially	O
on	O
c-11	B-T109
and	O
c-13	B-T109
of	I-T109
homologs	I-T109
with	I-T109
even	I-T109
total	I-T109
carbon	I-T109
number	I-T109
and	O
on	O
c-12	B-T109
of	I-T109
odd-numbered	I-T109
homologs	I-T109
.	O
	
biosynthetic	O
pathways	O
are	O
suggested	O
for	O
all	O
compounds	B-T080
,	O
based	O
on	O
common	O
structural	B-T170
features	B-T080
and	O
matching	O
chain	B-T081
length	I-T081
profiles	B-T169
with	O
other	O
wheat	O
wax	O
compound	O
pupillary	O
response	O
abnormalities	B-T033
in	O
depressive	O
disorders	O
depressive	O
disorders	O
lack	B-T080
objective	B-T080
physiological	B-T169
measurements	B-T169
to	O
characterize	B-T052
the	O
affected	O
population	O
and	O
facilitate	O
study	B-T062
of	O
relevant	B-T080
mechanisms	B-T169
.	O
	
the	O
melanopsin	B-T116
-	O
mediated	O
light	O
signaling	O
pathway	O
may	O
contribute	O
to	O
seasonal	B-T079
variation	I-T079
and	O
can	O
be	O
measured	B-T080
non-invasively	O
by	O
pupillometry	O
.	O
	
we	O
prospectively	B-T062
studied	I-T062
changes	O
in	O
melanopsin	B-T116
-	O
mediated	O
pupillary	O
constriction	O
in	O
19	O
participants	O
with	O
major	O
depressive	O
disorder	O
mdd	O
and	O
10	O
control	O
across	O
the	O
summer	B-T079
and	I-T079
winter	I-T079
solstices	I-T079
.	O
	
the	O
melanopsin	B-T116
-	O
mediated	O
response	O
,	O
as	O
measured	B-T080
by	O
the	O
pupil's	B-T033
sustained	I-T033
constriction	I-T033
six	O
s	O
after	O
a	O
high	O
intensity	O
blue	O
light	O
stimulus	O
,	O
was	O
marginally	O
attenuated	B-T052
in	O
those	O
with	O
mdd	O
relative	O
to	O
controls	O
p	B-T081
=0	O
.	O
	
the	O
participants	O
with	O
mdd	O
unexpectedly	O
showed	O
a	O
significantly	B-T078
reduced	B-T080
transient	B-T079
pupillary	O
response	O
to	O
low	O
intensity	O
red	O
p	B-T081
=0	O
and	O
blue	O
light	O
p	B-T081
=0	O
,	O
but	O
not	O
high	O
intensity	O
red	O
and	O
blue	O
light	O
.	O
	
sustained	O
pupillary	O
constriction	O
in	O
response	O
to	O
high	O
intensity	O
blue	O
light	O
was	O
more	O
pronounced	O
with	O
increasing	B-T169
daylight	O
hours	B-T079
p	B-T081
=0	O
and	O
was	O
more	O
strongly	O
related	O
to	O
objectively	B-T080
measured	B-T080
versus	O
estimated	B-T081
light	O
exposure	O
.	O
	
melanopsin	B-T116
-	O
mediated	O
impairments	B-T169
in	O
pupil	O
response	O
may	O
serve	O
as	O
a	O
biological	O
marker	O
for	O
vulnerability	B-T033
to	O
depression	O
in	O
low	O
light	O
conditions	B-T080
.	O
	
assessment	O
of	O
these	O
and	O
other	O
responses	O
to	O
light	O
stimuli	O
,	O
such	O
as	O
response	O
to	O
low	O
intensity	O
light	O
,	O
may	O
be	O
useful	O
for	O
the	O
study	B-T062
of	O
the	O
neurobiology	O
of	O
mdd	O
and	O
related	O
mood	O
disorders	O
.	O
	
long	O
noncoding	O
rnas	O
in	O
cardiovascular	B-T047
pathology	I-T047
,	O
diagnosis	B-T062
,	O
and	O
therapy	B-T061
vast	O
parts	O
of	O
mammalian	O
genomes	O
encode	B-T052
for	O
transcripts	O
that	O
are	O
not	O
further	O
translated	O
into	O
proteins	O
.	O
	
the	O
purpose	B-T169
of	O
the	O
majority	B-T080
of	O
such	O
noncoding	O
ribonucleic	O
acids	O
rnas	O
remained	O
paradoxical	B-T080
for	O
a	O
long	O
time	O
.	O
	
however	O
,	O
a	O
growing	B-T169
body	O
of	O
evidence	B-T078
demonstrates	B-T052
that	O
long	O
noncoding	O
rnas	O
are	O
dynamically	B-T169
expressed	O
in	O
different	B-T080
cell	O
types	O
,	O
diseases	B-T047
,	O
or	O
developmental	B-T079
stages	I-T079
to	O
execute	B-T052
a	O
wide	O
variety	O
of	O
regulatory	O
roles	O
at	O
virtually	B-T080
every	O
step	O
of	O
gene	O
expression	O
and	O
translation	O
.	O
	
indeed	O
,	O
long	O
noncoding	O
rnas	O
influence	O
gene	O
expression	O
via	O
epigenetic	O
modulations	O
,	O
through	O
regulating	O
alternative	O
splicing	O
,	O
or	O
by	O
acting	O
as	O
molecular	B-T080
sponges	I-T080
.	O
	
the	O
abundance	B-T080
of	O
long	O
noncoding	O
rnas	O
in	O
the	O
cardiovascular	O
system	O
indicates	O
that	O
they	O
may	O
be	O
part	O
of	O
a	O
complex	B-T080
regulatory	O
network	O
governing	O
physiology	O
and	O
pathology	O
of	O
the	O
heart	O
.	O
	
in	O
this	O
review	O
,	O
we	O
discuss	O
the	O
multifaceted	B-T082
functions	B-T169
of	O
long	O
noncoding	O
rnas	O
and	O
highlight	O
the	O
current	B-T170
literature	I-T170
with	O
an	O
emphasis	O
on	O
cardiac	O
development	O
and	O
disease	B-T047
.	O
	
furthermore	B-T082
,	O
as	O
the	O
enormous	B-T080
spectrum	O
of	O
long	O
noncoding	O
rnas	O
potentially	B-T080
opens	O
up	O
new	O
avenues	B-T082
for	O
diagnosis	B-T062
and	O
prevention	B-T061
of	O
heart	B-T047
failure	I-T047
,	O
we	O
ultimately	O
evaluate	O
the	O
futuristic	B-T079
prospects	I-T079
of	O
long	O
noncoding	O
rnas	O
as	O
biomarkers	O
,	O
and	O
therapeutic	B-T169
targets	O
for	O
the	O
treatment	B-T061
of	O
cardiovascular	B-T047
disorders	I-T047
,	O
flexible	B-T080
coordination	B-T169
of	O
stationary	B-T080
and	O
mobile	B-T169
conversations	O
with	O
gaze	B-T033
resource	B-T081
allocation	I-T081
among	O
multiple	O
joint	O
activities	O
gaze	B-T033
is	O
instrumental	O
in	O
coordinating	B-T169
face-to-face	B-T169
social	B-T033
interactions	I-T033
.	O
	
but	O
little	O
is	O
known	O
about	O
gaze	B-T033
use	O
when	O
social	B-T033
interactions	I-T033
co-occur	B-T052
with	O
other	O
joint	O
activities	O
.	O
	
we	O
investigated	B-T169
the	O
case	O
of	O
walking	O
while	O
talking	O
.	O
	
we	O
assessed	B-T052
how	O
gaze	B-T033
gets	O
allocated	B-T052
among	O
various	O
targets	B-T098
in	O
mobile	B-T169
conversations	O
,	O
whether	O
allocation	B-T052
of	O
gaze	B-T033
to	O
other	O
targets	B-T098
affects	O
conversational	O
coordination	B-T169
,	O
and	O
whether	O
reduced	B-T080
availability	B-T169
of	I-T169
gaze	B-T033
for	O
conversational	O
coordination	B-T169
affects	O
conversational	O
performance	O
and	O
content	O
.	O
	
in	O
an	O
experimental	B-T062
study	I-T062
,	O
pairs	O
were	O
videotaped	O
in	O
four	O
conditions	B-T080
of	O
mobility	B-T033
standing	B-T082
still	I-T082
,	O
talking	O
while	O
walking	O
along	O
a	O
straight-line	O
itinerary	O
,	O
talking	O
while	O
walking	O
along	O
a	O
complex	B-T080
itinerary	I-T080
,	O
or	O
walking	O
along	O
a	O
complex	B-T080
itinerary	I-T080
with	O
no	B-T033
conversational	I-T033
task	O
.	O
	
gaze	B-T033
to	O
partners	B-T098
was	O
substantially	B-T080
reduced	I-T080
in	O
mobile	B-T169
conversations	O
,	O
but	O
gaze	B-T033
was	O
still	O
used	O
to	O
coordinate	B-T169
conversation	O
via	O
displays	B-T169
of	O
mutual	B-T080
orientation	B-T082
,	O
and	O
conversational	O
performance	O
and	O
content	O
was	O
not	O
different	B-T080
between	O
stationary	B-T080
and	O
mobile	B-T169
conditions	B-T080
.	O
	
results	O
expand	O
the	O
phenomena	O
of	O
multitasking	O
to	O
joint	O
activities	O
.	O
	
sepsis	B-T047
clinical	B-T080
criteria	I-T080
in	O
emergency	O
department	O
patients	O
admitted	O
to	O
an	O
intensive	O
care	O
unit	O
an	O
external	B-T062
validation	I-T062
study	I-T062
of	O
quick	B-T033
sequential	I-T033
organ	I-T033
failure	I-T033
assessment	I-T033
quick	B-T033
sequential	I-T033
organ	I-T033
failure	I-T033
assessment	I-T033
qsofa	B-T033
is	O
a	O
prognostic	B-T081
score	I-T081
for	O
patients	O
with	O
sepsis	B-T047
.	O
	
our	O
aim	B-T078
was	O
to	O
compare	O
the	O
area	B-T081
under	I-T081
the	I-T081
receiver	I-T081
operating	I-T081
curve	I-T081
auroc	B-T081
,	O
sensitivity	B-T081
,	O
specificity	B-T081
,	O
and	O
likelihood	B-T081
ratios	I-T081
of	O
qsofa	B-T033
vs	O
.	O
	
systemic	B-T047
inflammation	I-T047
response	I-T047
syndrome	I-T047
sirs	B-T047
in	O
predicting	O
in-hospital	B-T080
mortality	I-T080
among	O
emergency	O
department	O
ed	O
patients	O
with	O
suspected	O
infection	O
admitted	O
to	O
intensive	O
care	O
units	O
icus	O
.	O
	
we	O
conducted	O
a	O
retrospective	B-T062
cohort	I-T062
chart	I-T062
review	I-T062
study	I-T062
of	O
ed	O
patients	O
admitted	O
to	O
an	O
icu	O
with	O
suspected	O
infection	O
from	O
august	B-T080
1	O
,	O
2012	O
to	O
february	B-T080
28	O
,	O
2015	O
.	O
	
we	O
included	O
all	O
patients	O
with	O
body	O
fluid	O
cultures	O
sampled	O
either	O
during	O
their	O
ed	O
stay	O
without	O
antibiotic	B-T061
administration	I-T061
or	O
within	O
24	O
h	O
of	O
antibiotics	B-T061
administered	I-T061
in	O
the	O
ed	O
.	O
	
trained	O
chart	O
abstractors	O
blinded	O
to	O
the	O
study	B-T062
hypothesis	O
double-entered	B-T078
data	I-T078
from	O
each	O
patient's	O
electronic	B-T170
medical	I-T170
record	I-T170
including	O
demographic	O
characteristics	O
,	O
vital	O
signs	O
,	O
laboratory	O
study	O
results	O
,	O
physical	O
examination	O
findings	B-T033
,	O
and	O
in-hospital	B-T080
mortality	I-T080
.	O
	
we	O
then	O
calculated	O
the	O
auroc	B-T081
,	O
sensitivity	B-T081
,	O
specificity	B-T081
,	O
and	O
likelihood	B-T081
ratios	I-T081
for	O
qsofa	B-T033
and	O
sirs	B-T047
for	O
predicting	O
in-hospital	B-T080
mortality	I-T080
.	O
	
of	O
214	O
patients	O
admitted	O
to	O
an	O
icu	O
with	O
presumed	B-T047
sepsis	I-T047
,	O
39	O
18.2	O
died	B-T033
during	I-T033
hospitalization	I-T033
.	O
	
the	O
auroc	B-T081
value	O
was	O
0.65	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
0.56	O
for	O
sirs	B-T047
vs	O
.	O
	
0.66	O
95%	O
ci	B-T081
0.57	O
for	O
qsofa	B-T033
2+	O
qsofa	B-T033
criteria	O
predicted	O
in-hospital	B-T080
mortality	I-T080
with	O
89.7	O
sensitivity	B-T081
,	O
27.4	O
specificity	B-T081
,	O
1.2	O
positive	B-T081
likelihood	I-T081
ratio	I-T081
,	O
and	O
0.4	O
negative	B-T081
likelihood	I-T081
ratio	I-T081
.	O
	
among	O
ed	O
patients	O
admitted	O
to	O
an	O
icu	O
,	O
the	O
sirs	B-T047
and	O
qsofa	B-T033
criteria	O
had	O
comparable	O
prognostic	B-T081
value	I-T081
for	O
predicting	O
in-hospital	B-T080
mortality	I-T080
.	O
	
these	O
prognostic	B-T081
values	I-T081
are	O
similar	O
to	O
those	O
reported	O
by	O
the	O
sepsis-3	B-T170
guidelines	I-T170
for	O
icu	O
encounters	B-T170
.	O
	
repetitive	B-T061
transcranial	I-T061
magnetic	I-T061
stimulation	I-T061
improves	O
cognitive	O
function	O
of	O
alzheimer's	B-T047
disease	I-T047
patients	O
repetitive	B-T061
transcranial	I-T061
magnetic	I-T061
stimulation	I-T061
rtms	B-T061
acts	O
as	O
a	O
kind	O
of	O
widely-applied	O
and	O
non-invasive	O
method	O
in	O
the	O
intervention	B-T061
of	O
some	O
neurological	B-T047
disorders	I-T047
.	O
	
this	O
prospective	B-T062
,	O
randomized	B-T062
,	O
double-blind	B-T062
,	O
placebo-controlled	B-T062
trial	I-T062
investigates	B-T169
the	O
effect	O
of	O
rtms	B-T061
on	O
30	O
cases	B-T169
of	O
alzheimer's	B-T047
disease	I-T047
ad	B-T047
participants	B-T098
,	O
who	O
were	O
classified	O
into	O
mild	B-T080
and	O
moderate	B-T080
groups	B-T098
.	O
	
neuropsychological	O
tests	O
were	O
carried	O
out	O
using	O
the	O
ad	B-T170
assessment	I-T170
scale	I-T170
-	O
cognitive	B-T170
subscale	I-T170
adas	B-T170
-	O
cog	B-T170
,	O
mini-mental	O
state	O
examination	O
mmse	O
,	O
montreal	B-T170
cognitive	I-T170
assessment	I-T170
moca	B-T170
,	O
and	O
world	B-T170
health	I-T170
organization	I-T170
university	I-T170
of	I-T170
california-los	I-T170
angeles	I-T170
,	O
auditory	I-T170
verbal	I-T170
learning	I-T170
test	I-T170
who-ucla	B-T170
avlt	I-T170
before	O
,	O
immediately	O
after	O
,	O
and	O
6	O
weeks	B-T079
after	O
the	O
intervention	B-T061
.	O
	
in	O
this	O
work	O
,	O
data	B-T078
from	O
30	O
ad	B-T047
patients	O
revealed	O
that	O
there	O
was	O
no	O
obvious	O
interaction	O
effect	O
of	O
time-by-group	O
.	O
	
the	O
adas	B-T170
-	O
cog	B-T170
,	O
mmse	O
and	O
who-ucla	B-T170
avlt	I-T170
score	B-T081
in	O
the	O
rtms	B-T061
group	B-T098
was	O
significantly	O
improved	O
compared	B-T052
with	O
baselines	B-T081
at	O
6	O
weeks	B-T079
after	O
treatment	B-T061
all	O
p<0	O
.	O
	
meanwhile	O
,	O
moca	B-T170
scores	B-T081
were	O
also	O
obviously	O
ameliorated	B-T033
in	O
the	O
mild	B-T080
ad	B-T047
patients	O
with	O
rtms	B-T061
.	O
	
besides	O
,	O
subgroup	B-T062
analysis	I-T062
showed	O
that	O
the	O
effect	O
of	O
rtms	B-T061
on	O
the	O
memory	O
and	O
language	O
of	O
mild	B-T080
ad	B-T047
patients	O
was	O
superior	O
to	O
those	O
of	O
moderate	B-T080
ad	B-T047
patients	O
.	O
	
in	O
conclusion	O
,	O
our	O
findings	B-T033
suggested	O
that	O
repetitive	B-T061
transcranial	I-T061
magnetic	I-T061
stimulation	I-T061
improves	O
cognitive	O
function	O
,	O
memory	O
and	O
language	O
level	B-T080
of	O
ad	B-T047
patients	O
,	O
especially	O
in	O
the	O
mild	B-T080
stage	B-T079
of	O
ad	B-T047
.	O
	
thus	O
,	O
rtms	B-T061
can	O
be	O
recommended	O
as	O
a	O
promising	O
adjuvant	B-T061
therapy	I-T061
combined	O
with	O
cholinesterase	B-T109
inhibitors	I-T109
at	O
the	O
mild	B-T080
stage	B-T079
of	O
ad	B-T047
patients	O
.	O
	
a	O
novel	B-T080
insulin/glucose	B-T081
model	B-T170
after	O
a	O
mixed-meal	O
test	O
in	O
patients	O
with	O
type	B-T047
1	I-T047
diabetes	I-T047
on	O
insulin	O
pump	O
therapy	B-T061
current	B-T079
closed-loop	O
insulin	O
delivery	O
methods	O
stem	O
from	O
sophisticated	O
models	O
of	O
the	O
glucose-insulin	B-T081
g/i	I-T081
system	I-T081
,	O
mostly	B-T078
based	O
on	O
complex	B-T080
studies	B-T062
employing	B-T033
glucose	O
tracer	O
technology	O
.	O
	
we	O
tested	B-T169
the	O
performance	B-T052
of	O
a	O
new	O
minimal	B-T170
model	I-T170
glukinsloop	B-T170
2.0	I-T170
of	O
the	O
g/i	B-T081
system	I-T081
to	O
characterize	B-T052
the	O
glucose	B-T081
and	I-T081
insulin	I-T081
dynamics	O
during	O
multiple	B-T081
mixed	O
meal	O
tests	O
mmt	O
of	O
different	B-T080
sizes	B-T082
in	O
patients	O
with	O
type	B-T047
1	I-T047
diabetes	I-T047
t1d	B-T047
on	O
insulin	O
pump	O
therapy	B-T061
continuous	B-T061
subcutaneous	I-T061
insulin	I-T061
infusion	I-T061
,	O
csii	B-T061
.	O
	
the	O
glukinsloop	B-T170
2.0	I-T170
identified	B-T080
the	O
g/i	B-T081
system	I-T081
,	O
provided	B-T052
a	O
close	O
fit	O
of	O
the	O
g/i	B-T081
time-courses	B-T079
and	O
showed	O
acceptable	B-T080
reproducibility	B-T080
of	O
the	O
g/i	B-T081
system	I-T081
parameters	B-T033
in	O
repeated	B-T169
studies	B-T062
of	O
identical	B-T080
and	O
double-sized	B-T081
mmts	O
.	O
	
this	O
model	B-T170
can	O
provide	B-T052
a	O
fairly	O
good	O
and	O
reproducible	O
description	B-T170
of	O
the	O
g/i	B-T081
system	I-T081
in	O
t1d	B-T047
patients	O
on	O
csii	B-T061
,	O
and	O
it	O
may	O
be	O
applied	B-T169
to	O
create	O
a	O
bank	O
of	O
"""virtual"""	O
patients	O
.	O
	
our	O
results	O
might	O
be	O
relevant	B-T080
at	O
improving	B-T080
the	O
architecture	O
of	O
upcoming	O
closed-loop	B-T169
csii	B-T061
impact	B-T080
of	O
strategically	O
located	O
white	O
matter	O
hyperintensities	O
on	O
cognition	O
in	O
memory	O
clinic	O
patients	O
with	O
small	B-T047
vessel	I-T047
disease	I-T047
studies	O
on	O
the	O
impact	B-T080
of	O
small	B-T047
vessel	I-T047
disease	I-T047
svd	B-T047
on	O
cognition	O
generally	O
focus	B-T082
on	O
white	O
matter	O
hyperintensity	O
wmh	O
volume	B-T081
.	O
	
the	O
extent	B-T082
to	O
which	O
wmh	O
location	O
relates	B-T080
to	O
cognitive	O
performance	O
has	O
received	B-T080
less	B-T081
attention	O
,	O
but	O
is	O
likely	O
to	O
be	O
functionally	B-T169
important	B-T080
.	O
	
we	O
examined	O
the	O
relation	B-T080
between	O
wmh	O
location	O
and	O
cognition	O
in	O
a	O
memory	O
clinic	O
cohort	B-T098
of	O
patients	O
with	O
sporadic	B-T079
svd	B-T047
.	O
	
a	O
total	O
of	O
167	O
patients	O
with	O
svd	B-T047
were	O
recruited	O
from	O
memory	O
clinics	O
.	O
	
assumption-free	B-T062
region	I-T062
of	I-T062
interest-based	I-T062
analyses	I-T062
based	B-T169
on	O
major	O
white	O
matter	O
tracts	O
and	O
voxel	O
-	O
wise	B-T169
analyses	B-T062
were	O
used	B-T169
to	O
determine	O
the	O
association	B-T080
between	O
wmh	O
location	O
and	O
executive	O
functioning	O
,	O
visuomotor	O
speed	O
and	O
memory	O
.	O
	
region	B-T062
of	I-T062
interest-based	I-T062
analyses	I-T062
showed	O
that	O
wmhs	O
located	O
particularly	O
within	B-T082
the	O
anterior	O
thalamic	O
radiation	O
and	O
forceps	O
minor	O
were	O
inversely	B-T080
associated	B-T080
with	I-T080
both	O
executive	O
functioning	O
and	O
visuomotor	O
speed	O
,	O
independent	B-T169
of	I-T169
total	B-T080
wmh	O
volume	B-T081
.	O
	
memory	O
was	O
significantly	O
associated	B-T080
with	I-T080
wmh	O
volume	B-T081
in	O
the	O
forceps	O
minor	O
,	O
independent	B-T169
of	I-T169
total	B-T080
wmh	O
volume	B-T081
.	O
	
an	O
independent	B-T062
assumption-free	I-T062
voxel-wise	I-T062
analysis	I-T062
identified	B-T080
strategic	O
voxels	O
in	O
these	O
same	B-T080
tracts	O
.	O
	
region	B-T062
of	I-T062
interest-based	I-T062
analyses	I-T062
showed	O
that	O
wmh	O
volume	B-T081
within	B-T082
the	O
anterior	O
thalamic	O
radiation	O
explained	O
6.8	O
of	O
variance	B-T080
in	O
executive	O
functioning	O
,	O
compared	B-T052
to	O
3.9	O
for	O
total	B-T080
wmh	O
volume	B-T081
wmh	O
volume	B-T081
within	B-T082
the	O
forceps	O
minor	O
explained	O
4.6	O
of	O
variance	B-T080
in	O
visuomotor	O
speed	O
and	O
4.2	O
of	O
variance	B-T080
in	O
memory	O
,	O
compared	B-T052
to	O
1.8	O
and	O
1.3	O
respectively	O
for	O
total	B-T080
wmh	O
volume	B-T081
.	O
	
our	O
findings	B-T033
identify	B-T080
the	O
anterior	O
thalamic	O
radiation	O
and	O
forceps	O
minor	O
as	O
strategic	O
white	O
matter	O
tracts	O
in	O
which	O
wmhs	O
are	O
most	O
strongly	O
associated	B-T080
with	I-T080
cognitive	O
impairment	O
in	O
memory	O
clinic	O
patients	O
with	O
svd	B-T047
.	O
	
wmh	O
volumes	B-T081
in	O
individual	O
tracts	O
explained	O
more	O
variance	B-T080
in	O
cognition	O
than	O
total	B-T080
wmh	O
burden	O
,	O
emphasizing	O
the	O
importance	B-T080
of	O
lesion	B-T033
location	I-T033
when	O
addressing	O
the	O
functional	B-T169
consequences	B-T169
of	I-T169
wmhs	O
.	O
	
natural	B-T169
competence	B-T080
for	O
transformation	O
while	O
most	O
molecular	O
biologists	O
are	O
familiar	O
with	O
the	O
artificial	B-T080
transformation	O
of	O
bacteria	O
in	O
the	O
context	B-T078
of	O
laboratory	O
cloning	B-T062
experiments	B-T062
,	O
natural	B-T169
competence	B-T080
for	O
transformation	O
refers	O
to	O
a	O
specific	B-T080
physiological	B-T169
state	B-T169
in	O
which	O
prokaryotes	O
are	O
able	O
to	O
take	O
up	O
genetic	O
material	O
from	O
their	O
surroundings	B-T082
.	O
	
occasionally	O
,	O
such	O
absorbed	B-T169
dna	O
is	O
recombined	B-T080
into	O
the	O
organism's	O
own	O
genome	O
,	O
resulting	O
in	O
natural	B-T169
transformation	O
figure	O
1	O
.	O
	
as	O
a	O
consequence	B-T169
,	O
natural	B-T169
competence	B-T080
for	O
transformation	O
is	O
considered	O
a	O
primary	B-T080
mode	B-T169
of	O
horizontal	O
gene	O
transfer	O
hgt	O
in	O
prokaryotes	O
,	O
together	O
with	O
conjugation	O
direct	B-T080
cell	O
to	O
cell	O
transfer	B-T078
of	O
dna	O
via	O
a	O
specialized	O
conjugal	O
pilus	O
and	O
phage	O
transduction	O
dna	O
transfer	B-T078
mediated	O
by	O
viruses	O
.	O
	
hgt	O
plays	O
a	O
major	O
role	O
in	O
bacterial	B-T080
evolution	O
,	O
and	O
past	B-T079
research	B-T062
has	O
demonstrated	O
that	O
hgt	O
,	O
including	O
natural	B-T169
competence	B-T080
for	O
transformation	O
,	O
contributes	B-T052
to	O
the	O
emergence	O
of	O
pathogens	O
and	O
the	O
spread	B-T080
of	O
virulence	B-T109
factors	I-T109
.	O
	
indeed	O
,	O
frederick	O
griffith	O
discovered	O
natural	B-T169
competence	B-T080
for	O
transformation	O
in	O
1928	O
while	O
he	O
was	O
investigating	B-T169
the	O
exchange	O
of	O
pathogenic	B-T033
traits	O
in	O
pneumococci	O
.	O
	
due	O
to	O
the	O
increase	B-T169
in	O
the	O
abundance	B-T080
and	O
spread	B-T080
of	O
multidrug-resistant	O
microbes	O
,	O
research	B-T062
on	O
hgt	O
three-dimensional	B-T169
constructive	I-T169
interference	I-T169
in	I-T169
steady-state	I-T169
3d-ciss	I-T169
sequences	I-T169
and	O
phase-contrast	O
mri	O
of	O
arrested	B-T047
hydrocephalus	I-T047
to	O
evaluate	O
role	O
of	O
three-dimensional	B-T169
constructive	I-T169
interference	I-T169
in	I-T169
steady-state	I-T169
3d-ciss	I-T169
sequences	I-T169
and	O
phase-contrast	O
magnetic	O
resonance	O
imaging	O
pc-mri	O
in	O
patients	O
with	O
arrested	B-T047
hydrocephalus	I-T047
.	O
	
prospective	B-T062
study	I-T062
was	O
conducted	O
on	O
20	O
patients	O
with	O
arrested	B-T047
hydrocephalus	I-T047
.	O
	
all	O
patients	O
underwent	O
pc-mri	O
and	O
3d-ciss	B-T169
for	O
assessment	O
of	O
the	O
aqueduct	O
.	O
	
axial	B-T082
through-plane	B-T082
,	O
sagittal	B-T082
in-plane	B-T082
pc-mri	O
and	O
sagittal	B-T082
3d-ciss	B-T169
were	O
applied	O
to	O
assess	O
the	O
cerebral	O
aqueduct	O
and	O
the	O
spontaneous	B-T169
third	B-T061
ventriculostomy	I-T061
if	O
present	O
.	O
	
aqueductal	O
patency	B-T082
was	O
graded	O
using	O
3d-ciss	B-T169
and	O
pc-mri	O
.	O
	
quantitative	O
analysis	O
of	O
flow	O
through	O
the	O
aqueduct	O
was	O
done	O
using	O
pc-mri	O
.	O
	
the	O
causes	O
of	O
obstruction	O
were	O
aqueductal	O
obstruction	O
in	O
75%	O
n=15	O
,	O
3rd	O
ventricular	B-T047
obstruction	I-T047
in	O
5%	O
n=1	O
and	O
4th	O
ventricular	B-T047
obstruction	I-T047
in	O
20	O
%	O
n=4	O
.	O
	
the	O
cause	O
of	O
arrest	B-T079
of	O
hydrocephalus	B-T047
was	O
spontaneous	B-T169
third	B-T061
ventriculostomy	I-T061
in	O
65%	O
n=13	O
,	O
endoscopic	B-T061
third	I-T061
ventriculostomy	I-T061
in	O
10%	O
n=2	O
,	O
ventriculo-peritoneal	O
shunt	O
in	O
5%	O
n=1	O
and	O
no	O
cause	O
could	O
be	O
detected	B-T033
in	O
20%	O
of	O
patients	O
n=4	O
.	O
	
there	O
is	O
a	O
positive	B-T033
correlation	B-T080
r=	O
0.80	O
and	O
moderate	B-T080
agreement	O
κ=	O
0.509	O
of	O
grading	O
with	O
pc-mri	O
and	O
3d-ciss	B-T169
sequences	I-T169
.	O
	
the	O
mean	B-T081
peak	I-T081
systolic	I-T081
velocity	I-T081
of	O
csf	O
was	O
1.86	O
2.48	O
cm/sec	O
,	O
the	O
stroke	O
volume	O
was	O
6.43	O
13.81μl	O
,	O
and	O
the	O
mean	B-T081
flow	I-T081
was	O
0.21	O
0.32	O
ml/min	O
.	O
	
we	O
concluded	O
that	O
3d-ciss	B-T169
and	O
pc-mri	O
are	O
non-invasive	B-T169
sequences	O
for	O
diagnosis	B-T033
of	O
the	O
level	O
and	O
cause	B-T169
of	O
arrested	B-T047
hydrocephalus	I-T047
.	O
	
historical	B-T079
environment	B-T082
is	O
reflected	O
in	O
modern	O
population	O
genetics	O
and	O
biogeography	O
of	O
an	O
island	O
endemic	B-T169
lizard	O
xantusia	O
riversiana	O
reticulata	O
the	O
restricted	B-T169
distribution	I-T169
and	O
isolation	B-T169
of	O
island	O
endemics	B-T169
often	O
produces	O
unique	O
genetic	O
and	O
phenotypic	O
diversity	B-T080
of	O
conservation	B-T080
interest	O
to	O
management	O
agencies	O
.	O
	
however	O
,	O
these	O
isolated	B-T169
species	O
,	O
especially	O
those	O
with	O
sensitive	B-T169
life	O
history	O
traits	O
,	O
are	O
at	O
high	B-T033
risk	I-T033
for	O
the	O
adverse	O
effects	O
of	O
genetic	O
drift	O
and	O
habitat	B-T082
degradation	B-T169
by	O
non-native	O
wildlife	O
.	O
	
here	O
,	O
we	O
study	B-T062
the	O
population	B-T098
genetic	O
diversity	O
,	O
structure	B-T082
,	O
and	O
stability	B-T080
of	O
a	O
classic	O
""""	O
island	O
giant	O
""""	O
xantusia	O
riversiana	O
,	O
the	O
island	O
night	O
lizard	O
on	O
san	O
clemente	O
island	O
,	O
california	O
following	O
the	O
removal	B-T052
of	O
feral	O
goats	O
.	O
	
using	O
dna	O
microsatellites	O
,	O
we	O
found	O
that	O
this	O
population	B-T098
is	O
reasonably	O
genetically	B-T169
robust	B-T080
despite	O
historical	B-T079
grazing	O
,	O
with	O
similar	O
effective	O
population	B-T081
sizes	I-T081
and	O
genetic	O
diversity	O
metrics	O
across	O
all	O
sampling	B-T078
locations	O
irrespective	O
of	O
habitat	B-T082
type	O
and	O
degree	B-T080
of	I-T080
degradation	I-T080
.	O
	
however	O
,	O
we	O
also	O
found	O
strong	O
site-specific	B-T082
patterns	B-T082
of	O
genetic	O
variation	O
and	O
low	O
genetic	O
diversity	O
compared	O
to	O
mainland	O
congeners	O
,	O
warranting	O
continued	O
special	O
management	O
as	O
an	O
island	O
endemic	B-T169
.	O
	
we	O
identify	O
both	O
high	B-T080
and	O
low	B-T080
elevation	B-T082
areas	I-T082
that	O
remain	O
valuable	O
repositories	O
of	O
genetic	O
diversity	O
and	O
provide	O
a	O
case	B-T170
study	I-T170
for	O
other	O
low-dispersal	O
coastal	B-T082
organisms	O
in	O
the	O
face	O
of	O
future	B-T079
climate	O
change	O
.	O
	
cross-species	O
rhesus	O
cytomegalovirus	B-T047
infection	I-T047
of	O
cynomolgus	O
macaques	O
cytomegaloviruses	O
cmv	O
are	O
highly	O
species-specific	O
due	O
to	O
millennia	O
of	O
co-evolution	O
and	O
adaptation	O
to	O
their	O
host	O
,	O
with	O
no	O
successful	O
experimental	O
cross-	O
species	O
infection	O
in	O
primates	O
reported	O
to	O
date	O
.	O
	
accordingly	O
,	O
full	O
genome	O
phylogenetic	B-T062
analysis	I-T062
of	O
multiple	O
new	O
cmv	O
field	O
isolates	O
derived	O
from	O
two	O
closely	O
related	O
nonhuman	O
primate	O
species	O
,	O
indian-origin	B-T033
rhesus	O
macaques	O
rm	O
and	O
mauritian	O
-origin	O
cynomolgus	O
macaques	O
mcm	O
,	O
revealed	O
distinct	O
and	O
tight	O
lineage	O
clustering	O
according	O
to	O
the	O
species	B-T033
of	I-T033
origin	I-T033
,	O
with	O
mcm	O
cmv	O
isolates	O
mirroring	O
the	O
limited	O
genetic	O
diversity	O
of	O
their	O
primate	O
host	O
that	O
underwent	O
a	O
population	O
bottleneck	O
400	O
years	O
ago	O
.	O
	
despite	O
the	O
ability	O
of	O
rhesus	O
cmv	O
rhcmv	O
laboratory	O
strain	O
68-1	O
to	O
replicate	B-T080
efficiently	O
in	O
mcm	O
fibroblasts	O
and	O
potently	O
inhibit	O
antigen	O
presentation	O
to	O
mcm	O
t	O
cells	O
in	B-T080
vitro	I-T080
,	O
rhcmv	O
68-1	O
failed	O
to	O
productively	O
infect	O
mcm	O
in	B-T082
vivo	I-T082
,	O
even	O
in	O
the	O
absence	O
of	O
host	O
cd8+	O
t	O
and	O
nk	O
cells	O
.	O
	
in	O
contrast	O
,	O
rhcmv	O
clone	O
68-1	O
,	O
genetically	B-T169
repaired	O
to	O
express	O
the	O
homologues	O
of	O
the	O
hcmv	O
anti-apoptosis	O
gene	B-T116
ul36	I-T116
and	O
epithelial	O
cell	O
tropism	O
genes	B-T116
ul128	I-T116
and	O
ul130	B-T116
absent	O
in	O
68-1	O
,	O
efficiently	O
infected	O
mcm	B-T098
as	O
evidenced	O
by	O
the	O
induction	O
of	O
transgene	O
-specific	O
t	O
cells	O
and	O
virus	O
shedding	O
.	O
	
recombinant	B-T116
variants	I-T116
of	O
rhcmv	O
68-1	O
and	O
68-1	O
revealed	O
that	O
expression	O
of	O
either	O
ul36	B-T116
or	O
ul128	B-T116
together	O
with	O
ul130	B-T116
enabled	O
productive	O
mcm	B-T098
infection	O
,	O
indicating	O
that	O
multiple	O
layers	O
of	O
cross-	O
species	O
restriction	B-T169
operate	O
even	O
between	O
closely	O
related	O
hosts	O
.	O
	
cumulatively	O
,	O
these	O
results	O
implicate	O
cell	O
tropism	O
and	O
evasion	O
of	O
apoptosis	O
as	O
critical	O
determinants	B-T169
of	O
cmv	O
transmission	O
across	O
primate	O
species	O
barriers	O
,	O
and	O
extend	O
the	O
macaque	O
model	B-T170
of	O
human	O
cmv	O
infection	O
and	O
immunology	O
to	O
mcm	B-T098
,	O
a	O
nonhuman	O
primate	O
species	O
with	O
uniquely	O
simplified	O
host	O
immunogenetics	O
.	O
	
mildly	B-T080
raised	B-T080
tricuspid	B-T033
regurgitant	I-T033
velocity	I-T033
2.5	O
m/s	O
in	O
pregnant	B-T098
women	I-T098
with	O
sickle	B-T047
cell	I-T047
disease	I-T047
is	O
not	O
associated	B-T080
with	I-T080
poor	B-T080
obstetric	B-T169
outcome	B-T169
-	O
an	O
observational	B-T062
cross-sectional	I-T062
study	I-T062
pulmonary	O
hypertension	O
is	O
associated	B-T080
with	I-T080
36%	O
mortality	B-T081
in	O
pregnancy	O
,	O
and	O
6-10%	O
of	O
patients	O
with	O
sickle	B-T047
cell	I-T047
disease	I-T047
have	O
pulmonary	O
hypertension	O
.	O
	
tricuspid	B-T033
regurgitant	I-T033
velocity	I-T033
2.5	O
m/s	O
on	O
echocardiography	O
is	O
a	O
well	O
validated	O
means	O
of	O
screening	O
for	O
pulmonary	O
hypertension	O
in	O
the	O
non-pregnant	B-T033
population	B-T098
.	O
	
this	O
is	O
a	O
pilot	B-T062
study	I-T062
to	O
determine	O
if	O
this	O
is	O
a	O
useful	O
non-invasive	B-T169
screening	O
test	O
for	O
pulmonary	O
hypertension	O
in	O
pregnancy	O
,	O
and	O
whether	O
raised	O
tricuspid	B-T033
regurgitant	I-T033
velocity	I-T033
2.5	O
m/s	O
was	O
associated	B-T080
with	I-T080
poor	B-T080
outcomes	B-T169
.	O
	
this	O
is	O
a	O
cross-sectional	B-T062
study	I-T062
over	O
a	O
five-year	O
period	O
in	O
a	O
tertiary	O
referral	O
centre	O
with	O
a	O
specialised	O
multidisciplinary	O
clinic	O
for	O
pregnant	B-T098
women	I-T098
with	O
sickle	B-T047
cell	I-T047
disease	I-T047
.	O
	
women	B-T098
with	O
sickle	B-T047
cell	I-T047
disease	I-T047
,	O
no	O
prior	O
pulmonary	O
hypertension	O
and	O
singleton	O
pregnancies	O
who	O
had	O
echocardiography	O
with	O
a	O
measurable	O
tricuspid	B-T033
regurgitant	I-T033
velocity	I-T033
in	O
pregnancy	O
were	O
included	O
.	O
	
there	O
were	O
34	O
pregnancies	O
,	O
of	O
which	O
eight	O
had	O
tricuspid	B-T033
regurgitant	I-T033
velocity	I-T033
2.5	O
m/s	O
.	O
	
there	O
were	O
no	B-T033
significant	I-T033
differences	O
in	O
their	O
characteristics	B-T080
,	O
sickle	O
cell	O
-related	O
complications	O
or	O
medical	B-T169
co-morbidities	B-T081
.	O
	
the	O
women	B-T098
with	O
tricuspid	B-T033
regurgitant	I-T033
velocity	I-T033
2.5	O
m/s	O
had	O
similar	O
obstetric	B-T169
and	O
perinatal	B-T079
outcomes	B-T169
as	O
those	O
with	O
a	O
tricuspid	B-T033
regurgitant	I-T033
velocity	I-T033
a	O
randomized	B-T062
trial	I-T062
of	O
tlr-2	B-T116
agonist	O
cadi-05	B-T109
targeting	B-T169
desmocollin-3	B-T116
for	O
advanced	B-T080
non-small-cell	O
lung	O
cancer	O
randomized	B-T062
controlled	I-T062
trial	I-T062
to	O
evaluate	O
synergy	O
between	O
taxane	B-T109
plus	O
platinum	O
chemotherapy	B-T061
and	O
cadi-05	B-T109
,	O
a	O
toll	B-T116
like	I-T116
receptor-2	I-T116
agonist	O
targeting	B-T169
desmocollin-3	B-T116
as	O
a	O
first-line	B-T061
therapy	I-T061
in	O
advanced	B-T080
non-small-cell	O
lung	O
cancer	O
nsclc	O
.	O
	
patients	O
with	O
advanced	B-T080
nsclc	O
stage	O
iiib	O
or	O
iv	O
were	O
randomized	B-T033
to	O
cisplatin-paclitaxel	B-T061
chemotherapy	B-T061
group	B-T078
,	O
n	O
=	O
112	O
or	O
cisplatin-paclitaxel	B-T061
plus	O
cadi-05	B-T109
chemoimmunotherapy	B-T061
group	B-T078
,	O
n	O
=	O
109	O
.	O
	
cadi-05	B-T109
was	O
administered	B-T169
a	O
week	B-T079
before	O
chemotherapy	B-T061
and	O
on	O
days	B-T079
8	O
and	O
15	O
of	O
each	O
cycle	B-T061
and	O
every	O
month	B-T079
subsequently	O
for	O
12	O
months	B-T079
or	O
disease	O
progression	O
.	O
	
overall	B-T081
survival	I-T081
was	O
compared	O
using	O
a	O
log-rank	B-T170
test	I-T170
.	O
	
computed	O
tomography	O
was	O
carried	O
out	O
at	O
baseline	B-T081
,	O
end	O
of	O
two	O
cycles	B-T061
and	O
four	O
cycles	B-T061
.	O
	
response	B-T079
rate	I-T079
was	O
evaluated	O
using	O
response	B-T170
evaluation	I-T170
criteria	I-T170
in	I-T170
solid	I-T170
tumors	I-T170
criteria	B-T078
by	O
an	O
independent	O
radiologist	O
.	O
	
as	O
per	O
intention-to-treat	B-T062
analysis	I-T062
,	O
no	O
survival	B-T052
benefit	B-T081
was	O
observed	O
between	O
two	O
groups	B-T078
208	O
versus	O
196	O
days	B-T079
hazard	B-T081
ratio	I-T081
,	O
0.86	O
95%	O
confidence	B-T081
interval	I-T081
ci	O
0.63	O
p	O
=	O
0.3804	O
.	O
	
in	O
a	O
subgroup	B-T062
analysis	I-T062
,	O
improvement	O
in	O
median	B-T079
survival	I-T079
by	O
127	O
days	B-T079
was	O
observed	O
in	O
squamous	O
nscc	O
with	O
chemoimmunotherapy	B-T061
hazard	B-T081
ratio	I-T081
,	O
0.55	O
95%	O
ci	O
0.32	O
p	O
=	O
0.046	O
.	O
	
in	O
patients	O
receiving	O
planned	O
four	O
cycles	B-T061
of	O
chemotherapy	B-T061
,	O
there	O
was	O
improved	O
median	B-T081
overall	B-T081
survival	I-T081
by	O
66	O
days	B-T079
299	O
versus	O
233	O
days	B-T079
hazard	B-T081
ratio	I-T081
,	O
0.64	O
95%	O
ci	O
0.41	O
to	O
0.98	O
p	O
=	O
0.04	O
in	O
the	O
chemoimmunotherapy	B-T061
group	B-T078
compared	O
with	O
the	O
chemotherapy	B-T061
group	B-T078
.	O
	
this	O
was	O
associated	B-T080
with	I-T080
the	O
improved	O
survival	B-T052
by	O
17.48	O
at	O
the	O
end	O
of	O
1	O
year	B-T079
,	O
in	O
the	O
chemoimmunotherapy	B-T061
group	B-T078
.	O
	
systemic	O
adverse	O
events	O
were	O
identical	B-T080
in	O
both	O
the	O
group	B-T078
s	O
.	O
	
there	O
was	O
no	O
survival	B-T052
benefit	B-T081
with	O
the	O
addition	B-T169
of	O
cadi-05	B-T109
to	O
the	O
combination	B-T080
of	O
cisplatin-paclitaxel	B-T061
in	O
patients	O
with	O
advanced	B-T080
nsclc	O
however	O
,	O
the	O
squamous	O
cell	O
subset	O
did	O
demonstrate	O
a	O
survival	B-T052
sex	B-T078
life	I-T078
and	O
impact	B-T080
of	O
operative	B-T169
intervention	B-T061
on	O
sex	O
life-related	O
pain	O
in	O
degenerative	O
spinal	O
conditions	O
an	O
analysis	B-T062
of	O
the	O
sport	B-T062
study	I-T062
this	O
study	B-T062
is	O
a	O
therapeutic	B-T062
retrospective	I-T062
cohort	I-T062
study	I-T062
objectives	O
this	O
study	B-T062
aims	O
to	O
determine	O
whether	O
sexual	O
function	O
is	O
relevant	O
for	O
patients	O
with	O
spinal	O
stenosis	O
sps	O
and	O
degenerative	B-T047
spondylolisthesis	I-T047
ds	B-T047
and	O
to	O
determine	O
the	O
impact	B-T080
of	O
operative	B-T169
inter	O
vqavention	O
on	O
sexual	O
function	O
for	O
these	O
patients	O
.	O
	
the	O
benefits	O
of	O
nonoperative	B-T169
versus	O
operative	B-T169
treatment	B-T169
for	O
patients	O
with	O
sps	O
and	O
ds	B-T047
with	O
regards	O
to	O
sexual	O
function	O
are	O
unknown	O
.	O
	
demographic	O
,	O
treatment	B-T169
,	O
and	O
follow-up	O
data	B-T078
,	O
including	O
the	O
oswestry	O
disability	O
index	O
odi	O
,	O
were	O
obtained	O
on	O
patients	O
enrolled	O
in	O
the	O
sport	B-T062
study	I-T062
.	O
	
based	O
on	O
the	O
response	O
to	O
question	O
9	O
in	O
the	O
odi	O
,	O
patients	O
were	O
classified	O
into	O
a	O
sexual	B-T078
life	I-T078
relevant	I-T078
slr	B-T078
or	O
sexual	B-T078
life	I-T078
not	I-T078
relevant	I-T078
nr	I-T078
group	I-T078
.	O
	
univariate	B-T062
and	O
multivariate	B-T081
analysis	I-T081
of	O
patient	O
characteristics	B-T080
comparing	O
the	O
nr	B-T078
and	O
slr	B-T078
group	I-T078
were	O
performed	O
.	O
	
operative	B-T169
treatment	B-T169
groups	B-T078
were	O
compared	O
to	O
the	O
nonoperative	B-T169
group	B-T078
with	O
regards	O
to	O
response	O
to	O
odi	O
question	O
9	O
to	O
determine	O
the	O
impact	B-T080
of	O
surgery	B-T061
on	O
sexual	O
function	O
.	O
	
a	O
total	O
of	O
1235	O
patients	O
were	O
included	O
to	O
determine	O
relevance	O
of	O
sex	B-T078
life	I-T078
.	O
	
three	O
hundred	O
sixty-six	O
patients	O
29%	O
were	O
included	O
in	O
the	O
nr	B-T078
group	I-T078
.	O
	
eight	O
hundred	O
sixty-nine	O
patients	O
71%	O
were	O
included	O
in	O
the	O
slr	B-T078
group	I-T078
.	O
	
patients	O
that	O
were	O
older	B-T098
,	O
female	O
,	O
unmarried	B-T098
,	O
had	O
three	O
or	O
more	O
stenotic	B-T080
levels	I-T080
,	O
and	O
had	O
central	B-T169
stenosis	I-T169
were	O
more	O
likely	O
to	O
be	O
in	O
the	O
nr	B-T078
group	I-T078
.	O
	
eight	O
hundred	O
twenty-five	O
patients	O
were	O
included	O
in	O
the	O
analysis	B-T062
comparing	O
operative	B-T169
versus	O
nonoperative	B-T169
treatment	B-T169
.	O
	
at	O
all	O
follow-up	O
time	O
points	O
,	O
the	O
operative	B-T169
groups	B-T078
had	O
a	O
lower	O
percentage	B-T081
of	O
patients	O
reporting	O
pain	O
with	O
their	O
sex	B-T078
life	I-T078
compared	O
to	O
the	O
nonoperative	B-T169
group	B-T078
p	O
<	O
0.05	O
at	O
all	O
time	O
points	O
except	O
between	O
more	O
than	O
one	O
level	O
fusion	O
and	O
nonoperative	B-T169
at	O
4	O
years	B-T079
'	O
follow-up	O
.	O
	
sex	B-T078
life	I-T078
is	O
a	O
relevant	O
consideration	O
for	O
the	O
majority	O
of	O
patients	O
with	O
ds	B-T047
and	O
sps	O
operative	B-T169
treatment	B-T169
leads	O
to	O
improved	B-T033
sex	O
life-related	O
pain	O
.	O
	
functional	B-T062
analyses	I-T062
of	O
ocrhs1	B-T116
and	O
ocuer1	B-T116
involved	O
in	O
udp-l-rhamnose	O
biosynthesis	B-T169
in	O
ornithogalum	O
caudatum	O
udp-l-rhamnose	O
udp-rha	O
is	O
an	O
important	O
sugar	O
donor	O
for	O
the	O
synthesis	B-T169
of	O
rhamnose	B-T109
-containing	O
compounds	O
in	O
plants	O
.	O
	
however	O
,	O
only	O
a	O
few	O
enzymes	B-T116
and	O
their	O
encoding	B-T052
genes	O
involved	O
in	O
udp-rha	O
biosynthesis	B-T169
are	O
available	O
in	O
plants	O
.	O
	
here	O
,	O
two	O
genes	O
encoding	B-T052
rhamnose	B-T116
synthase	I-T116
rhs	B-T116
and	O
bi-functional	B-T116
udp-4-keto-6-deoxy-d-glucose	B-T116
udp-4k6dg	B-T116
3	B-T116
,	O
5-epimerase/udp-4-keto-l-rhamnose	I-T116
udp-4kr	B-T116
4-keto-reductase	B-T116
uer	B-T116
were	O
isolated	O
from	O
ornithogalum	O
caudatum	O
based	O
on	O
the	O
rna	O
-	O
seq	B-T170
data	I-T170
.	O
	
the	O
ocrhs1	O
gene	O
has	O
an	O
orf	O
open	O
reading	O
frame	O
of	O
2019	O
bp	O
encoding	B-T052
a	O
tri-functional	O
rhs	O
enzyme	O
.	O
	
in	B-T080
vitro	I-T080
enzymatic	O
assays	O
revealed	B-T080
ocrhs1	B-T116
can	O
really	O
convert	O
udp-d-glucose	B-T109
udp-glc	B-T109
into	O
udp-rha	O
via	O
three	O
consecutive	B-T080
reactions	B-T169
.	O
	
biochemical	B-T169
evidences	B-T169
indicated	O
that	O
the	O
recombinant	B-T116
ocrhs1	I-T116
was	O
active	O
in	O
the	O
ph	O
range	O
of	O
5-11	O
and	O
over	O
the	O
temperature	B-T081
range	I-T081
of	O
0-60	O
c	O
.	O
	
the	O
km	B-T081
value	B-T081
of	O
ocrhs1	B-T116
for	O
udp-glc	B-T109
was	O
determined	O
to	O
be	O
1.52	O
10	O
m	O
.	O
	
ocrhs1	B-T116
is	O
a	O
multi-domain	B-T116
protein	I-T116
with	O
two	O
sets	O
of	O
cofactor-binding	O
motifs	O
.	O
	
the	O
cofactors	O
dependent	O
properties	O
of	O
ocrhs1	B-T116
were	O
thus	O
characterized	O
in	O
this	O
research	B-T062
.	O
	
moreover	O
,	O
the	O
n-terminal	B-T116
portion	I-T116
of	I-T116
ocrhs1	I-T116
ocrhs1-n	B-T116
was	O
observed	O
to	O
metabolize	B-T169
udp-glc	B-T109
to	O
form	O
intermediate	O
udp-4k6dg	O
.	O
	
ocuer1	O
contains	O
an	O
orf	O
of	O
906	O
bp	O
encoding	B-T052
a	O
polypeptide	B-T116
of	O
301	O
aa	B-T116
.	O
	
ocuer1	B-T116
shared	O
high	O
similarity	O
with	O
the	O
carboxy-terminal	B-T116
domain	I-T116
of	I-T116
ocrhs1	I-T116
ocrhs1-c	B-T116
,	O
suggesting	O
its	O
intrinsic	O
ability	O
of	O
converting	O
udp-4k6dg	O
into	O
udp-rha	O
.	O
	
it	O
was	O
thus	O
reasonably	O
inferred	O
that	O
udp-glc	B-T109
could	O
be	O
bio-transformed	B-T169
into	O
udp-rha	O
under	O
the	O
collaborating	O
action	O
of	O
ocrhs1-n	B-T116
and	O
ocuer1	B-T116
.	O
	
the	O
subsequently	O
biochemical	O
assay	O
verified	O
this	O
notion	O
.	O
	
importantly	O
,	O
expression	O
profiles	O
of	O
ocrhs1	B-T116
and	O
ocuer1	B-T116
revealed	B-T080
their	O
possible	O
involvement	O
in	O
the	O
biosynthesis	B-T169
of	O
rhamnose	B-T109
-containing	O
polysaccharides	B-T109
in	O
o	O
.	O
	
caudatum	O
.	O
	
differing	O
rates	O
of	O
antibody	B-T116
acquisition	B-T052
to	O
merozoite	O
antigens	O
in	O
malaria	B-T047
implications	O
for	O
immunity	O
and	O
surveillance	O
antibodies	B-T116
play	O
a	O
key	O
role	O
in	O
acquired	O
human	O
immunity	O
to	O
plasmodium	B-T047
falciparum	I-T047
pf	I-T047
malaria	I-T047
and	O
target	O
merozoites	O
to	O
reduce	O
or	O
prevent	O
blood	O
-stage	O
replication	O
and	O
the	O
development	O
of	O
disease	B-T047
.	O
	
merozoites	O
present	O
a	O
complex	O
array	O
of	O
antigens	O
to	O
the	O
immune	O
system	O
,	O
and	O
currently	O
,	O
there	O
is	O
only	O
a	O
partial	O
understanding	O
of	O
the	O
targets	O
of	O
protective	O
antibodies	B-T116
and	O
how	O
responses	O
to	O
different	O
antigens	O
are	O
acquired	B-T080
and	O
boosted	B-T169
.	O
	
we	O
hypothesized	O
that	O
there	O
would	O
be	O
differences	O
in	O
the	O
rate	O
of	O
acquisition	B-T052
of	O
antibodies	B-T116
to	O
different	O
antigens	O
and	O
how	O
well	O
they	O
are	O
boosted	O
by	O
infection	O
,	O
which	O
impacts	O
the	O
acquisition	B-T052
of	O
immunity	O
.	O
	
we	O
examined	O
responses	O
to	O
a	O
range	O
of	O
merozoite	O
antigens	O
in	O
2	O
different	O
cohorts	O
of	O
children	O
and	O
adults	O
with	O
different	O
age	O
structures	O
and	O
levels	O
of	O
malaria	B-T047
exposure	O
.	O
	
overall	O
,	O
antibodies	B-T116
were	O
associated	O
with	O
age	O
,	O
exposure	O
,	O
and	O
active	O
infection	O
,	O
and	O
the	O
repertoire	O
of	O
responses	O
increased	O
with	O
age	O
and	O
active	O
infection	O
.	O
	
however	O
,	O
rates	O
of	O
antibody	B-T116
acquisition	B-T052
varied	O
between	O
antigens	O
and	O
different	O
regions	O
within	O
an	O
antigen	O
following	O
exposure	O
to	O
malaria	B-T047
,	O
supporting	O
our	O
hypothesis	B-T078
.	O
	
antigen	O
-specific	O
responses	O
could	O
be	O
broadly	O
classified	O
into	O
early	O
response	O
types	O
in	O
which	O
antibodies	B-T116
were	O
acquired	B-T080
early	O
in	O
childhood	B-T079
exposure	O
and	O
late	B-T079
response	I-T079
types	O
that	O
appear	O
to	O
require	O
substantially	O
more	O
exposure	O
for	O
the	O
development	O
of	O
substantial	O
levels	O
.	O
	
we	O
identified	O
antigen	O
-specific	O
responses	O
that	O
were	O
effectively	O
boosted	O
after	O
recent	O
infection	O
,	O
whereas	O
other	O
responses	O
were	O
not	O
.	O
	
these	O
findings	O
advance	O
our	O
understanding	O
of	O
the	O
acquisition	O
of	O
human	O
immunity	O
to	O
malaria	O
and	O
are	O
relevant	O
to	O
the	O
development	O
of	O
malaria	O
vaccines	O
targeting	O
merozoite	O
antigens	O
and	O
the	O
selection	O
of	O
antigens	O
for	O
use	O
in	O
malaria	O
surveillance	O
variety	O
of	O
dna	O
replication	O
activity	O
among	O
cyanobacteria	O
correlates	O
with	O
distinct	O
respiration	O
activity	O
in	O
the	O
dark	O
cyanobacteria	O
exhibit	O
light	O
-dependent	O
cell	O
growth	O
since	O
most	O
of	O
their	O
cellular	O
energy	B-T081
is	O
obtained	O
by	O
photosynthesis	O
.	O
	
in	O
synechococcus	O
elongatus	O
pcc	O
7942	O
,	O
one	O
of	O
the	O
model	O
cyanobacteria	O
,	O
dna	O
replication	O
depends	O
on	O
photosynthetic	O
electron	O
transport	O
.	O
	
however	O
,	O
the	O
critical	O
signal	O
for	O
the	O
regulatory	O
mechanism	B-T169
of	O
dna	O
replication	O
has	O
not	O
been	O
identified	O
.	O
	
in	O
addition	O
,	O
conservation	B-T080
of	O
this	O
regulatory	B-T169
mechanism	I-T169
has	O
not	O
been	O
investigated	B-T169
among	O
cyanobacteria	O
.	O
	
to	O
understand	O
this	O
regulatory	O
signal	O
and	O
its	O
dependence	O
on	O
light	O
,	O
we	O
examined	O
the	O
regulation	O
of	O
dna	O
replication	O
under	O
both	O
light	O
and	O
dark	O
conditions	O
among	O
three	O
model	O
cyanobacteria	O
,	O
s	O
.	O
	
elongatus	O
pcc	O
7942	O
,	O
synechocystis	O
sp	O
.	O
	
pcc	O
6803	O
and	O
anabaena	O
sp	O
.	O
	
pcc	O
7120	O
.	O
	
interestingly	O
,	O
dna	O
replication	O
activity	O
in	O
synechocystis	O
and	O
anabaena	O
was	O
retained	B-T169
when	O
cells	O
were	O
transferred	B-T033
to	I-T033
the	O
dark	O
,	O
although	O
it	O
was	O
drastically	O
decreased	B-T081
in	O
s	O
.	O
	
elongatus	O
.	O
	
glycogen	O
metabolism	O
and	O
respiration	O
were	O
higher	O
in	O
synechocystis	O
and	O
anabaena	O
than	O
in	O
s	O
.	O
	
elongatus	O
in	O
the	O
dark	O
.	O
	
moreover	O
,	O
dna	O
replication	O
activity	O
in	O
synechocystis	O
and	O
anabaena	O
was	O
reduced	B-T081
to	O
the	O
same	O
level	O
as	O
that	O
in	O
s	O
.	O
	
elongatus	O
by	O
inhibition	B-T052
of	O
respiratory	B-T169
electron	O
transport	O
after	O
transfer	O
to	O
the	O
dark	O
.	O
	
these	O
results	O
demonstrate	O
that	O
there	O
is	O
disparity	B-T033
in	O
dna	O
replication	O
occurring	O
in	O
the	O
dark	O
among	O
cyanobacteria	O
,	O
which	O
is	O
caused	O
by	O
the	O
difference	B-T080
in	O
activity	B-T169
of	O
respiratory	B-T169
electron	O
transport	O
.	O
	
radiosensitization	B-T061
of	O
non-small-cell	O
lung	O
cancer	O
cells	O
and	O
xenografts	B-T061
by	O
the	O
interactive	B-T169
effects	I-T169
of	O
pemetrexed	B-T109
and	O
methoxyamine	B-T109
the	O
anti-folate	O
pemetrexed	B-T109
is	O
a	O
radiosensitizer	O
.	O
	
in	O
pre-clinical	B-T170
models	I-T170
,	O
pemetrexed	B-T109
is	O
more	O
effective	B-T080
along	O
with	O
the	O
base-excision-repair	O
inhibitor	B-T080
methoxyamine	B-T109
.	O
	
we	O
tested	B-T169
whether	O
methoxyamine	B-T109
enhances	B-T052
pemetrexed	B-T109
-mediated	O
radiosensitization	B-T061
of	O
lung	O
adenocarcinoma	O
cells	O
and	O
xenografts	B-T061
.	O
	
a549	O
and	O
h1299	O
cells	O
were	O
evaluated	O
for	O
cell	O
cycle	O
distribution	B-T169
by	O
flow	O
cytometry	O
,	O
radiosensitization	B-T061
by	O
clonogenic	O
assay	O
,	O
and	O
dna	O
repair	O
by	O
neutral	O
comet	O
assay	O
and	O
repair	O
protein	O
activation	O
.	O
	
h460	O
cells	O
were	O
included	O
in	O
some	O
studies	O
.	O
	
xenografts	B-T061
in	O
nude	O
mice	O
received	B-T033
drug	I-T033
s	O
and/or	O
radiation	O
,	O
and	O
tumor	O
growth	O
was	O
monitored	O
by	O
caliper	O
and	O
in	B-T062
vivo	I-T062
toxicity	O
by	O
animal	O
weight	O
.	O
	
exposure	B-T080
to	I-T080
pemetrexed	B-T109
/	O
methoxyamine	B-T109
for	O
24	O
h1299	O
,	O
h460	O
or	O
48	O
a549	O
before	O
irradiation	O
resulted	O
in	O
accumulation	B-T033
of	O
cells	O
near	O
the	O
radiosensitive	B-T082
g1/s	I-T082
border	I-T082
dose	B-T081
-	O
enhancement	B-T052
factors	B-T169
of	O
1.62	O
,	O
1.97	O
,	O
and	O
1.67	O
,	O
respectively	O
reduction	O
of	O
mean	O
inactivation	B-T169
dose	B-T081
by	O
32%	O
,	O
30%	O
,	O
and	O
46%	O
,	O
respectively	O
and	O
significant	O
reductions	O
of	O
sf2	O
and	O
sf4	O
p<0	O
.	O
	
radiosensitization	B-T061
was	O
associated	O
with	O
rapid	O
dna	O
double-strand-break	O
rejoining	O
and	O
increased	O
levels	O
of	O
dna-pkcs	B-T116
.	O
	
both	O
tumor-growth	O
rate	B-T079
and	O
tumor-growth	O
delay	B-T079
were	O
significantly	O
improved	O
by	O
adding	O
methoxyamine	B-T109
to	O
pemetrexed	B-T109
pre-irradiation	O
p<0	O
no	O
mice	O
lost	O
weight	O
during	O
treatment	B-T169
.	O
	
addition	O
of	O
methoxyamine	B-T109
to	O
pemetrexed	B-T109
and	O
fractionated	O
radiotherapy	O
may	O
improve	O
outcome	O
for	O
patients	O
with	O
locally	O
advanced	O
non-squamous	O
non-small-cell	O
lung	O
cancer	O
.	O
	
using	O
language	O
for	O
social	B-T033
interaction	I-T033
communication	O
mechanisms	O
promote	O
recovery	O
from	O
chronic	B-T079
non-fluent	O
aphasia	O
clinical	B-T062
research	I-T062
highlights	O
the	O
importance	O
of	O
massed	B-T170
practice	I-T170
in	O
the	O
rehabilitation	B-T061
of	O
chronic	B-T079
post-stroke	B-T079
aphasia	O
.	O
	
however	O
,	O
while	O
necessary	O
,	O
massed	B-T170
practice	I-T170
may	O
not	O
be	O
sufficient	O
for	O
ensuring	O
progress	B-T169
in	O
speech-language	O
therapy	O
.	O
	
motivated	O
by	O
recent	O
advances	O
in	O
neuroscience	O
,	O
it	O
has	O
been	O
claimed	O
that	O
using	O
language	O
as	O
a	O
tool	O
for	O
communication	O
and	O
social	B-T033
interaction	I-T033
leads	O
to	O
synergistic	B-T080
effects	I-T080
in	O
left	O
perisylvian	O
eloquent	O
areas	O
.	O
	
here	O
,	O
we	O
conducted	O
a	O
crossover	O
randomized	O
controlled	O
trial	O
to	O
determine	O
the	O
influence	O
of	O
communicative	O
language	O
function	O
on	O
the	O
outcome	B-T169
of	O
intensive	B-T061
aphasia	I-T061
therapy	I-T061
.	O
	
eighteen	O
individuals	B-T098
with	O
left-hemisphere	B-T033
lesions	I-T033
and	O
chronic	B-T079
non-fluent	O
aphasia	O
each	O
received	O
two	O
types	O
of	O
training	O
in	O
counterbalanced	B-T080
order	I-T080
i	O
intensive	B-T061
language-action	I-T061
therapy	I-T061
ilat	B-T061
,	O
an	O
extended	O
form	O
of	O
constraint-induced	B-T061
aphasia	I-T061
therapy	I-T061
embedding	O
verbal	B-T061
utterances	I-T061
in	O
the	O
context	O
of	O
communication	O
and	O
social	B-T033
interaction	I-T033
,	O
and	O
ii	O
naming	O
therapy	O
focusing	O
on	O
speech	O
production	O
per	O
se	O
.	O
	
both	O
types	O
of	O
training	O
were	O
delivered	O
with	O
the	O
same	O
high	O
intensity	O
3.5	O
h	O
per	O
session	O
and	O
duration	B-T079
six	O
consecutive	O
working	O
days	B-T079
,	O
with	O
therapy	B-T061
materials	O
and	O
number	B-T033
of	I-T033
utterances	I-T033
matched	O
between	O
treatment	B-T061
groups	I-T061
.	O
	
a	O
standardized	O
aphasia	O
test	O
battery	O
revealed	O
significantly	O
improved	O
language	O
performance	O
with	O
ilat	B-T061
,	O
independent	O
of	O
when	O
this	O
method	B-T170
was	O
administered	O
.	O
	
in	O
contrast	O
,	O
naming	O
therapy	O
tended	O
to	O
benefit	O
language	O
performance	O
only	O
when	O
given	O
at	O
the	O
onset	O
of	O
the	O
treatment	B-T061
,	O
but	O
not	O
when	O
applied	O
after	O
previous	O
intensive	O
training	O
.	O
	
the	O
current	O
results	O
challenge	O
the	O
notion	O
that	O
massed	B-T170
practice	I-T170
alone	O
promotes	O
recovery	O
from	O
chronic	B-T079
post-stroke	B-T079
aphasia	O
.	O
	
instead	O
,	O
our	O
results	O
demonstrate	O
that	O
using	O
language	O
for	O
communication	O
and	O
social	B-T033
interaction	I-T033
increases	O
the	O
efficacy	O
of	O
intensive	B-T061
aphasia	I-T061
therapy	I-T061
.	O
	
mir-27b	O
inhibits	B-T052
gastric	O
cancer	O
metastasis	O
by	O
targeting	B-T169
nr2f2	B-T116
increasing	B-T169
attention	O
is	O
focused	O
on	O
the	O
down-regulation	O
of	O
mirnas	O
in	O
cancer	O
process	O
.	O
	
nuclear	B-T116
receptor	I-T116
subfamily	I-T116
2	I-T116
nr2f2	B-T116
,	O
also	O
known	O
as	O
coup-tfii	B-T116
is	O
involved	B-T169
in	O
the	O
development	B-T169
of	O
many	O
types	B-T080
of	O
cancers	O
,	O
but	O
its	O
role	O
in	O
gastric	O
cancer	O
remains	O
elusive	O
.	O
	
in	O
this	O
experiment	B-T062
,	O
oncomine	B-T170
and	O
kaplan-meier	B-T170
database	I-T170
revealed	B-T080
that	O
nr2f2	B-T116
was	O
up-regulated	O
in	O
gastric	O
cancer	O
and	O
that	O
the	O
high	B-T080
nr2f2	B-T116
expression	O
contributed	B-T052
to	O
poor	B-T080
survival	B-T081
.	O
	
microrna-27b	O
was	O
targeted	B-T169
and	O
down-regulated	O
by	O
nr2f2	B-T116
in	O
human	O
gastric	O
cancer	O
tissues	O
and	O
cells	O
.	O
	
the	O
ectopic	O
expression	O
of	O
mir-27b	O
inhibited	B-T080
gastric	O
cancer	O
cell	O
proliferation	O
and	O
tumor	O
growth	O
in	B-T080
vitro	I-T080
and	O
in	B-T082
vivo	I-T082
.	O
	
assays	O
suggested	B-T078
that	O
the	O
overexpression	O
of	O
mir-27b	O
could	O
promote	B-T052
mgc-803	O
cells	O
'	O
migration	O
and	O
invasion	O
and	O
retard	B-T080
their	O
metastasis	O
to	O
the	O
liver	O
.	O
	
in	O
addition	O
,	O
down-regulation	O
of	O
mir-27b	O
enhanced	O
ges-1	O
cells	O
'	O
proliferation	O
and	O
metastasis	O
in	B-T080
vitro	I-T080
.	O
	
these	O
findings	B-T033
reveal	B-T080
that	O
mir-27b	O
is	O
a	O
tumor	O
suppressor	O
in	O
gastric	O
cancer	O
and	O
a	O
biomarker	O
for	O
improving	B-T080
patients	O
'	O
promoting	B-T052
healthy	B-T080
growth	O
or	O
feeding	B-T052
obesity	B-T047
the	O
need	B-T080
for	O
evidence	B-T078
-based	O
oversight	O
of	O
infant	O
nutritional	O
supplement	O
claims	O
the	O
developmental	B-T170
origins	I-T170
of	I-T170
health	I-T170
and	I-T170
disease	I-T170
dohad	B-T170
model	O
recognizes	O
growth	O
in	O
infancy	B-T079
and	O
childhood	B-T079
as	O
a	O
fundamental	O
determinant	O
of	O
lifespan	O
health	B-T078
.	O
	
evidence	B-T169
of	I-T169
long-term	B-T079
health	B-T078
risks	B-T078
among	O
small	B-T081
neonates	O
who	O
subsequently	O
grow	O
rapidly	B-T080
poses	O
a	O
challenge	O
for	O
interventions	O
aiming	O
to	O
support	O
healthy	B-T080
growth	O
,	O
not	O
merely	O
drive	O
weight	B-T033
gain	I-T033
.	O
	
defining	O
healthy	B-T080
growth	O
beyond	O
"""getting"	O
"bigger"""	O
is	O
essential	B-T080
as	O
infant	O
and	O
young	B-T079
child	O
feeding	B-T052
industries	O
expand	O
.	O
	
liquid	O
-based	O
nutritional	O
supplements	O
,	O
originally	O
formulated	O
for	O
undernourished	B-T047
children	O
,	O
are	O
increasingly	B-T169
marketed	O
for	O
and	O
consumed	B-T052
by	O
children	O
generally	O
.	O
	
clarifying	B-T052
the	O
nature	O
of	O
the	O
evidentiary	O
base	O
on	O
which	O
structure/function	O
claims	O
promoting	B-T052
""""	O
healthy	B-T080
growth	O
""""	O
are	O
constructed	O
is	O
important	B-T080
to	O
curb	O
invalid	O
generalizations	O
.	O
	
evidence	B-T078
points	O
to	O
changing	O
social	B-T169
beliefs	B-T078
and	O
cultural	B-T169
practices	O
surrounding	O
supplementary	B-T061
feeding	I-T061
,	O
raising	O
specific	B-T080
concerns	B-T078
about	O
the	O
long-term	B-T079
health	B-T078
consequences	B-T169
of	I-T169
an	O
associated	B-T080
altered	B-T169
feeding	B-T052
culture	B-T169
,	O
including	O
reduced	B-T080
dietary	O
variety	O
and	O
weight	B-T033
gain	I-T033
.	O
	
reassessing	B-T052
the	O
evidence	B-T169
for	I-T169
and	O
relevance	B-T080
of	O
dietary	O
supplements'	O
""""	O
promoting	B-T052
healthy	B-T080
growth	O
""""	O
claims	O
for	O
otherwise	O
healthy	B-T080
children	O
is	O
both	O
needed	B-T080
in	O
a	O
time	O
of	O
global	B-T080
obesity	B-T047
and	O
an	O
opportunity	B-T062
to	O
refine	O
intervention	B-T061
approaches	I-T061
among	O
small	B-T081
children	O
for	O
whom	O
rapid	B-T080
subsequent	O
growth	O
in	O
early	O
life	O
augments	O
risk	B-T078
for	O
chronic	B-T047
disease	I-T047
.	O
	
scientific	O
and	O
health	O
care	O
partnerships	O
are	O
needed	B-T080
to	O
consider	O
current	O
governmental	O
oversight	O
shortfalls	O
in	O
protecting	O
vulnerable	O
populations	B-T098
from	O
overconsumption	B-T052
.	O
	
this	O
is	O
important	B-T080
on-site	B-T082
fertility	B-T061
preservation	I-T061
services	I-T061
for	O
adolescents	O
and	O
young	O
adults	O
in	O
a	O
comprehensive	O
cancer	O
center	O
adolescents	O
and	O
young	O
adults	O
ayas	O
receiving	O
cancer	B-T061
treatments	I-T061
that	O
may	O
impair	O
fertility	O
should	O
receive	O
counseling	O
about	O
risk	B-T033
of	I-T033
infertility	I-T033
and	O
options	O
for	O
fertility	B-T061
preservation	I-T061
fp	B-T061
before	O
treatment	B-T061
and/or	O
during	O
survivorship	B-T079
.	O
	
our	O
objective	B-T170
was	O
to	O
define	O
the	O
aya	O
patient	O
population	B-T098
referred	O
to	O
an	O
on-site	O
fertility	O
consultation	O
service	O
within	O
a	O
comprehensive	O
cancer	O
center	O
and	O
determine	O
factors	B-T169
associated	O
with	O
patients	O
proceeding	O
with	O
fp	B-T061
treatment	I-T061
.	O
	
we	O
conducted	O
a	O
retrospective	B-T062
chart	I-T062
review	I-T062
of	O
aya	O
women	B-T098
who	O
completed	O
a	O
consultation	O
at	O
the	O
md	O
anderson	O
fertility	O
preservation	O
and	O
family	O
building	O
service	O
during	O
the	O
first	O
year	O
of	O
service	O
.	O
	
records	B-T170
of	O
154	O
referred	O
aya	O
patients	O
were	O
reviewed	B-T080
for	O
age	O
,	O
ethnicity	B-T098
,	O
cancer	B-T033
type	I-T033
gravidity	B-T033
and	O
parity	B-T033
,	O
survivorship	B-T079
status	B-T080
,	O
and	O
decision	O
to	O
pursue	O
fp	B-T061
treatment	I-T061
.	O
	
patients	O
mean	O
age	O
29.7	O
were	O
caucasian	B-T098
55%	O
,	O
hispanic	B-T098
23%	O
,	O
and	O
african	B-T098
american	I-T098
10%	O
.	O
	
the	O
majority	O
of	O
women	B-T098
67%	O
were	O
seen	O
for	O
fp	B-T061
before	O
cancer	B-T061
treatment	I-T061
and	O
the	O
remaining	O
sought	O
options	B-T169
for	O
family	O
building	O
while	O
in	O
survivorship	B-T079
.	O
	
the	O
most	O
common	O
cancer	B-T033
types	I-T033
were	O
hematologic	O
29%	O
,	O
breast	O
25%	O
,	O
and	O
gynecologic	O
23%	O
.	O
	
patients	O
referred	O
to	O
an	O
on-site	O
fertility	O
consultation	O
service	O
were	O
medically	O
and	O
ethnically	B-T080
diverse	B-T080
.	O
	
interest	O
in	O
fertility	O
counseling	O
and	O
treatment	B-T061
was	O
apparent	O
in	O
both	O
survivorship	B-T079
pre-	B-T061
and	I-T061
postcancer	I-T061
treatment	I-T061
.	O
	
although	O
the	O
referral	O
group	B-T078
was	O
ethnically	B-T080
diverse	B-T080
,	O
caucasian	B-T098
women	B-T098
were	O
most	O
likely	O
to	O
pursue	O
fp	B-T061
treatment	I-T061
compared	O
to	O
women	B-T098
of	O
other	O
results	B-T169
of	O
a	O
multicenter	B-T062
,	O
randomized	B-T062
,	O
controlled	B-T170
trial	I-T170
of	O
a	O
hydrogen	O
peroxide	O
-based	O
kit	O
versus	O
a	O
benzoyl	B-T109
peroxide	I-T109
-based	O
kit	O
in	O
mild-to-moderate	B-T080
acne	B-T047
objective	O
evaluate	O
the	O
efficacy	B-T080
and	O
tolerability	B-T062
of	O
a	O
novel	O
hydrogen	O
peroxide	O
-based	O
regimen	B-T061
versus	O
a	O
benzoyl	B-T109
peroxide	I-T109
-based	O
regimen	B-T061
in	O
mild-to-moderate	B-T080
acne	B-T047
.	O
	
methods	B-T170
in	O
this	O
eight-	O
week	B-T079
multicenter	B-T062
study	I-T062
,	O
patients	O
were	O
randomized	B-T062
to	O
either	O
a	O
hydrogen	O
peroxide	O
-based	O
or	O
a	O
benzoyl	B-T109
peroxide	I-T109
-based	O
regimen	B-T061
the	O
primary	B-T080
outcome	I-T080
measure	I-T080
of	O
clinical	B-T033
response	I-T033
was	O
assessed	B-T052
using	O
the	O
global	O
acne	O
grading	O
system	O
gags	O
at	O
baseline	B-T081
four	O
weeks	B-T079
,	O
and	O
eight	O
weeks	B-T079
.	O
	
at	O
week	B-T079
8	O
,	O
a	O
patient	O
self-satisfaction	B-T170
questionnaire	I-T170
was	O
administered	B-T169
.	O
	
investigators	O
were	O
also	O
queried	B-T170
at	O
that	O
time	O
regarding	O
assessment	O
of	O
tolerability	B-T062
and	O
cosmetic	O
acceptability	B-T080
.	O
	
tolerability	B-T062
was	O
also	O
measured	B-T080
at	O
each	O
visit	O
.	O
	
results	O
both	O
treatment	B-T061
regimens	I-T061
were	O
associated	B-T080
with	I-T080
improvement	O
of	O
gags	B-T081
score	I-T081
at	O
week	B-T079
8	O
compared	B-T052
to	O
baseline	B-T081
p<0	O
.	O
	
gags	B-T081
score	I-T081
did	O
not	O
differ	O
significantly	O
between	O
the	O
two	O
regimens	B-T061
over	O
the	O
same	O
period	B-T079
p=0	O
.	O
	
no	B-T033
significant	I-T033
adverse	I-T033
events	I-T033
were	O
reported	O
or	O
observed	B-T169
in	O
either	O
treatment	B-T062
arm	I-T062
.	O
	
both	O
patients	O
and	O
investigators	O
found	O
both	O
regimens	B-T061
to	O
be	O
similarly	O
effective	B-T080
and	O
cosmetically	O
acceptable	B-T080
.	O
	
conclusion	O
a	O
novel	O
hydrogen	O
peroxide	O
-based	O
regimen	B-T061
was	O
shown	O
to	O
be	O
comparable	B-T052
in	O
efficacy	B-T080
,	O
safety	O
,	O
and	O
cosmetic	O
acceptability	B-T080
to	O
a	O
benzoyl	B-T109
peroxide	I-T109
-based	O
regimen	B-T061
in	O
the	O
treatment	B-T061
of	O
mild-to-moderate	B-T080
acne	B-T047
.	O
	
multisensory	O
integration	O
in	O
the	O
virtual	O
hand	O
illusion	O
with	O
active	O
movement	O
improving	O
the	O
sense	O
of	O
immersion	O
is	O
one	O
of	O
the	O
core	O
issues	O
in	O
virtual	O
reality	O
.	O
	
perceptual	O
illusions	O
of	O
ownership	O
can	O
be	O
perceived	O
over	O
a	O
virtual	O
body	O
in	O
a	O
multisensory	O
virtual	O
reality	O
environment	O
.	O
	
rubber	O
hand	O
and	O
virtual	O
hand	O
illusions	O
showed	O
that	O
body	O
ownership	O
can	O
be	O
manipulated	O
by	O
applying	O
suitable	O
visual	O
and	O
tactile	O
stimulation	O
.	O
	
in	O
this	O
study	O
,	O
we	O
investigate	O
the	O
effects	O
of	O
multisensory	O
integration	O
in	O
the	O
virtual	O
hand	O
illusion	O
with	O
active	O
movement	O
.	O
	
a	O
virtual	O
xylophone	O
playing	O
system	O
which	O
can	O
interactively	O
provide	O
synchronous	O
visual	O
,	O
tactile	O
,	O
and	O
auditory	O
stimulation	O
was	O
constructed	O
.	O
	
we	O
conducted	O
two	O
experiments	O
regarding	O
different	O
movement	O
conditions	O
and	O
different	O
sensory	O
stimulations	O
.	O
	
our	O
results	O
demonstrate	O
that	O
multisensory	O
integration	O
with	O
free	O
active	O
movement	O
can	O
improve	O
the	O
sense	B-T033
of	I-T033
immersion	I-T033
in	O
virtual	O
reality	O
.	O
	
obstructive	B-T169
acute	B-T047
pancreatitis	I-T047
secondary	O
to	O
peg	O
tube	O
migration	B-T033
percutaneous	B-T061
gastrostomy	I-T061
is	O
a	O
well-established	O
method	B-T169
of	O
providing	O
enteral	B-T061
nutrition	I-T061
to	O
patients	O
incapable	B-T033
of	O
oral	B-T033
intake	I-T033
,	O
or	O
for	O
whom	O
oral	B-T033
intake	I-T033
is	O
insufficient	B-T080
to	O
meet	O
metabolic	B-T169
needs	B-T080
.	O
	
in	O
comparison	O
to	O
total	B-T061
parenteral	I-T061
nutrition	I-T061
,	O
enteral	O
feeding	O
is	O
advantageous	O
in	O
that	O
it	O
helps	O
maintain	O
gut	O
mucosal	O
integrity	B-T080
,	O
which	O
decreases	O
the	O
risk	B-T078
of	O
bacterial	O
translocation	O
through	O
the	O
gastrointestinal	O
tract	O
.	O
	
complications	O
include	O
bleeding	O
,	O
aspiration	O
,	O
internal	O
organ	O
injury	O
,	O
perforation	B-T047
,	O
periostomal	B-T047
leaks	I-T047
,	O
tube	O
dislodgement	O
,	O
and	O
occlusion	O
.	O
	
acute	B-T047
pancreatitis	I-T047
secondary	O
to	O
percutaneous	O
gastrostomy	O
tube	O
migration	B-T033
is	O
rare	O
.	O
	
we	O
present	O
a	O
patient	O
with	O
acute	B-T079
obstructive	B-T169
pancreatitis	B-T047
secondary	O
to	O
percutaneous	O
gastrostomy	O
tube	O
migration	B-T033
.	O
	
a	O
tractable	B-T080
method	B-T170
for	O
measuring	B-T080
nanomaterial	O
risk	B-T078
using	O
bayesian	B-T170
networks	I-T170
while	O
control	O
banding	B-T061
has	O
been	O
identified	O
as	O
a	O
suitable	O
framework	O
for	O
the	O
evaluation	B-T078
and	O
the	O
determination	O
of	O
potential	B-T080
human	O
health	B-T061
risks	I-T061
associated	O
with	O
exposure	B-T080
to	I-T080
nanomaterials	O
nms	O
,	O
the	O
approach	O
currently	O
lacks	O
any	O
implementation	B-T052
that	O
enjoys	O
widespread	O
support	O
.	O
	
large	O
inconsistencies	O
in	O
characterisation	O
data	B-T078
,	O
toxicological	O
measurements	B-T169
and	O
exposure	O
scenarios	O
make	O
it	O
difficult	O
to	O
map	O
and	O
compare	O
the	O
risk	B-T078
associated	O
with	O
nms	O
based	O
on	O
physicochemical	O
data	B-T078
,	O
concentration	B-T081
and	O
exposure	O
route	O
.	O
	
here	O
we	O
demonstrate	O
the	O
use	O
of	O
bayesian	B-T170
networks	I-T170
as	O
a	O
reliable	O
tool	B-T169
for	O
nm	O
risk	B-T078
estimation	O
.	O
	
this	O
tool	B-T169
is	O
tractable	B-T080
,	O
accessible	B-T080
and	O
scalable	B-T081
.	O
	
most	O
importantly	O
,	O
it	O
captures	O
a	O
broad	O
span	O
of	O
data	B-T078
types	O
,	O
from	O
complete	O
,	O
high	O
quality	B-T080
data	B-T170
sets	I-T170
through	O
to	O
data	B-T170
sets	I-T170
with	O
missing	O
data	B-T078
and/or	O
values	B-T081
with	O
a	O
relatively	O
high	O
spread	O
of	O
probability	B-T081
distribution	I-T081
.	O
	
the	O
tool	B-T169
is	O
able	O
to	O
learn	O
iteratively	O
in	O
order	O
to	O
further	O
refine	O
forecasts	O
as	O
the	O
quality	B-T080
of	O
data	B-T078
available	O
improves	O
.	O
	
we	O
demonstrate	O
how	O
this	O
risk	B-T078
measurement	B-T169
approach	O
works	O
on	O
nms	O
with	O
varying	O
degrees	O
of	O
risk	B-T078
potential	B-T080
,	O
namely	O
,	O
carbon	O
nanotubes	O
,	O
silver	O
and	O
titanium	O
dioxide	O
.	O
	
the	O
results	O
afford	O
even	O
non-experts	B-T098
an	O
accurate	O
picture	O
of	O
the	O
occupational	O
risk	B-T078
probabilities	O
associated	O
with	O
these	O
nms	O
and	O
,	O
in	O
doing	O
so	O
,	O
demonstrated	O
how	O
nm	O
risk	B-T078
can	O
be	O
evaluated	B-T078
into	O
a	O
tractable	B-T080
,	O
quantitative	B-T081
risk	B-T078
gender	O
and	O
direction	B-T082
of	O
effect	B-T080
of	O
alcohol	O
problems	O
and	O
internalizing	O
symptoms	O
in	O
a	O
longitudinal	B-T062
sample	I-T062
of	O
college	B-T098
students	I-T098
alcohol	O
problems	O
and	O
internalizing	O
symptoms	O
are	O
consistently	O
found	O
to	O
be	O
associated	B-T080
but	O
how	O
they	O
relate	B-T080
to	O
each	O
other	O
is	O
unclear	B-T033
.	O
	
the	O
present	O
study	B-T062
aimed	O
to	O
address	O
limitations	B-T169
in	O
the	O
literature	B-T170
of	O
comorbidity	B-T078
of	O
alcohol	O
problems	O
and	O
internalizing	O
symptoms	O
by	O
investigating	B-T169
the	O
direction	B-T082
of	O
effect	B-T080
between	O
the	O
phenotypes	O
and	O
possible	O
gender	O
differences	O
in	O
college	B-T098
students	I-T098
.	O
	
we	O
utilized	O
data	B-T078
from	O
a	O
large	O
longitudinal	B-T062
study	I-T062
of	O
college	B-T098
students	I-T098
from	O
the	O
united	O
states	O
n	O
=	O
2607	O
.	O
	
three	O
waves	O
of	O
questionnaire-based	B-T170
data	B-T078
were	O
collected	O
over	O
the	O
first	O
two	O
years	B-T079
of	O
college	O
in	O
2011-2013	O
.	O
	
cross-lagged	B-T081
models	I-T081
were	O
applied	O
to	O
examine	O
the	O
possible	O
direction	B-T082
of	O
effect	B-T080
of	O
internalizing	O
symptoms	O
and	O
alcohol	O
problems	O
.	O
	
possible	O
effects	B-T080
of	O
gender	O
were	O
investigated	B-T169
using	O
multigroup	B-T081
modeling	I-T081
.	O
	
there	O
were	O
significant	B-T078
correlations	B-T080
between	O
alcohol	O
problems	O
and	O
internalizing	O
symptoms	O
.	O
	
a	O
direction	B-T082
of	O
effect	B-T080
was	O
found	O
between	O
alcohol	O
problems	O
and	O
internalizing	O
symptoms	O
but	O
differed	O
between	O
genders	O
.	O
	
a	O
unidirectional	O
relationship	B-T080
varying	O
with	O
age	O
was	O
identified	O
for	O
males	O
where	O
alcohol	O
problems	O
initially	O
predicted	B-T078
internalizing	O
symptoms	O
followed	O
by	O
internalizing	O
symptoms	O
predicting	O
alcohol	O
problems	O
.	O
	
for	O
females	O
,	O
a	O
unidirectional	O
relationship	B-T080
existed	O
wherein	O
alcohol	O
problems	O
predicted	O
internalizing	O
symptoms	O
.	O
	
conclusions/importance	O
we	O
conclude	O
that	O
the	O
relationship	B-T080
between	O
alcohol	O
problems	O
and	O
internalizing	O
symptoms	O
is	O
complex	B-T080
and	O
differ	O
between	O
genders	O
.	O
	
in	O
males	O
,	O
both	O
phenotypes	O
are	O
predictive	B-T080
of	O
each	O
other	O
,	O
while	O
in	O
females	O
the	O
relationship	B-T080
is	O
driven	O
by	O
alcohol	O
problems	O
.	O
	
importantly	O
,	O
our	O
study	B-T062
examines	O
a	O
population-based	B-T081
sample	I-T081
,	O
revealing	O
that	O
the	O
observed	O
relationships	B-T080
between	O
alcohol	O
problems	O
and	O
internalizing	O
symptoms	O
are	O
not	O
limited	O
to	O
individuals	B-T098
with	O
clinically	O
diagnosed	O
mental	O
health	O
or	O
substance	O
use	O
problems	O
.	O
	
real-time	B-T079
monitoring	O
of	O
vesicle	O
ph	B-T081
in	O
an	O
endocytic	O
pathway	O
using	O
an	O
egf	B-T116
-	O
conjugated	O
two-photon	O
probe	O
herein	O
,	O
we	O
developed	O
a	O
ratiometric	O
two-photon	O
probe	O
bhs3	O
-	O
egf	B-T116
,	O
derived	O
from	O
a	O
ph	B-T081
sensitive	B-T169
dye	O
and	O
epidermal	B-T116
growth	I-T116
factor	I-T116
egf	B-T116
,	O
for	O
real-time	B-T079
monitoring	O
and	O
quantitative	B-T081
analysis	B-T062
of	O
acidic	O
luminal	O
ph	B-T081
values	B-T080
during	O
endocytic	O
pathway	O
activity	O
.	O
	
two-photon	O
microscopy	O
imaging	O
with	O
bhs3	O
-	O
egf	B-T116
allows	O
the	O
quantitative	B-T081
analysis	B-T062
of	O
ph	B-T081
distributions	B-T169
of	O
single	O
vesicles	O
and	O
their	O
dynamics	O
in	O
receptor-mediated	O
endocytosis	O
in	O
body	B-T081
burden	I-T081
of	O
heavy	O
metals	O
among	O
hiv	B-T033
high	B-T098
risk	I-T098
population	I-T098
in	O
usa	O
hiv	B-T033
high	B-T098
risk	I-T098
population	I-T098
may	O
face	O
not	O
only	O
the	O
threat	B-T078
of	O
hiv	B-T047
infection	I-T047
but	O
also	O
a	O
higher	B-T080
chance	B-T080
of	O
exposure	O
to	O
environmental	O
contaminants	O
.	O
	
however	O
,	O
no	O
previous	O
studies	B-T062
have	O
examined	B-T080
the	O
body	B-T081
burden	I-T081
of	O
environmental	O
pollutants	O
including	O
heavy	O
metals	O
among	O
hiv	B-T033
high	B-T098
risk	I-T098
populations	I-T098
.	O
	
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
whether	O
adults	O
aged	O
20-59	O
years	O
old	O
at	O
high	B-T033
risk	I-T033
of	I-T033
hiv	B-T047
infection	I-T047
have	O
higher	B-T080
blood	B-T033
levels	I-T033
of	I-T033
heavy	I-T033
metals	I-T033
compared	B-T052
to	O
those	O
with	O
low	B-T081
risk	I-T081
of	O
hiv	B-T047
infection	I-T047
in	O
united	O
states	O
.	O
	
we	O
used	O
the	O
national	B-T062
health	I-T062
and	I-T062
nutrition	I-T062
examination	I-T062
survey	I-T062
nhanes	B-T062
1999-2010	O
to	O
compare	B-T052
exposures	B-T080
to	I-T080
heavy	O
metals	O
including	O
cadmium	O
,	O
lead	O
,	O
and	O
total	O
mercury	O
by	O
hiv	B-T033
risk	B-T033
status	I-T033
.	O
	
the	O
results	B-T169
showed	O
that	O
people	B-T098
at	O
high	B-T033
risk	I-T033
of	I-T033
hiv	B-T033
had	O
higher	B-T080
blood	O
concentrations	O
of	O
all	O
heavy	O
metals	O
compared	B-T052
to	O
their	O
counterparts	O
with	O
lower	B-T080
hiv	B-T033
risks	I-T033
.	O
	
in	O
multivariate	B-T081
linear	I-T081
regression	I-T081
models	O
,	O
hiv	B-T033
risk	I-T033
status	O
was	O
significantly	O
associated	B-T080
with	I-T080
increased	B-T081
blood	O
cadmium	O
,	O
lead	O
,	O
and	O
total	O
mercury	O
after	O
adjusting	B-T169
for	O
age	O
,	O
sex	O
,	O
race	B-T098
,	O
education	O
,	O
and	O
poverty	O
income	B-T081
ratio	B-T081
.	O
	
our	O
study	B-T062
suggests	O
that	O
people	B-T098
at	O
high	B-T033
risk	I-T033
of	I-T033
hiv	B-T033
have	O
significantly	O
higher	B-T080
body	B-T081
burden	I-T081
of	O
heavy	O
metals	O
including	O
cadmium	O
,	O
lead	O
,	O
and	O
mercury	O
compared	B-T052
to	O
those	O
with	O
low	B-T081
risk	I-T081
of	O
hiv	B-T033
.	O
	
further	O
longitudinal	B-T062
study	I-T062
collecting	O
more	B-T081
pollutants	O
are	O
warranted	B-T169
to	O
determine	O
the	O
potential	B-T080
health	B-T078
effects	B-T080
of	O
these	O
elevated	B-T080
pollutants	O
on	O
both	O
hiv-infected	B-T047
and	O
hiv	B-T033
high-risk	B-T098
populations	I-T098
.	O
	
fluorescence-	O
and	O
magnetic-activated	O
cell	O
sorting	O
strategies	B-T169
to	O
separate	B-T080
spermatozoa	O
involving	O
plural	B-T081
contributors	B-T098
from	O
biological	O
mixtures	O
for	O
human	O
identification	O
no	O
effective	O
method	B-T169
has	O
been	O
developed	O
to	O
distinguish	B-T080
sperm	O
cells	O
originating	O
from	O
different	O
men	B-T098
in	O
multi-suspect	B-T078
sexual	O
assault	O
cases	B-T169
.	O
	
here	O
we	O
combined	O
macs	O
and	O
facs	O
to	O
isolate	O
single	B-T081
donor	B-T098
sperm	O
cells	O
from	O
forensic	O
mixture	O
samples	O
including	O
female	B-T098
vaginal	O
epithelial	O
cells	O
and	O
sperm	O
cells	O
from	O
multiple	B-T081
contributors	B-T098
.	O
	
sperms	O
from	O
vaginal	O
swab	O
were	O
isolated	B-T169
by	O
macs	O
using	O
fitc	B-T109
-conjugated	O
a	B-T116
kinase	I-T116
anchor	I-T116
protein	I-T116
3	I-T116
akap3	B-T116
antibody	B-T116
target	B-T098
individual	I-T098
sperm	O
cells	O
involving	O
two	O
or	O
three	O
donors	B-T098
were	O
separated	B-T080
by	O
facs	O
using	O
fitc	B-T109
-labeled	O
blood	B-T116
group	I-T116
a/b	I-T116
antigen	I-T116
antibody	B-T116
.	O
	
this	O
procedure	B-T169
was	O
further	O
tested	B-T169
in	O
two	O
mock	B-T033
multi-suspect	B-T078
sexual	O
assault	O
samples	O
and	O
one	O
practical	O
casework	O
sample	O
.	O
	
our	O
results	O
showed	O
that	O
complete	B-T080
single	B-T081
donor	B-T098
str	O
profiles	O
could	O
be	O
successfully	O
obtained	O
from	O
sperm	O
/	O
epithelial	O
cell	O
and	O
sperm	O
mixtures	O
from	O
two	O
contributors	B-T098
.	O
	
for	O
unbalanced	O
sperm	O
/	O
epithelial	O
cells	O
and	O
sperm	O
cells	O
mixtures	O
,	O
sensitivity	B-T081
results	O
revealed	O
that	O
target	O
cells	O
could	O
be	O
detected	B-T033
at	O
as	O
low	O
as	O
1	O
and	O
1	O
mixed	O
ratios	O
,	O
respectively	O
.	O
	
although	O
highly	O
relies	O
on	O
cell	O
number	O
and	O
blood	O
types	O
or	O
secretor	O
status	O
of	O
the	O
individuals	B-T098
,	O
this	O
procedure	B-T169
would	O
still	O
be	O
useful	O
tools	O
for	O
forensic	O
dna	O
analysis	O
of	O
multi-suspect	B-T078
sexual	O
assault	O
cases	B-T169
by	O
the	O
combined	O
use	B-T169
of	I-T169
facs	O
and	O
macs	O
based	O
on	O
sperm	O
-specific	O
akap3	B-T116
antigen	O
and	O
human	O
blood	O
type	O
antigen	O
.	O
	
the	O
role	O
of	O
the	O
iron	O
stain	O
in	O
assessing	B-T052
intracranial	B-T047
hemorrhage	I-T047
the	O
timing	B-T079
of	O
the	O
breakdown	O
of	O
red	O
blood	O
cells	O
and	O
organization	B-T169
of	O
hemorrhage	O
has	O
significance	B-T081
in	O
the	O
catabolism	O
of	O
heme	B-T109
and	O
the	O
processing	B-T052
of	O
iron	O
,	O
but	O
also	O
has	O
a	O
practical	O
application	B-T169
in	O
terms	O
of	O
assigning	B-T169
,	O
or	O
attempting	O
to	O
assign	B-T169
,	O
a	O
time	B-T079
course	I-T079
with	O
respect	O
to	O
traumatic	O
events	O
e.g	O
.	O
	
contusions	O
and	O
hemorrhages	O
.	O
	
attempts	O
to	O
date	O
contusions	O
,	O
however	O
,	O
have	O
generally	O
been	O
unsuccessful	B-T080
by	O
macroscopic	O
observation	O
,	O
whereas	O
the	O
microscopic	O
observations	O
provide	O
broad	O
data	B-T078
but	O
are	O
also	O
anatomically	B-T080
imprecise	B-T080
as	O
a	O
function	B-T169
of	O
time	B-T079
.	O
	
intracranial	B-T033
lesions	I-T033
are	O
of	O
particular	O
significance	B-T081
with	O
respect	O
to	O
the	O
timing	B-T079
of	O
organizing	B-T169
hemorrhage	O
given	O
the	O
acute	B-T079
,	O
and	O
often	O
life-threatening	B-T033
nature	B-T078
of	O
the	O
hemorrhages	O
,	O
and	O
the	O
medicolegal	O
investigation	O
into	O
potential	B-T080
crimes	O
.	O
	
of	O
concern	O
is	O
that	O
the	O
prussian	O
blue	O
reaction	O
for	O
iron	O
,	O
a	O
relatively	O
straightforward	O
histochemical	O
reaction	B-T169
that	O
has	O
been	O
in	O
use	O
for	O
over	O
150	O
years	B-T079
,	O
is	O
sometimes	O
suggested	O
as	O
a	O
diagnostic	O
test	O
for	O
chronicity	B-T079
.	O
	
therefore	O
,	O
this	O
study	B-T062
examined	B-T033
the	O
utility	O
of	O
the	O
prussian	O
blue	O
iron	O
stain	O
in	O
living	O
patients	O
with	O
intracranial	B-T047
hemorrhages	I-T047
and	O
well-defined	O
symptom	B-T079
onset	I-T079
,	O
to	O
test	O
whether	O
the	O
presence	B-T033
of	O
prussian	O
blue	O
reactivity	O
could	O
be	O
correlated	B-T080
with	O
chronicity	B-T079
.	O
	
it	O
was	O
found	B-T033
that	O
out	O
of	O
12	O
cases	B-T169
with	O
intracranial	B-T047
hemorrhage	I-T047
,	O
eight	O
cases	B-T169
showed	O
at	O
least	O
focal	O
iron	O
reactivity	O
.	O
	
the	O
duration	B-T079
from	O
symptom	B-T079
onset	I-T079
to	O
surgery	B-T061
in	O
those	O
eight	O
cases	B-T169
ranged	B-T081
from	O
<	O
24	O
hours	B-T079
to	O
more	O
than	O
3	O
days	B-T079
.	O
	
of	O
those	O
cases	B-T169
with	O
no	B-T033
iron	I-T033
reactivity	I-T033
,	O
the	O
duration	B-T079
from	O
symptom	B-T079
onset	I-T079
to	O
surgery	B-T061
ranged	O
from	O
<	O
24	O
hours	B-T079
to	O
six	O
days	B-T079
.	O
	
in	O
conclusion	O
,	O
the	O
prussian	O
blue	O
reaction	O
was	O
unreliable	B-T078
as	O
an	O
indicator	O
of	O
timing	B-T079
in	O
intracranial	B-T047
hemorrhage	I-T047
.	O
	
the	O
use	O
of	O
the	O
prussian	O
blue	O
reaction	O
as	O
an	O
independent	O
indicator	O
of	O
chronicity	B-T079
is	O
therefore	O
not	O
valid	B-T080
and	O
can	O
be	O
misleading	O
.	O
	
caution	O
is	O
indicated	B-T033
when	O
employing	O
iron	O
staining	O
for	O
timing	B-T079
purposes	O
,	O
as	O
its	O
only	O
use	O
is	O
to	O
highlight	O
,	O
as	O
opposed	O
to	O
identify	O
,	O
pre-existing	B-T080
lesions	B-T033
.	O
	
with	O
respect	O
to	O
brain	B-T047
lesions	I-T047
,	O
the	O
prussian	O
blue	O
reaction	O
should	O
not	O
be	O
used	O
in	O
place	O
of	O
the	O
clinical	B-T080
timing	B-T079
of	O
the	O
neurologic	B-T033
decline	I-T033
,	O
or	O
clinical	B-T170
data	I-T170
that	O
is	O
otherwise	O
more	O
accurate	B-T080
and	O
less	O
susceptible	B-T169
to	O
false	O
positive	O
results	O
.	O
	
successful	B-T080
fetal	O
tele-echo	O
at	O
a	O
small	O
regional	O
hospital	O
prenatal	O
diagnosis	O
of	O
complex	B-T080
congenital	O
heart	O
disease	O
chd	O
has	O
been	O
shown	O
to	O
improve	B-T033
newborn	B-T033
outcomes	B-T169
.	O
	
the	O
rate	O
of	O
prenatal	O
diagnosis	O
and	O
access	B-T082
to	O
fetal	O
echocardiography	O
vary	O
widely	O
across	O
the	O
united	O
states	O
.	O
	
a	O
clinical	O
fetal	O
tele-echo	O
service	O
was	O
established	O
at	O
king's	O
daughters	O
medical	O
center	O
kdmc	O
in	O
ashland	O
,	O
ky	O
,	O
a	O
region	O
in	O
eastern	O
kentucky	O
that	O
is	O
3	O
h	O
from	O
the	O
nearest	O
congenital	O
heart	O
surgeon	O
.	O
	
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
determine	O
if	O
fetal	O
tele-echo	O
utilizing	O
local	O
sonographers	O
at	O
a	O
small	O
regional	O
hospital	O
can	O
accurately	B-T080
and	O
efficiently	B-T080
identify	O
fetuses	O
with	O
complex	B-T080
chd	O
.	O
	
medical	B-T170
records	I-T170
were	O
reviewed	B-T080
for	O
all	O
mother-infant	O
pairs	O
who	O
had	O
fetal	O
tele-echoes	O
performed	B-T169
at	O
kdmc	O
and	O
interpreted	B-T169
by	O
university	O
of	O
louisville	O
pediatric	O
cardiology	O
between	O
march	O
2011	O
and	O
december	O
2013	O
.	O
	
findings	B-T033
on	O
fetal	O
tele-echo	O
were	O
compared	O
to	O
newborn	O
echo	O
and	O
clinical	O
course	O
,	O
and	O
divided	O
into	O
four	O
groups	O
1	O
correct	O
-	O
no	O
difference	O
between	O
fetal	O
tele-echo	O
and	O
newborn	O
echo	O
,	O
2	O
likely	O
correct-normal	O
fetal	O
tele-echo	O
and	O
benign	O
newborn	O
course	O
,	O
3	O
major	O
difference	O
-one	O
that	O
affected	O
newborn	O
clinical	B-T079
course	I-T079
,	O
and	O
4	O
minor	O
difference	O
-did	O
not	O
affect	O
clinical	O
course	O
.	O
	
seventy-five	O
mother-infant	O
pairs	O
were	O
analyzed	O
.	O
	
fetal	O
tele-echoes	O
were	O
correct	B-T080
in	O
21%	O
,	O
likely	O
correct	O
in	O
56%	O
,	O
showed	O
major	O
differences	O
in	O
0%	O
,	O
and	O
showed	O
minor	O
differences	O
in	O
23%	O
.	O
	
for	O
identifying	O
complex	O
chd	O
,	O
fetal	O
tele-echo	O
had	O
a	O
sensitivity	O
and	O
specificity	O
of	O
100%	O
.	O
	
the	O
average	O
number	O
of	O
fetal	O
echocardiograms	O
per	O
mother-infant	O
pair	O
was	O
1.1	O
.	O
	
fetal	O
tele-echocardiography	O
performed	O
by	O
local	O
sonographers	O
at	O
a	O
small	O
regional	O
hospital	O
can	O
accurately	O
and	O
efficiently	O
identify	O
fetuses	O
with	O
complex	O
chd	O
identification	B-T080
of	O
mineral	O
-	O
binding	B-T052
peptides	B-T116
that	O
discriminate	B-T080
between	O
chalcopyrite	O
and	O
enargite	O
innovative	O
approaches	O
to	O
the	O
separation	B-T080
of	O
minerals	O
and	O
subsequent	B-T079
extraction	O
of	O
metals	O
are	O
imperative	B-T080
owing	O
to	O
the	O
increasing	B-T169
mineralogical	O
complexity	B-T080
of	O
ore	O
deposits	O
that	O
are	O
difficult	B-T080
or	O
even	O
impossible	B-T033
to	O
separate	B-T080
into	O
slurries	O
or	O
solutions	O
containing	B-T169
only	O
the	O
minerals	O
or	O
metals	O
of	O
interest	O
.	O
	
low	B-T080
recovery	B-T052
of	O
metal	O
is	O
typical	B-T080
for	O
these	O
complex	B-T080
deposits	O
leading	O
to	O
significant	B-T078
losses	B-T081
to	O
tailings	O
.	O
	
in	B-T169
addition	I-T169
,	O
the	O
minerals	O
often	O
contain	O
impurities	O
,	O
some	O
toxic	B-T080
,	O
which	O
are	O
difficult	B-T080
and	O
costly	B-T169
to	O
control	B-T169
or	O
manage	O
during	O
the	O
processing	B-T052
of	O
a	O
concentrate	B-T080
or	O
other	O
mineral	O
product	O
.	O
	
one	O
example	O
of	O
this	O
complex	B-T080
situation	O
is	O
the	O
significant	B-T078
economic	B-T169
and	O
environmental	B-T082
costs	B-T081
associated	B-T080
with	I-T080
diluting	B-T169
and	O
processing	B-T052
copper	O
concentrates	B-T080
containing	B-T169
arsenic	O
in	O
the	O
form	O
of	O
the	O
mineral	O
enargite	O
,	O
cu3	O
ass4	O
in	O
the	O
production	O
of	O
pure	B-T081
copper	O
.	O
	
to	O
overcome	O
these	O
separation	B-T080
problems	B-T033
,	O
we	O
have	O
utilized	O
phage	O
display	O
to	O
identify	B-T080
peptides	B-T116
that	O
demonstrate	O
selective	B-T080
recognition	B-T080
of	O
enargite	O
and	O
the	O
arsenic	O
-	O
free	B-T169
copper	O
sulfide	O
,	O
chalcopyrite	O
.	O
	
screening	O
of	O
two	O
random	B-T080
peptide	B-T116
phage	I-T116
display	I-T116
libraries	I-T116
resulted	O
in	O
the	O
identification	B-T080
of	O
an	O
enargite	O
-	O
selective	B-T080
peptide	B-T116
with	O
the	O
sequence	O
mhkptvhikgpt	O
and	O
a	O
chalcopyrite	O
-	O
selective	B-T080
peptide	B-T116
with	O
the	O
sequence	O
rkkkckgnccytpq	O
.	O
	
mineral	O
-	O
binding	B-T052
selectivity	B-T080
was	O
demonstrated	O
by	O
binding	B-T052
studies	B-T062
,	O
zeta	O
potential	O
determination	O
and	O
immunochemistry	O
.	O
	
peptides	B-T116
that	O
have	O
the	O
ability	B-T033
to	O
discriminate	B-T080
between	O
enargite	O
and	O
chalcopyrite	O
provide	O
a	O
greener	O
option	B-T169
for	O
the	O
separation	B-T080
of	O
arsenic	O
containing	B-T169
contaminants	O
from	O
copper	O
concentrates	B-T080
.	O
	
this	O
represents	O
the	O
first	O
step	O
towards	O
a	O
major	B-T080
advance	B-T079
in	O
the	O
replacement	B-T169
or	O
reduction	B-T080
of	O
toxic	B-T080
collectors	B-T169
as	O
well	O
as	O
reducing	B-T080
the	O
level	B-T080
of	O
arsenic	O
-	O
bearing	B-T052
minerals	O
in	O
the	O
early	B-T079
stages	B-T079
of	O
mineral	O
processing	B-T052
.	O
	
high-density	B-T116
lipoprotein	I-T116
-associated	O
sphingosine-1-phosphate	B-T109
activity	O
in	O
heterozygous	B-T047
familial	I-T047
hypercholesterolaemia	I-T047
patients	O
with	O
heterozygous	B-T047
familial	I-T047
hypercholesterolaemia	I-T047
fh	B-T047
suffer	O
from	O
high	B-T033
plasma	I-T033
cholesterol	I-T033
and	O
an	O
environment	B-T082
of	O
increased	O
oxidative	O
stress	O
.	O
	
we	O
examined	O
its	O
potential	O
effects	O
on	O
high-density	B-T116
lipoprotein	I-T116
hdl	B-T116
sphingosine-1-phosphate	B-T109
s1p	B-T109
content	O
hdl	B-T116
-	O
s1p	B-T109
and	O
hdl	B-T116
-mediated	O
protection	O
against	O
oxidative	O
stress	O
,	O
both	O
with	O
and	O
without	O
statin	O
treatment	O
.	O
	
in	O
a	O
case-control	B-T062
study	I-T062
,	O
hdl	B-T116
was	O
isolated	B-T169
from	O
12	O
fh	B-T047
patients	O
with	O
and	O
without	O
statin	O
treatment	O
and	O
from	O
12	O
healthy	B-T080
controls	I-T080
.	O
	
the	O
hdl	B-T116
-	O
s1p	B-T109
content	O
and	O
the	O
capacity	O
of	O
hdl	B-T116
to	O
protect	B-T033
cardiomyocytes	O
against	O
oxidative	O
stress	O
in	B-T062
vitro	I-T062
were	O
measured	O
.	O
	
hdl	B-T116
-associated	O
s1p	B-T109
was	O
significantly	O
correlated	O
with	O
cell	O
protection	O
,	O
but	O
not	O
with	O
hdl-cholesterol	B-T109
or	O
apolipoprotein	B-T116
ai	I-T116
.	O
	
the	O
latter	O
did	O
not	O
correlate	O
with	O
hdl	B-T116
-mediated	O
cell	O
protection	O
.	O
	
neither	O
the	O
hdl	B-T116
-	O
s1p	B-T109
content	O
nor	O
hdl	B-T116
protective	O
capacity	O
differed	O
between	O
nontreated	O
fh	B-T047
patients	O
and	O
controls	O
.	O
	
the	O
relative	O
amounts	O
of	O
apolipoprotein	B-T116
ai	I-T116
and	O
apolipoprotein	B-T116
m	I-T116
were	O
similar	O
between	O
controls	O
and	O
fh	B-T047
patients	O
.	O
	
statin	O
treatment	O
had	O
no	O
effect	O
on	O
any	O
of	O
these	O
measures	O
.	O
	
the	O
fh	B-T047
environment	B-T082
is	O
not	O
detrimental	O
to	O
hdl	B-T116
-	O
s1p	B-T109
content	O
or	O
hdl	B-T116
-	O
s1p	B-T109
-mediated	O
cell	O
protection	O
.	O
	
statin	O
treatment	O
does	O
not	O
modulate	O
hdl	B-T116
moberg	O
picking-up	O
test	O
in	O
patients	O
with	O
hand	B-T047
osteoarthritis	I-T047
clinical	O
measurement	O
.	O
	
the	O
moberg	O
pick-up	O
test	O
mput	O
was	O
previously	O
used	O
to	O
evaluate	O
functional	B-T033
performance	I-T033
in	O
patients	O
with	O
hand	O
inflammatory	B-T047
disease	I-T047
.	O
	
this	O
is	O
the	O
first	O
study	O
using	O
the	O
mput	O
in	O
hand	B-T047
osteoarthritis	I-T047
oa	B-T047
.	O
	
compare	O
the	O
functional	B-T033
performance	I-T033
mput	O
in	O
hand	B-T047
oa	I-T047
patients	O
and	O
healthy	B-T080
controls	I-T080
.	O
	
fifty	O
hand	B-T047
oa	I-T047
patients	O
and	O
50	O
controls	O
were	O
assessed	O
using	O
the	O
mput	O
,	O
auscan	B-T170
and	O
cochin	B-T170
questionnaires	I-T170
,	O
grip	B-T033
and	O
pinch	O
strength	O
,	O
pain	O
using	O
a	O
visual	O
analog	O
scale	O
and	O
a	O
likert	B-T170
scale	I-T170
regarding	O
difficulty	O
to	O
perform	O
mput	O
.	O
	
in	O
the	O
mput	O
evaluation	O
,	O
the	O
oa	B-T047
group	O
presented	O
a	O
statistically	B-T081
significant	I-T081
difference	O
from	O
the	O
control	O
group	O
.	O
	
the	O
oa	B-T047
group	O
spent	O
more	B-T081
time	B-T079
executing	O
test	B-T170
.	O
	
the	O
grip	B-T033
and	O
pinch	O
strength	O
measurements	O
showed	O
higher	O
values	O
for	O
the	O
control	O
group	O
.	O
	
the	O
oa	B-T047
group	O
reported	O
a	O
greater	O
difficulty	B-T080
than	O
the	O
control	O
group	O
in	O
performing	O
the	O
test	B-T170
.	O
	
the	O
mput	O
is	O
a	O
short	O
and	O
easy	O
to	O
apply	O
test	B-T170
,	O
which	O
can	O
be	O
safely	O
used	O
to	O
assess	O
the	O
functional	B-T033
performance	I-T033
of	O
the	O
hand	B-T047
oa	I-T047
.	O
	
soymilk	O
residue	O
okara	B-T116
as	O
a	O
natural	B-T169
immobilization	B-T080
carrier	I-T080
for	O
lactobacillus	O
plantarum	O
cells	O
enhances	B-T052
soymilk	O
fermentation	O
,	O
glucosidic	B-T109
isoflavone	I-T109
bioconversion	B-T169
,	O
and	O
cell	O
survival	O
under	O
simulated	B-T080
gastric	I-T080
and	O
intestinal	O
conditions	B-T080
cell	O
immobilization	O
is	O
an	O
alternative	O
to	O
microencapsulation	B-T061
for	O
the	O
maintenance	O
of	O
cells	O
in	O
a	O
liquid	O
medium	O
.	O
	
however	O
,	O
artificial	B-T080
immobilization	B-T080
carriers	I-T080
are	O
expensive	O
and	O
pose	O
a	O
high	O
safety	O
risk	B-T078
.	O
	
okara	B-T116
,	O
a	O
food-grade	O
byproduct	O
from	O
soymilk	O
production	O
,	O
is	O
rich	O
in	O
prebiotics	B-T109
.	O
	
lactobacilli	O
could	O
provide	O
health	B-T078
enhancing	B-T052
effects	B-T080
to	O
the	O
host	O
.	O
	
this	O
study	B-T062
aimed	O
to	O
evaluate	O
the	O
potential	O
of	O
okara	B-T116
as	O
a	O
natural	O
immobilizer	O
for	O
l	O
.	O
	
plantarum	O
70810	O
cells	O
.	O
	
the	O
study	O
also	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
okara-immobilized	B-T116
l	O
.	O
	
plantarum	O
70810	O
cells	O
il	O
on	O
soymilk	O
fermentation	O
,	O
glucosidic	B-T109
isoflavone	I-T109
bioconversion	B-T169
,	O
and	O
cell	O
resistance	B-T169
to	O
simulated	B-T080
gastric	I-T080
and	O
intestinal	O
stresses	O
.	O
	
scanning	O
electron	O
microscopy	O
sem	O
was	O
used	O
to	O
show	O
cells	O
adherence	B-T169
to	O
the	O
surface	B-T082
of	O
okara	B-T116
.	O
	
lactic	B-T109
acid	I-T109
,	O
acetic	B-T109
acid	I-T109
and	O
isoflavone	B-T109
analyses	B-T062
in	O
unfermented	O
and	O
fermented	O
soymilk	O
were	O
performed	B-T169
by	O
hplc	O
with	O
uv	O
detection	O
.	O
	
viability	B-T080
and	O
growth	O
kinetics	O
of	O
immobilized	O
and	O
free	O
l	O
.	O
	
plantarum	O
70810	O
cells	O
fl	O
were	O
followed	O
during	O
soymilk	O
fermentation	O
.	O
	
moreover	O
,	O
changes	B-T169
in	O
ph	O
,	O
titrable	O
acidity	O
and	O
viscosity	O
were	O
measured	B-T080
by	O
conventional	B-T170
methods	I-T170
.	O
	
for	O
in	B-T080
vitro	I-T080
testing	B-T169
of	O
simulated	O
gastrointestinal	B-T082
resistance	B-T169
,	O
fermented	O
soymilk	O
was	O
inoculated	B-T061
with	O
fl	O
or	O
il	O
and	O
an	O
aliquot	B-T081
incubated	O
into	O
acidic	O
mrs	O
broth	O
which	O
was	O
conveniently	O
prepared	O
to	O
simulate	O
gastric	B-T080
,	O
pancreatic	O
juices	O
and	O
bile	B-T109
salts	I-T109
.	O
	
survival	O
to	O
simulated	B-T080
gastric	I-T080
and	O
intestinal	O
stresses	O
was	O
evaluated	O
by	O
plate	O
count	O
of	O
colony	O
forming	O
units	O
on	O
mrs	O
agar	O
.	O
	
sem	O
revealed	O
that	O
the	O
lactobacilli	O
cells	O
attached	O
and	O
bound	O
to	O
the	O
surface	B-T082
of	O
okara	B-T116
.	O
	
compared	B-T052
with	O
fl	O
,	O
il	O
exhibited	O
a	O
significantly	O
higher	B-T080
specific	B-T080
growth	B-T079
rate	I-T079
,	O
shorter	B-T081
lag	B-T079
phase	I-T079
of	O
growth	O
,	O
higher	O
productions	O
of	O
lactic	B-T109
and	O
acetic	B-T109
acids	I-T109
,	O
a	O
faster	B-T080
decrease	B-T081
in	O
ph	O
and	O
increase	B-T169
in	O
titrable	O
acidity	O
,	O
and	O
a	O
higher	B-T080
soymilk	O
viscosity	O
.	O
	
similarly	O
,	O
il	O
in	O
soymilk	O
showed	O
higher	O
productions	O
of	O
daizein	B-T109
and	O
genistein	B-T109
compared	B-T052
with	O
the	O
control	O
.	O
	
compared	B-T052
with	O
fl	O
,	O
il	O
showed	O
reinforced	O
resistance	O
to	O
simulatedgastric	B-T080
and	O
intestinal	O
stresses	O
in	B-T080
vitro	I-T080
that	O
included	O
low	B-T033
ph	I-T033
,	O
low	B-T033
ph	I-T033
plus	I-T033
pepsin	B-T116
,	O
pancreatin	B-T116
,	O
and	O
bile	B-T109
salt	I-T109
.	O
	
our	O
results	B-T169
indicate	O
that	O
okara	B-T116
is	O
a	O
new	O
potential	O
immobilization	B-T080
carrier	I-T080
to	O
enhance	B-T052
the	O
growth	O
and	O
glucosidic	B-T109
isoflavone	I-T109
bioconversion	B-T169
activities	B-T052
of	O
l	O
.	O
	
plantarum	O
in	O
soymilk	O
and	O
improve	B-T033
cell	O
survivability	O
following	O
simulated	B-T080
gastric	I-T080
and	O
intestinal	O
conditions	B-T080
.	O
	
comparison	O
of	O
a	O
new	O
visual	B-T061
stylet	I-T061
discopo	I-T061
laryngeal	B-T061
mask	I-T061
airway	I-T061
placement	I-T061
vs	O
conventional	B-T061
blind	I-T061
technique	I-T061
a	O
prospective	O
randomized	B-T062
study	O
to	O
compare	O
the	O
ease	O
of	O
laryngeal	B-T061
mask	I-T061
airway	I-T061
lma	I-T061
insertion	I-T061
and	O
fiberoptic	B-T082
view	I-T082
of	O
lma	O
after	O
placement	B-T080
using	O
the	O
discopo	B-T061
visual	I-T061
stylet-guided	I-T061
insertion	I-T061
and	O
conventional	B-T061
blind	I-T061
technique	I-T061
.	O
	
prospective	O
,	O
randomized	B-T062
controlled	B-T062
study	I-T062
.	O
	
operating	O
room	O
in	O
a	O
university	O
hospital	O
.	O
	
one	O
hundred	O
adult	O
patients	O
scheduled	O
for	O
elective	B-T061
surgery	I-T061
under	O
lma	O
general	B-T061
anesthesia	I-T061
were	O
enrolled	O
.	O
	
patients	O
were	O
randomly	B-T062
allocated	O
to	O
2	O
groups	O
glma	O
group	O
using	O
a	O
visual	B-T061
stylet-guided	I-T061
technique	I-T061
n=50	O
and	O
blma	O
group	O
using	O
standard	O
blind	B-T061
technique	I-T061
n=50	O
.	O
	
correct	O
placement	B-T080
of	O
the	O
lma	O
was	O
confirmed	O
using	O
clinical	O
test	O
along	O
with	O
fiberoptic	O
assessment	O
.	O
	
unblinded	B-T078
data	I-T078
were	O
collected	O
about	O
the	O
insertion	B-T061
time	O
,	O
the	O
first	O
attempt	O
success	B-T081
rate	I-T081
,	O
the	O
lma	O
position	B-T082
adjustment	O
rate	O
,	O
fiberoptic	B-T082
view	I-T082
of	O
lma	O
anatomical	O
position	O
,	O
hemodynamic	O
responses	O
,	O
and	O
the	O
adverse	B-T169
insertion	B-T061
responses	O
bucking	O
,	O
breathholding	B-T033
,	O
and	O
laryngospasm	O
.	O
	
blinded	B-T078
data	I-T078
were	O
recorded	O
about	O
postoperative	B-T079
airway	B-T047
morbidity	I-T047
visible	O
blood	O
staining	O
on	O
lma	O
at	O
removal	O
,	O
sore	O
throat	O
,	O
and	O
hoarseness	O
.	O
	
insertion	B-T061
was	O
more	O
frequently	O
successful	O
at	O
the	O
first	O
attempt	O
in	O
glma	O
than	O
that	O
in	O
blma	O
group	O
100%	O
vs	O
92%	O
p=	O
.	O
	
the	O
time	O
taken	O
for	O
establishing	O
effective	O
airway	O
was	O
shorter	O
in	O
glma	O
than	O
that	O
in	O
blma	O
54.8	O
vs	O
62.9	O
seconds	O
p=	O
.	O
	
the	O
patients	O
in	O
blma	O
group	O
required	O
more	O
readjustment	O
and	O
reinsertion	B-T061
than	O
those	O
in	O
glma	O
group	O
38%	O
vs	O
0%	O
p=	O
.	O
	
the	O
fiberoptic	B-T082
view	I-T082
was	O
significantly	O
better	O
in	O
glma	O
group	O
p<	O
.	O
	
no	O
difference	O
between	O
the	O
2	O
groups	O
existed	O
regarding	O
hemodynamic	O
stress	O
responses	O
,	O
incidences	B-T081
of	O
adverse	B-T169
insertion	B-T061
responses	O
,	O
and	O
postoperative	B-T079
airway	B-T047
morbidity	I-T047
.	O
	
by	O
direct	O
visualizing	O
the	O
whole	O
process	O
of	O
lma	O
insertion	B-T061
,	O
the	O
discopo	B-T061
visual	I-T061
stylet	I-T061
increases	O
the	O
success	B-T081
rate	I-T081
and	O
accuracy	B-T080
rate	I-T080
of	O
lma	O
placement	B-T080
without	O
increasing	O
hemodynamic	O
stress	O
response	O
or	O
incidences	B-T081
of	O
adverse	O
events	O
.	O
	
targeting	B-T169
brain	O
and	O
peripheral	O
plasticity	O
of	O
the	O
lipidome	B-T109
in	O
acute	B-T079
kainic	B-T109
acid	I-T109
-	O
induced	B-T169
epileptic	B-T047
seizures	I-T047
in	O
mice	O
via	O
quantitative	O
mass	O
spectrometry	O
epilepsy	B-T047
is	O
a	O
highly	O
common	O
chronic	B-T047
neurological	I-T047
disorder	I-T047
,	O
manifested	B-T169
in	O
many	O
different	O
types	B-T080
,	O
affecting	O
1%	O
of	O
the	O
worldwide	O
human	O
population	B-T098
.	O
	
the	O
molecular	O
mechanisms	O
of	O
epileptogenesis	B-T047
have	O
not	O
yet	O
been	O
clarified	O
,	O
and	O
pharmacoresistance	B-T047
exhibited	O
by	O
30-40%	O
of	O
epilepsy	B-T047
patients	O
remains	O
a	O
major	O
obstacle	O
in	O
medical	B-T169
care	O
.	O
	
growing	O
evidence	B-T078
indicates	O
a	O
role	O
of	O
lipid	B-T109
signalling	O
pathways	O
in	O
epileptogenesis	B-T047
,	O
thus	O
lipid	B-T109
signals	O
emerge	O
as	O
potential	B-T080
biomarkers	O
for	O
the	O
onset	O
and	O
evolving	O
course	O
of	O
the	O
epileptic	B-T047
disorder	I-T047
,	O
as	O
well	O
as	O
potential	B-T080
therapeutic	O
agents	O
and	O
targets	B-T169
.	O
	
for	O
this	O
purpose	O
,	O
we	O
applied	O
a	O
lipidomic	B-T109
strategy	B-T062
to	O
unravel	O
lipid	B-T109
alterations	O
in	O
brain	O
regions	O
,	O
periphery	O
tissues	O
and	O
plasma	O
that	O
are	O
specific	B-T080
for	O
acute	B-T079
epileptic	B-T047
seizures	I-T047
in	O
mice	O
at	O
1h	O
after	O
seizure	B-T047
induction	B-T169
by	O
systemic	B-T062
kainic	B-T109
acid	I-T109
injection	B-T062
as	O
compared	B-T052
to	O
vehicle	O
controls	O
.	O
	
specifically	O
,	O
levels	B-T080
of	O
i	O
selected	O
phospholipids	B-T109
and	O
sphingomyelins	B-T109
,	O
ii	O
the	O
endocannabinoids	B-T109
anandamide	B-T109
aea	B-T109
and	O
2-arachidonoyl	B-T109
glycerol	I-T109
2-ag	B-T109
,	O
and	O
the	O
endocannabinoid	B-T109
-related	O
compounds	O
oleoylethanolamide	B-T109
oea	B-T109
and	O
palmitoylethanolamide	B-T109
pea	B-T109
,	O
iii	O
arachidonic	B-T109
acid	I-T109
aa	B-T109
,	O
iv	O
selected	O
eicosanoids	B-T109
,	O
and	O
v	O
fatty	O
acyl	O
content	O
of	O
lipidome	B-T109
were	O
determined	O
in	O
pulverized	B-T062
tissues	O
from	O
six	O
brain	O
regions	O
of	O
kainic	B-T109
acid	I-T109
induced	B-T169
epileptic	B-T047
seizure	I-T047
models	O
and	O
vehicle	O
controls	O
hypothalamus	O
,	O
hippocampus	O
,	O
thalamus	O
,	O
striatum	O
,	O
cerebellum	O
and	O
cerebral	O
cortex	O
,	O
and	O
from	O
peripheral	B-T082
organs	O
,	O
such	O
as	O
heart	O
and	O
lungs	O
,	O
and	O
in	O
plasma	O
.	O
	
alterations	O
in	O
lipid	B-T109
levels	O
after	O
acute	B-T079
epileptic	B-T047
seizures	I-T047
as	O
compared	B-T052
to	O
non-seizure	O
controls	O
were	O
found	O
to	O
be	O
brain	O
region	O
-	O
and	O
periphery	O
tissue	O
-	O
specific	B-T080
,	O
including	O
specific	B-T080
plasma	O
lipid	B-T109
correlates	O
,	O
highlighting	O
their	O
value	O
as	O
marker	O
candidates	O
in	O
translational	O
research	B-T062
studies	I-T062
,	O
and/or	O
drug	B-T062
discovery	I-T062
and	O
response	O
monitoring	O
.	O
	
panitumumab	B-T116
-associated	O
encephalopathy	B-T047
after	O
accidental	O
intra-arterial	B-T169
application	O
through	O
dislocated	O
central	O
venous	O
access	O
device	O
acute	B-T079
central	O
nervous	O
system	O
cns	O
toxicity	O
and	O
immune	B-T169
-related	O
side	O
effects	O
are	O
increasingly	O
recognized	O
with	O
the	O
use	O
of	O
monoclonal	B-T116
antibodies	I-T116
for	O
cancer	B-T061
therapy	I-T061
.	O
	
here	O
,	O
we	O
report	O
a	O
patient	O
who	O
developed	O
of	O
acute-onset	B-T033
encephalopathy	I-T033
and	O
coma	B-T047
,	O
which	O
began	O
shortly	O
after	O
administration	B-T169
of	O
panitumumab	B-T116
for	O
the	O
treatment	B-T061
of	O
metastatic	O
colorectal	O
cancer	O
.	O
	
echocardiography	O
revealed	O
that	O
the	O
drug	O
had	O
been	O
infused	O
into	O
the	O
left	O
cardiac	O
ventricle	O
via	O
a	O
dislocated	O
central	O
venous	O
line	O
.	O
	
diffusion-weighted	O
magnetic	O
resonance	O
imaging	O
disclosed	O
multiple	O
cortical	B-T033
hyperintensities	I-T033
,	O
which	O
were	O
preferentially	O
located	O
in	O
the	O
frontal	O
lobes	O
.	O
	
while	O
the	O
neurological	B-T047
condition	I-T047
improved	O
within	O
a	O
few	O
days	B-T079
,	O
the	O
patient	O
died	O
4	O
weeks	B-T079
later	O
.	O
	
it	O
seems	O
likely	O
that	O
the	O
administration	B-T169
of	O
the	O
antibody	B-T116
via	O
the	O
intra-arterial	B-T169
route	I-T169
contributed	O
to	O
the	O
development	O
of	O
this	O
condition	B-T047
.	O
	
toxic	O
encephalopathy	O
may	O
be	O
a	O
hitherto	B-T079
unrecognized	O
complication	O
of	O
panitumumab	B-T116
treatment	B-T061
and	O
should	O
be	O
taken	O
into	O
consideration	O
in	O
patients	O
developing	O
cns	O
symptoms	O
undergoing	O
this	O
abundance	B-T080
and	O
characterization	B-T052
of	O
perfect	O
microsatellites	O
on	O
the	O
cattle	O
y	O
chromosome	O
microsatellites	O
or	O
simple	O
sequence	O
repeats	O
ssrs	O
are	O
found	O
in	O
most	O
organisms	O
and	O
play	O
an	O
important	O
role	O
in	O
genomic	O
organization	O
and	O
function	O
.	O
	
to	O
characterize	B-T052
the	O
abundance	B-T080
of	O
ssrs	O
1-6	O
base-pairs	O
bp	O
on	O
the	O
cattle	O
y	O
chromsome	O
,	O
the	O
relative	O
frequency	B-T079
and	O
density	B-T081
of	O
perfect	O
or	O
uninterrupted	O
ssrs	O
based	O
on	O
the	O
published	O
y	O
chromosome	O
sequence	O
were	O
examined	B-T033
.	O
	
a	O
total	O
of	O
17	O
perfect	O
ssrs	O
were	O
found	O
,	O
with	O
total	O
length	B-T081
of	O
324.78	O
kb	O
,	O
indicating	O
that	O
approximately	O
0.75	O
of	O
the	O
cattle	O
y	O
chromosome	O
sequence	O
43.30	O
mb	O
comprises	O
perfect	O
ssrs	O
,	O
with	O
an	O
average	O
length	O
of	O
18.80	O
bp	O
.	O
	
the	O
relative	O
frequency	B-T079
and	O
density	B-T081
were	O
398.92	O
loci/mb	O
and	O
7500.62	O
bp	O
/mb	O
,	O
respectively	O
.	O
	
the	O
proportions	O
of	O
the	O
six	O
classes	O
of	O
perfect	O
ssrs	O
were	O
highly	O
variable	O
on	O
the	O
cattle	O
y	O
chromosome	O
.	O
	
mononucleotide	O
repeats	O
had	O
a	O
total	O
number	O
of	O
8073	O
46.74	O
and	O
an	O
average	O
length	O
of	O
15.45	O
bp	O
,	O
and	O
were	O
the	O
most	O
abundant	O
ssrs	O
class	O
,	O
while	O
the	O
percentages	O
of	O
di-	O
,	O
tetra-	O
,	O
tri-	O
,	O
penta-	O
,	O
and	O
hexa-nucleotide	O
repeats	O
were	O
22.86	O
,	O
11.98	O
,	O
11.58	O
,	O
6.65	O
,	O
and	O
0.19	O
,	O
respectively	O
.	O
	
different	O
classes	O
of	O
ssrs	O
varied	O
in	O
their	O
repeat	O
number	O
,	O
with	O
the	O
highest	O
being	O
42	O
for	O
dinucleotides	O
.	O
	
results	O
reveal	O
that	O
repeat	O
categories	O
a	O
,	O
ac	O
,	O
at	O
,	O
aac	O
,	O
agc	O
,	O
gttt	O
,	O
cttt	O
,	O
attt	O
,	O
and	O
aactg	O
predominate	O
on	O
the	O
y	O
chromosome	O
.	O
	
this	O
study	B-T062
provides	O
insight	O
into	O
the	O
organization	O
of	O
cattle	O
y	O
chromosome	O
repetitive	O
dna	O
,	O
as	O
well	O
as	O
information	O
useful	O
for	O
developing	O
more	O
polymorphic	B-T080
cattle	O
y-chromosome	O
-specific	O
antenatal	B-T079
stressful	O
life	O
events	O
and	O
postpartum	B-T079
depressive	O
symptoms	O
in	O
the	O
united	O
states	O
the	O
role	O
of	O
women's	B-T098
socioeconomic	B-T080
status	I-T080
indices	B-T170
at	O
the	O
state	B-T081
level	I-T081
approximately	O
10%-20%	O
of	O
women	B-T098
suffer	O
from	O
postpartum	O
depression	O
ppd	O
,	O
important	O
predictors	B-T078
of	O
which	O
are	O
antenatal	B-T079
stressful	O
life	O
event	O
sle	O
experiences	O
.	O
	
the	O
association	B-T080
between	O
women's	B-T098
state-level	B-T081
socioeconomic	B-T080
status	I-T080
ses	B-T080
and	O
ppd	O
has	O
not	O
been	O
explored	O
.	O
	
this	O
study	B-T062
aimed	O
to	O
examine	O
whether	O
the	O
association	B-T080
between	O
antenatal	B-T079
sle	O
and	O
ppd	O
symptoms	O
was	O
moderated	B-T080
by	O
women's	B-T098
state-level	B-T081
ses	B-T080
.	O
	
data	B-T078
from	O
the	O
2009-2011	O
pregnancy	B-T170
risk	I-T170
assessment	I-T170
monitoring	I-T170
system	I-T170
prams	B-T170
were	O
used	O
.	O
	
state-level	B-T081
women's	B-T098
employment	B-T080
/	O
earnings	B-T081
and	O
social	B-T169
/	O
economic	B-T169
autonomy	B-T078
indices	B-T170
were	O
computed	O
from	O
indicators	O
published	O
by	O
the	O
institute	O
of	O
women's	O
policy	O
research	O
iwpr	O
.	O
	
multilevel	O
multivariable	O
logistic	O
regression	O
analyses	O
were	O
performed	O
.	O
	
among	O
91	O
women	B-T098
with	O
valid	B-T080
responses	O
,	O
11.3	O
had	O
ppd	O
symptoms	O
,	O
prevalence	B-T081
ranging	O
from	O
7.1	O
in	O
illinois	O
to	O
17.1	O
in	O
arkansas	O
.	O
	
women	B-T098
who	O
experienced	O
all	O
four	O
stressor	B-T078
categories	B-T170
,	O
including	O
partner	B-T098
related	B-T033
,	O
traumatic	B-T169
,	O
emotional	B-T033
,	O
and	O
financial	B-T081
,	O
had	O
the	O
highest	O
odds	B-T081
adjusted	B-T081
odds	I-T081
ratio	I-T081
aor	B-T081
5.43	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
5.36	O
of	O
ppd	O
symptoms	O
.	O
	
the	O
odds	B-T081
of	O
experiencing	O
ppd	O
symptoms	O
decreased	B-T081
with	O
an	O
increase	B-T169
in	O
the	O
state-level	B-T081
social	B-T169
/	O
economic	B-T169
autonomy	B-T078
index	B-T170
aor	B-T081
0.75	O
95%	O
ci	B-T081
0.64	O
.	O
	
there	O
was	O
significant	O
cross-level	B-T080
interaction	I-T080
between	O
number	O
of	O
stressor	B-T078
categories	B-T170
experienced	O
and	O
state-level	B-T081
index	B-T170
.	O
	
screening	B-T169
for	O
antenatal	B-T079
sles	O
can	O
help	O
identify	O
women	B-T098
at	B-T080
risk	I-T080
for	O
ppd	O
symptoms	O
.	O
	
that	O
the	O
odds	B-T081
of	O
having	O
ppd	O
symptoms	O
decreased	B-T081
with	O
increasing	B-T169
state-level	B-T081
social	B-T169
/	O
economic	B-T169
autonomy	B-T078
and	O
women	B-T098
residing	O
in	O
states	O
with	O
lower	O
indices	B-T170
were	O
more	B-T169
vulnerable	I-T169
to	O
the	O
impacts	O
of	O
antenatal	B-T079
stressors	B-T078
,	O
could	O
have	O
policy	O
implications	O
related	O
to	O
improving	O
the	O
ses	B-T080
of	O
women	B-T098
in	O
these	O
multi-component	O
model	O
of	O
intramural	O
hematoma	O
a	O
novel	O
multi-component	O
model	O
is	O
introduced	O
for	O
studying	B-T062
interaction	B-T169
between	O
blood	O
flow	O
and	O
deforming	B-T033
aortic	O
wall	O
with	O
intramural	O
hematoma	O
imh	O
.	O
	
the	O
aortic	O
wall	O
is	O
simulated	B-T062
by	O
a	O
composite	O
structure	O
submodel	O
representing	O
material	B-T080
properties	I-T080
of	O
the	O
three	O
main	O
wall	O
layers	O
.	O
	
the	O
imh	O
is	O
described	O
by	O
a	O
poroelasticity	O
submodel	O
which	O
takes	O
into	O
account	O
both	O
the	O
pressure	O
inside	O
hematoma	O
and	O
its	O
deformation	B-T033
.	O
	
the	O
submodel	O
of	O
the	O
hematoma	O
is	O
fully	O
coupled	O
with	O
the	O
aortic	O
submodel	O
as	O
well	O
as	O
with	O
the	O
submodel	O
of	O
the	O
pulsatile	O
blood	O
flow	O
.	O
	
model	B-T062
simulations	I-T062
are	O
used	O
to	O
investigate	B-T169
the	O
relation	O
between	O
the	O
peak	O
wall	O
stress	O
,	O
hematoma	O
thickness	O
and	O
permeability	O
in	O
patients	O
of	O
different	O
age	O
.	O
	
the	O
results	O
indicate	O
that	O
an	O
increase	O
in	O
hematoma	O
thickness	O
leads	O
to	O
larger	O
wall	B-T033
stress	I-T033
,	O
which	O
is	O
in	O
agreement	O
with	O
clinical	B-T170
data	I-T170
.	O
	
further	O
simulations	B-T062
demonstrate	O
that	O
a	O
hematoma	O
with	O
smaller	O
permeability	O
results	O
in	O
larger	O
wall	B-T033
stress	I-T033
,	O
suggesting	O
that	O
blood	O
coagulation	O
in	O
hematoma	O
might	O
increase	O
its	O
mechanical	B-T033
stability	I-T033
.	O
	
this	O
is	O
in	O
agreement	O
with	O
previous	O
experimental	B-T080
observations	B-T062
of	O
coagulation	O
having	O
a	O
beneficial	B-T080
effect	I-T080
on	O
the	O
condition	O
of	O
a	O
patient	O
with	O
the	O
the	O
impact	B-T080
of	I-T080
diabetes	B-T047
on	O
the	O
risk	B-T078
of	O
prostate	O
cancer	O
development	B-T169
according	O
to	O
body	O
mass	O
index	O
a	O
10-year	O
nationwide	O
cohort	B-T081
study	I-T081
purpose	O
we	O
examined	O
the	O
association	O
between	O
obesity	B-T047
and	O
prostate	O
cancer	O
both	O
with	O
and	O
without	B-T080
diabetic	B-T047
patients	O
included	O
in	O
the	O
analysis	O
using	O
nationally	O
representative	O
data	B-T078
of	O
the	O
korean	B-T098
population	I-T098
from	O
the	O
national	O
health	O
insurance	O
system	O
nhis	O
.	O
	
materials	O
and	O
methods	O
of	O
the	O
424	O
participants	B-T098
who	O
underwent	O
health	B-T061
examinations	I-T061
in	O
2002-2008	O
,	O
139	O
men	B-T098
40	I-T098
years	I-T098
old	I-T098
and	O
without	B-T080
prostate	O
cancer	O
were	O
followed	O
from	O
the	O
beginning	O
of	O
2002	O
to	O
the	O
end	O
of	O
2012	O
.	O
	
multivariate	B-T081
adjusted	I-T081
cox	B-T081
regression	I-T081
analysis	I-T081
was	O
conducted	O
to	O
examine	O
the	O
hazard	B-T081
ratio	I-T081
hr	B-T081
and	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
for	O
the	O
association	O
between	O
prostate	O
cancer	O
and	O
body	O
mass	O
index	O
bmi	O
both	O
with	O
and	O
without	B-T080
diabetes	B-T047
.	O
	
results	O
the	O
hr	B-T081
for	O
prostate	O
cancer	O
according	O
to	O
the	O
existence	O
of	O
diabetes	B-T047
was	O
stratified	B-T080
by	O
bmi	O
in	O
both	O
age	O
-	O
and	O
multivariable-adjusted	B-T081
models	I-T081
.	O
	
in	O
the	O
population	B-T098
without	B-T080
diabetes	B-T047
,	O
the	O
hr	B-T081
for	O
prostate	O
cancer	O
significantly	B-T081
increased	I-T081
as	O
bmi	O
increased	O
beyond	O
the	O
reference	O
range	O
in	O
a	O
model	B-T081
adjusted	I-T081
for	I-T081
age	I-T081
and	I-T081
multiple	I-T081
variables	I-T081
however	O
,	O
the	O
increase	O
in	O
the	O
hr	B-T081
was	O
small	O
.	O
	
in	O
the	O
population	B-T098
with	O
diabetes	B-T047
,	O
the	O
hr	B-T081
for	O
prostate	O
cancer	O
significantly	B-T081
increased	I-T081
as	O
bmi	O
increased	O
from	O
<	O
18.5	O
kg/m	O
to	O
within	O
the	O
reference	O
range	O
18.5	O
to	O
22.9	O
in	O
the	O
multivariable-adjusted	B-T081
model	I-T081
.	O
	
in	O
addition	O
,	O
a	O
marked	B-T081
decrease	I-T081
in	O
hr	B-T081
in	O
the	O
population	B-T098
with	O
bmi	O
of	O
<	O
18.5	O
kg/m	O
was	O
seen	O
compared	O
to	O
the	O
reference	O
or	O
higher	O
bmi	O
population	B-T098
.	O
	
conclusion	O
this	O
population	B-T098
-based	O
study	O
shows	O
the	O
evidence	O
of	O
association	O
between	O
obesity	B-T047
and	O
development	B-T169
of	O
prostate	O
cancer	O
,	O
and	O
the	O
risk	B-T033
increases	I-T033
vary	O
according	O
to	O
the	O
change	O
of	O
bmi	O
category	O
and	O
the	O
existence	O
of	O
bioinformatic	O
analysis	B-T062
of	O
codon	O
usage	B-T169
and	O
phylogenetic	B-T080
relationships	I-T080
in	O
different	O
genotypes	O
of	O
the	O
hepatitis	O
c	O
virus	O
the	O
hepatitis	O
c	O
virus	O
hcv	O
has	O
six	O
major	O
genotypes	O
.	O
	
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
phylogenetically	B-T062
investigate	I-T062
the	O
differences	O
between	O
the	O
genotypes	O
of	O
hcv	O
,	O
and	O
to	O
determine	O
the	O
types	O
of	O
amino	B-T116
acid	I-T116
codon	O
usage	B-T169
in	O
the	O
structure	O
of	O
the	O
virus	O
in	O
order	O
to	O
discover	O
new	O
methods	O
for	O
treatment	O
regimes	O
.	O
	
the	O
codon	O
usage	B-T169
of	O
the	O
six	O
genotypes	O
of	O
the	O
hcv	O
nucleotide	O
sequence	O
was	O
investigated	B-T169
through	O
the	O
online	O
application	O
available	O
on	O
the	O
website	B-T170
gene	I-T170
infinity	I-T170
.	O
	
also	O
,	O
phylogenetic	B-T062
analysis	I-T062
and	O
the	O
evolutionary	B-T080
relationship	I-T080
of	O
hcv	O
genotypes	O
were	O
analyzed	B-T062
with	O
mega	O
7	O
software	O
.	O
	
the	O
six	O
genotypes	O
of	O
hcv	O
were	O
divided	O
into	O
two	O
groups	B-T078
based	O
on	O
their	O
codon	O
usage	B-T169
properties	B-T080
.	O
	
in	O
the	O
first	O
group	B-T078
,	O
genotypes	O
1	O
and	O
5	O
74.02	O
,	O
and	O
in	O
the	O
second	O
group	B-T078
,	O
genotypes	O
2	O
and	O
6	O
72.43	O
were	O
shown	O
to	O
have	O
the	O
most	O
similarity	B-T080
in	O
terms	O
of	O
codon	O
usage	B-T169
.	O
	
unlike	O
the	O
results	O
with	O
respect	O
to	O
determining	O
the	O
similarity	B-T080
of	O
codon	O
usage	B-T169
,	O
the	O
phylogenetic	B-T062
analysis	I-T062
showed	O
the	O
closest	O
resemblance	B-T080
and	O
correlation	B-T080
between	O
genotypes	O
1	O
and	O
4	O
.	O
	
the	O
results	O
also	O
showed	O
that	O
hcv	O
has	O
a	O
gc	O
guanine	O
-	O
cytosine	O
abundant	O
genome	O
structure	O
and	O
prefers	O
codons	O
with	O
gc	O
for	O
translation	O
.	O
	
genotypes	O
1	O
and	O
4	O
demonstrated	O
remarkable	O
similarity	O
in	O
terms	O
of	O
genome	O
sequences	O
and	O
proteins	O
,	O
but	O
surprisingly	O
,	O
in	O
terms	O
of	O
the	O
preferred	O
codons	O
for	O
gene	O
expression	O
,	O
they	O
showed	O
the	O
greatest	O
difference	O
.	O
	
more	O
studies	O
are	O
therefore	O
needed	O
to	O
confirm	O
the	O
results	O
and	O
select	O
the	O
best	O
approach	O
for	O
treatment	O
of	O
these	O
genotypes	O
based	O
on	O
their	O
codon	O
usage	O
properties	B-T080
chronic	B-T079
adiponectin	B-T047
deficiency	I-T047
leads	O
to	O
alzheimer's	B-T047
disease	I-T047
-like	O
cognitive	O
impairments	O
and	O
pathologies	O
through	O
ampk	B-T116
inactivation	O
and	O
cerebral	O
insulin	O
resistance	O
in	O
aged	O
mice	O
insulin	O
resistance	O
is	O
the	O
major	O
pathogenesis	O
underlying	O
type	B-T047
2	I-T047
diabetes	I-T047
mellitus	I-T047
t2dm	B-T047
and	O
these	O
patients	O
have	O
doubled	O
risk	B-T078
of	O
alzheimer's	B-T047
disease	I-T047
ad	B-T047
.	O
	
increasing	O
evidence	O
suggests	O
that	O
insulin	O
resistance	O
plays	O
an	O
important	O
role	O
in	O
ad	O
pathogenesis	O
,	O
possibly	O
due	O
to	O
abnormal	O
gsk3β	B-T116
activation	O
,	O
causing	O
intra-	O
and	O
extracellular	O
amyloid-beta	B-T116
aβ	B-T116
accumulation	O
.	O
	
adiponectin	B-T116
apn	B-T116
is	O
an	O
adipokine	B-T116
with	O
insulin-sensitizing	O
and	O
anti-inflammatory	B-T080
effects	I-T080
.	O
	
reduced	O
circulatory	O
apn	B-T116
level	O
is	O
associated	O
with	O
insulin	O
resistance	O
and	O
t2dm	B-T047
.	O
	
the	O
role	O
of	O
apn	B-T116
in	O
ad	B-T047
has	O
not	O
been	O
elucidated	O
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
aim	O
to	O
examine	O
if	O
adiponectin	B-T047
deficiency	I-T047
would	O
lead	O
to	O
cerebral	O
insulin	O
resistance	O
,	O
cognitive	O
decline	O
and	O
alzheimer's-like	O
pathology	O
in	O
mice	O
.	O
	
to	O
study	O
the	O
role	O
of	O
adiponectin	B-T047
in	O
cognitive	O
functions	O
,	O
we	O
employed	O
adiponectin-knockout	O
apn-ko	O
mice	O
and	O
demonstrated	O
chronic	O
apn	O
deficiency	I-T047
in	O
their	O
cns	O
.	O
	
behavioral	O
tests	O
were	O
performed	O
to	O
study	O
the	O
cognitions	O
of	O
male	O
apn-ko	O
mice	O
.	O
	
brains	O
and	O
tissue	O
lysates	O
were	O
collected	O
to	O
study	O
the	O
pathophysiological	O
and	O
molecular	O
changes	O
in	O
the	O
brain	O
of	O
apn-ko	O
mice	O
.	O
	
sh-sy5y	O
neuroblastoma	O
cell	O
line	O
was	O
used	O
to	O
study	O
the	O
molecular	O
mechanism	O
upon	O
apn	O
and	O
insulin	O
treatment	O
.	O
	
aged	O
apn	O
-deficient	O
mice	O
displayed	O
spatial	O
memory	O
and	O
learning	O
impairments	O
,	O
fear-conditioned	O
memory	O
deficit	O
as	O
well	O
as	O
anxiety	O
.	O
	
these	O
mice	O
also	O
developed	O
ad	O
pathologies	O
including	O
increased	O
cerebral	O
aβ42	O
level	O
,	O
aβ	O
deposition	O
,	O
hyperphosphorylated	O
tau	O
proteins	O
,	O
microgliosis	O
and	O
astrogliosis	O
with	O
increased	O
cerebral	O
il-1β	O
and	O
tnfα	O
levels	O
that	O
associated	O
with	O
increased	O
neuronal	O
apoptosis	O
and	O
reduced	O
synaptic	O
proteins	O
levels	O
,	O
suggesting	O
apn	O
deficiency	O
may	O
lead	O
to	O
neuronal	O
and	O
synaptic	O
loss	O
in	O
the	O
brain	O
.	O
	
ad	O
pathologies	O
-associated	O
apn	O
-	O
ko	O
mice	O
displayed	O
attenuated	O
ampk	O
phosphorylation	O
and	O
impaired	O
insulin	O
signaling	O
including	O
decreased	O
akt	O
induction	O
and	O
increased	O
gsk3β	O
activation	O
in	O
the	O
hippocampus	O
and	O
frontal	O
cortex	O
.	O
	
aged	O
apn	O
-ko	O
mice	O
developed	O
hippocampal	O
insulin	O
resistance	O
with	O
reduced	O
pakt	O
induction	O
upon	O
intracerebral	O
insulin	O
injection	O
.	O
	
consistently	O
,	O
apn	O
treatment	O
in	O
sh-sy5y	O
cells	O
with	O
insulin	O
resistance	O
and	O
overexpressing	O
aβ	O
induce	O
higher	O
pakt	O
levels	O
through	O
adipor1	O
upon	O
insulin	O
treatment	O
whereas	O
the	O
induction	O
was	O
blocked	O
by	O
compound	O
c	O
,	O
indicating	O
apn	O
can	O
enhance	O
neuronal	O
insulin	O
sensitivity	O
through	O
ampk	O
activation	O
.	O
	
our	O
results	O
indicated	O
that	O
chronic	O
apn	O
deficiency	O
inactivated	O
ampk	O
causing	O
insulin	O
desensitization	O
and	O
elicited	O
ad-like	O
pathogenesis	O
in	O
aged	O
mice	O
which	O
also	O
developed	O
significant	O
cognitive	O
impairments	O
and	O
psychiatric	O
symptoms	O
can	O
inorganic	O
phosphate	O
explain	O
sag	B-T080
during	O
unfused	B-T080
tetanic	O
contractions	O
of	O
skeletal	O
muscle	O
we	O
test	O
the	O
hypothesis	B-T078
that	O
cytosolic	O
inorganic	O
phosphate	O
pi	O
can	O
account	O
for	O
the	O
contraction	O
-	O
induced	B-T169
reductions	O
in	O
twitch	B-T033
duration	B-T079
which	O
impair	B-T169
summation	O
and	O
cause	O
force	O
to	O
decline	B-T080
sag	B-T080
during	O
unfused	B-T080
tetanic	O
contractions	O
of	O
fast-twitch	O
muscle	O
.	O
	
a	O
five-state	O
model	O
of	O
crossbridge	O
cycling	O
was	O
used	O
to	O
simulate	B-T169
twitch	B-T033
and	O
unfused	B-T080
tetanic	O
contractions	O
.	O
	
as	O
pi	O
concentration	B-T081
pi	O
was	O
increased	B-T081
from	O
0	O
to	O
30	O
mmol	O
,	O
twitch	B-T033
duration	B-T079
decreased	B-T081
,	O
with	O
progressive	B-T169
reductions	B-T061
in	O
sensitivity	B-T169
to	O
pi	O
as	O
pi	O
was	O
increased	B-T081
.	O
	
when	O
unfused	B-T080
tetani	O
were	O
simulated	B-T062
with	O
rising	O
pi	O
,	O
sag	B-T080
was	O
most	O
pronounced	B-T080
when	O
initial	B-T079
pi	O
was	O
low	B-T080
,	O
and	O
when	O
the	O
magnitude	B-T081
of	O
pi	O
increase	B-T081
was	O
large	B-T081
.	O
	
fast-twitch	B-T033
extensor	O
digitorum	O
longus	O
edl	O
muscles	O
sag-prone	B-T169
,	O
typically	O
low	O
basal	O
pi	O
and	O
slow-twitch	B-T033
soleus	O
muscles	O
sag	B-T080
-	O
resistant	O
,	O
typically	O
high	O
basal	O
pi	O
were	O
isolated	B-T169
from	O
14	O
female	O
c57bl/6	O
mice	O
.	O
	
muscles	O
were	O
sequentially	O
incubated	O
in	O
solutions	O
containing	O
either	O
glucose	B-T109
or	O
pyruvate	B-T109
to	O
create	O
typical	B-T080
and	O
low	B-T080
pi	O
environments	B-T082
,	O
respectively	O
.	O
	
twitch	B-T033
duration	B-T079
was	O
greater	O
p	O
<	O
0.05	O
in	O
pyruvate	B-T109
than	O
glucose	B-T109
in	O
both	O
muscles	O
.	O
	
stimuli	O
applied	B-T169
at	O
intervals	B-T079
approximately	O
three	O
times	O
the	O
time	O
to	O
peak	B-T080
twitch	B-T033
tension	B-T033
resulted	O
in	O
sag	B-T080
of	O
35.0	O
3.7	O
in	O
glucose	B-T109
and	O
50.5	O
1.4	O
in	O
pyruvate	B-T109
in	O
the	O
edl	O
pyruvate	B-T109
>	O
glucose	B-T109
p	O
<	O
0.05	O
,	O
and	O
3.9	O
0.3	O
in	O
glucose	B-T109
and	O
37.8	O
2.7	O
in	O
pyruvate	B-T109
in	O
the	O
soleus	O
pyruvate	B-T109
>	O
glucose	B-T109
p	O
<	O
0.05	O
.	O
	
the	O
influence	O
of	O
pi	O
on	O
crossbridge	O
cycling	O
provides	O
a	O
tenable	B-T169
mechanism	I-T169
for	O
sag	B-T080
.	O
	
moreover	O
,	O
the	O
low	B-T033
basal	I-T033
pi	O
in	O
fast-twitch	B-T033
relative	O
to	O
slow-twitch	B-T033
muscle	I-T033
has	O
promise	O
as	O
an	O
explanation	B-T170
for	O
the	O
fiber-type	O
dependency	O
of	O
pancreatic	O
cancer	O
a	O
survival	B-T062
analysis	I-T062
study	B-T062
in	O
oklahoma	O
pancreatic	O
cancer	O
is	O
among	O
the	O
most	O
deadly	O
cancers	O
.	O
	
risk	B-T033
factors	I-T033
associated	B-T080
with	I-T080
the	O
disease	B-T047
include	O
age	O
,	O
race	B-T098
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
diabetes	B-T033
status	I-T033
.	O
	
we	O
conducted	O
a	O
prospective	B-T062
analysis	I-T062
of	O
risk	B-T033
factors	I-T033
and	O
length	B-T079
of	I-T079
survival	I-T079
among	O
pancreatic	O
cancer	O
patients	O
living	O
in	O
oklahoma	O
between	O
1997	O
and	O
2012	O
n=6	O
.	O
	
kaplan-meier	B-T081
survival	I-T081
curves	I-T081
were	O
created	B-T052
followed	O
by	O
the	O
log-rank	B-T169
test	I-T169
to	O
compare	O
difference	B-T080
in	O
the	O
survival	O
time	O
.	O
	
cox	B-T081
proportional	I-T081
hazard	I-T081
regression	I-T081
models	I-T081
were	O
used	O
to	O
examine	O
the	O
strength	B-T080
of	I-T080
association	I-T080
through	O
the	O
estimated	B-T081
hazard	B-T081
ratios	I-T081
.	O
	
the	O
median	B-T079
survival	I-T079
time	I-T079
of	O
the	O
cohort	B-T098
was	O
three	O
months	B-T079
.	O
	
significant	B-T078
risk	B-T033
factors	I-T033
for	O
reduced	B-T080
survival	O
times	O
included	O
age	O
,	O
stage	O
at	O
diagnosis	O
,	O
and	O
year	O
of	O
diagnosis	O
.	O
	
results	O
are	O
in	O
agreement	O
with	O
previous	O
research	B-T033
findings	I-T033
.	O
	
there	O
have	O
been	O
small	O
but	O
noteworthy	O
improvements	O
in	O
survival	O
times	O
for	O
pancreatic	O
cancer	O
patients	O
in	O
oklahoma	O
.	O
	
length	B-T079
of	I-T079
survival	I-T079
during	O
the	O
study	B-T062
period	I-T062
was	O
significantly	B-T078
associated	B-T080
with	I-T080
known	O
risk	B-T033
factors	I-T033
such	O
as	O
age	O
and	O
stage	O
of	O
diagnosis	O
.	O
	
biochemical	B-T169
and	O
proteomic	O
analyses	B-T062
of	O
the	O
physiological	O
response	O
induced	O
by	O
individual	O
housing	O
in	O
gilts	O
provide	O
new	O
potential	B-T080
stress	O
markers	O
the	O
objective	B-T080
assessment	O
of	O
animal	O
stress	O
and	O
welfare	O
requires	O
proper	O
laboratory	O
biomarkers	O
.	O
	
in	O
this	O
work	O
,	O
we	O
have	O
analyzed	O
the	O
changes	O
in	O
serum	O
composition	O
in	O
gilts	O
after	O
switching	O
their	O
housing	O
,	O
from	O
pen	O
to	O
individual	O
stalls	O
,	O
which	O
is	O
generally	O
accepted	O
to	O
cause	O
animal	O
discomfort	O
.	O
	
blood	O
and	O
saliva	O
samples	O
were	O
collected	O
a	O
day	O
before	O
and	O
up	O
to	O
four	O
days	O
after	O
changing	O
the	O
housing	O
system	O
.	O
	
biochemical	B-T169
analyses	B-T062
showed	O
adaptive	B-T169
changes	O
in	O
lipid	B-T109
and	O
protein	O
metabolism	O
after	O
the	O
housing	O
switch	O
,	O
whereas	O
cortisol	B-T109
and	O
muscular	O
markers	O
showed	O
a	O
large	O
variability	O
between	O
animals	O
.	O
	
2d-dige	O
and	O
itraq	B-T170
proteomic	O
approaches	O
revealed	O
variations	O
in	O
serum	B-T116
protein	I-T116
composition	O
after	O
changing	O
housing	O
and	O
diet	O
of	O
gilts	O
.	O
	
both	O
techniques	B-T169
showed	O
alterations	B-T078
in	O
two	O
main	O
homeostatic	O
mechanisms	O
the	O
innate	O
immune	O
and	O
redox	O
systems	O
.	O
	
the	O
acute	B-T116
phase	I-T116
proteins	I-T116
haptoglobin	B-T116
,	O
apolipoprotein	B-T116
a-i	I-T116
and	O
α1-antichymotrypsin	O
3	O
,	O
and	O
the	O
antioxidant	O
enzyme	O
peroxiredoxin	B-T116
2	I-T116
were	O
found	O
differentially	O
expressed	O
by	O
2d-dige	O
.	O
	
other	O
proteins	B-T116
related	O
to	O
the	O
innate	O
immune	O
system	O
,	O
including	O
lactotransferrin	B-T116
,	O
protegrin	B-T116
3	I-T116
and	O
galectin	B-T116
1	I-T116
were	O
also	O
identified	O
by	O
itraq	B-T170
,	O
as	O
well	O
as	O
oxidative	O
stress	O
enzymes	B-T116
such	O
as	O
peroxiredoxin	B-T116
2	I-T116
and	O
glutathione	B-T116
peroxidase	I-T116
3	I-T116
.	O
	
proteomics	O
also	O
revealed	O
the	O
decrease	B-T080
of	O
apolipoproteins	B-T116
,	O
and	O
the	O
presence	O
of	O
intracellular	B-T082
proteins	B-T116
in	O
serum	O
,	O
which	O
may	O
indicate	O
physical	O
injury	O
to	O
tissues	O
.	O
	
housing	O
of	O
gilts	O
in	O
individual	O
stalls	O
and	O
diet	O
change	O
increase	O
lipid	B-T109
and	O
protein	O
catabolism	O
,	O
oxidative	O
stress	O
,	O
activate	O
the	O
innate	O
immune	O
system	O
and	O
cause	O
a	O
certain	O
degree	O
of	O
tissue	O
damage	O
.	O
	
we	O
propose	O
that	O
valuable	O
assays	O
for	O
stress	O
assessment	O
in	O
gilts	O
may	O
be	O
based	O
on	O
a	O
score	B-T081
composed	O
by	O
a	O
combination	O
of	O
salivary	O
cortisol	O
,	O
lipid	B-T109
metabolites	O
,	O
innate	O
immunity	O
and	O
oxidative	O
stress	O
markers	O
and	O
intracellular	B-T082
proteins	B-T116
.	O
	
cultivation	O
of	O
four	O
microalgae	O
species	O
in	O
the	O
effluent	O
of	O
anaerobic	O
digester	O
for	O
biodiesel	B-T109
production	O
this	O
study	B-T062
investigated	B-T169
if	O
an	O
effluent	O
from	O
anaerobic	O
digestion	O
ad	O
system	O
can	O
be	O
used	B-T169
as	O
a	O
nutrients	O
source	B-T033
for	O
the	O
microalgae	O
cultivation	O
,	O
and	O
in	O
so	O
doing	O
,	O
if	O
the	O
effluent	O
can	O
be	O
properly	O
treated	B-T169
.	O
	
nitrogen	O
and	O
phosphorus	O
in	O
the	O
ad	O
effluent	O
well	O
supported	O
microalgal	O
growth	O
,	O
and	O
their	O
removal	O
efficiency	O
reached	O
>97	O
and	O
99.2	O
,	O
respectively	O
.	O
	
among	O
four	O
different	O
algal	O
species	O
tested	O
,	O
micractinium	O
inermum	O
particularly	O
stood	O
out	O
,	O
showing	O
the	O
highest	O
biomass	O
and	O
fame	O
productivity	O
0.16gl	O
with	O
3.23gl	O
of	O
dry	O
cell	O
weight	O
,	O
and	O
0.04gl	O
with	O
27.54	O
w/w	O
of	O
fame	O
contents	O
,	O
respectively	O
.	O
	
as	O
the	O
concentrations	O
of	O
the	O
nutrients	O
decreased	O
over	O
time	O
,	O
the	O
fame	O
contents	O
were	O
increased	O
and	O
its	O
quality	O
as	O
well	O
,	O
satisfying	O
several	O
biodiesel	O
quality	O
standards	O
.	O
	
this	O
study	O
supports	O
that	O
the	O
ad	O
effluent	O
can	O
indeed	O
serve	O
as	O
a	O
cheap	O
and	O
nutrient	O
-	O
rich	O
medium	O
for	O
microalgae	O
cultivation	O
,	O
and	O
equally	O
importantly	O
,	O
microalgae	O
can	O
be	O
a	O
workable	O
treatment	O
option	O
for	O
antiviral	B-T033
activities	I-T033
of	O
selected	O
antimalarials	O
against	B-T080
dengue	O
virus	O
type	O
2	O
and	O
zika	O
virus	O
in	O
a	O
previous	B-T079
study	B-T062
,	O
twelve	O
antimalarial	O
compounds	O
,	O
amodiaquine	B-T109
aq	B-T109
and	O
derivatives	O
,	O
were	O
shown	O
to	O
have	O
potent	B-T080
anti-dengue	B-T033
viral	I-T033
denv	I-T033
activity	I-T033
by	O
using	O
the	O
stable	B-T080
denv2	O
renilla	B-T116
luciferase	I-T116
reporter	O
replicon	O
expressing	O
bhk-21	O
cells	O
,	O
infectivity	B-T080
plaque	O
,	O
and	O
the	O
qrt-pcr	O
assays	O
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
performed	B-T169
molecular	B-T062
modeling	I-T062
on	O
these	O
compounds	O
to	O
determine	O
their	O
stereo-electronic	B-T080
properties	I-T080
required	O
for	O
optimal	B-T080
antiviral	B-T033
activity	I-T033
.	O
	
based	O
on	O
the	O
similarity	B-T080
of	O
calculated	O
stereo-electronic	B-T080
profiles	I-T080
,	O
specifically	O
the	O
electrostatic	B-T081
potential	I-T081
profiles	I-T081
of	O
the	O
compounds	O
,	O
and	O
in	B-T062
silico	I-T062
screening	I-T062
of	O
related	O
compounds	O
from	O
literature	B-T170
,	O
we	O
identified	B-T080
three	O
additional	B-T169
compounds	O
,	O
quinacrine	B-T109
qc	B-T109
,	O
mefloquine	B-T109
mq	B-T109
,	O
and	O
gsk369796	B-T109
.	O
	
analysis	O
of	O
their	O
antiviral	B-T033
activities	I-T033
indicated	O
that	O
all	O
three	O
compounds	O
have	O
high	B-T080
anti-denv	B-T033
activity	I-T033
in	O
the	O
denv2	O
replicon	O
expressing	O
cells	O
with	O
ec50	B-T081
values	I-T081
of	O
5.30	O
1.31	O
μm	O
qc	B-T109
,	O
3.22	O
0.37	O
μm	O
mq	B-T109
,	O
and	O
5.06	O
0.86	O
μm	O
gsk369796	B-T109
.	O
	
the	O
infectivity	O
assays	O
revealed	B-T080
the	O
ec50	B-T081
values	I-T081
of	O
7.09	O
1.67	O
μm	O
qc	B-T109
,	O
4.36	O
0.31	O
μm	O
mq	B-T109
and	O
3.03	O
0.35	O
μm	O
gsk369796	B-T109
.	O
	
the	O
mode	B-T169
of	I-T169
action	I-T169
of	O
these	O
compounds	O
is	O
through	B-T169
inhibition	B-T052
of	O
autophagy	O
,	O
thereby	O
affecting	B-T169
denv2	O
replication	O
.	O
	
moreover	O
,	O
these	O
compounds	O
also	O
showed	O
antiviral	B-T033
activity	I-T033
against	B-T080
the	O
rapidly	O
emerging	O
zika	O
virus	O
zikv	O
with	O
ec50	B-T081
values	I-T081
of	O
2.27	O
0.14	O
μm	O
qc	B-T109
,	O
3.95	O
0.21	O
μm	O
mq	B-T109
,	O
and	O
2.57	O
0.09	O
μm	O
1	O
in	O
100	O
babies	O
the	O
fetal	O
alcohol	O
spectrum	O
disorder	O
pathway	O
alcohol	O
consumed	O
during	O
pregnancy	O
is	O
the	O
nation's	O
leading	O
preventable	B-T080
cause	B-T169
of	O
developmental	O
disabilities	O
and	O
birth	O
defects	O
.	O
	
one	O
in	O
100	O
babies	O
is	O
estimated	O
to	O
be	O
born	O
with	O
alcohol-related	B-T047
damage	I-T047
,	O
according	O
to	O
the	O
world	O
health	O
organization	O
.	O
	
fetal	O
alcohol	O
spectrum	O
disorders	O
fasds	O
are	O
more	O
common	O
than	O
autism	O
but	O
are	O
under-	O
genotyping	O
of	O
german	B-T098
and	O
austrian	B-T098
taylorella	O
equigenitalis	O
isolates	O
using	O
repetitive	O
extragenic	O
palindromic	O
rep	O
pcr	O
and	O
pulsed-field	O
gel	O
electrophoresis	O
pfge	O
a	O
total	B-T080
of	O
124	O
taylorella	O
t	O
equigenitalis	O
and	O
five	O
t	O
.	O
	
asinigenitalis	O
field	O
isolates	O
collected	B-T169
between	O
2002	O
and	O
2014	O
were	O
available	B-T169
for	O
genotyping	O
using	O
rep-	O
repetitive	O
extragenic	O
palindromic	O
pcr	O
and	O
pfge	O
pulsed-field	O
gel	O
electrophoresis	O
.	O
	
the	O
study	B-T062
comprised	O
79	O
t	O
.	O
	
equigenitalis	O
field	O
isolates	O
originating	O
from	O
ten	O
defined	O
breeds	O
of	O
german	O
horses	O
and	O
revealed	B-T080
a	O
spectrum	O
of	O
five	O
rep	O
rep-e1-e4	O
,	O
rep-e3a	O
and	O
15	O
pfge	O
te-a1-a9	O
,	O
te-b1-b3	O
,	O
te-c	O
,	O
te-e1	O
,	O
and	O
te-e2	O
genotypes	O
.	O
	
t	O
.	O
	
equigenitalis	O
field	O
isolates	O
n=40	O
obtained	B-T169
from	O
austrian	O
lipizzaner	O
horses	O
were	O
differentiated	B-T080
into	O
three	O
rep	O
rep-e1	O
,	O
rep-e3a	O
,	O
and	O
rep-e4	O
and	O
three	O
pfge	O
genotypes	O
te-a2	O
,	O
te-a5	O
,	O
and	O
te-d	O
those	O
isolated	B-T169
from	O
four	O
austrian	O
trotters	O
belonged	O
to	O
the	O
rep	O
/	O
pfge	O
genotype	O
rep-e2/te-a1	O
.	O
	
interestingly	O
,	O
a	O
t	O
.	O
	
equigenitalis	O
isolate	O
recovered	B-T080
from	I-T080
a	O
holsteiner	O
stallion	O
living	B-T078
in	O
south	O
africa	O
revealed	B-T080
the	O
rep	O
/	O
pfge	O
genotype	O
rep-e1/te-a5	O
which	O
was	O
otherwise	O
exclusively	B-T078
present	B-T033
in	O
the	O
majority	O
of	O
austrian	O
lipizzaner	O
horses	O
in	O
our	O
study	B-T062
.	O
	
the	O
type	O
strain	O
included	O
in	O
this	O
study	B-T062
revealed	B-T080
the	O
genotype	O
rep	O
/	O
pfge	O
rep-e1/te-f	O
.	O
	
six	O
strains	O
of	O
t	O
.	O
	
asinigenitalis	O
including	O
the	O
type	O
strain	O
were	O
separated	B-T080
into	O
three	O
rep	O
rep-a1-a3	O
and	O
six	O
pfge	O
genotypes	O
ta-a1	O
,	O
ta-a2	O
,	O
ta-a3	O
,	O
ta-b	O
,	O
ta-c	O
,	O
ta-d	O
.	O
	
overall	B-T080
,	O
the	O
generated	B-T052
rep	O
and	O
pfge	O
genotypes	O
showed	O
a	O
good	B-T080
correlation	B-T080
,	O
whereas	O
rep-pcr	O
proved	O
to	O
be	O
a	O
suitable	O
method	O
for	O
molecular	O
epidemiological	O
screening	O
of	O
t	O
.	O
	
equigenitalis	O
and	O
t	O
.	O
	
asinigenitalis	O
isolates	O
that	O
should	O
be	O
differentiated	B-T080
in	O
detail	B-T080
by	O
genotyping	O
using	O
the	O
urokinase	B-T116
/	O
urokinase	B-T116
receptor	I-T116
system	O
in	O
mast	O
cells	O
effects	B-T080
of	O
its	O
functional	B-T169
interaction	B-T169
with	O
fmlf	B-T116
receptors	I-T116
mast	O
cell	O
and	O
basophils	O
express	O
the	O
high	B-T116
affinity	I-T116
receptor	I-T116
for	O
ige	B-T116
fcɛri	B-T116
and	O
are	O
primary	O
effector	O
cells	O
of	O
allergic	O
disorders	O
.	O
	
the	O
urokinase	B-T116
upa	B-T116
plasminogen	O
activation	O
system	O
is	O
involved	O
in	O
physiological	O
and	O
pathological	O
events	O
based	O
on	O
cell	O
migration	O
and	O
tissue	O
remodelling	O
,	O
such	O
as	O
inflammation	O
,	O
wound	O
healing	O
,	O
angiogenesis	O
and	O
metastasis	O
.	O
	
upa	B-T116
is	O
a	O
serine	B-T116
protease	I-T116
that	O
binds	O
upar	B-T116
,	O
a	O
high	B-T109
affinity	I-T109
glycosyl-phosphatidyl-inositol	I-T109
gpi	I-T109
receptor	B-T116
.	O
	
upar	B-T116
focuses	O
upa	B-T116
activity	O
at	O
the	O
cell	O
surface	O
and	O
activates	O
intracellular	O
signaling	O
through	O
lateral	O
interactions	B-T169
with	O
integrins	B-T116
,	O
receptor	B-T116
tyrosine	I-T116
kinases	I-T116
and	O
the	O
g-protein-coupled	B-T116
family	I-T116
of	O
fmlf	B-T116
chemotaxis	I-T116
receptors	I-T116
fprs	B-T116
.	O
	
we	O
investigated	B-T169
the	O
expression	O
of	O
the	O
upa	B-T116
-	O
upar	B-T116
system	O
and	O
its	O
functional	B-T169
interaction	B-T169
with	O
fprs	B-T116
in	O
human	O
mast	O
cells	O
mcs	O
.	O
	
differently	O
from	O
basophils	O
,	O
mcs	O
produced	O
upa	B-T116
that	O
was	O
able	O
to	O
induce	O
their	O
chemotaxis	O
.	O
	
indeed	O
,	O
mcs	O
also	O
expressed	O
upar	B-T116
,	O
both	O
in	O
the	O
intact	O
and	O
in	O
a	O
cleaved	O
form	O
dii-diii-upar	B-T116
that	O
can	O
expose	O
,	O
at	O
the	O
n-terminus	O
,	O
the	O
srsry	O
sequence	O
,	O
able	O
to	O
interact	O
with	O
fprs	B-T116
and	O
to	O
mediate	O
cell	O
chemotaxis	O
.	O
	
mcs	O
also	O
expressed	O
mrnas	O
for	O
fprs	B-T116
that	O
were	O
functionally	O
active	O
indeed	O
,	O
upa	B-T116
and	O
a	O
soluble	B-T116
peptide	I-T116
upar84-95	B-T116
,	O
containing	O
the	O
srsry	O
chemotactic	O
sequence	O
of	O
upar	B-T116
and	O
able	O
to	O
interact	O
with	O
fprs	B-T116
,	O
were	O
able	O
to	O
induce	O
mcs	O
chemotaxis	O
.	O
	
thus	O
,	O
upa	B-T116
is	O
a	O
potent	O
chemoattractant	O
for	O
mcs	O
acting	O
through	O
the	O
exposure	B-T080
of	O
the	O
chemotactic	O
epitope	O
of	O
upar	B-T116
,	O
that	O
is	O
an	O
endogenous	B-T169
ligand	O
for	O
fprs	B-T116
.	O
	
the	O
same	O
mechanism	B-T169
could	O
be	O
involved	O
in	O
vegf-a	B-T116
secretion	O
by	O
human	O
mcs	O
,	O
also	O
induced	B-T169
by	O
upa	B-T116
and	O
upar84-95	B-T116
stimulation	O
.	O
	
psychogenic	O
non-epileptic	O
seizure	O
in	O
patients	O
with	O
intellectual	O
disability	O
with	O
special	O
focus	O
on	O
choice	B-T052
of	O
therapeutic	B-T061
intervention	I-T061
there	O
have	O
been	O
a	O
number	O
of	O
studies	B-T062
exploring	O
treatments	B-T061
for	O
psychogenic	O
non-epileptic	O
seizure	O
pnes	O
but	O
largely	O
neglecting	B-T033
the	O
sizable	O
subgroup	O
of	O
patients	O
with	O
intellectual	O
disability	O
id	O
.	O
	
in	O
the	O
present	B-T079
study	B-T062
,	O
we	O
attempted	O
to	O
demonstrate	B-T169
effects	B-T080
and	O
preferred	B-T078
modes	O
of	O
therapeutic	B-T061
intervention	I-T061
in	O
pnes	O
patients	O
with	O
id	O
being	O
treated	B-T169
at	O
a	O
japanese	O
municipal	O
center	O
with	O
a	O
short	B-T081
referral	O
chain	O
.	O
	
we	O
examined	B-T033
46	O
pnes	O
patients	O
with	O
id	O
id	O
group	B-T078
and	O
106	O
pnes	O
patients	O
without	O
id	O
non-id	B-T033
group	B-T078
retrospectively	B-T080
in	O
case	B-T170
charts	I-T170
.	O
	
in	B-T169
addition	I-T169
to	I-T169
examining	B-T033
basic	O
demographic	O
and	O
clinical	B-T170
data	I-T170
,	O
effects	B-T080
of	I-T080
different	B-T080
therapeutic	B-T061
intervention	I-T061
were	O
examined	B-T033
as	O
a	O
function	B-T169
of	O
decrease	B-T081
or	O
disappearance	B-T079
of	O
pnes	O
attacks	O
in	O
the	O
id	O
group	B-T078
.	O
	
age	O
at	O
the	O
first	O
visit	O
as	O
well	O
as	O
pnes	O
onset	B-T080
was	O
younger	B-T079
in	O
the	O
id	O
than	O
in	O
the	O
non-id	B-T033
group	B-T078
t=2	O
,	O
p=0	O
t=3	O
,	O
p=0	O
,	O
respectively	O
.	O
	
pnes	O
-free	O
ratio	B-T081
at	O
the	O
last	O
visit	O
tended	O
to	O
be	O
higher	B-T080
in	O
the	O
non-id	B-T033
group	B-T078
chi	O
square	O
=3	O
p=0	O
.	O
	
psychosis	O
was	O
more	O
often	O
encountered	O
in	O
the	O
id	O
group	B-T078
chi	B-T081
square	I-T081
=13	O
p=0	O
.	O
	
although	O
cognitive	O
therapy	O
and	O
pharmaco-therapeutic	O
approaches	O
were	O
quite	O
similarly	O
distributed	O
in	O
both	O
groups	O
,	O
environmental	O
adjustment	O
was	O
often	O
introduced	O
in	O
the	O
id	O
group	O
44%	O
as	O
compared	O
to	O
the	O
non-id	O
group	O
15%	O
chi	O
square	O
=14	O
p=0	O
.	O
	
brief	O
weekly	O
visit	O
service	O
is	O
also	O
more	O
often	O
utilized	O
by	O
the	O
patients	O
with	O
id	O
54%	O
than	O
by	O
those	O
without	O
id	O
35%	O
chi	O
square	O
=5	O
,	O
p=0	O
.	O
	
optimal	O
treatment	O
approaches	O
in	O
this	O
sizable	O
patient	O
subgroup	O
should	O
be	O
the	O
subject	O
of	O
future	O
prospective	O
studies	I-T062
effect	B-T080
of	I-T080
an	O
immunomodulatory	B-T061
regimen	I-T061
for	O
cancer	B-T061
prevention	I-T061
a	O
case	B-T170
report	I-T170
in	O
the	O
present	B-T033
case	B-T170
study	I-T170
,	O
an	O
immunomodulatory	B-T061
regimen	I-T061
for	O
cancer	B-T061
prevention	I-T061
is	O
reported	O
.	O
	
a	O
patient	O
with	O
an	O
abnormally	B-T080
high	I-T080
level	B-T080
of	O
the	O
tumor	O
markers	O
,	O
carbohydrate	B-T109
antigen-724	I-T109
ca724	B-T109
,	O
ca19-9	B-T109
and	O
carcinoembryonic	B-T116
antigen	I-T116
cea	B-T116
,	O
although	O
without	B-T080
any	O
detectable	O
tumor	O
,	O
was	O
treated	B-T061
with	I-T061
an	O
immunomodulatory	B-T061
therapy	I-T061
featuring	O
an	O
infusion	B-T061
of	O
cytokine-induced	O
autologous	O
killer	O
cells	O
ciks	O
at	O
the	O
request	B-T052
of	O
the	O
patient	O
.	O
	
following	O
the	O
therapy	B-T061
,	O
the	O
three	O
tumor	O
markers	O
rapidly	B-T080
decreased	B-T081
to	O
below	O
the	O
normal	B-T081
reference	I-T081
level	I-T081
,	O
although	O
there	O
still	O
were	O
slight	B-T080
fluctuations	B-T079
within	O
a	O
narrow	B-T080
range	B-T081
frequently	B-T079
.	O
	
the	O
patient	O
was	O
monitored	O
for	O
21	O
months	B-T079
to	O
the	O
present	B-T033
day	B-T079
and	O
no	B-T033
abnormality	I-T033
was	O
observed	B-T169
.	O
	
the	O
results	B-T033
indicated	O
that	O
this	O
therapy	B-T061
may	O
be	O
applied	O
as	O
a	O
novel	B-T080
strategy	O
that	O
is	O
effective	B-T080
and	O
reliable	B-T080
for	O
cancer	B-T061
prevention	I-T061
.	O
	
as	O
there	O
is	O
no	O
promising	O
regimen	B-T061
for	O
the	O
prevention	B-T061
of	I-T061
malignancies	I-T061
to	O
date	O
,	O
such	O
a	O
treatment	B-T061
may	O
become	O
a	O
major	B-T080
cancer	O
prophylactic	B-T061
regimen	I-T061
,	O
particularly	O
for	O
patients	O
who	O
are	O
at	O
a	O
high	B-T033
risk	I-T033
of	I-T033
cancer	O
.	O
	
the	O
relationships	B-T080
between	O
rugby	O
players'	B-T098
tackle	O
training	O
attitudes	O
and	O
behaviour	O
and	O
their	O
match	O
tackle	O
attitudes	O
and	O
behaviour	O
the	O
tackle	O
event	O
in	O
rugby	O
is	O
a	O
technical	B-T080
and	O
physical	B-T169
contest	O
between	O
opposing	O
players	B-T098
.	O
	
a	O
player's	B-T098
ability	O
to	O
tolerate	O
and	O
contest	O
during	O
a	O
tackle	O
is	O
a	O
prerequisite	B-T078
for	O
safe	O
participation	B-T169
and	O
success	O
in	O
rugby	O
.	O
	
little	O
is	O
known	O
about	O
the	O
relationship	B-T080
between	O
tackle	O
training	O
and	O
tackling	O
in	O
matches	O
in	O
rugby	O
union	O
.	O
	
therefore	O
,	O
we	O
investigated	B-T169
the	O
relationships	B-T080
between	O
players'	B-T098
training	O
attitudes	O
and	O
behaviour	O
and	O
their	O
match	O
attitudes	O
and	O
behaviour	O
for	O
tackling	O
in	O
rugby	O
union	O
.	O
	
a	O
questionnaire	B-T170
was	O
designed	O
to	O
assess	O
attitude	O
importance	O
and	O
behaviours	O
frequency	B-T080
and	O
quantity	B-T081
among	O
junior	B-T078
under	O
19	O
players	B-T098
on	O
a	O
5-point	B-T170
likert	I-T170
scale	I-T170
.	O
	
questionnaires	B-T170
were	O
handed	O
out	O
to	O
220	O
players	B-T098
10	O
schools	O
at	O
a	O
tournament	O
and	O
75%	O
9	O
schools	O
,	O
n=164	O
were	O
returned	O
for	O
analysis	B-T062
.	O
	
associations	O
between	O
training	O
attitudes	O
and	O
behaviours	O
were	O
tested	B-T169
using	O
the	O
χ	B-T170
test	I-T170
,	O
cramer's	I-T170
v	I-T170
and	I-T170
τ-b	I-T170
.	O
	
the	O
more	O
time	O
spent	O
on	O
emphasising	O
proper	O
technique	B-T169
to	O
prevent	B-T080
injuries	O
in	O
training	O
,	O
the	O
more	O
important	O
players	B-T098
rated	O
'own	O
safety'	O
τ-b=0	O
,	O
moderate	B-T080
,	O
z=3	O
,	O
p<0	O
,	O
'going	O
for	O
the	O
ball	O
only'	O
τ-b=0	O
,	O
moderate	B-T080
,	O
z=4	O
,	O
p<0	O
and	O
'staying	O
on	O
feet'	O
τ-b=0	O
,	O
moderate	B-T080
,	O
z=3	O
,	O
p<0	O
in	O
match	O
play	O
.	O
	
the	O
more	O
time	O
spent	O
on	O
emphasising	O
proper	O
technique	B-T169
to	O
improve	B-T033
performance	B-T052
in	O
training	O
,	O
the	O
more	O
important	O
players	B-T098
rated	O
actions	O
'going	O
for	O
ball	O
only'	O
τ-b=0	O
,	O
moderate	B-T080
,	O
z=3	O
,	O
p<0	O
and	O
'	O
preventing	B-T080
the	O
ball	O
carrier	O
from	O
retaining	B-T169
position	B-T082
'	O
τ-b=0	O
,	O
moderate	B-T080
,	O
z=3	O
,	O
p<0	O
in	O
match	O
play	O
.	O
	
this	O
is	O
the	O
first	O
study	B-T062
to	O
report	O
on	O
the	O
relationships	B-T080
between	O
players	B-T098
'	O
training	O
attitudes	O
and	O
behaviour	O
and	O
their	O
match	O
attitudes	O
and	O
behaviour	O
s	O
for	O
tackling	O
in	O
rugby	O
union	O
.	O
	
the	O
importance	O
of	O
tackle	O
training	O
to	O
prevent	B-T080
injury	O
,	O
and	O
the	O
amount	O
of	O
time	O
spent	O
on	O
technique	B-T169
to	O
prevent	B-T080
injuries	O
,	O
was	O
associated	B-T080
with	I-T080
behaviours	O
that	O
reduce	B-T080
the	O
risk	B-T033
of	I-T033
injury	I-T033
in	O
role	O
of	O
oxidative	O
stress	O
and	O
inflammatory	B-T169
factors	B-T169
in	O
diabetic	B-T047
kidney	I-T047
disease	I-T047
diabetic	B-T047
nephropathy	I-T047
dn	B-T047
is	O
a	O
serious	B-T080
complication	O
of	O
diabetes	B-T047
mellitus	I-T047
,	O
and	O
its	O
prevalence	B-T081
has	O
been	O
increasing	B-T169
in	O
developed	B-T080
countries	I-T080
.	O
	
diabetic	B-T047
nephropathy	I-T047
has	O
become	O
the	O
most	O
common	B-T081
single	B-T081
cause	O
of	O
end-stage	B-T047
renal	I-T047
disease	I-T047
worldwide	B-T098
.	O
	
oxidative	O
stress	O
and	O
inflammation	O
factors	B-T169
are	O
hypothesized	B-T078
to	O
play	O
a	O
role	O
in	O
the	O
development	B-T169
of	O
late	B-T079
diabetes	B-T047
complications	I-T047
.	O
	
chronic	O
hyperglycemia	O
increases	B-T169
oxidative	O
stress	O
,	O
significantly	B-T169
modifies	I-T169
the	O
structure	B-T082
and	O
function	O
of	O
proteins	B-T116
and	O
lipids	B-T109
,	O
and	O
induces	B-T169
glycoxidation	O
and	O
peroxidation	O
.	O
	
therefore	O
,	O
hyperglycemia	B-T047
causes	O
auto-oxidation	O
of	O
glucose	B-T109
,	O
glycation	O
of	O
proteins	B-T116
,	O
and	O
activation	B-T052
of	O
polyol	B-T169
mechanism	I-T169
.	O
	
overproduction	O
of	O
intracellular	B-T082
reactive	O
oxygen	O
species	O
contributes	B-T052
to	O
several	B-T081
microvascular	B-T169
and	O
macrovascular	B-T169
complications	O
of	O
dn	B-T047
.	O
	
on	O
the	O
other	O
hand	O
,	O
reactive	O
oxygen	O
species	O
modulates	B-T082
signaling	O
cascade	O
of	O
immune	O
factors	O
.	O
	
an	O
increase	B-T169
in	O
reactive	O
oxygen	O
species	O
can	O
increase	B-T169
the	O
production	O
of	O
inflammatory	B-T169
cytokines	B-T116
,	O
and	O
likewise	O
,	O
an	O
increase	B-T169
in	O
inflammatory	B-T169
cytokines	B-T116
can	O
stimulate	O
the	O
production	O
of	O
free	O
radicals	O
.	O
	
some	O
studies	B-T062
have	O
shown	O
that	O
kidney	B-T047
inflammation	I-T047
is	O
serious	B-T080
in	O
promoting	B-T052
the	O
development	B-T169
and	O
progression	B-T169
of	O
dn	B-T047
.	O
	
inflammatory	B-T169
factors	B-T169
which	O
are	O
activated	B-T052
by	O
the	O
metabolic	B-T169
,	O
biochemical	B-T169
,	O
and	O
hemodynamic	O
derangements	O
are	O
known	O
to	O
exist	O
in	O
the	O
diabetic	B-T047
kidney	I-T047
.	O
	
this	O
review	B-T170
discusses	O
facts	O
for	O
oxidative	O
stress	O
and	O
inflammatory	B-T169
factors	B-T169
in	O
dn	B-T047
and	O
encompasses	O
the	O
role	O
of	O
immune	O
and	O
inflammatory	O
cells	O
,	O
inflammatory	B-T169
cytokines	B-T116
,	O
and	O
stress	O
oxidative	O
factors	B-T169
.	O
	
cobalt-60	O
machines	O
and	O
medical	O
linear	O
accelerators	O
competing	O
technologies	O
for	O
external	B-T061
beam	I-T061
radiotherapy	I-T061
medical	O
linear	O
accelerators	O
linacs	O
and	O
cobalt-60	O
machines	O
are	O
both	O
mature	O
technologies	O
for	O
external	B-T061
beam	I-T061
radiotherapy	I-T061
.	O
	
a	O
comparison	B-T052
is	O
made	O
between	O
these	O
two	O
technologies	O
in	O
terms	O
of	O
infrastructure	O
and	O
maintenance	B-T052
,	O
dosimetry	O
,	O
shielding	B-T033
requirements	B-T169
,	O
staffing	O
,	O
costs	B-T081
,	O
security	O
,	O
patient	O
throughput	B-T081
and	O
clinical	B-T169
use	I-T169
.	O
	
infrastructure	O
and	O
maintenance	B-T052
are	O
more	O
demanding	B-T078
for	O
linacs	O
due	O
to	O
the	O
complex	O
electric	O
componentry	O
.	O
	
in	O
dosimetry	O
,	O
a	O
higher	B-T080
beam	B-T081
energy	I-T081
,	O
modulated	B-T082
dose	B-T081
rate	I-T081
and	O
smaller	B-T080
focal	B-T080
spot	I-T080
size	I-T080
mean	O
that	O
it	O
is	O
easier	B-T033
to	O
create	B-T052
an	O
optimised	B-T052
treatment	B-T061
with	O
a	O
linac	O
for	O
conformal	O
dose	B-T081
coverage	B-T169
of	O
the	O
tumour	O
while	O
sparing	O
healthy	O
organs	O
at	O
risk	B-T078
.	O
	
in	O
shielding	B-T033
,	O
the	O
requirements	B-T169
for	O
a	O
concrete	O
bunker	O
are	O
similar	O
for	O
cobalt-60	O
machines	O
and	O
linacs	O
but	O
extra	O
shielding	B-T033
and	O
protection	B-T033
from	O
neutrons	O
are	O
required	O
for	O
linacs	O
.	O
	
staffing	B-T033
levels	I-T033
can	O
be	O
higher	B-T080
for	O
linacs	O
and	O
more	O
staff	O
training	O
is	O
required	O
for	O
linacs	O
.	O
	
life	B-T169
cycle	I-T169
costs	I-T169
are	O
higher	B-T080
for	O
linacs	O
,	O
especially	O
multi-energy	O
linacs	O
.	O
	
security	O
is	O
more	O
complex	B-T080
for	O
cobalt-60	O
machines	O
because	O
of	O
the	O
high	B-T080
activity	B-T052
radioactive	O
source	O
.	O
	
patient	O
throughput	B-T081
can	O
be	O
affected	B-T169
by	O
source	B-T033
decay	O
for	O
cobalt-60	O
machines	O
but	O
poor	B-T080
maintenance	B-T052
and	O
breakdowns	O
can	O
severely	O
affect	B-T169
patient	O
throughput	B-T081
for	O
linacs	O
.	O
	
in	O
clinical	B-T169
use	I-T169
,	O
more	O
complex	B-T080
treatment	B-T061
techniques	B-T169
are	O
easier	B-T033
to	O
achieve	O
with	O
linacs	O
,	O
and	O
the	O
availability	B-T169
of	I-T169
electron	O
beams	O
on	O
high	B-T080
-	O
energy	B-T081
linacs	O
can	O
be	O
useful	O
for	O
certain	O
treatments	B-T061
.	O
	
in	O
summary	O
,	O
there	O
is	O
no	O
simple	O
answer	O
to	O
the	O
question	O
of	O
the	O
choice	O
of	O
either	O
cobalt-60	O
machines	O
or	O
linacs	O
for	O
radiotherapy	B-T061
in	O
low-	B-T033
and	O
middle-income	B-T080
countries	O
.	O
	
in	O
fact	O
a	O
radiotherapy	O
department	O
with	O
a	O
combination	B-T080
of	O
technologies	O
,	O
including	O
orthovoltage	O
x-ray	O
units	O
,	O
may	O
be	O
an	O
option	B-T169
.	O
	
local	B-T082
needs	B-T080
,	O
conditions	B-T080
and	O
resources	B-T078
will	O
have	O
to	O
be	O
factored	O
into	O
any	O
decision	O
on	O
technology	O
taking	O
into	O
account	O
the	O
characteristics	B-T080
of	O
both	O
forms	O
of	O
teletherapy	B-T061
,	O
with	O
the	O
primary	O
goal	B-T170
being	O
the	O
sustainability	B-T169
of	O
the	O
radiotherapy	O
service	O
over	O
the	O
useful	O
lifetime	B-T079
of	O
the	O
design	B-T052
,	O
synthesis	B-T052
,	O
molecular	B-T170
docking	I-T170
,	O
anti-proteus	O
mirabilis	O
and	O
urease	B-T116
inhibition	O
of	O
new	O
fluoroquinolone	O
carboxylic	O
acid	O
derivatives	O
new	O
hydroxamic	B-T109
acid	I-T109
,	O
hydrazide	B-T109
and	O
amide	B-T109
derivatives	I-T109
of	O
ciprofloxacin	B-T109
in	O
addition	O
to	O
their	O
analogues	O
of	O
levofloxacin	B-T109
were	O
prepared	O
and	O
identified	O
by	O
different	O
spectroscopic	B-T169
techniques	I-T169
.	O
	
some	O
of	O
the	O
prepared	O
compounds	O
revealed	O
good	O
activity	O
against	O
the	O
urease	B-T116
splitting	O
bacteria	O
,	O
proteus	O
mirabilis	O
.	O
	
the	O
urease	B-T116
inhibitory	O
activity	O
was	O
investigated	O
using	O
indophenol	O
method	O
.	O
	
most	O
of	O
the	O
tested	B-T170
compounds	O
showed	O
better	O
activity	O
than	O
the	O
reference	O
acetohydroxamic	B-T109
acid	I-T109
aha	B-T109
.	O
	
the	O
ciprofloxacin	O
hydrazide	O
derivative	O
3a	O
and	O
levofloxacin	O
hydroxamic	O
acid	O
7	O
experienced	O
the	O
highest	O
activity	O
ic50	B-T081
=1	O
and	O
2.20μm	O
,	O
respectively	O
.	O
	
molecular	B-T170
docking	I-T170
study	I-T170
revealed	O
high	O
spontaneous	O
binding	O
ability	O
of	O
the	O
tested	B-T170
compounds	O
to	O
the	O
active	B-T169
site	I-T169
of	O
interobserver	B-T170
and	O
intraobserver	O
reliability	B-T081
of	O
clinical	B-T033
assessments	I-T033
in	O
knee	B-T047
osteoarthritis	I-T047
clinical	B-T033
examination	I-T033
of	O
the	O
knee	O
is	O
subject	O
to	O
measurement	B-T081
error	I-T081
.	O
	
the	O
aim	O
of	O
this	O
analysis	O
was	O
to	O
determine	O
interobserver	B-T170
and	O
intraobserver	O
reliability	B-T081
of	O
commonly	O
used	O
clinical	O
tests	O
in	O
patients	O
with	O
knee	B-T047
osteoarthritis	I-T047
oa	B-T047
.	O
	
we	O
studied	O
subjects	O
with	O
symptomatic	B-T169
knee	B-T047
oa	I-T047
who	O
were	O
participants	B-T098
in	O
an	O
open-label	B-T062
clinical	I-T062
trial	I-T062
of	O
intraarticular	B-T061
steroid	I-T061
therapy	I-T061
.	O
	
following	O
standardization	B-T062
of	O
the	O
clinical	O
test	O
procedures	O
,	O
2	O
clinicians	O
assessed	O
25	O
subjects	O
independently	O
at	O
the	O
same	O
visit	O
,	O
and	O
the	O
same	O
clinician	O
assessed	O
88	O
subjects	O
over	O
an	O
interval	B-T079
period	I-T079
of	O
2-10	O
weeks	O
in	O
both	O
cases	O
prior	O
to	O
the	O
steroid	B-T061
intervention	B-T061
.	O
	
clinical	B-T033
examination	I-T033
included	B-T169
assessment	O
of	O
bony	O
enlargement	O
,	O
crepitus	O
,	O
quadriceps	B-T033
wasting	I-T033
,	O
knee	B-T033
effusion	I-T033
,	O
joint-line	O
and	O
anserine	O
tenderness	O
,	O
and	O
knee	B-T033
range	I-T033
of	I-T033
movement	I-T033
rom	B-T033
.	O
	
intraclass	B-T081
correlation	I-T081
coefficients	I-T081
icc	B-T081
,	O
estimated	B-T081
kappa	I-T081
κ	B-T081
,	O
weighted	B-T081
kappa	I-T081
κω	B-T081
,	O
and	O
bland-altman	B-T081
plots	I-T081
were	O
used	O
to	O
determine	O
interobserver	B-T170
and	O
intraobserver	O
levels	B-T080
of	O
agreement	O
.	O
	
using	O
landis	B-T081
and	I-T081
koch	I-T081
criteria	I-T081
,	O
interobserver	B-T080
κ	I-T080
scores	I-T080
were	O
moderate	B-T080
for	O
patellofemoral	O
joint	O
κ	B-T081
=	O
0.53	O
and	O
anserine	O
tenderness	O
κ	B-T081
=	O
0.48	O
good	B-T080
for	O
bony	O
enlargement	O
κ	B-T081
=	O
0.66	O
,	O
quadriceps	B-T033
wasting	I-T033
κ	B-T081
=	O
0.78	O
,	O
crepitus	O
κ	B-T081
=	O
0.78	O
,	O
medial	B-T082
tibiofemoral	O
joint	O
tenderness	O
κ	B-T081
=	O
0.76	O
,	O
and	O
effusion	B-T033
assessed	O
by	O
ballottement	O
κ	B-T081
=	O
0.73	O
and	O
bulge	O
sign	O
κω	B-T081
=	O
0.78	O
and	O
excellent	B-T080
for	O
lateral	B-T082
tibiofemoral	O
joint	O
tenderness	O
κ	B-T081
=	O
1.00	O
,	O
flexion	O
icc	B-T081
=	O
0.97	O
,	O
and	O
extension	B-T169
icc	B-T081
=	O
0.87	O
rom	B-T033
.	O
	
intraobserver	B-T080
κ	I-T080
scores	I-T080
were	O
moderate	B-T080
for	O
lateral	B-T082
tibiofemoral	O
joint	O
tenderness	O
κ	B-T081
=	O
0.60	O
good	O
for	O
crepitus	O
κ	B-T081
=	O
0.78	O
,	O
effusion	B-T033
assessed	O
by	O
ballottement	O
test	O
κ	B-T081
=	O
0.77	O
,	O
patellofemoral	O
joint	O
κ	B-T081
=	O
0.66	O
,	O
medial	B-T082
tibiofemoral	O
joint	O
κ	B-T081
=	O
0.64	O
,	O
and	O
anserine	O
tenderness	O
κ	B-T081
=	O
0.73	O
and	O
excellent	B-T080
for	O
effusion	B-T033
assessed	O
by	O
bulge	O
sign	O
κω	B-T081
=	O
0.83	O
,	O
bony	O
enlargement	O
κ	B-T081
=	O
0.98	O
,	O
quadriceps	B-T033
wasting	I-T033
κ	B-T081
=	O
0.83	O
,	O
flexion	O
icc	B-T081
=	O
0.99	O
,	O
and	O
extension	B-T169
icc	B-T081
=	O
0.96	O
rom	B-T033
.	O
	
among	O
individuals	B-T098
with	O
symptomatic	B-T169
knee	B-T047
oa	I-T047
,	O
the	O
reliability	B-T081
of	O
clinical	B-T033
examination	I-T033
of	O
the	O
knee	O
was	O
at	O
least	O
good	O
for	O
the	O
majority	O
of	O
clinical	B-T033
signs	I-T033
of	O
knee	B-T047
oa	I-T047
.	O
	
assessing	O
the	O
benefits	B-T081
of	O
targeted	B-T169
drug	O
delivery	O
by	O
nanocarriers	O
a	O
partico/pharmacokinetic	B-T169
framework	I-T169
an	O
in	B-T082
vivo	I-T082
kinetic	B-T169
framework	I-T169
is	O
introduced	O
to	O
analyze	B-T062
and	O
predict	O
the	O
quantitative	B-T081
advantage	O
of	O
using	O
nanocarriers	O
to	O
deliver	O
drugs	O
,	O
especially	O
anticancer	B-T109
agents	I-T109
,	O
compared	B-T052
to	O
administering	B-T061
the	O
same	O
drugs	O
in	O
their	O
free	O
form	O
.	O
	
this	O
framework	B-T078
recognizes	O
three	O
levels	B-T080
of	O
kinetics	O
.	O
	
first	O
is	O
the	O
particokinetics	O
associated	B-T080
with	I-T080
deposition	B-T169
of	O
nanocarriers	O
into	O
tissues	O
associated	B-T080
with	I-T080
drug	B-T169
effect	I-T169
and	O
toxicity	O
,	O
their	O
residence	B-T082
inside	O
those	O
tissues	O
,	O
and	O
elimination	O
of	O
the	O
nanocarriers	O
from	O
the	O
body	O
.	O
	
second	O
is	O
the	O
release	B-T033
pattern	I-T033
in	O
time	O
of	O
free	B-T081
drug	I-T081
from	O
the	O
nanocarriers	O
.	O
	
third	O
is	O
the	O
pharmacokinetics	O
of	O
free	B-T081
drug	I-T081
,	O
as	O
it	O
relates	O
to	O
deposition	B-T169
and	O
elimination	O
processes	O
in	O
the	O
target	B-T169
and	O
toxicity	O
associated	B-T080
tissues	O
,	O
and	O
total	O
body	O
clearance	O
.	O
	
a	O
figure	O
of	O
merit	O
,	O
the	O
drug	B-T081
targeting	I-T081
index	I-T081
dti	B-T081
,	O
is	O
used	O
to	O
quantitate	B-T081
the	O
benefit	O
of	O
nanocarrier	O
based	O
drug	O
delivery	O
by	O
considering	O
the	O
effects	B-T080
of	O
preferential	O
deposition	B-T169
of	O
nanoparticles	O
into	O
target	B-T169
tissues	O
and	O
relative	O
avoidance	O
of	O
tissues	O
associated	B-T080
with	I-T080
drug	O
toxicity	O
,	O
compared	B-T052
to	O
drug	O
that	O
is	O
administered	B-T061
in	O
its	O
free	O
form	O
.	O
	
general	O
methods	B-T170
are	O
derived	O
for	O
calculating	B-T052
dti	B-T081
when	O
appropriate	O
particokinetic	O
,	O
pharmacokinetic	B-T169
,	O
and	O
drug	B-T081
release	I-T081
rate	I-T081
information	O
is	O
available	O
,	O
and	O
it	O
is	O
shown	O
that	O
relatively	O
simple	O
algebraic	O
forms	O
result	B-T169
when	O
some	O
common	O
assumptions	O
are	O
made	O
.	O
	
this	O
approach	O
may	O
find	O
use	O
in	O
developing	O
and	O
selecting	O
nanocarrier	O
formulations	O
,	O
either	O
for	O
populations	B-T098
or	O
for	O
recombinant	O
mhc	O
tetramers	O
for	O
isolation	B-T061
of	O
virus	O
-	O
specific	B-T080
cd8	O
cells	O
from	O
healthy	B-T080
donors	I-T080
potential	B-T080
approach	O
for	O
cell	B-T061
therapy	I-T061
of	O
posttransplant	B-T047
cytomegalovirus	I-T047
infection	I-T047
patients	O
undergoing	O
allogeneic	B-T080
hematopoietic	B-T061
stem	I-T061
cell	I-T061
transplantation	I-T061
have	O
a	O
high	O
risk	O
of	O
cytomegalovirus	B-T047
reactivation	I-T047
,	O
which	O
in	O
the	O
absence	O
of	O
t-cell	O
immunity	O
can	O
result	O
in	O
the	O
development	O
of	O
an	O
acute	B-T033
inflammatory	I-T033
reaction	I-T033
and	O
damage	O
of	O
internal	O
organs	O
.	O
	
transfusion	B-T061
of	O
the	O
virus-specific	B-T080
donor	O
t-lymphocytes	O
represents	O
an	O
alternative	O
to	O
a	O
highly	B-T080
toxic	I-T080
and	O
often	O
ineffective	B-T078
antiviral	B-T061
therapy	I-T061
.	O
	
potentially	B-T080
promising	O
cell	B-T061
therapy	I-T061
approach	O
comprises	O
transfusion	B-T061
of	O
cytotoxic	O
t-lymphocytes	O
,	O
specific	B-T080
to	O
the	O
viral	O
antigens	O
,	O
immediately	O
after	O
their	O
isolation	B-T061
from	O
the	O
donor's	O
blood	O
circulation	O
without	O
any	O
in	B-T080
vitro	I-T080
expansion	I-T080
.	O
	
specific	B-T080
t-cells	O
could	O
be	O
separated	O
from	O
potentially	B-T080
alloreactive	O
lymphocytes	O
using	O
recombinant	O
major	O
histocompatibility	O
complex	O
mhc	O
multimers	O
,	O
carrying	O
synthetic	B-T116
viral	I-T116
peptides	I-T116
.	O
	
rapid	O
transfusion	B-T061
of	O
virus	O
-	O
specific	B-T080
t-cells	O
to	O
patients	O
has	O
several	O
crucial	O
advantages	O
in	B-T080
comparison	O
with	O
methods	O
based	O
on	O
the	O
in	O
vitro	I-T080
expansion	I-T080
of	O
the	O
cells	O
.	O
	
about	O
30%	O
of	O
hematopoietic	B-T169
stem	B-T080
cell	I-T080
donors	I-T080
and	O
46%	O
of	O
transplant	O
recipients	O
at	O
the	O
national	O
research	O
center	O
for	O
hematology	O
were	O
carriers	O
of	O
the	O
hla-a*02	O
allele	O
.	O
	
moreover	O
,	O
94%	O
of	O
russian	B-T098
donors	B-T080
have	O
an	O
immune	O
response	O
against	O
the	O
cytomegalovirus	O
cmv	O
.	O
	
using	O
recombinant	O
hla-a*02	O
multimers	O
carrying	O
an	O
immunodominant	B-T080
cytomegalovirus	B-T116
peptide	I-T116
nlv	B-T116
,	O
we	O
have	O
shown	O
that	O
the	O
majority	O
of	O
healthy	B-T080
donors	I-T080
have	O
pronounced	O
t-cell	O
immunity	O
against	O
this	O
antigen	O
,	O
whereas	O
shortly	O
after	O
the	O
transplantation	B-T061
the	O
patients	O
do	O
not	O
have	O
specific	B-T080
t-lymphocytes	O
.	O
	
the	O
donor	O
cells	O
have	O
the	O
immune	O
phenotype	O
of	O
memory	O
cells	O
and	O
can	O
be	O
activated	O
and	O
proliferate	O
after	O
stimulation	O
with	O
the	O
specific	B-T080
antigen	O
.	O
	
donor	B-T033
lymphocytes	I-T033
can	O
be	O
substantially	O
enriched	O
to	O
significant	O
purity	B-T081
by	O
magnetic	O
separation	O
with	O
recombinant	O
mhc	O
multimers	O
and	O
are	O
not	O
activated	O
upon	O
cocultivation	O
with	O
the	O
antigen	O
-presenting	O
cells	O
from	O
hla	B-T116
-	O
incompatible	B-T098
donors	I-T098
without	O
addition	O
of	O
the	O
specific	B-T080
antigen	O
.	O
	
this	O
study	B-T062
demonstrated	O
that	O
strong	O
immune	O
response	O
to	O
cmv	O
of	O
healthy	B-T080
donors	I-T080
and	O
prevalence	O
of	O
hla-a*02	O
allele	O
in	O
the	O
russian	B-T098
population	I-T098
make	O
it	O
possible	O
to	O
isolate	O
a	O
significant	O
number	O
of	O
virus-specific	B-T080
cells	O
using	O
hla-a*02-nlv	O
multimers	O
.	O
	
after	O
the	O
transfusion	B-T061
,	O
these	O
cells	O
should	O
protect	O
patients	O
from	O
cmv	O
without	O
development	O
of	O
allogeneic	B-T080
immune	O
response	O
.	O
	
outcomes	B-T080
of	O
chest	B-T061
wall	I-T061
resections	I-T061
in	O
pediatric	B-T080
sarcoma	O
patients	O
chest	O
wall	O
tumors	O
in	O
pediatric	B-T080
patients	O
are	O
rare	O
.	O
	
this	O
study	B-T062
evaluates	O
outcomes	B-T080
in	O
pediatric	B-T080
patients	O
who	O
have	O
undergone	O
chest	B-T061
wall	I-T061
resections	I-T061
secondary	O
to	O
sarcomas	O
.	O
	
a	O
retrospective	B-T062
review	I-T062
was	O
performed	O
for	O
patients	O
<19years	O
old	O
who	O
underwent	O
chest	B-T061
wall	I-T061
resections	I-T061
for	O
sarcoma	O
1999-2014	O
at	O
the	O
university	O
of	O
texas	O
md	O
anderson	O
cancer	O
center	O
.	O
	
of	O
44	O
patients	O
,	O
ewing's	O
sarcoma	O
n=18	O
and	O
osteosarcoma	O
n=16	O
were	O
most	O
common	O
.	O
	
other	O
sarcomas	O
included	O
synovial	O
sarcoma	O
,	O
chondrosarcoma	O
,	O
and	O
rhabdomyosarcoma	O
.	O
	
gore-tex	B-T109
or	O
a	O
marlex	O
mesh	O
and	O
methyl	O
methacrylate	O
sandwich	O
was	O
used	O
in	O
22	O
patients	O
,	O
and	O
9	O
children	O
did	O
not	B-T033
require	I-T033
reconstruction	I-T033
.	O
	
twenty-four	O
54.5	O
patients	O
had	O
normal	B-T080
activity	B-T052
,	O
3	O
6.8	O
had	O
occasional	O
discomfort	O
,	O
2	O
4.5	O
had	O
pain	O
impairing	O
function	O
,	O
7	O
15.9	O
required	O
medication	O
or	O
physical	B-T061
therapy	I-T061
for	O
impairment	O
,	O
and	O
8	O
18.2	O
needed	O
additional	O
surgery	O
.	O
	
five	O
children	O
11.4	O
developed	O
scoliosis	O
,	O
and	O
all	O
of	O
these	O
patients	O
had	O
posterior	B-T082
rib	O
tumors	O
.	O
	
median	B-T081
overall	I-T081
survival	I-T081
for	O
the	O
entire	B-T098
cohort	I-T098
was	O
41.9	O
months	B-T079
.	O
	
histology	O
p=0	O
,	O
location	B-T082
of	O
tumor	O
on	O
the	O
ribs	O
p=0	O
,	O
and	O
surgical	O
margins	O
p=0	O
were	O
significantly	B-T080
associated	I-T080
with	I-T080
overall	B-T081
survival	I-T081
.	O
	
tumors	O
on	O
the	O
middle	O
and	O
posterior	B-T082
p=0	O
portions	O
of	O
the	O
ribs	O
had	O
a	O
lower	O
chance	O
of	O
death	O
.	O
	
scoliosis	O
is	O
more	O
common	O
in	O
posterior	B-T082
rib	B-T061
resections	I-T061
.	O
	
histology	O
,	O
location	B-T082
of	O
the	O
tumor	O
,	O
and	O
surgical	O
margins	O
impact	O
survival	B-T052
,	O
but	O
,	O
type	O
of	O
reconstruction	O
does	O
not	O
.	O
	
iii	O
.	O
	
treatment	B-T062
study	I-T062
.	O
	
tetrabromobisphenol	B-T109
a	I-T109
activates	B-T052
the	O
hepatic	O
interferon	O
pathway	O
in	O
rats	O
tetrabromobisphenol	B-T109
a	I-T109
tbbpa	B-T109
is	O
a	O
widely	O
used	O
flame	O
retardant	O
in	O
printed	O
circuit	O
boards	O
,	O
paper	O
,	O
and	O
textiles	O
.	O
	
in	O
a	O
two-year	B-T079
study	B-T062
,	O
tbbpa	B-T109
showed	O
evidence	O
of	O
uterine	O
tumors	O
in	O
female	O
wistar-han	O
rats	O
and	O
liver	O
and	O
colon	O
tumors	O
in	O
b6c3f1	O
mice	O
.	O
	
in	O
order	O
to	O
gain	O
further	O
insight	O
into	O
early	O
gene	O
and	O
pathway	O
changes	O
leading	O
to	O
cancer	O
,	O
we	O
exposed	O
female	O
wistar	O
han	O
rats	O
to	O
tbbpa	B-T109
at	O
0	O
,	O
25	O
,	O
250	O
,	O
or	O
1000mg/kg	O
oral	B-T169
gavage	I-T169
in	O
corn	B-T109
oil	I-T109
,	O
5	O
week	B-T079
for	O
13	O
weeks	B-T079
.	O
	
because	O
at	O
the	O
end	O
of	O
the	O
tbbpa	B-T109
exposure	B-T080
period	O
,	O
there	O
were	O
no	O
treatment-related	O
effects	O
on	O
body	O
weights	O
,	O
liver	B-T033
or	O
uterus	B-T033
lesions	I-T033
,	O
and	O
liver	O
and	O
uterine	O
organ	O
weights	B-T081
were	O
within	O
10%	O
of	O
controls	O
,	O
only	O
the	O
high	O
dose	B-T081
animals	O
were	O
analyzed	B-T062
.	O
	
analysis	B-T062
of	O
the	O
hepatic	O
and	O
uterine	O
transcriptomes	O
showed	O
tbbpa	B-T109
-induced	O
changes	O
primarily	O
in	O
the	O
liver	O
1000mg/kg	O
,	O
with	O
159	O
transcripts	O
corresponding	O
to	O
132	O
genes	O
differentially	O
expressed	O
compared	O
to	O
controls	O
fdr=0	O
.	O
	
pathway	B-T170
analysis	I-T170
showed	O
activation	B-T052
of	O
interferon	B-T116
ifn	B-T116
and	O
metabolic	O
networks	O
.	O
	
tbbpa	B-T109
induced	O
few	O
molecular	O
changes	O
in	O
the	O
uterus	O
.	O
	
activation	B-T052
of	O
the	O
interferon	O
pathway	O
in	O
the	O
liver	O
occurred	O
after	O
13-weeks	B-T079
of	O
tbbpa	B-T109
exposure	B-T080
,	O
and	O
with	O
longer	O
term	O
tbbpa	B-T109
exposure	B-T080
this	O
may	O
lead	O
to	O
immunomodulatory	B-T061
changes	B-T169
that	O
contribute	O
to	O
carcinogenic	O
processes	O
.	O
	
famous	O
faces	O
and	O
voices	O
differential	B-T080
profiles	B-T082
in	O
early	B-T079
right	O
and	O
left	O
semantic	O
dementia	O
and	O
in	O
alzheimer's	B-T047
disease	I-T047
famous	O
face	O
and	O
voice	O
recognition	O
is	O
reported	O
to	O
be	O
impaired	B-T169
both	O
in	O
semantic	O
dementia	O
sd	O
and	O
in	O
alzheimer's	B-T047
disease	I-T047
ad	B-T047
,	O
although	O
more	O
severely	B-T080
in	O
the	O
former	O
.	O
	
in	O
ad	B-T047
a	O
coexistence	O
of	O
perceptual	O
impairment	B-T169
in	O
face	O
and	O
voice	O
processing	O
has	O
also	O
been	O
reported	O
and	O
this	O
could	O
contribute	O
to	O
the	O
altered	O
performance	B-T052
in	O
complex	B-T080
semantic	B-T078
tasks	B-T052
.	O
	
on	O
the	O
other	O
hand	O
,	O
in	O
sd	O
both	O
face	O
and	O
voice	O
recognition	O
disorders	B-T047
could	O
be	O
related	O
to	O
the	O
prevalence	B-T081
of	O
atrophy	O
in	O
the	O
right	O
temporal	O
lobe	O
rtl	O
.	O
	
the	O
aim	O
of	O
the	O
present	O
study	B-T062
was	O
twofold	O
1	O
to	O
investigate	B-T169
famous	O
faces	O
and	O
voices	O
recognition	O
in	O
sd	O
and	O
ad	B-T047
to	O
verify	O
if	O
the	O
two	O
diseases	B-T047
show	O
a	O
differential	B-T080
pattern	B-T082
of	O
impairment	B-T169
,	O
resulting	O
from	O
disruption	B-T169
of	O
different	O
cognitive	O
mechanisms	B-T169
2	O
to	O
check	O
if	O
face	O
and	O
voice	O
recognition	O
disorders	B-T047
prevail	O
in	O
patients	O
with	O
atrophy	O
mainly	O
affecting	O
the	O
rtl	O
.	O
	
to	O
avoid	O
the	O
potential	B-T080
influence	O
of	O
primary	B-T080
perceptual	O
problems	B-T033
in	O
face	O
and	O
voice	O
recognition	O
,	O
a	O
pool	O
of	O
patients	O
suffering	O
from	O
early	B-T079
sd	O
and	O
ad	B-T047
were	O
administered	B-T169
a	O
detailed	O
set	O
of	O
tests	O
exploring	O
face	O
and	O
voice	O
perception	O
.	O
	
thirteen	O
sd	O
8	O
with	O
prevalence	B-T081
of	O
right	O
and	O
5	O
with	O
prevalence	B-T081
of	O
left	O
temporal	O
atrophy	O
and	O
25	O
ce	O
patients	O
,	O
who	O
did	O
not	O
show	O
visual	B-T169
and	O
auditory	B-T169
perceptual	O
impairment	B-T169
,	O
were	O
finally	O
selected	O
and	O
were	O
administered	B-T169
an	O
experimental	B-T080
battery	B-T170
exploring	O
famous	O
face	O
and	O
voice	O
recognition	O
and	O
naming	B-T170
.	O
	
twelve	O
sd	O
patients	O
underwent	O
cerebral	O
pet	O
imaging	O
and	O
were	O
classified	O
in	O
right	O
and	O
left	O
sd	O
according	O
to	O
the	O
onset	O
modality	B-T078
and	O
to	O
the	O
prevalent	O
decrease	B-T081
in	O
fdg	B-T109
uptake	I-T109
in	O
right	O
or	O
left	O
temporal	O
lobe	O
respectively	O
.	O
	
correlation	B-T080
of	O
pet	O
imaging	O
and	O
famous	O
face	O
and	O
voice	O
recognition	O
was	O
performed	O
.	O
	
results	B-T169
showed	O
a	O
differential	B-T080
performance	B-T052
profile	B-T082
in	O
the	O
two	O
diseases	B-T047
,	O
because	O
ad	B-T047
patients	O
were	O
significantly	O
impaired	B-T169
in	O
the	O
naming	B-T170
tests	I-T170
,	O
but	O
showed	O
preserved	O
recognition	O
,	O
whereas	O
sd	O
patients	O
were	O
profoundly	O
impaired	B-T169
both	O
in	O
naming	B-T170
and	O
in	O
recognition	O
of	O
famous	O
faces	O
and	O
voices	O
.	O
	
furthermore	O
,	O
face	O
and	O
voice	O
recognition	O
disorders	B-T047
prevailed	O
in	O
sd	O
patients	O
with	O
rtl	O
atrophy	O
,	O
who	O
also	O
showed	O
a	O
conceptual	O
impairment	B-T169
on	O
the	O
pyramids	B-T170
and	I-T170
palm	I-T170
trees	I-T170
test	I-T170
more	O
important	O
in	O
the	O
pictorial	O
than	O
in	O
the	O
verbal	B-T080
modality	B-T078
.	O
	
finally	O
,	O
in	O
12	O
sd	O
patients	O
in	O
whom	O
pet	O
was	O
available	O
,	O
a	O
strong	O
correlation	B-T080
between	O
fdg	B-T109
uptake	I-T109
and	O
face-to-name	B-T080
and	O
voice-to-name	B-T080
matching	I-T080
data	B-T078
was	O
found	O
in	O
the	O
right	O
but	O
not	O
in	O
the	O
left	O
temporal	O
lobe	O
.	O
	
the	O
data	B-T078
support	O
the	O
hypothesis	B-T078
of	O
a	O
different	O
cognitive	O
basis	O
for	O
impairment	B-T169
of	O
face	O
and	O
voice	O
recognition	O
in	O
the	O
two	O
dementias	O
and	O
suggest	O
that	O
the	O
pattern	B-T082
of	O
impairment	B-T169
in	O
sd	O
may	O
be	O
due	O
to	O
a	O
loss	O
of	O
semantic	B-T078
representations	B-T052
,	O
while	O
a	O
defect	O
of	O
semantic	B-T078
control	B-T169
,	O
with	O
impaired	B-T169
naming	B-T170
and	O
preserved	O
recognition	O
might	O
be	O
hypothesized	O
in	O
ad	B-T047
.	O
	
furthermore	O
,	O
the	O
correlation	B-T080
between	O
face	O
and	O
voice	O
recognition	O
disorders	B-T047
and	O
rtl	O
damage	O
are	O
consistent	O
with	O
the	O
hypothesis	B-T078
assuming	O
that	O
in	O
the	O
rtl	O
person	B-T098
-specific	O
knowledge	B-T170
may	O
be	O
mainly	O
based	O
upon	O
non-verbal	O
representations	O
.	O
	
dry	O
skin	O
conditions	O
are	O
related	B-T080
to	O
the	O
recovery	B-T081
rate	I-T081
of	O
skin	O
temperature	O
after	O
cold	O
stress	O
rather	O
than	O
to	O
blood	O
flow	O
cutaneous	B-T082
blood	O
flow	O
plays	O
an	O
important	B-T080
role	O
in	O
the	O
thermoregulation	O
,	O
oxygen	O
supply	O
,	O
and	O
nutritional	B-T061
support	I-T061
necessary	O
to	O
maintain	B-T052
the	O
skin	O
.	O
	
however	O
,	O
there	O
is	O
little	O
evidence	B-T078
for	O
a	O
link	O
between	O
blood	O
flow	O
and	O
skin	O
physiology	O
.	O
	
therefore	O
,	O
we	O
conducted	O
surveys	B-T170
of	O
healthy	B-T098
volunteers	I-T098
to	O
determine	O
the	O
relationship	B-T080
s	O
between	O
dry	O
skin	O
properties	O
and	O
cutaneous	B-T082
vascular	O
function	O
.	O
	
water	O
content	O
of	O
the	O
stratum	O
corneum	O
,	O
transepidermal	B-T033
water	I-T033
loss	I-T033
,	O
and	O
visual	B-T080
dryness	I-T080
score	I-T080
were	O
investigated	B-T169
as	O
dry	O
skin	O
parameters	B-T033
.	O
	
cutaneous	B-T082
blood	O
flow	O
in	O
the	O
resting	B-T033
state	I-T033
,	O
the	O
recovery	B-T081
rate	I-T081
rr	B-T081
of	O
skin	O
temperature	O
on	O
the	O
hand	O
after	O
a	O
cold-stress	O
test	O
,	O
and	O
the	O
responsiveness	B-T169
of	O
facial	O
skin	O
blood	O
flow	O
to	O
local	B-T061
cooling	I-T061
were	O
examined	B-T033
as	O
indices	B-T170
of	O
cutaneous	B-T082
vascular	O
functions	O
.	O
	
the	O
relationships	B-T080
between	O
dry	O
skin	O
parameters	B-T033
and	O
cutaneous	B-T082
vascular	O
functions	O
were	O
assessed	B-T052
.	O
	
the	O
rr	B-T081
correlated	B-T080
negatively	O
with	O
the	O
visual	B-T080
dryness	I-T080
score	I-T080
of	O
skin	O
on	O
the	O
leg	O
but	O
correlated	B-T080
positively	O
with	O
water	O
content	O
of	O
the	O
stratum	O
corneum	O
on	O
the	O
arm	O
.	O
	
no	O
significant	O
correlation	B-T080
between	O
the	O
resting	B-T033
state	I-T033
of	O
blood	O
flow	O
and	O
dry	O
skin	O
parameters	B-T033
was	O
observed	B-T169
.	O
	
in	O
both	O
the	O
face	O
and	O
the	O
body	O
,	O
deterioration	O
in	O
skin	O
dryness	O
from	O
summer	B-T079
to	O
winter	B-T079
was	O
significant	B-T078
in	O
subjects	O
with	O
low	O
rr	B-T081
.	O
	
the	O
rr	B-T081
correlated	B-T080
well	O
with	O
the	O
responsiveness	B-T169
of	O
facial	O
skin	O
blood	O
flow	O
to	O
local	B-T061
cooling	I-T061
,	O
indicating	B-T033
that	O
the	O
rr	B-T081
affects	O
systemic	O
dry	O
skin	O
conditions	O
.	O
	
these	O
results	O
suggest	O
that	O
the	O
rr	B-T081
but	O
not	O
blood	O
flow	O
at	O
the	O
resting	B-T033
state	I-T033
is	O
associated	O
with	O
dry	O
skin	O
conditions	O
and	O
is	O
involved	O
in	O
skin	O
homeostasis	O
during	O
seasonal	B-T079
environmental	B-T033
changes	I-T033
.	O
	
molar	O
loss	O
and	O
powder	B-T061
diet	I-T061
leads	O
to	O
memory	O
deficit	O
and	O
modifies	O
the	O
mrna	O
expression	O
of	O
brain-derived	B-T116
neurotrophic	I-T116
factor	I-T116
in	O
the	O
hippocampus	O
of	O
adult	O
mice	O
it	O
is	O
known	O
that	O
tooth	O
loss	O
is	O
known	O
to	O
be	O
a	O
risk	B-T033
factor	I-T033
for	O
alzheimer's	B-T047
disease	I-T047
and	O
soft	B-T061
diet	I-T061
feeding	B-T052
induces	O
memory	O
impairment	O
.	O
	
recent	O
studies	O
have	O
shown	O
that	O
brain-derived	B-T116
neurotrophic	I-T116
factor	I-T116
bdnf	B-T116
is	O
associated	B-T080
with	I-T080
tooth	O
loss	O
or	O
soft	B-T061
diet	I-T061
in	O
young	O
animal	O
model	O
,	O
and	O
that	O
bdnf	O
expression	O
is	O
decreased	O
in	O
patients	O
with	O
alzheimer's	B-T047
disease	I-T047
.	O
	
however	O
,	O
single	O
or	O
combined	O
effect	B-T080
of	I-T080
tooth	O
loss	O
and/or	O
soft	B-T061
diet	I-T061
on	O
brain	O
function	O
has	O
not	O
fully	O
understood	O
.	O
	
here	O
we	O
examined	O
the	O
effect	B-T080
of	I-T080
molar	O
loss	O
and	O
powder	B-T061
diet	I-T061
on	O
memory	O
ability	O
and	O
the	O
expression	O
of	O
bdnf	O
mrna	O
in	O
the	O
hippocampus	O
of	O
adult	O
c57bl/6j	O
mice	O
.	O
	
twenty	O
eight-weeks-old	O
c57bl/6j	O
mice	O
were	O
divided	O
into	O
intact	O
molar	O
group	O
and	O
extracted	O
molar	O
group	O
.	O
	
they	O
were	O
randomly	B-T062
divided	O
into	O
the	O
i/s	O
group	O
intact	O
upper	O
molar	O
teeth	O
/	O
solid	O
diet	O
feeding	B-T052
,	O
the	O
e/s	O
group	O
extracted	B-T061
upper	O
molar	O
teeth	O
/	O
solid	O
diet	O
feeding	B-T052
,	O
the	O
i/p	O
group	O
intact	O
upper	O
molar	O
teeth	O
/	O
powder	B-T061
diet	I-T061
feeding	B-T052
,	O
and	O
the	O
e/p	O
group	O
extracted	O
upper	O
molar	O
teeth	O
/	O
powder	B-T061
diet	I-T061
feeding	B-T052
.	O
	
the	O
observation	O
periods	O
were	O
4	O
and	O
16-week	O
.	O
	
to	O
analyze	B-T062
the	O
memory	O
ability	O
,	O
the	O
step-through	O
passive	O
avoidance	O
test	O
was	O
conducted	O
.	O
	
bdnf-related	O
mrna	O
in	O
the	O
hippocampus	O
was	O
analyzed	B-T062
by	O
real-time	O
polymerase	O
chain	O
reaction	O
rt-pcr	O
.	O
	
at	O
4	O
weeks	O
later	O
,	O
we	O
performed	O
memory	O
test	O
and	O
isolated	O
brains	O
to	O
analyze	B-T062
.	O
	
there	O
were	O
no	B-T033
differences	I-T033
in	O
memory	O
function	O
and	O
bdnf	O
mrna	O
level	O
between	O
these	O
four	O
groups	O
.	O
	
however	O
,	O
at	O
16	O
weeks	O
later	O
,	O
e/s	O
and	O
e/p	O
group	O
showed	O
memory	O
impairment	O
,	O
and	O
decreased	O
level	O
of	O
bdnf	O
mrna	O
.	O
	
whereas	O
,	O
the	O
powder	B-T061
diet	I-T061
had	O
no	B-T080
effect	I-T080
on	O
memory	O
function	O
and	O
bdnf	O
mrna	O
level	O
even	O
at	O
16	O
weeks	O
later	O
.	O
	
these	O
results	O
suggest	O
that	O
the	O
effect	B-T080
of	I-T080
molar	O
loss	O
and	O
powder	B-T061
diet	I-T061
on	O
memory	O
function	O
and	O
bdnf	O
mrna	O
levels	O
were	O
different	O
,	O
molar	O
loss	O
may	O
have	O
a	O
greater	O
long-term	O
effect	O
on	O
memory	O
ability	O
than	O
powder	B-T061
diet	I-T061
description	O
of	O
the	O
first	O
species	O
of	O
fiorianteon	O
olmi	O
hymenoptera	O
,	O
dryinidae	O
from	O
the	O
afrotropical	O
region	O
fiorianteon	O
sulcatumsp	O
.	O
	
n	O
.	O
	
is	O
described	O
from	O
fianarantsoa	O
province	O
madagascar	O
.	O
	
it	O
is	O
the	O
first	O
species	O
of	O
fiorianteon	O
found	O
in	O
the	O
afrotropical	O
region	O
.	O
	
the	O
genus	O
fiorianteon	O
can	O
be	O
distinguished	O
from	O
the	O
closely	O
related	O
genus	O
conganteon	O
by	O
the	O
distal	B-T082
part	O
of	O
the	O
stigmal	O
vein	O
,	O
which	O
is	O
as	O
long	B-T080
as	O
,	O
or	O
shorter	B-T033
than	O
the	O
proximal	B-T082
part	O
of	O
the	O
stigmal	O
vein	O
longer	O
than	O
the	O
proximal	B-T082
part	O
of	O
the	O
vein	O
in	O
the	B-T170
daniel	I-T170
k	I-T170
.	O
	
inouye	I-T170
college	I-T170
of	I-T170
pharmacy	I-T170
scripts	I-T170
poha	O
berry	O
physalis	O
peruviana	O
with	O
potential	B-T080
anti-inflammatory	B-T080
and	O
cancer	B-T061
prevention	I-T061
activities	B-T052
the	O
daniel	O
k	O
.	O
	
inouye	O
college	O
of	O
pharmacy	O
,	O
during	O
a	O
historic	O
event	O
in	O
spring	B-T079
2016	O
,	O
graduated	B-T098
the	O
first	O
two	O
students	B-T098
in	O
the	O
pacific	O
region	O
to	O
earn	O
a	O
phd	B-T170
in	O
pharmaceutical	O
sciences	O
at	O
the	O
university	O
of	O
hawai'i	O
at	O
hilo	O
.	O
	
the	O
college	O
offers	O
phd	B-T170
programs	B-T169
in	O
these	O
five	O
disciplines	O
cancer	O
biology	O
,	O
medicinal	O
chemistry	O
,	O
pharmaceutics	B-T062
,	O
pharmacognosy	O
,	O
and	O
pharmacology	O
.	O
	
one	O
of	O
the	O
pharmacognosy	O
dissertations	O
focused	O
on	O
plant-derived	O
natural	O
products	O
with	O
potential	B-T080
anti-inflammatory	B-T080
and	O
cancer	O
chemopreventive	B-T080
activities	B-T052
.	O
	
physalis	O
peruviana	O
pp	O
l	O
.	O
	
originated	O
in	O
tropical	O
south	O
america	O
.	O
	
it	O
has	O
become	O
naturalized	B-T169
and	O
is	O
found	O
readily	O
on	O
the	O
island	O
of	O
hawai'i	O
.	O
	
the	O
edible	O
fruits	O
are	O
commonly	O
known	O
as	O
cape	O
gooseberry	O
or	O
poha	O
in	O
hawai'i	O
.	O
	
in	O
part	O
of	O
our	O
study	O
,	O
three	O
new	O
withanolides	B-T109
,	O
physaperuvin	O
g	O
1	O
,	O
physaperuvins	O
i-j	O
2-3	O
,	O
along	O
with	O
four	O
known	O
withanolides	B-T109
,	O
namely	O
,	O
4β-hydroxywithanolide	O
e	O
4	O
,	O
withaperuvin	O
c	O
5	O
,	O
and	O
physalactone	O
6	O
,	O
coagulin	O
7	O
were	O
isolated	B-T169
from	O
the	O
aerial	O
parts	O
of	O
p	O
.	O
	
peruviana	O
.	O
	
in	O
addition	O
,	O
two	O
known	O
compounds	O
,	O
phyperunolide	O
f	O
8	O
,	O
and	O
withanolide	O
s	O
9	O
,	O
were	O
isolated	B-T169
and	O
identified	O
from	O
the	O
poha	O
berry	O
fruits	O
.	O
	
the	O
structures	B-T082
and	O
absolute	B-T082
stereochemistry	I-T082
of	O
new	O
compounds	O
from	O
poha	O
were	O
elucidated	O
by	O
several	O
spectroscopy	B-T169
methods	I-T169
nuclear	O
magnetic	O
resonance	O
nmr	O
spectroscopy	O
,	O
x-ray	O
diffraction	O
,	O
and	O
mass	O
spectrometry	O
analyses	B-T062
.	O
	
all	O
isolated	B-T169
poha	O
compounds	O
aerial	O
parts	O
and	O
fruits	O
were	O
evaluated	O
for	O
their	O
anti-inflammatory	B-T080
activity	I-T080
with	O
lipopolysaccharide	B-T109
lps	B-T109
murine	O
macrophage	O
raw	O
264.7	O
cells	O
,	O
and	O
tumor	B-T116
necrosis	I-T116
factor	I-T116
alpha	I-T116
tnf-α	B-T116
nuclear	B-T116
factor-kappa	I-T116
b	I-T116
nf-κb	B-T116
with	O
transfected	O
human	O
embryonic	O
kidney	O
cells	O
293	O
.	O
	
most	O
of	O
the	O
isolated	B-T169
natural	O
compounds	O
showed	O
activity	B-T169
with	O
these	O
assays	O
.	O
	
additional	O
studies	O
were	O
performed	O
with	O
models	B-T170
of	O
colon	O
cancer	O
.	O
	
specifically	O
,	O
4β-hydroxywithanolide	O
e	O
4hwe	O
inhibited	B-T080
the	O
growth	O
of	O
colon	O
cancer	O
monolayer	O
and	O
spheroid	O
cultures	O
.	O
	
the	O
compound	O
induced	B-T169
cell	O
cycle	O
arrest	O
at	O
low	B-T081
concentrations	I-T081
and	O
apoptosis	O
at	O
higher	B-T081
concentrations	I-T081
.	O
	
these	O
data	B-T078
suggest	O
the	O
ingestion	O
of	O
poha	O
berries	O
may	O
have	O
some	O
effect	O
on	O
the	O
prevalence	O
of	O
colon	O
cancer	O
.	O
	
additionally	O
,	O
poha	O
isolates	O
compounds	O
were	O
evaluated	O
for	O
their	O
growth	O
inhibitory	O
effects	O
with	O
u251mg	O
glioblastoma	O
and	O
mda-mb-231	O
breast	O
cancer	O
cells	O
that	O
harbor	O
aberrantly-active	O
signal	B-T116
transducer	I-T116
and	I-T116
activation	I-T116
of	I-T116
transcription	I-T116
3	I-T116
stat3	I-T116
,	O
compared	O
to	O
normal	O
nih-3t3	O
mouse	O
fibroblasts	O
.	O
	
this	O
work	O
has	O
led	O
to	O
the	O
filing	O
of	O
three	O
provisional	B-T170
patents	I-T170
with	O
the	O
university	O
of	O
hawai'i	O
office	O
of	O
technology	O
transfer	O
and	O
economic	O
development	O
.	O
	
air	O
pollutant	O
exposure	B-T080
within	O
a	O
few	O
days	O
of	O
delivery	B-T061
and	O
placental	O
abruption	O
in	O
japan	O
placental	O
abruption	O
is	O
an	O
emergency	O
obstetric	O
complication	O
.	O
	
although	O
the	O
etiology	B-T169
of	O
abruption	O
is	O
not	O
fully	O
understood	O
,	O
acute	B-T079
stimuli	O
,	O
such	O
as	O
ischemia	O
and/or	O
inflammation	O
,	O
are	O
associated	B-T080
with	I-T080
rupture	B-T047
of	I-T047
the	I-T047
decidual	I-T047
artery	I-T047
,	O
resulting	O
in	O
placental	O
separation	O
.	O
	
ischemia	O
and	O
inflammation	O
are	O
acute	B-T079
biologic	B-T080
effects	B-T080
of	O
air	O
pollution	O
.	O
	
using	O
a	O
case-crossover	B-T062
design	I-T062
,	O
we	O
tested	O
the	O
hypothesis	B-T078
that	O
a	O
short-term	B-T079
increase	B-T169
in	O
exposure	B-T080
to	O
air	O
pollutants	O
is	O
a	O
potential	B-T080
trigger	O
of	O
placental	O
abruption	O
.	O
	
we	O
received	O
data	B-T078
for	O
western	O
japan	O
kyushu-okinawa	O
districts	O
from	O
the	O
japan	B-T170
perinatal	I-T170
registry	I-T170
network	I-T170
database	I-T170
.	O
	
from	O
2005	O
to	O
2010	O
,	O
821	O
singleton	O
pregnant	B-T098
women	I-T098
with	O
placental	O
abruption	O
were	O
identified	O
.	O
	
we	O
assigned	O
daily	B-T079
concentrations	B-T081
of	O
air	O
pollutants	O
,	O
including	O
nitrogen	O
dioxide	O
no2	O
,	O
suspended	O
particulate	O
matter	O
,	O
ozone	O
,	O
and	O
sulfur	O
dioxide	O
so2	O
,	O
from	O
the	O
nearest	O
monitoring	O
station	O
to	O
the	O
respective	O
delivery	B-T061
hospital	O
of	O
each	O
woman	B-T098
.	O
	
because	O
information	B-T078
on	O
the	O
onset	B-T079
day	I-T079
of	O
abruption	O
was	O
not	O
obtained	O
,	O
we	O
assumed	O
the	O
case	B-T169
day	B-T079
to	O
be	O
1	O
day	B-T079
before	O
the	O
day	O
of	O
delivery	B-T061
.	O
	
exposure	B-T080
to	O
no2	O
at	O
2	O
days'	O
lag	O
was	O
associated	B-T080
with	I-T080
placental	O
abruption	O
temperature	B-T081
adjusted	O
odds	B-T081
ratio	I-T081
per	O
10	O
ppb	O
increase	B-T169
=	O
1.4	O
95%	O
confidence	B-T081
interval	I-T081
=	O
1.1	O
,	O
1.8	O
.	O
	
the	O
association	B-T080
patterns	O
were	O
similar	O
,	O
when	O
we	O
restricted	O
to	O
participants	B-T098
who	O
delivered	B-T061
by	O
emergency	B-T061
cesarean	I-T061
1.4	O
,	O
1.1	O
,	O
1.9	O
,	O
or	O
who	O
delivered	B-T061
after	O
35	B-T079
weeks	I-T079
of	I-T079
gestation	I-T079
1.4	O
,	O
1.0	O
,	O
2.0	O
.	O
	
there	O
was	O
no	B-T033
association	I-T033
with	O
suspended	O
particulate	O
matter	O
,	O
ozone	O
,	O
or	O
so2	O
.	O
	
we	O
observed	O
an	O
association	B-T080
between	O
no2	O
exposure	B-T080
at	O
2	O
days	B-T079
before	O
the	O
day	B-T079
of	O
delivery	B-T061
and	O
placental	O
abruption	O
in	O
pregnant	B-T098
japanese	I-T098
women	I-T098
.	O
	
the	O
2016	O
infusion	B-T061
therapy	I-T061
standards	B-T081
of	O
practice	O
approximately	O
every	O
5	O
years	O
,	O
the	O
infusion	O
nurses	O
society	O
publishes	O
evidence-based	B-T169
practice	I-T169
standards	B-T081
.	O
	
this	O
article	B-T170
provides	O
an	O
overview	O
of	O
the	O
process	O
used	B-T169
in	O
standards	B-T081
development	B-T169
,	O
describes	O
the	O
format	B-T170
of	O
the	O
standards	B-T081
,	O
and	O
provides	B-T052
a	O
short	O
summary	B-T170
of	O
selected	B-T052
standards	B-T081
as	O
applied	B-T169
to	O
home	O
care	O
.	O
	
the	O
standards	B-T081
are	O
an	O
important	B-T080
document	B-T170
that	O
should	O
be	O
available	B-T169
to	O
every	B-T080
home	O
care	O
organization	O
that	O
provides	B-T052
home	B-T061
infusion	I-T061
therapy	I-T061
.	O
	
datasets	B-T170
for	O
the	O
validation	B-T062
of	O
the	O
""""	O
in	B-T082
vivo	I-T082
""""	O
sirna	O
-	O
silencing	O
of	O
cd40	O
and	O
for	O
the	O
detection	B-T061
of	O
new	O
markers	O
of	O
atherosclerosis	B-T047
progression	O
in	O
apoe	O
-	O
deficient	B-T169
mice	O
data	B-T078
presented	O
in	O
this	O
data	B-T078
in	B-T082
brief	O
article	O
correspond	O
to	O
the	O
article	O
""""	O
in	O
vivo	I-T082
""""	O
silencing	O
of	O
cd40	O
reduces	O
progression	O
of	O
experimental	B-T062
atherogenesis	O
through	O
a	O
nfκb	B-T116
/	O
mir-125b	O
axis	O
and	O
reveals	O
new	O
potential	B-T080
mediators	B-T116
in	O
the	O
pathogenesis	O
of	O
atherosclerosis	B-T047
""""	O
m	B-T170
.	O
	
hueso	I-T170
,	O
l	B-T170
.	O
	
de	I-T170
ramon	I-T170
,	O
e	B-T170
.	O
	
navarro	I-T170
,	O
e	B-T170
.	O
	
ripoll	I-T170
,	O
j.m	B-T170
.	O
	
cruzado	I-T170
,	O
j.m	B-T170
.	O
	
grinyo	I-T170
,	O
j	B-T170
.	O
	
torras	I-T170
,	O
2016	O
1	O
.	O
	
here	O
,	O
we	O
describe	O
the	O
validation	B-T062
of	O
the	O
silencing	O
of	O
cd40	O
expression	O
with	O
a	O
specific	O
sirna	O
in	O
apoe	O
mouse	O
aortas	O
,	O
and	O
its	O
systemic	O
effects	O
on	O
splenic	O
lymphocytic	O
subpopulations	O
as	O
well	O
as	O
on	O
the	O
infiltration	O
of	O
aortic	O
intima	O
by	O
f4/80	O
,	O
galectin-3	O
macrophages	O
or	O
by	O
nf-κb	O
cells	O
.	O
	
we	O
also	O
show	O
the	O
output	O
of	O
a	O
gene	B-T170
ontology	I-T170
and	O
tlda	B-T062
analysis	I-T062
which	O
allowed	O
the	O
detection	B-T061
of	O
potential	B-T080
mediators	B-T116
of	O
atherosclerosis	B-T047
progression	O
.	O
	
we	O
provide	O
the	O
scientific	O
community	O
with	O
a	O
set	O
of	O
genes	O
whose	O
expression	O
is	O
increased	B-T081
during	O
atherosclerosis	B-T047
progression	O
but	O
downregulated	O
upon	O
cd40	O
silencing	O
.	O
	
investigation	B-T170
on	O
evaluation	O
criteria	B-T078
of	O
backwashing	O
effects	B-T080
for	O
a	O
pilot-scale	B-T062
baf	O
treating	B-T169
petrochemical	O
wastewater	O
parameters	O
for	O
evaluation	O
criteria	B-T078
of	O
air	O
-	O
water	O
backwashing	O
effect	B-T080
s	O
of	O
a	O
pilot-scale	B-T062
biological	O
aerated	O
filter	O
baf	O
treating	B-T169
petrochemical	O
wastewater	O
were	O
investigated	B-T169
.	O
	
the	O
parameters	O
included	O
the	O
suspended	B-T169
solids	O
ss	O
and	O
specific	B-T033
oxygen	I-T033
uptake	I-T033
rate	I-T033
sour	B-T033
of	O
the	O
backwashing	O
effluent	B-T170
,	O
recovery	B-T052
of	O
the	O
baf	O
after	O
backwashing	O
,	O
and	O
the	O
removal	B-T052
of	O
the	O
biomass	B-T081
/	O
bioactivity	B-T080
attached	O
on	O
the	O
filter	O
media	O
after	O
backwashing	O
.	O
	
results	B-T169
showed	O
that	O
the	O
weight	B-T081
of	O
the	O
total	B-T080
sludge	O
produced	O
in	O
the	O
backwashing	O
effluent	B-T170
increased	B-T081
with	O
the	O
increase	B-T169
in	O
water	O
-	O
backwashing	O
intensity	B-T080
,	O
while	O
the	O
total	B-T080
sour	B-T033
of	O
backwashing	O
effluent	B-T170
rose	O
notably	B-T080
with	O
the	O
increase	B-T169
of	O
air	O
-	O
backwashing	O
intensity	B-T080
.	O
	
the	O
optimal	B-T080
backwashing	O
intensity	B-T080
of	O
14	O
l/	O
for	O
air	O
and	O
4	O
l/	O
for	O
water	O
were	O
obtained	B-T169
.	O
	
when	O
the	O
baf	O
was	O
backwashed	O
on	O
this	O
condition	O
,	O
the	O
baf	O
recovered	B-T080
with	O
high	B-T080
average	B-T081
removal	B-T052
of	O
chemical	O
oxygen	O
demand	O
cod	O
and	O
ammonia	O
nitrogen	O
formula	O
see	O
text	O
of	O
14.3	O
and	O
50.3	O
,	O
respectively	O
.	O
	
high	B-T080
amount	B-T081
of	O
biomass	B-T081
removal	B-T052
at	O
15.8	O
and	O
low	B-T080
level	B-T080
of	O
bioactivity	B-T080
removal	B-T052
at	O
8.8	O
attached	O
on	O
the	O
filter	O
media	O
were	O
also	O
found	O
.	O
	
concentrations	B-T081
of	O
the	O
benzene	B-T109
,	O
toluene	B-T109
,	O
ethylbenzene	B-T109
and	O
o-	B-T109
,	O
m-	I-T109
,	O
p-	I-T109
xylenes	I-T109
btex	B-T109
and	O
phenol	B-T109
in	O
the	O
backwashed	O
sludge	O
were	O
analyzed	B-T062
,	O
showing	O
that	O
the	O
backwashing	O
was	O
essential	B-T080
to	O
remove	B-T052
some	O
aromatic	B-T109
compounds	I-T109
adsorbed	O
in	O
the	O
implementation	B-T052
of	O
infrared	O
and	O
raman	O
modalities	B-T078
for	O
glycosaminoglycan	B-T109
characterization	O
in	O
complex	B-T080
systems	B-T169
glycosaminoglycans	B-T109
gags	B-T109
are	O
natural	B-T169
,	O
linear	B-T082
and	O
negatively	O
charged	O
heteropolysaccharides	B-T109
which	O
are	O
incident	O
in	O
every	O
mammalian	O
tissue	O
.	O
	
they	O
consist	O
of	O
repeating	O
disaccharide	B-T109
units	B-T081
,	O
which	O
are	O
composed	O
of	O
either	O
sulfated	B-T109
or	O
non-sulfated	B-T109
monosaccharides	I-T109
.	O
	
depending	O
on	O
tissue	O
types	B-T080
,	O
gags	B-T109
exhibit	O
structural	B-T082
heterogeneity	B-T080
such	O
as	O
the	O
position	B-T082
and	O
degree	B-T081
of	O
sulfation	O
or	O
within	O
their	O
disaccharide	B-T109
units	B-T081
composition	B-T080
being	O
heparin	B-T109
,	O
heparan	B-T109
sulfate	I-T109
,	O
chondroitine	B-T109
sulfate	I-T109
,	O
dermatan	B-T109
sulfate	I-T109
,	O
keratan	B-T109
sulfate	I-T109
,	O
and	O
hyaluronic	B-T109
acid	I-T109
.	O
	
they	O
are	O
covalently	O
linked	O
to	O
a	O
core	B-T082
protein	B-T116
proteoglycans	B-T116
or	O
as	O
free	B-T080
chains	B-T078
hyaluronan	B-T109
.	O
	
gags	B-T109
affect	O
cell	O
properties	B-T080
and	O
functions	O
either	O
by	O
direct	B-T080
interaction	B-T169
with	O
cell	B-T116
receptors	I-T116
or	O
by	O
sequestration	B-T169
of	O
growth	B-T116
factors	I-T116
.	O
	
these	O
evidences	B-T169
of	I-T169
divert	B-T080
biological	B-T080
roles	O
of	O
gags	B-T109
make	O
their	O
characterization	O
at	O
cell	O
and	O
tissue	O
levels	B-T080
of	O
importance	O
.	O
	
thus	O
,	O
non-invasive	B-T169
techniques	B-T169
are	O
interesting	O
to	O
investigate	B-T169
,	O
to	O
qualitatively	B-T080
and	O
quantitatively	B-T081
characterize	O
gags	B-T109
in	B-T080
vitro	I-T080
in	O
order	O
to	O
use	O
them	O
as	O
diagnostic	B-T169
biomarkers	O
and/or	O
as	O
therapeutic	B-T169
targets	O
in	O
several	O
human	O
diseases	B-T047
including	O
cancer	O
.	O
	
infrared	O
and	O
raman	O
microspectroscopies	O
and	O
imaging	O
are	O
sensitive	B-T169
enough	O
to	O
differentiate	O
and	O
classify	O
gag	B-T109
types	B-T080
and	O
subtypes	O
in	O
spite	O
of	O
their	O
close	O
molecular	B-T082
structures	I-T082
.	O
	
spectroscopic	O
markers	B-T080
characteristic	O
of	O
reference	O
gag	B-T109
molecules	O
were	O
identified	B-T080
.	O
	
beyond	O
these	O
investigations	O
of	O
the	O
standard	O
gag	B-T109
spectral	O
signature	O
,	O
infrared	O
and	O
raman	O
spectral	O
signatures	O
of	O
gag	B-T109
were	O
searched	O
in	O
complex	B-T080
biological	B-T080
systems	B-T169
like	O
cells	O
.	O
	
the	O
aim	O
of	O
the	O
present	O
review	O
is	O
to	O
describe	O
the	O
implementation	B-T052
of	O
these	O
complementary	O
vibrational	O
spectroscopy	O
techniques	O
,	O
and	O
to	O
discuss	O
their	O
potentials	O
,	O
advantages	O
and	O
disadvantages	O
for	O
gag	B-T109
analysis	O
.	O
	
in	O
addition	O
,	O
this	O
review	O
presents	O
new	O
data	O
as	O
we	O
show	O
for	O
the	O
first	O
time	O
gag	B-T109
infrared	O
and	O
raman	O
spectral	O
signatures	O
from	O
conditioned	O
media	O
and	O
live	O
cells	O
,	O
targeting	B-T169
hif2	B-T116
in	O
clear	O
cell	O
renal	O
cell	O
carcinoma	O
inactivation	O
of	O
the	O
von	B-T116
hippel-lindau	I-T116
tumor-suppressor	I-T116
protein	I-T116
pvhl	B-T116
is	O
the	O
signature	B-T033
"""truncal"""	I-T033
event	I-T033
in	O
clear	O
cell	O
renal	O
cell	O
carcinoma	O
,	O
which	O
is	O
the	O
most	O
common	O
form	O
of	O
kidney	O
cancer	O
.	O
	
pvhl	B-T116
is	O
part	O
of	O
a	O
ubiquitin	B-T116
ligase	I-T116
the	O
targets	B-T169
the	O
α	B-T116
subunit	I-T116
of	O
the	O
hypoxia-inducible	B-T116
factor	I-T116
hif	I-T116
transcription	I-T116
factor	I-T116
for	O
destruction	B-T052
when	O
oxygen	O
is	O
available	O
.	O
	
preclinical	B-T080
studies	B-T062
strongly	O
suggest	O
that	O
deregulation	O
of	O
hif	B-T116
,	O
and	O
particularly	O
hif2	B-T116
,	O
drives	O
pvhl	B-T116
-defective	O
renal	O
carcinogenesis	O
.	O
	
although	O
hif2α	B-T116
was	O
classically	O
considered	O
undruggable	B-T080
,	O
structural	O
and	O
chemical	O
work	O
by	O
rick	B-T170
bruick	I-T170
and	O
kevin	B-T170
gardner	I-T170
at	O
university	O
of	O
texas	O
southwestern	O
laid	O
the	O
foundation	O
for	O
the	O
development	O
of	O
small	B-T109
molecule	I-T109
direct	O
hif2α	O
antagonists	O
pt2385	B-T109
and	O
the	O
related	O
tool	O
compound	O
pt2399	O
by	O
peloton	O
therapeutics	O
that	O
block	B-T169
the	O
dimerization	O
of	O
hif2α	B-T116
with	O
its	O
partner	O
protein	B-T116
arnt1	I-T116
.	O
	
these	O
compounds	O
inhibit	O
clear	O
cell	O
renal	O
cell	O
carcinoma	O
growth	O
in	O
preclinical	B-T170
models	I-T170
,	O
and	O
pt2385	B-T109
has	O
now	O
entered	O
the	O
clinic	O
.	O
	
nonetheless	O
,	O
the	O
availability	O
of	O
such	O
compounds	O
,	O
together	O
with	O
clustered	O
regularly	O
interspaced	O
short	O
palindromic	O
repeat	O
crispr	O
gene	O
editing	O
approaches	O
,	O
has	O
revealed	O
a	O
previously	O
unappreciated	B-T080
heterogeneity	I-T080
among	O
clear	O
cell	O
renal	O
carcinomas	O
and	O
patient	O
-derived	O
xenografts	B-T061
with	O
respect	O
to	O
hif2	B-T116
dependence	O
,	O
suggesting	O
that	O
predictive	O
biomarkers	O
will	O
be	O
needed	O
to	O
optimize	B-T052
the	O
use	O
of	O
such	O
agents	O
in	O
the	O
prevalence	B-T081
of	O
high-risk	B-T033
human	B-T047
papillomavirus	I-T047
infection	I-T047
among	O
women	O
in	O
shaanxi	O
province	O
of	O
china	O
a	O
hospital	O
-based	O
investigation	O
this	O
study	O
aimed	O
to	O
investigate	B-T169
the	O
characteristics	B-T080
of	O
female	O
high-risk	B-T047
human	I-T047
papillomavirus	I-T047
hr-hpv	I-T047
infection	I-T047
in	O
shaanxi	O
province	O
of	O
china	O
.	O
	
a	O
total	O
of	O
14	O
111	O
women	O
were	O
enrolled	O
for	O
hpv	O
genotyping	O
test	O
,	O
and	O
a	O
cytology	O
,	O
and/or	O
cervix	O
biopsy	O
were	O
performed	O
in	O
partial	O
women	O
.	O
	
of	O
these	O
women	O
,	O
the	O
hpv	B-T047
infection	I-T047
rate	B-T081
was	O
30.21	O
,	O
and	O
26.73	O
were	O
caused	O
by	O
hr-hpv	O
.	O
	
the	O
most	O
common	O
hr-hpv	O
genotypes	O
were	O
hpv-16	O
,	O
hpv-58	O
,	O
hpv-52	O
,	O
hpv-18	O
,	O
and	O
hpv-31	O
.	O
	
the	O
prevalence	B-T081
of	O
hr-hpv	O
among	O
women	O
older	O
than	O
50	O
years	O
was	O
significantly	O
higher	O
than	O
the	O
other	O
groups	O
p	O
<	O
0.05	O
.	O
	
the	O
main	O
carcinogenic	O
genotypes	O
were	O
hpv-16	O
,	O
hpv-18	O
,	O
hpv-58	O
,	O
hpv-52	O
,	O
and	O
hpv-31	O
.	O
	
hpv-16	O
and	O
hpv-18	O
combined	O
caused	O
80.79	O
of	O
cervical	O
cancer	O
cases	O
.	O
	
the	O
infection	O
with	O
multiple	O
hr-hpvs	O
was	O
not	B-T033
a	O
risk	B-T033
factor	I-T033
for	O
cervical	O
lesions	O
.	O
	
in	O
conclusion	O
,	O
hpv	B-T047
infection	I-T047
was	O
common	O
among	O
women	O
in	O
shaanxi	O
province	O
.	O
	
women	O
older	O
than	O
50	O
years	O
were	O
a	O
high-risk	B-T098
group	I-T098
for	O
hr-hpv	B-T047
infection	I-T047
and	O
cervical	O
cancer	O
.	O
	
hpv-16	O
and	O
hpv-18	O
were	O
the	O
main	O
carcinogenic	O
genotypes	O
in	O
this	O
novel	B-T080
and	O
lost	B-T169
forests	O
in	O
the	O
upper	O
midwestern	O
united	O
states	O
,	O
from	O
new	B-T080
estimates	B-T081
of	O
settlement-era	B-T079
composition	O
,	O
stem	O
density	B-T081
,	O
and	O
biomass	B-T081
euroamerican	B-T098
land-use	O
and	O
its	O
legacies	B-T081
have	O
transformed	B-T081
forest	O
structure	O
and	O
composition	O
across	O
the	O
united	O
states	O
us	O
.	O
	
more	B-T081
accurate	B-T080
reconstructions	B-T052
of	O
historical	O
states	O
are	O
critical	B-T080
to	O
understanding	O
the	O
processes	O
governing	B-T080
past	B-T079
,	O
current	B-T079
,	O
and	O
future	B-T079
forest	O
dynamics	O
.	O
	
here	O
we	O
present	O
new	O
gridded	O
8x8km	O
reconstructions	B-T052
of	O
pre-settlement	B-T079
1800s	O
forest	O
composition	O
and	O
structure	O
from	O
the	O
upper	O
midwestern	O
us	O
minnesota	O
,	O
wisconsin	O
,	O
and	O
most	O
of	O
michigan	O
,	O
using	O
19th	O
century	B-T170
public	I-T170
land	I-T170
survey	I-T170
system	I-T170
plss	B-T170
,	O
with	O
estimates	B-T081
of	O
relative	B-T080
composition	O
,	O
above-ground	B-T082
biomass	B-T081
,	O
stem	O
density	B-T081
,	O
and	O
basal	B-T082
area	I-T082
for	O
28	O
tree	O
types	B-T080
.	O
	
this	O
mapping	B-T052
is	O
more	O
robust	B-T080
than	O
past	B-T079
efforts	O
,	O
using	O
spatially	O
varying	O
correction	B-T081
factors	I-T081
to	O
accommodate	O
sampling	B-T170
design	I-T170
,	O
azimuthal	B-T080
censoring	I-T080
,	O
and	O
biases	B-T078
in	O
tree	O
selection	B-T052
.	O
	
we	O
compare	O
pre-settlement	B-T079
to	O
modern	B-T079
forests	O
using	O
us	O
forest	O
service	O
forest	B-T170
inventory	I-T170
and	I-T170
analysis	I-T170
fia	I-T170
data	I-T170
to	O
show	O
the	O
prevalence	B-T081
of	O
lost	B-T169
forests	O
pre-settlement	B-T079
forests	O
with	O
no	B-T169
current	B-T079
analog	B-T080
,	O
and	O
novel	B-T080
forests	O
modern	B-T079
forests	O
with	O
no	B-T169
past	B-T079
analogs	B-T080
.	O
	
differences	O
between	O
pre-settlement	B-T079
and	O
modern	B-T079
forests	O
are	O
spatially	O
structured	O
owing	O
to	O
differences	O
in	O
land-use	O
impacts	B-T080
and	O
accompanying	O
ecological	O
responses	O
.	O
	
modern	B-T079
forests	O
are	O
more	O
homogeneous	B-T080
,	O
and	O
ecotonal	B-T081
gradients	B-T081
are	O
more	O
diffuse	B-T082
today	O
than	O
in	B-T079
the	I-T079
past	I-T079
.	O
	
novel	B-T080
forest	O
assemblages	B-T169
represent	O
28%	O
of	O
all	O
fia	B-T170
cells	O
,	O
and	O
28%	O
of	O
pre-settlement	B-T079
forests	O
no	B-T033
longer	I-T033
exist	O
in	O
a	O
modern	B-T079
context	B-T078
.	O
	
lost	B-T169
forests	O
include	O
tamarack	O
forests	O
in	O
northeastern	B-T082
minnesota	O
,	O
hemlock	O
and	O
cedar	O
dominated	O
forests	O
in	O
north-central	O
wisconsin	O
and	O
along	O
the	O
upper	O
peninsula	O
of	O
michigan	O
,	O
and	O
elm	O
,	O
oak	O
,	O
basswood	O
and	O
ironwood	O
forests	O
along	O
the	O
forest	O
-	O
prairie	B-T082
boundary	I-T082
in	O
south	O
central	O
minnesota	O
and	O
eastern	B-T082
wisconsin	O
.	O
	
novel	B-T080
fia	B-T170
forest	O
assemblages	B-T169
are	O
distributed	O
evenly	O
across	O
the	O
region	O
,	O
but	O
novelty	B-T080
shows	O
a	O
strong	B-T080
relationship	B-T080
to	O
spatial	B-T081
distance	I-T081
from	O
remnant	B-T080
forests	O
in	O
the	O
upper	O
midwest	O
,	O
with	O
novelty	B-T080
predicted	B-T078
at	O
between	O
20	O
to	O
60km	O
from	O
remnants	B-T080
,	O
depending	O
on	O
historical	B-T079
forest	O
type	O
.	O
	
the	O
spatial	B-T082
relationships	B-T080
between	O
remnant	B-T080
and	O
novel	B-T080
forests	O
,	O
shifts	B-T169
in	O
ecotone	B-T082
structure	I-T082
and	O
the	O
loss	B-T081
of	O
historic	B-T079
forest	O
types	O
point	O
to	O
significant	B-T078
challenges	O
for	O
land	O
managers	O
if	O
landscape	B-T082
restoration	O
is	O
a	O
priority	B-T079
.	O
	
the	O
spatial	O
signals	O
of	O
novelty	B-T080
and	O
ecological	O
change	B-T169
also	O
point	O
to	O
potential	B-T080
challenges	O
in	O
using	O
modern	B-T079
spatial	B-T082
distributions	I-T082
of	O
species	O
and	O
communities	O
and	O
their	O
relationship	B-T080
to	O
underlying	O
geophysical	O
and	O
climatic	O
attributes	O
in	O
understanding	O
potential	B-T080
responses	O
to	O
changing	B-T169
climate	O
.	O
	
the	O
signal	O
of	O
human	O
settlement	B-T052
on	O
modern	B-T079
forests	O
is	O
broad	B-T082
,	O
spatially	O
varying	O
and	O
acts	O
to	O
homogenize	B-T080
modern	B-T079
forests	O
relative	B-T080
to	O
their	O
historic	B-T079
counterparts	O
,	O
with	O
significant	B-T078
implications	O
for	O
future	B-T079
management	O
.	O
	
prevalence	B-T081
of	O
self-reported	B-T062
prescription	O
drug	O
use	B-T169
in	O
a	O
national	B-T082
sample	O
of	O
u.s	O
.	O
	
drivers	B-T098
drug	O
-involved	O
driving	O
has	O
become	O
an	O
increasing	B-T169
concern	B-T078
.	O
	
although	O
the	O
focus	O
has	O
been	O
on	O
illegal	O
drugs	O
,	O
there	O
is	O
evidence	B-T078
that	O
prescribed	O
medications	O
can	O
impair	B-T033
driving	I-T033
ability	I-T033
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
self-reported	B-T062
prevalence	B-T081
of	O
prescription	O
drug	O
use	B-T169
,	O
including	O
medical	B-T169
and	O
nonmedical	B-T033
use	B-T169
,	O
among	O
a	O
nationally	B-T082
representative	B-T052
sample	O
of	O
drivers	B-T098
and	O
to	O
report	O
related	O
driver	B-T098
characteristics	B-T080
.	O
	
as	O
part	O
of	O
the	O
2013-2014	O
national	B-T062
roadside	I-T062
survey	I-T062
,	O
drivers	B-T098
from	O
60	O
sites	O
were	O
randomly	B-T080
recruited	O
and	O
asked	O
to	O
complete	B-T080
a	O
survey	B-T062
on	O
prescription	O
drug	O
use	B-T169
.	O
	
almost	O
20%	O
of	O
drivers	B-T098
reported	O
using	O
a	O
prescription	O
drug	O
within	O
the	O
past	B-T079
2	O
days	B-T079
,	O
with	O
the	O
most	O
common	O
drug	O
class	O
being	O
sedatives	O
8.0	O
,	O
followed	O
by	O
antidepressants	O
7.7	O
,	O
narcotics	O
7.5	O
,	O
and	O
stimulants	O
3.9	O
.	O
	
drivers	B-T098
who	O
reported	O
prescription	O
drug	O
use	B-T169
were	O
significantly	O
more	O
likely	O
to	O
be	O
female	O
,	O
older	B-T098
,	O
non-hispanic	B-T098
white	I-T098
,	O
and	O
report	O
disability	B-T033
.	O
	
three	O
of	O
four	O
drivers	B-T098
who	O
reported	O
medication	O
use	B-T169
78.2	O
said	O
the	O
drug	O
was	O
prescribed	O
for	O
their	O
use	B-T169
the	O
odds	O
of	O
using	O
without	O
a	O
prescription	B-T170
were	O
significantly	B-T081
higher	I-T081
for	O
males	O
,	O
black/african	B-T098
american	I-T098
,	O
and	O
hispanic	B-T098
drivers	B-T098
,	O
and	O
lower	O
for	O
older	B-T098
drivers	B-T098
.	O
	
among	O
those	O
with	O
a	O
prescription	B-T170
,	O
taking	O
more	O
than	O
prescribed	O
was	O
most	O
common	O
for	O
narcotics	O
6.8	O
,	O
followed	O
by	O
sedatives	O
4.8	O
,	O
stimulants	O
3.8	O
,	O
and	O
antidepressants	O
1.5	O
.	O
	
these	O
findings	B-T169
help	O
to	O
identify	O
drivers	B-T098
using	O
potentially	B-T169
impairing	I-T169
prescription	O
drugs	O
,	O
both	O
medically	B-T169
and	O
nonmedically	B-T033
,	O
and	O
may	O
inform	O
the	O
targeting	B-T169
of	O
interventions	O
to	O
reduce	O
impaired	B-T033
driving	I-T033
related	O
to	O
repetitive	B-T079
and	O
prolonged	B-T079
omega-3	B-T109
fatty	I-T109
acid	I-T109
treatment	B-T061
after	B-T079
traumatic	O
brain	O
injury	O
enhances	B-T052
long-term	B-T079
tissue	O
restoration	B-T061
and	O
cognitive	B-T061
recovery	I-T061
traumatic	O
brain	O
injury	O
tbi	O
is	O
one	O
of	O
the	O
most	O
disabling	B-T033
clinical	I-T033
conditions	I-T033
that	O
could	O
lead	B-T169
to	O
neurocognitive	O
disorders	O
in	O
survivors	O
.	O
	
our	O
group	B-T098
and	O
others	B-T098
previously	O
reported	B-T170
that	O
prophylactic	B-T061
enrichment	I-T061
of	O
dietary	B-T169
omega-3	B-T109
polyunsaturated	I-T109
fatty	I-T109
acids	I-T109
n-3	B-T109
pufas	I-T109
markedly	O
ameliorate	B-T169
cognitive	O
deficits	O
after	B-T079
tbi	O
.	O
	
however	O
,	O
it	O
remains	O
unclear	B-T033
whether	O
a	O
clinically	B-T080
relevant	B-T080
therapeutic	B-T061
regimen	I-T061
with	O
n-3	B-T109
pufas	I-T109
administered	B-T169
after	B-T079
tbi	O
would	O
still	O
offer	O
significant	O
improvement	O
of	O
long-term	B-T079
cognitive	B-T061
recovery	I-T061
.	O
	
in	O
the	O
present	O
study	B-T062
,	O
we	O
employed	O
the	O
decline	B-T080
of	O
spatial	O
cognitive	O
function	O
as	O
a	O
main	B-T080
outcome	B-T169
after	B-T079
tbi	O
to	O
investigate	B-T169
the	O
therapeutic	B-T080
efficacy	I-T080
of	O
post	B-T079
-	O
tbi	O
n-3	B-T109
pufa	I-T109
treatment	B-T061
and	O
the	O
underlying	O
mechanisms	B-T169
.	O
	
mice	O
were	O
subjected	O
to	O
sham	B-T061
operation	I-T061
or	O
controlled	B-T169
cortical	O
impact	B-T080
,	O
followed	O
by	O
random	O
assignment	O
to	O
receive	B-T080
the	O
following	O
four	B-T081
treatments	B-T061
1	O
vehicle	O
control	B-T169
2	O
daily	B-T079
intraperitoneal	B-T061
injections	I-T061
of	O
n-3	B-T109
pufas	I-T109
for	O
2	O
weeks	B-T079
,	O
beginning	B-T079
2	O
h	B-T079
after	B-T079
tbi	O
3	O
fish	O
oil	O
dietary	O
supplementation	B-T061
throughout	O
the	O
study	B-T062
,	O
beginning	B-T079
1	O
day	B-T079
after	B-T079
tbi	O
or	O
4	O
combination	B-T080
of	O
treatments	B-T061
2	O
and	O
3	O
.	O
	
spatial	O
cognitive	O
deficits	O
and	O
chronic	B-T079
brain	O
tissue	O
loss	B-T081
,	O
as	O
well	O
as	O
endogenous	B-T169
brain	B-T061
repair	I-T061
processes	I-T061
such	O
as	O
neurogenesis	O
,	O
angiogenesis	O
,	O
and	O
oligodendrogenesis	O
,	O
were	O
evaluated	O
up	O
to	O
35	O
days	B-T079
after	B-T079
tbi	O
.	O
	
the	O
results	B-T169
revealed	B-T080
prominent	O
spatial	O
cognitive	O
deficits	O
and	O
massive	B-T080
tissue	O
loss	B-T081
caused	O
by	O
tbi	O
.	O
	
among	O
all	O
mice	O
receiving	B-T080
post-tbi	O
n-3	B-T109
pufa	I-T109
treatments	B-T061
,	O
the	O
combined	B-T080
treatment	B-T061
of	O
fish	O
oil	O
dietary	O
supplement	O
and	O
n-3	B-T109
pufa	I-T109
injections	O
demonstrated	B-T052
a	O
reproducible	O
beneficial	O
effect	O
in	O
attenuating	O
cognitive	O
deficits	O
although	O
without	O
reducing	B-T080
gross	B-T080
tissue	O
loss	B-T081
.	O
	
mechanistically	O
,	O
the	O
combined	O
treatment	B-T061
promoted	B-T052
post-tbi	O
restorative	B-T061
processes	I-T061
in	O
the	O
brain	O
,	O
including	B-T169
generation	O
of	O
immature	O
neurons	O
,	O
microvessels	O
,	O
and	O
oligodendrocytes	O
,	O
each	O
of	O
which	O
was	O
significantly	O
correlated	B-T080
with	O
the	O
improved	B-T033
cognitive	B-T169
recovery	I-T169
.	O
	
these	O
results	B-T169
indicated	B-T033
that	O
repetitive	B-T079
and	O
prolonged	B-T079
n-3	B-T109
pufa	I-T109
treatments	B-T061
after	B-T079
tbi	O
are	O
capable	O
of	O
enhancing	B-T052
brain	O
remodeling	O
and	O
could	O
be	O
developed	O
as	O
a	O
potential	B-T080
therapy	B-T061
to	O
treat	O
tbi	O
victims	B-T098
in	O
the	O
influence	O
of	O
yeast	O
and	O
lactic	O
acid	O
bacterium	O
on	O
the	O
constituent	O
profile	O
of	O
soy	O
sauce	O
during	B-T079
fermentation	O
soy	O
sauce	O
is	O
a	O
japanese	O
traditional	B-T169
seasoning	O
composed	B-T081
of	O
various	B-T081
constituents	O
that	O
are	O
produced	O
by	O
various	O
microbes	O
during	B-T079
a	O
long-term	B-T079
fermentation	O
process	O
.	O
	
due	B-T169
to	I-T169
the	O
complexity	B-T169
of	O
the	O
process	O
,	O
the	O
investigation	B-T062
of	O
the	O
constituent	O
profile	O
during	B-T079
fermentation	O
is	O
difficult	B-T033
.	O
	
metabolomics	O
,	O
the	O
comprehensive	B-T080
study	B-T062
of	O
low	B-T080
molecular	B-T081
weight	I-T081
compounds	B-T080
in	O
biological	B-T080
samples	O
,	O
is	O
thought	O
to	O
be	O
a	O
promising	O
strategy	O
for	O
deep	O
understanding	O
of	O
the	O
constituent	O
contribution	B-T052
to	O
food	B-T080
flavor	I-T080
characteristics	B-T080
.	O
	
therefore	O
,	O
metabolomics	O
is	O
suitable	B-T080
for	O
the	O
analysis	B-T062
of	O
soy	O
sauce	O
fermentation	O
.	O
	
unfortunately	O
,	O
only	O
few	O
and	O
unrefined	O
studies	B-T062
of	O
soy	O
sauce	O
fermentation	O
using	B-T169
metabolomics	O
approach	B-T082
have	O
been	O
reported	B-T170
.	O
	
therefore	O
,	O
we	O
investigated	B-T169
changes	B-T169
in	O
low	B-T080
molecular	B-T081
weight	I-T081
hydrophilic	B-T081
and	O
volatile	O
compounds	O
of	O
soy	O
sauce	O
using	O
gas	O
chromatography/mass	O
spectrometry	O
gc/ms	O
based	B-T169
non-targeted	B-T169
metabolic	O
profiling	O
.	O
	
the	O
data	B-T078
were	O
analyzed	B-T062
by	O
statistical	B-T062
analysis	I-T062
to	O
evaluate	O
influences	O
of	O
yeast	O
and	O
lactic	O
acid	O
bacterium	O
on	O
the	O
constituent	O
profile	O
.	O
	
consequently	O
,	O
our	O
results	B-T169
suggested	B-T078
a	O
novel	B-T080
finding	B-T033
that	O
lactic	O
acid	O
bacterium	O
affected	B-T169
the	O
production	O
of	O
several	B-T081
constituents	O
such	O
as	O
cyclotene	B-T109
,	O
furfural	B-T109
,	O
furfuryl	B-T109
alcohol	I-T109
and	O
methional	B-T109
in	O
the	O
soy	O
sauce	O
fermentation	O
process	O
.	O
	
low	B-T080
intensity	B-T080
sprint	B-T061
training	I-T061
with	O
blood	O
flow	O
restriction	O
improves	O
100	O
m	O
dash	O
we	O
investigated	B-T169
the	O
effects	B-T080
of	I-T080
practical	O
blood	O
flow	O
restriction	O
pbfr	O
of	O
leg	O
muscles	O
during	O
sprint	B-T061
training	I-T061
on	O
the	O
100	O
m	O
dash	O
time	B-T079
in	O
well-trained	B-T098
sport	I-T098
students	I-T098
.	O
	
participants	B-T098
performed	O
6x100	O
m	O
sprints	O
at	O
60-70%	O
of	O
their	O
maximal	O
100	O
m	O
sprinting	B-T081
speed	I-T081
twice	B-T079
a	I-T079
week	I-T079
for	O
6	O
weeks	B-T079
,	O
either	O
with	O
ig	B-T098
n=12	O
or	O
without	O
pbfr	O
cg	O
n=12	O
.	O
	
the	O
100	O
m	O
dash	O
time	B-T079
significantly	O
decreased	B-T081
more	O
in	O
the	O
ig	B-T098
-0	O
s	O
than	O
in	O
the	O
cg	O
-0	O
s	O
.	O
	
the	O
muscle	O
thickness	B-T080
of	O
the	O
rectus	O
femoris	O
increased	B-T081
only	O
in	O
the	O
ig	B-T098
,	O
while	O
no	O
group	B-T078
by	O
time	B-T079
interactions	B-T169
were	O
found	O
for	O
the	O
muscle	O
thickness	B-T080
of	O
the	O
biceps	O
femoris	O
and	O
the	O
biceps	O
brachii	O
.	O
	
the	O
maximal	B-T081
isometric	I-T081
force	I-T081
,	O
measured	O
using	O
a	O
leg	O
press	O
,	O
did	O
not	B-T033
change	I-T033
in	O
either	O
group	B-T078
.	O
	
however	O
,	O
the	O
rate	B-T081
of	I-T081
force	I-T081
development	I-T081
improved	O
in	O
the	O
ig	B-T098
.	O
	
growth	B-T116
hormone	I-T116
,	O
testosterone	B-T109
,	O
insulin-like	B-T116
growth	I-T116
factor	I-T116
1	I-T116
,	O
and	O
cortisol	B-T109
concentrations	B-T081
did	O
not	B-T033
significantly	I-T033
differ	I-T033
between	O
both	O
groups	B-T078
at	O
any	O
measurement	B-T169
time	B-T079
point	I-T079
pre	O
,	O
1	O
min	O
,	O
20	O
min	O
,	O
120	O
min	O
,	O
and	O
24	O
h	O
after	O
the	O
six	O
all-out	O
sprints	O
of	O
the	O
first	O
training	O
session	O
.	O
	
the	O
muscle	O
damage	O
marker	O
h-fabp	B-T116
increased	B-T081
significantly	O
more	O
in	O
the	O
cg	O
than	O
in	O
the	O
ig	B-T098
.	O
	
the	O
pbfr	O
improved	O
the	O
100	O
m	O
dash	O
time	B-T079
significantly	O
more	O
than	O
low	B-T080
-	O
intensity	B-T080
sprint	B-T061
interval	I-T061
training	I-T061
alone	O
.	O
	
other	O
noted	O
benefits	B-T081
of	O
training	O
with	O
pbfr	O
were	O
a	O
decreased	B-T081
level	B-T080
of	O
muscle	O
damage	O
,	O
a	O
greater	O
increase	B-T169
of	O
the	O
rectus	O
femoris	O
muscle	O
thickness	B-T080
,	O
and	O
a	O
higher	B-T080
rate	B-T081
of	I-T081
force	I-T081
development	I-T081
.	O
	
however	O
,	O
the	O
tested	B-T169
hormones	O
were	O
unable	O
to	O
explain	O
the	O
additional	O
beneficial	B-T080
effects	I-T080
.	O
	
sedation	B-T061
of	O
patients	O
with	O
disorders	O
of	O
consciousness	O
during	O
neuroimaging	O
effects	O
on	O
resting	O
state	O
functional	O
brain	O
connectivity	O
to	O
reduce	O
head	O
movement	O
during	O
resting	O
state	O
functional	O
magnetic	O
resonance	O
imaging	O
,	O
post-coma	O
patients	O
with	O
disorders	O
of	O
consciousness	O
doc	O
are	O
frequently	O
sedated	B-T061
with	O
propofol	B-T109
.	O
	
however	O
,	O
little	O
is	O
known	O
about	O
the	O
effects	O
of	O
this	O
sedation	B-T061
on	O
the	O
brain	B-T082
connectivity	I-T082
patterns	I-T082
in	O
the	O
damaged	O
brain	O
essential	O
for	O
differential	O
diagnosis	O
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
aimed	O
to	O
assess	O
these	O
effects	O
.	O
	
using	O
resting	O
state	O
functional	O
magnetic	O
resonance	O
imaging	O
3t	O
data	O
obtained	O
over	O
several	O
years	O
of	O
scanning	O
patients	O
for	O
diagnostic	B-T169
and	O
research	B-T062
purposes	B-T169
,	O
we	O
employed	O
a	O
seed-based	O
approach	O
to	O
examine	O
resting	B-T169
state	I-T169
connectivity	I-T169
in	O
higher-order	O
default	O
mode	O
,	O
bilateral	B-T082
external	O
control	O
,	O
and	O
salience	O
and	O
lower-order	O
auditory	B-T169
,	O
sensorimotor	O
,	O
and	O
visual	B-T169
resting	B-T169
state	I-T169
networks	I-T169
and	O
connectivity	B-T169
with	O
the	O
thalamus	O
,	O
in	O
20	O
healthy	B-T080
unsedated	B-T033
controls	O
,	O
8	O
unsedated	B-T033
patients	O
with	O
doc	O
,	O
and	O
8	O
patients	O
with	O
doc	O
sedated	B-T061
with	O
propofol	B-T109
.	O
	
the	O
doc	O
groups	O
were	O
matched	O
for	O
age	B-T081
at	I-T081
onset	I-T081
,	O
etiology	B-T169
,	O
time	B-T033
spent	I-T033
in	O
doc	O
,	O
diagnosis	B-T033
,	O
standardized	B-T081
behavioral	I-T081
assessment	I-T081
scores	I-T081
,	O
movement	O
intensities	B-T080
,	O
and	O
pattern	O
of	O
structural	O
brain	O
injury	O
as	O
assessed	O
with	O
t1-based	O
voxel-based	O
morphometry	O
.	O
	
doc	O
were	O
associated	B-T080
with	I-T080
severely	O
impaired	O
resting	B-T169
state	I-T169
network	I-T169
connectivity	I-T169
in	O
all	O
but	O
the	O
visual	B-T169
network	B-T169
.	O
	
thalamic	O
connectivity	B-T169
to	O
higher-order	O
network	O
regions	O
was	O
also	O
reduced	B-T080
.	O
	
propofol	B-T109
administration	B-T061
to	O
patients	O
was	O
associated	B-T080
with	I-T080
minor	O
further	O
decreases	B-T081
in	O
thalamic	O
and	O
insular	O
connectivity	B-T169
.	O
	
our	O
findings	B-T169
indicate	O
that	O
connectivity	B-T169
decreases	B-T081
associated	B-T080
with	I-T080
propofol	B-T109
sedation	B-T061
,	O
involving	O
the	O
thalamus	O
and	O
insula	O
,	O
are	O
relatively	O
small	O
compared	O
with	O
those	O
already	O
caused	O
by	O
doc	O
-associated	O
structural	O
brain	O
injury	O
.	O
	
nonetheless	O
,	O
given	O
the	O
known	O
importance	O
of	O
the	O
thalamus	O
in	O
brain	O
arousal	O
,	O
its	O
disruption	B-T169
could	O
well	O
reflect	O
the	O
diminished	B-T081
movement	O
obtained	O
in	O
these	O
patients	O
.	O
	
however	O
,	O
more	O
research	B-T062
is	O
needed	O
on	O
this	O
topic	O
to	O
fully	O
address	O
the	O
research	B-T078
question	I-T078
.	O
	
potassium	B-T047
depletion	I-T047
stimulates	O
na-cl	B-T116
cotransporter	I-T116
via	O
phosphorylation	O
and	O
inactivation	B-T169
of	O
the	O
ubiquitin	B-T116
ligase	I-T116
kelch-like	B-T116
3	I-T116
kelch-like	B-T116
3	I-T116
klhl3	B-T116
is	O
a	O
component	B-T116
of	O
an	O
e3	B-T116
ubiquitin	I-T116
ligase	I-T116
complex	I-T116
that	O
regulates	O
blood	O
pressure	O
by	O
targeting	B-T169
with-no-lysine	B-T116
wnk	I-T116
kinases	I-T116
for	O
degradation	B-T169
.	O
	
mutations	O
in	O
klhl3	B-T116
cause	O
constitutively	O
increased	B-T033
renal	I-T033
salt	I-T033
reabsorption	I-T033
and	O
impaired	B-T169
k	O
secretion	O
,	O
resulting	O
in	O
hypertension	B-T047
and	O
hyperkalemia	B-T033
.	O
	
although	O
clinical	B-T062
studies	I-T062
have	O
shown	O
that	O
dietary	O
k	O
intake	B-T169
affects	B-T169
blood	O
pressure	O
,	O
the	O
mechanisms	B-T169
have	O
been	O
obscure	B-T033
.	O
	
in	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
the	O
klhl3	B-T116
ubiquitin	B-T116
ligase	I-T116
complex	B-T116
is	O
involved	O
in	O
the	O
low-	O
k	O
-mediated	O
activation	O
of	O
na-cl	B-T116
cotransporter	I-T116
ncc	B-T116
in	O
the	O
kidney	O
.	O
	
in	O
the	O
distal	O
convoluted	O
tubules	O
of	O
mice	O
eating	O
a	O
low-k	B-T061
diet	I-T061
,	O
we	O
found	O
increased	O
klhl3	B-T116
phosphorylation	O
at	O
s433	B-T082
klhl3	B-T116
,	O
a	O
modification	B-T033
that	O
impairs	B-T169
wnk	B-T116
binding	B-T052
,	O
and	O
also	O
reduced	O
total	O
klhl3	B-T116
levels	B-T080
.	O
	
these	O
changes	O
are	O
accompanied	O
by	O
the	O
accumulation	B-T033
of	O
the	O
target	B-T169
substrate	O
wnk4	B-T116
,	O
and	O
activation	O
of	O
the	O
downstream	B-T082
kinases	B-T116
spak	I-T116
ste20	B-T116
/	O
sps1	B-T116
-related	O
proline-alanine-rich	B-T116
protein	I-T116
kinase	I-T116
and	O
osr1	B-T116
oxidative	B-T116
stress-responsive	I-T116
1	I-T116
,	O
resulting	O
in	O
ncc	B-T116
phosphorylation	O
and	O
its	O
accumulation	B-T033
at	O
the	O
plasma	O
membrane	O
.	O
	
increased	O
phosphorylation	O
of	O
s433	B-T082
was	O
explained	O
by	O
increased	O
levels	B-T080
of	O
active	B-T169
,	O
phosphorylated	O
protein	B-T116
kinase	I-T116
c	I-T116
but	O
not	O
protein	B-T116
kinase	I-T116
a	I-T116
,	O
which	O
directly	O
phosphorylates	O
s433	B-T082
.	O
	
moreover	O
,	O
in	O
hek	O
cells	O
expressing	O
klhl3	B-T116
and	O
wnk4	B-T116
,	O
we	O
showed	O
that	O
the	O
activation	O
of	O
protein	B-T116
kinase	I-T116
c	I-T116
by	O
phorbol	B-T109
12-myristate	I-T109
13-acetate	I-T109
induces	B-T169
klhl3	B-T116
and	O
increases	O
wnk4	B-T116
levels	B-T080
by	O
abrogating	O
its	O
ubiquitination	O
.	O
	
these	O
data	B-T078
demonstrate	O
the	O
role	O
of	O
klhl3	B-T116
in	O
low-	O
k	O
-mediated	O
induction	B-T169
of	O
ncc	B-T116
this	O
physiologic	O
adaptation	O
reduces	O
distal	B-T082
electrogenic	O
na	O
reabsorption	O
,	O
preventing	B-T169
further	O
renal	O
k	O
loss	B-T081
but	O
promoting	B-T052
increased	O
blood	O
pressure	O
.	O
	
the	O
relationship	B-T080
between	O
thoracic	O
configuration	O
and	O
changes	B-T169
in	O
volumes	B-T081
of	O
hemithoraces	O
in	O
upright	B-T033
sitting	I-T033
purpose	O
some	O
patients	O
with	O
respiratory	B-T047
disease	I-T047
exhibit	O
asymmetrical	B-T033
movement	I-T033
of	I-T033
the	I-T033
thorax	I-T033
.	O
	
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	B-T169
the	O
relationship	B-T080
of	O
thoracic	O
configuration	O
with	O
changes	B-T169
in	O
thoracic	O
volume	O
in	O
13	O
sedentary	B-T080
healthy	B-T080
men	B-T098
.	O
	
subjects	O
and	O
methods	O
in	O
upright	B-T033
sitting	I-T033
,	O
84	O
reflective	B-T080
markers	I-T080
were	O
placed	O
on	O
the	O
anterior	B-T082
and	O
posterior	B-T082
aspects	B-T080
of	O
the	O
trunk	O
to	O
record	O
thoracic	O
volume	O
during	O
quiet	B-T080
and	O
volitional	O
deep	B-T033
breathing	I-T033
.	O
	
using	O
a	O
three-dimensional	O
motion	O
analyzer	O
,	O
the	O
difference	B-T081
in	O
volume	B-T081
within	O
the	O
upper	B-T082
and	O
lower	B-T082
hemithoraces	O
was	O
measured	B-T080
.	O
	
for	O
calculation	B-T052
of	O
the	O
thoracic	O
volume	O
six	O
imaginary	B-T082
hexahedra	I-T082
were	O
visualized	O
for	O
the	O
upper	B-T082
and	O
lower	B-T082
thorax	O
using	O
four	O
reflective	B-T080
markers	I-T080
for	O
each	O
on	O
the	O
anterior	B-T082
and	O
posterior	B-T082
aspects	B-T080
of	O
the	O
thorax	O
.	O
	
each	O
hexahedron	B-T082
was	O
then	O
divided	O
into	O
three	O
imaginary	B-T082
triangular	I-T082
pyramids	I-T082
to	O
calculate	B-T052
positional	B-T033
vectors	B-T082
.	O
	
finally	O
,	O
the	O
volume	B-T081
for	O
both	O
the	O
hexahedra	B-T082
and	O
triangular	B-T082
pyramids	I-T082
was	O
calculated	B-T052
.	O
	
four	O
thoracic	O
volumes	O
were	O
obtained	O
.	O
	
results	O
the	O
findings	B-T169
showed	O
that	O
the	O
left	B-T082
upper	B-T082
and	O
right	B-T082
lower	B-T082
hemithorax	O
yielded	O
significantly	O
larger	B-T081
thoracic	O
volumes	O
.	O
	
conclusion	O
in	O
conclusion	B-T078
the	O
left	B-T082
upper	B-T082
and	O
right	B-T082
lower	B-T082
hemithoraces	O
were	O
found	O
to	O
expand	B-T082
more	O
than	O
their	O
corresponding	O
sides	B-T082
.	O
	
understanding	O
the	O
characteristics	B-T080
of	O
thoracic	O
excursion	O
during	O
quiet	B-T080
and	O
volitional	O
deep	B-T033
breathing	I-T033
could	O
be	O
of	O
value	B-T080
in	O
assessment	O
and	O
instruction	B-T170
of	O
breathing	O
techniques	O
to	O
development	B-T169
of	O
the	O
four-item	O
letter	O
and	O
shape	O
drawing	O
test	O
lsd-4	O
a	O
brief	O
bedside	O
test	O
of	O
visuospatial	O
function	O
conventional	B-T080
bedside	O
tests	O
of	O
visuospatial	O
function	O
such	O
as	O
the	O
clock	O
drawing	O
cdt	O
and	O
intersecting	O
pentagons	O
ipt	O
lack	B-T080
consistency	B-T080
in	O
delivery	O
and	O
interpretation	B-T033
.	O
	
we	O
compared	B-T052
performance	B-T052
on	O
a	O
novel	O
test	O
of	O
visuospatial	O
ability	O
-	O
the	O
lsd	O
-	O
with	O
the	O
ipt	O
,	O
cdt	O
and	O
mmse	O
in	O
180	O
acute	B-T079
elderly	B-T098
medical	B-T169
inpatients	O
mean	B-T081
age	O
79.7	O
range	B-T081
62-96	O
91	O
females	O
50.6	O
.	O
	
124	O
69%	O
scored	B-T081
23	O
on	O
the	O
mmse	O
60	O
with	O
mild	B-T080
score	B-T081
18-23	O
and	O
64	O
with	O
severe	B-T080
score	B-T081
17	O
impairment	B-T169
.	O
	
78	O
43%	O
scored	B-T081
6	O
on	O
the	O
cdt	O
,	O
while	O
for	O
the	O
ipt	O
,	O
87	O
47%	O
scored	B-T081
4	O
.	O
	
the	O
cdt	O
and	O
ipt	O
agreed	B-T033
on	O
the	O
classification	O
of	O
138	O
patients	O
77%	O
with	O
modest-	O
strong	B-T080
agreement	O
with	O
the	O
mmse	O
categories	B-T170
.	O
	
correlation	B-T080
between	O
the	O
lsd	O
and	O
visuospatial	O
tests	O
was	O
high	B-T080
.	O
	
a	O
four-item	B-T170
version	I-T170
of	O
the	O
lsd	O
incorporating	O
items	O
1	O
had	O
high	B-T080
correlation	B-T080
with	O
the	O
lsd-15	O
and	O
strong	B-T080
association	B-T080
with	I-T080
mmse	O
categories	B-T170
.	O
	
the	O
lsd-4	O
provides	O
a	O
brief	O
and	O
easily	B-T033
interpreted	B-T169
bedside	O
test	O
of	O
visuospatial	O
function	O
that	O
has	O
high	B-T080
coverage	B-T169
of	O
elderly	B-T098
patients	O
with	O
neurocognitive	O
impairment	O
,	O
good	O
agreement	O
with	O
conventional	B-T080
tests	O
of	O
visuospatial	O
ability	O
and	O
favourable	O
ability	O
to	O
identify	B-T080
significant	B-T078
cognitive	O
impairment	O
.	O
	
salvage	B-T061
therapy	I-T061
with	O
ceftolozane-tazobactam	O
for	O
multidrug-resistant	O
pseudomonas	O
aeruginosa	O
infections	B-T047
infections	B-T047
caused	O
by	O
multidrug-resistant	O
pseudomonas	O
aeruginosa	O
mdrpa	O
present	O
a	O
major	O
problem	O
for	O
therapeutic	O
management	O
.	O
	
we	O
report	O
here	O
our	O
experience	O
with	O
12	O
patients	O
with	O
a	O
severe	O
mdrpa	O
infection	B-T047
6	O
of	O
which	O
were	O
pneumonia	B-T047
who	O
received	O
salvage	B-T061
therapy	I-T061
with	O
ceftolozane-tazobactam	O
after	O
inappropriate	O
empirical	B-T061
treatment	I-T061
and/or	O
suboptimal	B-T080
targeted	O
treatment	B-T061
.	O
	
although	O
10	O
of	O
the	O
12	O
patients	O
83.3	O
experienced	O
septic	O
shock	O
,	O
only	O
3	O
patients	O
25%	O
died	O
during	O
the	O
follow-up	O
period	O
.	O
	
microbiological	O
cure	O
in	O
7	O
patients	O
ankaflavin	B-T109
and	O
monascin	B-T109
induce	B-T169
apoptosis	O
in	O
activated	B-T052
hepatic	O
stellate	O
cells	O
through	O
suppression	O
of	O
the	O
akt	B-T116
/	O
nf-κb	B-T116
/	O
p38	B-T116
signaling	O
pathway	O
the	O
increased	B-T081
proliferation	O
of	O
activated	B-T052
hepatic	O
stellate	O
cells	O
hscs	O
is	O
associated	B-T080
with	I-T080
hepatic	B-T047
fibrosis	I-T047
and	O
excessive	B-T080
extracellular	O
matrix	O
ecm	O
protein	B-T116
production	O
.	O
	
we	O
examined	O
the	O
inhibitory	B-T052
effects	B-T080
of	I-T080
the	O
monascus	O
purpureus	O
-fermented	O
metabolites	O
,	O
ankaflavin	B-T109
and	O
monascin	B-T109
15	O
and	O
30	O
μm	O
,	O
on	O
the	O
akt	B-T116
/	O
nuclear	B-T116
factor	I-T116
nf	I-T116
and	O
p38	B-T116
mitogen-activated	I-T116
protein	I-T116
kinase	I-T116
mapk	B-T116
signaling	O
pathways	O
in	O
hsc-t6	O
activated	O
hepatic	O
stellate	O
cell	O
line	O
.	O
	
ankaflavin	B-T109
and	O
monascin	B-T109
30	O
μm	O
induced	B-T169
apoptosis	O
and	O
significantly	B-T078
inhibited	B-T080
cell	O
growth	O
cell	O
viabilities	O
80.2	O
5.43	O
and	O
62.8	O
8.20	O
,	O
respectively	O
,	O
versus	O
control	O
cells	O
p	O
<	O
0.05	O
.	O
	
apoptosis	O
and	O
g1	O
phase	O
arrest	O
g1	B-T079
phase	I-T079
percentages	B-T081
76.1	O
2.85	O
and	O
79.9	O
1.80	O
,	O
respectively	O
,	O
versus	O
control	O
cells	O
65.9	O
4.94	O
p	O
<	O
0.05	O
correlated	B-T080
with	O
increased	B-T081
p53	B-T116
and	O
p21	B-T116
levels	O
and	O
caspase	O
3	O
activity	O
and	O
decreased	B-T081
cyclin	B-T116
d1	I-T116
and	O
bcl-2-family	O
protein	O
levels	O
p	O
<	O
0.05	O
,	O
all	O
cases	O
.	O
	
the	O
apoptotic	B-T080
effects	B-T080
of	I-T080
ankaflavin	B-T109
and	O
monascin	B-T109
were	O
hsc-t6	O
-	O
specific	B-T080
,	O
suggesting	O
their	O
potential	B-T080
in	O
treating	B-T169
liver	B-T047
fibrosis	I-T047
.	O
	
low-volume	O
vs	O
high-volume	O
centers	O
and	O
management	O
of	O
fournier's	O
gangrene	O
in	O
washington	O
state	O
fournier's	B-T047
gangrene	O
fg	O
is	O
a	O
life-threatening	O
infection	O
affecting	O
the	O
perineum	O
and	O
genitals	O
.	O
	
complex	O
patient	O
management	O
often	O
necessitates	O
transfer	O
to	O
tertiary	O
centers	O
.	O
	
we	O
aimed	O
to	O
characterize	O
hospital	O
transfer	O
patterns	O
and	O
assess	O
morbidity	O
among	O
patients	O
with	O
fg	O
in	O
washington	O
state	O
.	O
	
the	O
washington	O
state	O
comprehensive	O
hospital	O
abstract	O
reporting	O
system	O
includes	O
claims	O
from	O
all	O
hospital	O
discharges	O
in	O
washington	O
.	O
	
we	O
identified	O
patients	O
with	O
fg	O
between	O
2007	O
and	O
2013	O
,	O
based	O
on	O
diagnosis	O
and	O
treatment	O
codes	O
.	O
	
analyses	O
were	O
stratified	O
by	O
center	O
volume	O
low-volume	O
centers	O
lvcs	O
or	O
high-volume	O
centers	O
hvcs	O
,	O
and	O
transfer	O
status	O
.	O
	
variables	O
of	O
interest	O
included	O
number	O
of	O
debridements	O
,	O
septic	O
shock	O
,	O
acute	O
renal	O
failure	O
,	O
acute	O
respiratory	O
failure	O
,	O
length	O
of	O
hospitalization	O
,	O
and	O
death	O
.	O
	
we	O
identified	O
165	O
fg	O
patients	O
.	O
	
only	O
1	O
hvc	O
treated	O
more	O
than	O
2	O
fg	O
patients	O
per	O
year	O
.	O
	
overall	O
mortality	O
was	O
6.7	O
.	O
	
most	O
patients	O
57%	O
were	O
treated	O
entirely	O
at	O
lvcs	O
87%	O
of	O
patients	O
treated	O
at	O
the	O
hvc	O
were	O
transferred	O
from	O
an	O
lvc	O
.	O
	
high-volume	O
center	O
-treated	O
patients	O
had	O
similar	O
baseline	O
comorbidities	O
p	O
=	O
0.77	O
and	O
similar	O
mortality	O
p	O
=	O
0.87	O
,	O
despite	O
higher	O
rates	O
of	O
septic	O
shock	O
p	O
<	O
0.01	O
and	O
respiratory	O
failure	O
p	O
=	O
0.01	O
compared	O
with	O
lvc	O
patients	O
.	O
	
among	O
hvc	O
-	O
transferred	O
patients	O
,	O
immediate	O
compared	O
with	O
delayed	O
transfer	O
was	O
associated	O
with	O
fewer	O
debridements	O
p	O
<	O
0.01	O
,	O
lower	O
rates	O
of	O
septic	O
shock	O
p	O
=	O
0.05	O
,	O
and	O
acute	O
renal	O
failure	O
p	O
=	O
0.04	O
.	O
	
patients	O
treated	O
at	O
the	O
hvc	O
were	O
more	O
acutely	O
ill	O
,	O
yet	O
mortality	O
was	O
similar	O
compared	O
with	O
patients	O
treated	O
solely	O
at	O
lvcs	O
,	O
suggesting	O
a	O
benefit	O
to	O
transfer	O
of	O
high	O
acuity	O
patients	O
.	O
	
immediate	O
vs	O
delayed	O
transfer	O
may	O
benefit	O
fg	O
health	O
outcomes	O
however	O
,	O
this	O
may	O
also	O
reflect	O
greater	O
disease	O
acuity	O
of	O
patients	O
with	O
delayed	O
transfer	O
status	I-T033
functional	O
characterization	O
of	O
pneumocystis	O
carinii	O
inositol	B-T116
transporter	I-T116
1	I-T116
fungi	O
in	O
the	O
genus	O
pneumocystis	O
live	O
in	O
the	O
lungs	O
of	O
mammals	O
,	O
where	O
they	O
can	O
cause	O
a	O
fatal	B-T080
pneumonia	B-T047
pcp	B-T047
pneumocystis	B-T047
pneumonia	I-T047
in	O
hosts	O
with	O
compromised	O
immune	O
systems	O
.	O
	
the	O
absence	O
of	O
a	O
continuous	O
in	B-T080
vitro	I-T080
culture	O
system	O
for	O
any	O
species	O
of	O
pneumocystis	O
has	O
led	O
to	O
limited	O
understanding	O
of	O
these	O
fungi	O
,	O
especially	O
for	O
the	O
discovery	B-T052
of	O
new	O
therapies	B-T061
.	O
	
we	O
recently	O
reported	O
that	O
pneumocystis	O
carinii	O
,	O
pneumocystis	O
murina	O
,	O
and	O
most	O
significantly	O
,	O
pneumocystis	O
jirovecii	O
lack	O
both	O
enzymes	B-T116
necessary	O
for	O
myo-inositol	O
biosynthesis	O
but	O
contain	O
genes	O
with	O
homologies	O
to	O
fungal	O
myo-inositol	B-T109
transporters	B-T116
.	O
	
since	O
myo-inositol	B-T109
is	O
essential	O
for	O
eukaryotic	O
viability	O
,	O
the	O
primary	O
transporter	B-T116
,	O
itr1	B-T116
,	O
was	O
functionally	B-T169
and	O
structurally	B-T082
characterized	O
in	O
p	O
.	O
	
carinii	O
the	O
predicted	O
structure	B-T116
of	O
p	O
.	O
	
carinii	O
itr1	B-T116
pcitr1	B-T116
contained	O
12	O
transmembrane	O
alpha-helices	B-T082
with	O
intracellular	B-T082
c	O
and	O
n	O
termini	O
,	O
consistent	O
with	O
other	O
inositol	B-T109
transporters	B-T116
.	O
	
the	O
apparent	O
km	O
was	O
0.94	O
0.08	O
mean	O
standard	O
deviation	O
,	O
suggesting	O
that	O
myo-inositol	O
transport	O
in	O
p	O
.	O
	
carinii	O
is	O
likely	O
through	O
a	O
low-affinity	O
,	O
highly	O
selective	O
transport	O
system	O
,	O
as	O
no	O
other	O
sugars	B-T109
or	O
inositol	B-T109
stereoisomers	O
were	O
significant	O
competitive	O
inhibitors	O
.	O
	
glucose	O
transport	O
was	O
shown	O
to	O
use	O
a	O
different	O
transport	O
system	O
.	O
	
the	O
myo-inositol	O
transport	O
was	O
distinct	O
from	O
mammalian	O
transporters	B-T116
,	O
as	O
it	O
was	O
not	O
sodium	O
dependent	O
and	O
was	O
cytochalasin	O
b	O
resistant	B-T169
.	O
	
inositol	O
transport	O
in	O
these	O
fungi	O
offers	O
an	O
attractive	B-T080
new	O
drug	O
target	B-T169
because	O
of	O
the	O
reliance	O
of	O
the	O
fungi	O
on	O
its	O
transport	O
,	O
clear	O
differences	O
between	O
the	O
mammalian	O
and	O
fungal	O
transporters	B-T116
,	O
and	O
the	O
ability	O
of	O
the	O
host	O
to	O
both	O
synthesize	O
and	O
transport	O
this	O
critical	B-T080
nutrient	O
,	O
predicting	O
low	B-T080
toxicity	O
of	O
potential	B-T080
inhibitors	O
to	O
the	O
fungal	O
transporter	B-T116
.	O
	
myo-inositol	B-T109
is	O
a	O
sugarlike	B-T109
nutrient	O
that	O
is	O
essential	B-T080
for	O
life	B-T078
in	O
most	O
organisms	O
.	O
	
humans	O
and	O
microbes	O
alike	O
can	O
obtain	O
it	O
by	O
making	O
it	O
,	O
which	O
involves	O
only	O
2	O
enzymes	B-T116
,	O
by	O
taking	O
it	O
from	O
the	O
environment	B-T082
by	O
a	O
transport	O
process	O
,	O
or	O
by	O
recycling	O
it	O
from	O
other	O
cellular	O
constituents	O
.	O
	
inspection	O
of	O
the	O
genomes	O
of	O
the	O
pathogenic	O
fungi	O
of	O
the	O
genus	O
pneumocystis	O
showed	O
that	O
these	O
pneumonia	B-T047
-	O
causing	B-T169
parasites	O
could	O
not	O
make	O
myo-inositol	B-T109
,	O
as	O
they	O
lacked	O
the	O
2	O
enzymes	B-T116
.	O
	
instead	O
,	O
we	O
found	O
evidence	O
of	O
inositol	B-T109
transporters	B-T116
,	O
which	O
would	O
import	O
the	O
sugar	B-T109
from	O
the	O
lungs	O
where	O
the	O
fungi	O
reside	O
.	O
	
in	O
the	O
present	O
report	O
,	O
we	O
characterized	O
the	O
transport	O
of	O
myo-inositol	B-T109
in	O
the	O
fungus	O
and	O
found	O
that	O
the	O
transporter	B-T116
was	O
highly	O
selective	O
for	O
myo-inositol	B-T109
and	O
did	O
not	O
transport	O
any	O
other	O
molecules	O
.	O
	
the	O
transport	O
was	O
distinct	O
from	O
that	O
in	O
mammalian	O
cells	O
,	O
and	O
since	O
mammals	O
can	O
both	O
make	O
and	O
transport	O
myo-inositol	B-T109
,	O
while	O
pneumocystis	O
fungi	O
must	O
transport	O
it	O
,	O
this	O
process	O
offers	O
a	O
potential	B-T080
new	O
drug	O
target	B-T169
.	O
	
worldwide	B-T082
occurrence	B-T079
of	O
mycotoxins	B-T109
in	O
cereals	O
and	O
cereal	O
-	O
derived	B-T080
food	O
products	O
public	O
health	B-T078
perspectives	B-T078
of	O
their	O
co-occurrence	O
cereal	O
grains	O
and	O
their	O
processed	O
food	O
products	O
are	O
frequently	O
contaminated	B-T169
with	O
mycotoxins	B-T109
.	O
	
among	O
many	O
,	O
five	B-T081
major	B-T080
mycotoxins	B-T109
of	O
aflatoxins	B-T109
,	O
ochratoxins	B-T109
,	O
fumonisins	B-T109
,	O
deoxynivalenol	B-T109
,	O
and	O
zearalenone	B-T109
are	O
of	O
significant	O
public	O
health	B-T078
concern	B-T078
as	O
they	O
can	O
cause	B-T169
adverse	O
effects	O
in	O
humans	O
.	O
	
being	O
airborne	B-T169
or	O
soilborne	B-T169
,	O
the	O
cosmopolitan	O
nature	B-T080
of	O
mycotoxigenic	O
fungi	O
contribute	O
to	O
the	O
worldwide	B-T082
occurrence	B-T079
of	O
mycotoxins	B-T109
.	O
	
on	O
the	O
basis	B-T169
of	O
the	O
global	B-T080
occurrence	B-T079
data	B-T078
reported	O
during	O
the	O
past	O
10	O
years	O
,	O
the	O
incidences	B-T081
and	O
maximum	B-T081
levels	B-T080
in	O
raw	B-T080
cereal	O
grains	O
were	O
55%	O
and	O
1642	O
μg/kg	O
for	O
aflatoxins	B-T109
,	O
29%	O
and	O
1164	O
μg/kg	O
for	O
ochratoxin	B-T109
a	I-T109
,	O
61%	O
and	O
71	O
μg/kg	O
for	O
fumonisins	B-T109
,	O
58%	O
and	O
41	O
μg/kg	O
,	O
for	O
deoxynivalenol	B-T109
,	O
and	O
46%	O
and	O
3049	O
μg/kg	O
for	O
zearalenone	B-T109
.	O
	
the	O
concentrations	B-T081
of	O
mycotoxins	B-T109
tend	O
to	O
be	O
lower	B-T080
in	O
processed	O
food	O
products	O
the	O
incidences	B-T081
varied	O
depending	O
on	O
the	O
individual	O
mycotoxins	B-T109
,	O
possibly	O
due	B-T169
to	I-T169
the	O
varying	B-T169
stability	B-T080
during	B-T079
processing	O
and	O
distribution	B-T169
of	O
mycotoxins	B-T109
.	O
	
it	O
should	O
be	O
noted	O
that	O
more	O
than	O
one	O
mycotoxin	B-T109
,	O
produced	B-T169
by	O
a	O
single	B-T081
or	O
several	B-T081
fungal	O
species	O
,	O
may	O
occur	O
in	O
various	B-T081
combinations	B-T080
in	O
a	O
given	O
sample	O
or	O
food	O
.	O
	
most	O
studies	B-T062
reported	O
additive	B-T080
or	O
synergistic	B-T080
effects	B-T080
,	O
suggesting	B-T078
that	O
these	O
mixtures	O
may	O
pose	O
a	O
significant	B-T078
threat	B-T078
to	O
public	O
health	B-T078
,	O
particularly	O
to	O
infants	O
and	O
young	O
children	O
.	O
	
therefore	O
,	O
information	B-T078
on	O
the	O
co-occurrence	O
of	O
mycotoxins	B-T109
and	O
their	O
interactive	B-T169
toxicity	O
is	O
summarized	B-T170
locating	O
the	O
seventh	O
cervical	O
spinous	O
process	O
development	O
and	O
validation	O
of	O
a	O
multivariate	B-T081
model	I-T081
using	O
palpation	O
and	O
personal	O
information	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
develop	O
and	O
validate	O
a	O
multivariate	B-T081
prediction	I-T081
model	I-T081
,	O
guided	O
by	O
palpation	O
and	O
personal	O
information	O
,	O
for	O
locating	O
the	O
seventh	O
cervical	O
spinous	O
process	O
c7sp	O
.	O
	
a	O
single-blinded	B-T062
,	O
cross-sectional	I-T062
study	I-T062
at	O
a	O
primary	O
to	O
tertiary	O
health	O
care	O
center	O
was	O
conducted	O
for	O
model	B-T170
development	I-T170
and	O
temporal	B-T062
validation	I-T062
.	O
	
one-hundred	O
sixty	O
participants	B-T098
were	O
prospectively	O
included	O
for	O
model	B-T170
development	I-T170
n	O
=	O
80	O
and	O
time-split	B-T081
validation	I-T081
stages	I-T081
n	O
=	O
80	O
.	O
	
the	O
c7sp	O
was	O
located	O
using	O
the	O
thorax-rib	O
static	O
method	O
trsm	O
.	O
	
participants	B-T098
underwent	O
chest	O
radiography	O
for	O
assessment	O
of	O
the	O
inner	B-T082
body	O
structure	O
located	O
with	O
trsm	O
and	O
using	O
radio-opaque	O
markers	O
placed	O
over	O
the	O
skin	O
.	O
	
age	O
,	O
sex	O
,	O
height	O
,	O
body	B-T033
mass	I-T033
,	O
body	O
mass	O
index	O
,	O
and	O
vertex-marker	B-T081
distanc	I-T081
e	O
dv-m	B-T081
were	O
used	O
to	O
predict	O
the	O
distance	B-T081
from	O
the	O
c7sp	O
to	O
the	O
vertex	O
dv-c7	B-T081
.	O
	
multivariate	B-T170
linear	I-T170
regression	I-T170
modeling	I-T170
,	O
limits	O
of	O
agreement	O
plot	O
,	O
histogram	B-T170
of	I-T170
residues	I-T170
,	O
receiver	B-T081
operating	I-T081
characteristic	I-T081
curves	I-T081
,	O
and	O
confusion	B-T170
tables	I-T170
were	O
analyzed	O
.	O
	
the	O
multivariate	B-T081
linear	I-T081
prediction	I-T081
model	I-T081
for	O
dv-c7	B-T081
in	O
centimeters	O
was	O
dv-c7	B-T081
=	O
0.986dv	O
+	O
0.018	O
+	O
0.014	O
-	O
1.008	O
.	O
	
receiver	B-T081
operating	I-T081
characteristic	I-T081
curves	I-T081
had	O
better	O
discrimination	O
of	O
dv-c7	B-T081
area	O
under	O
the	O
curve	O
=	O
0.661	O
95%	O
confidence	B-T081
interval	I-T081
=	O
0.541	O
p	O
=	O
015	O
than	O
dv-m	B-T081
area	O
under	O
the	O
curve	O
=	O
0.480	O
95%	O
confidence	B-T081
interval	I-T081
=	O
0.345	O
p	O
=	O
761	O
,	O
with	O
respective	O
cutoff	O
points	O
at	O
23.40	O
cm	O
sensitivity	B-T081
=	O
41%	O
,	O
specificity	B-T081
=	O
63%	O
and	O
24.75	O
cm	O
sensitivity	B-T081
=	O
69%	O
,	O
specificity	B-T081
=	O
52%	O
.	O
	
the	O
c7sp	O
was	O
correctly	O
located	O
more	O
often	O
when	O
using	O
predicted	O
dv-c7	B-T081
in	O
the	O
validation	O
sample	O
than	O
when	O
using	O
the	O
trsm	O
in	O
the	O
development	O
sample	O
n	O
=	O
53	O
66%	O
vs	O
n	O
=	O
32	O
40%	O
,	O
p	O
<	O
001	O
.	O
	
better	O
accuracy	O
was	O
obtained	O
when	O
locating	O
the	O
c7sp	O
by	O
use	O
of	O
a	O
multivariate	B-T081
model	I-T081
that	O
incorporates	O
palpation	O
and	O
personal	O
information	O
.	O
	
comparison	B-T052
of	O
leishmania	O
typing	O
results	O
obtained	B-T169
from	O
16	O
european	O
clinical	O
laboratories	O
in	O
2014	O
leishmaniasis	B-T047
is	O
endemic	O
in	O
southern	O
europe	O
,	O
and	O
in	O
other	O
european	O
countries	O
cases	B-T081
are	O
diagnosed	B-T033
in	O
travellers	O
who	O
have	O
visited	O
affected	B-T033
areas	I-T033
both	O
within	B-T082
the	O
continent	O
and	O
beyond	O
.	O
	
prompt	B-T080
and	O
accurate	B-T080
diagnosis	B-T033
poses	O
a	O
challenge	O
in	O
clinical	B-T170
practice	I-T170
in	O
europe	O
.	O
	
different	B-T080
methods	B-T170
exist	O
for	O
identification	B-T080
of	O
the	O
infecting	B-T033
leishmania	O
species	O
.	O
	
sixteen	O
clinical	O
laboratories	O
in	O
10	O
european	O
countries	O
,	O
plus	O
israel	O
and	O
turkey	O
,	O
conducted	O
a	O
study	B-T062
to	O
assess	O
their	O
genotyping	O
performance	B-T052
.	O
	
dna	O
from	O
21	O
promastigote	O
cultures	O
of	O
13	O
species	O
was	O
analysed	B-T062
blindly	B-T080
by	O
the	O
routinely	B-T080
used	O
typing	O
method	B-T170
.	O
	
five	O
different	B-T080
molecular	O
targets	O
were	O
used	O
,	O
which	O
were	O
analysed	B-T062
with	O
pcr-based	O
methods	B-T170
.	O
	
different	B-T080
levels	B-T080
of	O
identification	B-T080
were	O
achieved	B-T033
,	O
and	O
either	O
the	O
leishmania	O
subgenus	O
,	O
species	O
complex	O
,	O
or	O
actual	O
species	O
were	O
reported	B-T170
.	O
	
the	O
overall	B-T080
error	B-T080
rate	B-T081
of	O
strains	O
placed	O
in	O
the	O
wrong	B-T080
complex	O
or	O
species	O
was	O
8.5	O
.	O
	
various	O
reasons	B-T078
for	O
incorrect	B-T080
typing	O
were	O
identified	B-T080
.	O
	
the	O
study	B-T062
shows	O
there	O
is	O
considerable	B-T080
room	O
for	O
improvement	O
and	O
standardisation	B-T062
of	O
leishmania	O
typing	O
.	O
	
the	O
use	O
of	O
well	O
validated	B-T062
standard	O
operating	O
procedures	O
is	O
recommended	B-T078
,	O
covering	O
testing	B-T169
,	O
interpretation	B-T170
,	O
and	O
reporting	O
guidelines	B-T170
.	O
	
application	O
of	O
the	O
internal	B-T082
transcribed	B-T080
spacer	O
1	O
of	O
the	O
rdna	O
array	O
should	O
be	O
restricted	B-T169
to	O
old	B-T080
world	I-T080
samples	O
,	O
while	O
the	O
heat-shock	O
protein	O
70	O
gene	O
and	O
the	O
mini-exon	O
can	O
be	O
applied	B-T169
globally	B-T080
.	O
	
scoparone	B-T109
inhibits	O
lps	B-T109
-	O
simulated	B-T169
inflammatory	O
response	O
by	O
suppressing	B-T169
irf3	B-T116
and	O
erk	B-T116
in	O
bv-2	O
microglial	O
cells	O
microglia	O
activation	O
and	O
the	O
release	O
of	O
various	O
inflammatory	B-T169
cytokines	B-T116
are	O
largely	O
related	O
to	O
neurological	B-T047
diseases	I-T047
,	O
including	O
parkinson's	B-T047
,	O
alzheimer's	B-T047
,	O
and	O
other	B-T080
brain	B-T047
diseases	I-T047
.	O
	
the	O
suppression	O
of	O
microglial	O
cells	O
using	O
natural	B-T169
bioactive	O
compounds	O
has	O
become	O
increasingly	B-T169
important	B-T080
for	O
brain	B-T061
therapy	I-T061
owing	O
to	O
the	O
expected	O
beneficial	O
effect	O
of	O
lower	B-T080
toxicity	B-T080
.	O
	
scoparone	B-T109
6	B-T109
,	O
a	O
major	O
bioactive	O
compound	O
found	B-T033
in	O
various	O
plant	O
parts	O
,	O
including	O
the	O
inner	O
shell	B-T080
of	O
chestnut	O
castanea	O
crenata	O
,	O
was	O
evaluated	O
on	O
lipopolysaccharide	B-T109
lps	B-T109
activated	B-T169
bv-2	O
microglia	O
cells	O
.	O
	
the	O
results	B-T169
indicated	B-T033
that	O
scoparone	B-T109
suppresses	B-T169
the	O
lps	B-T109
-	O
stimulated	B-T169
increase	B-T169
of	O
neuroinflammatory	O
responses	O
and	O
inhibited	B-T080
the	O
pro-inflammatory	B-T169
cytokine	B-T116
production	O
in	O
the	O
bv-2	O
microglial	O
cells	O
.	O
	
a	O
mechanistic	B-T169
study	I-T169
showed	O
that	O
scoparone	B-T109
specifically	O
inhibited	B-T080
the	O
lps	B-T109
-	O
stimulated	B-T169
activation	O
via	O
a	O
major	O
regulation	O
of	O
irf-3	B-T116
and	O
a	O
regulation	O
of	O
erk	B-T116
,	O
whereby	O
the	O
phosphorylation	O
in	O
the	O
bv-2	O
microglial	O
cells	O
is	O
blocked	B-T169
.	O
	
these	O
data	B-T078
suggest	B-T078
that	O
scoparone	B-T109
has	O
anti-neuroinflammatory	B-T080
effects	I-T080
in	O
lps	B-T109
-	O
activated	B-T169
bv-2	O
microglial	O
cells	O
,	O
and	O
could	O
possibly	O
be	O
used	B-T169
in	O
the	O
development	B-T169
of	O
novel	B-T080
drugs	O
for	O
the	O
prevention	B-T080
and	O
treatment	B-T169
of	O
neuroinflammatory	B-T047
diseases	I-T047
.	O
	
efficient	O
genome	O
editing	O
of	O
differentiated	B-T080
renal	O
epithelial	O
cells	O
recent	O
advances	O
in	O
genome	O
editing	O
technologies	O
have	O
enabled	O
the	O
rapid	O
and	O
precise	O
manipulation	O
of	O
genomes	O
,	O
including	O
the	O
targeted	O
introduction	O
,	O
alteration	O
,	O
and	O
removal	O
of	O
genomic	O
sequences	O
.	O
	
however	O
,	O
respective	O
methods	B-T170
have	O
been	O
described	O
mainly	O
in	O
non-differentiated	B-T170
or	O
haploid	O
cell	B-T170
types	I-T170
.	O
	
genome	O
editing	O
of	O
well-differentiated	B-T080
renal	O
epithelial	O
cells	O
has	O
been	O
hampered	O
by	O
a	O
range	O
of	O
technological	B-T033
issues	I-T033
,	O
including	O
optimal	B-T080
design	B-T052
,	O
efficient	B-T080
expression	O
of	O
multiple	O
genome	O
editing	O
constructs	O
,	O
attainable	B-T080
mutation	B-T080
rates	I-T080
,	O
and	O
best	O
screening	B-T170
strategies	I-T170
.	O
	
here	O
,	O
we	O
present	O
an	O
easily	O
implementable	O
workflow	O
for	O
the	O
rapid	B-T080
generation	O
of	O
targeted	O
heterozygous	O
and	O
homozygous	O
genomic	O
sequence	O
alterations	O
in	O
renal	O
cells	O
using	O
transcription	B-T116
activator-like	I-T116
effector	I-T116
nucleases	I-T116
talens	B-T116
and	O
the	O
clustered	O
regularly	O
interspaced	O
short	O
palindromic	O
repeat	O
crispr	O
system	O
.	O
	
we	O
demonstrate	O
the	O
versatility	O
of	O
established	O
protocols	B-T170
by	O
generating	B-T052
novel	B-T080
cellular	O
models	O
for	O
studying	B-T062
autosomal	O
dominant	O
polycystic	O
kidney	O
disease	O
adpkd	O
.	O
	
furthermore	O
,	O
we	O
show	O
that	O
cell	O
culture-validated	O
genetic	O
modifications	O
can	O
be	O
readily	O
applied	O
to	O
mouse	O
embryonic	O
stem	O
cells	O
mescs	O
for	O
the	O
generation	B-T052
of	O
corresponding	O
mouse	O
models	O
.	O
	
the	O
described	O
procedure	B-T169
for	O
efficient	O
genome	O
editing	O
can	O
be	O
applied	O
to	O
any	O
cell	B-T170
type	I-T170
to	O
study	B-T062
physiological	O
and	O
pathophysiological	O
functions	O
in	O
the	O
context	O
of	O
precisely	O
engineered	O
genotypes	O
.	O
	
right	O
ventricular	O
response	O
during	B-T079
exercise	O
in	O
patients	O
with	O
chronic	B-T047
obstructive	I-T047
pulmonary	I-T047
disease	I-T047
right	O
ventricular	O
rv	O
pump	O
function	O
is	O
of	O
essential	B-T080
clinical	B-T080
and	O
prognostic	B-T170
importance	B-T080
in	O
a	O
variety	O
of	O
heart	B-T047
and	O
lung	B-T047
diseases	I-T047
.	O
	
while	O
the	O
evaluation	O
of	O
rv	O
performance	B-T052
at	O
rest	O
has	O
been	O
implemented	O
in	O
the	O
clinical	B-T082
setting	I-T082
,	O
it	O
is	O
unknown	O
whether	O
this	O
assessment	O
during	B-T079
exercise	O
may	O
provide	O
additional	B-T169
benefit	B-T081
.	O
	
with	O
this	O
aim	B-T078
,	O
we	O
evaluated	O
the	O
exercise	O
-	O
induced	B-T169
pulmonary	O
arterial	O
systolic	O
pressure	O
pasp	O
increase	B-T169
during	B-T079
exercise	O
in	O
patients	O
with	O
severe	B-T080
chronic	B-T047
obstructive	I-T047
pulmonary	I-T047
disease	I-T047
copd	B-T047
as	O
an	O
expression	O
of	O
rv	O
contractile	B-T081
reserve	I-T081
.	O
	
cardiopulmonary	O
exercise	O
testing	O
cpet	O
with	O
synchronic	O
echocardiography	O
was	O
performed	B-T169
in	O
81	O
patients	O
.	O
	
patients	O
were	O
classified	O
into	O
two	O
groups	B-T078
according	O
to	O
an	O
exercise	O
-	O
induced	B-T169
pasp	O
increase	B-T169
above	O
30mmhg	O
high	B-T080
psap	O
or	O
below	O
30mmhg	O
low	B-T080
psap	O
during	B-T079
maximal	B-T080
exercise	O
.	O
	
patients	O
were	O
then	O
followed	B-T079
for	O
three	O
years	B-T079
.	O
	
sixteen	O
patients	O
20%	O
had	O
low	B-T080
psap	O
and	O
65	O
80%	O
showed	O
high	B-T080
psap	O
.	O
	
these	O
were	O
not	B-T033
significant	I-T033
clinical	B-T080
and	O
functional	B-T169
differences	B-T081
.	O
	
low	B-T080
psap	O
was	O
associated	B-T080
with	I-T080
a	O
significantly	B-T081
lower	I-T081
peak	B-T080
vo2	B-T033
mean	B-T081
sd	B-T081
,	O
35	O
2	O
%	O
predicted	B-T078
compared	B-T052
to	O
high	B-T080
psap	O
response	O
peak	B-T080
vo2	B-T033
45	O
3	O
%	O
predicted	B-T078
,	O
p=0	O
.	O
	
factors	B-T169
associated	B-T080
with	I-T080
mortality	B-T081
were	O
age	O
and	O
exercise	O
-	O
induced	B-T169
pasp	O
.	O
	
seventeen	O
patients	O
died	O
during	B-T079
the	O
three	O
years	B-T079
of	O
follow-up	O
7	O
39%	O
in	O
the	O
low	B-T080
psap	O
group	B-T078
and	O
only	O
10	O
1%	O
in	O
the	O
high	B-T080
psap	O
group	B-T078
,	O
p=0	O
.	O
	
cardiopulmonary	O
exercise	O
testing	O
with	O
a	O
synchronic	O
echocardiography	O
may	O
be	O
a	O
useful	O
tool	O
for	O
the	O
assessment	O
of	O
rv	O
contractile	B-T081
reserve	I-T081
in	O
severe	B-T080
copd	B-T047
patients	O
.	O
	
exercise	O
-	O
induced	B-T169
psap	O
emerges	O
as	O
a	O
possible	O
prognostic	O
factor	O
in	O
these	O
adverse	B-T169
outcomes	I-T169
in	O
older	B-T098
adults	I-T098
attending	B-T169
emergency	O
departments	O
a	O
systematic	B-T170
review	I-T170
and	O
meta-analysis	B-T062
of	O
the	O
identification	B-T170
of	I-T170
seniors	I-T170
at	I-T170
risk	I-T170
isar	I-T170
screening	I-T170
tool	I-T170
older	B-T098
adults	I-T098
are	O
frequent	B-T079
users	O
of	O
emergency	O
services	O
and	O
demonstrate	O
high	B-T080
rates	B-T081
of	O
adverse	B-T169
outcomes	I-T169
following	O
emergency	B-T061
care	I-T061
.	O
	
to	O
perform	O
a	O
systematic	B-T170
review	I-T170
and	O
meta-analysis	B-T062
of	O
the	O
identification	B-T170
of	I-T170
seniors	I-T170
at	I-T170
risk	I-T170
isar	I-T170
screening	I-T170
tool	I-T170
,	O
to	O
determine	O
its	O
predictive	B-T080
value	I-T080
in	O
identifying	O
adults	O
65	O
years	B-T079
at	O
risk	B-T078
of	O
functional	B-T033
decline	I-T033
,	O
unplanned	O
emergency	O
department	O
ed	O
readmission	O
,	O
emergency	O
hospitalisation	O
or	O
death	B-T033
within	O
180	O
days	B-T079
after	O
index	O
ed	O
visit	O
/	O
hospitalisation	O
.	O
	
a	O
systematic	B-T169
literature	B-T170
search	B-T052
was	O
conducted	O
in	O
pubmed	B-T170
,	O
embase	B-T170
,	O
cinahl	B-T170
,	O
ebsco	B-T170
and	O
the	O
cochrane	B-T170
library	I-T170
to	O
identify	O
validation	B-T062
and	O
impact	B-T080
analysis	B-T062
studies	O
of	O
the	O
isar	B-T170
tool	I-T170
.	O
	
a	O
pre-specified	B-T080
isar	B-T170
score	B-T081
of	O
2	O
maximum	O
score	B-T081
6	O
points	O
was	O
used	O
to	O
identify	O
patients	O
at	O
high	B-T033
risk	I-T033
of	I-T033
adverse	B-T169
outcomes	I-T169
.	O
	
a	O
bivariate	B-T170
random	I-T170
effects	I-T170
model	I-T170
generated	O
pooled	B-T169
estimates	B-T081
of	O
sensitivity	B-T081
and	I-T081
specificity	I-T081
.	O
	
statistical	B-T080
heterogeneity	I-T080
was	O
explored	O
and	O
methodological	O
quality	O
was	O
assessed	O
using	O
validated	B-T078
criteria	I-T078
.	O
	
thirty-two	O
validation	B-T062
studies	I-T062
n	O
=	O
12	O
are	O
included	B-T169
.	O
	
at	O
2	O
,	O
the	O
pooled	B-T169
sensitivity	B-T081
of	O
the	O
isar	B-T170
for	O
predicting	O
ed	O
return	B-T080
,	O
emergency	O
hospitalisation	O
and	O
mortality	B-T081
at	O
6	O
months	B-T079
is	O
0.80	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
0.70	O
,	O
0.82	O
95%	O
ci	B-T081
0.74	O
and	O
0.87	O
95%	O
ci	B-T081
0.75	O
,	O
respectively	O
,	O
with	O
a	O
pooled	B-T169
specificity	B-T081
of	O
0.31	O
95%	O
ci	B-T081
0.24	O
,	O
0.32	O
95%	O
ci	B-T081
0.24	O
and	O
0.35	O
95%	O
ci	B-T081
0.26	O
.	O
	
similar	O
values	B-T080
are	O
demonstrated	O
at	O
30	O
and	O
90	O
days	B-T079
.	O
	
three	O
heterogeneous	B-T080
impact	B-T080
analysis	B-T062
studies	O
examined	B-T033
the	O
clinical	B-T080
implementation	B-T052
of	O
the	O
isar	B-T170
and	O
reported	O
mixed	B-T169
findings	I-T169
across	O
patient	O
and	O
process	O
outcomes	B-T169
.	O
	
the	O
isar	B-T170
has	O
modest	O
predictive	B-T080
accuracy	B-T080
and	O
may	O
serve	O
as	O
a	O
decision-making	O
adjunct	B-T169
when	O
determining	O
which	O
older	B-T098
adults	I-T098
can	O
be	O
safely	O
ecohydrological	B-T062
modeling	I-T062
and	O
environmental	B-T082
flow	O
regime	B-T080
in	O
the	O
formoso	O
river	O
,	O
minas	O
gerais	O
state	O
,	O
brazil	O
this	O
paper	B-T170
aimed	O
at	O
determining	B-T080
the	O
environmental	B-T082
flow	O
regime	O
in	O
a	O
1	B-T081
km	I-T081
stretch	B-T081
of	O
the	O
formoso	O
river	O
,	O
mg	O
,	O
using	O
river2d	B-T062
model	I-T062
.	O
	
to	O
carry	O
out	O
the	O
ecohydrological	B-T062
modeling	I-T062
,	O
the	O
following	B-T079
information	B-T078
was	O
used	O
bathymetry	B-T081
,	O
physical	B-T169
and	O
hydraulic	B-T169
features	B-T080
,	O
and	O
the	O
habitat	B-T082
suitability	B-T080
index	I-T080
for	O
species	O
of	O
the	O
hypostomus	O
auroguttatus	O
.	O
	
in	O
the	O
river2d	B-T062
,	O
the	O
weighted	B-T081
usable	B-T080
areas	B-T082
were	O
determined	B-T080
from	O
the	O
average	B-T081
long-term	B-T079
streamflows	O
with	O
percentage	B-T081
from	O
10%	O
to	O
100%	O
.	O
	
those	O
streamflows	O
were	O
simulated	O
for	O
the	O
later	B-T079
construction	B-T169
of	O
optimization	B-T052
matrices	B-T082
that	O
maximize	B-T081
the	O
habitat	B-T082
area	B-T082
throughout	B-T169
the	O
year	B-T079
.	O
	
for	O
h	O
.	O
	
auroguttatus	O
juvenile	O
,	O
higher	B-T080
values	B-T080
of	O
weighted	B-T081
usable	B-T080
area	B-T082
were	O
associated	B-T080
with	I-T080
the	O
percentage	B-T081
of	O
60%	O
and	O
70%	O
of	O
the	O
average	B-T081
long-term	B-T079
streamflows	O
in	O
october	B-T079
and	O
september	B-T079
,	O
respectively	O
.	O
	
for	O
h	O
.	O
	
auroguttatus	O
adult	O
,	O
the	O
highest	B-T080
value	B-T080
of	O
weighted	B-T081
usable	B-T080
area	O
was	O
associated	O
with	O
the	O
percentage	O
of	O
100%	O
of	O
the	O
average	O
long-term	O
streamflow	O
in	O
september	O
.	O
	
the	O
environmental	O
flows	O
found	O
for	O
this	O
stretch	O
of	O
the	O
formoso	O
river	O
varied	O
over	O
the	O
year	O
.	O
	
the	O
lowest	O
environmental	O
flow	O
was	O
observed	O
in	O
december	O
2.85	O
m3	O
s-1	O
,	O
while	O
the	O
highest	O
was	O
observed	O
in	O
may	O
4.13	O
m3	O
s-1	O
.	O
	
this	O
paper	O
shows	O
the	O
importance	O
of	O
ecohydrological	O
studies	O
in	O
forming	O
a	O
basis	O
for	O
water	O
resources	O
management	O
actions	B-T052
risk	B-T033
factors	I-T033
for	O
hepatitis	B-T047
c	I-T047
virus	I-T047
infection	I-T047
in	O
the	O
colombian	B-T098
caribbean	O
coast	O
a	O
case-control	B-T062
study	I-T062
an	O
estimated	O
6.8	O
million	B-T081
people	B-T098
are	O
infected	B-T033
with	O
hepatitis	O
c	O
virus	O
in	O
latin	O
america	O
,	O
of	O
which	O
less	B-T081
than	I-T081
1%	O
receives	O
antiviral	B-T061
treatment	I-T061
.	O
	
studies	B-T062
so	O
far	O
in	O
colombia	O
have	O
attempted	O
to	O
determine	O
the	O
prevalence	B-T081
of	O
the	O
disease	B-T047
in	O
some	O
risk	B-T078
groups	B-T098
,	O
thus	O
preventing	B-T169
the	O
identification	B-T080
of	O
other	O
factors	B-T169
potentially	B-T080
involved	O
in	O
the	O
spread	O
of	O
the	O
infection	O
.	O
	
to	O
identify	B-T080
traditional	O
and	O
non-traditional	O
risk	B-T033
factors	I-T033
for	O
chronic	B-T047
hepatitis	I-T047
c	I-T047
in	O
the	O
colombian	B-T098
caribbean	O
coast	O
.	O
	
this	O
was	O
a	O
case-control	B-T062
study	I-T062
1	O
matched	O
by	O
health	O
care	O
provider	O
and	O
age	O
10	O
years	B-T079
conducted	O
at	O
the	O
primary	O
care	O
level	O
of	O
gastroenterology	O
and	O
hepatology	O
outpatient	O
services	O
.	O
	
all	O
patients	O
with	O
a	O
positive	B-T033
elisa	O
underwent	O
a	O
confirmatory	O
viral	O
load	O
test	O
.	O
	
a	O
multivariate	O
logistic	O
regression	O
analysis	O
identified	B-T080
the	O
independent	B-T078
predictors	I-T078
of	O
infection	O
.	O
	
blood	B-T061
transfusion	I-T061
or	B-T081
=159	O
95%	O
ci	B-T081
35.4	O
p<0	O
and	O
history	O
of	O
hospitalization	O
before	O
1994	O
or	B-T081
=4	O
95%	O
ci	B-T081
1.3	O
p=0	O
were	O
identified	B-T080
as	O
the	O
only	O
two	O
independent	B-T078
predictors	I-T078
of	O
infection	O
.	O
	
it	O
is	O
necessary	O
to	O
check	O
the	O
reproducibility	B-T081
of	I-T081
these	I-T081
results	I-T081
and	O
to	O
conduct	O
cost-effectiveness	B-T081
studies	B-T062
before	O
recommending	B-T078
their	O
use	B-T169
in	O
the	O
design	B-T052
of	O
new	B-T062
screening	I-T062
strategies	I-T062
.	O
	
quo	O
vadis	O
g	O
protein-coupled	O
receptor	O
ligands	O
a	O
tool	O
for	O
analysis	B-T062
of	O
the	O
emergence	B-T078
of	O
new	O
groups	B-T078
of	O
compounds	O
over	B-T079
time	I-T079
exponential	B-T081
growth	O
in	O
the	O
number	B-T081
of	O
compounds	O
with	O
experimentally	B-T080
verified	B-T169
activity	B-T052
towards	O
particular	O
target	B-T169
has	O
led	O
to	O
the	O
emergence	B-T078
of	O
various	O
databases	B-T170
gathering	O
data	B-T078
on	O
biological	B-T080
activity	B-T052
.	O
	
in	O
this	O
study	B-T062
,	O
the	O
ligands	O
of	O
family	B-T116
a	I-T116
of	I-T116
the	I-T116
g	I-T116
protein-coupled	I-T116
receptors	I-T116
that	O
are	O
collected	B-T078
in	O
the	O
chembl	B-T170
database	I-T170
were	O
examined	B-T033
,	O
and	O
special	O
attention	O
was	O
given	O
to	O
serotonin	B-T116
receptors	I-T116
.	O
	
sets	O
of	O
compounds	O
were	O
examined	B-T033
in	O
terms	O
of	O
their	O
appearance	B-T080
over	B-T079
time	I-T079
,	O
they	O
were	O
mapped	B-T052
to	O
the	O
chemical	O
space	O
of	O
drugs	O
deposited	O
in	O
drugbank	B-T170
,	O
and	O
the	O
emergence	B-T078
of	O
structurally	O
new	O
clusters	O
of	O
compounds	O
was	O
indicated	B-T033
.	O
	
in	O
addition	O
,	O
a	O
tool	O
for	O
detailed	O
analysis	B-T062
of	O
the	O
obtained	B-T169
visualizations	B-T170
was	O
prepared	B-T033
and	O
made	O
available	B-T169
online	O
at	O
http	B-T170
,	O
which	O
enables	O
the	O
investigation	B-T080
of	O
chemical	B-T170
structures	I-T170
while	O
referring	B-T169
to	O
particular	O
data	B-T033
points	I-T033
depicted	O
in	O
the	O
figures	O
and	O
changes	B-T169
in	O
compounds	O
datasets	B-T170
over	B-T079
time	I-T079
.	O
	
diabetes	B-T047
and	O
breast	O
cancer	O
mortality	B-T081
in	O
black	B-T098
women	I-T098
breast	O
cancer	O
mortality	B-T081
is	O
higher	O
in	O
black	B-T098
women	I-T098
than	O
in	O
white	B-T098
women	I-T098
.	O
	
the	O
prevalence	B-T081
of	O
type	B-T047
2	I-T047
diabetes	I-T047
mellitus	I-T047
is	O
also	O
higher	O
,	O
yet	O
data	B-T078
on	O
whether	O
diabetes	B-T047
affects	B-T080
breast	O
cancer	O
mortality	B-T081
in	O
this	O
population	B-T098
are	O
lacking	B-T080
.	O
	
we	O
investigated	B-T169
the	O
relation	O
of	O
diabetes	B-T047
at	O
the	O
time	O
of	O
breast	O
cancer	O
diagnosis	B-T033
to	O
breast	O
cancer	O
mortality	B-T081
in	O
the	O
black	B-T098
women's	I-T098
health	O
study	B-T062
,	O
a	O
prospective	B-T062
cohort	I-T062
study	I-T062
.	O
	
1	O
black	B-T098
women	I-T098
with	O
invasive	B-T080
breast	O
cancer	O
diagnosed	B-T033
in	O
1995-2013	O
were	O
followed	B-T079
by	I-T079
mailed	O
questionnaires	B-T170
and	O
searches	O
of	O
the	O
national	B-T170
death	I-T170
index	I-T170
.	O
	
multivariable	B-T170
cox	I-T170
regression	I-T170
analysis	I-T170
was	O
used	O
to	O
compute	O
hazard	B-T081
ratios	I-T081
hrs	B-T081
for	O
diabetes	B-T047
in	O
relation	O
to	O
breast	O
cancer	O
mortality	B-T081
and	O
all-cause	O
mortality	B-T081
,	O
with	O
adjustment	O
for	O
age	O
,	O
stage	O
,	O
treatment	B-T061
modality	I-T061
,	O
estrogen	B-T116
receptor	I-T116
er	B-T116
status	B-T080
,	O
and	O
body	O
mass	O
index	O
.	O
	
there	O
were	O
368	O
deaths	B-T033
during	O
follow-up	O
,	O
of	O
which	O
273	O
were	O
due	O
to	O
breast	O
cancer	O
.	O
	
breast	O
cancer	O
mortality	B-T081
was	O
significantly	B-T081
increased	I-T081
in	O
women	B-T098
who	O
had	O
been	O
diagnosed	B-T033
with	O
diabetes	B-T047
at	O
least	O
5	O
years	O
before	O
breast	O
cancer	O
occurrence	B-T079
,	O
hr	B-T081
1.86	O
95%	O
ci	O
1.20	O
,	O
with	O
elevations	B-T082
observed	B-T169
for	O
both	O
er+	B-T033
and	O
er-	B-T033
breast	O
cancer	O
.	O
	
all-cause	O
mortality	B-T081
was	O
also	O
higher	O
in	O
diabetics	B-T033
,	O
with	O
hrs	B-T081
of	O
1.54	O
95%	O
ci	O
1.12	O
overall	B-T080
and	O
2.26	O
95%	O
ci	O
1.62	O
for	O
5-year	O
duration	O
of	O
diabetes	B-T047
relative	B-T080
to	O
non-diabetics	B-T033
.	O
	
our	O
results	O
present	B-T033
the	O
first	O
solid	O
evidence	B-T078
of	O
a	O
positive	B-T033
association	O
of	O
type	B-T047
2	I-T047
diabetes	I-T047
with	O
breast	O
cancer	O
mortality	B-T081
in	O
black	B-T098
women	I-T098
.	O
	
given	O
the	O
higher	O
prevalence	B-T081
and	O
earlier	B-T033
onset	I-T033
of	O
type	B-T047
2	I-T047
diabetes	I-T047
in	O
black	B-T098
women	I-T098
,	O
it	O
is	O
likely	O
that	O
diabetes	B-T047
contributes	B-T052
to	O
racial	B-T098
disparities	B-T033
in	O
breast	O
cancer	O
mortality	B-T081
.	O
	
neuro-behcet	B-T047
disease	I-T047
presenting	B-T078
as	O
a	O
solitary	O
cerebellar	O
hemorrhagic	O
lesion	B-T033
a	O
case	B-T170
report	I-T170
and	O
review	B-T170
of	I-T170
the	I-T170
literature	I-T170
behcet's	B-T047
disease	I-T047
is	O
a	O
heterogeneous	B-T033
,	O
multisystem	B-T047
,	O
inflammatory	B-T047
disorder	I-T047
of	O
unknown	B-T033
etiology	I-T033
.	O
	
the	O
classic	O
triad	O
of	O
oral	B-T047
and	O
genital	B-T047
ulcerations	I-T047
in	O
conjunction	B-T078
with	O
uveitis	B-T047
was	O
originally	O
described	B-T078
by	O
the	O
turkish	B-T098
dermatologist	O
hulusi	O
behcet	O
in	O
1937	O
,	O
but	O
associated	O
symptoms	O
of	O
the	O
cardiovascular	O
,	O
central	O
nervous	O
,	O
pulmonary	O
,	O
and	O
gastrointestinal	O
systems	O
were	O
later	O
identified	B-T080
.	O
	
in	O
fact	O
,	O
behcet's	B-T047
disease	I-T047
with	O
neurological	B-T047
involvement	I-T047
neuro-behcet's	B-T047
disease	I-T047
is	O
not	O
uncommon	O
.	O
	
patients	O
with	O
neuro-behcet's	B-T047
disease	I-T047
typically	O
exhibit	O
a	O
diverse	O
array	O
of	O
symptoms	O
,	O
most	B-T081
commonly	B-T081
in	O
the	O
brainstem	O
and	O
diencephalic	O
regions	B-T082
.	O
	
herein	O
,	O
we	O
report	B-T170
an	O
unusual	B-T080
case	B-T169
of	O
neuro-behcet's	B-T047
disease	I-T047
in	O
a	O
patient	O
who	O
presented	B-T078
with	O
a	O
solitary	O
cerebellar	O
hemorrhage	O
.	O
	
a	O
39-year-old	O
asian	B-T098
woman	B-T098
was	O
admitted	O
to	O
our	O
hospital	O
with	O
complaints	B-T033
of	O
a	O
sudden	B-T080
speech	B-T033
difficulty	I-T033
that	O
had	O
manifested	B-T169
the	O
same	B-T080
morning	B-T079
,	O
and	O
dizziness	O
and	O
mild	B-T080
vomiting	O
experienced	O
over	B-T079
the	O
previous	B-T079
3	O
days	B-T079
.	O
	
magnetic	B-T170
resonance	I-T170
images	I-T170
revealed	B-T080
target-like	O
hemorrhagic	O
lesions	B-T033
in	O
the	O
right	O
hemisphere	O
of	O
the	O
cerebellum	O
.	O
	
risk	B-T033
factors	I-T033
that	O
may	O
result	B-T169
in	O
cerebellar	O
hemorrhage	O
,	O
such	O
as	O
high	B-T047
blood	I-T047
pressure	I-T047
or	O
bleeding	O
diathesis	O
,	O
were	O
ruled	B-T033
out	I-T033
,	O
and	O
subsequent	B-T079
brain	O
angiograms	O
were	O
normal	B-T080
.	O
	
these	O
findings	B-T033
suggest	B-T078
that	O
the	O
patient's	O
cerebellar	O
hemorrhage	O
could	O
have	O
been	O
due	B-T169
to	I-T169
intracranial	O
vasculitis	B-T047
in	O
a	O
rare	B-T080
,	O
if	O
not	O
unique	O
,	O
complication	O
of	O
neuro-behcet's	B-T047
disease	I-T047
.	O
	
intrinsic	B-T082
rifamycin	B-T109
resistance	O
of	O
mycobacterium	O
abscessus	O
is	O
mediated	O
by	O
adp-ribosyltransferase	B-T116
mab_0591	O
rifampicin	B-T109
,	O
a	O
potent	O
first-line	O
tb	O
drug	O
of	O
the	O
rifamycin	B-T109
group	I-T109
,	O
shows	O
only	O
little	O
activity	B-T169
against	O
the	O
emerging	O
pathogen	O
mycobacterium	O
abscessus	O
.	O
	
reportedly	O
,	O
bacterial	O
resistance	O
to	O
rifampicin	B-T109
is	O
associated	O
with	O
polymorphisms	O
in	O
the	O
target	O
gene	O
rpob	O
or	O
the	O
presence	O
of	O
enzymes	B-T116
that	O
modify	O
and	O
thereby	O
inactivate	O
rifampicin	B-T109
.	O
	
the	O
aim	B-T078
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
role	O
of	O
the	O
mab_0591	O
arrmab	O
rifampicin	B-T109
adp-ribosyltransferase	B-T116
arr_mab	B-T116
in	O
innate	O
high-level	O
rifampicin	B-T109
resistance	O
in	O
m	O
.	O
	
abscessus	O
.	O
	
recombinant	O
escherichia	O
coli	O
and	O
mycobacterium	O
tuberculosis	O
strains	O
expressing	O
mab_0591	O
were	O
generated	O
,	O
as	O
was	O
an	O
m	O
.	O
	
abscessus	O
deletion	O
mutant	O
deficient	B-T169
for	O
mab_0591	O
.	O
	
mic	O
assays	O
were	O
used	O
to	O
study	O
susceptibility	B-T169
to	O
rifampicin	B-T109
and	O
c25	B-T109
carbamate	I-T109
-modified	O
rifamycin	B-T109
derivatives	I-T109
.	O
	
heterologous	B-T080
expression	O
of	O
mab_0591	O
conferred	O
rifampicin	B-T109
resistance	O
to	O
e	O
.	O
	
coli	O
and	O
m	O
.	O
	
tuberculosis	O
rifamycin	B-T109
mic	O
values	O
were	O
consistently	O
lower	O
for	O
the	O
m	O
.	O
	
abscessus	O
δarrmab	O
mutant	O
as	O
compared	B-T052
with	O
the	O
m	O
.	O
	
abscessus	O
atcc	O
19977	O
parental	O
type	O
strain	O
.	O
	
the	O
rifamycin	B-T109
wt	O
phenotype	O
was	O
restored	O
after	O
complementation	O
of	O
the	O
m	O
.	O
	
abscessus	O
δarrmab	O
mutant	O
with	O
arrmab	B-T116
further	O
mic	O
data	O
demonstrated	O
that	O
a	O
c25	B-T109
modification	B-T033
increases	O
rifamycin	B-T109
activity	B-T169
in	O
wt	O
m	O
.	O
	
abscessus	O
however	O
,	O
mic	B-T062
studies	I-T062
in	O
the	O
m	O
.	O
	
abscessus	O
δarrmab	O
mutant	O
suggest	O
that	O
c25	B-T109
modified	O
rifamycins	B-T109
are	O
still	O
subject	O
to	O
modification	B-T033
by	O
arr_mab	B-T116
conclusions	O
our	O
findings	O
identify	O
arr_mab	B-T116
as	O
the	O
major	O
innate	O
rifamycin	B-T109
resistance	O
determinant	O
of	O
m	O
.	O
	
abscessus	O
.	O
	
our	O
data	O
also	O
indicate	O
that	O
arr_mab	B-T116
-mediated	O
rifamycin	B-T109
resistance	O
in	O
m	O
.	O
	
abscessus	O
can	O
only	O
in	O
part	O
be	O
overcome	O
by	O
c25	B-T109
carbamate	I-T109
modification	B-T033
.	O
	
the	O
silorane-based	O
resin	O
composites	O
a	O
review	B-T170
this	O
article	B-T170
aims	O
to	O
review	B-T170
the	O
research	B-T062
done	O
on	O
the	O
silorane-based	O
resin	O
composites	O
sbrc	O
regarding	O
polymerization	O
shrinkage	B-T169
and	O
contraction	O
stresses	O
and	O
their	O
ability	O
to	O
improve	O
the	O
shortcomings	O
of	O
the	O
methacrylate-based	O
resin	O
composites	O
mrbc	O
.	O
	
special	O
attention	O
is	O
given	O
to	O
their	O
physical	O
and	O
mechanical	O
properties	O
,	O
bond	B-T081
strength	I-T081
,	O
marginal	B-T061
adaptation	I-T061
,	O
and	O
cusp	O
deflection	O
.	O
	
the	O
clinical	B-T033
significance	I-T033
of	O
this	O
material	O
is	O
critically	O
appraised	O
with	O
a	O
focus	O
on	O
the	O
ability	O
of	O
sbrc	O
to	O
strengthen	O
the	O
tooth	O
structure	O
as	O
a	O
direct	O
restorative	O
material	O
.	O
	
a	O
search	O
of	O
english	O
peer-reviewed	B-T170
dental	I-T170
literature	I-T170
2003-2015	O
from	O
pubmed	B-T170
and	O
medline	B-T170
databases	B-T170
was	O
conducted	O
with	O
the	O
terms	O
""""	O
low	B-T080
shrinkage	B-T169
""""	O
and	O
""""	O
silorane	O
composites	O
""""	O
the	O
list	O
was	O
screened	O
,	O
and	O
70	O
articles	B-T170
that	O
were	O
relevant	O
to	O
the	O
objectives	B-T170
endoscopic	O
endonasal	O
surgery	B-T061
for	O
remission	B-T033
of	O
cushing's	B-T047
disease	I-T047
caused	O
by	O
ectopic	B-T082
intracavernous	B-T169
macroadenoma	O
case	B-T170
report	I-T170
and	O
literature	B-T170
review	I-T170
complete	O
surgical	B-T061
resection	I-T061
of	O
an	O
acth-secreting	O
pituitary	O
adenoma	O
is	O
the	O
gold	B-T080
standard	I-T080
of	O
treatment	B-T061
of	O
cushing's	B-T047
disease	I-T047
.	O
	
ectopic	B-T082
location	B-T082
of	O
these	O
adenomas	O
is	O
an	O
extremely	O
rare	B-T080
condition	O
that	O
may	O
compromise	O
the	O
diagnosis	B-T033
and	O
surgical	B-T061
success	O
.	O
	
we	O
present	O
the	O
first	O
case	O
of	O
an	O
ectopic	B-T082
intracavernous	B-T169
acth-secreting	O
macroadenoma	O
totally	O
resected	O
with	O
endoscopic	O
endonasal	O
surgery	B-T061
ees	B-T061
.	O
	
a	O
36	O
year	O
old	O
female	O
presented	O
with	O
cushing	B-T047
syndrome	I-T047
.	O
	
increased	B-T081
acth	B-T116
,	O
serum	B-T109
cortisol	I-T109
and	O
free	B-T109
urine	I-T109
cortisol	I-T109
levels	B-T080
were	O
identified	O
,	O
however	O
the	O
pituitary	O
mri	O
failed	O
to	O
reveal	O
a	O
pituitary	O
tumor	O
instead	O
,	O
a	O
parasellar	B-T033
lesion	I-T033
in	O
the	O
left	O
cavernous	O
sinus	O
cs	O
was	O
noticed	O
.	O
	
inferior	O
petrosal	O
sinus	O
sampling	O
demonstrated	O
a	O
significant	O
central	B-T082
-to-	O
peripheral	B-T082
and	O
lateralized	O
left-sided	O
acth	B-T116
gradient	O
.	O
	
the	O
patient	O
underwent	O
ees	B-T061
.	O
	
no	B-T033
tumor	I-T033
was	O
found	O
in	O
the	O
sella	O
,	O
however	O
,	O
the	O
left	O
cs	O
was	O
widely	O
explored	O
and	O
a	O
tumor	O
was	O
found	O
lateral	B-T082
to	O
the	O
paraclival	O
segment	O
of	O
the	O
carotid	O
artery	O
.	O
	
there	O
were	O
no	B-T033
complications	O
following	O
ees	B-T061
.	O
	
pathology	O
confirmed	O
the	O
diagnosis	B-T033
of	O
an	O
acth-secreting	O
adenoma	O
.	O
	
during	O
the	O
immediately	O
postoperative	B-T079
course	O
serum	B-T109
cortisol	I-T109
levels	B-T080
dropped	O
below	O
5	O
mcg/dl	O
.	O
	
postoperative	B-T079
mri	O
demonstrated	O
complete	O
tumor	B-T061
resection	I-T061
.	O
	
at	O
20	O
months	O
follow-up	O
,	O
the	O
patient	O
remains	O
in	O
clinical	B-T080
and	O
biochemical	B-T169
remission	B-T033
of	O
cushing's	B-T047
disease	I-T047
.	O
	
only	O
12	O
cases	O
of	O
ectopic	B-T082
intracavernous	B-T169
acth-secreting	O
adenomas	O
have	O
been	O
reported	O
to	O
date	O
and	O
all	O
were	O
microadenomas	O
.	O
	
the	O
presence	O
of	O
an	O
ectopic	B-T082
acth-secreting	O
macroadenoma	O
in	O
the	O
cs	O
represents	O
a	O
surgical	B-T061
challenge	O
.	O
	
ees	B-T061
is	O
the	O
ideal	O
approach	O
for	O
complete	O
resection	B-T061
of	O
ectopic	B-T082
intracavernous	B-T169
adenomas	O
allowing	O
for	O
a	O
wide	O
exploration	B-T061
of	O
the	O
cs	O
with	O
no	B-T033
surgical	B-T061
complications	O
.	O
	
preliminary	O
randomized	B-T062
controlled	I-T062
trial	I-T062
of	O
habit	B-T061
reversal	I-T061
training	I-T061
for	O
treatment	B-T061
of	O
hair	O
pulling	O
in	O
youth	O
this	O
study	B-T062
evaluated	O
the	O
treatment	B-T061
efficacy	B-T080
of	O
habit	B-T061
reversal	I-T061
training	I-T061
hrt	B-T061
relative	O
to	O
treatment	O
as	O
usual	O
tau	O
for	O
children	O
and	O
adolescents	O
aged	O
7-17	O
years	B-T079
with	O
a	O
primary	O
diagnosis	B-T062
of	O
trichotillomania	O
ttm	O
.	O
	
an	O
initial	O
assessment	O
consisting	O
of	O
semistructured	O
interviews	B-T052
and	O
rating	B-T081
scales	I-T081
was	O
conducted	O
.	O
	
participants	B-T098
n	O
=	O
40	O
,	O
85%	O
female	O
meeting	O
diagnostic	B-T170
criteria	I-T170
for	O
ttm	O
were	O
randomized	B-T062
to	O
either	O
8	O
weekly	B-T079
sessions	O
of	O
hrt	B-T061
by	O
trained	O
therapists	O
or	O
8	O
weeks	B-T079
of	O
tau	O
.	O
	
one	O
week	B-T079
after	O
the	O
final	O
hrt	B-T061
session	O
or	O
final	O
tau	O
week	B-T079
,	O
patients	O
completed	O
a	O
posttreatment	O
assessment	O
,	O
followed	O
by	O
1-	O
and	O
3-	O
month	B-T079
follow-up	O
assessments	O
.	O
	
all	O
assessments	O
were	O
conducted	O
by	O
a	O
trained	O
rater	O
who	O
was	O
blinded	B-T062
to	O
treatment	B-T061
condition	B-T080
.	O
	
the	O
group	O
by	O
time	O
analysis	B-T081
of	I-T081
variance	I-T081
yielded	O
a	O
significant	B-T078
interaction	O
on	O
the	O
national	O
institute	O
of	O
mental	O
health	O
-	O
trichotillomania	B-T081
severity	I-T081
scale	I-T081
total	I-T081
score	I-T081
f1	O
=	O
16.47	O
,	O
p	O
<	O
0.001	O
,	O
η	O
=	O
0.30	O
.	O
	
the	O
mean	B-T033
score	I-T033
decreased	O
from	O
12.67	O
4.60	O
at	O
baseline	B-T081
to	O
5.62	O
4.38	O
at	O
posttreatment	O
in	O
the	O
hrt	B-T061
group	B-T098
t20	O
=	O
5.99	O
,	O
p	O
<	O
0.001	O
,	O
d	O
=	O
1.31	O
,	O
whereas	O
the	O
tau	O
group	B-T098
changed	O
from	O
10.42	O
4.35	O
to	O
9.32	O
4.11	O
t18	O
=	O
1.34	O
,	O
p	O
=	O
0.20	O
,	O
d	O
=	O
0.31	O
.	O
	
the	B-T081
massachusetts	I-T081
general	I-T081
hospital-hair	I-T081
pulling	I-T081
scale	I-T081
total	I-T081
score	I-T081
decreased	O
from	O
15.14	O
3.86	O
at	O
baseline	B-T081
to	O
7.14	O
5.54	O
at	O
posttreatment	O
in	O
the	O
hrt	B-T061
group	B-T098
t20	O
=	O
6.16	O
,	O
p	O
<	O
0.001	O
,	O
d	O
=	O
1.34	O
the	O
tau	O
group	B-T098
changed	O
from	O
14.16	O
4.51	O
to	O
12.26	O
4.34	O
t18	O
=	O
1.50	O
,	O
p	O
=	O
0.15	O
,	O
d	O
=	O
0.34	O
.	O
	
on	O
the	O
clinical	B-T170
global	I-T170
impressions-improvement	I-T170
,	O
16/21	O
participants	B-T098
76%	O
were	O
rated	O
as	O
treatment	B-T061
responders	B-T098
in	O
the	O
hrt	B-T061
group	B-T098
versus	O
4/19	O
21%	O
in	O
the	O
tau	O
group	B-T098
χ	O
=	O
12.13	O
,	O
p	O
<	O
0.001	O
,	O
v	O
=	O
0.55	O
.	O
	
at	O
1-	O
month	B-T079
follow-up	O
,	O
10-12	O
treatment	B-T061
responders	B-T098
who	O
completed	O
the	O
assessment	O
maintained	O
improvement	O
.	O
	
at	O
3-	O
month	B-T079
follow-up	O
,	O
six	O
of	O
eight	O
maintained	O
improvement	O
.	O
	
hrt	B-T061
can	O
be	O
an	O
effective	O
treatment	B-T061
for	O
ttm	O
in	O
fully	B-T080
endoscope	O
-	O
controlled	B-T169
clipping	B-T061
bilateral	B-T047
middle	I-T047
cerebral	I-T047
artery	I-T047
aneurysm	I-T047
via	O
unilateral	B-T061
supraorbital	I-T061
keyhole	I-T061
approach	I-T061
clipping	B-T061
bilateral	B-T047
middle	I-T047
cerebral	I-T047
artery	I-T047
bmca	I-T047
aneurysms	I-T047
via	O
unilateral	B-T061
approach	I-T061
in	O
a	O
single-stage	B-T061
operation	I-T061
is	O
considered	O
as	O
a	O
challenge	O
procedure	O
.	O
	
to	O
our	O
knowledge	O
,	O
there	O
is	O
no	O
study	O
in	O
surgical	O
management	O
of	O
patients	O
with	O
bmca	B-T047
aneurysms	I-T047
by	O
fully	O
endoscope	O
-	O
controlled	B-T169
techniques	B-T169
.	O
	
the	O
author	O
reported	O
a	O
patient	O
with	O
bmca	B-T047
aneurysms	I-T047
who	O
underwent	O
aneurysms	B-T061
clipping	I-T061
via	O
a	O
unilateral	B-T061
supraorbital	I-T061
keyhole	I-T061
approach	I-T061
by	O
endoscope	O
-	O
controlled	B-T169
microneurosurgery	B-T061
,	O
and	O
the	O
patient	O
had	O
an	O
uneventful	O
postoperative	B-T079
course	I-T079
without	B-T080
neurologic	B-T080
impairment	O
and	O
complication	O
.	O
	
furthermore	O
,	O
the	O
author	O
discussed	O
the	O
advantages	O
and	O
adaptation	B-T170
of	O
endoscope	O
-	O
controlled	B-T169
clipping	B-T061
bmca	B-T047
aneurysms	I-T047
via	O
unilateral	B-T061
supraorbital	I-T061
keyhole	I-T061
approach	I-T061
.	O
	
novel	B-T080
observations	B-T062
in	O
11	O
heteroresistant	O
vancomycin-intermediate	B-T116
methicillin-resistant	O
staphylococcus	O
aureus	O
strains	O
from	O
south	O
india	O
we	O
report	O
here	O
the	O
draft	O
genome	O
sequences	O
of	O
11	O
heteroresistant	O
vancomycin-intermediate	O
staphylococcus	O
aureus	O
hvisa	O
strains	O
from	O
bloodstream	O
infection	O
.	O
	
all	O
strains	O
harbor	O
mutations	O
in	O
vrasr	O
,	O
grasr	O
,	O
walkr	O
,	O
and/or	O
tcarab	O
and	O
are	O
often	O
implicated	O
as	O
the	O
frequently	O
mutated	O
candidate	O
genes	O
in	O
hvisa	O
phenotypes	O
.	O
	
endpoints	B-T080
for	O
screening	O
thyroid	O
cancer	O
in	O
the	O
republic	O
of	O
korea	O
thyroid	O
specialists	O
'	O
perspectives	O
cancer	O
screening	O
is	O
aimed	O
primarily	O
at	O
reducing	B-T080
deaths	B-T033
from	O
the	O
specific	O
cancer	O
.	O
	
thyroid-specific	O
cancer	O
mortality	B-T081
may	O
be	O
the	O
most	O
ambitious	O
endpoint	B-T080
for	O
obtaining	O
estimates	B-T081
of	O
screening	O
effect	B-T080
.	O
	
numerous	B-T081
observations	O
have	O
accumulated	B-T033
over	O
the	O
years	O
,	O
indicating	O
that	O
thyroid	O
cancer	O
mortality	B-T081
endpoint	B-T080
has	O
been	O
difficult	B-T080
to	O
study	O
and	O
is	O
confounded	O
by	O
population	O
heterogeneity	O
,	O
provision	O
of	O
randomization	B-T062
,	O
and	O
requirement	B-T169
of	O
large	O
cohorts	B-T098
with	O
sufficiently	O
long	O
follow-up	O
due	O
to	O
the	O
excellent	B-T080
prognosis	O
of	O
the	O
cancer	O
.	O
	
accordingly	O
,	O
it	O
may	O
be	O
important	B-T080
to	O
reconsider	O
how	O
to	O
best	O
measure	O
thyroid	O
cancer	O
screening	O
efficacy	B-T080
.	O
	
recommendations	B-T078
against	O
thyroid	O
cancer	O
screening	O
should	O
be	O
based	O
upon	O
trials	O
designed	O
to	O
evaluate	O
its	O
effectiveness	B-T080
not	O
only	O
in	O
significant	B-T080
reduction	I-T080
in	O
cancer	O
mortality	B-T081
,	O
but	O
also	O
of	O
other	O
distinct	O
endpoint	B-T080
s	O
.	O
	
it	O
is	O
desirable	O
to	O
evaluate	O
derivative	O
endpoints	B-T080
that	O
can	O
reliably	O
predict	O
reductions	B-T081
in	I-T081
mortality	I-T081
.	O
	
the	O
term	O
"""derivative"""	O
means	O
a	O
variable	O
that	O
is	O
related	O
to	O
the	O
true	O
endpoint	B-T080
and	O
is	O
likely	O
to	O
be	O
observable	O
before	O
the	O
primary	O
endpoint	B-T080
.	O
	
derivative	O
endpoints	B-T080
may	O
include	O
thyroid	O
cancer	O
incidence	B-T081
,	O
the	O
proportion	B-T081
of	O
early-stage	B-T079
tumors	O
detected	B-T033
,	O
more	O
treatable	O
stage	O
,	O
the	O
identification	B-T080
of	O
small	B-T080
tumors	I-T080
to	O
maintain	O
in	O
observation	O
,	O
decrease	O
in	O
the	O
number	O
of	O
people	O
who	O
develop	O
metastatic	O
disease	O
,	O
the	O
increased	B-T081
chance	O
of	O
lesser	O
extent	O
surgery	B-T061
,	O
and	O
the	O
application	O
of	O
minimally	B-T169
invasive	I-T169
approaches	I-T169
,	O
as	O
well	O
as	O
no	O
need	O
for	O
lifelong	B-T079
thyroid	B-T061
replacement	I-T061
therapy	I-T061
,	O
a	O
consistent	B-T078
follow-up	O
,	O
low-dose	B-T081
or	O
no	O
rai	O
administration	O
and	O
risk	B-T170
factor	I-T170
assessments	I-T170
where	O
case	O
findings	O
should	O
be	O
continuous	B-T078
.	O
	
the	O
korean	B-T098
guidelines	O
for	O
thyroid	O
cancer	O
national-level	O
screening	O
were	O
published	O
by	O
a	O
relevant	O
group	O
of	O
multidisciplinary	O
thyroid	O
experts	O
.	O
	
it	O
was	O
concluded	O
that	O
the	O
evidence	O
is	O
insufficient	O
to	O
balance	O
the	O
benefits	O
and	O
harms	O
of	O
thyroid	O
cancer	O
screening	O
.	O
	
however	O
,	O
the	O
paper	O
seems	O
to	O
raise	O
the	O
necessary	O
investments	O
in	O
future	O
research	O
and	O
demand	O
a	O
complete	O
analysis	O
for	O
derivative	O
endpoints	O
,	O
and	O
offer	O
screening	O
participants	O
with	O
complete	O
information	O
necessary	O
to	O
make	O
decisions	O
that	O
will	O
provide	O
them	O
with	O
the	O
most	O
value	O
when	O
a	O
small	O
thyroid	O
cancer	O
is	O
screen-	O
identified	B-T080
zebrafish	O
adult	O
pigment	O
stem	O
cells	O
are	O
multipotent	O
and	O
form	O
pigment	O
cells	O
by	O
a	O
progressive	B-T169
fate	O
restriction	O
process	O
clonal	O
analysis	O
identifies	B-T080
shared	O
origin	O
of	O
all	O
pigment	O
cell	O
types	O
skin	B-T033
pigment	I-T033
pattern	O
formation	O
is	O
a	O
paradigmatic	B-T061
example	O
of	O
pattern	O
formation	O
.	O
	
in	O
zebrafish	O
,	O
the	O
adult	O
body	O
stripes	O
are	O
generated	B-T052
by	O
coordinated	B-T169
rearrangement	O
of	O
three	B-T081
distinct	O
pigment	O
cell-types	O
,	O
black	B-T080
melanocytes	O
,	O
shiny	B-T080
iridophores	O
and	O
yellow	B-T080
xanthophores	O
.	O
	
a	O
stem	O
cell	O
origin	O
of	O
melanocytes	O
and	O
iridophores	O
has	O
been	O
proposed	O
although	O
the	O
potency	B-T080
of	O
those	O
stem	O
cells	O
has	O
remained	B-T080
unclear	B-T033
.	O
	
xanthophores	O
,	O
however	O
,	O
seemed	O
to	O
originate	O
predominantly	B-T080
from	O
proliferation	O
of	O
embryonic	O
xanthophores	O
.	O
	
now	O
,	O
data	B-T078
from	O
singh	O
et	O
al	O
.	O
	
shows	O
that	O
all	O
three	B-T081
cell-types	O
derive	B-T080
from	O
shared	O
stem	O
cells	O
,	O
and	O
that	O
these	O
cells	O
generate	B-T052
peripheral	B-T082
neural	O
cell-types	O
too	O
.	O
	
furthermore	O
,	O
clonal	O
compositions	B-T080
are	O
best	O
explained	O
by	O
a	O
progressive	B-T169
fate	O
restriction	O
model	O
generating	B-T052
the	O
individual	B-T080
cell-types	O
.	O
	
the	O
numbers	B-T081
of	O
adult	O
pigment	O
stem	O
cells	O
associated	B-T080
with	I-T080
the	O
dorsal	O
root	O
ganglia	O
remain	B-T033
low	B-T080
,	O
but	O
progenitor	O
numbers	B-T081
increase	B-T169
significantly	O
during	B-T079
larval	O
development	O
up	O
to	O
metamorphosis	O
,	O
likely	O
via	O
production	O
of	O
partially	B-T081
restricted	B-T169
progenitors	O
on	O
the	O
spinal	O
nerves	O
.	O
	
covalent	O
modulators	O
of	O
the	O
vacuolar	B-T116
atpase	I-T116
the	O
vacuolar	B-T116
h	I-T116
atpase	I-T116
v-atpase	B-T116
is	O
a	O
complex	O
multisubunit	O
machine	B-T169
that	O
regulates	O
important	O
cellular	O
processes	O
through	O
controlling	B-T169
acidity	B-T081
of	O
intracellular	B-T082
compartments	O
in	O
eukaryotes	O
.	O
	
existing	O
small-molecule	B-T109
modulators	O
of	O
v-atpase	B-T116
either	O
are	O
restricted	B-T169
to	O
targeting	O
one	O
membranous	B-T080
subunit	B-T081
of	O
v-atpase	B-T116
or	O
have	O
poorly	O
understood	O
mechanisms	B-T169
of	O
action	O
.	O
	
small	B-T109
molecules	I-T109
with	O
novel	B-T080
and	O
defined	B-T080
mechanisms	B-T169
of	O
inhibition	O
are	O
thus	O
needed	B-T080
to	O
functionally	B-T169
characterize	B-T052
v-atpase	B-T116
and	O
to	O
fully	O
evaluate	O
the	O
therapeutic	B-T169
relevance	B-T080
of	O
v-atpase	B-T116
in	O
human	O
diseases	B-T047
.	O
	
we	O
have	O
discovered	O
electrophilic	B-T080
quinazolines	B-T109
that	O
covalently	O
modify	O
a	O
soluble	B-T080
catalytic	O
subunit	O
of	O
v-atpase	B-T116
with	O
high	B-T080
potency	B-T081
and	O
exquisite	O
proteomic	B-T080
selectivity	I-T080
as	O
revealed	B-T080
by	O
fluorescence	O
imaging	O
and	O
chemical	O
proteomic	O
activity-based	O
profiling	O
.	O
	
the	O
site	B-T082
of	O
covalent	O
modification	B-T169
was	O
mapped	B-T052
to	O
a	O
cysteine	B-T116
residue	O
located	B-T082
in	I-T082
a	O
region	O
of	O
v-atpase	B-T116
subunit	B-T116
a	I-T116
that	O
is	O
thought	O
to	O
regulate	O
the	O
dissociation	O
of	O
v-atpase	B-T116
.	O
	
we	O
further	O
demonstrate	O
that	O
a	O
previously	O
reported	O
v-atpase	O
inhibitor	O
,	O
3-bromopyruvate	B-T109
,	O
also	O
targets	B-T169
the	O
same	B-T080
cysteine	B-T116
residue	O
and	O
that	O
our	O
electrophilic	B-T080
quinazolines	B-T109
modulate	B-T082
the	O
function	B-T169
of	O
v-atpase	B-T116
in	O
cells	O
.	O
	
with	O
their	O
well-defined	B-T080
mechanism	B-T169
of	O
action	B-T052
and	O
high	B-T080
proteomic	B-T081
specificity	I-T081
,	O
the	O
described	O
quinazolines	B-T109
offer	O
a	O
powerful	B-T081
set	O
of	O
chemical	O
probes	O
to	O
investigate	B-T169
the	O
physiological	B-T169
and	O
pathological	B-T169
roles	O
of	O
association	B-T080
of	O
radiomics	O
and	O
metabolic	B-T169
tumor	B-T081
volumes	I-T081
in	O
radiation	B-T061
treatment	I-T061
of	O
glioblastoma	O
multiforme	O
to	O
build	O
a	O
framework	O
for	O
investigation	O
of	O
the	O
associations	B-T080
between	O
imaging	O
,	O
clinical	B-T081
target	I-T081
volumes	I-T081
ctvs	B-T081
,	O
and	O
metabolic	B-T169
tumor	B-T081
volumes	I-T081
mtvs	B-T081
features	B-T080
for	O
better	O
understanding	O
of	O
the	O
underlying	O
information	B-T078
in	O
the	O
ctvs	B-T081
and	O
dependencies	O
between	O
these	O
volumes	B-T081
.	O
	
high-throughput	B-T170
extraction	I-T170
of	O
imaging	O
and	O
metabolomic	O
quantitative	B-T081
features	B-T080
from	O
magnetic	O
resonance	O
imaging	O
mri	O
and	O
magnetic	O
resonance	O
spectroscopic	O
imaging	O
of	O
glioblastoma	O
multiforme	O
gbm	O
results	O
in	O
tens	O
of	O
variables	O
per	O
patient	O
.	O
	
in	O
radiation	B-T061
therapy	I-T061
of	O
gbm	O
the	O
relevant	B-T080
metabolic	B-T169
tumor	B-T081
volumes	I-T081
mtvs	B-T081
are	O
related	O
to	O
aberrant	B-T080
levels	B-T080
of	O
n-acetyl	B-T116
aspartate	I-T116
naa	B-T116
and	O
choline	B-T109
cho	B-T109
.	O
	
the	O
corresponding	O
clinical	B-T081
target	I-T081
volumes	I-T081
ctvs	B-T081
for	O
radiation	B-T061
therapy	I-T061
are	O
based	O
on	O
contrast-enhanced	O
t1-weighted	O
ce-t1w	O
and	O
t2-weighted	O
t2w	O
inversion	O
recovery	O
mri	O
.	O
	
necrotic	B-T033
portions	I-T033
,	O
enhancing	B-T033
lesion	I-T033
,	O
and	O
edema	O
were	O
manually	O
contoured	O
on	O
ce-t1w	B-T170
/	O
t2w	B-T170
images	I-T170
for	O
17	O
gbm	O
patients	O
.	O
	
clinical	B-T081
target	I-T081
volumes	I-T081
and	O
mtvs	B-T081
for	O
naa	B-T116
mtvnaa	B-T081
and	O
cho	B-T109
mtvcho	B-T081
were	O
constructed	O
.	O
	
imaging	O
and	O
metabolic	O
features	O
related	O
to	O
size	B-T082
,	O
shape	B-T082
,	O
and	O
signal	B-T081
intensities	I-T081
of	O
the	O
volumes	B-T081
were	O
extracted	O
.	O
	
tumors	O
were	O
also	O
scored	O
categorically	O
for	O
10	O
semantic	B-T078
imaging	B-T080
traits	I-T080
by	O
a	O
neuroradiologist	O
.	O
	
all	O
features	B-T080
were	O
investigated	B-T169
for	O
redundancy	B-T169
.	O
	
two-way	B-T080
correlations	I-T080
between	O
imaging	B-T170
and	O
ctvs	B-T081
/	O
mtvs	B-T081
features	O
were	O
visualized	O
as	O
heatmaps	O
.	O
	
associations	B-T080
between	O
mtvnaa	B-T081
and	O
mtvcho	B-T081
and	O
imaging	B-T080
features	I-T080
were	O
studied	O
using	O
spearman	B-T170
correlation	I-T170
.	O
	
forty-eight	O
imaging	B-T080
features	I-T080
were	O
extracted	O
per	O
patient	O
.	O
	
half	B-T081
of	O
the	O
imaging	B-T080
traits	I-T080
were	O
replaced	B-T169
with	O
automatically	O
extracted	O
continuous	B-T080
variables	I-T080
.	O
	
twenty	O
features	B-T080
were	O
extracted	O
from	O
ctvs	B-T081
and	O
mtvs	B-T081
.	O
	
a	O
series	O
of	O
semantic	B-T078
imaging	B-T080
traits	I-T080
were	O
replaced	B-T169
with	O
automatically	O
extracted	O
continuous	B-T080
variables	I-T080
.	O
	
there	O
were	O
multiple	O
22	O
significant	O
correlations	B-T080
of	O
imaging	B-T080
measures	I-T080
with	O
ctvs	B-T081
/	O
mtvnaa	B-T081
,	O
whereas	O
there	O
were	O
only	O
6	O
with	O
ctvs	B-T081
/	O
mtvcho	B-T081
.	O
	
a	O
framework	O
for	O
investigation	O
of	O
codependencies	O
between	O
mri	O
and	O
magnetic	O
resonance	O
spectroscopic	O
imaging	O
radiomic	O
features	B-T080
and	O
ctvs	B-T081
/	O
mtvs	B-T081
has	O
been	O
established	O
.	O
	
the	O
mtv	B-T081
for	O
naa	B-T116
was	O
found	O
to	O
be	O
closely	O
associated	B-T080
with	I-T080
mri	O
volumes	B-T081
,	O
whereas	O
very	O
few	O
imaging	B-T080
features	I-T080
were	O
related	O
to	O
mtvcho	B-T081
,	O
indicating	O
that	O
cho	B-T109
provides	O
additional	B-T079
information	I-T079
to	O
measurement	B-T169
of	O
fidgeting	B-T033
in	O
patients	O
with	O
anorexia	O
nervosa	O
using	O
a	O
novel	O
shoe	O
-based	O
monitor	O
to	O
objectively	O
assess	O
seated	B-T033
non-exercise	O
physical	O
activity	O
in	O
patients	O
with	O
anorexia	O
nervosa	O
an	O
relative	O
to	O
healthy	B-T080
controls	I-T080
hcs	B-T080
and	O
examine	O
the	O
associations	B-T080
between	O
this	O
physical	O
activity	O
,	O
eating	O
disorder	O
pathology	O
,	O
and	O
levels	B-T080
of	O
anxiety	B-T033
and	O
depression	O
.	O
	
eleven	O
inpatients	O
with	O
an	O
and	O
10	O
hcs	B-T080
wore	O
a	O
shoe	O
-based	O
accelerometer	O
smartshoe	O
at	O
three	O
time	B-T079
points	I-T079
a	O
while	B-T079
eating	I-T079
lunch	I-T079
,	O
b	O
filling	B-T079
out	I-T079
questionnaires	I-T079
,	O
and	O
c	O
watching	B-T079
television	I-T079
for	I-T079
1h	I-T079
.	O
	
across	O
all	O
three	O
tasks	O
,	O
patients	O
with	O
an	O
were	O
significantly	O
more	B-T169
active	I-T169
than	O
hcs	B-T080
,	O
thereby	O
engaging	O
in	O
a	O
greater	B-T081
degree	I-T081
of	O
restless	O
or	O
fidgeting	B-T033
behavior	O
.	O
	
degree	B-T081
of	O
physical	O
activity	O
was	O
positively	B-T033
correlated	I-T033
with	O
eating	O
disorder	O
psychopathology	O
in	O
the	O
sample	O
with	O
an	O
,	O
and	O
a	O
trend	O
towards	O
a	O
positive	B-T033
association	I-T033
between	O
physical	O
activity	O
and	O
levels	B-T080
of	O
depression	O
and	O
anxiety	B-T033
was	O
also	O
found	O
in	O
this	O
sample	O
.	O
	
among	O
individuals	B-T098
with	O
an	O
,	O
physical	O
activity	O
was	O
not	B-T033
significantly	O
correlated	B-T080
with	O
bmi	O
,	O
duration	B-T079
of	I-T079
illness	I-T079
,	O
or	O
number	B-T081
of	I-T081
days	I-T081
since	O
hospital	O
admission	O
.	O
	
use	O
of	O
a	O
minimally	B-T169
invasive	I-T169
,	O
shoe	O
-based	O
monitor	O
revealed	O
patients	O
with	O
an	O
engaged	O
in	O
a	O
greater	B-T081
degree	I-T081
of	O
fidgeting	B-T033
relative	O
to	O
hcs	B-T080
during	O
quiet	O
,	O
seated	B-T033
tasks	O
and	O
this	O
heightened	O
activity	O
was	O
related	O
to	O
measures	B-T081
of	O
pathology	O
.	O
	
non-exercise	O
physical	O
activity	O
,	O
including	O
fidgeting	B-T033
,	O
may	O
warrant	O
further	O
clinical	B-T080
attention	O
in	O
this	O
patient	O
population	O
.	O
	
hospital	O
clowning	O
a	O
paediatrician's	O
view	O
this	O
study	B-T062
investigates	B-T169
the	O
current	B-T079
position	O
of	O
hospital	O
clowns	O
from	O
the	O
perspective	O
of	O
paediatricians	O
and	O
paediatric	O
residents	O
.	O
	
a	O
total	B-T080
of	O
14	O
attending	O
paediatricians	O
and	O
paediatric	O
residents	O
participated	B-T169
in	O
two	O
focus	O
group	O
sessions	O
.	O
	
data	B-T078
were	O
analysed	B-T062
using	O
atlas.ti	O
5.0	O
.	O
	
in	O
general	B-T082
,	O
physicians	O
reported	B-T170
positive	B-T033
experiences	O
regarding	O
the	O
interaction	B-T033
between	O
hospital	O
clowns	O
and	O
paediatric	O
patients	O
on	O
the	O
ward	O
.	O
	
physicians	O
were	O
more	O
interested	O
in	O
research	B-T062
on	O
children's	O
perception	O
of	O
hospital	O
clowns	O
than	O
in	O
research	B-T062
on	O
the	O
clinical	B-T080
efficacy	I-T080
of	O
hospital	O
clowning	O
.	O
	
no	B-T080
direct	I-T080
collaboration	O
between	O
physicians	O
and	O
hospital	O
clowns	O
was	O
reported	B-T170
.	O
	
however	O
,	O
physicians	O
proposed	B-T080
conditions	B-T080
which	O
may	O
streamline	B-T080
their	O
encounters	O
with	O
hospital	O
clowns	O
such	O
as	O
clear	O
communication	O
prior	B-T079
to	O
hospital	O
clown	O
visits	O
,	O
and	O
the	O
condition	B-T080
that	O
visits	O
do	O
not	O
impede	B-T080
medical	B-T061
interventions	I-T061
.	O
	
overall	B-T080
,	O
paediatricians	O
and	O
paediatric	O
residents	O
view	O
the	O
positive	B-T033
impact	B-T080
on	O
paediatric	O
patients	O
as	O
the	O
most	O
important	B-T080
aspect	B-T080
of	O
hospital	O
clown	O
visits	O
,	O
rather	O
than	O
the	O
clinical	B-T080
efficacy	I-T080
of	O
hospital	O
clowning	O
.	O
	
in	O
light	O
of	O
the	O
growing	O
number	O
of	O
hospital	O
clowns	O
worldwide	B-T098
,	O
this	O
article	B-T170
provides	O
recommendations	B-T078
for	O
arranging	O
their	O
encounters	O
with	O
paediatricians	O
and	O
paediatric	O
residents	O
to	O
maintain	B-T052
optimal	B-T080
health	O
care	O
.	O
	
what	O
is	O
known	O
previous	B-T079
studies	B-T062
show	O
a	O
clinically	B-T078
significant	I-T078
pain	O
-	O
and	O
anxiety	B-T033
-	O
reducing	B-T080
effect	I-T080
of	O
hospital	O
clowning	O
in	O
paediatric	O
patients	O
admitted	O
to	O
hospitals	O
or	O
undergoing	B-T080
invasive	B-T080
medical	O
procedures	O
.	O
	
in	O
general	O
,	O
paediatricians	O
have	O
positive	B-T033
ideas	B-T078
about	O
hospital	O
clowns	O
,	O
aside	O
from	O
personal	O
prejudices	O
.	O
	
what	O
is	O
new	O
this	O
novel	B-T080
study	B-T062
gives	O
deeper	O
insight	O
into	O
day-to-day	B-T079
interaction	B-T033
between	O
paediatricians	O
and	O
hospital	O
clowns	O
on	O
the	O
ward	O
.	O
	
this	O
study	B-T062
provides	O
recommendations	B-T078
for	O
clinical	B-T170
practice	I-T170
to	O
arrange	O
encounters	O
between	O
physicians	O
and	O
hospital	O
clowns	O
during	O
hospital	O
clown	O
visits	O
.	O
	
multiparametric	B-T062
estimation	I-T062
of	O
brain	O
hemodynamics	O
with	O
mr	O
fingerprinting	O
asl	O
assessment	O
of	O
brain	O
hemodynamics	O
without	O
exogenous	B-T169
contrast	O
agents	O
is	O
of	O
increasing	B-T169
importance	B-T080
in	O
clinical	O
applications	O
.	O
	
this	O
study	O
aims	O
to	O
develop	O
an	O
mr	O
perfusion	O
technique	O
that	O
can	O
provide	O
noncontrast	B-T033
and	O
multiparametric	B-T062
estimation	I-T062
of	O
hemodynamic	O
markers	O
.	O
	
we	O
devised	O
an	O
arterial	O
spin	O
labeling	O
asl	O
method	O
based	O
on	O
the	O
principle	O
of	O
mr	O
fingerprinting	O
mrf	O
,	O
referred	B-T169
to	O
as	O
mrf-asl	O
.	O
	
by	O
taking	O
advantage	O
of	O
the	O
rich	O
information	B-T078
contained	O
in	O
mrf	O
sequence	O
,	O
up	O
to	O
seven	O
hemodynamic	O
parameters	B-T033
can	O
be	O
estimated	B-T081
concomitantly	B-T079
.	O
	
feasibility	B-T062
demonstration	I-T062
,	O
flip	B-T080
angle	I-T080
optimization	B-T052
,	O
comparison	B-T052
with	O
look-locker	O
asl	O
,	O
reproducibility	B-T080
test	I-T080
,	O
sensitivity	B-T169
to	O
hypercapnia	B-T033
challenge	I-T033
,	O
and	O
initial	O
clinical	O
application	O
in	O
an	O
intracranial	B-T061
steno-occlusive	I-T061
process	I-T061
,	O
moyamoya	B-T047
disease	I-T047
,	O
were	O
performed	B-T169
to	O
evaluate	O
this	O
technique	B-T169
.	O
	
magnetic	O
resonance	O
fingerprinting	O
asl	O
provided	B-T052
estimation	O
of	O
up	O
to	O
seven	O
parameters	B-T033
,	O
including	O
b1+	B-T081
,	O
tissue	O
t1	B-T081
,	O
cerebral	B-T033
blood	I-T033
flow	I-T033
cbf	B-T033
,	O
tissue	O
bolus	B-T033
arrival	I-T033
time	I-T033
bat	B-T033
,	O
pass-through	O
arterial	O
bat	B-T033
,	O
pass-through	O
blood	O
volume	O
,	O
and	O
pass-through	O
blood	O
travel	O
time	O
.	O
	
coefficients	B-T081
of	O
variation	B-T080
of	O
the	O
estimated	B-T081
parameters	B-T033
ranged	O
from	O
0.2	O
to	O
9.6	O
.	O
	
hypercapnia	B-T033
resulted	O
in	O
an	O
increase	B-T169
in	O
cbf	B-T033
by	O
57.7	O
,	O
and	O
a	O
decrease	B-T081
in	O
bat	B-T033
by	O
13.7	O
and	O
24.8	O
in	O
tissue	O
and	O
vessels	O
,	O
respectively	O
.	O
	
patients	O
with	O
moyamoya	B-T047
disease	I-T047
showed	O
diminished	B-T081
cbf	B-T033
and	O
lengthened	B-T169
bat	B-T033
that	O
could	B-T033
not	I-T033
be	I-T033
detected	I-T033
with	O
regular	B-T080
asl	O
.	O
	
magnetic	O
resonance	O
fingerprinting	O
asl	O
is	O
a	O
promising	O
technique	B-T169
for	O
noncontrast	B-T033
,	O
multiparametric	B-T062
perfusion	O
assessment	O
.	O
	
magn	O
reson	O
med	O
,	O
2016	O
.	O
	
2016	O
international	O
society	O
for	O
magnetic	O
resonance	O
in	O
medicine	O
.	O
	
acute	B-T079
sensitivity	B-T169
of	O
the	O
vernal	O
pool	O
fairy	O
shrimp	O
,	O
branchinecta	O
lynchi	O
anostraca	O
branchinectidae	O
,	O
and	O
surrogate	O
species	O
to	O
10	O
chemicals	O
vernal	O
pool	O
fairy	O
shrimp	O
,	O
branchinecta	O
lynchi	O
,	O
branchiopoda	O
anostraca	O
and	O
other	O
fairy	O
shrimp	O
species	O
have	O
been	O
listed	O
as	O
threatened	B-T098
or	O
endangered	B-T098
under	O
the	O
us	O
endangered	O
species	O
act	O
.	O
	
because	O
few	O
data	B-T078
exist	O
about	O
the	O
sensitivity	B-T169
of	O
branchinecta	O
spp	O
.	O
	
to	O
toxic	O
effects	O
of	O
contaminants	O
,	O
it	O
is	O
difficult	O
to	O
determine	O
whether	O
they	O
are	O
adequately	O
protected	O
by	O
water	B-T080
quality	I-T080
criteria	B-T078
.	O
	
a	O
series	O
of	O
acute	O
24-h	O
lethality/immobilization	O
tests	O
was	O
conducted	O
with	O
3	O
species	O
of	O
fairy	O
shrimp	O
b	O
.	O
	
lynchi	O
,	O
branchinecta	O
lindahli	O
,	O
and	O
thamnocephalus	O
platyurus	O
and	O
10	O
chemicals	O
with	O
varying	O
modes	O
of	O
toxic	O
action	O
ammonia	O
,	O
potassium	O
,	O
chloride	O
,	O
sulfate	O
,	O
chromium	O
,	O
copper	O
,	O
nickel	O
,	O
zinc	O
,	O
alachlor	B-T109
,	O
and	O
metolachlor	B-T109
.	O
	
the	O
same	O
chemicals	O
were	O
tested	O
in	O
48-	O
h	B-T079
tests	O
with	O
other	O
branchiopods	O
the	O
cladocerans	O
daphnia	O
magna	O
and	O
ceriodaphnia	O
dubia	O
and	O
an	O
amphipod	O
hyalella	O
azteca	O
,	O
and	O
in	O
96-	O
h	B-T079
tests	O
with	O
snails	O
physa	O
gyrina	O
and	O
lymnaea	O
stagnalis	O
.	O
	
median	O
effect	B-T081
concentrations	I-T081
ec50s	B-T081
for	O
b	O
.	O
	
lynchi	O
were	O
strongly	O
correlated	B-T080
r	O
=	O
0.975	O
with	O
ec50s	B-T081
for	O
the	O
commercially	O
available	O
fairy	O
shrimp	O
species	O
t	O
.	O
	
platyurus	O
for	O
most	O
chemicals	O
tested	O
.	O
	
comparison	B-T052
of	O
ec50s	B-T081
for	O
fairy	O
shrimp	O
and	O
ec50s	B-T081
for	O
invertebrate	O
taxa	O
tested	O
concurrently	O
and	O
with	O
other	O
published	O
toxicity	O
data	B-T078
indicated	O
that	O
fairy	O
shrimp	O
were	O
relatively	O
sensitive	B-T169
to	O
potassium	O
and	O
several	O
trace	O
metals	O
compared	B-T052
with	O
other	O
invertebrate	O
taxa	O
,	O
although	O
cladocerans	O
,	O
amphipods	O
,	O
and	O
mussels	O
had	O
similar	O
broad	O
toxicant	O
sensitivity	B-T169
.	O
	
interspecies	B-T170
correlation	I-T170
estimation	I-T170
models	I-T170
for	O
predicting	O
toxicity	O
to	O
fairy	O
shrimp	O
from	O
surrogate	O
species	O
indicated	O
that	O
models	B-T170
with	O
cladocerans	O
and	O
freshwater	O
mussels	O
as	O
surrogates	O
produced	O
the	O
best	O
predictions	O
of	O
the	O
sensitivity	B-T169
of	O
fairy	O
shrimp	O
to	O
contaminants	O
.	O
	
the	O
results	O
of	O
these	O
studies	B-T062
indicate	O
that	O
fairy	O
shrimp	O
are	O
relatively	O
sensitive	B-T169
to	O
a	O
range	O
of	O
toxicants	O
,	O
but	O
endangered	O
species	O
act	O
-listed	O
fairy	O
shrimp	O
of	O
the	O
genus	O
branchinecta	O
were	O
not	O
consistently	O
more	O
sensitive	B-T169
than	O
other	O
fairy	O
shrimp	O
taxa	O
.	O
	
bi-layered	O
constructs	O
of	O
poly	B-T109
-	O
β-tricalcium	O
phosphate	O
for	O
bone-soft	O
tissue	O
interface	B-T169
applications	I-T169
this	O
study	B-T062
aims	O
to	O
establish	O
a	O
facile	O
protocol	B-T170
for	O
the	O
preparation	B-T052
of	O
a	O
bi-layered	B-T080
poly	B-T109
pgs	B-T109
β-tricalcium	O
phosphate	O
β-tcp	O
construct	O
and	O
to	O
investigate	B-T169
its	O
potential	O
for	O
bone-soft	O
tissue	O
engineering	B-T061
applications	B-T169
.	O
	
the	O
layered	B-T082
structure	I-T082
was	O
prepared	O
by	O
distributing	B-T169
the	O
ceramic	O
particles	O
within	O
a	O
prepolymer	O
synthesized	B-T052
in	O
a	O
microwave	O
reactor	O
followed	O
by	O
a	O
cross-linking	O
of	O
the	O
final	O
construct	O
in	O
vacuum	O
<10mbar	O
.	O
	
the	O
vacuum	O
stage	B-T079
led	O
to	O
the	O
separation	O
of	O
cross-linked	O
elastomer	B-T109
top	B-T082
and	O
ceramic	O
bottom	B-T082
phases	B-T079
.	O
	
results	O
showed	O
that	O
addition	O
of	O
β-tcp	O
particles	O
to	O
the	O
elastomer	B-T109
matrix	I-T109
after	O
the	O
polymerization	O
led	O
to	O
an	O
increase	B-T169
in	O
compression	B-T081
strength	I-T081
up	O
to	O
14	O
.	O
	
tensile	B-T081
strength	I-T081
σ	O
,	O
young's	B-T081
modulus	I-T081
e	O
,	O
and	O
elongation	B-T081
at	I-T081
break	I-T081
%	O
values	O
were	O
calculated	O
as	O
0.29	O
and	O
0.21	O
0.38	O
and	O
1.95	O
and	O
240	O
and	O
24	O
for	O
pgs	B-T109
and	O
pgs	B-T109
/	O
β-tcp	O
bi-layered	O
constructs	O
,	O
respectively	O
.	O
	
morphology	B-T082
was	O
characterized	O
by	O
using	O
scanning	O
electron	O
microscopy	O
sem	O
and	O
micro-computed	O
tomography	O
μ-ct	O
.	O
	
tomography	O
data	B-T078
revealed	O
an	O
open	B-T080
porosity	I-T080
of	O
35%	O
for	O
the	O
construct	O
,	O
mostly	O
contributed	O
from	O
the	O
ceramic	B-T079
phase	I-T079
since	O
the	O
elastomer	B-T109
side	B-T082
has	O
no	O
pore	B-T082
.	O
	
homogeneous	B-T080
β-tcp	O
distribution	B-T169
within	O
the	O
elastomeric	B-T082
structure	I-T082
was	O
observed	O
.	O
	
cell	O
culture	O
studies	O
confirmed	O
biocompatibility	O
with	O
poor	O
elastomer	B-T109
-	O
side	B-T082
and	O
good	O
bone	O
-	O
side	B-T082
cell	O
attachment	O
.	O
	
in	O
a	O
further	O
study	O
to	O
investigate	B-T169
the	O
osteogenic	O
properties	B-T080
,	O
the	O
construct	O
were	O
loaded	O
with	O
bmp-2	B-T116
and/or	O
tgf-β1	B-T116
.	O
	
the	O
pgs	B-T109
/	O
β-tcp	O
bi-layered	O
constructs	O
with	O
improved	O
mechanical	B-T080
and	O
biological	B-T080
properties	B-T080
have	O
the	O
potential	O
to	O
be	O
used	O
in	O
bone-soft	O
tissue	O
interface	B-T169
applications	I-T169
where	O
soft	O
tissue	O
penetration	B-T169
is	O
a	O
effects	B-T080
of	I-T080
high-intensity	O
training	O
on	O
cardiovascular	B-T047
risk	I-T047
factors	I-T047
in	O
premenopausal	B-T033
and	O
postmenopausal	B-T033
women	B-T098
menopause	O
is	O
associated	B-T080
with	I-T080
increased	B-T081
risk	O
of	O
cardiovascular	B-T047
disease	I-T047
and	O
the	O
causal	O
factors	B-T169
have	O
been	O
proposed	O
to	O
be	O
the	O
loss	B-T081
of	O
estrogen	B-T109
and	O
the	O
subsequent	O
alterations	O
of	O
the	O
hormonal	O
milieu	O
.	O
	
however	O
,	O
which	O
factors	B-T169
contribute	B-T052
to	O
the	O
deterioration	O
of	O
cardiometabolic	O
health	O
in	O
postmenopausal	B-T033
women	B-T098
is	O
debated	O
as	O
the	O
menopausal	O
transition	B-T052
is	O
also	O
associated	B-T080
with	I-T080
increased	B-T081
age	O
and	O
fat	O
mass	O
.	O
	
furthermore	O
,	O
indications	B-T078
of	O
reduced	B-T080
cardiometabolic	O
adaptations	O
to	O
exercise	O
in	O
postmenopausal	B-T033
women	B-T098
add	O
to	O
the	O
adverse	O
health	B-T080
profile	I-T080
.	O
	
we	O
sought	O
to	O
evaluate	O
risk	B-T033
factors	I-T033
for	O
type	B-T047
2	I-T047
diabetes	I-T047
and	O
cardiovascular	B-T047
disease	I-T047
in	O
late	B-T079
premenopausal	B-T033
and	O
early	B-T079
postmenopausal	B-T033
women	B-T098
,	O
matched	O
by	O
age	O
and	O
body	O
composition	O
,	O
and	O
investigate	B-T169
the	O
effect	O
of	O
high-intensity	O
training	O
.	O
	
a	O
3-month	O
high-intensity	O
aerobic	O
training	O
intervention	B-T061
,	O
involving	O
healthy	B-T080
,	O
nonobese	B-T033
,	O
late	B-T079
premenopausal	B-T033
n	O
=	O
40	O
and	O
early	B-T079
postmenopausal	B-T033
n	O
=	O
39	O
women	B-T098
was	O
conducted	O
and	O
anthropometrics	O
,	O
body	O
composition	O
,	O
blood	O
pressure	O
,	O
lipid	O
profile	O
,	O
glucose	O
tolerance	O
,	O
and	O
maximal	O
oxygen	O
consumption	O
were	O
determined	O
at	O
baseline	B-T081
and	O
after	O
the	O
intervention	B-T061
.	O
	
at	O
baseline	B-T081
,	O
the	O
groups	B-T098
matched	O
in	O
anthropometrics	O
and	O
body	O
composition	O
,	O
and	O
only	O
differed	O
by	O
4.2	O
years	O
in	O
age	O
mean	O
95%	O
confidence	B-T081
limits	I-T081
49.2	O
48.5	O
vs	O
53.4	O
52.4	O
years	O
.	O
	
time	O
since	O
last	O
menstrual	O
period	O
for	O
the	O
postmenopausal	B-T033
women	B-T098
was	O
mean	O
95%	O
confidecnce	B-T081
limits	I-T081
3.1	O
2.6	O
years	O
.	O
	
hormonal	O
levels	O
estrogen	B-T109
,	O
follicle	B-T116
stimulation	I-T116
hormone	I-T116
,	O
luteinizing	B-T116
hormone	I-T116
confirmed	O
menopausal	O
status	O
.	O
	
at	O
baseline	B-T081
the	O
postmenopausal	B-T033
women	B-T098
had	O
higher	O
total	B-T109
cholesterol	I-T109
p	O
<	O
001	O
,	O
low-density	B-T109
lipoprotein-cholesterol	I-T109
p	O
<	O
05	O
,	O
and	O
high-density	B-T109
lipoprotein-cholesterol	I-T109
p	O
<	O
001	O
than	O
the	O
premenopausal	B-T033
women	B-T098
.	O
	
the	O
training	O
intervention	B-T061
reduced	B-T080
body	O
weight	O
p	O
<	O
01	O
,	O
waist	O
circumference	O
p	O
<	O
01	O
,	O
and	O
improved	B-T033
body	O
composition	O
by	O
increasing	B-T169
lean	O
body	O
mass	O
p	O
<	O
001	O
and	O
decreasing	B-T033
fat	O
mass	O
p	O
<	O
001	O
similarly	O
in	O
both	O
groups	B-T098
.	O
	
moreover	O
,	O
training	O
resulted	O
in	O
lower	B-T033
diastolic	I-T033
blood	I-T033
pressure	I-T033
p	O
<	O
05	O
,	O
resting	B-T033
heart	I-T033
rate	I-T033
p	O
<	O
001	O
,	O
total	B-T109
cholesterol	I-T109
p	O
<	O
01	O
,	O
low-density	B-T109
lipoprotein-cholesterol	I-T109
p	O
<	O
01	O
,	O
total	B-T109
cholesterol	I-T109
/	O
high-density	B-T109
lipoprotein-cholesterol	I-T109
index	O
p	O
<	O
01	O
,	O
and	O
improved	B-T033
plasma	O
insulin	O
concentration	O
during	O
the	O
oral	O
glucose	O
tolerance	O
test	O
p	O
<	O
05	O
in	O
both	O
groups	B-T098
.	O
	
cardiovascular	B-T047
risk	I-T047
factors	I-T047
are	O
similar	O
in	O
late	B-T079
premenopausal	B-T033
and	O
early	B-T079
postmenopausal	B-T033
women	B-T098
,	O
matched	O
by	O
age	O
and	O
body	O
composition	O
,	O
with	O
the	O
exception	O
that	O
postmenopausal	B-T033
women	B-T098
have	O
higher	O
high-	O
and	O
low-density	O
lipoprotein-cholesterol	O
levels	O
.	O
	
a	O
3-month	O
intervention	B-T061
of	O
high-intensity	O
aerobic	O
training	O
reduces	O
risk	B-T033
factors	I-T033
for	O
type	B-T047
2	I-T047
diabetes	I-T047
and	O
cardiovascular	B-T047
disease	I-T047
to	O
a	O
similar	O
extent	O
in	O
late	B-T079
premenopausal	B-T033
and	O
early	B-T079
postmenopausal	B-T033
women	B-T098
.	O
	
correlation	B-T080
between	O
preoperative	B-T079
physical	B-T033
signs	I-T033
and	O
functional	B-T169
outcomes	B-T169
after	O
laminoplasty	B-T061
for	O
ossification	O
of	O
the	O
posterior	O
longitudinal	O
ligament	O
ossification	O
of	O
the	O
posterior	O
longitudinal	O
ligament	O
opll	O
can	O
cause	O
myelopathy	B-T047
that	O
is	O
often	B-T079
managed	O
surgically	B-T061
.	O
	
knowledge	O
of	O
predictors	B-T078
of	O
surgical	B-T061
outcomes	B-T080
can	O
provide	B-T052
decision	B-T170
support	I-T170
to	O
surgeons	O
.	O
	
the	O
aims	B-T078
of	O
this	O
study	B-T062
were	O
to	O
investigate	B-T169
the	O
relationships	B-T080
between	O
preoperative	B-T079
physical	B-T033
signs	I-T033
and	O
postoperative	B-T079
functional	B-T169
outcomes	B-T169
in	O
patients	O
with	O
opll	O
and	O
to	O
clarify	B-T052
whether	O
physical	B-T033
signs	I-T033
could	O
predict	B-T078
functional	B-T169
outcomes	B-T169
.	O
	
fifty-five	O
patients	O
with	O
opll	O
who	O
had	O
undergone	O
cervical	B-T061
laminoplasty	I-T061
were	O
included	B-T169
in	O
this	O
study	B-T062
.	O
	
six	O
physical	B-T033
signs	I-T033
including	O
hyperreflexia	B-T033
,	O
babinski	B-T033
sign	I-T033
,	O
sensory	B-T047
disturbance	I-T047
,	O
grip	B-T081
strength	I-T081
,	O
10-s	O
grip	O
and	O
release	O
test	O
,	O
and	O
bladder	O
dysfunction	O
,	O
and	O
four	O
other	O
factors	B-T169
including	O
age	O
,	O
duration	B-T079
of	I-T079
symptoms	I-T079
,	O
history	O
of	O
minor	O
trauma	O
and	O
preoperative	B-T079
japanese	B-T081
orthopaedic	I-T081
association	I-T081
joa	I-T081
score	I-T081
were	O
investigated	B-T169
as	O
potential	B-T080
predictive	B-T080
prognostic	O
factors	O
using	O
both	O
univariate	B-T062
and	O
multivariate	B-T081
analyses	I-T081
.	O
	
the	O
mean	B-T081
recovery	B-T081
rate	I-T081
of	O
joa	B-T081
score	I-T081
was	O
62.5	O
32.5	O
.	O
	
the	O
neurological	B-T080
recovery	B-T081
rate	I-T081
was	O
negatively	B-T033
associated	B-T080
with	I-T080
age	O
p	O
=	O
0.002	O
,	O
the	O
duration	B-T079
of	I-T079
symptoms	I-T079
p	O
=	O
0.002	O
and	O
babinski	B-T033
sign	I-T033
p	O
=	O
0.007	O
,	O
whereas	O
it	O
was	O
positively	B-T033
correlated	B-T080
with	O
grip	B-T081
strength	I-T081
p	O
=	O
0.011	O
.	O
	
multiple	B-T170
logistic	I-T170
regression	I-T170
analyses	I-T170
revealed	B-T080
that	O
age	O
odds	B-T081
ratio	I-T081
0.89	O
,	O
95%	O
ci	B-T081
0.81	O
and	O
babinski	B-T033
sign	I-T033
odds	B-T081
ratio	I-T081
0.18	O
,	O
95%	O
ci	B-T081
0.04	O
were	O
factors	B-T169
associated	B-T080
with	I-T080
functional	B-T169
outcomes	B-T169
.	O
	
satisfactory	B-T080
functional	B-T169
outcomes	B-T169
could	O
be	O
expected	B-T170
for	O
patients	O
who	O
are	O
young	B-T079
and	O
do	O
not	O
exhibit	O
the	O
babinski	B-T033
sign	I-T033
,	O
showing	O
that	O
the	O
babinski	B-T033
sign	I-T033
could	O
be	O
useful	B-T080
as	O
an	O
indicator	B-T169
of	O
the	O
window	B-T080
of	I-T080
opportunity	I-T080
for	O
achieving	B-T080
satisfactory	B-T080
functional	B-T169
outcomes	B-T169
.	O
	
bacteria	O
and	O
hoverflies	O
diptera	O
syrphidae	O
in	O
tree	O
hollows	O
from	O
the	O
iberian	O
mediterranean	O
forest	O
saproxylic	O
insect	O
communities	O
inhabiting	B-T082
tree	O
hollows	O
in	O
mediterranean	O
forests	O
depend	O
on	O
a	O
combination	O
of	O
physical	B-T080
characteristics	I-T080
and	O
interactions	B-T169
occurring	O
between	O
community	O
member	O
species	O
.	O
	
despite	O
the	O
need	O
to	O
preserve	O
these	O
organisms	O
,	O
little	O
is	O
known	O
about	O
their	O
interrelationships	B-T080
,	O
in	O
particular	O
those	O
relationships	B-T080
between	O
saproxylic	O
insects	O
and	O
microbiota	O
occurring	O
in	O
these	O
microhabitats	B-T082
.	O
	
in	O
tree	O
hollows	O
of	O
quercus	O
rotundifolia	O
lamark	O
that	O
hold	B-T169
water	I-T169
and	O
contain	O
dead	O
leaves	O
,	O
abundant	O
microbial	O
populations	O
can	O
be	O
found	O
.	O
	
developing	O
on	O
them	O
are	O
the	O
larvae	O
of	O
mallota	O
dusmeti	O
andréu	O
,	O
1926	O
diptera	O
syrphidae	O
,	O
a	O
vulnerable	O
species	O
iucn	B-T170
category	I-T170
marcos-garcía	B-T098
and	O
quinto	B-T098
2011	O
.	O
	
this	O
study	O
provides	O
the	O
first	O
data	O
on	O
the	O
microbiota	O
living	B-T082
inside	I-T082
the	O
gut	O
of	O
the	O
larvae	O
of	O
m	O
.	O
	
dusmeti	O
,	O
as	O
well	O
as	O
the	O
microbiota	O
in	O
the	O
hollow	B-T082
where	O
these	O
larvae	O
develop	O
.	O
	
bacteria	O
were	O
identified	O
by	O
amplification	O
and	O
partial	O
sequencing	O
of	O
the	O
v1-v3	O
regions	O
and	O
the	O
complete	O
nucleotide	O
sequence	O
of	O
16s	O
rrna	O
genes	O
.	O
	
we	O
found	O
eight	O
species	O
of	O
bacteria	O
living	B-T082
in	I-T082
tree	O
hollows	O
and	O
three	O
species	O
in	O
the	O
gut	O
of	O
m	O
.	O
	
dusmeti	O
larvae	O
bacillus	O
cereus	O
,	O
bacillus	O
toyonensis	O
,	O
and	O
lysinibacillus	O
sphaericus	O
the	O
filter-feeding	B-T033
mechanism	I-T033
characteristic	I-T033
of	O
m	O
.	O
	
dusmeti	O
larvae	O
is	O
selective	O
in	O
enabling	O
ingestion	O
of	O
bacteria	O
impact	O
sports	O
and	O
bone	O
fractures	O
among	O
adolescents	O
the	O
objective	O
of	O
the	O
present	O
study	B-T062
was	O
to	O
investigate	B-T169
the	O
effects	B-T080
of	I-T080
different	B-T080
sports	O
on	O
stress	O
fractures	O
among	O
adolescents	O
during	O
a	O
9-	O
month	B-T079
follow-up	O
period	B-T079
.	O
	
the	O
sample	B-T098
was	O
composed	O
of	O
184	O
adolescents	O
divided	O
into	O
three	O
groups	B-T098
impact	O
sports	O
n	O
=	O
102	O
swimming	O
n	O
=	O
35	O
non-sports	O
n	O
=	O
47	O
.	O
	
the	O
occurrence	B-T079
of	O
stress	O
fracture	O
was	O
reported	O
by	O
participants	B-T098
and	O
coaches	O
.	O
	
as	O
potential	O
confounders	B-T169
we	O
considered	O
age	O
,	O
sex	O
,	O
resistance	B-T061
training	I-T061
,	O
body	O
composition	O
variables	B-T080
and	O
age	O
at	O
peak	B-T080
of	O
height	B-T081
velocity	I-T081
.	O
	
there	O
were	O
13	O
adolescents	O
who	O
reported	O
fractures	O
during	O
the	O
9-	O
month	B-T079
period	B-T079
.	O
	
bone	O
mineral	O
density	O
values	B-T080
were	O
higher	O
in	O
adolescents	O
engaged	O
in	O
impact	O
sports	O
p-value	B-T081
=	O
0.002	O
.	O
	
independently	O
of	O
confounders	B-T169
,	O
the	O
risk	B-T078
of	O
stress	O
fracture	O
was	O
lower	O
in	O
adolescents	O
engaged	O
in	O
impact	O
sports	O
than	O
in	O
non-active	O
adolescents	O
hazard	B-T081
ratio	I-T081
hr	B-T081
=	O
0.23	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
=	O
0.05	O
to	O
0.98	O
,	O
while	O
swimming	O
practice	O
was	O
not	O
associated	O
to	O
lower	O
risk	B-T078
of	O
fracture	O
hr	B-T081
=	O
0.49	O
95%	O
ci	B-T081
=	O
0.09	O
to	O
2.55	O
.	O
	
in	O
conclusion	O
,	O
the	O
findings	B-T033
from	O
this	O
study	B-T062
indicate	O
the	O
importance	O
of	O
sports	O
participation	B-T169
among	O
adolescents	O
in	O
the	O
reduction	B-T080
of	O
stress	O
fracture	O
risk	B-T078
,	O
especially	O
with	O
impact	O
sports	O
.	O
	
more	O
importantly	O
,	O
these	O
results	B-T169
could	O
be	O
relevant	B-T080
for	O
recognising	O
adolescents	O
in	O
danger	O
of	O
not	O
reaching	O
their	O
potential	O
for	O
peak	B-T080
bone	O
mass	O
and	O
later	O
an	O
increased	B-T081
risk	B-T078
of	O
the	O
business	O
of	O
health	O
physics	O
-	O
jobs	O
in	O
a	O
changing	O
market	O
the	O
health	O
physics	O
profession	O
was	O
born	O
abruptly	O
when	O
once	O
rare	O
and	O
precious	O
radioactive	O
materials	O
became	O
commonplace	B-T081
.	O
	
the	O
technological	O
advancements	O
that	O
triggered	O
an	O
industrial	B-T080
complex	I-T080
and	O
ended	O
world	O
war	O
ii	O
demanded	O
radiation	O
safety	O
on	O
an	O
unprecedented	B-T170
scale	I-T170
.	O
	
until	O
then	O
,	O
protective	O
measures	O
against	O
radiation	O
were	O
largely	O
absent	O
in	O
laboratories	O
.	O
	
over	O
the	O
subsequent	O
decades	O
,	O
health	O
physicists	O
began	O
protecting	B-T061
people	I-T061
and	O
the	O
environment	O
in	O
a	O
wide	O
range	O
of	O
settings	O
including	O
medical	O
,	O
research	B-T062
,	O
and	O
industrial	O
.	O
	
the	O
use	B-T033
of	I-T033
radioactive	I-T033
materials	I-T033
and	O
radiation-generating	O
devices	O
is	O
prevalent	B-T082
today	I-T082
.	O
	
radiation	B-T081
doses	I-T081
occur	O
continuously	O
including	O
during	O
airline	O
flights	O
,	O
in	O
our	O
homes	O
,	O
during	O
medical	O
procedures	O
,	O
and	O
in	O
energy	O
production	O
.	O
	
radiation	O
is	O
integral	B-T169
to	I-T169
numerous	I-T169
applications	I-T169
including	O
those	O
in	O
medicine	O
,	O
dentistry	O
,	O
manufacturing	O
,	O
construction	O
,	O
scientific	B-T062
research	I-T062
,	O
nuclear	O
electric	O
power	O
generation	O
,	O
and	O
oil	O
and	O
gas	O
exploration	O
.	O
	
activities	O
that	O
were	O
once	O
groundbreaking	O
have	O
now	O
become	O
routine	B-T080
and	O
scripted	B-T170
.	O
	
at	O
higher	B-T081
doses	I-T081
,	O
health	B-T033
effects	I-T033
are	O
understood	B-T169
and	I-T169
avoided	I-T169
.	O
	
instruments	O
for	O
the	O
detection	O
and	O
measurement	O
of	O
radiation	O
are	O
at	O
times	O
smarter	O
than	O
their	O
users	O
.	O
	
ironically	O
,	O
the	O
same	O
health	O
physics	O
community	O
that	O
has	O
been	O
successful	O
in	O
demonstrating	O
that	O
exposures	O
to	O
radiation	O
and	O
to	O
radioactive	O
materials	O
can	O
be	O
effectively	O
managed	O
is	O
shrinking	O
at	O
an	O
increasingly	O
rapid	B-T081
rate	I-T081
.	O
	
this	O
paper	O
highlights	O
the	O
creation	B-T052
of	O
past	O
and	O
current	O
jobs	O
,	O
predicts	O
the	O
future	O
opportunities	B-T078
in	I-T078
the	I-T078
profession	I-T078
,	O
and	O
makes	O
recommendations	B-T078
necessary	O
to	O
protect	O
the	O
disappearing	O
specialties	O
.	O
	
permanence	B-T079
can	O
be	O
defended	O
in	O
donation	O
after	O
the	O
circulatory-respiratory	O
determination	O
of	O
death	O
dcdd	O
,	O
the	O
dead	O
donor	B-T098
rule	B-T170
requires	B-T080
that	O
the	O
donor	B-T098
be	O
dead	O
before	B-T079
organ	O
procurement	O
can	O
proceed	O
.	O
	
under	O
the	O
relevant	B-T080
limb	I-T080
of	O
the	O
uniform	B-T170
determination	I-T170
of	I-T170
death	I-T170
act	I-T170
1981	I-T170
usa	I-T170
,	O
a	O
person	B-T098
is	O
dead	O
when	O
the	O
cessation	B-T052
of	O
circulatory-respiratory	B-T169
function	I-T169
is	O
'	O
irreversible	B-T033
'	O
.	O
	
critics	O
of	O
current	B-T079
practice	O
in	O
dcdd	O
have	O
argued	O
that	O
the	O
donor	B-T098
is	O
not	O
dead	O
at	O
the	O
time	B-T079
organs	O
are	O
procured	O
,	O
and	O
so	O
the	O
procurement	O
of	O
organs	O
from	O
these	O
donors	B-T098
violates	O
the	O
dead	O
donor	B-T098
rule	B-T170
.	O
	
we	O
offer	B-T033
a	O
new	B-T080
argument	O
here	O
in	O
defence	O
of	O
current	B-T079
dcdd	O
practice	O
,	O
and	O
,	O
in	O
particular	O
,	O
of	O
the	O
interpretation	B-T170
of	O
the	O
requirement	B-T169
of	O
'	O
irreversibility	B-T033
'	O
as	O
untypeable	B-T080
hepatitis	O
c	O
virus	O
subtypes	O
in	O
pakistan	O
a	O
neglected	O
section	O
diagnostically	B-T169
untypeable	B-T080
subtypes	O
contribute	O
a	O
considerable	O
percent	O
of	O
hepatitis	O
c	O
virus	O
hcv	O
subtypes	O
in	O
pakistan	O
.	O
	
in	O
the	O
present	O
study	B-T062
,	O
chronically	B-T047
infected	I-T047
hcv	O
patients	O
with	O
known	O
viremia	B-T047
were	O
subjected	O
to	O
hcv	O
genotyping	O
.	O
	
among	O
the	O
total	O
retrieved	O
samples	O
,	O
92.7	O
64/69	O
were	O
found	O
typeable	B-T080
while	O
7.24	O
5/69	O
were	O
diagnostically	B-T169
untypeable	B-T080
.	O
	
in	O
conclusion	B-T078
,	O
the	O
presence	O
of	O
large	O
number	O
of	O
untypeable	B-T080
hcv	O
subtypes	O
emphasizes	O
the	O
need	O
of	O
an	O
updated	O
type	B-T080
-	O
specific	B-T080
genotyping	O
assay	O
and	O
consideration	O
of	O
primers	O
for	O
proportionally	O
rare	B-T080
subtypes	O
to	O
minimize	B-T080
the	O
number	O
of	O
untypeable	B-T080
hcv	O
subtypes	O
.	O
	
itpr3	O
gene	O
haplotype	O
is	O
associated	O
with	O
cervical	O
squamous	O
cell	O
carcinoma	O
risk	B-T078
in	O
taiwanese	B-T098
women	B-T098
host	O
immunogenetic	O
background	O
plays	O
an	O
important	O
role	O
in	O
human	B-T047
papillomavirus	I-T047
hpv	I-T047
infection	I-T047
and	O
cervical	O
cancer	O
development	O
.	O
	
inositol	O
1	O
receptor	O
type	O
3	O
itpr3	O
is	O
essential	O
for	O
both	O
immune	O
activation	O
and	O
cancer	O
pathogenesis	O
.	O
	
we	O
aim	O
to	O
investigate	O
if	O
itpr3	O
genetic	O
polymorphisms	O
are	O
associated	O
with	O
the	O
risk	B-T081
of	I-T081
cervical	I-T081
cancer	I-T081
in	O
taiwanese	B-T098
women	B-T098
.	O
	
itpr3	O
rs3748079	O
a/g	O
and	O
rs2229634	O
c/t	O
polymorphisms	O
were	O
genotyped	O
in	O
a	O
hospital-based	B-T062
study	I-T062
of	O
462	O
women	B-T098
with	O
cervical	O
squamous	O
cell	O
carcinoma	O
cscc	O
and	O
921	O
age-matched	O
healthy	B-T080
control	I-T080
women	B-T098
.	O
	
the	O
presence	O
and	O
genotypes	O
of	O
hpv	O
in	O
cscc	O
was	O
determined	O
.	O
	
no	O
significant	O
association	O
of	O
individual	O
itpr3	O
variants	O
were	O
found	O
among	O
controls	O
,	O
cscc	O
,	O
and	O
hpv-16	O
positive	O
cscc	O
.	O
	
however	O
,	O
we	O
found	O
a	O
significant	O
association	O
of	O
haplotype	O
at	O
between	O
cscc	O
and	O
controls	O
or	B-T081
=	O
2.28	O
,	O
95%	O
ci	B-T081
1.31	O
,	O
p	O
=	O
2.83	O
10-3	O
and	O
the	O
or	B-T081
increased	O
further	O
in	O
cscc	O
patients	O
infected	O
with	O
hpv-16	O
or	B-T081
=	O
2.89	O
,	O
95%	O
ci	B-T081
1.55	O
,	O
p	O
=	O
4.54	O
10-4	O
.	O
	
the	O
linkage	O
disequilibrium	O
analysis	O
demonstrated	O
that	O
itpr3	O
association	O
with	O
cscc	O
was	O
independent	O
of	O
hla-drb1	O
alleles	O
.	O
	
in	O
conclusion	O
,	O
these	O
findings	O
suggest	O
that	O
at	O
haplotype	O
in	O
the	O
itpr3	O
gene	O
may	O
serve	O
as	O
a	O
potential	O
marker	O
for	O
genetic	O
susceptibility	O
to	O
defining	O
categories	B-T170
of	O
actionability	B-T052
for	O
secondary	B-T080
findings	B-T033
in	O
next-generation	O
sequencing	O
next-generation	O
sequencing	O
is	O
increasingly	O
used	O
in	O
clinical	O
practice	O
for	O
the	O
diagnosis	B-T033
of	O
mendelian	B-T047
diseases	I-T047
.	O
	
because	O
of	O
the	O
high	O
likelihood	O
of	O
secondary	B-T080
findings	B-T033
associated	O
with	O
this	O
technique	B-T169
,	O
the	O
process	O
of	O
informing	O
patients	O
is	O
beset	O
with	O
new	O
challenges	O
.	O
	
one	O
of	O
them	O
is	O
regarding	O
the	O
type	O
of	O
secondary	B-T080
findings	B-T033
that	O
ought	O
to	O
be	O
disclosed	O
to	O
patients	O
.	O
	
the	O
aim	O
of	O
this	O
research	B-T062
is	O
to	O
propose	O
a	O
practical	O
implementation	B-T052
of	O
the	O
notion	O
of	O
actionability	B-T052
,	O
a	O
common	O
criteria	O
justifying	O
the	O
disclosure	O
of	O
secondary	B-T080
findings	B-T033
but	O
whose	O
interpretation	B-T170
varies	O
greatly	O
among	O
professionals	O
.	O
	
we	O
distinguish	O
three	O
types	O
of	O
actionability	B-T052
corresponding	O
to	O
1	O
well-established	O
medical	B-T169
actions	B-T052
,	O
2	O
patient	O
-initiated	O
health-related	O
actions	O
and	O
3	O
life-plan	O
decisions	O
.	O
	
we	O
argue	O
that	O
actionability	B-T052
depends	O
on	O
the	O
characteristics	O
of	O
the	O
mutation	O
or	O
gene	O
and	O
on	O
the	O
values	O
of	O
patients	O
.	O
	
in	O
discussing	O
the	O
return	O
of	O
secondary	B-T080
findings	B-T033
,	O
it	O
is	O
important	O
that	O
the	O
physician	O
tries	O
to	O
get	O
an	O
impression	B-T080
of	O
the	O
specific	O
situation	O
and	O
values	O
of	O
patients	O
.	O
	
regarding	O
variants	O
of	O
uncertain	O
clinical	B-T033
significance	I-T033
in	O
actionable	O
genes	O
,	O
we	O
found	O
that	O
different	O
understandings	O
of	O
autonomy	B-T078
lead	O
to	O
different	O
conclusions	B-T078
and	O
that	O
,	O
for	O
some	O
of	O
them	O
,	O
it	O
may	O
be	O
legitimate	O
to	O
refrain	O
from	O
returning	O
uncertain	O
allergen	O
valency	B-T081
,	O
dose	B-T081
,	O
and	O
fcεri	B-T116
occupancy	B-T080
set	O
thresholds	B-T080
for	O
secretory	O
responses	O
to	O
pen	B-T116
a	I-T116
1	I-T116
and	O
motivate	O
design	B-T052
of	O
hypoallergens	O
ag	O
-mediated	O
crosslinking	O
of	O
ige	B-T116
-	O
fcεri	B-T116
complexes	B-T116
activates	O
mast	O
cells	O
and	O
basophils	O
,	O
initiating	O
the	O
allergic	O
response	O
.	O
	
of	O
34	O
donors	O
recruited	O
having	O
self-reported	B-T062
shrimp	O
allergy	O
,	O
only	O
35%	O
had	O
significant	O
levels	O
of	O
shrimp-specific	B-T116
ige	I-T116
in	O
serum	O
and	O
measurable	O
basophil	O
secretory	O
responses	O
to	O
rpen	O
a	O
1	O
shrimp	O
tropomyosin	B-T116
.	O
	
we	O
report	O
that	O
degranulation	O
is	O
linked	O
to	O
the	O
number	O
of	O
fcεri	B-T116
occupied	O
with	O
allergen-specific	B-T116
ige	I-T116
,	O
as	O
well	O
as	O
the	O
dose	B-T081
and	O
valency	B-T081
of	O
pen	B-T116
a	I-T116
1	I-T116
.	O
	
using	O
clustered	O
regularly	O
interspaced	O
palindromic	O
repeat-based	O
gene	O
editing	O
,	O
human	O
rbl	O
cells	O
were	O
created	O
that	O
exclusively	O
express	O
the	O
human	O
fcεriα	B-T116
subunit	O
.	O
	
pen	B-T116
a	I-T116
1	I-T116
-	O
specific	B-T116
ige	I-T116
was	O
affinity	O
purified	O
from	O
shrimp	O
-	O
positive	B-T033
plasma	O
.	O
	
cells	O
primed	O
with	O
a	O
range	O
of	O
pen	B-T116
a	I-T116
1	I-T116
-	O
specific	B-T116
ige	I-T116
and	O
challenged	O
with	O
pen	B-T116
a	I-T116
1	I-T116
showed	O
a	O
bell-shaped	O
dose	B-T081
response	O
for	O
secretion	O
,	O
with	O
optimal	O
pen	B-T116
a	I-T116
1	I-T116
doses	B-T081
of	O
0.1	O
ng/ml	O
.	O
	
mathematical	B-T170
modeling	I-T170
provided	O
estimates	O
of	O
receptor	O
aggregation	O
kinetics	O
based	O
on	O
fcεri	B-T116
occupancy	O
with	O
ige	B-T116
and	O
allergen	O
dose	B-T081
.	O
	
maximal	O
degranulation	O
was	O
elicited	O
when	O
2700	O
i	O
ge	B-T116
-	O
fcεri	B-T116
complexes	B-T116
were	O
occupied	O
with	O
specific	B-T116
ige	I-T116
and	O
challenged	O
with	O
pen	B-T116
a	I-T116
1	I-T116
ige	B-T116
epitope	O
valency	B-T081
of	O
8	O
,	O
although	O
measurable	O
responses	O
were	O
achieved	O
when	O
only	O
a	O
few	O
hundred	O
fcεri	B-T116
were	O
occupied	O
.	O
	
prolonged	O
periods	O
of	O
pepsin	B-T116
-mediated	O
pen	B-T116
a	I-T116
1	I-T116
proteolysis	O
,	O
which	O
simulates	O
gastric	B-T080
digestion	O
,	O
were	O
required	O
to	O
diminish	O
secretory	O
responses	O
.	O
	
recombinant	B-T116
fragments	I-T116
60-79	O
aa	O
,	O
which	O
together	O
span	O
the	O
entire	O
length	O
of	O
tropomyosin	B-T116
,	O
were	O
weak	O
secretagogues	O
.	O
	
these	O
fragments	O
have	O
reduced	O
dimerization	O
capacity	B-T081
,	O
compete	O
with	O
intact	O
pen	B-T116
a	I-T116
1	I-T116
for	O
binding	O
to	O
ige	B-T116
-	O
fcεri	B-T116
complexes	B-T116
,	O
and	O
represent	O
a	O
starting	O
point	O
for	O
the	O
design	O
of	O
promising	O
hypoallergens	O
for	O
selected	B-T052
flavonoid	B-T109
compounds	I-T109
as	O
promising	O
inhibitors	O
of	O
protein	B-T116
kinase	I-T116
ck2α	B-T116
and	O
ck2α'	B-T116
,	O
the	O
catalytic	O
subunits	O
of	O
ck2	B-T116
ck2	B-T116
is	O
a	O
ubiquitous	O
protein	B-T116
kinase	I-T116
involved	O
in	O
many	O
cell	O
functions	O
.	O
	
during	O
the	O
last	O
years	B-T079
it	O
became	O
an	O
interesting	O
target	B-T169
in	O
cancer	B-T062
research	I-T062
.	O
	
a	O
series	O
of	O
flavonoid	B-T109
compounds	I-T109
was	O
tested	B-T169
as	O
inhibitors	O
of	O
protein	B-T116
kinase	I-T116
ck2	B-T116
.	O
	
several	O
substances	O
were	O
found	O
to	O
be	O
highly	B-T080
active	B-T078
against	I-T078
both	O
catalytic	O
subunits	O
with	O
ic50	B-T081
values	B-T080
below	O
1	O
μm	O
in	O
case	O
of	O
ck2α'	B-T116
.	O
	
the	O
most	O
promising	O
inhibitor	O
we	O
identified	B-T080
is	O
chrysoeriol	B-T109
with	O
ic50	B-T081
values	B-T080
of	O
250	O
and	O
34	O
nm	O
for	O
ck2α	B-T116
and	O
ck2α'	B-T116
,	O
fibrinogen	B-T116
a	O
marker	O
in	O
predicting	O
diabetic	B-T047
foot	I-T047
ulcer	I-T047
severity	B-T080
aims	O
.	O
	
to	O
examine	O
whether	O
fibrinogen	O
levels	O
are	O
a	O
valuable	O
biomarker	O
for	O
assessing	O
disease	B-T080
severity	I-T080
and	O
monitoring	O
disease	O
progression	O
in	O
patients	O
with	O
diabetic	B-T047
foot	I-T047
ulcer	I-T047
dfu	B-T047
.	O
	
methods	O
.	O
	
a	O
retrospective	B-T062
study	I-T062
was	O
designed	O
to	O
examine	O
the	O
utility	B-T169
of	O
fibrinogen	B-T116
in	O
estimating	O
disease	B-T080
severity	I-T080
in	O
patients	O
with	O
dfu	B-T047
admitted	O
to	O
our	O
hospital	O
between	O
january	B-T080
2015	O
and	O
january	B-T080
2016	O
.	O
	
in	O
total	O
,	O
152	O
patients	O
with	O
dfu	B-T047
were	O
enrolled	O
in	O
the	O
study	O
group	O
,	O
and	O
52	O
age	O
and	O
gender	O
matched	O
people	O
with	O
diabetes	B-T047
but	O
no	O
dfu	B-T047
were	O
included	O
as	O
the	O
control	O
group	O
.	O
	
dfu	B-T047
severity	B-T080
was	O
assessed	O
using	O
wagner	O
criteria	O
.	O
	
results	O
.	O
	
patients	O
with	O
dfu	B-T047
were	O
divided	O
into	O
2	O
subgroups	O
based	O
on	O
the	O
wagner	O
criteria	O
.	O
	
mean	O
fibrinogen	O
values	O
were	O
significantly	B-T081
higher	I-T081
in	O
patients	O
with	O
dfu	B-T047
grade	O
3	O
compared	O
to	O
those	O
with	O
dfu	B-T047
grades	O
1-2	O
5.23	O
1.37	O
g/l	O
versus	O
3.61	O
1.04	O
g/l	O
.	O
	
using	O
roc	B-T081
statistic	I-T081
,	O
a	O
cut-off	B-T081
value	I-T081
of	O
5.13	O
g/l	O
indicated	O
the	O
possible	O
amputation	B-T061
with	O
a	O
sensitivity	B-T081
of	O
81.8	O
and	O
a	O
specificity	B-T081
of	O
78.9	O
positive	B-T081
predictive	I-T081
value	I-T081
ppv	B-T081
78.6	O
,	O
negative	B-T081
predictive	I-T081
value	I-T081
89.0	O
.	O
	
fibrinogen	O
values	O
were	O
found	O
to	O
be	O
correlated	O
with	O
crp	O
levels	O
,	O
neutrophil	O
,	O
and	O
wbc	O
count	O
.	O
	
conclusions	O
.	O
	
fibrinogen	O
levels	O
might	O
be	O
a	O
valuable	O
tool	O
for	O
assessing	O
the	O
disease	B-T080
severity	I-T080
and	O
monitoring	O
the	O
disease	O
progression	O
in	O
patients	O
with	O
nitrogen	O
utilization	O
efficiency	B-T081
and	O
prediction	B-T078
of	O
nitrogen	O
excretion	O
in	O
sheep	O
offered	B-T033
fresh	O
perennial	O
ryegrass	O
nitrogen	O
excretion	O
from	O
sheep	O
production	B-T082
systems	I-T082
is	O
an	O
important	O
source	O
of	O
nitrate	O
,	O
ammonia	O
,	O
and	O
nitrous	O
oxide	O
responsible	O
for	O
groundwater	B-T082
pollution	O
and	O
global	O
warming	O
.	O
	
the	O
present	O
study	B-T062
aimed	O
to	O
identify	B-T080
key	O
parameters	O
influencing	O
n	O
utilization	O
efficiency	B-T081
and	O
develop	O
prediction	B-T078
equations	O
for	O
manure	O
n	O
,	O
feces	O
n	O
,	O
and	O
urine	O
n	O
outputs	O
in	O
sheep	O
.	O
	
data	B-T078
used	O
were	O
collected	O
from	O
82	O
sheep	O
offered	B-T033
fresh	O
perennial	O
ryegrass	O
as	O
the	O
sole	O
diet	O
in	O
6	O
metabolism	O
experiments	B-T062
data	B-T078
from	O
non-grass-only	O
diets	O
were	O
not	B-T169
used	I-T169
.	O
	
sheep	O
were	O
from	O
breeds	O
of	O
highlander	B-T098
,	O
texel	O
,	O
scottish	O
blackface	O
,	O
and	O
swaledale	O
at	O
the	O
age	O
of	O
5	O
to	O
18	O
mo	B-T079
and	O
weighing	O
from	O
24.5	O
to	O
62.7	O
kg	O
.	O
	
herbage	O
was	O
harvested	O
daily	B-T079
from	O
6	O
swards	O
of	O
contrasting	O
harvest	O
dates	B-T079
may	O
to	O
december	O
,	O
offering	B-T033
wide	O
variation	B-T080
in	O
feed	O
value	O
to	O
cover	O
the	O
range	B-T081
that	O
would	O
be	O
offered	B-T033
in	O
most	O
practical	O
farm	B-T082
situations	I-T082
.	O
	
before	O
the	O
commencement	O
of	O
each	O
study	B-T062
,	O
the	O
experimental	B-T080
sward	O
was	O
harvested	O
at	O
a	O
residual	O
height	O
of	O
4	O
cm	O
and	O
allowed	O
to	O
grow	O
for	O
2	O
to	O
4	O
wk	B-T079
to	O
target	B-T169
an	O
average	O
pregrazing	O
sward	O
height	O
in	O
a	O
range	B-T081
of	O
8	O
to	O
15	O
cm	O
depending	B-T169
on	O
the	O
time	B-T081
of	I-T081
year	I-T081
.	O
	
sheep	O
were	O
housed	B-T082
in	O
individual	O
pens	O
for	O
14	O
d	B-T079
and	O
then	O
transferred	B-T033
to	I-T033
individual	O
metabolism	O
crates	O
for	O
4	O
d	B-T079
with	O
feed	B-T052
intake	B-T169
and	O
feces	O
and	O
urine	O
outputs	O
measured	O
.	O
	
data	B-T078
were	O
analyzed	B-T062
using	O
the	O
linear	B-T081
mixed	I-T081
model	I-T081
procedure	I-T081
to	O
develop	O
prediction	B-T078
equations	O
for	O
feces	O
n	O
,	O
urine	O
n	O
,	O
and	O
manure	O
n	O
outputs	O
using	O
n	B-T033
intake	I-T033
,	O
herbage	O
chemical	O
composition	O
,	O
and	O
digestibility	O
with	O
effects	B-T080
of	I-T080
sex	O
,	O
breed	O
,	O
and	O
experimental	O
periods	B-T079
removed	B-T080
.	O
	
nitrogen	O
intake	B-T169
was	O
the	O
best	B-T080
single	B-T078
predictor	I-T078
for	O
n	O
output	O
in	O
feces	O
,	O
urine	O
,	O
and	O
manure	O
,	O
and	O
the	O
value	O
for	O
prediction	B-T078
of	O
manure	O
n	O
output	O
was	O
greater	B-T081
than	O
those	O
for	O
feces	O
n	O
and	O
urine	O
n	O
0.86	O
vs	O
.	O
	
0.70	O
and	O
0.77	O
,	O
respectively	O
<	O
0.001	O
.	O
	
animal	O
bw	O
and	O
herbage	O
dm	O
,	O
ether	B-T081
extract	I-T081
,	O
ndf	O
,	O
adf	O
,	O
water	O
soluble	O
carbohydrate	O
,	O
and	O
de	O
concentrations	O
and	O
n	O
digestibility	O
were	O
also	O
used	O
to	O
predict	B-T078
n	O
outputs	O
because	O
n	O
intake	B-T169
may	O
not	B-T080
be	I-T080
available	I-T080
in	O
commercial	B-T078
practice	I-T078
.	O
	
the	O
prediction	B-T078
equations	O
for	O
n	O
utilizatio	O
n	O
efficiency	B-T081
indicated	O
that	O
increasing	B-T169
feeding	B-T052
level	B-T080
and	O
me	B-T081
concentration	B-T081
and	O
reducing	B-T080
n	B-T033
concentration	I-T033
could	O
improve	B-T033
n	O
utilization	O
efficiency	B-T081
and	O
shift	O
n	O
excretion	O
into	O
feces	O
rather	B-T033
than	I-T033
urine	O
<	O
0.001	O
.	O
	
the	O
equations	O
developed	O
in	O
the	O
current	O
study	B-T062
provide	O
an	O
approach	B-T082
for	O
sheep	O
producers	B-T098
to	O
quantify	B-T081
n	O
excretion	O
against	O
production	O
and	O
,	O
consequently	O
,	O
to	O
develop	O
their	O
own	O
mitigation	B-T062
strategies	I-T062
to	O
reduce	B-T080
the	O
environmental	O
impact	O
of	O
sheep	O
production	B-T082
systems	I-T082
.	O
	
improving	B-T080
protein	B-T116
complex	I-T116
prediction	B-T078
by	O
reconstructing	B-T170
a	O
high-confidence	B-T080
protein-protein	B-T169
interaction	I-T169
network	I-T169
of	O
escherichia	O
coli	O
from	O
different	O
physical	B-T169
interaction	I-T169
data	B-T081
sources	I-T081
although	O
different	O
protein-protein	O
physical	O
interaction	O
ppi	O
datasets	B-T170
exist	O
for	O
escherichia	O
coli	O
,	O
no	O
common	O
methodology	B-T078
exists	O
to	O
integrate	O
these	O
datasets	B-T170
and	O
extract	O
reliable	O
modules	O
reflecting	O
the	O
existing	O
biological	O
process	O
and	O
protein	B-T116
complexes	I-T116
.	O
	
naïve	B-T170
bayesian	I-T170
formula	I-T170
is	O
the	O
highly	O
accepted	O
method	O
to	O
integrate	O
different	O
ppi	O
datasets	B-T170
into	O
a	O
single	O
weighted	B-T081
ppi	B-T169
network	I-T169
,	O
but	O
detecting	O
proper	O
weights	B-T081
in	O
such	O
network	B-T169
is	O
still	O
a	O
major	O
problem	O
.	O
	
in	O
this	O
paper	O
,	O
we	O
proposed	O
a	O
new	O
methodology	B-T078
to	O
integrate	O
various	O
physical	O
ppi	O
datasets	B-T170
into	O
a	O
single	O
weighted	B-T081
ppi	B-T169
network	I-T169
in	O
a	O
way	O
that	O
the	O
detected	B-T033
modules	O
in	O
ppi	B-T169
network	I-T169
exhibit	O
the	O
highest	O
similarity	O
to	O
available	O
functional	B-T169
modules	O
.	O
	
we	O
used	O
the	O
co-expression	B-T061
modules	O
as	O
functional	B-T169
modules	O
,	O
and	O
we	O
shown	O
that	O
direct	O
functional	B-T169
modules	O
detected	B-T033
from	O
gene	B-T170
ontology	I-T170
terms	B-T078
could	O
be	O
used	O
as	O
an	O
alternative	O
dataset	B-T170
.	O
	
after	O
running	O
this	O
integrating	O
methodology	B-T078
over	O
six	O
different	O
physical	O
ppi	O
datasets	B-T170
,	O
orthologous	B-T080
high-confidence	B-T080
interactions	B-T169
from	O
a	O
related	O
organism	O
and	O
two	O
ap-ms	O
ppi	O
datasets	B-T170
gained	B-T033
high	I-T033
weights	I-T033
in	O
the	O
integrated	O
networks	B-T169
,	O
while	O
the	O
weights	B-T081
for	O
one	O
ap-ms	O
ppi	O
dataset	B-T170
and	O
two	O
other	O
datasets	B-T170
derived	O
from	O
public	B-T170
databases	I-T170
have	O
converged	O
to	O
zero	O
.	O
	
the	O
majority	O
of	O
detected	B-T033
modules	O
shaped	O
around	O
one	O
or	O
few	O
hub	B-T116
protein	I-T116
.	O
	
still	O
,	O
a	O
large	O
number	O
of	O
highly	O
interacting	O
protein	B-T116
modules	O
were	O
detected	B-T033
which	O
are	O
functionally	B-T169
relevant	B-T080
and	O
are	O
likely	O
to	O
construct	O
protein	B-T116
complexes	I-T116
.	O
	
we	O
provided	O
a	O
new	O
high	B-T080
confidence	I-T080
protein	B-T116
complex	I-T116
prediction	B-T078
method	O
supported	O
by	O
functional	B-T169
studies	O
and	O
literature	B-T170
aav9	O
-	O
npc1	O
significantly	B-T078
ameliorates	B-T033
purkinje	O
cell	O
death	O
and	O
behavioral	O
abnormalities	O
in	O
mouse	O
npc	B-T047
disease	I-T047
niemann-pick	B-T047
type	I-T047
c	I-T047
npc	I-T047
disease	I-T047
is	O
a	O
fatal	B-T080
inherited	B-T169
neurodegenerative	B-T047
disorder	I-T047
caused	O
by	O
loss-of-function	B-T033
mutations	O
in	O
the	O
npc1	O
or	O
npc2	O
gene	O
.	O
	
there	O
is	O
no	O
effective	O
way	O
to	O
treat	B-T169
npc	B-T047
disease	I-T047
.	O
	
in	O
this	O
study	O
,	O
we	O
used	O
adeno-associated	O
virus	O
aav	O
serotype	B-T170
9	I-T170
aav9	O
to	O
deliver	O
a	O
functional	B-T169
npc1	O
gene	O
systemically	B-T169
into	O
npc1	O
mice	O
at	O
postnatal	B-T061
day	I-T061
4	I-T061
.	O
	
one	O
single	B-T081
aav9-npc1	B-T061
injection	I-T061
resulted	O
in	O
robust	B-T080
npc1	O
expression	O
in	O
various	O
tissues	O
,	O
including	O
brain	O
,	O
heart	O
,	O
and	O
lung	O
.	O
	
strikingly	O
,	O
aav9-mediated	O
npc1	O
delivery	O
significantly	B-T078
promoted	B-T052
purkinje	O
cell	O
survival	B-T052
,	O
restored	O
locomotor	O
activity	O
and	O
coordination	O
,	O
and	O
increased	B-T081
the	O
lifespan	B-T079
of	O
npc1	O
mice	O
.	O
	
our	O
work	O
suggests	O
that	O
aav-based	B-T061
gene	I-T061
therapy	I-T061
is	O
a	O
promising	O
means	O
to	O
treat	B-T169
npc	B-T047
disease	I-T047
.	O
	
executive	O
functions	O
deficits	B-T080
impair	B-T169
extinction	O
of	O
generalization	O
of	O
fear	O
of	O
movement-related	B-T033
pain	I-T033
generalization	O
of	O
fear	O
of	O
movement-related	B-T033
pain	I-T033
across	O
novel	O
but	O
similar	O
movements	O
can	O
lead	O
to	O
fear	O
responses	O
to	O
movements	O
that	O
are	O
actually	O
not	O
associated	B-T080
with	I-T080
pain	O
.	O
	
the	O
peak-shift	B-T080
effect	I-T080
describes	O
a	O
phenomenon	O
whereby	O
particular	O
novel	O
movements	O
elicit	B-T080
even	O
greater	O
fear	O
responses	O
than	O
the	O
original	O
pain-provoking	O
movement	O
cs+	O
,	O
because	O
they	O
represent	O
a	O
more	O
extreme	O
version	O
of	O
the	O
cs+	O
.	O
	
there	O
is	O
great	O
variance	B-T080
in	O
the	O
propensity	O
to	O
generalize	O
as	O
well	O
as	O
the	O
speed	O
of	O
extinction	O
learning	O
when	O
these	O
novel	O
movements	O
are	O
not	O
followed	O
by	O
pain	O
.	O
	
it	O
can	O
be	O
argued	O
that	O
this	O
variance	B-T080
may	O
be	O
associated	B-T080
with	I-T080
executive	O
function	O
capacity	O
,	O
as	O
individuals	B-T098
may	O
be	O
unable	O
to	O
intentionally	O
inhibit	O
fear	O
responses	O
.	O
	
this	O
study	O
examined	B-T033
whether	O
executive	O
function	O
capacity	O
contributes	O
to	O
generalization	O
and	O
extinction	O
of	O
generalization	O
as	O
well	O
as	O
peak-shift	B-T169
of	O
conditioned	O
fear	O
of	O
movement-related	B-T033
pain	I-T033
and	O
expectancy	B-T078
.	O
	
healthy	B-T098
participants	I-T098
performed	O
a	O
proprioceptive	O
fear	O
conditioning	O
task	O
.	O
	
executive	O
function	O
tests	O
assessing	O
updating	B-T079
,	O
switching	O
,	O
and	O
inhibition	O
were	O
used	O
to	O
predict	O
changes	O
in	O
extinction	O
of	O
fear	O
of	O
movement-related	B-T033
pain	I-T033
and	O
pain	O
expectancy	B-T078
generalization	O
.	O
	
low	O
inhibitory	O
capacity	O
was	O
associated	B-T080
with	I-T080
slower	O
extinction	O
of	O
generalized	O
fear	O
of	O
movement-related	B-T033
pain	I-T033
and	O
pain	O
expectancy	B-T078
.	O
	
evidence	O
was	O
found	O
in	O
favor	O
of	O
an	O
area-shift	B-T169
,	O
rather	O
than	O
a	O
peak-shift	B-T080
effect	I-T080
,	O
which	O
implies	O
that	O
the	O
peak	B-T080
conditioned	O
fear	O
response	O
extended	O
to	O
,	O
but	O
did	O
not	O
shift	O
to	O
a	O
novel	O
stimulus	O
.	O
	
participants	B-T098
with	O
low	O
inhibitory	O
capacity	O
may	O
have	O
difficulties	O
withholding	O
fear	O
responses	O
,	O
leading	O
to	O
a	O
slower	O
decrease	O
of	O
generalized	O
fear	O
over	O
time	B-T079
.	O
	
the	O
findings	B-T033
may	O
be	O
relevant	O
to	O
inform	O
treatments	B-T169
.	O
	
low	O
inhibitory	O
capacity	O
is	O
not	O
associated	B-T080
with	I-T080
slower	O
generalization	O
,	O
but	O
extinction	O
of	O
fear	O
generalization	O
.	O
	
fear	O
elicited	B-T080
by	I-T080
a	O
novel	O
safe	O
movement	O
,	O
situated	O
outside	O
the	O
cs+/-	O
continuum	O
on	O
the	O
cs+	O
side	O
,	O
can	O
be	O
as	O
strong	O
as	O
to	O
the	O
original	O
stimulus	O
predicting	O
the	O
robust	B-T080
dlpp	B-T081
with	O
nongreedy	B-T080
ℓ₁	I-T080
minimization	I-T080
and	O
maximization	B-T080
recently	O
,	O
discriminant	B-T081
locality	I-T081
preserving	I-T081
projection	I-T081
based	I-T081
on	I-T081
l1-norm	I-T081
dlpp-l1	B-T081
was	O
developed	O
for	O
robust	B-T080
subspace	O
learning	O
and	O
image	B-T170
classification	O
.	O
	
it	O
obtains	O
projection	B-T082
vectors	B-T082
by	O
greedy	B-T062
strategy	I-T062
,	O
i.e	O
,	O
all	O
projection	B-T082
vectors	B-T082
are	O
optimized	O
individually	O
through	O
maximizing	B-T080
the	O
objective	B-T080
function	B-T169
.	O
	
thus	O
,	O
the	O
obtained	O
solution	B-T170
does	O
not	O
necessarily	O
best	O
optimize	O
the	O
corresponding	O
trace	B-T170
ratio	I-T170
optimization	I-T170
algorithm	I-T170
,	O
which	O
is	O
the	O
essential	O
objective	B-T080
function	B-T169
for	O
general	O
dimensionality	B-T170
reduction	I-T170
.	O
	
it	O
results	O
in	O
insufficient	O
recognition	O
accuracy	B-T080
.	O
	
to	O
tackle	O
this	O
problem	O
,	O
we	O
propose	O
a	O
nongreedy	B-T170
algorithm	I-T170
to	O
solve	O
the	O
trace	B-T170
ratio	I-T170
formula	I-T170
of	O
dlpp-l1	B-T081
,	O
and	O
analyze	O
its	O
convergence	B-T052
.	O
	
experimental	O
results	O
on	O
three	O
databases	B-T170
illustrate	O
the	O
effectiveness	O
of	O
our	O
proposed	O
a	O
double-blind	B-T062
randomized	B-T062
controlled	I-T062
trial	I-T062
of	O
maternal	B-T047
postpartum	I-T047
deworming	B-T061
to	O
improve	O
infant	O
weight	B-T033
gain	I-T033
in	O
the	O
peruvian	B-T098
amazon	O
nutritional	B-T061
interventions	I-T061
targeting	O
the	O
critical	B-T080
growth	B-T033
and	I-T033
development	I-T033
period	I-T033
before	O
two	O
years	O
of	O
age	O
can	O
have	O
the	O
greatest	O
impact	O
on	O
health	B-T078
trajectories	B-T079
over	O
the	O
life	B-T079
course	I-T079
.	O
	
compelling	O
evidence	B-T078
has	O
demonstrated	O
that	O
interventions	B-T061
investing	O
in	O
maternal	B-T081
health	I-T081
in	O
the	O
first	O
1000	O
days	B-T079
of	O
life	B-T078
are	O
beneficial	O
for	O
both	O
mothers	O
and	O
their	O
children	O
.	O
	
one	O
such	O
potential	O
intervention	B-T061
is	O
deworming	B-T061
integrated	O
into	O
maternal	O
postpartum	O
care	O
in	O
areas	B-T082
where	O
soil	O
-	O
transmitted	B-T169
helminth	O
sth	O
infections	B-T047
are	O
endemic	B-T047
.	O
	
from	O
february	B-T080
to	O
august	B-T080
2014	O
,	O
1010	O
mother	O
-	O
infant	O
pairs	O
were	O
recruited	O
into	O
a	O
trial	B-T062
aimed	O
at	O
assessing	O
the	O
effectiveness	B-T080
of	O
maternal	B-T047
postpartum	I-T047
deworming	B-T061
on	O
infant	O
and	O
maternal	B-T081
health	I-T081
outcomes	B-T080
.	O
	
following	B-T079
delivery	O
,	O
mothers	O
were	O
randomly	O
assigned	O
to	O
receive	O
either	O
single-	O
dose	B-T081
400	O
mg	O
albendazole	B-T109
or	O
placebo	O
.	O
	
participants	B-T098
were	O
followed-up	O
at	O
1	B-T079
and	O
6	B-T079
months	I-T079
postpartum	B-T079
.	O
	
there	O
was	O
no	B-T033
statistically	I-T033
significant	I-T033
difference	B-T081
in	O
mean	O
weight	B-T033
gain	I-T033
between	O
infants	O
in	O
the	O
experimental	O
and	O
control	O
groups	O
mean	B-T081
difference	I-T081
-0	O
95%	O
ci	B-T081
-0	O
,	O
0.08	O
at	O
6	B-T079
months	I-T079
of	O
age	O
.	O
	
further	O
,	O
deworming	B-T061
had	O
no	B-T080
effect	I-T080
on	O
measured	O
infant	O
morbidity	O
indicators	B-T081
.	O
	
however	O
,	O
ad	B-T081
hoc	I-T081
analyses	I-T081
restricted	O
to	O
mothers	O
who	O
tested	O
positive	B-T033
for	O
sths	O
at	O
baseline	B-T081
suggest	O
that	O
infants	O
of	O
mothers	O
in	O
the	O
experimental	O
group	O
had	O
greater	O
mean	O
length	O
gain	B-T081
in	O
cm	O
mean	B-T081
difference	I-T081
0.8	O
95%	O
ci	B-T081
0.1	O
,	O
1.4	O
and	O
length-for-age	B-T081
z-score	I-T081
mean	B-T081
difference	I-T081
0.5	O
95%	O
ci	B-T081
0.2	O
,	O
0.8	O
at	O
6	B-T079
months	I-T079
of	O
age	O
.	O
	
in	O
a	O
study	B-T098
population	I-T098
composed	O
of	O
both	O
sth-infected	B-T047
and	O
uninfected	B-T080
mothers	O
,	O
maternal	B-T047
postpartum	I-T047
deworming	B-T061
was	O
insufficient	B-T080
to	O
impact	O
infant	O
growth	O
and	O
morbidity	O
indicators	B-T081
up	O
to	O
6	B-T079
months	I-T079
postpartum	B-T079
.	O
	
among	O
sth-infected	B-T047
mothers	O
,	O
however	O
,	O
important	O
improvements	O
in	O
infant	O
length	O
gain	O
and	O
length-for-age	B-T033
were	O
observed	O
.	O
	
the	O
benefits	O
of	O
maternal	B-T047
postpartum	I-T047
deworming	B-T061
should	O
be	O
further	O
investigated	O
in	O
study	B-T098
populations	I-T098
having	O
higher	O
overall	O
prevalences	B-T081
and	O
intensities	O
of	O
sth	B-T047
infections	I-T047
and	O
,	O
in	O
particular	O
,	O
where	O
whipworm	B-T047
and	O
hookworm	B-T047
infections	I-T047
are	O
of	O
public	O
health	O
concern	O
.	O
	
technical	O
note	O
a	O
preliminary	B-T079
comparative	B-T062
study	I-T062
between	O
classical	B-T169
and	O
interventional	O
radiological	O
approaches	O
for	O
multi-phase	B-T079
post-mortem	O
ct	O
angiography	O
multi-phase	B-T079
post-mortem	O
computed	O
tomography	O
angiography	O
mpmcta	O
is	O
a	O
new	B-T080
diagnostic	O
tool	O
,	O
used	O
in	O
forensic	O
pathology	O
.	O
	
on	O
the	O
one	O
hand	O
,	O
this	O
technique	B-T169
allows	O
a	O
better	O
and	O
direct	B-T033
visualization	I-T033
of	O
vascular	B-T047
and	O
solid	O
organ	O
lesions	B-T033
.	O
	
on	O
the	O
other	O
hand	O
,	O
the	O
invasiveness	B-T080
of	O
the	O
procedure	B-T169
-which	O
requires	O
surgical	B-T033
denudation	I-T033
inguinal	O
and/or	O
cervical	B-T082
and	O
the	O
insertion	B-T061
of	O
surgical	O
cannulas	O
-leads	O
to	O
many	O
relatives	O
refusing	B-T052
scientific	O
autopsies	O
.	O
	
our	O
hypothesis	B-T078
states	O
that	O
a	O
minimally-invasive	B-T169
procedure	I-T169
combining	O
interventional	B-T061
radiological	I-T061
techniques	I-T061
with	O
mpmcta	O
replacement	B-T169
of	O
surgical	O
cannulas	O
by	O
radiological	O
catheters	O
will	O
improve	B-T033
the	O
approval	B-T080
rate	B-T081
of	O
scientific	O
autopsies	O
by	O
families	O
.	O
	
the	O
aim	B-T078
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
feasibility	B-T062
of	O
the	O
minimally-invasive	B-T169
mpmcta	O
approach	O
and	O
to	O
compare	B-T052
its	O
performance	B-T052
to	O
the	O
current	B-T079
reference-standard	B-T081
the	O
conventional	O
approach	O
.	O
	
we	O
included	O
consecutively	B-T080
16	O
corpses	O
divided	O
in	O
two	O
groups	B-T078
according	O
to	O
the	O
contrast	B-T080
enhancement	B-T052
approach	O
radiological	O
catheters	O
n=8	O
,	O
and	O
surgical	O
cannulas	O
n=8	O
.	O
	
corpses	O
were	O
chosen	O
and	O
assigned	O
randomly	O
from	O
our	O
local	O
data	B-T078
.	O
	
the	O
quality	B-T080
of	O
the	O
imaging	O
procedure	O
was	O
compared	B-T052
according	O
to	O
four	O
items	O
global	O
vascular	O
opacification	B-T080
,	O
cerebral	B-T080
venous	I-T080
opacification	I-T080
,	O
and	O
lower	O
limbs	O
opacification	B-T080
arterial	B-T082
and	O
venous	B-T082
.	O
	
a	O
minimally-invasive	B-T169
approach	I-T169
for	O
scientific	O
autopsies	O
is	O
feasible	O
through	O
a	O
radiological	O
catheter	O
.	O
	
vascular	O
opacification	B-T080
was	O
optimal	B-T080
in	O
8	O
out	O
of	O
8	O
cases	O
and	O
was	O
no	O
less	O
effective	B-T080
than	O
the	O
control	O
reference	O
group	O
using	O
surgical	O
cannula	O
incision	B-T061
associated	B-T080
with	I-T080
their	O
non-occlusive	B-T080
aspects	I-T080
.	O
	
correlations	B-T080
between	O
physical	O
activity	O
and	O
neurocognitive	O
domain	O
functions	O
in	O
patients	O
with	O
schizophrenia	O
a	O
cross-sectional	B-T062
study	I-T062
neurocognitive	O
dysfunction	O
is	O
a	O
critical	O
target	O
symptom	O
of	O
schizophrenia	O
treatment	B-T061
.	O
	
a	O
positive	O
correlation	B-T080
between	O
physical	O
activity	O
level	O
and	O
neurocognitive	O
function	O
has	O
been	O
reported	O
in	O
healthy	B-T098
individuals	I-T098
,	O
but	O
it	O
is	O
unclear	O
whether	O
such	O
a	O
correlation	B-T080
exists	O
in	O
patients	O
with	O
schizophrenia	O
and	O
whether	O
the	O
relationship	B-T080
is	O
different	O
according	O
to	O
inpatients	O
or	O
outpatients	O
.	O
	
this	O
study	B-T062
aimed	O
to	O
examine	O
the	O
differences	O
in	O
the	O
correlations	B-T080
between	O
physical	O
activity	O
and	O
multiple	O
neurocognitive	O
domains	O
in	O
inpatients	O
and	O
outpatients	O
with	O
schizophrenia	O
and	O
obtain	O
suggestions	B-T078
for	O
further	O
study	B-T062
to	O
facilitate	O
this	O
field	O
.	O
	
twenty-nine	O
patients	O
with	O
schizophrenia	O
were	O
examined	O
16	O
inpatients	O
and	O
13	O
outpatients	O
,	O
56.0	O
11.4	O
years	B-T079
of	O
age	O
.	O
	
current	O
symptoms	O
were	O
assessed	B-T052
using	O
the	O
positive	B-T033
and	O
negative	B-T033
symptom	B-T170
scale	I-T170
and	O
neurocognitive	O
functions	O
using	O
cognitrax	B-T170
,	O
which	O
yields	O
a	O
composite	O
neurocognitive	O
index	O
nci	O
and	O
11	O
domain	O
scores	B-T081
.	O
	
after	O
testing	O
,	O
participants	B-T098
wore	O
an	O
hja-750c	O
accelerometer	O
for	O
one	B-T079
week	I-T079
to	O
measure	B-T081
physical	O
activity	O
levels	O
and	O
durations	B-T079
.	O
	
partial	B-T062
correlation	I-T062
analyses	I-T062
were	O
performed	O
between	O
exercise	O
and	O
cognitive	O
parameters	B-T033
.	O
	
in	O
the	O
outpatient	O
group	O
,	O
higher	B-T080
physical	O
activity	O
was	O
associated	O
with	O
faster	O
motor	B-T169
and	O
psychomotor	O
speeds	B-T081
in	O
outpatients	O
.	O
	
however	O
,	O
higher	B-T080
physical	O
activity	O
was	O
associated	B-T080
with	I-T080
lower	B-T080
overall	O
nci	O
,	O
attention	O
score	B-T081
,	O
and	O
memory	O
scores	B-T081
in	O
inpatients	O
.	O
	
although	O
higher	B-T080
physical	O
activity	O
was	O
associated	B-T080
with	I-T080
better	O
neurocognitive	O
functions	O
of	O
outpatients	O
,	O
in	O
inpatients	O
with	O
non-remitted	O
schizophrenia	O
,	O
higher	B-T080
physical	O
activity	O
was	O
associated	B-T080
with	I-T080
worsening	O
of	O
several	O
cognitive	O
domains	O
.	O
	
in	O
a	O
future	O
study	B-T062
examining	O
the	O
relationship	B-T080
between	O
physical	O
activity	O
and	O
neurocognitive	O
function	O
for	O
facilitating	O
this	O
research	O
field	O
,	O
separation	O
between	O
inpatients	O
and	O
outpatients	O
are	O
needed	O
because	O
the	O
relationship	B-T080
is	O
different	O
between	O
inpatients	O
and	O
a	O
completely	B-T080
calcified	B-T080
prostate	O
prostatic	B-T047
calcification	I-T047
and	O
prostatic	B-T047
calculus	I-T047
formation	B-T169
is	O
commonly	O
seen	O
in	O
adult	O
population	B-T098
with	O
chronic	B-T047
prostatitis	I-T047
,	O
however	O
,	O
gross	O
prostatic	B-T047
calcification	I-T047
which	O
involves	O
more	O
than	O
3	O
cm	O
of	O
the	O
gland	O
is	O
quite	O
rare	B-T080
.	O
	
we	O
are	O
presenting	B-T078
here	O
one	O
such	O
case	B-T169
in	O
which	O
almost	O
whole	O
glandular	O
prostate	O
was	O
converted	B-T169
into	O
stone	O
a	O
rare	B-T080
cause	B-T169
of	O
gastric	B-T047
obstruction	I-T047
lighters	O
swallowing	O
the	O
majority	B-T080
of	O
swallowed	B-T033
foreign	I-T033
bodies	I-T033
are	O
thrown	B-T080
spontaneously	B-T169
without	B-T080
causing	B-T169
complications	O
in	O
the	O
digestive	O
system	O
.	O
	
multiple	B-T081
number	B-T081
of	O
foreign	O
bodies	O
may	O
be	O
swallowed	O
by	O
psychiatric	O
patients	O
which	O
delay	B-T080
diagnosis	I-T080
and	O
increase	B-T169
the	O
complication	O
rate	B-T081
.	O
	
long	B-T080
and	O
hard	B-T080
objects	O
cannot	O
pass	O
through	O
the	O
pylorus	O
,	O
and	O
may	O
cause	B-T169
obstruction	O
,	O
ulceration	O
,	O
bleeding	O
and	O
perforation	B-T033
.	O
	
endoscopy	O
is	O
used	B-T169
as	O
an	O
effective	B-T080
method	B-T169
in	O
such	O
cases	B-T169
.	O
	
an	O
exploratory	O
laparatomy	O
was	O
performed	B-T169
after	O
unsuccessful	B-T080
endoscopic	B-T082
foreign	O
object	O
removal	B-T061
in	O
a	O
28-year-old	O
schizophrenic	O
patient	O
with	O
gastric	B-T047
outlet	I-T047
obstruction	I-T047
due	B-T169
to	I-T169
multiple	B-T081
cigarette	O
lighter	O
swallowing	O
.	O
	
ten	O
lighters	O
were	O
removed	B-T080
from	O
the	O
stomach	O
through	B-T169
gastrotomy	B-T061
and	O
one	O
more	O
lighter	O
was	O
removed	B-T080
from	O
the	O
descending	O
colon	O
by	O
milking	B-T061
through	B-T169
the	O
anus	O
.	O
	
the	O
aim	O
of	O
this	O
paper	O
is	O
to	O
discuss	O
encountered	O
difficulties	B-T033
in	O
psychiatric	O
patients	O
who	O
underwent	O
surgery	B-T061
due	B-T169
to	I-T169
intake	B-T169
of	O
foreign	O
bodies	O
.	O
	
ceftaroline	B-T109
fosamil	I-T109
for	O
community-acquired	B-T047
pneumonia	I-T047
and	O
skin	O
and	O
skin	O
structure	O
infections	O
a	O
systematic	B-T170
review	I-T170
background	O
ceftaroline	B-T109
is	O
a	O
parentally	O
administered	B-T169
cephalosporin	B-T109
that	O
has	O
an	O
in	B-T080
vitro	I-T080
expanded	B-T082
spectrum	O
of	O
activity	O
compared	B-T052
with	O
other	O
cephalosporins	B-T109
yet	O
data	B-T078
is	O
conflicting	O
regarding	O
its	O
place	O
in	O
therapy	B-T061
.	O
	
aim	O
of	O
the	O
review	B-T170
to	O
compare	B-T052
the	O
efficacy	B-T080
and	O
safety	O
of	O
ceftaroline	B-T109
against	O
standard	O
antibiotic	O
regimens	B-T061
for	O
community-acquired	B-T047
pneumonia	I-T047
cap	B-T047
and	O
complicated	O
skin	O
and	O
skin	O
structure	O
infections	O
csssis	O
.	O
	
method	O
the	O
databases	B-T170
of	O
medline	B-T170
,	O
ebsco	B-T170
,	O
and	O
embase	B-T170
were	O
searched	O
up	O
to	O
june	O
2016	O
.	O
	
manual	B-T170
review	I-T170
of	I-T170
references	I-T170
was	I-T170
completed	I-T170
and	O
experts	O
in	O
the	O
field	O
were	O
contacted	O
for	O
unpublished	B-T170
data	I-T170
.	O
	
randomized	B-T062
controlled	I-T062
trials	I-T062
of	O
ceftaroline	B-T109
in	O
cap	B-T047
or	O
csssi	O
populations	B-T098
were	O
included	O
.	O
	
outcomes	B-T169
included	O
clinical	B-T033
cure	I-T033
,	O
mortality	B-T081
,	O
adverse	O
events	O
,	O
serious	B-T033
adverse	I-T033
events	I-T033
,	O
and	O
discontinuation	B-T061
due	O
to	O
adverse	O
events	O
.	O
	
meta-analysis	B-T170
was	O
used	O
to	O
pool	O
results	O
for	O
these	O
outcomes	B-T169
.	O
	
we	O
performed	O
subgroup	O
analyses	B-T062
for	O
gram	B-T047
positive	I-T047
infections	I-T047
in	O
cap	B-T047
and	O
infections	O
caused	O
by	O
methicillin-resistant	O
staphylococcus	O
aureus	O
in	O
csssis	O
.	O
	
risk	B-T078
of	O
bias	B-T078
was	O
assessed	O
for	O
all	O
studies	B-T062
.	O
	
results	O
six	O
trials	B-T062
three	O
for	O
each	O
indication	O
were	O
included	O
,	O
each	O
of	O
which	O
had	O
an	O
unclear	O
or	O
high	O
risk	B-T078
of	O
bias	B-T078
in	O
at	O
least	O
one	O
domain	O
.	O
	
for	O
cap	B-T047
,	O
ceftaroline	B-T109
was	O
significantly	O
more	O
efficacious	B-T080
in	O
achieving	O
clinical	B-T033
cure	I-T033
than	O
ceftriaxone	B-T109
risk	B-T081
ratio	I-T081
rr	B-T081
1.11	O
,	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
1.04	O
i	O
=	O
47%	O
.	O
	
for	O
csssis	O
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
clinical	B-T033
cure	I-T033
between	O
ceftaroline	B-T109
and	O
vancomycin	B-T116
plus	O
aztreonam	B-T109
rr	B-T081
1.01	O
,	O
95%	O
ci	B-T081
0.97	O
i	O
=	O
0%	O
.	O
	
no	O
differences	O
were	O
found	O
for	O
overall	O
mortality	B-T081
,	O
serious	B-T033
adverse	I-T033
events	I-T033
,	O
discontinuation	B-T061
due	O
to	O
adverse	O
events	O
,	O
and	O
overall	O
adverse	O
events	O
.	O
	
conclusion	O
ceftaroline	B-T109
is	O
a	O
viable	O
therapeutic	B-T061
alternative	I-T061
for	O
patients	O
with	O
cap	B-T047
and	O
csssis	O
,	O
yet	O
identified	O
risks	B-T078
of	O
bias	B-T078
and	O
poor	B-T033
external	I-T033
validity	I-T033
preclude	O
it	O
from	O
being	O
recommended	O
as	O
a	O
first-line	O
agent	O
.	O
	
direct	O
effects	B-T080
of	I-T080
glucose	B-T109
,	O
insulin	B-T116
,	O
glp-1	B-T116
,	O
and	O
gip	B-T116
on	O
bulbospinal	O
neurons	O
in	O
the	O
rostral	O
ventrolateral	O
medulla	O
in	O
neonatal	O
wistar	O
rats	O
although	O
patients	O
with	O
diabetes	B-T047
mellitus	I-T047
dm	B-T047
often	O
exhibit	O
hypertension	B-T047
,	O
the	O
mechanisms	B-T169
responsible	O
for	O
this	O
correlation	B-T080
are	O
not	O
well	O
known	O
.	O
	
we	O
hypothesized	O
that	O
the	O
bulbospinal	O
neurons	O
in	O
the	O
rostral	O
ventrolateral	O
medulla	O
rvlm	O
are	O
affected	B-T169
by	O
the	O
levels	B-T080
of	O
glucose	B-T109
,	O
insulin	B-T116
,	O
or	O
incretins	B-T116
glucagon	B-T116
like	I-T116
peptide-1	I-T116
glp-1	B-T116
or	O
glucose-dependent	B-T116
insulinotropic	I-T116
peptide	I-T116
gip	B-T116
in	O
patients	O
with	O
dm	B-T047
.	O
	
to	O
investigate	B-T169
whether	O
rvlm	O
neurons	O
are	O
activated	B-T052
by	O
glucose	B-T109
,	O
insulin	B-T116
,	O
glp-1	B-T116
,	O
or	O
gip	B-T116
,	O
we	O
examined	O
changes	B-T169
in	O
the	O
membrane	O
potentials	O
of	O
bulbospinal	O
rvlm	O
neurons	O
using	O
whole-cell	O
patch-clamp	B-T062
technique	I-T062
during	O
superfusion	O
with	O
various	O
levels	B-T080
of	O
glucose	B-T109
or	O
these	O
hormones	O
in	O
neonatal	O
wistar	O
rats	O
.	O
	
a	O
brainstem	O
-	O
spinal	O
cord	O
preparation	B-T052
was	O
used	O
for	O
the	O
experiments	B-T062
.	O
	
a	O
low	B-T080
level	B-T080
of	O
glucose	B-T109
stimulated	O
bulbospinal	O
rvlm	O
neurons	O
.	O
	
during	O
insulin	B-T116
superfusion	O
,	O
almost	O
all	O
the	O
rvlm	O
neurons	O
were	O
depolarized	O
,	O
while	O
during	O
glp-1	B-T116
or	O
gip	B-T116
superfusion	O
,	O
almost	O
all	O
the	O
rvlm	O
neurons	O
were	O
hyperpolarized	O
.	O
	
next	O
,	O
histological	O
examinations	O
were	O
performed	O
to	O
examine	O
transporters	B-T116
for	I-T116
glucose	I-T116
and	O
receptors	B-T116
for	O
insulin	B-T116
,	O
glp-1	B-T116
,	O
and	O
gip	B-T116
on	O
rvlm	O
neurons	O
.	O
	
low	B-T080
-	O
level	B-T080
glucose	B-T109
-	O
depolarized	O
rvlm	O
neurons	O
exhibited	O
the	O
presence	B-T080
of	O
glucose	B-T116
transporter	I-T116
3	I-T116
glut3	B-T116
.	O
	
meanwhile	O
,	O
insulin	B-T116
-	O
depolarized	O
,	O
glp-1	B-T116
-	O
hyperpolarized	O
,	O
and	O
gip	B-T116
-	O
hyperpolarized	O
rvlm	O
neurons	O
showed	O
each	O
of	O
the	O
respective	O
specific	B-T080
receptor	B-T116
.	O
	
these	O
results	O
indicate	O
that	O
a	O
low	B-T080
level	B-T080
of	O
glucose	B-T109
stimulates	O
bulbospinal	O
rvlm	O
neurons	O
via	O
specific	B-T080
transporters	B-T116
on	O
these	O
neurons	O
,	O
inducing	B-T169
hypertension	B-T047
.	O
	
furthermore	O
,	O
an	O
increase	B-T169
in	O
insulin	B-T116
or	O
a	O
reduction	B-T080
in	O
incretins	B-T116
may	O
also	O
activate	B-T052
the	O
sympathetic	O
nervous	O
system	O
and	O
induce	B-T169
hypertension	B-T047
by	O
activating	B-T052
rvlm	O
neurons	O
via	O
their	O
own	O
mechanisms	B-T169
of	O
compensation	O
in	O
the	O
gait	B-T033
of	O
patients	O
with	O
drop	B-T047
foot	I-T047
drop	B-T047
foot	I-T047
is	O
a	O
complex	O
syndrome	B-T047
,	O
with	O
multiple	B-T081
interactions	B-T169
between	O
joints	O
and	O
muscles	O
.	O
	
abnormalities	B-T033
in	O
movement	B-T033
patterns	I-T033
can	O
be	O
measured	O
using	O
motion	O
capture	O
techniques	O
,	O
but	O
identifying	O
compensation	O
mechanisms	B-T169
remains	O
challenging	O
.	O
	
in	O
order	O
to	O
identify	O
compensatory	O
mechanisms	B-T169
in	O
patients	O
with	O
drop	O
foot	O
,	O
this	O
study	O
evaluated	O
a	O
sample	O
of	O
15	O
such	O
patients	O
using	O
a	O
computerized	O
gait	O
analysis	O
system	O
,	O
as	O
compared	O
to	O
a	O
group	O
of	O
15	O
healthy	O
subjects	O
.	O
	
four	O
classes	O
of	O
parameters	O
were	O
distinguished	O
,	O
falling	O
in	O
differing	O
intervals	O
of	O
percentage	O
differences	O
between	O
the	O
groups	O
in	O
the	O
study	O
.	O
	
the	O
first	O
class	O
comprised	O
two	O
kinematic	O
parameters	O
for	O
which	O
the	O
values	O
of	O
percentage	O
differences	O
in	O
the	O
control	O
group	O
were	O
more	O
than	O
100%	O
greater	O
than	O
for	O
the	O
patient	O
group	O
.	O
	
the	O
second	O
class	O
comprised	O
two	O
kinetic	O
parameters	O
falling	O
in	O
the	O
interval	O
of	O
100-49%	O
.	O
	
in	O
the	O
third	O
class	O
,	O
in	O
the	O
49-20%	O
interval	O
the	O
main	O
differences	O
were	O
observed	O
for	O
spatiotemporal	O
parameters	O
,	O
whereas	O
in	O
the	O
20-4%	O
interval	O
the	O
differences	O
were	O
distributed	O
similarly	O
for	O
kinematic	O
,	O
kinetic	O
and	O
spatiotemporal	O
parameters	O
.	O
	
these	O
differences	O
in	O
gait	O
pattern	O
between	O
the	O
groups	O
may	O
be	O
related	O
to	O
both	O
primary	O
motor	O
deficits	O
and	O
secondary	O
compensatory	B-T169
mechanisms	B-T169
.	O
	
generally	O
,	O
we	O
conclude	O
that	O
drop	O
foot	O
affects	O
the	O
patients	O
'	O
overall	O
kinematic	O
and	O
kinetic	O
gait	O
parameters	O
,	O
with	O
compensation	O
seen	O
as	O
a	O
chain	O
originating	O
from	O
a	O
change	O
of	O
movement	O
within	O
the	O
ankle	O
joint	O
inhibitory	B-T052
effects	B-T080
of	I-T080
lactobacillus	O
rhamnosus	O
and	O
lactobacillus	O
casei	O
on	O
candida	O
biofilm	O
of	O
denture	B-T033
surface	I-T033
candida	O
albicans	O
biofilm	O
is	O
associated	B-T080
with	I-T080
denture-related	B-T047
stomatitis	I-T047
and	O
oral	B-T047
candidiasis	I-T047
of	O
elderly	B-T098
.	O
	
probiotics	O
are	O
beneficial	O
bacteria	O
and	O
have	O
antibacterial	B-T033
activity	I-T033
against	O
pathogenic	O
bacteria	O
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	B-T169
the	O
antifungal	B-T033
activity	I-T033
of	O
various	O
probiotics	O
against	O
c	O
.	O
	
albicans	O
and	O
the	O
inhibitory	B-T052
effects	B-T080
of	I-T080
probiotics	O
on	O
candida	O
biofilm	O
on	O
the	O
denture	B-T033
surface	I-T033
.	O
	
the	O
spent	O
culture	O
media	O
of	O
various	O
probiotics	O
were	O
investigated	O
the	O
antifungal	B-T080
efficacy	I-T080
against	O
c	O
.	O
	
albicans	O
.	O
	
candida	O
biofilm	O
was	O
formed	O
on	O
a	O
denture	O
base	O
resin	O
and	O
was	O
then	O
treated	B-T169
with	O
lactobacillus	O
rhamnosus	O
and	O
lactobacillus	O
casei	O
.	O
	
also	O
,	O
the	O
biofilm	O
s	O
of	O
l	O
.	O
	
rhamnosus	O
and	O
l	O
.	O
	
casei	O
were	O
formed	O
and	O
were	O
sequentially	O
treated	B-T169
with	O
c	O
.	O
	
albicans	O
.	O
	
colony-forming	B-T081
units	I-T081
of	O
c	O
.	O
	
albicans	O
on	O
the	O
denture	B-T033
surface	I-T033
were	O
counted	O
after	O
spreading	B-T080
on	O
agar	B-T109
plate	O
.	O
	
the	O
denture	O
base	O
resin	O
was	O
treated	B-T169
with	O
the	O
spent	O
culture	O
media	O
for	O
30	O
days	B-T079
,	O
after	O
which	O
the	O
denture	B-T033
surface	I-T033
roughness	B-T033
was	O
analyzed	O
with	O
an	O
atomic	O
force	O
microscope	O
.	O
	
l	O
.	O
	
rhamnosus	O
and	O
l	O
.	O
	
casei	O
exhibited	O
stronger	O
antifungal	B-T033
activity	I-T033
than	O
other	O
probiotics	O
.	O
	
the	O
spent	O
culture	O
medium	O
of	O
l	O
.	O
	
rhamnosus	O
and	O
l	O
.	O
	
casei	O
exhibited	O
the	O
antifungal	B-T033
activity	I-T033
against	O
blastoconidia	O
and	O
biofilm	O
of	O
c	O
.	O
	
albicans	O
.	O
	
l	O
.	O
	
rhamnosus	O
and	O
l	O
.	O
	
casei	O
showed	O
the	O
antifungal	B-T033
activity	I-T033
against	O
candida	O
biofilm	O
,	O
and	O
the	O
biofilm	O
of	O
l	O
.	O
	
rhamnosus	O
and	O
l	O
.	O
	
casei	O
inhibited	B-T052
formation	B-T169
of	O
candida	O
biofilm	O
on	O
denture	B-T033
surface	I-T033
.	O
	
neither	O
of	O
the	O
probiotics	O
affected	O
the	O
surface	B-T033
roughness	I-T033
of	O
the	O
denture	O
base	O
resin	O
.	O
	
l	O
.	O
	
rhamnosus	O
and	O
l	O
.	O
	
casei	O
may	O
be	O
the	O
ideal	O
probiotics	O
for	O
the	O
prevention	B-T080
and	O
treatment	B-T169
of	O
denture-related	B-T047
stomatitis	I-T047
.	O
	
persistent	O
organic	O
pollutants	O
pops	O
in	O
the	O
atmosphere	O
of	O
three	O
chilean	B-T098
cities	O
using	O
passive	B-T080
air	O
samplers	O
in	O
this	O
study	B-T062
passive	B-T080
air	O
samplers	O
containing	O
polyurethane	B-T109
foam	I-T109
puf	B-T109
disks	O
were	O
deployed	B-T052
in	O
three	O
cities	O
across	O
chile	O
santiago	O
stg	O
n=5	O
,	O
sampling	B-T082
sites	I-T082
,	O
concepciόn	O
con	O
n=6	O
and	O
temuco	O
tem	O
n=6	O
from	O
2008	O
to	O
2009	O
.	O
	
polychlorinated	B-T109
biphenyls	I-T109
pcbs	B-T109
7	O
indicator	B-T169
congeners	O
,	O
chlorinated	O
pesticides	O
hexachlorocyclohexanes	B-T109
hchs	B-T109
,	O
dichlorodiphenyl	B-T109
trichloroethanes	I-T109
ddts	B-T109
and	O
flame	O
retardants	O
such	O
as	O
polybrominated	B-T109
diphenyl	I-T109
ethers	I-T109
pbdes	B-T109
were	O
determined	B-T080
by	I-T080
gas	O
chromatography	O
coupled	O
mass	O
spectrometry	O
gc/ms	O
.	O
	
a	O
sampling	B-T078
rate	B-T081
r	B-T081
typical	O
of	O
urban	B-T082
sites	I-T082
4m	O
was	O
used	O
to	O
estimate	B-T081
the	O
atmospheric	O
concentrations	B-T081
of	O
individual	B-T081
compounds	B-T080
.	O
	
pcb	B-T109
concentrations	B-T081
in	O
the	O
air	O
pg/m	O
ranged	B-T081
from	O
1-10	O
tem	O
,	O
1-40	O
stg	O
and	O
4-30	O
con	O
.	O
	
higher	B-T080
molecular	I-T080
weight	I-T080
pcbs	B-T109
pcb	B-T109
-153	O
,	O
-180	O
were	O
detected	B-T033
at	O
industrial	B-T082
sites	I-T082
in	O
concepción	O
.	O
	
the	O
hchs	B-T109
showed	O
a	O
prevalence	B-T081
of	O
γ-hch	B-T109
across	O
all	O
sites	B-T082
,	O
indicative	B-T169
of	O
inputs	O
from	O
the	O
use	O
of	O
lindane	B-T109
but	O
a	O
limited	B-T169
use	O
of	O
technical	B-T081
hchs	B-T109
in	O
chile	O
.	O
	
ddts	B-T109
were	O
detected	B-T033
with	O
a	O
prevalence	B-T081
of	O
p	B-T109
accounting	O
for	O
50%	O
of	O
the	O
total	O
ddts	B-T109
.	O
	
pbde	B-T109
concentrations	B-T081
in	O
air	O
pg/m	O
ranged	B-T081
from	O
1	O
to	O
55	O
stg	O
,	O
0.5	O
to	O
20	O
con	O
and	O
from	O
0.4	O
to	O
10	O
tem	O
,	O
and	O
were	O
generally	O
similar	B-T080
to	O
those	O
reported	B-T170
for	O
many	O
other	O
urban	B-T082
areas	I-T082
globally	B-T080
.	O
	
the	O
pattern	B-T082
of	O
pbdes	B-T109
was	O
different	O
among	O
the	O
three	O
cities	O
however	O
,	O
pbde	B-T109
-209	O
was	O
dominant	B-T169
at	O
most	O
of	O
the	O
sites	B-T082
.	O
	
these	O
results	B-T033
represent	O
one	O
of	O
the	O
few	O
assessments	O
of	O
air	O
concentrations	B-T081
of	O
pops	O
across	O
different	O
urban	B-T082
areas	I-T082
within	O
the	O
same	O
country	O
.	O
	
these	O
data	B-T078
will	O
support	O
chilean	B-T098
commitments	O
as	O
a	O
signatory	B-T169
to	O
the	O
stockholm	O
convention	O
on	O
pops	O
and	O
for	O
reporting	B-T062
as	O
a	O
member	O
country	O
of	O
the	O
group	O
of	O
latin	O
america	O
and	O
caribbean	O
countries	O
grulac	O
region	O
.	O
	
intraoperative	B-T079
ketamine	B-T109
reduces	B-T080
immediate	B-T079
postoperative	B-T079
opioid	B-T109
consumption	B-T169
after	O
spinal	B-T061
fusion	I-T061
surgery	I-T061
in	O
chronic	O
pain	O
patients	O
with	O
opioid	B-T109
dependency	B-T080
a	O
randomized	B-T062
,	O
blinded	B-T062
trial	I-T062
perioperative	B-T079
handling	B-T033
of	O
surgical	O
patients	O
with	O
opioid	B-T109
dependency	B-T080
represents	O
an	O
important	B-T080
clinical	B-T080
problem	B-T033
.	O
	
animal	O
studies	O
suggest	O
that	O
ketamine	B-T109
attenuates	B-T052
central	B-T047
sensitization	I-T047
and	O
hyperalgesia	O
and	O
thereby	O
reduces	B-T080
postoperative	B-T079
opioid	B-T109
tolerance	O
.	O
	
we	O
hypothesized	O
that	O
intraoperative	O
ketamine	O
would	O
reduce	O
immediate	O
postoperative	O
opioid	O
consumption	O
compared	O
with	O
placebo	O
in	O
chronic	O
pain	O
patients	O
with	O
opioid	O
dependency	O
undergoing	O
lumbar	O
spinal	O
fusion	O
surgery	O
.	O
	
primary	O
outcome	O
was	O
morphine	O
consumption	O
0	O
to	O
24	O
hours	O
postoperatively	O
.	O
	
secondary	O
outcomes	O
were	O
acute	O
pain	O
at	O
rest	O
and	O
during	O
mobilization	O
2	O
to	O
24	O
hours	O
postoperatively	O
visual	O
analogue	O
scale	O
,	O
adverse	O
events	O
,	O
and	O
persistent	O
pain	O
6	O
months	O
postoperatively	O
.	O
	
one	O
hundred	O
fifty	O
patients	O
were	O
randomly	O
assigned	O
to	O
intraoperative	O
s-ketamine	O
bolus	O
0.5	O
mg/kg	O
and	O
infusion	O
0.25	O
mg	O
or	O
placebo	O
.	O
	
postoperatively	O
,	O
patients	O
received	O
their	O
usual	O
opioids	O
,	O
paracetamol	O
and	O
iv	O
patient-controlled	O
analgesia	O
with	O
morphine	O
.	O
	
in	O
the	O
final	O
analyses	O
,	O
147	O
patients	O
were	O
included	O
.	O
	
patient-controlled	O
analgesia	O
iv	O
morphine	O
consumption	O
0	O
to	O
24	O
hours	O
postoperatively	O
was	O
significantly	O
reduced	O
in	O
the	O
ketamine	O
group	O
compared	O
with	O
the	O
placebo	O
group	O
79	O
47	O
vs	O
121	O
53	O
mg	O
iv	O
,	O
mean	O
difference	O
42	O
mg	O
95%	O
confidence	O
interval	O
-59	O
to	O
-25	O
,	O
p	O
<	O
0.001	O
.	O
	
sedation	O
was	O
significantly	O
reduced	O
in	O
the	O
ketamine	O
group	O
6	O
and	O
24	O
hours	O
postoperatively	O
.	O
	
there	O
were	O
no	O
significant	O
differences	O
regarding	O
acute	O
pain	O
,	O
nausea	O
,	O
vomiting	O
,	O
hallucinations	O
,	O
or	O
nightmares	O
.	O
	
back	O
pain	O
at	O
6	O
months	O
postoperatively	O
compared	O
with	O
preoperative	O
pain	O
was	O
significantly	O
more	O
improved	O
in	O
the	O
ketamine	O
group	O
compared	O
with	O
the	O
placebo	O
group	O
,	O
p	O
=	O
0.005	O
.	O
	
in	O
conclusion	O
,	O
intraoperative	O
ketamine	O
significantly	O
reduced	O
morphine	O
consumption	O
0	O
to	O
24	O
hours	O
after	O
lumbar	O
fusion	O
surgery	O
in	O
opioid	O
-	O
dependent	O
patients	O
.	O
	
the	O
trend	O
regarding	O
less	O
persistent	O
pain	O
6	O
months	O
postoperatively	O
needs	O
further	O
investigation	B-T169
effects	B-T080
of	I-T080
argan	B-T109
oil	I-T109
on	O
the	O
mitochondrial	O
function	O
,	O
antioxidant	O
system	O
and	O
the	O
activity	O
of	O
nadph	O
-	O
generating	B-T052
enzymes	B-T116
in	O
acrylamide	B-T109
treated	B-T061
rat	O
brain	O
argan	B-T109
oil	I-T109
ao	B-T109
is	O
rich	O
in	O
minor	O
compounds	O
such	O
as	O
polyphenols	B-T109
and	O
tocopherols	B-T109
which	O
are	O
powerful	O
antioxidants	O
.	O
	
acrylamide	B-T109
acr	B-T109
has	O
been	O
classified	O
as	O
a	O
neurotoxic	O
agent	O
in	O
animals	O
and	O
humans	O
.	O
	
mitochondrial	O
oxidative	O
stress	O
and	O
dysfunction	B-T033
is	O
one	O
of	O
the	O
most	O
probable	B-T081
molecular	O
mechanisms	O
of	O
neurodegenerative	B-T047
diseases	I-T047
.	O
	
female	O
sprague	O
dawley	O
rats	O
were	O
exposed	B-T080
to	I-T080
acr	B-T109
50mg/kg	O
i.p	O
.	O
	
three	O
times	O
a	O
week	O
,	O
ao	B-T109
6ml/kg	O
,	O
per	O
day	O
or	O
together	O
for	O
30days	O
.	O
	
the	O
activities	B-T052
of	O
cytosolic	O
enzymes	B-T116
such	O
as	O
xanthine	B-T116
oxidase	I-T116
xo	B-T116
,	O
glucose	B-T116
6-phosphate	I-T116
dehydrogenase	I-T116
g6pdh	B-T116
,	O
glutathione-s-transferase	B-T116
gst	B-T116
,	O
mitochondrial	O
oxidative	O
stress	O
,	O
oxidative	O
phosphorylation	O
oxphos	O
and	O
tricarboxylic	O
acid	O
cycle	O
tca	O
enzymes	B-T116
,	O
mitochondrial	O
metabolic	O
function	O
,	O
adenosine	O
triphosphate	O
atp	O
level	B-T080
and	O
acetylcholinesterase	O
ache	O
activity	O
were	O
assessed	B-T052
in	O
rat	O
brain	O
.	O
	
cytosolic	O
and	O
mitochondrial	O
antioxidant	B-T116
enzymes	I-T116
were	O
significantly	B-T078
diminished	B-T081
in	O
the	O
brains	O
of	O
rats	O
treated	B-T061
with	I-T061
acr	B-T109
compared	B-T052
to	O
those	O
in	O
control	O
.	O
	
besides	O
,	O
acr	B-T109
treatment	B-T061
resulted	B-T169
in	O
a	O
significant	B-T078
reduction	B-T080
in	O
brain	O
atp	O
level	B-T080
,	O
mitochondrial	O
metabolic	O
function	O
,	O
oxphos	O
and	O
tca	O
enzymes	B-T116
.	O
	
administration	B-T061
of	O
ao	B-T109
restored	O
both	O
the	O
cytosolic	O
and	O
mitochondrial	O
oxidative	O
stress	O
by	O
normalizing	B-T062
nicotinamide	O
adenine	O
dinucleotide	O
phosphate	O
nadph	O
generating	B-T052
enzymes	B-T116
.	O
	
in	O
addition	O
,	O
improved	B-T033
mitochondrial	O
function	O
primarily	O
enhancing	B-T052
nicotinamide	O
adenine	O
dinucleotide	O
nadh	O
generated	B-T052
enzymes	O
activities	O
and	O
atp	O
level	B-T080
in	O
the	O
mitochondria	O
.	O
	
the	O
reason	B-T078
for	O
ao's	B-T109
obvious	O
beneficial	O
effects	O
in	O
this	O
study	B-T062
may	O
be	O
due	O
to	O
synergistic	O
effects	O
of	O
its	O
different	B-T080
bioactive	O
compounds	O
which	O
is	O
especially	O
effective	B-T080
on	O
mitochondria	O
.	O
	
modulation	B-T082
of	O
the	O
brain	O
mitochondrial	O
functions	O
and	O
antioxidant	O
systems	O
by	O
ao	B-T109
may	O
lead	O
to	O
the	O
development	B-T169
of	O
new	O
mitochondria	O
-	O
targeted	O
antioxidants	O
in	O
the	O
encaged	O
chironomus	O
riparius	O
larvae	O
in	O
assessment	B-T052
of	O
trace	O
metal	O
bioavailability	B-T169
and	O
transfer	B-T169
in	O
a	O
landfill	O
leachate	O
collection	B-T169
pond	O
household	O
wastes	O
may	O
constitute	O
a	O
vector	B-T080
of	O
environmental	O
contamination	O
when	O
buried	B-T082
,	O
in	O
particular	O
through	O
degradation	B-T169
and	O
production	O
of	O
leachates	O
containing	B-T169
significant	B-T078
trace	O
metal	O
tm	O
concentrations	B-T081
that	O
may	O
constitute	O
a	O
serious	O
risk	B-T078
to	O
biota	O
.	O
	
the	O
objectives	B-T170
of	O
this	O
study	B-T062
were	O
to	O
assess	B-T052
the	O
bioavailability	B-T169
and	O
transfer	B-T169
potential	B-T080
of	O
various	O
tms	O
present	B-T033
in	O
water	O
and	O
sediments	O
in	O
a	O
reservoir	O
receiving	B-T080
landfill	O
leachates	O
.	O
	
an	O
active	B-T169
biomonitoring	O
approach	O
was	O
adopted	O
consisting	O
of	O
exposing	B-T080
naive	O
laboratory	O
organisms	O
in	O
cages	O
deployed	B-T052
in	B-T082
the	I-T082
field	I-T082
.	O
	
aquatic	O
insects	O
such	O
as	O
chironomus	O
riparius	O
larvae	O
are	O
good	O
candidates	O
since	O
they	O
represent	B-T052
key	O
organisms	O
in	O
the	O
trophic	O
functioning	B-T169
of	O
aquatic	O
ecosystems	O
.	O
	
the	O
results	B-T033
show	O
that	O
water	O
,	O
suspended	B-T169
particles	O
,	O
and	O
sediments	O
were	O
significant	B-T078
ly	O
contaminated	B-T169
by	O
various	O
tms	O
as	O
,	O
cd	O
,	O
cu	O
,	O
ni	O
,	O
pb	O
,	O
and	O
zn	O
.	O
	
their	O
contribution	B-T052
to	O
the	O
transfer	B-T169
of	O
tms	O
depends	O
,	O
however	O
,	O
on	O
the	O
specific	B-T080
element	O
considered	B-T078
,	O
e.g	O
,	O
cd	O
in	O
sediments	O
or	O
pb	O
in	O
both	O
suspended	B-T169
particles	O
and	O
sediments	O
.	O
	
the	O
internal	O
fate	O
of	O
tms	O
was	O
investigated	B-T169
according	O
to	O
their	O
fractionation	O
between	O
an	O
insoluble	B-T080
and	O
a	O
cytosolic	O
fraction	B-T081
.	O
	
this	O
approach	O
revealed	B-T080
different	O
detoxification	B-T061
strategies	O
capable	O
of	O
preventing	B-T169
the	O
induction	B-T169
of	O
deleterious	O
effects	O
at	O
the	O
individual	B-T098
scale	O
.	O
	
however	O
,	O
the	O
accumulation	B-T033
of	O
several	O
tms	O
in	O
c	O
.	O
	
riparius	O
larvae	O
tissues	O
may	O
also	O
represent	B-T052
a	O
significant	B-T078
load	O
potentially	B-T080
transferable	B-T169
to	O
higher	B-T080
trophic	O
levels	B-T080
.	O
	
effects	O
of	O
binge-like	O
ethanol	O
exposure	O
during	O
adolescence	B-T079
on	O
the	O
febrile	O
response	O
in	O
rats	O
ethanol	O
etoh	O
exposure	O
during	O
different	O
phases	B-T079
of	O
life	B-T078
may	O
increase	O
the	O
risk	B-T033
of	I-T033
infections	I-T033
and	O
cause	O
alterations	B-T078
in	O
the	O
central	O
nervous	O
system	O
.	O
	
the	O
present	O
study	O
investigated	O
the	O
effects	O
of	O
binge-like	O
etoh	O
exposure	O
in	O
adolescent	B-T079
rats	O
on	O
the	O
febrile	O
response	O
that	O
was	O
induced	O
by	O
lipopolysaccharide	B-T109
lps	B-T109
and	O
interleukin-1β	B-T116
il-1β	B-T116
.	O
	
male	O
rats	O
were	O
exposed	O
to	O
etoh	O
from	O
postnatal	B-T079
days	I-T079
25	O
to	O
38	O
in	O
a	O
binge-like	O
pattern	O
.	O
	
fever	O
was	O
induced	O
by	O
lps	B-T109
5	O
and	O
50	O
μg/kg	O
,	O
intraperitoneally	B-T082
and	O
evaluated	O
on	O
postnatal	B-T079
days	I-T079
51	O
and	O
63	O
,	O
or	O
by	O
il-β	B-T116
3	O
ng	O
and	O
evaluated	O
on	O
postnatal	B-T079
day	I-T079
51	O
.	O
	
hematological	O
parameters	O
,	O
the	O
status	O
of	O
peritoneal	O
macrophages	O
,	O
and	O
plasma	O
and	O
cerebrospinal	B-T169
il-1β	B-T116
levels	B-T080
were	O
also	O
evaluated	O
on	O
postnatal	B-T079
day	I-T079
51	O
.	O
	
etoh	O
exposure	O
during	O
adolescence	B-T079
did	O
not	O
alter	O
normal	B-T033
body	I-T033
temperature	I-T033
.	O
	
however	O
,	O
a	O
significant	O
reduction	O
in	O
the	O
febrile	O
response	O
that	O
was	O
induced	O
by	O
lps	B-T109
at	O
both	O
doses	O
was	O
observed	O
on	O
postnatal	B-T079
day	O
51	O
.	O
	
however	O
,	O
no	O
changes	O
in	O
the	O
febrile	O
response	O
were	O
observed	O
on	O
postnatal	B-T079
day	I-T079
63	O
in	O
etoh-exposed	O
animals	O
.	O
	
the	O
febrile	O
response	O
that	O
was	O
induced	O
by	O
intracerebroventricular	B-T082
il-1β	B-T116
also	O
significantly	O
decreased	O
in	O
animals	O
that	O
received	O
binge-like	O
etoh	O
exposure	O
during	O
adolescence	B-T079
.	O
	
acute	B-T169
oral	I-T169
treatment	I-T169
with	O
etoh	B-T109
24	O
h	O
prior	O
to	O
lps	B-T109
administration	B-T061
did	O
not	O
alter	O
the	O
febrile	O
response	O
that	O
was	O
induced	O
by	O
lps	B-T109
.	O
	
binge-like	O
etoh	O
exposure	O
during	O
adolescence	B-T079
did	O
not	O
alter	O
hematological	O
parameters	O
or	O
the	O
number	O
or	O
viability	O
of	O
peritoneal	O
macrophages	O
.	O
	
binge-like	O
etoh	O
exposure	O
did	O
not	O
alter	O
plasma	O
il-1β	B-T116
levels	B-T080
but	O
reduced	O
the	O
cerebrospinal	O
fluid	O
levels	B-T080
of	O
this	O
cytokine	B-T116
.	O
	
these	O
results	O
suggest	O
that	O
binge-like	O
etoh	O
exposure	O
during	O
adolescence	B-T079
causes	O
changes	O
in	O
the	O
central	O
nervous	O
system	O
that	O
can	O
impair	O
the	O
febrile	O
response	O
that	O
can	O
be	O
observed	O
after	O
the	O
cessation	B-T052
of	O
etoh	O
exposure	O
.	O
	
these	O
changes	O
were	O
reversible	O
and	O
appeared	O
to	O
involve	O
the	O
lps	B-T109
/	O
il-1β	B-T116
genital	B-T047
and	O
extragenital	B-T047
gonorrhea	I-T047
and	O
chlamydia	B-T047
in	O
children	O
and	O
adolescents	O
evaluated	O
for	O
sexual	O
abuse	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
describe	O
the	O
use	O
of	O
a	O
nucleic	O
acid	O
amplification	O
test	O
in	O
detecting	B-T061
genital	O
and	O
extragenital	O
neisseria	O
gonorrhoeae	O
ng	O
and	O
chlamydia	O
trachomatis	O
ct	O
in	O
children	O
and	O
adolescents	O
assessed	O
for	O
sexual	O
abuse	O
/	O
assault	O
.	O
	
the	O
charts	O
of	O
children	O
aged	O
0	O
to	O
17	O
years	B-T079
,	O
consecutively	O
evaluated	O
for	O
sexual	O
victimization	O
,	O
in	O
emergency	O
department	O
and	O
outpatient	O
settings	O
were	O
reviewed	O
.	O
	
data	B-T078
extracted	O
included	O
age	O
,	O
sex	O
,	O
type	O
of	O
sexual	B-T033
contact	I-T033
,	O
anogenital	O
findings	B-T033
,	O
previous	B-T079
sexual	B-T033
contact	I-T033
,	O
toxicology	B-T033
results	I-T033
,	O
and	O
sites	B-T082
tested	O
for	O
ng	O
and	O
ct	O
.	O
	
of	O
the	O
1319	O
patients	O
who	O
were	O
tested	O
,	O
579	O
were	O
tested	O
at	O
more	O
than	O
1	O
site	B-T082
,	O
and	O
120	O
had	O
at	O
least	O
1	O
infected	B-T033
site	B-T082
.	O
	
chlamydia	O
trachomatis	O
was	O
identified	O
in	O
104	O
patients	O
,	O
and	O
ng	O
was	O
found	O
in	O
33	O
.	O
	
in	O
bivariate	O
analysis	O
,	O
a	O
positive	O
test	O
was	O
associated	B-T080
with	I-T080
female	O
sex	O
,	O
age	O
older	O
than	O
11	O
years	B-T079
,	O
previous	B-T079
sexual	B-T033
contact	I-T033
,	O
acute	O
or	O
healed	B-T169
genital	O
injury	O
,	O
drug/alcohol	B-T033
intoxication	I-T033
,	O
and	O
examination	O
within	O
72	O
hours	B-T079
of	O
sexual	B-T033
contact	I-T033
.	O
	
fifty-one	O
patients	O
had	O
positive	B-T033
anal	O
tests	O
,	O
and	O
24	O
had	O
positive	B-T033
oral	B-T082
tests	O
.	O
	
more	O
than	O
75%	O
of	O
patients	O
with	O
positive	B-T033
extragenital	O
tests	O
had	O
additional	O
positive	B-T033
tests	O
or	O
anogenital	O
injury	O
.	O
	
most	O
with	O
a	O
positive	B-T033
anal	O
59%	O
or	O
oral	B-T082
77%	O
test	O
did	O
not	O
report	O
that	O
the	O
assailant's	O
genitals	O
came	O
into	O
contact	O
with	O
that	O
site	B-T082
.	O
	
positive	B-T033
tests	O
for	O
ng	O
and	O
ct	O
in	O
patients	O
evaluated	O
for	O
sexual	O
victimization	O
may	O
represent	O
infection	O
from	O
sexual	B-T033
contact	I-T033
,	O
contiguous	B-T080
spread	I-T080
of	O
infection	O
,	O
or	O
the	O
presence	O
of	O
infected	O
assailant	O
secretions	O
.	O
	
relying	O
on	O
patient	O
reports	O
of	O
symptoms	O
,	O
or	O
types	O
of	O
sexual	B-T033
contact	I-T033
,	O
to	O
determine	O
need	O
for	O
testing	O
may	O
miss	O
ng	B-T047
and	O
ct	B-T047
infections	I-T047
in	O
patients	O
evaluated	O
for	O
sexual	O
victimization	O
.	O
	
the	O
longitudinal	B-T082
effects	B-T080
of	I-T080
parenting	O
on	O
adaptive	O
behavior	O
in	O
children	O
with	O
fragile	B-T047
x	I-T047
syndrome	I-T047
several	O
studies	B-T062
have	O
reported	O
declines	B-T080
in	O
adaptive	O
behavior	O
amongst	O
children	O
with	O
fragile	B-T047
x	I-T047
syndrome	I-T047
fxs	B-T047
starting	O
in	O
middle	B-T079
childhood	B-T079
.	O
	
we	O
examined	B-T033
the	O
effects	B-T080
of	I-T080
maternal	O
responsivity	O
on	O
adaptive	O
behavior	O
in	O
55	O
children	O
with	O
fxs	B-T047
visited	O
5-6	O
times	O
in	O
their	O
homes	O
from	O
early	O
through	O
middle	B-T079
childhood	B-T079
.	O
	
our	O
analyses	B-T062
indicated	O
that	O
sustained	B-T169
maternal	O
responsivity	O
had	O
a	O
significant	B-T078
positive	B-T080
impact	I-T080
on	O
the	O
trajectories	B-T082
of	O
communication	O
and	O
to	O
a	O
lesser	O
extent	O
other	O
adaptive	O
behavior	O
domains	O
through	O
middle	B-T079
childhood	B-T079
with	O
many	O
effects	B-T080
remaining	O
significant	B-T078
after	O
controlling	O
for	O
autism	B-T033
symptoms	I-T033
and	O
developmental	O
level	O
.	O
	
for	O
children	O
who	O
showed	O
declines	B-T080
in	O
adaptive	O
behavior	O
during	O
middle	B-T079
childhood	B-T079
,	O
sustained	B-T169
high	B-T080
levels	I-T080
of	O
maternal	O
responsivity	O
minimized	B-T080
the	O
amount	O
of	O
decline	B-T080
observed	B-T169
in	O
the	O
communication	O
,	O
socialization	O
,	O
and	O
daily	O
living	O
domains	O
.	O
	
development	B-T169
and	O
validation	B-T062
of	O
a	O
new	O
reliable	O
method	O
for	O
the	O
diagnosis	B-T033
of	O
avian	O
botulism	O
liver	O
is	O
a	O
reliable	O
matrix	O
for	O
laboratory	O
confirmation	B-T080
of	I-T080
avian	O
botulism	O
using	O
real-time	O
pcr	O
.	O
	
here	O
,	O
we	O
developed	B-T169
,	O
optimized	B-T052
,	O
and	O
validated	B-T062
the	O
analytical	B-T062
steps	O
preceding	B-T079
pcr	O
to	O
maximize	O
the	O
detection	B-T033
of	O
clostridium	O
botulinum	O
group	O
iii	O
in	O
avian	O
liver	O
.	O
	
these	O
pre	B-T079
-	O
pcr	O
steps	O
included	O
enrichment	O
incubation	O
of	O
the	O
whole	O
liver	O
maximum	O
25	O
g	O
at	O
37	O
for	O
at	O
least	O
24	O
h	B-T079
in	O
an	O
anaerobic	O
chamber	O
and	O
dna	O
extraction	O
using	O
an	O
enzymatic	O
digestion	O
step	O
followed	O
by	O
a	O
dna	O
purification	O
step	O
.	O
	
conditions	O
of	O
sample	O
storage	B-T169
before	O
analysis	B-T062
appear	O
to	O
have	O
a	O
strong	O
effect	B-T080
on	O
the	O
detection	B-T033
of	O
group	O
iii	O
c	O
.	O
	
botulinum	O
strains	O
and	O
our	O
results	B-T169
recommend	O
storage	B-T169
at	O
temperatures	B-T081
below	O
-18	O
.	O
	
short-term	B-T079
storage	B-T169
at	O
5	O
is	O
possible	O
for	O
up	O
to	O
24	O
h	B-T079
,	O
but	O
a	O
decrease	B-T081
in	O
sensitivity	B-T169
was	O
observed	O
at	O
48	O
h	B-T079
of	O
storage	B-T169
at	O
this	O
temperature	B-T081
.	O
	
analysis	B-T062
of	O
whole	O
livers	O
maximum	O
25	O
g	O
is	O
required	O
and	O
pooling	B-T169
samples	O
before	O
enrichment	O
culturing	O
must	O
be	O
avoided	O
.	O
	
pooling	B-T169
is	O
however	O
possible	O
before	O
or	O
after	O
dna	O
extraction	O
under	O
certain	O
conditions	O
.	O
	
whole	O
livers	O
should	O
be	O
10-fold	O
diluted	O
in	O
enrichment	O
medium	O
and	O
homogenized	O
using	O
a	O
pulsifier	O
blender	O
microgen	O
,	O
surrey	O
,	O
uk	O
instead	O
of	O
a	O
conventional	O
paddle	O
blender	O
.	O
	
spiked	O
liver	O
samples	O
showed	O
a	O
limit	O
of	O
detection	B-T033
of	O
5	O
spores	O
/g	O
liver	O
for	O
types	O
c	O
and	O
d	O
and	O
250	O
spores	O
/g	O
for	O
type	O
e	O
.	O
	
using	O
the	O
method	O
developed	B-T169
here	O
,	O
the	O
analysis	B-T062
of	O
268	O
samples	O
from	O
73	O
suspected	O
outbreaks	B-T081
showed	O
100%	O
specificity	B-T081
and	O
95.35	O
sensitivity	B-T169
compared	B-T052
with	O
other	O
pcr	O
-based	O
methods	O
considered	O
as	O
reference	O
.	O
	
the	O
mosaic	O
type	O
c	O
/	O
d	O
was	O
the	O
most	O
common	O
neurotoxin	O
type	O
found	O
in	O
examined	O
samples	O
,	O
which	O
included	O
both	O
wild	O
and	O
domestic	O
birds	O
.	O
	
quality	O
improvement	O
of	O
liver	O
ultrasound	O
images	B-T170
using	O
fuzzy	B-T170
techniques	B-T170
liver	O
ultrasound	O
images	B-T170
are	O
so	O
common	O
and	O
are	O
applied	O
so	O
often	O
to	O
diagnose	B-T033
diffuse	B-T047
liver	I-T047
diseases	I-T047
like	O
fatty	B-T047
liver	I-T047
.	O
	
however	O
,	O
the	O
low	B-T080
quality	B-T080
of	O
such	O
images	B-T170
makes	O
it	O
difficult	O
to	O
analyze	B-T062
them	O
and	O
diagnose	B-T033
diseases	B-T047
.	O
	
the	O
purpose	O
of	O
this	O
study	B-T062
,	O
therefore	O
,	O
is	O
to	O
improve	O
the	O
contrast	B-T080
and	O
quality	B-T080
of	O
liver	O
ultrasound	O
images	B-T170
.	O
	
in	O
this	O
study	B-T062
,	O
a	O
number	O
of	O
image	B-T170
contrast	B-T080
enhancement	B-T170
algorithms	I-T170
which	O
are	O
based	O
on	O
fuzzy	B-T170
logic	I-T170
were	O
applied	O
to	O
liver	O
ultrasound	O
images	B-T170
-	O
in	O
which	O
the	O
view	O
of	O
kidney	O
is	O
observable	O
-	O
using	O
matlab2013b	O
to	O
improve	O
the	O
image	B-T170
contrast	B-T080
and	O
quality	B-T080
which	O
has	O
a	O
fuzzy	B-T170
definition	B-T170
just	O
like	O
image	B-T170
contrast	B-T080
improvement	O
algorithms	B-T170
using	O
a	O
fuzzy	B-T170
intensification	O
operator	O
,	O
contrast	B-T080
improvement	O
algorithms	B-T170
applying	O
fuzzy	B-T170
image	B-T170
histogram	B-T170
hyperbolization	I-T170
,	O
and	O
contrast	B-T080
improvement	O
algorithms	B-T170
by	O
fuzzy	B-T170
if-then	B-T170
rules	I-T170
.	O
	
with	O
the	O
measurement	B-T169
of	O
mean	B-T080
squared	I-T080
error	I-T080
and	O
peak	B-T080
signal	B-T081
to	I-T081
noise	I-T081
ratio	I-T081
obtained	O
from	O
different	O
images	B-T170
,	O
fuzzy	B-T170
methods	B-T170
provided	O
better	O
results	B-T169
,	O
and	O
their	O
implementation	B-T052
-	O
compared	B-T052
with	O
histogram	B-T170
equalization	I-T170
method	I-T170
-	O
led	O
both	O
to	O
the	O
improvement	O
of	O
contrast	B-T080
and	O
visual	B-T033
quality	I-T033
of	O
images	B-T170
and	O
to	O
the	O
improvement	O
of	O
liver	O
segmentation	B-T170
algorithms	I-T170
results	O
in	O
images	B-T170
.	O
	
comparison	B-T052
of	O
the	O
four	O
algorithms	B-T170
revealed	O
the	O
power	O
of	O
fuzzy	B-T170
logic	I-T170
in	O
improving	O
image	B-T170
contrast	B-T080
compared	B-T052
with	O
traditional	O
image	O
processing	O
algorithms	B-T170
.	O
	
moreover	O
,	O
contrast	B-T080
improvement	O
algorithm	O
based	O
on	O
a	O
fuzzy	B-T170
intensification	O
operator	O
was	O
selected	O
as	O
the	O
strongest	O
algorithm	B-T170
considering	O
the	O
measured	O
indicators	O
.	O
	
this	O
method	B-T170
can	O
also	O
be	O
used	O
in	O
future	O
studies	B-T062
on	O
other	O
ultrasound	O
images	B-T170
for	O
quality	O
improvement	O
and	O
other	O
image	O
processing	O
and	O
analysis	B-T062
applications	B-T169
.	O
	
development	B-T169
of	O
the	O
pediatric	B-T170
quality	I-T170
of	I-T170
life	I-T170
inventory	I-T170
neurofibromatosis	O
type	O
1	O
module	B-T170
items	B-T062
for	O
children	O
,	O
adolescents	O
and	O
young	O
adults	O
qualitative	B-T062
methods	I-T062
health-related	B-T078
quality	I-T078
of	I-T078
life	I-T078
hrqol	B-T078
is	O
arguably	O
one	O
of	O
the	O
most	O
important	B-T080
measures	B-T081
in	O
evaluating	O
effectiveness	B-T080
of	O
clinical	B-T061
treatments	I-T061
.	O
	
at	O
present	O
,	O
there	O
is	O
no	O
disease	B-T047
-	O
specific	B-T080
outcome	B-T081
measure	I-T081
to	O
assess	O
the	O
hrqol	B-T078
of	O
children	O
,	O
adolescents	O
and	O
young	O
adults	O
with	O
neurofibromatosis	O
type	O
1	O
nf1	O
.	O
	
this	O
study	B-T062
aimed	O
to	O
develop	O
the	O
items	B-T062
and	O
support	O
the	O
content	B-T080
validity	I-T080
for	O
the	O
pediatric	B-T170
quality	I-T170
of	I-T170
life	I-T170
inventory	I-T170
pedsql	B-T170
nf1	O
module	B-T170
for	O
children	O
,	O
adolescents	O
and	O
young	O
adults	O
.	O
	
the	O
iterative	B-T033
process	O
included	O
multiphase	B-T062
qualitative	I-T062
methods	I-T062
including	O
a	O
literature	B-T170
review	I-T170
,	O
survey	B-T170
of	O
expert	O
opinions	O
,	O
semi-structured	B-T052
interviews	I-T052
,	O
cognitive	B-T169
interviews	B-T052
and	O
pilot	B-T062
testing	I-T062
.	O
	
fifteen	O
domains	B-T169
were	O
derived	O
from	O
the	O
qualitative	B-T062
methods	I-T062
,	O
with	O
content	O
saturation	O
achieved	O
,	O
resulting	O
in	O
115	O
items	B-T062
.	O
	
the	O
domains	B-T169
include	O
skin	O
,	O
pain	O
,	O
pain	O
impact	B-T080
,	O
pain	B-T061
management	I-T061
,	O
cognitive	O
functioning	O
,	O
speech	O
,	O
fine	O
motor	O
,	O
balance	B-T169
,	O
vision	O
,	O
perceived	O
physical	O
appearance	O
,	O
communication	O
,	O
worry	B-T033
,	O
treatment	B-T061
,	O
medicines	O
and	O
gastrointestinal	O
symptoms	O
.	O
	
this	O
study	O
is	O
limited	B-T169
because	O
all	O
participants	B-T098
are	O
recruited	O
from	O
a	O
single	B-T081
-	O
site	B-T082
.	O
	
qualitative	B-T062
methods	I-T062
support	O
the	O
content	B-T080
validity	I-T080
for	O
the	O
pedsql	B-T170
nf1	O
module	B-T170
for	O
children	O
,	O
adolescents	O
and	O
young	O
adults	O
.	O
	
the	O
pedsql	B-T170
nf1	O
module	B-T170
is	O
now	O
undergoing	O
national	B-T169
multisite	I-T169
field	I-T169
testing	I-T169
for	O
the	O
psychometric	O
validation	B-T062
of	O
the	O
instrument	B-T170
development	B-T169
.	O
	
mimiviruses	O
and	O
the	O
human	O
interferon	B-T116
system	O
viral	O
evasion	O
of	O
classical	B-T169
antiviral	O
activities	O
,	O
but	O
inhibition	B-T052
by	O
a	O
novel	O
interferon-β	B-T116
regulated	O
immunomodulatory	B-T061
pathway	O
in	O
this	O
review	B-T170
we	O
discuss	O
the	O
role	O
of	O
mimiviruses	O
as	O
potential	B-T080
human	O
pathogens	O
focusing	O
on	O
clinical	B-T080
and	O
evolutionary	O
evidence	B-T078
.	O
	
we	O
also	O
propose	B-T080
a	O
novel	O
antiviral	O
immunomodulatory	O
pathway	O
controlled	B-T169
by	O
interferon-β	B-T116
ifn-β	B-T116
and	O
mediated	O
by	O
immune-responsive	B-T116
gene	I-T116
1	I-T116
irg1	B-T116
and	O
itaconic	B-T109
acid	I-T109
,	O
its	O
product	O
.	O
	
acanthamoeba	O
polyphaga	O
mimivirus	O
apmv	O
was	O
isolated	B-T169
from	O
amoebae	O
in	O
a	O
hospital	O
while	O
investigating	B-T169
a	O
pneumonia	B-T047
outbreak	O
.	O
	
mimivirus	O
ubiquity	B-T080
and	O
role	O
as	O
protist	O
pathogens	O
are	O
well	O
understood	O
,	O
and	O
its	O
putative	B-T082
status	B-T169
as	O
a	O
human	O
pathogen	O
has	O
been	O
gaining	B-T081
strength	B-T078
as	O
more	O
evidence	B-T078
is	O
being	O
found	O
.	O
	
the	O
study	B-T062
of	O
apmv	O
and	O
human	O
cells	O
interaction	O
revealed	O
that	O
the	O
virus	O
is	O
able	O
to	O
evade	O
the	O
ifn	B-T116
system	O
by	O
inhibiting	B-T052
the	O
regulation	O
of	O
interferon	B-T116
-stimulated	O
genes	O
,	O
suggesting	O
that	O
the	O
virus	O
and	O
humans	O
have	O
had	O
host-pathogen	O
interactions	O
.	O
	
it	O
also	O
has	O
shown	O
that	O
the	O
virus	O
is	O
capable	B-T080
of	O
growing	O
on	O
ifn-α2	B-T116
,	O
but	O
not	O
on	O
ifn-β	B-T116
-	O
treated	B-T169
cells	O
,	O
hinting	O
at	O
an	O
exclusive	B-T078
ifn-β	B-T116
antiviral	O
pathway	O
.	O
	
our	O
hypothesis	B-T078
based	B-T078
on	O
preliminary	B-T078
data	I-T078
and	O
published	B-T170
articles	I-T170
is	O
that	O
ifn-β	B-T116
preferentially	B-T078
upregulates	O
irg1	B-T116
in	I-T116
human	I-T116
macrophagic	O
cells	O
,	O
which	O
in	O
turn	O
produces	O
itaconic	B-T109
acid	I-T109
.	O
	
this	O
metabolite	O
links	O
metabolism	O
to	O
antiviral	O
activity	O
by	O
inactivating	B-T169
the	O
virus	O
,	O
in	O
a	O
novel	O
immunomodulatory	B-T061
pathway	O
relevant	B-T080
for	O
apmv	O
infections	O
and	O
probably	O
to	O
other	O
infectious	B-T047
diseases	I-T047
heteroprotein	B-T116
complex	O
formation	O
of	O
bovine	B-T116
lactoferrin	I-T116
and	O
pea	B-T116
protein	I-T116
isolate	O
a	O
multiscale	O
structural	O
analysis	O
associative	B-T080
electrostatic	O
interactions	O
between	O
two	O
oppositely	B-T080
charged	O
globular	B-T116
proteins	I-T116
,	O
lactoferrin	B-T116
lf	B-T116
and	O
pea	B-T116
protein	I-T116
isolate	O
ppi	B-T116
,	O
the	O
latter	O
being	O
a	O
mixture	O
of	O
vicilin	B-T116
,	O
legumin	B-T116
,	O
and	O
convicilin	B-T116
,	O
was	O
studied	B-T062
with	O
a	O
specific	B-T080
ppi	B-T116
/	O
lf	B-T116
molar	B-T081
ratio	I-T081
at	O
room	B-T033
temperature	I-T033
.	O
	
structural	B-T082
aspects	B-T080
of	O
the	O
electrostatic	O
complexes	O
probed	O
at	O
different	B-T080
length	B-T081
scales	B-T081
were	O
investigated	B-T169
as	O
a	O
function	B-T169
of	O
ph	B-T081
by	O
means	O
of	O
different	B-T080
complementary	B-T169
techniques	I-T169
,	O
namely	O
,	O
with	O
dynamic	O
light	O
scattering	O
,	O
small-angle	O
x-ray	O
scattering	O
saxs	O
,	O
turbidity	O
measurements	O
,	O
and	O
atomic	O
force	O
microscopy	O
afm	O
.	O
	
irrespective	O
of	O
the	O
applied	O
techniques	B-T169
,	O
the	O
results	O
consistently	B-T078
displayed	B-T169
that	O
complexation	O
between	O
lf	B-T116
and	O
ppi	B-T116
did	O
occur	B-T052
.	O
	
in	O
an	O
optimum	B-T080
narrow	B-T080
range	B-T081
of	O
ph	B-T081
5.0	O
,	O
a	O
viscous	B-T080
liquid	B-T033
phase	B-T079
of	O
complex	O
coacervate	O
was	O
obtained	B-T169
upon	O
mild	O
centrifugation	O
of	O
the	O
turbid	B-T080
lf	B-T116
-	O
ppi	B-T116
mixture	O
with	O
a	O
maximum	B-T081
rh	O
,	O
turbidity	B-T080
and	O
the	O
ζ-potential	O
being	O
close	O
to	O
zero	O
observed	B-T169
at	O
ph	B-T081
5.4	O
.	O
	
in	O
particular	O
,	O
the	O
saxs	O
data	B-T078
demonstrated	O
that	O
the	O
coacervates	O
were	O
densely	B-T080
assembled	B-T052
with	O
a	O
roughly	B-T080
spherical	B-T082
size	B-T082
distribution	B-T082
exhibiting	O
a	O
maximum	B-T081
extension	B-T169
of	O
80	O
nm	O
at	O
ph	B-T081
5.4	O
.	O
	
equally	O
,	O
afm	O
image	O
analysis	O
showed	O
size	B-T082
distributions	B-T082
containing	B-T169
most	O
frequent	B-T079
cluster	B-T081
sizes	B-T082
around	O
40-80	O
nm	O
with	O
spherical	B-T082
to	O
elliptical	B-T082
shapes	I-T082
axis	O
aspect	O
ratio	O
2	O
as	O
well	O
as	O
less	O
frequent	B-T079
elongated	O
to	O
chainlike	B-T080
structures	B-T082
.	O
	
the	O
most	O
frequently	B-T079
observed	B-T169
compact	O
complexes	O
,	O
we	O
identify	O
as	O
mainly	O
leading	O
to	O
lf	B-T116
-	O
ppi	B-T116
coacervation	O
,	O
whereas	O
for	O
the	O
less	O
frequent	B-T079
chain-like	B-T080
aggregates	I-T080
,	O
we	O
hypothesize	O
that	O
additionally	O
ppi	B-T116
-	O
ppi	B-T116
facilitated	O
complexes	O
visual	B-T169
outcome	B-T169
,	O
endocrine	O
function	O
and	O
tumor	O
control	B-T169
after	O
fractionated	B-T061
stereotactic	I-T061
radiation	I-T061
therapy	I-T061
of	O
craniopharyngiomas	O
in	O
adults	O
findings	O
in	O
a	O
prospective	B-T062
cohort	I-T062
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
examine	O
visual	B-T169
outcome	B-T169
,	O
endocrine	O
function	O
and	O
tumor	O
control	B-T169
in	O
a	O
prospective	B-T062
cohort	I-T062
of	O
craniopharyngioma	O
patients	O
,	O
treated	B-T061
with	I-T061
fractionated	B-T061
stereotactic	I-T061
radiation	I-T061
therapy	I-T061
fsrt	B-T061
.	O
	
sixteen	O
adult	O
patients	O
with	O
craniopharyngiomas	O
were	O
eligible	B-T080
for	O
analysis	B-T062
.	O
	
they	O
were	O
treated	B-T061
with	I-T061
linear	O
accelerator-based	O
fsrt	B-T061
during	O
1999-2015	O
.	O
	
in	O
all	O
cases	O
,	O
diagnosis	B-T062
was	O
confirmed	O
by	O
histological	B-T169
analysis	B-T062
.	O
	
the	O
prescription	O
dose	B-T081
to	O
the	O
tumor	O
was	O
54	O
gy	B-T081
median	B-T081
,	O
range	B-T081
48-54	O
in	O
1.8	O
or	O
2.0	O
gy	B-T081
per	O
fraction	B-T081
,	O
and	O
the	O
maximum	O
radiation	B-T081
dose	I-T081
to	O
the	O
optic	O
nerves	O
and	O
chiasm	O
was	O
54.2	O
gy	B-T081
median	B-T081
,	O
range	B-T081
48.6	O
for	O
the	O
cohort	B-T098
.	O
	
serial	O
ophthalmological	B-T061
and	O
endocrine	O
evaluations	O
and	O
magnetic	O
resonance	O
imaging	O
mri	O
scans	O
were	O
performed	O
at	O
regular	O
intervals	O
.	O
	
median	B-T081
follow-up	O
was	O
3.3	O
years	B-T079
range	B-T081
1.1	O
,	O
3.7	O
years	B-T079
range	B-T081
0.8	O
,	O
and	O
3.6	O
years	B-T079
range	B-T081
0.7	O
for	O
visual	B-T169
outcome	B-T169
,	O
endocrine	O
function	O
,	O
and	O
tumor	O
control	B-T169
,	O
respectively	O
.	O
	
visual	O
acuity	O
impairment	B-T169
was	O
present	O
in	O
10	O
patients	O
62.5	O
and	O
visual	B-T033
field	I-T033
defects	I-T033
were	O
present	O
in	O
12	O
patients	O
75%	O
before	O
fsrt	B-T061
.	O
	
one	O
patient	O
developed	O
radiation-induced	B-T047
optic	I-T047
neuropathy	I-T047
at	O
seven	O
years	B-T079
after	O
fsrt	B-T061
.	O
	
thirteen	O
of	O
16	O
patients	O
81.3	O
had	O
pituitary	B-T047
deficiency	I-T047
before	O
fsrt	B-T061
,	O
and	O
did	O
not	O
develop	O
further	O
pituitary	B-T047
deficiency	I-T047
after	O
fsrt	B-T061
.	O
	
mean	B-T081
tumor	B-T081
volume	I-T081
pre-	O
fsrt	B-T061
was	O
2.72	O
cm	O
range	B-T081
0.20	O
and	O
post-	O
fsrt	B-T061
1.2	O
cm	O
range	B-T081
0.00	O
.	O
	
tumor	O
control	B-T169
rate	B-T081
was	O
81.3	O
at	O
two	O
,	O
five	O
,	O
and	O
10	O
years	B-T079
after	O
fsrt	B-T061
.	O
	
fsrt	B-T061
was	O
relatively	O
safe	O
in	O
this	O
prospective	O
cohort	B-T098
of	O
craniopharyngiomas	O
,	O
with	O
only	O
one	O
case	O
of	O
radiation-induced	B-T047
optic	I-T047
neuropathy	I-T047
and	O
no	O
case	O
of	O
new	O
endocrinopathy	B-T047
.	O
	
tumor	O
control	B-T169
rate	B-T081
scutellaria	O
barbata	O
d	O
.	O
	
don	O
extract	O
inhibits	B-T052
the	O
tumor	O
growth	O
through	O
down-regulating	O
of	O
treg	O
cells	O
and	O
manipulating	O
th1	O
/	O
th17	O
immune	O
response	O
in	O
hepatoma	O
h22	O
-bearing	O
mice	O
previous	O
studies	O
showed	O
scutellaria	O
barbata	O
d	O
.	O
	
don	O
extract	O
sbe	O
is	O
a	O
potent	O
inhibitor	O
in	O
hepatoma	O
and	O
could	O
improve	O
immune	O
function	O
of	O
hepatoma	O
h22	O
-bearing	O
mice	O
.	O
	
however	O
,	O
the	O
immunomodulatory	O
function	O
of	O
sbe	O
on	O
the	O
tumor	O
growth	O
of	O
hepatoma	O
remains	O
unclear	B-T033
.	O
	
this	O
study	B-T062
aimed	O
to	O
investigate	B-T169
the	O
anti-tumor	B-T080
effects	B-T080
of	O
sbe	O
on	O
hepatoma	O
h22	O
-bearing	O
mice	O
and	O
explore	O
the	O
underlying	O
immunomodulatory	O
function	O
.	O
	
the	O
hepatoma	O
h22	O
-bearing	O
mice	O
were	O
treated	B-T169
by	O
sbe	O
for	O
30	O
days	B-T079
.	O
	
the	O
effect	B-T080
of	I-T080
sbe	O
on	O
the	O
proliferation	O
of	O
hepg2	O
cells	O
in	B-T080
vitro	I-T080
,	O
the	O
growth	O
of	O
transplanted	O
tumor	O
,	O
the	O
cytotoxicity	O
of	O
natural	O
killer	O
nk	O
cells	O
in	O
spleen	O
,	O
the	O
amount	B-T081
of	O
cd4	O
treg	O
cells	O
and	O
th17	O
cells	O
in	O
tumor	O
tissue	O
,	O
and	O
the	O
levels	B-T080
of	O
il-10	B-T116
,	O
tgf-β	B-T116
,	O
il-17a	B-T116
,	O
il-2	B-T116
,	O
and	O
ifn-γ	B-T116
in	O
serum	O
of	O
the	O
hepatoma	O
h22	O
-bearing	O
mice	O
was	O
observered	O
.	O
	
il-17a	B-T116
was	O
injected	B-T169
to	O
the	O
sbe	O
treated	B-T169
mice	O
from	O
day	B-T079
9	O
post	B-T079
h22	O
inoculation	B-T061
to	O
examine	O
its	O
effect	B-T080
on	O
tumor	O
growth	O
.	O
	
sbe	O
treatment	B-T169
inhibited	B-T080
the	O
proliferation	O
of	O
hepg2	O
cells	O
in	B-T080
vitro	I-T080
with	O
a	O
dose-dependent	B-T169
manner	I-T169
and	O
significantly	O
suppressed	B-T169
the	O
tumor	O
growth	O
of	O
hepatoma	O
h22	O
-bearing	O
mice	O
.	O
	
meanwhile	O
,	O
it	O
increased	B-T081
nk	O
cells'	O
cytotoxicity	O
in	O
spleen	O
,	O
down-regulated	O
the	O
amount	B-T081
of	O
cd4	O
treg	O
cells	O
and	O
th17	O
cells	O
in	O
tumor	O
tissue	O
,	O
and	O
decreased	B-T081
il-10	B-T116
,	O
tgf-β	B-T116
,	O
and	O
il-17a	B-T116
levels	B-T080
p	O
<	O
0.01	O
whereas	O
increased	B-T081
il-2	B-T116
and	O
ifn-γ	B-T116
levels	B-T080
p	O
<	O
0.01	O
in	O
the	O
serum	O
of	O
hepatoma	O
h22	O
-bearing	O
mice	O
.	O
	
moreover	O
,	O
administration	B-T081
of	O
recombinant	O
mouse	O
il-17a	B-T116
reversed	B-T169
the	O
anti-tumor	B-T080
effects	B-T080
of	O
sbe	O
.	O
	
sbe	O
could	O
inhibit	B-T052
the	O
proliferation	O
of	O
hepg2	O
cells	O
in	B-T080
vitro	I-T080
.	O
	
meanwhile	O
,	O
sbe	O
also	O
could	O
inhibit	B-T052
the	O
growth	O
of	O
h22	O
implanted	O
tumor	O
in	O
hepatoma	O
h22	O
-bearing	O
mice	O
,	O
and	O
this	O
function	B-T169
might	O
be	O
associated	B-T080
with	I-T080
immunomodulatory	O
activity	O
through	O
down-regulating	O
of	O
treg	O
cells	O
and	O
manipulating	O
th1	O
/	O
th17	O
immune	O
response	O
.	O
	
clinical	O
characteristics	O
of	O
genital	B-T047
chlamydia	I-T047
infection	I-T047
in	O
pelvic	B-T047
inflammatory	I-T047
disease	I-T047
chlamydia	B-T047
infection	I-T047
in	O
acute	B-T047
pelvic	I-T047
inflammatory	I-T047
disease	I-T047
pid	B-T047
is	O
associated	O
with	O
serious	O
complications	O
including	O
ectopic	O
pregnancy	O
,	O
tubal	B-T047
infertility	I-T047
,	O
fitz-hugh-curtis	B-T047
syndrome	I-T047
and	O
tubo-ovarian	B-T047
abscess	I-T047
toa	B-T047
.	O
	
this	O
study	B-T062
compared	O
clinical	B-T170
and	O
laboratory	B-T170
data	I-T170
between	O
pid	B-T047
with	O
and	O
without	O
chlamydia	B-T047
infection	I-T047
.	O
	
the	O
medical	B-T170
records	I-T170
of	O
497	O
women	B-T098
who	O
were	O
admitted	O
with	O
pid	B-T047
between	O
2002	O
and	O
2011	O
were	O
reviewed	O
.	O
	
the	O
patients	O
were	O
divided	O
into	O
two	O
groups	B-T098
pid	B-T047
with	O
and	O
without	O
chlamydia	B-T047
infection	I-T047
,	O
which	O
were	O
compared	O
in	O
terms	O
of	O
the	O
patients'	O
characteristics	O
,	O
clinical	B-T170
presentation	I-T170
,	O
and	O
laboratory	O
findings	O
,	O
including	O
inflammatory	B-T169
markers	O
.	O
	
the	O
chlamydia	B-T098
and	O
non-chlamydia	B-T098
groups	I-T098
comprised	O
175	O
and	O
322	O
women	B-T098
,	O
respectively	O
.	O
	
the	O
patients	O
in	O
the	O
chlamydia	B-T098
group	I-T098
were	O
younger	B-T079
and	O
had	O
a	O
higher	O
rate	O
of	O
toa	B-T047
,	O
a	O
longer	O
mean	B-T081
hospital	B-T079
stay	I-T079
,	O
and	O
had	O
undergone	O
more	O
surgeries	B-T061
than	O
the	O
patients	O
in	O
the	O
non-	B-T098
chlamydia	I-T098
group	I-T098
.	O
	
the	O
erythrocyte	O
sedimentation	O
rate	O
esr	O
,	O
c-reactive	B-T116
protein	I-T116
crp	B-T116
,	O
and	O
ca-125	B-T109
level	B-T080
were	O
higher	O
in	O
the	O
chlamydia	B-T098
group	I-T098
than	O
in	O
the	O
non-chlamydia	B-T098
group	I-T098
,	O
but	O
there	O
was	O
no	O
significant	B-T078
difference	O
in	O
the	O
white	B-T033
blood	I-T033
cell	I-T033
count	I-T033
between	O
the	O
two	O
groups	B-T098
.	O
	
the	O
ca-125	B-T109
level	B-T080
was	O
the	O
strongest	O
predictor	B-T078
of	O
chlamydia	B-T047
infection	I-T047
,	O
followed	O
by	O
the	O
esr	O
and	O
crp	B-T116
level	B-T080
.	O
	
the	O
area	B-T082
under	O
the	O
receiving	B-T081
operating	I-T081
curve	I-T081
for	O
ca-125	B-T109
,	O
esr	O
,	O
and	O
crp	B-T116
was	O
0.804	O
,	O
0.755	O
,	O
and	O
0.663	O
,	O
respectively	O
.	O
	
chlamydia	B-T047
infection	I-T047
in	O
acute	B-T047
pid	I-T047
is	O
associated	O
with	O
increased	O
level	B-T080
of	O
inflammatory	B-T169
markers	O
,	O
such	O
as	O
ca-125	B-T109
,	O
esr	O
and	O
crp	B-T116
,	O
incidence	O
of	O
toa	B-T047
,	O
operation	B-T061
risk	B-T078
,	O
and	O
longer	O
incidence	B-T081
and	O
effect	B-T080
of	I-T080
variant	B-T080
histology	O
on	O
oncological	B-T080
outcomes	I-T080
in	O
patients	O
with	O
bladder	O
cancer	O
treated	B-T169
with	O
radical	B-T061
cystectomy	I-T061
we	O
sought	O
to	O
describe	O
incidence	B-T081
of	O
histological	B-T169
variants	B-T080
after	O
radical	B-T061
cystectomy	I-T061
rc	B-T061
due	O
to	O
bladder	O
cancer	O
bca	O
.	O
	
moreover	O
,	O
we	O
investigated	O
survival	B-T169
outcomes	B-T080
accounting	O
for	O
this	O
parameter	O
.	O
	
we	O
retrospectively	B-T080
evaluated	O
data	B-T078
from	O
1	O
patients	O
with	O
bca	O
treated	B-T169
with	O
rc	B-T061
between	O
1990	O
and	O
2013	O
at	O
a	O
single	O
tertiary	O
care	O
referral	O
center	O
.	O
	
all	O
specimen	O
were	O
evaluated	O
by	O
dedicated	O
uropathologists	O
.	O
	
univariable	B-T170
and	I-T170
multivariable	I-T170
cox	I-T170
regression	I-T170
analyses	I-T170
tested	O
the	O
effect	B-T080
of	I-T080
different	O
histopathological	B-T169
variant	B-T080
on	O
recurrence	O
,	O
cancer-specific	B-T081
mortality	I-T081
csm	B-T081
,	O
and	O
overall	B-T081
mortality	I-T081
om	B-T081
after	O
accounting	O
for	O
all	O
available	O
confounders	B-T169
.	O
	
of	O
1	O
patients	O
,	O
729	O
68.3	O
harbored	O
pure	O
urothelial	O
bca	O
while	O
338	O
31.7	O
were	O
found	O
to	O
have	O
a	O
variant	B-T080
.	O
	
considering	O
uncommon	O
variants	B-T080
,	O
21	O
2.0	O
were	O
sarcomatoid	O
,	O
10	O
0.9	O
lymphoepitelial	O
,	O
19	O
1.8	O
small	O
cell	O
,	O
109	O
10.2	O
squamous	O
,	O
89	O
8.3	O
micropapillary	O
,	O
23	O
2.2	O
glandular	O
,	O
34	O
3.2	O
mixed	O
variants	B-T080
,	O
and	O
33	O
3.1	O
were	O
found	O
with	O
other	O
types	O
of	O
variants	B-T080
.	O
	
with	O
a	O
median	B-T081
follow-up	O
of	O
6.2	O
years	B-T079
,	O
343	O
recurrence	O
,	O
365	O
csm	B-T081
,	O
and	O
451	O
om	B-T081
were	O
recorded	O
,	O
respectively	O
.	O
	
at	O
multivariable	B-T170
cox	I-T170
regression	I-T170
analyses	I-T170
,	O
the	O
presence	O
of	O
small	O
cell	O
variant	O
was	O
associated	B-T080
with	I-T080
higher	O
recurrence	O
hazard	B-T081
ratio	I-T081
hr	B-T081
=	O
3.47	O
,	O
p<0	O
,	O
csm	B-T081
hr	B-T081
=	O
3.30	O
,	O
p<0	O
,	O
and	O
om	B-T081
hr	B-T081
=	O
2.97	O
,	O
p<0	O
as	O
compared	O
with	O
pure	O
urothelial	O
cancer	O
.	O
	
conversely	O
,	O
no	B-T033
survival	I-T033
differences	I-T033
were	O
recorded	O
considering	O
other	O
histological	B-T169
variants	B-T080
all	O
p>	O
0.1	O
.	O
	
our	O
study	O
confirms	O
that	O
histological	B-T169
variant	B-T080
is	O
not	O
an	O
infrequent	O
event	O
at	O
rc	B-T061
specimen	O
.	O
	
however	O
,	O
in	O
our	O
single-center	O
series	O
,	O
only	O
patients	O
found	O
with	O
small	O
cell	O
variant	O
were	O
associated	B-T080
with	I-T080
a	O
negative	B-T033
effect	B-T080
on	O
survival	B-T169
after	O
psychometric	O
properties	B-T080
of	O
the	O
japanese	O
version	B-T170
of	O
short	B-T170
forms	I-T170
of	O
the	O
pain	B-T170
catastrophizing	I-T170
scale	I-T170
in	O
participants	B-T098
with	O
musculoskeletal	B-T033
pain	I-T033
a	O
cross-sectional	B-T062
study	I-T062
the	O
pain	B-T170
catastrophizing	I-T170
scale	I-T170
pcs	B-T170
is	O
a	O
commonly	O
used	O
as	O
measure	B-T081
of	O
pain	O
catastrophizing	O
.	O
	
the	O
scale	B-T170
comprises	O
13	O
items	B-T062
related	O
to	O
magnification	O
,	O
rumination	O
,	O
and	O
helplessness	O
.	O
	
to	O
facilitate	O
quick	O
screening	O
and	O
to	O
reduce	B-T080
participant's	B-T098
burden	B-T078
,	O
the	O
four-	O
item	B-T062
and	O
six-	O
item	B-T062
short	B-T170
forms	I-T170
of	O
the	O
english	O
version	B-T170
of	O
the	O
pcs	B-T170
were	O
developed	O
.	O
	
the	O
purpose	O
of	O
the	O
present	O
study	B-T062
was	O
to	O
evaluate	O
the	O
psychometric	O
properties	B-T080
of	O
a	O
japanese	O
version	B-T170
of	O
the	O
short	B-T170
forms	I-T170
of	O
pcs	B-T170
using	O
a	O
contemporary	O
approach	B-T169
called	O
rasch	B-T062
analysis	I-T062
.	O
	
a	O
total	O
of	O
216	O
patients	O
with	O
musculoskeletal	B-T047
disorders	I-T047
were	O
recruited	O
in	O
this	O
study	B-T062
.	O
	
participants	B-T098
completed	O
study	B-T062
measures	B-T081
,	O
which	O
included	O
the	O
pain	O
intensity	O
,	O
the	O
pain	B-T170
catastrophizing	I-T170
scale	I-T170
pcs	B-T170
,	O
and	O
the	O
tampa	B-T170
scale	I-T170
of	I-T170
kinesiophobia	I-T170
tsk	B-T170
.	O
	
furthermore	O
,	O
the	O
four-	O
item	B-T062
items	B-T062
3	O
,	O
6	O
,	O
8	O
,	O
and	O
11	O
and	O
six-	O
item	B-T062
items	B-T062
4	O
,	O
5	O
,	O
6	O
,	O
10	O
,	O
11	O
,	O
and	O
13	O
short	B-T170
forms	I-T170
of	O
the	O
japanese	O
version	B-T170
of	O
pcs	B-T170
were	O
measured	O
.	O
	
we	O
used	O
rasch	B-T062
analysis	I-T062
to	O
analyze	B-T169
the	O
psychometric	O
properties	B-T080
of	O
the	O
original	O
,	O
four-	O
item	B-T062
,	O
and	O
six-	O
item	B-T062
short	B-T170
forms	I-T170
of	O
pcs	B-T170
.	O
	
rasch	B-T062
analysis	I-T062
showed	O
that	O
both	O
short	B-T170
forms	I-T170
of	O
pcs	B-T170
had	O
acceptable	O
internal	O
consistency	B-T080
,	O
unidimensionality	B-T082
,	O
and	O
no	O
notable	O
dif	O
and	O
were	O
functional	B-T169
on	O
the	O
category	B-T170
rating	I-T170
scale	I-T170
.	O
	
however	O
,	O
four-	O
item	B-T062
short	B-T170
form	I-T170
of	O
pcs	B-T170
had	O
two	O
misfit	O
items	B-T062
.	O
	
six-	O
item	B-T062
short	B-T170
form	I-T170
of	O
pcs	B-T170
has	O
acceptable	O
psychometric	O
properties	B-T080
and	O
is	O
suitable	O
for	O
use	O
in	O
participants	B-T098
with	O
musculoskeletal	B-T033
pain	I-T033
.	O
	
thus	O
,	O
six-	O
item	B-T062
can	O
be	O
used	O
as	O
brief	O
instruments	O
to	O
evaluate	O
pain	O
catastrophizing	O
.	O
	
a	O
novel	O
quantitative	O
pcr	O
detects	O
babesia	O
infection	O
in	O
patients	O
not	O
identified	O
by	O
currently	O
available	O
non-nucleic	O
acid	O
amplification	O
tests	O
ticks	O
transmit	B-T169
babesia	O
microti	O
,	O
the	O
causative	B-T033
agents	I-T033
of	O
babesiosis	B-T047
in	O
north	O
america	O
and	O
europe	O
.	O
	
babesiosis	B-T047
is	O
now	O
endemic	B-T047
in	O
northeastern	O
usa	O
and	O
affects	O
people	B-T098
of	O
all	O
ages	O
.	O
	
babesia	O
species	O
infect	O
erythrocytes	O
and	O
can	O
be	O
transmitted	O
through	O
blood	B-T061
transfusion	I-T061
.	O
	
whole	O
blood	O
and	O
blood	O
products	O
,	O
which	O
are	O
not	O
tested	O
for	O
babesia	O
,	O
can	O
cause	O
transfusion	B-T061
-	O
transmitted	O
babesiosis	B-T047
ttb	B-T047
resulting	O
in	O
severe	B-T080
consequences	B-T169
in	O
the	O
immuno-compromised	B-T033
patients	O
.	O
	
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
epidemiological	B-T062
evaluation	I-T062
of	O
babesiosis	B-T047
in	O
a	O
tick-infested	B-T047
state	I-T047
.	O
	
we	O
examined	B-T033
blood	O
samples	O
from	O
192	O
patients	O
who	O
visited	O
clinics	O
during	O
the	O
active	O
tick-borne	B-T047
diseases	I-T047
season	B-T079
,	O
using	O
a	O
newly	O
developed	O
qpcr	O
assay	O
that	O
uses	O
the	O
specific	O
molecular	O
beacon	O
probe	O
.	O
	
due	O
to	O
the	O
absence	B-T169
of	O
clear	O
symptomology	O
,	O
clinical	O
laboratories	O
did	O
not	O
test	O
131	O
samples	O
by	O
ifa	O
,	O
fish	O
or	O
microscopic	O
examination	O
of	O
giemsa-stained	B-T109
blood	O
smears	O
.	O
	
babesia	O
infection	O
was	O
detected	O
in	O
all	O
age	O
groups	O
by	O
fish	O
and	O
microscopy	O
notably	O
patients	O
>40	O
years	B-T079
of	O
age	O
represented	O
64%	O
of	O
tested	O
samples	O
and	O
13%	O
were	O
younger	B-T079
patients	O
.	O
	
we	O
tested	O
all	O
samples	O
using	O
qpcr	O
and	O
found	O
that	O
38%	O
were	O
positive	B-T033
for	O
babesia	O
.	O
	
of	O
28	O
samples	O
that	O
were	O
positive	B-T033
by	O
fish	O
,	O
27	O
96%	O
were	O
also	O
positive	B-T033
by	O
qpcr	O
indicating	O
high	O
congruency	O
between	O
nucleic	O
acid	O
based	O
tests	O
.	O
	
interestingly	O
,	O
of	O
78	O
asymptomatic	B-T033
samples	O
not	O
tested	O
by	O
fish	O
,	O
22	O
were	O
positive	B-T033
by	O
our	O
qpcr	O
.	O
	
direct	O
detection	B-T061
of	O
babesia	O
relies	O
upon	O
microscopic	O
examination	O
of	O
patient	O
blood	O
smears	O
,	O
which	O
is	O
labor	O
intensive	O
,	O
difficult	O
to	O
scale	O
up	O
,	O
requires	O
specific	O
expertise	O
and	O
is	O
hence	O
,	O
often	O
not	O
performed	O
.	O
	
in	O
fact	O
,	O
a	O
clinical	O
laboratory	O
examined	B-T033
only	O
23	O
of	O
86	O
blood	O
samples	O
obtained	O
from	O
two	O
different	O
counties	O
by	O
microscopy	O
.	O
	
by	O
considering	O
individuals	B-T098
positive	B-T033
for	O
babesia	O
infection	O
when	O
results	O
from	O
currently	O
available	O
microscopy	O
,	O
fish	O
or	O
serological	O
tests	O
were	O
positive	B-T033
,	O
we	O
found	O
that	O
our	O
qpcr	O
is	O
highly	O
sensitive	B-T169
96.2	O
and	O
showed	O
a	O
specificity	B-T081
of	O
70.5	O
for	O
babesia	O
.	O
	
robust	O
qpcr	O
using	O
specific	O
probes	O
can	O
be	O
highly	O
useful	O
for	O
efficient	O
and	O
appropriate	O
diagnosis	B-T062
of	O
babesiosis	B-T047
in	O
patients	O
in	O
conjunction	O
with	O
conventional	O
diagnostics	B-T062
,	O
or	O
as	O
a	O
stand-alone	O
test	O
,	O
especially	O
for	O
donated	O
blood	O
screening	O
.	O
	
the	O
use	O
of	O
a	O
nucleic	O
acid	O
amplification	O
test	O
based	O
screening	O
of	O
blood	O
and	O
blood	O
products	O
could	O
prevent	O
historical	B-T079
relationships	I-T079
of	O
three	O
enigmatic	B-T080
phasianid	O
genera	O
aves	O
galliformes	O
inferred	O
using	O
phylogenomic	B-T170
and	I-T170
mitogenomic	I-T170
data	I-T170
the	O
phylogeny	B-T078
of	O
the	O
phasianidae	O
pheasants	O
,	O
partridges	O
,	O
and	O
allies	O
has	O
been	O
studied	O
extensively	O
.	O
	
however	O
,	O
these	O
studies	O
have	O
largely	O
ignored	O
three	O
enigmatic	B-T080
genera	I-T080
because	O
of	O
scarce	B-T080
dna	O
source	B-T033
material	I-T033
and	O
limited	O
overlapping	O
phylogenetic	B-T170
data	I-T170
blood	O
pheasants	O
ithaginis	O
,	O
snow	O
partridges	O
lerwa	O
,	O
and	O
long-billed	O
partridges	O
rhizothera	O
.	O
	
thus	O
,	O
phylogenetic	O
positions	O
of	O
these	O
three	O
genera	O
remain	O
uncertain	O
in	O
what	O
is	O
otherwise	O
a	O
well-resolved	O
phylogeny	B-T078
.	O
	
previous	O
studies	O
using	O
different	O
data	B-T078
types	O
place	O
lerwa	O
and	O
ithaginis	O
in	O
similar	O
positions	O
,	O
but	O
the	O
absence	O
of	O
overlapping	B-T079
data	I-T079
means	O
the	O
relationship	B-T080
between	O
them	O
could	O
not	O
be	O
inferred	O
.	O
	
rhizothera	O
was	O
originally	O
described	O
in	O
the	O
genus	O
perdix	O
true	O
partridges	O
,	O
although	O
a	O
partial	O
cytochrome	B-T116
b	I-T116
cyb	B-T116
sequence	O
suggests	O
it	O
is	O
sister	O
to	O
pucrasia	O
koklass	O
pheasant	O
.	O
	
to	O
identify	O
robust	O
relationships	B-T080
among	O
ithaginis	O
,	O
lerwa	O
,	O
rhizothera	O
,	O
and	O
their	O
phasianid	O
relatives	O
,	O
we	O
used	O
3692	O
ultra-conserved	O
element	O
uce	O
loci	O
and	O
complete	O
mitogenomes	O
from	O
19	O
species	O
including	O
previously	O
hypothesized	B-T078
relatives	B-T080
of	O
the	O
three	O
focal	O
genera	O
and	O
representatives	O
from	O
all	O
major	O
phasianid	O
clades	O
.	O
	
we	O
used	O
dna	O
extracted	O
from	O
historical	O
specimen	B-T033
toepads	I-T033
for	O
species	O
that	O
lacked	O
fresh	O
tissue	O
in	O
museum	O
collections	O
.	O
	
maximum	O
likelihood	O
and	O
multispecies	B-T081
coalescent	I-T081
uce	I-T081
analyses	I-T081
strongly	O
supported	O
lerwa	O
sister	O
to	O
a	O
large	O
clade	O
which	O
included	O
ithaginis	O
at	O
its	O
base	O
,	O
and	O
also	O
including	O
turkey	O
,	O
grouse	O
,	O
typical	O
pheasants	O
,	O
tragopans	O
,	O
pucrasia	O
,	O
and	O
perdix	O
.	O
	
rhizothera	O
was	O
also	O
in	O
this	O
clade	O
,	O
sister	O
to	O
a	O
diverse	O
group	O
comprising	O
perdix	O
,	O
typical	O
pheasants	O
,	O
pucrasia	O
,	O
turkey	O
and	O
grouse	O
.	O
	
mitogenomic	B-T170
genealogies	I-T170
differed	O
from	O
uces	B-T169
topologies	I-T169
,	O
supporting	O
a	O
sister	O
relationship	O
between	O
ithaginis	O
and	O
lerwa	O
rather	O
than	O
a	O
grade	O
.	O
	
the	O
position	O
of	O
rhizothera	O
using	O
mitogenomes	O
depended	O
on	O
analytical	B-T062
choices	I-T062
.	O
	
unpartitioned	O
and	O
codon-based	O
analyses	O
placed	O
rhizothera	O
sister	O
to	O
a	O
tragopan	O
clade	O
,	O
whereas	O
a	O
partitioned	O
dna	B-T170
model	I-T170
of	O
the	O
mitogenome	O
was	O
congruent	B-T080
with	O
uce	B-T033
results	I-T033
.	O
	
in	O
all	O
mitogenome	O
analyses	O
,	O
pucrasia	O
was	O
sister	O
to	O
a	O
clade	O
including	O
perdix	O
and	O
the	O
typical	O
pheasants	O
with	O
high	O
support	O
,	O
in	O
contrast	O
to	O
uces	O
and	O
published	B-T170
nuclear	I-T170
intron	I-T170
data	I-T170
.	O
	
due	O
to	O
the	O
strong	O
support	O
and	O
consistent	O
topology	B-T170
provided	O
by	O
all	O
uce	B-T170
analyses	I-T170
,	O
we	O
have	O
identified	O
phylogenetic	B-T078
relationships	B-T080
of	O
these	O
three	O
enigmatic	B-T080
,	O
poorly-studied	O
,	O
phasianid	O
taxa	O
.	O
	
a	O
novel	B-T080
combination	O
treatment	B-T169
to	O
stimulate	B-T061
bone	B-T033
healing	I-T033
and	O
regeneration	O
under	O
hypoxic	O
conditions	O
photobiomodulation	B-T061
and	O
melatonin	B-T109
melatonin	B-T109
has	O
anabolic	O
effects	O
on	O
the	O
bone	O
,	O
even	O
under	O
hypoxia	O
,	O
and	O
laser	B-T061
irradiation	I-T061
has	O
been	O
shown	O
to	O
improve	O
osteoblastic	O
differentiation	O
.	O
	
the	O
aim	B-T078
of	O
this	O
study	B-T062
was	O
to	O
investigate	B-T169
whether	O
laser	B-T061
irradiation	I-T061
and	O
melatonin	B-T109
would	O
have	O
synergistic	B-T080
effects	B-T080
on	O
osteoblastic	O
differentiation	O
and	O
mineralization	O
under	O
hypoxic	O
conditions	O
.	O
	
mc3t3-e1	O
cells	O
were	O
exposed	O
to	O
1%	O
oxygen	B-T033
tension	I-T033
for	O
the	O
hypoxia	O
condition	O
.	O
	
the	O
cells	O
were	O
divided	O
into	O
four	O
groups	B-T078
g1	B-T078
-	O
osteoblast	O
differentiation	O
medium	O
only	O
as	O
the	O
hypoxic	O
condition	O
,	O
g2	B-T078
-	O
treatment	B-T169
with	O
50	O
μm	O
melatonin	B-T109
only	O
,	O
g3	B-T078
-	O
laser	B-T061
irradiation	I-T061
808	O
nm	O
,	O
80	O
mw	O
,	O
gaalas	O
diode	O
only	O
,	O
and	O
g4	B-T078
-	O
treatment	B-T169
with	O
50	O
μm	O
melatonin	B-T109
and	O
laser	B-T061
irradiation	I-T061
808	O
nm	O
,	O
80	O
mw	O
,	O
gaalas	O
diode	O
.	O
	
immunoblotting	O
showed	O
that	O
osterix	B-T116
expression	O
was	O
markedly	O
increased	B-T081
in	O
the	O
melatonin	B-T109
-	O
treated	B-T169
and	O
laser-irradiated	B-T061
cells	O
at	O
48	O
and	O
72	O
h	O
.	O
	
in	O
addition	O
,	O
alkaline	B-T116
phosphatase	I-T116
activity	B-T052
significantly	O
increased	B-T081
and	O
continued	B-T078
to	O
rise	O
throughout	O
the	O
experiment	B-T062
.	O
	
alizarin	O
red	O
staining	O
showed	O
markedly	O
increased	B-T081
mineralized	O
nodules	O
as	O
compared	O
with	O
only	O
melatonin	B-T109
-	O
treated	B-T169
or	O
laser-irradiated	B-T061
cells	O
at	O
day	O
7	O
,	O
which	O
significantly	O
increased	B-T081
by	O
day	O
14	O
.	O
	
moreover	O
,	O
when	O
melatonin	B-T109
-	O
treated	B-T169
cells	O
were	O
laser-irradiated	B-T061
,	O
the	O
differentiation	O
and	O
mineralization	O
of	O
cells	O
were	O
found	O
to	O
involve	O
p38	B-T116
mapk	I-T116
and	O
prkd1	B-T116
signaling	O
mechanisms	O
.	O
	
however	O
,	O
the	O
enhanced	B-T052
effects	B-T080
of	I-T080
laser	B-T061
irradiation	I-T061
with	O
melatonin	B-T109
were	O
markedly	O
inhibited	B-T080
when	O
the	O
cells	O
were	O
treated	B-T169
with	O
luzindole	B-T109
,	O
a	O
selective	O
melatonin	O
receptor	O
antagonist	O
.	O
	
therefore	O
,	O
we	O
concluded	O
that	O
laser	B-T061
irradiation	I-T061
could	O
promote	O
the	O
effect	B-T080
of	I-T080
melatonin	B-T109
on	O
the	O
differentiation	O
and	O
mineralization	O
of	O
mc3t3-e1	O
cells	O
under	O
hypoxic	O
conditions	O
,	O
and	O
that	O
this	O
process	O
is	O
mediated	O
through	O
melatonin	B-T116
1/2	I-T116
receptors	I-T116
and	O
pkrd	B-T116
/	O
p38	B-T116
signaling	O
pathways	O
.	O
	
aquaporin-2	B-T116
excretion	O
in	O
hospitalized	O
patients	O
with	O
cirrhosis	B-T047
relation	O
to	O
development	B-T169
of	O
renal	B-T047
insufficiency	I-T047
and	O
mortality	B-T081
urinary	B-T080
aquaporin-2	B-T116
aqp2	B-T116
is	O
a	O
parameter	O
of	O
water	O
transport	O
in	O
the	O
principal	O
cells	O
in	O
the	O
distal	O
part	O
of	O
the	O
nephron	O
and	O
involved	O
in	O
water	O
retention	O
in	O
cirrhosis	B-T047
and	O
may	O
be	O
a	O
marker	O
of	O
renal	O
function	O
.	O
	
the	O
aim	B-T078
of	O
the	O
study	B-T062
was	O
to	O
evaluate	O
aqp2	B-T116
as	O
a	O
predictor	B-T170
of	O
renal	B-T047
insufficiency	I-T047
and	O
death	O
in	O
patients	O
with	O
cirrhosis	B-T047
.	O
	
urine	O
samples	O
from	O
199	O
patients	O
90	O
patients	O
without	O
organ	O
failure	O
group	O
1	O
,	O
58	O
patients	O
with	O
organ	O
failure	O
excluding	O
renal	B-T047
failure	I-T047
group	O
2	O
,	O
and	O
51	O
patients	O
with	O
organ	O
failure	O
including	O
renal	B-T047
failure	I-T047
group	O
3	O
from	O
the	O
canonic	B-T062
study	I-T062
were	O
analyzed	O
for	O
urine	O
aqp2	B-T116
and	O
urine	O
osmolality	O
.	O
	
there	O
was	O
no	B-T033
difference	I-T033
in	O
aqp2	B-T116
between	O
the	O
three	O
groups	O
.	O
	
urine	O
osmolality	O
was	O
significantly	B-T081
lower	I-T081
in	O
patients	O
in	O
group	O
3	O
versus	O
group	O
1	O
and	O
group	O
2	O
p	O
=	O
0.0004	O
.	O
	
no	B-T033
relation	I-T033
was	O
found	O
between	O
aqp2	B-T116
and	O
glomerular	O
filtration	O
rate	O
or	O
creatinine	B-T109
however	O
,	O
aqp2	B-T116
was	O
a	O
significant	O
predictor	B-T170
of	O
the	O
development	B-T169
of	O
renal	B-T047
insufficiency	I-T047
p	O
=	O
0.0485	O
.	O
	
in	O
a	O
univariate	B-T062
analysis	I-T062
,	O
aqp2	B-T116
was	O
a	O
significant	O
predictor	B-T170
of	O
14	O
and	O
28-day	O
survival	B-T169
,	O
but	O
this	O
was	O
not	O
confirmed	O
in	O
multivariate	B-T081
analysis	I-T081
.	O
	
aquaporin-2	B-T116
was	O
not	O
associated	O
with	O
disease	B-T080
severity	I-T080
or	O
markers	B-T080
of	O
renal	O
function	O
but	O
was	O
a	O
predictor	B-T170
for	O
the	O
development	B-T169
of	O
renal	B-T047
insufficiency	I-T047
and	O
death	O
.	O
	
therefore	O
,	O
its	O
future	O
use	O
as	O
marker	O
of	O
renal	B-T047
insufficiency	I-T047
could	O
be	O
promising	O
,	O
but	O
further	O
research	B-T062
is	O
needed	O
before	O
it	O
can	O
be	O
considered	O
a	O
clinical	B-T080
decompression	B-T061
surgery	I-T061
alone	O
versus	O
decompression	B-T061
plus	O
fusion	B-T061
in	O
symptomatic	B-T169
lumbar	B-T047
spinal	I-T047
stenosis	I-T047
a	O
swiss	B-T098
prospective	B-T062
multi-center	I-T062
cohort	I-T062
study	I-T062
with	O
3	O
years	B-T079
of	O
follow-up	B-T062
retrospective	B-T062
analysis	I-T062
of	O
a	O
prospective	B-T062
,	O
multicenter	I-T062
cohort	I-T062
study	I-T062
.	O
	
to	O
estimate	O
the	O
added	O
effect	B-T080
of	O
surgical	B-T061
fusion	I-T061
as	O
compared	O
to	O
decompression	B-T061
surgery	I-T061
alone	O
in	O
symptomatic	B-T169
lumbar	B-T047
spinal	I-T047
stenosis	I-T047
patients	O
with	O
spondylolisthesis	B-T047
.	O
	
the	O
optimal	O
surgical	O
management	O
of	O
lumbar	B-T047
spinal	I-T047
stenosis	I-T047
patients	O
with	O
spondylolisthesis	B-T047
remains	O
controversial	O
.	O
	
patients	O
of	O
the	O
lsos	B-T062
with	O
confirmed	O
dlss	B-T047
and	O
spondylolisthesis	B-T047
were	O
enrolled	O
in	O
this	O
study	O
.	O
	
the	O
outcomes	B-T062
of	O
this	O
study	O
were	O
spinal	O
stenosis	O
measure	O
ssm	O
symptoms	O
score	O
range	O
1-5	O
,	O
best-worst	O
and	O
function	O
1-4	O
over	O
time	O
,	O
measured	O
at	O
baseline	O
,	O
6	O
,	O
12	O
,	O
24	O
and	O
36	O
months	O
follow-up	O
.	O
	
in	O
order	O
to	O
quantify	O
the	O
effect	O
of	O
fusion	O
surgery	O
as	O
compared	O
to	O
decompression	O
alone	O
and	O
number	O
of	O
decompressed	O
levels	O
,	O
we	O
used	O
mixed	O
effects	O
models	O
and	O
accounted	O
for	O
the	O
repeated	O
observations	O
in	O
main	O
outcomes	O
ssm	O
symptoms	O
and	O
ssm	O
function	O
over	O
time	O
.	O
	
in	O
addition	O
to	O
individual	O
patients	O
'	O
random	O
effects	O
,	O
we	O
also	O
fitted	O
random	O
slopes	O
for	O
follow-up	O
time	O
points	O
and	O
compared	O
these	O
two	O
approaches	O
with	O
akaike's	O
information	O
criterion	O
aic	O
and	O
the	O
chi-squared	O
test	O
.	O
	
confounders	O
were	O
adjusted	O
with	O
fixed	O
effects	O
for	O
age	O
,	O
gender	O
,	O
bmi	O
,	O
diabetes	O
,	O
cirs	O
musculoskeletal	O
disorders	O
and	O
duration	O
of	O
symptoms	O
.	O
	
one	O
hundred	O
and	O
thirty-one	O
patients	O
undergoing	O
decompression	O
surgery	O
alone	O
n	O
=	O
85	O
or	O
decompression	O
plus	O
fusion	O
surgery	O
n	O
=	O
46	O
were	O
included	O
in	O
this	O
study	O
.	O
	
in	O
the	O
multiple	O
mixed	O
effects	O
model	O
the	O
adjusted	O
effect	O
of	O
fusion	O
versus	O
decompression	O
alone	O
surgery	O
on	O
ssm	O
symptoms	O
was	O
0.06	O
95%	O
confidence	O
interval	O
,	O
ci	O
-0	O
to	O
0.27	O
and	O
-0	O
95%	O
ci	O
-0	O
to	O
0.10	O
on	O
ssm	O
function	O
,	O
respectively	O
.	O
	
among	O
the	O
patients	O
with	O
degenerative	O
lumbar	O
spinal	O
stenosis	O
and	O
spondylolisthesis	O
our	O
study	O
confirms	O
that	O
in	O
the	O
two	O
groups	O
,	O
decompression	O
alone	O
and	O
decompression	O
plus	O
fusion	O
,	O
patients	O
distinctively	O
benefited	O
from	O
surgical	O
treatment	O
.	O
	
when	O
adjusted	O
for	O
confounders	O
,	O
fusion	O
surgery	O
was	O
not	O
associated	O
with	O
a	O
more	O
favorable	O
outcome	O
in	O
both	O
ssm	O
scores	O
as	O
compared	O
to	O
decompression	O
alone	O
surgery	O
.	O
	
muscle	O
synergies	B-T169
after	O
stroke	B-T047
are	O
correlated	O
with	O
perilesional	B-T082
high	B-T081
gamma	I-T081
movements	B-T033
can	O
be	O
factored	O
into	O
modules	O
termed	O
""""	O
muscle	O
synergies	B-T169
""""	O
.	O
	
after	O
stroke	B-T047
,	O
abnormal	B-T033
synergies	B-T169
are	O
linked	O
to	O
impaired	B-T169
movements	B-T033
however	O
,	O
their	O
neural	O
basis	B-T169
is	O
not	O
understood	O
.	O
	
in	O
a	O
single	O
subject	O
,	O
we	O
examined	O
how	O
electrocorticography	O
signals	O
from	O
the	O
perilesional	B-T082
cortex	O
were	O
associated	O
with	O
synergies	B-T169
.	O
	
the	O
measured	O
synergies	B-T169
contained	B-T169
a	O
mix	O
of	O
both	O
normal	B-T080
and	O
abnormal	B-T033
patterns	B-T082
and	O
were	O
remarkably	O
similar	O
to	O
those	O
described	O
in	O
past	O
work	O
.	O
	
interestingly	O
,	O
we	O
found	O
that	O
both	O
normal	B-T080
and	O
abnormal	B-T033
synergies	B-T169
were	O
correlated	O
with	O
perilesional	B-T082
high	B-T081
gamma	I-T081
.	O
	
given	O
the	O
link	O
between	O
high	B-T081
gamma	I-T081
and	O
cortical	B-T033
spiking	I-T033
,	O
our	O
results	O
suggest	O
that	O
perilesional	B-T033
spiking	I-T033
may	O
organize	O
synergies	B-T169
after	O
assessing	O
nitrous	O
oxide	O
effect	B-T080
using	O
electroencephalographically	O
-based	O
depth	B-T033
of	I-T033
anesthesia	I-T033
measures	B-T081
cortical	O
state	B-T170
and	O
cortical	O
input	B-T170
existing	O
electroencephalography	O
eeg	O
based	O
depth	B-T033
of	I-T033
anesthesia	I-T033
monitors	O
cannot	O
reliably	O
track	O
sedative	O
or	O
anesthetic	O
states	B-T080
during	O
n-methyl-d-aspartate	O
nmda	O
receptor	O
antagonist	O
based	O
anesthesia	B-T061
with	O
ketamine	B-T109
or	O
nitrous	O
oxide	O
n2o	O
.	O
	
here	O
,	O
a	O
physiologically	B-T169
-motivated	O
depth	B-T033
of	I-T033
anesthesia	I-T033
monitoring	O
algorithm	B-T170
based	O
on	O
autoregressive-moving-average	B-T170
arma	I-T170
modeling	I-T170
and	O
derivative	O
measures	O
of	O
interest	O
,	O
cortical	O
state	B-T170
cs	B-T170
and	O
cortical	O
input	B-T170
ci	B-T170
,	O
is	O
retrospectively	B-T062
applied	O
in	O
an	O
exploratory	B-T169
manner	O
to	O
the	O
nmda	O
receptor	O
antagonist	O
n2o	O
,	O
an	O
adjuvant	O
anesthetic	O
gas	O
used	O
in	O
clinical	B-T169
practice	I-T169
.	O
	
composite	B-T170
cortical	I-T170
state	I-T170
ccs	B-T170
and	O
composite	B-T170
cortical	I-T170
state	I-T170
distance	I-T170
ccsd	B-T170
,	O
two	O
new	O
modifications	B-T033
of	O
cs	B-T170
,	O
along	O
with	O
cs	B-T170
and	O
ci	B-T170
were	O
evaluated	O
on	O
electroencephalographic	O
eeg	O
data	B-T078
of	O
healthy	B-T080
control	I-T080
individuals	I-T080
undergoing	O
n2o	O
inhalation	O
up	O
to	O
equilibrated	B-T081
peak	B-T081
gas	I-T081
concentrations	I-T081
of	O
20	O
,	O
40	O
or	O
60%	O
n2o	O
/	O
o2	O
.	O
	
in	O
particular	O
,	O
ccsd	B-T170
has	O
been	O
devised	O
to	O
vary	O
consistently	O
for	O
increasing	B-T081
levels	B-T080
of	O
anesthetic	B-T033
concentration	I-T033
independent	B-T169
of	I-T169
the	O
anesthetic's	O
microscopic	B-T080
mode	B-T169
of	I-T169
action	I-T169
for	O
both	O
n2o	O
and	O
propofol	B-T109
.	O
	
the	O
strongest	O
effects	B-T080
were	O
observed	O
for	O
the	O
60%	O
peak	B-T081
gas	I-T081
concentration	I-T081
group	B-T098
.	O
	
for	O
the	O
50-60%	O
peak	B-T080
gas	I-T080
levels	I-T080
,	O
individuals	B-T098
showed	O
statistically	B-T081
significant	I-T081
reductions	B-T061
in	O
responsiveness	B-T033
compared	B-T052
to	O
rest	O
,	O
and	O
across	O
the	O
group	B-T098
cs	B-T170
and	O
ccs	B-T170
increased	B-T081
by	O
39	O
and	O
42%	O
,	O
respectively	O
,	O
while	O
ccsd	B-T170
was	O
found	O
to	O
decrease	B-T081
by	O
398%	O
.	O
	
on	O
the	O
other	O
hand	O
a	O
clear	O
conclusion	B-T078
regarding	O
the	O
changes	O
in	O
ci	B-T170
could	O
not	O
be	O
reached	O
.	O
	
these	O
results	B-T169
indicate	O
that	O
,	O
contrary	B-T082
to	O
previous	O
depth	B-T033
of	I-T033
anesthesia	I-T033
monitoring	O
measures	B-T081
,	O
the	O
cs	B-T170
,	O
ccs	B-T170
,	O
and	O
especially	O
ccsd	B-T170
measures	B-T081
derived	B-T080
from	O
frontal	B-T082
eeg	O
are	O
potentially	B-T080
useful	O
for	O
differentiating	O
gas	B-T081
concentration	I-T081
and	O
responsiveness	B-T033
levels	I-T033
in	O
people	B-T098
under	O
n2o	O
.	O
	
on	O
the	O
other	O
hand	O
,	O
determining	O
the	O
utility	B-T169
of	O
ci	B-T170
in	O
this	O
regard	O
will	O
require	O
larger	B-T081
sample	B-T081
sizes	I-T081
and	O
potentially	B-T080
higher	B-T080
gas	B-T081
concentrations	I-T081
.	O
	
future	O
work	O
will	O
assess	O
the	O
sensitivity	B-T081
of	O
cs	B-T170
-based	O
and	O
ci	B-T170
measures	B-T081
to	O
other	O
anesthetics	O
and	O
their	O
utility	B-T169
in	O
a	O
clinical	O
environment	B-T082
.	O
	
dt	O
mri	O
microstructural	B-T080
cortical	O
lesion	B-T047
damage	B-T169
does	O
not	O
explain	O
cognitive	O
impairment	O
in	O
ms	B-T047
we	O
combined	O
double	O
inversion	O
recovery	O
dir	O
and	O
diffusion	O
tensor	O
dt	O
magnetic	O
resonance	O
imaging	O
mri	O
to	O
quantify	B-T081
the	O
severity	B-T080
of	O
cortical	O
lesion	B-T047
cl	B-T047
microstructural	B-T080
tissue	O
abnormalities	O
in	O
a	O
large	B-T081
cohort	B-T098
of	O
relapse	O
-	O
onset	B-T080
multiple	B-T047
sclerosis	I-T047
ms	B-T047
patients	O
and	O
its	O
contribution	B-T052
to	O
cognitive	O
dysfunction	O
.	O
	
dir	O
,	O
dt	O
,	O
dual-echo	O
,	O
and	O
three-dimensional	B-T082
3d	B-T082
t1-weighted	O
scans	O
were	O
acquired	O
from	O
149	O
ms	B-T047
patients	O
and	O
40	O
controls	O
.	O
	
cognitively	O
impaired	O
ci	O
patients	O
had	O
2	O
abnormal	B-T033
neuropsychological	O
tests	O
.	O
	
diffusivity	O
values	O
in	O
cls	B-T047
,	O
cortex	O
,	O
white	B-T033
matter	I-T033
wm	I-T033
lesions	I-T033
,	O
and	O
normal-appearing	O
na	O
wm	O
were	O
assessed	B-T052
.	O
	
predictors	B-T078
of	O
cognitive	O
impairment	O
were	O
identified	B-T080
using	O
a	O
random	B-T062
forest	I-T062
analysis	I-T062
.	O
	
compared	O
to	O
controls	O
,	O
ms	B-T047
patients	O
had	O
lower	B-T080
normalized	B-T081
brain	I-T081
volume	I-T081
nbv	B-T081
,	O
gray	B-T081
matter	I-T081
volume	I-T081
gmv	B-T081
,	O
wm	B-T033
volume	I-T033
,	O
lower	B-T080
fractional	B-T081
anisotropy	I-T081
fa	B-T081
,	O
and	O
higher	B-T080
mean	O
diffusivity	O
in	O
cortex	O
and	O
normal-appearing	O
white	O
matter	O
nawm	O
.	O
	
a	O
total	O
of	O
44	O
29.5	O
patients	O
were	O
ci	O
.	O
	
compared	O
to	O
cognitively	O
preserved	O
cp	O
,	O
ci	O
patients	O
had	O
higher	B-T080
t2	B-T081
wm	I-T081
lesion	I-T081
volume	I-T081
lv	B-T081
,	O
lower	B-T080
nbv	B-T081
and	O
gmv	B-T081
,	O
and	O
more	O
severe	B-T080
diffusivity	O
abnormalities	O
in	O
wm	B-T033
lesions	I-T033
,	O
cortex	O
,	O
and	O
nawm	O
.	O
	
cl	B-T047
measures	B-T081
did	O
not	B-T033
differ	I-T033
between	O
ci	O
and	O
cp	O
patients	O
.	O
	
cortex	O
fa	B-T081
,	O
age	O
,	O
disease	B-T079
duration	I-T079
,	O
t2	B-T081
wm	I-T081
lv	I-T081
,	O
and	O
gmv	B-T081
best	O
predicted	O
ms	B-T047
-related	O
cognitive	O
impairment	O
c-statistic	O
=	O
0.88	O
.	O
	
""""	O
diffuse	B-T082
""""	O
gm	O
and	O
nawm	O
damage	B-T169
and	O
wm	B-T033
lesions	I-T033
,	O
rather	O
than	O
intrinsic	B-T082
cl	B-T047
damage	B-T169
,	O
contribute	O
to	O
cognitive	O
impairment	O
in	O
correlation	B-T080
between	O
the	O
histopathology	B-T169
of	O
chronic	B-T047
urticaria	I-T047
and	O
its	O
clinical	O
picture	O
chronic	B-T047
urticaria	I-T047
is	O
characterized	O
by	O
transient	B-T079
,	O
pruritic	O
lesions	O
of	O
varying	O
sizes	B-T082
,	O
with	O
central	B-T082
pallor	B-T033
and	O
well-defined	O
edges	O
,	O
with	O
disease	B-T047
duration	O
longer	O
than	O
six	O
weeks	B-T079
.	O
	
its	O
cellular	O
infiltrate	O
consists	O
of	O
neutrophils	O
,	O
lymphocytes	O
and	O
eosinophils	O
.	O
	
there	O
is	O
a	O
subgroup	O
of	O
patients	O
with	O
eosinophilic	O
or	O
neutrophilic	B-T047
urticaria	I-T047
,	O
resistant	O
to	O
the	O
treatment	B-T061
with	O
antihistamines	B-T109
,	O
but	O
that	O
respond	O
to	O
a	O
combination	O
of	O
antihistamine	B-T109
with	O
other	O
drugs	O
.	O
	
to	O
evaluate	O
the	O
present	O
infiltration	O
in	O
chronic	B-T047
urticaria	I-T047
biopsies	O
and	O
correlate	O
it	O
with	O
the	O
clinical	O
disease	O
activity	O
and	O
response	O
to	O
treatment	O
.	O
	
forty-one	O
patients	O
with	O
chronic	B-T047
urticaria	I-T047
were	O
classified	O
according	O
to	O
the	O
score	B-T081
of	I-T081
severity	I-T081
of	O
the	O
disease	B-T047
,	O
response	O
to	O
treatment	O
and	O
type	O
of	O
perivascular	O
infiltrate	O
.	O
	
inflammatory	O
infiltrates	O
were	O
divided	O
in	O
eosinophilic	O
46.30	O
,	O
neutrophilic	O
and	O
mixed	O
.	O
	
an	O
association	B-T080
was	O
found	O
between	O
the	O
eosinophilic	O
infiltrate	O
and	O
clinical	B-T081
scores	I-T081
of	O
greater	O
severity	B-T080
p	O
=	O
0.002	O
.	O
	
this	O
association	B-T080
shows	O
that	O
the	O
eosinophilic	O
inflammatory	O
infiltrates	O
denote	O
high	O
clinical	O
activity	O
,	O
which	O
means	O
more	O
severe	B-T080
and	O
exuberant	O
clinical	O
pictures	O
of	O
the	O
barriers	B-T080
to	O
access	B-T080
and	I-T080
uptake	I-T080
of	O
antiretroviral	B-T061
therapy	I-T061
among	O
hiv-positive	O
men	B-T098
who	I-T098
have	I-T098
sex	I-T098
with	I-T098
men	I-T098
in	O
hanoi	O
,	O
vietnam	O
from	O
hiv	O
testing	O
to	O
treatment	B-T061
little	O
is	O
known	O
about	O
the	O
experiences	O
of	O
vietnamese	B-T098
men	B-T098
who	I-T098
have	I-T098
sex	I-T098
with	I-T098
men	I-T098
in	O
accessing	B-T082
hiv	O
testing	O
and	O
treatment	B-T061
.	O
	
we	O
aimed	O
to	O
explore	O
barriers	B-T080
to	O
access	B-T080
and	I-T080
uptake	I-T080
of	O
antiretroviral	B-T061
therapy	I-T061
art	B-T061
among	O
hiv-positive	O
men	B-T098
who	I-T098
have	I-T098
sex	I-T098
with	I-T098
men	I-T098
in	O
hanoi	O
.	O
	
during	O
2015	O
,	O
we	O
conducted	O
qualitative	B-T080
interviews	B-T052
with	O
35	O
participants	B-T098
recruited	O
using	O
snowball	B-T062
sampling	I-T062
based	O
on	O
previous	O
research	B-T062
and	O
social	B-T098
networks	I-T098
.	O
	
key	O
individual	O
impediments	O
to	O
art	B-T061
uptake	O
included	O
inadequate	B-T080
preparation	B-T052
for	O
a	O
positive	B-T033
diagnosis	B-T033
and	O
the	O
dual	O
stigmatisation	B-T078
of	O
homosexuality	O
and	O
hiv	O
and	O
its	O
consequences	B-T062
,	O
leading	O
to	O
fear	O
of	O
disclosure	O
of	O
hiv	B-T033
status	I-T033
.	O
	
health	O
system	O
barriers	B-T080
included	O
lack	O
of	O
clarity	O
and	O
consistency	B-T080
about	O
how	O
to	O
register	O
for	O
and	O
access	B-T080
art	B-T061
,	O
failure	O
to	O
protect	O
patient	O
confidentiality	B-T078
and	O
a	O
reticence	O
by	O
providers	B-T169
to	O
discuss	O
sexual	O
identity	O
and	O
same-sex	O
issues	O
.	O
	
results	O
suggest	O
fundamental	O
problems	O
in	O
the	O
way	O
hiv	O
testing	O
is	O
currently	O
delivered	O
in	O
hanoi	O
,	O
including	O
a	O
lack	O
of	O
client-centred	O
counselling	O
,	O
peer	B-T061
support	I-T061
and	O
clear	O
referral	O
pathways	O
.	O
	
overcoming	O
these	O
barriers	B-T080
will	O
require	O
educating	O
men	B-T098
who	I-T098
have	I-T098
sex	I-T098
with	I-T098
men	I-T098
about	O
the	O
benefits	B-T081
of	O
routine	O
testing	O
,	O
improving	B-T080
access	B-T080
to	O
quality	O
diagnostic	O
services	O
and	O
building	O
a	O
safe	O
,	O
confidential	B-T033
treatment	B-T061
environment	B-T082
for	O
hiv-positive	O
men	B-T098
to	O
access	B-T080
,	O
receive	B-T052
and	I-T052
remain	I-T052
in	I-T052
care	I-T052
.	O
	
cdc45	B-T116
-	O
induced	B-T169
loading	B-T052
of	O
human	B-T116
rpa	I-T116
onto	O
single-stranded	O
dna	O
cell	B-T116
division	I-T116
cycle	I-T116
protein	I-T116
45	I-T116
cdc45	B-T116
is	O
an	O
essential	O
component	O
of	O
the	O
eukaryotic	O
replicative	B-T080
dna	B-T116
helicase	I-T116
.	O
	
we	O
found	O
that	O
human	B-T116
cdc45	I-T116
forms	O
a	O
complex	O
with	O
the	O
single-stranded	B-T116
dna	I-T116
ssdna	I-T116
binding	I-T116
protein	I-T116
rpa	I-T116
.	O
	
moreover	O
,	O
it	O
actively	O
loads	B-T052
rpa	B-T116
onto	O
nascent	O
ssdna	O
.	O
	
pull-down	O
assays	O
and	O
surface	O
plasmon	O
resonance	O
studies	O
revealed	O
that	O
cdc45	B-T116
-	O
bound	O
rpa	B-T116
complexed	O
with	O
ssdna	O
in	O
the	O
8-10	O
nucleotide	O
binding	O
mode	O
,	O
but	O
dissociated	O
when	O
rpa	B-T116
covered	O
a	O
30-mer	O
.	O
	
real-time	O
analysis	O
of	O
rpa	B-T116
-	O
ssdna	O
binding	O
demonstrated	O
that	O
cdc45	B-T116
catalytically	O
loaded	B-T052
rpa	B-T116
onto	O
ssdna	O
.	O
	
this	O
placement	B-T080
reaction	B-T169
required	O
physical	O
contacts	O
of	O
cdc45	B-T116
with	O
the	O
rpa70a	O
subdomain	O
.	O
	
our	O
results	O
imply	O
that	O
cdc45	B-T116
controlled	O
stabilization	B-T061
of	O
the	O
8-	O
nt	O
rpa	B-T116
binding	O
mode	O
,	O
the	O
subsequent	O
rpa	B-T116
transition	O
into	O
30-mer	O
mode	B-T169
and	O
facilitated	O
an	O
ordered	O
binding	O
to	O
ssdna	O
.	O
	
we	O
propose	O
that	O
a	O
cdc45	B-T116
-mediated	O
loading	B-T052
guarantees	O
a	O
seamless	O
deposition	B-T169
of	O
rpa	B-T116
on	O
newly	O
emerging	O
ssdna	O
at	O
the	O
nascent	O
replication	O
fork	O
.	O
	
the	O
antineoplastic	B-T109
drug	I-T109
,	O
trastuzumab	B-T116
,	O
dysregulates	B-T033
metabolism	O
in	O
ipsc	O
-derived	O
cardiomyocytes	O
the	O
targeted	B-T061
erbb2	I-T061
therapy	I-T061
,	O
trastuzumab	B-T116
,	O
has	O
had	O
a	O
tremendous	O
impact	B-T080
on	O
management	O
of	O
patients	O
with	O
her2+	O
breast	O
cancer	O
,	O
leading	O
to	O
development	B-T169
and	O
increased	B-T081
use	O
of	O
further	O
her2	B-T116
targeted	B-T061
therapies	I-T061
.	O
	
the	O
major	O
clinical	B-T080
side	O
effect	O
is	O
cardiotoxicity	O
but	O
the	O
mechanism	B-T169
is	O
largely	O
unknown	O
.	O
	
on	O
the	O
basis	O
that	O
gene	O
expression	O
is	O
known	O
to	O
be	O
altered	B-T169
in	O
multiple	B-T081
models	B-T170
of	O
heart	B-T047
failure	I-T047
,	O
we	O
examined	O
differential	O
gene	O
expression	O
of	O
ipsc	O
-derived	O
cardiomyocytes	O
treated	B-T169
at	O
day	B-T079
11	O
with	O
the	O
erbb2	B-T116
targeted	O
monoclonal	B-T116
antibody	I-T116
,	O
trastuzumab	B-T116
for	O
48	O
h	O
and	O
the	O
small	O
molecule	O
tyrosine	O
kinase	O
inhibitor	O
of	O
egfr	B-T116
and	O
erbb2	B-T116
.	O
	
transcriptome	O
sequencing	O
was	O
performed	B-T169
on	O
four	O
replicates	B-T080
from	O
each	O
group	B-T078
48	O
h	O
untreated	O
,	O
48	O
h	O
trastuzumab	B-T116
and	O
48	O
h	O
lapatinib	B-T109
and	O
differential	O
gene	O
expression	O
analyses	B-T062
were	O
performed	B-T169
on	O
each	O
treatment	B-T169
group	B-T078
relative	O
to	O
untreated	O
cardiomyocytes	O
.	O
	
517	O
and	O
1358	O
genes	O
were	O
differentially	O
expressed	O
,	O
p	O
<	O
0.05	O
,	O
respectively	O
in	O
cardiomyocytes	O
treated	B-T169
with	O
trastuzumab	B-T116
and	O
lapatinib	B-T109
.	O
	
gene	B-T170
ontology	I-T170
analyses	B-T062
revealed	O
in	O
cardiomyocytes	O
treated	B-T169
with	O
trastuzumab	B-T116
,	O
significant	B-T078
down-regulation	O
of	O
genes	O
involved	O
in	O
small	O
molecule	O
metabolism	O
p	O
=	O
3.22	O
10	O
and	O
cholesterol	B-T109
p	O
=	O
0.01	O
and	O
sterol	B-T109
p	O
=	O
0.03	O
processing	O
.	O
	
we	O
next	O
measured	B-T080
glucose	O
uptake	O
and	O
lactate	B-T109
production	B-T169
in	O
ipsc	O
-derived	O
cardiomyocytes	O
13	O
days	B-T079
post-plating	O
,	O
treated	B-T169
with	O
trastuzumab	B-T116
up	O
to	O
96	O
h	O
.	O
	
we	O
observed	B-T169
significantly	B-T081
decreased	B-T081
glucose	O
uptake	O
from	O
the	O
media	O
of	O
ipsc	O
-derived	O
cardiomyocytes	O
treated	B-T169
with	O
trastuzumab	B-T116
as	O
early	O
as	O
24	O
h	O
p	O
=	O
0.001	O
and	O
consistently	B-T080
up	O
to	O
96	O
h	O
p	O
=	O
0.03	O
.	O
	
our	O
study	B-T062
suggests	O
dysregulation	B-T033
of	O
cardiac	O
gene	O
expression	O
and	O
metabolism	O
as	O
key	O
elements	O
of	O
erbb2	O
signaling	O
that	O
could	O
potentially	B-T080
be	O
early	O
biomarkers	O
of	O
simvastatin	B-T109
promotes	O
hematoma	O
absorption	O
and	O
reduces	O
hydrocephalus	B-T047
following	O
intraventricular	O
hemorrhage	O
in	O
part	O
by	O
upregulating	O
cd36	O
we	O
previously	O
found	O
that	O
hematoma	O
worsens	B-T033
hydrocephalus	B-T047
after	O
intraventricular	O
hemorrhage	O
ivh	O
via	O
increasing	B-T169
iron	O
deposition	O
and	O
aggravating	O
ependymal	O
cilia	O
injury	O
therefore	O
,	O
promoting	O
hematoma	O
absorption	O
may	O
be	O
a	O
promising	O
strategy	O
for	O
ivh	O
.	O
	
recently	O
,	O
some	O
investigations	O
imply	O
that	O
simvastatin	B-T109
has	O
the	O
ability	O
of	O
accelerating	O
hematoma	O
absorption	O
.	O
	
thus	O
,	O
this	O
study	O
was	O
designed	O
to	O
examine	O
the	O
efficacy	B-T080
of	O
simvastatin	B-T109
for	O
ivh	O
in	O
rats	O
.	O
	
intracerebral	O
hemorrhage	O
with	O
ventricular	O
extension	O
was	O
induced	O
in	O
adult	O
male	O
sprague-dawley	O
rats	O
after	O
autologous	B-T061
blood	I-T061
injection	I-T061
.	O
	
simvastatin	B-T109
or	O
vehicle	O
was	O
administered	B-T061
orally	I-T061
at	O
1	O
day	O
after	O
ivh	O
and	O
then	O
daily	O
for	O
1	O
week	O
.	O
	
mri	O
studies	O
were	O
performed	O
to	O
measure	B-T169
the	O
volumes	O
of	O
intracranial	O
hematoma	O
and	O
lateral	O
ventricle	O
at	O
days	O
1	O
,	O
3	O
,	O
7	O
,	O
14	O
,	O
and	O
28	O
after	O
ivh	O
.	O
	
motor	O
and	O
neurocognitive	O
functions	O
were	O
assessed	B-T052
at	O
days	O
1	O
to	O
7	O
and	O
23	O
to	O
28	O
,	O
respectively	O
.	O
	
iron	O
deposition	O
,	O
iron	O
-related	O
protein	O
expression	O
,	O
ependymal	B-T033
damage	I-T033
,	O
and	O
histology	B-T169
were	O
detected	B-T033
at	O
day	O
28	O
.	O
	
expression	O
of	O
cd36	O
scavenger	B-T116
receptor	I-T116
facilitating	O
phagocytosis	O
was	O
examined	B-T033
at	O
day	O
3	O
after	O
ivh	O
using	O
western	O
blotting	O
and	O
immunofluorescence	O
.	O
	
simvastatin	B-T109
significantly	O
increased	B-T081
hematoma	O
absorption	O
ratio	B-T081
,	O
reduced	B-T080
ventricular	B-T078
volume	I-T078
,	O
and	O
attenuated	B-T033
neurological	I-T033
dysfunction	I-T033
post-	O
ivh	O
.	O
	
in	O
addition	O
,	O
less	B-T033
iron	I-T033
accumulation	I-T033
and	O
more	O
cilia	O
survival	B-T081
was	O
observed	O
in	O
the	O
simvastatin	B-T109
group	O
when	O
compared	O
with	O
the	O
control	O
.	O
	
what's	O
more	O
,	O
higher	B-T080
expression	O
of	O
cd36	O
was	O
detected	B-T033
around	O
the	O
hematoma	O
after	O
simvastatin	B-T109
administration	B-T061
.	O
	
simvastatin	B-T109
significantly	O
enhanced	O
brain	O
hematoma	O
absorption	O
,	O
alleviated	B-T047
hydrocephalus	I-T047
,	O
and	O
improved	B-T033
neurological	B-T080
recovery	O
after	O
experimental	B-T080
ivh	O
,	O
which	O
may	O
in	O
part	O
by	O
upregulating	O
cd36	O
expression	O
.	O
	
our	O
data	B-T078
suggest	O
that	O
early	O
simvastatin	B-T109
use	O
may	O
be	O
a	O
novel	B-T080
therapy	B-T061
for	O
ivh	O
patients	O
.	O
	
ampk	B-T116
-	O
autophagy	O
inhibition	B-T052
sensitizes	O
icaritin	B-T109
-	O
induced	B-T169
anti-colorectal	B-T033
cancer	I-T033
cell	O
activity	O
the	O
current	B-T079
research	B-T062
studied	O
the	O
potential	B-T080
effect	I-T080
of	O
autophagy	O
on	O
icaritin	B-T109
-	O
induced	B-T169
anti-colorectal	B-T033
cancer	I-T033
crc	O
cell	O
activity	O
.	O
	
treatment	B-T169
of	O
icaritin	B-T109
in	O
both	O
primary	B-T080
and	O
established	B-T080
ht-29	O
crc	O
cells	O
induced	B-T169
feedback	B-T052
activation	I-T052
of	O
autophagy	O
,	O
evidenced	O
by	O
p62	O
degradation	O
,	O
beclin-1	O
and	O
autophagy-related	O
gene-5	O
atg-5	O
upregulation	O
,	O
as	O
well	O
as	O
light	B-T116
chain	I-T116
3b	I-T116
lc3b	B-T116
gfp	B-T116
puncta	O
formation	B-T169
.	O
	
pharmacological	B-T169
inhibiting	B-T052
of	O
autophagy	O
dramatically	O
potentiated	O
icaritin	B-T109
-	O
induced	B-T169
crc	O
cell	O
death	O
and	O
apoptosis	O
.	O
	
meanwhile	O
,	O
shrna	O
-mediated	O
knockdown	O
of	O
beclin-1	O
or	O
atg-5	O
also	O
sensitized	O
icaritin	B-T109
-	O
induced	B-T169
crc	O
cell	O
death	O
and	O
apoptosis	O
.	O
	
icaritin	B-T109
activated	B-T052
amp-activated	B-T116
protein	I-T116
kinase	I-T116
ampk	B-T116
signaling	O
in	O
crc	O
cells	O
,	O
functioning	B-T169
as	O
the	O
upstream	O
signaling	O
for	O
autophagy	O
activation	B-T052
.	O
	
shrna	O
/	O
sirna	O
-mediated	O
knockdown	O
of	O
ampkα1	O
inhibited	B-T080
icaritin	B-T109
-	O
induced	B-T169
autophagy	O
activation	B-T052
,	O
but	O
exacerbated	B-T080
crc	O
cell	O
death	O
.	O
	
on	O
the	O
other	O
hand	O
,	O
the	O
ampk	B-T116
activator	O
compound	O
13	O
c13	O
or	O
the	O
autophagy	O
activator	O
mhy1485	B-T109
attenuated	B-T052
icaritin	B-T109
-	O
induced	B-T169
cytotoxicity	O
.	O
	
in	O
nude	O
mice	O
,	O
icaritin	B-T109
oral	B-T061
administration	I-T061
induced	B-T169
ht-29	O
tumor	O
growth	O
inhibition	B-T052
was	O
potentiated	O
when	O
combined	O
with	O
ampkα1	O
shrna	O
knockdown	O
in	O
tumors	O
.	O
	
we	O
conclude	O
that	O
feedback	B-T052
activation	I-T052
of	O
ampk	B-T116
-	O
autophagy	O
pathway	O
could	O
be	O
a	O
primary	O
resistance	B-T169
factor	B-T169
of	O
classification	O
of	O
edible	O
oils	O
based	O
on	O
atr-ftir	B-T062
spectral	B-T078
information	I-T078
during	O
a	O
long	O
heating	O
treatment	O
identification	B-T080
of	O
oil	O
type	B-T080
and	O
its	O
qc	B-T169
are	O
important	O
concerns	O
in	O
food	O
control	O
laboratories	O
.	O
	
classifying	O
edible	O
oils	O
that	O
have	O
not	O
been	O
used	O
i.e	O
,	O
unheated	O
with	O
the	O
aid	O
of	O
vibrational	O
spectroscopy	O
has	O
previously	O
been	O
reported	O
.	O
	
however	O
,	O
the	O
classification	O
of	O
used	O
i.e	O
,	O
heat-treated	O
oils	O
needs	O
special	O
attention	O
.	O
	
the	O
effect	O
of	O
long	O
heating	O
times	O
on	O
the	O
classification	O
of	O
four	O
kinds	O
of	O
edible	O
oils	O
canola	O
,	O
corn	O
,	O
frying	O
,	O
and	O
sunflower	O
based	O
on	O
attenuated	O
total	O
reflectance	O
atr	O
spectra	O
was	O
surveyed	O
.	O
	
the	O
sampling	O
was	O
done	O
on	O
the	O
oils	O
during	O
a	O
36	O
h	O
heating	O
process	O
at	O
170	O
.	O
	
the	O
atr-ftir	O
spectra	O
of	O
the	O
samples	O
were	O
collected	O
in	O
the	O
range	O
of	O
4000-550	O
cm-1	O
.	O
	
interval	O
extended	O
canonical	O
variates	O
analysis	O
ecva	O
,	O
as	O
a	O
variable	O
selection	O
and	O
classification	O
tool	O
,	O
was	O
used	O
to	O
determine	O
the	O
best	O
intervals	O
during	O
the	O
heating	O
procedure	O
for	O
classification	O
.	O
	
principal	O
component	O
analysis	O
discriminate	O
analysis	O
,	O
partial	O
least-squares	O
discriminate	O
analysis	O
,	O
and	O
ecva	O
were	O
performed	O
on	O
the	O
selected	O
intervals	O
and	O
on	O
the	O
total	O
heating	O
time	O
.	O
	
the	O
effect	O
of	O
autoscaling	O
and	O
mean-centering	O
,	O
as	O
data	O
preprocessing	O
methods	O
,	O
was	O
also	O
investigated	O
.	O
	
the	O
ecva	O
method	O
resulted	O
in	O
the	O
best	O
performances	O
for	O
classification	O
,	O
with	O
a	O
94%	O
cross-validated	O
nonerror	O
rate	O
one	O
misclassification	O
for	O
the	O
heating	O
process	O
times	O
of	O
24-27	O
and	O
33-36	O
intravitreal	B-T169
chemotherapy	B-T061
in	O
the	O
management	O
of	O
vitreous	B-T047
disease	I-T047
in	O
retinoblastoma	O
to	O
evaluate	O
the	O
therapeutic	B-T080
outcome	I-T080
of	O
intravitreal	B-T169
melphalan	B-T116
injection	O
in	O
the	O
management	O
of	O
vitreous	B-T047
disease	I-T047
in	O
patients	O
with	O
retinoblastoma	O
.	O
	
we	O
particularly	O
aimed	O
to	O
assess	O
whether	O
higher	B-T080
melphalan	B-T116
dose	B-T081
with	O
lower	B-T080
number	B-T081
of	O
injections	O
was	O
more	O
effective	B-T080
and	O
associated	B-T080
with	I-T080
fewer	B-T081
side	O
effects	O
.	O
	
this	O
retrospective	B-T062
,	O
interventional	B-T062
,	O
noncomparative	B-T062
,	O
and	O
nonrandomized	B-T062
study	I-T062
included	O
39	O
eyes	O
of	O
37	O
patients	O
.	O
	
vitreous	B-T033
seeds	I-T033
were	O
classified	O
as	O
dust	O
,	O
sphere	O
,	O
and	O
cloud	O
types	O
.	O
	
intravitreal	B-T169
injections	O
were	O
performed	B-T169
through	B-T169
pars	O
plana	O
free	O
of	O
any	O
visible	B-T080
tumor	O
using	B-T169
30-g	O
needle	O
.	O
	
response	O
of	O
the	O
seeds	O
disappearance	B-T033
,	O
conversion	B-T169
into	O
inactive	B-T033
debris	I-T033
,	O
or	O
progression	O
and	O
enucleation	B-T061
rate	B-T081
were	O
determined	O
as	O
outcome	B-T080
measures	B-T081
.	O
	
all	O
patients	O
previously	O
received	B-T080
systemic	B-T061
or	O
intra-arterial	B-T061
chemotherapy	I-T061
.	O
	
vitreous	B-T033
seeding	I-T033
was	O
primary	B-T080
in	O
54%	O
of	O
eyes	O
and	O
secondary	B-T080
in	O
46%	O
of	O
eyes	O
.	O
	
vitreous	B-T033
seeds	I-T033
were	O
classified	O
as	O
dust	O
in	O
9	O
23.1	O
eyes	O
,	O
sphere	O
in	O
24	O
61.5	O
eyes	O
,	O
and	O
cloud	O
in	O
6	O
15.4	O
eyes	O
.	O
	
melphalan	B-T116
dose	B-T081
varied	O
between	O
20	O
and	O
40	O
µg	O
and	O
20	O
51.3	O
eyes	O
received	B-T080
>30	O
µg	O
.	O
	
the	O
total	B-T081
number	I-T081
of	O
injections	O
was	O
70	O
range	O
1-5	O
,	O
mean	B-T081
1.8	O
per	O
eye	O
.	O
	
various	B-T081
types	B-T080
of	O
regression	O
were	O
obtained	B-T169
in	O
27	O
69.2	O
eyes	O
.	O
	
sphere-type	O
seeds	O
were	O
the	O
most	B-T081
responsive	B-T169
to	O
melphalan	B-T116
.	O
	
nonresponse	B-T033
and	O
disease	O
progression	O
were	O
noted	B-T080
in	O
12	O
30.8	O
eyes	O
.	O
	
after	O
a	O
mean	B-T081
follow-up	O
of	O
11.8	O
months	B-T079
,	O
17	O
44%	O
eyes	O
were	O
enucleated	O
.	O
	
vitreous	O
hemorrhage	O
18%	O
and	O
retinal	O
pigment	O
epithelial	O
alterations	B-T078
8%	O
were	O
the	O
most	B-T081
common	B-T081
side	O
effects	O
.	O
	
intravitreal	B-T169
melphalan	B-T116
at	O
30-40	O
µg	O
in	O
1	O
or	O
2	O
injections	O
proved	O
effective	B-T080
in	O
69.2	O
of	O
eyes	O
with	O
vitreous	B-T047
disease	I-T047
.	O
	
fine	B-T082
structure	I-T082
of	O
the	O
anterior	O
median	O
eyes	O
of	O
the	O
funnel	B-T082
-	O
web	O
spider	O
agelena	O
labyrinthica	O
araneae	O
agelenidae	O
only	O
few	O
electron	O
microscopic	O
studies	O
exist	O
on	O
the	O
structure	B-T082
of	O
the	O
main	O
eyes	O
anterior	O
median	O
eyes	O
,	O
ame	O
of	O
web	O
spiders	O
.	O
	
the	O
present	O
paper	O
provides	O
details	O
on	O
the	O
anatomy	O
of	O
the	O
ame	O
in	O
the	O
funnel-web	O
spider	O
agelena	O
labyrinthica	O
.	O
	
the	O
retina	O
consists	O
of	O
two	O
separate	O
regions	B-T082
with	O
differently	O
arranged	O
photoreceptor	O
cells	O
.	O
	
its	O
central	B-T082
part	I-T082
has	O
sensory	O
cells	O
with	O
rhabdomeres	O
on	O
2	O
,	O
3	O
,	O
or	O
4	O
sides	O
,	O
whereas	O
those	O
of	O
the	O
ventral	B-T082
retina	O
have	O
only	O
two	O
rhabdomeres	O
on	O
opposite	O
sides	O
.	O
	
in	O
addition	O
,	O
the	O
rhabdomeres	O
of	O
the	O
ventral	B-T082
retina	O
are	O
arranged	O
in	O
a	O
specific	O
way	O
whereas	O
in	O
the	O
most	O
ventral	B-T082
part	O
they	O
form	O
long	B-T082
tangential	I-T082
rows	I-T082
,	O
those	O
towards	O
the	O
center	B-T082
are	O
detached	O
and	O
are	O
arranged	O
radially	O
.	O
	
all	O
sensory	O
cells	O
are	O
wrapped	O
by	O
unpigmented	B-T033
pigment	O
cell	O
processes	O
.	O
	
in	O
agelenid	O
spiders	O
the	O
axons	O
of	O
the	O
sensory	O
cells	O
exit	O
from	O
the	O
middle	O
of	O
the	O
cell	O
body	O
their	O
fine	B-T082
structure	I-T082
and	O
course	O
through	O
the	O
eye	O
cup	O
is	O
described	O
in	O
detail	O
.	O
	
in	O
the	O
central	B-T082
part	I-T082
of	O
the	O
retina	O
efferent	O
nerve	O
fibres	O
were	O
found	O
forming	O
synapses	O
along	O
the	O
distal	B-T082
region	I-T082
of	O
the	O
receptor	O
cells	O
.	O
	
a	O
muscle	O
is	O
attached	O
laterally	O
to	O
each	O
eye	O
cup	O
that	O
allows	O
mainly	O
rotational	B-T082
movements	O
of	O
the	O
eyes	O
.	O
	
the	O
optical	O
performance	O
image	O
resolution	O
of	O
these	O
main	O
eyes	O
with	O
relatively	O
few	O
visual	O
cells	O
knocking	O
down	O
tcf8	O
inhibits	O
high	B-T033
glucose	I-T033
-	O
and	O
angiotensin	B-T116
ii	I-T116
-	O
induced	B-T169
epithelial	O
to	O
mesenchymal	O
transition	O
in	O
podocytes	O
epithelial	O
to	O
mesenchymal	O
transition	O
emt	O
is	O
a	O
physiological	O
phenomenon	O
in	O
mammalian	O
embryogenesis	O
by	O
which	O
epithelial	O
cells	O
become	O
mesenchymal	O
stem	O
cells	O
.	O
	
studies	O
have	O
indicated	O
that	O
an	O
inappropriate	O
emt	O
plays	O
a	O
key	O
role	O
in	O
a	O
variety	O
of	O
pathogenic	B-T033
processes	O
such	O
as	O
embryonic	O
development	O
and	O
tumor	O
metastasis	O
.	O
	
moreover	O
,	O
recent	O
studies	O
have	O
indicated	O
emt	O
also	O
plays	O
an	O
important	O
role	O
in	O
renal	B-T047
fibrosis	I-T047
.	O
	
in	O
the	O
current	O
study	O
,	O
glucose	B-T109
and	O
angiotensin	B-T116
ii	I-T116
promoted	O
emt	O
in	O
podocytes	O
as	O
well	O
as	O
changes	O
in	O
the	O
cellular	O
morphology	O
of	O
podocytes	O
.	O
	
a	O
high	B-T080
concentration	B-T081
of	O
glucose	B-T109
and	O
angiotensin	B-T116
ii	I-T116
also	O
promoted	O
podocyte	O
movement	O
and	O
migration	O
.	O
	
moreover	O
,	O
a	O
high	B-T080
concentration	B-T081
of	O
glucose	B-T109
and	O
angiotensin	B-T116
ii	I-T116
promoted	O
tcf8	O
expression	O
.	O
	
inhibiting	B-T052
tcf8	O
expression	O
with	O
sirna	O
reversed	O
emt	O
in	O
podocytes	O
in	O
the	O
presence	O
of	O
a	O
high	B-T080
concentration	B-T081
of	O
glucose	B-T109
and	O
angiotensin	B-T116
.	O
	
inhibiting	B-T052
tcf8	O
expression	O
also	O
reversed	O
changes	O
in	O
cellular	O
morphology	O
and	O
podocyte	O
movement	O
and	O
migration	O
.	O
	
therefore	O
,	O
glucose	B-T109
and	O
angiotensin	B-T116
ii	I-T116
may	O
promote	O
emt	O
in	O
podocytes	O
via	O
temporal	O
upregulation	O
of	O
host	B-T116
surface	I-T116
receptors	I-T116
provides	O
a	O
window	O
of	O
opportunity	O
for	O
bacterial	O
adhesion	O
and	O
disease	B-T047
host	B-T116
surface	I-T116
receptors	I-T116
provide	O
bacteria	O
with	O
a	O
foothold	O
from	O
which	O
to	O
attach	O
,	O
colonize	O
and	O
,	O
in	O
some	O
cases	O
,	O
invade	O
tissue	O
and	O
elicit	O
human	O
disease	B-T047
.	O
	
in	O
this	O
review	O
,	O
we	O
discuss	O
several	O
key	O
host	B-T116
receptors	I-T116
and	O
cognate	O
adhesins	O
that	O
function	O
in	O
bacterial	O
pathogenesis	O
.	O
	
in	O
particular	O
,	O
we	O
examine	O
the	O
elevated	B-T080
expression	O
of	O
host	B-T116
surface	I-T116
receptors	I-T116
such	O
as	O
ceacam-1	B-T116
,	O
ceacam-6	B-T116
,	O
icam-1	B-T116
and	O
pafr	B-T116
in	O
response	O
to	O
specific	O
stimuli	O
.	O
	
we	O
explore	O
how	O
upregulated	O
receptors	O
,	O
in	O
turn	O
,	O
expose	O
the	O
host	O
to	O
a	O
range	O
of	O
bacterial	B-T047
infections	I-T047
in	O
the	O
respiratory	O
tract	O
.	O
	
it	O
is	O
apparent	O
that	O
exploitation	O
of	O
receptor	B-T116
induction	B-T169
for	O
bacterial	O
adherence	O
is	O
not	O
unique	O
to	O
one	O
body	O
system	O
,	O
but	O
is	O
also	O
observed	O
in	O
the	O
central	O
nervous	O
,	O
gastrointestinal	O
and	O
urogenital	O
systems	O
.	O
	
prokaryotic	O
pathogens	O
which	O
utilize	O
this	O
mechanism	O
for	O
their	O
infectivity	O
include	O
streptococcus	O
pneumoniae	O
,	O
haemophilus	O
influenzae	O
,	O
neisseria	O
meningitidis	O
and	O
escherichia	O
coli	O
.	O
	
a	O
number	O
of	O
approaches	O
have	O
been	O
used	O
,	O
in	B-T062
both	O
in	O
vitro	I-T062
and	O
in	B-T062
vivo	I-T062
experimental	I-T062
models	I-T062
,	O
to	O
inhibit	O
bacterial	O
attachment	O
to	O
temporally	O
expressed	O
host	B-T116
receptors	I-T116
.	O
	
some	O
of	O
these	O
novel	O
strategies	O
may	O
advance	O
future	O
targeted	B-T169
interventions	O
for	O
the	O
prevention	B-T061
and	O
treatment	B-T061
of	O
bacterial	B-T047
disease	I-T047
.	O
	
optogenetic	O
demonstration	B-T052
of	O
functional	B-T169
innervation	O
of	O
mouse	O
colon	O
by	O
neurons	O
derived	O
from	O
transplanted	B-T169
neural	O
cells	O
cell	B-T061
therapy	I-T061
offers	O
the	O
potential	O
to	O
treat	B-T169
gastrointestinal	B-T047
motility	I-T047
disorders	I-T047
caused	O
by	O
diseased	O
or	O
absent	B-T169
enteric	B-T082
neurons	O
.	O
	
we	O
examined	O
whether	O
neurons	O
generated	O
from	O
transplanted	B-T169
enteric	B-T082
neural	O
cells	O
provide	O
a	O
functional	B-T169
innervation	O
of	O
bowel	O
smooth	O
muscle	O
in	O
mice	O
.	O
	
enteric	B-T082
neural	O
cells	O
expressing	O
the	O
light-sensitive	B-T116
ion	I-T116
channel	I-T116
,	O
channelrhodopsin	B-T116
,	O
were	O
isolated	B-T169
from	O
the	O
fetal	B-T169
or	O
postnatal	B-T079
mouse	O
bowel	O
and	O
transplanted	B-T169
into	O
the	O
distal	O
colon	O
of	O
3-	O
to	O
4-	O
week	B-T079
-old	O
wild-type	O
recipient	O
mice	O
.	O
	
intracellular	B-T082
electrophysiological	O
recordings	O
of	O
responses	B-T169
to	O
light	O
stimulation	O
of	O
the	O
transplanted	B-T169
cells	O
were	O
made	O
from	O
colonic	O
smooth	O
muscle	O
cells	O
in	O
recipient	O
mice	O
.	O
	
electrical	O
stimulation	O
of	O
endogenous	B-T169
enteric	B-T082
neurons	O
was	O
used	O
as	O
a	O
control	O
.	O
	
the	O
axons	O
of	O
graft	O
-derived	O
neurons	O
formed	O
a	O
plexus	O
in	O
the	O
circular	O
muscle	O
layer	O
.	O
	
selective	O
stimulation	O
of	O
graft	O
-derived	O
cells	O
by	O
light	O
resulted	O
in	O
excitatory	O
and	O
inhibitory	O
junction	O
potentials	O
,	O
the	O
electrical	B-T169
events	O
underlying	O
contraction	O
and	O
relaxation	O
,	O
respectively	O
,	O
in	O
colonic	O
muscle	O
cells	O
.	O
	
graft	O
-derived	O
excitatory	O
and	O
inhibitory	O
motor	O
neurons	O
released	O
the	O
same	O
neurotransmitters	O
as	O
endogenous	B-T169
motor	O
neurons	O
-	O
acetylcholine	B-T109
and	O
a	O
combination	O
of	O
adenosine	O
triphosphate	O
and	O
nitric	O
oxide	O
,	O
respectively	O
.	O
	
graft	O
-derived	O
neurons	O
also	O
included	O
interneurons	O
that	O
provided	O
synaptic	O
inputs	O
to	O
motor	O
neurons	O
,	O
but	O
the	O
pharmacologic	B-T080
properties	I-T080
of	O
interneurons	O
varied	O
with	O
the	O
age	O
of	O
the	O
donors	B-T098
from	O
which	O
enteric	B-T082
neural	O
cells	O
were	O
obtained	O
.	O
	
enteric	B-T082
neural	O
cells	O
transplanted	B-T169
into	O
the	O
bowel	O
give	O
rise	O
to	O
multiple	B-T081
functional	B-T169
types	B-T080
of	O
neurons	O
that	O
integrate	O
and	O
provide	O
a	O
functional	B-T169
innervation	O
of	O
the	O
smooth	O
muscle	O
of	O
the	O
bowel	O
wall	O
.	O
	
circuits	O
composed	O
of	O
both	O
motor	O
neurons	O
and	O
interneurons	O
were	O
established	O
,	O
but	O
the	O
age	O
at	O
which	O
cells	O
are	O
isolated	O
influences	O
the	O
neurotransmitter	O
phenotype	O
of	O
interneurons	O
assessment	O
of	O
vascular	O
stent	O
heating	O
with	O
repetitive	B-T061
transcranial	I-T061
magnetic	I-T061
stimulation	I-T061
a	O
high	O
proportion	O
of	O
patients	O
with	O
stroke	B-T047
do	O
not	O
qualify	O
for	O
repetitive	B-T061
transcranial	I-T061
magnetic	I-T061
stimulation	I-T061
rtms	B-T061
clinical	B-T062
studies	I-T062
due	O
to	O
the	O
presence	O
of	O
metallic	O
stents	O
.	O
	
the	O
ultimate	O
concern	O
is	O
that	O
any	O
metal	O
could	O
become	O
heated	O
due	O
to	O
eddy	O
currents	O
.	O
	
however	O
,	O
to	O
date	O
,	O
no	O
clinical	B-T170
safety	I-T170
data	I-T170
are	O
available	O
regarding	O
the	O
risk	B-T078
of	O
metallic	O
stents	O
heating	O
with	O
rtms	B-T061
.	O
	
we	O
tested	B-T169
the	O
safety	B-T062
of	O
common	O
rtms	B-T061
protocols	B-T170
1	O
hz	O
and	O
10	O
hz	O
with	O
stents	O
used	O
commonly	O
in	O
stroke	B-T047
,	O
nitinol	O
and	O
elgiloy	O
.	O
	
in	O
our	O
method	O
,	O
stents	O
were	O
tested	B-T170
in	O
gelled	O
saline	O
at	O
2	O
different	O
locations	B-T082
at	B-T082
the	I-T082
center	I-T082
and	O
at	O
the	O
lobe	O
of	O
the	O
coil	O
.	O
	
in	O
addition	O
,	O
at	O
each	O
location	B-T082
,	O
stent	O
heating	O
was	O
evaluated	O
in	O
3	O
different	O
orientations	B-T082
parallel	B-T082
to	O
the	O
long	B-T082
axis	I-T082
of	O
coil	O
,	O
parallel	B-T082
to	O
the	O
short	B-T082
axis	I-T082
of	O
the	O
coil	O
,	O
and	O
perpendicular	B-T082
to	O
the	O
plane	O
of	O
the	O
coil	O
.	O
	
we	O
found	O
that	O
stents	O
did	O
not	O
heat	O
to	O
more	O
than	O
1	O
with	O
either	O
1	O
hz	O
rtms	B-T061
or	O
10	O
hz	O
rtms	B-T061
in	O
any	O
configuration	O
or	O
orientation	B-T082
.	O
	
heating	O
in	O
general	O
was	O
greater	B-T081
at	O
the	O
lobe	O
when	O
the	O
stent	O
was	O
oriented	B-T082
perpendicularly	B-T082
.	O
	
our	O
study	O
represents	O
a	O
new	O
method	O
for	O
ex	B-T169
vivo	I-T169
quantification	B-T081
of	O
stent	O
heating	O
.	O
	
we	O
have	O
found	O
that	O
heating	O
of	O
stents	O
was	O
well	O
below	O
the	O
food	O
and	O
drug	O
administration	O
standards	B-T170
of	O
2	O
.	O
	
thus	O
,	O
our	O
study	O
paves	O
the	O
way	O
for	O
in	B-T082
vivo	I-T082
testing	B-T169
of	O
rtms	B-T061
10	O
hz	O
in	O
the	O
presence	O
of	O
implanted	O
magnetic	O
resonance	O
imaging	O
-	O
compatible	B-T080
stents	O
in	O
animal	O
studies	O
.	O
	
when	O
planning	O
human	O
safety	B-T062
studies	I-T062
though	O
,	O
geometry	O
,	O
orientation	B-T082
,	O
and	O
location	B-T082
relative	O
to	O
the	O
coil	O
clinical	O
observation	O
of	O
treatment	B-T169
of	O
chronic	O
subdural	O
hematoma	O
with	O
novel	O
double	O
needle	O
minimally	O
invasive	O
aspiration	O
technology	O
the	O
aim	B-T078
of	O
the	O
present	O
study	B-T062
was	O
to	O
explore	O
the	O
clinical	B-T080
effects	I-T080
,	O
including	O
the	O
prevention	O
of	O
complications	O
,	O
of	O
the	O
treatment	B-T169
of	O
chronic	O
subdural	O
hematoma	O
with	O
double	O
needle	O
aspiration	O
.	O
	
the	O
clinical	B-T170
data	I-T170
of	O
31	O
patients	O
with	O
chronic	O
subdural	O
hematoma	O
treated	B-T169
by	O
double	O
yl-1	O
needle	O
double	O
skull	B-T061
drilling	I-T061
and	O
31	O
controls	O
treated	B-T169
by	O
traditional	O
drilling	B-T061
and	O
drainage	B-T061
were	O
analyzed	O
retrospectively	O
.	O
	
in	O
the	O
yl-1	O
needle	O
group	B-T078
,	O
only	O
1	O
patient	O
was	O
with	O
hematoma	O
recurrence	O
,	O
1	O
patient	O
was	O
with	O
intracranial	B-T047
pneumocephalus	I-T047
,	O
and	O
the	O
remaining	O
patients	O
who	O
were	O
followed	O
up	O
for	O
3	O
months	B-T079
achieved	O
a	O
clinical	B-T033
cure	I-T033
.	O
	
in	O
the	O
traditional	B-T061
drilling	I-T061
and	O
drainage	B-T061
group	B-T078
,	O
13	O
patients	O
were	O
with	O
hematoma	O
recurrence	O
within	O
3	O
months	B-T079
after	O
the	O
operation	B-T061
and	O
7	O
patients	O
were	O
with	O
postoperative	B-T079
intracranial	B-T047
pneumocephalus	I-T047
.	O
	
the	O
method	B-T170
of	O
double	O
yl-1	O
needle	O
is	O
better	O
than	O
the	O
traditional	B-T061
drilling	I-T061
and	O
drainage	B-T061
method	I-T061
for	O
the	O
treatment	B-T169
of	O
chronic	O
subdural	O
hematoma	O
because	O
it	O
reduces	O
the	O
postoperative	B-T079
recurrence	O
rate	O
and	O
the	O
impact	B-T080
of	O
adjunctive	B-T061
guanfacine	B-T109
extended	O
release	O
on	O
stimulant	O
adherence	B-T169
in	O
children	O
/	O
adolescents	O
with	O
attention-deficit	O
/	O
hyperactivity	O
disorder	O
to	O
assess	O
stimulant	O
adherence	B-T169
among	O
children	O
/	O
adolescents	O
with	O
attention-deficit	O
/	O
hyperactivity	O
disorder	O
adhd	O
augmenting	O
stimulants	O
with	O
guanfacine	O
extended-release	O
gxr	O
.	O
	
inclusion	O
criteria	O
6-17	O
years	O
,	O
1	O
adhd	O
diagnosis	O
,	O
1	O
long-acting	O
and/or	O
short-acting	O
stimulant	O
with	O
gxr	O
augmentation	O
.	O
	
modified	O
medication	O
possession	O
ratio	O
mmpr	O
days	O
medication	O
available	O
/	O
days	O
in	O
period	O
,	O
excluding	O
medication	O
holidays	O
was	O
assessed	O
mmpr	O
<	O
0.80	O
nonadherent	O
.	O
	
regression	O
models	O
assessed	O
change	O
in	O
mmpr	O
adjusting	O
for	O
demographic	O
and	O
clinical	O
characteristics	O
.	O
	
among	O
patients	O
nonadherent	O
to	O
stimulants	O
pre	O
-	O
augmentation	O
n	O
=	O
165	O
,	O
unadjusted	O
mean	O
sd	O
pre	O
-	O
and	O
post	O
-	O
stimulant	O
mmprs	O
were	O
0.68	O
0.11	O
and	O
0.87	O
0.16	O
.	O
	
adjusted	O
mean	O
change	O
in	O
mmpr	O
was	O
0.20	O
for	O
long-acting	O
versus	O
0.18	O
for	O
short-acting	O
stimulants	O
p	O
=	O
0.34	O
.	O
	
among	O
patients	O
nonadherent	O
to	O
stimulants	O
,	O
gxr	O
augmentation	O
was	O
associated	O
with	O
increased	O
stimulant	O
adherence	B-T169
bxb1	O
phage	O
recombinase	B-T116
assists	O
genome	O
engineering	O
in	O
drosophila	O
melanogaster	O
rapid	B-T080
and	O
reliable	B-T080
genome	O
modifications	O
provide	O
the	O
basis	O
for	O
detailed	O
in	B-T082
vivo	I-T082
functional	O
analysis	O
of	O
any	O
genomic	B-T169
entity	I-T169
gene	O
,	O
regulatory	O
dna	O
,	O
non-coding	O
rna	O
,	O
etc	O
.	O
	
with	O
the	O
advent	O
of	O
crispr	O
/	O
cas9	O
genome	O
editing	O
technology	O
,	O
manipulation	O
of	O
a	O
particular	O
genomic	O
locus	O
has	O
become	O
a	O
routine	O
undertaking	O
in	O
variety	O
of	O
model	O
organisms	O
,	O
including	O
the	O
fruit	O
fly	O
drosophila	O
melanogaster	O
.	O
	
to	O
further	O
diversify	O
the	O
available	O
tools	O
for	O
genome	O
engineering	O
,	O
we	O
successfully	O
harnessed	O
the	O
phage	O
recombinase	B-T116
bxb1	I-T116
to	O
perform	O
recombinase-mediated	O
cassette	O
exchange	O
rmce	O
in	O
d	O
.	O
	
melanogaster	O
.	O
	
we	O
demonstrate	O
that	O
bxb1	O
possesses	O
highly	O
efficient	O
recombinase	O
activity	O
and	O
could	O
be	O
used	O
alone	O
or	O
in	O
conjunction	O
with	O
other	O
currently	O
available	O
recombinases	B-T116
for	O
creating	O
platforms	O
for	O
cassette	O
exchange	O
of	O
targeted	O
loci	O
.	O
	
tailor-made	O
drug	O
carrier	O
comparison	B-T052
of	O
formation-dependent	O
physicochemical	B-T080
properties	I-T080
within	O
self-assembled	O
aggregates	B-T080
for	O
an	O
optimal	B-T080
drug	O
carrier	O
self-assembled	O
surfactant	O
aggregates	B-T080
,	O
such	O
as	O
micelles	B-T109
and	O
vesicles	O
,	O
have	O
been	O
investigated	O
for	O
their	O
application	B-T169
as	O
drug	O
carriers	O
in	O
the	O
treatment	B-T061
of	O
various	O
diseases	B-T047
.	O
	
however	O
,	O
the	O
characteristics	B-T080
that	O
decide	O
which	O
aggregate	B-T080
is	O
the	O
best	B-T080
drug	O
carrier	O
for	O
each	O
disease	B-T047
have	O
not	O
yet	O
been	O
clarified	O
.	O
	
in	O
order	O
to	O
design	B-T052
an	O
optimal	B-T080
drug	O
carrier	O
for	O
each	O
disease	B-T047
,	O
various	O
kinds	O
of	O
self-assembled	O
aggregates	B-T080
,	O
such	O
as	O
spherical	B-T109
micelles	I-T109
,	O
lens-like	O
vesicles	O
,	O
and	O
tube-like	O
vesicles	O
,	O
were	O
evaluated	O
by	O
""""	O
multiple	B-T169
techniques	I-T169
""""	O
including	O
dynamic	O
light	O
scattering	O
,	O
differential	O
scanning	O
calorimetry	O
,	O
nuclear	O
magnetic	O
resonance	O
spectroscopy	O
,	O
and	O
fluorescence	O
measurement	O
using	O
the	O
laurdan	B-T109
probe	O
.	O
	
these	O
studies	B-T062
led	O
to	O
the	O
compilation	O
of	O
a	O
database	B-T170
on	O
the	O
formation-dependent	O
properties	O
of	O
self-assembled	O
aggregates	B-T080
.	O
	
as	O
the	O
relationship	B-T080
between	O
physicochemical	B-T080
properties	I-T080
of	O
self-assembled	O
aggregates	B-T080
and	O
their	O
functions	B-T169
as	O
drug	O
carriers	O
have	O
been	O
extensively	O
reported	O
,	O
this	O
database	B-T170
can	O
be	O
utilized	O
for	O
designing	O
an	O
optimal	B-T080
drug	O
carrier	O
,	O
i.e	O
,	O
a	O
tailor-made	O
drug	O
carrier	O
.	O
	
uridine	O
stimulate	O
laxative	O
effect	B-T080
in	O
the	O
loperamide	B-T109
-	O
induced	B-T169
constipation	O
of	O
sd	O
rats	O
through	O
regulation	O
of	O
the	O
machrs	B-T116
signaling	O
pathway	O
and	O
mucin	B-T116
secretion	O
uridine	O
urd	O
,	O
which	O
has	O
been	O
reported	O
as	O
a	O
major	B-T080
component	O
of	O
rna	O
,	O
plays	O
an	O
important	B-T080
role	O
in	O
various	O
biological	O
process	O
including	O
neuroprotection	O
,	O
biochemical	O
modulation	O
and	O
glycolysis	O
,	O
although	O
its	O
role	O
in	O
constipation	O
has	O
yet	O
to	O
be	O
established	B-T080
.	O
	
therefore	O
,	O
in	O
this	O
study	B-T062
,	O
we	O
investigated	B-T169
the	O
laxative	O
effects	B-T080
of	O
urd	O
on	O
chronic	B-T079
constipation	O
.	O
	
the	O
constipation	O
phenotypes	O
and	O
their	O
related	O
mechanisms	B-T169
were	O
investigated	B-T169
in	O
the	O
transverse	O
colons	O
of	O
sd	O
rats	O
with	O
loperamide	B-T109
lop	B-T109
induced	B-T169
constipation	O
after	O
treatment	B-T061
with	O
100	O
mg/kg	O
of	O
urd	O
.	O
	
the	O
number	B-T081
,	O
weight	B-T081
and	O
water	O
contents	O
of	O
stools	O
were	O
significantly	B-T078
higher	B-T080
in	O
the	O
lop	B-T109
+	O
urd	O
treated	B-T033
group	B-T078
than	O
the	O
lop	B-T109
+	O
vehicle	O
treated	B-T033
group	B-T078
,	O
while	O
food	O
intake	O
and	O
water	O
consumption	O
of	O
the	O
same	O
group	B-T078
were	O
maintained	O
at	O
a	O
constant	B-T080
level	B-T080
.	O
	
the	O
thickness	B-T080
of	O
the	O
mucosa	O
layer	O
,	O
muscle	O
and	O
flat	O
luminal	O
surface	O
,	O
as	O
well	O
as	O
the	O
number	B-T081
of	O
goblet	O
cells	O
,	O
paneth	O
cells	O
and	O
lipid	O
droplets	O
were	O
enhanced	B-T052
in	O
the	O
lop	B-T109
+	O
urd	O
treated	B-T033
group	B-T078
.	O
	
furthermore	O
,	O
the	O
expression	O
of	O
the	O
muscarinic	B-T116
acetylcholine	I-T116
receptors	I-T116
m2	I-T116
and	O
m3	B-T116
machr	B-T116
m2	I-T116
and	O
m3	B-T116
at	O
the	O
transcriptional	O
and	O
translational	O
level	B-T080
was	O
recovered	B-T080
in	O
the	O
lop	B-T109
+	O
urd	O
treated	B-T033
group	B-T078
,	O
while	O
some	O
markers	O
such	O
as	O
gα	B-T116
and	O
inositol	O
triphosphate	O
ip3	O
in	O
their	O
downstream	B-T082
signaling	O
pathway	O
were	O
completely	O
recovered	B-T080
by	O
urd	O
treatment	B-T061
.	O
	
moreover	O
,	O
the	O
ability	O
for	O
mucin	B-T116
secretion	O
and	O
the	O
expression	O
of	O
membrane	B-T116
water	I-T116
channel	I-T116
aquaporine	B-T116
8	I-T116
,	O
aqp8	B-T116
were	O
increased	B-T081
significantly	B-T078
in	O
the	O
lop	B-T109
+	O
urd	O
treated	B-T033
group	B-T078
compared	B-T052
with	O
lop	B-T109
+	O
vehicle	O
treated	B-T033
group	B-T078
.	O
	
finally	O
,	O
the	O
activity	B-T052
of	O
urd	O
was	O
confirmed	O
in	O
primary	O
smooth	O
muscle	O
of	O
rat	O
intestine	O
cells	O
prismc	O
based	O
on	O
gα	B-T116
expression	O
and	O
ip3	O
concentration	B-T081
.	O
	
the	O
results	B-T033
of	O
the	O
present	O
study	B-T062
provide	O
the	O
first	O
strong	B-T080
evidence	B-T078
that	O
urd	O
can	O
be	O
considered	O
an	O
important	B-T080
candidate	O
for	O
improving	B-T080
chronic	B-T079
constipation	O
induced	B-T169
by	O
lop	B-T109
treatment	B-T061
in	O
animal	O
models	O
.	O
	
characterization	B-T052
of	O
phytochrome	O
interacting	O
factors	O
from	O
the	O
moss	O
physcomitrella	O
patens	O
illustrates	O
conservation	B-T080
of	O
phytochrome	O
signaling	O
modules	O
in	O
land	O
plants	O
across	O
the	O
plant	O
kingdom	O
,	O
phytochrome	B-T116
phy	B-T116
photoreceptors	O
play	O
an	O
important	O
role	O
during	O
adaptive	B-T169
and	O
developmental	O
responses	O
to	O
light	O
.	O
	
in	O
arabidopsis	O
thaliana	O
,	O
light-activated	O
phys	B-T116
accumulate	O
in	O
the	O
nucleus	O
,	O
where	O
they	O
regulate	O
downstream	O
signaling	O
components	O
,	O
such	O
as	O
phytochrome	O
interacting	O
factors	O
pifs	O
.	O
	
pifs	O
are	O
transcription	B-T116
factors	I-T116
that	O
act	O
as	O
repressors	B-T116
of	O
photomorphogenesis	O
their	O
inhibition	O
by	O
phys	B-T116
leads	O
to	O
substantial	O
changes	O
in	O
gene	O
expression	O
.	O
	
the	O
nuclear	O
function	O
of	O
phys	B-T116
,	O
however	O
,	O
has	O
so	O
far	O
been	O
investigated	O
in	O
only	O
a	O
few	O
non-seed	O
plants	O
.	O
	
here	O
,	O
we	O
identified	O
putative	O
target	O
genes	O
of	O
phy	B-T116
signaling	O
in	O
the	O
moss	O
physcomitrella	O
patens	O
and	O
found	O
light-regulated	O
genes	O
that	O
are	O
putative	O
orthologs	O
of	O
pif-controlled	O
genes	O
in	O
arabidopsis	O
.	O
	
phylogenetic	B-T062
analyses	I-T062
revealed	O
that	O
an	O
ancestral	O
pif-like	O
gene	O
was	O
already	O
present	O
in	O
streptophyte	O
algae	O
,	O
i.e	O
,	O
before	O
the	O
water-to-land	B-T052
transition	I-T052
of	O
plants	O
.	O
	
the	O
pif	O
homologs	O
in	O
the	O
genome	O
of	O
p	O
.	O
	
patens	O
resemble	O
arabidopsis	O
pifs	O
in	O
their	O
protein	B-T116
domain	I-T116
structure	I-T116
,	O
molecular	B-T080
properties	I-T080
,	O
and	O
physiological	O
effects	O
,	O
albeit	O
with	O
notable	O
differences	O
in	O
the	O
motif-dependent	O
phy	B-T116
interaction	B-T082
.	O
	
our	O
results	O
suggest	O
that	O
p	O
.	O
	
patens	O
pifs	O
are	O
involved	O
in	O
phy	B-T116
signaling	O
.	O
	
the	O
phy-pif	O
signaling	O
node	O
that	O
relays	O
light	O
signals	O
to	O
target	O
genes	O
has	O
been	O
largely	O
conserved	O
during	O
land	O
plant	O
evolution	O
,	O
with	O
evidence	O
of	O
lineage-specific	O
diversification	O
.	O
	
conditional	O
reprogramming	O
and	O
long-term	B-T079
expansion	O
of	O
normal	O
and	O
tumor	O
cells	O
from	O
human	O
biospecimens	O
historically	O
,	O
it	O
has	O
been	O
difficult	O
to	O
propagate	B-T052
cells	O
in	B-T080
vitro	I-T080
that	O
are	O
derived	O
directly	O
from	O
human	O
tumors	O
or	O
healthy	O
tissue	O
.	O
	
however	O
,	O
in	B-T080
vitro	I-T080
preclinical	B-T170
models	I-T170
are	O
essential	O
tools	O
for	O
both	O
the	O
study	O
of	O
basic	O
cancer	O
biology	O
and	O
the	O
promotion	O
of	O
translational	B-T062
research	I-T062
,	O
including	O
drug	B-T062
discovery	I-T062
and	O
drug	O
target	O
identification	O
.	O
	
this	O
protocol	O
describes	O
conditional	O
reprogramming	O
cr	O
,	O
which	O
involves	O
coculture	O
of	O
irradiated	O
mouse	O
fibroblast	O
feeder	O
cells	O
with	O
normal	O
and	O
tumor	O
human	O
epithelial	O
cells	O
in	O
the	O
presence	O
of	O
a	O
rho	B-T116
kinase	I-T116
inhibitor	O
y-27632	B-T109
.	O
	
cr	O
cells	O
can	O
be	O
used	O
for	O
various	O
applications	O
,	O
including	O
regenerative	O
medicine	O
,	O
drug	O
sensitivity	O
testing	O
,	O
gene	O
expression	O
profiling	O
and	O
xenograft	B-T061
studies	I-T061
.	O
	
the	O
method	O
requires	O
a	O
pathologist	O
to	O
differentiate	O
healthy	O
tissue	O
from	O
tumor	O
tissue	O
,	O
and	O
basic	O
tissue	O
culture	O
skills	O
.	O
	
the	O
protocol	O
can	O
be	O
used	O
with	O
cells	O
derived	O
from	O
both	O
fresh	O
and	O
cryopreserved	O
tissue	O
samples	O
.	O
	
as	O
approximately	O
1	O
million	O
cells	O
can	O
be	O
generated	B-T052
in	O
7	O
d	O
,	O
the	O
technique	O
is	O
directly	O
applicable	O
to	O
diagnostic	O
and	O
predictive	B-T080
medicine	O
.	O
	
moreover	O
,	O
the	O
epithelial	O
cells	O
can	O
be	O
propagated	B-T052
indefinitely	O
in	B-T080
vitro	I-T080
,	O
yet	O
retain	O
the	O
capacity	B-T081
to	O
become	O
fully	O
differentiated	O
when	O
placed	O
into	O
conditions	B-T082
that	O
mimic	O
their	O
natural	B-T082
environment	I-T082
.	O
	
types	O
of	O
internal	O
facilitation	O
activities	B-T052
in	O
hospitals	O
implementing	O
evidence-based	O
interventions	O
implementation	B-T052
models	B-T170
,	O
frameworks	O
,	O
and	O
theories	B-T078
recognize	O
the	O
importance	O
of	O
activities	B-T052
that	O
facilitate	O
implementation	B-T052
success	O
.	O
	
however	O
,	O
little	O
is	O
known	O
about	O
internal	O
facilitation	O
activities	B-T052
that	O
hospital	O
personnel	O
engage	B-T169
in	O
during	O
implementation	B-T052
efforts	I-T052
.	O
	
the	O
aim	O
of	O
the	O
study	B-T062
was	O
to	O
examine	O
internal	O
facilitation	O
activities	B-T052
at	O
10	O
critical	O
access	O
hospitals	O
in	O
rural	O
iowa	O
during	O
their	O
implementation	B-T052
of	O
teamstepps	O
,	O
a	O
patient	O
safety	O
intervention	B-T061
,	O
and	O
to	O
identify	O
characteristics	B-T080
that	O
distinguish	O
different	O
types	O
of	O
facilitation	O
activities	B-T052
.	O
	
we	O
followed	O
10	O
critical	O
access	O
hospitals	O
for	O
2	O
years	B-T079
after	O
the	O
onset	B-T080
of	I-T080
implementation	B-T052
,	O
conducting	O
quarterly	B-T079
interviews	B-T052
with	O
key	B-T098
informants	I-T098
.	O
	
on	O
the	O
basis	O
of	O
the	O
transcripts	B-T170
from	O
the	O
first	O
two	O
quarters	B-T081
,	O
a	O
coding	B-T078
template	I-T078
was	O
developed	O
using	O
inductive	B-T062
analyses	I-T062
.	O
	
the	O
template	B-T078
was	O
then	O
applied	O
deductively	B-T080
to	O
code	O
all	O
interview	B-T052
transcripts	B-T170
.	O
	
using	O
comparative	B-T062
analysis	I-T062
,	O
we	O
examined	O
the	O
characteristics	B-T080
that	O
distinguish	O
between	O
the	O
facilitation	O
types	O
.	O
	
we	O
identified	O
four	O
types	O
of	O
facilitation	O
activities	B-T052
-	O
leadership	O
,	O
buy-in	O
,	O
customization	B-T052
,	O
and	O
accountability	B-T078
.	O
	
individuals	B-T098
and	O
teams	O
engaged	B-T169
in	O
different	O
types	O
of	O
facilitation	O
activities	B-T052
,	O
both	O
in	O
a	O
planned	O
and	O
an	O
ad	B-T033
hoc	I-T033
manner	I-T033
.	O
	
these	O
activities	B-T052
targeted	O
at	O
both	O
people	B-T098
and	O
practices	O
and	O
exhibited	O
varying	O
temporal	B-T079
patterns	I-T079
start	B-T079
and	O
peak	B-T079
time	I-T079
.	O
	
there	O
are	O
four	O
types	O
of	O
facilitation	O
activities	B-T052
that	O
hospitals	O
engage	B-T169
in	O
while	O
implementing	B-T052
evidence-based	O
practices	O
,	O
offering	O
a	O
parsimonious	B-T080
way	O
to	O
characterize	O
facilitation	O
activities	B-T052
.	O
	
new	O
theoretical	B-T078
and	O
empirical	B-T062
research	B-T062
opportunities	I-T062
are	O
discussed	O
.	O
	
understanding	O
the	O
types	O
of	O
facilitation	O
activities	B-T052
and	O
their	O
distinguishing	O
characteristics	B-T080
can	O
assist	O
managers	O
in	O
planning	B-T169
and	O
executing	B-T052
implementations	B-T052
of	O
evidence-based	O
interventions	O
.	O
	
directing	O
traffic	O
on	O
dna	O
-how	O
transcription	B-T116
factors	I-T116
relieve	B-T169
or	O
induce	B-T169
transcriptional	O
interference	O
transcriptional	O
interference	O
ti	O
is	O
increasingly	O
recognized	O
as	O
a	O
widespread	B-T082
mechanism	O
of	O
gene	O
control	O
,	O
particularly	O
given	O
the	O
pervasive	B-T081
nature	I-T081
of	O
transcription	O
,	O
both	O
sense	B-T169
and	O
antisense	O
,	O
across	O
all	O
kingdoms	O
of	O
life	O
.	O
	
here	O
,	O
we	O
discuss	O
how	O
transcription	B-T116
factor	I-T116
binding	O
kinetics	O
strongly	O
influence	O
the	O
ability	O
of	O
a	O
transcription	B-T116
factor	I-T116
to	O
relieve	B-T169
or	O
induce	B-T169
ti	O
.	O
	
acoustic	O
startle	O
response	O
in	O
rats	O
predicts	O
inter-individual	B-T098
variation	B-T080
in	O
fear	O
extinction	O
although	O
a	O
large	O
portion	O
of	O
the	O
population	B-T098
is	O
exposed	O
to	O
a	O
traumatic	B-T169
event	O
at	O
some	O
point	O
,	O
only	O
a	O
small	O
percentage	B-T081
of	O
the	O
population	B-T098
develops	O
post-traumatic	O
stress	O
disorder	O
ptsd	O
,	O
suggesting	O
the	O
presence	O
of	O
predisposing	B-T079
factors	I-T079
.	O
	
abnormal	B-T033
acoustic	O
startle	O
response	O
asr	O
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
ptsd	O
,	O
implicating	O
it	O
as	O
a	O
potential	B-T080
predictor	B-T078
of	O
the	O
development	O
of	O
ptsd	O
-like	O
behavior	O
.	O
	
since	O
poor	O
extinction	O
and	O
retention	O
of	O
extinction	O
learning	O
are	O
characteristic	O
of	O
ptsd	O
patients	O
,	O
it	O
is	O
of	O
interest	O
to	O
determine	O
if	O
abnormal	B-T033
asr	O
is	O
predictive	O
of	O
development	O
of	O
such	O
deficits	B-T080
.	O
	
to	O
determine	O
whether	O
baseline	B-T081
asr	O
has	O
utility	O
in	O
predicting	O
the	O
development	O
of	O
ptsd	O
-like	O
behavior	O
,	O
the	O
relationship	O
between	O
baseline	B-T081
asr	O
and	O
freezing	O
behavior	O
following	O
pavlovian	B-T062
fear	I-T062
conditioning	I-T062
was	O
examined	O
in	O
a	O
group	O
of	O
adult	O
,	O
male	O
sprague-dawley	O
rats	O
.	O
	
baseline	B-T081
acoustic	O
startle	O
response	O
asr	O
was	O
assessed	O
preceding	O
exposure	O
to	O
a	O
pavlovian	B-T062
fear	I-T062
conditioning	I-T062
paradigm	I-T062
where	O
freezing	O
behavior	O
was	O
measured	O
during	O
fear	B-T062
conditioning	I-T062
,	O
extinction	O
training	O
,	O
and	O
extinction	O
testing	B-T169
.	O
	
although	O
there	O
was	O
no	O
relationship	O
between	O
baseline	B-T081
asr	O
and	O
fear	O
memory	O
following	O
conditioning	B-T062
,	O
rats	O
with	O
low	O
baseline	B-T081
asr	O
had	O
significantly	O
lower	O
magnitude	O
of	O
retention	O
of	O
the	O
extinction	O
memory	O
than	O
rats	O
with	O
high	O
baseline	B-T081
asr	O
.	O
	
the	O
results	O
suggest	O
that	O
baseline	B-T081
asr	O
has	O
value	O
as	O
a	O
predictive	B-T080
index	B-T170
of	O
the	O
development	O
of	O
a	O
ptsd	O
-like	O
high	O
tacrolimus	B-T109
blood	B-T081
concentrations	I-T081
early	O
after	O
lung	B-T061
transplantation	I-T061
and	O
the	O
risk	B-T078
of	O
kidney	O
injury	O
lung	O
transplant	O
recipients	O
often	O
develop	O
acute	O
kidney	O
injury	O
aki	O
evolving	O
into	O
chronic	B-T047
kidney	I-T047
disease	I-T047
ckd	B-T047
.	O
	
the	O
immunosuppressant	O
tacrolimus	B-T109
might	O
be	O
associated	B-T080
with	I-T080
the	O
emergence	O
of	O
aki	O
.	O
	
we	O
analyzed	O
the	O
development	B-T169
and	O
recovery	O
of	O
kidney	O
injury	O
after	O
lung	B-T061
transplantation	I-T061
and	O
related	O
aki	O
to	O
whole-blood	O
tacrolimus	B-T109
trough	B-T081
concentrations	I-T081
and	O
other	O
factors	O
causing	O
kidney	O
injury	O
.	O
	
we	O
retrospectively	B-T062
studied	I-T062
kidney	O
injury	O
in	O
186	O
lung-transplantation	B-T061
patients	O
at	O
the	O
umc	O
utrecht	O
between	O
2001	O
and	O
2011	O
.	O
	
kidney	O
function	O
and	O
whole-blood	O
tacrolimus	B-T109
trough	B-T081
concentrations	I-T081
were	O
determined	O
from	O
day	B-T079
1	O
to	O
14	O
and	O
at	O
1	O
,	O
3	O
,	O
6	O
,	O
and	O
12	O
months	B-T079
postoperative	B-T079
.	O
	
systemic	B-T047
inflammatory	I-T047
response	I-T047
syndrome	I-T047
sirs	B-T047
,	O
septic	O
shock	O
,	O
and	O
nephrotoxic	B-T080
medications	B-T170
were	O
evaluated	O
as	O
covariates	O
for	O
aki	O
.	O
	
we	O
analyzed	O
liver	O
injury	O
and	O
drug-drug	O
interactions	O
.	O
	
aki	O
was	O
present	B-T033
in	O
85	O
46%	O
patients	O
.	O
	
tacrolimus	B-T109
concentrations	B-T081
were	O
supra-therapeutic	O
in	O
135	O
of	O
186	O
patients	O
73%	O
.	O
	
aki	O
in	O
the	O
first	O
week	B-T079
after	O
transplantation	B-T061
was	O
related	O
to	O
supra-therapeutic	O
tacrolimus	B-T109
concentrations	B-T081
or	B-T081
1.55	O
95%	O
ci	B-T081
1.06	O
,	O
3	O
other	O
nephrotoxic	B-T061
drugs	I-T061
or	B-T081
1.96	O
95%	O
ci	B-T081
1.02	O
,	O
infection	O
or	B-T081
2.48	O
95%	O
ci	B-T081
1.31	O
,	O
and	O
cystic	B-T047
fibrosis	I-T047
or	B-T081
2.17	O
95%	O
ci	B-T081
1.16	O
.	O
	
recovery	B-T081
rate	I-T081
of	O
aki	O
was	O
lower	O
than	O
expected	O
19%	O
,	O
and	O
the	O
cumulative	O
incidence	B-T169
of	O
severe	O
ckd	B-T047
at	O
1	O
year	B-T079
was	O
15%	O
.	O
	
after	O
lung	B-T061
transplantation	I-T061
,	O
aki	O
is	O
common	O
and	O
often	O
evolves	O
into	O
severe	B-T080
ckd	B-T047
,	O
which	O
is	O
a	O
known	O
cause	O
of	O
morbidity	B-T081
and	O
mortality	B-T081
.	O
	
supra-therapeutic	O
whole-blood	O
tacrolimus	B-T109
trough	B-T081
concentrations	I-T081
are	O
related	O
to	O
the	O
early	O
onset	O
of	O
aki	O
.	O
	
conscientious	B-T033
targeting	B-T169
tacrolimus	B-T109
blood	B-T081
concentrations	I-T081
might	O
be	O
vital	B-T080
in	O
the	O
early	O
phase	O
after	O
lung	B-T061
transplantation	I-T061
.	O
	
what	O
is	O
known	O
about	O
this	O
subject	O
lung	O
transplant	O
recipients	O
often	O
develop	O
acute	O
kidney	O
injury	O
evolving	O
into	O
chronic	B-T047
kidney	I-T047
disease	I-T047
increasing	O
both	O
morbidity	B-T081
and	O
mortality	B-T081
.	O
	
to	O
date	O
,	O
the	O
pathophysiology	B-T169
of	O
kidney	O
injury	O
after	O
lung	B-T061
transplantation	I-T061
has	O
not	O
been	O
fully	O
elucidated	O
.	O
	
the	O
immunosuppressant	O
tacrolimus	B-T109
is	O
difficult	O
to	O
dose	B-T081
,	O
especially	O
in	O
the	O
unstable	B-T033
clinical	B-T082
setting	I-T082
,	O
and	O
is	O
nephrotoxic	B-T080
.	O
	
for	O
the	O
first	O
time	O
,	O
supra-therapeutic	O
whole-blood	O
tacrolimus	B-T109
trough	B-T081
concentrations	I-T081
are	O
related	O
to	O
the	O
emergence	O
of	O
acute	O
kidney	O
injury	O
in	O
the	O
first	O
days	B-T079
after	O
lung	B-T061
transplantation	I-T061
.	O
	
supra-therapeutic	O
whole-blood	O
tacrolimus	B-T109
trough	B-T081
concentrations	I-T081
often	O
occur	O
early	O
after	O
lung	B-T061
transplantation	I-T061
.	O
	
aki	O
after	O
lung	B-T061
transplantation	I-T061
shows	O
low	B-T080
recovery	O
rates	B-T081
.	O
	
zebrafish	O
akt2	O
is	O
essential	B-T080
for	O
survival	B-T052
,	O
growth	O
,	O
bone	O
development	O
,	O
and	O
glucose	O
homeostasis	O
as	O
one	O
of	O
three	O
akt	B-T116
isoforms	B-T116
,	O
akt2	B-T116
plays	O
a	O
key	O
role	O
in	O
the	O
regulation	O
of	O
widely	O
divergent	O
cellular	O
processes	O
in	O
mammals	O
.	O
	
however	O
,	O
its	O
role	O
and	O
underlying	O
mechanisms	B-T169
in	O
zebrafish	O
remain	O
largely	O
unknown	B-T080
.	O
	
to	O
elucidate	O
the	O
function	B-T169
of	O
akt2	O
in	O
zebrafish	O
,	O
we	O
generated	B-T080
zebrafish	O
lacking	B-T080
akt2	O
gene	O
via	O
crispr/cas9	O
technology	O
.	O
	
akt2	O
-	O
null	B-T081
zebrafish	O
exhibit	O
partial	O
lethality	B-T033
and	O
severe	B-T080
growth	O
deficiency	B-T169
,	O
which	O
is	O
different	O
from	O
those	O
observed	O
in	O
akt2	O
-	O
null	B-T081
mice	O
.	O
	
furthermore	O
,	O
akt2	O
-	O
null	B-T081
zebrafish	O
display	B-T169
deficiency	B-T169
in	O
fin	O
ray	O
development	O
,	O
but	O
their	O
cartilage	O
is	O
not	O
affected	O
.	O
	
similar	O
to	O
observations	B-T062
in	O
akt2	O
-	O
null	B-T081
mice	O
,	O
akt2	O
-	O
null	B-T081
zebrafish	O
display	B-T169
impaired	B-T169
glucose	O
homeostasis	O
.	O
	
however	O
,	O
in	O
contrast	O
to	O
that	O
in	O
akt2	O
-	O
null	B-T081
mice	O
,	O
insulin	O
level	O
is	O
lower	B-T080
in	O
akt2	O
-	O
null	B-T081
zebrafish	O
,	O
implicating	O
the	O
symptoms	O
of	O
type	B-T047
i	I-T047
diabetes	I-T047
exhibited	O
in	O
akt2	O
-	O
null	B-T081
zebrafish	O
.	O
	
in	O
addition	O
,	O
transcriptome	O
analysis	O
reveals	B-T080
that	O
the	O
genes	O
involved	O
in	O
metabolism	O
and	O
osteogenesis	O
are	O
disturbed	O
in	O
akt2	O
-	O
null	B-T081
zebrafish	O
.	O
	
taken	O
together	O
,	O
these	O
data	B-T078
not	O
only	O
support	O
an	O
important	O
role	O
of	O
akt2	O
in	O
zebrafish	O
survival	B-T052
,	O
growth	O
,	O
bone	O
development	O
and	O
glucose	O
homeostasis	O
,	O
but	O
also	O
suggest	O
that	O
akt2	O
has	O
divergent	O
functions	B-T169
between	O
mice	O
and	O
zebrafish	O
,	O
even	O
though	O
they	O
are	O
evolutionarily	O
conserved	O
.	O
	
physiological	B-T169
properties	B-T080
and	O
behavioral	O
correlates	B-T080
of	O
hippocampal	O
granule	O
cells	O
and	O
mossy	O
cells	O
the	O
hippocampal	O
dentate	O
gyrus	O
is	O
often	O
viewed	O
as	O
a	O
segregator	B-T169
of	O
upstream	O
information	O
.	O
	
physiological	O
support	O
for	O
such	O
function	B-T169
has	O
been	O
hampered	O
by	O
a	O
lack	B-T080
of	O
well-defined	B-T080
characteristics	B-T080
that	O
can	O
identify	O
granule	O
cells	O
and	O
mossy	O
cells	O
.	O
	
we	O
developed	O
an	O
electrophysiology	O
-based	O
classification	O
of	O
dentate	O
granule	O
cells	O
and	O
mossy	O
cells	O
in	O
mice	O
that	O
we	O
validated	O
by	O
optogenetic	O
tagging	O
of	O
mossy	O
cells	O
.	O
	
granule	O
cells	O
exhibited	O
sparse	O
firing	O
,	O
had	O
a	O
single	B-T081
place	B-T082
field	I-T082
,	O
and	O
showed	O
only	O
modest	O
changes	B-T169
when	O
the	O
mouse	O
was	O
tested	B-T169
in	O
different	O
mazes	O
in	O
the	O
same	O
room	B-T082
.	O
	
in	O
contrast	O
,	O
mossy	O
cells	O
were	O
more	O
active	B-T169
,	O
had	O
multiple	B-T081
place	B-T082
fields	I-T082
and	O
showed	O
stronger	O
remapping	O
of	O
place	B-T082
fields	I-T082
under	O
the	O
same	O
conditions	B-T080
.	O
	
although	O
the	O
granule	O
cell	O
-	O
mossy	O
cell	O
synapse	O
was	O
strong	O
and	O
facilitating	O
,	O
mossy	O
cells	O
rarely	O
"""inherited"""	O
place	B-T082
fields	I-T082
from	O
single	B-T081
granule	O
cells	O
.	O
	
our	O
findings	B-T169
suggest	O
that	O
the	O
granule	O
cells	O
and	O
mossy	O
cells	O
could	O
be	O
modulated	B-T082
separately	O
and	O
their	O
joint	O
action	B-T052
may	O
be	O
critical	O
for	O
pattern	B-T169
separation	I-T169
.	O
	
a	O
primer	O
on	O
intraosseous	B-T169
access	I-T169
history	B-T033
,	O
clinical	B-T033
considerations	I-T033
,	O
and	O
current	O
devices	O
intraosseous	B-T169
io	I-T169
access	I-T169
is	O
a	O
method	B-T170
recommended	O
by	O
the	O
american	O
heart	O
association	O
and	O
the	O
european	O
resuscitation	O
council	O
to	O
administer	B-T169
resuscitative	O
drugs	O
and	O
fluids	O
when	O
intravenous	B-T082
iv	I-T082
access	I-T082
cannot	O
be	O
rapidly	O
or	O
easily	O
obtained	O
.	O
	
many	O
clinicians	O
have	O
limited	B-T170
knowledge	I-T170
or	O
experience	O
with	O
the	O
io	B-T169
route	I-T169
.	O
	
the	O
purpose	O
of	O
this	O
review	B-T170
was	O
to	O
provide	O
the	O
reader	O
with	O
a	O
succinct	B-T170
review	I-T170
of	O
the	O
history	B-T033
,	O
clinical	B-T033
considerations	I-T033
,	O
and	O
devices	O
associated	B-T080
with	I-T080
io	B-T169
access	I-T169
.	O
	
narrative	O
review	O
.	O
	
university-based	O
academic	O
research	O
cell	O
.	O
	
not	O
applicable	O
.	O
	
not	O
applicable	O
.	O
	
io	B-T169
access	I-T169
is	O
a	O
lifesaving	O
bridge	O
to	O
definitive	O
vascular	O
access	O
that	O
may	O
be	O
considered	O
when	O
an	O
iv	O
cannot	O
be	O
rapidly	O
attained	O
and	O
the	O
patient's	O
outcome	O
may	O
be	O
negatively	O
affected	O
without	O
prompt	O
circulatory	O
access	O
.	O
	
the	O
io	B-T169
route	O
has	O
few	O
contraindications	O
for	O
use	O
and	O
a	O
low	O
rate	O
of	O
serious	O
complications	O
.	O
	
multiple	O
manual	O
and	O
powered	O
devices	O
that	O
may	O
be	O
placed	O
in	O
several	O
anatomic	O
sites	O
are	O
commercially	O
available	O
.	O
	
all	O
clinicians	O
who	O
provide	O
acute	O
care	O
or	O
respond	O
to	O
cardiovascular	O
emergencies	O
should	O
obtain	O
training	O
and	O
maintain	O
proficiency	O
in	O
placing	O
and	O
using	O
io	O
devices	O
as	O
the	O
io	O
route	O
is	O
recommended	O
by	O
the	O
major	O
resuscitation	O
organizations	O
as	O
the	O
preferred	O
route	O
of	O
infusion	O
when	O
rapid	O
,	O
reliable	O
iv	O
access	I-T169
is	O
c-5a-substituted	B-T109
validamine	I-T109
type	I-T109
glycosidase	B-T116
inhibitors	I-T116
a	O
series	O
of	O
n-alkyl	O
derivatives	O
of	O
the	O
d-galactosidase	B-T116
inhibitor	O
1	O
featuring	O
lipophilic	B-T081
substituents	O
at	O
position	O
c-5a	O
was	O
prepared	O
and	O
screened	O
for	O
their	O
glycosidase	B-T116
inhibitory	O
properties	O
.	O
	
products	O
turned	O
out	O
selective	O
for	O
β-galactosidases	B-T116
as	O
well	O
as	O
exposure	B-T033
to	I-T033
suicidal	I-T033
behaviors	I-T033
a	O
common	O
suicide	B-T033
risk	B-T033
factor	I-T033
or	O
a	O
personal	O
negative	B-T033
life	I-T033
event	I-T033
numerous	B-T081
suicide	B-T033
risk	B-T033
factors	I-T033
have	O
been	O
proposed	O
but	O
not	O
adequately	O
validated	B-T080
for	I-T080
epidemiology	I-T080
,	O
treatment	B-T061
and	O
prevention	B-T080
efforts	I-T080
.	O
	
exposures	B-T033
to	I-T033
suicidal	I-T033
behaviors	I-T033
esb	B-T033
,	O
from	O
family	O
and	O
friend	B-T098
suicide	B-T033
attempts	I-T033
and	O
completions	B-T033
,	O
were	O
tested	O
for	O
validity	B-T080
as	O
a	O
suicidal	B-T033
risk	B-T033
factor	I-T033
and	O
also	O
for	O
measurement	B-T169
and	O
construct	O
adequacy	B-T080
.	O
	
an	O
anonymous	B-T080
online	O
survey	B-T170
yielded	O
713	O
participants	B-T098
aged	O
18-71	O
,	O
who	O
reported	O
esb	B-T033
,	O
completed	O
the	O
suicidal	B-T170
affect-behavior-cognition	I-T170
scale	I-T170
sabcs	B-T170
,	O
and	O
comprised	O
a	O
broad	O
spectrum	O
on	O
those	O
variables	B-T080
.	O
	
tests	B-T170
of	O
dimensionality	B-T082
and	O
internal	B-T081
consistency	I-T081
showed	O
the	O
four	O
esb	B-T033
variables	B-T080
attempts	B-T033
/	O
completions	B-T033
through	O
family	O
/	O
friends	B-T098
were	O
independent	B-T169
and	O
did	O
not	O
form	O
a	O
common	O
factor	O
or	O
an	O
identifiable	O
esb	B-T033
latent	B-T080
trait	O
.	O
	
esb	B-T033
variables	B-T080
were	O
,	O
however	O
,	O
associated	O
with	O
demographic	B-T033
and	O
psychiatric	B-T033
histories	I-T033
.	O
	
a	O
battery	O
of	O
tests	B-T170
revealed	O
no	O
meaningful	O
associations	B-T080
between	O
esb	B-T033
and	O
total	O
suicidality	O
or	O
suicide	B-T033
risk	B-T033
factors	I-T033
social	O
support	O
,	O
depression	O
,	O
anxiety	B-T033
,	O
stress	B-T033
,	O
satisfaction	B-T080
with	I-T080
life	I-T080
and	O
emotional	O
stability	O
.	O
	
in	O
addition	O
,	O
in	O
contrast	O
to	O
previous	O
reports	B-T170
,	O
young	O
adults	O
n	O
=	O
200	O
aged	O
18-20	O
showed	O
no	O
increased	B-T081
suicidality	O
due	O
to	O
esb	B-T033
.	O
	
results	B-T169
showed	O
no	O
validity	B-T080
for	O
esb	B-T033
as	O
a	O
common	O
risk	B-T033
factor	I-T033
for	O
suicidality	O
or	O
other	O
psychopathology	O
,	O
or	O
as	O
a	O
latent	B-T080
trait	O
.	O
	
esb	B-T033
showed	O
evidence	B-T078
as	O
a	O
personal	O
negative	B-T033
life	I-T033
event	I-T033
with	O
individual	B-T098
effects	B-T080
and	O
direct	B-T082
anterior	I-T082
approach	I-T082
for	O
total	B-T061
hip	I-T061
arthroplasty	I-T061
with	O
a	O
novel	O
mobile	O
traction	O
table	O
-a	O
prospective	B-T062
cohort	I-T062
study	I-T062
the	O
purpose	O
of	O
this	O
prospective	B-T062
cohort	I-T062
study	I-T062
was	O
to	O
clarify	O
the	O
safety	O
and	O
efficacy	O
of	O
total	B-T061
hip	I-T061
arthroplasty	I-T061
via	O
the	O
direct	B-T082
anterior	I-T082
approach	I-T082
in	O
the	O
supine	B-T082
position	I-T082
with	O
a	O
novel	O
mobile	O
traction	O
table	O
.	O
	
the	O
first	O
experience	O
of	O
consecutive	B-T061
surgeries	I-T061
by	O
a	O
single	O
surgeon	O
using	O
the	O
direct	B-T082
anterior	I-T082
approach	I-T082
with	O
a	O
traction	O
table	O
is	O
described	O
with	O
a	O
two-year	O
follow-up	O
period	O
.	O
	
of	O
121	O
patients	O
,	O
100	O
patients	O
without	O
previous	B-T033
hip	I-T033
surgeries	I-T033
,	O
severe	O
deformity	O
,	O
or	O
cemented	B-T061
implants	I-T061
were	O
divided	O
into	O
two	O
groups	B-T078
comprising	O
the	O
first	O
50	O
patients	O
and	O
the	O
second	O
50	O
patients	O
.	O
	
the	O
implant	B-T081
survival	I-T081
rate	I-T081
was	O
99%	O
at	O
the	O
two-year	O
follow-up	O
.	O
	
revision	B-T061
surgery	I-T061
was	O
required	O
for	O
periprosthetic	O
femoral	O
fracture	O
in	O
one	O
patient	O
.	O
	
the	O
complication	O
rate	B-T081
possibly	O
related	O
to	O
the	O
traction	O
table	O
was	O
5%	O
5	O
patients	O
three	O
anterior	O
dislocations	O
,	O
one	O
periprosthetic	O
femoral	O
fracture	O
,	O
and	O
one	O
intraoperative	O
perforation	O
caused	O
by	O
femoral	O
rasping	O
.	O
	
the	O
complication	O
rate	B-T081
tended	O
to	O
decrease	B-T081
in	O
the	O
second	O
group	B-T078
compared	O
to	O
the	O
first	O
group	O
4%	O
versus	O
6%	O
.	O
	
mean	B-T079
surgical	I-T079
time	I-T079
72.0	O
minutes	O
versus	O
82.5	O
min	O
,	O
p	O
=	O
0.027	O
,	O
rate	B-T081
of	O
allogeneic	B-T061
blood	I-T061
transfusion	I-T061
2%	O
versus	O
24%	O
,	O
p	O
=	O
0.001	O
,	O
and	O
cup	B-T033
alignment	I-T033
in	O
the	O
safe	B-T082
zone	I-T082
100%	O
versus	O
88%	O
,	O
p	O
=	O
0.027	O
were	O
significantly	O
improved	O
in	O
the	O
second	O
group	B-T078
compared	O
to	O
the	O
first	O
group	B-T078
.	O
	
the	O
direct	B-T082
anterior	I-T082
approach	I-T082
with	O
a	O
novel	O
mobile	O
traction	O
table	O
showed	O
a	O
positive	B-T033
learning	I-T033
curve	I-T033
for	O
surgical	B-T079
time	I-T079
,	O
rate	B-T081
of	O
allogeneic	B-T061
blood	I-T061
transfusion	I-T061
,	O
and	O
cup	B-T033
alignment	I-T033
in	O
the	O
safe	B-T082
zone	I-T082
.	O
	
the	O
binding	O
orientations	B-T082
of	O
structurally	B-T082
-related	O
ligands	O
can	O
differ	B-T080
a	O
cautionary	O
note	O
crystal	O
structures	O
can	O
identify	O
ligand-receptor	O
interactions	O
and	O
assist	O
the	O
development	O
of	O
novel	O
therapeutics	B-T061
,	O
but	O
experimental	B-T080
challenges	O
sometimes	O
necessitate	O
the	O
use	O
of	O
homologous	B-T116
proteins	I-T116
.	O
	
tropisetron	B-T109
is	O
an	O
orthosteric	O
ligand	O
at	O
both	O
5-ht3	B-T116
and	O
α7	B-T116
nach	I-T116
receptors	I-T116
and	O
its	O
binding	O
orientation	B-T082
has	O
been	O
determined	O
in	O
the	O
structural	O
homologue	O
achbp	B-T116
pdbid	O
2wnc	O
.	O
	
co-crystallisation	O
with	O
a	O
structurally	B-T082
-related	O
ligand	O
,	O
granisetron	B-T109
,	O
reveals	O
an	O
almost	O
identical	B-T080
orientation	B-T082
pdbid	O
2yme	O
.	O
	
however	O
,	O
there	O
is	O
a	O
>1000-fold	O
difference	B-T080
in	O
the	O
affinity	O
of	O
tropisetron	B-T109
at	O
5-ht3	B-T116
versus	O
α7	B-T116
nach	I-T116
receptors	I-T116
,	O
and	O
α7	B-T116
nach	I-T116
receptors	I-T116
do	O
not	B-T169
bind	O
granisetron	B-T109
.	O
	
these	O
striking	O
pharmacological	B-T169
differences	B-T080
prompt	O
questions	O
about	O
which	O
receptor	B-T116
the	O
crystal	O
structures	O
most	O
closely	O
represent	O
and	O
whether	O
the	O
ligand	O
orientations	B-T082
are	O
correct	O
.	O
	
here	O
we	O
probe	O
the	O
binding	O
orientation	B-T082
of	O
tropisetron	B-T109
and	O
granisetron	B-T109
at	O
5-ht3	B-T116
receptors	I-T116
by	O
in	O
silico	O
modelling	O
and	O
docking	O
,	O
radioligand	O
binding	O
on	O
cysteine	B-T116
-	O
substituted	O
5-ht3	B-T116
receptor	I-T116
mutants	O
transiently	O
expressed	O
in	O
hek	O
293	O
cells	O
,	O
and	O
synthetic	O
modification	O
of	O
the	O
ligands	O
.	O
	
for	O
15	O
of	O
the	O
23	O
cysteine	B-T116
substitutions	O
,	O
the	O
effects	B-T080
on	O
tropisetron	B-T109
and	O
granisetron	B-T109
were	O
different	O
.	O
	
structure-activity	B-T080
relationships	I-T080
on	O
synthesised	O
derivatives	O
of	O
both	O
ligands	O
were	O
also	O
consistent	O
with	O
different	O
orientations	B-T082
,	O
revealing	B-T080
that	O
contrary	O
to	O
the	O
crystallographic	O
evidence	B-T078
from	O
achbp	B-T116
,	O
the	O
two	O
ligands	O
adopt	O
different	B-T080
orientations	B-T082
in	O
the	O
5-ht3	B-T116
receptor	I-T116
binding	O
site	O
.	O
	
our	O
results	O
show	O
that	O
even	O
quite	O
structurally	B-T082
similar	O
molecules	O
can	O
adopt	O
different	O
orientations	B-T082
in	O
the	O
same	O
binding	O
site	O
,	O
and	O
that	O
caution	O
may	O
be	O
needed	O
when	O
using	O
homologous	B-T116
proteins	I-T116
to	O
predict	O
ligand	O
binding	O
.	O
	
pancreatic	O
neuroendocrine	O
cancer	O
with	O
liver	O
metastases	O
and	O
multiple	O
peritoneal	O
metastases	O
report	O
of	O
one	O
case	O
pancreatic	O
neuroendocrine	O
tumor	O
pnet	O
is	O
a	O
rare	O
pancreatic	O
tumor	O
,	O
with	O
its	O
incidence	O
showing	O
a	O
rising	O
trend	O
in	O
recent	O
years	O
.	O
	
most	O
of	O
its	O
distant	O
metastases	O
are	O
found	B-T033
in	O
the	O
liver	O
.	O
	
this	O
article	O
describes	O
a	O
59-year-old	O
male	O
patient	O
with	O
pnet	O
with	O
liver	O
metastasis	O
and	O
multiple	O
abdominal	O
metastases	O
,	O
focusing	O
on	O
the	O
management	O
of	O
this	O
tumor	O
in	O
its	O
advanced	B-T079
stage	I-T079
.	O
	
lignans	B-T109
from	O
the	O
fruits	O
of	O
schisandra	O
chinensis	O
turcz	O
baill	O
inhibit	B-T052
proprotein	O
convertase	O
subtilisin/kexin	O
type	O
9	O
expression	O
bioactivity-guided	O
fractionation	O
of	O
the	O
fruits	O
of	O
schisandra	O
chinensis	O
,	O
using	O
the	O
proprotein	O
convertase	O
subtilisin-kexin	O
type	O
9	O
pcsk9	O
mrna	O
expression	O
screening	O
assay	O
,	O
led	O
to	O
isolation	B-T169
of	O
two	B-T081
previously	B-T080
unknown	I-T080
lignans	B-T109
,	O
14-tigloylschinlignan	B-T109
d	I-T109
and	O
rel-	B-T109
,	O
8r	I-T109
,	O
7'r	I-T109
,	O
8'r	I-T109
e	I-T109
,	O
along	O
with	O
28	O
known	O
compounds	O
.	O
	
all	O
structures	B-T170
were	O
established	B-T080
by	O
nmr	O
spectroscopic	O
data	B-T078
as	O
well	O
as	O
cd	O
and	O
ms	O
analysis	B-T062
.	O
	
all	O
isolates	O
were	O
tested	B-T169
for	O
their	O
inhibitory	B-T052
activities	B-T052
on	O
the	O
mrna	O
expression	O
of	O
pcsk9	O
.	O
	
of	O
the	O
tested	B-T169
compounds	O
,	O
four	B-T081
of	O
the	O
compounds	O
rel-	B-T109
,	O
8r	I-T109
,	O
7'r	I-T109
,	O
8'r	I-T109
e	I-T109
,	O
-	B-T109
c	I-T109
,	O
schinlignan	B-T109
d	I-T109
,	O
and	O
+	B-T109
b	I-T109
potently	O
inhibited	B-T080
pcsk9	O
mrna	O
expression	O
with	O
ic50	B-T081
values	O
of	O
3.15	O
,	O
3.85	O
,	O
0.36	O
,	O
and	O
1.10	O
μm	O
,	O
respectively	O
.	O
	
furthermore	O
,	O
schinlignan	O
d	O
and	O
+	B-T109
b	I-T109
were	O
found	O
to	O
suppress	B-T169
pcsk9	B-T116
protein	O
expressions	O
and	O
schinlignan	B-T109
d	I-T109
deemed	O
to	O
increase	O
low	B-T116
density	I-T116
lipoprotein	I-T116
receptor	I-T116
expression	O
.	O
	
a	O
comparison	O
of	O
outcomes	B-T080
in	O
morbidly	B-T047
obese	I-T047
,	O
obese	B-T047
and	O
non-obese	O
patients	O
undergoing	O
primary	B-T061
total	I-T061
knee	I-T061
and	O
total	B-T061
hip	I-T061
arthroplasty	I-T061
obesity	B-T047
is	O
a	O
growing	O
public	O
health	B-T033
issue	I-T033
with	O
the	O
prevalence	B-T081
of	O
morbid	B-T033
obesity	I-T033
,	O
body	I-T033
mass	I-T033
index	I-T033
bmi	I-T033
40	I-T033
kg/m	I-T033
increasing	B-T169
.	O
	
there	O
is	O
some	O
evidence	B-T078
these	O
patients	O
have	O
more	O
peri-	B-T047
and	I-T047
post-operative	I-T047
complications	I-T047
and	O
poorer	B-T080
outcomes	I-T080
when	O
undergoing	O
arthroplasty	B-T061
procedures	I-T061
.	O
	
this	O
audit	O
aimed	O
to	O
determine	O
and	O
compare	O
the	O
outcomes	B-T080
of	O
non-obese	O
,	O
obese	B-T047
and	O
morbidly	B-T047
obese	I-T047
patients	O
undergoing	O
arthroplasty	B-T061
at	O
our	O
institution	O
.	O
	
this	O
was	O
a	O
retrospective	O
audit	O
of	O
patients	O
from	O
our	O
institution	O
who	O
had	O
undergone	O
total	B-T061
knee	I-T061
tka	B-T061
or	O
total	B-T061
hip	I-T061
arthroplasty	I-T061
tha	B-T061
in	O
2009	O
.	O
	
data	B-T078
collected	B-T078
were	O
age	O
,	O
gender	O
,	O
bmi	O
,	O
length	B-T079
of	I-T079
stay	I-T079
los	B-T079
,	O
oxford	O
knee	O
or	O
hip	O
score	O
oks	O
/	O
ohs	O
,	O
satisfaction	B-T033
and	O
complications	O
up	O
to	O
two	O
years	B-T079
post	B-T061
operation	I-T061
.	O
	
patients	O
were	O
divided	O
into	O
three	O
groups	B-T078
bmi	B-T033
<	I-T033
30	I-T033
,	O
bmi	O
30-40	O
and	O
bmi	B-T033
>	I-T033
40	I-T033
.	O
	
outcomes	B-T080
for	O
each	O
bmi	O
group	B-T078
were	O
compared	O
.	O
	
1014	O
tka	B-T061
and	O
906	O
tha	B-T061
operations	B-T061
were	O
included	O
.	O
	
when	O
compared	O
to	O
obese	B-T047
and	O
non-obese	O
patients	O
,	O
morbidly	B-T047
obese	I-T047
patients	O
undergoing	O
tka	B-T061
had	O
a	O
mean	O
los	B-T079
one	O
day	B-T079
longer	O
,	O
a	O
mean	O
oks	O
four	O
points	O
lower	O
and	O
higher	O
rates	O
of	O
postoperative	O
problems	O
,	O
37%	O
vs	O
.	O
	
21%	O
.	O
	
for	O
tha	B-T061
patients	O
there	O
was	O
no	B-T033
difference	I-T033
in	O
los	B-T079
,	O
ohs	O
score	O
was	O
two	O
points	O
lower	O
for	O
each	O
increasing	B-T169
bmi	O
category	B-T170
and	O
postoperative	O
problems	O
increase	B-T169
from	O
25%	O
for	O
non-obese	O
to	O
31%	O
for	O
obese	B-T047
and	O
38%	O
for	O
morbidly	B-T047
obese	I-T047
patients	O
.	O
	
these	O
results	O
will	O
be	O
useful	O
in	O
informing	O
obese	B-T047
patients	O
of	O
their	O
potential	O
outcomes	B-T080
following	O
tka	B-T061
or	O
tha	B-T061
.	O
	
these	O
patients	O
can	O
then	O
make	O
a	O
more	O
informed	O
choice	O
before	O
proceeding	O
with	O
vitamin	O
d	O
receptor	O
activator	O
use	O
and	O
cause-specific	B-T081
death	I-T081
among	O
dialysis	B-T061
patients	O
a	O
nationwide	B-T081
cohort	I-T081
study	I-T081
using	O
coarsened	B-T081
exact	I-T081
matching	I-T081
vitamin	O
d	O
receptor	O
activators	O
vdra	O
may	O
exert	O
pleiotropic	O
effects	O
on	O
cardiovascular	B-T047
disease	I-T047
,	O
malignancy	O
,	O
and	O
infections	O
among	O
dialysis	B-T061
patients	O
,	O
but	O
recent	O
studies	O
have	O
mainly	O
focused	O
on	O
cardiovascular	B-T033
outcomes	I-T033
.	O
	
among	O
8	O
patients	O
who	O
started	O
dialysis	B-T061
in	O
2007	O
and	O
who	B-T081
survived	I-T081
until	O
january	O
1	O
,	O
2010	O
,	O
listed	O
in	O
the	O
renal	B-T062
data	I-T062
registry	I-T062
of	O
the	O
japanese	O
society	O
for	O
dialysis	B-T061
therapy	I-T061
,	O
5	O
vdra	O
users	O
were	O
matched	O
to	O
3	O
non-users	O
based	O
on	O
clinically	B-T079
relevant	I-T079
variables	I-T079
at	O
the	O
end	O
of	O
2009	O
using	O
the	O
coarsened	B-T081
exact	I-T081
matching	I-T081
procedure	I-T081
.	O
	
until	O
december	O
31	O
,	O
2011	O
,	O
a	O
total	O
of	O
1	O
deaths	B-T081
occurred	O
,	O
of	O
which	O
468	O
42%	O
were	O
cardiovascular	O
deaths	O
,	O
229	O
20%	O
were	O
infection-related	B-T033
deaths	I-T033
,	O
and	O
141	O
12%	O
were	O
malignancy-related	B-T081
deaths	I-T081
.	O
	
multivariable	B-T062
survival	I-T062
analyses	I-T062
accounting	O
for	O
intra-region	B-T080
correlation	I-T080
revealed	O
that	O
vdra	O
use	O
was	O
significantly	O
associated	O
with	O
lower	B-T081
rates	I-T081
of	O
infection	O
-	O
and	O
malignancy	O
-related	O
deaths	B-T081
subhazard	B-T081
ratio	I-T081
0.62	O
95%	O
ci	B-T081
,	O
0.52	O
and	O
0.70	O
95%	O
ci	B-T081
,	O
0.50	O
,	O
respectively	O
but	O
not	O
with	O
cardiovascular	O
death	O
subhazard	B-T081
ratio	I-T081
0.86	O
95%	O
ci	B-T081
,	O
0.72	O
.	O
	
future	O
randomized	B-T062
clinical	I-T062
trials	I-T062
with	O
a	O
sufficient	O
sample	B-T081
size	I-T081
and	O
an	O
adequate	O
follow-up	O
period	O
are	O
warranted	O
to	O
test	O
the	O
clinical	B-T080
effectiveness	I-T080
of	O
vdra	O
on	O
infection	O
and	O
malignancy	O
,	O
rather	O
than	O
cardiovascular	B-T047
disease	I-T047
,	O
among	O
dialysis	B-T061
patients	O
.	O
	
burden	B-T078
of	O
cervical	O
cancer	O
and	O
role	O
of	O
screening	O
in	O
india	O
cervical	O
cancer	O
is	O
a	O
major	O
cause	O
of	O
cancer	B-T081
mortality	I-T081
in	O
women	B-T098
and	O
more	O
than	O
a	O
quarter	B-T081
of	O
its	O
global	B-T080
burden	B-T078
is	O
contributed	B-T052
by	O
developing	B-T080
countries	I-T080
.	O
	
in	O
india	O
,	O
in	O
spite	O
of	O
alarmingly	O
high	O
figures	O
,	O
there	O
is	O
no	O
nationwide	O
government-sponsored	O
screening	O
program	O
.	O
	
this	O
study	B-T062
was	O
conducted	B-T169
to	O
assess	B-T052
the	O
burden	B-T078
of	O
cervical	O
cancer	O
in	O
india	O
and	O
review	B-T169
the	O
performance	B-T052
characteristics	B-T080
of	O
available	O
cervical	O
cancer	O
screening	O
tools	O
,	O
so	O
as	O
to	O
provide	B-T052
evidence	B-T078
-based	O
recommendations	B-T078
for	O
application	O
of	O
most	O
practically	O
suited	O
screening	O
test	O
to	O
be	O
used	O
in	O
resource	B-T078
-poor	O
field	O
settings	O
.	O
	
medline	B-T170
and	O
web	B-T170
of	I-T170
science	I-T170
electronic	I-T170
database	I-T170
were	O
searched	B-T052
from	O
january	B-T080
1990	O
to	O
december	B-T080
2015	O
,	O
using	O
the	O
keywords	B-T170
such	O
as	O
""""	O
cervical	O
cancer	O
""""	O
,	O
""""	O
screening	O
""""	O
,	O
""""	O
early	O
detection	O
""""	O
,	O
""""	O
cervical	O
cytology	O
""""	O
and	O
""""	O
visual	O
inspection	O
""""	O
,	O
and	O
their	O
corresponding	O
mesh	B-T170
terms	I-T170
in	O
combination	B-T080
with	O
boolean	B-T169
operators	I-T169
"""or"	O
,	O
and	O
two	O
authors	O
independently	O
selected	B-T052
studies	B-T062
that	O
are	O
published	B-T170
in	O
english	O
and	O
conducted	B-T169
in	O
india	O
.	O
	
a	O
total	B-T080
of	O
11	O
studies	B-T062
were	O
found	B-T033
to	O
be	O
relevant	B-T080
and	O
eligible	B-T080
to	O
be	O
included	B-T169
in	O
the	O
present	B-T033
study	B-T062
.	O
	
in	O
india	O
,	O
cervical	O
cancer	O
contributes	B-T052
to	O
approximately	B-T080
6-29%	O
of	O
all	O
cancers	O
in	O
women	B-T098
.	O
	
the	O
age-adjusted	B-T081
incidence	I-T081
rate	I-T081
of	O
cervical	O
cancer	O
varies	O
widely	O
among	O
registries	B-T170
highest	B-T080
is	O
23.07	O
in	O
mizoram	O
state	O
and	O
the	O
lowest	B-T080
is	O
4.91	O
in	O
dibrugarh	O
district	O
.	O
	
the	O
pooled	O
estimates	B-T081
of	O
sensitivity	B-T081
and	O
specificity	B-T081
of	O
visual	O
inspection	O
with	O
acetic	O
acid	O
via	O
,	O
magnified	O
via	O
,	O
visual	O
inspection	O
with	O
lugol's	O
iodine	O
vili	O
,	O
cytology	O
pap	O
smear	O
,	O
and	O
human	O
papillomavirus	O
dna	O
were	O
found	O
to	O
be	O
67.65	O
and	O
84.32	O
,	O
65.36	O
and	O
85.76	O
,	O
78.27	O
and	O
87.10	O
,	O
62.11	O
and	O
93.51	O
,	O
and	O
77.81	O
and	O
91.54	O
,	O
respectively	O
.	O
	
in	O
developing	B-T080
countries	I-T080
because	O
of	O
lack	B-T080
of	O
necessary	O
infrastructure	O
and	O
quality	B-T169
control	I-T169
,	O
high-quality	B-T080
cytology	O
screening	O
may	O
not	O
be	O
feasible	O
for	O
wide-scale	O
implementation	B-T052
.	O
	
hence	O
,	O
cervical	O
cancer	O
screening	O
program	B-T169
based	O
on	O
visual	O
screening	O
test	O
such	O
as	O
via	O
/	O
vili	O
should	O
be	O
adopted	O
as	O
an	O
integral	O
part	O
of	O
primary	O
health-care	O
setup	O
in	O
resource	B-T078
-	O
poor	B-T080
countries	O
like	O
structural	B-T052
and	I-T052
tribometric	I-T052
characterization	I-T052
of	O
biomimetically	O
inspired	O
synthetic	O
""""	O
insect	O
adhesives	O
""""	O
background	O
based	O
on	O
previous	O
chemical	O
analyses	O
of	O
insect	O
tarsal	O
adhesives	O
,	O
we	O
prepared	O
12	O
heterogeneous	B-T080
synthetic	B-T052
emulsions	O
mimicking	O
the	O
polar/non-polar	B-T033
principle	I-T033
,	O
analysed	O
their	O
microscopical	B-T082
structure	I-T082
and	O
tested	O
their	O
adhesive	B-T080
,	O
frictional	B-T080
,	O
and	O
rheological	B-T080
properties	I-T080
.	O
	
results	O
the	O
prepared	B-T033
emulsions	O
varied	O
in	O
their	O
consistency	B-T080
from	O
solid	B-T080
rubber-like	B-T109
,	O
over	O
soft	B-T080
elastic	O
,	O
to	O
fluid	O
watery	B-T080
or	O
oily	B-T080
.	O
	
with	O
droplet	B-T082
sizes	I-T082
>100	O
nm	O
,	O
all	O
the	O
emulsions	O
belonged	O
to	O
the	O
common	O
type	O
of	O
macroemulsions	O
.	O
	
the	O
emulsions	O
of	O
the	O
first	B-T079
generation	I-T079
generally	O
showed	O
broader	O
droplet-size	B-T082
ranges	O
compared	O
with	O
the	O
second	B-T079
generation	I-T079
,	O
especially	O
when	O
less	O
defined	O
components	B-T078
such	O
as	O
petrolatum	B-T109
or	O
waxes	O
were	O
present	O
in	O
the	O
lipophilic	B-T081
fraction	B-T081
of	O
the	O
first	B-T079
generation	I-T079
of	O
emulsions	O
.	O
	
some	O
of	O
the	O
prepared	B-T033
emulsions	O
showed	O
a	O
yield	B-T033
point	I-T033
and	O
were	O
bingham	O
fluids	O
.	O
	
tribometric	O
adhesion	O
was	O
tested	O
via	O
probe	O
tack	O
tests	O
.	O
	
compared	O
with	O
the	O
""""	O
second	B-T079
generation	I-T079
""""	O
containing	O
less	O
viscous	B-T080
components	O
,	O
the	O
""""	O
first	B-T079
generation	I-T079
""""	O
emulsions	O
were	O
much	O
more	B-T033
adhesive	I-T033
31-93	O
mn	O
,	O
a	O
finding	O
attributable	O
to	O
their	O
highly	O
viscous	B-T080
components	O
,	O
i.e	O
,	O
wax	O
,	O
petrolatum	B-T109
,	O
gelatin	B-T116
and	O
poly	B-T109
alcohol	I-T109
.	O
	
in	O
the	O
second	B-T079
generation	I-T079
emulsions	O
,	O
we	O
attained	O
much	O
lower	O
adhesivenesses	O
,	O
ranging	O
between	O
1-18	O
mn	O
.	O
	
the	O
adhesive	O
performance	B-T052
was	O
drastically	O
reduced	B-T080
in	O
the	O
emulsions	O
that	O
contained	O
albumin	B-T116
as	O
the	O
protein	B-T116
component	I-T116
or	O
that	O
lacked	O
protein	B-T116
.	O
	
tribometric	O
shear	O
tests	O
were	O
performed	O
at	O
moderate	O
normal	B-T080
loads	I-T080
.	O
	
our	O
measured	O
friction	O
forces	O
4-93	O
mn	O
in	O
the	O
first	O
and	O
0.1	O
mn	O
in	O
the	O
second	B-T079
generation	I-T079
emulsions	O
were	O
comparatively	O
low	O
.	O
	
differences	B-T081
in	O
shear	O
performance	B-T052
were	O
related	O
to	O
the	O
chemical	O
composition	O
and	O
emulsion	O
structure	B-T082
.	O
	
conclusion	O
by	O
varying	O
their	O
chemical	O
composition	O
,	O
synthetic	O
heterogeneous	B-T080
adhesive	O
emulsions	O
can	O
be	O
adjusted	O
to	O
have	O
diverse	O
consistencies	B-T080
and	O
are	O
able	O
to	O
mimic	O
certain	O
rheological	B-T080
and	O
tribological	B-T080
properties	I-T080
of	O
natural	B-T169
tarsal	O
insect	O
adhesives	O
.	O
	
opioids	B-T109
for	O
chronic	O
pain	O
the	O
cdc's	O
12	O
recommendations	B-T078
the	O
centers	O
for	O
disease	O
control	O
and	O
prevention	O
has	O
issued	O
12	O
recommendations	B-T078
to	O
help	O
clinicians	O
prescribe	O
an	O
optimal	B-T080
and	O
safe	O
course	O
of	O
treatment	B-T061
for	O
three-dimensional	B-T082
hycosy	O
with	O
perfluoropropane-albumin	B-T109
microspheres	I-T109
as	O
contrast	O
agents	O
and	O
normal	O
saline	O
injections	B-T061
into	O
the	O
pelvic	O
cavity	O
for	O
morphological	B-T080
assessment	O
of	O
the	O
fallopian	O
tube	O
in	O
infertile	O
women	B-T098
to	O
apply	O
the	O
three-dimensional	B-T082
3d	B-T082
hysterosalpingo-contrast	O
sonography	O
hycosy	O
with	O
perfluoropropane-albumin	B-T109
microspheres	I-T109
as	O
contrast	O
agents	O
and	O
normal	O
saline	O
injections	B-T061
into	O
the	O
pelvic	O
cavity	O
for	O
assessment	O
of	O
the	O
tubal	O
patency	O
and	O
adhesions	B-T047
of	I-T047
fimbrial	I-T047
parts	I-T047
.	O
	
fifty-five	O
infertile	O
female	O
patients	O
were	O
recruited	O
to	O
undergo	O
3d	B-T082
hycosy	O
with	O
normal	O
saline	O
injected	B-T061
into	O
the	O
pelvic	O
cavity	O
,	O
in	O
which	O
the	O
tubal	O
patency	O
was	O
observed	O
by	O
visualizing	O
the	O
spillage	O
of	O
contrast	O
agents	O
from	O
the	O
fimbriae	O
,	O
and	O
the	O
fimbrial	B-T047
adhesion	I-T047
was	O
confirmed	O
by	O
the	O
finger-like	B-T082
projections	I-T082
of	O
the	O
fimbriae	O
and	O
their	O
floating	B-T080
and	O
moving	B-T078
status	I-T078
.	O
	
of	O
the	O
55	O
patients	O
,	O
bilateral	B-T033
tubal	I-T033
patency	I-T033
was	O
observed	O
in	O
44	O
80.0	O
,	O
unilateral	B-T033
tubal	I-T033
patency	I-T033
and	O
the	O
other	O
partial	B-T047
occlusion	I-T047
in	O
7	O
12.7	O
,	O
unilateral	B-T082
partial	B-T047
occlusion	I-T047
and	O
the	O
other	O
complete	O
occlusion	O
in	O
3	O
5.4	O
,	O
and	O
bilateral	B-T082
complete	O
occlusion	O
in	O
1	O
1.8	O
.	O
	
the	O
fimbrial	O
parts	O
were	O
observed	O
in	O
105	O
fallopian	O
tubes	O
,	O
among	O
which	O
101	O
were	O
seen	O
with	O
the	O
finger-like	B-T082
fimbriae	O
floated	B-T080
and	O
moved	B-T078
in	O
the	O
pelvic	O
cavity	O
,	O
whereas	O
4	O
tubes	O
were	O
not	O
because	O
of	O
adhesion	B-T047
to	O
the	O
pelvic	O
cavity	O
n	O
=	O
3	O
or	O
the	O
ovary	O
and	O
intestine	O
n	O
=	O
1	O
.	O
	
more	O
than	O
three	O
visible	O
,	O
quite	O
long	O
,	O
and	O
distributed	O
evenly	O
finger-like	B-T082
projection	I-T082
s	O
were	O
present	O
for	O
the	O
patent	B-T082
fimbrial	O
parts	O
however	O
,	O
fewer	B-T081
,	O
flat	B-T082
,	O
and	O
not	O
evenly	O
distributed	O
finger-like	B-T082
projection	I-T082
s	O
were	O
present	O
for	O
the	O
adhesive	B-T047
tubes	I-T047
.	O
	
no	O
serious	O
complications	O
occurred	O
during	O
or	O
after	O
this	O
procedure	O
.	O
	
combination	B-T080
of	O
3d	B-T082
hycosy	O
with	O
normal	O
saline	O
injected	B-T061
into	O
the	O
pelvic	O
cavity	O
may	O
be	O
a	O
feasible	O
and	O
safe	O
procedure	O
to	O
assess	O
tubal	O
patency	O
and	O
adhesions	B-T047
of	I-T047
the	I-T047
fimbrial	I-T047
parts	I-T047
.	O
	
challenging	O
some	O
assumptions	O
about	O
empathy	O
in	O
new	O
zealand	O
little	O
nursing	O
or	O
medical	O
curricula	O
time	B-T079
,	O
if	O
any	O
,	O
is	O
specifically	O
devoted	O
to	O
the	O
enhancement	B-T052
of	O
empathy	O
.	O
	
if	O
being	O
empathic	B-T033
is	O
important	B-T080
in	O
the	O
context	O
of	O
patient	O
care	O
,	O
it	O
is	O
a	O
quality	O
that	O
is	O
already	O
present	O
in	O
students	B-T098
or	O
is	O
learned	O
by	O
students	B-T098
during	O
their	O
practicum	O
in	O
the	O
company	O
of	O
experienced	O
clinicians	O
.	O
	
this	O
study	B-T062
aimed	O
to	O
compare	B-T052
self-reported	B-T062
empathy	O
ratings	O
between	O
different	O
groups	B-T098
of	O
medical	O
students	O
and	O
one	O
cohort	B-T098
of	O
nursing	O
students	O
who	O
were	O
either	O
exposed	O
or	O
not	O
exposed	O
to	O
explicit	O
empathy	O
training	O
or	O
learning	O
in	O
clinical	B-T082
settings	I-T082
in	O
the	O
presence	O
of	O
patients	O
.	O
	
the	O
jefferson	B-T080
scale	I-T080
of	I-T080
physician	I-T080
empathy	I-T080
jspe	B-T080
was	O
completed	O
before	O
and	O
after	O
groups	O
of	O
medical	O
and	O
nursing	O
students	O
had	O
been	O
exposed	O
to	O
various	O
extended	B-T079
periods	B-T079
of	O
practicum	O
.	O
	
some	O
medical	O
student	O
cohorts	B-T098
undertook	O
brief	B-T079
empathy	O
training	O
,	O
whereas	O
others	O
had	O
no	O
exposure	O
.	O
	
the	O
nursing	O
student	O
cohort	O
had	O
no	O
formal	O
,	O
explicit	O
empathy	O
training	O
.	O
	
irrespective	O
of	O
profession	O
,	O
length	O
of	O
practicum	O
or	O
exposure	O
to	O
specific	O
empathy	O
training	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
the	O
self-reported	O
jspe	O
scores	O
across	O
the	O
seven	O
different	O
cohorts	O
of	O
students	O
.	O
	
empathy	O
is	O
a	O
quality	O
that	O
is	O
already	O
present	O
in	O
students	O
or	O
is	O
learned	O
by	O
students	O
during	O
their	O
practicum	O
discussion	O
if	O
empathy	O
is	O
caught	O
rather	O
than	O
taught	O
,	O
then	O
brief	O
efforts	O
to	O
enhance	O
empathy	O
may	O
be	O
futile	O
.	O
	
to	O
optimise	O
the	O
inherent	O
empathic	O
qualities	O
of	O
aspirant	O
health	O
professionals	O
,	O
explicit	O
consideration	O
should	O
be	O
given	O
to	O
how	O
empathy	O
is	O
influenced	O
by	O
the	O
practicum	O
experience	O
surface	B-T082
mediated	O
cooperative	O
interactions	O
of	O
drugs	O
enhance	B-T052
mechanical	O
forces	O
for	O
antibiotic	O
action	B-T052
the	O
alarming	B-T169
increase	I-T169
of	O
pathogenic	O
bacteria	O
that	O
are	O
resistant	O
to	O
multiple	O
antibiotics	O
is	O
now	O
recognized	O
as	O
a	O
major	B-T033
health	I-T033
issue	I-T033
fuelling	O
demand	B-T061
for	O
new	O
drugs	O
.	O
	
bacterial	O
resistance	O
is	O
often	O
caused	O
by	O
molecular	B-T033
changes	I-T033
at	O
the	O
bacterial	O
surface	O
,	O
which	O
alter	O
the	O
nature	O
of	O
specific	O
drug-target	O
interactions	O
.	O
	
here	O
,	O
we	O
identify	O
a	O
novel	O
mechanism	B-T169
by	O
which	O
drug-target	O
interactions	O
in	O
resistant	O
bacteria	O
can	O
be	O
enhanced	B-T052
.	O
	
we	O
examined	O
the	O
surface	B-T082
forces	O
generated	O
by	O
four	O
antibiotics	O
vancomycin	O
,	O
ristomycin	O
,	O
chloroeremomycin	O
and	O
oritavancin	O
against	O
drug-susceptible	O
and	O
drug-resistant	O
targets	O
on	O
a	O
cantilever	O
and	O
demonstrated	O
significant	O
differences	O
in	O
mechanical	O
response	O
when	O
drug-resistant	O
targets	O
are	O
challenged	O
with	O
different	O
antibiotics	O
although	O
no	O
significant	O
differences	O
were	O
observed	O
when	O
using	O
susceptible	O
targets	O
.	O
	
remarkably	O
,	O
the	O
binding	O
affinity	O
for	O
oritavancin	O
against	O
drug-resistant	O
targets	O
70	O
nm	O
was	O
found	O
to	O
be	O
11	O
times	O
stronger	O
than	O
for	O
vancomycin	O
800	O
μm	O
,	O
a	O
powerful	O
antibiotic	O
used	O
as	O
the	O
last	O
resort	O
treatment	O
for	O
streptococcal	O
and	O
staphylococcal	O
bacteria	O
including	O
methicillin-resistant	O
staphylococcus	O
aureus	O
mrsa	O
.	O
	
using	O
an	O
exactly	O
solvable	O
model	O
,	O
which	O
takes	O
into	O
account	O
the	O
solvent	O
and	O
membrane	O
effects	O
,	O
we	O
demonstrate	O
that	O
drug-target	O
interactions	O
are	O
strengthened	O
by	O
pronounced	O
polyvalent	O
interactions	O
catalyzed	O
by	O
the	O
surface	B-T082
itself	O
.	O
	
these	O
findings	O
further	O
enhance	O
our	O
understanding	O
of	O
antibiotic	O
mode	O
of	O
action	O
and	O
will	O
enable	O
development	O
of	O
more	O
effective	O
therapies	B-T061
intra-articular	B-T082
corticosteroids	O
versus	O
intra-articular	B-T082
corticosteroids	O
plus	B-T169
methotrexate	B-T109
in	O
oligoarticular	B-T047
juvenile	I-T047
idiopathic	I-T047
arthritis	I-T047
a	O
multicentre	B-T062
,	O
prospective	B-T062
,	O
randomised	B-T062
,	O
open-label	B-T062
trial	I-T062
little	O
evidence-based	O
information	O
is	O
available	O
to	O
guide	B-T170
the	O
treatment	B-T061
of	O
oligoarticular	B-T047
juvenile	I-T047
idiopathic	I-T047
arthritis	I-T047
.	O
	
we	O
aimed	O
to	O
investigate	B-T169
whether	O
oral	O
methotrexate	O
increases	B-T169
the	O
efficacy	B-T080
of	O
intra-articular	B-T061
corticosteroid	I-T061
therapy	I-T061
.	O
	
we	O
did	O
this	O
prospective	B-T062
,	O
open-label	B-T062
,	O
randomised	B-T062
trial	I-T062
at	O
ten	O
hospitals	O
in	O
italy	O
.	O
	
using	O
a	O
concealed	B-T080
computer-generated	B-T170
list	I-T170
,	O
children	O
younger	B-T033
than	I-T033
18	O
years	B-T079
with	O
oligoarticular	B-T082
-	O
onset	B-T079
disease	I-T079
were	O
randomly	B-T080
assigned	B-T169
1	O
to	O
intra-articular	B-T082
corticosteroids	O
alone	B-T081
or	O
in	B-T080
combination	I-T080
with	I-T080
oral	O
methotrexate	O
15	O
mg/m	O
maximum	B-T081
20	O
mg	O
.	O
	
corticosteroids	O
used	O
were	O
triamcinolone	B-T109
hexacetonide	I-T109
shoulder	O
,	O
elbow	O
,	O
wrist	O
,	O
knee	O
,	O
and	O
tibiotalar	O
joints	O
or	O
methylprednisolone	B-T109
acetate	I-T109
ie	O
,	O
subtalar	O
and	O
tarsal	O
joints	O
.	O
	
we	O
did	O
not	O
mask	O
patients	O
or	O
investigators	O
to	O
treatment	B-T061
assignments	B-T169
.	O
	
our	O
primary	B-T169
outcome	I-T169
was	O
the	O
proportion	B-T081
of	O
patients	O
in	O
the	O
intention-to-treat	B-T062
population	B-T098
who	O
had	O
remission	B-T033
of	O
arthritis	B-T047
in	O
all	O
injected	B-T061
joints	O
at	O
12	O
months	B-T079
.	O
	
this	O
trial	B-T062
is	O
registered	O
with	O
european	O
union	O
clinical	O
trials	O
register	O
,	O
eudract	B-T170
number	I-T170
2008-006741-70	O
.	O
	
between	O
july	B-T080
7	O
,	O
2009	O
,	O
and	O
march	B-T079
31	O
,	O
2013	O
,	O
we	O
screened	B-T169
226	O
participants	B-T098
and	O
randomly	B-T080
assigned	B-T169
102	O
to	O
intra-articular	B-T082
corticosteroids	O
alone	B-T081
and	O
105	O
to	O
intra-articular	B-T082
corticosteroids	O
plus	B-T169
methotrexate	B-T109
.	O
	
33	O
32%	O
patients	O
assigned	B-T169
to	O
intra-articular	B-T082
corticosteroids	O
alone	B-T081
and	O
39	O
37%	O
assigned	B-T169
to	O
intra-articular	B-T082
corticosteroids	O
and	O
methotrexate	B-T109
therapy	B-T061
had	O
remission	B-T033
of	O
arthritis	B-T047
in	O
all	O
injected	B-T061
joints	O
p=0	O
.	O
	
adverse	O
events	O
were	O
recorded	O
for	O
20	O
17%	O
patients	O
who	O
received	O
methotrexate	B-T109
,	O
which	O
led	O
to	O
permanent	B-T079
treatment	B-T061
discontinuation	B-T033
in	O
two	O
patients	O
one	O
due	O
to	O
increased	B-T033
liver	I-T033
transaminases	I-T033
and	O
one	O
due	O
to	O
gastrointestinal	O
discomfort	O
.	O
	
no	B-T033
patient	O
had	O
a	O
serious	B-T080
adverse	O
event	O
.	O
	
concomitant	B-T169
administration	I-T169
of	O
methotrexate	B-T109
did	O
not	O
augment	B-T169
the	O
effectiveness	B-T080
of	O
intra-articular	B-T061
corticosteroid	I-T061
therapy	I-T061
.	O
	
future	B-T062
studies	I-T062
are	O
needed	O
to	O
define	O
the	O
optimal	B-T080
therapeutic	B-T061
strategies	I-T061
for	O
oligoarticular	B-T047
juvenile	I-T047
idiopathic	I-T047
arthritis	I-T047
.	O
	
italian	O
agency	O
of	O
drug	O
evaluation	O
.	O
	
methylation	O
analysis	O
of	O
brca1	O
and	O
apc	O
in	O
breast	O
cancer	O
and	O
it's	O
relationship	B-T080
to	O
clinicopathological	B-T169
features	B-T080
promoter	O
methylation	O
of	O
tumor	O
suppressor	O
genes	O
is	O
an	O
important	O
epigenetic	O
alteration	O
that	O
occurs	O
in	O
the	O
primary	B-T080
stages	B-T079
of	O
human	O
tumors	O
,	O
including	O
breast	O
cancer	O
.	O
	
identification	O
of	O
methylated	O
genes	O
and	O
their	O
relationship	B-T080
to	O
clinical	B-T080
features	B-T080
can	O
contribute	O
to	O
the	O
prognosis	O
and	O
early	O
detection	O
of	O
tumors	O
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
explored	O
the	O
methylation	O
status	B-T080
of	O
apc	O
and	O
brca1	O
genes	O
and	O
their	O
relationship	B-T080
to	O
clinical	B-T080
factors	B-T169
in	O
breast	O
cancer	O
patients	O
.	O
	
brca1	O
and	O
apc	O
promoter	O
methylation	O
was	O
examined	O
by	O
methylation	O
-	O
specific	O
multiplex	O
ligation-dependent	O
probe	O
amplification	O
ms-mlpa	O
assay	O
in	O
formalin-fixed	O
paraffin	O
embedded	O
ffpe	O
breast	O
tissue	O
from	O
75	O
patients	O
.	O
	
apc	O
promoter	O
methylation	O
was	O
detected	B-T033
in	O
30.67	O
breast	O
cancer	O
tissues	O
and	O
brca1	O
was	O
methylated	O
in	O
9.33	O
of	O
breast	O
tumors	O
.	O
	
methylation	O
of	O
apc	O
was	O
associated	B-T080
with	I-T080
low	O
histological	O
grade	O
p	O
=	O
0.006	O
and	O
methylation	O
of	O
brca1	O
was	O
related	O
with	O
lymph	O
node	O
metastasis	O
p	O
=	O
0.017	O
.	O
	
these	O
findings	B-T033
suggest	O
that	O
the	O
methylation	O
status	B-T080
of	O
apc	O
and	O
brca1	O
can	O
be	O
a	O
predictive	O
marker	O
for	O
early	O
detection	O
and	O
better	O
management	O
of	O
breast	O
cancer	O
patients	O
.	O
	
recombinant	B-T116
fibrinogen	B-T116
reveals	O
the	O
differential	B-T080
roles	O
of	O
α-	B-T116
and	O
γ-chain	B-T116
cross-linking	O
and	O
molecular	B-T080
heterogeneity	B-T080
in	O
fibrin	O
clot	O
strain-stiffening	O
essentials	O
fibrinogen	B-T116
circulates	B-T169
in	O
human	O
plasma	O
as	O
a	O
complex	O
mixture	O
of	O
heterogeneous	B-T080
molecular	B-T080
variants	B-T080
.	O
	
we	O
measured	B-T080
strain-stiffening	O
of	O
recombinantly	O
produced	O
fibrinogen	B-T116
upon	O
clotting	O
.	O
	
factor	B-T116
xiii	I-T116
and	O
molecular	B-T080
heterogeneity	B-T080
alter	O
clot	O
elasticity	O
at	O
the	O
protofibril	B-T116
and	O
fiber	O
level	O
.	O
	
this	O
highlights	O
the	O
hitherto	O
unknown	O
role	O
of	O
molecular	B-T080
composition	B-T080
in	O
fibrin	O
clot	O
mechanics	O
.	O
	
background	O
fibrin	B-T116
plays	O
a	O
crucial	O
role	O
in	O
haemostasis	O
and	O
wound	O
healing	O
by	O
forming	O
strain-stiffening	O
fibrous	O
networks	O
that	O
reinforce	O
blood	O
clots	O
.	O
	
the	O
molecular	B-T080
origin	O
of	O
fibrin's	B-T116
strain-stiffening	O
behavior	O
remains	O
poorly	O
understood	O
,	O
primarily	O
because	O
plasma	O
fibrinogen	B-T116
is	O
a	O
complex	O
mixture	O
of	O
heterogeneous	B-T080
molecular	B-T080
variants	B-T080
and	O
is	O
often	O
contaminated	O
by	O
plasma	B-T116
factors	I-T116
that	O
affect	O
clot	O
properties	B-T080
.	O
	
objectives	O
and	O
methods	O
to	O
facilitate	O
mechanistic	B-T169
dissection	I-T169
of	O
fibrin	B-T116
nonlinear	O
elasticity	O
,	O
we	O
produced	O
a	O
homogeneous	B-T080
recombinant	B-T116
fibrinogen	B-T116
corresponding	O
to	O
the	O
main	O
variant	B-T080
in	O
human	O
plasma	O
,	O
termed	O
rfib610	B-T116
.	O
	
we	O
characterized	O
the	O
structure	B-T082
of	O
rfib610	B-T116
clots	O
using	O
turbidimetry	O
,	O
microscopy	O
and	O
x-ray	O
scattering	O
.	O
	
we	O
used	O
rheology	O
to	O
measure	B-T081
the	O
strain-stiffening	O
behavior	O
of	O
the	O
clots	O
and	O
determined	O
the	O
fiber	O
properties	B-T080
by	O
modeling	B-T062
the	O
clots	O
as	O
semi-flexible	B-T169
polymer	I-T169
networks	I-T169
.	O
	
results	O
we	O
show	O
that	O
addition	O
of	O
fxiii	B-T116
to	O
rfib610	B-T116
clots	O
causes	O
a	O
dose-dependent	B-T080
stiffness	I-T080
increase	O
at	O
small	O
deformations	B-T169
and	O
renders	O
the	O
strain-stiffening	O
response	O
reversible	O
.	O
	
we	O
find	O
that	O
γ-chain	B-T116
cross-linking	O
contributes	O
to	O
clot	O
elasticity	O
by	O
changing	O
the	O
force-extension	B-T169
behavior	I-T169
of	O
the	O
protofibrils	B-T116
,	O
whereas	O
α-chain	B-T116
cross-linking	O
stiffens	O
the	O
fibers	O
,	O
as	O
a	O
consequence	O
of	O
tighter	B-T169
coupling	I-T169
between	O
the	O
constituent	O
protofibrils	B-T116
.	O
	
interestingly	O
,	O
rfib610	B-T116
protofibrils	B-T116
have	O
a	O
25%	O
larger	O
bending	B-T080
rigidity	I-T080
than	O
plasma	O
-purified	O
fibrin	B-T116
protofibrils	B-T116
and	O
a	O
delayed	O
strain-stiffening	O
,	O
indicating	O
that	O
molecular	B-T080
heterogeneity	B-T080
influences	O
clot	O
mechanics	O
at	O
the	O
protofibril	B-T116
scale	I-T116
.	O
	
conclusions	O
fibrinogen	B-T116
molecular	B-T080
heterogeneity	B-T080
and	O
fxiii	B-T116
affect	O
the	O
mechanical	B-T169
function	I-T169
of	O
fibrin	O
clots	O
by	O
altering	O
the	O
nonlinear	B-T080
viscoelastic	I-T080
properties	I-T080
at	O
the	O
protofibril	O
and	O
fiber	O
scale	O
.	O
	
this	O
work	O
provides	O
a	O
starting	O
point	O
to	O
investigate	B-T169
the	O
role	O
of	O
molecular	B-T080
heterogeneity	B-T080
of	O
plasma	O
fibrinogen	B-T116
in	O
fibrin	O
clot	O
mechanics	O
and	O
effects	O
of	O
display	B-T169
curvature	B-T082
,	O
display	B-T169
zone	B-T082
,	O
and	O
task	O
duration	B-T079
on	O
legibility	B-T033
and	O
visual	B-T047
fatigue	I-T047
during	O
visual	O
search	O
task	O
this	O
study	O
examined	O
the	O
effects	O
of	O
display	B-T169
curvature	B-T082
400	O
,	O
600	O
,	O
1200	O
mm	O
,	O
and	O
flat	B-T082
,	O
display	B-T169
zone	B-T082
5	O
zones	B-T082
,	O
and	O
task	O
duration	B-T079
15	O
and	O
30	O
min	O
on	O
legibility	B-T033
and	O
visual	B-T047
fatigue	I-T047
.	O
	
each	O
participant	B-T098
completed	O
two	O
15-min	O
visual	O
search	O
task	O
sets	O
at	O
each	O
curvature	B-T082
setting	B-T082
.	O
	
the	O
600-mm	O
and	O
1200-mm	O
settings	B-T082
yielded	O
better	O
results	O
than	O
the	O
flat	B-T082
setting	B-T082
in	O
terms	O
of	O
legibility	B-T033
and	O
perceived	O
visual	B-T047
fatigue	I-T047
.	O
	
relative	O
to	O
the	O
corresponding	O
centre	B-T082
zone	B-T082
,	O
the	O
outermost	O
zones	B-T082
of	O
the	O
1200-mm	O
and	O
flat	B-T082
settings	B-T082
showed	O
a	O
decrease	O
of	O
8%-37%	O
in	O
legibility	B-T033
,	O
whereas	O
those	O
of	O
the	O
flat	B-T082
setting	B-T082
showed	O
an	O
increase	B-T169
of	O
26%-45%	O
in	O
perceived	O
visual	B-T047
fatigue	I-T047
.	O
	
across	O
curvature	B-T082
s	O
,	O
legibility	B-T033
decreased	B-T081
by	O
2%-8%	O
,	O
whereas	O
perceived	O
visual	B-T047
fatigue	I-T047
increased	B-T169
by	O
22%	O
during	O
the	O
second	O
task	O
set	O
.	O
	
the	O
two	O
task	O
sets	O
induced	O
an	O
increase	B-T169
of	O
102%	O
in	O
the	O
eye	B-T081
complaint	I-T081
score	I-T081
and	O
a	O
decrease	O
of	O
0.3	O
hz	O
in	O
the	O
critical	O
fusion	O
frequency	O
,	O
both	O
of	O
which	O
indicated	O
an	O
increase	B-T169
in	O
visual	B-T047
fatigue	I-T047
.	O
	
in	O
summary	O
,	O
a	O
curvature	B-T082
of	O
around	O
600	O
mm	O
,	O
central	B-T082
display	B-T169
zones	B-T082
,	O
and	O
frequent	O
breaks	B-T082
are	O
recommended	O
to	O
improve	B-T033
legibility	B-T033
and	O
reduce	O
visual	B-T047
fatigue	I-T047
.	O
	
predicting	O
changes	O
in	O
adaptive	B-T169
functioning	B-T169
and	O
behavioral	O
adjustment	B-T169
following	O
treatment	B-T061
for	O
a	O
pediatric	O
brain	O
tumor	O
a	O
report	O
from	O
the	O
brain	O
radiation	O
investigative	O
study	O
consortium	O
children	O
are	O
at	O
risk	B-T078
for	O
behavioral	O
and	O
adaptive	B-T169
difficulties	B-T080
following	O
pediatric	O
brain	O
tumor	O
.	O
	
this	O
study	B-T062
explored	O
whether	O
familial	B-T169
/	O
demographic	O
,	O
developmental	B-T080
,	O
diagnostic	B-T169
,	O
or	O
treatment	B-T061
-related	O
variables	B-T080
best	O
predict	O
posttreatment	B-T079
behavioral	O
and	O
adaptive	B-T169
functioning	B-T169
.	O
	
participants	B-T098
included	O
40	O
children	O
mean	B-T081
age	O
=	O
12.76	O
years	O
,	O
sd	B-T081
=	O
4.01	O
posttreatment	B-T079
mean	B-T081
time	B-T079
since	O
diagnosis	B-T033
=	O
1.99	O
years	O
,	O
sd	B-T081
=	O
0.21	O
for	O
pediatric	O
brain	O
tumor	O
.	O
	
parents	O
rated	O
children	O
's	O
behavioral	O
adjustment	B-T169
and	O
adaptive	B-T169
functioning	B-T169
and	O
provided	O
demographic	O
and	O
developmental	B-T080
histories	B-T033
.	O
	
diagnostic	B-T033
and	O
treatment	B-T061
-related	O
information	B-T078
was	O
abstracted	O
from	O
medical	B-T170
records	I-T170
.	O
	
ratings	B-T052
of	O
adaptive	B-T169
and	O
behavioral	O
functioning	B-T169
approximately	O
2	O
years	O
postdiagnosis	B-T033
were	O
within	O
the	O
average	B-T081
range	B-T081
,	O
although	O
the	O
percentage	B-T081
of	O
children	O
exceeding	O
clinical	B-T080
cutoffs	B-T169
for	O
impairment	B-T169
in	O
adaptive	B-T169
skills	O
exceeded	O
expectation	B-T078
,	O
particularly	O
practical	O
skills	O
.	O
	
premorbid	O
behavior	O
problems	B-T078
and	O
tumor	B-T082
size	I-T082
predicted	O
posttreatment	B-T079
adaptive	B-T169
functioning	B-T169
.	O
	
after	O
accounting	O
for	O
adaptive	B-T169
functioning	B-T169
near	O
diagnosis	B-T033
,	O
premorbid	O
behavior	O
problems	B-T078
predicted	O
declines	O
in	O
adaptive	B-T169
functioning	B-T169
2	O
years	O
postdiagnosis	B-T033
.	O
	
after	O
accounting	O
for	O
adjustment	B-T169
near	O
diagnosis	B-T033
,	O
no	O
variables	B-T080
predicted	O
declines	O
in	O
behavioral	O
adjustment	B-T169
.	O
	
children	O
may	O
be	O
vulnerable	B-T169
to	O
reduced	O
adaptive	B-T169
functioning	B-T169
following	O
pediatric	O
brain	O
tumor	O
treatment	B-T061
,	O
especially	O
in	O
practical	O
skills	O
.	O
	
assessing	O
prediagnosis	B-T033
functioning	B-T169
and	O
diagnostic	B-T033
and	O
treatment	B-T061
-related	O
variables	B-T080
may	O
improve	B-T033
our	O
ability	O
to	O
predict	O
those	O
at	O
greatest	O
risk	B-T078
,	O
although	O
those	O
factors	B-T169
may	O
be	O
less	O
helpful	B-T080
in	O
identifying	B-T080
children	O
likely	O
to	O
develop	O
behavioral	O
difficulties	B-T080
.	O
	
screening	O
of	O
these	O
factors	B-T169
in	O
tertiary	O
care	O
and	O
long-term	B-T079
follow-up	O
settings	O
may	O
improve	B-T033
identification	B-T080
of	O
those	O
at	O
greatest	O
need	B-T080
for	O
support	O
services	O
.	O
	
spine	O
fracture	O
prevalence	B-T081
in	O
a	O
nationally	B-T082
representative	I-T082
sample	O
of	O
us	O
women	B-T098
and	O
men	B-T098
aged	O
40	O
years	O
results	O
from	O
the	O
national	B-T062
health	I-T062
and	I-T062
nutrition	I-T062
examination	I-T062
survey	I-T062
nhanes	B-T062
2013-2014	O
spine	O
fracture	O
prevalence	B-T081
is	O
similar	O
in	O
men	B-T098
and	O
women	B-T098
,	O
increasing	O
from	O
<5	O
%	O
in	O
those	O
<60	O
to	O
11	O
%	O
in	O
those	O
70-79	O
and	O
18	O
%	O
in	O
those	O
80	O
years	O
.	O
	
prevalence	B-T081
was	O
higher	B-T080
with	O
age	O
,	O
lower	O
bone	O
mineral	O
density	O
bmd	O
,	O
and	O
in	O
those	O
meeting	O
criteria	O
for	O
spine	O
imaging	O
.	O
	
most	O
subjects	O
with	O
spine	O
fractures	O
were	O
unaware	O
of	O
them	O
.	O
	
spine	O
fractures	O
have	O
substantial	O
medical	O
significance	O
but	O
are	O
seldom	O
recognized	O
.	O
	
this	O
study	O
collected	O
contemporary	O
nationally	O
representative	O
spine	O
fracture	O
prevalence	O
data	O
.	O
	
cross-sectional	O
analysis	O
of	O
3330	O
us	O
adults	O
aged	O
40	O
years	O
participating	O
in	O
nhanes	O
2013-2014	O
with	O
evaluable	O
vertebral	O
fracture	O
assessment	O
vfa	O
.	O
	
vfa	O
was	O
graded	O
by	O
semiquantitative	O
measurement	O
.	O
	
bmd	O
and	O
an	O
osteoporosis	O
questionnaire	O
were	O
collected	O
.	O
	
overall	O
spine	O
fracture	O
prevalence	O
was	O
5.4	O
%	O
and	O
similar	O
in	O
men	O
and	O
women	O
.	O
	
prevalence	O
increased	O
with	O
age	O
from	O
<5	O
%	O
in	O
those	O
<60	O
to	O
11	O
%	O
in	O
those	O
70-79	O
and	O
18	O
%	O
in	O
those	O
80	O
years	O
.	O
	
fractures	O
were	O
more	O
common	O
in	O
non-hispanic	O
whites	O
and	O
in	O
people	O
with	O
lower	B-T080
body	O
mass	O
index	O
and	O
bmd	O
.	O
	
among	O
subjects	O
with	O
spine	O
fracture	O
,	O
26	O
%	O
met	O
bmd	O
criteria	O
for	O
osteoporosis	O
.	O
	
prevalence	O
was	O
higher	O
in	O
subjects	O
who	O
met	O
national	O
osteoporosis	O
foundation	O
nof	O
criteria	O
for	O
spine	O
imaging	O
14	O
vs	O
4.7	O
%	O
,	O
p	O
<	O
0.001	O
.	O
	
only	O
8	O
%	O
of	O
people	O
with	O
a	O
spine	O
fracture	O
diagnosed	O
by	O
vfa	O
had	O
a	O
self-reported	O
fracture	O
,	O
and	O
among	O
those	O
who	O
self-reported	O
a	O
spine	O
fracture	O
,	O
only	O
21	O
%	O
were	O
diagnosed	O
with	O
fracture	O
by	O
vfa	O
.	O
	
spine	O
fracture	O
prevalence	O
is	O
similar	O
in	O
women	O
and	O
men	O
and	O
increases	O
with	O
age	O
and	O
lower	O
bmd	O
,	O
although	O
most	O
subjects	O
with	O
spine	O
fracture	O
do	O
not	O
meet	O
bmd	O
criteria	O
for	O
osteoporosis	O
.	O
	
since	O
most	O
>90	O
%	O
individuals	O
were	O
unaware	O
of	O
their	O
spine	O
fractures	O
,	O
lateral	O
spine	O
imaging	O
is	O
needed	O
to	O
identify	O
these	O
women	O
and	O
men	O
.	O
	
spine	O
fracture	O
prevalence	O
was	O
threefold	O
higher	O
in	O
individuals	O
meeting	O
nof	O
criteria	O
for	O
spine	O
imaging	O
1	O
in	O
7	O
undergoing	O
vfa	O
.	O
	
identifying	O
spine	O
fractures	O
as	O
part	O
of	O
comprehensive	O
risk	O
assessment	O
may	O
improve	O
clinical	O
decision	O
making	O
renieramycin	B-T109
m	I-T109
attenuates	O
cancer	O
stem	O
cell	O
-like	O
phenotypes	O
in	O
h460	O
lung	O
cancer	O
cells	O
cancer	O
stem	O
cells	O
cscs	O
are	O
a	O
subpopulation	O
of	O
cancer	O
cells	O
that	O
possess	O
self-renewal	O
and	O
differentiation	O
capacities	O
.	O
	
cscs	O
contribute	O
to	O
drug-resistance	O
,	O
cancer	O
recurrence	O
and	O
metastasis	O
,	O
thus	O
development	B-T169
of	O
csc	O
-targeted	O
therapeutic	B-T061
strategies	I-T061
has	O
recently	O
received	O
significant	O
attention	O
in	O
cancer	B-T062
research	I-T062
.	O
	
in	O
this	O
study	B-T062
,	O
the	O
potential	O
efficacy	B-T080
of	O
renieramycin	B-T109
m	I-T109
rm	B-T109
isolated	O
from	O
the	O
sponge	O
xestospongia	O
species	O
,	O
was	O
examined	B-T033
against	O
lung	O
cscs	O
.	O
	
colony	O
and	O
spheroid	O
formation	O
assays	O
,	O
as	O
well	O
as	O
western	O
blotting	O
analysis	O
of	O
lung	O
csc	O
protein	B-T116
markers	O
were	O
employed	O
to	O
determine	O
the	O
csc	O
-like	O
phenotypes	O
of	O
h460	O
lung	O
cancer	O
cells	O
after	O
treatment	B-T061
with	O
rm	B-T109
at	O
non-toxic	O
concentrations	O
.	O
	
rm	B-T109
treatment	B-T061
reduced	O
significantly	O
colony	O
and	O
spheroid	O
formation	O
of	O
h460	O
cells	O
.	O
	
moreover	O
,	O
the	O
csc	O
markers	O
cd133	B-T116
,	O
cd44	B-T116
and	O
aldh1a1	B-T116
of	O
csc	O
-enriched	O
h460	O
cells	O
were	O
reduced	O
significantly	O
following	O
rm	B-T109
treatment	B-T061
.	O
	
rm	B-T109
could	O
be	O
a	O
potent	O
anti-metastatic	O
agent	O
by	O
suppressing	O
lung	O
csc	O
-like	O
phenotypes	O
in	O
h460	O
cells	O
.	O
	
physicochemical	O
characterization	O
of	O
chitosan	B-T109
-	O
hyaluronan	B-T109
-coated	O
solid	O
lipid	O
nanoparticles	O
for	O
the	O
targeted	O
delivery	B-T061
of	O
paclitaxel	B-T109
a	O
proof-of-concept	B-T062
study	I-T062
in	O
breast	O
cancer	O
cells	O
to	O
investigate	O
the	O
potential	O
of	O
modified	O
solid	O
lipid	O
nanoparticles	O
sln	O
for	O
the	O
delivery	O
of	O
paclitaxel	B-T109
pax	B-T109
.	O
	
sln	B-T109
loaded	I-T109
with	I-T109
pax	I-T109
were	O
prepared	O
via	O
modified	O
high-pressure	O
hot	O
homogenization	O
.	O
	
formulation	B-T062
parameters	I-T062
were	O
optimized	O
to	O
obtain	O
a	O
high-quality	O
delivery	O
system	O
.	O
	
sln	O
cores	O
were	O
coated	B-T080
,	O
layer-by-layer	I-T080
,	O
with	O
a	O
chitosan	B-T109
and	O
hyaluronan	B-T109
ha	B-T109
shell	O
.	O
	
selectivity	O
toward	O
ha	B-T109
receptors	B-T116
was	O
tested	O
in	O
a	O
breast	O
cancer	O
cell	O
line	O
,	O
mcf-7	O
.	O
	
stable	B-T080
and	I-T080
reproducible	I-T080
nano-sized	B-T080
and	O
negatively	O
charged	O
nanoparticles	O
resulted	O
.	O
	
findings	O
reveal	O
that	O
chitosan	B-T109
-	O
ha	B-T109
-coated	O
sln	O
facilitated	O
the	O
targeting	B-T169
,	O
cellular	O
uptake	O
and	O
the	O
time-/dose-controlled	O
delivery	O
and	O
release	O
of	O
pax	B-T109
,	O
enhancing	O
intrinsic	B-T061
chemotherapeutic	I-T061
activities	I-T061
.	O
	
sln	O
are	O
suitable	O
carrier	O
candidates	O
for	O
nano-oncology	O
given	O
their	O
localized	O
,	O
and	O
potent	O
cytotoxic	O
potential	O
overcoming	B-T033
multidrug-resistant	O
cancer	O
cells	O
.	O
	
epigenetic	O
editing	O
of	O
ascl1	O
gene	O
in	O
neural	O
stem	O
cells	O
by	O
optogenetics	O
enzymes	B-T116
involved	O
in	O
epigenetic	O
processes	O
such	O
as	O
methyltransferases	B-T116
or	O
demethylases	B-T116
are	O
becoming	O
highly	B-T080
utilized	B-T169
for	O
their	O
persistent	O
dna	O
or	O
histone	O
modifying	O
efficacy	B-T080
.	O
	
herein	O
,	O
we	O
have	O
developed	O
an	O
optogenetic	O
toolbox	B-T170
fused	O
to	O
the	O
catalytic	O
domain	O
cd	O
of	O
dna-methyltransferase3a	B-T116
dnmt3a	B-T116
-	O
cd	O
or	O
ten-eleven	B-T116
dioxygenase-1	I-T116
tet1	B-T116
-	O
cd	O
for	O
loci	B-T082
-	O
specific	B-T080
alteration	O
of	O
the	O
methylation	O
state	B-T169
at	O
the	O
promoter	O
of	O
ascl1	O
mash1	O
,	O
a	O
candidate	O
proneuron	O
gene	O
.	O
	
optogenetical	B-T116
protein	I-T116
pairs	I-T116
,	O
cry2	B-T116
linked	O
to	O
dnmt3a	B-T116
-	O
cd	O
or	O
tet1	B-T116
-	O
cd	O
and	O
cib1	B-T116
fused	B-T169
to	O
a	O
transcription	B-T116
activator-like	I-T116
element	I-T116
tale	B-T116
locating	O
an	O
ascl1	O
promoter	O
region	O
,	O
were	O
designed	O
for	O
site	B-T082
specific	I-T082
epigenetic	O
editing	O
.	O
	
a	O
differentially	B-T080
methylated	B-T082
region	I-T082
at	O
the	O
ascl1	O
promoter	O
,	O
isolated	B-T169
from	O
murine	O
dorsal	O
root	O
ganglion	O
hypermethylated	O
and	O
striated	B-T080
cells	O
hypomethylated	O
,	O
was	O
targeted	B-T169
with	O
these	O
optogenetic-epigenetic	B-T116
constructs	I-T116
.	O
	
optimized	O
blue-light	O
illumination	O
triggered	B-T080
the	O
co-localization	O
of	O
tale	B-T116
constructs	I-T116
with	O
dnmt3a	B-T116
-	O
cd	O
or	O
tet1	B-T116
-	O
cd	O
fusion	B-T116
proteins	I-T116
at	O
the	O
targeted	B-T082
site	I-T082
of	O
the	O
ascl1	O
promoter	O
.	O
	
we	O
found	O
that	O
this	O
spatiotemporal	B-T080
association	O
of	O
the	O
fusion	B-T116
proteins	I-T116
selectively	O
alters	B-T169
the	O
methylation	O
state	B-T169
and	O
also	O
regulates	O
gene	O
activity	O
.	O
	
this	O
proof	O
of	O
concept	B-T078
developed	O
herein	O
holds	O
immense	B-T081
promise	B-T078
for	O
the	O
ability	O
to	O
regulate	O
gene	O
activity	O
via	O
epigenetic	O
modulation	O
with	O
spatiotemporal	B-T080
precision	B-T080
.	O
	
vaginal	B-T047
infections	I-T047
of	O
albanian	O
women	B-T098
infected	O
with	O
hpv	O
and	O
their	O
impact	O
in	O
intraepithelial	O
cervical	O
lesions	O
evidenced	O
by	O
pap	O
test	O
cervical	O
cytology	O
is	O
the	O
best	O
single	O
method	O
for	O
large	O
screening	O
of	O
the	O
population	O
in	O
identifying	O
precancerous	O
lesions	O
of	O
the	O
uterine	O
cervix	O
.	O
	
to	O
estimate	O
the	O
frequency	O
of	O
human	O
papillomavirus	O
hpv	O
positivity	O
in	O
a	O
group	O
of	O
albanian	O
women	B-T098
,	O
the	O
prevalence	B-T081
of	O
vaginal	B-T047
coinfections	I-T047
,	O
and	O
the	O
relationship	O
of	O
coinfections	B-T047
with	O
hpv	O
,	O
as	O
well	O
as	O
their	O
role	O
in	O
metaplasia	O
or	O
cervical	O
intraepithelial	O
lesions	O
cin	O
.	O
	
in	O
this	O
retrospective	B-T062
study	I-T062
,	O
2075	O
vaginal	O
smears	O
were	O
examined	O
.	O
	
the	O
papanicolaou	O
stain	O
was	O
used	O
for	O
all	O
slides	O
.	O
	
the	O
new	O
bethesda	O
system	O
2001	O
was	O
used	O
for	O
the	O
interpretations	O
of	O
the	O
smears	O
.	O
	
data	O
analysis	O
was	O
completed	O
using	O
the	O
statistical	B-T081
package	I-T081
for	I-T081
the	I-T081
social	I-T081
sciences	I-T081
version	I-T081
19.0	O
.	O
	
prevalence	B-T081
of	O
hpv	O
positivity	O
was	O
43.9	O
with	O
an	O
average	O
age	O
of	O
35.48	O
9.27	O
years	O
.	O
	
candida	B-T047
coinfection	I-T047
resulted	O
in	O
57.8	O
of	O
hpv	O
positive	O
women	B-T098
with	O
a	O
significant	O
relationship	O
between	O
them	O
.	O
	
gardnerella	B-T047
coinfection	I-T047
resulted	O
in	O
36	O
23%	O
,	O
mixed	B-T047
flora	I-T047
in	O
34	O
8%	O
,	O
and	O
trichomonas	B-T047
vaginalis	I-T047
in	O
50%	O
of	O
hpv	O
positive	O
woman	B-T098
.	O
	
among	O
the	O
women	B-T098
with	O
positive	O
hpv	O
,	O
19%	O
had	O
cin	O
,	O
8%	O
had	O
metaplasia	O
,	O
and	O
1%	O
had	O
metaplasia	O
and	O
cin	O
9%	O
of	O
the	O
women	B-T098
with	O
hpv	O
had	O
cin1	O
and	O
one	O
of	O
the	O
coinfections	B-T047
.	O
	
there	O
is	O
a	O
strong	O
relationship	O
between	O
cin1	O
and	O
hpv	O
positivity	O
as	O
well	O
as	O
between	O
cin1	O
and	O
coinfections	B-T047
.	O
	
hpv	B-T047
infection	I-T047
is	O
a	O
major	O
factor	O
contributing	O
to	O
metaplasia	O
,	O
and	O
bacterial	B-T047
coinfections	I-T047
in	O
hpv	O
positive	O
women	B-T098
have	O
a	O
statistically	B-T081
significant	I-T081
impact	O
in	O
the	O
development	O
of	O
a	O
case	O
of	O
acute	B-T079
hepatitis	B-T047
e	I-T047
infection	I-T047
in	O
a	O
patient	O
with	O
non-hodgkin	O
lymphoma	O
treated	B-T061
successfully	O
with	O
ribavirin	O
we	O
present	O
the	O
case	O
of	O
a	O
man	B-T098
who	O
,	O
following	O
immunosuppressive	B-T061
treatment	I-T061
for	O
non-hodgkin	O
lymphoma	O
,	O
became	O
infected	B-T033
with	O
viral	B-T047
hepatitis	I-T047
e	I-T047
.	O
	
acute	B-T079
hepatitis	B-T047
e	I-T047
virus	I-T047
infection	I-T047
should	O
be	O
considered	O
in	O
patients	O
with	O
deranged	B-T080
liver	O
function	O
on	O
a	O
background	O
of	O
haematological	O
malignancies	O
or	O
immunosuppression	B-T047
,	O
even	O
without	O
travel	O
to	O
endemic	O
regions	O
.	O
	
whilst	O
clearance	O
is	O
usually	O
spontaneous	O
in	O
immune	B-T169
-	O
competent	B-T080
individuals	B-T098
,	O
these	O
at-risk	B-T098
groups	I-T098
may	O
develop	O
a	O
more	O
complicated	O
and	O
protracted	B-T033
disease	I-T033
course	I-T033
.	O
	
thus	O
awareness	O
is	O
important	O
as	O
additional	O
treatment	B-T061
with	O
ribavirin	O
or	O
pegylated	B-T109
interferon	I-T109
may	O
be	O
required	O
,	O
as	O
in	O
this	O
case	O
,	O
in	O
order	O
to	O
help	O
achieve	O
commissioning	O
through	O
competition	O
and	O
cooperation	O
in	O
the	O
english	B-T098
nhs	O
under	O
the	O
health	O
and	O
social	O
care	O
act	O
2012	O
evidence	O
from	O
a	O
qualitative	B-T062
study	I-T062
of	O
four	O
clinical	O
commissioning	O
groups	O
the	O
health	O
and	O
social	O
care	O
act	O
2012	O
'	O
hsca	O
2012	O
'	O
introduced	O
a	O
new	O
,	O
statutory	O
,	O
form	O
of	O
regulation	O
of	O
competition	O
into	O
the	O
national	O
health	O
service	O
nhs	O
,	O
while	O
at	O
the	O
same	O
time	O
recognising	O
that	O
cooperation	O
was	O
necessary	O
.	O
	
nhs	O
england's	B-T170
policy	I-T170
document	I-T170
,	O
the	O
five	B-T170
year	I-T170
forward	I-T170
view	I-T170
'	O
5yfv	B-T170
'	O
of	O
2014	O
placed	O
less	O
emphasis	O
on	O
competition	O
without	O
altering	O
the	O
legislation	B-T170
.	O
	
we	O
explored	O
how	O
commissioners	B-T062
and	O
providers	B-T169
understand	O
the	O
complex	B-T080
regulatory	O
framework	O
,	O
and	O
how	O
they	O
behave	O
in	O
relation	O
to	O
competition	O
and	O
cooperation	O
.	O
	
we	O
carried	O
out	O
detailed	O
case	B-T170
studies	I-T170
in	O
four	O
clinical	O
commissioning	O
groups	O
,	O
using	O
interviews	B-T052
and	O
documentary	B-T062
analysis	I-T062
to	O
explore	O
the	O
commissioners	B-T062
'	O
and	O
providers	B-T169
'	O
understanding	O
and	O
experience	O
of	O
competition	O
and	O
cooperation	O
.	O
	
we	O
conducted	O
42	O
interviews	B-T052
with	O
senior	O
managers	O
in	O
commissioning	O
organisations	O
and	O
senior	O
managers	O
in	O
nhs	O
and	O
independent	O
provider	O
organisations	O
acute	O
and	O
community	O
services	O
.	O
	
neither	O
commissioners	B-T062
nor	O
providers	B-T169
fully	O
understand	O
the	O
regulatory	O
regime	O
in	O
respect	O
of	O
competition	O
in	O
the	O
nhs	O
,	O
and	O
have	O
not	O
found	O
that	O
the	O
regulatory	O
authorities	O
have	O
provided	O
adequate	O
guidance	O
.	O
	
despite	O
the	O
hsca	O
2012	O
promoting	B-T052
competition	O
,	O
commissioners	B-T062
chose	O
mainly	O
to	O
use	O
collaborative	B-T062
strategies	I-T062
to	O
effect	O
major	O
service	O
reconfigurations	O
,	O
which	O
is	O
endorsed	O
as	O
a	O
suitable	O
approach	O
by	O
providers	B-T169
.	O
	
nevertheless	O
,	O
commissioners	B-T062
are	O
using	O
competitive	O
tendering	O
in	O
respect	O
of	O
more	O
peripheral	O
services	O
in	O
order	O
to	O
improve	O
quality	O
of	O
care	O
and	O
value	B-T078
for	I-T078
money	I-T078
.	O
	
commissioners	B-T062
regard	O
the	O
use	O
of	O
competition	O
and	O
cooperation	O
as	O
appropriate	O
in	O
the	O
nhs	O
currently	O
,	O
although	O
collaborative	B-T062
strategies	I-T062
appear	O
more	O
helpful	O
in	O
respect	O
of	O
large-scale	O
changes	O
.	O
	
however	O
,	O
the	O
current	O
regulatory	O
framework	O
contained	O
in	O
the	O
hsca	O
2012	O
,	O
particularly	O
since	O
the	O
publication	O
of	O
the	O
5yfv	B-T170
,	O
is	O
not	O
clear	O
.	O
	
better	O
guidance	O
should	O
be	O
issued	O
by	O
the	O
regulatory	O
authorities	O
.	O
	
prevalence	B-T081
and	O
correlates	B-T080
of	O
antibiotic	O
sharing	O
in	O
the	O
philippines	O
antibiotic	O
misconceptions	O
and	O
community	O
-	O
level	B-T080
access	O
to	O
non-medical	O
sources	B-T033
of	O
antibiotics	O
to	O
identify	O
sociodemographic	B-T078
,	O
knowledge	B-T170
and	O
attitudinal	O
correlates	B-T080
to	O
antibiotic	O
sharing	O
among	O
a	O
community-based	B-T081
sample	I-T081
of	O
adults	O
age	O
18	O
and	O
older	O
in	O
a	O
low-income	B-T033
setting	I-T033
of	O
the	O
philippines	O
and	O
to	O
explore	O
community	O
-	O
level	B-T080
data	B-T078
on	O
informal	B-T033
antibiotic	O
distribution	O
in	O
roadside	B-T082
stands	I-T082
i.e	O
,	O
sari-sari	B-T082
stands	I-T082
.	O
	
participants	B-T098
n	O
=	O
307	O
completed	B-T080
self-administered	B-T169
surveys	B-T170
.	O
	
correlates	B-T080
to	O
antibiotic	O
sharing	O
were	O
assessed	B-T052
using	O
logistic	B-T062
regression	I-T062
with	O
firth's	B-T170
bias-adjusted	I-T170
estimate	I-T170
s	O
.	O
	
study	O
staff	O
also	O
visited	O
106	O
roadside	B-T082
stands	I-T082
and	O
collected	B-T033
data	I-T033
on	O
availability	B-T169
and	O
characteristics	O
of	O
antibiotics	O
in	O
the	O
stands	B-T082
.	O
	
78%	O
had	O
shared	O
antibiotics	O
in	O
their	O
lifetime	B-T079
,	O
most	O
often	B-T079
with	O
family	O
members	O
.	O
	
in	O
multivariable	B-T081
analysis	I-T081
,	O
agreement	O
with	O
the	O
belief	B-T078
that	O
it	O
is	O
safe	O
to	O
prematurely	B-T079
stop	B-T052
an	O
antibiotic	O
course	B-T079
or	B-T081
2.8	O
,	O
ci	O
1.3	O
and	O
concerns	B-T078
about	O
antibiotic	O
side	O
effects	O
or	B-T081
2.1	O
,	O
ci	O
1.1	O
were	O
significantly	O
associated	B-T080
with	I-T080
increased	B-T081
odds	O
of	O
reported	O
antibiotic	O
sharing	O
.	O
	
antibiotic	O
sharing	O
was	O
not	O
associated	B-T080
with	I-T080
sociodemographic	O
characteristics	O
or	O
antibiotic	O
knowledge	B-T170
.	O
	
antibiotics	O
were	O
widely	O
available	B-T169
in	O
60%	O
of	O
sampled	O
sari-sari	B-T082
stands	I-T082
,	O
in	O
which	O
59%	O
of	O
antibiotics	O
were	O
missing	B-T033
expiration	I-T033
dates	I-T033
.	O
	
amoxicillin	B-T109
and	O
cephalexin	B-T109
were	O
the	O
most	O
commonly	B-T081
available	B-T169
antibiotics	O
for	O
sale	O
at	O
the	O
stands	B-T082
60%	O
and	O
21%	O
,	O
respectively	O
.	O
	
antibiotic	O
sharing	O
was	O
common	B-T081
and	O
was	O
associated	B-T080
with	I-T080
misconceptions	O
about	O
proper	O
antibiotic	O
use	O
.	O
	
antibiotics	O
were	O
widely	O
available	B-T169
in	O
sari-sari	B-T082
stands	I-T082
,	O
and	O
usually	O
without	B-T080
expiration	B-T170
information	I-T170
.	O
	
this	O
study	O
suggests	O
that	O
multipronged	O
and	O
locally	O
tailored	O
approaches	O
to	O
curbing	B-T169
informal	B-T033
antibiotic	O
access	O
are	O
needed	O
in	O
the	O
philippines	O
and	O
similar	O
southeast-asian	O
countries	O
.	O
	
automated	B-T169
characterization	B-T052
and	O
counting	B-T081
of	O
ki-67	B-T116
protein	I-T116
for	O
breast	O
cancer	O
prognosis	O
a	O
quantitative	B-T081
immunohistochemistry	O
approach	B-T082
ki-67	B-T116
protein	I-T116
expression	O
plays	O
an	O
important	O
role	O
in	O
predicting	O
the	O
proliferative	B-T081
status	I-T081
of	O
tumour	O
cell	O
s	O
and	O
deciding	O
the	O
future	B-T079
course	B-T079
of	O
therapy	B-T061
in	O
breast	O
cancer	O
.	O
	
immunohistochemical	O
ihc	O
determination	O
of	O
ki-67	O
score	O
or	O
labelling	O
index	O
,	O
by	O
estimating	O
the	O
fraction	B-T081
of	I-T081
ki67	B-T116
positively	B-T033
stained	B-T080
tumour	O
cells	O
,	O
is	O
the	O
most	O
widely	O
practiced	O
method	O
to	O
assess	O
tumour	O
proliferation	B-T169
dowsett	O
et	O
al	O
.	O
	
2011	O
.	O
	
accurate	B-T080
manual	O
counting	O
of	O
these	O
cells	O
specifically	B-T080
nuclei	O
due	O
to	O
complex	B-T080
and	O
dense	B-T080
distribution	B-T169
of	O
cells	O
,	O
therefore	O
,	O
becomes	O
critical	B-T080
and	O
presents	B-T078
a	O
major	B-T080
challenge	O
to	O
pathologists	O
.	O
	
in	O
this	O
paper	O
,	O
we	O
suggest	O
a	O
hybrid	B-T170
clustering	I-T170
algorithm	I-T170
to	O
quantify	B-T081
the	O
proliferative	B-T081
index	I-T081
of	O
breast	O
cancer	O
cells	O
based	O
on	O
automated	O
counting	O
of	O
ki-67	B-T116
nuclei	O
.	O
	
the	O
proposed	O
methodology	O
initially	B-T079
pre-processes	O
the	O
ihc	O
images	B-T170
of	O
ki-67	B-T116
stained	B-T080
slides	O
of	O
breast	O
cancer	O
.	O
	
the	O
rgb	O
images	O
are	O
converted	O
to	O
grey	B-T080
,	O
l*a*b*	O
,	O
hsi	O
,	O
ycbcr	O
,	O
yiq	O
and	O
xyz	O
colour	B-T170
space	I-T170
.	O
	
all	O
the	O
stained	B-T080
cells	O
are	O
then	O
characterized	B-T052
by	O
two	O
stage	O
segmentation	O
process	O
.	O
	
fuzzy	B-T170
c-means	I-T170
quantifies	B-T081
all	O
the	O
stained	B-T080
cells	O
as	O
one	O
cluster	B-T081
.	O
	
the	O
blue	B-T080
channel	O
of	O
the	O
first	O
stage	O
output	O
is	O
given	O
as	O
input	O
to	O
k-means	B-T062
algorithm	I-T062
,	O
which	O
provides	O
separate	B-T080
cluster	B-T081
for	O
ki-67	B-T116
positive	B-T033
and	I-T033
negative	I-T033
cells	O
.	O
	
the	O
count	B-T081
of	O
positive	B-T033
and	I-T033
negative	I-T033
nuclei	O
is	O
used	O
to	O
calculate	O
the	O
f-measure	B-T081
for	O
each	O
colour	B-T170
space	I-T170
.	O
	
a	O
comparative	B-T062
study	I-T062
of	O
our	O
work	O
with	O
the	O
expert	O
opinion	O
is	O
studied	O
to	O
evaluate	O
the	O
error	B-T080
rate	B-T081
.	O
	
the	O
positive	B-T033
and	I-T033
negative	I-T033
nuclei	O
detection	B-T033
results	B-T169
for	O
all	O
colour	B-T170
space	I-T170
s	O
are	O
compared	B-T052
with	O
the	O
ground	O
truth	O
for	O
validation	O
and	O
f-measure	B-T081
is	O
calculated	O
.	O
	
the	O
f-measure	B-T081
for	O
l*a*b*	O
colour	B-T170
space	I-T170
0.8847	O
provides	O
the	O
best	O
statistical	B-T081
result	B-T169
as	O
compared	B-T052
to	O
grey	B-T080
,	O
hsi	O
,	O
ycbcr	O
,	O
yiq	O
and	O
xyz	O
colour	B-T170
space	I-T170
.	O
	
further	O
,	O
a	O
study	B-T062
is	O
carried	O
out	O
to	O
count	B-T081
nuclei	O
manually	O
and	O
automatically	O
from	O
the	O
proposed	O
algorithm	B-T170
with	O
an	O
average	B-T081
error	B-T080
rate	B-T081
of	O
6.84	O
which	O
is	O
significant	B-T078
.	O
	
the	O
study	B-T062
provides	O
an	O
automated	B-T169
count	B-T081
of	O
positive	B-T033
and	I-T033
negative	I-T033
nuclei	O
using	O
l*a*b*	O
colour	B-T170
space	I-T170
and	O
hybrid	O
segmentation	O
technique	O
.	O
	
computerized	O
evaluation	O
of	O
proliferation	B-T081
index	I-T081
can	O
aid	O
pathologist	O
in	O
assessing	O
breast	O
cancer	O
severity	B-T080
.	O
	
the	O
proposed	O
methodology	O
,	O
further	O
,	O
has	O
the	O
potential	B-T080
advantage	O
of	O
saving	O
time	O
and	O
assisting	O
in	O
decision	O
making	O
over	O
the	O
present	O
manual	O
procedure	O
and	O
could	O
evolve	O
as	O
an	O
assistive	O
pathological	B-T169
decision	O
support	O
system	O
.	O
	
multitarget	B-T169
sensing	O
of	O
glucose	O
and	O
cholesterol	O
based	O
on	O
janus	B-T109
hydrogel	I-T109
microparticles	I-T109
a	O
visualized	B-T169
sensing	O
method	O
for	O
glucose	O
and	O
cholesterol	O
was	O
developed	O
based	O
on	O
the	O
hemispheres	O
of	O
the	O
same	O
janus	B-T109
hydrogel	I-T109
microparticles	I-T109
.	O
	
single-phase	O
and	O
janus	B-T109
hydrogel	I-T109
microparticles	I-T109
were	O
both	O
generated	O
using	O
a	O
centrifugal	B-T080
microfluidic	O
chip	O
.	O
	
for	O
glucose	O
sensing	O
,	O
concanavalin	B-T116
a	I-T116
and	O
fluorescein	B-T109
labeled	I-T109
dextran	I-T109
used	O
for	O
competitive	O
binding	O
assay	O
were	O
encapsulated	B-T080
in	O
alginate	B-T109
microparticles	O
,	O
and	O
the	O
fluorescence	O
of	O
the	O
microparticles	O
was	O
positively	B-T033
correlated	B-T080
with	O
glucose	B-T109
concentration	B-T081
.	O
	
for	O
cholesterol	O
sensing	O
,	O
the	O
microparticles	O
embedded	O
with	O
γ-fe2o3	O
nanoparticles	O
were	O
used	O
as	O
catalyst	O
for	O
the	O
oxidation	O
of	O
3	B-T109
by	O
h2o2	O
,	O
an	O
enzymatic	B-T116
hydrolysis	O
product	O
of	O
cholesterol	B-T109
.	O
	
and	O
the	O
color	B-T080
transition	B-T052
was	O
more	O
sensitive	B-T169
in	O
the	O
microparticles	O
than	O
in	O
solutions	O
,	O
indicating	O
the	O
microparticles	O
are	O
more	O
applicable	B-T080
for	O
visualized	B-T169
determination	O
.	O
	
furthermore	O
,	O
janus	O
microparticles	O
were	O
employed	B-T033
for	O
multitarget	B-T169
sensing	B-T080
in	O
the	O
two	O
hemespheres	O
,	O
and	O
glucose	B-T109
and	O
cholesterol	B-T109
were	O
detected	B-T033
within	O
the	O
same	O
microparticles	O
without	O
obvious	O
interference	B-T169
.	O
	
besides	O
,	O
the	O
particles	O
could	O
be	O
manipulated	O
by	O
an	O
external	B-T082
magnetic	O
field	O
.	O
	
the	O
glucose	O
and	O
cholesterol	O
levels	O
were	O
measured	B-T080
in	O
human	O
serum	O
utilizing	O
the	O
microparticles	O
,	O
which	O
confirmed	B-T033
the	O
potential	B-T080
application	O
of	O
the	O
microparticles	O
in	O
real	O
sample	O
detection	B-T061
.	O
	
pi3k	B-T116
/	O
akt	B-T116
pathway	O
a	O
potential	O
therapeutic	B-T169
target	B-T169
for	O
chronic	O
pain	O
chronic	O
pain	O
is	O
among	O
the	O
most	O
disabling	B-T047
and	O
costly	O
disorders	B-T047
,	O
with	O
prevalence	B-T081
ranging	B-T081
from	O
10%	O
to	O
55%	O
.	O
	
however	O
,	O
current	O
therapeutic	B-T169
strategies	O
for	O
chronic	O
pain	O
are	O
unsatisfactory	B-T080
due	O
to	O
our	O
poor	B-T080
understanding	O
of	O
its	O
mechanisms	B-T169
.	O
	
thus	O
,	O
novel	O
therapeutic	B-T169
targets	B-T169
need	O
to	O
be	O
found	O
in	O
order	O
to	O
improve	B-T033
these	O
patients'	O
quality	B-T078
of	I-T078
life	I-T078
.	O
	
pi3k	B-T116
and	O
its	O
downstream	B-T082
akt	B-T116
are	O
widely	O
expressed	O
in	O
the	O
spinal	O
cord	O
,	O
particularly	O
in	O
the	O
laminae	O
i-iv	O
of	O
the	O
dorsal	O
horn	O
,	O
where	O
nociceptive	O
c	O
and	O
aδ	O
fibers	O
of	O
primary	B-T080
afferents	O
principally	O
terminate	B-T079
.	O
	
recent	O
studies	B-T062
have	O
demonstrated	O
their	O
critical	B-T080
roles	O
in	O
the	O
development	B-T169
and	O
maintenance	B-T052
of	O
chronic	O
pain	O
.	O
	
in	O
this	O
review	B-T170
,	O
we	O
summarized	O
the	O
roles	O
and	O
mechanisms	B-T169
of	O
pi3k	B-T116
/	O
akt	B-T116
pathway	O
in	O
the	O
progression	O
of	O
chronic	O
pain	O
through	O
sciatic	O
nerve	O
injury	O
,	O
diabetic	B-T047
neuropathy	I-T047
,	O
spinal	O
cord	O
injury	O
,	O
bone	O
cancer	O
,	O
opioid	O
tolerance	O
,	O
or	O
opioid	B-T109
-	O
induced	B-T169
hyperalgesia	O
.	O
	
no	O
free	O
bed	O
with	O
ventilator	O
experience	O
of	O
a	O
public	O
health	O
specialist	O
while	O
the	O
author	O
was	O
dealing	O
with	O
a	O
poor	O
elderly	O
father	O
struggling	O
to	O
shift	O
his	O
gravely	B-T169
injured	I-T169
young	B-T079
son	O
to	O
a	O
government	O
hospital	O
due	O
to	O
the	O
high	O
cost	O
of	O
intensive	O
care	O
,	O
her	O
friends	B-T098
across	O
the	O
globe	B-T082
were	O
discussing	O
euthanasia	O
in	O
the	O
social	B-T170
media	I-T170
.	O
	
while	O
marginalised	O
groups	B-T098
of	I-T098
people	I-T098
are	O
struggling	O
to	O
access	B-T078
care	B-T052
in	O
india	O
,	O
friends	B-T098
who	O
have	O
moved	O
to	O
developed	B-T080
parts	I-T080
of	I-T080
the	I-T080
world	I-T080
were	O
discussing	O
one's	O
choice	B-T052
to	O
live	B-T080
or	O
die	O
the	O
poor	O
father	O
,	O
after	O
battling	O
to	O
save	B-T078
his	O
son	O
and	O
reaching	O
out	O
to	O
many	O
people	B-T098
for	O
help	B-T080
,	O
could	O
not	O
save	B-T078
him	O
.	O
	
early	O
treatment	O
might	O
have	O
helped	B-T080
the	O
young	B-T079
boy	O
.	O
	
the	O
incident	O
left	O
the	O
author	O
thinking	O
about	O
how	O
the	O
poor	O
are	O
denied	B-T052
care	B-T052
simply	O
because	O
they	O
cannot	O
afford	O
it	O
.	O
	
others	O
debate	B-T052
when	O
to	O
pull	B-T078
the	I-T078
plug	I-T078
on	O
the	O
patient	O
.	O
	
how	O
many	O
families	O
can	O
afford	O
such	O
care	B-T052
in	O
india	O
when	O
nearly	O
71%	O
of	O
the	O
people	B-T098
are	O
paying	B-T081
out	I-T081
of	I-T081
pocket	I-T081
for	O
healthcare	O
and	O
16%	O
are	O
pushed	O
below	O
the	O
poverty	O
line	O
every	B-T079
year	I-T079
,	O
can	O
we	O
even	O
think	O
of	O
universal	B-T078
health	I-T078
coverage	I-T078
it	O
just	O
sounds	O
like	O
a	O
fancy	O
term	O
to	O
be	O
used	O
at	O
conferences	O
and	O
meetings	O
because	O
the	O
ground	O
reality	O
is	O
completely	O
different	I-T080
quantitative	B-T081
determination	O
of	O
five	O
metabolites	O
of	O
aspirin	B-T109
by	O
uhplc-ms	O
/	O
ms	O
coupled	B-T169
with	O
enzymatic	O
reaction	O
and	O
its	O
application	O
to	O
evaluate	O
the	O
effects	B-T080
of	O
aspirin	B-T109
dosage	B-T081
on	O
the	O
metabolic	O
profile	O
acetylsalicylic	B-T109
acid	I-T109
aspirin	B-T109
,	O
asa	B-T109
is	O
a	O
famous	O
drug	O
for	O
cardiovascular	B-T047
diseases	I-T047
in	O
recent	O
years	B-T079
.	O
	
effects	O
of	O
asa	B-T109
dosage	B-T081
on	O
the	O
metabolic	O
profile	O
have	O
not	O
been	O
fully	O
understood	O
.	O
	
the	O
purpose	O
of	O
our	O
study	B-T062
is	O
to	O
establish	O
a	O
rapid	B-T080
and	O
reliable	B-T170
method	O
to	O
quantify	B-T081
asa	B-T109
metabolites	O
in	O
biological	O
matrices	O
,	O
especially	O
for	O
glucuronide	B-T109
metabolites	O
whose	O
standards	O
are	O
not	O
commercially	O
available	O
.	O
	
then	O
we	O
applied	O
this	O
method	O
to	O
evaluate	O
the	O
effects	O
of	O
asa	B-T109
dosage	B-T081
on	O
the	O
metabolic	O
and	O
excretion	O
profile	B-T081
of	O
asa	B-T109
metabolites	O
in	O
rat	O
urine	O
.	O
	
salicylic	B-T109
acid	I-T109
sa	B-T109
,	O
gentisic	B-T109
acid	I-T109
ga	B-T109
and	O
salicyluric	B-T109
acid	I-T109
sua	B-T109
were	O
determined	O
directly	O
by	O
uhplc-ms	O
/	O
ms	O
,	O
while	O
salicyl	B-T109
phenolic	I-T109
glucuronide	I-T109
sapg	B-T109
and	O
salicyluric	B-T109
acid	I-T109
phenolic	I-T109
glucuronide	I-T109
suapg	B-T109
were	O
quantified	B-T081
indirectly	O
by	O
measuring	O
the	O
released	O
sa	B-T109
and	O
sua	B-T109
from	O
sapg	B-T109
and	O
suapg	B-T109
after	O
β-glucuronidase	B-T116
digestion	O
.	O
	
sua	B-T109
and	O
suapg	B-T109
were	O
the	O
major	O
metabolites	O
of	O
asa	B-T109
in	O
rat	O
urine	O
24	O
h	B-T079
after	O
asa	B-T109
administration	B-T081
,	O
which	O
accounted	O
for	O
50%	O
sua	B-T109
and	O
26%	O
suapg	B-T109
.	O
	
when	O
asa	B-T109
dosage	B-T081
was	O
increased	B-T081
,	O
the	O
contributions	O
dropped	O
to	O
32%	O
and	O
18%	O
,	O
respectively	O
.	O
	
the	O
excretion	O
of	O
other	O
three	O
metabolites	O
ga	B-T109
,	O
sa	B-T109
and	O
sapg	B-T109
however	O
showed	O
remarkable	O
increases	O
by	O
16%	O
,	O
6%	O
and	O
4%	O
,	O
respectively	O
.	O
	
in	O
addition	O
,	O
sua	B-T109
and	O
suapg	B-T109
were	O
mainly	O
excreted	O
in	O
the	O
time	B-T079
period	I-T079
of	O
12-24	O
h	B-T079
,	O
while	O
ga	B-T109
was	O
excreted	O
in	O
the	O
earlier	O
time	B-T079
periods	I-T079
0-4	O
h	B-T079
and	O
4-8	O
h	B-T079
.	O
	
sa	B-T109
was	O
mainly	O
excreted	O
in	O
the	O
time	B-T079
period	I-T079
of	O
0-4	O
h	B-T079
and	O
12-24	O
h	B-T079
.	O
	
and	O
the	O
excretion	O
of	O
sapg	B-T109
was	O
equally	O
distributed	O
in	O
the	O
four	O
time	B-T079
periods	I-T079
.	O
	
we	O
went	O
further	O
to	O
show	O
that	O
the	O
excretion	O
of	O
five	O
metabolites	O
in	O
rat	O
urine	O
was	O
delayed	O
when	O
asa	B-T109
dosage	B-T081
was	O
increased	B-T081
.	O
	
in	O
conclusion	O
,	O
we	O
have	O
developed	O
a	O
rapid	B-T080
and	O
sensitive	B-T169
method	O
to	O
determine	O
the	O
five	O
asa	B-T109
metabolites	O
sa	B-T109
,	O
ga	B-T109
,	O
sua	B-T109
,	O
sapg	B-T109
and	O
suapg	B-T109
in	O
rat	O
urine	O
.	O
	
we	O
showed	O
that	O
asa	B-T109
dosage	B-T081
could	O
significantly	O
influence	O
the	O
metabolic	O
and	O
excretion	O
profile	B-T081
of	O
asa	B-T109
metabolites	O
in	O
rat	O
urine	O
.	O
	
mismatch	O
repair	O
incompatibilities	O
in	O
diverse	B-T080
yeast	O
populations	O
an	O
elevated	B-T080
mutation	B-T080
rate	I-T080
can	O
provide	O
cells	O
with	O
a	O
source	B-T033
of	O
mutations	O
to	O
adapt	O
to	O
changing	B-T169
environments	B-T082
.	O
	
we	O
identified	B-T080
a	O
negative	B-T033
epistatic	O
interaction	O
involving	B-T169
naturally	O
occurring	O
variants	B-T080
in	O
the	O
mlh1	O
and	O
pms1	O
mismatch	O
repair	O
mmr	O
genes	O
of	O
saccharomyces	O
cerevisiae	O
we	O
hypothesized	O
that	O
this	O
mmr	O
incompatibility	O
,	O
created	O
through	O
mating	O
between	O
divergent	O
s	O
.	O
	
cerevisiae	O
,	O
yields	O
mutator	O
progeny	O
that	O
can	O
rapidly	B-T080
but	O
transiently	O
adapt	O
to	O
an	O
environmental	O
stress	O
.	O
	
here	O
we	O
analyzed	B-T062
the	O
mlh1	O
and	O
pms1	O
genes	O
across	O
1010	O
s	O
.	O
	
cerevisiae	O
natural	B-T169
isolates	O
spanning	O
a	O
wide	O
range	B-T081
of	O
ecological	O
sources	B-T033
tree	O
exudates	O
,	O
drosophila	O
,	O
fruits	O
,	O
and	O
various	O
fermentation	O
and	O
clinical	B-T080
isolates	O
and	O
geographical	B-T082
sources	B-T033
europe	O
,	O
america	O
,	O
africa	O
,	O
and	O
asia	O
.	O
	
we	O
identified	B-T080
one	O
homozygous	O
clinical	B-T080
isolate	O
and	O
18	O
heterozygous	O
isolates	O
containing	B-T169
the	O
incompatible	O
mmr	O
genotype	O
.	O
	
the	O
mlh1	O
-	O
pms1	O
gene	O
combination	B-T080
isolated	B-T169
from	O
the	O
homozygous	O
clinical	B-T080
isolate	O
conferred	O
a	O
mutator	O
phenotype	O
when	O
expressed	O
in	O
the	O
s288c	O
laboratory	O
background	O
.	O
	
using	O
a	O
novel	O
reporter	O
to	O
measure	B-T081
mutation	B-T080
rates	I-T080
,	O
we	O
showed	O
that	O
the	O
overall	B-T080
mutation	B-T080
rate	I-T080
in	O
the	O
homozygous	O
incompatible	O
background	O
was	O
similar	O
to	O
that	O
seen	O
in	O
compatible	B-T080
strains	O
,	O
indicating	O
the	O
presence	O
of	O
suppressor	O
mutations	O
in	O
the	O
clinical	B-T080
isolate	O
that	O
lowered	O
its	O
mutation	B-T080
rate	I-T080
.	O
	
this	O
observation	B-T062
and	O
the	O
identification	B-T080
of	O
18	O
heterozygous	O
isolates	O
,	O
which	O
can	O
lead	O
to	O
mmr	O
incompatible	O
genotypes	O
in	O
the	O
offspring	O
,	O
are	O
consistent	O
with	O
an	O
elevated	O
mutation	O
rate	O
rapidly	O
but	O
transiently	O
facilitating	O
adaptation	O
.	O
	
to	O
avoid	O
long-term	O
fitness	O
costs	O
,	O
the	O
incompatibility	O
is	O
apparently	O
buffered	O
by	O
mating	O
or	O
by	O
acquiring	O
suppressors	O
.	O
	
these	O
observations	O
highlight	O
effective	O
strategies	O
in	O
eukaryotes	O
to	O
avoid	O
long-term	O
fitness	O
costs	O
associated	O
with	O
elevated	O
mutation	O
rates	I-T080
mapping	B-T052
circulating	B-T169
serum	O
mirnas	O
to	O
their	O
immune	B-T169
-	O
related	B-T080
target	B-T169
mrnas	O
evidence	B-T078
suggests	B-T078
that	O
circulating	B-T169
serum	O
micrornas	O
mirnas	O
might	O
preferentially	O
target	B-T169
immune	B-T169
-	O
related	B-T080
mrnas	O
.	O
	
if	O
this	O
were	O
the	O
case	O
,	O
we	O
hypothesized	O
that	O
immune	B-T169
-	O
related	B-T080
mrnas	O
would	O
have	O
more	O
predicted	B-T078
serum	O
mirna	O
binding	O
sites	B-T082
than	O
other	O
mrnas	O
and	O
,	O
reciprocally	B-T080
,	O
that	O
serum	O
mirnas	O
would	O
have	O
more	O
immune	B-T169
-	O
related	B-T080
mrna	O
targets	B-T169
than	O
non	B-T169
-	O
serum	O
mirnas	O
.	O
	
we	O
developed	B-T169
a	O
consensus	O
target	B-T169
predictor	O
using	O
the	O
random	B-T169
forest	I-T169
framework	I-T169
and	O
calculated	B-T169
the	O
number	O
of	O
predicted	B-T078
mirna	O
-	O
mrna	O
interactions	O
in	O
various	O
subsets	O
of	O
mirnas	O
serum	O
,	O
non	B-T169
-	O
serum	O
and	O
mrnas	O
immune	B-T169
related	B-T080
,	O
nonimmune	B-T080
related	I-T080
.	O
	
immune	B-T169
-	O
related	B-T080
mrnas	O
were	O
predicted	B-T078
to	O
be	O
targeted	B-T169
by	O
serum	O
mirna	O
more	O
than	O
other	O
mrnas	O
.	O
	
moreover	O
,	O
serum	O
mirnas	O
were	O
predicted	B-T078
to	O
target	B-T169
many	O
more	O
immune	B-T169
-	O
related	B-T080
mrna	O
targets	B-T169
than	O
non	B-T169
-	O
serum	O
mirnas	O
however	O
,	O
these	O
two	O
biases	B-T078
in	O
immune	B-T169
-	O
related	B-T080
mrnas	O
and	O
serum	O
mirnas	O
appear	O
to	O
be	O
completely	B-T080
independent	B-T078
.	O
	
immune	B-T169
-	O
related	B-T080
mrnas	O
have	O
more	O
mirna	O
binding	O
sites	B-T082
in	O
general	O
,	O
not	O
just	O
for	O
serum	O
mirnas	O
likewise	O
,	O
serum	O
mirnas	O
target	B-T169
many	O
more	O
mrnas	O
than	O
non	B-T169
-	O
serum	O
mirnas	O
overall	O
,	O
regardless	B-T080
of	O
whether	O
they	O
are	O
immune	B-T169
related	B-T080
or	O
not	O
.	O
	
nevertheless	O
,	O
these	O
two	O
independent	B-T078
phenomena	O
result	B-T169
in	O
a	O
significantly	O
larger	O
number	O
of	O
predicted	B-T078
serum	O
mirna	O
-	O
immune	B-T169
mrna	O
interactions	O
oxidative	O
stress	O
and	O
immunosenescence	O
in	O
spleen	O
of	O
obese	O
mice	O
can	O
be	O
reversed	O
by	O
2-hydroxyoleic	B-T109
acid	I-T109
we	O
aimed	O
to	O
investigate	O
the	O
effects	O
of	O
obesity	B-T047
on	O
oxidative	O
stress	O
and	O
leukocyte	O
function	O
in	O
spleen	O
of	O
mice	O
,	O
and	O
to	O
assess	O
whether	O
supplementation	B-T061
with	O
2-hydroxyoleic	B-T109
acid	I-T109
2-ohoa	B-T109
or	O
n-3	B-T109
polyunsaturated	I-T109
fatty	I-T109
acids	I-T109
pufa	B-T109
could	O
reverse	O
those	O
effects	O
.	O
	
female	O
icr/cd1	O
mice	O
8	O
weeks	B-T079
old	O
,	O
n	O
=	O
24	O
received	O
an	O
obesogenic	O
diet	O
22%	O
fat	B-T109
for	O
4	O
weeks	B-T079
and	O
60%	O
fat	B-T109
for	O
14	O
weeks	B-T079
.	O
	
after	O
6	O
weeks	B-T079
,	O
mice	O
were	O
split	O
in	O
three	O
groups	O
n	O
=	O
8/	O
group	O
no	O
supplementation	O
,	O
2-ohoa	O
supplementation	O
1500	O
mg	O
kg	O
and	O
n-3	O
pufa	O
supplementation	O
epa	B-T109
+	O
dha	B-T109
,	O
3000	O
mg	O
kg	O
diet	O
.	O
	
eight	O
mice	O
were	O
fed	O
standard	O
diet	O
for	O
the	O
whole	O
duration	B-T079
of	O
the	O
study	B-T062
control	O
group	O
.	O
	
at	O
the	O
end	O
of	O
the	O
experiment	B-T062
,	O
the	O
following	O
variables	B-T080
were	O
assessed	B-T052
in	O
spleens	O
levels	B-T080
of	O
reduced	B-T116
gsh	B-T116
and	O
oxidized	B-T116
gssg	I-T116
glutathione	I-T116
,	O
gsh	B-T116
/	O
gssg	B-T116
,	O
xanthine	O
oxidase	O
xo	O
activity	O
,	O
lipid	O
peroxidation	O
,	O
lymphocyte	O
chemotaxis	O
,	O
natural	O
killer	O
nk	O
activity	O
and	O
mitogen	O
cona	B-T116
and	O
lps	B-T109
lymphocyte	O
proliferation	O
.	O
	
obese	O
animals	O
presented	O
higher	B-T080
gssg	B-T116
levels	B-T080
p	O
=	O
0.003	O
,	O
gssg	B-T116
/	O
gsh	B-T116
ratio	B-T081
p	O
=	O
0.013	O
,	O
lipid	O
peroxidation	O
p	O
=	O
0.004	O
,	O
xo	O
activity	O
p	O
=	O
0.015	O
and	O
lymphocyte	O
chemotaxis	O
p	O
<	O
0.001	O
,	O
and	O
lower	O
nk	O
activity	O
p	O
=	O
0.003	O
and	O
proliferation	B-T169
in	O
response	O
to	O
cona	B-T116
p	O
<	O
0.001	O
than	O
controls	O
.	O
	
2-ohoa	B-T109
reversed	O
totally	O
or	O
partially	O
most	O
of	O
the	O
changes	B-T081
body	O
weight	O
,	O
fat	O
content	O
,	O
gssg	B-T116
levels	B-T080
,	O
gsh	B-T116
/	O
gssg	B-T116
,	O
lipid	O
peroxidation	O
,	O
chemotaxis	O
and	O
proliferation	O
,	O
all	O
p	O
<	O
0.05	O
,	O
while	O
n-3	B-T109
pufa	I-T109
reversed	O
the	O
increase	B-T169
in	O
xo	O
activity	O
p	O
=	O
0.032	O
.	O
	
in	O
conclusion	O
,	O
2-ohoa	B-T109
,	O
and	O
to	O
a	O
lesser	O
extent	O
n-3	B-T109
pufa	I-T109
,	O
could	O
ameliorate	O
the	O
oxidative	O
stress	O
and	O
alteration	B-T078
of	O
leukocyte	O
function	O
in	O
spleen	O
of	O
obese	O
mice	O
.	O
	
our	O
findings	B-T033
support	O
a	O
link	O
between	O
obesity	B-T047
and	O
immunosenescence	O
and	O
suggest	O
a	O
potential	O
therapeutic	B-T169
tool	I-T169
for	O
obesity	B-T047
-related	O
immune	B-T047
dysfunction	I-T047
.	O
	
assembly	O
of	O
the	O
outermost	O
spore	O
layer	O
pieces	O
of	O
the	O
puzzle	O
are	O
coming	O
together	O
certain	O
endospore-forming	O
soil	O
dwelling	O
bacteria	O
are	O
important	O
human	O
,	O
animal	O
or	O
insect	O
pathogens	O
.	O
	
these	O
organisms	O
produce	O
spores	O
containing	O
an	O
outer	O
layer	O
,	O
the	O
exosporium	O
.	O
	
the	O
exosporium	O
is	O
the	O
site	B-T080
of	I-T080
interactions	B-T169
between	O
the	O
spore	O
and	O
the	O
soil	O
environment	B-T082
and	O
between	O
the	O
spore	O
and	O
the	O
infected	B-T033
host	O
during	O
the	O
initial	B-T079
stages	B-T079
of	O
infection	O
.	O
	
the	O
composition	O
and	O
assembly	O
process	O
of	O
the	O
exosporium	O
are	O
poorly	O
understood	O
.	O
	
this	O
is	O
partly	O
due	O
to	O
the	O
extreme	O
stability	B-T080
of	O
the	O
exosporium	O
that	O
has	O
proven	O
to	O
be	O
refractive	O
to	O
existing	O
methods	B-T169
to	O
deconstruct	O
the	O
intact	B-T080
structure	B-T082
into	O
its	O
component	O
parts	B-T082
.	O
	
although	O
more	O
than	O
20	O
proteins	B-T116
have	O
been	O
identified	B-T080
as	O
exosporium	O
-	O
associated	B-T080
,	O
their	O
abundance	B-T080
,	O
relationship	B-T080
to	O
other	O
proteins	B-T116
and	O
the	O
processes	O
by	O
which	O
they	O
are	O
assembled	O
to	O
create	O
the	O
exosporium	O
are	O
largely	O
unknown	O
.	O
	
in	O
this	O
issue	O
of	O
molecular	O
microbiology	O
,	O
terry	O
,	O
jiang	O
,	O
and	O
colleagues	O
in	O
per	O
bullough's	O
laboratory	O
show	O
that	O
the	O
exsy	B-T116
protein	I-T116
is	O
a	O
major	O
structural	B-T116
protein	I-T116
of	O
the	O
exosporium	O
basal	O
layer	O
of	O
b	O
.	O
	
cereus	O
family	O
spores	O
and	O
that	O
it	O
can	O
self-assemble	B-T052
into	O
complex	B-T080
structures	B-T082
that	O
possess	O
many	O
of	O
the	O
structural	B-T082
features	B-T080
characteristic	B-T080
of	O
the	O
exosporium	O
basal	O
layer	O
.	O
	
the	O
authors	O
refined	O
a	O
model	B-T170
for	O
exosporium	O
assembly	O
.	O
	
their	O
findings	B-T033
may	O
have	O
implications	O
for	O
exosporium	O
formation	B-T169
in	O
other	O
spore	O
forming	O
bacteria	O
,	O
including	O
clostridium	O
species	O
.	O
	
skeletal	O
muscle	O
metabolic	O
adaptations	O
to	O
endurance	B-T079
exercise	O
training	O
are	O
attainable	B-T052
in	O
mice	O
with	O
simvastatin	B-T109
treatment	B-T061
we	O
tested	O
the	O
hypothesis	B-T078
that	O
a	O
6-week	O
regimen	B-T061
of	O
simvastatin	B-T109
would	O
attenuate	B-T052
skeletal	O
muscle	O
adaptation	O
to	O
low-intensity	O
exercise	O
.	O
	
male	O
c57bl/6j	O
wildtype	O
mice	O
were	O
subjected	O
to	O
6-weeks	O
of	O
voluntary	O
wheel	O
running	O
or	O
normal	O
cage	O
activities	B-T052
with	O
or	O
without	O
simvastatin	B-T109
treatment	B-T061
20	O
mg/kg/d	O
,	O
n	O
=	O
7-8	O
per	O
group	O
.	O
	
adaptations	O
in	B-T062
in	O
vivo	I-T062
fatigue	O
resistance	B-T169
were	O
determined	O
by	O
a	O
treadmill	O
running	O
test	O
,	O
and	O
by	O
ankle	O
plantarflexor	O
contractile	O
assessment	O
.	O
	
the	O
tibialis	O
anterior	O
,	O
gastrocnemius	O
,	O
and	O
plantaris	O
muscles	O
were	O
evaluated	O
for	O
exercised	O
-induced	O
mitochondrial	O
adaptations	O
i.e	O
,	O
biogenesis	O
,	O
function	B-T169
,	O
autophagy	O
.	O
	
there	O
was	O
no	B-T033
difference	I-T033
in	O
weekly	O
wheel	B-T052
running	I-T052
distance	I-T052
between	O
control	O
and	O
simvastatin	B-T109
-	O
treated	B-T169
mice	O
p	O
=	O
0.51	O
.	O
	
trained	O
mice	O
had	O
greater	O
treadmill	O
running	O
distance	B-T081
296%	O
,	O
p<0	O
,	O
and	O
ankle	O
plantarflexor	O
contractile	O
fatigue	O
resistance	B-T169
9%	O
,	O
p<0	O
compared	O
to	O
sedentary	O
mice	O
,	O
independent	O
of	O
simvastatin	B-T109
treatment	B-T061
.	O
	
at	O
the	O
cellular	O
level	O
,	O
trained	O
mice	O
had	O
greater	O
mitochondrial	O
biogenesis	O
e.g	O
,	O
2-fold	O
greater	O
pgc1α	B-T116
expression	O
,	O
p<0	O
and	O
mitochondrial	O
content	O
e.g	O
,	O
25%	O
greater	O
citrate	B-T116
synthase	I-T116
activity	O
,	O
p<0	O
,	O
independent	O
of	O
simvastatin	B-T109
treatment	B-T061
.	O
	
mitochondrial	O
autophagy	O
-related	O
protein	B-T116
contents	O
were	O
greater	O
in	O
trained	O
mice	O
e.g	O
,	O
40%	O
greater	O
bnip3	B-T116
,	O
p<0	O
,	O
independent	O
of	O
simvastatin	B-T109
treatment	B-T061
.	O
	
however	O
,	O
drp1	B-T116
,	O
a	O
marker	O
of	O
mitochondrial	O
fission	O
,	O
was	O
less	O
in	O
simvastatin	B-T109
treated	B-T169
mice	O
,	O
independent	O
of	O
exercise	O
training	O
,	O
and	O
there	O
was	O
a	O
significant	O
interaction	B-T169
between	O
training	O
and	O
statin	O
treatment	B-T061
p<0	O
for	O
lc3-ii	B-T116
protein	I-T116
content	B-T081
,	O
a	O
marker	O
of	O
autophagy	O
flux	O
.	O
	
these	O
data	O
indicate	O
that	O
whole	O
body	O
and	O
skeletal	O
muscle	O
adaptations	O
to	O
endurance	B-T079
exercise	O
training	O
are	O
attainable	B-T052
with	O
simvastatin	B-T109
treatment	B-T061
,	O
but	O
simvastatin	B-T109
may	O
have	O
side	O
effects	O
on	O
muscle	O
mitochondrial	O
maintenance	O
via	O
autophagy	O
,	O
which	O
could	O
have	O
long-term	B-T079
implications	O
on	O
muscle	O
health	B-T078
.	O
	
evaluation	O
and	O
treatment	B-T169
of	O
anemia	B-T047
in	O
premature	B-T047
infants	I-T047
anemia	B-T047
in	O
preterm	O
infants	O
is	O
the	O
pathophysiological	B-T169
process	O
with	O
greater	O
and	O
more	O
rapid	O
decline	B-T081
in	O
hemoglobin	B-T116
compared	B-T052
to	O
the	O
physiological	B-T169
anemia	B-T047
in	O
infants	O
.	O
	
there	O
is	O
a	O
need	O
for	O
transfusions	B-T061
and	O
administration	B-T061
of	O
human	B-T116
recombinant	I-T116
erythropoietin	I-T116
.	O
	
to	O
determine	B-T078
the	O
frequency	B-T079
of	O
anemia	B-T047
in	O
premature	B-T047
infants	I-T047
at	O
the	O
pediatric	O
clinic	O
,	O
university	O
clinical	O
center	O
sarajevo	O
,	O
as	O
well	O
as	O
parameter	O
values	O
in	O
the	O
blood	O
count	O
of	O
premature	B-T047
infants	I-T047
and	O
to	O
explore	O
a	O
relationship	B-T080
between	O
blood	B-T061
transfusions	I-T061
with	O
the	O
advent	O
of	O
intraventricular	O
hemorrhage	O
determine	B-T078
treatment	B-T169
outcome	O
in	O
preterm	O
infants	O
.	O
	
research	B-T062
is	O
retrospective	B-T062
study	I-T062
and	O
it	O
included	O
the	O
period	B-T079
of	O
six	O
months	B-T079
in	O
year	B-T079
2014	O
.	O
	
research	B-T062
included	O
100	O
patients	O
,	O
gestational	O
age	O
<	O
37	O
weeks	B-T079
premature	B-T047
infants	I-T047
.	O
	
data	B-T078
were	O
collected	B-T078
by	O
examining	B-T033
the	O
medical	B-T170
records	I-T170
of	O
patients	O
at	O
the	O
pediatric	O
clinic	O
,	O
uccs	O
.	O
	
the	O
first	B-T081
group	B-T078
of	O
patients	O
were	O
premature	B-T047
infants	I-T047
of	O
gestational	O
age	O
32	O
weeks	B-T079
62/100	O
and	O
the	O
second	B-T081
group	B-T078
were	O
premature	B-T047
infants	I-T047
of	O
gestational	O
age	O
33-37	O
weeks	B-T079
38/100	O
.	O
	
among	O
the	O
patients	O
,	O
5%	O
were	O
boys	O
and	O
46%	O
girls	O
.	O
	
there	O
was	O
significant	B-T081
difference	I-T081
in	O
birth	O
weight	O
and	O
apgar	O
score	O
among	O
the	O
groups	B-T078
.	O
	
in	O
the	O
first	B-T081
group	B-T078
,	O
there	O
were	O
27.42	O
of	O
deaths	B-T033
,	O
while	O
in	O
the	O
second	B-T081
group	B-T078
,	O
there	O
were	O
only	O
10.53	O
of	O
deaths	B-T033
.	O
	
there	O
was	O
a	O
significant	B-T081
difference	I-T081
in	O
the	O
length	O
of	O
treatment	B-T169
.	O
	
there	O
was	O
a	O
statistically	B-T081
significant	I-T081
difference	B-T081
in	O
the	O
need	O
for	O
transfusion	B-T061
among	O
the	O
groups	B-T078
.	O
	
18	O
patients	O
in	O
the	O
first	B-T081
group	B-T078
required	O
a	O
transfusion	B-T061
,	O
while	O
in	O
the	O
second	B-T081
group	B-T078
only	O
3	O
patients	O
.	O
	
preterm	O
infants	O
of	O
gestational	O
age	O
32	O
weeks	B-T079
are	O
likely	O
candidates	O
for	O
blood	B-T061
transfusion	I-T061
during	O
treatment	B-T169
.	O
	
preterm	O
infants	O
of	O
gestational	O
age	O
32	O
weeks	B-T079
have	O
the	O
risk	B-T078
of	O
intracranial	B-T047
bleeding	I-T047
associated	B-T080
with	I-T080
the	O
application	O
of	O
blood	B-T061
transfusion	I-T061
in	O
the	O
first	O
week	B-T079
of	O
medial	O
patellofemoral	O
ligament	O
reconstruction	B-T061
femoral	O
tunnel	B-T082
accuracy	B-T080
relationship	O
to	O
disease	B-T047
-	O
specific	B-T080
quality	B-T078
of	I-T078
life	I-T078
medial	O
patellofemoral	O
ligament	O
mpfl	O
reconstruction	B-T061
is	O
a	O
procedure	O
aimed	O
to	O
reestablish	O
the	O
checkrein	O
to	O
lateral	O
patellar	O
translation	O
in	O
patients	O
with	O
symptomatic	O
patellofemoral	O
instability	O
.	O
	
correct	O
femoral	O
tunnel	B-T082
position	B-T082
is	O
thought	O
to	O
be	O
crucial	O
to	O
successful	O
mpfl	O
reconstruction	B-T061
,	O
but	O
the	O
accuracy	B-T080
of	O
this	O
statement	O
in	O
terms	O
of	O
patient	O
outcomes	O
has	O
not	O
been	O
tested	O
.	O
	
to	O
assess	O
the	O
accuracy	B-T080
of	O
femoral	O
tunnel	B-T082
placement	O
in	O
an	O
mpfl	O
reconstruction	B-T061
cohort	B-T098
and	O
to	O
determine	O
the	O
correlation	B-T080
between	O
tunnel	B-T082
accuracy	B-T080
and	O
a	O
validated	B-T062
disease	B-T047
-	O
specific	B-T080
,	O
patient	O
-reported	O
quality-of-life	B-T078
outcome	B-T081
measure	I-T081
.	O
	
case	O
series	O
level	O
of	O
evidence	O
,	O
4	O
.	O
	
between	O
june	B-T079
2008	O
and	O
february	B-T080
2014	O
,	O
a	O
total	O
of	O
206	O
subjects	B-T098
underwent	O
an	O
mpfl	O
reconstruction	B-T061
.	O
	
lateral	B-T082
radiographs	O
were	O
measured	O
to	O
determine	O
the	O
accuracy	B-T080
of	O
the	O
femoral	O
tunnel	B-T082
by	O
measuring	O
the	O
distance	O
from	O
the	O
center	O
of	O
the	O
femoral	O
tunnel	B-T082
to	O
the	O
schöttle	B-T082
point	I-T082
.	O
	
banff	B-T081
patella	I-T081
instability	I-T081
instrument	I-T081
bpii	I-T081
scores	I-T081
were	O
collected	O
a	O
mean	B-T081
24	O
months	B-T079
postoperatively	B-T079
.	O
	
a	O
total	O
of	O
155	O
79.5	O
subjects	O
had	O
adequate	O
postoperative	B-T079
lateral	B-T082
radiographs	O
and	O
complete	O
bpii	B-T081
scores	I-T081
.	O
	
the	O
mean	B-T081
duration	B-T079
of	O
follow-up	O
sd	B-T081
was	O
24.4	O
8.2	O
months	B-T079
range	O
,	O
12-74	O
months	B-T079
.	O
	
measurement	B-T169
from	O
the	O
center	B-T082
of	O
the	O
femoral	O
tunnel	B-T082
to	O
the	O
schöttle	B-T082
point	I-T082
resulted	O
in	O
143	O
92.3	O
tunnel	B-T082
s	O
being	O
categorized	O
as	O
""""	O
good	B-T080
""""	O
or	O
""""	O
ideal	B-T080
""""	O
there	O
were	O
8	O
failures	O
in	O
the	O
cohort	B-T098
,	O
none	O
of	O
which	O
occurred	O
in	O
malpositioned	B-T082
tunnels	B-T082
.	O
	
the	O
mean	B-T081
distance	O
from	O
the	O
center	B-T082
of	O
the	O
mpfl	O
tunnel	B-T082
to	O
the	O
center	B-T082
of	O
the	O
schöttle	B-T082
point	I-T082
was	O
5.9	O
4.2	O
mm	O
range	O
,	O
0.5	O
mm	O
.	O
	
the	O
mean	B-T081
postoperative	B-T079
bpii	B-T081
score	I-T081
was	O
65.2	O
22.5	O
range	O
,	O
9.2	O
.	O
	
pearson	B-T170
r	I-T170
correlation	I-T170
demonstrated	O
no	B-T033
statistically	I-T033
significant	I-T033
relationship	B-T080
between	O
accuracy	B-T080
of	O
femoral	O
tunnel	B-T082
position	B-T082
and	O
bpii	B-T081
score	I-T081
r	O
=	O
-0	O
95%	O
ci	O
,	O
-0	O
to	O
0.08	O
.	O
	
there	O
was	O
no	B-T080
evidence	I-T080
of	I-T080
a	O
correlation	B-T080
between	O
the	O
accuracy	B-T080
of	O
mpfl	O
reconstruction	B-T061
femoral	O
tunnel	B-T082
in	O
relation	O
to	O
the	O
schöttle	B-T082
point	I-T082
and	O
disease	B-T047
-	O
specific	B-T080
quality-of-life	B-T080
scores	I-T080
.	O
	
graft	O
failure	O
was	O
not	O
related	O
to	O
femoral	O
tunnel	B-T082
placement	O
.	O
	
the	O
patellofemoral	O
instability	O
population	O
is	O
complex	O
,	O
and	O
patients	O
present	O
with	O
multiple	O
risk	B-T033
factors	I-T033
that	O
,	O
in	O
addition	O
to	O
the	O
accuracy	B-T080
of	O
femoral	O
tunnel	B-T082
position	B-T082
,	O
contribute	O
to	O
quality	B-T078
of	I-T078
life	I-T078
and	O
warrant	O
further	O
evidence	O
for	O
instructions	O
-based	O
updating	O
of	O
task-set	B-T061
representations	I-T061
the	O
informed	B-T080
fadeout	O
effect	O
the	O
cognitive	O
system	O
can	O
be	O
updated	O
rapidly	O
and	O
efficiently	O
to	O
maximize	O
performance	B-T061
in	O
cognitive	O
tasks	O
.	O
	
this	O
paper	O
used	O
a	O
task	O
-	O
switching	B-T169
task	O
to	O
explore	O
updating	O
at	O
the	O
level	B-T080
of	O
the	O
plausible	O
task	O
-sets	O
held	O
for	O
future	O
performance	B-T061
.	O
	
previous	O
research	B-T062
suggested	O
a	O
""""	O
fadeout	O
effect	O
""""	O
,	O
performance	B-T061
improvement	B-T061
when	O
moving	O
from	O
task	O
-	O
switching	B-T169
context	O
to	O
single-task	B-T169
context	O
,	O
yet	O
this	O
effect	O
could	O
reflect	O
passive	B-T080
learning	O
rather	O
than	O
intentional	B-T080
control	B-T080
.	O
	
in	O
a	O
novel	O
""""	O
informed	B-T080
fadeout	B-T078
paradigm	B-T062
""""	O
,	O
one	O
of	O
two	O
tasks	O
was	O
canceled	O
for	O
a	O
certain	O
number	O
of	O
trials	B-T062
and	O
participants	B-T098
were	O
informed	B-T080
or	O
uninformed	B-T033
regarding	O
task	O
cancelation	B-T080
.	O
	
the	O
""""	O
informed	B-T080
fadeout	O
effect	O
""""	O
indicates	O
better	O
performance	B-T061
in	O
the	O
informed	B-T080
than	O
uninformed	B-T033
fadeout	O
after	O
one	O
informed	B-T080
trial	B-T062
had	O
been	O
executed	B-T052
.	O
	
however	O
,	O
the	O
results	O
regarding	O
the	O
first	O
trial	B-T062
were	O
inconclusive	O
.	O
	
possible	O
underlying	O
mechanisms	B-T169
metacarpophalangeal	B-T061
joint	I-T061
arthrodesis	I-T061
of	O
the	O
thumb	O
-	O
minimum	O
of	O
eight	O
months	B-T079
follow-up	O
disorders	B-T047
of	O
the	O
thumb	O
metacarpophalangeal	O
mcp	O
joint	O
can	O
lead	O
to	O
significant	O
loss	B-T081
of	O
function	O
and	O
pain	O
.	O
	
thumb	O
mcp	O
arthrodesis	B-T061
following	O
traumatic	O
injuries	O
is	O
inadequately	O
described	B-T078
and	O
recent	O
studies	B-T062
have	O
questioned	O
the	O
outcome	B-T169
of	O
this	O
treatment	B-T061
.	O
	
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
report	O
outcome	B-T169
and	O
disability	B-T033
following	O
thumb	O
mcp	O
joint	O
arthrodesis	B-T061
in	O
the	O
treatment	B-T061
of	O
chronic	O
instability	O
after	O
traumatic	O
injuries	O
.	O
	
a	O
retrospective	B-T080
review	B-T061
of	O
26	O
patients	O
operated	B-T061
on	O
with	O
mcp	O
joint	O
arthrodesis	B-T061
,	O
median	O
follow-up	O
42	O
months	B-T079
8-104	O
months	B-T079
.	O
	
subjective	O
outcome	B-T169
was	O
assessed	B-T052
using	O
the	O
disabilities	B-T170
of	I-T170
the	I-T170
arm	I-T170
,	O
shoulder	I-T170
,	O
and	I-T170
hand-questionnaire	I-T170
dash	B-T170
.	O
	
in	O
addition	O
,	O
patient	B-T080
satisfaction	I-T080
,	O
pain	O
,	O
stiffness	O
,	O
and	O
impairment	B-T169
of	O
activities	O
of	O
daily	O
living	O
were	O
assessed	B-T052
on	O
a	O
visual	O
analogue	O
scale	O
vas	O
followed	O
by	O
a	O
question	O
stating	O
whether	O
they	O
would	O
undergo	O
the	O
same	O
procedure	B-T169
again	O
.	O
	
two	O
patients	O
7.7	O
needed	O
re-operation	B-T061
due	O
to	O
nonunion	B-T033
.	O
	
four	O
patients	O
15.4	O
needed	O
hardware	B-T061
removal	I-T061
.	O
	
median	B-T081
dash	B-T170
-	O
score	B-T081
was	O
18	O
25-75%	O
range	B-T081
6-47	O
,	O
with	O
lower	O
dash	B-T170
score	B-T081
s	I-T081
being	O
better	O
.	O
	
score	B-T081
s	I-T081
were	O
significantly	O
worse	O
in	O
gender	O
and	O
age	O
matched	O
individuals	B-T098
p<0	O
.	O
	
median	B-T081
vas	O
for	O
pain	O
was	O
3.7	O
range	B-T081
0-8	O
.	O
	
more	O
than	O
50%	O
of	O
patients	O
reported	O
mild	B-T033
,	O
moderate	O
or	O
severe	B-T033
pain	I-T033
,	O
but	O
all	O
patients	O
reported	O
that	O
they	O
were	O
willing	O
to	O
undergo	O
the	O
same	O
procedure	B-T169
again	O
.	O
	
our	O
data	B-T078
suggest	O
,	O
that	O
patients	O
with	O
post-traumatic	B-T079
thumb	O
injuries	O
managed	O
with	O
thumb	O
mcp	O
joint	O
arthrodesis	B-T061
perform	O
worse	O
than	O
gender	O
and	O
age	O
matched	O
individuals	B-T098
.	O
	
many	O
lived	O
with	O
pain	O
,	O
but	O
all	O
reported	O
that	O
they	O
were	O
willing	O
to	O
undergo	O
the	O
same	O
procedure	B-T169
again	O
.	O
	
we	O
suggest	O
that	O
the	O
disability	B-T170
scale	I-T170
by	O
the	O
national	O
board	O
of	O
industrial	O
injuries	O
should	O
be	O
reconsidered	O
for	O
patients	O
operated	B-T061
on	O
with	O
thumb	O
mcp	O
arthrodesis	B-T061
.	O
	
pyoderma	B-T047
gangrenosum	I-T047
a	O
clinician's	O
nightmare	O
pyoderma	B-T047
gangrenosum	I-T047
pg	B-T047
is	O
a	O
rare	B-T047
disease	I-T047
and	O
that	O
affecting	O
specifically	O
the	O
sole	O
of	O
the	O
foot	O
,	O
is	O
even	O
rarer	O
.	O
	
here	O
,	O
we	O
report	B-T170
the	O
case	O
of	O
a	O
54-year-	O
old	B-T079
female	O
admitted	O
with	O
a	O
painful	O
ulcer	B-T047
on	O
the	O
sole	O
of	O
the	O
right	O
foot	O
which	O
was	O
initially	O
treated	B-T061
with	I-T061
empirical	O
antibiotics	O
and	O
debridement	B-T061
.	O
	
the	O
disease	B-T047
was	O
found	O
to	O
spread	O
rapidly	B-T080
after	O
each	O
debridement	B-T061
.	O
	
the	O
culture	O
reports	O
were	O
negative	B-T033
rheumatology	O
workup	O
and	O
doppler	O
study	O
were	O
within	O
normal	B-T033
limits	I-T033
.	O
	
a	O
clinical	B-T080
suspicion	B-T078
of	O
pg	B-T047
was	O
made	O
and	O
was	O
confirmed	O
with	O
tissue	O
biopsy	O
.	O
	
she	O
was	O
started	B-T061
on	I-T061
oral	I-T061
steroids	I-T061
following	O
which	O
she	O
dramatically	O
improved	B-T033
.	O
	
thus	O
,	O
when	O
a	O
patient	O
presents	O
with	O
a	O
rapidly	B-T080
expanding	O
painful	O
ulcer	B-T047
in	O
a	O
vascular	O
limb	O
that	O
is	O
refractory	B-T169
to	O
antibiotic	B-T061
treatment	I-T061
and	O
exacerbating	B-T080
on	O
debridement	B-T061
,	O
it	O
is	O
imperative	O
to	O
consider	O
the	O
possibility	O
of	O
visualization	O
for	O
understanding	O
uncertainty	B-T033
in	O
activation	B-T052
volumes	B-T081
for	O
deep	B-T061
brain	I-T061
stimulation	I-T061
we	O
have	O
created	O
the	O
neurostimulation	B-T170
uncertainty	I-T170
viewer	I-T170
nuview	I-T170
or	I-T170
νview	I-T170
tool	I-T170
for	O
exploring	O
data	B-T078
arising	O
from	O
deep	B-T061
brain	I-T061
stimulation	I-T061
dbs	B-T061
.	O
	
simulated	B-T062
volume	B-T081
of	I-T081
tissue	I-T081
activated	I-T081
vta	B-T081
,	O
using	O
clinical	O
electrode	O
placements	O
,	O
are	O
recorded	B-T052
along	O
with	O
patient	O
outcomes	B-T080
in	O
the	O
unified	B-T170
parkinson's	I-T170
disease	I-T170
rating	I-T170
scale	I-T170
updrs	B-T170
.	O
	
the	O
data	B-T078
is	O
volumetric	B-T080
and	O
sparse	B-T080
,	O
with	O
multi-value	B-T080
patient	O
results	B-T169
for	O
each	O
activated	B-T052
voxel	O
in	O
the	O
simulation	B-T062
.	O
	
νview	O
provides	O
a	O
collection	B-T169
of	O
visual	B-T170
methods	I-T170
to	O
explore	O
the	O
activated	B-T052
tissue	O
to	O
enhance	O
understanding	O
of	O
electrode	O
usage	B-T169
for	O
improved	O
therapy	B-T061
with	O
post-synthetic	O
conversion	B-T169
of	O
5-pivaloyloxymethyluridine	O
present	B-T033
in	O
a	O
support-bound	O
rna	O
oligomer	O
into	O
biologically	B-T080
relevant	B-T080
derivatives	O
of	O
5-methyluridine	O
a	O
post-synthetic	O
reaction	B-T169
of	O
5-pivaloyloxymethyluridine	O
present	B-T033
in	O
a	O
support-bound	O
rna	O
oligomer	O
with	O
various	O
nucleophilic	O
reagents	O
furnished	O
efficiently	O
the	O
corresponding	O
products	O
bearing	O
one	O
aof	O
the	O
trna	O
wobble	O
5-methyluridines	O
mnm	O
,	O
cmnm	O
,	O
τm	O
,	O
nm	O
,	O
inm	O
or	O
cnm	O
.	O
	
the	O
syntheses	B-T052
of	O
oligoribonucleotides	O
modified	B-T169
with	O
inm	O
and	O
cnm	O
non-pharmacological	B-T169
treatments	B-T061
for	O
pain	B-T061
relief	I-T061
tens	B-T061
and	O
acupuncture	B-T061
acupuncture	B-T061
and	O
transcutaneous	B-T061
electrical	I-T061
nerve	I-T061
stimulation	I-T061
tens	B-T061
are	O
non-pharmacological	B-T169
methods	B-T169
that	O
have	O
been	O
used	O
for	O
millennia	B-T079
to	O
relieve	B-T061
pain	I-T061
.	O
	
as	O
with	O
all	O
complementary	B-T061
treatments	I-T061
,	O
efficacy	B-T080
evaluations	O
face	O
two	O
hurdles	O
the	O
non-feasibility	O
of	O
double-blinding	B-T062
and	O
the	O
difficulty	O
in	O
identifying	O
the	O
optimal	B-T081
control	I-T081
population	I-T081
or	O
treatment	B-T061
.	O
	
nevertheless	O
,	O
recent	O
studies	O
of	O
good	B-T080
methodological	O
quality	O
have	O
demonstrated	O
benefits	B-T081
in	O
many	O
types	O
of	O
pain	O
compared	O
to	O
conventional	B-T080
treatment	B-T061
.	O
	
the	O
mechanisms	B-T169
of	I-T169
action	I-T169
of	O
acupuncture	B-T061
and	O
tens	B-T061
,	O
which	O
are	O
increasingly	B-T169
well	O
understood	O
,	O
involve	O
endogenous	B-T169
pain	B-T061
control	I-T061
systems	I-T061
,	O
cerebral	O
plasticity	O
,	O
and	O
nonspecific	O
effects	B-T080
e.g	O
,	O
expectations	B-T078
and	O
placebo	B-T078
effect	I-T078
.	O
	
no	O
serious	O
adverse	O
effects	O
have	O
been	O
reported	O
.	O
	
these	O
data	B-T078
support	O
the	O
more	O
widespread	O
use	O
of	O
non-pharmacological	B-T169
pain	B-T061
management	I-T061
,	O
most	O
notably	O
in	O
patients	O
with	O
chronic	O
pain	O
inadequately	O
relieved	B-T169
by	I-T169
medications	O
synaptic	O
and	O
neuronal	O
autoantibody	B-T116
-	O
associated	B-T080
psychiatric	O
syndromes	O
controversies	O
and	O
hypotheses	B-T078
autoimmune	B-T047
encephalitis	I-T047
ae	B-T047
mediated	O
by	O
antibodies	B-T116
against	O
synaptic	O
and	O
neuronal	O
surface	B-T082
targets	B-T169
frequently	B-T079
presents	B-T033
with	O
a	O
psychiatric	O
syndrome	O
.	O
	
in	O
these	O
patients	O
,	O
removal	B-T061
of	I-T061
autoantibodies	B-T116
treats	B-T169
the	O
disease	B-T047
and	O
outcomes	B-T080
are	O
closely	O
linked	O
to	O
early	O
intervention	B-T061
.	O
	
the	O
discovery	B-T052
of	O
these	O
autoantibodies	B-T116
in	O
isolated	B-T169
psychiatric	O
syndromes	O
has	O
raised	B-T080
the	O
possibility	O
that	O
these	O
patients	O
may	O
derive	O
similar	O
benefits	B-T081
from	O
immunotherapy	B-T061
,	O
a	O
potentially	B-T080
transformational	O
approach	B-T082
to	O
the	O
treatment	B-T169
of	O
mental	O
illness	O
.	O
	
although	O
open-label	B-T062
case	I-T062
series	I-T062
suggest	O
impressive	O
therapeutic	B-T080
outcomes	I-T080
,	O
the	O
pathological	B-T169
relevance	B-T080
of	O
these	O
autoantibodies	B-T116
outside	O
of	O
canonical	B-T081
presentations	I-T081
is	O
debated	O
.	O
	
the	O
advent	O
of	O
diagnostic	B-T170
criteria	I-T170
for	O
ae	B-T047
attempts	O
to	O
facilitate	O
its	O
prompt	O
identification	B-T080
but	O
risks	B-T078
prematurely	O
neglecting	O
the	O
potential	B-T080
scientific	O
and	O
clinical	B-T033
significance	I-T033
of	O
isolated	B-T169
syndromes	B-T047
that	O
do	O
not	O
satisfy	O
these	O
criteria	O
.	O
	
here	O
,	O
we	O
propose	O
using	O
a	O
syndrome	B-T047
-	O
level	B-T080
taxonomy	O
that	O
has	O
occasional	B-T079
,	O
but	O
not	O
necessary	O
,	O
overlap	B-T079
with	O
ae	B-T047
synaptic	O
and	O
neuronal	O
autoantibody	B-T116
-	O
associated	B-T080
psychiatric	O
syndromes	O
or	O
""""	O
snaps	O
""""	O
.	O
	
this	O
will	O
prevent	B-T169
confusion	O
with	O
ae	B-T047
and	O
act	B-T170
heuristically	I-T170
to	O
promote	B-T052
active	B-T169
investigation	O
into	O
this	O
rare	B-T080
example	O
of	O
psychopathology	O
defined	B-T170
on	O
a	O
molecular	B-T081
level	I-T081
.	O
	
we	O
suggest	O
that	O
this	O
concept	B-T078
would	O
have	O
application	O
in	O
other	O
autoantibody	B-T116
-	O
associated	B-T080
syndromes	B-T047
including	B-T169
seizure	O
,	O
cognitive	B-T169
,	O
and	O
movement	B-T047
disorders	I-T047
,	O
in	O
which	O
similar	B-T080
issues	B-T033
arise	O
.	O
	
we	O
review	B-T169
putative	O
direct	B-T080
and	O
indirect	B-T080
mechanisms	B-T169
and	O
outline	O
experimentally	B-T080
testable	O
hypotheses	B-T078
that	O
would	O
help	O
to	O
determine	O
prospectively	B-T062
in	O
whom	O
autoantibody	B-T116
detection	B-T061
is	O
relevant	B-T080
,	O
and	O
as	O
important	B-T080
,	O
in	O
whom	O
it	O
is	O
not	O
.	O
	
we	O
summarize	O
a	O
pragmatic	O
approach	O
to	O
autoantibody	B-T116
testing	B-T169
and	O
management	O
in	O
severe	B-T080
mental	O
illness	O
in	O
order	O
to	O
promptly	O
diagnose	B-T033
ae	B-T047
and	O
advocate	O
a	O
research	B-T062
-	O
orientated	B-T033
experimental	B-T080
medicine	O
paradigm	B-T062
for	O
snaps	O
,	O
where	O
there	O
is	O
greater	B-T081
equipoise	B-T109
.	O
	
we	O
conclude	O
that	O
snaps	O
remains	O
a	O
nascent	O
area	O
of	O
clinical	B-T080
neuroscience	O
with	O
great	O
potential	B-T080
and	O
in	O
ongoing	B-T078
need	B-T080
of	O
psychiatry	O
-led	O
basic	O
and	O
clinical	B-T062
research	I-T062
.	O
	
nf-κb	B-T116
links	O
tlr2	B-T116
and	O
par1	B-T116
to	O
soluble	B-T080
immunomodulator	O
factor	O
secretion	O
in	O
human	O
platelets	O
the	O
primary	B-T080
toll-like	B-T116
receptor	I-T116
tlr	B-T116
immune	O
cell	O
response	O
pathway	O
common	O
for	O
all	O
tlrs	B-T116
is	O
myd88	B-T116
-dependent	O
activation	O
of	O
nf-κb	B-T116
,	O
a	O
seminal	O
transcription	B-T116
factor	I-T116
for	O
many	O
chemokines	B-T116
and	O
cytokines	B-T116
.	O
	
remarkably	O
,	O
anucleate	O
platelets	O
express	O
the	O
nf-κb	B-T116
machinery	O
,	O
whose	O
role	O
in	O
platelets	O
remains	O
poorly	O
understood	O
.	O
	
here	O
,	O
we	O
investigated	B-T169
the	O
contribution	B-T052
of	O
nf-κb	B-T116
in	O
the	O
release	B-T169
of	O
cytokines	B-T116
and	O
serotonin	B-T109
by	O
human	O
platelets	O
,	O
following	B-T079
selective	O
stimulation	O
of	O
tlr2	B-T116
and	O
protease	B-T116
activated	I-T116
receptor	I-T116
1	I-T116
par1	B-T116
,	O
a	O
classical	O
and	O
non-classical	O
pattern-recognition	B-T116
receptor	I-T116
,	O
respectively	O
,	O
able	O
to	O
participate	O
to	O
the	O
innate	O
immune	O
system	O
.	O
	
we	O
discovered	O
that	O
platelet	O
par1	B-T116
activation	O
drives	O
the	O
process	O
of	O
nf-κb	B-T116
phosphorylation	O
,	O
in	O
contrast	O
to	O
tlr2	B-T116
activation	O
,	O
which	O
induces	B-T169
a	O
slower	O
phosphorylation	O
process	O
.	O
	
conversely	O
,	O
platelet	O
par1	B-T116
and	O
tlr2	B-T116
activation	B-T052
induces	B-T169
similar	O
erk1/2	O
,	O
p38	B-T116
,	O
and	O
akt	B-T116
phosphorylation	O
.	O
	
moreover	O
,	O
we	O
found	O
that	O
engagement	O
of	O
platelet	O
tlr2	B-T116
with	O
its	O
ligand	O
,	O
pam3csk4	B-T116
,	O
significantly	B-T081
increases	I-T081
the	O
release	B-T169
of	O
scd62p	B-T116
,	O
rantes	B-T116
,	O
and	O
scd40l	B-T116
this	O
effect	B-T080
was	O
attenuated	B-T080
by	I-T080
incubating	O
platelets	O
with	O
a	O
blocking	B-T169
anti-tlr2	B-T116
antibody	I-T116
.	O
	
this	O
effect	B-T080
appeared	I-T080
selective	O
since	O
no	O
modulation	B-T082
of	O
serotonin	O
secretion	O
was	O
observed	B-T169
following	B-T079
platelet	O
tlr2	B-T116
activation	O
.	O
	
platelet	O
release	B-T169
of	O
scd62p	B-T116
,	O
rantes	B-T116
,	O
and	O
scd40l	B-T116
following	B-T079
tlr2	B-T116
or	O
par1	B-T116
triggering	O
was	O
abolished	O
in	O
the	O
presence	B-T033
of	O
the	O
nf-κb	B-T116
inhibitor	O
bay11-7082	B-T109
,	O
while	O
serotonin	O
release	O
following	B-T079
par1	B-T116
activation	O
was	O
significantly	B-T081
decreased	I-T081
.	O
	
these	O
new	B-T080
findings	B-T169
support	O
the	O
concept	O
that	O
nf-κb	B-T116
is	O
an	O
important	O
player	O
in	O
platelet	O
immunoregulations	O
and	O
optical	B-T062
tweezers	I-T062
studies	B-T062
of	O
transcription	O
by	O
eukaryotic	O
rna	B-T116
polymerases	I-T116
transcription	O
is	O
the	O
first	O
step	O
in	O
the	O
expression	O
of	O
genetic	B-T169
information	B-T078
and	O
it	O
is	O
carried	B-T052
out	O
by	O
large	O
macromolecular	O
enzymes	B-T116
called	O
rna	B-T116
polymerases	I-T116
.	O
	
transcription	O
has	O
been	O
studied	B-T062
for	O
many	O
years	O
and	O
with	O
a	O
myriad	B-T170
of	O
experimental	B-T080
techniques	B-T169
,	O
ranging	B-T081
from	O
bulk	O
studies	B-T062
to	O
high-resolution	O
transcript	O
sequencing	O
.	O
	
in	O
this	O
review	B-T170
,	O
we	O
emphasise	O
the	O
advantages	O
of	O
using	O
single-molecule	O
techniques	B-T169
,	O
particularly	O
optical	B-T062
tweezers	I-T062
,	O
to	O
study	B-T062
transcription	O
dynamics	O
.	O
	
we	O
give	O
an	O
overview	B-T170
of	O
the	O
latest	O
results	B-T169
in	O
the	O
single-molecule	O
transcription	O
field	O
,	O
focusing	O
on	O
transcription	O
by	O
eukaryotic	O
rna	B-T116
polymerases	I-T116
.	O
	
finally	O
,	O
we	O
evaluate	O
recent	O
quantitative	B-T081
models	O
that	O
describe	B-T078
the	O
biophysics	O
of	O
rna	B-T116
polymerase	I-T116
translocation	O
and	O
backtracking	O
decreased	B-T080
frequencies	I-T080
of	O
peripheral	O
blood	O
cd4+cd25+cd127-foxp3+	O
in	O
patients	O
with	O
graves'	B-T047
disease	I-T047
and	O
graves'	B-T047
orbitopathy	I-T047
enhancing	B-T080
effect	I-T080
of	O
insulin	B-T116
growth	I-T116
factor-1	I-T116
on	O
treg	O
cells	O
graves'	B-T047
orbitopathy	I-T047
go	B-T047
is	O
characterized	B-T052
by	O
orbital	O
t	O
cell	O
infiltration	O
.	O
	
we	O
evaluated	O
the	O
regulatory	O
t	O
treg	O
cell	O
fractions	B-T081
induced	B-T169
with	O
igf-1	B-T116
in	O
graves'	B-T047
disease	I-T047
gd	B-T047
with	O
and	O
without	O
go	B-T047
.	O
	
peripheral	O
blood	O
mononuclear	O
cells	O
pbmcs	O
were	O
obtained	O
from	O
13	O
patients	O
with	O
gd	B-T047
without	O
eye	O
manifestations	O
10	O
patients	O
with	O
active	B-T169
go	B-T047
and	O
12	O
patients	O
with	O
nodular	B-T047
goiter	I-T047
ng	B-T047
.	O
	
all	O
the	O
patients	O
from	O
gd	B-T047
,	O
go	B-T047
,	O
and	O
ng	B-T047
were	O
subclinical	O
hyperthyroid	O
.	O
	
we	O
analyzed	B-T062
the	O
expression	O
of	O
treg	O
cell	O
markers	O
cd4	B-T116
,	O
cd25	B-T116
,	O
cd127	B-T116
,	O
foxp3	B-T116
on	O
t	O
cells	O
and	O
their	O
ability	O
to	O
respond	B-T170
to	I-T170
igf-1	B-T116
stimulation	O
.	O
	
in	O
patients	O
with	O
gd	B-T047
without	O
go	B-T047
,	O
we	O
found	O
lowered	B-T081
percentages	I-T081
of	O
cd4	O
foxp3	O
cells	O
,	O
as	O
compared	O
to	O
nodular	B-T047
goiter	I-T047
1.77	O
vs	O
.	O
	
5.42	O
p=0	O
.	O
	
similarly	O
,	O
significantly	B-T080
reduced	I-T080
frequencies	I-T080
of	O
cd4	O
and	O
cd4	O
cells	O
were	O
observed	B-T169
in	O
gd	B-T047
patients	O
as	O
compared	O
to	O
nodular	B-T047
goiter	I-T047
patients	O
with	O
hyperthyreosis	B-T047
,	O
0.7	O
vs	O
.	O
	
1.48	O
p=0	O
and	O
14.5	O
vs	O
.	O
	
37.2	O
p=0	O
,	O
respectively	O
.	O
	
in	O
go	B-T047
with	O
active	B-T169
go	B-T047
,	O
only	O
the	O
percentage	B-T081
of	O
cd4	O
cells	O
was	O
found	O
to	O
be	O
decreased	B-T081
versus	O
nodular	B-T047
goiter	I-T047
9.35	O
vs	O
.	O
	
37.2	O
p=0	O
.	O
	
stimulation	O
of	O
pbmc	O
derived	O
from	O
go	B-T047
patients	O
with	O
igf-1	B-T116
resulted	O
in	O
significant	B-T080
increase	I-T080
of	I-T080
frequency	I-T080
of	O
both	O
cd4	O
foxp3	O
and	O
cd4	O
foxp3	O
cells	O
.	O
	
decreased	B-T080
frequencies	I-T080
of	O
peripheral	O
blood	O
cd4	O
in	O
patients	O
with	O
gd	B-T047
and	O
go	B-T047
could	O
be	O
an	O
useful	O
marker	O
of	O
autoimmune	O
process	O
and	O
perhaps	O
a	O
possible	O
target	O
for	O
future	B-T169
therapies	I-T169
.	O
	
this	O
is	O
the	O
first	O
study	B-T062
demonstrating	O
treg	O
-	O
enhancing	B-T080
effects	I-T080
of	O
igf-1	B-T116
.	O
	
thus	O
igf-1	B-T116
can	O
be	O
accounted	O
for	O
modulating	B-T082
treg	O
cell	O
-related	O
action	B-T052
in	O
γ-butenolide	O
and	O
furanone	O
derivatives	O
from	O
the	O
soil	O
-derived	O
fungus	O
aspergillus	O
sclerotiorum	O
psu-rspg178	O
chromatographic	O
separation	O
of	O
the	O
broth	O
extract	O
of	O
the	O
soil	O
-derived	O
fungus	O
aspergillus	O
sclerotiorum	O
psu-rspg178	O
resulted	O
in	O
isolation	B-T169
of	O
four	O
γ-butenolide-furanone	O
dimers	O
,	O
aspersclerotiorones	O
a-d	O
,	O
a	O
furanone	O
derivative	O
,	O
aspersclerotiorone	O
e	O
,	O
and	O
two	O
γ-butenolide	O
derivatives	O
,	O
aspersclerotiorones	O
f	O
and	O
g	O
,	O
together	O
with	O
six	O
known	O
compounds	O
,	O
penicillic	B-T109
acid	I-T109
,	O
dihydropenicillic	O
acid	O
,	O
5	O
acid	O
,	O
6-methoxy-5	O
acid	O
,	O
coculnol	O
and	O
4r	O
.	O
	
their	O
structures	B-T170
were	O
determined	O
by	O
spectroscopic	O
evidence	O
.	O
	
for	O
aspersclerotiorones	O
a	O
and	O
b	O
,	O
the	O
structures	B-T170
were	O
confirmed	O
by	O
single-crystal	O
x-ray	O
diffraction	O
crystallography	O
.	O
	
penicillic	O
acid	O
displayed	O
weak	O
antibacterial	O
activity	O
against	O
staphylococcus	O
aureus	O
and	O
escherichia	O
coli	O
with	O
equal	O
mic	O
values	O
of	O
128	O
μg/ml	O
,	O
and	O
it	O
was	O
noncytotoxic	B-T080
towards	O
african	O
green	O
monkey	O
kidney	O
fibroblast	O
cells	O
.	O
	
e3	B-T116
ligase	I-T116
rnf126	B-T116
directly	O
ubiquitinates	O
frataxin	B-T116
,	O
promoting	B-T052
its	O
degradation	B-T169
identification	B-T080
of	O
a	O
potential	O
therapeutic	B-T169
target	B-T169
for	O
friedreich	B-T047
ataxia	I-T047
friedreich	B-T047
ataxia	I-T047
frda	B-T047
is	O
a	O
severe	O
genetic	B-T169
neurodegenerative	B-T047
disease	I-T047
caused	O
by	O
reduced	O
expression	O
of	O
the	O
mitochondrial	B-T116
protein	I-T116
frataxin	B-T116
.	O
	
to	O
date	O
,	O
there	O
is	O
no	O
therapy	B-T169
to	O
treat	B-T061
this	O
condition	B-T080
.	O
	
the	O
amount	O
of	O
residual	B-T080
frataxin	B-T116
critically	O
affects	O
the	O
severity	B-T080
of	O
the	O
disease	B-T047
thus	O
,	O
attempts	O
to	O
restore	O
physiological	B-T169
frataxin	B-T116
levels	B-T080
are	O
considered	O
therapeutically	B-T169
relevant	B-T080
.	O
	
frataxin	B-T116
levels	B-T080
are	O
controlled	B-T169
by	I-T169
the	O
ubiquitin-proteasome	O
system	O
therefore	O
,	O
inhibition	B-T052
of	O
the	O
frataxin	B-T116
e3	B-T116
ligase	I-T116
may	O
represent	O
a	O
strategy	B-T062
to	O
achieve	O
an	O
increase	O
in	O
frataxin	B-T116
levels	B-T080
.	O
	
here	O
,	O
we	O
report	O
the	O
identification	B-T080
of	O
the	O
ring	B-T116
e3	I-T116
ligase	I-T116
rnf126	B-T116
as	O
the	O
enzyme	B-T116
that	O
specifically	O
mediates	O
frataxin	B-T116
ubiquitination	O
and	O
targets	O
it	O
for	O
degradation	B-T169
.	O
	
rnf126	B-T116
interacts	B-T169
with	O
frataxin	B-T116
and	O
promotes	B-T052
its	O
ubiquitination	O
in	O
a	O
catalytic	B-T169
activity	I-T169
-	O
dependent	B-T080
manner	O
,	O
both	O
in	B-T082
vivo	I-T082
and	O
in	B-T080
vitro	I-T080
.	O
	
most	O
importantly	O
,	O
rnf126	B-T116
depletion	B-T169
results	O
in	O
frataxin	B-T116
accumulation	B-T033
in	O
cells	O
derived	O
from	O
frda	B-T047
patients	O
,	O
highlighting	O
the	O
relevance	B-T080
of	O
rnf126	B-T116
as	O
a	O
new	O
therapeutic	B-T169
target	B-T169
for	O
friedreich	B-T047
ataxia	I-T047
.	O
	
enhancing	O
doctors'	O
competencies	B-T080
in	O
communication	O
with	O
and	O
activation	B-T052
of	O
older	B-T098
patients	O
the	O
promoting	B-T052
active	B-T169
aging	O
practa	O
computer-based	O
intervention	O
study	O
demographic	O
changes	B-T169
over	O
the	O
past	O
decades	B-T081
call	O
for	O
the	O
promotion	O
of	O
health	O
and	O
disease	O
prevention	O
for	O
older	B-T098
patients	O
,	O
as	O
well	O
as	O
strategies	O
to	O
enhance	O
their	O
independence	B-T078
,	O
productivity	B-T081
,	O
and	O
quality	B-T078
of	I-T078
life	I-T078
.	O
	
our	O
objective	O
was	O
to	O
examine	O
the	O
effects	O
of	O
a	O
computer-based	B-T061
educational	I-T061
intervention	I-T061
designed	O
for	O
general	O
practitioners	O
gps	O
to	O
promote	O
active	B-T169
aging	O
.	O
	
the	O
promoting	B-T052
active	O
aging	O
practa	O
study	O
consisted	O
of	O
a	O
baseline	B-T170
questionnaire	I-T170
,	O
implementation	B-T052
of	O
an	O
intervention	B-T061
,	O
and	O
a	O
follow-up	B-T170
questionnaire	I-T170
that	O
was	O
administered	B-T169
1	O
month	O
after	O
the	O
intervention	O
.	O
	
a	O
total	O
of	O
151	O
primary	O
care	O
facilities	O
response	B-T079
rate	I-T079
151/767	O
,	O
19.7	O
and	O
503	O
gps	O
response	B-T079
rate	I-T079
503/996	O
,	O
50.5	O
agreed	O
to	O
participate	B-T169
in	O
the	O
baseline	B-T062
assessment	I-T062
.	O
	
at	O
the	O
follow-up	B-T062
,	O
393	O
gps	O
filled	O
in	O
the	O
questionnaires	B-T170
response	B-T079
rate	I-T079
,	O
393/503	O
,	O
78.1	O
,	O
but	O
not	O
all	O
of	O
them	O
took	O
part	O
in	O
the	O
intervention	B-T061
.	O
	
the	O
final	O
study	O
group	O
of	O
225	O
gps	O
participated	O
in	O
3	O
study	O
conditions	O
e-learning	O
knowledge	O
plus	O
skills	O
modelling	B-T170
,	O
n=42	O
,	O
a	O
pdf	B-T170
article	I-T170
knowledge	O
only	O
,	O
n=89	O
,	O
and	O
control	O
no	B-T080
intervention	O
,	O
n=94	O
.	O
	
we	O
measured	O
the	O
outcome	O
as	O
scores	B-T081
on	O
the	O
patients	O
expectations	B-T170
scale	I-T170
,	O
communication	B-T170
scale	I-T170
,	O
attitude	B-T170
toward	I-T170
treatment	I-T170
and	I-T170
health	I-T170
scale	I-T170
,	O
and	O
self-efficacy	B-T170
scale	I-T170
.	O
	
gps	O
participating	O
in	O
e-learning	O
demonstrated	O
a	O
significant	B-T078
rise	O
in	O
their	O
perception	O
of	O
older	B-T098
patients	O
'	O
expectations	B-T078
for	O
disease	B-T170
explanation	I-T170
wald	O
χ	O
,	O
p<	O
and	O
in	O
perception	O
of	O
motivational	O
aspect	O
of	O
older	B-T098
patients	O
'	O
attitude	O
toward	O
treatment	B-T169
and	O
health	B-T078
wald	O
χ	O
,	O
p=	O
in	O
comparison	O
with	O
both	O
the	O
control	O
and	O
pdf	O
article	O
groups	O
.	O
	
we	O
observed	O
additional	O
between-	O
group	O
differences	O
at	O
the	O
level	B-T080
of	O
statistical	O
trend	O
.	O
	
gps	O
participating	O
in	O
the	O
pdf	B-T170
article	I-T170
intervention	B-T061
demonstrated	O
a	O
decline	O
in	O
self-assessed	O
communication	O
,	O
both	O
at	O
the	O
level	B-T080
of	O
global	B-T081
scoring	I-T081
wald	O
χ	O
,	O
p<	O
and	O
at	O
the	O
level	B-T080
of	O
20	O
of	O
26	O
specific	O
behaviors	O
all	O
p<	O
.	O
	
factors	O
moderating	O
the	O
effects	B-T080
of	I-T080
the	O
intervention	B-T061
were	O
the	O
number	O
of	O
patients	O
per	O
gp	O
and	O
the	O
facility's	O
organizational	B-T170
structure	I-T170
.	O
	
both	O
methods	O
were	O
suitable	O
,	O
but	O
in	O
different	O
areas	B-T082
and	O
under	O
different	O
conditions	B-T080
.	O
	
the	O
key	O
benefit	O
of	O
the	O
pdf	B-T170
article	I-T170
intervention	B-T061
was	O
raising	O
doctors	O
'	O
reflection	O
on	O
limitations	B-T169
in	O
their	O
communication	O
skills	O
,	O
whereas	O
e-learning	O
was	O
more	O
effective	B-T080
in	O
changing	O
their	O
perception	O
of	O
older	B-T098
patients	O
'	O
proactive	O
attitude	O
,	O
especially	O
among	O
gps	O
working	O
in	O
privately	O
owned	O
facilities	O
and	O
having	O
a	O
greater	O
number	O
of	O
assigned	B-T169
patients	O
.	O
	
although	O
we	O
did	O
not	O
achieve	O
all	O
expected	O
effects	B-T080
of	I-T080
the	O
practa	O
intervention	O
,	O
both	O
its	O
forms	O
seem	O
promising	O
in	O
terms	O
of	O
enhancing	O
the	O
competencies	B-T080
of	O
doctors	O
in	O
communication	O
with	O
and	O
activation	O
of	O
older	B-T098
patients	O
.	O
	
the	O
consummatory	O
and	O
motivational	O
behaviors	O
for	O
natural	B-T169
rewards	O
following	O
long-term	O
withdrawal	B-T061
from	O
morphine	B-T109
no	O
anhedonia	O
but	O
persistent	O
maladaptive	B-T033
behaviors	I-T033
for	O
high-value	O
rewards	O
the	O
negative	O
affective	O
state	O
,	O
e.g	O
,	O
anhedonia	O
,	O
emerges	O
after	O
abstinence	B-T061
from	O
abused	O
drugs	O
may	O
be	O
linked	O
to	O
the	O
motivational	O
processes	O
of	O
drug	B-T033
craving	I-T033
and	O
relapse	O
.	O
	
although	O
anhedonia	O
diminishes	O
over	O
time	O
with	O
drug	O
abstinence	O
,	O
it	O
is	O
not	O
yet	O
rather	O
explicit	O
whether	O
anhedonia	O
exists	O
or	O
not	O
following	O
protracted	O
withdrawal	B-T061
.	O
	
the	O
behavioral	O
responses	O
to	O
natural	B-T169
rewards	O
were	O
examined	O
after	O
2	O
to	O
3	O
weeks	B-T079
withdrawal	B-T061
from	O
morphine	B-T109
.	O
	
male	O
rats	O
were	O
pretreated	O
with	O
either	O
a	O
binge-like	O
morphine	B-T109
paradigm	B-T062
or	O
daily	B-T079
saline	B-T061
injection	I-T061
for	O
5	O
days	B-T079
.	O
	
the	O
consummatory	O
and	O
motivational	O
behaviors	O
for	O
three	O
natural	B-T169
rewards	O
sucrose	B-T109
solutions	I-T109
4	O
,	O
15	O
,	O
and	O
60%	O
,	O
social	B-T169
stimulus	O
male	O
rat	O
,	O
and	O
sexual	O
stimulus	O
estrous	O
female	O
rat	O
were	O
examined	O
under	O
varied	O
testing	B-T080
conditions	I-T080
.	O
	
the	O
morphine	B-T109
-	O
withdrawn	B-T061
rats	O
significantly	O
increased	O
their	O
intake	O
of	O
15%	O
sucrose	B-T109
solution	I-T109
during	O
the	O
1-h	O
consumption	O
test	O
and	O
their	O
operant	O
responding	O
for	O
15%	O
sucrose	B-T109
solution	I-T109
under	O
a	O
progressive	B-T062
ratio	I-T062
pr	I-T062
schedule	I-T062
of	I-T062
reinforcement	I-T062
.	O
	
when	O
obtaining	O
a	O
reinforcer	B-T078
was	O
associated	O
with	O
a	O
0.5	O
ma	O
foot	O
shock	B-T061
under	O
a	O
pr-punishment	B-T062
schedule	I-T062
,	O
the	O
morphine	B-T109
-	O
withdrawn	B-T061
rats	O
showed	O
a	O
higher	O
performance	O
for	O
60%	O
sucrose	B-T109
solution	I-T109
.	O
	
meanwhile	O
,	O
the	O
morphine	B-T109
-	O
withdrawn	B-T061
rats	O
displayed	O
a	O
higher	O
motivation	O
to	O
sexual	O
stimulus	O
during	O
the	O
free-approach	O
test	O
and	O
more	O
approaching	O
behaviors	O
towards	O
sexual	O
stimulus	O
in	O
a	O
conflict-based	O
approach	O
test	O
concurrent	O
presence	O
of	O
reward	O
and	O
aversive	B-T169
stimulus	I-T169
.	O
	
no	B-T033
anhedonia	O
-like	O
behavior	O
but	O
sensitized	B-T169
behaviors	O
for	O
natural	B-T169
rewards	O
were	O
found	O
after	O
long-term	O
morphine	B-T109
withdrawal	B-T061
.	O
	
notably	O
,	O
the	O
morphine	B-T109
-	O
withdrawn	B-T061
rats	O
displayed	O
persistent	O
motivated	O
behaviors	O
for	O
high-value	O
rewards	O
60%	O
sucrose	B-T109
and	O
sexual	O
stimulus	O
in	O
the	O
conflict	O
tests	O
suggesting	O
impairments	O
in	O
inhibitory	O
control	O
in	O
morphine	B-T109
-	O
treated	B-T169
rats	O
.	O
	
extracellular	O
self-assembly	O
of	O
functional	B-T169
and	O
tunable	B-T116
protein	I-T116
conjugates	I-T116
from	O
bacillus	O
subtilis	O
the	O
ability	O
to	O
stably	B-T080
and	O
specifically	O
conjugate	O
recombinant	B-T116
proteins	I-T116
to	O
one	O
another	O
is	O
a	O
powerful	O
approach	O
for	O
engineering	O
multifunctional	B-T169
enzymes	B-T116
,	O
protein	O
therapeutics	O
,	O
and	O
novel	B-T080
biological	O
materials	O
.	O
	
while	O
many	O
of	O
these	O
applications	O
have	O
been	O
illustrated	O
through	O
in	B-T080
vitro	I-T080
and	O
in	B-T082
vivo	I-T082
intracellular	B-T082
protein	O
conjugation	O
methods	O
,	O
extracellular	O
self-assembly	O
of	O
protein	B-T116
conjugates	I-T116
offers	O
unique	O
advantages	O
simplifying	O
purification	O
,	O
reducing	B-T080
toxicity	O
and	O
burden	B-T078
,	O
and	O
enabling	O
tunability	B-T080
.	O
	
exploiting	O
the	O
recently	O
described	O
spytag-spycatcher	O
system	O
,	O
we	O
describe	O
here	O
how	O
enzymes	B-T116
and	O
structural	B-T116
proteins	I-T116
can	O
be	O
genetically	O
encoded	O
to	O
covalently	O
conjugate	O
in	O
culture	O
media	O
following	O
programmable	O
secretion	O
from	O
bacillus	O
subtilis	O
.	O
	
using	O
this	O
approach	O
,	O
we	O
demonstrate	O
how	O
self-conjugation	O
of	O
a	O
secreted	O
industrial	O
enzyme	B-T116
,	O
xyna	B-T116
,	O
dramatically	O
increases	B-T081
its	O
resilience	B-T033
to	O
boiling	O
,	O
and	O
we	O
show	O
that	O
cellular	O
consortia	O
can	O
be	O
engineered	O
to	O
self-assemble	O
functional	B-T169
protein-protein	B-T116
conjugates	I-T116
with	O
tunable	O
composition	O
.	O
	
this	O
novel	B-T080
genetically	O
encoded	O
modular	B-T169
system	I-T169
provides	O
a	O
flexible	B-T080
strategy	I-T080
for	O
protein	O
conjugation	O
harnessing	O
the	O
substantial	O
advantages	O
of	O
extracellular	O
self-assembly	O
.	O
	
vascular	O
smooth	O
muscle	O
cell	O
peroxisome	B-T116
proliferator-activated	I-T116
receptor	I-T116
γ	I-T116
protects	O
against	O
endothelin-1	B-T116
-	O
induced	B-T169
oxidative	O
stress	O
and	O
inflammation	O
peroxisome	B-T116
proliferator-activated	I-T116
receptor	I-T116
γ	I-T116
pparγ	B-T116
agonists	O
reduce	B-T080
blood	O
pressure	O
and	O
vascular	O
injury	O
in	O
hypertensive	B-T033
rodents	O
.	O
	
pparγ	B-T116
inactivation	O
in	O
vascular	O
smooth	O
muscle	O
cells	O
vsmc	O
enhances	B-T052
vascular	O
injury	O
.	O
	
transgenic	O
mice	O
overexpressing	O
endothelin	B-T116
et	I-T116
selectively	O
in	O
the	O
endothelium	O
eet-1	B-T116
exhibit	O
endothelial	B-T047
dysfunction	I-T047
,	O
increased	B-T081
oxidative	O
stress	O
and	O
inflammation	O
.	O
	
we	O
hypothesized	B-T078
that	O
inactivation	O
of	O
the	O
pparγ	O
gene	O
in	O
vsmc	O
smpparγ	O
would	O
exaggerate	B-T080
et-1	B-T116
-	O
induced	B-T169
vascular	O
injury	O
.	O
	
eet-1	B-T116
,	O
smpparγ	B-T116
and	O
eet-1	B-T116
/	O
smpparγ	B-T116
mice	O
were	O
treated	B-T033
with	O
tamoxifen	B-T109
for	O
5	O
days	O
and	O
studied	B-T062
4	O
weeks	O
later	O
.	O
	
sbp	O
was	O
higher	B-T080
in	O
eet-1	B-T116
and	O
unaffected	O
by	O
smpparγ	B-T116
inactivation	O
.	O
	
mesenteric	O
artery	O
vasodilatory	O
responses	O
to	O
acetylcholine	B-T109
were	O
impaired	B-T169
only	O
in	O
smpparγ	B-T116
.	O
	
n-nitro-l-arginine	B-T116
methyl	I-T116
ester	I-T116
abrogated	B-T169
relaxation	B-T052
responses	O
,	O
and	O
the	O
ednra	O
/	O
ednrb	O
mrna	O
ratio	B-T081
was	O
decreased	B-T081
in	O
eet-1	B-T116
/	O
smpparγ	B-T116
,	O
which	O
could	O
indicate	B-T078
that	O
nitric	O
oxide	O
production	B-T052
was	O
enhanced	B-T052
by	O
et-1	B-T116
stimulation	O
of	O
endothelin	B-T116
type	I-T116
b	I-T116
receptors	I-T116
.	O
	
mesenteric	O
artery	O
media	O
/	O
lumen	B-T080
was	O
greater	B-T081
only	O
in	O
eet-1	B-T116
/	O
smpparγ	B-T116
.	O
	
mesenteric	O
artery	O
reactive	O
oxygen	O
species	O
increased	B-T081
in	O
smpparγ	B-T116
and	O
were	O
further	O
enhanced	B-T052
in	O
eet-1	B-T116
/	O
smpparγ	B-T116
.	O
	
perivascular	B-T082
fat	O
monocyte	O
/	O
macrophage	O
infiltration	O
was	O
higher	B-T080
in	O
eet-1	B-T116
and	O
smpparγ	B-T116
and	O
increased	B-T081
further	O
in	O
eet-1	B-T116
/	O
smpparγ	B-T116
.	O
	
spleen	O
cd11b	O
cells	O
were	O
increased	B-T081
in	O
smpparγ	B-T116
and	O
further	O
enhance	B-T052
d	O
in	O
eet-1	B-T116
/	O
smpparγ	B-T116
,	O
whereas	O
ly-6c	O
monocytes	O
increased	B-T081
in	O
eet-1	B-T116
and	O
smpparγ	B-T116
but	O
not	O
in	O
eet-1	B-T116
/	O
smpparγ	B-T116
.	O
	
spleen	O
t	O
regulatory	O
lymphocytes	O
increased	B-T081
in	O
smpparγ	B-T116
and	O
decreased	B-T081
in	O
eet-1	B-T116
,	O
and	O
decreased	B-T081
further	O
in	O
eet-1	B-T116
/	O
smpparγ	B-T116
.	O
	
vsmc	O
pparγ	B-T116
inactivation	O
exaggerates	B-T080
et-1	B-T116
-	O
induced	B-T169
vascular	O
injury	O
,	O
supporting	O
a	O
protective	O
role	O
for	O
pparγ	B-T116
in	O
hypertension	B-T047
through	O
modulation	B-T082
of	O
pro-oxidant	O
and	O
proinflammatory	B-T169
pathways	O
.	O
	
paradoxically	O
,	O
et-1	B-T116
overexpression	O
preserved	O
endothelial	O
function	B-T169
in	O
smpparγ	B-T116
mice	O
,	O
presumably	O
by	O
enhancing	B-T052
nitric	O
oxide	O
through	O
stimulation	O
of	O
endothelin	B-T116
type	I-T116
b	I-T116
receptors	I-T116
.	O
	
prospective	O
evaluation	O
of	O
opioid	O
consumption	O
after	O
distal	O
radius	O
fracture	O
repair	B-T061
surgery	I-T061
pain	B-T061
management	I-T061
and	O
opioid	O
consumption	O
after	O
distal	O
radius	O
fracture	O
drf	O
open	B-T061
reduction	I-T061
and	I-T061
internal	I-T061
fixation	I-T061
orif	I-T061
are	O
highly	O
variable	O
and	O
poorly	O
understood	O
.	O
	
to	O
optimize	B-T061
postoperative	B-T079
opioid	B-T109
dosage	B-T081
and	O
better	O
understand	O
opioid	O
consumption	O
patterns	O
after	O
drf	O
-	O
orif	B-T061
,	O
we	O
conducted	O
a	O
prospective	B-T062
study	I-T062
with	O
the	O
hypothesis	B-T078
that	O
opioid	O
consumption	O
would	O
increase	B-T169
with	O
worsening	B-T080
fracture	O
classification	O
and	O
various	O
patient	B-T078
demographics	I-T078
.	O
	
all	O
patients	O
who	O
underwent	O
drf	O
-	O
orif	B-T061
were	O
consecutively	O
enrolled	O
over	O
a	O
6-month	B-T079
period	I-T079
.	O
	
information	O
collected	O
included	O
patient	B-T078
demographics	I-T078
,	O
fracture	B-T080
type	I-T080
,	O
anesthesia	O
type	O
,	O
amount	B-T081
and	O
type	B-T080
of	O
opioid	B-T109
prescribed	O
,	O
number	B-T081
of	O
pills	B-T109
taken	O
,	O
reason	B-T078
for	O
stopping	B-T061
,	O
and	O
adverse	O
events	O
.	O
	
statistical	B-T062
analysis	I-T062
was	O
performed	O
.	O
	
ninety-eight	O
patients	O
79	O
female	B-T098
,	O
19	O
male	B-T098
were	O
eligible	O
for	O
the	O
study	O
.	O
	
mean	O
age	O
was	O
58	O
years	O
.	O
	
of	O
the	O
98	O
patients	O
,	O
45	O
received	O
general	B-T061
anesthesia	I-T061
,	O
and	O
53	O
received	O
regional	B-T061
anesthesia	I-T061
with	O
a	O
single-shot	O
peripheral	B-T061
nerve	I-T061
block	I-T061
.	O
	
mean	O
opioid	O
consumption	O
morphine	B-T109
equivalence	B-T080
over	O
a	O
mean	O
of	O
4.8	O
postoperative	B-T079
days	I-T079
range	O
,	O
0-16	O
days	O
was	O
58.5	O
mg	O
range	O
,	O
0-280	O
mg	O
.	O
	
there	O
were	O
no	B-T033
significant	I-T033
differences	O
in	O
opioid	O
consumption	O
between	O
the	O
general	B-T061
and	O
regional	B-T061
anesthesia	I-T061
groups	O
.	O
	
mean	O
opioid	O
consumption	O
for	O
the	O
3	O
fracture-type	B-T080
groups	O
ao/ota	B-T170
arbeitsgemeinschaft	I-T170
für	I-T170
osteosynthesefragen/orthopaedic	I-T170
trauma	I-T170
association	I-T170
classification	I-T170
was	O
57.7	O
mg	O
class	O
a	O
,	O
60.3	O
mg	O
class	O
b	O
,	O
and	O
62.0	O
mg	O
class	O
c	O
.	O
	
demographic	B-T062
analysis	I-T062
revealed	O
an	O
inverse	B-T080
relationship	B-T080
between	O
age	O
and	O
opioid	O
use	O
.	O
	
similarly	O
,	O
there	O
was	O
a	O
trend	O
toward	O
more	O
opioid	O
consumption	O
among	O
self-pay	B-T033
and	O
medicaid	O
patients	O
.	O
	
opioid	O
consumption	O
after	O
drf	O
-	O
orif	B-T061
was	O
equivalent	B-T080
for	O
general	B-T061
and	O
regional	B-T061
anesthesia	I-T061
.	O
	
a	O
significant	O
relationship	B-T080
was	O
found	O
between	O
increasing	B-T033
age	I-T033
and	O
decreasing	B-T033
opioid	O
consumption	O
.	O
	
worsening	B-T080
fracture	B-T170
classification	I-T170
and	O
self-payment	B-T033
/	O
medicaid	O
payment	O
trended	O
toward	O
increasing	B-T169
opioid	O
consumption	O
.	O
	
mean	O
overall	O
opioid	O
consumption	O
morphine	B-T109
equivalence	B-T080
was	O
58.5	O
mg	O
,	O
or	O
14.6	O
pills	O
of	O
oxycodone/acetaminophen	O
5/325	O
mg	O
.	O
	
surgeons	O
should	O
take	O
these	O
findings	O
into	O
account	O
when	O
optimizing	B-T061
opioid	B-T109
prescribing	O
after	O
drf	O
repair	B-T061
.	O
	
entrapment	B-T047
of	O
the	O
posterior	O
femoral	O
cutaneous	O
nerve	O
and	O
its	O
inferior	O
cluneal	O
branches	O
anatomical	O
basis	O
of	O
surgery	O
for	O
inferior	O
cluneal	O
neuralgia	O
the	O
apparent	O
failure	O
of	O
pudendal	O
nerve	O
surgery	O
in	O
some	O
patients	O
has	O
led	O
us	O
to	O
suggest	O
the	O
possibility	O
of	O
entrapment	B-T047
of	O
other	O
adjacent	O
nerve	O
structures	O
,	O
leading	O
to	O
the	O
concept	O
of	O
inferior	O
cluneal	O
neuralgia	O
.	O
	
via	O
its	O
numerous	O
collateral	O
branches	O
,	O
the	O
posterior	O
femoral	O
cutaneous	O
nerve	O
innervates	O
a	O
very	O
extensive	O
territory	O
including	O
the	O
posterior	O
surface	O
of	O
the	O
thigh	O
,	O
the	O
infragluteal	O
fold	O
,	O
the	O
skin	O
over	O
the	O
ischial	O
tuberosity	O
,	O
but	O
also	O
the	O
lateral	O
anal	O
region	O
,	O
scrotum	O
or	O
labium	O
majus	O
via	O
its	O
perineal	O
branch	O
.	O
	
we	O
described	O
the	O
pathophysiological	B-T169
features	B-T080
of	O
cluneal	O
neuralgia	O
,	O
the	O
surgical	O
technique	O
and	O
our	O
preliminary	B-T078
results	I-T078
.	O
	
we	O
performed	O
a	O
transmuscular	B-T061
approach	I-T061
leading	O
to	O
the	O
fat	O
of	O
the	O
deep	O
gluteal	O
region	O
.	O
	
exploration	B-T061
was	O
continued	O
cranially	O
underneath	O
the	O
piriformis	O
,	O
looking	O
for	O
potential	O
entrapments	B-T047
affecting	O
the	O
posterior	O
femoral	O
cutaneous	O
nerve	O
and	O
the	O
sciatic	O
nerve	O
.	O
	
nerve	B-T061
decompression	I-T061
on	O
the	O
lateral	O
surface	O
of	O
the	O
ischial	O
tuberosity	O
was	O
then	O
performed	O
.	O
	
a	O
constant	O
anatomical	O
finding	O
must	O
be	O
highlighted	O
the	O
presence	O
of	O
a	O
lateral	O
fibrous	O
expansion	B-T061
from	O
the	O
ischium	O
passing	O
behind	O
the	O
nerves	O
and	O
vessels	O
,	O
especially	O
the	O
posterior	O
femoral	O
cutaneous	O
nerve	O
and	O
its	O
perineal	O
branches	O
.	O
	
in	O
our	O
patients	O
,	O
release	O
of	O
this	O
expansion	B-T061
allowed	O
decompression	B-T061
of	O
the	O
nerve	B-T047
trapped	I-T047
by	O
this	O
expansion	B-T061
.	O
	
cluneal	O
neuralgia	O
constitutes	O
a	O
distinct	O
entity	O
of	O
perineal	O
pain	O
,	O
which	O
must	O
be	O
identified	O
and	O
distinguished	O
from	O
pudendal	B-T047
neuralgia	I-T047
.	O
	
surgery	O
should	O
be	O
performed	O
via	O
a	O
transgluteal	B-T082
approach	I-T082
.	O
	
a	O
lateral	O
ischial	O
obstacle	O
must	O
be	O
investigated	B-T169
,	O
in	O
the	O
form	O
of	O
a	O
constant	O
fibrous	O
expansion	B-T061
,	O
which	O
,	O
like	O
a	O
retinaculum	O
,	O
can	O
cause	O
nerve	B-T047
entrapment	I-T047
.	O
	
methods	B-T170
to	O
study	B-T062
autophagy	O
in	O
zebrafish	O
autophagy	O
cellular	O
self-eating	O
is	O
a	O
highly	O
regulated	O
degradation	O
process	O
of	O
the	O
eukaryotic	O
cell	O
during	O
which	O
parts	O
of	O
the	O
cytoplasm	O
are	O
delivered	B-T169
into	O
,	O
and	O
broken	B-T080
down	I-T080
within	O
,	O
the	O
lysosomal	O
compartment	O
.	O
	
the	O
process	O
serves	O
as	O
a	O
main	O
route	O
for	O
the	O
elimination	O
of	O
superfluous	O
and	O
damaged	O
cellular	O
constituents	O
,	O
thereby	O
mediating	O
macromolecular	O
and	O
organellar	O
turnover	O
.	O
	
in	O
addition	O
to	O
maintaining	O
cellular	O
homeostasis	O
,	O
autophagy	O
is	O
involved	O
in	O
various	O
other	O
cellular	O
and	O
developmental	O
processes	O
by	O
degrading	O
specific	O
regulatory	B-T116
proteins	I-T116
,	O
and	O
contributing	O
to	O
the	O
clearance	O
of	O
intracellular	B-T082
pathogens	O
.	O
	
the	O
physiological	B-T169
roles	I-T169
and	O
pathological	B-T169
involvement	O
of	O
autophagy	O
can	O
be	O
effectively	O
studied	O
in	O
divergent	O
eukaryotic	O
model	O
systems	O
ranging	O
from	O
yeast	O
to	O
mice	O
.	O
	
such	O
a	O
tractable	O
animal	O
model	O
applied	O
only	O
recently	O
for	O
autophagy	O
researchis	O
the	O
zebrafish	O
danio	O
rerio	O
,	O
which	O
also	O
facilitates	O
the	O
analysis	B-T062
of	O
more	O
specific	O
biological	O
processes	O
such	O
as	O
tissue	O
regeneration	O
.	O
	
in	O
this	O
chapter	O
,	O
we	O
overview	O
the	O
main	O
methods	B-T169
and	I-T169
tools	I-T169
that	O
are	O
used	O
to	O
monitor	O
autophagic	O
structures	O
and	O
to	O
assay	O
autophagic	O
responses	O
in	O
this	O
vertebrate	O
organism	O
.	O
	
we	O
place	O
emphasis	O
on	O
genetic	B-T062
functional	I-T062
approaches	I-T062
applied	O
for	O
exploring	O
novel	O
cellular	O
and	O
developmental	O
roles	O
of	O
the	O
autophagic	O
process	O
.	O
	
healthcare	O
usage	B-T169
and	O
economic	B-T081
impact	I-T081
of	O
non-treated	B-T033
obesity	B-T047
in	O
italy	O
findings	B-T169
from	O
a	O
retrospective	B-T080
administrative	B-T033
and	O
clinical	B-T170
database	I-T170
analysis	B-T062
investigate	B-T169
the	O
prevalence	B-T081
of	O
obesity	B-T047
in	O
italy	O
and	O
examine	O
its	O
resource	B-T078
consumption	B-T033
and	O
economic	B-T081
impact	I-T081
on	O
the	O
italian	O
national	B-T170
healthcare	I-T170
system	I-T170
nhs	B-T170
.	O
	
retrospective	B-T080
,	O
observational	B-T062
and	O
real-life	B-T062
study	I-T062
.	O
	
data	B-T078
from	O
three	O
health	O
units	O
from	O
northern	B-T082
bergamo	O
,	O
lombardy	O
,	O
central	B-T082
grosseto	O
,	O
tuscany	O
and	O
southern	B-T082
naples	O
,	O
campania	O
italy	O
.	O
	
all	O
patients	O
aged	O
18	B-T079
years	I-T079
with	O
at	O
least	O
one	O
recorded	O
body	O
mass	O
index	O
bmi	O
measurement	B-T169
between	O
1	O
january	O
2009	O
and	O
31	O
december	O
2012	O
were	O
included	O
.	O
	
information	B-T078
retrieved	O
from	O
the	O
databases	B-T170
included	O
primary	B-T078
care	I-T078
data	I-T078
,	O
medical	B-T170
prescriptions	I-T170
,	O
specialist	O
consultations	O
and	O
hospital	B-T170
discharge	I-T170
records	I-T170
from	O
2009-2013	O
.	O
	
costs	B-T081
associated	B-T080
with	I-T080
these	O
data	B-T078
were	O
also	O
calculated	B-T052
.	O
	
data	B-T078
are	O
presented	O
for	O
two	O
time	B-T079
periods	I-T079
1	B-T079
year	I-T079
after	O
bmi	O
measurement	B-T169
and	O
study	O
end	O
.	O
	
primary	B-T080
-to	O
estimate	B-T081
health	B-T078
resources	I-T078
consumption	B-T033
and	O
the	O
associated	O
economic	B-T081
impact	I-T081
on	O
the	O
italian	O
nhs	B-T170
.	O
	
secondary	B-T081
-the	O
prevalence	B-T081
and	O
characteristics	B-T080
of	O
subjects	B-T098
by	O
bmi	O
category	B-T170
.	O
	
20	O
159	O
adult	O
subjects	B-T098
with	O
at	O
least	O
one	O
documented	B-T033
bmi	I-T033
measurement	B-T169
.	O
	
subjects	B-T098
with	O
bmi	O
30	O
kg/m	O
were	O
defined	O
as	O
obese	B-T047
.	O
	
the	O
prevalence	B-T081
of	O
obesity	B-T047
was	O
22.2	O
n=4471	O
and	O
increased	B-T081
with	O
age	O
.	O
	
at	O
the	O
1-year	B-T079
observation	B-T062
period	B-T079
,	O
obese	B-T047
subjects	B-T098
who	O
did	O
not	O
receive	O
treatment	B-T061
for	O
their	O
obesity	B-T047
experienced	O
longer	B-T079
durations	I-T079
of	O
hospitalisation	O
median	O
length	O
5	B-T079
days	I-T079
vs	O
3	B-T079
days	I-T079
,	O
used	O
more	O
prescription	O
drugs	O
75.0	O
vs	O
57.7	O
,	O
required	O
more	O
specialised	O
outpatient	O
healthcare	O
mean	B-T081
number	I-T081
5.3	O
vs	O
4.4	O
and	O
were	O
associated	B-T080
with	I-T080
greater	B-T081
costs	I-T081
,	O
primarily	O
owing	O
to	O
prescription	O
drugs	O
and	O
hospital	O
admissions	O
mean	B-T081
annual	I-T081
cost	I-T081
per	O
year	B-T079
per	O
patient	O
460.6	O
vs	O
288.0	O
for	O
drug	B-T170
prescriptions	I-T170
,	O
422.7	O
vs	O
279.2	O
for	O
hospitalisations	O
and	O
283.2	O
vs	O
251.7	O
for	O
outpatient	O
care	O
,	O
compared	O
with	O
normal	B-T033
weight	I-T033
subjects	B-T098
.	O
	
similar	O
findings	B-T169
were	O
observed	O
for	O
the	O
period	B-T079
up	O
to	O
data	B-T078
cut-off	O
mean	O
follow-up	O
of	O
2.7	O
years	O
.	O
	
untreated	B-T033
obesity	B-T047
has	O
a	O
significant	O
economic	B-T081
impact	I-T081
on	O
the	O
italian	O
healthcare	B-T170
system	I-T170
,	O
highlighting	O
the	O
need	O
to	O
raise	O
awareness	O
and	O
proactively	O
treat	B-T061
obese	O
effects	B-T080
of	I-T080
heat	O
treatment	B-T169
on	O
conformation	B-T082
and	O
cell	O
growth	O
activity	O
of	O
alpha-	B-T116
lactalbumin	I-T116
and	O
beta-lactoglobulin	B-T116
from	O
market	O
milk	O
heat	O
processes	O
,	O
low	B-T080
temperature	B-T081
for	O
long	B-T080
time	B-T079
ltlt	O
pasteurization	O
and	O
ultra-heat	B-T061
treatment	I-T061
uht	I-T061
sterilization	I-T061
,	O
are	O
essential	O
for	O
commercial	O
market	O
milk	O
to	O
improve	O
the	O
shelf	O
life	O
of	O
raw	O
milk	O
and	O
ensure	O
microbial	O
safety	O
.	O
	
we	O
evaluated	O
the	O
effects	O
of	O
heat	O
experience	O
on	O
the	O
molecular	O
properties	O
of	O
α-lactalbumin	O
α-la	O
and	O
β-lactoglobulin	O
β-lg	O
isolated	O
from	O
four	O
types	O
of	O
market	O
milk	O
such	O
as	O
ltlt-a	O
66	O
for	O
30	O
min	O
,	O
ltlt-b	O
65	O
for	O
30	O
min	O
,	O
uht-i	O
130	O
for	O
2	O
s	O
,	O
indirect	O
heating	O
and	O
uht-d	O
135	O
for	O
2	O
s	O
,	O
direct	O
heating	O
samples	O
.	O
	
we	O
examined	O
molecular	O
conformations	O
using	O
circular	O
dichroism	O
spectrum	O
measurement	O
and	O
cell	O
growth	O
activity	O
using	O
the	O
wst-1	O
method	O
for	O
the	O
proteins	O
.	O
	
α-la	O
isolated	O
from	O
each	O
of	O
these	O
four	O
types	O
of	O
market	O
milk	O
displayed	O
no	O
significant	O
structural	O
difference	O
as	O
compared	O
to	O
raw	O
milk	O
α-la	O
,	O
while	O
α-la	O
of	O
uht-i	O
only	O
inhibited	O
cell	O
growth	O
of	O
an	O
intestinal	O
epithelial	O
cell	O
line	O
more	O
potently	O
than	O
raw	O
milk	O
α-la	O
.	O
	
in	O
the	O
case	O
of	O
β-lg	O
,	O
only	O
the	O
uht-i	O
sample	O
demonstrated	O
a	O
drastic	O
change	O
in	O
structure	O
,	O
while	O
it	O
did	O
not	O
exhibit	O
any	O
cytotoxicity	O
.	O
	
we	O
found	O
that	O
cell	O
viability	O
effects	O
of	O
α-la	O
and	O
β-lg	O
are	O
attributable	O
to	O
the	O
type	O
of	O
uht	O
indirect	O
and	O
direct	O
.	O
	
these	O
findings	O
indicate	O
that	O
the	O
effect	O
of	O
heat	O
treatment	O
on	O
whey	O
proteins	O
should	O
carefully	O
be	O
investigated	O
comparison	B-T052
of	O
270	O
versus	O
320	O
mg	O
i/ml	O
of	O
iodixanol	O
in	O
1	O
image	O
assessment	O
of	O
both	O
renal	O
arteries	O
and	O
veins	O
with	O
dual-energy	O
spectral	O
ct	O
imaging	O
in	O
late	B-T079
arterial	I-T079
phase	I-T079
and	O
their	O
influence	O
on	O
renal	O
function	O
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
compare	B-T052
the	O
image	B-T080
quality	I-T080
of	O
renal	O
arteries	O
and	O
veins	O
with	O
dual-energy	O
spectral	O
computed	O
tomography	O
ct	O
imaging	O
in	O
late	B-T079
arterial	I-T079
phase	I-T079
using	O
270	O
and	O
320	O
mg	O
i/ml	O
of	O
iodixanol	O
and	O
their	O
influence	O
on	O
renal	O
function	O
.	O
	
a	O
total	O
of	O
1062	O
patients	O
underwent	O
renal	O
ct	O
angiography	O
with	O
270	O
or	O
320	O
mg	O
i/ml	O
of	O
iodixanol	O
with	O
dual-energy	O
spectral	O
ct	O
imaging	O
in	O
late	B-T079
arterial	I-T079
phase	I-T079
.	O
	
image	B-T080
quality	I-T080
and	O
their	O
influence	O
on	O
renal	O
function	O
were	O
compared	B-T052
.	O
	
there	O
were	O
no	O
significant	O
differences	O
of	O
ct	B-T081
value	I-T081
,	O
signal-to-noise	B-T081
ratio	I-T081
,	O
contrast-to-noise	B-T081
ratio	I-T081
,	O
and	O
subjective	O
score	B-T081
of	O
renal	O
vessels	O
between	O
2	O
groups	O
all	O
p	O
>	O
0.05	O
.	O
	
the	O
incidence	B-T081
of	O
contrast-induced	B-T047
nephropathy	I-T047
in	O
patients	O
with	O
abnormal	O
renal	O
function	O
using	O
320	O
mg	O
i/ml	O
of	O
iodixanol	O
was	O
significantly	O
higher	O
than	O
using	O
270	O
mg	O
i/ml	O
of	O
iodixanol	O
p	O
=	O
0.043	O
.	O
	
the	O
renal	O
arteries	O
and	O
veins	O
can	O
be	O
fully	O
assessed	O
in	O
late	B-T079
arterial	I-T079
phase	I-T079
with	O
270	O
mg	O
i/ml	O
of	O
iodixanol	O
using	O
dual-energy	O
spectral	O
ct	O
scan	O
with	O
better	O
preserved	O
renal	O
function	O
.	O
	
effect	O
of	O
magnesium	B-T061
supplementation	I-T061
on	O
depression	O
status	B-T033
in	O
depressed	O
patients	O
with	O
magnesium	B-T047
deficiency	I-T047
a	O
randomized	B-T062
,	O
double-blind	B-T062
,	O
placebo-controlled	B-T062
trial	I-T062
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
effect	B-T169
of	O
magnesium	B-T061
supplementation	I-T061
on	O
the	O
depression	O
status	B-T033
of	O
depressed	O
patients	O
suffering	B-T033
from	O
magnesium	B-T047
deficiency	I-T047
.	O
	
sixty	B-T033
depressed	I-T033
people	I-T033
suffering	B-T033
from	O
hypomagnesemia	B-T033
participated	O
in	O
this	B-T062
trial	I-T062
.	O
	
the	O
individuals	B-T098
were	O
randomly	B-T062
categorized	I-T062
into	O
two	O
groups	B-T078
of	O
30	O
members	O
one	O
receiving	O
two	O
250-mg	O
tablets	O
of	O
magnesium	O
oxide	O
mg	O
daily	O
and	O
the	O
other	O
receiving	O
placebo	O
pg	O
for	O
8	O
wk	O
.	O
	
the	O
beck	O
depression	O
inventory-ii	O
was	O
conducted	O
and	O
the	O
concentration	O
of	O
serum	O
magnesium	O
was	O
measured	O
.	O
	
at	O
the	O
end	O
of	O
intervention	O
,	O
88.5	O
of	O
the	O
mg	O
and	O
48.1	O
of	O
the	O
pg	O
p	O
=	O
0.002	O
had	O
a	O
normal	O
level	O
of	O
magnesium	O
.	O
	
the	O
mean	O
changes	B-T033
of	I-T033
serum	I-T033
magnesium	I-T033
were	O
significantly	O
different	O
across	O
the	O
two	O
groups	B-T078
.	O
	
after	O
the	O
intervention	O
,	O
the	O
mean	O
beck	O
score	O
significantly	B-T081
declined	I-T081
.	O
	
however	O
,	O
in	O
the	O
mg	O
,	O
this	O
reduction	O
was	O
more	B-T080
significant	I-T080
than	O
in	O
the	O
pg	O
p	O
=	O
0.02	O
,	O
so	O
that	O
the	O
mean	O
changes	O
in	O
this	O
group	B-T078
experienced	O
15.65	O
8.9	O
reduction	O
,	O
but	O
in	O
the	O
pg	O
,	O
it	O
declined	O
by	O
10.40	O
7.9	O
.	O
	
daily	O
consumption	O
of	O
500	O
mg	O
magnesium	O
oxide	O
tablets	O
for	O
8	O
wk	O
by	O
depressed	O
patients	O
suffering	B-T033
from	O
magnesium	B-T047
deficiency	I-T047
leads	O
to	O
improvements	O
in	O
depression	O
status	B-T033
and	O
magnesium	O
levels	O
.	O
	
therefore	O
,	O
assessment	O
of	O
the	O
magnesium	O
serum	O
and	O
resolving	O
this	O
deficiency	B-T047
positively	O
influence	O
the	O
treatment	B-T061
of	O
depressed	O
patients	O
.	O
	
the	O
influence	O
of	O
cognitive	B-T081
load	I-T081
on	O
metabolic	O
cost	B-T081
of	O
transport	B-T078
during	O
overground	O
walking	O
in	O
healthy	B-T080
,	O
young	O
adults	O
our	O
aim	O
was	O
to	O
examine	O
whether	O
cognitive	O
processing	O
during	O
walking	O
increases	B-T169
the	O
metabolic	O
cost	B-T081
of	O
transport	B-T078
in	O
healthy	B-T080
young	O
adults	O
.	O
	
twenty	O
healthy	B-T080
,	O
young	O
adults	O
completed	O
five	O
conditions	B-T080
1	O
walking	O
at	O
a	O
self	B-T078
-	O
selected	B-T052
speed	B-T081
spontaneous	B-T169
single-task	B-T052
,	O
2	O
seated	B-T033
resting	O
baseline	B-T081
,	O
3	O
performing	O
cognitive	O
task	B-T052
while	O
seated	B-T033
cognitive	O
single-task	B-T052
,	O
4	O
walking	O
while	O
simultaneously	B-T079
performing	B-T169
the	O
cognitive	O
task	B-T052
dual-task	B-T052
,	O
and	O
5	O
single-task	B-T052
walking	O
at	O
a	O
speed	B-T081
that	O
matched	B-T080
the	O
participant's	B-T098
dual-task	B-T052
gait	O
speed	O
matched	B-T080
single-task	B-T052
.	O
	
rate	B-T081
of	I-T081
oxygen	I-T081
consumption	I-T081
v	B-T081
was	O
recorded	O
during	O
all	O
conditions	B-T080
.	O
	
gait	O
speed	O
and	O
cost	B-T081
of	O
walking	O
cw	B-T081
oxygen	O
consumed	O
per	O
distance	O
traveled	O
were	O
recorded	O
during	O
all	O
walking	O
conditions	B-T080
.	O
	
reaction	B-T079
time	I-T079
and	O
accuracy	B-T080
of	O
responses	O
in	O
the	O
cognitive	O
task	B-T052
were	O
recorded	O
during	O
all	O
cognitive	O
task	B-T052
conditions	B-T080
.	O
	
data	B-T078
from	O
the	O
fifth	O
minute	B-T079
of	O
each	O
5-	O
min	B-T079
condition	B-T080
were	O
analyzed	B-T062
.	O
	
there	O
was	O
no	O
difference	O
in	O
v	B-T081
between	O
the	O
dual-task	B-T052
and	O
matched	B-T080
single-task	B-T052
walking	O
conditions	B-T080
.	O
	
v	B-T081
in	O
the	O
seated	B-T033
cognitive	O
condition	B-T080
was	O
significantly	O
smaller	O
than	O
both	O
walking	O
conditions	B-T080
,	O
but	O
was	O
not	O
significantly	O
different	O
than	O
zero	O
.	O
	
cw	B-T081
was	O
significantly	O
greater	O
during	O
the	O
matched	B-T080
single-task	B-T052
walking	O
condition	B-T080
than	O
during	O
the	O
dual-task	B-T052
walking	O
condition	B-T080
.	O
	
however	O
,	O
the	O
difference	O
in	O
cw	B-T081
was	O
so	O
small	O
that	O
it	O
is	O
unlikely	O
to	O
be	O
clinically	B-T080
significant	B-T078
0.008	O
mlo2/kg/m	O
,	O
95%	O
ci	O
0.002	O
.	O
	
cognitive	O
processing	O
while	O
walking	O
may	O
not	O
increase	B-T169
energy	B-T081
demands	O
of	O
walking	O
in	O
healthy	B-T080
young	O
adults	O
.	O
	
maintaining	O
non-preferred	O
gait	O
speed	O
matched	B-T080
speed	B-T081
overground	O
continuously	O
for	O
5	O
min	B-T079
may	O
require	O
attentional	O
resources	B-T078
,	O
and	O
thereby	O
increase	B-T169
metabolic	O
costs	B-T081
relative	O
to	O
walking	O
at	O
habitual	B-T079
speed	B-T081
.	O
	
problem-based	O
learning	O
using	O
patient	O
-simulated	O
videos	O
showing	O
daily	O
life	O
for	O
a	O
comprehensive	O
clinical	O
approach	O
we	O
examined	O
whether	O
problem-based	O
learning	O
tutorials	O
using	O
patient	B-T170
-simulated	I-T170
videos	I-T170
showing	O
daily	B-T079
life	B-T078
are	O
more	O
practical	O
for	O
clinical	O
learning	O
,	O
compared	O
with	O
traditional	O
paper-based	O
problem-based	O
learning	O
,	O
for	O
the	O
consideration	O
rate	O
of	O
psychosocial	O
issues	O
and	O
the	O
recall	O
rate	O
for	O
experienced	O
learning	O
.	O
	
twenty-two	O
groups	O
with	O
120	O
fifth-	O
year	O
students	O
were	O
each	O
assigned	O
paper-based	O
problem-based	O
learning	O
and	O
video	O
-based	O
problem-based	O
learning	O
using	O
patient	O
-simulated	O
videos	O
.	O
	
we	O
compared	O
target	O
achievement	O
rates	O
in	O
questionnaires	O
using	O
the	O
wilcoxon	O
signed-rank	O
test	O
and	O
discussion	O
contents	O
diversity	O
using	O
the	O
mann-whitney	O
u	O
test	O
.	O
	
a	O
follow-up	O
survey	O
used	O
a	O
chi-square	O
test	O
to	O
measure	O
students	O
'	O
recall	O
of	O
cases	O
in	O
three	O
categories	O
video	O
,	O
paper	O
,	O
and	O
non-experienced	O
.	O
	
video	O
-based	O
problem-based	O
learning	O
displayed	O
significantly	O
higher	O
achievement	O
rates	O
for	O
imagining	O
authentic	O
patients	O
p=0	O
,	O
incorporating	O
a	O
comprehensive	B-T080
approach	O
including	O
psychosocial	O
aspects	O
p<0	O
,	O
and	O
satisfaction	O
with	O
sessions	O
p=0	O
.	O
	
no	O
significant	O
differences	O
existed	O
in	O
the	O
discussion	O
contents	O
diversity	O
regarding	O
the	O
international	O
classification	O
of	O
primary	O
care	O
second	O
edition	O
codes	O
and	O
chapter	O
types	O
or	O
in	O
the	O
rate	O
of	O
psychological	O
codes	O
.	O
	
in	O
a	O
follow-up	O
survey	O
comparing	O
video	O
and	O
paper	O
groups	O
to	O
non-experienced	O
groups	O
,	O
the	O
rates	O
were	O
higher	O
for	O
video	O
χ	O
,	O
p<0	O
and	O
paper	O
χ	O
,	O
p=0	O
.	O
	
although	O
the	O
video	O
rate	O
tended	O
to	O
be	O
higher	O
than	O
the	O
paper	O
rate	O
,	O
no	O
significant	O
difference	O
was	O
found	O
between	O
the	O
two	O
.	O
	
patient	O
-simulated	O
videos	O
showing	O
daily	O
life	O
facilitate	O
imagining	O
true	O
patients	O
and	O
support	O
a	O
comprehensive	O
approach	O
that	O
fosters	O
better	O
memory	O
.	O
	
the	O
clinical	B-T080
patient	O
-simulated	O
video	O
method	O
is	O
more	O
practical	O
and	O
clinical	O
problem-based	O
tutorials	O
can	O
be	O
implemented	O
if	O
we	O
create	O
patient	O
-simulated	O
videos	O
for	O
each	O
symptom	O
as	O
teaching	O
materials	O
forensic	O
characteristics	O
and	O
phylogenetic	B-T062
analyses	I-T062
of	O
the	O
chinese	B-T098
yi	B-T098
population	I-T098
via	O
19	O
x-chromosomal	O
str	O
loci	O
the	O
demographic	O
characteristics	O
and	O
genetic	O
polymorphism	O
data	B-T078
of	O
56	O
chinese	B-T098
nationalities	O
or	O
31	O
administrative	O
divisions	O
in	O
chinese	O
mainland	O
have	O
repeatedly	O
been	O
the	O
genetic	B-T062
research	I-T062
hotspots	B-T082
.	O
	
while	O
most	O
genetic	B-T062
studies	I-T062
focused	O
on	O
some	O
particular	O
chinese	B-T098
populations	B-T098
based	O
on	O
autosomal	O
or	O
y-chromosomal	O
genetic	O
markers	O
,	O
the	O
forensic	O
characteristics	O
and	O
phylogenetic	B-T062
analyses	I-T062
of	O
the	O
seventh	O
largest	O
chinese	B-T098
population	B-T098
yi	B-T098
ethnicity	I-T098
on	O
the	O
x-chromosomal	O
genetic	O
markers	O
are	O
scarce	O
.	O
	
here	O
,	O
allele	B-T081
frequencies	I-T081
and	O
forensic	B-T033
statistical	I-T033
parameters	I-T033
for	O
19	O
x-chromosomal	O
short	O
tandem	O
repeat	O
loci	O
dxs7424-dxs101	O
,	O
dxs6789-dxs6809	O
,	O
dxs7423-dxs10134	O
,	O
dxs10103-hprtb-dxs10101	O
,	O
dxs10159-dxs10162-dxs10164	O
,	O
dxs10148-dxs10135-dxs8378	O
,	O
and	O
dxs7132-dxs10079-dxs10074-dxs10075	O
of	O
331	O
chinese	B-T098
yi	B-T098
individuals	I-T098
were	O
obtained	O
.	O
	
all	O
19	O
x-chromosomal	O
short	O
tandem	O
repeat	O
str	O
loci	O
in	O
females	B-T098
were	O
consistent	O
with	O
the	O
hardy-weinberg	O
equilibrium	O
test	O
.	O
	
a	O
total	O
of	O
214	O
alleles	O
were	O
identified	B-T080
with	O
the	O
corresponding	O
allele	B-T081
frequencies	I-T081
spanned	O
from	O
0.0019	O
to	O
0.6106	O
.	O
	
the	O
combined	O
pe	B-T081
,	O
pdf	B-T081
,	O
and	O
pdm	B-T081
were	O
0.9999999214	O
,	O
0.9999999999999999999993	O
,	O
and	O
0.9999999999998	O
,	O
respectively	O
.	O
	
the	O
high	O
combined	O
meckrüger	B-T081
,	O
meckishida	B-T081
,	O
mecdesmarais	B-T081
,	O
and	O
mecdesmarais	B-T081
duo	I-T081
were	O
achieved	O
as	O
0.9999999617638	O
,	O
0.9999999999971	O
,	O
0.9999999999971	O
,	O
and	O
0.9999999931538	O
,	O
respectively	O
.	O
	
the	O
findings	B-T033
suggested	O
that	O
the	O
panel	B-T078
of	O
19	O
x-str	O
loci	O
is	O
highly	O
polymorphic	B-T080
and	O
informative	B-T080
in	O
the	O
yi	B-T098
ethnic	I-T098
population	I-T098
and	O
can	O
be	O
considered	O
to	O
be	O
a	O
powerful	O
tool	O
in	O
forensic	B-T078
complex	I-T078
kinship	I-T078
identification	I-T078
.	O
	
population	B-T062
differentiation	I-T062
analyses	I-T062
among	O
12	O
populations	B-T098
indicated	O
that	O
significant	O
differences	B-T080
in	O
genetic	O
structure	O
were	O
observed	O
in	O
between	O
the	O
yi	B-T098
ethnicity	I-T098
and	O
the	O
chinese	B-T098
uyghur	B-T098
as	O
well	O
as	O
kazakh	B-T098
,	O
and	O
genetic	B-T080
homogeneity	I-T080
existed	O
in	O
similar	O
ethno-origin	B-T098
or	O
geographic	B-T081
origin	I-T081
populations	I-T081
.	O
	
loss	B-T081
of	O
snf5	O
induces	B-T169
formation	B-T169
of	O
an	O
aberrant	B-T080
swi/snf	O
complex	O
the	O
swi/snf	O
chromatin	O
remodeling	O
complex	O
is	O
highly	O
conserved	O
from	O
yeast	O
to	O
human	O
,	O
and	O
aberrant	B-T080
swi/snf	O
complexes	O
contribute	O
to	O
human	O
disease	B-T047
.	O
	
the	O
snf5/smarcb1/ini1	O
subunit	B-T081
of	O
swi/snf	O
is	O
a	O
tumor	O
suppressor	O
frequently	O
lost	B-T169
in	O
pediatric	B-T080
rhabdoid	O
cancers	O
.	O
	
we	O
examined	O
the	O
effects	B-T080
of	I-T080
snf5	O
loss	B-T081
on	O
the	O
composition	B-T033
,	O
nucleosome	O
binding	O
,	O
recruitment	O
,	O
and	O
remodeling	O
activities	O
of	O
yeast	O
swi/snf	O
.	O
	
the	O
snf5	O
subunit	B-T081
is	O
shown	O
by	O
crosslinking-mass	O
spectrometry	O
cx-ms	O
and	O
subunit	B-T081
deletion	O
analysis	O
to	O
interact	O
with	O
the	O
atpase	O
domain	O
of	O
snf2	B-T116
and	O
to	O
form	O
a	O
submodule	O
consisting	O
of	O
snf5	O
,	O
swp82	O
,	O
and	O
taf14	O
.	O
	
snf5	O
promotes	O
binding	O
of	O
the	O
snf2	B-T116
atpase	O
domain	O
to	O
nucleosomal	O
dna	O
and	O
enhances	O
the	O
catalytic	O
and	O
nucleosome	O
remodeling	O
activities	O
of	O
swi/snf	O
.	O
	
snf5	O
is	O
also	O
required	O
for	O
swi/snf	O
recruitment	O
by	O
acidic	B-T116
transcription	I-T116
factors	I-T116
.	O
	
rna-seq	O
analysis	O
suggests	O
that	O
both	O
the	O
recruitment	O
and	O
remodeling	O
functions	O
of	O
snf5	O
are	O
required	O
in	B-T082
vivo	I-T082
for	O
swi/snf	O
regulation	O
of	O
gene	O
expression	O
.	O
	
thus	O
,	O
loss	B-T081
of	O
snf5	O
alters	O
the	O
structure	B-T082
and	O
function	B-T169
of	O
identifying	O
the	O
presence	B-T033
of	O
parkinson's	B-T047
disease	I-T047
using	O
low-frequency	B-T079
fluctuations	O
in	O
bold	O
signals	O
parkinson's	B-T047
disease	I-T047
pd	B-T047
is	O
a	O
chronic	B-T079
,	O
progressive	B-T169
,	O
and	O
degenerative	B-T169
neurological	B-T047
disorder	I-T047
that	O
is	O
characterized	B-T052
by	O
the	O
degeneration	B-T169
of	O
dopamine	O
neurons	O
in	O
the	O
substantia	O
nigra	O
and	O
the	O
formation	B-T169
of	O
intracellular	B-T082
lewy	O
inclusion	O
bodies	O
.	O
	
resting-state	O
functional	O
magnetic	O
resonance	O
imaging	O
rs-fmri	O
has	O
demonstrated	O
evidence	B-T078
of	O
changes	O
in	O
metabolic	B-T169
patterns	B-T082
in	O
individuals	B-T098
with	O
pd	B-T047
.	O
	
the	O
purpose	B-T169
of	O
this	O
study	B-T062
was	O
to	O
determine	O
whether	O
the	O
presence	B-T033
of	O
pd	B-T047
could	O
be	O
""""	O
predicted	B-T078
""""	O
based	O
on	O
resting	O
fluctuations	O
in	O
the	O
blood	O
oxygenation	O
level	O
dependent	O
signal	O
.	O
	
we	O
utilized	O
rs-fmri	O
to	O
measure	O
the	O
amplitude	B-T082
of	O
low-frequency	B-T079
fluctuation	O
alff	O
and	O
the	O
fractional	O
alff	O
falff	O
in	O
51	O
patients	O
with	O
pd	B-T047
and	O
50	O
age	O
-	O
and	O
sex	O
-matched	O
healthy	B-T080
controls	I-T080
.	O
	
compared	O
with	O
the	O
healthy	B-T080
controls	I-T080
,	O
the	O
individuals	B-T098
with	O
pd	B-T047
exhibited	O
altered	O
alffs	O
in	O
the	O
bilateral	B-T082
lingual	O
gyrus	O
and	O
left	O
putamen	O
and	O
an	O
altered	O
falff	O
in	O
the	O
right	O
cerebellum	O
posterior	O
lobe	O
.	O
	
support	B-T081
vector	I-T081
machines	I-T081
svms	B-T081
,	O
which	O
comprise	O
a	O
supervised	O
pattern	O
recognition	O
method	B-T170
that	O
enables	O
predictions	B-T078
at	O
the	O
individual	B-T098
level	B-T080
,	O
were	O
trained	O
to	O
separate	O
individuals	B-T098
with	O
pd	B-T047
from	O
healthy	B-T080
controls	I-T080
based	O
on	O
the	O
alff	O
and	O
falff	O
.	O
	
using	O
the	O
leave-one-out	O
cross-validation	B-T062
method	I-T062
to	O
analyze	B-T062
our	O
sample	O
,	O
we	O
reliably	O
distinguished	O
the	O
participants	B-T098
with	O
pd	B-T047
from	O
the	O
controls	O
with	O
92%	O
sensitivity	B-T080
and	O
87%	O
specificity	B-T081
.	O
	
overall	O
,	O
these	O
findings	B-T169
suggest	O
that	O
the	O
svm	B-T081
-	O
neuroimaging	O
approach	O
may	O
be	O
of	O
particular	O
clinical	B-T080
value	O
because	O
it	O
enables	O
the	O
accurate	O
identification	O
of	O
pd	B-T047
at	O
the	O
individual	B-T098
level	B-T080
.	O
	
rs-fmri	O
should	O
be	O
considered	O
for	O
development	B-T169
as	O
a	O
biomarker	O
and	O
an	O
analytical	O
tool	O
for	O
the	O
evaluation	O
of	O
methylation	O
dynamics	O
during	O
folliculogenesis	O
and	O
early	B-T079
embryo	O
development	O
in	O
sheep	O
genome	O
-wide	O
dna	O
methylation	O
reprogramming	O
occurs	O
during	O
mammalian	O
gametogenesis	O
and	O
early	B-T079
embryogenesis	O
.	O
	
post	B-T079
-	O
fertilization	O
demethylation	O
of	O
paternal	B-T080
and	O
maternal	B-T033
genomes	O
is	O
considered	O
to	O
occur	O
by	O
an	O
active	O
and	O
passive	O
mechanism	O
respectively	O
,	O
in	O
most	O
mammals	O
but	O
sheep	O
in	O
this	O
species	O
no	O
loss	O
of	O
methylation	O
was	O
observed	O
in	O
either	O
pronucleus	O
.	O
	
post	B-T079
-	O
fertilization	O
reprogramming	O
relies	O
on	O
methylating	B-T116
and	O
demethylating	B-T116
enzymes	I-T116
and	O
co-factors	O
that	O
are	O
stored	O
during	O
oocyte	O
growth	O
,	O
concurrently	O
with	O
the	O
re-methylation	O
of	O
the	O
oocyte	O
itself	O
.	O
	
the	O
crucial	O
remodelling	O
of	O
the	O
oocyte	O
epigenetic	O
baggage	O
often	O
overlaps	O
with	O
potential	O
interfering	O
events	O
such	O
as	O
exposure	O
to	O
assisted	O
reproduction	B-T061
technologies	I-T061
or	O
environmental	B-T033
changes	I-T033
.	O
	
here	O
,	O
we	O
report	O
a	O
temporal	O
analysis	O
of	O
methylation	O
dynamics	O
during	O
folliculogenesis	O
and	O
early	B-T079
embryo	O
development	O
in	O
sheep	O
.	O
	
we	O
characterized	O
global	O
dna	O
methylation	O
and	O
hydroxymethylation	O
by	O
immunofluorescence	O
and	O
relatively	O
quantified	O
the	O
expression	O
of	O
the	O
enzymes	B-T116
and	O
co-factors	O
mainly	O
responsible	O
for	O
their	O
remodelling	O
dna	B-T116
methyltransferases	I-T116
dnmts	B-T116
,	O
ten-eleven	B-T116
translocation	I-T116
tet	I-T116
proteins	I-T116
and	O
methyl-cpg-binding	O
domain	O
mbd	O
proteins	B-T116
.	O
	
our	O
results	O
illustrate	O
for	O
the	O
first	O
time	O
the	O
patterns	O
of	O
hydroxymethylation	O
during	O
oocyte	O
growth	O
.	O
	
we	O
observed	O
different	O
patterns	O
of	O
methylation	O
and	O
hydroxymethylation	O
between	O
the	O
two	O
parental	O
pronuclei	O
,	O
suggesting	O
that	O
male	O
pronucleus	O
undergoes	O
active	O
demethylation	O
also	O
in	O
sheep	O
.	O
	
finally	O
,	O
we	O
describe	O
gene	O
-specific	O
accumulation	O
dynamics	O
for	O
methylating	B-T116
and	O
demethylating	B-T116
enzymes	I-T116
during	O
oocyte	O
growth	O
and	O
observe	O
patterns	O
of	O
expression	O
associated	O
with	O
developmental	B-T080
competence	B-T080
in	O
a	O
differential	O
model	O
of	O
oocyte	O
potential	O
.	O
	
our	O
work	O
contributes	O
to	O
the	O
understanding	O
of	O
the	O
methylation	O
dynamics	O
during	O
folliculogenesis	O
and	O
early	B-T079
embryo	O
development	O
and	O
improves	O
the	O
overall	O
picture	O
of	O
early	B-T079
rearrangements	O
that	O
will	O
originate	O
the	O
embryo	O
epigenome	O
.	O
	
network	B-T169
analysis	B-T062
reveals	B-T080
why	O
xylella	O
fastidiosa	O
will	O
persist	O
in	O
europe	O
the	O
insect	O
vector	O
borne	O
bacterium	O
xylella	O
fastidiosa	O
was	O
first	O
detected	O
in	O
olive	O
trees	O
in	O
southern	O
italy	O
in	O
2013	O
,	O
and	O
identified	O
as	O
the	O
main	O
culprit	O
behind	O
the	O
'	O
olive	B-T047
quick	I-T047
decline	I-T047
syndrome	I-T047
'	O
.	O
	
since	O
then	O
,	O
the	O
disease	B-T047
has	O
spread	O
rapidly	O
through	O
italy's	O
main	O
olive	B-T109
oil	I-T109
producing	O
region	O
.	O
	
the	O
epidemiology	B-T062
of	O
the	O
outbreak	O
is	O
largely	O
unstudied	O
,	O
with	O
the	O
list	O
of	O
x	O
.	O
	
fastidiosa	O
hosts	O
and	O
vectors	O
in	O
europe	O
likely	O
incomplete	O
,	O
and	O
the	O
role	O
humans	O
play	O
in	O
dispersal	B-T080
unknown	B-T080
.	O
	
these	O
knowledge	B-T170
gaps	B-T082
have	O
led	O
to	O
management	O
strategies	O
based	O
on	O
general	O
assumptions	O
that	O
require	O
,	O
among	O
others	O
,	O
local	O
vector	O
control	O
and	O
,	O
in	O
certain	O
areas	O
,	O
the	O
destruction	B-T052
of	O
infected	O
plants	O
and	O
healthy	B-T080
ones	O
around	O
them	O
in	O
an	O
attempt	O
to	O
eradicate	B-T052
or	O
halt	B-T079
the	O
spreading	B-T080
pest	B-T047
.	O
	
here	O
we	O
show	O
that	O
,	O
regardless	O
of	O
epidemiological	B-T169
uncertainties	B-T033
,	O
the	O
mere	O
distribution	O
of	O
olive	O
orchards	O
in	O
southern	O
italy	O
makes	O
the	O
chances	O
of	O
eradicating	O
x	O
.	O
	
fastidiosa	O
from	O
the	O
region	O
extremely	O
slim	O
.	O
	
our	O
results	O
imply	O
that	O
southern	O
italy	O
is	O
becoming	O
a	O
reservoir	O
for	O
x	O
.	O
	
fastidiosa	O
.	O
	
as	O
a	O
consequence	O
,	O
management	O
strategies	O
should	O
keep	O
the	O
prevalence	O
of	O
x	O
.	O
	
fastidiosa	O
in	O
the	O
region	O
as	O
low	O
as	O
possible	O
,	O
primarily	O
through	O
vector	O
control	O
,	O
lest	O
the	O
pathogen	O
,	O
that	O
has	O
also	O
been	O
detected	O
in	O
southern	O
france	O
and	O
the	O
island	O
of	O
mallorca	O
spain	O
,	O
continues	O
spreading	O
through	O
italy	O
and	O
europe	O
novel	O
biomarkers	O
for	O
patients	O
with	O
idiopathic	B-T169
acute	B-T047
anterior	I-T047
uveitis	I-T047
neutrophil	O
to	O
lymphocyte	O
ratio	B-T081
and	O
platelet	O
to	O
lymphocyte	O
ratio	B-T081
to	O
assess	B-T052
the	O
levels	B-T080
of	O
the	O
neutrophil	O
to	O
lymphocyte	O
ratio	B-T081
n	O
/	O
l	O
and	O
the	O
platelet	O
to	O
lymphocyte	O
ratio	B-T081
p	O
/	O
l	O
in	O
patients	O
with	O
idiopathic	B-T169
acute	B-T047
anterior	I-T047
uveitis	I-T047
aau	B-T047
and	O
to	O
compare	B-T052
with	O
healthy	B-T080
controls	I-T080
.	O
	
thirty-six	O
male	B-T098
patients	O
with	O
idiopathic	B-T169
aau	B-T047
and	O
36	O
male	B-T098
healthy	B-T080
subjects	B-T098
were	O
enrolled	O
in	O
this	O
retrospective	B-T062
study	I-T062
.	O
	
complete	B-T080
ophthalmological	B-T061
examination	I-T061
and	O
complete	O
blood	O
count	O
measurements	O
results	B-T033
of	O
all	O
subjects	B-T098
were	O
evaluated	O
.	O
	
there	O
was	O
a	O
significant	B-T078
difference	O
in	O
n	O
/	O
l	O
and	O
p	O
/	O
l	O
between	O
idiopathic	B-T169
aau	B-T047
and	O
control	O
groups	O
p=0	O
,	O
p=0	O
.	O
	
also	O
,	O
correlation	B-T062
analysis	I-T062
revealed	O
a	O
significant	B-T078
correlation	B-T080
between	O
c-reactive	B-T116
protein	I-T116
crp	B-T116
and	O
n	O
/	O
l	O
p=0	O
r=0	O
.	O
	
our	O
study	B-T062
for	O
the	O
first	O
time	O
provides	O
evidence	B-T169
of	I-T169
n	O
/	O
l	O
and	O
p	O
/	O
l	O
may	O
be	O
useful	B-T080
biomarkers	O
in	O
patients	O
with	O
idiopathic	B-T169
aau	B-T047
.	O
	
n	O
/	O
l	O
is	O
correlated	B-T080
with	O
crp	B-T116
,	O
so	O
it	O
can	O
be	O
a	O
useful	B-T080
biomarker	O
to	O
predict	O
the	O
prognosis	O
in	O
idiopathic	B-T169
aau	B-T047
.	O
	
comparison	B-T052
between	O
magnetic	O
resonance	O
imaging	O
and	O
b-mode	O
ultrasound	O
in	O
detecting	B-T033
and	O
estimating	B-T081
the	O
extent	B-T082
of	O
human	O
carotid	B-T047
atherosclerosis	I-T047
in	O
mri	O
studies	O
of	O
carotid	O
plaques	O
,	O
ultrasound	O
is	O
used	O
to	O
find	B-T033
plaques	B-T033
,	O
which	O
are	O
later	O
imaged	B-T170
using	O
mri	O
.	O
	
the	O
performance	B-T052
in	O
plaque	B-T033
detection	B-T033
has	O
not	O
been	O
compared	B-T052
between	O
the	O
modalities	B-T169
.	O
	
the	O
aim	O
of	O
the	O
current	O
study	B-T062
was	O
to	O
compare	B-T052
the	O
performance	B-T052
of	O
mri	O
and	O
ultrasound	O
in	O
detecting	B-T033
carotid	O
artery	O
plaques	O
and	O
measuring	B-T080
extent	B-T082
of	O
atherosclerosis	B-T047
.	O
	
subjects	O
with	O
at	O
least	O
one	O
plaque	B-T033
height	B-T081
2	O
mm	O
on	O
ultrasound	O
were	O
imaged	B-T170
using	O
mri	O
.	O
	
the	O
number	B-T081
of	O
plaques	B-T033
and	O
their	O
height	B-T081
was	O
measured	B-T080
in	O
both	O
modalities	B-T169
plaque	B-T033
area	B-T082
and	O
volume	B-T081
were	O
analysed	B-T062
on	O
ultrasound	O
and	O
mri	O
,	O
respectively	O
.	O
	
thirty-eight	B-T081
subjects	O
were	O
included	B-T169
.	O
	
mri	O
detected	B-T033
plaques	B-T033
in	O
95%	O
of	O
carotid	O
arteries	O
with	O
a	O
plaque	B-T033
height	B-T081
of	O
2	O
mm	O
on	O
ultrasound	O
and	O
in	O
all	O
carotid	O
arteries	O
with	O
a	O
plaque	B-T033
exceeding	O
2	O
mm	O
.	O
	
mri	O
detected	B-T033
53%	O
of	O
the	O
plaques	B-T033
with	O
a	O
height	B-T081
below	O
2	O
mm	O
.	O
	
the	O
plaque	B-T033
height	B-T081
measured	B-T080
with	O
both	O
techniques	B-T169
correlated	B-T080
significantly	O
,	O
0	O
,	O
p<0	O
.	O
	
ultrasound	O
-derived	O
plaque	B-T033
height	B-T081
and	O
plaque	B-T033
area	B-T082
correlated	B-T080
similarly	B-T080
to	O
mri	O
-derived	O
plaque	B-T033
volume	B-T081
,	O
r	O
=	O
0	O
p<0	O
and	O
r	O
=	O
0	O
p	O
=	O
0	O
,	O
respectively	O
.	O
	
we	O
conclude	O
that	O
mri	O
has	O
a	O
similar	B-T080
sensitivity	B-T081
to	O
ultrasound	O
in	O
finding	B-T033
carotid	O
artery	O
plaques	O
that	O
are	O
2	O
mm	O
or	O
higher	B-T080
.	O
	
in	O
smaller	B-T080
plaques	B-T033
,	O
mri	O
detects	B-T033
fewer	B-T081
plaques	B-T033
.	O
	
multiple	O
carotid	O
plaques	O
seen	O
on	O
ultrasound	O
most	O
often	O
are	O
a	O
misinterpretation	O
of	O
the	O
anatomy	B-T080
and	O
correspond	O
to	O
a	O
single	B-T033
plaque	I-T033
.	O
	
plaque	B-T033
height	B-T081
on	O
ultrasound	O
is	O
comparable	O
to	O
plaque	B-T033
height	B-T081
on	O
mri	O
and	O
correlates	B-T080
fairly	O
well	O
with	O
plaque	B-T033
volume	B-T081
on	O
mri	O
making	O
it	O
an	O
interesting	O
proxy	O
for	O
plaque	B-T033
burden	B-T078
.	O
	
lightweight	O
open-cell	O
scaffolds	O
from	O
sea	O
urchin	O
spines	O
with	O
superior	O
material	O
properties	B-T080
for	O
bone	B-T061
defect	I-T061
repair	I-T061
sea	O
urchin	O
spines	O
heterocentrotus	O
mammillatus	O
,	O
with	O
a	O
hierarchical	O
open-cell	O
structure	O
similar	O
to	O
that	O
of	O
human	O
trabecular	O
bone	O
and	O
superior	O
mechanical	B-T080
property	I-T080
compressive	B-T081
strength	I-T081
43.4	O
mpa	O
suitable	B-T080
for	O
machining	B-T052
to	O
shape	B-T080
,	O
were	O
explored	O
for	O
potential	B-T080
applications	B-T169
of	O
bone	B-T061
defect	I-T061
repair	I-T061
.	O
	
finite	B-T170
element	I-T170
analyses	I-T170
reveal	O
that	O
the	O
compressive	O
stress	B-T033
concentrates	B-T052
along	O
the	O
dense	B-T080
growth	O
rings	O
and	O
dissipates	B-T082
through	O
strut	O
structures	O
of	O
the	O
stereoms	O
,	O
indicating	O
that	O
the	O
exquisite	O
mesostructures	B-T082
play	O
an	O
important	B-T080
role	O
in	O
high	O
strength	B-T080
-to-	O
weight	B-T081
ratios	B-T081
.	O
	
the	O
fracture	O
strength	B-T080
of	O
magnesium	O
-	O
substituted	O
tricalcium	O
phosphate	O
β-tcmp	O
scaffolds	O
produced	O
by	O
hydrothermal	O
conversion	B-T169
of	O
urchin	O
spines	O
is	O
about	O
9.3	O
mpa	O
,	O
comparable	B-T052
to	O
that	O
of	O
human	O
trabecular	O
bone	O
.	O
	
new	O
bone	O
forms	B-T169
along	O
outer	O
surfaces	B-T082
of	O
β-tcmp	O
scaffolds	O
after	O
implantation	B-T061
in	O
rabbit	O
femoral	O
defects	O
for	O
one	O
month	B-T079
and	O
grows	O
into	O
the	O
majority	O
of	O
the	O
inner	O
open-cell	O
spaces	O
postoperation	B-T079
in	O
three	O
month	B-T079
s	O
,	O
showing	O
tight	O
interface	O
between	O
the	O
scaffold	O
and	O
regenerative	O
bone	O
tissue	O
.	O
	
fusion	B-T061
of	O
beagle	O
lumbar	O
facet	O
joints	O
using	O
a	O
ti-6al-4v	O
cage	O
and	O
β-tcmp	O
scaffold	O
can	O
be	O
completed	B-T080
within	O
seven	O
months	B-T079
with	O
obvious	O
biodegradation	O
of	O
the	O
β-tcmp	O
scaffold	O
,	O
which	O
is	O
nearly	O
completely	B-T080
degraded	O
and	O
replaced	B-T169
by	I-T169
newly	O
formed	B-T169
bone	O
ten	O
months	B-T079
after	O
implantation	B-T061
.	O
	
thus	O
,	O
sea	O
urchin	O
spines	O
suitable	O
for	O
machining	B-T052
to	O
shape	B-T080
have	O
advantages	O
for	O
production	O
of	O
biodegradable	O
artificial	O
grafts	O
for	O
bone	B-T061
defect	I-T061
repair	I-T061
.	O
	
melatonin	B-T109
and	O
nitric	O
oxide	O
regulate	O
sunflower	O
seedling	O
growth	O
under	O
salt	O
stress	O
accompanying	O
differential	O
expression	O
of	O
cu/zn	B-T116
sod	I-T116
and	O
mn	B-T116
sod	I-T116
salinity	O
results	O
in	O
significant	B-T080
reduction	I-T080
in	O
sunflower	O
helianthus	O
annuus	O
l	O
seedling	O
growth	O
and	O
excessive	O
generation	O
of	O
reactive	O
oxygen	O
species	O
ros	O
.	O
	
present	O
work	O
highlights	O
the	O
possible	O
role	O
of	O
melatonin	B-T109
as	O
an	O
antioxidant	O
through	O
its	O
interaction	O
with	O
nitric	O
oxide	O
no	O
,	O
and	O
as	O
an	O
early	O
and	O
long	O
distance	O
nacl-stress	O
sensing	O
signaling	O
molecule	O
in	O
seedling	O
cotyledons	O
.	O
	
exogenous	B-T169
melatonin	B-T109
15µm	O
nacl	O
120mm	O
inhibit	B-T052
seedling	O
growth	O
,	O
which	O
is	O
also	O
correlated	O
with	O
no	O
availability	O
,	O
accumulation	O
of	O
potential	O
superoxide	O
anion	O
o2	O
and	O
peroxynitrite	O
anion	O
onoo	O
,	O
extent	O
of	O
tyrosine-nitration	O
of	O
proteins	B-T116
,	O
spatial	B-T169
localization	I-T169
and	O
activity	O
of	O
superoxide	O
dismutase	O
sod	B-T116
isoforms	B-T116
.	O
	
no	O
acts	O
as	O
a	O
positive	O
modulator	O
of	O
melatonin	B-T109
accumulation	O
in	O
seedling	O
cotyledons	O
as	O
a	O
long-distance	O
signaling	O
response	O
.	O
	
modulation	O
of	O
superoxide	O
anion	O
and	O
peroxynitrite	O
anion	O
content	O
by	O
melatonin	B-T109
highlights	O
its	O
crucial	O
role	O
in	O
combating	O
deleterious	O
effects	O
of	O
ros	O
and	O
reactive	O
nitrogen	O
species	O
rns	O
.	O
	
present	O
findings	O
provide	O
evidence	O
for	O
an	O
interaction	O
between	O
melatonin	B-T109
and	O
no	O
in	O
their	O
effect	O
on	O
seedling	O
growth	O
under	O
salt	O
stress	O
accompanying	O
differential	O
modulation	O
of	O
two	O
sod	B-T116
isoforms	B-T116
,	O
i.e	O
.	O
	
cu/zn	B-T116
sod	I-T116
and	O
mn	B-T116
sod	I-T116
.	O
	
the	O
physiological	B-T169
role	O
and	O
regulation	O
of	O
aquaporins	B-T116
in	O
teleost	O
germ	O
cells	O
the	O
unicellular	O
germ	O
cells	O
and	O
gametes	O
of	O
oviparous	O
teleosts	O
lack	O
the	O
osmoregulatory	O
organs	O
present	O
in	O
juveniles	O
and	O
adults	O
,	O
yet	O
during	O
development	O
and	O
particularly	O
at	O
spawning	O
,	O
they	O
face	O
tremendous	O
osmotic	B-T169
challenges	B-T033
when	O
released	O
into	O
the	O
external	B-T082
aquatic	O
environment	O
.	O
	
increasing	O
evidence	O
suggests	O
that	O
transmembrane	B-T116
water	I-T116
channels	I-T116
aquaporins	B-T116
evolved	O
to	O
play	O
vital	O
adaptive	O
roles	O
that	O
mitigate	O
the	O
osmotic	O
and	O
oxidative	O
stress	O
problems	B-T033
of	O
the	O
developing	O
oocytes	O
,	O
embryos	O
and	O
spermatozoa	O
.	O
	
in	O
this	O
chapter	O
,	O
we	O
provide	O
a	O
short	O
overview	O
of	O
the	O
diversity	B-T080
of	O
the	O
aquaporin	B-T116
superfamily	O
in	O
teleosts	O
,	O
and	O
summarize	O
the	O
findings	O
that	O
uncovered	O
a	O
highly	O
specific	O
molecular	O
regulation	O
of	O
aquaporins	B-T116
during	O
oogenesis	O
and	O
spermatogenesis	O
.	O
	
we	O
further	O
review	O
the	O
multiple	O
functions	O
that	O
these	O
channels	B-T116
play	O
during	O
the	O
establishment	O
of	O
egg	O
buoyancy	O
and	O
the	O
activation	B-T052
and	O
detoxification	B-T061
of	O
spermatozoa	O
in	O
the	O
marine	O
environment	B-T082
.	O
	
caribbean	O
massive	O
corals	O
not	B-T080
recovering	I-T080
from	I-T080
repeated	O
thermal	O
stress	O
events	O
during	O
2005-2013	O
massive	O
coral	O
bleaching	O
events	O
associated	O
with	O
high	O
sea	O
surface	B-T082
temperatures	B-T081
are	O
forecast	O
to	O
become	O
more	O
frequent	B-T079
and	O
severe	B-T080
in	O
the	O
future	O
due	O
to	O
climate	O
change	O
.	O
	
monitoring	B-T062
colony	O
recovery	B-T052
from	O
bleaching	O
disturbances	O
over	O
multiyear	B-T079
time	I-T079
frames	I-T079
is	O
important	O
for	O
improving	O
predictions	O
of	O
future	O
coral	O
community	O
changes	B-T169
.	O
	
however	O
,	O
there	O
are	O
currently	O
few	O
multiyear	B-T062
studies	I-T062
describing	O
long-term	B-T079
outcomes	B-T169
for	O
coral	O
colonies	O
following	O
acute	O
bleaching	O
events	O
.	O
	
we	O
recorded	O
colony	O
pigmentation	O
and	O
size	B-T082
for	O
bleached	B-T078
and	O
unbleached	B-T078
groups	I-T078
of	O
co-located	O
conspecifics	O
of	O
three	O
major	O
reef-building	O
scleractinian	O
corals	O
orbicella	O
franksi	O
,	O
siderastrea	O
siderea	O
,	O
and	O
stephanocoenia	O
michelini	O
n	O
=	O
198	O
total	O
in	O
bocas	O
del	O
toro	O
,	O
panama	O
,	O
during	O
the	O
major	O
2005	O
bleaching	O
event	O
and	O
then	O
monitored	B-T062
pigmentation	O
status	B-T080
and	O
changes	O
live	O
tissue	O
colony	O
size	B-T082
for	O
8	O
years	B-T079
2005-2013	O
.	O
	
corals	O
that	O
were	O
bleached	O
in	O
2005	O
demonstrated	O
markedly	O
different	O
response	O
trajectories	O
compared	O
to	O
unbleached	O
colony	O
groups	B-T078
,	O
with	O
extensive	O
live	O
tissue	O
loss	B-T081
for	O
bleached	O
corals	O
of	O
all	O
species	O
following	O
bleaching	O
,	O
with	O
mean	O
live	O
tissue	O
losses	B-T081
per	O
colony	O
9	O
months	B-T079
postbleaching	B-T079
of	O
26.2	O
5.4	O
se	O
for	O
o	O
.	O
	
franksi	O
,	O
35.7	O
4.7	O
se	O
for	O
s	O
.	O
	
michelini	O
,	O
and	O
11.2	O
3.9	O
se	O
for	O
s	O
.	O
	
siderea	O
.	O
	
two	O
species	O
,	O
o	O
.	O
	
franksi	O
and	O
s	O
.	O
	
michelini	O
,	O
later	O
recovered	O
to	O
net	O
positive	B-T033
growth	O
,	O
which	O
continued	O
until	O
a	O
second	O
thermal	O
stress	O
event	O
in	O
2010	O
.	O
	
following	O
this	O
event	O
,	O
all	O
species	O
again	O
lost	B-T169
tissue	O
,	O
with	O
previously	O
unbleached	O
colony	O
species	O
groups	B-T078
experiencing	O
greater	O
declines	O
than	O
conspecific	O
sample	O
groups	B-T078
,	O
which	O
were	O
previously	O
bleached	O
,	O
indicating	O
a	O
possible	O
positive	O
acclimative	O
response	O
.	O
	
however	O
,	O
despite	O
this	O
beneficial	O
effect	O
for	O
previously	O
bleached	O
corals	O
,	O
all	O
groups	B-T078
experienced	O
substantial	O
net	O
tissue	O
loss	B-T081
between	O
2005	O
and	O
2013	O
,	O
indicating	O
that	O
many	O
important	O
caribbean	O
reef-building	O
corals	O
will	O
likely	O
suffer	O
continued	O
tissue	O
loss	B-T081
and	O
may	O
be	O
unable	O
to	O
maintain	O
current	O
benthic	B-T082
coverage	I-T082
when	O
faced	O
with	O
future	O
thermal	O
stress	O
forecast	O
for	O
the	O
region	O
,	O
even	O
with	O
potential	O
benefits	O
from	O
bleaching	O
-related	O
preparation	B-T052
and	O
characterization	B-T052
of	O
gastrointestinal	B-T082
wafer	O
formulations	O
many	O
active	O
pharmaceutical	O
ingredients	O
api	O
have	O
a	O
very	O
poor	O
or	O
highly	O
variable	B-T080
bioavailability	B-T081
after	O
oral	B-T061
administration	I-T061
.	O
	
one	O
possibility	O
to	O
overcome	B-T052
this	O
problem	O
might	O
be	O
found	O
in	O
the	O
application	O
of	O
mucoadhesive	O
dosage	O
forms	O
like	O
gastrointestinal	B-T082
wafers	O
.	O
	
however	O
,	O
a	O
currently	B-T079
unsolved	O
challenge	O
is	O
the	O
control	B-T080
of	O
the	O
adhesion	O
of	O
the	O
wafer	O
to	O
the	O
intestinal	O
mucus	O
.	O
	
one	O
suggested	O
solution	O
might	O
be	O
the	O
combination	B-T080
of	O
gastrointestinal	B-T082
wafers	O
and	O
expanding	B-T169
systems	I-T169
.	O
	
such	O
a	O
combination	B-T080
requires	O
thin	O
and	O
elastic	O
wafers	O
which	O
are	O
further	O
characterized	B-T052
by	O
an	O
unidirectional	O
drug	O
release	O
.	O
	
in	O
this	O
study	B-T062
gastrointestinal	B-T082
,	O
twolayered	O
wafers	O
containing	O
a	O
water-insoluble	B-T080
backing	I-T080
layer	I-T080
and	O
a	O
drug-loaded	B-T081
,	O
mucoadhesive	B-T080
layer	I-T080
were	O
fabricated	O
by	O
casting	B-T169
solvent	I-T169
technique	I-T169
.	O
	
the	O
backing	B-T080
layer	I-T080
consists	O
of	O
ethocel	O
standard	O
10	O
premium	O
and	O
the	O
mucoadhesive	B-T080
layer	I-T080
was	O
prepared	O
using	O
a	O
mixture	O
of	O
methocel	B-T109
e15	I-T109
premium	I-T109
lv	I-T109
,	O
polyvinyl	O
alcohol	O
and	O
macrogol	B-T109
400	I-T109
.	O
	
the	O
wafers	O
were	O
characterized	B-T052
regarding	O
their	O
appearance	B-T080
,	O
mechanical	B-T080
properties	I-T080
and	O
dissolution	O
profiles	O
as	O
well	O
as	O
the	O
influence	O
of	O
backing	B-T080
layer	I-T080
thickness	B-T080
on	O
drug	B-T052
transfer	I-T052
and	O
their	O
ability	O
of	O
unidirectional	O
drug	O
release	O
.	O
	
the	O
wafers	O
with	O
backing	B-T080
layer	I-T080
thickness	B-T080
of	O
500μg	B-T109
ethocel	I-T109
/cm	O
presented	O
adequate	B-T080
mechanical	B-T080
properties	I-T080
,	O
a	O
drug	B-T052
transfer	I-T052
about	O
73%	O
and	O
unidirectional	O
drug	O
release	O
.	O
	
discovery	B-T052
of	O
<i>neopanorpa	O
chillcotti</i>	O
byers	O
mecoptera	O
panorpidae	O
from	O
tibet	O
,	O
china	O
,	O
with	O
discussion	O
of	O
its	O
generic	B-T078
status	I-T078
neopanorpa	O
chillcotti	O
byers	O
,	O
1971	O
was	O
originally	O
described	O
from	O
kathmandu	O
in	O
nepal	O
and	O
is	O
now	O
found	O
to	O
be	O
distributed	O
in	O
gyirong	O
,	O
tibet	O
in	O
china	O
.	O
	
the	O
species	O
is	O
redescribed	O
and	O
illustrated	O
based	O
on	O
new	O
material	O
from	O
china	O
and	O
nepal	O
.	O
	
the	O
generic	B-T078
status	I-T078
of	O
this	O
species	O
is	O
briefly	O
passive	B-T062
case	I-T062
detection	I-T062
of	O
malaria	B-T047
in	O
ratanakiri	O
province	O
cambodia	O
to	O
detect	B-T033
villages	O
at	B-T033
higher	I-T033
risk	I-T033
for	O
malaria	B-T047
cambodia	O
reduced	B-T080
malaria	B-T047
incidence	B-T081
by	O
more	O
than	O
75%	O
between	O
2000	O
and	O
2015	O
,	O
a	O
target	B-T169
of	O
the	O
millennium	B-T170
development	I-T170
goal	I-T170
6	I-T170
.	O
	
the	O
cambodian	O
government	O
aims	B-T078
to	O
eliminate	B-T080
all	O
forms	O
of	O
malaria	B-T047
by	O
2025	O
.	O
	
the	O
country's	O
malaria	B-T047
incidence	B-T081
is	O
highly	B-T080
variable	B-T080
at	O
provincial	O
level	B-T080
,	O
but	O
less	O
is	O
known	O
at	O
village	O
level	B-T080
.	O
	
this	O
study	B-T062
used	O
passive	B-T062
case	I-T062
detection	I-T062
pcd	B-T062
data	O
at	O
village	O
level	B-T080
in	O
ratanakiri	O
province	O
from	O
2010	O
to	O
2014	O
to	O
describe	O
incidence	B-T081
trends	B-T079
and	O
identify	B-T080
high-risk	B-T033
areas	I-T033
of	I-T033
malaria	B-T047
to	O
be	O
primarily	B-T080
targeted	B-T169
towards	O
malaria	B-T047
elimination	B-T080
.	O
	
in	O
2010	O
,	O
the	O
cambodian	O
malaria	B-T047
programme	B-T170
created	O
a	O
malaria	B-T170
information	I-T170
system	I-T170
mis	B-T170
to	O
capture	O
malaria	B-T047
information	B-T078
at	O
village	O
level	B-T080
through	O
pcd	B-T062
by	O
village	O
malaria	O
workers	O
and	O
health	O
facilities	O
.	O
	
the	O
mis	B-T170
data	B-T078
of	O
ratanakiri	O
province	O
2010-2014	O
were	O
used	O
to	O
calculate	B-T052
annual	B-T079
incidence	B-T081
rates	I-T081
by	O
plasmodium	O
species	O
at	O
province	O
and	O
commune	B-T098
levels	B-T080
.	O
	
for	O
estimating	B-T081
the	O
trend	B-T079
at	O
provincial	O
level	B-T080
only	O
villages	O
reporting	O
each	O
year	B-T079
were	O
selected	O
.	O
	
the	O
communal	O
incidences	B-T081
and	O
the	O
number	O
of	O
cases	B-T169
per	B-T080
village	O
were	O
visualized	O
on	O
a	O
map	O
per	O
plasmodium	O
species	O
and	O
per	B-T079
year	I-T079
.	O
	
analysis	O
of	O
spatial	O
clustering	O
of	O
village	O
malaria	B-T047
cases	B-T169
by	O
plasmodium	O
species	O
was	O
performed	B-T169
by	O
year	B-T079
.	O
	
overall	O
,	O
malaria	B-T047
annual	B-T079
incidence	B-T081
rates	I-T081
per	O
1000	O
inhabitants	O
decreased	B-T080
from	O
86	O
2010	O
to	O
30	O
2014	O
.	O
	
falciparum	O
incidence	B-T081
decreased	B-T080
by	O
79%	O
in	O
2014	O
compared	B-T052
to	O
2010	O
ci	B-T081
95%	O
76-82%	O
more	O
rapidly	B-T080
than	O
vivax	O
incidence	B-T081
by	O
19%	O
in	O
2014	O
compared	B-T052
to	O
2010	O
ci	B-T081
95%	O
5-32%	O
.	O
	
there	O
were	O
ten	O
to	O
16	O
significant	B-T078
spatial	B-T081
clusters	I-T081
each	O
year	B-T079
.	O
	
big	B-T081
clusters	I-T081
tended	O
to	O
extend	B-T082
along	O
the	O
cambodian-vietnamese	O
border	O
and	O
along	O
the	O
sesan	O
river	O
.	O
	
three	O
clusters	B-T081
appeared	O
throughout	O
all	O
years	B-T079
2010-2014	O
one	O
with	O
21	O
villages	O
appeared	O
each	O
year	B-T079
,	O
the	O
second	O
shrunk	B-T081
progressively	B-T169
from	O
2012	O
to	O
2014	O
and	O
the	O
third	O
was	O
split	B-T169
into	O
two	O
smaller	O
clusters	B-T081
in	O
2013	O
and	O
2014	O
.	O
	
the	O
decline	O
of	O
malaria	B-T047
burden	B-T078
can	O
be	O
attributed	O
to	O
intensive	B-T169
malaria	B-T052
control	I-T052
activities	I-T052
implemented	B-T052
in	O
the	O
areas	B-T082
distribution	B-T078
of	O
a	O
long-lasting	B-T078
insecticidal	O
net	O
per	O
person	B-T098
and	O
early	O
diagnosis	O
and	O
prompt	B-T169
treatment	B-T169
.	O
	
dihydro-artemisinin	B-T109
piperaquine	B-T109
was	O
the	O
only	O
first-line	B-T061
treatment	I-T061
for	O
all	O
malaria	B-T047
cases	B-T169
.	O
	
no	O
radical	B-T080
treatment	B-T169
with	O
primaquine	B-T109
was	O
provided	O
for	O
plasmodium	O
vivax	O
cases	B-T169
,	O
which	O
could	O
explain	O
the	O
slow	B-T080
decrease	B-T081
of	O
p	O
.	O
	
vivax	O
due	O
to	O
relapses	O
.	O
	
to	O
achieve	B-T080
malaria	B-T047
elimination	B-T080
by	O
2025	O
,	O
priority	B-T079
should	O
be	O
given	O
to	O
the	O
control	O
of	O
stable	B-T080
malaria	B-T081
clusters	I-T081
interaction	O
of	O
lifestyle	O
,	O
behaviour	O
or	O
systemic	B-T047
diseases	I-T047
with	O
dental	B-T047
caries	I-T047
and	O
periodontal	B-T047
diseases	I-T047
consensus	O
report	O
of	O
group	O
2	O
of	O
the	O
joint	O
efp/orca	O
workshop	O
on	O
the	O
boundaries	O
between	O
caries	B-T047
and	O
periodontal	B-T047
diseases	I-T047
periodontal	B-T047
diseases	I-T047
and	O
dental	B-T047
caries	I-T047
are	O
the	O
most	O
common	B-T047
diseases	I-T047
of	O
humans	O
and	O
the	O
main	O
cause	O
of	O
tooth	O
loss	O
.	O
	
both	O
diseases	B-T047
can	O
lead	O
to	O
nutritional	B-T169
compromise	I-T169
and	O
negative	O
impacts	O
upon	O
self-esteem	O
and	O
quality	B-T078
of	I-T078
life	I-T078
.	O
	
as	O
complex	B-T047
chronic	I-T047
diseases	I-T047
,	O
they	O
share	O
common	B-T033
risk	I-T033
factors	I-T033
,	O
such	O
as	O
a	O
requirement	O
for	O
a	O
pathogenic	O
plaque	O
biofilm	O
,	O
yet	O
they	O
exhibit	O
distinct	O
pathophysiologies	O
.	O
	
multiple	B-T080
exposures	I-T080
contribute	O
to	O
their	O
causal	O
pathways	O
,	O
and	O
susceptibility	O
involves	O
risk	B-T033
factors	I-T033
that	O
are	O
inherited	B-T169
e.g	O
.	O
	
genetic	O
variants	O
,	O
and	O
those	O
that	O
are	O
acquired	O
e.g	O
.	O
	
socio-economic	B-T080
factors	I-T080
,	O
biofilm	O
load	O
or	O
composition	O
,	O
smoking	O
,	O
carbohydrate	O
intake	O
.	O
	
identification	O
of	O
these	O
factors	O
is	O
crucial	O
in	O
the	O
prevention	B-T061
of	I-T061
both	I-T061
diseases	I-T061
as	O
well	O
as	O
in	O
their	O
management	O
.	O
	
to	O
systematically	O
appraise	O
the	O
scientific	B-T170
literature	I-T170
to	O
identify	O
potential	B-T033
risk	I-T033
factors	I-T033
for	O
caries	B-T047
and	O
periodontal	B-T047
diseases	I-T047
.	O
	
one	O
systematic	B-T170
review	I-T170
genetic	B-T080
risk	I-T080
factors	I-T080
,	O
one	O
narrative	O
review	O
role	B-T062
of	I-T062
diet	I-T062
and	I-T062
nutrition	I-T062
and	O
reference	B-T170
documentation	I-T170
for	O
modifiable	B-T033
acquired	I-T033
risk	I-T033
factors	I-T033
common	O
to	O
both	O
disease	O
groups	O
,	O
formed	O
the	O
basis	O
of	O
the	O
report	O
.	O
	
there	O
is	O
moderately	O
strong	O
evidence	O
for	O
a	O
genetic	B-T033
contribution	I-T033
to	O
periodontal	B-T047
diseases	I-T047
and	O
caries	O
susceptibility	O
,	O
with	O
an	O
attributable	B-T080
risk	I-T080
estimated	O
to	O
be	O
up	O
to	O
50%	O
.	O
	
the	O
genetics	B-T169
literature	I-T169
for	O
periodontal	B-T047
disease	I-T047
is	O
more	O
substantial	O
than	O
for	O
caries	B-T047
and	O
genes	O
associated	B-T080
with	I-T080
chronic	B-T047
periodontitis	I-T047
are	O
the	O
vitamin	O
d	O
receptor	O
vdr	O
,	O
fc	O
gamma	O
receptor	O
iia	O
fc-γriia	O
and	O
interleukin	O
10	O
il10	O
genes	O
.	O
	
for	O
caries	O
,	O
genes	O
involved	O
in	O
enamel	O
formation	O
amelx	O
,	O
ambn	O
,	O
enam	O
,	O
tuft	O
,	O
mmp20	O
,	O
and	O
klk4	O
,	O
salivary	O
characteristics	O
aqp5	O
,	O
immune	O
regulation	O
and	O
dietary	O
preferences	O
had	O
the	O
largest	O
impact	O
.	O
	
no	O
common	O
genetic	O
variants	O
were	O
found	O
.	O
	
fermentable	O
carbohydrates	O
sugars	O
and	O
starches	O
were	O
the	O
most	O
relevant	O
common	O
dietary	O
risk	O
factor	O
for	O
both	O
diseases	O
,	O
but	O
associated	O
mechanisms	O
differed	O
.	O
	
in	O
caries	O
,	O
the	O
fermentation	O
process	O
leads	O
to	O
acid	O
production	O
and	O
the	O
generation	O
of	O
biofilm	O
components	O
such	O
as	O
glucans	O
.	O
	
in	O
periodontitis	O
,	O
glycaemia	O
drives	O
oxidative	O
stress	O
and	O
advanced	O
glycation	O
end-products	O
may	O
also	O
trigger	O
a	O
hyper	O
inflammatory	O
state	O
.	O
	
micronutrient	O
deficiencies	O
,	O
such	O
as	O
for	O
vitamin	O
c	O
,	O
vitamin	O
d	O
or	O
vitamin	O
b12	O
,	O
may	O
be	O
related	O
to	O
the	O
onset	O
and	O
progression	O
of	O
both	O
diseases	O
.	O
	
functional	O
foods	O
or	O
probiotics	O
could	O
be	O
helpful	O
in	O
caries	O
prevention	O
and	O
periodontal	O
disease	O
management	O
,	O
although	O
evidence	O
is	O
limited	O
and	O
biological	O
mechanisms	O
not	O
fully	O
elucidated	O
.	O
	
hyposalivation	O
,	O
rheumatoid	O
arthritis	O
,	O
smoking/tobacco	O
use	O
,	O
undiagnosed	O
or	O
sub-optimally	O
controlled	O
diabetes	O
and	O
obesity	O
are	O
common	O
acquired	O
risk	O
factors	O
for	O
both	O
caries	O
and	O
periodontal	O
diseases	I-T033
intestinal	O
micropatches	O
for	O
oral	B-T082
insulin	B-T061
delivery	I-T061
diabetes	B-T047
mellitus	I-T047
has	O
become	O
a	O
major	O
public	B-T078
health	I-T078
issue	I-T078
that	O
has	O
almost	O
reached	O
epidemic	B-T169
proportions	I-T169
worldwide	O
.	O
	
injectable	O
insulin	O
has	O
been	O
typically	O
utilized	O
for	O
the	O
management	O
of	O
this	O
chronic	B-T047
disease	I-T047
.	O
	
however	O
,	O
lack	B-T033
of	I-T033
patient	I-T033
compliance	I-T033
with	O
injectable	O
formulations	O
has	O
spurred	O
the	O
development	O
of	O
oral	B-T082
insulin	B-T116
formulations	O
,	O
which	O
although	O
appealing	O
,	O
face	O
several	O
delivery	B-T061
challenges	O
.	O
	
we	O
have	O
developed	O
novel	O
mucoadhesive	O
intestinal	O
patches	O
,	O
several	O
hundred	O
micrometers	B-T081
in	O
dimension	B-T081
micropatches	O
that	O
address	O
the	O
challenges	O
of	O
oral	B-T082
insulin	B-T061
delivery	I-T061
.	O
	
the	O
micropatches	O
adhere	O
to	O
the	O
intestinal	O
mucosa	O
,	O
release	O
their	O
drug	O
load	O
rapidly	B-T080
within	O
30	O
min	O
and	O
are	O
effective	B-T080
in	O
lowering	B-T033
blood	I-T033
glucose	I-T033
levels	I-T033
in	B-T082
vivo	I-T082
.	O
	
when	O
insulin	B-T116
-loaded	O
micropatches	O
were	O
administered	B-T061
with	O
a	O
permeation	O
enhancer	O
and	O
protease	O
inhibitor	O
,	O
a	O
peak	B-T080
efficacy	B-T080
of	O
34%	O
drop	B-T033
in	I-T033
blood	I-T033
glucose	I-T033
levels	I-T033
was	O
observed	O
within	O
3	O
h	O
.	O
	
efficacy	B-T080
further	O
improved	O
to	O
41%	O
when	O
micropatches	O
were	O
administered	B-T061
in	O
multiple	O
doses	O
.	O
	
here	O
,	O
we	O
describe	O
the	O
design	O
of	O
micropatches	O
as	O
an	O
oral	B-T082
insulin	B-T116
formulation	O
and	O
report	O
their	O
in	B-T082
vivo	I-T082
efficacy	B-T080
.	O
	
hybrid	O
automata	O
models	O
of	O
cardiac	O
ventricular	O
electrophysiology	O
for	O
real-time	B-T079
computational	B-T169
applications	I-T169
virtual	O
heart	O
models	O
have	O
been	O
proposed	O
for	O
closed	B-T169
loop	I-T169
validation	B-T062
of	O
safety	O
-	O
critical	B-T080
embedded	O
medical	O
devices	O
,	O
such	O
as	O
pacemakers	O
.	O
	
these	O
models	O
must	O
react	O
in	O
real-time	B-T079
to	O
off-the-shelf	O
medical	O
devices	O
.	O
	
real-time	B-T079
performance	B-T052
can	O
be	O
obtained	B-T169
by	O
implementing	O
models	O
in	O
computer	O
hardware	O
,	O
and	O
methods	B-T169
of	O
compiling	O
classes	O
of	O
hybrid	O
automata	O
ha	O
onto	O
fpga	O
have	O
been	O
developed	O
.	O
	
models	O
of	O
ventricular	O
cardiac	O
cell	O
electrophysiology	O
have	O
been	O
described	B-T078
using	O
ha	O
which	O
capture	O
the	O
complex	O
nonlinear	O
behavior	B-T080
of	O
biological	B-T169
systems	I-T169
.	O
	
however	O
,	O
many	O
models	O
that	O
have	O
been	O
used	O
for	O
closed-loop	B-T169
validation	B-T062
of	O
pacemakers	O
are	O
highly	O
abstract	B-T078
and	O
do	O
not	O
capture	O
important	B-T080
characteristics	B-T080
of	O
the	O
dynamic	B-T169
rate	B-T079
response	I-T079
.	O
	
we	O
developed	O
a	O
new	O
ha	O
model	O
of	O
cardiac	O
cells	O
which	O
captures	O
dynamic	B-T169
behavior	B-T080
and	O
we	O
implemented	O
the	O
model	O
in	O
hardware	O
.	O
	
this	O
potentially	B-T080
enables	O
modeling	B-T062
the	O
heart	O
with	O
over	O
1	O
million	B-T081
dynamic	B-T169
cells	O
,	O
making	O
the	O
approach	O
ideal	B-T080
for	O
closed	B-T169
loop	I-T169
testing	B-T169
of	O
medical	O
devices	O
.	O
	
comparison	B-T052
of	O
pulse	B-T081
wave	I-T081
velocity	I-T081
derived	O
from	O
accelerometer	O
and	O
reflective	O
photo-plethysmography	O
signals	O
placed	O
at	O
the	O
carotid	O
and	O
femoral	O
artery	O
carotid	O
-	O
femoral	O
pulse	B-T081
wave	I-T081
velocity	I-T081
is	O
an	O
established	B-T081
measure	I-T081
to	O
assess	O
cardiovascular	B-T033
risk	I-T033
and	O
an	O
interesting	O
surrogate	O
parameter	O
towards	O
non-invasive	O
continuous	O
blood	O
pressure	O
inference	O
.	O
	
due	O
to	O
progress	B-T169
in	O
sensing	O
technologies	O
for	O
wearable	O
wrist	O
worn	O
sensors	O
,	O
there	O
are	O
low	O
cost	O
sensor	O
combinations	O
of	O
photo-plethysmography	O
and	O
high	O
fidelity	O
accelerometer	O
s	O
available	O
offering	O
access	O
to	O
pulse	O
information	O
from	O
larger	O
arteries	O
complemented	O
by	O
blood	O
volume	O
changes	O
in	O
the	O
superficial	O
tissue	O
.	O
	
in	O
this	O
work	O
we	O
compare	O
pulse	B-T081
wave	I-T081
velocities	I-T081
derived	O
from	O
accelerometer	O
and	O
reflective	O
photo-plethysmography	O
signals	O
placed	O
at	O
the	O
carotid	O
and	O
femoral	O
artery	O
.	O
	
we	O
discuss	O
the	O
different	O
underlying	O
physiological	O
processes	O
for	O
the	O
two	O
sensing	B-T078
principles	I-T078
and	O
present	O
experimental	B-T033
results	I-T033
obtained	O
in	O
a	O
study	B-T062
with	O
healthy	B-T098
subjects	I-T098
.	O
	
constructive	B-T033
and	I-T033
unproductive	I-T033
processing	I-T033
of	O
traumatic	O
experiences	O
in	O
trauma-focused	B-T061
cognitive-behavioral	I-T061
therapy	I-T061
for	O
youth	O
although	O
there	O
is	O
substantial	O
evidence	B-T078
to	O
support	O
the	O
efficacy	B-T080
of	O
cognitive-behavioral	B-T061
treatments	I-T061
cbt	B-T061
for	O
posttraumatic	O
stress	O
disorder	O
ptsd	O
,	O
there	O
is	O
some	O
debate	O
about	O
how	O
these	O
treatments	B-T061
have	O
their	O
effects	O
.	O
	
modern	O
learning	B-T170
theory	I-T170
and	O
cognitive	B-T170
and	I-T170
emotional	I-T170
processing	I-T170
theories	I-T170
highlight	O
the	O
importance	O
of	O
reducing	O
avoidance	O
,	O
facilitating	O
the	O
constructive	B-T033
processing	I-T033
of	I-T033
feared	I-T033
experiences	I-T033
,	O
and	O
strengthening	O
new	O
inhibitory	O
learning	O
.	O
	
we	O
examined	O
variables	O
thought	O
to	O
be	O
associated	O
with	O
unproductive	B-T033
and	I-T033
constructive	I-T033
processing	I-T033
of	O
traumatic	O
experiences	O
in	O
a	O
sample	O
of	O
81	O
youth	O
with	O
elevated	O
ptsd	O
symptoms	O
,	O
who	O
received	O
trauma-focused	B-T061
cognitive	I-T061
behavioral	I-T061
therapy	I-T061
tf-cbt	B-T061
for	O
abuse	B-T033
or	O
traumatic	O
interpersonal	O
loss	O
.	O
	
sessions	O
during	O
the	O
trauma	B-T061
narrative	I-T061
phase	I-T061
of	O
tf-cbt	B-T061
were	O
coded	O
for	O
indicators	O
of	O
unproductive	B-T033
processing	I-T033
overgeneralization	B-T033
,	O
rumination	O
,	O
avoidance	O
and	O
constructive	B-T033
processing	I-T033
decentering	B-T033
,	O
accommodation	B-T033
of	I-T033
corrective	I-T033
information	I-T033
,	O
as	O
well	O
as	O
levels	O
of	O
negative	O
emotion	O
.	O
	
in	O
previous	B-T079
analyses	O
of	O
this	O
trial	O
ready	O
et	O
al	O
,	O
2015	O
,	O
more	O
overgeneralization	B-T033
during	O
the	O
narrative	B-T061
phase	I-T061
predicted	O
less	O
improvement	O
in	O
internalizing	O
symptoms	O
at	O
posttreatment	O
and	O
a	O
worsening	B-T080
of	O
externalizing	O
symptoms	O
over	O
the	O
12-month	O
follow-up	O
.	O
	
in	O
contrast	O
,	O
more	O
accommodation	B-T033
predicted	I-T033
improvement	I-T033
in	O
internalizing	O
symptoms	O
and	O
also	O
moderated	B-T080
the	O
negative	B-T033
effects	B-T080
of	I-T080
overgeneralization	B-T033
on	O
internalizing	O
and	O
externalizing	O
symptoms	O
.	O
	
the	O
current	O
study	O
examined	O
correlates	O
of	O
overgeneralization	B-T033
and	O
accommodation	B-T033
.	O
	
overgeneralization	B-T033
was	O
associated	B-T080
with	I-T080
more	O
rumination	O
,	O
less	O
decentering	O
,	O
and	O
more	O
negative	O
emotion	O
,	O
suggesting	B-T078
immersion	O
in	O
trauma	O
-related	O
material	O
.	O
	
accommodation	B-T033
was	O
associated	B-T080
with	I-T080
less	O
avoidance	O
and	O
more	O
decentering	B-T033
,	O
suggesting	O
a	O
healthy	B-T080
distance	O
from	O
trauma	O
-related	O
material	O
that	O
might	O
allow	O
for	O
processing	O
and	O
cognitive	O
change	O
.	O
	
decentering	O
also	O
predicted	B-T078
improvement	O
in	O
externalizing	O
symptoms	O
at	O
posttreatment	O
.	O
	
rumination	O
and	O
avoidance	O
showed	O
important	O
associations	O
with	O
overgeneralization	B-T033
and	O
accommodation	B-T033
,	O
respectively	O
,	O
but	O
did	O
not	O
predict	O
treatment	B-T080
outcomes	I-T080
.	O
	
this	O
study	O
identifies	O
correlates	O
of	O
overgeneralization	B-T033
and	O
accommodation	B-T033
that	O
might	O
shed	O
light	O
on	O
how	O
these	O
variables	O
relate	O
to	O
unproductive	B-T033
and	I-T033
constructive	I-T033
processing	I-T033
of	O
traumatic	O
experiences	O
.	O
	
giant	O
antrochoanal	O
polyp	O
-a	O
rare	B-T080
presentation	B-T078
antrochoanal	O
polyp	O
acp	O
,	O
also	O
called	O
as	O
killian	O
polyp	O
,	O
is	O
an	O
infrequent	O
,	O
benign	B-T033
lesion	I-T033
of	O
maxillary	O
origin	O
in	O
non-atopic	O
patients	O
.	O
	
the	O
antrochoanal	O
polyp	O
is	O
shaped	O
according	O
to	O
the	O
anatomical	B-T080
constraints	O
of	O
the	O
lateral	O
nasal	O
wall	O
,	O
particularly	O
the	O
middle	O
meatus	O
and	O
antrum	O
,	O
resembling	O
typically	O
a	O
dumbbell	B-T082
.	O
	
here	O
presenting	O
a	O
common	O
problem	B-T033
with	O
unusual	B-T080
presentation	B-T078
.	O
	
effects	B-T080
of	O
obesity	B-T047
on	O
il-33	B-T116
/	O
st2	B-T116
system	B-T169
in	O
heart	O
,	O
adipose	O
tissue	O
and	O
liver	O
study	B-T062
in	O
the	O
experimental	B-T170
model	I-T170
of	O
zucker	O
rats	O
suppression	B-T116
of	I-T116
tumorigenicity	I-T116
2	I-T116
st2	B-T116
mediates	O
the	O
effect	B-T080
of	O
interleukin-33	B-T116
il-33	B-T116
.	O
	
few	O
data	O
are	O
reported	O
on	O
the	O
relationship	B-T080
between	O
il-33	B-T116
/	O
st2	B-T116
and	O
obesity	B-T047
.	O
	
we	O
aimed	O
to	O
investigate	O
effects	B-T080
of	O
obesity	B-T047
on	O
il-33	B-T116
/	O
st2	B-T116
system	B-T169
in	O
heart	O
,	O
adipose	O
tissue	O
and	O
liver	O
in	O
a	O
rodent	O
model	O
of	O
obesity	B-T047
.	O
	
the	O
relationship	B-T080
of	O
cardiac	O
expression	O
of	O
il-33	B-T116
/	O
st2	B-T116
system	B-T169
with	O
natriuretic	B-T116
peptides	I-T116
nps	B-T116
system	B-T169
and	O
inflammatory	O
mediators	O
was	O
also	O
studied	O
.	O
	
mrna	O
expression	O
of	O
il-33	O
/	O
st2	O
system	B-T169
was	O
evaluated	O
in	O
cardiac	O
,	O
adipose	O
and	O
hepatic	O
biopsies	O
from	O
obese	O
zucker	O
rats	O
o	O
and	O
controls	O
co	O
.	O
	
expression	O
levels	O
of	O
sst2	B-T116
was	O
significantly	O
lower	O
in	O
o	O
rats	O
compared	O
with	O
co	O
p<0	O
in	O
all	O
tissues	O
.	O
	
besides	O
,	O
the	O
mrna	O
levels	O
of	O
il-33	O
decreased	O
significant	O
in	O
fat	O
of	O
o	O
respect	O
to	O
co	O
,	O
while	O
,	O
expression	O
levels	O
of	O
st2l	O
was	O
significantly	O
higher	O
in	O
liver	O
of	O
co	O
than	O
in	O
o	O
.	O
	
a	O
strong	O
relationship	B-T080
of	O
il-33	B-T116
/	O
st2	B-T116
with	O
nps	B-T116
and	O
classical	O
inflammatory	O
mediators	O
was	O
observed	O
in	O
cardiac	O
tissue	O
.	O
	
expression	O
of	O
sst2	B-T116
in	O
cardiac	O
,	O
adipose	O
and	O
liver	O
tissue	O
decreased	O
in	O
o	O
compared	O
with	O
controls	O
,	O
suggesting	O
an	O
involvement	O
for	O
il-33	B-T116
/	O
st2	B-T116
system	B-T169
in	O
molecular	O
mechanisms	O
of	O
obesity	B-T047
.	O
	
the	O
strong	O
relationships	B-T080
with	O
np	B-T116
systems	B-T169
and	O
inflammatory	O
mediators	O
could	O
suggest	O
an	O
involvement	O
for	O
il-33	B-T116
/	O
st2	B-T116
in	O
molecular	O
pathways	O
leading	O
to	O
cardiac	B-T033
dysfunction	I-T033
and	O
inflammation	O
associated	O
with	O
cxcl14	B-T116
-	O
cxcr4	B-T116
and	O
cxcl12	B-T116
-	O
cxcr4	B-T116
axes	O
may	O
play	O
important	O
roles	O
in	O
the	O
unique	O
invasion	B-T033
process	O
of	O
endometrioid	O
carcinoma	O
with	O
melf-pattern	B-T082
myoinvasion	B-T033
the	O
term	O
""""	O
melf-pattern	B-T082
myometrial	O
invasion	B-T033
""""	O
melf	B-T082
pattern	I-T082
denotes	O
an	O
unusual	B-T080
morphology	B-T080
of	O
myometrial	O
invasion	B-T033
in	O
endometrioid	O
carcinomas	O
,	O
and	O
is	O
associated	B-T080
with	I-T080
frequent	O
lymphovascular	B-T033
invasion	I-T033
and	O
lymph	O
node	O
metastasis	O
.	O
	
in	O
this	O
study	O
,	O
tumor	O
cells	O
were	O
directly	O
collected	B-T078
from	O
a	O
melf	B-T082
pattern	I-T082
site	O
,	O
using	O
laser	O
microdissection	O
.	O
	
comprehensive	B-T080
microarray	O
analysis	O
of	O
the	O
genes	O
was	O
conducted	O
,	O
and	O
based	O
on	O
the	O
results	O
,	O
expression	O
of	O
a	O
metastasis	B-T116
progression	I-T116
gene	I-T116
,	O
cxcr4	I-T116
,	O
and	O
its	O
ligands	O
cxcl14	B-T116
and	O
cxcl12	B-T116
,	O
was	O
further	O
investigated	B-T169
.	O
	
in	B-T062
vitro	I-T062
studies	I-T062
of	O
endometrioid	O
carcinoma	O
cell	O
lines	O
revealed	O
elevated	B-T080
invasion	B-T033
activity	B-T052
in	O
a	O
manner	O
dependent	O
on	O
the	O
cxcl14	B-T116
-	O
cxcr4	B-T116
or	O
cxcl12	B-T116
-	O
cxcr4	B-T116
axis	O
.	O
	
immunohistochemical	O
analysis	O
of	O
93	O
melf	B-T078
group	I-T078
,	O
46	O
non-melf	B-T078
group	I-T078
,	O
47	O
cases	O
illustrated	O
cxcr4	B-T116
was	O
expressed	O
in	O
all	O
endometrioid	O
carcinomas	O
,	O
while	O
based	O
on	O
cxcl14	B-T116
and	O
cxcl12	B-T116
expression	O
score	B-T081
,	O
high	B-T081
proportions	I-T081
of	O
cells	O
were	O
positive	B-T033
at	O
the	O
sites	B-T082
of	O
the	O
melf	B-T082
pattern	I-T082
p<0	O
.	O
	
there	O
was	O
no	B-T033
significant	I-T033
difference	I-T033
in	O
progression-free	B-T081
survival	I-T081
or	O
overall	B-T081
survival	I-T081
between	O
melf	B-T078
group	I-T078
and	O
non-melf	B-T078
group	I-T078
by	O
kaplan-meier	B-T081
analysis	I-T081
.	O
	
these	O
findings	O
suggest	O
a	O
possibility	O
that	O
cells	O
at	O
the	O
sites	B-T082
of	O
melf	B-T082
pattern	I-T082
had	O
acquired	O
increased	B-T081
invasiveness	O
through	O
the	O
function	O
of	O
the	O
cxcl14	B-T116
-	O
cxcr4	B-T116
and	O
cxcl12	B-T116
-	O
cxcr4	B-T116
crude	B-T080
4-methylcyclohexanemethanol	B-T109
mchm	B-T109
did	O
not	O
cause	B-T169
skin	B-T033
irritation	I-T033
in	O
humans	O
in	O
48-h	B-T079
patch	O
test	O
crude	B-T080
4-methylcyclohexanemethanol	B-T109
mchm	B-T109
is	O
an	O
industrial	O
chemical	O
used	O
to	O
wash	B-T052
and	O
clean	B-T052
coal	B-T109
.	O
	
on	O
january	O
9th	O
,	O
2014	O
approximately	O
10	B-T081
gallons	I-T081
of	O
a	O
mixture	O
containing	O
crude	B-T080
mchm	B-T109
were	O
released	O
into	O
the	O
elk	O
river	O
near	O
charleston	O
,	O
west	O
virginia	O
,	O
contaminating	B-T169
the	O
local	B-T082
water	B-T081
supply	I-T081
.	O
	
following	O
the	O
spill	O
,	O
residents	B-T098
reported	O
numerous	B-T081
health	O
complaints	O
,	O
and	O
sought	O
medical	B-T033
attention	I-T033
for	O
ailments	O
including	O
rashes	O
and	O
itching	O
.	O
	
the	O
relationship	B-T080
between	O
the	O
complaints	O
and	O
the	O
spill	O
were	O
unknown	O
,	O
as	O
such	O
symptoms	O
are	O
reported	O
frequently	B-T079
in	O
the	O
background	O
.	O
	
in	O
this	O
study	B-T062
,	O
the	O
primary	B-T080
irritation	B-T033
potential	B-T080
of	O
crude	B-T080
mchm	B-T109
was	O
evaluated	B-T169
in	O
206	O
individuals	B-T098
who	O
underwent	O
48	B-T079
hour	I-T079
semi-occluded	B-T169
patch	O
testing	O
.	O
	
mchm	B-T109
concentrations	B-T081
assessed	O
in	O
this	O
study	B-T062
were	O
1	O
,	O
5	O
,	O
15	O
,	O
and	O
100	O
ppm	O
.	O
	
no	O
appreciable	O
skin	O
reactions	O
were	O
observed	O
in	O
individuals	B-T098
at	O
any	O
concentration	B-T081
.	O
	
three	O
of	O
the	O
five	O
concentrations	B-T081
evaluated	B-T169
were	O
above	O
the	O
highest	O
measured	B-T081
concentration	I-T081
of	O
mchm	B-T109
in	O
the	O
tap	O
water	O
of	O
residents	B-T098
in	O
west	O
virginia	O
3.7	O
ppm	O
.	O
	
the	O
results	B-T169
of	O
this	O
study	B-T062
suggest	O
that	O
crude	B-T080
mchm	B-T109
would	O
not	O
be	O
a	O
dermal	B-T080
irritant	O
for	O
the	O
vast	O
majority	O
,	O
if	O
not	O
all	O
,	O
potentially	O
exposed	O
persons	B-T098
at	O
the	O
concentrations	B-T081
in	O
the	O
water	O
reported	O
after	O
the	O
new	B-T080
metabolites	O
from	O
the	O
sponge	O
-derived	O
fungus	O
aspergillus	O
sydowii	O
j05b-7f-4	O
two	O
new	B-T080
metabolites	O
,	O
diorcinolic	O
acid	O
1	O
and	O
β-d-glucopyranosyl	B-T109
aspergillusene	I-T109
a	I-T109
8	O
,	O
together	O
with	O
six	O
diphenylethers	O
2-7	O
,	O
a	O
diketopiperazine	B-T109
9	O
,	O
a	O
chromone	B-T109
10	O
and	O
a	O
xanthone	B-T109
11	O
were	O
isolated	B-T169
from	O
the	O
fungus	O
aspergillus	O
sydowii	O
derived	O
from	O
the	O
marine	O
sponge	O
stelletta	O
sp	O
.	O
	
the	O
planar	O
structures	O
and	O
their	O
relative	O
configurations	B-T082
were	O
elucidated	O
by	O
analysing	O
1d	O
,	O
2d	O
nmr	O
and	O
hresims	O
data	B-T078
.	O
	
compound	O
8	O
is	O
the	O
first	O
glycoside	B-T109
of	O
phenolic	B-T109
bisabolane	B-T109
sesquiterpenes	I-T109
.	O
	
compounds	O
1	O
and	O
8	O
exhibited	O
mild	B-T080
cytotoxicity	O
against	O
kb	O
human	O
nasopharyngeal	O
carcinoma	O
cells	O
,	O
hepg2	O
human	O
liver	O
cancer	O
cells	O
and	O
hct	O
116	O
human	O
colon	O
cancer	O
cells	O
.	O
	
all	O
compounds	O
were	O
evaluated	O
for	O
antibacterial	B-T052
activity	I-T052
and	O
their	O
abilities	O
to	O
suppress	B-T169
lps	B-T109
-induced	O
nitric	O
oxide	O
no	O
production	O
.	O
	
compounds	O
2	O
and	O
4-7	O
showed	O
mild	B-T080
antibacterial	B-T033
activity	I-T033
against	O
human	O
pathogen	O
staphylococcus	O
aureus	O
and	O
fish	O
pathogens	O
streptococcus	O
iniae	O
and	O
vibrio	O
ichthyoenteri	O
,	O
and	O
compounds	O
4	O
and	O
7	O
weakly	O
suppressed	B-T169
no	O
the	O
neural	B-T169
legacy	B-T081
of	O
a	O
single	O
concussion	O
it	O
has	O
been	O
hypothesized	B-T078
that	O
concussions	O
impart	B-T080
lasting	B-T079
brain	O
damage	O
,	O
even	O
after	O
a	O
patient	O
has	O
ostensibly	O
recovered	B-T080
.	O
	
this	O
hypothesis	B-T078
is	O
based	O
largely	B-T081
upon	O
neuropathological	B-T169
studies	B-T062
in	O
deceased	O
athletes	O
,	O
however	O
,	O
leaving	O
open	O
the	O
question	O
of	O
whether	O
it	O
can	O
be	O
detected	B-T061
in	B-T062
vivo	I-T062
.	O
	
we	O
measured	B-T080
neural	B-T169
responses	O
to	O
speech	O
in	O
collegiate	B-T098
student	I-T098
-	O
athletes	O
with	O
a	O
history	B-T033
of	O
a	O
single	O
concussion	O
from	O
which	O
they	O
had	O
recovered	B-T080
.	O
	
these	O
student	B-T098
-	O
athletes	O
had	O
weaker	B-T080
responses	O
to	O
speech	O
than	O
age	O
-	O
and	O
position	B-T082
-	O
matched	B-T080
peers	B-T098
.	O
	
this	O
group	O
difference	B-T080
suggests	B-T078
that	O
concussions	O
engender	B-T169
small	B-T081
,	O
but	O
detectable	O
,	O
changes	B-T169
in	O
brain	O
function	O
prior	B-T079
to	O
the	O
emergence	B-T079
of	O
frank	B-T080
behavioral	O
indications	O
.	O
	
enhanced	O
performance	B-T052
of	O
colorimetric	O
biosensing	O
on	O
paper	O
microfluidic	O
platforms	O
through	O
chemical	B-T169
modification	I-T169
and	O
incorporation	B-T169
of	O
nanoparticles	O
this	O
chapter	O
describes	O
two	O
different	O
methodologies	B-T062
used	O
to	O
improve	O
the	O
analytical	B-T052
performance	I-T052
of	O
colorimetric	O
paper	O
-based	O
biosensors	O
.	O
	
microfluidic	O
paper-based	O
analytical	O
devices	O
μpads	O
have	O
been	O
produced	O
by	O
a	O
stamping	O
process	O
and	O
co2	O
laser	B-T061
ablation	I-T061
and	O
modified	B-T080
,	O
respectively	O
,	O
through	O
an	O
oxidation	O
step	O
and	O
incorporation	O
of	O
silica	O
nanoparticles	O
on	O
the	O
paper	O
structure	O
.	O
	
both	O
methods	B-T170
are	O
employed	O
in	O
order	O
to	O
overcome	O
the	O
largest	O
problem	B-T033
associated	B-T080
with	I-T080
colorimetric	O
detection	O
,	O
the	O
heterogeneity	B-T080
of	O
the	O
color	B-T080
distribution	B-T169
in	O
the	O
detection	B-T082
zones	I-T082
.	O
	
the	O
modification	B-T169
steps	O
are	O
necessary	O
to	O
improve	O
the	O
interaction	B-T169
between	O
the	O
paper	O
surface	B-T082
and	O
the	O
selected	O
enzymes	B-T116
.	O
	
the	O
enhanced	O
performance	B-T052
has	O
ensured	O
reliability	B-T081
for	O
quantitative	B-T081
analysis	B-T062
of	O
clinically	B-T080
relevant	O
cxcr4	B-T116
cd184	B-T116
expression	O
on	O
stem	B-T061
cell	I-T061
harvest	I-T061
and	O
cd34	B-T116
cells	O
post-transplant	B-T079
cxcr4	B-T116
is	O
a	O
receptor	B-T116
for	O
stromal-derived	B-T116
factor-1	I-T116
sdf-1	B-T116
,	O
a	O
molecule	O
that	O
has	O
a	O
chemotactic	O
activity	B-T052
for	O
lymphocytes	O
and	O
is	O
important	O
in	O
homing	O
of	O
hematopoietic	O
stem	O
cells	O
to	O
their	O
adult	O
marrow	O
.	O
	
we	O
evaluated	O
the	O
cxcr4	B-T116
cd184	B-T116
expression	O
in	O
the	O
harvest	O
cells	O
and	O
in	O
the	O
post-transplant	B-T079
bone	O
marrow	O
bm	O
and	O
its	O
relation	B-T080
to	O
engraftment	O
,	O
as	O
determined	O
by	O
the	O
consensus	B-T170
criteria	I-T170
and	O
chimerism	O
.	O
	
this	O
is	O
a	O
prospective	B-T062
study	I-T062
which	O
included	O
30	O
patients	O
undergoing	O
hematopoietic	B-T061
stem	I-T061
cell	I-T061
transplantation	I-T061
15	O
patients	O
received	B-T080
autograft	B-T061
and	O
15	O
patients	O
received	B-T080
allograft	B-T061
on	O
dates	O
between	O
january	O
2012	O
and	O
may	O
2014	O
.	O
	
we	O
assessed	B-T052
cd184	B-T116
cxcr4	B-T116
using	O
flow	O
cytometry	O
in	O
the	O
harvest	O
cells	O
together	O
with	O
post-transplant	B-T079
bm	O
assessment	O
on	O
day	O
28	O
and	O
day	O
90	O
for	O
complete	B-T080
morphologic	B-T082
,	O
molecular	O
studies	O
,	O
and	O
detection	B-T061
of	O
cd184	B-T116
expression	O
on	O
cd34	B-T116
cells	O
with	O
chimerism	O
studies	O
on	O
total	B-T080
peripheral	O
blood	O
mononuclear	O
cells	O
.	O
	
diagnoses	B-T033
of	O
the	O
enrolled	O
patients	O
were	O
as	O
follows	O
seven	O
24.1	O
with	O
acute	O
myeloid	O
leukemia	O
,	O
eight	O
27.6	O
with	O
multiple	O
myeloma	O
,	O
four	O
13.8	O
with	O
acute	O
lymphoblastic	O
leukemia	O
,	O
three	O
10.3	O
with	O
non-hodgkin	O
lymphoma	O
,	O
two	O
6.9	O
with	O
myelodysplastic	O
syndromes	O
,	O
two	O
6.9	O
with	O
aplastic	B-T047
anemia	I-T047
,	O
two	O
6.9	O
with	O
chronic	O
myeloid	O
leukemia	O
,	O
one	O
3.4	O
with	O
hodgkin	O
lymphoma	O
,	O
and	O
one	O
3.4	O
with	O
plasmacytomas	O
.	O
	
one	O
patient	O
died	B-T033
and	O
was	O
excluded	B-T052
from	O
the	O
study	B-T062
because	O
there	O
were	O
not	O
enough	O
data	O
about	O
engraftment	O
.	O
	
there	O
was	O
no	B-T033
statistical	B-T081
significance	I-T081
between	O
the	O
level	O
of	O
cd184	B-T116
in	O
stem	B-T061
cell	I-T061
harvest	I-T061
and	O
the	O
prediction	B-T078
of	O
successful	B-T080
engraftment	O
p>0	O
as	O
well	O
as	O
in	O
day	O
28	O
bm	O
sample	O
p>0	O
,	O
whereas	O
there	O
was	O
a	O
statistical	B-T081
significance	I-T081
between	O
the	O
level	O
of	O
cd184	B-T116
in	O
day	O
90	O
bm	O
sample	O
and	O
the	O
occurrence	B-T079
of	O
successful	B-T080
engraftment	O
p=0	O
.	O
	
sdf-1	B-T116
/	O
cxcr4	B-T116
axis	O
plays	O
a	O
crucial	O
role	O
in	O
engraftment	O
however	O
,	O
more	O
studies	O
are	O
warranted	O
to	O
assess	B-T052
their	O
expression	O
post-transplant	B-T079
.	O
	
evaluating	O
the	O
ligand	O
chemokine	B-T116
,	O
sdf-1	B-T116
or	O
its	O
receptor	B-T116
cxcr4	B-T116
may	O
serve	O
as	O
potential	B-T080
surrogate	B-T080
markers	I-T080
for	O
assessment	O
of	O
genetic	O
diversity	O
of	O
taenia	O
saginata	O
cestoda	O
cyclophyllidea	O
from	O
lao	O
people's	O
democratic	O
republic	O
and	O
northeastern	O
thailand	O
based	O
on	O
mitochondrial	O
dna	O
taenia	O
saginata	O
is	O
a	O
tapeworm	O
found	O
in	O
cattle	O
worldwide	O
.	O
	
analysis	B-T062
of	O
genetic	O
diversity	O
in	O
different	O
geographical	B-T081
populations	I-T081
of	O
t	O
.	O
	
saginata	O
not	O
only	O
helps	O
to	O
understand	O
the	O
origin	B-T079
,	O
transmission	O
and	O
spread	B-T080
of	O
this	O
organism	O
,	O
but	O
also	O
to	O
evaluate	O
the	O
selection	O
pressures	O
acting	O
on	O
t	O
.	O
	
saginata	O
and	O
how	O
it	O
is	O
responding	O
to	O
them	O
.	O
	
however	O
,	O
there	O
are	O
few	O
reports	O
of	O
the	O
genetic	O
variability	O
of	O
t	O
.	O
	
saginata	O
populations	O
in	O
different	O
regions	O
of	O
the	O
world	B-T098
,	O
including	O
lao	O
pdr	O
and	O
thailand	O
.	O
	
we	O
report	O
the	O
genetic	O
diversity	O
of	O
t	O
.	O
	
saginata	O
populations	O
in	O
lao	O
pdr	O
and	O
northeastern	O
thailand	O
together	O
with	O
sequences	O
of	O
t	O
.	O
	
saginata	O
from	O
other	O
countries	O
deposited	O
in	O
genbank	B-T170
.	O
	
mitochondrial	O
cox1	O
sequence	O
analysis	O
revealed	O
that	O
15	O
and	O
8	O
haplotypes	O
were	O
identified	O
in	O
30	O
and	O
21	O
t	O
.	O
	
saginata	O
isolates	O
from	O
lao	O
pdr	O
and	O
northeastern	O
thailand	O
,	O
respectively	O
.	O
	
fifty-three	O
haplotypes	O
were	O
identified	O
from	O
98	O
sequences	O
.	O
	
phylogenetic	B-T062
tree	I-T062
and	O
haplotype	B-T062
network	I-T062
analyses	I-T062
revealed	O
that	O
global	B-T080
isolates	O
of	O
t	O
.	O
	
saginata	O
were	O
genetically	O
divided	O
into	O
five	O
groups	B-T078
a	B-T078
,	O
b	B-T078
,	O
c1	B-T078
,	O
c2	B-T078
and	O
d	B-T078
.	O
	
taenia	O
saginata	O
isolates	O
from	O
lao	O
pdr	O
and	O
northeastern	O
thailand	O
belonged	O
to	O
either	O
group	B-T078
a	I-T078
or	O
b	B-T078
.	O
	
taenia	O
saginata	O
from	O
western	O
thailand	O
clustered	O
in	O
groups	B-T078
c1	I-T078
,	O
c2	B-T078
and	O
d	B-T078
,	O
and	O
populations	O
from	O
the	O
northeast	O
and	O
western	O
thailand	O
were	O
found	O
to	O
be	O
genetically	O
distinct	O
.	O
	
taenia	O
saginata	O
isolates	O
in	O
lao	O
pdr	O
and	O
thailand	O
were	O
also	O
found	O
to	O
be	O
genetically	O
diverse	O
but	O
the	O
degree	O
of	O
genetic	O
differentiation	O
was	O
low	O
.	O
	
taenia	O
saginata	O
populations	O
from	O
lao	O
pdr	O
and	O
northeastern	O
thailand	O
are	O
genetically	O
distinct	O
from	O
the	O
population	O
in	O
western	O
thailand	O
and	O
it	O
is	O
proposed	O
that	O
t	O
.	O
	
saginata	O
has	O
been	O
dispersed	O
by	O
different	O
transmission	O
routes	O
in	O
southeast	O
asia	O
.	O
	
development	O
of	O
a	O
novel	B-T080
near-infrared	O
fluorescent	O
theranostic	O
combretastain	B-T109
a-4	I-T109
analogue	O
,	O
yk-5-252	O
,	O
to	O
target	O
triple	O
negative	O
breast	O
cancer	O
the	O
treatment	B-T061
of	O
triple	O
negative	O
breast	O
cancer	O
tnbc	O
is	O
a	O
significant	O
challenge	O
to	O
cancer	B-T062
research	I-T062
.	O
	
the	O
lack	O
of	O
hormone	B-T116
receptors	I-T116
limits	O
the	O
treatment	B-T061
options	O
available	O
to	O
patients	O
with	O
this	O
diagnosis	B-T033
,	O
forcing	O
them	O
to	O
endure	O
prolonged	O
radiation	B-T061
and	O
chemotherapy	B-T061
.	O
	
anti-angiogenesis	B-T061
is	O
a	O
chemotherapeutic	O
strategy	O
that	O
targets	O
the	O
vasculature	O
of	O
tumors	O
.	O
	
combretastatin	B-T109
a-4	I-T109
ca-4	B-T109
is	O
a	O
well-known	O
vasculature	O
-	O
disrupting	O
agent	O
,	O
which	O
has	O
been	O
shown	O
to	O
effectively	O
kill	O
a	O
variety	O
of	O
cancers	O
through	O
inhibition	B-T052
of	O
tubulin	B-T116
polymerization	O
.	O
	
due	O
to	O
its	O
toxicity	O
,	O
small	O
molecule	O
analogues	O
of	O
ca-4	B-T109
have	O
been	O
sought	O
out	O
.	O
	
we	O
have	O
designed	O
a	O
novel	B-T080
dual	O
action	O
ca-4	B-T109
prodrug	O
,	O
yk-5-252	O
,	O
which	O
releases	O
the	O
drug	O
through	O
a	O
disulfide	O
bond	O
cleavage	O
mechanism	B-T169
and	O
contains	O
a	O
near-infrared	O
nir	O
fluorophore	O
,	O
which	O
allows	O
fluorescence	O
monitoring	O
of	O
cleavage	O
.	O
	
this	O
disulfide	O
linkage	O
causes	O
ca-4	B-T109
to	O
become	O
effective	O
only	O
when	O
released	O
by	O
glutathione	B-T116
gsh	B-T116
reducing	O
the	O
toxicity	O
of	O
the	O
drug	O
while	O
simultaneously	O
releasing	O
the	O
nir	O
fluorophore	O
.	O
	
therefore	O
the	O
prodrug	O
,	O
yk-5-252	O
,	O
represents	O
a	O
novel	B-T080
ca-4	B-T109
analogue	O
which	O
has	O
reduced	O
toxicity	O
and	O
can	O
be	O
used	O
for	O
theranostics	O
imaging	O
.	O
	
epidemiological	B-T169
patterns	B-T082
of	O
bovine	O
besnoitiosis	B-T047
in	O
an	O
endemic	B-T169
beef	O
cattle	O
herd	O
reared	B-T082
under	O
extensive	O
conditions	O
bovine	O
besnoitiosis	B-T047
is	O
a	O
parasitic	B-T047
disease	I-T047
caused	O
by	O
the	O
protozoan	O
besnoitia	O
besnoiti	O
.	O
	
described	O
many	O
decades	O
ago	O
,	O
recent	O
epidemiological	B-T062
studies	I-T062
reveal	O
its	O
important	O
spread	O
within	O
europe	O
in	O
the	O
last	O
years	B-T079
.	O
	
to	O
date	O
,	O
many	O
epidemiological	B-T169
aspects	B-T080
related	O
to	O
life	O
cycle	O
,	O
routes	O
of	O
transmission	O
,	O
incidence	B-T081
rates	I-T081
and	O
associated	O
risk	B-T033
factors	I-T033
are	O
lacking	B-T080
hence	O
,	O
the	O
establishment	O
of	O
appropriate	O
disease	O
control	O
programmes	B-T170
poses	O
an	O
important	O
challenge	O
.	O
	
thus	O
,	O
the	O
aim	O
of	O
the	O
present	O
study	B-T062
was	O
to	O
determine	O
the	O
epidemiological	B-T169
pattern	B-T082
of	O
the	O
disease	B-T047
in	O
an	O
endemic	B-T169
herd	O
reared	B-T082
under	O
extensive	O
conditions	O
spanish	O
pyrenees	O
by	O
identifying	O
main	O
factors	O
associated	B-T080
with	I-T080
infection	O
and	O
clinical	B-T047
disease	I-T047
dynamics	O
.	O
	
the	O
study	B-T062
population	I-T062
consisted	O
of	O
276	O
brown	O
swiss	O
and	O
pirenaica	O
adult	O
animals	O
and	O
145	O
calves	O
born	O
and	O
weaned	B-T033
at	O
the	O
farm	B-T082
during	O
the	O
study	B-T062
.	O
	
three	O
sampling	B-T078
time	B-T079
frames	I-T079
were	O
used	O
january	O
2010	O
,	O
september	O
2010	O
and	O
february	O
2011	O
,	O
which	O
allowed	O
us	O
to	O
differentiate	O
two	O
periods	B-T079
designated	O
as	O
mountain	O
and	O
valley	B-T082
periods	B-T079
.	O
	
the	O
data	B-T078
related	O
to	O
animals	O
breed	O
,	O
sex	O
and	O
age	O
and	O
herd	O
management	O
animal	O
grouping	O
and	O
time	B-T079
in	O
housing	O
were	O
recorded	O
.	O
	
the	O
data	B-T062
collection	I-T062
methodology	B-T078
was	O
mainly	O
based	O
on	O
clinical	B-T033
examinations	I-T033
and	O
defining	O
the	O
serological	B-T169
status	B-T080
against	O
bovine	O
besnoitiosis	B-T047
by	O
the	O
immunofluorescent	O
antibody	O
testing	O
of	O
blood	O
samples	O
.	O
	
the	O
total	O
prevalence	B-T081
among	O
adult	O
animals	O
was	O
38.34	O
ci	B-T081
95%	O
34.53	O
,	O
with	O
18.54	O
of	O
seropositive	B-T080
animals	O
showing	O
clinical	O
signs	O
.	O
	
in	O
regard	O
to	O
the	O
cumulative	B-T081
incidence	I-T081
,	O
34.57	O
of	O
new	B-T080
infections	O
were	O
detected	B-T033
during	O
the	O
mountain	O
period	B-T079
,	O
in	O
contrast	O
to	O
the	O
24.59	O
observed	O
in	O
the	O
valley	B-T082
period	B-T079
.	O
	
the	O
incidence	B-T081
density	I-T081
was	O
0.058	O
and	O
0.061	O
new	B-T080
infections	O
per	O
animal	O
-	O
month	B-T079
for	O
the	O
mountain	O
and	O
valley	B-T082
periods	B-T079
,	O
respectively	O
.	O
	
according	O
to	O
the	O
seroepidemiological	B-T062
study	I-T062
,	O
the	O
seroconversion	O
probability	B-T081
of	O
b	O
.	O
	
besnoiti	O
infection	O
was	O
directly	O
associated	B-T080
with	I-T080
the	O
number	B-T081
of	O
seropositive	B-T080
cows	O
with	O
whom	O
an	O
animal	O
had	O
been	O
stabled	O
as	O
well	O
as	O
the	O
housing	O
period	B-T079
duration	B-T079
,	O
supporting	O
horizontal	O
transmission	O
by	O
close	O
contact	O
as	O
one	O
of	O
the	O
most	O
important	O
methods	O
of	O
disease	B-T047
spread	B-T080
.	O
	
in	O
addition	O
,	O
the	O
risk	B-T078
of	O
developing	O
the	O
clinical	B-T079
course	I-T079
increased	B-T081
with	O
age	O
,	O
and	O
the	O
presence	B-T033
of	O
clinical	B-T033
signs	I-T033
was	O
related	O
to	O
higher	B-T080
antibody	O
responses	O
.	O
	
among	O
calves	O
from	O
3.1	O
to	O
7.1	O
months	B-T079
old	B-T079
sampled	O
once	O
at	O
weaning	B-T033
,	O
the	O
total	O
seroprevalence	B-T062
was	O
15.17	O
ci	B-T081
95%	O
9.36	O
,	O
and	O
the	O
chronic	B-T079
stage	B-T079
was	O
observed	O
in	O
three	O
animals	O
,	O
supporting	O
the	O
ability	O
of	O
b	O
.	O
	
besnoiti	O
to	O
infect	O
and	O
even	O
cause	B-T169
disease	B-T047
in	O
animals	O
less	O
than	O
6	O
months	B-T079
old	B-T079
.	O
	
finally	O
,	O
the	O
risk	B-T078
of	O
calf	O
seroconversion	O
was	O
positively	O
related	O
to	O
the	O
serological	B-T169
status	B-T080
of	O
the	O
cows	O
,	O
suggesting	O
postnatal	B-T079
transmission	O
between	O
dams	O
and	O
offspring	O
by	O
contact	O
during	O
the	O
suckling	O
period	B-T079
.	O
	
a	O
fast	B-T170
small-sample	I-T170
kernel	I-T170
independence	I-T170
test	I-T170
for	O
microbiome	O
community	O
-	O
level	B-T062
association	I-T062
analysis	I-T062
to	O
fully	O
understand	O
the	O
role	O
of	O
microbiome	O
in	O
human	O
health	B-T078
and	O
diseases	B-T047
,	O
researchers	O
are	O
increasingly	O
interested	O
in	O
assessing	B-T052
the	O
relationship	B-T080
between	O
microbiome	O
composition	O
and	O
host	O
genomic	O
data	B-T078
.	O
	
the	O
dimensionality	B-T082
of	O
the	O
data	B-T078
as	O
well	O
as	O
complex	B-T080
relationships	B-T080
between	O
microbiota	O
and	O
host	O
genomics	O
pose	O
considerable	O
challenges	O
for	O
analysis	B-T062
.	O
	
in	O
this	O
article	O
,	O
we	O
apply	O
a	O
kernel	B-T170
rv	I-T170
coefficient	I-T170
krv	I-T170
test	I-T170
to	O
evaluate	O
the	O
overall	B-T080
association	B-T080
between	O
host	O
gene	O
expression	O
and	O
microbiome	O
composition	O
.	O
	
the	O
krv	B-T170
statistic	I-T170
can	O
capture	O
nonlinear	B-T080
correlations	I-T080
and	O
complex	B-T080
relationships	B-T080
among	O
the	O
individual	O
data	B-T078
types	I-T078
and	O
between	O
gene	O
expression	O
and	O
microbiome	O
composition	O
through	O
measuring	O
general	O
dependency	B-T078
.	O
	
testing	B-T169
proceeds	O
via	O
a	O
similar	O
route	O
as	O
existing	O
tests	B-T170
of	O
the	O
generalized	O
rv	B-T081
coefficients	I-T081
and	O
allows	O
for	O
rapid	O
p-value	B-T081
calculation	B-T052
.	O
	
strategies	B-T169
to	O
allow	O
adjustment	O
for	O
confounding	B-T169
effects	I-T169
,	O
which	O
is	O
crucial	O
for	O
avoiding	O
misleading	O
results	B-T169
,	O
and	O
to	O
alleviate	O
the	O
problem	B-T033
of	O
selecting	O
the	O
most	O
favorable	O
kernel	B-T170
are	O
considered	O
.	O
	
simulation	B-T062
studies	I-T062
show	O
that	O
krv	B-T081
is	O
useful	O
in	O
testing	B-T169
statistical	B-T078
independence	I-T078
with	O
finite	O
samples	O
given	O
the	O
kernels	B-T170
are	O
appropriately	O
chosen	O
,	O
and	O
can	O
powerfully	O
identify	O
existing	O
associations	B-T080
between	O
microbiome	O
composition	O
and	O
host	O
genomic	O
data	B-T078
while	O
protecting	O
type	O
i	O
error	B-T080
.	O
	
we	O
apply	O
the	O
krv	B-T081
to	O
a	O
microbiome	O
study	B-T062
examining	O
the	O
relationship	B-T080
between	O
host	O
transcriptome	O
and	O
microbiome	O
composition	O
within	O
the	O
context	B-T078
of	O
inflammatory	B-T047
bowel	I-T047
disease	I-T047
and	O
are	O
able	O
to	O
derive	O
new	O
biological	O
insights	O
and	O
provide	O
formal	O
inference	O
on	O
prior	O
qualitative	B-T080
observations	I-T080
.	O
	
an	O
analysis	B-T062
of	O
systematic	B-T169
elemental	O
changes	B-T081
in	O
decomposing	O
bone	O
the	O
aim	B-T078
of	O
this	O
pilot	B-T062
study	I-T062
was	O
to	O
investigate	B-T169
compositional	O
changes	B-T081
in	O
bone	O
during	O
decomposition	O
.	O
	
elemental	O
concentrations	B-T081
of	O
barium	O
,	O
calcium	O
,	O
iron	O
,	O
potassium	O
,	O
magnesium	O
,	O
zinc	O
and	O
phosphorus	O
in	O
porcine	O
bone	O
as	O
an	O
experimental	B-T080
analog	O
for	O
human	O
bone	O
were	O
analyzed	B-T062
by	O
inductively	O
coupled	O
plasma	O
optical	O
emission	O
spectroscopy	O
icp-oes	O
.	O
	
the	O
samples	O
were	O
taken	O
from	O
porcine	O
bone	O
subjected	B-T169
to	O
shallow	B-T052
burial	I-T052
and	O
surface	O
depositions	B-T169
at	O
28-	O
day	B-T079
intervals	B-T079
for	O
a	O
period	B-T079
of	O
140	O
days	B-T079
.	O
	
results	B-T033
indicated	B-T033
that	O
icp-oes	O
elemental	O
profiling	B-T169
has	O
potential	B-T080
to	O
be	O
developed	B-T080
as	O
a	O
forensic	O
test	O
for	O
determining	B-T080
whether	O
a	O
bone	O
sample	O
originates	O
from	O
the	O
early	B-T079
stages	B-T079
of	O
soft	O
tissue	O
putrefaction	O
.	O
	
significant	B-T081
changes	I-T081
in	O
iron	O
,	O
sodium	O
and	O
potassium	O
concentrations	B-T081
were	O
found	B-T033
over	B-T079
140	O
days	B-T079
.	O
	
these	O
elements	O
are	O
known	B-T080
to	O
be	O
primarily	B-T080
associated	B-T080
with	I-T080
proteins	B-T116
and/or	O
tissue	O
fluids	O
within	O
the	O
bone	O
.	O
	
changes	B-T081
in	O
their	O
respective	O
concentrations	B-T081
may	O
therefore	O
be	O
linked	O
to	O
dehydration	B-T033
over	O
time	B-T079
and	O
in	O
turn	O
may	O
be	O
indicative	O
of	O
time	B-T079
since	B-T079
deposition	B-T169
.	O
	
chasing	O
ghosts	O
allopolyploid	O
origin	O
of	O
oxyria	O
sinensis	O
polygonaceae	O
from	O
its	O
only	O
diploid	O
congener	O
and	O
an	O
unknown	O
ancestor	O
reconstructing	O
the	O
origin	O
of	O
a	O
polyploid	O
species	O
is	O
particularly	O
challenging	O
when	O
an	O
ancestor	O
has	O
become	O
extinct	O
.	O
	
under	O
such	O
circumstances	O
,	O
the	O
extinct	O
donor	O
of	O
a	O
genome	O
found	O
in	O
the	O
polyploid	O
may	O
be	O
treated	O
as	O
a	O
'ghost'	O
species	O
in	O
that	O
its	O
prior	O
existence	B-T081
is	O
recognized	O
through	O
the	O
presence	B-T080
of	O
its	O
genome	O
in	O
the	O
polyploid	O
.	O
	
in	O
this	O
study	O
,	O
we	O
aimed	O
to	O
determine	O
the	O
polyploid	O
origin	O
of	O
oxyria	O
sinensis	O
2n	O
=	O
40	O
for	O
which	O
only	O
one	O
congeneric	O
species	O
is	O
known	O
,	O
that	O
is	O
diploid	O
o	O
.	O
	
digyna	O
2n	O
=	O
14	O
.	O
	
genomic	O
in	O
situ	O
hybridization	O
gish	O
,	O
transcriptome	O
,	O
phylogenetic	B-T062
and	O
demographic	B-T062
analyses	I-T062
,	O
and	O
ecological	B-T170
niche	I-T170
modelling	I-T170
were	O
conducted	O
for	O
this	O
purpose	O
.	O
	
gish	O
revealed	O
that	O
o	O
.	O
	
sinensis	O
comprised	O
14	O
chromosomes	O
from	O
o	O
.	O
	
digyna	O
and	O
26	O
chromosomes	O
from	O
an	O
unknown	O
ancestor	O
.	O
	
transcriptome	O
analysis	O
indicated	O
that	O
following	O
divergence	B-T082
from	O
o	O
.	O
	
digyna	O
,	O
involving	O
genome	O
duplication	O
around	O
12	O
million	O
years	O
ago	O
ma	O
,	O
a	O
second	O
genome	O
duplication	O
occurred	O
approximately	O
6	O
ma	O
to	O
give	O
rise	O
to	O
o	O
.	O
	
sinensis	O
.	O
	
oxyria	O
sinensis	O
was	O
shown	O
to	O
contain	O
homologous	O
gene	O
sequences	O
divergent	B-T082
from	O
those	O
present	O
in	O
o	O
.	O
	
digyna	O
in	O
addition	O
to	O
a	O
set	O
that	O
clustered	O
with	O
those	O
in	O
o	O
.	O
	
digyna	O
.	O
	
coalescent	B-T170
simulations	I-T170
indicated	O
that	O
o	O
.	O
	
sinensis	O
expanded	O
its	O
distribution	O
approximately	O
6-7	O
ma	O
,	O
possibly	O
following	O
the	O
second	O
polyploidization	O
event	O
,	O
whereas	O
o	O
.	O
	
digyna	O
expanded	O
its	O
range	O
much	O
later	O
.	O
	
it	O
was	O
also	O
indicated	O
that	O
the	O
distributions	O
of	O
both	O
species	O
contracted	B-T169
and	I-T169
re-expanded	I-T169
during	O
the	O
pleistocene	O
climatic	O
oscillations	O
.	O
	
ecological	B-T170
niche	I-T170
modelling	I-T170
similarly	O
suggested	O
that	O
both	O
species	O
experienced	O
changes	O
in	O
their	O
distributional	O
ranges	O
in	O
response	O
to	O
quaternary	O
climatic	O
changes	O
.	O
	
the	O
extinction	O
of	O
the	O
unknown	O
'ghost'	O
tetraploid	O
species	O
implicated	O
in	O
the	O
origin	O
of	O
o	O
.	O
	
sinensis	O
could	O
have	O
resulted	O
from	O
superior	O
adaptation	O
of	O
o	O
.	O
	
sinensis	O
to	O
repeated	O
climatic	O
changes	O
primitive	O
neuroectodermal	O
tumors	O
of	O
the	O
female	O
genital	O
tract	O
a	O
morphologic	B-T080
,	O
immunohistochemical	O
,	O
and	O
molecular	B-T080
study	B-T062
of	O
19	O
cases	O
primary	O
primitive	O
neuroectodermal	O
tumor	O
pnet	O
of	O
the	O
female	O
genital	O
tract	O
is	O
rare	O
,	O
and	O
its	O
proper	O
classification	O
remains	O
unclear	O
.	O
	
the	O
clinical	B-T080
,	O
histologic	B-T169
,	O
and	O
immunophenotypic	O
features	B-T080
as	O
well	O
as	O
ewsr1	O
rearrangement	O
status	O
of	O
19	O
gynecologic	B-T082
pnets	O
,	O
including	O
10	O
ovarian	O
,	O
8	O
uterine	O
,	O
and	O
1	O
vulvar	O
tumors	O
,	O
are	O
herein	O
reported	B-T170
.	O
	
patient	O
age	O
ranged	B-T081
from	O
12	O
to	O
68	O
years	B-T079
,	O
with	O
a	O
median	O
age	O
of	O
20	O
and	O
51	O
years	B-T079
among	O
those	O
with	O
ovarian	O
and	O
uterine	O
pnets	O
,	O
respectively	O
.	O
	
morphologic	B-T080
features	B-T080
of	O
central	O
nervous	O
system	O
cns	O
tumors	O
were	O
seen	O
in	O
15	O
pnets	O
,	O
including	O
9	O
medulloblastomas	O
,	O
3	O
ependymomas	O
,	O
2	O
medulloepitheliomas	O
,	O
and	O
1	O
glioblastoma	O
,	O
consistent	O
with	O
central	O
pnet	O
.	O
	
the	O
remaining	O
4	O
pnets	O
were	O
composed	O
entirely	O
of	O
undifferentiated	B-T080
small	O
round	O
blue	O
cells	O
and	O
were	O
classified	O
as	O
ewing	O
sarcoma/peripheral	O
pnet	O
.	O
	
eight	O
pnets	O
were	O
associated	O
with	O
another	O
tumor	O
type	O
,	O
including	O
5	O
ovarian	O
mature	O
cystic	O
teratomas	O
,	O
2	O
endometrial	B-T080
low-grade	I-T080
endometrioid	O
carcinomas	O
,	O
and	O
a	O
uterine	O
carcinosarcoma	O
.	O
	
by	O
immunohistochemistry	O
,	O
17	O
pnets	O
expressed	O
at	O
least	O
1	O
marker	O
of	O
neuronal	B-T033
differentiation	I-T033
,	O
including	O
synaptophysin	B-T116
,	O
nse	B-T116
,	O
cd56	B-T116
,	O
s100	B-T116
,	O
and	O
chromogranin	B-T116
in	O
10	O
,	O
8	O
,	O
14	O
,	O
8	O
,	O
and	O
1	O
tumors	O
,	O
respectively	O
.	O
	
gfap	B-T116
was	O
positive	O
in	O
4	O
pnets	O
,	O
all	O
of	O
which	O
were	O
of	O
central	O
type	O
.	O
	
membranous	O
cd99	B-T116
and	O
nuclear	B-T082
fli-1	B-T116
staining	O
was	O
seen	O
in	O
10	O
and	O
16	O
tumors	O
,	O
respectively	O
,	O
and	O
concurrent	O
expression	O
of	O
both	O
markers	O
was	O
seen	O
in	O
both	O
central	O
and	O
ewing	O
sarcoma/peripheral	O
pnet	O
s	O
.	O
	
all	O
tumors	O
expressed	O
vimentin	B-T116
,	O
whereas	O
keratin	B-T116
cocktail	O
cam5.2	B-T116
,	O
ae1/ae3	B-T116
staining	O
was	O
only	O
focally	O
present	O
in	O
4	O
pnets	O
.	O
	
fluorescence	O
in	O
situ	O
hybridization	O
was	O
successful	O
in	O
all	O
cases	O
and	O
confirmed	O
ewsr1	O
rearrangement	O
in	O
2	O
of	O
4	O
tumors	O
demonstrating	O
morphologic	B-T080
features	B-T080
of	O
ewing	O
sarcoma/peripheral	O
pnet	O
and	O
concurrent	O
cd99	B-T116
and	O
fli-1	B-T116
expression	O
.	O
	
in	O
conclusion	O
,	O
central	O
and	O
ewing	O
sarcoma/peripheral	O
pnets	O
may	O
be	O
encountered	O
in	O
the	O
female	O
genital	O
tract	O
with	O
central	O
pnets	O
being	O
more	O
common	O
.	O
	
central	O
pnets	O
show	O
a	O
spectrum	O
of	O
morphologic	B-T080
features	B-T080
that	O
overlaps	O
with	O
cns	O
tumors	O
but	O
lack	O
ewsr1	O
rearrangement	O
s	O
.	O
	
gfap	B-T116
expression	O
supports	O
a	O
morphologic	B-T080
impression	O
of	O
central	O
pnet	O
and	O
is	O
absent	O
in	O
ewing	O
sarcoma/peripheral	O
pnet	O
.	O
	
ewing	O
sarcoma/peripheral	O
pnets	O
lack	O
morphologic	B-T080
features	B-T080
of	O
cns	O
tumors	O
.	O
	
surgical	B-T061
excision	I-T061
of	O
heterotopic	O
ossification	O
leads	O
to	O
re-emergence	B-T079
of	O
mesenchymal	O
stem	O
cell	O
populations	O
responsible	O
for	O
recurrence	O
trauma-induced	O
heterotopic	O
ossification	O
ho	O
occurs	O
after	O
severe	B-T080
musculoskeletal	O
injuries	O
and	O
burns	O
,	O
and	O
presents	O
a	O
significant	B-T078
barrier	O
to	O
patient	O
rehabilitation	B-T061
.	O
	
interestingly	O
,	O
the	O
incidence	B-T081
of	O
ho	O
significantly	O
increases	B-T081
with	O
repeated	B-T061
operations	I-T061
and	O
after	O
resection	B-T061
of	O
previous	O
ho	O
.	O
	
treatment	B-T061
of	O
established	O
heterotopic	O
ossification	O
is	O
challenging	O
because	O
surgical	B-T061
excision	I-T061
is	O
often	O
incomplete	B-T080
,	O
with	O
evidence	B-T169
of	I-T169
persistent	B-T079
heterotopic	B-T033
bone	I-T033
.	O
	
as	O
a	O
result	O
,	O
patients	O
may	O
continue	B-T078
to	O
report	O
the	O
signs	B-T033
or	I-T033
symptoms	I-T033
of	O
ho	O
,	O
including	O
chronic	O
pain	O
,	O
nonhealing	B-T033
wounds	O
,	O
and	O
joint	B-T033
restriction	I-T033
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
designed	O
a	O
model	O
of	O
recurrent	B-T079
ho	O
that	O
occurs	O
after	O
surgical	B-T061
excision	I-T061
of	O
mature	B-T079
ho	O
in	O
a	O
mouse	O
model	O
of	O
hind-limb	O
achilles'	O
tendon	O
transection	B-T061
with	O
dorsal	B-T082
burn	O
injury	O
.	O
	
we	O
first	O
demonstrated	O
that	O
key	B-T080
signaling	O
mediators	B-T116
of	O
ho	O
,	O
including	O
bone	O
morphogenetic	O
protein	O
signaling	O
,	O
are	O
diminished	O
in	O
mature	O
bone	O
.	O
	
however	O
,	O
upon	O
surgical	B-T061
excision	I-T061
,	O
we	O
have	O
noted	O
upregulation	O
of	O
downstream	B-T082
mediators	B-T116
of	O
osteogenic	B-T116
differentiation	B-T169
,	O
including	O
psmad	B-T116
1	I-T116
/	O
5	B-T116
.	O
	
additionally	O
,	O
surgical	B-T061
excision	I-T061
resulted	O
in	O
re-emergence	B-T079
of	O
a	O
mesenchymal	O
cell	O
population	O
marked	O
by	O
expression	O
of	O
platelet-derived	B-T116
growth	I-T116
factor	I-T116
receptor-α	I-T116
pdgfrα	B-T116
and	O
present	B-T033
in	O
the	O
initial	B-T079
developing	O
ho	O
lesion	B-T033
but	O
absent	B-T169
in	O
mature	B-T079
ho	O
.	O
	
in	O
the	O
recurrent	B-T079
lesion	B-T033
,	O
these	O
pdgfrα	B-T116
+	O
mesenchymal	O
cells	O
are	O
also	O
highly	O
proliferative	O
,	O
similar	O
to	O
the	O
initial	B-T079
developing	O
ho	O
lesion	B-T033
.	O
	
these	O
findings	O
indicate	O
that	O
surgical	B-T061
excision	I-T061
of	O
ho	O
results	B-T033
in	O
recurrence	O
through	O
similar	O
mesenchymal	O
cell	O
populations	O
and	O
signaling	O
mechanisms	B-T169
that	O
are	O
present	B-T033
in	O
the	O
initial	B-T079
developing	O
ho	O
lesion	B-T033
.	O
	
these	O
results	B-T033
are	O
consistent	B-T078
with	I-T078
findings	B-T033
in	O
patients	O
that	O
new	O
foci	B-T082
of	O
ectopic	O
bone	O
can	O
develop	O
in	O
excision	B-T061
sites	O
and	O
are	O
likely	O
related	O
to	O
de	B-T078
novo	I-T078
formation	B-T169
rather	O
than	O
extension	B-T169
of	O
unresected	O
bone	O
.	O
	
extended	B-T079
release	I-T079
of	O
flurbiprofen	B-T109
from	O
tromethamine	B-T109
-	O
buffered	O
hpmc	B-T109
hydrophilic	B-T080
matrix	O
tablets	O
the	O
ph	B-T081
-	O
dependent	B-T169
solubility	B-T080
of	O
a	O
drug	O
can	O
lead	O
to	O
ph	B-T081
-	O
dependent	B-T169
drug	O
release	O
from	O
hydrophilic	B-T080
matrix	O
tablets	O
.	O
	
adding	O
buffer	O
salts	O
to	O
the	O
formulation	O
to	O
attempt	O
to	O
mitigate	O
this	O
can	O
impair	B-T169
matrix	O
hydration	O
and	O
negatively	B-T033
impact	B-T080
drug	O
release	O
.	O
	
an	O
evaluation	O
of	O
the	O
buffering	O
of	O
hydrophilic	B-T080
matrix	O
tablets	O
containing	O
a	O
ph	B-T081
-	O
dependent	B-T169
solubility	B-T080
weak	O
acid	O
drug	O
flurbiprofen	B-T109
,	O
identified	B-T080
as	O
possessing	B-T078
a	O
deleterious	B-T080
effect	I-T080
on	O
hydroxypropyl	B-T109
methylcellulose	I-T109
hpmc	B-T109
solubility	B-T080
,	O
swelling	O
and	O
gelation	O
,	O
with	O
respect	O
to	O
drug	O
dissolution	O
and	O
the	O
characteristics	B-T080
of	O
the	O
hydrophilic	B-T080
matrix	O
gel	O
layer	O
in	O
the	O
presence	O
of	O
tromethamine	B-T109
as	O
a	O
buffer	O
was	O
undertaken	O
.	O
	
the	O
inclusion	B-T080
of	O
tromethamine	B-T109
as	O
an	O
alkalizing	O
agent	O
afforded	O
ph	B-T081
-	O
independent	B-T169
flurbiprofen	B-T109
release	B-T079
from	O
matrices	O
based	O
on	O
both	O
hpmc	B-T109
2910	I-T109
e	I-T109
series	I-T109
and	O
2208	B-T109
k	I-T109
series	I-T109
,	O
while	O
concomitantly	B-T079
decreasing	B-T033
the	O
apparent	O
critical	B-T080
effect	I-T080
on	O
dissolution	O
mediated	O
by	O
this	O
drug	O
with	O
respect	O
to	O
the	O
early	O
pseudo-gel	B-T169
layer	I-T169
formation	I-T169
and	O
functionality	B-T169
.	O
	
drug	O
release	O
profiles	O
were	O
unaffected	O
by	O
matrix	O
ph-changes	B-T033
resulting	O
from	O
loss	B-T081
of	O
tromethamine	B-T109
over	B-T079
time	I-T079
,	O
suggesting	O
that	O
hpmc	B-T109
inhibited	B-T080
precipitation	O
of	O
drug	O
from	O
supersaturated	O
solution	O
in	O
the	O
hydrated	O
matrix	O
.	O
	
we	O
propose	O
that	O
facilitation	O
of	O
diffusion-based	O
release	B-T079
of	O
potentially	O
deleterious	O
drugs	O
in	O
hydrophilic	B-T080
matrices	O
may	O
be	O
achieved	O
through	O
judicious	O
selection	O
of	O
a	O
buffering	O
species	O
.	O
	
the	O
influence	O
of	O
slope	B-T082
on	O
spartium	O
junceum	O
root	O
system	O
morphological	B-T080
,	O
anatomical	B-T080
and	O
biomechanical	B-T080
adaptation	O
root	O
systems	O
have	O
a	O
pivotal	O
role	O
in	O
plant	O
anchorage	B-T052
and	O
their	O
mechanical	B-T169
interactions	I-T169
with	O
the	O
soil	O
may	O
contribute	O
to	O
soil	O
reinforcement	B-T169
and	O
stabilization	B-T080
of	O
slide-prone	B-T082
slopes	I-T082
.	O
	
in	O
order	O
to	O
understand	O
the	O
responses	O
of	O
root	O
system	O
to	O
mechanical	O
stress	O
induced	B-T169
by	O
slope	B-T082
,	O
samples	O
of	O
spartium	O
junceum	O
l	O
,	O
growing	B-T169
in	O
slope	B-T082
and	O
in	O
plane	B-T082
natural	B-T169
conditions	I-T169
,	O
were	O
compared	O
in	O
their	O
morphology	B-T080
,	O
biomechanical	B-T080
properties	I-T080
and	O
anatomical	B-T082
features	I-T082
.	O
	
soils	O
sampled	B-T078
in	O
slope	B-T082
and	O
plane	B-T082
revealed	O
similar	O
characteristics	B-T080
,	O
with	O
the	O
exception	O
of	O
organic	O
matter	O
content	O
and	O
penetrometer	B-T169
resistance	I-T169
,	O
both	O
higher	O
in	O
slope	B-T082
.	O
	
slope	B-T082
significantly	O
influenced	O
root	O
morphology	B-T080
and	O
in	O
particular	O
the	O
distribution	B-T169
of	O
lateral	B-T082
roots	O
along	O
the	O
soil	O
depth	B-T082
.	O
	
indeed	O
,	O
first-order	B-T169
lateral	B-T082
roots	O
of	O
plants	O
growing	B-T169
on	O
slope	B-T082
condition	B-T080
showed	O
an	O
asymmetric	B-T082
distribution	B-T169
between	O
up-	B-T082
and	O
down-slope	B-T082
.	O
	
contrarily	O
,	O
this	O
asymmetric	B-T082
distribution	B-T169
was	O
not	O
observed	O
in	O
plants	O
growing	B-T169
in	O
plane	B-T082
.	O
	
the	O
tensile	B-T081
strength	I-T081
was	O
higher	O
in	O
lateral	B-T082
roots	O
growing	B-T169
up-slope	B-T082
and	O
in	O
plane	B-T082
conditions	B-T080
than	O
in	O
those	O
growing	B-T169
down-slope	B-T082
.	O
	
anatomical	B-T062
investigations	I-T062
revealed	O
that	O
,	O
while	O
roots	O
grown	O
up-slope	B-T082
had	O
higher	O
area	B-T082
covered	O
by	O
xylem	O
fibers	O
,	O
the	O
ratio	B-T081
of	O
xylem	O
and	O
phloem	O
fibers	O
to	O
root	O
diameter	B-T081
did	O
not	O
differ	O
among	O
the	O
three	O
conditions	B-T080
,	O
as	O
also	O
,	O
no	B-T033
differences	I-T033
were	O
found	O
for	O
xylem	O
fiber	O
cell	O
wall	O
thickness	B-T080
.	O
	
roots	O
growing	B-T169
up-slope	B-T082
were	O
the	O
main	O
contributors	O
to	O
anchorage	B-T052
properties	B-T080
,	O
which	O
included	O
higher	O
strength	B-T081
and	O
higher	O
number	O
of	O
fibers	O
in	O
the	O
xylematic	O
tissues	O
.	O
	
results	O
suggested	O
that	O
a	O
combination	O
of	O
root	O
-	O
specific	B-T080
morphological	B-T080
,	O
anatomical	B-T080
and	O
biomechanical	B-T080
traits	O
,	O
determines	O
anchorage	B-T052
functions	B-T169
in	O
slope	B-T082
conditions	B-T080
.	O
	
altered	O
expression	O
of	O
the	O
olr59	O
,	O
ethe1	O
,	O
and	O
slc10a2	O
genes	O
in	O
the	O
liver	O
of	O
f344	O
rats	O
by	O
neonatal	O
thyroid	O
hormone	O
disruption	O
many	O
concerns	O
have	O
been	O
expressed	O
regarding	O
the	O
possible	O
adverse	O
effects	O
of	O
thyroid	O
hormone-disrupting	O
chemicals	O
in	O
the	O
environment	B-T082
.	O
	
the	O
disruption	O
of	O
thyroid	O
hormones	O
in	O
the	O
neonatal	B-T079
period	I-T079
may	O
lead	O
to	O
permanent	B-T080
effects	I-T080
on	O
thyroid	B-T116
hormone	I-T116
homeostasis	O
as	O
well	O
as	O
related	O
developmental	O
disorders	O
,	O
as	O
thyroid	B-T116
hormones	I-T116
are	O
essential	O
for	O
regulating	O
the	O
growth	O
and	O
differentiation	B-T033
of	I-T033
many	I-T033
tissues	I-T033
.	O
	
to	O
understand	O
the	O
long-term	O
alteration	O
in	O
gene	O
expressions	O
by	O
neonatal	O
administration	B-T061
of	I-T061
thyroid	I-T061
hormone	I-T061
-like	O
chemicals	O
in	O
general	O
,	O
we	O
identified	O
genes	O
whose	O
expression	O
was	O
altered	B-T169
in	O
the	O
liver	O
,	O
an	O
important	O
component	O
of	O
the	O
thyroid	B-T116
hormone	I-T116
axis	O
,	O
by	O
neonatal	O
exposure	B-T080
to	I-T080
triiodothyronine	B-T116
t3	B-T116
.	O
	
t3	B-T116
was	O
administered	B-T061
to	O
male	O
f344	O
rats	O
on	O
postnatal	B-T079
days	I-T079
1	O
,	O
3	O
,	O
and	O
5	O
week	O
0	O
.	O
	
at	O
8	O
weeks	O
of	O
age	O
,	O
cdna	B-T062
microarray	I-T062
analysis	I-T062
was	O
used	O
to	O
identify	O
hepatic	O
genes	O
whose	O
expression	O
was	O
altered	O
by	O
neonatal	O
exposure	B-T080
to	I-T080
t3	B-T116
.	O
	
among	O
the	O
up-regulated	O
genes	O
that	O
were	O
identified	O
,	O
the	O
expression	O
of	O
olr59	O
,	O
ethe1	O
,	O
and	O
slc10a2	O
increased	O
specifically	O
in	O
rats	O
neonatally	O
exposed	B-T080
to	I-T080
t3	B-T116
.	O
	
interestingly	O
,	O
altered	O
hepatic	O
expression	O
of	O
these	O
genes	O
indeed	O
increased	O
when	O
a	O
hydroxylated	B-T109
polybrominated	I-T109
diphenyl	I-T109
ether	I-T109
pbde	B-T109
,	O
oh-bde42	B-T109
,	O
which	O
is	O
capable	O
of	O
binding	O
to	O
the	O
tr	O
,	O
was	O
given	O
neonatally	O
.	O
	
our	O
data	O
demonstrated	O
that	O
neonatal	O
exposure	O
to	O
thyroid	B-T116
hormones	I-T116
could	O
affect	O
the	O
long-term	O
expression	O
of	O
the	O
genes	O
,	O
which	O
could	O
be	O
useful	O
markers	O
for	O
neonatal	B-T047
effects	I-T047
by	O
thyroid	B-T116
hormone	I-T116
-	O
disrupting	O
chemicals	O
.	O
	
the	O
psychometric	O
costs	O
of	O
applicants	B-T098
'	O
faking	O
examining	O
measurement	B-T169
invariance	O
and	O
retest	B-T062
correlations	I-T062
across	O
response	O
conditions	O
this	O
study	O
examines	B-T080
the	I-T080
stability	I-T080
of	O
the	O
response	O
process	O
and	O
the	O
rank-order	B-T062
of	O
respondents	B-T098
responding	O
to	O
3	O
personality	B-T170
scales	I-T170
in	O
4	O
different	O
response	O
conditions	O
.	O
	
applicants	B-T098
to	O
the	O
university	O
college	O
of	O
teacher	O
education	O
styria	O
n	O
=	O
243	O
completed	O
personality	B-T170
scales	I-T170
as	O
part	O
of	O
their	O
college	B-T170
admission	I-T170
process	I-T170
.	O
	
half	O
a	O
year	O
later	O
,	O
they	O
retook	O
the	O
same	O
personality	B-T170
scales	I-T170
in	O
1	O
of	O
3	O
randomly	O
assigned	O
experimental	O
response	O
conditions	O
honest	O
,	O
faking-good	O
,	O
or	O
reproduce	O
.	O
	
longitudinal	B-T062
means	I-T062
and	O
covariance	B-T081
structure	I-T081
analyses	I-T081
showed	O
that	O
applicants	B-T098
'	O
response	O
processes	O
could	O
be	O
partially	O
reproduced	O
after	O
half	O
a	O
year	O
,	O
and	O
respondents	B-T098
seemed	O
to	O
rely	O
on	O
an	O
honest	O
response	O
behavior	O
as	O
a	O
frame	O
of	O
reference	O
.	O
	
additionally	O
,	O
applicants	B-T098
'	O
faking	O
behavior	O
and	O
instructed	O
faking	O
faking-good	O
caused	O
differences	O
in	O
the	O
latent	B-T080
retest	B-T062
correlations	I-T062
and	O
consistently	O
affected	O
measurement	B-T169
properties	O
.	O
	
the	O
varying	O
latent	B-T080
retest	B-T062
correlations	I-T062
indicated	B-T033
that	O
faking	O
can	O
distort	B-T169
respondents	B-T098
'	O
rank-order	B-T062
and	O
thus	O
the	O
fairness	B-T080
of	O
subsequent	O
selection	O
decisions	O
,	O
depending	O
on	O
the	O
kind	O
of	O
faking	O
behavior	O
.	O
	
instructed	O
faking	O
faking-good	O
even	O
affected	O
weak	O
measurement	B-T169
invariance	O
,	O
whereas	O
applicants	B-T098
'	O
faking	O
behavior	O
did	O
not	O
.	O
	
consequently	O
,	O
correlations	B-T080
with	O
personality	B-T170
scales	I-T170
-which	O
can	O
be	O
utilized	O
for	O
predictive	B-T080
validity	I-T080
-may	O
be	O
readily	O
interpreted	B-T169
for	O
applicants	B-T098
.	O
	
faking	O
behavior	O
also	O
introduced	O
a	O
uniform	B-T078
bias	I-T078
,	O
implying	O
that	O
the	O
classically	O
observed	O
mean	B-T081
raw	I-T081
score	I-T081
differences	O
may	O
not	O
be	O
readily	O
intraspinal	O
meningioma	O
with	O
malignant	O
transformation	O
and	O
distant	O
metastasis	O
meningioma	O
is	O
typically	O
considered	O
to	O
be	O
a	O
benign	O
tumor	O
.	O
	
malignant	O
transformation	O
and	O
metastasis	O
of	O
meningiomas	O
are	O
rare	B-T080
.	O
	
moreover	O
,	O
most	O
meningiomas	O
are	O
intracranial	O
,	O
and	O
there	O
are	O
few	O
reports	B-T170
on	O
intraspinal	O
meningiomas	O
.	O
	
this	O
report	B-T170
aimed	O
to	O
describe	O
the	O
clinical	O
features	O
and	O
pathological	B-T169
findings	B-T033
of	O
a	O
case	O
of	O
malignant	O
transformation	O
and	O
distant	O
metastasis	O
of	O
intraspinal	O
meningioma	O
,	O
with	O
a	O
review	B-T169
of	I-T169
the	O
literature	B-T170
.	O
	
a	O
44-year-old	O
man	B-T098
with	O
a	O
bilateral	B-T082
lower	O
limb	O
paresis	O
was	O
diagnosed	B-T033
with	O
an	O
intradural	O
extramedullary	O
tumor	O
of	O
the	O
thoracic	O
spine	O
.	O
	
primary	B-T080
tumor	B-T061
resection	I-T061
was	O
performed	B-T169
,	O
and	O
the	O
histological	B-T033
findings	I-T033
revealed	O
atypical	O
meningioma	O
.	O
	
the	O
meningioma	O
recurred	O
2	O
years	B-T079
after	O
the	O
primary	B-T080
surgery	B-T061
,	O
and	O
a	O
second	B-T081
resection	B-T061
was	O
performed	B-T169
,	O
but	O
only	O
partial	B-T081
resection	B-T061
was	O
possible	O
because	O
of	O
decreased	B-T081
motor	O
evoked	O
potential	O
.	O
	
at	O
age	O
48	O
,	O
the	O
patient's	O
lower	O
limb	O
weakness	O
returned	O
,	O
and	O
a	O
third	B-T081
resection	B-T061
was	O
performed	B-T169
,	O
and	O
the	O
histological	B-T033
finding	I-T033
remained	O
atypical	O
meningioma	O
.	O
	
at	O
age	O
54	O
,	O
the	O
tumor	O
increased	B-T081
and	O
stereotactic	B-T061
irradiation	I-T061
was	O
performed	B-T169
.	O
	
at	O
age	O
60	O
,	O
the	O
patient	O
was	O
diagnosed	B-T033
with	O
metastatic	O
tumors	O
of	O
the	O
rib	O
,	O
lumbar	O
vertebra	O
,	O
cervical	O
spine	O
,	O
and	O
sacrum	O
.	O
	
biopsy	O
of	O
the	O
rib	O
metastatic	O
tumor	O
was	O
performed	B-T169
,	O
and	O
the	O
histological	B-T033
findings	I-T033
revealed	O
anaplastic	O
meningioma	O
.	O
	
this	O
case	O
is	O
the	O
first	O
report	B-T170
of	O
an	O
intraspinal	O
meningioma	O
that	O
transformed	O
from	O
atypical	O
to	O
anaplastic	O
meningioma	O
with	O
distant	O
hematogenous	O
metastasis	O
.	O
	
epidemiology	O
and	O
risk	B-T033
factors	I-T033
associated	B-T080
with	I-T080
surgical	O
site	O
infection	O
after	O
different	O
types	B-T080
of	O
hepatobiliary	O
and	O
pancreatic	O
surgery	O
surgical	O
site	O
infection	O
ssi	O
is	O
one	O
of	O
the	O
most	O
common	O
healthcare-associated	O
infections	O
hais	O
however	O
,	O
ssi	O
after	O
hepatobiliary	O
and	O
pancreatic	O
surgery	O
hbps	O
has	O
not	O
been	O
well	O
investigated	B-T169
in	O
a	O
large	B-T081
cohort	B-T098
of	O
patients	O
.	O
	
this	O
study	O
analyzed	O
the	O
factors	B-T169
associated	B-T080
with	I-T080
ssi	O
following	O
hbps	O
in	O
japan	O
,	O
using	O
a	O
japanese	B-T170
national	I-T170
database	I-T170
.	O
	
data	B-T078
on	O
hbps	O
performed	B-T169
between	O
2012	O
and	O
2014	O
were	O
extracted	B-T062
from	O
a	O
national	B-T170
monitoring	I-T170
system	I-T170
for	O
hai	O
the	O
japan	B-T061
nosocomial	I-T061
infections	I-T061
surveillance	I-T061
.	O
	
using	O
multivariate	B-T062
logistic	I-T062
regression	I-T062
,	O
i	O
assessed	B-T052
the	O
factors	B-T169
associated	B-T080
with	I-T080
ssi	O
.	O
	
the	O
cumulative	B-T080
incidence	B-T081
of	O
ssi	O
following	O
hbps	O
was	O
15.6	O
2873/18	O
.	O
	
the	O
incidence	B-T081
of	O
ssi	O
after	O
pancreatoduodenectomy	B-T061
was	O
28.0	O
,	O
which	O
was	O
significantly	B-T081
higher	I-T081
than	O
that	O
after	O
liver	B-T061
resection	I-T061
and	O
other	O
types	B-T080
of	O
hbps	O
8.8	O
and	O
15.5	O
,	O
respectively	O
.	O
	
among	O
the	O
four	O
traditional	B-T169
risk	B-T033
factors	I-T033
,	O
the	O
american	O
society	O
of	O
anesthesiologists	O
score	B-T081
was	O
ineffective	B-T078
for	O
predicting	B-T078
ssi	O
in	O
the	O
final	O
model	B-T170
of	O
all	O
three	O
types	B-T080
of	O
surgery	B-T061
.	O
	
additional	O
risk	B-T033
factors	I-T033
were	O
identified	B-T080
,	O
including	O
age	O
and	O
male	O
gender	O
.	O
	
the	O
incidence	B-T081
of	O
and	O
factors	B-T169
associated	B-T080
with	I-T080
ssi	O
after	O
the	O
three	O
types	B-T080
of	O
hbps	O
analyzed	O
differed	O
significantly	O
.	O
	
to	O
accurately	B-T080
compare	B-T052
hospital	O
performance	B-T080
in	O
relation	B-T080
to	O
ssi	O
following	O
hbps	O
,	O
the	O
operative	B-T061
procedure	I-T061
category	B-T170
in	O
the	O
surveillance	O
system	O
must	O
be	O
divided	B-T169
into	O
three	O
signature	O
of	O
an	O
aggregation	B-T169
-	O
prone	B-T082
conformation	O
of	O
tau	B-T116
the	O
self-assembly	O
of	O
the	O
microtubule	O
associated	B-T080
tau	B-T116
protein	I-T116
into	O
fibrillar	O
cell	O
inclusions	O
is	O
linked	B-T082
to	O
a	O
number	B-T081
of	O
devastating	O
neurodegenerative	B-T047
disorders	I-T047
collectively	O
known	O
as	O
tauopathies	B-T047
.	O
	
the	O
mechanism	B-T169
by	O
which	O
tau	B-T116
self-assembles	O
into	O
pathological	B-T169
entities	O
is	O
a	O
matter	O
of	O
much	O
debate	B-T052
,	O
largely	B-T081
due	B-T169
to	I-T169
the	O
lack	O
of	O
direct	B-T080
experimental	B-T080
insights	O
into	O
the	O
earliest	B-T079
stages	I-T079
of	O
aggregation	B-T169
.	O
	
we	O
present	O
pulsed	O
double	O
electron-electron	O
resonance	O
measurements	B-T169
of	O
two	O
key	O
fibril	O
-	O
forming	B-T169
regions	B-T082
of	O
tau	B-T116
,	O
phf6	B-T116
and	O
phf6*	B-T116
,	O
in	O
transient	B-T079
as	O
aggregation	B-T169
happens	O
.	O
	
by	O
monitoring	O
the	O
end-to-end	B-T081
distance	I-T081
distribution	B-T169
of	O
these	O
segments	O
as	O
a	O
function	B-T169
of	O
aggregation	B-T169
time	B-T079
,	O
we	O
show	O
that	O
the	O
phf6	B-T116
regions	B-T082
dramatically	O
extend	B-T169
to	O
distances	B-T081
commensurate	B-T080
with	O
extended	B-T082
β-strand	B-T082
structures	I-T082
within	O
the	O
earliest	B-T079
stages	I-T079
of	O
aggregation	B-T169
,	O
well	O
before	O
fibril	O
formation	B-T169
.	O
	
combined	B-T080
with	O
simulations	B-T062
,	O
our	O
experiments	B-T062
show	O
that	O
the	O
extended	B-T082
β-strand	B-T082
conformational	I-T082
state	B-T169
of	O
phf6	B-T116
is	O
readily	O
populated	O
under	O
aggregating	B-T169
conditions	B-T080
,	O
constituting	O
a	O
defining	O
signature	O
of	O
aggregation	B-T169
-	O
prone	B-T082
tau	B-T116
,	O
and	O
as	O
such	O
,	O
a	O
possible	O
target	B-T169
for	O
therapeutic	B-T061
interventions	I-T061
.	O
	
design	B-T052
,	O
synthesis	O
,	O
and	O
cytotoxic	O
evaluation	O
of	O
certain	O
7-chloro-4-	B-T109
derivatives	O
as	O
vegfr-ii	B-T116
inhibitors	O
signaling	O
pathway	O
inhibition	B-T052
of	O
vegfr-ii	B-T116
is	O
visualized	O
as	O
valuable	O
tool	O
in	O
cancer	O
management	O
.	O
	
in	O
the	O
current	B-T062
study	I-T062
,	O
the	O
synthesis	O
of	O
novel	B-T080
1-4-	B-T109
derivatives	O
4a-t	B-T109
was	O
achieved	O
through	O
the	O
amination	O
of	O
2-chloro-1-	B-T109
3	I-T109
with	O
different	O
secondary	B-T109
amines	I-T109
.	O
	
the	O
structures	O
of	O
the	O
target	B-T169
compounds	O
were	O
confirmed	B-T080
by	I-T080
ir	O
,	O
1	O
h-nmr	O
,	O
13	O
c-nmr	O
,	O
hrms	O
,	O
and	O
microanalysis	O
.	O
	
compounds	O
4a-t	B-T109
were	O
subjected	O
to	O
in	B-T080
vitro	I-T080
anticancer	B-T061
screening	O
against	O
human	O
breast	O
cancer	O
mcf-7	O
and	O
prostate	O
cancer	O
pc3	O
cell	O
lines	O
.	O
	
the	O
highest	O
cytotoxicty	O
against	O
both	O
cell	O
lines	O
was	O
displayed	O
by	O
2-	B-T109
4q	I-T109
,	O
with	O
ic50	B-T081
values	I-T081
of	O
6.502	O
and	O
11.751	O
μm	O
against	O
mcf-7	O
and	O
pc3	O
cells	O
,	O
respectively	O
,	O
compared	B-T052
with	O
the	O
standard	B-T170
drug	I-T170
doxorubicin	B-T109
mcf-7	O
6.774	O
μm	O
,	O
pc3	O
7.7316	O
μm	O
.	O
	
due	O
to	O
its	O
notable	O
activity	B-T052
toward	O
mcf-7	O
cells	O
,	O
4q	B-T109
was	O
further	O
evaluated	O
as	O
vegfr-ii	B-T116
inhibitor	O
,	O
showing	O
an	O
ic50	B-T081
of	O
1.38	O
μm	O
compared	O
to	O
sorafenib	B-T109
0.33	O
μm	O
.	O
	
the	O
docking	O
study	O
proved	O
that	O
4q	B-T109
has	O
a	O
binding	O
mode	O
akin	O
to	O
that	O
of	O
vegfr-ii	B-T116
inhibitors	O
.	O
	
the	O
erbb3	B-T116
receptor	I-T116
tyrosine	I-T116
kinase	I-T116
negatively	O
regulates	O
paneth	O
cells	O
by	O
pi3k	B-T116
-	O
dependent	B-T169
suppression	O
of	O
atoh1	O
paneth	O
cells	O
pcs	O
,	O
a	O
secretory	O
population	O
located	O
at	O
the	O
base	O
of	O
the	O
intestinal	O
crypt	O
,	O
support	O
the	O
intestinal	O
stem	O
cells	O
isc	O
with	O
growth	B-T116
factors	I-T116
and	O
participate	O
in	O
innate	O
immunity	O
by	O
releasing	O
antimicrobial	B-T116
peptides	I-T116
,	O
including	O
lysozyme	B-T116
and	O
defensins	B-T116
.	O
	
pc	O
dysfunction	O
is	O
associated	O
with	O
disorders	B-T047
such	O
as	O
crohn's	B-T047
disease	I-T047
and	O
necrotizing	B-T047
enterocolitis	I-T047
,	O
but	O
the	O
specific	O
pathways	O
regulating	O
pc	O
development	O
and	O
function	O
are	O
not	O
fully	O
understood	O
.	O
	
here	O
we	O
tested	O
the	O
role	O
of	O
the	O
neuregulin	B-T116
receptor	I-T116
erbb3	I-T116
in	O
control	O
of	O
pc	O
differentiation	O
and	O
the	O
isc	O
niche	O
.	O
	
intestinal	O
epithelial	B-T080
erbb3	O
knockout	O
caused	O
precocious	B-T079
appearance	B-T080
of	O
pcs	O
as	O
early	O
as	O
postnatal	B-T079
day	B-T033
7	I-T033
,	O
and	O
substantially	O
increased	B-T081
the	O
number	O
of	O
mature	B-T079
pcs	O
in	O
adult	O
mouse	O
ileum	O
.	O
	
erbb3	B-T116
loss	O
had	O
no	O
effect	O
on	O
other	O
secretory	B-T078
lineages	I-T078
,	O
but	O
increased	B-T081
expression	O
of	O
the	O
isc	O
marker	O
lgr5	B-T116
.	O
	
erbb3	B-T116
-null	O
intestines	O
had	O
elevated	O
levels	O
of	O
the	O
atoh1	O
transcription	B-T116
factor	I-T116
,	O
which	O
is	O
required	O
for	O
secretory	O
fate	O
determination	O
,	O
while	O
atoh1	B-T116
cells	O
had	O
reduced	O
erbb3	O
,	O
suggesting	O
reciprocal	B-T080
negative	B-T033
regulation	O
.	O
	
erbb3	B-T116
-null	O
intestinal	O
progenitor	O
cells	O
showed	O
reduced	B-T080
activation	B-T052
of	O
the	O
pi3k-akt	B-T169
and	O
erk	O
mapk	O
pathways	O
.	O
	
inhibiting	O
these	O
pathways	O
in	O
ht29	O
cells	O
increased	B-T081
levels	O
of	O
atoh1	O
and	O
the	O
pc	O
marker	O
lyz	O
.	O
	
conversely	O
,	O
erbb3	B-T116
activation	O
suppressed	O
lyz	O
and	O
atoh1	O
in	O
a	O
pi3k	B-T116
-	O
dependent	B-T169
manner	O
.	O
	
expansion	O
of	O
the	O
pc	O
compartment	O
in	O
erbb3	B-T116
-null	O
intestines	O
was	O
accompanied	O
with	O
elevated	O
er	O
stress	O
and	O
inflammation	O
markers	O
,	O
raising	O
the	O
possibility	O
that	O
negative	B-T033
regulation	O
of	O
pcs	O
by	O
erbb3	B-T116
is	O
necessary	O
to	O
maintain	O
homeostasis	O
.	O
	
taken	O
together	O
,	O
our	O
data	B-T078
suggest	O
that	O
erbb3	B-T116
restricts	O
pc	O
numbers	O
through	O
pi3k	B-T116
-mediated	O
suppression	O
of	O
atoh1	O
levels	O
leading	O
to	O
inhibition	O
of	O
pc	O
differentiation	O
,	O
with	O
important	O
implications	O
for	O
regulation	O
of	O
the	O
isc	O
niche	O
.	O
	
cdf	B-T081
-	O
quantile	B-T081
distributions	B-T081
for	O
modelling	B-T170
random	B-T081
variables	I-T081
on	O
the	O
unit	B-T170
interval	I-T170
this	O
paper	O
introduces	O
a	O
two-parameter	O
family	O
of	O
distributions	B-T081
for	O
modelling	B-T170
random	B-T081
variables	I-T081
on	O
the	O
0	O
interval	B-T170
by	O
applying	O
the	O
cumulative	B-T081
distribution	I-T081
function	I-T081
of	O
one	O
'	O
parent'	B-T081
distribution	I-T081
to	O
the	O
quantile	B-T081
function	B-T170
of	O
another	O
.	O
	
family	O
members	O
have	O
explicit	O
probability	B-T081
density	I-T081
functions	B-T170
,	O
cumulative	B-T081
distribution	I-T081
functions	I-T081
and	O
quantile	B-T081
s	O
in	O
a	O
location	B-T082
parameter	O
and	O
a	O
dispersion	B-T082
parameter	O
.	O
	
they	O
capture	O
a	O
wide	O
variety	O
of	O
shapes	B-T082
that	O
the	O
beta	B-T081
and	O
kumaraswamy	B-T081
distributions	I-T081
cannot	B-T033
.	O
	
they	O
are	O
amenable	B-T080
to	O
likelihood	B-T081
inference	I-T081
,	O
and	O
enable	O
a	O
wide	O
variety	O
of	O
quantile	B-T081
regression	B-T170
models	I-T170
,	O
with	O
predictors	B-T078
for	O
both	O
the	O
location	B-T082
and	O
dispersion	B-T082
parameters	O
.	O
	
we	O
demonstrate	O
their	O
applicability	O
to	O
psychological	O
research	B-T062
problems	I-T062
and	O
their	O
utility	B-T169
in	O
modelling	B-T170
real	B-T170
data	I-T170
.	O
	
first	B-T081
and	O
second	B-T081
generation	B-T079
dess	O
reduce	B-T080
diabetes	B-T047
adverse	O
effect	O
on	O
mortality	B-T081
and	O
re-intervention	B-T061
in	O
multivessel	O
coronary	B-T047
disease	I-T047
9-	O
year	B-T079
analysis	B-T062
diabetes	B-T047
portends	B-T169
an	O
increased	B-T081
risk	B-T078
of	O
adverse	O
early	B-T079
and	O
late	B-T079
outcomes	B-T169
in	O
patients	O
undergoing	O
pci	B-T061
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
aimed	O
to	O
investigate	B-T169
if	O
the	O
adverse	O
effect	O
of	O
diabetes	B-T047
mellitus	I-T047
dm	B-T047
on	O
early	B-T079
and	O
late	B-T079
pci	B-T061
outcomes	B-T169
is	O
reduced	B-T080
with	O
drug-eluting	O
des	O
compared	O
to	O
bare-metal	O
bms	O
stents	O
.	O
	
we	O
reviewed	B-T078
the	O
mount	O
sinai	O
beth	O
israel	O
hospital	O
first	B-T081
pci	B-T061
experience	O
for	O
multivessel	O
coronary	B-T047
artery	I-T047
disease	I-T047
cad	B-T047
,	O
1998-2009	O
.	O
	
patients	O
were	O
excluded	B-T052
if	O
they	O
had	O
single-vessel	B-T047
cad	I-T047
,	O
emergency	B-T078
,	O
no	B-T033
stent	O
,	O
prior	B-T079
bypass	B-T061
graft	I-T061
or	O
myocardial	B-T047
infarction	I-T047
<24h	O
.	O
	
diabetes	B-T047
-	O
effect	B-T080
was	O
derived	O
from	O
9-	O
year	B-T079
all-cause	O
mortality	B-T081
and	O
re-intervention	B-T061
risk-adjusted	B-T081
hazard	I-T081
ratios	I-T081
ahr	B-T081
95%	O
confidence	B-T081
intervals	I-T081
for	O
des	O
n=2679	O
48%	O
three-vessel	B-T047
39%	O
dm	B-T047
and	O
bms	O
n=2651	O
40%	O
three-vessel	B-T047
33%	O
dm	B-T047
and	O
then	O
stratified	O
based	O
on	O
stent	O
des	O
/	O
bms	O
and	O
vessel	B-T047
disease	I-T047
two	B-T047
/	O
three	B-T047
.	O
	
diabetes	B-T047
-	O
effect	B-T080
on	O
mortality	B-T081
was	O
lower	B-T080
for	O
des	O
ahrdm/nodm	B-T081
=1	O
1.14	O
versus	O
bms	O
ahrdm/nodm	B-T081
=1	O
1.50	O
,	O
but	O
this	O
was	O
predominantly	B-T080
driven	O
by	O
two-vessel	B-T047
patients	O
.	O
	
this	O
diabetes	B-T047
effect	B-T080
was	O
similar	O
for	O
first	B-T081
des1	O
ahrdm/nodm	B-T081
=1	O
1.14	O
and	O
second	B-T081
des2	O
ahrdm/nodm	B-T081
=1	O
0.77	O
generation	B-T079
des	O
.	O
	
re-intervention	B-T061
comparisons	B-T052
were	O
similarly	O
increased	B-T081
by	O
diabetes	B-T047
in	O
all	O
sub-cohorts	B-T098
.	O
	
our	O
analysis	B-T062
of	O
a	O
large	O
real-world	O
pci	B-T061
series	O
indicates	O
that	O
diabetes	B-T047
is	O
associated	B-T080
with	I-T080
worse	B-T033
9-	O
year	B-T079
mortality	B-T081
irrespective	O
of	O
stent	O
type	B-T080
,	O
albeit	O
this	O
is	O
mitigated	O
to	O
varying	O
degrees	O
with	O
des	O
,	O
particularly	O
in	O
des2	O
and	O
in	O
case	O
of	O
2-vessel	B-T047
disease	I-T047
.	O
	
a	O
complementary	O
stent	O
-	O
effect	B-T080
analysis	B-T062
confirmed	B-T033
des	O
-to-	O
bms	O
and	O
des2	O
-to-	O
des1	O
superiority	B-T080
in	O
both	O
diabetics	B-T033
and	O
lycopene	B-T109
and	O
risk	B-T078
of	O
cardiovascular	B-T047
diseases	I-T047
a	O
meta-analysis	B-T062
of	O
observational	B-T033
studies	I-T033
the	O
aim	O
of	O
current	O
meta-analysis	B-T062
was	O
to	O
investigate	B-T169
the	O
relation	O
between	O
lycopene	B-T109
and	O
risk	B-T078
of	O
cardiovascular	B-T047
diseases	I-T047
cvd	B-T047
.	O
	
studies	B-T062
concerning	O
about	O
the	O
association	O
between	O
lycopene	B-T109
and	O
risk	B-T078
of	O
cvd	B-T047
were	O
searched	O
on	O
pubmed	B-T170
,	O
embase	B-T170
,	O
and	O
web	B-T170
of	I-T170
science	I-T170
from	O
inception	O
to	O
october	O
2016	O
.	O
	
a	O
total	O
of	O
14	O
eligible	B-T062
studies	I-T062
were	O
identified	B-T080
.	O
	
a	O
significantly	O
inverse	O
association	O
with	O
a	O
pooled	O
risk	B-T081
ratio	I-T081
rr	B-T081
of	O
0.83	O
95%	O
ci	B-T081
0.76	O
was	O
shown	O
between	O
lycopene	B-T109
exposure	B-T080
and	O
risk	B-T078
of	O
cvd	B-T047
.	O
	
findings	B-T033
were	O
similar	O
restricting	O
to	O
dietary	O
studies	B-T062
rr	B-T081
=	O
0.87	O
,	O
95%	O
ci	B-T081
=	O
0.79	O
and	O
biomarker	O
studies	B-T062
rr	B-T081
=	O
0.74	O
,	O
95%	O
ci	B-T081
=	O
0	O
.	O
	
62-0	O
.	O
	
dietary	O
lycopene	B-T109
intake	B-T169
was	O
statistically	B-T081
significant	I-T081
for	O
coronary	B-T047
heart	I-T047
disease	I-T047
chd	B-T047
rr	B-T081
0.87	O
95%	O
ci	B-T081
0.76	O
and	O
stroke	B-T047
rr	B-T081
0.83	O
95%	O
ci	B-T081
0.69	O
pooled	O
risk	B-T081
estimate	I-T081
was	O
generally	O
similar	O
for	O
lycopene	B-T109
biomarker	O
concentrations	O
,	O
but	O
the	O
association	O
was	O
only	O
statistically	B-T081
significant	I-T081
for	O
stroke	B-T047
rr	B-T081
0.65	O
95%	O
ci	B-T081
0.42	O
.	O
	
subgroup	O
analyses	B-T062
showed	O
that	O
retrospective	B-T062
and	O
low	O
quality	O
studies	B-T062
were	O
statistically	B-T081
significant	I-T081
sources	O
of	O
heterogeneity	B-T080
.	O
	
higher	O
lycopene	B-T109
exposure	B-T080
is	O
inversely	O
associated	O
with	O
a	O
lower	O
risk	B-T078
of	O
cvd	B-T047
.	O
	
further	O
well-designed	O
randomized	B-T062
clinical	I-T062
trials	I-T062
are	O
required	O
to	O
assess	O
the	O
role	O
of	O
lycopene	B-T109
on	O
bacteria	O
from	O
wheat	O
and	O
cucurbit	O
plant	O
roots	O
metabolize	O
pahs	B-T109
and	O
aromatic	B-T109
root	O
exudates	O
implications	B-T078
for	O
rhizodegradation	O
the	O
chemical	O
interaction	O
between	O
plants	O
and	O
bacteria	O
in	O
the	O
root	O
zone	B-T082
can	O
lead	O
to	O
soil	O
decontamination	B-T169
.	O
	
bacteria	O
which	O
degrade	B-T169
pahs	B-T109
have	O
been	O
isolated	B-T169
from	O
the	O
rhizospheres	O
of	O
plant	O
species	O
with	O
varied	O
biological	B-T080
traits	O
,	O
however	O
,	O
it	O
is	O
not	O
known	O
what	O
phytochemicals	B-T109
promote	O
contaminant	O
degradation	B-T169
.	O
	
one	O
monocot	O
and	O
two	O
dicotyledon	O
plants	O
were	O
grown	O
in	O
pah	B-T109
-	O
contaminated	B-T169
soil	O
from	O
a	O
manufactured	O
gas	O
plant	O
mgp	O
site	B-T082
.	O
	
a	O
phytotoxicity	O
assay	O
confirmed	O
greater	O
soil	O
decontamination	B-T169
in	O
rhizospheres	O
when	O
compared	B-T052
to	O
bulk	O
soil	O
controls	B-T169
.	O
	
bacteria	O
were	O
isolated	B-T169
from	O
plant	O
roots	O
rhizobacteria	O
and	O
selected	B-T052
for	O
growth	O
on	O
anthracene	B-T109
and	O
chrysene	B-T109
on	O
pah	B-T109
-	O
amended	B-T080
plates	O
.	O
	
rhizosphere	O
isolates	O
metabolized	O
3-	O
and	O
4-ring	O
pahs	B-T109
and	O
pah	B-T109
catabolic	B-T169
intermediates	O
in	O
liquid	O
incubations	O
.	O
	
aromatic	B-T109
root	O
exudate	O
compounds	O
,	O
namely	O
flavonoids	B-T109
and	O
simple	B-T109
phenols	I-T109
,	O
were	O
also	O
substrates	O
for	O
isolated	B-T169
rhizobacteria	O
.	O
	
in	O
particular	O
,	O
the	O
phenolic	B-T109
compounds	I-T109
-	O
morin	B-T109
,	O
caffeic	B-T109
acid	I-T109
,	O
and	O
protocatechuic	B-T109
acid	I-T109
-	O
appear	O
to	O
be	O
linked	O
to	O
bacterial	O
degradation	B-T169
of	O
3-	O
and	O
4-	O
ring	O
pahs	B-T109
in	O
the	O
joint	B-T081
model	I-T081
imputation	I-T081
to	O
estimate	B-T081
the	O
treatment	B-T033
effect	I-T033
on	O
long-term	B-T079
survival	B-T052
using	O
auxiliary	O
events	O
clinical	B-T062
trial	I-T062
duration	B-T079
may	O
be	O
a	O
concern	O
in	O
clinical	B-T062
research	I-T062
,	O
especially	O
in	O
cancer	B-T062
trials	I-T062
where	O
the	O
endpoint	O
is	O
overall	B-T081
survival	I-T081
.	O
	
a	O
surrogate	B-T080
endpoint	I-T080
can	O
be	O
used	O
as	O
an	O
auxiliary	B-T080
variable	I-T080
to	O
analyze	B-T062
the	O
treatment	B-T033
effect	I-T033
earlier	O
.	O
	
at	O
an	O
early	O
time	O
point	O
,	O
the	O
high	O
number	O
of	O
censored	B-T052
observations	B-T062
can	O
be	O
compensated	B-T080
by	O
the	O
imputation	B-T081
of	O
the	O
unobserved	B-T033
deaths	B-T033
times	O
.	O
	
we	O
propose	O
to	O
use	O
predictions	B-T078
of	O
the	O
risk	B-T078
of	O
death	O
from	O
a	O
joint	B-T081
model	I-T081
for	O
a	O
recurrent	B-T079
event	O
and	O
a	O
terminal	B-T080
event	O
,	O
which	O
account	O
for	O
disease	B-T047
relapse	I-T047
information	B-T078
.	O
	
two	O
imputation	B-T081
methods	I-T081
were	O
compared	B-T052
sampling	B-T062
from	O
the	O
estimated	B-T081
parametric	I-T081
distribution	I-T081
of	O
the	O
survival	O
time	O
and	O
sampling	B-T062
using	O
its	O
nonparametric	B-T081
estimation	I-T081
.	O
	
the	O
treatment	B-T033
effect	I-T033
and	O
its	O
standard	B-T081
error	I-T081
were	O
estimated	B-T081
via	O
multiple	B-T081
imputations	I-T081
.	O
	
the	O
performances	B-T052
of	O
the	O
two	O
methods	B-T170
were	O
compared	B-T052
in	O
terms	O
of	O
bias	B-T078
in	O
the	O
estimates	B-T081
,	O
standard	B-T081
errors	I-T081
,	O
and	O
coverage	B-T052
probability	B-T081
.	O
	
both	O
methods	B-T170
were	O
then	O
retrospectively	B-T080
applied	B-T169
to	O
two	O
randomized	B-T062
clinical	I-T062
trials	I-T062
studying	O
the	O
effect	B-T080
of	O
adjuvant	B-T169
chemotherapy	B-T061
in	O
breast	O
cancer	O
patients	O
.	O
	
the	O
corneal	O
epithelial	O
barrier	B-T033
and	O
its	O
developmental	B-T080
role	O
in	O
isolating	B-T169
corneal	O
epithelial	O
and	O
conjunctival	O
cells	O
from	O
one	O
another	O
during	O
development	B-T169
,	O
the	O
corneal	O
epithelium	O
ce	O
and	O
the	O
conjunctiva	O
are	O
derived	O
from	O
the	O
surface	O
ectoderm	O
.	O
	
here	O
we	O
have	O
examined	B-T033
how	O
,	O
during	O
development	B-T169
,	O
the	O
cells	O
of	O
these	O
two	O
issues	O
become	O
isolated	B-T169
from	O
each	O
other	O
.	O
	
epithelia	O
from	O
the	O
anterior	O
eyes	O
of	O
chicken	O
embryos	O
were	O
labeled	O
with	O
the	O
fluorescent	O
,	O
lipophilic	O
dye	O
,	O
1	B-T109
perchlorate	I-T109
dii	B-T109
.	O
	
dii	B-T109
was	O
placed	O
on	O
the	O
epithelial	O
surface	O
of	O
the	O
developing	O
anterior	O
eye	O
and	O
its	O
diffusion	O
was	O
monitored	O
by	O
fluorescence	O
microscopy	O
.	O
	
concomitant	O
morphologic	B-T080
changes	B-T169
in	O
the	O
surface	O
cells	O
of	O
these	O
epithelial	O
were	O
examined	B-T033
by	O
scanning	O
electron	O
microscopy	O
.	O
	
immunofluorescence	O
was	O
used	O
to	O
analyze	O
the	O
expression	O
of	O
cytokeratin	B-T116
k3	I-T116
,	O
zo-1	B-T116
,	O
n-cadherin	B-T116
and	O
connexin-43	B-T116
and	O
the	O
function	O
of	O
gap	O
junctions	O
was	O
analyzed	B-T062
using	O
a	O
cut-loading	B-T081
with	O
the	O
fluorescent	O
dye	O
rhodamine-dextran	B-T109
.	O
	
prior	O
to	O
embryonic	O
day	B-T079
8	O
e	O
8	O
,	O
dii	B-T109
placed	O
on	O
the	O
surface	B-T082
of	O
the	O
ce	O
spreads	B-T080
throughout	O
all	O
the	O
epithelial	O
cells	O
of	O
the	O
anterior	O
eye	O
.	O
	
when	O
older	O
eyes	O
were	O
similarly	O
labeled	O
,	O
dye	O
diffusion	O
was	O
restricted	B-T169
to	O
the	O
ce	O
.	O
	
similarly	O
,	O
diffusion	O
of	O
dii	B-T109
placed	O
on	O
the	O
conjunctival	O
surface	B-T082
after	O
e	O
8	O
was	O
restricted	B-T169
to	O
the	O
conjunctiva	O
.	O
	
scanning	O
electron	O
microscopy	O
showed	O
that	O
developmentally	B-T169
1	O
physical	B-T033
separations	I-T033
progressively	B-T169
form	O
between	O
the	O
cells	O
of	O
the	O
ce	O
and	O
those	O
of	O
the	O
conjunctiva	O
,	O
and	O
2	O
by	O
e	O
8	O
these	O
separations	B-T169
form	O
a	O
ring	O
that	O
completely	O
encompasses	O
the	O
cornea	O
.	O
	
the	O
functional	B-T169
restriction	B-T169
of	O
gap	O
junctions	O
between	O
these	O
tissues	O
did	O
not	O
occur	B-T052
until	O
e	O
14	O
.	O
	
during	O
ocular	O
development	O
,	O
a	O
barrier	B-T033
to	O
the	O
diffusion	O
of	O
dii	B-T109
forms	O
between	O
the	O
contiguous	B-T082
ce	O
and	O
conjunctiva	O
prior	O
to	O
the	O
differential	B-T080
expression	O
of	O
gap	O
junctions	O
within	O
these	O
longitudinal	B-T062
study	I-T062
of	O
bovine	O
rotavirus	O
group	O
a	O
in	O
newborn	O
calves	O
from	O
vaccinated	B-T033
and	O
unvaccinated	B-T033
dairy	O
herds	O
reports	O
of	O
rotavirus	O
excretion	O
in	O
calves	O
usually	O
result	O
from	O
cross-sectional	B-T062
studies	I-T062
,	O
and	O
in	O
face	O
of	O
the	O
conflicting	O
results	O
regarding	O
protection	B-T061
of	O
calves	O
born	O
to	O
vaccinated	B-T033
dams	O
against	O
diarrhea	O
,	O
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
rotavirus	O
excretion	O
in	O
dairy	O
calves	O
born	O
to	O
vaccinated	B-T033
or	O
unvaccinated	B-T033
dams	O
,	O
to	O
identify	O
the	O
genotypes	O
of	O
bovine	O
rotavirus	O
group	O
a	O
rva	O
strains	O
isolated	O
from	O
these	O
animals	O
as	O
well	O
as	O
to	O
investigate	O
characteristics	O
of	O
the	O
disease	B-T047
in	O
naturally	B-T169
occurring	B-T052
circumstances	O
throughout	O
the	O
first	B-T033
month	I-T033
of	I-T033
life	I-T033
.	O
	
five	O
hundred	O
fifty-two	O
fecal	O
samples	O
were	O
taken	O
from	O
56	O
calves	O
,	O
28	O
from	O
each	O
farm	B-T082
and	O
,	O
in	O
the	O
vaccinated	B-T033
herd	O
,	O
11/281	O
samples	O
3.91	O
taken	O
from	O
six	O
different	O
calves	O
tested	B-T033
positive	I-T033
for	O
rva	O
while	O
in	O
the	O
unvaccinated	B-T033
herd	O
,	O
3/271	O
samples	O
1.11	O
taken	O
from	O
3	O
different	O
calves	O
tested	B-T033
positive	I-T033
.	O
	
the	O
genotyping	O
of	O
the	O
vp7	O
genes	O
showed	O
91.2	O
nucleotide	O
sequence	O
identity	O
to	O
g6	O
genotype	O
ncdv	O
strain	O
,	O
and	O
for	O
the	O
vp4	O
gene	O
,	O
strains	O
from	O
the	O
vaccinated	B-T033
herd	O
were	O
96.6	O
related	O
to	O
b223	O
strain	O
,	O
while	O
strains	O
from	O
the	O
unvaccinated	B-T033
herd	O
were	O
88%	O
related	O
to	O
p	O
genotype	O
uk	O
strain	O
.	O
	
genotypes	O
found	O
in	O
this	O
study	O
were	O
g6p	O
in	O
the	O
vaccinated	B-T033
herd	O
and	O
g6p	O
in	O
the	O
unvaccinated	B-T033
herd	O
.	O
	
all	O
calves	O
infected	B-T033
with	O
rotavirus	O
presented	O
an	O
episode	O
of	O
diarrhea	O
in	O
the	O
first	O
month	O
of	O
life	O
,	O
and	O
the	O
discrepancy	O
between	O
the	O
genotypes	O
found	O
in	O
the	O
commercial	O
vaccine	O
g6p	O
and	O
g10p	O
and	O
the	O
rotavirus	O
strains	O
circulating	O
in	O
both	O
vaccinated	B-T033
and	O
unvaccinated	B-T033
herds	O
show	O
the	O
importance	O
of	O
keeping	O
constant	B-T080
surveillance	B-T061
in	O
order	O
to	O
avoid	O
potential	B-T080
causes	B-T169
of	O
vaccination	B-T061
failure	B-T033
.	O
	
gene	O
-based	O
genome-wide	O
association	O
study	O
identified	B-T080
19p13.3	O
for	O
lean	O
body	O
mass	O
lean	O
body	O
mass	O
lbm	O
is	O
a	O
complex	O
trait	O
for	O
human	O
health	B-T078
.	O
	
to	O
identify	O
genomic	O
loci	O
underlying	O
lbm	O
,	O
we	O
performed	O
a	O
gene	O
-based	O
genome-wide	O
association	O
study	O
of	O
lean	B-T081
mass	I-T081
index	I-T081
lmi	B-T081
in	O
1000	O
unrelated	B-T033
caucasian	B-T098
subjects	B-T098
,	O
and	O
replicated	B-T169
in	O
2283	O
unrelated	B-T033
caucasians	B-T098
subjects	B-T098
.	O
	
gene	O
-based	O
association	O
analyses	O
highlighted	O
the	O
significant	O
associations	B-T080
of	O
three	O
genes	O
uqcr	O
,	O
tcf3	O
and	O
mbd3	O
in	O
one	O
single	B-T081
locus	O
19p13.3	O
discovery	B-T080
p	O
=	O
6.10	O
10	O
,	O
1.65	O
10	O
and	O
1.10	O
10	O
replication	B-T080
p	O
=	O
2.21	O
10	O
,	O
1.84	O
10	O
and	O
6.95	O
10	O
combined	O
p	O
=	O
2.26	O
10	O
,	O
4.86	O
10	O
and	O
1.15	O
10	O
,	O
respectively	O
.	O
	
these	O
results	O
,	O
together	O
with	O
the	O
known	O
functional	B-T169
relevance	B-T080
of	O
the	O
three	O
genes	O
to	O
lmi	B-T081
,	O
suggested	O
that	O
the	O
19p13.3	O
region	B-T082
containing	O
uqcr	O
,	O
tcf3	O
and	O
mbd3	O
genes	O
was	O
a	O
novel	O
locus	O
underlying	O
lean	O
mass	O
variation	O
.	O
	
basal	B-T082
ryanodine	O
receptor	O
activity	O
suppresses	B-T169
autophagic	O
flux	O
the	O
inositol	B-T116
1	I-T116
receptors	I-T116
ip3rs	B-T116
and	O
intracellular	O
ca	O
signaling	O
are	O
critically	B-T080
involved	B-T169
in	O
regulating	O
different	B-T080
steps	O
of	O
autophagy	O
,	O
a	O
lysosomal	O
degradation	O
pathway	O
.	O
	
the	O
ryanodine	B-T116
receptors	I-T116
ryr	B-T116
,	O
intracellular	O
ca	O
channels	O
mainly	O
expressed	O
in	O
excitable	B-T033
cell	B-T170
types	I-T170
including	B-T169
muscle	O
and	O
neurons	O
,	O
have	O
however	O
not	O
yet	O
been	O
extensively	B-T080
studied	B-T062
in	O
relation	O
to	O
autophagy	O
.	O
	
yet	O
,	O
aberrant	B-T080
expression	O
and	O
excessive	B-T080
activity	O
of	O
ryrs	B-T116
in	O
these	O
tissues	O
has	O
been	O
implicated	B-T033
in	O
the	O
onset	B-T080
of	I-T080
several	B-T081
diseases	B-T047
including	B-T169
alzheimer's	B-T047
disease	I-T047
,	O
where	O
impaired	B-T169
autophagy	O
regulation	O
contributes	B-T052
to	O
the	O
pathology	B-T169
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
determined	O
whether	O
pharmacological	O
ryr	B-T116
inhibition	B-T052
could	O
modulate	B-T082
autophagic	O
flux	O
in	O
ectopic	B-T082
ryr	B-T116
-	O
expressing	O
models	B-T170
,	O
like	O
hek293	O
cells	O
and	O
in	O
cell	B-T170
types	I-T170
that	O
endogenously	B-T169
express	O
ryr	B-T116
s	O
,	O
like	O
c2c12	O
myoblasts	O
and	O
primary	B-T080
hippocampal	O
neurons	O
.	O
	
importantly	B-T080
,	O
ryr3	B-T116
overexpression	O
in	O
hek293	O
cells	O
impaired	B-T169
the	O
autophagic	O
flux	O
.	O
	
conversely	O
,	O
in	O
all	O
cell	O
models	B-T170
tested	B-T169
,	O
pharmacological	O
inhibition	B-T052
of	O
endogenous	B-T169
or	O
ectopically	B-T082
expressed	O
ryrs	B-T116
,	O
using	O
dantrolene	B-T109
or	O
ryanodine	B-T109
,	O
augmented	B-T081
autophagic	O
flux	O
by	O
increasing	B-T169
lysosomal	O
turn-over	O
number	B-T081
of	O
autophagosomes	O
and	O
autolysosomes	O
measured	B-T080
as	O
mcherry	B-T116
-	O
lc3	B-T116
punctae	I-T116
/	O
cell	O
increased	B-T081
from	O
70.37	O
in	O
control	O
hek	O
ryr3	O
cells	O
to	O
111.18	O
and	O
98.14	O
after	O
dantrolene	B-T109
and	O
ryanodine	B-T109
treatments	B-T061
,	O
respectively	O
.	O
	
moreover	O
,	O
in	O
differentiated	O
c2c12	O
cells	O
,	O
transmission	O
electron	O
microscopy	O
demonstrated	B-T080
that	O
dantrolene	B-T109
treatment	B-T061
decreased	B-T081
the	O
number	B-T081
of	O
early	O
autophagic	O
vacuoles	O
from	O
5.9	O
to	O
1.8	O
per	O
cellular	O
cross	B-T082
section	I-T082
.	O
	
the	O
modulation	O
of	O
the	O
autophagic	O
flux	O
could	O
be	O
linked	O
to	O
the	O
functional	B-T169
inhibition	B-T052
of	O
ryr	B-T116
channels	I-T116
as	O
both	O
ryr	B-T116
inhibitors	O
efficiently	B-T080
diminished	O
the	O
number	B-T081
of	O
cells	O
showing	O
spontaneous	B-T169
ryr3	B-T116
activity	O
in	O
the	O
hek293	O
cell	O
model	B-T170
from	O
41.14	O
in	O
control	O
cells	O
to	O
18.70	O
and	O
9.74	O
after	O
dantrolene	B-T109
and	O
ryanodine	B-T109
treatments	B-T061
,	O
respectively	O
.	O
	
in	O
conclusion	B-T078
,	O
basal	B-T082
ryr	B-T116
-mediated	O
ca	O
events	O
suppress	B-T169
autophagic	O
flux	O
at	O
the	O
level	B-T080
of	O
the	O
fluoride	O
concentration	B-T081
in	O
saliva	O
and	O
biofilm	O
fluid	O
following	O
the	O
application	O
of	O
three	O
fluoride	O
varnishes	O
most	O
of	O
the	O
commercially	O
available	O
fluoride	O
varnishes	O
fv	O
have	O
not	O
been	O
evaluated	O
for	O
their	O
cariostatic	O
properties	O
.	O
	
consequently	B-T033
,	O
the	O
aim	B-T078
of	O
this	O
in	B-T082
vivo	I-T082
study	B-T062
was	O
to	O
investigate	O
intra	B-T082
-	O
oral	B-T082
fluoride	O
retention	B-T169
and	O
clearance	B-T033
patterns	I-T033
from	O
three	O
different	O
fv	O
.	O
	
eighteen	O
subjects	B-T098
7-11	O
years	B-T079
participated	O
in	O
a	O
laboratory	O
analyst	O
-	O
blinded	B-T062
,	O
randomized	B-T062
,	O
crossover	B-T062
study	I-T062
comparing	B-T052
the	O
ability	O
of	O
5%	O
sodium	O
fluoride	O
varnishes	O
cavityshield-cs	O
,	O
enamel	O
pro-ep	O
,	O
vanish-v	O
to	O
enhance	B-T052
fluoride	O
concentrations	B-T081
in	O
biofilm	O
fluid	O
,	O
centrifuged	O
and	O
whole	B-T081
saliva	O
over	O
a	O
period	B-T079
of	O
48h	O
after	O
a	O
single	O
fv	O
application	O
.	O
	
similar	O
fluoride	O
concentration	B-T081
time	B-T079
patterns	I-T079
were	O
noted	B-T170
for	O
all	O
investigated	B-T080
fv	O
and	O
studied	B-T062
variables	B-T080
,	O
with	O
the	O
highest	B-T080
fluoride	O
concentrations	B-T081
observed	B-T169
for	O
the	O
first	O
biological	O
sample	O
collected	B-T169
after	O
fv	O
application	O
30min	O
.	O
	
mean	B-T081
area	B-T081
under	I-T081
fluoride	I-T081
clearance	I-T081
curve	I-T081
values	B-T080
were	O
μg	O
f/g	O
or	O
ml	O
biofilm	O
fluid	O
-	O
cs	O
472	O
,	O
ep	O
423	O
,	O
v	O
1264	O
centrifuged	O
saliva	O
-	O
cs	O
42	O
,	O
ep	O
19	O
,	O
v	O
41	O
whole	B-T081
saliva	O
-	O
cs	O
68	O
,	O
ep	O
64	O
,	O
v	O
60	O
.	O
	
v	O
delivered	O
more	O
fluoride	O
to	O
biofilm	O
fluid	O
than	O
cs	O
p=0	O
and	O
ep	O
p=0	O
,	O
which	O
did	O
not	O
differ	O
p=0	O
.	O
	
for	O
centrifuged	O
saliva	O
,	O
cs	O
and	O
v	O
were	O
not	O
significantly	B-T078
different	O
p=0	O
,	O
but	O
resulted	B-T169
in	O
higher	B-T080
fluoride	O
retention	B-T169
than	O
ep	O
p<0	O
.	O
	
no	O
significant	B-T078
differences	O
among	O
fv	O
were	O
observed	B-T169
for	O
whole	B-T081
saliva	O
p=0	O
.	O
	
the	O
present	B-T033
study	B-T062
has	O
shown	O
that	O
fv	O
vary	O
in	O
their	O
ability	O
to	O
deliver	O
fluoride	O
intra	B-T082
-	O
orally	B-T082
potentially	B-T080
related	B-T080
to	O
formulation	O
differences	B-T080
.	O
	
to	O
what	O
extent	B-T082
the	O
present	B-T033
findings	B-T033
relate	B-T080
to	O
clinical	B-T080
efficacy	I-T080
remains	O
,	O
however	O
,	O
to	O
be	O
determined	O
.	O
	
clinical	B-T062
research	I-T062
that	O
investigates	O
fluoride	O
release	B-T080
patterns	B-T082
into	O
saliva	O
and	O
biofilm	O
fluid	O
from	O
different	O
fv	O
products	O
is	O
insufficient	B-T080
.	O
	
more	O
research	B-T062
is	O
needed	O
to	O
investigate	O
different	O
fv	O
formulations	O
for	O
their	O
efficacy	B-T080
in	O
order	O
to	O
help	O
clinicians	O
make	O
better	B-T080
evidence	B-T078
based	O
treatment	B-T169
the	O
prognostic	O
value	O
of	O
extranodal	B-T033
extension	I-T033
in	O
human	O
papillomavirus	O
-associated	O
oropharyngeal	O
squamous	O
cell	O
carcinoma	O
extranodal	B-T033
or	I-T033
extracapsular	I-T033
extension	I-T033
ene	B-T033
is	O
an	O
adverse	O
prognostic	O
factor	O
in	O
patients	O
with	O
head	O
and	O
neck	O
cancers	O
who	O
undergo	O
primary	O
surgery	O
.	O
	
however	O
,	O
the	O
significance	O
of	O
ene	B-T033
in	O
human	O
papillomavirus	O
hpv	O
oropharyngeal	O
squamous	O
cell	O
carcinoma	O
opscc	O
is	O
not	O
well	O
established	O
,	O
and	O
single-institution	O
studies	B-T062
have	O
not	B-T080
established	I-T080
that	O
ene	B-T033
predicts	B-T078
inferior	B-T082
outcome	B-T169
.	O
	
the	O
authors	O
investigated	O
the	O
prognostic	O
value	O
of	O
ene	B-T033
in	O
hpv	O
-	O
positive	B-T033
patients	O
who	O
underwent	O
primary	O
surgery	O
and	O
whether	O
adjuvant	B-T061
chemoradiation	I-T061
improved	O
overall	B-T081
survival	I-T081
os	B-T081
compared	B-T052
with	O
radiation	O
alone	O
in	O
ene	B-T033
-	O
positive	B-T033
patients	O
.	O
	
patients	O
who	O
underwent	O
primary	O
surgery	O
for	O
pathologic	B-T169
t1	I-T169
pt1	B-T169
through	O
pt4	O
tumors	O
,	O
pathologic	B-T169
n1	I-T169
pn1	B-T169
through	O
pn3	O
lymph	O
node	O
status	B-T080
,	O
hpv-positive	O
opscc	O
were	O
identified	B-T080
in	O
the	O
national	B-T170
cancer	I-T170
data	I-T170
base	I-T170
from	O
2010	O
through	O
2012	O
.	O
	
features	B-T080
associated	B-T080
with	I-T080
ene	B-T033
were	O
analyzed	B-T062
.	O
	
univariable	B-T170
and	I-T170
multivariable	I-T170
cox	I-T170
regression	I-T170
analyses	I-T170
identified	B-T080
predictors	B-T078
of	O
os	B-T081
.	O
	
the	O
effect	B-T080
of	O
adjuvant	B-T061
treatment	I-T061
on	O
os	B-T081
in	O
ene	B-T033
-	O
positive	B-T033
cohort	B-T081
was	O
also	O
evaluated	O
.	O
	
in	O
total	O
,	O
1043	O
patients	O
met	O
inclusion	B-T080
criteria	I-T080
,	O
among	O
whom	O
43.5	O
were	O
ene	B-T033
-	O
positive	B-T033
.	O
	
of	O
the	O
ene	B-T033
-	O
positive	B-T033
patients	O
who	O
had	O
treatment	B-T061
details	O
available	O
,	O
72%	O
received	B-T080
concurrent	B-T061
chemoradiotherapy	I-T061
,	O
16%	O
received	B-T080
radiotherapy	B-T061
,	O
and	O
12%	O
received	B-T080
no	B-T080
adjuvant	B-T061
treatment	I-T061
.	O
	
after	O
a	O
median	B-T081
follow-up	O
of	O
28.4	O
months	B-T079
,	O
ene	B-T033
was	O
associated	B-T080
with	I-T080
worse	B-T033
3-	O
year	B-T079
os	B-T081
89.3	O
vs	O
93.6	O
p	O
=	O
01	O
.	O
	
on	O
multivariable	B-T170
analysis	I-T170
that	O
included	B-T169
involved	O
lymph	O
nodes	O
,	O
only	O
ene	B-T033
,	O
lymphovascular	B-T033
invasion	I-T033
,	O
pt3/pt4	O
tumors	O
,	O
and	O
charlson-deyo	B-T081
score	I-T081
were	O
associated	B-T080
with	I-T080
worse	B-T033
os	B-T081
.	O
	
among	O
ene	B-T033
-	O
positive	B-T033
patients	O
,	O
there	O
was	O
no	B-T033
difference	I-T033
in	O
3-	O
year	B-T079
os	B-T081
between	O
those	O
who	O
received	B-T080
adjuvant	B-T061
concurrent	I-T061
chemoradiotherapy	I-T061
versus	O
radiotherapy	B-T061
alone	I-T061
89.6	O
vs	O
89.3	O
,	O
respectively	O
p	O
=	O
55	O
.	O
	
propensity	B-T081
score	I-T081
-	O
matched	B-T081
comparison	I-T081
revealed	B-T080
similar	O
results	B-T169
.	O
	
ene	B-T033
is	O
associated	B-T080
with	I-T080
inferior	B-T082
os	B-T081
in	O
patients	O
with	O
hpv-positive	O
opscc	O
.	O
	
however	O
,	O
os	B-T081
was	O
not	B-T033
better	I-T033
with	O
adjuvant	B-T061
chemoradiotherapy	I-T061
compared	B-T052
with	O
radiotherapy	B-T061
alone	I-T061
in	O
ene	B-T033
-	O
positive	B-T033
patients	O
.	O
	
the	O
current	B-T081
findings	I-T081
support	I-T081
the	O
need	O
for	O
prospective	B-T062
studies	I-T062
of	O
adjuvant	B-T061
chemoradiation	I-T061
in	O
hpv	O
-	O
positive	B-T033
patients	O
with	O
ene	B-T033
.	O
	
psychological	O
distress	O
is	O
more	O
prevalent	O
in	O
fertile	O
age	O
and	O
premenopausal	O
women	B-T098
with	O
pcos	B-T047
symptoms	O
-15-yr	O
follow-up	O
polycystic	B-T047
ovary	I-T047
syndrome	I-T047
pcos	B-T047
is	O
associated	O
with	O
increased	O
psychological	O
distress	O
obesity	B-T047
and	O
hyperandrogenism	B-T047
being	O
suggested	O
as	O
key	O
promoters	B-T052
.	O
	
to	O
investigate	B-T169
the	O
prevalence	B-T081
of	O
anxiety	O
/	O
depression	O
and	O
their	O
coexistence	O
in	O
women	B-T098
with	O
pcos	B-T047
/	O
pcos	B-T047
symptoms	O
at	O
age	O
s	O
31	O
and	O
46	O
.	O
	
the	O
roles	O
of	O
obesity	B-T047
,	O
hyperandrogenism	B-T047
and	O
awareness	O
of	O
pcos	B-T047
on	O
psychological	O
distress	O
were	O
also	O
assessed	B-T052
.	O
	
population	B-T062
based	I-T062
follow-up	I-T062
.	O
	
northern	O
finland	O
birth	B-T081
cohort	I-T081
1966	O
with	O
15-	O
year	B-T079
follow-up	O
.	O
	
at	O
age	O
31	O
a	O
questionnaire-based	B-T062
screening	I-T062
for	O
oligoamenorrhea	O
oa	O
and	O
hirsutism	B-T047
h	B-T047
2188	O
asymptomatic	B-T033
controls	O
,	O
331	O
oa	O
,	O
323	O
h	B-T047
,	O
125	O
oa	O
+	O
h	B-T047
pcos	B-T047
.	O
	
46	O
year	B-T079
old	O
follow-up	O
1576	O
controls	O
,	O
239	O
oa	O
,	O
231	O
h	B-T047
and	O
85	O
pcos	B-T047
.	O
	
questionnaire-based	B-T062
screening	I-T062
for	O
anxiety	O
and	O
depression	O
symptoms	O
hopkins	B-T170
symptom	I-T170
checklist-25	I-T170
and	O
previously	O
diagnosed	B-T033
/	O
treated	B-T033
depression	O
at	O
age	O
31	O
and	O
46	O
.	O
	
bmi	O
,	O
serum	O
testosterone	O
/	O
free	O
androgen	O
index	O
fai	O
and	O
awareness	O
of	O
polycystic	B-T047
ovaries	I-T047
/	O
pcos	B-T047
on	O
psychological	O
distress	O
were	O
also	O
assessed	B-T052
.	O
	
population-based	B-T081
prevalence	I-T081
of	O
anxiety	O
and/or	O
depression	O
in	O
women	B-T098
with	O
pcos	B-T047
/	O
pcos	B-T047
symptoms	O
at	O
age	O
s	O
31	O
and	O
46	O
.	O
	
anxiety	O
and/or	O
depression	O
symptoms	O
,	O
their	O
coexistence	O
and	O
rate	O
of	O
depression	O
were	O
increased	O
at	O
age	O
31	O
and	O
46	O
in	O
women	B-T098
with	O
pcos	B-T047
or	O
isolated	O
h	B-T047
compared	O
with	O
controls	O
.	O
	
high	O
bmi	O
or	O
hyperandrogenism	B-T047
did	O
not	O
associate	O
with	O
increased	O
anxiety	O
or	O
depression	O
symptoms	O
.	O
	
the	O
awareness	O
of	O
pcos	B-T047
was	O
associated	O
with	O
increased	O
anxiety	O
.	O
	
women	B-T098
with	O
pcos	B-T047
or	O
isolated	O
h	B-T047
present	O
more	O
often	O
with	O
anxiety	O
and/or	O
depression	O
symptoms	O
and	O
their	O
coexistence	O
compared	O
with	O
controls	O
.	O
	
high	O
bmi	O
or	O
hyperandrogenism	B-T047
did	O
not	O
provoke	O
psychological	O
distress	O
in	O
pcos	B-T047
.	O
	
the	O
awareness	O
of	O
pcos	B-T047
increased	O
anxiety	O
but	O
did	O
not	O
associate	O
with	O
severe	O
anxiety	O
or	O
the	O
use	B-T169
of	I-T169
oxford	O
nanopore	O
native	B-T169
barcoding	B-T062
for	O
complete	B-T080
genome	O
assembly	O
the	O
oxford	O
nanopore	O
technologies	O
minion	O
is	O
a	O
mobile	B-T169
dna	O
sequencer	O
that	O
can	O
produce	O
long	O
read	O
sequences	O
with	O
a	O
short	O
turn-around	B-T079
time	I-T079
.	O
	
here	O
we	O
report	B-T170
the	O
first	O
demonstration	O
of	O
single	O
contig	O
genome	O
assembly	O
using	B-T169
oxford	O
nanopore	O
native	B-T169
barcoding	B-T062
when	O
applied	B-T169
to	O
a	O
multiplexed	O
library	O
of	O
12	O
samples	O
and	O
combined	B-T080
with	O
existing	O
illumina	O
short-read	B-T170
data	I-T170
.	O
	
this	O
paves	O
the	O
way	O
for	O
the	O
closure	B-T062
of	O
multiple	B-T081
bacterial	O
genomes	O
from	O
a	O
single	B-T081
minion	O
sequencing	O
run	B-T169
,	O
given	O
the	O
availability	B-T169
of	I-T169
existing	O
short-read	B-T170
data	I-T170
.	O
	
the	O
strain	O
we	O
used	B-T169
,	O
mho_001	O
,	O
represents	O
the	O
important	O
community-acquired	O
methicillin	O
resistant	O
staphylococcus	O
aureus	O
lineage	O
usa300	O
.	O
	
using	B-T169
a	O
hybrid	O
assembly	O
of	O
existing	O
short	B-T080
read	I-T080
and	O
barcoded	O
long	O
read	O
sequences	O
from	O
multiplexed	B-T078
data	I-T078
,	O
we	O
completed	O
a	O
genome	O
of	O
the	O
s	O
.	O
	
aureus	O
usa300	O
strain	O
mho_001	O
.	O
	
the	O
long-read	B-T170
data	I-T170
represented	O
only	O
5-10%	O
of	O
an	O
average	B-T081
minion	O
run	B-T169
7x	O
genomic	O
coverage	B-T169
,	O
but	O
,	O
using	B-T169
standard	B-T081
tools	B-T170
,	O
this	O
was	O
sufficient	B-T080
to	O
complete	B-T080
the	O
circular	O
chromosome	O
of	O
s	O
.	O
	
aureus	O
strain	O
mho_001	O
2.86	O
mb	O
and	O
two	O
complete	B-T080
plasmids	O
27	O
kb	O
and	O
3	O
kb	O
.	O
	
minor	B-T080
differences	B-T080
were	O
noted	B-T080
when	O
compared	B-T052
to	O
usa300	O
reference	O
genome	O
,	O
usa300_fpr3757	O
,	O
including	B-T169
the	O
translocation	O
,	O
loss	B-T081
and	O
gain	B-T081
of	O
mobile	O
genetic	O
elements	O
.	O
	
here	O
we	O
demonstrate	O
that	O
minion	O
reads	B-T169
,	O
multiplexed	B-T169
using	B-T169
native	B-T169
barcoding	B-T062
,	O
can	O
be	O
used	B-T169
in	O
combination	B-T080
with	O
short-read	B-T170
data	I-T170
,	O
to	O
fully	O
complete	B-T080
a	O
bacterial	O
genome	O
.	O
	
the	O
ability	O
to	O
complete	B-T080
multiple	B-T081
genomes	O
,	O
for	O
which	O
short-read	B-T170
data	I-T170
is	O
already	O
available	B-T033
,	O
from	O
a	O
single	B-T081
minion	O
run	B-T169
is	O
set	O
to	O
impact	B-T080
on	O
our	O
understanding	O
of	O
accessory	B-T081
genome	O
content	O
,	O
plasmid	O
diversity	B-T080
and	O
genome	O
rearrangements	O
.	O
	
doxorubicin	B-T109
has	O
dose-dependent	B-T081
toxicity	O
on	O
mouse	O
ovarian	O
follicle	O
development	O
,	O
hormone	O
secretion	O
,	O
and	O
oocyte	O
maturation	O
doxorubicin	B-T109
dox	B-T109
,	O
one	O
of	O
the	O
most	O
commonly	B-T081
used	O
anticancer	B-T109
medications	I-T109
,	O
has	O
been	O
reported	O
to	O
affect	O
fertility	O
by	O
damaging	B-T169
ovarian	O
follicles	O
however	O
,	O
the	O
dose-dependent	B-T081
toxicity	O
of	O
dox	B-T109
on	O
the	O
dynamic	B-T169
follicle	O
development	O
and	O
oocyte	O
maturation	O
has	O
not	O
been	O
well-defined	O
.	O
	
our	O
objective	B-T170
is	O
to	O
determine	O
the	O
effects	B-T080
of	I-T080
human	O
-	O
relevant	B-T080
exposure	B-T080
levels	B-T080
of	O
dox	B-T109
on	O
follicular	O
functions	B-T169
across	O
developmental	O
time	B-T079
.	O
	
in	B-T080
vitro	I-T080
cultured	O
multilayered	O
secondary	O
mouse	O
follicles	O
were	O
treated	B-T169
with	O
dox	B-T109
at	O
0	O
,	O
2	O
,	O
20	O
,	O
100	O
,	O
and	O
200	O
nm	O
for	O
24	O
h	O
,	O
and	O
follicle	O
development	O
,	O
hormone	O
secretion	O
,	O
and	O
oocyte	O
maturation	O
were	O
analyzed	O
.	O
	
dox	B-T109
caused	O
dose-dependent	B-T081
toxicity	O
on	O
follicle	O
growth	O
,	O
survival	B-T169
,	O
and	O
secretion	O
of	O
17β-estradiol	B-T109
e2	B-T109
.	O
	
at	O
200	O
nm	O
,	O
dox	B-T109
induced	B-T169
dna	O
damage	O
and	O
apoptosis	O
in	O
follicle	O
somatic	O
cells	O
first	O
and	O
then	O
in	O
oocytes	O
,	O
which	O
was	O
correlated	O
with	O
the	O
uptake	O
of	O
dox	B-T109
first	O
to	O
the	O
somatic	O
cells	O
followed	O
by	O
germ	O
cells	O
.	O
	
follicles	O
treated	B-T169
with	O
dox	B-T109
at	O
0	O
,	O
2	O
,	O
and	O
20	O
nm	O
showed	O
similar	O
oocyte	O
metaphase	O
ii	O
mii	O
percentages	B-T081
after	O
in	B-T080
vitro	I-T080
oocyte	O
maturation	O
however	O
,	O
20	O
nm	O
dox	B-T109
significantly	O
increased	B-T081
the	O
number	O
of	O
mii	O
oocytes	O
with	O
abnormal	B-T033
spindle	O
morphology	B-T080
and	O
chromosome	O
misalignment	B-T080
.	O
	
in	O
an	O
effort	O
to	O
harmonize	O
the	O
in	B-T062
vitro	I-T062
study	I-T062
to	O
in	B-T082
vivo	I-T082
treatment	B-T169
,	O
dose-dependent	B-T081
toxicity	O
on	O
oocyte	O
meiotic	O
maturation	O
was	O
found	O
in	O
16-day-old	O
cd-1	O
mice	O
treated	B-T169
with	O
dox	B-T109
at	O
0	O
,	O
0.4	O
,	O
2	O
,	O
and	O
10	O
mg/kg	O
,	O
consistent	B-T078
with	I-T078
the	O
in	B-T080
vitro	I-T080
oocyte	O
maturation	O
outcomes	B-T169
.	O
	
our	O
study	B-T062
demonstrates	O
that	O
dox	B-T109
has	O
dose-dependent	B-T081
toxicity	O
on	O
ovarian	O
follicle	O
development	O
,	O
hormone	O
secretion	O
,	O
and	O
oocyte	O
maturation	O
,	O
which	O
are	O
three	O
key	O
factors	B-T169
to	O
support	O
the	O
female	O
reproductive	O
and	O
endocrine	O
functions	O
.	O
	
involvement	O
of	O
apoptotic	O
pathways	O
in	O
docosahexaenoic	B-T109
acid	I-T109
-induced	O
benefit	O
in	O
prostate	O
cancer	O
pathway-focused	O
gene	O
expression	O
analysis	O
using	O
rt	O
profile	O
pcr	O
array	O
system	O
present	O
study	O
aimed	O
to	O
better	O
understand	O
the	O
potential	O
apoptotic	O
pathways	O
that	O
involved	O
in	O
docosahexaenoic	B-T109
acid	I-T109
dha	B-T109
apoptosis	O
of	O
prostate	O
cancer	O
cells	O
.	O
	
human	O
prostate	O
cancer	O
du145	O
cells	O
were	O
treated	O
with	O
different	O
concentrations	O
of	O
fish	B-T109
oil	I-T109
,	O
omega-3	B-T109
pufa	I-T109
dha	B-T109
,	O
and	O
eicosapentaenoic	B-T109
acid	I-T109
,	O
epa	B-T109
,	O
or	O
omega-6	B-T109
pufa	I-T109
arachidonic	B-T109
acid	I-T109
,	O
aa	B-T109
.	O
	
cell	O
viability	O
and	O
apoptosis	O
were	O
evaluated	O
by	O
mtt	B-T062
assay	I-T062
and	O
hoechst	O
staining	O
.	O
	
pathway-focused	O
gene	O
expression	O
profiling	O
of	O
du145	O
cells	O
was	O
analyzed	O
with	O
the	O
rt	O
profile	O
pcr	O
array	O
system	O
.	O
	
the	O
results	O
were	O
verified	O
by	O
real	O
time	O
quantitative	O
polymerase	O
chain	O
reaction	O
rt-qpcr	O
.	O
	
aa	B-T109
exposure	O
showed	O
no	O
obvious	O
effect	O
on	O
viability	O
of	O
du145	O
cells	O
.	O
	
however	O
,	O
exposure	O
with	O
fish	B-T109
oil	I-T109
,	O
epa	B-T109
,	O
or	O
dha	B-T109
for	O
24	O
h	O
significantly	O
affected	O
cell	O
viability	O
.	O
	
the	O
growth	O
inhibition	O
of	O
dha	B-T109
was	O
more	O
pronounced	O
than	O
that	O
of	O
epa	B-T109
and	O
showed	O
a	O
time-dependent	O
increase	O
.	O
	
dha	B-T109
exposure	O
caused	O
typical	O
apoptotic	B-T080
characteristics	O
.	O
	
ten	O
genes	O
were	O
more	O
expressed	O
,	O
while	O
5	O
genes	O
were	O
less	O
expressed	O
following	O
dha	B-T109
exposure	O
.	O
	
rt-qpcr	O
confirmed	O
the	O
time	O
dependent	O
effect	O
of	O
dha	B-T109
on	O
the	O
expression	O
of	O
these	O
differentially	O
expressed	O
genes	O
.	O
	
kegg	O
pathway	O
analysis	O
showed	O
that	O
dha	B-T109
may	O
induce	O
the	O
apoptosis	O
of	O
cancer	O
cells	O
preferentially	O
through	O
mediating	O
p53	O
,	O
mapk	O
,	O
tnf	O
,	O
pi3k/akt	B-T169
,	O
and	O
nf-κb	O
signaling	O
pathways	O
.	O
	
our	O
study	O
demonstrated	O
the	O
beneficial	O
action	O
of	O
dha	B-T109
on	O
human	O
prostate	O
carcinoma	O
cell	O
line	O
du145	O
.	O
	
the	O
pro-apoptotic	O
effect	O
of	O
dha	B-T109
on	O
du145	O
cells	O
may	O
involve	O
mediation	O
various	O
pathways	O
,	O
especially	O
p53	O
,	O
mapk	O
,	O
tnf	O
,	O
pi3k/akt	B-T169
,	O
and	O
nf-κb	O
signaling	O
pathways	O
.	O
	
molecular	O
mechanisms	O
of	O
dha	B-T109
on	O
apoptosis	O
of	O
cancer	O
cells	O
medication	O
reconciliation	O
during	O
hospitalization	O
and	O
in	O
hospital-home	O
interface	O
an	O
observational	B-T062
retrospective	I-T062
study	I-T062
medication	B-T080
errors	I-T080
are	O
one	O
of	O
the	O
leading	O
causes	O
of	O
patient	B-T080
harms	I-T080
.	O
	
medication	O
reconciliation	O
is	O
a	O
fundamental	O
process	O
that	O
to	O
be	O
effective	O
,	O
it	O
should	O
be	O
embraced	O
during	O
each	O
single	O
care	O
transition	O
.	O
	
our	O
objectives	O
were	O
to	O
investigate	B-T169
current	O
medication	O
reconciliation	O
practices	O
in	O
the	O
2	O
fondazione	O
toscana	O
gabriele	O
monasterio	O
hospitals	O
and	O
comprehensively	O
assess	B-T080
the	I-T080
quality	I-T080
of	O
medication	O
reconciliation	O
practices	O
between	O
inpatient	O
and	O
outpatient	O
care	B-T052
by	O
analyzing	B-T062
the	O
medication	O
patterns	O
6	O
months	B-T079
before	O
admission	O
,	O
during	O
hospitalization	O
,	O
and	O
9	O
months	B-T079
after	O
discharge	O
for	O
a	O
selected	O
group	O
of	O
patients	O
with	O
cardiovascular	B-T047
diseases	I-T047
.	O
	
a	O
retrospective	B-T062
observational	I-T062
study	I-T062
was	O
conducted	O
in	O
the	O
cardiothoracic	O
department	O
of	O
the	O
fondazione	O
toscana	O
gabriele	O
monasterio	O
hospitals	O
.	O
	
medication	B-T170
history	I-T170
was	O
reviewed	B-T080
for	O
all	O
the	O
patients	O
admitted	O
from	O
and	O
discharged	O
to	O
the	O
community	O
,	O
from	O
january	O
to	O
march	O
2013	O
.	O
	
patients	O
were	O
excluded	O
if	O
they	O
had	O
less	O
than	O
4	O
drugs	B-T061
or	O
less	O
than	O
2	O
drugs	B-T061
for	O
cardiovascular	O
system	O
in	O
their	O
prescription	B-T170
list	I-T170
at	O
admission	O
or	O
if	O
they	O
died	B-T033
during	O
follow-up	O
.	O
	
we	O
selected	O
714	O
patients	O
,	O
and	O
we	O
obtained	O
the	O
clinical	B-T170
charts	I-T170
and	O
all	O
drug	B-T170
prescriptions	I-T170
collected	O
during	O
patients	O
'	O
hospitalization	O
by	O
the	O
electronic	B-T170
clinical	I-T170
recording	I-T170
system	I-T170
.	O
	
we	O
also	O
analyzed	B-T062
the	O
list	B-T170
of	I-T170
prescriptions	I-T170
of	O
this	O
sample	O
of	O
patients	O
,	O
from	O
6	O
months	B-T079
before	O
admission	O
to	O
9	O
months	B-T079
after	O
discharge	O
,	O
extracted	O
from	O
the	O
regional	B-T170
prescription	I-T170
registry	I-T170
.	O
	
in	O
the	O
resulting	O
sample	O
,	O
prescriptions	B-T170
were	O
analyzed	B-T062
to	O
assess	O
unintentional	B-T169
discrepancies	B-T033
.	O
	
the	O
study	B-T062
included	O
298	O
patients	O
mean	O
age	O
,	O
71.2	O
years	B-T079
,	O
according	O
to	O
the	O
inclusion	B-T078
and	I-T078
exclusion	I-T078
criteria	I-T078
.	O
	
among	O
14	O
prescriptions	B-T170
analyzed	B-T062
,	O
we	O
found	O
4363	O
discrepancies	B-T033
14.6	O
discrepancies	B-T033
per	O
patient	O
.	O
	
among	O
these	O
discrepancies	B-T033
,	O
1310	O
were	O
classified	O
as	O
unintentional	B-T169
4.4	O
discrepancies	B-T033
per	O
patient	O
.	O
	
among	O
unintentional	B-T169
discrepancies	B-T033
,	O
only	O
63	O
4.8	O
took	O
place	O
during	O
hospitalization	O
.	O
	
although	O
at	O
the	O
hospital-home	O
interface	O
,	O
33.1	O
of	O
unintentional	B-T169
discrepancies	B-T033
were	O
detected	O
through	O
the	O
comparison	B-T052
between	O
the	O
patients	O
'	O
declared	O
therapy	B-T169
and	O
the	O
previous	O
medication	O
consumption	O
and	O
62.1	O
were	O
identified	O
in	O
the	O
comparison	B-T052
between	O
the	O
prescription	B-T170
at	O
the	O
discharge	O
and	O
the	O
following	O
medication	O
pattern	O
at	O
home	B-T082
.	O
	
medication	B-T080
errors	I-T080
have	O
important	O
implications	O
for	O
patient	O
safety	O
,	O
and	O
their	O
identification	O
is	O
a	O
main	O
target	O
for	O
improving	O
clinical	O
practice	O
.	O
	
the	O
comparison	B-T052
between	O
the	O
medication	O
patterns	O
acquired	O
through	O
the	O
regional	B-T170
prescription	I-T170
registry	I-T170
before	O
and	O
after	O
hospitalization	O
outlined	O
critical	O
touchpoint	O
in	O
the	O
current	O
medication	O
reconciliation	O
process	O
,	O
calling	O
for	O
the	O
definition	O
of	O
shared	O
medication	O
reconciliation	O
standards	O
between	O
hospitals	O
and	O
primary	O
care	O
services	O
to	O
minimize	O
medication	B-T080
discrepancies	I-T080
and	O
enhance	O
patient	O
safety	O
.	O
	
autologous	O
vs	O
irradiated	O
homologous	O
costal	O
cartilage	O
as	O
graft	O
material	O
in	O
rhinoplasty	B-T061
studies	O
comparing	O
surgical	O
results	O
of	O
rhinoplasty	B-T061
using	O
autologous	O
costal	O
cartilage	O
acc	O
and	O
irradiated	O
homologous	O
costal	O
cartilage	O
ihcc	O
are	O
rare	O
.	O
	
to	O
compare	O
the	O
clinical	O
results	O
of	O
major	O
augmentation	B-T061
rhinoplasty	I-T061
using	O
acc	O
vs	O
ihcc	O
and	O
analyze	O
the	O
histologic	B-T169
properties	I-T169
of	O
both	O
types	O
of	O
cartilage	O
.	O
	
a	O
retrospective	B-T062
clinical	I-T062
study	I-T062
was	O
conducted	O
among	O
patients	O
who	O
had	O
undergone	O
rhinoseptoplasty	B-T061
using	O
acc	O
or	O
ihcc	O
from	O
january	O
1	O
,	O
2009	O
,	O
to	O
december	O
31	O
,	O
2014	O
.	O
	
patients	O
were	O
followed	O
up	O
for	O
more	O
than	O
1	O
year	O
after	O
surgery	B-T061
and	O
the	O
histologic	B-T169
characteristics	I-T169
of	O
acc	O
and	O
ihcc	O
were	O
compared	B-T052
.	O
	
the	O
details	O
of	O
the	O
surgical	B-T061
procedures	I-T061
and	O
complications	B-T033
,	O
including	O
warping	B-T033
,	O
infection	O
,	O
resorption	O
,	O
and/or	O
donor-site	O
morbidity	B-T081
,	O
were	O
evaluated	O
by	O
reviewing	O
medical	B-T170
records	I-T170
and	O
facial	O
photographs	O
.	O
	
patients	O
'	O
subjective	B-T080
satisfaction	O
with	O
aesthetic	O
and	O
functional	B-T169
results	B-T169
was	O
evaluated	O
using	O
a	O
questionnaire	B-T170
.	O
	
the	O
details	O
of	O
the	O
surgical	B-T061
procedures	I-T061
and	O
complications	B-T033
,	O
including	O
warping	B-T033
,	O
infection	O
,	O
resorption	O
,	O
and/or	O
donor-site	O
morbidity	B-T081
patients	O
'	O
subjective	B-T080
satisfaction	O
with	O
aesthetic	O
and	O
functional	B-T169
results	B-T169
'	O
objective	B-T080
evaluation	O
of	O
surgical	B-T061
outcomes	B-T169
,	O
including	O
symmetry	O
,	O
dorsal	B-T082
height	O
,	O
dorsal	B-T082
length	B-T081
,	O
dorsal	B-T082
width	B-T081
,	O
tip	B-T033
projection	I-T033
,	O
tip	B-T033
rotation	I-T033
,	O
tip	B-T033
width	I-T033
,	O
and	O
overall	B-T080
result	B-T169
and	O
histologic	B-T169
structures	B-T082
.	O
	
objective	B-T080
evaluation	O
of	O
surgical	B-T061
outcomes	B-T169
was	O
graded	O
using	O
the	O
objective	B-T080
rhinoplasty	B-T061
outcome	B-T033
score	I-T033
,	O
which	O
assessed	O
symmetry	O
,	O
dorsal	B-T082
height	O
,	O
dorsal	B-T082
length	B-T081
,	O
dorsal	B-T082
width	B-T081
,	O
tip	B-T033
projection	I-T033
,	O
tip	B-T033
rotation	I-T033
,	O
tip	B-T033
width	I-T033
,	O
and	O
overall	B-T080
result	B-T169
.	O
	
histologic	B-T169
structures	I-T169
were	O
evaluated	O
using	O
hematoxylin	O
and	O
eosin	O
,	O
masson	O
trichrome	O
,	O
alcian	O
blue	O
,	O
and	O
verhoeff	O
elastic	O
stains	O
.	O
	
a	O
total	O
of	O
63	O
patients	O
27	O
males	O
and	O
36	O
females	O
mean	O
sd	O
age	O
,	O
30.6	O
9.5	O
years	O
had	O
rhinoseptoplasty	B-T061
using	O
acc	O
and	O
20	O
9	O
males	O
and	O
11	O
females	O
mean	O
sd	O
age	O
,	O
35.4	O
15.4	O
years	O
had	O
rhinoseptoplasty	B-T061
using	O
ihcc	O
.	O
	
among	O
observed	B-T169
complications	B-T033
,	O
only	O
notable	B-T080
resorption	O
occurred	B-T052
more	O
frequently	B-T079
in	O
patients	O
using	O
ihcc	O
6	O
30%	O
than	O
with	O
acc	O
2	O
3%	O
p	O
=	O
002	O
.	O
	
in	O
subjective	B-T080
evaluations	O
of	O
aesthetic	O
satisfaction	O
,	O
patients	O
who	O
received	B-T080
acc	O
showed	O
significantly	B-T078
greater	B-T081
satisfaction	O
37	O
of	O
51	O
patients	O
73%	O
were	O
very	B-T033
satisfied	I-T033
than	O
did	O
those	O
who	O
received	B-T080
ihcc	O
6	O
of	O
20	O
30%	O
p	O
=	O
001	O
.	O
	
however	O
,	O
there	O
was	O
no	O
between-group	O
difference	O
in	O
subjective	B-T080
functional	B-T169
outcomes	B-T169
4	O
of	O
51	O
patients	O
receiving	B-T080
acc	O
8%	O
and	O
5	O
of	O
20	O
receiving	B-T080
ihcc	O
25%	O
were	O
satisfied	O
p	O
=	O
50	O
and	O
45	O
of	O
51	O
receiving	B-T080
acc	O
88%	O
and	O
15	O
of	O
20	O
receiving	B-T080
ihcc	O
75%	O
were	O
very	B-T033
satisfied	I-T033
p	O
=	O
15	O
.	O
	
regarding	O
objective	B-T080
aesthetic	O
outcomes	B-T169
,	O
all	O
scores	B-T081
for	O
both	O
acc	O
and	O
ihcc	O
were	O
more	O
than	O
3.1	O
between	O
good	B-T080
and	O
excellent	B-T080
.	O
	
histologic	O
analyses	O
showed	O
larger	B-T081
,	O
more	O
evenly	O
distributed	O
,	O
uniform	B-T080
chondrocytes	O
and	O
more	O
collagens	B-T116
and	O
proteoglycan	B-T116
contents	B-T078
in	O
acc	O
than	O
in	O
ihcc	O
.	O
	
compared	B-T052
with	O
patients	O
receiving	B-T080
ihcc	O
,	O
those	O
receiving	B-T080
acc	O
for	O
rhinoseptoplasty	B-T061
showed	O
superior	B-T080
aesthetic	O
satisfaction	O
acc	O
also	O
had	O
less	B-T080
frequent	B-T079
notable	B-T080
resorption	O
.	O
	
autologous	O
costal	O
cartilage	O
also	O
had	O
better	B-T080
histologic	B-T169
properties	I-T169
than	O
ihcc	O
did	O
,	O
suggesting	O
it	O
as	O
an	O
ideal	B-T080
graft	O
material	O
with	O
less	B-T080
chance	B-T080
of	O
long-term	B-T079
resorption	O
.	O
	
testing	O
the	O
ret	O
and	O
sema3d	O
genetic	O
interaction	O
in	O
mouse	O
enteric	O
nervous	O
system	O
development	O
for	O
most	O
multigenic	B-T047
disorders	I-T047
,	O
clinical	B-T080
manifestation	I-T080
penetrance	B-T081
and	O
presentation	B-T078
expressivity	B-T078
are	O
likely	O
to	O
be	O
an	O
outcome	B-T169
of	O
genetic	O
interaction	O
between	O
multiple	O
susceptibility	O
genes	O
.	O
	
here	O
,	O
using	O
gene	O
knockouts	O
in	O
mice	O
we	O
evaluated	O
genetic	O
interaction	O
between	O
loss	O
of	O
ret	O
and	O
loss	O
of	O
sema3d	O
,	O
two	O
hirschsprung	O
disease	O
susceptibility	O
genes	O
.	O
	
we	O
intercrossed	O
ret	O
and	O
sema3d	O
double	O
null	O
heterozygotes	O
to	O
generate	B-T169
mice	I-T169
with	O
the	O
nine	O
possible	O
genotypes	O
and	O
assessed	B-T052
survival	I-T052
by	O
counting	O
various	O
genotypes	O
,	O
myenteric	O
plexus	O
presence	O
by	O
acetylcholinesterase	O
staining	O
and	O
embryonic	O
day	O
12.5	O
e12.5	O
intestine	O
transcriptome	O
by	O
rna-sequencing	O
.	O
	
survival	B-T081
rates	I-T081
of	O
ret	O
wildtype	O
,	O
null	O
heterozygote	O
and	O
null	O
homozygote	O
mice	O
at	O
e12.5	O
,	O
birth	O
and	O
weaning	B-T033
were	O
not	O
influenced	O
by	O
the	O
genotypes	O
at	O
sema3d	O
locus	B-T082
and	O
vice-versa	O
.	O
	
loss	O
of	O
myenteric	O
plexus	O
was	O
observed	O
only	O
in	O
all	O
ret	O
null	O
homozygotes	O
,	O
irrespective	O
of	O
the	O
genotypes	O
at	O
sema3d	O
locus	B-T082
,	O
and	O
sema3d	O
null	O
heterozygote	O
and	O
homozygote	O
mice	O
had	O
normal	O
intestinal	B-T080
innervation	I-T080
.	O
	
as	O
compared	O
to	O
wildtype	O
mice	O
intestinal	O
gene	O
expression	O
,	O
loss	O
of	O
ret	O
in	O
null	O
homozygotes	O
led	O
to	O
differential	O
expression	O
of	O
300	O
genes	O
,	O
whereas	O
loss	O
of	O
sema3d	O
in	O
null	O
homozygotes	O
had	O
no	B-T080
major	O
consequence	O
and	O
there	O
was	O
no	O
evidence	I-T080
supporting	O
major	O
interaction	O
between	O
the	O
two	O
genes	O
influencing	O
intestine	O
transcriptome	O
.	O
	
overall	O
,	O
given	O
the	O
null	O
alleles	O
and	O
phenotypic	O
assays	O
used	O
,	O
we	O
did	O
not	B-T080
find	I-T080
evidence	I-T080
for	O
genetic	O
interaction	O
between	O
ret	O
and	O
sema3d	O
affecting	O
survival	O
,	O
presence	O
of	O
myenteric	O
plexus	O
or	O
intestine	O
transcriptome	O
.	O
	
pembrolizumab	B-T116
for	O
the	O
treatment	B-T061
of	O
non-small	O
cell	O
lung	O
cancer	O
in	O
the	O
last	O
years	O
,	O
a	O
spectacular	O
development	B-T169
of	O
immunotherapeutic	O
agents	O
aimed	O
at	O
the	O
pd-1	B-T116
/	O
pd-l1	O
axis	O
has	O
taken	O
place	O
.	O
	
this	O
development	B-T169
of	O
these	O
checkpoint	O
inhibitors	O
has	O
greatly	O
influenced	O
our	O
approach	O
to	O
the	O
treatment	B-T061
of	O
lung	O
cancer	O
in	O
first	B-T061
and	O
second	B-T061
line	I-T061
.	O
	
the	O
limited	B-T169
toxicity	O
profile	O
and	O
the	O
ability	O
to	O
treat	B-T061
for	O
prolonged	B-T079
periods	B-T079
,	O
even	O
in	O
smokers	B-T033
,	O
is	O
a	O
welcome	O
expansion	O
of	O
the	O
therapeutic	O
arsenal	O
of	O
the	O
oncologist	O
.	O
	
areas	O
covered	O
this	O
review	B-T170
highlights	O
the	O
results	B-T169
of	O
recent	O
clinical	B-T062
trials	I-T062
on	O
pembrolizumab	B-T116
for	O
the	O
treatment	B-T061
of	O
non-small	O
cell	O
lung	O
cancer	O
.	O
	
the	O
authors	O
discuss	O
both	O
first	B-T061
and	O
second	B-T061
line	I-T061
treatment	I-T061
with	O
pembrolizumab	B-T116
as	O
monotherapy	B-T061
and	O
in	O
combination	B-T061
therapies	I-T061
.	O
	
additionally	O
,	O
implications	O
of	O
the	O
pd-l1	O
immunohistochemistry	O
assay	O
with	O
the	O
22c3	B-T116
antibody	I-T116
and	O
its	O
use	B-T169
in	O
clinical	B-T062
practice	I-T062
and	O
trials	B-T062
is	O
discussed	O
.	O
	
expert	O
commentary	O
a	O
higher	B-T080
overall	B-T033
response	I-T033
,	O
overall	B-T081
survival	I-T081
and	O
a	O
moderate	B-T080
toxicity	O
profile	O
is	O
observed	O
with	O
the	O
use	B-T169
of	O
pembrolizumab	B-T116
,	O
compared	O
to	O
chemotherapy	B-T061
,	O
in	O
both	O
first	B-T061
and	O
second	B-T061
line	I-T061
.	O
	
these	O
promising	O
results	B-T169
have	O
already	O
translated	O
into	O
the	O
registration	O
of	O
pembrolizumab	B-T116
in	O
first	B-T061
and	O
second	B-T061
line	I-T061
in	O
patients	O
with	O
a	O
high	B-T080
expression	O
of	O
pd-l1	O
.	O
	
however	O
,	O
as	O
pd-l1	O
staining	O
does	O
not	O
sufficiently	O
discriminate	O
responders	B-T033
from	O
non-responders	B-T033
for	O
all	O
checkpoint	O
inhibitors	O
,	O
there	O
still	O
is	O
a	O
need	O
for	O
a	O
better	O
predictive	B-T080
biomarker	O
.	O
	
synchronisms	B-T079
between	O
bud	O
and	O
cambium	O
phenology	B-T080
in	O
black	O
spruce	O
early	B-T079
-	O
flushing	B-T052
provenances	O
exhibit	O
early	B-T079
xylem	O
formation	B-T169
bud	O
and	O
cambial	O
phenology	B-T080
represent	B-T052
the	O
adaptation	O
of	O
species	O
to	O
the	O
local	B-T082
environment	B-T082
that	O
allows	O
the	O
growing	B-T079
season	I-T079
to	O
be	O
maximized	B-T169
while	O
minimizing	B-T080
the	O
risk	B-T078
of	O
frost	O
for	O
the	O
developing	B-T169
tissues	O
.	O
	
the	O
temporal	B-T079
relationship	B-T080
between	O
the	O
apical	B-T082
and	O
radial	O
meristems	O
can	O
help	O
in	O
the	O
understanding	O
of	O
tree	O
growth	O
as	O
a	O
whole	O
process	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
cambial	O
phenology	O
in	O
black	O
spruce	O
picea	O
mariana	O
mill	O
b.s	O
provenances	O
classified	O
as	O
early	O
and	O
late	O
bud	O
flushing	O
.	O
	
the	O
different	O
phases	O
of	O
cambial	O
phenology	O
were	O
assessed	O
on	O
wood	O
microcores	O
sampled	O
weekly	O
from	O
april	O
to	O
october	O
in	O
2014	O
and	O
2015	O
from	O
61	O
trees	O
growing	O
in	O
a	O
provenance	O
trial	O
in	O
quebec	O
,	O
canada	O
.	O
	
trees	O
showing	O
an	O
early	O
bud	O
flush	O
also	O
exhibited	O
early	O
reactivation	O
of	O
xylem	O
differentiation	O
,	O
although	O
an	O
average	O
difference	O
of	O
12	O
days	O
for	O
buds	O
corresponded	O
to	O
small	O
although	O
significant	O
differences	O
of	O
4	O
days	O
for	O
xylem	O
.	O
	
provenances	O
with	O
early	O
bud	O
flush	O
had	O
an	O
early	O
bud	O
set	O
and	O
completed	O
xylem	O
formation	O
earlier	O
than	O
late	O
bud	O
flush	O
provenances	O
.	O
	
no	O
significant	O
difference	O
in	O
the	O
period	O
of	O
xylem	O
formation	O
and	O
total	O
growth	O
was	O
observed	O
between	O
the	O
flushing	O
classes	O
.	O
	
our	O
results	O
demonstrate	O
that	O
the	O
ecotype	O
differentiation	O
of	O
black	O
spruce	O
provenances	O
represented	O
by	O
the	O
phenological	O
adaptation	O
of	O
buds	O
to	O
the	O
local	O
climate	O
corresponds	O
to	O
specific	O
growth	O
dynamics	O
of	O
the	O
xylem	O
an	O
approach	O
for	O
liposome	B-T109
immobilization	B-T061
using	O
sterically	B-T080
stabilized	I-T080
micelles	B-T109
ssms	B-T109
as	O
a	O
precursor	B-T078
for	O
bio-layer	O
interferometry	O
-	O
based	B-T169
interaction	B-T169
studies	B-T062
non-fluidic	B-T080
bio-layer	O
interferometry	O
bli	O
has	O
rapidly	B-T080
become	O
a	O
standard	B-T080
tool	O
for	O
monitoring	O
almost	O
all	O
biomolecular	B-T080
interactions	B-T169
in	O
a	O
label-free	B-T080
,	O
real-time	B-T079
and	O
high-throughput	B-T080
manner	O
.	O
	
high	B-T080
-	O
efficiency	B-T081
screening	O
methods	O
which	O
measure	B-T081
the	O
kinetics	O
of	O
liposomes	B-T109
with	O
a	O
variety	O
of	O
compounds	O
require	O
the	O
immobilization	B-T061
of	O
liposomes	B-T109
.	O
	
in	O
this	O
work	O
,	O
a	O
method	B-T169
is	O
described	B-T078
for	O
immobilizing	B-T061
liposomes	B-T109
for	O
interaction	B-T169
studies	B-T062
,	O
based	B-T169
on	O
the	O
biophysical	O
principles	O
of	O
this	O
biosensor	O
platform	O
.	O
	
the	O
immobilization	B-T061
approach	O
includes	B-T169
the	O
loading	B-T052
of	O
dspe-peg	B-T109
-	O
biotin	B-T109
containing	O
sterically	B-T080
stabilized	I-T080
micelles	B-T109
ssms	B-T109
which	O
are	O
restructured	B-T080
in	O
a	O
buffer	B-T080
change	I-T080
step	O
,	O
resulting	B-T169
in	I-T169
an	O
accessible	O
substrate	O
for	O
liposome	B-T109
immobilization	B-T061
.	O
	
liposomes	B-T109
in	O
a	O
concentration	B-T081
of	O
5mm	O
of	O
varying	O
composition	O
and	O
fluidity	B-T081
were	O
immobilized	B-T061
on	O
the	O
sensor	O
surface	B-T082
by	O
inserting	O
the	O
hydrophobic	B-T080
residues	O
of	O
the	O
former	B-T079
loaded	O
ssms	B-T109
.	O
	
this	O
proof	O
of	O
principle	O
was	O
carried	O
out	O
using	O
cytochrome	B-T116
c	I-T116
as	O
a	O
membrane-interacting	B-T080
model	O
protein	B-T116
.	O
	
the	O
binding	O
of	O
cytochrome	B-T116
c	I-T116
to	O
the	O
immobilized	B-T061
liposomes	B-T109
was	O
demonstrated	O
,	O
and	O
the	O
derived	O
kinetic	O
and	O
affinity	O
constants	B-T081
were	O
similar	B-T080
to	O
values	B-T080
given	O
in	O
the	O
literature	B-T170
.	O
	
in	O
order	O
to	O
obtain	O
a	O
detailed	B-T080
understanding	O
of	O
this	O
surface	B-T082
,	O
and	O
to	O
show	O
the	O
integrity	B-T080
of	O
the	O
liposomes	B-T109
,	O
confocal	O
fluorescence	O
microscopy	O
was	O
used	O
.	O
	
images	O
of	O
immobilized	B-T061
liposomes	B-T109
containing	B-T169
calcein	B-T109
in	O
the	O
aqueous	B-T080
core	B-T082
indicated	B-T033
intact	B-T080
vesicles	O
.	O
	
a	O
combination	B-T080
of	O
this	O
simple	O
liposome	B-T109
immobilization	B-T061
approach	O
,	O
the	O
possibility	O
of	O
automation	O
on	O
bli	O
systems	B-T169
with	O
high	B-T080
throughput	I-T080
within	O
an	O
acceptable	B-T080
timescale	O
and	O
excellent	B-T080
reproducibility	B-T080
makes	O
this	O
assay	O
suitable	B-T080
for	O
basic	O
research	B-T062
as	O
well	O
as	O
for	O
industrial	B-T169
and	O
regulatory	B-T170
applications	I-T170
.	O
	
exercise	O
increases	B-T081
lactoferrin	B-T116
,	O
but	O
decreases	B-T081
lysozyme	B-T116
in	O
salivary	B-T082
granulocytes	O
intracellular	B-T116
lactoferrin	I-T116
lac	B-T116
and	O
lysozyme	B-T116
lys	B-T116
content	O
play	O
an	O
important	O
role	O
in	O
regulating	O
inflammation	O
and	O
promoting	B-T052
host	O
protection	O
.	O
	
while	O
exercise	O
has	O
demonstrated	O
an	O
increase	B-T081
in	O
lac	B-T116
and	O
lys	B-T116
concentration	B-T081
in	O
exocrine	O
solutions	O
,	O
little	O
is	O
known	O
regarding	O
intracellular	B-T081
concentration	I-T081
changes	I-T081
in	O
response	O
to	O
exercise	O
.	O
	
to	O
quantify	B-T081
intracellular	O
lac	B-T116
and	O
lys	B-T116
concentration	B-T081
before	O
and	O
after	O
exercise	O
in	O
salivary	B-T082
cd45	O
cells	O
.	O
	
11	O
males	O
20.3	O
0.8	O
years	B-T079
,	O
57.2	O
7.6	O
ml/kg/min	O
v	B-T081
,	O
11.1	O
3.9	O
body	O
fat	O
ran	O
for	O
45	O
min	B-T079
at	O
75%	O
of	O
vo2pk	B-T081
.	O
	
12	O
ml	O
of	O
stimulated	O
saliva	O
were	O
collected	B-T169
pre	B-T079
and	O
immediately	O
post	B-T079
exercise	I-T079
.	O
	
saliva	O
was	O
filtered	O
through	O
a	O
30-µm	O
filter	O
before	O
analysis	O
of	O
leukocytes	O
cd45	O
and	O
granulocytes	O
cd45	O
using	O
flow	O
cytometry	O
.	O
	
median	B-T081
fluorescent	I-T081
intensity	I-T081
mfi	B-T081
of	O
lac	B-T116
increased	B-T081
from	O
pre	B-T079
64	O
46	O
mfi	B-T081
to	O
post	B-T079
117	O
88	O
mfi	B-T081
exercise	O
p	O
<0	O
.	O
	
lys	B-T116
mfi	B-T081
decreased	B-T081
with	O
exercise	O
pre	B-T079
16	O
8249	O
post	B-T079
11	O
6875	O
p	O
<0	O
.	O
	
acute	O
running	O
resulted	O
in	O
an	O
increased	B-T081
lac	B-T116
concentration	B-T081
which	O
could	O
lead	O
to	O
a	O
decrease	B-T081
in	O
inflammation	O
,	O
adding	O
further	O
evidence	O
of	O
the	O
anti-inflammatory	B-T080
effects	I-T080
of	O
exercise	O
.	O
	
conversely	O
,	O
the	O
exercise	O
-associated	O
decrease	B-T081
of	O
intracellular	B-T116
lys	I-T116
content	O
could	O
be	O
the	O
cause	B-T169
of	O
increased	B-T081
lys	B-T116
in	O
exocrine	O
solutions	O
.	O
	
chronic	B-T061
enzyme	I-T061
replacement	I-T061
to	O
the	O
brain	O
of	O
a	O
late	B-T047
infantile	I-T047
neuronal	I-T047
ceroid	I-T047
lipofuscinosis	I-T047
mouse	O
has	O
differential	O
effects	B-T080
on	O
phenotypes	O
of	O
disease	B-T047
late	B-T047
infantile	I-T047
neuronal	I-T047
ceroid	I-T047
lipofuscinosis	I-T047
lincl	B-T047
is	O
a	O
fatal	B-T080
inherited	O
neurodegenerative	B-T047
disease	I-T047
caused	O
by	O
loss	O
of	O
lysosomal	B-T116
protease	I-T116
tripeptidyl	I-T116
peptidase	I-T116
1	I-T116
tpp1	B-T116
.	O
	
we	O
have	O
investigated	O
the	O
effects	B-T080
of	O
chronic	B-T169
intrathecal	I-T169
it	I-T169
administration	I-T169
using	O
enzyme	B-T061
replacement	I-T061
therapy	I-T061
ert	B-T061
to	O
the	O
brain	O
of	O
an	O
lincl	B-T047
mouse	O
model	O
,	O
in	O
which	O
locomotor	O
function	O
declines	O
dramatically	O
prior	O
to	O
early	B-T033
death	I-T033
.	O
	
median	O
lifespan	O
was	O
significantly	O
extended	O
from	O
126	O
days	B-T079
to	O
>259	O
days	B-T079
when	O
chronic	B-T061
it	I-T061
treatment	I-T061
was	O
initiated	O
before	O
the	O
onset	B-T079
of	O
disease	B-T047
.	O
	
while	O
treated	O
animals	O
lived	O
longer	O
and	O
showed	O
little	O
sign	O
of	O
locomotor	B-T033
dysfunction	I-T033
as	O
measured	O
by	O
stride	O
length	O
,	O
some	O
or	O
all	O
depending	O
on	O
regimen	O
still	O
died	O
prematurely	O
.	O
	
one	O
explanation	O
is	O
that	O
cerebrospinal	O
fluid	O
csf	O
delivery	B-T169
may	O
not	O
deliver	B-T169
tpp1	B-T116
to	O
all	O
brain	O
regions	O
.	O
	
morphological	B-T082
studies	B-T062
support	O
this	O
,	O
showing	O
delivery	B-T169
of	O
tpp1	B-T116
to	O
ventral	O
,	O
but	O
not	O
deeper	O
and	O
dorsal	O
regions	O
.	O
	
when	O
it	B-T061
treatment	I-T061
is	O
initiated	O
in	O
severely	B-T080
affected	B-T169
lincl	B-T047
mice	O
,	O
lifespan	O
was	O
extended	O
modestly	O
in	O
most	O
but	O
dramatically	O
extended	O
in	O
approximately	O
one-third	O
of	O
the	O
cohort	B-T098
.	O
	
treatment	B-T169
improved	O
locomotor	O
function	O
in	O
these	O
severely	O
compromised	O
animals	O
after	O
it	O
had	O
declined	O
to	O
the	O
point	O
at	O
which	O
animals	O
normally	O
die	O
.	O
	
this	O
indicates	O
that	O
some	O
pathology	O
in	O
lincl	B-T047
is	O
reversible	B-T169
and	O
does	O
not	O
simply	O
reflect	O
neuronal	O
death	O
.	O
	
5-bromo-2-aryl	B-T109
benzimidazole	I-T109
derivatives	I-T109
as	O
non-cytotoxic	O
potential	B-T080
dual	O
inhibitors	O
of	O
α-glucosidase	B-T116
and	O
urease	B-T116
enzymes	I-T116
on	O
the	O
basis	O
of	O
previous	O
report	B-T170
on	O
promising	O
α-glucosidase	B-T116
inhibitory	O
activity	O
of	O
5-bromo-2-aryl	B-T109
benzimidazole	I-T109
derivatives	I-T109
,	O
these	O
derivatives	O
were	O
further	O
screened	O
for	O
urease	B-T116
inhibitory	O
and	O
cytotoxicity	O
activity	O
in	O
order	O
to	O
get	O
more	B-T080
potent	I-T080
and	O
non-cytotoxic	O
potential	B-T080
dual	O
inhibitor	O
for	O
the	O
patients	O
suffering	O
from	O
diabetes	B-T047
as	O
well	O
as	O
peptic	B-T047
ulcer	I-T047
.	O
	
in	O
this	O
study	B-T062
,	O
all	O
compounds	O
showed	O
varying	O
degree	O
of	O
potency	O
in	O
the	O
range	O
of	O
ic50	B-T081
=8	O
as	O
compared	O
to	O
standard	B-T081
thiourea	B-T109
ic50	B-T081
=21	O
.	O
	
it	O
is	O
worth	O
mentioning	O
that	O
derivatives	O
7	O
ic50	B-T081
=12	O
,	O
8	O
ic50	B-T081
=10	O
,	O
11	O
ic50	B-T081
=13	O
,	O
14	O
ic50	B-T081
=15	O
and	O
22	O
ic50	B-T081
=8	O
were	O
found	O
to	O
be	O
more	O
potent	O
inhibitors	O
than	O
standard	B-T081
.	O
	
all	O
compounds	O
were	O
also	O
evaluated	O
for	O
cytotoxicity	O
towards	O
3t3	O
mouse	O
fibroblast	O
cell	O
line	O
and	O
found	O
to	O
be	O
completely	O
non-toxic	B-T033
.	O
	
previously	O
benzimidazole	B-T109
1-25	I-T109
were	O
also	O
showed	O
α-glucosidase	B-T116
inhibitory	O
potential	O
.	O
	
in	O
silico	O
studies	B-T062
were	O
performed	O
on	O
the	O
lead	O
molecules	O
i.e	O
.	O
	
2	O
,	O
7	O
,	O
8	O
,	O
11	O
,	O
14	O
,	O
and	O
22	O
,	O
in	O
order	O
to	O
rationalize	O
the	O
binding	O
interaction	O
of	O
compounds	O
with	O
the	O
active	B-T169
site	I-T169
of	O
urease	B-T116
enzyme	I-T116
.	O
	
intra-articular	B-T082
implantation	B-T061
of	O
collagen	B-T116
scaffold	O
carriers	O
is	O
safe	B-T082
in	O
both	O
native	B-T169
and	O
arthrofibrotic	B-T047
rabbit	O
knee	O
joints	O
sustained	B-T169
intra-articular	B-T082
delivery	O
of	O
pharmacological	O
agents	O
is	O
an	O
attractive	B-T080
modality	B-T078
but	O
requires	O
use	B-T169
of	O
a	O
safe	B-T082
carrier	O
that	O
would	O
not	O
induce	B-T169
cartilage	O
damage	O
or	O
fibrosis	O
.	O
	
collagen	B-T116
scaffolds	O
are	O
widely	O
available	B-T169
and	O
could	O
be	O
used	O
intra-articularly	B-T082
,	O
but	O
no	O
investigation	O
has	O
looked	O
at	O
the	O
safety	O
of	O
collagen	B-T116
scaffolds	O
within	O
synovial	O
joints	O
.	O
	
the	O
aim	B-T078
of	O
this	O
study	B-T062
was	O
to	O
determine	B-T078
the	O
safety	O
of	O
collagen	B-T116
scaffold	O
implantation	B-T061
in	O
a	O
validated	B-T062
in	B-T082
vivo	I-T082
animal	O
model	O
of	O
knee	B-T047
arthrofibrosis	I-T047
.	O
	
a	O
total	O
of	O
96	O
rabbits	O
were	O
randomly	B-T080
and	O
equally	B-T080
assigned	B-T169
to	O
four	O
different	B-T080
groups	B-T078
arthrotomy	B-T061
alone	O
arthrotomy	B-T061
and	O
collagen	B-T116
scaffold	O
placement	O
contracture	O
surgery	B-T061
and	O
contracture	O
surgery	B-T061
and	O
collagen	B-T116
scaffold	O
placement	O
.	O
	
animals	O
were	O
killed	O
in	O
equal	B-T080
numbers	O
at	O
72	O
hours	B-T079
,	O
two	O
weeks	B-T079
,	O
eight	O
weeks	B-T079
,	O
and	O
24	O
weeks	B-T079
.	O
	
joint	O
contracture	O
was	O
measured	B-T080
,	O
and	O
cartilage	O
and	O
synovial	O
samples	O
underwent	O
histological	O
analysis	O
.	O
	
animals	O
that	O
underwent	O
arthrotomy	B-T061
had	O
equivalent	B-T080
joint	O
contractures	O
regardless	O
of	O
scaffold	O
implantation	B-T061
-13	O
versus	O
-10	O
,	O
equivalence	O
limit	O
15	O
.	O
	
animals	O
that	O
underwent	O
surgery	B-T061
to	O
induce	B-T169
contracture	O
did	O
not	O
demonstrate	O
equivalent	B-T080
joint	O
contracture	O
s	O
with	O
41.8	O
or	O
without	O
53.9	O
collagen	O
scaffold	O
implantation	O
.	O
	
chondral	O
damage	O
occurred	O
in	O
similar	O
rates	O
with	O
11	O
of	O
48	O
and	O
without	O
nine	O
of	O
48	O
scaffold	O
implantation	O
.	O
	
no	O
significant	O
difference	O
in	O
synovitis	O
was	O
noted	O
between	O
groups	O
.	O
	
absorption	O
of	O
the	O
collagen	O
scaffold	O
occurred	O
within	O
eight	O
weeks	O
in	O
all	O
animals	O
conclusion	O
our	O
data	O
suggest	O
that	O
intra-articular	O
implantation	O
of	O
a	O
collagen	O
sponge	O
does	O
not	O
induce	O
synovitis	O
or	O
cartilage	O
damage	O
.	O
	
implantation	O
in	O
a	O
native	O
joint	O
does	O
not	O
seem	O
to	O
induce	O
contracture	O
.	O
	
implantation	O
of	O
the	O
collagen	O
sponge	O
in	O
a	O
rabbit	O
knee	O
model	O
of	O
contracture	O
may	O
decrease	O
the	O
severity	O
of	O
the	O
contracture	O
cite	O
this	O
article	O
j	O
.	O
	
a	O
.	O
	
walker	O
,	O
t	O
.	O
	
j	O
.	O
	
ewald	O
,	O
e	O
.	O
	
lewallen	O
,	O
a	O
.	O
	
van	O
wijnen	O
,	O
a	O
.	O
	
d	O
.	O
	
hanssen	O
,	O
b	O
.	O
	
f	O
.	O
	
morrey	O
,	O
m	O
.	O
	
e	O
.	O
	
morrey	O
,	O
m	O
.	O
	
p	O
.	O
	
abdel	O
,	O
j	O
.	O
	
sanchez-sotelo	O
.	O
	
intra-articular	O
implantation	O
of	O
collagen	O
scaffold	O
carriers	O
is	O
safe	O
in	O
both	O
native	O
and	O
arthrofibrotic	O
rabbit	O
knee	O
joints	O
.	O
	
bone	O
joint	O
res	O
2016	O
.	O
	
doi	O
host	O
immune	O
recognition	O
of	O
the	O
epidemic	O
cystic	B-T047
fibrosis	I-T047
pathogen	O
burkholderia	O
dolosa	O
burkholderia	O
dolosa	O
caused	O
an	O
outbreak	O
in	O
the	O
cystic	B-T047
fibrosis	I-T047
cf	B-T047
clinic	O
at	O
boston	O
children's	O
hospital	O
from	O
1998	O
to	O
2005	O
and	O
led	O
to	O
the	O
infection	O
of	O
over	O
40	O
patients	O
,	O
many	O
of	O
whom	O
died	O
due	O
to	O
complications	O
from	O
infection	O
by	O
this	O
organism	O
.	O
	
to	O
assess	O
whether	O
b	O
.	O
	
dolosa	O
significantly	O
contributes	O
to	O
disease	B-T047
or	O
is	O
recognized	O
by	O
the	O
host	O
immune	O
response	O
,	O
mice	O
were	O
infected	B-T033
with	O
a	O
sequenced	O
outbreak	O
b	O
.	O
	
dolosa	O
strain	O
,	O
au0158	O
,	O
and	O
responses	O
compared	O
to	O
the	O
well-studied	O
cf	B-T047
pathogen	O
,	O
pseudomonas	O
aeruginosa	O
in	O
parallel	O
,	O
mice	O
were	O
also	O
infected	B-T033
with	O
a	O
polar	O
flagellin	O
mutant	O
of	O
b	O
.	O
	
dolosa	O
to	O
examine	O
the	O
role	O
of	O
flagella	O
in	O
b	O
.	O
	
dolosa	O
lung	O
colonization	B-T033
.	O
	
the	O
results	O
showed	O
a	O
higher	B-T080
persistence	O
in	O
the	O
host	O
by	O
b	O
.	O
	
dolosa	O
strains	O
and	O
yet	O
neutrophil	O
recruitment	O
and	O
cytokine	B-T116
production	B-T169
were	O
lower	O
compared	O
to	O
p	O
.	O
	
aeruginosa	O
the	O
ability	O
of	O
host	O
immune	O
cells	O
to	O
recognize	O
b	O
.	O
	
dolosa	O
was	O
then	O
assessed	O
and	O
b	O
.	O
	
dolosa	O
induced	O
a	O
robust	O
cytokine	B-T116
response	O
in	O
cultured	O
cells	O
and	O
this	O
effect	O
was	O
dependent	O
on	O
the	O
flagella	O
only	O
when	O
bacteria	O
were	O
dead	O
.	O
	
together	O
,	O
these	O
results	O
suggest	O
that	O
b	O
.	O
	
dolosa	O
can	O
be	O
recognized	O
by	O
host	O
cells	O
in	B-T080
vitro	I-T080
but	O
may	O
avoid	O
or	O
suppress	B-T169
the	O
host	O
immune	O
response	O
in	B-T082
vivo	I-T082
through	O
unknown	O
mechanisms	O
.	O
	
b	O
.	O
	
dolosa	O
was	O
then	O
compared	O
to	O
other	O
burkholderia	O
species	O
and	O
found	O
to	O
induce	O
similar	O
levels	O
of	O
cytokine	B-T116
production	B-T169
despite	O
being	O
internalized	O
by	O
macrophages	O
more	O
than	O
b	O
.	O
	
cenocepacia	O
strains	O
.	O
	
these	O
data	B-T078
suggest	O
that	O
b	O
.	O
	
dolosa	O
au0158	O
may	O
act	O
differently	O
with	O
host	O
cells	O
and	O
is	O
it	O
recognized	O
differently	O
by	O
immune	O
systems	O
compared	O
other	O
burkholderia	O
strains	O
or	O
visualization	B-T033
and	O
targeting	B-T169
of	O
lgr5	O
human	O
colon	O
cancer	O
stem	O
cells	O
the	O
cancer	O
stem	O
cell	O
csc	O
theory	B-T078
highlights	O
a	O
self-renewing	O
subpopulation	O
of	O
cancer	O
cells	O
that	O
fuels	O
tumour	O
growth	O
.	O
	
the	O
existence	B-T081
of	O
human	O
cscs	O
is	O
mainly	O
supported	O
by	O
xenotransplantation	B-T061
of	O
prospectively	O
isolated	B-T033
cells	I-T033
,	O
but	O
their	O
clonal	O
dynamics	O
and	O
plasticity	O
remain	O
unclear	O
.	O
	
here	O
,	O
we	O
show	O
that	O
human	O
lgr5	O
colorectal	O
cancer	O
cells	O
serve	O
as	O
cscs	O
in	O
growing	O
cancer	O
tissues	O
.	O
	
lineage	O
-	O
tracing	O
experiments	O
with	O
a	O
tamoxifen	B-T109
-inducible	O
cre	B-T116
knock-in	O
allele	O
of	O
lgr5	B-T116
reveal	O
the	O
self-renewal	O
and	O
differentiation	O
capacity	B-T081
of	O
lgr5	O
tumour	O
cells	O
.	O
	
selective	O
ablation	B-T061
of	O
lgr5	O
cscs	O
in	O
lgr5	O
-i	O
caspase9	O
knock-in	O
organoids	O
leads	O
to	O
tumour	O
regression	O
,	O
followed	O
by	O
tumour	O
regrowth	O
driven	O
by	O
re-emerging	O
lgr5	O
cscs	O
.	O
	
krt20	O
knock-in	O
reporter	O
marks	O
differentiated	O
cancer	O
cells	O
that	O
constantly	O
diminish	O
in	O
tumour	O
tissues	O
,	O
while	O
reverting	O
to	O
lgr5	O
cscs	O
and	O
contributing	O
to	O
tumour	O
regrowth	O
after	O
lgr5	O
csc	O
ablation	B-T061
.	O
	
we	O
also	O
show	O
that	O
combined	O
chemotherapy	B-T061
potentiates	O
targeting	B-T169
of	O
lgr5	O
cscs	O
.	O
	
these	O
data	B-T078
provide	O
insights	O
into	O
the	O
plasticity	O
of	O
cscs	O
and	O
their	O
potential	B-T080
as	O
a	O
therapeutic	B-T169
target	B-T169
in	O
human	O
colorectal	O
cancer	O
.	O
	
the	O
use	O
of	O
a	O
software	O
-	O
assisted	B-T080
method	B-T170
to	O
estimate	B-T081
fetal	O
weight	O
at	O
and	O
near	O
term	O
using	O
magnetic	O
resonance	O
imaging	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
apply	O
a	O
semi-automated	B-T169
calculation	B-T052
method	B-T170
of	O
fetal	O
body	O
volume	O
and	O
,	O
thus	O
,	O
of	O
magnetic	O
resonance-estimated	O
fetal	O
weight	O
mr-efw	O
prior	O
to	O
planned	B-T169
delivery	O
and	O
to	O
evaluate	O
whether	O
the	O
technique	B-T169
of	O
measurement	B-T169
could	O
be	O
simplified	B-T080
while	O
remaining	B-T080
accurate	B-T080
.	O
	
mr-efw	O
was	O
calculated	B-T169
using	O
a	O
semi-automated	B-T169
method	B-T170
at	O
38.6	O
weeks	B-T079
of	O
gestation	O
in	O
36	O
patients	O
and	O
compared	O
to	O
the	O
picture	O
archiving	O
and	O
communication	O
system	O
pacs	O
.	O
	
per	O
patient	O
,	O
8	O
sequences	B-T169
were	O
acquired	B-T080
with	O
a	O
slice	B-T081
thickness	I-T081
of	O
4-8	O
mm	O
and	O
an	O
intersection	B-T082
gap	I-T082
of	O
0	O
,	O
4	O
,	O
8	O
,	O
12	O
,	O
16	O
,	O
or	O
20	O
mm	O
.	O
	
the	O
median	B-T082
absolute	B-T080
relative	B-T080
errors	I-T080
for	O
mr-efw	O
and	O
the	O
time	B-T079
of	O
planimetric	B-T169
measurements	I-T169
were	O
calculated	B-T169
for	O
all	O
8	O
sequences	B-T169
and	O
for	O
each	O
method	B-T170
assisted	B-T170
vs	O
.	O
	
pacs	O
,	O
and	O
the	O
difference	O
between	O
the	O
methods	B-T170
was	O
calculated	B-T169
.	O
	
the	O
median	B-T082
delivery	O
weight	O
was	O
3	O
g	O
.	O
	
the	O
overall	O
median	B-T082
relative	B-T080
error	I-T080
for	O
all	O
288	O
mr-efw	O
calculations	B-T052
was	O
2.4	O
using	O
the	O
semi-automated	B-T169
method	B-T170
and	O
2.2	O
for	O
the	O
pacs	O
method	B-T170
.	O
	
measurements	B-T169
did	O
not	O
differ	O
between	O
the	O
8	O
sequences	B-T169
using	O
the	O
assisted	B-T170
method	B-T170
p	O
=	O
0.313	O
or	O
the	O
pacs	O
p	O
=	O
0.118	O
,	O
while	O
the	O
time	B-T079
of	O
planimetric	B-T169
measurement	I-T169
decreased	B-T081
significantly	O
with	O
a	O
larger	O
gap	B-T082
p	O
<	O
0.001	O
and	O
in	O
the	O
assisted	B-T170
method	B-T170
compared	O
to	O
the	O
pacs	O
method	B-T170
p	O
<	O
0.01	O
.	O
	
our	O
simplified	B-T080
mr-efw	O
measurement	B-T169
showed	O
a	O
dramatic	B-T081
decrease	I-T081
in	O
time	B-T079
of	O
planimetric	B-T169
measurement	I-T169
without	O
a	O
decrease	B-T081
in	O
the	O
accuracy	B-T080
of	O
weight	O
estimates	B-T081
.	O
	
abiraterone	B-T109
-	O
induced	B-T169
rhabdomyolysis	O
resulting	O
in	O
acute	O
kidney	O
injury	O
a	O
case	B-T170
report	I-T170
and	O
review	B-T170
of	I-T170
the	I-T170
literature	I-T170
abiraterone	B-T109
,	O
a	O
cyp17	O
inhibitor	O
,	O
blocks	O
androgen	O
biosynthesis	O
in	O
multiple	O
tissue	O
types	O
.	O
	
in	O
combination	O
with	O
prednisone	B-T109
,	O
it	O
is	O
approved	O
as	O
a	O
first-line	B-T061
treatment	I-T061
for	O
metastatic	O
castration-resistant	O
prostate	O
cancer	O
.	O
	
we	O
present	O
a	O
case	O
of	O
rhabdomyolysis	O
associated	O
with	O
abiraterone	B-T109
therapy	B-T061
resulting	O
in	O
acute	O
on	O
chronic	B-T079
kidney	O
injury	O
in	O
a	O
patient	O
with	O
metastatic	O
castration-resistant	O
prostate	O
cancer	O
.	O
	
strict	O
monitoring	B-T062
should	O
be	O
employed	O
in	O
patients	O
started	O
on	O
abiraterone	B-T109
who	O
have	O
additional	O
risk	B-T033
factors	I-T033
for	O
developing	O
association	B-T080
between	O
xrcc1	O
and	O
ercc1	O
single-nucleotide	O
polymorphisms	O
and	O
the	O
efficacy	B-T080
of	O
concurrent	B-T061
radiochemotherapy	I-T061
in	O
patients	O
with	O
esophageal	O
squamous	O
cell	O
carcinoma	O
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	B-T169
the	O
association	B-T080
between	O
single-nucleotide	O
polymorphisms	O
snps	O
in	O
x-ray	O
repair	O
cross-complementing	O
1-399	O
xrcc1-399	O
or	O
excision	O
repair	O
cross-complementation	O
group	O
1-118	O
ercc1-118	O
and	O
the	O
short-term	B-T079
efficacy	B-T080
of	O
radiochemotherapy	B-T061
,	O
tumor	O
metastasis	O
and	O
relapse	O
,	O
as	O
well	O
as	O
the	O
survival	O
time	O
in	O
patients	O
with	O
esophageal	O
squamous	O
cell	O
carcinoma	O
escc	O
.	O
	
taqman	O
probe-based	O
quantitative	O
polymerase	O
chain	O
reaction	O
qpcr	O
was	O
conducted	O
to	O
examine	B-T033
the	O
levels	B-T080
of	O
xrcc1-399	O
and	O
ercc1-118	O
snps	O
in	O
the	O
peripheral	O
blood	O
of	O
50	O
patients	O
with	O
pathologically	B-T169
confirmed	B-T033
escc	O
.	O
	
in	O
addition	O
,	O
the	O
associations	B-T080
between	O
different	B-T080
genotypes	O
and	O
short-term	B-T079
therapeutic	B-T080
efficacy	I-T080
the	O
complete	B-T033
remission	I-T033
cr	B-T033
rate	B-T081
,	O
tumor	O
metastasis	O
and	O
relapse	O
,	O
as	O
well	O
as	O
the	O
survival	O
time	O
following	O
concurrent	B-T061
radiochemotherapy	I-T061
,	O
were	O
determined	B-T080
.	O
	
a	O
total	O
of	O
50	O
escc	O
patients	O
who	O
received	O
concurrent	B-T061
radiochemotherapy	I-T061
were	O
enrolled	O
.	O
	
it	O
was	O
found	O
that	O
the	O
short-term	B-T079
therapeutic	B-T080
efficacy	I-T080
cr	B-T033
rate	B-T081
was	O
higher	O
in	O
the	O
group	B-T078
of	O
patients	O
carrying	O
the	O
homozygous	O
mutation	O
of	O
xrcc1-399	O
a	O
/	O
a	O
genotype	O
than	O
in	O
the	O
group	B-T078
of	O
patients	O
without	O
the	O
xrcc1-399	O
mutation	O
g	O
/	O
g	O
genotype	O
.	O
	
in	O
addition	O
,	O
the	O
cr	B-T033
rate	B-T081
was	O
significantly	B-T081
increased	I-T081
in	O
patients	O
carrying	O
one	O
or	O
two	O
ercc1-118	O
c	O
alleles	O
c	O
/	O
c	O
or	O
c	O
/	O
t	O
genotype	O
compared	B-T052
with	O
patients	O
lacking	O
the	O
c	O
allele	O
t	O
/	O
t	O
genotype	O
.	O
	
the	O
differences	O
were	O
statistically	B-T081
significant	I-T081
a	O
/	O
a	O
vs	O
.	O
	
g	O
/	O
g	O
,	O
p=0	O
t	O
t	O
vs	O
.	O
	
c	O
/	O
t	O
+	O
c	O
/	O
c	O
,	O
p=0	O
.	O
	
during	O
the	O
follow-up	B-T033
period	I-T033
,	O
the	O
group	B-T078
of	O
patients	O
carrying	O
the	O
homozygous	O
mutation	O
of	O
xrcc1-399	O
a	O
/	O
a	O
genotype	O
exhibited	O
a	O
markedly	B-T080
reduced	I-T080
risk	B-T078
of	O
metastasis	O
and	O
relapse	O
compared	B-T052
with	O
the	O
group	B-T078
of	O
patients	O
carrying	O
non-mutated	O
xrcc1-399	O
g	O
/	O
g	O
genotype	O
p=0	O
.	O
	
by	O
contrast	O
,	O
ercc1-118	O
snp	O
was	O
not	O
associated	B-T080
with	I-T080
the	O
risk	B-T078
of	O
metastasis	O
and	O
recurrence	O
p>0	O
.	O
	
the	O
combined	O
results	O
of	O
univariate	B-T062
and	O
multivariate	B-T170
cox	I-T170
regression	I-T170
analysis	I-T170
showed	O
that	O
the	O
snp	O
in	O
ercc1-118	O
was	O
closely	O
associated	B-T080
with	I-T080
survival	O
time	O
.	O
	
the	O
mean	B-T081
survival	I-T081
time	I-T081
was	O
significantly	B-T078
prolonged	B-T079
in	O
patients	O
carrying	O
1	O
or	O
2	O
c	O
alleles	O
c	O
/	O
c	O
or	O
c	O
/	O
t	O
genotype	O
compared	B-T052
with	O
patients	O
lacking	O
the	O
c	O
allele	O
t	O
/	O
t	O
genotype	O
t	O
/	O
t	O
vs	O
.	O
	
c	O
/	O
c	O
,	O
hr	B-T081
=12	O
,	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
,	O
p<0	O
t	O
t	O
vs	O
.	O
	
c	O
/	O
t	O
+	O
c	O
/	O
c	O
,	O
hr	B-T081
=11	O
,	O
95%	O
ci	B-T081
=3	O
,	O
p<0	O
.	O
	
however	O
,	O
xrcc1-399	O
snp	O
had	O
no	B-T080
effect	I-T080
on	O
survival	O
time	O
p>0	O
.	O
	
xrccl-399	O
snp	O
was	O
associated	B-T080
with	I-T080
the	O
short-term	B-T079
therapeutic	B-T080
efficacy	I-T080
the	O
cr	B-T033
rate	B-T081
and	O
tumor	O
metastasis	O
/	O
relapse	O
in	O
escc	O
patients	O
who	O
received	O
the	O
docetaxel	B-T061
plus	I-T061
cisplatin	I-T061
tp	I-T061
regimen	I-T061
-based	O
concurrent	B-T061
radiochemotherapy	I-T061
.	O
	
by	O
contrast	O
,	O
ercc1-118	O
snp	O
was	O
significantly	B-T078
associated	B-T080
with	I-T080
the	O
short-term	B-T079
therapeutic	B-T080
efficacy	I-T080
the	O
cr	B-T033
rate	B-T081
and	O
survival	O
time	O
in	O
escc	O
patients	O
who	O
received	O
tp	B-T061
regimen	I-T061
-based	O
concurrent	B-T061
radiochemotherapy	I-T061
.	O
	
ventricular	B-T061
pacing	I-T061
site	B-T082
separation	I-T082
by	O
cardiac	B-T082
computed	O
tomography	O
validation	B-T062
for	O
the	O
prediction	B-T078
of	O
clinical	B-T033
response	I-T033
to	O
cardiac	B-T061
resynchronization	I-T061
therapy	I-T061
cardiac	B-T061
resynchronization	I-T061
therapy	I-T061
crt	B-T061
fails	O
to	O
provide	B-T052
benefit	B-T081
in	O
up	O
to	O
one-third	O
of	O
patients	O
.	O
	
maximizing	O
the	O
geographic	B-T082
separation	I-T082
of	O
right	B-T082
and	O
left	B-T082
ventricular	B-T061
pacing	I-T061
lead	O
sites	O
has	O
been	O
suggested	B-T078
as	O
one	O
way	O
to	O
improve	B-T033
response	O
.	O
	
cardiac	O
ct	O
provides	B-T052
an	O
opportunity	B-T062
to	O
explore	O
3-dimensional	B-T082
inter-lead	B-T082
distance	I-T082
ild	B-T082
measures	B-T081
for	O
the	O
prediction	B-T078
of	O
crt	B-T061
response	O
.	O
	
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
investigate	B-T169
associations	B-T080
between	O
standardized	B-T080
measures	B-T081
of	O
ild	B-T082
by	O
cardiac	O
ct	O
and	O
echocardiographic	O
response	O
to	O
crt	B-T061
.	O
	
forty-two	O
consecutive	B-T080
patients	O
undergoing	O
crt	B-T061
had	O
serial	O
clinical	O
and	O
echocardiographic	O
evaluations	O
performed	B-T169
in	B-T169
addition	I-T169
to	I-T169
a	O
post-procedural	B-T079
cardiac	B-T082
-gated	O
ct	O
with	O
blinded	B-T062
measurement	B-T169
of	O
direct	B-T080
and	O
circumferential	B-T082
via	O
the	O
myocardium	O
ild	B-T082
measures	B-T081
.	O
	
clinical	B-T033
response	I-T033
to	O
crt	B-T061
,	O
the	O
primary	O
clinical	O
outcome	O
,	O
was	O
defined	O
as	O
a	O
15%	O
reduction	B-T080
in	O
lvesv	B-T033
using	O
echocardiography	O
at	O
6-months	O
.	O
	
the	O
mean	O
age	O
and	O
ejection	B-T033
fraction	I-T033
was	O
63.6	O
8.9	O
years	O
and	O
25.2	O
7.8	O
,	O
respectively	O
.	O
	
the	O
primary	B-T080
outcome	I-T080
occurred	B-T052
in	O
35	O
of	O
42	O
patients	O
83%	O
.	O
	
both	O
direct	B-T080
and	O
circumferential	B-T082
ct	O
-based	O
ild	B-T082
measures	B-T081
were	O
associated	B-T080
with	I-T080
the	O
primary	B-T080
outcome	I-T080
by	O
univariate	B-T062
analysis	I-T062
.	O
	
receiver	B-T081
operator	I-T081
characteristic	I-T081
analysis	B-T062
identified	O
circumferential	B-T082
ild	B-T082
to	O
have	O
the	O
strongest	O
predictive	B-T080
accuracy	B-T080
auc	O
0.78	O
.	O
	
inter-	B-T081
and	O
intra-observer	B-T081
reproducibility	B-T080
of	O
ct	O
-derived	O
ild	B-T082
measures	B-T081
was	O
excellent	B-T080
.	O
	
circumferential	B-T082
ild	B-T082
measures	B-T081
on	O
cardiac	O
ct	O
are	O
predictive	B-T080
of	O
clinical	B-T033
response	I-T033
to	O
crt	B-T061
.	O
	
incorporation	B-T169
of	O
these	O
measures	B-T081
into	O
the	O
selection	B-T052
of	O
optimal	B-T080
pacing	B-T061
targets	B-T169
,	O
particularly	O
from	O
pre-procedural	B-T079
ct	O
coronary	O
vein	O
imaging	O
may	O
be	O
of	O
therapeutic	B-T169
benefit	B-T081
and	O
warrants	O
further	O
iodine	O
storage	O
and	O
metabolism	O
of	O
mild	B-T080
to	I-T080
moderate	I-T080
iodine-deficient	O
pregnant	O
rats	O
severe	O
iodine	O
deficiency	O
during	B-T079
pregnancy	I-T079
results	I-T079
in	O
neurodevelopmental	O
disorders	O
in	O
children	O
,	O
while	O
the	O
consequences	B-T169
of	I-T169
mild	O
to	O
moderate	O
iodine	O
deficiency	O
mmid	O
are	O
uncertain	B-T033
.	O
	
the	O
concentration	O
of	O
iodine	O
in	O
the	O
thyroid	O
is	O
the	O
most	O
accurate	O
indicator	O
of	O
iodine	O
nutrition	O
.	O
	
this	O
study	O
aimed	O
to	O
evaluate	O
whether	O
the	O
iodine	O
stores	O
in	O
the	O
thyroid	O
cover	O
the	O
needs	O
of	O
the	O
mother	O
and	O
the	O
fetus	O
in	O
iodine	O
-	O
sufficient	B-T080
and	O
mmid	O
conditions	O
by	O
inductively	O
coupled	O
plasma-mass	O
spectrometry	O
.	O
	
one	O
hundred	O
four-week-old	O
female	O
wistar	O
rats	O
were	O
randomly	O
divided	O
into	O
mmid	O
low	B-T033
iodine	I-T033
intake	I-T033
l	O
and	O
normal	B-T033
normal	B-T033
iodine	I-T033
intake	I-T033
n	O
groups	B-T078
.	O
	
the	O
rats	O
were	O
fed	B-T052
for	I-T052
the	I-T052
next	I-T052
three	I-T052
months	I-T052
,	O
and	O
after	B-T079
pregnancy	I-T079
they	O
were	O
further	O
divided	O
into	O
two	O
subgroups	O
,	O
respectively	O
low	B-T033
iodine	I-T033
pregnancy	O
lp	B-T033
and	O
low	B-T033
iodine	I-T033
pregnancy	O
with	O
iodine	O
supplement	O
lp+	O
,	O
and	O
normal	B-T033
iodine	I-T033
intake	I-T033
pregnancy	O
np	O
and	O
normal	B-T033
iodine	I-T033
intake	I-T033
pregnancy	O
with	O
iodine	O
supplement	O
np+	O
.	O
	
the	O
iodine	B-T033
intake	I-T033
of	O
pregnant	O
rats	O
in	O
the	O
np+	O
and	O
lp+	O
groups	O
was	O
twice	O
as	O
much	O
as	O
in	O
the	O
np	B-T033
and	O
lp	B-T033
groups	I-T033
.	O
	
the	O
rats	O
were	O
sacrificed	O
on	O
gestational	B-T079
day	I-T079
15	O
and	O
postnatal	B-T079
day	I-T079
7	O
.	O
	
the	O
iodine	O
concentration	O
in	O
the	O
thyroid	O
of	O
the	O
maternal	B-T033
and	O
newborn	B-T033
rats	O
,	O
maternal	O
serum	O
,	O
placenta	O
,	O
and	O
amniotic	O
fluid	O
were	O
determined	O
by	O
inductively	O
coupled	O
plasma-mass	O
spectrometry	O
.	O
	
the	O
concentration	O
of	O
iodine	O
in	O
the	O
thyroid	O
of	O
the	O
n	B-T033
group	I-T033
was	O
significantly	B-T081
higher	I-T081
than	O
that	O
in	O
the	O
l	B-T033
group	I-T033
before	B-T033
pregnancy	I-T033
.	O
	
the	O
concentration	O
of	O
iodine	O
in	O
the	O
maternal	O
thyroids	O
of	O
the	O
lp	B-T033
group	I-T033
decreased	O
during	B-T079
pregnancy	I-T079
,	O
whereas	O
that	O
of	O
the	O
np	B-T033
group	I-T033
did	O
not	O
change	O
significantly	O
.	O
	
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
iodine	O
concentration	O
in	O
the	O
thyroid	O
of	O
mothers	O
and	O
offspring	O
between	O
the	O
np	B-T033
and	O
np+	O
groups	O
,	O
but	O
it	O
was	O
significant	O
between	O
lp	O
and	O
lp+	O
groups	O
.	O
	
the	O
concentration	O
of	O
iodine	O
in	O
amniotic	O
fluid	O
was	O
significantly	O
different	O
between	O
the	O
four	O
groups	B-T078
.	O
	
there	O
is	O
sufficient	O
iodine	O
storage	O
in	O
the	O
thyroid	O
of	O
maternal	B-T033
rats	O
with	O
normal	B-T033
iodine	I-T033
intake	I-T033
during	B-T079
pregnancy	I-T079
,	O
and	O
there	O
is	O
no	O
need	O
for	O
iodine	O
supplementation	O
.	O
	
however	O
,	O
iodine	O
stores	O
are	O
insufficient	O
in	O
rats	O
with	O
mmid	O
.	O
	
iodine	O
supplementation	O
can	O
increase	O
the	O
iodine	O
concentration	O
in	O
the	O
thyroid	O
of	O
maternal	B-T033
rats	O
with	O
mmid	O
and	O
their	O
offspring	O
,	O
as	O
well	O
as	O
in	O
the	O
amniotic	O
fluid	O
during	B-T079
pregnancy	I-T079
.	O
	
omega	B-T109
3	I-T109
fatty	I-T109
acids	I-T109
reduce	B-T080
bone	O
resorption	O
while	O
promoting	O
bone	O
generation	O
in	O
rat	O
apical	B-T047
periodontitis	I-T047
this	O
study	O
evaluated	O
the	O
effects	B-T080
of	I-T080
the	O
dietary	O
supplement	O
omega	B-T109
3	I-T109
polyunsaturated	I-T109
fatty	I-T109
acids	I-T109
ω-3	B-T109
pufas	I-T109
on	O
pulp	B-T047
exposure	I-T047
-induced	O
apical	B-T047
periodontitis	I-T047
ap	B-T047
in	O
rats	O
.	O
	
twenty-eight	O
male	O
rats	O
were	O
divided	O
into	O
groups	B-T098
control	O
untreated	B-T033
rats	O
c	O
,	O
control	O
rats	O
treated	B-T169
with	I-T169
ω-3	B-T109
pufas	I-T109
alone	O
c-o	O
,	O
rats	O
with	O
pulp	B-T047
exposure	I-T047
-induced	O
ap	B-T047
,	O
and	O
rats	O
with	O
pulp	B-T047
exposure	I-T047
-induced	O
ap	B-T047
treated	B-T169
with	I-T169
ω-3	B-T109
pufas	I-T109
ap	B-T047
-o	O
.	O
	
the	O
ω-3	B-T109
pufas	I-T109
were	O
administered	B-T061
orally	I-T061
,	O
once	O
a	O
day	O
,	O
for	O
15	O
days	O
before	O
pulp	B-T047
exposure	I-T047
and	O
,	O
subsequently	O
,	O
30	O
days	O
after	O
pulp	B-T047
exposure	I-T047
.	O
	
rats	O
were	O
killed	O
30	O
days	O
after	O
pulp	B-T047
exposure	I-T047
,	O
and	O
jaws	O
were	O
subjected	O
to	O
histologic	O
and	O
immunohistochemical	O
analyses	B-T062
.	O
	
immunohistochemical	O
analyses	B-T062
were	O
performed	O
to	O
detect	O
tartrate-resistant	B-T116
acid	I-T116
phosphatase	I-T116
-	O
positive	B-T033
osteoclasts	O
and	O
osteocalcin	B-T116
-	O
positive	B-T033
osteoblasts	O
on	O
the	O
bone	O
surface	O
of	O
periapical	B-T082
area	I-T082
.	O
	
results	O
were	O
statistically	O
evaluated	O
by	O
using	O
analysis	B-T081
of	I-T081
variance	I-T081
and	O
tukey	B-T081
honestly	I-T081
significant	I-T081
difference	I-T081
,	O
and	O
p	O
<	O
05	O
was	O
considered	O
statistically	B-T081
significant	I-T081
.	O
	
the	O
bone	O
resorption	O
lesion	B-T033
was	O
significantly	B-T081
larger	I-T081
in	O
the	O
ap	B-T047
group	O
compared	O
with	O
ap	B-T047
-o	O
,	O
c	O
,	O
and	O
c-o	O
groups	B-T098
p	O
<	O
05	O
.	O
	
the	O
level	B-T080
of	O
inflammatory	O
cell	O
infiltration	O
was	O
significantly	O
elevated	O
,	O
and	O
the	O
number	O
of	O
tartrate-resistant	B-T116
acid	I-T116
phosphatase	I-T116
-	O
positive	B-T033
osteoclasts	O
was	O
significantly	B-T081
higher	I-T081
in	O
the	O
periapical	B-T082
lesions	B-T033
of	O
the	O
ap	B-T047
group	O
compared	O
with	O
ap	B-T047
-o	O
,	O
c	O
,	O
and	O
c-o	O
groups	B-T098
p	O
<	O
05	O
.	O
	
the	O
number	O
of	O
osteocalcin	B-T116
-	O
positive	B-T033
osteoblasts	O
was	O
significantly	O
increased	B-T081
in	O
the	O
ap	B-T047
-o	O
group	O
compared	O
with	O
the	O
ap	B-T047
group	O
p	O
>	O
05	O
.	O
	
supplementation	B-T061
with	O
ω-3	B-T109
pufas	I-T109
not	O
only	O
suppresses	B-T169
bone	O
resorption	O
but	O
also	O
promotes	O
new	O
bone	O
formation	O
in	O
the	O
periapical	B-T082
area	I-T082
of	O
rats	O
with	O
ap	B-T047
in	O
conjunction	B-T078
with	O
downregulation	O
of	O
inflammatory	O
cell	O
infiltration	O
into	O
the	O
magr	B-T116
alone	O
is	O
insufficient	B-T080
to	O
confer	O
cellular	O
calcium	O
responses	O
to	O
magnetic	O
stimulation	B-T061
magnetic	O
manipulation	B-T061
of	O
cell	O
activity	O
offers	O
advantages	B-T081
over	O
optical	B-T061
manipulation	I-T061
but	O
an	O
ideal	O
tool	O
remains	O
elusive	O
.	O
	
the	O
magr	B-T116
protein	I-T116
was	O
found	O
through	O
its	O
interaction	O
with	O
cryptochrome	B-T116
cry	B-T116
and	O
the	O
protein	B-T116
in	O
solution	O
appeared	O
to	O
respond	O
to	O
magnetic	O
stimulation	B-T061
ms	B-T061
.	O
	
after	O
we	O
initiated	O
an	O
investigation	O
on	O
the	O
specific	O
role	O
of	O
magr	B-T116
in	O
cellular	O
response	O
to	O
ms	B-T061
,	O
a	O
subsequent	O
study	B-T062
claimed	O
that	O
magr	B-T116
expression	O
alone	O
could	O
achieve	O
cellular	O
activation	O
by	O
ms	B-T061
.	O
	
here	O
we	O
report	O
that	O
despite	O
systematically	B-T169
testing	B-T169
different	O
ways	O
of	O
measuring	B-T080
intracellular	B-T082
calcium	O
and	O
different	O
ms	B-T061
protocols	B-T170
,	O
it	O
was	O
not	O
possible	O
to	O
detect	B-T033
any	O
cellular	O
or	O
neuronal	O
responses	O
to	O
ms	B-T061
in	O
magr	B-T116
-	O
expressing	O
hek	O
cells	O
or	O
primary	B-T080
neurons	O
from	O
the	O
dorsal	B-T082
root	O
ganglion	O
and	O
the	O
hippocampus	O
.	O
	
by	O
contrast	O
,	O
in	O
neurons	O
co-expressing	O
magr	B-T116
and	O
channelrhodopin	B-T116
,	O
optical	B-T061
but	O
not	O
ms	B-T061
increased	B-T081
calcium	O
influx	O
in	O
hippocampal	O
neurons	O
.	O
	
our	O
results	O
indicate	O
that	O
magr	B-T116
alone	O
is	O
not	B-T080
sufficient	I-T080
to	O
confer	O
cellular	O
magnetic	O
responses	O
.	O
	
acute	O
kidney	O
injury	O
and	O
fluid	B-T047
overload	I-T047
in	O
infants	O
and	O
children	O
after	O
cardiac	B-T061
surgery	I-T061
acute	O
kidney	O
injury	O
is	O
a	O
common	O
and	O
serious	B-T080
complication	O
after	O
congenital	B-T061
heart	I-T061
surgery	I-T061
,	O
particularly	O
among	O
infants	O
.	O
	
this	O
comorbidity	B-T078
has	O
been	O
independently	O
associated	B-T080
with	I-T080
adverse	O
outcomes	O
including	O
an	O
increase	B-T169
in	O
mortality	B-T081
.	O
	
postoperative	B-T079
acute	O
kidney	O
injury	O
has	O
a	O
complex	O
pathophysiology	B-T169
with	O
many	O
risk	B-T033
factors	I-T033
,	O
and	O
therefore	O
no	B-T033
single	I-T033
medication	I-T033
or	O
therapy	B-T033
has	O
been	O
demonstrated	O
to	O
be	O
effective	B-T080
for	O
treatment	B-T061
or	O
prevention	B-T080
.	O
	
however	O
,	O
it	O
has	O
been	O
established	O
that	O
the	O
associated	O
fluid	B-T047
overload	I-T047
is	O
one	O
of	O
the	O
major	O
determinants	B-T169
of	O
morbidity	B-T081
,	O
particularly	O
in	O
infants	O
after	O
cardiac	B-T061
surgery	I-T061
.	O
	
therefore	O
,	O
in	O
the	O
absence	B-T169
of	O
an	O
intervention	B-T061
to	O
prevent	O
acute	O
kidney	O
injury	O
,	O
much	O
of	O
the	O
effort	O
to	O
improve	B-T080
outcomes	B-T080
has	O
focused	O
on	O
treating	B-T169
and	O
preventing	B-T080
fluid	B-T047
overload	I-T047
.	O
	
early	B-T079
renal	B-T061
replacement	I-T061
therapy	I-T061
,	O
often	O
in	O
the	O
form	O
of	O
peritoneal	B-T061
dialysis	I-T061
,	O
has	O
been	O
shown	O
to	O
be	O
safe	O
and	O
beneficial	B-T081
in	O
infants	O
with	O
oliguria	B-T047
after	O
heart	B-T061
surgery	I-T061
.	O
	
as	O
understanding	O
of	O
the	O
pathophysiology	B-T169
of	O
acute	O
kidney	O
injury	O
and	O
the	O
ability	O
to	O
confidently	O
diagnose	B-T033
it	O
earlier	O
continues	O
to	O
evolve	O
,	O
it	O
is	O
likely	O
that	O
novel	O
preventative	B-T080
and	O
therapeutic	B-T061
interventions	I-T061
systems	B-T169
toxicology	O
real	O
world	B-T098
applications	B-T169
and	O
opportunities	B-T078
systems	B-T169
toxicology	O
aims	O
to	O
change	O
the	O
basis	O
of	O
how	O
adverse	B-T169
biological	I-T169
effects	I-T169
of	O
xenobiotics	O
are	O
characterized	B-T052
from	O
empirical	B-T080
end	B-T080
points	I-T080
to	O
describing	O
modes	B-T169
of	O
action	B-T052
as	O
adverse	B-T169
outcome	B-T169
pathways	O
and	O
perturbed	B-T169
networks	I-T169
.	O
	
toward	O
this	O
aim	O
,	O
systems	B-T169
toxicology	O
entails	O
the	O
integration	O
of	O
in	B-T080
vitro	I-T080
and	O
in	B-T082
vivo	I-T082
toxicity	O
data	B-T078
with	O
computational	O
modeling	O
.	O
	
this	O
evolving	O
approach	B-T169
depends	O
critically	O
on	O
data	B-T078
reliability	B-T081
and	O
relevance	B-T080
,	O
which	O
in	O
turn	O
depends	O
on	O
the	O
quality	B-T080
of	O
experimental	B-T170
models	I-T170
and	O
bioanalysis	B-T062
techniques	I-T062
used	O
to	O
generate	O
toxicological	B-T169
data	B-T078
.	O
	
systems	B-T169
toxicology	O
involves	O
the	O
use	O
of	O
large-scale	O
data	B-T170
streams	I-T170
"""big"	O
data	B-T078
""""	O
,	O
such	O
as	O
those	O
derived	O
from	O
omics	B-T062
measurements	I-T062
that	O
require	O
computational	B-T052
means	O
for	O
obtaining	O
informative	B-T080
results	B-T169
.	O
	
thus	O
,	O
integrative	B-T062
analysis	I-T062
of	O
multiple	B-T081
molecular	B-T169
measurements	I-T169
,	O
particularly	O
acquired	O
by	O
omics	O
strategies	O
,	O
is	O
a	O
key	O
approach	B-T169
in	O
systems	B-T169
toxicology	O
.	O
	
in	O
recent	O
years	O
,	O
there	O
have	O
been	O
significant	O
advances	O
centered	O
on	O
in	B-T080
vitro	I-T080
test	O
systems	O
and	O
bioanalytical	O
strategies	O
,	O
yet	O
a	O
frontier	O
challenge	O
concerns	O
linking	B-T169
observed	O
network	B-T169
perturbations	B-T169
to	O
phenotypes	O
,	O
which	O
will	O
require	O
understanding	O
pathways	O
and	O
networks	B-T169
that	O
give	O
rise	O
to	O
adverse	B-T169
responses	I-T169
.	O
	
this	O
summary	B-T170
perspective	O
from	O
a	O
2016	O
systems	B-T169
toxicology	O
meeting	B-T052
,	O
an	O
international	O
conference	O
held	O
in	O
the	O
alps	O
of	O
switzerland	O
,	O
describes	O
the	O
limitations	B-T169
and	O
opportunities	B-T078
of	O
selected	O
emerging	O
applications	B-T169
in	O
this	O
rapidly	O
advancing	O
field	O
.	O
	
systems	B-T169
toxicology	O
aims	O
to	O
change	O
the	O
basis	O
of	O
how	O
adverse	B-T169
biological	I-T169
effects	I-T169
of	O
xenobiotics	O
are	O
characterized	B-T052
,	O
from	O
empirical	B-T080
end	B-T080
points	I-T080
to	O
pathways	O
of	O
toxicity	O
.	O
	
this	O
requires	O
the	O
integration	O
of	O
in	B-T080
vitro	I-T080
and	O
in	B-T082
vivo	I-T082
data	B-T078
with	O
computational	O
modeling	O
.	O
	
test	O
systems	O
and	O
bioanalytical	O
technologies	O
have	O
made	O
significant	O
advances	O
,	O
but	O
ensuring	O
data	B-T078
reliability	B-T081
and	O
relevance	B-T080
is	O
an	O
ongoing	O
concern	O
.	O
	
the	O
major	O
challenge	O
facing	O
the	O
new	O
pathway	O
approach	B-T169
is	O
determining	O
how	O
to	O
link	B-T169
observed	O
network	B-T169
perturbations	B-T169
to	O
phenotypic	O
toxicity	O
.	O
	
validating	B-T062
signs	O
and	O
symptoms	O
from	O
an	O
actual	O
mass	O
casualty	O
incident	O
to	O
characterize	B-T052
an	O
irritant	O
gas	O
syndrome	O
agent	O
igsa	O
exposure	O
a	O
first	O
step	O
in	O
the	O
development	B-T169
of	O
a	O
novel	B-T080
igsa	O
triage	B-T061
algorithm	B-T170
chemical	B-T033
exposures	I-T033
can	O
pose	O
a	O
significant	B-T078
threat	B-T078
to	O
life	B-T078
.	O
	
rapid	O
assessment	O
by	O
first	O
responders	O
/	O
emergency	O
nurses	O
is	O
required	B-T169
to	O
reduce	B-T080
death	O
and	O
disability	B-T033
.	O
	
currently	O
,	O
no	B-T169
informatics	B-T170
tools	I-T170
for	O
irritant	O
gas	O
syndrome	O
agent	O
s	O
igsa	O
exposures	B-T080
exist	O
to	O
process	O
victims	B-T098
efficiently	B-T080
,	O
continuously	B-T078
monitor	O
for	O
latent	B-T080
signs/symptoms	O
,	O
or	O
make	O
triage	B-T061
recommendations	B-T078
.	O
	
this	O
study	B-T062
describes	O
the	O
first	O
step	O
in	O
developing	O
ed	O
informatics	B-T170
tools	I-T170
for	O
chemical	O
incidents	O
validation	B-T062
of	O
signs/symptoms	O
that	O
characterize	B-T052
an	O
igsa	O
syndrome	B-T047
.	O
	
data	B-T079
abstracted	I-T079
from	O
146	O
patients	O
treated	B-T061
for	O
chlorine	B-T033
exposure	I-T033
in	O
one	O
emergency	O
department	O
during	B-T079
a	O
2005	O
train	O
derailment	O
and	O
152	O
patients	O
not	B-T169
exposed	B-T033
to	I-T033
chlorine	I-T033
a	O
comparison	O
group	O
were	O
mapped	B-T170
to	O
93	O
possible	O
signs/symptoms	O
within	O
2	O
tools	B-T170
wiser	B-T170
and	O
chemm-ist	B-T170
designed	B-T052
to	O
assist	B-T080
emergency	O
responders	O
/	O
emergency	O
nurses	O
with	O
managing	O
hazardous	O
material	O
exposures	B-T080
.	O
	
inferential	B-T081
statistics	I-T081
χ	O
fisher's	B-T170
exact	I-T170
test	I-T170
and	O
diagnostics	O
tests	O
were	O
used	B-T169
to	O
examine	O
mapped	B-T170
signs/symptoms	O
of	O
persons	B-T098
who	O
were	O
and	O
were	O
not	O
exposed	B-T033
to	I-T033
chlorine	I-T033
.	O
	
three	O
clusters	B-T081
of	O
signs/symptoms	O
are	O
statistically	B-T081
associated	B-T080
with	I-T080
an	O
igsa	O
syndrome	B-T047
p	O
<	O
01	O
respiratory	B-T169
shortness	O
of	O
breath	O
,	O
wheezing	O
,	O
coughing	O
,	O
and	O
choking	O
chest	O
discomfort	O
tightness	O
,	O
pain	O
,	O
and	O
burning	O
,	O
and	O
eye	O
,	O
nose	O
and/or	O
throat	O
pain	O
,	O
irritation	O
,	O
and	O
burning	O
.	O
	
the	O
syndrome	B-T047
requires	O
the	O
presence	B-T033
of	O
signs/symptoms	O
from	O
at	O
least	O
2	O
of	O
these	O
clusters	B-T081
.	O
	
the	O
latency	B-T079
period	I-T079
must	O
also	O
be	O
considered	B-T078
for	O
exposed	B-T098
/	O
potentially	B-T080
exposed	B-T098
persons	I-T098
.	O
	
this	O
study	B-T062
uses	B-T169
actual	O
patient	B-T170
data	I-T170
from	O
a	O
chemical	O
incident	O
to	O
characterize	B-T052
and	O
validate	B-T062
signs/symptoms	O
of	O
an	O
igsa	O
syndrome	B-T047
.	O
	
validating	B-T062
signs/symptoms	O
is	O
the	O
first	O
step	O
in	O
developing	O
new	B-T080
ed	O
informatics	B-T170
tools	I-T170
with	O
the	O
potential	B-T080
to	O
revolutionize	O
the	O
process	O
by	O
which	O
emergency	O
nurses	O
manage	O
triage	B-T061
victims	B-T098
of	O
chemical	O
incidents	O
.	O
	
fyn	B-T116
regulates	O
multipolar	B-T082
-	O
bipolar	B-T082
transition	B-T052
and	O
neurite	O
morphogenesis	O
of	O
migrating	O
neurons	O
in	O
the	O
developing	O
neocortex	O
fyn	B-T116
is	O
a	O
non-receptor	B-T033
protein	B-T116
tyrosine	I-T116
kinase	I-T116
that	O
belongs	O
to	O
src	B-T116
family	I-T116
kinases	I-T116
.	O
	
fyn	B-T116
plays	O
a	O
critical	O
role	O
in	O
neuronal	O
migration	O
,	O
but	O
the	O
mechanism	B-T169
remains	O
unclear	B-T033
.	O
	
here	O
,	O
we	O
reported	O
that	O
suppression	O
of	O
fyn	B-T116
expression	O
in	O
mouse	O
cerebral	O
cortex	O
led	O
to	O
migration	B-T033
defects	I-T033
of	O
both	O
early-born	B-T079
and	O
late-born	B-T079
neurons	O
.	O
	
morphological	B-T082
analysis	B-T062
showed	O
that	O
loss	O
of	O
fyn	B-T116
function	O
impaired	O
multipolar	B-T082
-	O
bipolar	B-T082
transition	B-T052
of	O
newly	O
generated	B-T052
neurons	O
and	O
neurite	O
formation	O
in	O
the	O
early	O
phase	B-T079
of	O
migration	O
.	O
	
moreover	O
,	O
fyn	B-T116
inhibition	O
increased	O
the	O
length	O
of	O
leading	O
process	O
and	O
decreased	O
the	O
branching	B-T082
number	O
of	O
the	O
migrating	O
cortical	O
neurons	O
.	O
	
together	O
,	O
these	O
results	O
indicate	O
that	O
fyn	B-T116
controls	B-T169
neuronal	O
migration	O
by	O
regulating	O
the	O
cytoskeletal	O
dynamics	O
and	O
multipolar	B-T082
-	O
bipolar	B-T082
transition	B-T052
of	O
newly	B-T078
generated	B-T052
neurons	O
during	O
cortical	O
development	O
.	O
	
closing	B-T169
the	I-T169
loop	I-T169
in	O
adults	O
,	O
children	O
and	O
adolescents	O
with	O
suboptimally	B-T033
controlled	I-T033
type	I-T033
1	I-T033
diabetes	I-T033
under	O
free	B-T078
living	B-T080
conditions	I-T080
a	O
psychosocial	B-T169
substudy	B-T062
the	O
objective	O
was	O
to	O
explore	O
psychosocial	B-T033
experiences	I-T033
of	O
closed	O
loop	O
technology	O
for	O
adults	O
,	O
children	O
,	O
and	O
adolescents	O
with	O
type	B-T047
1	I-T047
diabetes	I-T047
and	O
their	O
parents	O
taking	O
part	O
in	O
two	O
multicenter	B-T062
,	O
free	B-T078
-	O
living	B-T080
,	O
randomized	B-T062
crossover	B-T062
home	I-T062
studies	I-T062
.	O
	
participants	B-T098
using	O
insulin	O
pump	O
therapy	B-T061
were	O
randomized	B-T062
to	O
either	O
12	O
weeks	B-T079
of	O
automated	B-T169
closed-loop	B-T169
glucose	O
control	O
,	O
then	O
12	O
weeks	B-T079
of	O
sensor	O
augmented	B-T081
insulin	O
pump	O
therapy	B-T061
open	B-T169
loop	I-T169
,	O
or	O
vice	O
versa	O
.	O
	
closed	B-T169
loop	I-T169
was	O
used	O
for	O
24	O
hours	B-T079
by	O
adults	O
and	O
overnight	B-T079
only	O
by	O
children	O
and	O
adolescents	O
.	O
	
participants	B-T098
completed	O
the	O
diabetes	B-T170
technology	I-T170
questionnaire	I-T170
dtq	B-T170
periodically	B-T079
and	O
shared	O
their	O
views	B-T082
in	O
semistructured	O
interviews	O
.	O
	
this	O
analysis	B-T062
characterizes	B-T078
the	O
impact	B-T080
of	O
the	O
technology	O
,	O
positive	B-T033
and	O
negative	B-T080
aspects	O
of	O
living	B-T080
with	O
the	O
device	O
,	O
alongside	O
participants	B-T098
'	O
expectations	B-T078
,	O
hopes	O
,	O
and	O
anxieties	B-T033
.	O
	
participants	B-T098
were	O
32	O
adults	O
,	O
age	O
38.6	O
9.6	O
years	B-T079
,	O
55%	O
male	O
,	O
and	O
26	O
children	O
,	O
mean	O
age	O
12	O
years	B-T079
range	O
6-18	O
years	B-T079
,	O
54%	O
male	O
.	O
	
dtq	B-T170
results	B-T169
indicated	O
moderately	B-T080
favorable	I-T080
impact	I-T080
of	O
,	O
and	O
satisfaction	O
with	O
,	O
both	O
open	B-T169
and	O
closed	B-T169
loop	I-T169
interventions	B-T061
,	O
but	O
little	O
evidence	B-T078
of	O
a	O
comparative	O
advantage	O
of	O
either	O
.	O
	
key	O
positive	B-T033
themes	I-T033
included	O
perceived	O
improved	O
blood	O
glucose	O
control	O
,	O
improved	B-T033
general	I-T033
well-being	I-T033
,	O
particularly	O
on	O
waking	O
,	O
improved	O
sleep	O
,	O
reduced	B-T080
burden	B-T078
of	O
diabetes	B-T047
,	O
and	O
visibility	B-T080
of	O
data	B-T078
.	O
	
key	O
negative	B-T080
themes	I-T080
included	O
having	O
to	O
carry	O
around	O
the	O
equipment	O
and	O
dislike	O
of	O
the	O
pump	O
and	O
second	O
cannula	O
ie	O
,	O
sensor	O
inserted	O
.	O
	
overall	O
,	O
participants	B-T098
reported	O
a	O
positive	B-T033
experience	O
of	O
the	O
closed	O
loop	O
technology	O
.	O
	
results	B-T169
are	O
consistent	B-T078
with	I-T078
previous	O
research	O
with	O
size	B-T082
of	O
equipment	O
continuing	O
to	O
be	O
a	O
problem	B-T033
.	O
	
progress	O
is	O
being	O
made	O
in	O
the	O
usability	B-T169
of	O
the	O
closed-loop	O
system	O
.	O
	
serum	O
levels	B-T080
of	O
genomic	O
dna	O
of	O
α1	O
collagen	O
are	O
elevated	B-T080
in	O
scleroderma	B-T047
patients	O
recent	O
studies	O
have	O
indicated	O
that	O
various	O
nucleic	O
acids	O
are	O
present	O
in	O
human	O
sera	O
,	O
and	O
attracted	O
attention	O
for	O
their	O
potential	O
as	O
novel	O
disease	B-T078
markers	I-T078
in	O
many	O
human	O
diseases	B-T047
.	O
	
in	O
this	O
study	O
,	O
we	O
tried	O
to	O
evaluate	O
the	O
possibility	O
that	O
dna	O
and	O
rna	O
of	O
collagens	O
exist	O
in	O
human	O
sera	O
,	O
and	O
determined	O
whether	O
their	O
serum	O
levels	B-T080
can	O
be	O
useful	O
biomarkers	O
in	O
scleroderma	B-T047
patients	O
.	O
	
the	O
rna	O
or	O
dna	O
of	O
collagens	O
were	O
purified	B-T169
from	O
sera	O
,	O
and	O
detected	B-T033
by	O
polymerase	O
chain	O
reaction	O
or	O
quantitated	B-T081
by	O
real-time	O
polymerase	O
chain	O
reaction	O
.	O
	
among	O
approximately	O
18	O
360	O
bases	O
of	O
full-length	O
α1	O
collagen	O
dna	O
,	O
various	O
regions	O
were	O
detected	B-T033
by	O
polymerase	O
chain	O
reaction	O
in	O
human	O
sera	O
.	O
	
however	O
,	O
α2	O
collagen	O
dna	O
,	O
α1	O
collagen	O
rna	O
or	O
α2	O
collagen	O
rna	O
were	O
not	B-T033
detectable	I-T033
.	O
	
α1	O
collagen	O
dna	O
in	O
sera	O
was	O
quantitative	B-T081
using	O
our	O
method	O
.	O
	
the	O
levels	B-T080
of	O
serum	O
α1	O
collagen	O
dna	O
were	O
significantly	O
increased	B-T081
in	O
scleroderma	B-T047
patients	O
compared	O
with	O
healthy	B-T080
control	I-T080
subjects	B-T098
or	O
systemic	B-T047
lupus	I-T047
erythematosus	I-T047
patients	O
.	O
	
according	O
to	O
the	O
receiver-operator	B-T081
curve	I-T081
analysis	I-T081
,	O
serum	O
α1	O
collagen	O
dna	O
levels	B-T080
were	O
shown	O
to	O
be	O
effective	O
as	O
a	O
diagnostic	O
marker	O
of	O
scleroderma	B-T047
.	O
	
furthermore	O
,	O
when	O
we	O
determined	O
the	O
association	B-T080
of	O
serum	O
α1	O
collagen	O
dna	O
levels	B-T080
with	O
clinical	B-T080
/	O
laboratory	O
features	B-T080
in	O
scleroderma	B-T047
patients	O
,	O
those	O
with	O
elevated	B-T080
α1	O
collagen	O
dna	O
levels	B-T080
showed	O
significantly	O
higher	O
prevalence	B-T081
of	O
pitting	B-T047
scars	I-T047
/	O
ulcers	B-T047
.	O
	
in	O
summary	O
,	O
elevation	B-T080
of	O
serum	O
α1	O
collagen	O
dna	O
levels	B-T080
in	O
scleroderma	B-T047
patients	O
may	O
be	O
useful	O
as	O
the	O
diagnostic	O
marker	O
,	O
reflecting	O
the	O
presence	O
of	O
vasculopathy	B-T047
.	O
	
jou	O
metabolite	O
mapping	B-T052
by	O
consecutive	O
nanostructure	O
and	O
silver-assisted	O
mass	O
spectrometry	O
imaging	O
on	O
tissue	O
sections	O
nanostructure-based	O
mass	O
spectrometry	O
imaging	O
msi	O
is	O
a	O
promising	O
technology	O
for	O
molecular	O
imaging	O
of	O
small	B-T109
molecules	I-T109
,	O
without	O
the	O
complex	O
chemical	O
background	O
typically	O
encountered	O
in	O
matrix-assisted	O
molecular	O
imaging	O
approaches	O
.	O
	
here	O
,	O
we	O
have	O
enhanced	O
these	O
surfaces	B-T082
with	O
silver	O
ag	O
to	O
provide	O
a	O
second	O
tier	O
of	O
msi	B-T170
data	I-T170
from	O
a	O
single	O
sample	O
.	O
	
msi	B-T170
data	I-T170
was	O
acquired	O
through	O
the	O
application	B-T169
of	O
laser	O
desorption/ionization	O
mass	O
spectrometry	O
to	O
biological	O
samples	O
imprinted	O
onto	O
desorption/ionization	O
on	O
silicon	O
dios	O
substrates	O
.	O
	
following	O
initial	O
analysis	B-T062
,	O
ultra-thin	B-T080
ag	I-T080
layers	I-T080
were	O
overlaid	O
onto	O
the	O
followed	O
by	O
msi	O
analysis	O
ag-dios	O
msi	O
.	O
	
this	O
approach	O
was	O
first	O
demonstrated	O
for	O
fingermark	O
small	B-T109
molecules	I-T109
including	O
environmental	B-T082
contaminants	O
and	O
sebum	O
components	O
.	O
	
subsequently	O
,	O
this	O
bimodal	O
method	O
was	O
translated	O
to	O
lipids	B-T109
and	O
metabolites	O
in	O
fore-stomach	O
sections	O
from	O
a	O
6-bromoisatin	B-T109
chemopreventative	B-T080
murine	O
mouse	O
model	O
.	O
	
dios	O
msi	O
allowed	O
mapping	B-T052
of	O
common	O
ions	O
in	O
fingermarks	O
as	O
well	O
as	O
6-bromoisatin	B-T109
metabolites	O
and	O
lipids	B-T109
in	O
murine	O
fore-stomach	O
.	O
	
furthermore	O
,	O
dios	O
msi	O
was	O
complemented	O
by	O
the	O
ag-dios	O
msi	O
of	O
ag-adductable	B-T109
lipids	I-T109
such	O
as	O
wax	B-T109
esters	I-T109
in	O
fingermarks	O
and	O
cholesterol	B-T109
in	O
murine	O
fore-stomach	O
.	O
	
gastrointestinal	O
acid	O
condensation	O
products	O
of	O
6-bromoisatin	B-T109
,	O
such	O
as	O
the	O
6	O
mapped	O
herein	O
,	O
are	O
very	O
challenging	O
to	O
isolate	O
and	O
characterize	B-T052
.	O
	
by	O
re-analyzing	O
the	O
same	O
tissue	O
imprints	O
,	O
this	O
metabolite	O
was	O
readily	O
detected	O
by	O
dios	O
,	O
placed	O
in	O
a	O
tissue-specific	O
spatial	O
context	O
,	O
and	O
subsequently	O
overlaid	O
with	O
additional	O
lipid	O
distributions	O
acquired	O
using	O
ag-dios	O
msi	O
.	O
	
the	O
ability	O
to	O
place	O
metabolite	O
and	O
lipid	B-T109
classes	O
in	O
a	O
tissue-specific	O
context	O
makes	O
this	O
novel	O
method	O
suited	O
to	O
msi	O
analyses	O
where	O
the	O
collection	O
of	O
additional	O
information	O
from	O
the	O
same	O
sample	O
maximises	O
resource	O
use	O
,	O
and	O
also	O
maximises	O
the	O
number	O
of	O
annotated	O
small	B-T109
molecules	I-T109
,	O
in	O
particular	O
for	O
metabolites	O
that	O
are	O
typically	O
undetectable	O
towards	O
culturally	O
competent	O
paediatric	O
oncology	O
care	O
.	O
	
a	O
qualitative	B-T062
study	I-T062
from	O
the	O
perspective	O
of	O
care	O
providers	O
in	O
order	O
to	O
gain	O
more	O
insight	O
on	O
the	O
influence	O
of	O
ethnic	B-T033
diversity	B-T080
in	O
paediatric	O
cancer	B-T061
care	I-T061
,	O
the	O
perspectives	O
of	O
care	O
providers	O
were	O
explored	O
.	O
	
semi-structured	O
interviews	O
were	O
conducted	O
among	O
12	O
paediatric	O
oncologists	O
and	O
13	O
nurses	O
of	O
two	O
different	O
paediatric	O
oncology	O
wards	O
and	O
were	O
analysed	B-T062
using	O
a	O
framework	B-T170
method	I-T170
.	O
	
we	O
found	O
that	O
care	O
providers	O
described	O
the	O
contact	O
with	O
turkish	B-T098
and	O
moroccan	B-T098
parents	O
as	O
more	O
difficult	O
.	O
	
they	O
offered	O
two	O
reasons	O
for	O
this	O
1	O
language	B-T033
barriers	I-T033
between	O
care	O
provider	O
and	O
parents	O
hindered	B-T169
the	O
exchange	B-T170
of	I-T170
information	I-T170
2	O
cultural	O
barriers	O
between	O
care	O
provider	O
and	O
parents	O
about	O
sharing	O
the	O
diagnosis	B-T033
and	O
palliative	B-T080
perspective	O
hindered	B-T169
communication	O
.	O
	
care	O
providers	O
reported	O
different	O
solutions	O
to	O
deal	O
with	O
these	O
barriers	B-T078
,	O
such	O
as	O
using	O
an	O
interpreter	O
and	O
improving	O
their	O
cultural	B-T170
knowledge	I-T170
about	O
their	O
patients	O
.	O
	
they	O
,	O
however	O
,	O
were	O
not	O
using	O
interpreters	O
sufficiently	O
and	O
were	O
unaware	O
of	O
the	O
importance	O
of	O
eliciting	O
parents	O
'	O
perspectives	O
.	O
	
communication	O
techniques	B-T169
to	O
overcome	O
dilemmas	O
between	O
parents	O
and	O
care	O
providers	O
were	O
not	O
used	O
and	O
care	O
providers	O
were	O
unaware	O
of	O
stereotypes	O
and	O
prejudice	O
.	O
	
care	O
providers	O
should	O
be	O
offered	O
insight	O
in	O
cultural	O
barriers	O
they	O
are	O
unaware	O
of	O
.	O
	
training	O
in	O
cultural	O
competence	O
might	O
be	O
a	O
possibility	O
to	O
overcome	O
manifest	B-T169
barriers	B-T078
.	O
	
obesogenic	B-T047
eating	O
behaviors	O
mediate	O
the	O
relationships	B-T080
between	O
psychological	B-T033
problems	I-T033
and	O
bmi	O
in	O
children	O
to	O
examine	O
the	O
association	B-T080
between	O
psychological	B-T033
problems	I-T033
and	O
weight	O
status	B-T080
in	O
children	O
aged	O
3.5	O
to	O
4	O
years	B-T079
and	O
test	O
whether	O
obesogenic	B-T047
eating	O
behaviors	O
mediate	O
this	O
relationship	B-T080
.	O
	
this	O
study	O
is	O
a	O
cross-sectional	B-T062
secondary	I-T062
analysis	I-T062
of	O
data	B-T078
from	O
first-time	O
mothers	O
n	O
=	O
194	O
in	O
the	O
control	O
arm	O
of	O
the	O
nourish	B-T062
randomized	I-T062
controlled	I-T062
trial	I-T062
.	O
	
at	O
child	O
age	O
3.5	O
to	O
4	O
years	O
,	O
maternal	O
-reported	O
child	O
eating	O
behaviors	O
and	O
psychological	O
problems	O
were	O
collected	O
via	O
valid	O
tools	O
,	O
and	O
child	O
weight	O
and	O
height	O
data	O
were	O
collected	O
by	O
trained	O
study	O
staff	O
.	O
	
pearson's	O
correlations	O
and	O
linear	O
regressions	O
examined	O
associations	O
between	O
eating	O
behaviors	O
,	O
psychological	O
problems	O
,	O
and	O
bmi	O
z	O
score	O
.	O
	
multiple	O
mediation	O
models	O
were	O
tested	O
by	O
assessing	O
indirect	O
effects	O
of	O
psychological	O
problems	O
on	O
bmi	O
z	O
score	O
via	O
obesogenic	O
eating	O
behaviors	O
.	O
	
peer	O
problems	O
were	O
associated	O
with	O
both	O
higher	O
food	O
responsiveness	O
and	O
emotional	O
overeating	O
and	O
directly	O
with	O
higher	O
bmi	O
z	O
score	O
.	O
	
this	O
relationship	O
was	O
partially	O
mediated	O
by	O
emotional	O
overeating	O
.	O
	
both	O
emotional	O
overeating	O
and	O
food	O
responsiveness	O
fully	O
mediated	O
the	O
association	O
between	O
emotional	O
problems	O
and	O
bmi	O
z	O
score	O
,	O
and	O
food	O
responsiveness	O
fully	O
mediated	O
the	O
association	O
between	O
conduct	O
problems	O
and	O
bmi	O
z	O
score	O
.	O
	
the	O
findings	O
suggest	O
that	O
children	O
with	O
psychological	O
problems	O
may	O
also	O
display	O
obesogenic	O
eating	O
behaviors	O
,	O
which	O
may	O
result	O
in	O
higher	O
bmi	O
.	O
	
this	O
needs	O
to	O
be	O
considered	O
in	O
the	O
clinical	O
management	O
of	O
both	O
pediatric	O
overweight	O
/	O
obesity	O
and	O
psychological	O
problems	I-T033
homocysteine	B-T116
as	O
a	O
peripheral	B-T082
biomarker	O
in	O
bipolar	O
disorder	O
a	O
meta-analysis	B-T062
bipolar	O
disorder	O
bd	O
is	O
a	O
psychiatric	O
disorder	O
with	O
an	O
uncertain	B-T033
aetiology	B-T169
.	O
	
recently	O
,	O
special	O
attention	O
has	O
been	O
given	O
to	O
homocysteine	B-T116
hcy	B-T116
,	O
as	O
it	O
has	O
been	O
suggested	O
that	O
alterations	B-T078
in	O
1-carbon	O
metabolism	O
might	O
be	O
implicated	O
in	O
diverse	O
psychiatric	O
disorders	O
.	O
	
however	O
,	O
there	O
is	O
uncertainty	B-T033
regarding	O
possible	O
alterations	B-T078
in	O
peripheral	B-T082
hcy	B-T116
levels	O
in	O
bd	O
.	O
	
this	O
study	O
comprises	O
a	O
meta-analysis	B-T062
comparing	O
serum	O
and	O
plasma	O
hcy	O
levels	O
in	O
persons	B-T098
with	O
bd	O
and	O
healthy	B-T080
controls	I-T080
.	O
	
we	O
conducted	O
a	O
systematic	B-T169
search	B-T052
for	O
all	O
eligible	B-T080
english	O
and	O
non-english	O
peer-reviewed	B-T170
articles	I-T170
.	O
	
nine	O
cross-sectional	B-T062
studies	I-T062
were	O
included	B-T169
in	O
the	O
meta-analyses	B-T062
,	O
providing	B-T052
data	B-T078
on	O
1547	O
participants	B-T098
.	O
	
random-effects	B-T080
meta-analysis	B-T062
showed	O
that	O
serum	O
and	O
plasma	O
levels	O
of	O
hcy	O
were	O
increased	B-T081
in	O
subjects	O
with	O
bd	O
in	O
either	O
mania	O
or	O
euthymia	O
when	O
compared	B-T052
to	O
healthy	B-T080
controls	I-T080
,	O
with	O
a	O
large	O
effect	B-T081
size	I-T081
in	O
the	O
mania	O
group	B-T098
g=0	O
,	O
95%	O
ci	B-T081
0.8	O
,	O
p<0	O
,	O
n=495	O
and	O
a	O
small	O
effect	B-T080
in	O
the	O
euthymia	O
group	B-T098
g=0	O
,	O
95%	O
ci	B-T081
0.11	O
,	O
p=0	O
,	O
n=1052	O
.	O
	
our	O
meta-analysis	B-T062
provides	O
evidence	O
that	O
hcy	B-T033
levels	I-T033
are	I-T033
elevated	I-T033
in	O
persons	B-T098
with	O
bd	O
during	O
mania	O
and	O
euthymia	O
.	O
	
peripheral	B-T082
hcy	B-T116
could	O
be	O
considered	B-T078
as	O
a	O
potential	B-T080
biomarker	O
in	O
bd	O
,	O
both	O
of	O
trait	O
since	O
it	O
is	O
increased	B-T081
in	O
euthymia	O
,	O
and	O
also	O
of	O
state	B-T169
since	O
its	O
increase	B-T169
is	O
more	O
accentuated	B-T080
in	O
mania	O
.	O
	
longitudinal	B-T062
studies	I-T062
are	O
needed	O
to	O
clarify	O
the	O
relationship	B-T080
between	O
bipolar	O
disorder	O
and	O
hcy	B-T116
,	O
as	O
well	O
as	O
the	O
usefulness	B-T080
of	O
peripheral	B-T082
hcy	B-T116
as	O
both	O
a	O
trait	O
and	O
state	B-T169
biomarker	O
in	O
structural	B-T061
modification	I-T061
of	O
lipopolysaccharide	B-T109
conferred	O
by	O
mcr-1	O
in	O
gram-negative	O
eskape	O
pathogens	O
mcr-1	O
was	O
initially	O
reported	O
as	O
the	O
first	O
plasmid	O
-mediated	O
colistin	B-T116
resistance	O
gene	O
in	O
clinical	O
isolates	O
of	O
escherichia	O
coli	O
and	O
klebsiella	O
pneumoniae	O
in	O
china	O
and	O
has	O
subsequently	O
been	O
identified	O
worldwide	O
in	O
various	O
species	O
of	O
the	O
family	O
enterobacteriaceae	O
mcr-1	O
encodes	O
a	O
phosphoethanolamine	O
transferase	O
,	O
and	O
its	O
expression	O
has	O
been	O
shown	O
to	O
generate	O
phosphoethanolamine	B-T109
-modified	O
bis-phosphorylated	B-T109
hexa-acylated	I-T109
lipid	I-T109
a	I-T109
in	O
e	O
.	O
	
coli	O
here	O
,	O
we	O
investigated	O
the	O
effects	B-T080
of	I-T080
mcr-1	O
on	O
colistin	B-T116
susceptibility	B-T033
and	O
on	O
lipopolysaccharide	B-T109
structures	B-T082
in	O
laboratory	O
and	O
clinical	B-T080
strains	B-T080
of	O
the	O
gram-negative	O
eskape	O
enterococcus	O
faecium	O
,	O
staphylococcus	O
aureus	O
,	O
k	O
.	O
	
pneumoniae	O
,	O
acinetobacter	O
baumannii	O
,	O
pseudomonas	O
aeruginosa	O
,	O
and	O
enterobacter	O
species	O
pathogens	O
,	O
which	O
are	O
often	O
treated	O
clinically	O
by	O
colistin	O
.	O
	
the	O
effects	O
of	O
mcr-1	O
on	O
colistin	O
resistance	O
were	O
determined	O
using	O
mic	O
assays	O
of	O
laboratory	O
and	O
clinical	O
strains	O
of	O
e	O
.	O
	
coli	O
,	O
k	O
.	O
	
pneumoniae	O
,	O
a	O
.	O
	
baumannii	O
,	O
and	O
p	O
.	O
	
aeruginosa	O
lipid	O
a	O
structural	O
changes	O
resulting	O
from	O
mcr-1	O
were	O
analyzed	O
by	O
mass	O
spectrometry	O
.	O
	
the	O
introduction	O
of	O
mcr-1	O
led	O
to	O
colistin	O
resistance	O
in	O
e	O
.	O
	
coli	O
,	O
k	O
.	O
	
pneumoniae	O
,	O
and	O
a	O
.	O
	
baumannii	O
but	O
only	O
moderately	O
reduced	O
susceptibility	O
in	O
p	O
.	O
	
aeruginosa	O
phosphoethanolamine	O
modification	O
of	O
lipid	O
a	O
was	O
observed	O
consistently	O
for	O
all	O
four	O
species	O
.	O
	
these	O
findings	O
highlight	O
the	O
risk	O
of	O
colistin	O
resistance	O
as	O
a	O
consequence	O
of	O
mcr-1	O
expression	O
among	O
eskape	O
pathogens	O
,	O
especially	O
in	O
k	O
.	O
	
pneumoniae	O
and	O
a	O
.	O
	
baumannii	O
furthermore	O
,	O
the	O
observation	O
that	O
lipid	O
a	O
structures	O
were	O
modified	O
despite	O
only	O
modest	O
increases	O
in	O
colistin	O
mics	O
in	O
some	O
instances	O
suggests	O
more	O
sophisticated	O
surveillance	O
methods	O
may	O
need	O
to	O
be	O
developed	O
to	O
track	O
the	O
dissemination	O
of	O
mcr-1	O
or	O
plasmid	O
-mediated	O
phosphoethanolamine	O
transferases	O
in	O
effects	B-T080
of	O
transplanted	B-T061
human	O
cord	O
blood	O
-	O
mononuclear	O
cells	O
on	O
pulmonary	O
hypertension	O
in	O
immunodeficient	O
mice	O
and	O
their	O
distribution	B-T169
to	O
investigate	O
the	O
effects	B-T080
of	O
human	O
umbilical	O
cord	O
blood	O
-derived	O
mononuclear	O
cell	O
hucb	O
-	O
mnc	O
transplantation	B-T061
on	O
pulmonary	O
hypertension	O
ph	O
induced	B-T169
by	O
monocrotaline	B-T109
mct	B-T109
in	O
immunodeficient	O
mice	O
and	O
their	O
distribution	B-T169
.	O
	
mct	B-T109
was	O
administered	B-T169
to	O
balb/c	O
slc-nu/nu	O
mice	O
,	O
and	O
ph	O
was	O
induced	B-T169
in	O
mice	O
4	O
weeks	O
later	O
.	O
	
fresh	B-T080
hucb	O
-	O
mncs	O
harvested	B-T061
from	O
a	O
human	O
donor	B-T098
after	O
her	O
delivery	B-T169
were	O
injected	B-T169
intravenously	I-T169
into	O
those	O
ph	O
mice	O
.	O
	
the	O
medial	B-T082
thickness	B-T080
of	O
pulmonary	O
arterioles	O
,	O
ratio	B-T081
of	O
right	O
ventricular	O
to	O
septum	O
plus	B-T169
left	O
ventricular	O
weight	B-T081
rv	O
/	O
s	O
+	O
lv	O
,	O
and	O
ratio	B-T081
of	O
acceleration	B-T081
time	I-T081
to	O
ejection	O
time	O
of	O
pulmonary	O
blood	O
flow	O
waveform	O
at	B-T081
/	O
et	O
were	O
determined	B-T080
4	O
weeks	O
after	O
hucb	O
-	O
mnc	O
transplantation	B-T061
.	O
	
to	O
reveal	B-T080
the	O
incorporation	B-T169
into	O
the	O
lung	O
,	O
cmtmr	B-T109
-	O
labeled	O
hucb	O
-	O
mncs	O
were	O
observed	B-T169
in	O
the	O
lung	O
by	O
fluorescent	O
microscopy	O
.	O
	
dir-labeled	O
hucb	O
-	O
mncs	O
were	O
detected	B-T033
in	O
the	O
lung	O
and	O
other	O
organs	O
by	O
bioluminescence	O
images	O
.	O
	
medial	B-T082
thickness	B-T080
,	O
rv	O
/	O
s	O
+	O
lv	O
and	O
at	B-T081
/	O
et	O
were	O
significantly	B-T078
improved	B-T033
4	O
weeks	O
after	O
hucb	O
-	O
mnc	O
transplantation	B-T061
compared	B-T052
with	O
those	O
in	O
mice	O
without	O
hucb	O
-	O
mnc	O
transplantation	B-T061
.	O
	
cmtmr	B-T109
-	O
positive	B-T033
hucb	O
-	O
mncs	O
were	O
observed	B-T169
in	O
the	O
lung	O
3	O
hours	O
after	O
transplantation	B-T061
.	O
	
bioluminescence	O
signals	O
were	O
detected	B-T033
more	O
strongly	B-T080
in	O
the	O
lung	O
than	O
in	O
other	O
organs	O
for	O
24	O
hours	O
after	O
transplantation	B-T061
.	O
	
the	O
results	B-T033
indicate	B-T033
that	O
hucb	O
-	O
mncs	O
are	O
incorporated	B-T169
into	O
the	O
lung	O
early	B-T079
after	O
hucb	O
-	O
mnc	O
transplantation	B-T061
and	O
improve	B-T033
mct	B-T109
-	O
induced	B-T169
ph	O
.	O
	
interprofessional	B-T033
barriers	I-T033
a	O
study	O
of	O
quality	O
improvement	O
work	O
among	O
nurses	O
and	O
physicians	O
this	O
article	O
studies	O
interprofessional	B-T033
barriers	I-T033
between	O
nurses	O
and	O
physicians	O
in	O
the	O
context	B-T078
of	O
quality	O
improvement	O
work	O
.	O
	
a	O
total	O
of	O
17	O
nurses	O
and	O
10	O
physicians	O
were	O
interviewed	B-T062
at	O
2	O
hospitals	O
in	O
sweden	O
.	O
	
the	O
study	B-T169
uncovered	I-T169
a	O
number	B-T033
of	I-T033
barriers	I-T033
relating	O
to	O
both	O
the	O
relative	O
status	O
of	O
each	B-T078
group	I-T078
and	O
their	O
defined	O
areas	O
of	O
responsibility	O
.	O
	
recovery	B-T052
from	O
alcohol	O
dependence	O
do	O
smoking	O
indicators	B-T169
predict	O
abstinence	B-T061
there	O
is	O
inconsistent	B-T080
evidence	B-T078
about	O
the	O
potential	B-T080
influence	O
of	O
smoking	O
on	O
recovery	B-T052
from	O
alcohol	O
dependence	O
.	O
	
our	O
study	O
aimed	O
at	O
assessing	O
the	O
impact	B-T080
of	O
smoking-behavior	O
on	O
relapse	O
during	O
a	O
12	O
months	B-T079
follow-up	O
period	B-T079
following	O
a	O
detoxification	B-T061
in	O
patients	O
with	O
alcohol	O
use	O
disorder	O
aud	O
.	O
	
three	O
hundred	O
patients	O
with	O
aud	O
74.9	O
smoking	O
were	O
recruited	O
from	O
two	O
inpatient	O
detoxification	O
units	O
in	O
psychiatric	O
hospitals	O
in	O
germany	O
and	O
their	O
alcohol	O
consumption	O
was	O
prospectively	O
followed	O
for	O
1	O
year	B-T079
.	O
	
data	B-T078
on	O
different	O
indicators	B-T169
of	O
smoking	O
behavior	O
was	O
gathered	O
.	O
	
cox	B-T081
regression	I-T081
model	I-T081
was	O
used	O
to	O
evaluate	O
potential	B-T080
risk	B-T033
factors	I-T033
on	O
time	O
to	O
relapse	O
of	O
alcohol	O
consumption	O
.	O
	
two	O
hundred	O
seventy-nine	O
participants	B-T098
n	O
=	O
279	O
were	O
included	O
in	O
the	O
final	B-T079
analysis	B-T062
.	O
	
smoking	O
increased	B-T081
the	O
risk	B-T078
for	O
alcohol	O
relapse	O
hazard	B-T081
ratio	I-T081
=	O
3.962	O
,	O
95%	O
ci	B-T081
1.582	O
.	O
	
however	O
,	O
this	O
increased	B-T081
risk	B-T078
is	O
slightly	O
reduced	B-T080
with	O
higher	O
numbers	O
of	O
daily	B-T079
consumed	B-T033
cigarettes	I-T033
hazard	B-T081
ratio	I-T081
per	B-T080
cigarette	B-T033
=	O
986	O
,	O
95%	O
ci	B-T081
976-	O
.	O
	
smoking	B-T033
reduced	I-T033
the	O
probability	B-T081
of	O
maintaining	B-T052
alcohol	B-T061
abstinence	I-T061
significantly	B-T078
,	O
whereas	O
higher	B-T080
number	O
of	O
cigarettes	B-T033
smoked	I-T033
daily	B-T079
diminished	B-T081
the	O
increased	B-T081
risk	B-T078
of	O
alcohol	O
relapse	O
in	O
alcohol-dependent	O
patients	O
.	O
	
coordinated	B-T169
psychiatric	B-T169
and	O
substance	O
abuse	O
interventions	B-T061
for	O
different	O
subgroups	O
of	O
patients	O
with	O
aud	O
in	O
the	O
post-acute	O
treatment	O
phase	O
are	O
necessary	O
.	O
	
individualized	B-T080
treatment	B-T169
planning	O
is	O
especially	O
important	O
in	O
smoking	O
patients	O
with	O
aud	O
who	O
are	O
vulnerable	O
for	O
a	O
relapse	O
to	O
alcohol	O
drinking	O
and	O
for	O
somatic	B-T080
complications	O
.	O
	
our	O
findings	B-T033
might	O
support	O
individualized	B-T080
treatment	B-T170
plans	I-T170
similar	O
patterns	B-T082
of	O
neural	O
activity	O
predict	O
memory	O
function	O
during	O
encoding	O
and	O
retrieval	O
neural	O
networks	O
that	O
span	B-T081
the	O
medial	O
temporal	O
lobe	O
mtl	O
,	O
prefrontal	O
cortex	O
,	O
and	O
posterior	O
cortical	O
regions	O
are	O
essential	O
to	O
episodic	O
memory	O
function	O
in	O
humans	O
.	O
	
encoding	O
and	O
retrieval	O
are	O
supported	O
by	O
the	O
engagement	O
of	O
both	O
distinct	O
neural	O
pathways	O
across	O
the	O
cortex	O
and	O
common	O
structures	B-T082
within	O
the	O
medial	O
temporal	O
lobes	O
.	O
	
however	O
,	O
the	O
degree	O
to	O
which	O
memory	O
performance	O
can	O
be	O
determined	O
by	O
neural	O
processing	O
that	O
is	O
common	O
to	O
encoding	O
and	O
retrieval	O
remains	O
to	O
be	O
determined	O
.	O
	
to	O
identify	O
neural	B-T169
signatures	I-T169
of	O
successful	O
memory	O
function	O
,	O
we	O
administered	O
a	O
delayed	O
free-recall	O
task	O
to	O
187	O
neurosurgical	B-T061
patients	O
implanted	B-T061
with	O
subdural	O
or	O
intraparenchymal	O
depth	O
electrodes	O
.	O
	
we	O
developed	O
multivariate	B-T170
classifiers	I-T170
to	O
identify	O
patterns	B-T082
of	O
spectral	O
power	O
across	O
the	O
brain	O
that	O
independently	O
predicted	O
successful	O
episodic	O
encoding	O
and	O
retrieval	O
.	O
	
during	O
encoding	O
and	O
retrieval	O
,	O
patterns	B-T082
of	O
increased	O
high	B-T079
frequency	I-T079
activity	O
in	O
prefrontal	O
,	O
mtl	O
,	O
and	O
inferior	O
parietal	O
cortices	O
,	O
accompanied	O
by	O
widespread	O
decreases	O
in	O
low	B-T079
frequency	I-T079
power	O
across	O
the	O
brain	O
predicted	O
successful	O
memory	O
function	O
.	O
	
using	O
a	O
cross-decoding	B-T081
approach	I-T081
,	O
we	O
demonstrate	O
the	O
ability	O
to	O
predict	O
memory	O
function	O
across	O
distinct	O
phases	O
of	O
the	O
free-recall	O
task	O
.	O
	
furthermore	O
,	O
we	O
demonstrate	O
that	O
classifiers	B-T170
that	O
combine	O
information	O
from	O
both	O
encoding	O
and	O
retrieval	O
states	O
can	O
outperform	O
task-independent	B-T170
models	I-T170
.	O
	
these	O
findings	O
suggest	O
that	O
the	O
engagement	O
of	O
a	O
core	O
memory	O
network	O
during	O
either	O
encoding	O
or	O
retrieval	O
shapes	B-T082
the	O
ability	B-T033
to	I-T033
remember	I-T033
the	I-T033
past	I-T033
,	O
despite	O
distinct	O
neural	O
interactions	O
that	O
facilitate	O
encoding	O
and	O
trump's	O
got	O
the	O
right	B-T078
idea	I-T078
i	O
am	O
a	O
us	O
nursing	O
student	O
and	O
feel	O
that	O
obamacare	O
is	O
a	O
bad	B-T078
idea	I-T078
.	O
	
i'm	O
disappointed	O
that	O
president	O
trump	O
was	O
not	B-T033
able	I-T033
to	I-T033
get	I-T033
rid	I-T033
of	I-T033
it	O
last	B-T079
month	I-T079
.	O
	
bilirubin	B-T109
and	O
atherosclerotic	B-T047
diseases	B-T047
bilirubin	B-T109
is	O
the	O
final	O
product	O
of	O
heme	O
catabolism	O
in	O
the	O
systemic	O
circulation	O
.	O
	
for	O
decades	B-T081
,	O
increased	B-T081
serum	O
/	O
plasma	O
bilirubin	B-T109
levels	B-T080
were	O
considered	O
an	O
ominous	O
sign	B-T033
of	O
an	O
underlying	O
liver	B-T047
disease	I-T047
.	O
	
however	O
,	O
data	B-T078
from	O
recent	O
years	B-T079
convincingly	O
suggest	O
that	O
mildly	O
elevated	B-T080
bilirubin	B-T109
concentrations	B-T081
are	O
associated	B-T080
with	O
protection	B-T033
against	O
various	O
oxidative	O
stress	O
-mediated	O
diseases	B-T047
,	O
atherosclerotic	O
conditions	O
being	O
the	O
most	O
clinically	O
relevant	O
.	O
	
although	O
scarce	O
data	O
on	O
beneficial	O
effects	O
of	O
bilirubin	O
had	O
been	O
published	O
also	O
in	O
the	O
past	O
,	O
it	O
took	O
until	O
1994	O
when	O
the	O
first	O
clinical	O
study	O
demonstrated	O
an	O
increased	O
risk	O
of	O
coronary	O
heart	O
disease	O
in	O
subjects	O
with	O
low	O
serum	O
bilirubin	O
levels	O
,	O
and	O
bilirubin	O
was	O
found	O
to	O
be	O
a	O
risk	O
factor	O
for	O
atherosclerotic	O
diseases	B-T047
independent	O
of	O
standard	O
risk	O
factors	O
.	O
	
consistent	O
with	O
these	O
results	O
,	O
we	O
proved	O
in	O
our	O
own	O
studies	O
,	O
that	O
subjects	O
with	O
mild	O
elevation	O
of	O
serum	O
levels	O
of	O
unconjugated	O
bilirubin	O
benign	O
hyperbilirubinemia	O
,	O
gilbert	O
syndrome	O
have	O
much	O
lower	O
prevalence	O
/	O
incidence	O
of	O
coronary	O
heart	O
as	O
well	O
as	O
peripheral	O
vascular	O
disease	O
.	O
	
we	O
have	O
also	O
demonstrated	O
that	O
this	O
association	O
is	O
even	O
more	O
general	O
,	O
with	O
serum	O
bilirubin	O
being	O
a	O
biomarker	O
of	O
numerous	O
other	O
diseases	O
,	O
often	O
associated	O
with	O
increased	O
risk	O
of	O
atherosclerosis	O
.	O
	
in	O
addition	O
,	O
very	O
recent	O
data	O
have	O
demonstrated	O
biological	O
pathways	O
modulated	O
by	O
bilirubin	O
,	O
which	O
are	O
responsible	O
for	O
observed	O
strong	O
clinical	O
associations	B-T080
an	O
automated	B-T169
,	O
pharmacist	O
-driven	O
initiative	O
improves	B-T033
quality	O
of	O
care	O
for	O
staphylococcus	B-T047
aureus	I-T047
bacteremia	I-T047
infectious	B-T047
diseases	I-T047
id	B-T047
consultation	O
and	O
antimicrobial	O
stewardship	O
intervention	O
have	O
been	O
shown	O
to	O
improve	B-T033
the	O
management	O
of	O
staphylococcus	B-T047
aureus	I-T047
bacteremia	I-T047
sab	B-T047
.	O
	
as	O
the	O
workload	B-T081
of	O
antimicrobial	O
stewardship	O
programs	O
asps	O
continues	O
to	O
increase	O
,	O
asps	O
must	O
find	O
a	O
way	O
to	O
maximize	O
the	O
efficiency	B-T078
of	I-T078
the	I-T078
program	I-T078
while	O
optimizing	O
patient	O
outcomes	B-T169
.	O
	
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
impact	B-T080
of	O
incorporating	O
health	O
informatics	O
into	O
the	O
management	O
of	O
sab	B-T047
via	O
a	O
pharmacist	O
-driven	O
initiative	O
.	O
	
retrospective	B-T080
,	O
single-center	O
quasi-experimental	B-T062
study	B-T062
of	O
hospitalized	O
patients	O
with	O
sab	B-T047
.	O
	
during	O
the	O
intervention	B-T061
period	B-T079
,	O
pharmacists	O
were	O
alerted	O
to	O
patients	O
with	O
sab	B-T047
via	O
a	O
patient	O
scoring	O
tool	O
integrated	O
into	O
the	O
electronic	B-T170
medical	I-T170
record	I-T170
.	O
	
pharmacists	O
utilized	O
the	O
scoring	O
tool	O
and	O
the	O
institution's	O
evidence-based	B-T169
practice	I-T169
guideline	B-T170
to	O
make	O
standardized	B-T078
recommendations	I-T078
to	O
promote	O
adherence	B-T169
to	O
sab	B-T047
quality-of-care	O
measures	B-T081
and	O
encourage	O
id	B-T047
consultation	O
.	O
	
the	O
primary	B-T080
outcome	B-T169
was	O
overall	O
compliance	B-T033
along	O
with	O
adherence	B-T169
to	O
individual	B-T098
quality-of-care	O
components	O
.	O
	
secondary	B-T080
clinical	O
outcomes	B-T169
were	O
also	O
analyzed	B-T062
.	O
	
84	O
patients	O
were	O
identified	O
for	O
study	B-T062
inclusion	B-T080
,	O
45	O
in	O
the	O
pre-	O
intervention	B-T061
and	O
39	O
in	O
the	O
intervention	B-T061
group	B-T078
.	O
	
as	O
a	O
whole	O
,	O
all	O
four	O
quality-of-care	O
components	O
for	O
the	O
management	O
of	O
sab	B-T047
were	O
significantly	B-T078
more	O
frequently	O
adhered	O
to	O
in	O
the	O
intervention	B-T061
group	B-T078
68.9	O
vs	O
.	O
	
92.3	O
p=0	O
.	O
	
the	O
incidence	B-T081
of	O
id	B-T047
consult	O
improved	B-T033
significantly	B-T078
by	O
almost	O
20%	O
in	O
the	O
intervention	B-T061
group	B-T078
75.6	O
vs	O
.	O
	
94.9	O
,	O
p=0	O
.	O
	
no	O
statistically	B-T081
significant	I-T081
differences	B-T080
in	O
duration	O
of	O
bacteremia	B-T047
,	O
length-of-stay	B-T079
,	O
infection	O
-related	O
length-of-stay	B-T079
,	O
or	O
readmission	O
were	O
observed	O
between	O
the	O
groups	B-T078
.	O
	
the	O
incidence	B-T081
of	O
all-cause	O
mortality	B-T081
was	O
6-fold	O
higher	O
in	O
the	O
pre-	O
intervention	B-T061
group	B-T078
compared	O
to	O
the	O
intervention	B-T061
group	B-T078
15.6	O
vs	O
.	O
	
2.6	O
,	O
p=0	O
.	O
	
an	O
automated	B-T169
,	O
pharmacist	O
-driven	O
intervention	B-T061
for	O
the	O
management	O
of	O
patients	O
with	O
sab	B-T047
demonstrated	O
a	O
significant	B-T078
improvement	O
in	O
patients	O
receiving	O
an	O
id	B-T047
consult	O
,	O
targeted	B-T169
antimicrobial	O
therapy	O
,	O
and	O
adherence	B-T169
to	O
all	O
sab	B-T047
quality-of-care	O
measures	B-T081
.	O
	
as	O
antimicrobial	O
stewardship	O
becomes	O
a	O
mandatory	B-T169
aspect	O
of	O
healthcare	O
in	O
all	O
hospitals	O
in	O
the	O
u.s	O
,	O
asps	O
will	O
be	O
forced	B-T169
to	O
find	B-T033
ways	O
to	O
provide	O
more	O
efficient	B-T080
,	O
impactful	B-T080
,	O
disease	B-T047
state-based	O
patient	O
care	O
.	O
	
our	O
study	B-T062
provides	O
the	O
framework	O
for	O
and	O
data	B-T078
to	O
support	O
this	O
intervention	B-T061
in	O
one	O
of	O
the	O
most	O
clinically	B-T080
important	I-T080
infectious	B-T047
diseases	I-T047
.	O
	
involvement	O
of	O
intracellular	O
zn	O
signaling	O
in	O
ltp	O
at	O
perforant	O
pathway	O
-	O
ca1	O
pyramidal	O
cell	O
synapse	O
physiological	B-T169
significance	O
of	O
synaptic	O
zn	O
signaling	O
was	O
examined	O
at	O
perforant	O
pathway	O
-	O
ca1	O
pyramidal	O
cell	O
synapses	O
.	O
	
in	B-T082
vivo	I-T082
long-term	O
potentiation	O
ltp	O
at	O
perforant	O
pathway	O
-	O
ca1	O
pyramidal	O
cell	O
synapses	O
was	O
induced	O
using	O
a	O
recording	O
electrode	O
attached	O
to	O
a	O
microdialysis	O
probe	O
and	O
the	O
recording	O
region	O
was	O
locally	O
perfused	B-T061
with	O
artificial	O
cerebrospinal	O
fluid	O
acsf	O
via	O
the	O
microdialysis	O
probe	O
.	O
	
perforant	O
pathway	O
ltp	O
was	O
not	O
attenuated	O
under	O
perfusion	B-T061
with	O
caedta	O
10	O
mm	O
,	O
an	O
extracellular	O
zn	O
chelator	O
,	O
but	O
attenuated	O
under	O
perfusion	B-T061
with	O
znaf-2da	O
50	O
μm	O
,	O
an	O
intracellular	O
zn	O
chelator	O
,	O
suggesting	O
that	O
intracellular	O
zn	O
signaling	O
is	O
required	O
for	O
perforant	O
pathway	O
ltp	O
.	O
	
even	O
in	O
rat	O
brain	O
slices	O
bathed	O
in	O
caedta	O
in	O
acsf	O
,	O
intracellular	O
zn	O
level	O
,	O
which	O
was	O
measured	O
with	O
intracellular	O
znaf-2	O
,	O
was	O
increased	O
in	O
the	O
stratum	O
lacunosum-moleculare	O
where	O
perforant	O
pathway	O
-	O
ca1	O
pyramidal	O
cell	O
synapses	O
were	O
contained	O
after	O
tetanic	B-T061
stimulation	I-T061
.	O
	
these	O
results	O
suggest	O
that	O
intracellular	O
zn	O
signaling	O
,	O
which	O
originates	O
in	O
internal	O
stores/	O
proteins	B-T116
,	O
is	O
involved	O
in	O
ltp	O
at	O
perforant	O
pathway	O
-	O
ca1	O
pyramidal	O
cell	O
synapses	O
.	O
	
because	O
the	O
influx	O
of	O
extracellular	O
zn	O
,	O
which	O
originates	O
in	O
presynaptic	O
zn	O
release	O
,	O
is	O
involved	O
in	O
ltp	O
at	O
schaffer	O
collateral	O
-	O
ca1	O
pyramidal	O
cell	O
synapses	O
,	O
synapse	O
-dependent	O
zn	O
dynamics	O
may	O
be	O
involved	O
in	O
plasticity	O
of	O
postsynaptic	O
ca1	O
pyramidal	O
cells	O
.	O
	
20s	B-T116
immunoproteasomes	I-T116
remove	O
formaldehyde	B-T109
-	O
damaged	B-T169
cytoplasmic	B-T116
proteins	I-T116
suppressing	B-T169
caspase-independent	O
cell	O
death	O
immunoproteasomes	B-T116
are	O
known	O
for	O
their	O
involvement	B-T169
in	O
antigen	O
presentation	O
.	O
	
however	O
,	O
their	O
broad	B-T082
tissue	O
presence	B-T033
and	O
other	O
evidence	B-T169
are	O
indicative	B-T078
of	I-T078
nonimmune	O
functions	O
.	O
	
we	O
examined	O
a	O
role	O
for	O
immunoproteasomes	B-T116
in	O
cellular	O
responses	O
to	O
the	O
endogenous	B-T169
and	O
environmental	O
carcinogen	O
formaldehyde	B-T109
fa	B-T109
that	O
binds	O
to	O
cytosolic	O
and	O
nuclear	B-T116
proteins	I-T116
producing	O
proteotoxic	O
stress	O
and	O
genotoxic	O
dna	O
-	O
histone	B-T116
crosslinks	O
.	O
	
we	O
found	O
that	O
immunoproteasomes	B-T116
were	O
important	B-T080
for	O
suppression	B-T169
of	O
a	O
caspase-independent	O
cell	O
death	O
and	O
the	O
long-term	B-T079
survival	B-T169
of	O
fa-treated	O
cells	O
.	O
	
all	O
major	O
genotoxic	O
responses	O
to	O
fa	B-T109
,	O
including	O
replication	O
inhibition	O
and	O
activation	B-T052
of	O
the	O
transcription	B-T116
factor	I-T116
p53	I-T116
and	O
the	O
apical	B-T082
atm	B-T116
and	O
atr	B-T116
kinases	I-T116
,	O
were	O
unaffected	O
by	O
immunoproteasome	B-T116
inactivity	B-T080
.	O
	
immunoproteasome	O
inhibition	B-T052
enhanced	B-T052
activation	B-T052
of	O
the	O
cytosolic	O
protein	B-T116
damage	B-T169
sensor	B-T116
hsf1	I-T116
,	O
elevated	B-T080
levels	I-T080
of	O
k48-polyubiquitinated	O
cytoplasmic	B-T116
proteins	I-T116
and	O
increased	B-T081
depletion	B-T169
of	O
unconjugated	B-T080
ubiquitin	B-T116
.	O
	
we	O
further	O
found	O
that	O
fa	B-T109
induced	B-T169
the	O
disassembly	B-T052
of	O
26s	B-T116
immunoproteasomes	I-T116
,	O
but	O
not	O
standard	O
26s	B-T116
proteasomes	I-T116
,	O
releasing	O
the	O
20s	B-T116
catalytic	I-T116
immunoproteasome	I-T116
.	O
	
fa-treated	O
cells	O
also	O
had	O
higher	B-T081
amounts	I-T081
of	O
small	O
activators	B-T116
pa28αβ	I-T116
and	O
pa28γ	B-T116
bound	O
to	O
20s	B-T116
particles	I-T116
.	O
	
our	O
findings	O
highlight	O
the	O
significance	B-T078
of	O
nonnuclear	B-T169
damage	I-T169
in	O
fa	B-T109
injury	O
and	O
reveal	O
a	O
major	O
role	O
for	O
immunoproteasomes	B-T116
in	O
elimination	O
of	O
fa-damaged	B-T169
cytoplasmic	B-T116
proteins	I-T116
through	O
ubiquitin	B-T116
-	O
independent	B-T078
proteolysis	O
.	O
	
musculoskeletal	B-T033
pain	I-T033
profile	B-T170
of	O
obese	B-T047
individuals	B-T098
attending	B-T169
a	O
multidisciplinary	O
weight	O
management	O
service	O
obesity	B-T047
is	O
associated	B-T080
with	I-T080
numerous	B-T081
chronic	B-T047
diseases	I-T047
,	O
including	B-T169
musculoskeletal	B-T033
msk	I-T033
pain	I-T033
,	O
which	O
impacts	B-T080
on	O
quality	B-T078
of	I-T078
life	I-T078
qol	B-T078
.	O
	
there	O
is	O
,	O
however	O
,	O
limited	O
research	O
providing	O
a	O
comprehensive	B-T080
msk	B-T033
pain	I-T033
profile	B-T170
of	O
an	O
obese	B-T047
cohort	B-T098
.	O
	
this	O
retrospective	B-T062
study	I-T062
utilized	O
a	O
patient	O
database	B-T170
at	O
a	O
national	O
weight	O
management	O
service	O
wms	O
.	O
	
following	O
ethical	B-T078
approval	B-T170
,	O
anonymized	B-T170
patient	B-T170
data	I-T170
were	O
statistically	B-T062
analyzed	I-T062
to	O
develop	O
a	O
pain	O
profile	B-T170
,	O
investigate	B-T169
relationships	B-T080
between	O
pain	O
,	O
sleep	O
,	O
and	O
function	B-T033
,	O
and	O
explore	O
variables	B-T080
associated	B-T080
with	I-T080
having	O
low	O
back	O
pain	O
lbp	O
and	O
knee	B-T033
pain	I-T033
.	O
	
overall	O
,	O
915	O
individuals	B-T098
attended	O
the	O
wms	O
from	O
january	O
2011	O
to	O
september	O
2015	O
male	B-T098
,	O
35%	O
n=318	O
ci	B-T081
=32-38	O
female	B-T098
,	O
65%	O
n=597	O
ci	B-T081
=62-68	O
mean	B-T081
age	O
44.6	O
.	O
	
mean	B-T081
bmi	O
was	O
50.7	O
kg/m2	O
class	O
iii	O
obese	B-T047
bmi	O
40	O
kg/m2	O
,	O
92%	O
n=835	O
ci	B-T081
=91-94	O
.	O
	
approximately	B-T080
91%	O
reported	O
msk	B-T033
pain	I-T033
lbp	O
,	O
69%	O
n=539	O
ci	B-T081
=65-	O
72	O
mean	B-T081
nrs	O
7.4	O
knee	B-T033
pain	I-T033
,	O
58%	O
n=447	O
ci	B-T081
=55-61	O
mean	B-T081
nrs	O
6.8	O
.	O
	
class	O
iii	O
obese	B-T047
and	O
multi-site	B-T082
pain	O
patients	O
had	O
lower	B-T052
qol	B-T078
and	O
physical	O
activity	O
levels	B-T080
,	O
reduced	B-T080
sleep	O
,	O
and	O
poorer	B-T080
physical	B-T033
function	I-T033
than	O
less	B-T080
obese	B-T047
patients	O
and	O
those	O
without	B-T080
pain	O
p<0	O
.	O
	
relationships	B-T080
were	O
found	O
between	O
demographic	O
,	O
pain	O
,	O
self-report	B-T062
,	O
psychological	B-T169
,	O
and	O
functional	B-T169
measures	B-T081
p<0	O
.	O
	
patients	O
who	O
slept	B-T033
fewer	I-T033
hours	I-T033
and	O
had	O
poorer	B-T080
functional	B-T033
outcomes	I-T033
were	O
more	O
likely	O
to	O
have	O
lbp	O
patients	O
who	O
were	O
divorced	B-T033
,	O
had	O
lower	B-T052
qol	B-T078
,	O
and	O
more	O
frequent	B-T079
nocturia	B-T047
were	O
more	O
likely	O
to	O
have	O
knee	B-T033
pain	I-T033
p<0	O
.	O
	
multi-site	B-T082
msk	B-T033
pain	I-T033
is	O
prevalent	B-T081
and	O
severe	B-T080
in	O
obese	B-T047
patients	O
and	O
is	O
negatively	B-T033
associated	B-T080
with	I-T080
most	O
self-report	O
and	O
functional	B-T033
outcomes	I-T033
.	O
	
this	O
high	O
prevalence	B-T081
suggests	O
pain	B-T061
management	I-T061
strategies	O
must	O
be	O
considered	O
when	O
treating	B-T061
obesity	B-T047
.	O
	
primary	B-T080
management	O
and	O
outcome	B-T169
-	O
open	O
laryngotracheal	O
trauma	O
acute	B-T079
external	B-T080
injury	I-T080
to	O
the	O
larynx	O
is	O
both	O
life	B-T033
threatening	I-T033
and	O
a	O
potential	O
long	B-T079
term	I-T079
management	B-T170
challenge	O
.	O
	
as	O
otorhinolaryngologist	O
we	O
must	O
be	O
prepared	O
and	O
well	O
versed	O
to	O
manage	O
these	O
patients	O
.	O
	
in	O
our	O
study	O
seven	O
patients	O
of	O
open	O
laryngeal	O
traumas	O
were	O
managed	O
by	O
primary	B-T061
closure	I-T061
.	O
	
in	O
five	O
patients	O
nature	O
of	O
injury	O
was	O
known	O
in	O
other	O
two	O
patients	O
exact	O
nature	O
of	O
injury	O
was	O
not	O
known	O
.	O
	
after	O
primary	B-T061
closure	I-T061
five	O
patients	O
with	O
known	O
injury	O
survived	B-T052
and	O
two	O
patients	O
with	O
unknown	O
injury	O
died	O
.	O
	
as	O
per	O
our	O
experience	B-T033
,	O
we	O
recommend	O
primary	B-T061
closure	I-T061
,	O
if	O
the	O
exact	O
nature	O
of	O
injury	O
is	O
known	O
as	O
the	O
outcome	B-T169
is	O
definitely	O
comparative	O
kinematic	O
gait	O
analysis	O
in	O
young	B-T079
and	O
old	B-T079
beagle	O
dogs	O
age-related	B-T079
involution	O
in	O
dogs	O
involves	O
loss	B-T033
of	I-T033
muscle	I-T033
mass	I-T033
and	O
changes	O
in	O
connective	O
tissue	O
and	O
articular	O
cartilage	O
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	B-T033
whether	O
an	O
age-related	B-T079
influence	O
on	O
joint	B-T033
mobility	I-T033
can	O
be	O
detected	B-T033
in	O
the	O
absence	B-T169
of	O
diseases	B-T047
.	O
	
five	O
young	B-T079
ø	O
2.0	O
years	B-T079
and	O
five	O
old	B-T079
ø	O
10.4	O
years	B-T079
healthy	B-T080
and	O
sound	O
beagle	O
dogs	O
were	O
measured	B-T080
during	O
locomotion	O
on	O
a	O
treadmill	O
by	O
computer-assisted	O
gait	O
analysis	O
.	O
	
angles	B-T082
of	O
the	O
shoulder	O
,	O
elbow	O
,	O
carpal	O
,	O
hip	O
,	O
stifle	O
and	O
tarsal	O
joints	O
were	O
analyzed	B-T062
,	O
including	O
joint	B-T081
angle	I-T081
progression	I-T081
curves	I-T081
,	O
minimum	B-T080
and	O
maximum	B-T081
joint	O
angles	B-T082
and	O
range	O
of	O
motion	O
rom	O
.	O
	
the	O
old	B-T079
group	O
showed	O
a	O
smaller	O
maximum	O
joint	O
angle	B-T082
p	O
=	O
0.037	O
and	O
rom	O
p	O
=	O
0.037	O
of	O
the	O
carpal	O
joint	O
and	O
similar	O
tendencies	O
in	O
the	O
shoulder	O
,	O
elbow	O
and	O
carpal	O
joint	O
.	O
	
the	O
descriptive	B-T170
analysis	I-T170
of	O
the	O
progression	B-T081
curves	I-T081
revealed	O
less	B-T033
flexion	I-T033
and	O
extension	B-T169
of	O
the	O
joints	O
of	O
the	O
forelimb	O
.	O
	
this	O
indicates	O
restricted	B-T169
joint	B-T033
mobility	I-T033
of	O
the	O
forelimb	O
but	O
primarily	O
of	O
the	O
carpal	O
joint	O
.	O
	
findings	B-T169
in	O
the	O
joints	O
of	O
the	O
hindlimb	O
were	O
not	O
consistent	B-T078
contrasting	O
alterations	B-T078
may	O
be	O
due	O
to	O
a	O
compensatory	B-T169
mechanism	B-T169
.	O
	
as	O
most	O
alterations	B-T078
were	O
found	B-T033
in	O
the	O
distal	O
joints	O
,	O
these	O
should	O
receive	O
particular	O
attention	O
when	O
examining	O
elderly	O
dogs	O
.	O
	
propensity	B-T081
score	I-T081
matched	O
comparison	B-T052
of	O
partial	B-T081
to	O
whole	B-T081
gland	O
cryotherapy	B-T061
for	O
intermediate-risk	B-T033
prostate	O
cancer	O
an	O
analysis	B-T062
of	O
the	O
cold	B-T170
registry	I-T170
data	I-T170
to	O
compare	O
the	O
oncological	O
and	O
functional	B-T169
outcomes	B-T080
of	O
partial	B-T081
versus	O
whole	B-T081
-	O
gland	O
cryotherapy	B-T061
for	O
men	B-T098
with	O
intermediate-risk	B-T033
prostate	O
cancer	O
.	O
	
men	B-T098
with	O
intermediate-risk	B-T033
prostate	O
cancer	O
treated	B-T061
with	I-T061
primary	B-T080
prostate	B-T061
cryotherapy	I-T061
from	O
1993-2013	O
were	O
selected	O
from	O
the	O
cryo	B-T170
on-line	I-T170
data	I-T170
registry	I-T170
for	O
a	O
1	O
matched	B-T062
comparison	B-T052
between	O
those	O
undergoing	O
whole	B-T081
-	O
gland	O
and	O
partial	B-T081
prostate	B-T061
cryotherapy	I-T061
targeted-ablation	B-T061
,	O
unilateral/bilateral	B-T061
nerve-sparing	I-T061
ablations	I-T061
.	O
	
a	O
propensity	B-T081
score	I-T081
was	O
developed	O
based	O
on	O
age	O
,	O
pre-biopsy	O
serum	O
psa	B-T116
,	O
biopsy	B-T033
gleason	I-T033
score	I-T033
,	O
clinical	B-T079
stage	I-T079
,	O
prostate	B-T081
volume	I-T081
,	O
neoadjuvant	B-T061
androgen	I-T061
deprivation	I-T061
status	B-T080
,	O
year	B-T079
of	O
surgery	B-T061
and	O
pre-treatment	B-T079
potency	O
.	O
	
outcomes	B-T080
were	O
biochemical	B-T170
progression-free	B-T081
survival	I-T081
bpfs	B-T081
using	O
astro	B-T170
and	O
phoenix	B-T170
criteria	I-T170
,	O
12-month	O
continence	O
strictly	O
pad-free	O
and	O
sexual	O
function	O
potency	O
sufficient	B-T080
for	O
sexual	O
intercourse	O
.	O
	
after	O
propensity	B-T081
score	I-T081
-	O
matching	B-T062
,	O
bpfs	B-T081
was	O
compared	B-T052
using	O
kaplan-meier	B-T081
analysis	I-T081
and	O
functional	B-T169
outcomes	B-T080
using	O
chi-square	B-T170
tests	I-T170
.	O
	
in	O
all	O
,	O
897	O
men	B-T098
were	O
identified	B-T080
731	O
whole	B-T081
-	O
gland	O
and	O
166	O
partial	B-T081
.	O
	
post-matching	B-T079
,	O
166	O
pairs	O
of	O
men	B-T098
were	O
analysed	B-T062
mean	O
follow-up	O
31	O
months	O
.	O
	
the	O
2/5	O
year	O
bpfs	B-T081
rate	B-T081
was	O
87.2	O
for	O
whole	B-T081
-	O
gland	O
vs	O
.	O
	
80.7	O
for	O
partial	B-T081
ablation	B-T061
using	O
phoenix	B-T170
p=0	O
and	O
72.3	O
for	O
whole	B-T081
gland	O
vs	O
.	O
	
82.1	O
for	O
partial	B-T081
ablation	B-T061
using	O
astro	B-T170
criteria	O
p=0	O
.	O
	
of	O
164	O
pairs	O
,	O
the	O
12-month	O
continence	O
rate	B-T081
was	O
similar	B-T080
94.1	O
vs	O
.	O
	
95.1	O
p=0	O
.	O
	
of	O
139	O
pairs	O
,	O
the	O
12-month	O
rate	O
of	O
successful	B-T080
intercourse	O
was	O
29.5	O
for	O
whole	B-T081
-	O
gland	O
and	O
46.8	O
for	O
partial	B-T081
ablation	B-T061
or	O
2.1	O
,	O
p=0	O
.	O
	
the	O
incidence	B-T081
of	O
post-treatment	B-T079
urinary	B-T033
retention	I-T033
was	O
6.0	O
and	O
6.6	O
p=0	O
following	O
whole	B-T081
-	O
gland	O
and	O
partial	B-T081
ablation	B-T061
respectively	O
and	O
that	O
of	O
rectourethral	B-T047
fistula	I-T047
was	O
1.2	O
and	O
0%	O
p=0	O
conclusion	O
partial	B-T081
ablation	B-T061
results	B-T033
in	O
better	B-T080
post-treatment	B-T079
sexual	O
function	O
compared	B-T052
to	O
whole	B-T081
-	O
gland	O
ablation	B-T061
in	O
men	B-T098
with	O
intermediate-risk	B-T033
prostate	O
cancer	O
.	O
	
we	O
did	O
not	O
observe	O
a	O
difference	O
in	O
early	B-T079
bpfs	B-T081
between	O
the	O
two	O
abnormal	B-T033
metabolic	B-T169
brain	O
network	O
associated	O
with	O
parkinson's	B-T047
disease	I-T047
replication	B-T080
on	O
a	O
new	O
european	B-T098
sample	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
identify	B-T080
the	O
specific	O
metabolic	B-T169
brain	O
pattern	B-T082
characteristic	B-T080
for	O
parkinson's	B-T047
disease	I-T047
pd	B-T047
parkinson's	B-T081
disease-related	I-T081
pattern	I-T081
pdrp	B-T081
,	O
using	O
network	O
analysis	O
of	O
18f	O
positron	O
emission	O
tomography	O
fdg-pet	O
brain	O
images	B-T170
in	O
a	O
cohort	B-T098
of	O
slovenian	O
pd	B-T047
patients	O
.	O
	
twenty	O
pd	B-T047
patients	O
age	O
70.1	O
7.8	O
years	B-T079
,	O
movement	B-T170
disorder	I-T170
society	I-T170
unified	I-T170
parkinson's	I-T170
disease	I-T170
motor	I-T170
rating	I-T170
scale	I-T170
mds-updrs-iii	B-T170
38.3	O
12.2	O
disease	B-T079
duration	I-T079
4.3	O
4.1	O
years	B-T079
and	O
20	O
age	O
-	O
matched	B-T080
normal	O
controls	O
ncs	O
underwent	O
fdg-pet	O
brain	O
imaging	O
.	O
	
an	O
automatic	O
voxel-based	O
scaled	O
subprofile	O
model	O
/	O
principal	B-T081
component	I-T081
analysis	I-T081
ssm	O
/	O
pca	B-T081
was	O
applied	O
to	O
these	O
scans	O
for	O
pdrp	B-T081
-	O
slovenia	O
identification	B-T080
.	O
	
the	O
pattern	B-T081
was	O
characterized	B-T052
by	O
relative	O
hypermetabolism	B-T033
in	O
pallidum	O
,	O
putamen	O
,	O
thalamus	O
,	O
brain	O
stem	O
,	O
and	O
cerebellum	O
associated	O
with	O
hypometabolism	B-T033
in	O
sensorimotor	O
cortex	O
,	O
posterior	O
parietal	O
,	O
occipital	O
,	O
and	O
frontal	O
cortices	O
.	O
	
the	O
expression	B-T078
of	O
pdrp	B-T081
-	O
slovenia	O
discriminated	O
pd	B-T047
patients	O
from	O
ncs	O
p	O
<	O
0.0001	O
and	O
correlated	B-T080
positively	O
with	O
patients	O
'	O
clinical	B-T080
score	B-T081
mds-updrs-iii	B-T170
,	O
p	O
=	O
0.03	O
.	O
	
additionally	O
,	O
its	O
topography	O
agrees	O
well	O
with	O
the	O
original	O
pdrp	B-T081
p	O
<	O
0.001	O
identified	B-T080
in	O
american	B-T098
cohort	B-T098
of	O
pd	B-T047
patients	O
.	O
	
we	O
validated	O
the	O
pdrp	B-T081
-	O
slovenia	O
expression	B-T078
on	O
additional	O
fdg-pet	O
scans	O
of	O
20	O
pd	B-T047
patients	O
,	O
20	O
ncs	O
,	O
and	O
25	O
patients	O
with	O
atypical	B-T047
parkinsonism	I-T047
ap	B-T047
.	O
	
we	O
confirmed	O
that	O
the	O
expression	B-T078
of	O
pdrp	B-T081
-	O
slovenia	O
manifests	O
good	O
diagnostic	B-T080
accuracy	I-T080
with	O
specificity	B-T081
and	O
sensitivity	B-T081
of	O
85-90%	O
at	O
optimal	O
pattern	B-T081
expression	B-T078
cutoff	O
for	O
discrimination	O
of	O
pd	B-T047
patients	O
and	O
ncs	O
and	O
is	O
not	O
expressed	O
in	O
ap	B-T047
.	O
	
pdrp	B-T081
-	O
slovenia	O
proves	O
to	O
be	O
a	O
robust	O
and	O
reproducible	O
functional	O
imaging	O
biomarker	O
independent	O
of	O
patient	O
population	B-T098
.	O
	
it	O
accurately	O
differentiates	O
pd	B-T047
patients	O
from	O
ncs	O
and	O
ap	B-T047
and	O
correlates	O
well	O
with	O
the	O
clinical	B-T080
measure	B-T081
of	O
pd	B-T047
progression	O
.	O
	
the	O
effects	B-T080
of	I-T080
gestational	B-T079
use	B-T169
of	I-T169
antidepressants	O
and	O
antipsychotics	O
on	O
neonatal	O
outcomes	B-T169
for	O
women	B-T098
with	O
severe	B-T080
mental	O
illness	O
psychotropic	O
medication	O
use	B-T169
occurs	B-T079
in	O
8%	O
of	O
pregnancies	O
,	O
with	O
rates	B-T033
increasing	B-T169
,	O
and	O
often	B-T079
multiple	B-T081
medications	O
prescribed	O
.	O
	
this	O
study	B-T062
aims	O
to	O
determine	O
if	O
the	O
use	B-T169
of	I-T169
psychotropic	O
medication	O
,	O
in	O
a	O
cohort	B-T098
of	O
women	B-T098
with	O
severe	B-T080
mental	O
illness	O
,	O
increases	B-T169
rates	B-T081
of	O
special	B-T061
care	I-T061
nursery	I-T061
admission	O
and	O
reports	B-T170
differences	B-T080
between	O
antidepressant	O
and	O
antipsychotic	O
medication	O
use	B-T169
either	O
alone	B-T081
or	O
in	O
combination	O
.	O
	
a	O
retrospective	B-T062
database	I-T062
analysis	I-T062
from	I-T062
a	I-T062
cohort	I-T062
with	O
severe	B-T080
mental	O
illness	O
in	O
pregnancy	O
identified	B-T080
268	O
pregnant	B-T098
women	I-T098
who	O
were	O
grouped	O
according	O
to	O
medication	O
type	B-T080
.	O
	
demographic	B-T080
,	O
obstetric	B-T169
and	O
neonatal	O
variables	B-T080
were	O
analysed	B-T062
using	B-T169
t-tests	B-T170
,	O
χ	O
,	O
analysis	B-T062
of	O
variance	B-T080
and	O
logistic	O
regression	O
analysis	O
for	O
special	B-T061
care	I-T061
nursery	I-T061
admission	O
.	O
	
the	O
medication	O
groups	O
consisted	O
of	O
women	B-T098
taking	O
no	O
psychotropic	O
medications	O
n	O
=	O
67	O
those	O
taking	O
antipsychotics	O
n	O
=	O
87	O
those	O
taking	O
antidepressants	O
n	O
=	O
55	O
those	O
taking	O
and	O
a	O
combination	O
of	O
antidepressants/antipsychotics	O
n	O
=	O
59	O
.	O
	
rates	B-T033
of	O
special	B-T061
care	I-T061
nursery	I-T061
admission	O
in	O
women	B-T098
who	O
took	O
psychotropic	O
medication	O
41.3	O
were	O
elevated	O
compared	B-T052
to	O
those	O
who	O
did	O
not	O
26.9	O
p	O
=	O
0.035	O
,	O
and	O
were	O
significantly	B-T078
raised	B-T080
when	O
compared	B-T052
to	O
the	O
general	B-T098
population	I-T098
p	O
<	O
0.000	O
.	O
	
no	B-T033
significant	I-T033
difference	I-T033
occurred	O
between	O
the	O
medication	O
groups	O
.	O
	
a	O
significant	B-T078
adjusted	O
odds	B-T081
ratio	I-T081
of	O
2.79	O
95%	O
ci	O
1.286	O
was	O
found	B-T033
for	O
special	B-T061
care	I-T061
nursery	I-T061
and	O
psychiatric	O
admission	O
during	B-T079
pregnancy	O
but	O
not	O
for	O
psychotropic	O
medication	O
.	O
	
rates	B-T081
of	O
special	B-T061
care	I-T061
nursery	I-T061
admission	O
are	O
elevated	O
in	O
neonates	O
of	O
women	B-T098
with	O
severe	B-T080
mental	O
illness	O
taking	O
psychotropic	O
medication	O
,	O
but	O
were	O
not	O
different	O
for	O
monotherapy	B-T061
or	O
polytherapy	B-T061
when	O
prescribing	O
antidepressants	O
or	O
antipsychotic	O
medication	O
.	O
	
additional	O
vulnerability	B-T033
occurs	B-T079
in	O
the	O
neonates	O
of	O
women	B-T098
with	O
a	O
mental	O
illness	O
and	O
paediatric	O
presence	O
at	O
delivery	O
is	O
does	O
intrawound	B-T116
vancomycin	I-T116
application	B-T169
during	O
spine	B-T061
surgery	I-T061
create	O
vancomycin-resistant	O
organism	O
surgical	O
site	O
infection	O
ssi	O
following	O
spine	B-T061
surgery	I-T061
is	O
a	O
morbid	B-T080
and	O
expensive	B-T169
complication	I-T169
.	O
	
the	O
use	O
of	O
intrawound	B-T116
vancomycin	I-T116
is	O
emerging	O
as	O
a	O
solution	O
to	O
reduce	O
ssi	O
.	O
	
the	O
development	O
of	O
vancomycin-resistant	O
pathogens	O
is	O
an	O
understandable	O
concern	O
.	O
	
to	O
determine	O
the	O
occurrence	B-T079
of	O
vancomycin-resistant	O
ssi	O
in	O
patients	O
with	O
and	O
without	O
use	O
of	O
intrawound	B-T116
vancomycin	I-T116
.	O
	
patients	O
undergoing	O
elective	O
spine	O
surgery	O
were	O
dichotomized	O
based	O
on	O
whether	O
intrawound	O
vancomycin	O
was	O
applied	O
.	O
	
outcome	O
was	O
occurrence	O
of	O
ssi	O
requiring	O
return	O
to	O
the	O
operating	O
room	O
within	O
postoperative	O
90	O
days	O
.	O
	
the	O
intrawound	O
culture	O
and	O
vancomycin	O
minimal	O
inhibitory	O
concentrations	O
mic	O
were	O
reviewed	O
.	O
	
analyses	O
were	O
conducted	O
to	O
compare	O
the	O
pathogen	O
profile	O
and	O
mic	O
for	O
vancomycin	O
in	O
patients	O
who	O
received	O
vancomycin	O
and	O
those	O
who	O
did	O
not	O
.	O
	
of	O
the	O
total	O
2802	O
patients	O
,	O
43%	O
n	O
=	O
1215	O
had	O
intrawound	O
vancomycin	O
application	O
during	O
the	O
index	O
surgery	O
.	O
	
the	O
use	O
of	O
vancomycin	O
was	O
associated	O
with	O
significantly	O
lower	O
deep	O
ssi	O
rates	O
1.6	O
n	O
=	O
20	O
vs	O
2.5	O
n	O
=	O
40	O
,	O
p	O
=	O
02	O
.	O
	
the	O
occurrence	O
of	O
staphylococcus	O
aureus	O
ssi	O
was	O
significantly	O
lower	O
in	O
the	O
patients	O
who	O
had	O
application	O
of	O
intrawound	O
vancomycin	O
32%	O
vs	O
65%	O
,	O
p	O
=	O
003	O
.	O
	
none	O
of	O
the	O
patients	O
who	O
had	O
application	O
of	O
intrawound	O
vancomycin	O
powder	O
,	O
and	O
subsequently	O
developed	O
an	O
s	O
aureus	O
ssi	O
,	O
demonstrated	O
pathogens	O
with	O
resistance	O
to	O
vancomycin	O
.	O
	
all	O
patients	O
had	O
mic	O
<	O
2	O
μg/ml	O
,	O
the	O
vancomycin	O
susceptibility	O
threshold	O
.	O
	
the	O
occurrence	O
of	O
gram-negative	O
ssi	O
28%	O
vs	O
7%	O
and	O
culture	O
negative	O
fluid	O
collection	O
16%	O
vs	O
5%	O
was	O
higher	O
in	O
the	O
vancomycin	O
cohort	O
.	O
	
the	O
use	O
of	O
intrawound	O
vancomycin	O
during	O
the	O
index	O
spine	O
surgery	O
was	O
protective	O
against	O
ssi	O
following	O
spine	O
surgery	O
.	O
	
the	O
application	O
of	O
intrawound	O
vancomycin	O
during	O
index	O
surgery	O
does	O
not	O
appear	O
to	O
create	O
vancomycin-resistant	O
organisms	O
in	O
the	O
event	O
of	O
an	O
ssi	O
adequacy	B-T170
criteria	B-T078
for	O
thyroid	O
fna	O
evaluated	O
by	O
thinprep	O
slides	O
only	O
adequacy	B-T170
criteria	B-T078
for	O
thyroid	O
fine-needle	O
aspiration	O
fna	O
recommended	B-T078
by	O
the	O
bethesda	O
system	O
for	O
reporting	O
thyroid	O
cytopathology	O
tbs	O
were	O
developed	O
with	O
smears	O
,	O
but	O
they	O
are	O
commonly	O
applied	B-T169
to	O
thinpreps	O
tps	O
.	O
	
this	O
study	O
evaluated	O
adequacy	B-T170
in	O
tps	O
at	O
different	O
diagnostic	B-T169
thresholds	B-T080
.	O
	
all	O
fna	O
procedures	O
performed	B-T169
between	O
2010	O
and	O
2015	O
with	O
matched	B-T080
surgical	O
specimens	O
were	O
analyzed	B-T062
.	O
	
cell	O
counts	O
and	O
cytological	B-T169
features	B-T080
were	O
evaluated	O
in	O
all	O
initially	O
nondiagnostic	B-T033
nd	B-T033
cases	O
.	O
	
nd	B-T033
cases	O
were	O
reclassified	B-T080
into	O
tbs	O
categories	B-T170
by	O
2	O
pathologists	O
,	O
and	O
the	O
results	B-T169
were	O
compared	B-T052
with	O
surgical	B-T169
outcomes	I-T169
.	O
	
one	O
hundred	B-T081
forty-six	I-T081
of	O
the	O
151	O
cases	O
initially	O
classified	O
as	O
nd	B-T033
were	O
available	B-T169
for	O
review	B-T169
,	O
and	O
they	O
had	O
a	O
mean	B-T081
cell	O
count	O
of	O
60.5	O
standard	B-T081
deviation	I-T081
,	O
71.4	O
.	O
	
interobserver	O
agreement	O
on	O
the	O
reclassification	O
of	O
nd	B-T033
cases	O
was	O
moderate	B-T080
k	O
=	O
0.57	O
,	O
and	O
consensus	O
yielded	B-T081
48	O
nd	B-T033
cases	O
33%	O
,	O
72	O
benign	B-T080
cases	O
49%	O
,	O
24	O
cases	O
of	O
atypia	B-T033
of	O
undetermined	B-T033
significance	I-T033
16%	O
,	O
and	O
2	O
cases	O
suspicious	B-T033
for	I-T033
malignancy	I-T033
1%	O
.	O
	
lowering	B-T052
the	O
diagnostic	B-T169
threshold	B-T080
to	O
any	O
follicular	O
cells	O
yielded	B-T081
a	O
sensitivity	B-T081
of	O
92%	O
,	O
a	O
specificity	B-T081
of	O
60%	O
,	O
a	O
positive	B-T081
predictive	I-T081
value	I-T081
of	O
59%	O
,	O
a	O
negative	B-T081
predictive	I-T081
value	I-T081
of	O
92%	O
,	O
and	O
a	O
false-negative	O
rate	B-T081
of	O
7.7	O
,	O
whereas	O
the	O
values	O
for	O
the	O
initially	O
diagnostic	B-T169
cases	O
were	O
93%	O
,	O
58%	O
,	O
59%	O
,	O
93%	O
,	O
and	O
7.7	O
,	O
respectively	O
.	O
	
including	O
cases	O
with	O
>60	O
cells	O
but	O
lacking	B-T080
6	O
groups	O
containing	B-T052
at	O
least	O
10	O
cells	O
did	O
not	O
affect	O
test	O
performance	O
.	O
	
nuclear	O
enlargement	O
,	O
pallor	B-T033
,	O
grooves	O
,	O
and	O
the	O
presence	B-T033
of	O
histiocytoid	O
cells	O
in	O
initially	O
nd	B-T033
fna	O
correlated	B-T080
with	O
malignancy	O
.	O
	
in	O
thyroid	O
fna	O
examined	B-T033
with	O
tp	O
only	O
,	O
lowering	B-T052
the	O
adequacy	B-T170
threshold	B-T080
and	O
eliminating	O
the	O
requirement	B-T169
of	O
6	O
groups	O
of	O
at	O
least	O
10	O
cells	O
did	O
not	O
significantly	B-T078
affect	O
test	O
performance	O
if	O
cytological	B-T169
features	B-T080
associated	B-T080
with	I-T080
malignancy	O
were	O
absent	B-T169
.	O
	
silk	B-T116
i	I-T116
and	O
silk	B-T116
ii	I-T116
studied	B-T062
by	O
fast	O
scanning	O
calorimetry	O
using	O
fast	O
scanning	O
calorimetry	O
fsc	O
,	O
we	O
investigated	B-T169
the	O
glass	B-T052
transition	I-T052
and	O
crystal	O
melting	O
of	O
samples	O
of	O
b	O
.	O
	
mori	O
silk	B-T116
fibroin	I-T116
containing	O
silk	B-T116
i	I-T116
and/or	O
silk	B-T116
ii	I-T116
crystal	O
s	O
.	O
	
due	O
to	O
the	O
very	O
short	B-T081
residence	B-T082
times	B-T079
at	O
high	B-T080
temperatures	B-T081
during	O
such	O
measurements	B-T169
,	O
thermal	O
decomposition	O
of	O
silk	B-T116
protein	I-T116
can	O
be	O
significantly	B-T078
suppressed	B-T080
.	O
	
fsc	O
was	O
performed	B-T169
at	O
2000k/s	O
using	O
the	O
mettler	O
flash	O
dsc1	O
on	O
fibroin	B-T116
films	O
with	O
masses	B-T081
around	O
130-270ng	O
.	O
	
films	O
were	O
prepared	O
with	O
different	B-T080
crystalline	O
fractions	B-T081
ranging	O
from	O
0.26	O
to	O
0.50	O
and	O
with	O
different	B-T080
crystal	O
structures	O
silk	B-T116
i	I-T116
,	O
silk	B-T116
ii	I-T116
,	O
or	O
mixed	O
by	O
varying	O
the	O
processing	B-T052
conditions	B-T080
.	O
	
these	O
included	O
water	O
annealing	B-T061
at	O
different	B-T080
temperatures	B-T081
,	O
exposure	B-T080
to	I-T080
50%	O
meoh	B-T109
in	O
water	O
,	O
or	O
autoclaving	O
.	O
	
the	O
resulting	B-T169
crystal	O
structure	O
was	O
examined	O
using	O
wide	B-T082
angle	I-T082
x-ray	O
scattering	O
.	O
	
degree	B-T081
of	O
crystallinity	O
was	O
evaluated	B-T033
from	O
fourier	B-T062
transform	I-T062
infrared	I-T062
ftir	I-T062
spectroscopy	I-T062
and	O
from	O
analysis	B-T062
of	O
the	O
heat	B-T081
capacity	I-T081
increment	B-T081
at	O
the	O
glass	B-T080
transition	I-T080
temperature	I-T080
.	O
	
silk	B-T116
fibroin	I-T116
films	O
prepared	O
by	O
water	O
annealing	B-T061
at	O
25	O
were	O
the	O
least	O
crystalline	O
and	O
had	O
silk	B-T116
i	I-T116
structure	B-T116
.	O
	
ftir	B-T062
and	O
fsc	O
studies	B-T062
showed	O
that	O
films	O
prepared	O
by	O
autoclaving	O
or	O
50%	O
meoh	B-T109
exposure	B-T080
were	O
the	O
most	O
crystalline	O
and	O
had	O
silk	B-T116
ii	I-T116
structure	B-T116
.	O
	
intermediate	B-T082
crystalline	O
fraction	B-T081
and	O
mixed	O
silk	B-T116
i	I-T116
/	O
silk	B-T116
ii	I-T116
structure	B-T116
s	O
were	O
found	O
in	O
films	O
prepared	O
by	O
water	O
annealing	B-T061
at	O
37	O
.	O
	
fsc	O
results	B-T033
indicate	O
that	O
silk	B-T116
i	I-T116
i	O
crystals	O
exhibit	O
endotherms	O
of	O
narrower	O
width	O
and	O
have	O
higher	O
mean	O
melting	O
temperature	O
tm	O
,	O
compared	O
to	O
silk	B-T116
i	I-T116
crystals	O
which	O
melt	O
at	O
tm	O
.	O
	
films	O
containing	O
mixed	O
silk	O
i	I-T116
/	O
silk	O
ii	O
structure	O
showed	O
two	O
clearly	O
separated	O
endothermic	O
peaks	O
.	O
	
evidence	O
suggests	O
that	O
the	O
two	O
types	O
of	O
crystal	O
s	O
melt	O
separately	O
and	O
do	O
not	O
thermal	O
ly	O
interconvert	O
on	O
the	O
extremely	O
short	O
time	O
scale	O
0.065s	O
between	O
onset	O
and	O
end	O
of	O
melting	O
of	O
the	O
fsc	O
experiment	O
.	O
	
silkworm	O
silk	O
is	O
a	O
naturally	O
occurring	O
biomaterial	O
.	O
	
the	O
fibroin	O
component	O
of	O
silk	O
forms	O
two	O
types	O
of	O
crystals	O
.	O
	
silk	O
properties	O
depend	O
upon	O
the	O
amount	O
and	O
type	O
of	O
crystals	O
,	O
and	O
their	O
stability	O
.	O
	
one	O
measure	O
of	O
stability	O
is	O
crystal	O
melting	O
temperature	O
.	O
	
crystal	O
s	O
which	O
are	O
more	O
stable	O
have	O
a	O
higher	O
melting	O
temperature	O
.	O
	
until	O
now	O
,	O
it	O
has	O
been	O
challenging	O
to	O
study	O
thermal	O
behavior	O
of	O
silk	O
crystal	O
s	O
because	O
they	O
degrade	O
at	O
high	O
temperature	O
.	O
	
to	O
avoid	O
degradation	O
,	O
and	O
study	O
the	O
melting	O
properties	O
of	O
silk	O
biomaterial	O
,	O
we	O
heated	O
silk	O
at	O
a	O
very	O
fast	O
rate	O
of	O
2000k/s	O
using	O
a	O
special	O
calorimeter	O
.	O
	
we	O
have	O
shown	O
that	O
the	O
two	O
crystal	O
types	O
have	O
very	O
different	O
melting	O
temperature	O
s	O
,	O
indicating	O
that	O
one	O
crystal	O
type	O
is	O
much	O
more	O
stable	O
than	O
the	O
leonurine	B-T109
attenuates	B-T052
hyperalgesia	O
in	O
mice	O
with	O
induced	B-T169
adenomyosis	B-T047
background	O
adenomyosis	B-T047
,	O
defined	O
as	O
the	O
invasion	O
of	O
endometrial	O
glands	O
and	O
stroma	O
into	O
the	O
myometrium	O
,	O
is	O
a	O
common	B-T081
gynecological	B-T047
disorder	I-T047
.	O
	
in	O
the	O
present	O
study	O
we	O
report	B-T170
on	O
the	O
effect	B-T080
of	O
leonurine	B-T109
on	O
icr	O
mice	O
with	O
adenomyosis	B-T047
induced	B-T169
by	O
neonatal	B-T079
tamoxifen	B-T109
.	O
	
material	O
and	O
methods	O
after	O
being	O
treated	B-T169
with	O
tamoxifen	B-T109
for	O
4	O
,	O
8	O
,	O
and	O
12	O
weeks	O
,	O
we	O
assessed	B-T052
body	O
weight	O
and	O
pain	O
modulation	O
in	O
mice	O
in	O
hotplate	O
tests	O
.	O
	
the	O
mice	O
were	O
divided	B-T169
into	O
5	O
groups	B-T078
a	O
low-dose	B-T081
leonurine	B-T109
treatment	B-T061
group	B-T078
,	O
a	O
high-dose	B-T081
leonurine	B-T109
treatment	B-T061
group	B-T078
,	O
a	O
valproic	B-T109
acid	I-T109
vpa	B-T109
treatment	B-T061
group	B-T078
,	O
a	O
vehicle	O
only	B-T081
treatment	B-T061
group	B-T078
,	O
and	O
a	O
blank	B-T033
control	O
group	O
.	O
	
we	O
evaluated	O
body	O
weight	O
,	O
pain	O
modulation	O
in	O
hotplate	O
tests	O
,	O
and	O
the	O
depth	B-T082
of	O
myometrial	O
infiltration	O
.	O
	
immunoreactivity	O
staining	O
of	O
progesterone	B-T116
receptor	I-T116
pr	B-T116
,	O
nuclear	B-T116
factor-κb	I-T116
phosphorylated-p65	I-T116
p-p65	B-T116
,	O
cyclooxygenase-2	B-T116
cox-2	B-T116
,	O
and	O
oxytocin	B-T116
receptor	I-T116
otr	B-T116
was	O
evaluated	O
by	O
immunohistochemistry	O
.	O
	
results	O
the	O
measurement	B-T169
of	O
the	O
body	O
weight	O
,	O
myometrial	O
infiltration	O
,	O
and	O
pain	O
modulation	O
showed	O
that	O
neonatal	B-T079
tamoxifen	B-T109
treatment	B-T061
led	O
to	O
adenomyosis	B-T047
.	O
	
leonurine	B-T109
treatment	B-T061
appeared	O
to	O
decrease	B-T081
hyperalgesia	O
and	O
myometrial	O
infiltration	O
.	O
	
immunoreactivity	O
staining	O
showed	O
decreased	B-T081
p-p65	B-T116
,	O
cox-2	B-T116
,	O
and	O
otr	B-T116
protein	O
expressions	O
.	O
	
conclusions	O
our	O
results	O
indicate	O
that	O
leonurine	B-T109
attenuates	B-T052
hyperalgesia	O
in	O
mice	O
with	O
induced	B-T169
adenomyosis	B-T047
via	O
down-regulating	O
expressions	O
of	O
p-p65	B-T116
,	O
cox-2	B-T116
,	O
and	O
otr	B-T116
,	O
and	O
could	O
be	O
beneficial	O
for	O
treating	B-T169
adenomyosis	B-T047
.	O
	
a	O
randomized	B-T062
,	O
head-to-head	B-T080
study	B-T062
of	O
virtual	B-T061
reality	I-T061
exposure	I-T061
therapy	I-T061
for	O
posttraumatic	O
stress	O
disorder	O
virtual	B-T061
reality	I-T061
exposure	I-T061
therapy	I-T061
vret	B-T061
is	O
one	O
of	O
the	O
few	O
interventions	O
supported	O
by	O
randomized	B-T062
controlled	I-T062
trials	I-T062
for	O
the	O
treatment	B-T061
of	O
combat-related	O
posttraumatic	O
stress	O
disorder	O
ptsd	O
in	O
active	B-T033
duty	I-T033
service	I-T033
members	B-T098
.	O
	
a	O
comparative	B-T062
effectiveness	I-T062
study	I-T062
was	O
conducted	O
to	O
determine	O
if	O
virtual	O
reality	O
technology	O
itself	O
improved	B-T033
outcomes	B-T080
,	O
or	O
if	O
similar	B-T080
results	B-T169
could	O
be	O
achieved	O
with	O
a	O
control	B-T061
exposure	I-T061
therapy	I-T061
cet	B-T061
condition	B-T080
.	O
	
service	O
members	B-T098
with	O
combat-related	O
ptsd	O
were	O
randomly	B-T080
selected	B-T052
to	O
receive	B-T080
nine	O
weeks	B-T079
of	O
vret	B-T061
or	O
cet	B-T061
.	O
	
assessors	O
,	O
but	O
not	O
therapists	O
,	O
were	O
blinded	B-T062
.	O
	
ptsd	O
symptom	O
improvement	O
was	O
assessed	B-T052
one	O
week	B-T079
and	O
3	O
months	B-T079
after	O
the	O
conclusion	B-T078
of	O
treatment	B-T061
using	O
the	O
clinician-administered	B-T170
ptsd	I-T170
scale	I-T170
caps	B-T170
.	O
	
a	O
small	B-T081
crossover	O
component	O
was	O
included	B-T169
.	O
	
results	B-T169
demonstrated	O
that	O
ptsd	O
symptoms	O
improved	B-T033
with	O
both	O
treatments	B-T061
,	O
but	O
there	O
were	O
no	O
statistically	B-T081
significant	I-T081
differences	B-T033
between	O
groups	B-T078
.	O
	
dropout	B-T098
rates	B-T081
were	O
higher	B-T080
in	O
vret	B-T061
.	O
	
of	O
those	O
who	O
received	B-T080
vret	B-T061
,	O
13/42	O
31%	O
showed	O
>30%	O
improvement	O
on	O
the	O
caps	B-T170
,	O
versus	O
16/43	O
37%	O
who	O
received	B-T080
cet	B-T061
.	O
	
three	O
months	B-T079
after	O
treatment	B-T061
,	O
>30%	O
improvement	O
was	O
seen	O
in	O
10/33	O
30%	O
of	O
vret	B-T061
participants	B-T098
and	O
12/33	O
36%	O
in	O
cet	B-T061
.	O
	
participants	B-T098
who	O
crossed	B-T033
over	I-T033
n	O
=	O
11	O
showed	O
no	O
statistically	B-T081
significant	I-T081
improvements	O
in	O
a	O
second	B-T081
round	O
of	O
treatment	B-T061
,	O
regardless	B-T080
of	O
condition	B-T080
.	O
	
this	O
study	B-T062
supported	O
the	O
utility	B-T169
of	O
exposure	B-T061
therapy	I-T061
for	O
ptsd	O
,	O
but	O
did	O
not	O
support	O
additional	B-T169
benefit	B-T081
by	O
the	O
inclusion	B-T080
of	O
virtual	O
reality	O
.	O
	
accounting	O
for	O
linkage	B-T081
disequilibrium	I-T081
in	O
genome	B-T061
scans	I-T061
for	O
selection	O
without	B-T080
individual	B-T080
genotypes	O
the	O
local	B-T062
score	I-T062
approach	I-T062
detecting	O
genomic	O
footprints	O
of	O
selection	O
is	O
an	O
important	O
step	O
in	O
the	O
understanding	O
of	O
evolution	O
.	O
	
accounting	O
for	O
linkage	B-T081
disequilibrium	I-T081
in	O
genome	B-T061
scans	I-T061
increases	O
detection	B-T061
power	B-T081
,	O
but	O
haplotype	O
-based	O
methods	O
require	O
individual	B-T080
genotypes	O
and	O
are	O
not	O
applicable	O
on	O
pool-sequenced	O
samples	O
.	O
	
we	O
propose	O
to	O
take	O
advantage	O
of	O
the	O
local	B-T062
score	I-T062
approach	I-T062
to	O
account	O
for	O
linkage	B-T081
disequilibrium	I-T081
in	O
genome	B-T061
scans	I-T061
for	O
selection	O
,	O
cumulating	B-T169
possibly	O
small	O
signals	O
from	O
single	O
markers	O
over	O
a	O
genomic	O
segment	O
,	O
to	O
clearly	O
pinpoint	O
a	O
selection	O
signal	O
.	O
	
using	O
computer	O
simulations	O
,	O
we	O
demonstrate	O
that	O
this	O
approach	O
detects	B-T033
selection	O
with	O
higher	O
power	O
than	O
several	O
state-of-the-art	O
single-marker	O
,	O
windowing	O
or	O
haplotype	O
-based	O
approaches	O
.	O
	
we	O
illustrate	O
this	O
on	O
two	O
benchmark	B-T081
data	B-T170
sets	I-T170
including	O
individual	B-T080
genotypes	O
,	O
for	O
which	O
we	O
obtain	O
similar	O
results	O
with	O
the	O
local	B-T062
score	I-T062
and	O
one	O
haplotype	O
-based	O
approach	O
.	O
	
finally	O
,	O
we	O
apply	O
the	O
local	B-T062
score	I-T062
approach	I-T062
to	O
pool-seq	B-T170
data	I-T170
obtained	O
from	O
a	O
divergent	B-T080
selection	O
experiment	B-T062
on	O
behaviour	O
in	O
quail	O
and	O
obtain	O
precise	O
and	O
biologically	B-T080
coherent	B-T033
selection	O
signals	O
while	O
competing	O
methods	O
fail	O
to	O
highlight	O
any	O
clear	O
selection	O
signature	O
,	O
our	O
method	O
detects	B-T033
several	O
regions	O
involving	O
genes	O
known	O
to	O
act	O
on	O
social	B-T169
responsiveness	B-T169
or	O
autistic	B-T033
traits	I-T033
.	O
	
although	O
we	O
focus	O
here	O
on	O
the	O
detection	B-T033
of	O
positive	B-T033
selection	O
from	O
multiple	B-T170
population	I-T170
data	I-T170
,	O
the	O
local	B-T062
score	I-T062
approach	I-T062
is	O
general	O
and	O
can	O
be	O
applied	O
to	O
other	O
genome	B-T061
scans	I-T061
for	O
selection	O
or	O
other	O
genomewide	O
analyses	O
such	O
as	O
is	O
uv	O
-	O
induced	B-T169
electron-driven	O
proton	O
transfer	O
active	B-T169
in	O
a	O
chemically	B-T080
modified	I-T080
a	O
t	O
dna	O
base	O
pair	O
transient	O
electronic	O
and	O
vibrational	O
absorption	O
spectroscopies	O
have	O
been	O
used	O
to	O
investigate	B-T169
whether	O
uv	O
-	O
induced	B-T169
electron-driven	O
proton	O
transfer	O
edpt	O
mechanisms	B-T169
are	O
active	B-T169
in	O
a	O
chemically	B-T080
modified	I-T080
adenine	O
-	O
thymine	O
a	O
t	O
dna	O
base	O
pair	O
.	O
	
to	O
enhance	O
the	O
fraction	B-T081
of	I-T081
biologically	B-T080
relevant	I-T080
watson-crick	O
wc	O
hydrogen-bonding	O
motifs	O
and	O
eliminate	O
undesired	O
hoogsteen	O
structures	O
,	O
a	O
chemically	B-T080
modified	I-T080
derivative	B-T169
of	I-T169
a	I-T169
was	O
synthesized	O
,	O
8-	O
8tba	O
.	O
	
equimolar	O
solutions	O
of	O
8tba	O
and	O
silyl-protected	O
t	O
nucleosides	O
in	O
chloroform	O
yield	O
a	O
mixture	O
of	O
wc	O
pairs	O
,	O
reverse	O
wc	O
pairs	O
,	O
and	O
residual	O
monomers	O
.	O
	
unlike	O
previous	O
transient	O
absorption	O
studies	O
of	O
wc	O
guanine	O
-	O
cytosin	O
e	O
g	O
c	O
pairs	O
,	O
no	O
clear	O
spectroscopic	O
or	O
kinetic	O
evidence	O
was	O
identified	O
for	O
the	O
participation	O
of	O
edpt	O
in	O
the	O
excited-state	O
relaxation	O
dynamics	O
of	O
8tba	O
t	O
pairs	O
,	O
although	O
ultrafast	O
sub-100	O
fs	O
edpt	O
cannot	O
be	O
discounted	O
.	O
	
monomer-like	O
dynamics	O
are	O
proposed	O
to	O
dominate	O
in	O
8tba	O
t	O
monitoring	O
proteolytic	O
processing	O
events	O
by	O
quantitative	O
mass	O
spectrometry	O
protease	O
activity	O
plays	O
a	O
key	O
role	B-T170
in	O
a	O
wide	O
variety	O
of	O
biological	O
processes	O
including	B-T169
gene	O
expression	O
,	O
protein	O
turnover	O
and	O
development	O
.	O
	
misregulation	B-T033
of	O
these	O
proteins	B-T116
has	O
been	O
associated	B-T080
with	I-T080
many	O
cancer	B-T033
types	I-T033
such	O
as	O
prostate	O
,	O
breast	O
,	O
and	O
skin	O
cancer	O
.	O
	
thus	O
,	O
the	O
identification	B-T080
of	O
protease	B-T116
substrates	O
will	O
provide	B-T052
key	O
information	B-T078
to	O
understand	O
proteolysis	O
-related	O
pathologies	O
.	O
	
areas	O
covered	B-T169
proteomics	O
-based	O
methods	B-T170
to	O
investigate	B-T169
proteolysis	O
activity	O
,	O
focusing	O
on	O
substrate	O
identification	B-T080
,	O
protease	B-T116
specificity	O
and	O
their	O
applications	B-T061
in	O
systems	O
biology	O
are	O
reviewed	B-T080
.	O
	
their	O
quantification	B-T081
strategies	O
,	O
challenges	O
and	O
pitfalls	B-T080
are	O
underlined	O
and	O
the	O
biological	B-T080
implications	O
of	O
protease	B-T116
malfunction	B-T169
are	O
highlighted	O
.	O
	
expert	O
commentary	O
dysregulated	B-T033
protease	O
activity	O
is	O
a	O
hallmark	B-T080
for	O
some	O
disease	B-T047
pathologies	O
such	O
as	O
cancer	O
.	O
	
current	B-T079
biochemical	B-T169
approaches	B-T169
are	O
low	B-T080
throughput	B-T081
and	O
some	O
are	O
limited	B-T169
by	O
the	O
amount	B-T081
of	O
sample	O
required	B-T169
to	O
obtain	B-T169
reliable	O
results	O
.	O
	
mass	O
spectrometry	O
based	O
proteomics	O
provides	B-T052
a	O
suitable	B-T080
platform	O
to	O
investigate	B-T169
protease	O
activity	O
,	O
providing	B-T052
information	B-T078
about	O
substrate	B-T081
specificity	I-T081
and	O
mapping	O
cleavage	O
sites	O
.	O
	
diabetic	B-T047
nephropathy	I-T047
as	O
the	O
cause	B-T169
of	O
end-stage	B-T047
kidney	I-T047
disease	I-T047
reported	O
on	O
the	O
medical	B-T170
evidence	I-T170
form	I-T170
cms2728	B-T170
at	O
a	O
single	O
center	O
background	O
end-stage	B-T047
renal	I-T047
disease	I-T047
esrd	B-T047
incidence	B-T081
due	O
to	O
type	O
2	O
diabetic	B-T047
nephropathy	I-T047
dn	B-T047
is	O
35-50%	O
,	O
according	O
to	O
the	O
united	O
states	O
renal	O
data	O
system	O
.	O
	
methods	O
a	O
single-	O
center	O
,	O
retrospective	B-T062
cohort	I-T062
study	I-T062
to	O
determine	O
incidence	B-T081
and	O
diagnostic	B-T080
accuracy	I-T080
for	O
type	O
2	O
dn	B-T047
as	O
the	O
primary	B-T080
cause	B-T169
of	O
esrd	B-T047
code	O
250.40	O
on	O
the	O
center	O
for	O
medicare	O
medicaid	O
cms	O
medical	B-T170
evidence	I-T170
report	I-T170
form	I-T170
cms2728	B-T170
submitted	B-T169
at	O
renal	B-T061
replacement	I-T061
therapy	I-T061
initiation	O
.	O
	
all	O
patients	O
18	O
years	B-T079
of	O
age	O
with	O
a	O
cms2728	B-T170
submitted	B-T169
between	O
1	O
march	O
2006	O
and	O
31	O
march	O
2015	O
at	O
a	O
single	O
academic	O
military	O
medical	O
center	O
esrd	B-T047
network	O
5	O
were	O
included	O
.	O
	
medical	B-T170
records	I-T170
of	O
those	O
with	O
a	O
code	O
250.40	O
diagnosis	B-T033
were	O
reviewed	B-T080
to	O
determine	O
whether	O
they	O
met	O
the	O
kidney	O
disease	O
outcomes	O
quality	O
initiative	O
kdoqi	O
2007	O
criteria	B-T170
for	O
dn	B-T047
.	O
	
results	O
esrd	B-T047
incidence	B-T081
secondary	O
to	O
type	O
2	O
dn	B-T047
was	O
18.7	O
56/299	O
individual	B-T098
cms2728	B-T170
submissions	B-T169
over	O
9.09	O
years	O
.	O
	
in	O
all	O
,	O
12/56	O
21.4	O
did	O
not	O
meet	O
kdoqi	B-T170
criteria	I-T170
for	O
type	O
2	O
dn	B-T047
.	O
	
although	O
all	O
had	O
diabetes	B-T047
,	O
those	O
not	O
meeting	O
criteria	O
had	O
shorter	O
disease	B-T079
duration	I-T079
p	O
=	O
0.007	O
,	O
were	O
more	O
likely	O
to	O
have	O
active	B-T169
urine	O
sediment	O
p	O
=	O
0.006	O
,	O
and	O
were	O
less	O
likely	O
to	O
have	O
macroalbuminuria	B-T033
p	O
=	O
0.037	O
or	O
retinopathy	B-T047
p	O
=	O
0.002	O
prior	O
to	O
esrd	B-T047
.	O
	
on	O
exact	O
logistic	B-T062
regression	I-T062
,	O
retinopathy	B-T047
was	O
significantly	O
associated	B-T080
with	I-T080
kdoqi	O
-predicted	O
dn	B-T047
odds	B-T081
ratio	I-T081
=	O
19.16	O
confidence	B-T081
interval	I-T081
2.76	O
,	O
p	O
=	O
0.0009	O
.	O
	
conclusions	B-T078
in	O
this	O
single-	O
center	O
cohort	B-T062
,	O
21.4	O
identified	B-T080
as	O
having	O
type	O
2	O
dn	B-T047
as	O
the	O
primary	B-T080
cause	B-T169
of	O
esrd	B-T047
were	O
incorrectly	O
assigned	B-T169
per	O
kdoqi	O
2007	O
clinical	B-T080
criteria	B-T170
.	O
	
if	O
replicated	B-T169
in	O
larger	B-T081
populations	B-T098
,	O
this	O
could	O
have	O
substantial	O
implications	O
regarding	O
the	O
epidemiology	O
of	O
esrd	B-T047
in	O
the	O
socioeconomic	O
predictors	B-T078
of	O
adherence	B-T033
behavior	I-T033
among	O
hiv-positive	O
patients	O
receiving	B-T080
antiretroviral	B-T061
therapy	I-T061
in	O
selangor	O
,	O
malaysia	O
medication	B-T033
adherence	I-T033
remains	O
a	O
critical	B-T080
link	O
between	O
the	O
prescribed	O
art	B-T061
regimen	B-T061
and	O
treatment	B-T080
outcome	I-T080
.	O
	
several	B-T081
factors	B-T169
may	O
influence	O
adherence	B-T033
behavior	I-T033
.	O
	
this	O
cross-sectional	B-T062
study	I-T062
aimed	B-T078
to	O
highlight	O
socioeconomic	O
predictors	B-T078
of	O
adherence	B-T033
behavior	I-T033
among	O
a	O
cohort	B-T098
of	O
242	O
adult	O
malaysian	B-T098
patients	O
receiving	B-T080
antiretroviral	B-T061
therapy	I-T061
in	O
hospital	O
sungai	O
buloh	O
,	O
malaysia	O
,	O
where	O
they	O
were	O
enrolled	O
in	O
a	O
parent	O
study	O
single-blinded	B-T062
randomized	B-T062
controlled	I-T062
trial	I-T062
between	O
january	B-T080
and	O
december	B-T080
2014	O
.	O
	
statistical	B-T062
analysis	I-T062
of	O
secondary	O
data	O
on	O
adherence	B-T033
behavior	I-T033
and	O
sociodemographic	O
characteristics	O
of	O
the	O
patients	O
revealed	B-T080
mean	B-T033
age	I-T033
of	O
33.4	O
years	B-T079
and	O
ranged	B-T081
from	O
18	O
to	O
64	O
years	B-T079
88.8	O
were	O
males	O
.	O
	
a	O
total	O
of	O
224	O
93%	O
patients	O
who	O
completed	O
6	O
months'	O
adherence	O
assessment	O
were	O
included	B-T169
in	O
the	O
model	O
.	O
	
of	O
these	O
,	O
135	O
60.3	O
achieved	B-T033
optimal	B-T080
adherence	B-T169
.	O
	
multivariate	B-T170
binary	I-T170
logistic	I-T170
regression	I-T170
analysis	I-T170
revealed	B-T080
that	O
patient's	O
income	B-T081
and	O
ethnicity	B-T080
were	O
significant	B-T078
predictors	B-T078
of	O
adherence	B-T033
behavior	I-T033
.	O
	
this	O
may	O
be	O
valuable	O
for	O
targeted	B-T169
programmatic	B-T061
interventions	I-T061
to	O
further	O
enhance	B-T052
successful	O
treatment	O
outcomes	B-T169
among	O
the	O
target	B-T098
population	I-T098
.	O
	
a	O
tobramycin	B-T109
vector	I-T109
enhances	B-T052
synergy	O
and	O
efficacy	B-T080
of	O
efflux	O
pump	O
inhibitors	O
against	B-T080
multidrug-resistant	O
gram-negative	O
bacteria	O
drug	O
efflux	O
mechanisms	B-T169
interact	O
synergistically	B-T080
with	O
the	O
outer	O
membrane	O
permeability	O
barrier	O
of	O
gram-negative	O
bacteria	O
,	O
leading	B-T169
to	O
intrinsic	B-T082
resistance	B-T169
that	O
presents	O
a	O
major	B-T080
challenge	O
for	O
antibiotic	O
drug	B-T062
development	I-T062
.	O
	
efflux	O
pump	O
inhibitors	O
epis	O
which	O
block	B-T169
the	O
efflux	O
of	O
antibiotics	O
synergize	B-T080
antibiotics	O
,	O
but	O
the	O
clinical	B-T062
development	I-T062
of	O
epi	O
/	O
antibiotic	O
combination	B-T061
therapy	I-T061
to	O
treat	B-T061
multidrug-resistant	O
mdr	O
gram-negative	B-T047
infections	I-T047
has	O
been	O
challenging	O
.	O
	
this	O
is	O
in	O
part	O
caused	B-T169
by	O
the	O
inefficiency	B-T033
of	O
current	B-T079
epis	O
to	O
penetrate	B-T169
the	O
outer	O
membrane	O
and	O
resist	B-T169
efflux	O
.	O
	
we	O
demonstrate	O
that	O
conjugation	O
of	O
a	O
tobramycin	B-T109
tob	B-T109
vector	O
to	O
epis	O
like	O
nmp	B-T109
,	O
paroxetine	B-T109
,	O
or	O
dbp	O
enhances	B-T052
synergy	O
and	O
efficacy	B-T080
of	O
epis	O
in	O
combination	B-T080
with	O
tetracycline	B-T109
antibiotics	I-T109
against	O
mdr	O
gram-negative	O
bacteria	O
including	O
pseudomonas	O
aeruginosa	O
.	O
	
besides	O
potentiating	O
tetracycline	B-T109
antibiotics	I-T109
,	O
tob	B-T109
-	O
epi	O
conjugates	O
can	O
also	O
suppress	B-T169
resistance	B-T169
development	B-T169
to	O
the	O
tetracycline	B-T109
antibiotic	I-T109
minocycline	B-T109
,	O
thereby	O
providing	B-T052
a	O
strategy	O
to	O
develop	B-T169
more	O
effective	B-T080
adjuvants	O
to	O
rescue	O
tetracycline	B-T109
antibiotics	I-T109
from	O
resistance	B-T169
in	O
mdr	O
gram-negative	O
bacteria	O
.	O
	
detection	B-T061
of	O
ama-m2	B-T116
in	O
human	O
saliva	O
potentials	B-T080
in	O
diagnosis	B-T033
and	O
monitoring	O
of	O
primary	B-T047
biliary	I-T047
cholangitis	I-T047
serum	O
anti-mitochondrial	B-T116
antibody	I-T116
type	I-T116
2	I-T116
ama-m2	B-T116
is	O
considered	O
as	O
a	O
pivotal	O
biomarker	O
for	O
the	O
diagnosis	B-T033
of	O
primary	B-T047
biliary	I-T047
cholangitis	I-T047
pbc	B-T047
.	O
	
however	O
,	O
serological	O
tests	O
have	O
many	O
limitations	B-T169
,	O
including	O
inconvenience	B-T033
,	O
invasiveness	B-T080
,	O
and	O
infection	B-T033
risks	I-T033
.	O
	
thus	O
,	O
a	O
less	B-T080
invasive	B-T080
approach	B-T082
to	O
detect	B-T033
ama-m2	O
titer	O
is	O
desirable	O
.	O
	
we	O
examined	O
salivary	O
ama-m2	B-T116
of	O
potential	B-T080
pbc	B-T047
patients	O
and	O
found	O
that	O
ama-m2	B-T116
could	O
be	O
detected	B-T033
only	O
in	O
saliva	O
of	O
serum	O
ama-m2-positive	B-T033
pbc	B-T047
patients	O
,	O
but	O
not	O
in	O
saliva	O
of	O
serum	O
ama-m2-negative	B-T033
pbc	B-T047
patients	O
,	O
oral	B-T047
lichen	I-T047
planus	I-T047
patients	O
olp	B-T047
patients	O
,	O
or	O
healthy	B-T080
controls	I-T080
.	O
	
furthermore	O
,	O
the	O
concentration	B-T081
of	O
salivary	O
ama-m2	B-T116
was	O
positively	B-T080
correlated	I-T080
with	O
the	O
amount	B-T081
of	O
serum	O
ama-m2	B-T116
in	O
patients	O
.	O
	
the	O
salivary	O
inflammatory	B-T116
cytokines	I-T116
were	O
increased	B-T081
in	O
the	O
pbc	B-T047
,	O
consistent	B-T078
with	I-T078
the	O
results	B-T169
of	O
serum	O
test	O
.	O
	
these	O
findings	O
indicated	O
that	O
saliva	O
might	O
be	O
a	O
less	B-T080
invasive	B-T080
and	O
cost-effective	O
medium	O
to	O
accurately	O
test	B-T169
for	O
ama-m2	O
levels	O
and	O
this	O
is	O
a	O
promising	O
development	B-T169
for	O
the	O
diagnosis	B-T033
and	O
monitoring	O
of	O
mental	O
health	O
and	O
associated	B-T080
factors	B-T169
among	O
young	B-T079
offenders	B-T098
in	O
chile	O
a	O
cross-sectional	B-T062
study	I-T062
few	O
studies	O
in	O
latin	O
america	O
have	O
explored	O
mental	O
disorder	O
among	O
young	B-T079
offenders	B-T098
,	O
or	O
variables	B-T080
associated	B-T080
with	I-T080
it	O
.	O
	
our	O
aim	O
was	O
to	O
test	O
for	O
associations	B-T080
between	O
childhood	B-T079
adversity	O
or	O
substance	B-T033
misuse	I-T033
and	O
psychiatric	O
disorders	O
among	O
young	B-T079
offenders	B-T098
.	O
	
sentenced	O
adolescent	O
offenders	B-T098
were	O
recruited	B-T052
from	O
young	B-T079
offenders'	B-T098
institutions	O
or	O
community	O
centres	O
provided	O
by	O
the	O
chilean	O
national	O
service	O
for	O
minors	O
.	O
	
psychiatric	O
disorders	O
were	O
assessed	B-T052
using	O
the	O
mini	O
international	O
neuropsychiatric	O
interview	O
,	O
conducted	O
by	O
trained	O
psychologists	O
.	O
	
a	O
trained	O
sociologist	O
used	O
an	O
ad	B-T052
hoc	I-T052
interview	I-T052
to	O
collect	O
information	B-T078
about	O
childhood	O
experiences	O
,	O
including	O
parenting	B-T033
,	O
trauma	O
,	O
education	O
and	O
substance	B-T033
misuse	I-T033
.	O
	
multivariable	B-T062
logistic	I-T062
regressions	I-T062
were	O
used	O
to	O
analyse	B-T081
data	I-T081
.	O
	
the	O
most	O
prevalent	O
psychiatric	O
disorders	O
among	O
the	O
935	O
participants	B-T098
were	O
marijuana	O
dependence	O
disorder	O
,	O
major	O
depressive	O
disorder	O
,	O
and	O
anxiety	O
disorders	O
.	O
	
substance	O
use	O
disorders	O
were	O
less	O
frequent	O
among	O
young	B-T079
offenders	B-T098
who	O
were	O
serving	O
their	O
sentence	B-T033
in	O
young	B-T079
offenders'	B-T098
institutions	O
than	O
among	O
those	O
serving	O
in	O
community	O
centres	O
and	O
more	O
frequent	B-T079
among	O
those	O
who	O
started	B-T080
to	O
use	O
marijuana	O
at	O
an	O
earlier	O
age	O
.	O
	
among	O
other	O
variables	B-T081
,	O
childhood	O
maltreatment	O
was	O
related	O
to	O
major	O
depressive	O
disorder	O
,	O
and	O
maternal	O
death	O
to	O
anxiety	O
disorders	O
.	O
	
higher	O
educational	B-T033
status	I-T033
was	O
related	O
to	O
a	O
lower	B-T079
frequency	I-T079
of	O
depressive	O
and	O
anxiety	O
disorders	O
.	O
	
our	O
findings	B-T033
suggest	B-T078
that	O
greater	O
efforts	O
must	O
be	O
made	O
to	O
identify	B-T080
vulnerable	B-T169
young	B-T079
people	B-T098
much	O
earlier	B-T079
.	O
	
few	B-T081
of	O
these	O
young	B-T079
offenders	B-T098
with	O
mental	O
health	O
problems	B-T033
had	O
been	O
well	O
adjusted	B-T169
in	O
health	B-T078
,	O
education	O
or	O
socially	O
before	O
this	O
period	B-T079
of	O
detention	O
.	O
	
effects	B-T080
of	I-T080
regular	B-T080
water	O
-	O
and	O
land-based	O
exercise	O
on	O
physical	B-T033
function	I-T033
after	O
5	O
years	B-T079
a	O
long-term	B-T062
study	I-T062
on	O
the	O
well-being	O
of	O
older	B-T098
japanese	I-T098
adults	B-T098
to	O
investigate	B-T169
the	O
effects	B-T080
of	O
5	O
years	B-T079
of	O
physical	O
exercise	O
on	O
functional	B-T169
parameters	O
among	O
older	B-T098
japanese	I-T098
adults	B-T098
who	O
carried	O
out	O
water	O
-	O
or	O
land-based	O
exercise	O
.	O
	
we	O
retrospectively	B-T080
investigated	B-T169
data	B-T078
from	O
5707	O
medical	O
examinations	O
and	O
enrolled	O
77	O
older	B-T098
adults	I-T098
into	O
the	O
study	B-T062
.	O
	
eligible	O
participants	B-T098
had	O
to	O
be	O
aged	O
60	O
years	B-T079
,	O
and	O
engaged	O
in	O
water-based	O
exercise	O
n	O
=	O
38	O
or	O
a	O
combination	B-T080
of	O
water	O
-	O
and	O
land-based	O
exercise	O
n	O
=	O
39	O
for	O
at	O
least	O
80%	O
of	O
their	O
total	B-T079
exercise	I-T079
time	I-T079
for	O
over	O
5	O
years	B-T079
at	O
our	O
fitness	O
center	O
.	O
	
in	O
statistical	B-T062
analysis	I-T062
,	O
a	O
two-way	B-T081
repeated-measures	I-T081
analysis	I-T081
of	I-T081
variance	I-T081
was	O
carried	O
out	O
to	O
examine	B-T033
the	O
effects	B-T080
over	O
time	B-T079
and	O
by	O
exercise	B-T033
type	I-T033
,	O
and	O
the	O
changes	B-T169
in	O
each	O
parameter	O
over	O
5	O
years	B-T079
were	O
also	O
compared	B-T052
between	O
the	O
two	O
groups	B-T078
.	O
	
we	O
found	B-T033
significant	B-T078
main	B-T080
effects	B-T080
and	O
an	O
interaction	B-T169
between	O
time	B-T079
and	O
exercise	B-T033
type	I-T033
for	O
gait	O
speed	O
,	O
with	O
an	O
early	B-T081
decline	I-T081
in	O
the	O
combined	B-T080
exercise	B-T078
group	I-T078
,	O
as	O
well	O
as	O
significant	B-T078
main	B-T080
effects	B-T080
of	I-T080
time	B-T079
,	O
showing	O
a	O
functional	B-T033
decline	I-T033
in	O
grip	B-T081
strength	I-T081
,	O
one-leg	B-T082
standing	I-T082
time	B-T079
and	O
step/height	B-T033
ratio	B-T081
in	O
both	O
exercise	B-T033
types	I-T033
at	O
the	O
5-	O
year	B-T079
follow	O
up	O
.	O
	
the	O
5-	O
year	B-T079
changes	B-T169
in	O
each	O
parameter	O
did	O
not	O
differ	O
between	O
the	O
two	O
groups	B-T078
despite	O
the	O
frequency	B-T033
of	I-T033
exercise	I-T033
,	O
even	O
though	O
we	O
found	B-T033
a	O
negative	B-T033
correlation	B-T080
between	O
changes	B-T169
in	O
one-leg	B-T082
standing	I-T082
time	B-T079
and	O
total	B-T080
amount	B-T081
of	O
water-based	O
exercise	O
.	O
	
contrary	O
to	O
expectations	B-T078
,	O
these	O
results	B-T169
suggest	B-T078
that	O
regular	B-T080
engagement	O
in	O
water-based	O
exercise	O
,	O
even	O
combined	B-T080
with	O
land-based	O
exercise	O
,	O
might	O
have	O
poor	O
long-term	B-T079
benefits	B-T081
for	O
maintaining	B-T169
physical	O
performance	O
in	O
older	B-T098
adults	I-T098
.	O
	
combined	B-T080
exposures	O
of	O
whole-body	B-T033
vibration	I-T033
and	O
awkward	B-T033
posture	I-T033
a	O
cross	B-T062
sectional	I-T062
investigation	I-T062
among	O
occupational	O
drivers	B-T098
by	O
means	O
of	O
simultaneous	B-T079
field	B-T169
measurements	I-T169
multifactorial	B-T033
workloads	B-T081
such	O
as	O
whole-body	B-T033
vibration	I-T033
wbv	B-T033
,	O
awkward	B-T033
posture	I-T033
and	O
heavy	O
lifting	B-T052
are	O
potential	B-T080
predictors	B-T033
for	O
low	O
back	O
pain	O
lbp	O
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
investigate	B-T169
the	O
association	B-T080
between	O
lbp	O
and	O
these	O
exposures	O
among	O
102	O
professional	O
drivers	B-T098
.	O
	
the	O
combined	B-T080
exposures	O
of	O
wbv	B-T033
and	O
posture	O
are	O
measured	B-T080
at	O
different	B-T080
workplaces	B-T082
.	O
	
health	B-T078
and	O
personal	O
data	B-T078
as	O
well	O
as	O
information	B-T078
about	O
lifting	B-T052
tasks	O
are	O
collected	B-T169
by	O
a	O
questionnaire	B-T170
.	O
	
the	O
daily	B-T079
vibration	O
exposure	O
value	B-T081
odds	B-T081
ratio	I-T081
1.69	O
and	O
an	O
index	B-T081
for	O
awkward	B-T033
posture	I-T033
odds	B-T081
ratio	I-T081
1.63	O
show	O
significant	B-T078
association	B-T080
with	O
the	O
occurence	B-T079
of	O
lbp	O
.	O
	
awkward	B-T033
posture	I-T033
and	O
heavy	O
lifting	B-T052
appear	B-T080
to	O
be	O
more	O
strongly	O
associated	B-T080
with	I-T080
sick	B-T078
leave	I-T078
than	O
wbv	B-T033
exposure	O
.	O
	
furthermore	O
,	O
a	O
combination	B-T080
of	O
the	O
measurement	B-T169
results	B-T169
of	O
wbv	B-T033
and	O
awkward	B-T033
posture	I-T033
into	O
one	O
quantity	B-T081
also	O
shows	O
significant	B-T078
correlation	B-T080
to	O
lbp	O
.	O
	
the	O
combined	B-T080
exposure	O
of	O
wbv	B-T033
and	O
awkward	B-T033
posture	I-T033
can	O
be	O
described	B-T078
in	O
terms	O
of	O
the	O
daily	B-T079
vibration	O
exposure	O
and	O
the	O
index	B-T081
for	O
awkward	B-T033
posture	I-T033
.	O
	
this	O
facilitates	O
work	B-T082
place	I-T082
assessments	B-T052
and	O
future	B-T079
research	B-T062
in	O
this	O
area	B-T082
.	O
	
practitioner	O
summary	O
for	O
the	O
first	O
time	O
,	O
quantitative	B-T081
measures	B-T081
combining	O
whole-body	B-T033
vibration	I-T033
and	O
awkward	B-T033
posture	I-T033
exposures	O
have	O
shown	O
to	O
correlate	B-T080
with	O
the	O
occurrence	B-T079
of	O
low	O
back	O
pain	O
significantly	O
.	O
	
this	O
validates	O
the	O
proposed	O
quantities	B-T081
and	O
measurement	B-T169
methods	B-T169
,	O
which	O
facilitate	O
workplace	B-T082
assessments	B-T052
and	O
assist	B-T080
in	O
the	O
design	B-T052
of	O
further	B-T079
studies	B-T062
which	O
are	O
necessary	O
to	O
establish	B-T080
a	O
causal	O
exposure	O
-	O
response	O
relationship	B-T080
.	O
	
association	B-T080
of	O
ckip-1	O
p21a	O
polymorphism	O
with	O
risk	B-T078
of	O
chronic	B-T047
heart	I-T047
failure	I-T047
in	O
a	O
chinese	B-T098
population	I-T098
pathological	B-T169
cardiac	O
hypertrophy	O
is	O
an	O
independent	O
risk	B-T033
factor	I-T033
for	O
chronic	B-T047
heart	I-T047
failure	I-T047
.	O
	
casein	B-T116
kinase-2	I-T116
interacting	I-T116
protein-1	I-T116
ckip-1	B-T116
can	O
inhibit	O
pathological	B-T169
cardiac	O
hypertrophy	O
.	O
	
therefore	O
,	O
we	O
investigated	B-T169
whether	O
ckip-1	O
nonsynonymous	O
polymorphism	O
rs2306235	O
pro21ala	O
contributes	O
to	O
risk	B-T078
and	O
prognosis	O
of	O
chronic	B-T047
heart	I-T047
failure	I-T047
in	O
a	O
chinese	B-T098
population	I-T098
.	O
	
a	O
total	O
of	O
923	O
adult	O
patients	O
with	O
chronic	B-T047
heart	I-T047
failure	I-T047
and	O
1020	O
age	O
-	O
and	O
gender	O
-matched	O
healthy	B-T080
controls	I-T080
were	O
recruited	O
.	O
	
ckip-1	O
rs2306235	O
polymorphism	O
was	O
genotyped	O
using	O
pcr	O
-	O
restriction	O
fragment	O
length	O
polymorphism	O
.	O
	
additional	O
follow-up	O
data	B-T078
for	O
140	O
chronic	B-T047
heart	I-T047
failure	I-T047
patients	O
was	O
evaluated	O
.	O
	
the	O
rs2306235	O
g	O
allele	O
was	O
associated	O
with	O
an	O
increased	B-T081
risk	B-T078
of	O
chronic	B-T047
heart	I-T047
failure	I-T047
or	B-T081
=	O
1.38	O
,	O
95%	O
ci	B-T081
=	O
1.09	O
,	O
p	B-T081
=	O
0.007	O
,	O
especially	O
in	O
patients	O
with	O
hypertension	B-T047
or	B-T081
=	O
1.45	O
,	O
95%	O
ci	B-T081
=	O
1.09	O
,	O
p	O
=	O
0.006	O
and	O
coronary	B-T047
heart	I-T047
disease	I-T047
or	B-T081
=	O
1.41	O
,	O
95%	O
ci	B-T081
=	O
1.09	O
,	O
p	B-T081
=	O
0.010	O
after	O
adjustment	O
for	O
multiple	B-T033
cardiovascular	I-T033
risk	B-T033
factors	I-T033
.	O
	
however	O
,	O
rs2306235	O
polymorphism	O
was	O
not	O
associated	O
with	O
cardiovascular	B-T081
mortality	I-T081
in	O
chronic	B-T047
heart	I-T047
failure	I-T047
p	O
=	O
0.875	O
.	O
	
ckip-1	O
rs2306235	O
polymorphism	O
may	O
be	O
a	O
risk	B-T033
factor	I-T033
for	O
chronic	B-T047
heart	I-T047
failure	I-T047
in	O
a	O
chinese	O
han	O
population	O
.	O
	
linking	O
phenological	B-T079
events	I-T079
in	O
migratory	O
passerines	O
with	O
a	O
changing	O
climate	O
50	O
years	B-T079
in	O
the	O
laurel	O
highlands	O
of	O
pennsylvania	O
advanced	B-T079
timing	I-T079
of	O
both	O
seasonal	B-T079
migration	O
and	O
reproduction	O
in	O
birds	O
has	O
been	O
strongly	O
associated	B-T080
with	I-T080
a	O
warming	O
climate	O
for	O
many	O
bird	O
species	O
.	O
	
phenological	B-T079
responses	I-T079
to	O
climate	O
linking	O
these	O
stages	B-T079
may	O
ultimately	O
impact	B-T080
fitness	B-T052
.	O
	
we	O
analyzed	B-T062
five	O
decades	B-T081
of	O
banding	B-T078
data	I-T078
from	O
17	O
migratory	O
bird	O
species	O
to	O
investigate	O
1	O
how	O
spring	B-T079
arrival	B-T052
related	O
to	O
timing	B-T079
of	O
breeding	O
,	O
2	O
if	O
the	O
interval	B-T079
between	O
arrival	B-T052
and	O
breeding	O
has	O
changed	O
with	O
increasing	B-T169
spring	B-T079
temperatures	B-T081
,	O
and	O
3	O
whether	O
arrival	B-T052
timing	B-T079
or	O
breeding	O
timing	B-T079
best	O
predicted	O
local	B-T033
productivity	I-T033
.	O
	
four	O
of	O
17	O
species	O
,	O
all	O
mid-	O
to	O
long-distance	O
migrants	O
,	O
hatched	O
young	O
earlier	O
in	O
years	B-T079
when	O
migrants	B-T098
arrived	B-T052
earlier	B-T079
to	O
the	O
breeding	B-T082
grounds	I-T082
1	O
day	B-T079
advancement	I-T079
.	O
	
the	O
interval	B-T079
between	O
arrival	B-T052
on	O
breeding	B-T082
grounds	I-T082
and	O
appearance	B-T080
of	O
juveniles	O
shortened	B-T080
with	O
warmer	O
spring	B-T079
temperatures	B-T081
for	O
12	O
species	O
1-6	O
days	B-T079
for	O
every	O
1	O
increase	B-T169
and	O
over	O
time	O
for	O
seven	O
species	O
1-8	O
days	O
per	O
decade	B-T081
,	O
suggesting	O
that	O
some	O
migratory	O
passerines	O
adapt	O
to	O
climate	O
change	O
by	O
laying	O
more	B-T033
quickly	I-T033
after	O
arrival	B-T033
or	O
reducing	B-T080
the	O
time	B-T079
from	O
laying	O
to	O
fledging	O
.	O
	
we	O
found	O
more	O
support	O
for	O
the	O
former	B-T078
,	O
that	O
the	O
rate	B-T081
of	O
reproductive	O
advancement	O
was	O
higher	B-T080
than	O
that	O
for	O
arrival	B-T033
in	O
warm	O
years	O
.	O
	
timing	B-T079
of	O
spring	B-T079
arrival	B-T052
and	O
breeding	O
were	O
both	O
poor	B-T080
predictors	B-T078
of	O
avian	O
productivity	B-T081
for	O
most	O
migrants	O
analyzed	B-T062
.	O
	
nevertheless	O
,	O
we	O
found	O
evidence	B-T078
that	O
fitness	O
benefits	O
may	O
occur	O
from	O
shifts	O
to	O
earlier	O
spring	B-T079
arrival	B-T052
for	O
the	O
multi-brooded	O
song	O
sparrow	O
.	O
	
our	O
results	B-T169
uniquely	O
demonstrate	O
that	O
co-occurring	O
avian	O
species	O
are	O
phenologically	B-T079
plastic	I-T079
in	O
their	O
response	O
to	O
climate	O
change	O
on	O
their	O
breeding	B-T082
grounds	I-T082
.	O
	
if	O
migrants	B-T098
continue	O
to	O
show	O
a	O
weaker	B-T080
response	O
to	O
temperatures	B-T081
during	O
migration	O
than	O
breeding	O
,	O
and	O
the	O
window	B-T079
between	O
arrival	B-T052
and	O
optimal	O
breeding	O
shortens	B-T080
further	O
,	O
biological	O
constraints	O
to	O
plasticity	O
may	O
limit	O
the	O
ability	O
of	O
species	O
to	O
adapt	O
successfully	O
to	O
future	O
warming	O
.	O
	
mucosal	O
igm	B-T116
antibody	I-T116
with	O
d-mannose	B-T109
affinity	O
in	O
fugu	O
takifugu	O
rubripes	O
is	O
utilized	O
by	O
a	O
monogenean	O
parasite	O
heterobothrium	O
okamotoi	O
for	O
host	O
recognition	O
how	O
parasites	O
recognize	O
their	O
definitive	B-T079
hosts	O
is	O
a	O
mystery	O
however	O
,	O
parasitism	O
is	O
reportedly	O
initiated	O
by	O
recognition	O
of	O
certain	O
molecules	O
on	O
host	O
surfaces	O
.	O
	
fish	O
ectoparasites	O
make	O
initial	B-T033
contact	I-T033
with	O
their	O
hosts	O
at	O
body	O
surfaces	O
,	O
such	O
as	O
skin	O
and	O
gills	O
,	O
which	O
are	O
covered	B-T169
with	O
mucosa	O
that	O
are	O
similar	O
to	O
those	O
of	O
mammalian	O
guts	O
.	O
	
fish	O
are	O
among	O
the	O
most	O
primitive	O
vertebrates	O
with	O
immune	O
systems	O
that	O
are	O
equivalent	O
to	O
those	O
in	O
mammals	O
,	O
and	O
they	O
produce	O
and	O
secrete	O
igm	B-T116
into	O
mucus	O
.	O
	
in	O
this	O
study	O
,	O
we	O
showed	O
that	O
the	O
monogenean	O
parasite	O
heterobothrium	O
okamotoi	O
utilizes	O
igm	B-T116
to	O
recognize	O
its	O
host	O
,	O
fugu	O
takifugu	O
rubripes	O
oncomiracidia	O
are	O
infective	O
larvae	O
of	O
h	O
.	O
	
okamotoi	O
that	O
shed	O
their	O
cilia	O
and	O
metamorphose	O
into	O
juveniles	O
when	O
exposed	O
to	O
purified	B-T169
d-mannose	B-T109
-	O
binding	B-T052
fractions	B-T081
from	O
fugu	O
mucus	O
.	O
	
using	O
liquid	O
chromatography-tandem	O
mass	O
spectrometry	O
analysis	O
,	O
proteins	O
contained	O
in	O
the	O
fraction	O
were	O
identified	O
as	O
d-mannose	O
-specific	O
igm	O
with	O
two	O
d-mannose	O
-binding	O
lectins	O
.	O
	
however	O
,	O
although	O
deciliation	O
was	O
significantly	O
induced	O
by	O
igm	O
and	O
was	O
inhibited	O
by	O
d-mannose	O
or	O
a	O
specific	O
ab	O
against	O
fugu	O
igm	O
,	O
other	O
lectins	O
had	O
no	O
effect	O
,	O
and	O
igm	O
without	O
d-mannose	O
affinity	O
induced	O
deciliation	O
to	O
a	O
limited	O
degree	O
.	O
	
subsequent	O
immunofluorescent	O
staining	O
experiments	O
showed	O
that	O
fugu	O
d-mannose	O
-specific	O
igm	O
binds	O
ciliated	O
epidermal	O
cells	O
of	O
oncomiracidium	O
.	O
	
these	O
observations	O
suggest	O
that	O
deciliation	O
is	O
triggered	O
by	O
binding	O
of	O
fugu	O
igm	O
to	O
cell	O
surface	O
ags	O
via	O
ag	O
binding	O
sites	O
.	O
	
moreover	O
,	O
concentrations	O
of	O
d-mannose	O
-	O
binding	O
igm	O
in	O
gill	O
mucus	O
were	O
sufficient	O
to	O
induce	O
deciliation	O
in	O
vitro	O
,	O
indicating	O
that	O
h	O
.	O
	
okamotoi	O
parasites	O
initially	O
use	O
host	O
abs	O
to	O
colonize	O
host	O
gills	O
balb/c	O
mice	O
immunized	B-T061
with	O
a	O
combination	O
of	O
virus-like	O
particles	O
incorporating	O
kaposi	O
sarcoma-associated	O
herpesvirus	O
kshv	O
envelope	O
glycoproteins	B-T116
gpk8.1	I-T116
,	O
gb	B-T116
,	O
and	O
gh	B-T116
/	O
gl	B-T116
induced	O
comparable	O
serum	O
neutralizing	B-T116
antibody	I-T116
activity	O
to	O
uv	O
-	O
inactivated	B-T169
kshv	O
infection	O
with	O
kaposi	O
sarcoma-associated	O
herpesvirus	O
kshv	O
is	O
estimated	O
to	O
account	O
for	O
over	O
44	O
new	O
cases	O
of	O
kaposi	O
sarcoma	O
annually	O
,	O
with	O
84%	O
occurring	O
in	O
africa	O
,	O
where	O
the	O
virus	O
is	O
endemic	O
.	O
	
to	O
date	O
,	O
there	O
is	O
no	O
prophylactic	O
vaccine	O
against	O
kshv	O
.	O
	
kshv	O
gpk8.1	B-T116
,	O
gb	B-T116
,	O
and	O
gh	B-T116
/	O
gl	B-T116
glycoproteins	I-T116
,	O
implicated	O
in	O
the	O
virus	O
entry	O
into	O
host	O
cells	O
,	O
are	O
attractive	O
vaccine	O
targets	B-T169
for	O
eliciting	O
potent	O
neutralizing	B-T116
antibodies	I-T116
nabs	B-T116
against	O
virus	B-T047
infection	I-T047
.	O
	
we	O
incorporated	O
gpk8.1	B-T116
,	O
gb	B-T116
,	O
or	O
gh	O
/	O
gl	O
on	O
the	O
surface	O
of	O
virus-like	O
particles	O
vlps	O
and	O
characterized	O
these	O
vlps	O
for	O
their	O
composition	O
,	O
size	O
,	O
and	O
functionality	O
.	O
	
to	O
determine	O
which	O
viral	O
glycoprotein	O
elicit	O
the	O
most	O
effective	O
serum	O
-	O
nabs	O
,	O
we	O
immunized	O
balb/c	O
mice	O
with	O
gpk8.1	O
,	O
gb	B-T116
,	O
or	O
gh	B-T116
/	O
gl	B-T116
vlps	O
individually	O
or	O
in	O
combination	O
.	O
	
neutralizing	O
antibody	O
assay	O
revealed	O
that	O
sera	O
from	O
mice	O
immunized	O
with	O
the	O
vlps	O
inhibited	O
kshv	O
infection	O
of	O
hek-293	O
cells	O
in	O
a	O
dose-dependent	O
manner	O
.	O
	
as	O
a	O
single	O
immunogen	O
,	O
gpk8.1	O
vlps	O
stimulated	O
comparable	O
nab	O
activity	O
to	O
that	O
of	O
uv	O
-	O
inactivated	O
kshv	O
uv-kshv	O
.	O
	
in	O
contrast	O
,	O
uv-kshv	O
stimulated	O
higher	O
titers	O
of	O
nab	O
compared	O
to	O
gb	O
p	O
=	O
0.0316	O
or	O
gh	O
/	O
gl	O
p	O
=	O
0.0486	O
.	O
	
mice	O
immunized	O
with	O
the	O
combination	O
of	O
gb	O
and	O
gh	O
/	O
gl	O
vlps	O
had	O
a	O
better	O
nab	O
response	O
than	O
those	O
immunized	O
with	O
either	O
gb	O
p	O
=	O
0.0268	O
,	O
or	O
gh	O
/gl	O
p	O
=	O
0.0397	O
as	O
single	O
vlp	O
immunogens	O
.	O
	
immunization	O
with	O
any	O
vlp	O
combination	O
stimulated	O
comparable	O
nab	O
activity	O
to	O
uv-kshv	O
serum	O
.	O
	
our	O
data	O
provide	O
the	O
first	O
evidence	O
that	O
kshv	O
gpk8.1	O
,	O
gb	O
,	O
and	O
gh	O
/	O
gl	O
glycoproteins	O
can	O
be	O
incorporated	O
onto	O
the	O
surface	O
of	O
vlps	O
and	O
used	O
as	O
prophylactic	O
vaccine	O
candidates	O
,	O
with	O
potential	O
to	O
prevent	O
kshv	O
infection	B-T047
a	O
missense	O
variant	B-T080
,	O
rs373863828-a	O
p.arg457gln	O
,	O
of	O
crebrf	O
and	O
body	O
mass	O
index	O
in	O
oceanic	O
populations	O
it	O
has	O
been	O
suggested	O
that	O
a	O
'thrifty'	O
genotype	O
hypothesis	B-T078
can	O
account	O
for	O
high	B-T081
prevalence	I-T081
of	O
obesity	B-T047
in	O
the	O
island	O
populations	B-T098
of	O
oceania	O
.	O
	
a	O
recent	O
genome-wide	O
association	O
study	O
revealed	O
that	O
a	O
missense	O
variant	B-T080
,	O
rs373863828-a	O
p.arg457gln	O
,	O
of	O
the	O
crebrf	O
gene	O
encoding	O
creb3	B-T116
regulatory	I-T116
factor	I-T116
was	O
associated	B-T080
with	I-T080
an	O
excessive	B-T080
increase	B-T169
in	O
body	O
mass	O
index	O
bmi	O
in	O
samoans	B-T098
.	O
	
in	O
the	O
present	O
study	O
,	O
the	O
association	O
of	O
rs373863828-a	O
with	O
an	O
increase	B-T169
in	O
bmi	O
was	O
examined	B-T033
in	O
four	O
austronesian	O
an	O
speaking	O
populations	B-T098
in	O
oceania	O
.	O
	
we	O
found	O
that	O
rs373863828-a	O
was	O
frequently	O
observed	O
frequency	O
of	O
0.15	O
in	O
tongans	B-T098
polynesians	B-T098
,	O
and	O
was	O
strongly	O
associated	B-T080
with	I-T080
higher	O
bmi	O
p=6	O
10	O
.	O
	
a	O
single	O
copy	O
of	O
the	O
rs373863828-a	O
allele	O
increased	B-T081
bmi	O
by	O
3.09	O
kg	O
m	O
after	O
adjustment	O
of	O
age	O
and	O
sex	O
.	O
	
no	B-T033
significant	I-T033
association	B-T080
was	O
detected	B-T061
in	O
the	O
other	O
three	O
an	O
-	O
speaking	O
populations	B-T098
melanesians	B-T098
and	O
micronesians	B-T098
living	B-T078
in	O
solomon	O
islands	O
.	O
	
this	O
was	O
probably	O
due	O
to	O
the	O
low	B-T080
allele	B-T081
frequency	I-T081
0.02	O
of	O
rs373863828-a	O
as	O
well	O
as	O
small	O
sample	B-T081
size	I-T081
.	O
	
the	O
rs373863828-a	O
allele	O
was	O
not	O
found	O
in	O
both	O
an	O
-	O
speaking	O
and	O
non-	O
an	O
-	O
speaking	O
melanesians	B-T098
living	O
in	O
papua	O
new	O
guinea	O
.	O
	
our	O
results	O
suggest	O
that	O
rs373863828-a	O
of	O
crebrf	O
,	O
a	O
promising	O
thrifty	O
variant	B-T080
,	O
arose	O
in	O
recent	O
ancestors	O
of	O
an	O
-	O
speaking	O
polynesians	B-T098
vaccination	B-T061
of	O
piglets	O
at	O
2	O
and	O
3	O
weeks	O
of	O
age	O
with	O
ingelvac	O
prrsflex	O
eu	O
provides	O
protection	B-T033
against	O
heterologous	B-T080
field	O
challenge	O
in	O
the	O
face	O
of	O
homologous	O
maternally	B-T116
derived	I-T116
antibodies	I-T116
due	O
to	O
difficulties	O
in	O
eradicating	O
porcine	B-T047
reproductive	I-T047
and	I-T047
respiratory	I-T047
syndrome	I-T047
prrs	B-T047
linked	O
to	O
biosecurity	O
challenges	O
,	O
transmission	O
of	O
the	O
virus	O
and	O
the	O
lack	O
of	O
efficient	B-T080
diva	O
vaccines	O
,	O
successful	B-T080
control	B-T080
of	O
prrs	B-T047
requires	O
a	O
combination	O
of	O
strict	O
management	O
measures	O
and	O
vaccination	B-T061
of	O
both	O
sows	O
and	O
piglets	O
.	O
	
the	O
present	O
study	B-T062
aimed	O
to	O
assess	O
the	O
efficacy	B-T080
of	O
a	O
recently	O
developed	O
mlv	O
vaccine	O
ingelvac	O
prrsflex	O
eu	O
in	O
piglets	O
at	O
2	O
and	O
3-weeks	O
of	O
age	O
in	O
the	O
presence	B-T033
of	O
homologous	O
maternally	B-T116
derived	I-T116
antibodies	I-T116
as	O
the	O
dams	O
were	O
vaccinated	B-T061
with	O
the	O
same	O
vaccine	O
strain	O
reprocyc	O
prrs	O
eu	O
.	O
	
the	O
study	B-T062
was	O
carried	O
out	O
on	O
a	O
hungarian	O
farrow	O
to	O
finish	O
farm	B-T082
naturally	B-T033
infected	I-T033
with	O
prrsv	O
.	O
	
the	O
study	B-T062
was	O
designed	O
as	O
a	O
blind	B-T062
,	O
placebo	B-T062
controlled	I-T062
side	O
by	O
side	O
trial	O
.	O
	
orf5	B-T116
sequence	B-T081
similarity	I-T081
of	O
the	O
vaccine	O
strain	O
and	O
the	O
resident	B-T098
field	I-T098
strain	I-T098
was	O
87.8	O
%	O
.	O
	
prrs	B-T047
specific	O
real-time	O
quantitative	O
pcr	O
was	O
performed	O
from	O
serum	O
samples	O
to	O
measure	B-T081
both	O
the	O
viral	O
load	O
and	O
the	O
frequency	O
of	O
virus	O
positive	O
animals	O
.	O
	
at	O
the	O
time	O
of	O
the	O
natural	O
infection	O
observed	B-T169
in	O
the	O
control	O
group	O
at	O
10-12	O
weeks	O
of	O
age	O
,	O
the	O
number	O
of	O
viraemic	B-T033
animals	O
did	O
not	O
increase	O
significantly	O
in	O
the	O
vaccinated	B-T061
group	O
.	O
	
to	O
understand	O
the	O
infection	O
dynamics	O
,	O
positive	B-T033
pcr	O
samples	O
with	O
low	O
ct	O
values	O
were	O
sequenced	O
orf5	B-T116
and	O
the	O
data	O
analysis	O
indicated	B-T033
the	O
circulation	B-T033
of	O
wild	O
type	O
virus	O
in	O
both	O
groups	O
,	O
however	O
wild	O
type	O
virus	O
was	O
only	O
found	O
in	O
non-vaccinated	O
animals	O
.	O
	
our	O
data	B-T078
indicate	O
that	O
piglets	O
vaccinated	B-T061
at	O
as	O
early	O
as	O
2	O
weeks	O
of	O
age	O
with	O
ingelvac	O
prrsflex	O
eu	O
were	O
protected	O
both	O
in	O
terms	O
of	O
proportion	B-T081
of	O
viraemic	B-T033
animals	O
and	O
viraemia	B-T047
levels	O
.	O
	
it	O
has	O
to	O
be	O
highlighted	O
that	O
these	O
results	O
were	O
achieved	O
in	O
piglets	O
with	O
high	O
levels	O
of	O
homologous	O
maternally	B-T116
derived	I-T116
antibodies	I-T116
mda	B-T116
at	O
the	O
time	O
of	O
lung	B-T033
nodule	I-T033
in	O
french	O
guiana	O
in	O
a	O
immunocompetent	O
patient	O
we	O
report	O
the	O
case	O
of	O
an	O
immunocompetent	O
french	B-T098
soldier	O
stationed	O
in	O
french	O
guiana	O
,	O
who	O
developed	O
symptomatic	B-T169
pulmonary	B-T047
histoplasmosis	I-T047
.	O
	
comparison	B-T052
of	O
occlusive	B-T169
and	O
open	B-T082
application	B-T169
in	O
a	O
psoriasis	B-T062
plaque	I-T062
test	I-T062
design	I-T062
,	O
exemplarily	O
using	O
investigations	B-T169
of	O
mapracorat	B-T109
0.1	O
ointment	O
versus	O
vehicle	O
and	O
reference	O
drugs	O
psoriasis	B-T062
plaque	I-T062
tests	I-T062
ppts	B-T062
are	O
important	O
tools	O
in	O
the	O
early	O
phases	O
of	O
antipsoriatic	O
drug	O
development	O
.	O
	
two	O
distinct	O
ppt	B-T062
design	I-T062
variants	O
open	B-T169
vs	O
.	O
	
occluded	B-T169
drug	I-T169
application	I-T169
are	O
commonly	O
used	O
,	O
but	O
no	O
previous	O
work	O
has	O
aimed	O
to	O
directly	O
compare	O
and	O
contrast	O
their	O
performance	O
.	O
	
we	O
compared	O
the	O
antipsoriatic	O
efficacy	O
of	O
mapracorat	B-T109
0.1	O
ointment	O
and	O
reference	O
drugs	O
reported	O
in	O
2	O
separate	O
studies	B-T062
,	O
representing	O
open	B-T062
and	O
occluded	B-T062
ppt	I-T062
designs	I-T062
.	O
	
the	O
drug	B-T169
effect	I-T169
size	O
was	O
measured	O
by	O
sonography	O
mean	O
change	O
in	O
echo-poor	O
band	O
thickness	B-T080
,	O
chromametry	O
,	O
and	O
standardized	O
clinical	B-T033
assessment	I-T033
.	O
	
antipsoriatic	O
effects	B-T169
were	O
detectable	O
for	O
the	O
study	B-T062
drugs	O
in	O
both	O
occluded	B-T062
and	O
open	B-T062
ppts	I-T062
.	O
	
differences	O
between	O
the	O
potency	O
of	O
antipsoriatic	O
drugs	O
and	O
vehicle	O
were	O
observable	O
.	O
	
the	O
total	O
antipsoriatic	O
effect	B-T169
size	O
appeared	O
to	O
be	O
higher	O
in	O
the	O
occluded	B-T062
ppt	I-T062
than	O
the	O
open	B-T062
ppt	I-T062
,	O
despite	O
the	O
shorter	O
treatment	B-T079
duration	I-T079
2	O
vs	O
.	O
	
4	O
weeks	B-T079
.	O
	
effect	B-T169
dynamics	O
over	O
time	B-T079
revealed	O
greater	O
differences	O
between	O
some	O
study	B-T062
drugs	O
in	O
the	O
open	B-T062
ppt	I-T062
compared	O
to	O
the	O
occluded	B-T062
ppt	I-T062
.	O
	
taking	O
the	O
higher	O
technical	O
challenges	O
for	O
the	O
open	B-T062
ppt	I-T062
into	O
account	O
,	O
we	O
recommend	O
the	O
occluded	B-T062
ppt	I-T062
as	O
a	O
standard	O
screening	B-T062
setting	O
in	O
early	B-T079
drug	O
development	O
.	O
	
in	O
special	O
cases	O
,	O
considering	O
certain	O
drug	O
aspects	B-T080
or	O
study	B-T062
objectives	O
that	O
would	O
require	O
procedural	O
adaptations	O
,	O
an	O
open	B-T062
ppt	I-T062
could	O
be	O
the	O
better-suited	O
design	O
.	O
	
finally	O
,	O
both	O
ppt	B-T062
models	O
show	O
clear	O
advantages	O
classification	O
as	O
phase	B-T062
i	I-T062
studies	I-T062
,	O
small	O
number	O
of	O
psoriatic	O
subjects	O
,	O
relatively	O
short	O
study	B-T062
duration	B-T079
,	O
excellent	O
discrimination	O
between	O
compounds	O
and	O
concentrations	B-T081
,	O
parallel	O
measurement	B-T169
of	O
treatment	O
response	O
,	O
and	O
go/no	O
go	O
decisions	O
very	O
early	B-T079
in	O
clinical	B-T062
development	I-T062
.	O
	
insurance	B-T078
coverage	I-T078
and	O
utilization	B-T169
at	O
a	O
sexually	O
transmitted	O
disease	O
clinic	O
in	O
a	O
medicaid	O
expansion	O
state	O
in	O
rhode	O
island	O
,	O
the	O
patient	O
protection	O
and	O
affordable	O
care	O
act	O
has	O
led	O
to	O
over	O
95%	O
of	O
the	O
state's	O
population	B-T081
being	O
insured	B-T170
.	O
	
we	O
evaluated	O
insurance	B-T078
coverage	I-T078
and	O
barriers	B-T033
to	O
insurance	O
use	O
among	O
patients	O
presenting	O
for	O
services	O
at	O
the	O
rhode	O
island	O
sexually	O
transmitted	O
disease	O
std	O
clinic	O
.	O
	
we	O
analyzed	B-T062
factors	B-T169
associated	B-T080
with	I-T080
insurance	B-T078
coverage	I-T078
and	O
utilization	B-T169
among	O
patients	O
presenting	O
for	O
std	B-T047
services	O
between	O
july	B-T080
and	O
december	B-T080
2015	O
.	O
	
a	O
total	O
of	O
692	O
patients	O
had	O
insurance	B-T078
information	I-T078
available	O
of	O
those	O
,	O
40%	O
were	O
uninsured	B-T098
.	O
	
patients	O
without	B-T098
insurance	I-T098
were	O
more	O
likely	O
than	O
those	O
with	O
insurance	O
to	O
be	O
nonwhite	O
50%	O
among	O
uninsured	B-T098
,	O
compared	O
with	O
40%	O
among	O
insured	B-T170
p	O
=	O
0.014	O
and	O
hispanic	B-T098
or	O
latino/a	B-T098
25%	O
,	O
compared	O
with	O
16%	O
p	O
=	O
0.006	O
,	O
and	O
less	O
likely	O
to	O
be	O
men	B-T098
who	O
have	O
sex	O
with	O
men	B-T098
27%	O
,	O
compared	O
with	O
39%	O
p	O
=	O
0.001	O
.	O
	
of	O
those	O
with	O
health	O
insurance	O
,	O
26%	O
obtained	O
coverage	B-T078
as	O
a	O
result	B-T169
of	O
the	O
affordable	O
care	O
act	O
,	O
and	O
56%	O
of	O
those	O
were	O
previously	O
uninsured	B-T098
.	O
	
among	O
uninsured	B-T098
individuals	I-T098
,	O
barriers	B-T033
to	O
obtaining	O
health	O
insurance	O
included	O
cost	B-T081
and	O
unemployment	B-T033
.	O
	
among	O
those	O
with	B-T170
insurance	I-T170
,	O
43%	O
reported	O
willingness	B-T033
to	O
use	O
insurance	O
for	O
std	B-T047
services	O
.	O
	
barriers	B-T033
to	O
insurance	O
use	O
included	O
concerns	O
about	O
anonymity	B-T078
and	O
out-of-pocket	B-T081
costs	I-T081
.	O
	
despite	O
expanded	O
insurance	O
access	B-T078
,	O
many	O
individuals	B-T098
presenting	O
to	O
the	O
rhode	O
island	O
std	O
clinic	O
were	O
uninsured	B-T098
.	O
	
among	O
those	O
who	O
were	O
insured	B-T170
,	O
significant	O
barriers	B-T033
still	O
existed	O
to	O
using	O
insurance	O
.	O
	
std	O
clinics	O
continue	O
to	O
play	O
an	O
important	O
role	O
in	O
providing	O
safety-net	O
std	B-T047
services	O
in	O
states	O
with	O
low	O
uninsured	B-T098
rates	B-T081
.	O
	
both	O
public	O
and	O
private	O
insurers	O
are	O
needed	O
to	O
address	O
financial	B-T033
barriers	I-T033
and	O
optimize	B-T052
payment	B-T081
structures	B-T082
for	O
molecular	O
subtyping	O
of	O
treponema	O
pallidum	O
and	O
associated	B-T169
factors	I-T169
of	O
serofast	B-T033
status	B-T080
in	O
early	B-T047
syphilis	I-T047
patients	O
identified	B-T080
novel	O
genotype	O
and	O
cytokine	B-T116
marker	O
serofast	B-T033
,	O
a	O
persistent	B-T079
nontreponemal	B-T169
serological	I-T169
response	O
observed	B-T169
in	O
early	B-T047
syphilis	I-T047
patients	O
after	O
conventional	B-T061
treatment	I-T061
,	O
remains	O
a	O
concern	B-T078
of	O
clinicians	O
and	O
syphilis	B-T047
patients	O
.	O
	
no	O
consensus	O
has	O
been	O
established	O
,	O
however	O
,	O
that	O
defines	O
an	O
effective	B-T080
treatment	B-T061
strategy	I-T061
and	O
clarifies	B-T052
the	O
pathogenesis	O
.	O
	
in	O
this	O
study	B-T062
,	O
517	O
patients	O
with	O
early	B-T047
syphilis	I-T047
were	O
enrolled	O
and	O
treated	B-T169
.	O
	
twelve	O
months	B-T079
after	O
treatment	B-T061
,	O
79.3	O
410/517	O
of	O
patients	O
achieved	O
serological	B-T169
cure	O
,	O
20.1	O
104/517	O
were	O
serofast	B-T033
,	O
and	O
0.6	O
3/517	O
were	O
serological	B-T169
failures	B-T169
.	O
	
multivariate	B-T081
analysis	I-T081
demonstrated	O
that	O
older	B-T098
age	I-T098
>40	O
years	B-T079
and	O
lower	O
baseline	B-T081
rpr	O
titer	O
1	O
were	O
associated	B-T080
with	I-T080
serofast	B-T033
status	B-T080
.	O
	
we	O
also	O
identified	O
21	O
t	O
.	O
	
pallidum	O
molecular	O
subtypes	O
among	O
early	B-T047
syphilis	I-T047
patients	O
and	O
detected	O
a	O
new	O
subtype	O
,	O
14i/a	O
.	O
	
we	O
found	O
that	O
the	O
proportion	O
of	O
14i/a	O
type	O
in	O
serofast	B-T033
patients	O
was	O
significantly	O
higher	O
than	O
that	O
in	O
patients	O
with	O
serological	B-T169
cure	O
,	O
predicting	O
an	O
increasing	B-T169
risk	B-T078
of	O
serofast	B-T033
status	B-T080
.	O
	
levels	O
of	O
chemerin	O
were	O
higher	O
in	O
the	O
serum	O
of	O
serofast	O
cases	O
than	O
serological	O
cure	O
cases	O
,	O
potentially	O
indicating	O
a	O
novel	O
cytokine	O
marker	O
for	O
serofast	O
in	O
early	O
syphilis	O
patients	O
after	O
therapy	O
.	O
	
we	O
hope	O
that	O
these	O
results	O
contribute	O
to	O
improve	O
guidelines	O
for	O
the	O
management	O
of	O
syphilis	O
patients	O
who	O
experience	O
serofast	B-T033
total	O
fluorescence	O
fingerprinting	O
of	O
pesticides	O
a	O
reliable	O
approach	O
for	O
continuous	B-T078
monitoring	O
of	O
soils	O
and	O
waters	O
the	O
present	O
work	O
relates	O
to	O
the	O
creation	B-T052
/	O
extension	B-T169
of	O
a	O
database	B-T170
of	O
total	O
excitation-emission	O
and	O
total	O
synchronous	O
fluorescence	O
matrices	O
teems	O
and	O
tsfms	O
along	O
with	O
optimal	O
synchronous	O
fluorescence	O
spectra	O
sfs	O
to	O
fingerprint	O
pesticides	O
widely	O
used	O
in	O
morocco	O
.	O
	
this	O
spectrometric	O
multi-component	O
fingerprinting	O
may	O
permit	O
the	O
direct	O
detection	O
of	O
pesticides	O
persisting	O
in	O
soil	O
or	O
water	O
.	O
	
the	O
objective	O
of	O
the	O
current	O
investigation	O
is	O
to	O
detect	O
four	O
pesticide	O
remains	O
in	O
agricultural	B-T082
soils	I-T082
by	O
applying	O
the	O
spectrometric	O
fingerprinting	O
results	O
.	O
	
they	O
are	O
the	O
commercial	O
i	O
insecticide	O
axlera	O
5g	O
carbamate	O
,	O
ii	O
fungicide	O
orsalis	O
5%	O
sc	O
triazole	O
,	O
iii	O
insecticide	B-T109
force	I-T109
0	I-T109
g	I-T109
pyrethrinoid	B-T109
and	O
iv	O
insecticide	O
proclaim	O
05	O
sg	O
non-assigned	O
.	O
	
the	O
agricultural	O
plantations	O
monitored	O
are	O
located	O
in	O
the	O
great	O
agricultural	O
doukkala	O
region	O
at	O
the	O
western	O
atlantic	O
side	O
of	O
morocco	O
,	O
where	O
these	O
chemicals	O
engagement	O
of	O
cellular	B-T116
prion	I-T116
protein	I-T116
with	O
the	O
co-chaperone	B-T116
hsp70	B-T116
/	O
90	O
organizing	O
protein	O
regulates	O
the	O
proliferation	O
of	O
glioblastoma	O
stem-like	O
cells	O
glioblastoma	O
gbm	O
,	O
a	O
highly	O
aggressive	O
brain	O
tumor	O
,	O
contains	O
a	O
subpopulation	O
of	O
glioblastoma	O
stem-like	O
cells	O
gscs	O
that	O
play	O
roles	O
in	O
tumor	O
maintenance	O
,	O
invasion	O
,	O
and	O
therapeutic	O
resistance	O
.	O
	
gscs	O
are	O
therefore	O
a	O
promising	O
target	O
for	O
gbm	O
treatment	O
.	O
	
our	O
group	O
identified	O
the	O
cellular	O
prion	O
protein	O
prp	O
and	O
its	O
partner	O
,	O
the	O
co-chaperone	O
hsp70	B-T116
/	I-T116
90	I-T116
organizing	I-T116
protein	I-T116
hop	O
,	O
as	O
potential	O
target	O
candidates	O
due	O
to	O
their	O
role	O
in	O
gbm	O
tumorigenesis	O
and	O
in	O
neural	O
stem	O
cell	O
maintenance	O
.	O
	
gscs	O
expressing	O
different	O
levels	O
of	O
prp	O
were	O
cultured	O
as	O
neurospheres	O
with	O
growth	O
factors	O
,	O
and	O
characterized	O
with	O
stem	O
cells	O
markers	O
and	O
adhesion	O
molecules	O
markers	O
through	O
immunofluorescence	O
and	O
flow	O
cytometry	O
.	O
	
we	O
than	O
evaluated	O
gsc	O
self-renewal	O
and	O
proliferation	O
by	O
clonal	O
density	O
assays	O
and	O
brdu	O
incorporation	O
,	O
respectively	O
,	O
in	O
front	O
of	O
recombinant	O
hop	O
treatment	O
,	O
combined	O
or	O
not	O
with	O
a	O
hop	O
peptide	O
which	O
mimics	O
the	O
prp	O
binding	O
site	O
.	O
	
stable	O
silencing	O
of	O
hop	O
was	O
also	O
performed	O
in	O
parental	O
and/or	O
prp	O
-depleted	O
cell	O
populations	O
,	O
and	O
proliferation	O
in	O
vitro	O
and	O
tumor	O
growth	O
in	O
vivo	O
were	O
evaluated	O
.	O
	
migration	O
assays	O
were	O
performed	O
on	O
laminin-1	O
pre-coated	O
glass	O
.	O
	
we	O
observed	O
that	O
,	O
when	O
gbm	O
cells	O
are	O
cultured	O
as	O
neurospheres	O
,	O
they	O
express	O
specific	O
stemness	O
markers	O
such	O
as	O
cd133	O
,	O
cd15	O
,	O
oct4	O
,	O
and	O
sox2	O
prp	O
is	O
upregulated	O
compared	O
to	O
monolayer	O
culture	O
and	O
co-localizes	O
with	O
cd133	O
.	O
	
prp	O
silencing	O
downregulates	O
the	O
expression	O
of	O
molecules	O
associated	O
with	O
cancer	O
stem	O
cells	O
,	O
upregulates	O
markers	O
of	O
cell	O
differentiation	O
and	O
affects	O
gsc	O
self-renewal	O
,	O
pointing	O
to	O
a	O
pivotal	O
role	O
for	O
prp	O
in	O
the	O
maintenance	O
of	O
gscs	O
.	O
	
exogenous	O
hop	O
treatment	O
increases	O
proliferation	O
and	O
self-renewal	O
of	O
gscs	O
in	O
a	O
prp	O
-dependent	O
manner	O
while	O
hop	O
knockdown	O
disturbs	O
the	O
proliferation	O
process	O
.	O
	
in	O
vivo	O
,	O
prp	O
and/or	O
hop	O
knockdown	O
potently	O
inhibits	O
the	O
growth	O
of	O
subcutaneously	O
implanted	O
glioblastoma	O
cells	O
.	O
	
in	O
addition	O
,	O
disruption	O
of	O
the	O
prp	O
-	O
hop	O
complex	O
by	O
a	O
hop	O
peptide	O
,	O
which	O
mimics	O
the	O
prp	O
binding	O
site	O
,	O
affects	O
gsc	O
self-renewal	O
and	O
proliferation	O
indicating	O
that	O
the	O
hop	O
-	O
prp	O
complex	O
is	O
required	O
for	O
gsc	O
stemness	O
.	O
	
furthermore	O
,	O
prp	O
-depleted	O
gscs	O
downregulate	O
cell	O
adhesion-related	O
proteins	O
and	O
impair	O
cell	O
migration	O
indicating	O
a	O
putative	O
role	O
for	O
prp	O
in	O
the	O
cell	O
surface	O
stability	O
of	O
cell	O
adhesion	O
molecules	O
and	O
gbm	O
cell	O
invasiveness	O
,	O
respectively	O
.	O
	
in	O
conclusion	O
,	O
our	O
results	O
show	O
that	O
the	O
modulation	O
of	O
hop	O
-	O
prp	O
engagement	O
or	O
the	O
decrease	O
of	O
prp	O
and	O
hop	O
expression	O
may	O
represent	O
a	O
potential	O
therapeutic	O
intervention	O
in	O
gbm	O
,	O
regulating	O
glioblastoma	O
stem-like	O
cell	O
self-renewal	O
,	O
proliferation	O
,	O
and	O
migration	O
cyclic	B-T047
thrombocytopenia	I-T047
synchronizing	B-T079
with	O
the	O
menstrual	O
cycle	O
showing	O
periodic	B-T079
phases	B-T079
of	O
thrombocytopenia	B-T047
and	O
rebound	O
thrombocytosis	B-T047
a	O
37-	O
year	B-T079
-old	O
woman	B-T098
was	O
admitted	O
to	O
our	O
hospital	O
for	O
purpura	B-T047
involving	O
the	O
extremities	O
and	O
thrombocytopenia	B-T047
.	O
	
prednisolone	B-T109
psl	B-T109
was	O
administered	B-T169
based	O
on	O
a	O
diagnosis	B-T033
of	O
idiopathic	B-T047
thrombocytopenic	I-T047
purpura	I-T047
itp	B-T047
,	O
but	O
was	O
not	B-T080
effective	I-T080
for	O
maintaining	B-T052
her	O
platelet	O
count	O
within	O
the	O
normal	B-T081
range	I-T081
,	O
which	O
showed	O
cyclic	O
fluctuation	O
corresponding	O
to	O
the	O
menstrual	O
cycle	O
.	O
	
therefore	O
,	O
we	O
discontinued	B-T033
psl	B-T109
,	O
and	O
cyclic	B-T047
thrombocytopenia	I-T047
ctp	B-T047
was	O
diagnosed	B-T033
.	O
	
ctp	B-T047
is	O
a	O
rare	B-T047
disease	I-T047
which	O
is	O
usually	O
treated	B-T169
as	O
itp	B-T047
but	O
with	O
no	B-T033
response	I-T033
.	O
	
although	O
the	O
exact	O
cause	B-T078
of	O
ctp	B-T047
is	O
uncertain	B-T033
,	O
in	O
our	O
case	O
,	O
a	O
hormonal	O
mechanism	O
may	O
be	O
responsible	O
for	O
fluctuating	B-T079
platelet	O
count	O
.	O
	
comparative	O
evaluation	O
of	O
iodine-131	B-T109
metaiodobenzylguanidine	I-T109
and	O
18-fluorodeoxyglucose	B-T109
positron	O
emission	O
tomography	O
in	O
assessing	O
neural	B-T047
crest	I-T047
tumors	I-T047
will	O
they	O
play	O
a	O
complementary	O
role	O
18-fluorodeoxyglucose	B-T109
positron	O
emission	O
tomography	O
fdg-pet	O
has	O
established	O
a	O
role	O
in	O
the	O
evaluation	O
of	O
several	O
malignancies	O
.	O
	
however	O
,	O
its	O
precise	O
clinical	B-T078
role	I-T078
in	O
the	O
neural	B-T047
crest	I-T047
cell	I-T047
tumors	I-T047
continues	O
to	O
evolve	O
.	O
	
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
compare	O
iodine-131	B-T109
metaiodobenzylguanidine	I-T109
131	B-T109
and	O
fdg-pet	O
of	O
head	O
to	O
head	O
in	O
patients	O
with	O
neural	B-T047
crest	I-T047
tumors	I-T047
both	O
qualitatively	B-T080
and	O
semiquantitatively	O
and	O
to	O
determine	O
their	O
clinical	B-T033
utility	I-T033
in	O
disease	B-T033
status	I-T033
evaluation	I-T033
and	O
further	O
management	O
.	O
	
a	O
total	O
of	O
32	O
patients	O
who	O
had	O
undergone	O
131	B-T109
and	O
fdg-pet	O
prospectively	O
were	O
evaluated	O
and	O
clinicopathologically	B-T169
grouped	O
into	O
three	O
categories	O
neuroblastoma	O
,	O
pheochromocytoma	O
,	O
and	O
medullary	O
carcinoma	O
thyroid	O
.	O
	
in	O
18	O
patients	O
of	O
neuroblastoma	O
,	O
fdg	O
pet	O
and	O
131	B-T109
showed	O
patient-specific	B-T033
sensitivity	I-T033
of	O
84%	O
and	O
72%	O
,	O
respectively	O
.	O
	
the	O
mean	O
maximum	B-T081
standardized	I-T081
uptake	I-T081
value	I-T081
suvmax	B-T081
of	O
primary	B-T047
lesions	I-T047
in	O
patients	O
with	O
unfavorable	B-T169
histology	I-T169
was	O
found	O
to	O
be	O
relatively	O
higher	O
than	O
those	O
with	O
favorable	B-T169
histology	I-T169
5.18	O
2.38	O
vs	O
.	O
	
3.21	O
1.69	O
.	O
	
the	O
mean	O
suvmax	B-T081
of	O
two	O
common	O
sites	O
posterior	O
superior	O
iliac	O
spine	O
psis	O
and	O
greater	O
trochanter	O
was	O
higher	O
in	O
patients	O
with	O
involved	O
marrow	O
than	O
those	O
with	O
uninvolved	O
one	O
2.36	O
and	O
2.75	O
vs	O
.	O
	
1.26	O
and	O
1.34	O
,	O
respectively	O
.	O
	
the	O
ratio	O
of	O
suvmax	B-T081
of	O
the	O
involved/	O
contralateral	B-T082
normal	I-T082
sites	I-T082
was	O
2.16	O
1.9	O
.	O
	
in	O
equivocal	B-T080
bone	O
marrow	O
results	O
,	O
the	O
uptake	O
pattern	O
with	O
suv	B-T081
estimation	O
can	O
depict	O
metastatic	B-T169
involvement	I-T169
and	O
help	O
in	O
redirecting	O
the	O
biopsy	O
site	O
.	O
	
among	O
seven	O
patients	O
of	O
pheochromocytoma	O
,	O
fdg-pet	O
revealed	O
100%	O
patient-specific	B-T033
sensitivity	I-T033
.	O
	
fdg-pet	O
detected	O
more	O
metastatic	B-T082
foci	I-T082
than	O
131	B-T109
18	O
vs	O
.	O
	
13	O
sites	O
.	O
	
in	O
seven	O
patients	O
of	O
medullary	O
carcinoma	O
thyroid	O
,	O
fdg-pet	O
localized	O
residual	O
,	O
recurrent	B-T047
,	O
or	O
metastatic	O
disease	O
with	O
much	O
higher	O
sensitivity	O
32	O
metastatic	B-T082
foci	I-T082
with	O
72%	O
patient	B-T033
specific	I-T033
sensitivity	I-T033
than	O
131	B-T109
,	O
trending	O
along	O
the	O
higher	O
serum	O
calcitonin	O
levels	O
.	O
	
fdg-pet	O
is	O
not	O
only	O
a	O
good	O
complementary	B-T078
modality	I-T078
in	O
the	O
management	O
of	O
neural	B-T047
crest	I-T047
cell	I-T047
tumors	I-T047
but	O
also	O
it	O
can	O
even	O
be	O
superior	O
,	O
especially	O
in	O
cases	O
of	O
131	B-T109
nonavid	O
tumors	O
.	O
	
progressive	B-T169
occlusion	I-T169
and	O
recanalization	B-T061
after	O
endovascular	B-T061
treatment	I-T061
for	O
287	O
unruptured	B-T047
small	I-T047
aneurysms	I-T047
<5mm	O
a	O
single-center	O
6-year	B-T079
experience	O
we	O
aimed	O
to	O
investigate	O
the	O
effect	B-T080
of	O
coiling	B-T082
for	O
small	O
unruptured	B-T047
intracranial	I-T047
aneurysms	I-T047
uias	B-T047
on	O
progressive	B-T169
occlusio	I-T169
n	O
and	O
recanalization	B-T061
,	O
and	O
the	O
dubious	O
factors	O
related	O
to	O
progressive	B-T169
occlusion	I-T169
and	O
recanalization	B-T061
among	O
uias	B-T047
without	O
complete	O
occlusion	B-T169
.	O
	
a	O
total	O
of	O
264	O
patients	O
with	O
287	O
small	O
uias	B-T047
were	O
coiled	O
in	O
our	O
institute	O
between	O
june	O
2009	O
and	O
december	O
2014	O
.	O
	
all	O
uias	B-T047
enrolled	O
were	O
divided	O
into	O
small	O
3-5mm	O
and	O
very	O
small	O
<3mm	O
group	B-T078
s	O
,	O
and	O
uias	B-T047
without	O
initial	O
complete	O
occlusion	B-T169
were	O
divided	O
into	O
progressive	B-T169
,	O
stable	B-T080
and	O
recanalization	B-T061
groups	B-T078
.	O
	
baseline	B-T081
characteristics	B-T080
,	O
procedure	B-T061
-related	O
complications	O
,	O
angiographic	O
follow-up	O
results	O
,	O
and	O
clinical	B-T080
outcomes	I-T080
were	O
statistically	B-T062
analyzed	I-T062
.	O
	
among	O
287	O
aneurysms	B-T047
,	O
211	O
aneurysms	B-T047
73.5	O
were	O
completely	O
coiled	O
,	O
three	O
1.2	O
intraoperative	B-T079
ruptures	O
and	O
12	O
4.2	O
perioperative	B-T079
thromboembolic	O
events	O
occurred	O
.	O
	
angiographic	O
follow-up	O
was	O
available	O
for	O
174	O
patients	O
65.9	O
,	O
the	O
incidence	B-T081
of	O
recanalization	B-T061
was	O
5.7	O
.	O
	
among	O
56	O
aneurysms	B-T047
without	O
complete	O
occlusion	B-T169
,	O
43	O
76.8	O
had	O
progressive	B-T169
occlusion	I-T169
and	O
6	O
had	O
recanalization	B-T061
.	O
	
anatomic	B-T033
results	I-T033
of	O
initial	O
and	O
follow-up	O
between	O
small	O
and	O
very	O
small	O
groups	B-T078
were	O
similar	O
in	O
both	O
groups	B-T078
.	O
	
on	O
logistic	O
regression	O
analysis	O
,	O
smaller	O
size	B-T082
<3mm	O
without	O
complete	O
occlusion	B-T169
related	O
to	O
recanalization	B-T061
or	O
,	O
8.0	O
,	O
95%	O
ci	O
,	O
1.3	O
,	O
p=0	O
.	O
	
our	O
study	B-T062
suggested	O
that	O
coil	B-T061
embolization	I-T061
of	O
small	O
uias	B-T047
can	O
achieve	O
a	O
high	O
rate	O
of	O
progressive	B-T169
occlusion	I-T169
and	O
low	O
rate	O
of	O
recanalization	B-T061
during	O
follow-up	O
.	O
	
anatomic	B-T033
results	I-T033
of	O
initial	O
and	O
follow-up	O
between	O
small	O
3-5mm	O
and	O
very	O
small	O
<3mm	O
groups	B-T078
were	O
similar	O
in	O
both	O
groups	B-T078
.	O
	
what's	O
more	O
,	O
smaller	O
size	O
<3mm	O
without	O
complete	O
occlusion	B-T169
may	O
relate	O
to	O
selection	B-T052
of	O
an	O
artificial	B-T080
diet	O
for	O
laboratory	O
rearing	O
of	O
opogona	O
sacchari	O
lepidoptera	O
tineidae	O
bojer	O
,	O
1856	O
the	O
banana	O
moth	O
opogona	O
sacchari	O
bojer	O
lepidoptera	O
tineidae	O
is	O
a	O
polyphagous	O
pest	O
that	O
can	O
cause	O
serious	B-T080
damage	B-T169
,	O
in	O
particular	O
to	O
banana	O
crops	O
in	O
southern	B-T082
brazil	O
.	O
	
the	O
insect	O
is	O
a	O
quarantine	O
pest	O
in	O
several	O
countries	O
,	O
including	O
argentina	O
,	O
the	O
main	O
consumer	B-T098
market	O
for	O
bananas	O
from	O
southern	B-T082
brazil	O
.	O
	
little	O
information	B-T078
is	O
available	O
about	O
the	O
biology	O
and	O
ecology	O
of	O
this	O
moth	O
,	O
such	O
as	O
a	O
suitable	O
diet	O
for	O
laboratory	O
rearing	O
.	O
	
in	O
order	O
to	O
provide	O
support	O
for	O
integrated	O
pest	O
management	O
of	O
the	O
pest	O
,	O
this	O
study	B-T062
furnished	O
data	B-T078
for	O
selecting	O
two	O
diets	O
suitable	O
for	O
continuous	O
laboratory	O
rearing	O
of	O
o	O
.	O
	
sacchari	O
,	O
one	O
based	O
on	O
dried	B-T080
beans	O
,	O
wheat	O
germ	O
,	O
soy	O
bran	O
,	O
brewer's	O
yeast	O
,	O
and	O
casein	B-T116
and	O
another	O
diet	O
with	O
wheat	O
germ	O
and	O
casein	B-T116
as	O
protein	B-T116
sources	B-T033
.	O
	
with	O
both	O
diets	O
,	O
the	O
viability	B-T080
of	O
the	O
egg	O
-	O
adult	O
period	B-T079
exceeded	O
68%	O
,	O
with	O
fertility	O
over	O
338	O
eggs	O
per	O
female	B-T098
.	O
	
a	O
corrected	O
biotic	O
potential	B-T080
analysis	B-T062
gave	O
similar	O
values	B-T080
for	O
the	O
two	O
the	O
impact	B-T080
on	O
productivity	B-T081
of	O
a	O
hypothetical	B-T081
tax	I-T081
on	O
sugar-sweetened	O
beverages	O
to	O
quantify	O
the	O
potential	B-T080
impact	B-T080
of	O
an	O
additional	B-T169
20%	O
tax	B-T081
on	O
sugar-sweetened	O
beverages	O
ssbs	O
on	O
productivity	B-T081
in	O
australia	O
.	O
	
we	O
used	O
a	O
multi-state	B-T081
lifetable	I-T081
markov	I-T081
model	I-T081
to	O
examine	B-T033
the	O
potential	B-T080
impact	B-T080
of	O
an	O
additional	B-T169
20%	O
tax	B-T081
on	O
ssbs	O
on	O
total	B-T079
lifetime	I-T079
productivity	B-T081
in	O
the	O
paid	B-T078
and	I-T078
unpaid	I-T078
sectors	I-T078
of	O
the	O
economy	B-T081
.	O
	
the	O
study	B-T098
population	I-T098
consisted	O
of	O
australians	B-T098
aged	O
20	O
years	B-T079
or	O
older	B-T098
in	O
2010	O
,	O
whose	O
health	B-T170
and	O
other	O
relevant	B-T080
outcomes	B-T169
were	O
modelled	B-T062
over	O
their	O
remaining	B-T080
lifetime	B-T079
.	O
	
the	O
ssbs	O
tax	B-T081
was	O
estimated	B-T081
to	O
reduce	B-T080
the	O
number	B-T081
of	O
people	B-T098
with	O
obesity	B-T047
by	O
1.96	O
of	O
the	O
entire	O
population	B-T098
437	O
fewer	O
persons	B-T098
with	O
obesity	B-T047
,	O
and	O
reduce	B-T080
the	O
number	B-T081
of	O
employees	O
with	O
obesity	B-T047
by	O
317	O
persons	B-T098
.	O
	
these	O
effects	B-T080
translated	O
into	O
productivity	B-T081
gains	B-T081
in	O
the	O
paid	B-T078
sector	I-T078
of	O
au	O
million	B-T081
for	O
the	O
working	O
-	O
age	O
population	B-T098
95%	O
confidence	B-T081
interval	I-T081
au	O
million	B-T081
to	O
au	O
million	B-T081
,	O
using	O
the	O
human	B-T081
capital	I-T081
approach	B-T082
.	O
	
in	O
the	O
unpaid	B-T078
sector	I-T078
,	O
the	O
potential	B-T080
productivity	B-T081
gains	B-T081
amounted	B-T081
to	O
au	O
million	B-T081
au	O
million	B-T081
to	O
au	O
million	B-T081
using	O
the	O
replacement	B-T170
cost	I-T170
method	I-T170
.	O
	
these	O
productivity	B-T081
benefits	B-T081
are	O
in	O
addition	O
to	O
the	O
health	B-T081
benefits	I-T081
of	O
35	O
life	B-T079
years	I-T079
gained	B-T081
and	O
a	O
reduction	B-T080
in	O
healthcare	B-T081
costs	I-T081
of	O
au	O
million	B-T081
.	O
	
an	O
additional	B-T169
20%	O
tax	B-T081
on	O
ssbs	O
not	O
only	O
improves	B-T033
health	B-T170
outcomes	I-T170
and	O
reduces	B-T080
healthcare	B-T081
costs	I-T081
,	O
but	O
provides	O
productivity	B-T081
gains	B-T081
in	O
both	O
the	O
paid	B-T078
and	I-T078
unpaid	I-T078
sectors	I-T078
of	O
the	O
keeping	O
the	O
spirits	O
up	O
the	O
effect	B-T080
of	O
teachers'	O
and	O
parents'	O
emotional	O
support	O
on	O
children's	O
working	O
memory	O
performance	O
working	O
memory	O
,	O
used	O
to	O
temporarily	O
store	O
and	O
mentally	O
manipulate	O
information	B-T078
,	O
is	O
important	O
for	O
children's	O
learning	O
.	O
	
it	O
is	O
therefore	O
valuable	O
to	O
understand	O
which	O
contextual	O
factors	B-T169
promote	B-T052
or	O
hinder	B-T052
working	O
memory	O
performance	O
.	O
	
recent	O
research	B-T062
shows	O
positive	B-T033
associations	B-T080
between	O
positive	B-T033
parent-child	O
and	O
teacher-student	O
interactions	O
and	O
working	O
memory	O
performance	O
and	O
development	B-T169
.	O
	
however	O
,	O
no	O
study	B-T062
has	O
yet	O
experimentally	B-T169
investigated	I-T169
how	O
parents	O
and	O
teachers	O
affect	O
working	O
memory	O
performance	O
.	O
	
based	O
on	O
attachment	B-T078
theory	I-T078
,	O
the	O
current	O
study	B-T062
investigated	B-T169
the	O
role	O
of	O
parent	O
and	O
teacher	O
emotional	O
support	O
in	O
promoting	B-T052
working	O
memory	O
performance	O
by	O
buffering	O
the	O
negative	B-T033
effect	B-T080
of	O
social	O
stress	O
.	O
	
questionnaires	B-T170
and	O
an	O
experimental	B-T062
session	I-T062
were	O
completed	O
by	O
170	O
children	O
from	O
grade	O
1	O
to	O
2	O
mage	O
=	O
7	O
years	B-T079
6	O
months	B-T079
,	O
sd	O
=	O
7	O
months	B-T079
.	O
	
questionnaires	B-T170
were	O
used	O
to	O
assess	O
children's	O
perceptions	O
of	O
the	O
teacher-student	O
and	O
parent-child	O
relationship	O
.	O
	
during	O
an	O
experimental	B-T062
session	I-T062
,	O
working	O
memory	O
was	O
measured	O
with	O
the	O
corsi	O
task	O
backward	O
milner	O
,	O
1971	O
in	O
a	O
pre-	B-T052
and	O
post-test	B-T052
design	I-T052
.	O
	
in-between	O
the	O
tests	B-T170
stress	B-T033
was	O
induced	B-T169
in	O
the	O
children	O
using	O
the	O
cyberball	B-T062
paradigm	I-T062
williams	O
et	O
al	O
,	O
2000	O
.	O
	
emotional	O
support	O
was	O
manipulated	O
between-subjects	O
through	O
an	O
audio	O
message	B-T170
either	O
a	O
weather	O
report	B-T170
,	O
a	O
supportive	O
message	B-T170
of	O
a	O
stranger	B-T098
,	O
a	O
supportive	O
message	B-T170
of	O
a	O
parent	O
,	O
or	O
a	O
supportive	O
message	B-T170
of	O
a	O
teacher	O
.	O
	
results	B-T169
of	O
repeated	B-T062
measures	I-T062
anova	B-T081
showed	O
no	O
clear	O
effect	B-T080
of	O
the	O
stress	B-T033
induction	B-T169
.	O
	
nevertheless	O
,	O
an	O
effect	B-T080
of	O
parent	O
and	O
teacher	O
support	O
was	O
found	O
and	O
depended	O
on	O
the	O
quality	B-T080
of	O
the	O
parent-child	O
relationship	O
.	O
	
when	O
children	O
had	O
a	O
positive	B-T033
relationship	B-T080
with	O
their	O
parent	O
,	O
support	O
of	O
parents	O
and	O
teachers	O
had	O
little	O
effect	B-T080
on	O
working	O
memory	O
performance	O
.	O
	
when	O
children	O
had	O
a	O
negative	B-T033
relationship	B-T080
with	O
their	O
parent	O
,	O
a	O
supportive	O
message	B-T170
of	O
that	O
parent	O
decreased	O
working	O
memory	O
performance	O
,	O
while	O
a	O
supportive	O
message	B-T170
from	O
the	O
teacher	O
increased	O
performance	O
.	O
	
in	O
sum	O
,	O
the	O
current	O
study	B-T062
suggests	O
that	O
parents	O
and	O
teachers	O
can	O
support	O
working	O
memory	O
performance	O
by	O
being	O
supportive	O
for	O
the	O
child	O
.	O
	
teacher	O
support	O
is	O
most	O
effective	B-T080
when	O
the	O
child	O
has	O
a	O
negative	B-T033
relationship	B-T080
with	O
the	O
parent	O
.	O
	
these	O
insights	O
can	O
give	O
direction	O
to	O
specific	O
measures	O
aimed	O
at	O
preventing	B-T169
and	O
resolving	B-T033
working	O
memory	O
problems	B-T033
and	O
related	O
management	O
of	O
tachyarrhythmia	B-T033
during	O
pregnancy	O
maternal	B-T033
tachyarrhythmia	B-T033
is	O
a	O
common	B-T081
complication	O
during	O
pregnancy	O
due	O
to	O
hormonal	B-T033
changes	I-T033
that	O
enhance	B-T052
pre-existing	B-T080
arrhythmias	B-T033
or	O
induce	B-T169
new	O
arrhythmias	B-T033
in	O
the	O
presence	B-T033
of	O
congenital	O
heart	O
defects	O
in	O
pregnant	B-T098
females	I-T098
.	O
	
presence	B-T033
of	O
tachyarrhythmia	B-T033
during	O
pregnancy	O
poses	O
risk	B-T078
to	O
the	O
mother	O
and	O
fetus	O
,	O
calling	O
for	O
proper	B-T061
treatment	I-T061
with	O
medications	O
.	O
	
use	O
of	O
antiarrhythmic	O
drugs	O
in	O
cases	O
of	O
maternal	B-T033
tachyarrhythmia	B-T033
must	O
give	O
due	O
consideration	B-T078
of	O
potential	B-T080
teratogenic	O
side	O
effects	O
.	O
	
utilization	B-T169
of	O
antiarrhythmic	O
drugs	O
during	O
pregnancy	O
has	O
been	O
well	O
studied	B-T062
some	O
result	B-T169
in	O
minimal	B-T080
fetal	O
harm	O
or	O
none	O
at	O
all	O
.	O
	
new	O
techniques	B-T169
,	O
such	O
as	O
cardiac	B-T061
ablation	I-T061
,	O
have	O
also	O
been	O
implemented	B-T052
with	O
minimal	B-T080
or	O
no	O
radiation	O
exposure	O
to	O
the	O
fetus	O
or	O
mother	O
.	O
	
pregnant	B-T098
women	I-T098
with	O
tachyarrhythmia	B-T033
have	O
been	O
successfully	B-T080
treated	B-T033
with	O
little	B-T081
to	O
no	O
impact	B-T080
on	O
the	O
developing	O
fetus	O
as	O
result	B-T169
of	O
increasing	B-T169
experience	O
with	O
antiarrhythmic	O
drugs	O
and	O
progress	B-T169
of	O
new	O
procedural	B-T169
techniques	B-T169
.	O
	
hif-1α	B-T116
overexpression	O
improves	B-T033
transplanted	B-T061
bone	I-T061
mesenchymal	I-T061
stem	I-T061
cells	I-T061
survival	O
in	O
rat	O
mcao	O
stroke	O
model	O
bone	O
mesenchymal	O
stem	O
cells	O
bmscs	O
death	O
after	O
transplantation	B-T061
is	O
a	O
serious	O
obstacle	O
impacting	O
on	O
the	O
outcome	O
of	O
cell	B-T061
therapy	I-T061
for	O
cerebral	B-T047
infarction	I-T047
.	O
	
this	O
study	B-T062
was	O
aimed	B-T078
to	O
investigate	B-T169
whether	O
modification	B-T169
of	O
bmscs	O
with	O
hypoxia-inducible	B-T116
factor	I-T116
1α	I-T116
hif-1α	B-T116
could	O
enhance	B-T052
the	O
survival	O
of	O
the	O
implanted	B-T061
bmscs	I-T061
.	O
	
bmscs	O
were	O
isolated	O
from	O
wistar	O
rats	O
,	O
and	O
were	O
infected	O
with	O
hif-1α-gfp	O
lentiviral	O
vector	O
or	O
hif-1α	O
sirna	O
.	O
	
the	O
modified	B-T169
bmscs	O
were	O
exposed	O
to	O
oxygen-glucose	O
deprivation	O
ogd	O
condition	O
,	O
cellular	O
viability	O
and	O
apoptosis	O
were	O
then	O
assessed	B-T052
.	O
	
an	O
inhibitor	O
of	O
ampk	B-T116
compound	O
c	O
was	O
used	O
to	O
detect	B-T061
whether	O
ampk	B-T116
and	O
mtor	B-T116
were	O
implicated	O
in	O
the	O
functions	O
of	O
hif-1α	B-T116
on	O
bmscs	O
survival	O
.	O
	
besides	O
,	O
ultrastructure	O
of	O
bmscs	O
was	O
observed	O
and	O
the	O
expression	O
of	O
autophagy	O
markers	O
was	O
measured	O
.	O
	
the	O
modified	B-T169
bmscs	O
were	O
transplanted	B-T061
into	O
middle	O
cerebral	O
artery	O
occlusion	O
mcao	O
model	O
of	O
rats	O
,	O
and	O
the	O
cerebral	B-T047
infarction	I-T047
volume	B-T081
and	O
neurological	O
function	O
was	O
assessed	B-T052
.	O
	
the	O
results	O
indicated	O
that	O
hif-1α	O
overexpression	O
protected	O
ogd	O
induced	B-T169
injury	O
by	O
promoting	O
cellular	O
viability	O
and	O
inhibiting	O
apoptosis	O
.	O
	
ampk	B-T116
was	O
activated	O
while	O
mtor	B-T116
was	O
inactivated	B-T169
by	O
hif-1α	O
overexpression	O
,	O
and	O
that	O
might	O
be	O
through	O
which	O
hif-1α	B-T116
functioned	O
bmscs	O
survival	O
.	O
	
hif-1α	O
overexpression	O
promoted	O
autophagy	O
more	O
important	O
,	O
compound	O
c	O
abolished	O
the	O
induction	O
of	O
hif-1α	O
on	O
autophagy	O
.	O
	
transplantation	B-T061
of	I-T061
the	I-T061
overexpressed	I-T061
hif-1α	I-T061
of	I-T061
bmscs	I-T061
into	O
the	O
mcao	O
rats	O
reduced	O
brain	B-T047
infarct	I-T047
volume	B-T081
and	O
improved	B-T033
neurobehavioral	B-T080
outcome	I-T080
besides	O
,	O
it	O
inhibited	O
pro-inflammatory	B-T116
cytokines	I-T116
generation	O
while	O
promoted	O
neurotrophin	B-T116
secretion	O
.	O
	
in	O
conclusion	O
,	O
hif-1α	B-T116
might	O
be	O
contributed	O
in	O
the	O
survival	O
of	O
bmscs	O
by	O
regulating	O
the	O
activation	O
of	O
ampk	O
and	O
mtor	O
,	O
as	O
well	O
as	O
by	O
promoting	O
associations	B-T080
between	O
major	O
life	O
events	O
and	O
adherence	B-T169
,	O
glycemic	B-T061
control	I-T061
,	O
and	O
psychosocial	B-T080
characteristics	I-T080
in	O
teens	B-T098
with	O
type	B-T047
1	I-T047
diabetes	I-T047
this	O
cross-sectional	B-T062
study	I-T062
assessed	B-T052
the	O
type	O
of	O
major	O
life	O
events	O
occurring	O
in	O
a	O
contemporary	O
sample	O
of	O
teens	B-T098
with	O
type	B-T047
1	I-T047
diabetes	I-T047
and	O
the	O
association	B-T080
between	O
event	O
frequency	O
and	O
demographic	B-T078
,	O
diabetes	B-T061
management	I-T061
,	O
and	O
psychosocial	B-T080
characteristics	I-T080
.	O
	
parents	O
of	O
178	O
teens	B-T098
completed	O
the	O
life	O
events	O
checklist	B-T170
to	O
report	O
major	O
events	O
teens	B-T098
had	O
experienced	O
in	O
the	O
last	O
year	B-T079
42%	O
experienced	O
0	O
to	O
1	O
event	O
n	O
=	O
75	O
,	O
32%	O
experienced	O
2	O
to	O
3	O
events	O
n	O
=	O
57	O
,	O
and	O
26%	O
experienced	O
4+	O
events	O
n	O
=	O
46	O
.	O
	
teens	B-T098
and	O
parents	O
completed	O
validated	O
measures	B-T081
of	O
treatment	B-T033
adherence	I-T033
,	O
diabetes	B-T047
-specific	O
self-efficacy	O
,	O
quality	B-T078
of	I-T078
life	I-T078
,	O
and	O
diabetes	B-T047
-specific	O
family	B-T033
conflict	I-T033
.	O
	
parent-youth	B-T052
interview	I-T052
and	O
chart	O
review	O
provided	O
demographics	B-T062
and	O
diabetes	B-T061
management	I-T061
data	O
.	O
	
mean	O
number	O
of	O
events	O
/	O
teen	B-T098
was	O
2.6	O
2.7	O
range	O
=	O
0-15	O
.	O
	
the	O
most	O
common	O
events	O
were	O
""""	O
hospitalization	O
of	O
a	O
family	O
member	O
""""	O
24%	O
,	O
""""	O
getting	B-T033
a	I-T033
bad	I-T033
report	I-T033
card	I-T033
""""	O
20%	O
,	O
"""serious"	O
arguments	O
between	O
parents	O
""""	O
19%	O
,	O
and	O
""""	O
serious	O
illness	O
/	O
injury	O
in	O
a	O
family	O
member	O
""""	O
19%	O
.	O
	
compared	O
with	O
teens	B-T098
experiencing	O
0	O
to	O
1	O
event	O
,	O
teens	B-T098
experiencing	O
4+	O
events	O
were	O
less	O
likely	O
to	O
have	O
married	O
parents	O
p	O
=	O
01	O
and	O
a	O
parent	O
with	O
a	O
college	B-T170
degree	I-T170
p	O
=	O
006	O
.	O
	
teen	B-T098
s	O
with	O
4+	O
events	O
had	O
significantly	O
poorer	O
adherence	B-T169
p	O
=	O
002	O
teen	B-T098
,	O
p	O
=	O
02	O
parent	O
,	O
lower	O
self-efficacy	O
p	O
=	O
03	O
teen	B-T098
,	O
p	O
<	O
0001	O
parent	O
,	O
poorer	O
quality	B-T078
of	I-T078
life	I-T078
p	O
<	O
0001	O
teen	B-T098
,	O
p	O
<	O
0001	O
parent	O
,	O
and	O
more	O
conflict	B-T033
p	O
=	O
006	O
teen	B-T098
,	O
p	O
=	O
02	O
parent	O
than	O
teens	B-T098
with	O
fewer	O
events	O
.	O
	
in	O
a	O
multivariate	B-T170
model	I-T170
r	O
2	O
=	O
0.21	O
,	O
p	O
<	O
0001	O
controlling	O
for	O
demographic	B-T078
and	O
diabetes	B-T061
management	I-T061
characteristics	O
,	O
fewer	O
events	O
was	O
associated	O
with	O
lower	O
a1c	B-T116
p	O
=	O
0009	O
.	O
	
occurrence	O
of	O
more	O
major	O
life	O
events	O
was	O
associated	B-T080
with	I-T080
poorer	O
diabetes	B-T061
care	I-T061
and	O
a1c	B-T116
and	O
more	O
negative	O
psychosocial	B-T078
qualities	I-T078
in	O
teens	B-T098
with	O
type	B-T047
1	I-T047
diabetes	I-T047
.	O
	
metabolomics	O
,	O
nutrition	B-T033
,	O
and	O
potential	B-T080
biomarkers	O
of	O
food	B-T080
quality	I-T080
,	O
intake	B-T169
,	O
and	O
health	B-T080
status	I-T080
diet	O
,	O
dietary	B-T062
patterns	I-T062
,	O
and	O
other	O
environmental	B-T080
factors	I-T080
such	O
as	O
exposure	B-T080
to	I-T080
toxins	O
are	O
playing	O
an	O
important	O
role	O
in	O
the	O
prevention	B-T080
/	O
development	B-T169
of	O
many	O
diseases	B-T047
,	O
like	O
obesity	B-T047
,	O
type	B-T047
2	I-T047
diabetes	I-T047
,	O
and	O
consequently	O
on	O
the	O
health	B-T080
status	I-T080
of	O
individuals	B-T098
.	O
	
a	O
major	O
challenge	O
nowadays	O
is	O
to	O
identify	B-T080
novel	B-T080
biomarkers	O
to	O
detect	B-T033
as	O
early	B-T079
as	O
possible	O
metabolic	B-T169
dysfunction	O
and	O
to	O
predict	B-T078
evolution	B-T169
of	O
health	B-T080
status	I-T080
in	O
order	O
to	O
refine	O
nutritional	B-T061
advices	I-T061
to	O
specific	O
population	B-T098
groups	I-T098
.	O
	
omics	O
technologies	O
such	O
as	O
genomics	O
,	O
transcriptomics	O
,	O
proteomics	O
,	O
and	O
metabolomics	O
coupled	B-T169
with	O
statistical	B-T170
and	O
bioinformatics	B-T170
tools	I-T170
have	O
already	O
shown	O
great	O
potential	B-T080
in	O
this	O
research	O
field	O
even	O
if	O
so	O
far	O
only	O
few	O
biomarkers	O
have	O
been	O
validated	O
.	O
	
for	O
the	O
past	O
two	O
decades	B-T081
,	O
important	O
analytical	O
techniques	O
have	O
been	O
developed	B-T169
to	O
detect	B-T033
as	O
many	O
metabolites	O
as	O
possible	O
in	O
human	O
biofluids	O
such	O
as	O
urine	O
,	O
blood	O
,	O
and	O
saliva	O
.	O
	
in	O
the	O
field	O
of	O
food	O
science	O
and	O
nutrition	O
,	O
many	O
studies	B-T062
have	O
been	O
carried	O
out	O
for	O
food	O
authenticity	B-T080
,	O
quality	B-T080
,	O
and	O
safety	O
,	O
as	O
well	O
as	O
for	O
food	O
processing	O
.	O
	
furthermore	O
,	O
metabolomic	O
investigations	B-T169
have	O
been	O
carried	O
out	O
to	O
discover	B-T052
new	O
early	B-T079
biomarkers	O
of	O
metabolic	B-T169
dysfunction	O
and	O
predictive	B-T080
biomarkers	O
of	O
developing	O
pathologies	O
obesity	B-T047
,	O
metabolic	B-T047
syndrome	I-T047
,	O
type-2	B-T047
diabetes	I-T047
,	O
etc	O
.	O
	
great	O
emphasis	O
is	O
also	O
placed	O
in	O
the	O
development	B-T169
of	O
methodologies	B-T062
to	O
identify	B-T080
and	O
validate	O
biomarkers	O
of	O
nutrients	O
exposure	B-T080
.	O
	
draft	O
genome	O
sequence	O
of	O
bacillus	O
cereus	O
la2007	O
,	O
a	O
human-pathogenic	O
isolate	O
harboring	O
anthrax	O
-like	O
plasmids	O
we	O
present	O
the	O
genome	O
sequence	O
of	O
bacillus	O
cereus	O
la2007	O
,	O
a	O
strain	O
isolated	O
in	O
2007	O
from	O
a	O
fatal	O
pneumonia	O
case	O
in	O
louisiana	O
.	O
	
sequence-based	O
genome	O
analysis	O
revealed	O
that	O
la2007	O
carries	O
a	O
plasmid	O
highly	O
similar	O
to	O
bacillus	O
anthracis	O
pxo1	O
,	O
including	O
the	O
genes	O
responsible	O
for	O
the	O
production	O
and	O
regulation	O
of	O
anthrax	O
toxin	I-T116
developing	O
elite	B-T080
neurospora	O
crassa	O
strains	O
for	O
cellulosic	B-T109
ethanol	O
production	O
using	O
fungal	B-T169
breeding	O
the	O
demand	O
for	O
renewable	B-T169
and	O
sustainable	B-T169
energy	I-T169
has	O
generated	B-T052
considerable	O
interest	O
in	O
the	O
conversion	B-T169
of	O
cellulosic	B-T109
biomass	B-T081
into	O
liquid	O
fuels	O
such	O
as	O
ethanol	B-T109
using	O
a	O
filamentous	O
fungus	O
.	O
	
while	O
attempts	O
have	O
been	O
made	O
to	O
study	B-T062
cellulose	O
metabolism	O
through	O
the	O
use	B-T169
of	I-T169
knock-out	O
mutants	O
,	O
there	O
have	O
been	O
no	O
systematic	B-T169
effort	O
to	O
characterize	B-T052
natural	B-T169
variation	O
for	O
cellulose	O
metabolism	O
in	O
ecotypes	O
adapted	O
to	O
different	B-T080
habitats	B-T082
.	O
	
here	O
,	O
we	O
characterized	B-T052
natural	B-T169
variation	O
in	O
saccharification	O
of	O
cellulose	B-T109
and	O
fermentation	O
in	O
73	O
ecotypes	O
and	O
89	O
laboratory	O
strains	O
of	O
the	O
model	B-T170
fungus	O
neurospora	O
crassa	O
.	O
	
we	O
observed	B-T169
significant	B-T078
variation	O
in	O
both	O
traits	O
among	O
natural	B-T169
and	O
laboratory	B-T080
generated	I-T080
populations	O
,	O
with	O
some	O
elite	B-T080
strains	O
performing	B-T169
better	B-T080
than	O
the	O
reference	B-T081
strain	O
.	O
	
in	O
the	O
f1	O
population	O
n345	O
,	O
15%	O
of	O
the	O
population	O
outperformed	O
both	O
parents	O
with	O
the	O
top	O
performing	B-T169
strain	O
having	O
10%	O
improvement	O
in	O
ethanol	O
production	O
.	O
	
these	O
results	O
suggest	O
that	O
natural	B-T169
alleles	O
can	O
be	O
exploited	O
through	O
fungal	B-T169
breeding	O
for	O
developing	O
elite	B-T080
industrial	O
strains	O
for	O
bioethanol	O
production	O
.	O
	
the	O
role	O
of	O
the	O
hippocampus	O
and	O
the	O
function	O
of	O
calcitonin	B-T116
gene-related	I-T116
peptide	I-T116
in	O
the	O
mechanism	O
of	O
traumatic	O
brain	O
injury	O
accelerating	O
fracture-healing	O
this	O
research	O
attempts	O
to	O
identify	O
the	O
part	O
the	O
hippocampus	O
plays	O
in	O
accelerated	O
fracture-healing	O
after	O
traumatic	O
brain	O
injury	O
as	O
well	O
as	O
to	O
test	O
functions	O
of	O
calcitonin	B-T116
gene-related	I-T116
peptide	I-T116
cgrp	B-T116
during	O
this	O
process	O
.	O
	
experiments	O
were	O
carried	O
out	O
on	O
male	O
sprague-dawley	O
rats	O
that	O
were	O
split	O
into	O
four	O
groups	B-T078
at	O
random	O
tbi	O
-	O
fracture	O
group	B-T078
,	O
fracture	O
-	O
only	B-T081
group	B-T078
,	O
tbi	O
-	O
only	B-T081
group	B-T078
,	O
and	O
control	O
group	O
.	O
	
in	O
the	O
first	O
week	O
,	O
blood	O
specimen	O
would	O
be	O
drawn	O
from	O
rats	O
among	O
the	O
groups	B-T078
except	O
those	O
of	O
the	O
control	O
group	O
at	O
three-time	O
points	O
24	O
,	O
72	O
and	O
168	O
hours	O
post	B-T079
-	O
damage	O
.	O
	
these	O
rats	O
would	O
be	O
assessed	O
from	O
the	O
neurological	B-T080
perspective	O
based	O
on	O
their	O
grades	O
of	O
performance	O
in	O
a	O
sequence	O
of	O
tests	O
24	O
hours	O
before	O
and	O
12	O
hours	O
after	O
brain	O
injury	O
.	O
	
blood	O
samples	O
were	O
also	O
taken	O
from	O
the	O
control	O
group	O
24	O
hours	O
before	O
the	O
injury	O
,	O
and	O
whole	O
brain	O
tissues	O
in	O
the	O
injured	B-T169
groups	B-T078
were	O
harvested	B-T061
at	O
72	O
and	O
168	O
hours	O
post	B-T079
-	O
injury	O
.	O
	
we	O
compared	O
the	O
serum	O
cgrp	B-T116
concentration	B-T081
,	O
the	O
distribution	O
of	O
cgrp	B-T116
,	O
the	O
cgrp	B-T116
expression	O
,	O
and	O
the	O
expression	O
of	O
cgrp	B-T116
in	O
the	O
hippocampus	O
,	O
the	O
expression	O
of	O
cgrp	B-T116
in	O
the	O
hippocampus	O
,	O
the	O
expression	O
of	O
cgrp	B-T116
in	O
the	O
hippocampus	O
,	O
and	O
the	O
expression	O
of	O
cgrp	B-T116
in	O
the	O
brain	O
by	O
immunohistochemistry	O
,	O
western	O
blotting	O
,	O
rt	O
-	O
of	O
cgrp	O
rna	O
expression	O
levels	O
.	O
	
neurological	O
examinations	O
suggested	O
that	O
the	O
functions	O
of	O
the	O
cerebral	O
cortex	O
,	O
cerebellum	O
,	O
and	O
brain	O
stem	O
showed	O
significant	O
differences	O
pre	B-T079
-	O
and	O
post	B-T079
-	O
injury	O
p	O
<	O
0.001	O
.	O
	
elisa	O
analysis	O
indicated	O
a	O
great	O
density	O
of	O
cgrp	B-T116
in	O
tbi	O
-	O
fracture	O
group	B-T078
at	O
different	O
time	O
points	O
.	O
	
furthermore	O
,	O
in	O
the	O
tbi	O
-	O
fracture	O
group	B-T078
,	O
cgrp	B-T116
in	O
both	O
hippocampus	O
and	O
the	O
whole	O
brain	O
showed	O
a	O
noticeable	O
augment	O
in	O
rt-pcr	O
and	O
western	O
blot	O
analysis	O
at	O
72	O
and	O
168	O
h	O
post	B-T079
-	O
injury	O
,	O
and	O
only	B-T081
in	O
this	O
group	O
,	O
immunohistochemistry	O
analysis	O
indicated	O
that	O
cgrp	B-T116
was	O
present	O
in	O
the	O
hippocampus	O
at	O
168	O
hours	O
post	B-T079
-	O
injury	O
.	O
	
we	O
observed	O
that	O
the	O
hippocampus	O
and	O
cgrp	B-T116
were	O
responsible	O
for	O
quick	O
bone-healing	B-T047
mechanisms	O
.	O
	
we	O
suggest	O
a	O
role	O
for	O
the	O
hippocampus	O
in	O
accelerated	O
fracture	O
healing	O
.	O
	
cgrp	B-T116
expression	O
,	O
as	O
determined	O
by	O
ihc	O
,	O
cannot	O
be	O
observed	O
in	O
other	O
groups	B-T078
,	O
indicating	O
that	O
the	O
hippocampus	O
may	O
be	O
the	O
specific	O
component	O
of	O
the	O
brain	O
that	O
responds	O
to	O
""""	O
big	O
stress	O
bone	O
extracellular	O
matrix	O
hydrogel	O
enhances	O
osteogenic	O
differentiation	O
of	O
c2c12	O
myoblasts	O
and	O
mouse	O
primary	O
calvarial	O
cells	O
hydrogel	O
scaffolds	O
derived	O
from	O
the	O
extracellular	O
matrix	O
ecm	O
of	O
mammalian	O
tissues	O
have	O
been	O
successfully	O
used	O
to	O
promote	O
tissue	O
repair	O
in	B-T080
vitro	I-T080
and	O
in	B-T082
vivo	I-T082
.	O
	
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
osteogenic	O
potential	O
of	O
ecm	O
hydrogels	O
prepared	O
from	O
demineralized	O
and	O
decellularized	O
bovine	O
bone	O
in	O
the	O
presence	O
and	O
absence	O
of	O
osteogenic	O
medium	O
.	O
	
culture	O
of	O
c2c12	O
and	O
mouse	O
primary	O
calvarial	O
cells	O
mpcs	O
on	O
decellularized	O
bone	O
ecm	O
becm	O
and	O
demineralized	O
bone	O
matrix	O
dbm	O
gels	O
resulted	O
in	O
increased	O
expression	O
of	O
osteogenic	O
gene	O
markers	O
,	O
including	O
a	O
3.6	O
and	O
13.4	O
increase	O
in	O
osteopontin	B-T116
and	O
15.7	O
and	O
27.1	O
increase	O
in	O
osteocalcin	B-T116
when	O
mpcs	O
were	O
cultured	O
upon	O
becm	O
with	O
basal	O
and	O
osteogenic	O
media	O
,	O
respectively	O
.	O
	
becm	O
hydrogels	O
stimulated	O
the	O
osteogenic	O
differentiation	O
of	O
c2c12	O
and	O
mpcs	O
even	O
in	O
the	O
absence	O
of	O
osteogenic	O
medium	O
.	O
	
these	O
results	O
suggest	O
that	O
becm	O
hydrogel	O
scaffolds	O
may	O
have	O
great	O
utility	O
in	O
future	O
clinical	B-T080
applications	B-T169
for	O
bone	O
tissue	B-T061
engineering	I-T061
.	O
	
prostate-specific	B-T116
antigen	I-T116
increase	B-T169
during	O
dutasteride	B-T109
to	O
indicate	O
the	O
need	O
for	O
prostate	O
biopsy	O
influence	O
of	O
prostatic	B-T047
inflammation	I-T047
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	B-T062
the	O
significance	O
of	O
an	O
increase	B-T169
in	O
total	O
prostate-specific	O
antigen	O
psa	O
serum	O
levels	O
despite	O
dutasteride	B-T109
treatment	B-T061
as	O
a	O
predictor	B-T078
of	O
prostate	O
cancer	O
pc	O
at	O
biopsy	O
.	O
	
we	O
focused	O
our	O
attention	O
on	O
the	O
rate	B-T081
of	O
the	O
first	O
psa	B-T116
increase	O
and	O
on	O
the	O
influence	O
of	O
prostatic	O
inflammation	O
.	O
	
from	O
2011	O
to	O
2016	O
,	O
365	O
men	O
with	O
a	O
previous	O
negative	O
prostate	O
biopsy	O
and	O
persistent	O
elevated	O
psa	B-T116
levels	O
received	O
dutasteride	O
treatment	O
.	O
	
the	O
population	O
was	O
followed	O
for	O
a	O
range	O
of	O
12-48	O
months	O
.	O
	
one	O
hundred	O
twelve	O
cases	O
with	O
a	O
confirmed	O
psa	O
increase	B-T169
>0	O
ng/ml	O
over	O
the	O
nadir	O
value	O
during	O
the	O
follow-up	O
were	O
included	O
in	O
group	O
a	O
and	O
underwent	O
a	O
new	O
prostate	O
biopsy	O
.	O
	
in	O
group	O
a	O
,	O
the	O
psa	O
increase	O
was	O
associated	O
with	O
pc	O
at	O
the	O
re-biopsy	O
in	O
66%	O
of	O
cases	O
.	O
	
the	O
percentage	O
of	O
psa	O
reduction	O
after	O
6	O
months	O
of	O
treatment	O
was	O
not	O
a	O
significant	O
indicator	O
of	O
the	O
risk	O
for	O
pc	O
.	O
	
the	O
distribution	O
of	O
inflammatory	O
infiltrates	O
significantly	O
p<00	O
varied	O
from	O
positive	O
to	O
negative	O
prostate	O
biopsies	O
.	O
	
the	O
relative	O
risk	O
for	O
pc	O
at	O
biopsy	O
significantly	O
increase	O
d	O
according	O
to	O
psa	O
level	O
during	O
dutasteride	O
.	O
	
treatment	O
with	O
dutasteride	O
can	O
help	O
to	O
analyze	O
psa	O
kinetic	O
.	O
	
a	O
persistent	O
prostatic	B-T047
inflammation	I-T047
is	O
a	O
factor	O
able	O
to	O
reduce	O
the	O
performance	O
of	O
psa	O
kinetic	O
during	O
dutasteride	O
treatment	B-T061
neurological	B-T033
decline	I-T033
in	O
an	O
elderly	B-T098
with	O
repaired	B-T169
myelomeningocele	O
complicated	B-T169
with	O
lumbar	B-T047
canal	I-T047
stenosis	I-T047
a	O
case	B-T170
report	I-T170
tethered	B-T047
cord	I-T047
syndrome	I-T047
is	O
a	O
well-known	O
complication	O
after	O
myelomeningocele	O
mmc	O
repair	O
in	O
childhood	B-T079
.	O
	
however	O
,	O
late	O
complications	O
in	O
adults	O
with	O
a	O
repaired	B-T169
mmc	O
are	O
not	O
well	O
understood	O
.	O
	
in	O
particular	O
,	O
the	O
influence	O
of	O
a	O
degenerative	O
spinal	O
deformity	O
on	O
a	O
sustained	B-T169
tethered	B-T033
cord	I-T033
is	O
still	O
unclear	O
.	O
	
a	O
63-year-old	O
man	O
with	O
a	O
repaired	B-T169
mmc	O
presented	O
with	O
a	O
progressive	B-T033
gait	I-T033
disturbance	I-T033
and	O
numbness	O
in	O
both	O
lower	O
limbs	O
.	O
	
magnetic	B-T170
resonance	I-T170
images	I-T170
demonstrated	O
that	O
the	O
tethered	B-T033
spinal	I-T033
cord	I-T033
was	O
compressed	B-T169
by	O
severe	B-T080
canal	B-T047
stenosis	I-T047
along	O
the	O
entire	O
lumbar	O
spine	O
.	O
	
after	O
a	O
multi-level	B-T061
lumbar	I-T061
decompression	I-T061
surgery	B-T061
,	O
the	O
patient	O
recovered	O
to	O
baseline	B-T081
neurological	B-T080
status	O
.	O
	
in	O
adults	O
with	O
a	O
repaired	B-T169
mmc	O
,	O
lumbar	B-T047
canal	I-T047
stenosis	I-T047
should	O
be	O
investigated	B-T169
as	O
a	O
possible	O
cause	O
of	O
late	O
neurological	B-T033
decline	I-T033
.	O
	
clinical	O
manifestations	O
may	O
be	O
complicated	B-T169
by	O
the	O
coexistence	O
of	O
both	O
the	O
original	O
and	O
subsequent	O
neurological	B-T047
disorders	I-T047
.	O
	
because	O
these	O
additional	O
disorders	B-T047
result	O
from	O
compressive	B-T047
myelopathy	I-T047
,	O
early	O
surgical	B-T061
decompression	I-T061
is	O
indicated	O
to	O
avoid	O
irreversible	O
spinal	B-T047
cord	I-T047
dysfunction	I-T047
.	O
	
epidemiology	O
of	O
polyomavirus	O
bk	O
bkv	O
and	O
the	O
emergent	B-T078
african	O
variant	B-T080
in	O
kidney	O
and	O
bone	O
marrow	O
transplant	O
recipients	O
in	O
the	O
fundacion	O
valle	O
del	O
lili	O
in	O
cali	O
,	O
colombia	O
to	O
describe	O
the	O
epidemiology	O
of	O
bkv	O
and	O
to	O
assess	B-T052
the	O
presence	B-T033
of	O
the	O
african	O
variant	B-T080
in	O
bone	O
marrow	O
and	O
kidney	B-T033
transplant	I-T033
patients	I-T033
who	O
have	O
suspected	B-T080
bkv	O
reactivation	B-T052
.	O
	
a	O
descriptive	B-T062
study	I-T062
was	O
conducted	B-T033
,	O
using	O
institutional	B-T170
records	I-T170
,	O
at	O
the	O
fundación	O
valle	O
del	O
lili	O
,	O
cali	O
-	O
colombia	O
.	O
	
the	O
overall	B-T081
prevalence	I-T081
of	O
bkv	O
during	O
the	O
study	O
period	O
was	O
51%	O
.	O
	
the	O
african	O
variant	B-T080
was	O
identified	B-T080
in	O
49.4	O
of	O
samples	O
that	O
were	O
positive	B-T033
for	O
bkv	O
.	O
	
50.6	O
of	O
the	O
samples	O
were	O
found	O
to	O
have	O
the	O
wild	O
strain	B-T080
of	O
bkv	O
.	O
	
among	O
bkv	O
positive	B-T033
patients	O
,	O
57%	O
were	O
kidney	B-T033
transplant	I-T033
recipients	I-T033
and	O
43%	O
were	O
bone	O
marrow	O
transplant	O
recipients	O
.	O
	
this	O
is	O
the	O
first	O
epidemiological	B-T062
study	I-T062
describing	O
the	O
african	O
variant	B-T080
of	O
bkv	O
in	O
thaw	O
-and-use	O
target	O
cells	O
pre-labeled	B-T080
with	O
calcein	O
am	O
for	O
antibody-dependent	O
cell-mediated	O
cytotoxicity	O
assays	O
in	B-T080
vitro	I-T080
antibody-dependent	O
cell-mediated	O
cytotoxicity	O
adcc	O
assays	O
are	O
routinely	O
performed	O
to	O
support	O
the	O
research	O
and	O
development	O
of	O
therapeutic	B-T116
antibodies	I-T116
.	O
	
in	O
adcc	O
assays	O
,	O
target	O
cells	O
bound	O
by	O
the	O
antibodies	B-T116
are	O
lysed	O
by	O
activated	B-T052
effector	O
cells	O
following	O
interactions	O
between	O
the	O
fc	B-T116
region	I-T116
of	O
the	O
bound	O
antibody	B-T116
and	O
fcγ	B-T116
receptors	I-T116
on	O
effector	O
cells	O
.	O
	
target	O
cell	O
lysis	O
is	O
typically	O
measured	O
by	O
quantification	B-T081
of	O
released	O
endogenous	B-T169
enzymes	B-T116
,	O
e.g	O
,	O
lactate	B-T116
dehydrogenase	I-T116
,	O
or	O
measurement	O
of	O
released	O
exogenous	B-T169
labels	O
,	O
e.g	O
,	O
51	O
,	O
europium	O
or	O
calcein	B-T109
.	O
	
adcc	O
assays	O
based	O
on	O
the	O
detection	O
of	O
exogenous	B-T169
labels	O
released	O
from	O
lysed	O
target	O
cells	O
generally	O
show	O
higher	O
sensitivity	O
and	O
require	O
shorter	O
incubation	B-T033
times	I-T033
.	O
	
however	O
,	O
target	O
cells	O
are	O
usually	O
labeled	B-T080
immediately	O
prior	O
to	O
assay	O
,	O
which	O
inadvertently	O
introduces	O
additional	O
assay	O
variations	B-T080
due	O
to	O
differences	O
in	O
target	O
cell	O
conditions	O
and	O
labeling	O
/	O
handling	O
processes	O
.	O
	
in	O
this	O
report	O
,	O
we	O
describe	O
the	O
use	O
of	O
thaw	O
-and-use	O
pre-labeled	B-T080
target	O
cells	O
for	O
adcc	O
assays	O
.	O
	
thaw	O
-and-use	O
target	O
cells	O
in	O
our	O
experiments	O
were	O
pre-labeled	B-T080
with	O
the	O
fluorescent	O
dye	O
calcein	O
am	O
,	O
cryopreserved	O
in	O
single-use	O
aliquots	O
and	O
used	O
directly	O
in	O
assays	O
after	O
thawing	O
.	O
	
upon	O
thaw	O
,	O
the	O
pre-labeled	B-T080
cells	O
displayed	O
viability	O
and	O
label	O
retention	B-T169
comparable	O
to	O
freshly	O
labeled	B-T080
cells	O
,	O
responded	O
to	O
adcc	O
mediated	O
by	O
both	O
peripheral	O
blood	O
mononuclear	O
cells	O
and	O
engineered	O
natural	O
killer	O
cells	O
,	O
performed	O
stably	O
for	O
at	O
least	O
3	O
years	O
and	O
provided	O
favorable	O
precision	O
and	O
accuracy	O
to	O
adcc	O
assays	O
.	O
	
implementation	O
of	O
thaw	O
-and-use	O
pre-labeled	B-T080
target	O
cells	O
in	O
adcc	O
assays	O
can	O
help	O
to	O
alleviate	O
both	O
cell	O
culture	O
and	O
dye	O
labeling	O
derived	O
variability	O
,	O
increase	O
the	O
flexibility	O
of	O
assay	O
scheduling	O
and	O
improve	O
assay	B-T080
consistency	I-T080
and	O
pathways	O
and	O
genes	O
associated	B-T080
with	I-T080
immune	O
dysfunction	O
in	O
sheep	O
paratuberculosis	B-T047
multibacillary	B-T033
and	O
paucibacillary	B-T033
paratuberculosis	B-T047
are	O
both	O
caused	O
by	O
mycobacterium	O
avium	O
subspecies	O
paratuberculosis	O
.	O
	
multibacillary	B-T033
lesions	B-T033
are	O
composed	O
largely	O
of	O
infected	B-T033
epithelioid	O
macrophages	O
and	O
paucibacillary	B-T033
lesions	B-T033
contain	O
t	O
cells	O
but	O
few	O
bacteria	O
.	O
	
multibacillary	B-T033
disease	B-T047
is	O
similar	O
to	O
human	O
lepromatous	B-T047
leprosy	I-T047
,	O
with	O
variable/high	O
levels	O
of	O
antibody	B-T116
and	O
a	O
dysfunctional	B-T169
immune	O
response	O
.	O
	
animals	O
with	O
paucibacillary	B-T033
disease	B-T047
have	O
high	O
cell-mediated	O
immunity	O
and	O
variable	B-T080
levels	I-T080
of	O
antibody	B-T116
.	O
	
this	O
study	O
aims	O
to	O
characterize	O
the	O
immunological	B-T047
dysfunction	I-T047
using	O
truseq	B-T170
analysis	B-T062
of	O
the	O
ileocaecal	B-T082
lymph	O
node	O
that	O
drains	O
disease	B-T047
lesions	B-T033
.	O
	
immune	O
dysfunction	O
is	O
highlighted	O
by	O
repression	O
of	O
tcr	O
/	O
cd3	O
genes	O
,	O
t	B-T116
cell	I-T116
co-receptors	I-T116
/	O
co-stimulators	B-T116
,	O
t	O
cell	O
activation	O
and	O
signal-transduction	O
genes	O
.	O
	
inflammation	O
was	O
an	O
acute	O
phase	O
response	O
and	O
chronic	O
inflammation	O
,	O
with	O
little	O
evidence	O
of	O
acute	B-T033
inflammation	I-T033
.	O
	
the	O
high	O
levels	O
of	O
immunoglobulin	B-T116
and	O
plasma	O
cell	O
transcripts	O
is	O
consistent	O
with	O
the	O
anti-map	O
antibody	O
responses	O
in	O
paratuberculosis	B-T047
sheep	O
.	O
	
also	O
notable	O
was	O
the	O
overwhelming	O
reduction	B-T080
in	O
mast	O
cell	O
transcripts	O
,	O
potentially	O
affecting	B-T169
dc	O
activation	O
of	O
the	O
immune	O
response	O
.	O
	
this	O
study	O
also	O
shows	O
that	O
there	O
were	O
no	O
fundamental	O
differences	O
in	O
the	O
gene	O
expression	O
patterns	O
in	O
multibacillary	B-T033
and	O
paucibacillary	B-T033
disease	B-T047
,	O
no	O
shift	O
in	O
t	O
cell	O
genes	O
from	O
th1	O
to	O
th2	O
pattern	O
but	O
rather	O
an	O
incremental	B-T081
decline	O
into	O
immune	O
dysfunction	O
leading	O
to	O
multibacillary	B-T033
pathology	B-T047
.	O
	
modified	B-T169
frailty	B-T170
index	I-T170
predicts	B-T078
postoperative	B-T033
outcomes	B-T081
in	O
older	B-T098
gastrointestinal	O
cancer	O
patients	O
frailty	B-T033
disproportionately	B-T080
impacts	B-T080
older	B-T098
patients	O
with	O
gastrointestinal	O
cancer	O
,	O
rendering	B-T169
them	O
at	O
increased	B-T033
risk	I-T033
for	I-T033
poor	I-T033
outcomes	I-T033
.	O
	
a	O
frailty	B-T170
index	I-T170
may	O
aid	O
in	O
preoperative	B-T079
risk	B-T078
stratification	B-T062
.	O
	
we	O
hypothesized	B-T078
that	O
high	O
modified	B-T033
frailty	I-T033
index	I-T033
mfi	I-T033
scores	I-T033
are	O
associated	B-T080
with	I-T080
adverse	B-T033
outcomes	I-T033
after	O
tumor	O
resection	B-T061
in	O
older	B-T098
,	O
gastrointestinal	O
cancer	O
patients	O
.	O
	
patients	O
60-90	B-T098
years	I-T098
old	I-T098
who	O
underwent	B-T169
gastrointestinal	O
tumor	O
resection	O
were	O
identified	B-T080
in	O
the	O
2005-2012	O
nsqip	B-T033
participant	B-T098
use	O
file	O
.	O
	
mfi	B-T033
was	O
defined	O
by	O
11	O
previously	B-T079
described	B-T078
,	O
preoperative	B-T079
variables	B-T080
.	O
	
frailty	B-T033
was	O
defined	O
by	O
an	O
mfi	B-T033
score	I-T033
>0	O
.	O
	
the	O
postoperative	O
course	O
was	O
evaluated	O
using	O
univariate	B-T062
and	O
multivariate	B-T081
analysis	I-T081
.	O
	
41	O
455	O
patients	O
mean	O
age	O
72.4	O
years	O
,	O
47.4	O
female	O
were	O
identified	B-T080
.	O
	
the	O
most	O
prevalent	B-T082
form	I-T082
of	O
cancer	O
was	O
colorectal	O
69.3	O
,	O
n	O
=	O
28	O
708	O
and	O
2.8	O
of	O
patients	O
were	O
frail	B-T033
n	O
=	O
1	O
.	O
	
frail	B-T033
patients	O
were	O
significantly	B-T078
more	B-T078
likely	I-T078
to	O
have	O
increased	B-T079
length	I-T079
of	I-T079
stay	I-T079
11.7	O
vs	O
9.0	O
days	O
,	O
major	B-T080
complications	O
29.1	O
vs	O
17.9	O
,	O
and	O
30-day	O
mortality	B-T081
5.6	O
vs	O
2.5	O
,	O
all	O
p	O
<	O
0.001	O
.	O
	
multivariate	B-T081
analysis	I-T081
identified	B-T080
mfi	B-T033
as	O
an	O
independent	B-T078
predictor	B-T078
of	O
major	B-T080
complications	O
or	O
1.52	O
,	O
95%ci	O
1.39	O
,	O
p	O
<	O
0.001	O
and	O
30-day	O
mortality	B-T081
or	O
1.48	O
,	O
95%ci	O
1.24	O
,	O
p	O
<	O
0.001	O
.	O
	
mfi	B-T033
was	O
associated	B-T080
with	I-T080
the	O
incidence	B-T081
of	O
postoperative	B-T033
complications	O
and	O
mortality	B-T081
in	O
older	B-T098
surgical	O
patients	O
with	O
gastrointestinal	O
cancer	O
.	O
	
spermatocytic	O
tumor	O
with	O
sarcoma	O
a	O
rare	B-T080
testicular	O
neoplasm	O
spermatocytic	O
tumor	O
,	O
formerly	O
known	O
as	O
spermatocytic	O
seminoma	O
,	O
is	O
an	O
uncommon	B-T080
testicular	O
neoplasm	O
which	O
is	O
a	O
distinct	O
clinicopathologic	B-T169
entity	I-T169
from	O
classic	O
seminoma	O
.	O
	
these	O
tumors	O
are	O
not	O
associated	O
with	O
germ	O
cell	O
neoplasia	O
in	O
situ	O
,	O
other	O
germ	O
cell	O
tumors	O
,	O
or	O
isochromosome	O
12p	O
.	O
	
although	O
typically	O
,	O
these	O
tumors	O
have	O
an	O
excellent	B-T080
prognosis	O
occasional	B-T169
cases	I-T169
are	O
associated	B-T080
with	I-T080
sarcoma	O
and	O
have	O
a	O
very	B-T033
poor	I-T033
prognosis	I-T033
.	O
	
we	O
present	O
a	O
case	O
of	O
spermatocytic	O
tumor	O
with	O
sarcoma	O
showing	O
a	O
chondrosarcomatous	O
component	O
,	O
discuss	O
the	O
pathologic	B-T033
findings	I-T033
and	O
differential	O
diagnosis	O
and	O
provide	O
follow-up	O
information	B-T078
.	O
	
remote	B-T082
ischemic	B-T061
conditioning	I-T061
and	O
renal	O
protection	B-T033
over	O
the	O
course	O
of	O
the	O
last	O
2	O
decades	O
,	O
the	O
concept	O
of	O
remote	B-T082
ischemic	B-T061
conditioning	I-T061
ric	B-T061
has	O
attracted	O
considerable	O
research	B-T062
interest	O
,	O
because	O
ric	B-T061
,	O
in	O
most	O
of	O
its	O
embodiments	O
offers	O
an	O
inexpensive	O
way	O
of	O
protecting	B-T033
tissues	O
against	O
ischemic	B-T169
damage	O
inflicted	O
by	O
a	O
number	O
of	O
medical	B-T169
conditions	B-T080
or	O
procedures	O
.	O
	
acute	O
kidney	O
injury	O
aki	O
is	O
a	O
common	O
side	B-T169
effect	I-T169
in	O
the	O
context	O
of	O
various	O
medical	O
procedures	O
,	O
and	O
ric	B-T061
has	O
been	O
suggested	O
as	O
a	O
means	O
of	O
reducing	O
its	O
incidence	O
.	O
	
outcomes	B-T169
regarding	O
kidney	O
function	O
have	O
been	O
reported	O
in	O
numerous	O
studies	B-T062
that	O
evaluated	O
the	O
effects	B-T080
of	I-T080
ric	B-T061
in	O
a	O
variety	O
of	O
settings	O
eg	O
,	O
cardiac	B-T061
surgery	I-T061
,	O
interventions	B-T061
requiring	O
intravenous	B-T082
administration	I-T082
of	O
contrast	O
media	O
.	O
	
although	O
several	O
individual	O
studies	B-T062
have	O
implied	O
a	O
beneficial	O
effect	B-T080
of	I-T080
ric	B-T061
in	O
preserving	O
kidney	O
function	O
,	O
3	O
recently	O
published	O
randomized	B-T062
controlled	I-T062
trials	I-T062
evaluating	O
more	O
than	O
1000	O
patients	O
each	O
effect	B-T080
of	I-T080
remote	B-T061
ischemic	I-T061
preconditioning	I-T061
in	O
the	O
cardiac	B-T061
surgery	I-T061
,	O
remote	B-T061
ischaemic	I-T061
preconditioning	I-T061
for	O
heart	B-T061
surgery	I-T061
,	O
and	O
e	B-T061
ric	I-T061
ca	I-T061
were	O
negative	O
.	O
	
however	O
,	O
aki	O
or	O
any	O
other	O
index	O
of	O
renal	O
function	O
was	O
not	O
a	O
stand-alone	O
primary	O
end	O
point	O
in	O
any	O
of	O
these	O
trials	O
.	O
	
on	O
the	O
other	O
hand	O
,	O
a	O
range	O
of	O
meta-analyses	O
each	O
including	O
thousands	O
of	O
participants	O
have	O
reported	O
mixed	O
results	O
,	O
with	O
the	O
most	O
recent	O
among	O
them	O
showing	O
benefit	O
from	O
ric	B-T061
,	O
pinpointing	O
at	O
the	O
same	O
time	O
a	O
number	O
of	O
shortcomings	O
in	O
published	O
studies	O
,	O
adversely	O
affecting	O
the	O
quality	O
of	O
available	O
data	O
.	O
	
the	O
present	O
review	O
provides	O
a	O
critical	O
appraisal	O
of	O
the	O
current	O
state	O
of	O
this	O
field	O
of	O
research	O
.	O
	
it	O
is	O
the	O
opinion	O
of	O
the	O
authors	O
of	O
this	O
review	O
that	O
there	O
is	O
a	O
clear	O
need	O
for	O
a	O
common	O
clinical	O
trial	O
framework	O
for	O
ischemic	O
conditioning	O
studies	O
.	O
	
if	O
the	O
current	O
babel	O
of	O
definitions	O
,	O
procedures	O
,	O
outcomes	O
,	O
and	O
goals	O
persists	O
,	O
it	O
is	O
most	O
likely	O
that	O
soon	O
ischemic	O
conditioning	O
will	O
be	O
"""yesterday's"	O
"news"""	O
with	O
no	O
definitive	O
conclusions	O
having	O
been	O
reached	O
in	O
terms	O
of	O
its	O
real	O
clinical	O
utility	I-T061
temporal	B-T079
and	O
spatial	B-T082
variability	O
of	O
fungal	O
structures	O
and	O
host	O
responses	O
in	O
an	O
incompatible	O
rust-wheat	O
interaction	O
information	B-T078
about	O
temporal	B-T079
and	O
spatial	B-T082
variability	O
of	O
fungal	O
structures	O
and	O
host	O
responses	O
is	O
scarce	B-T080
in	O
comparison	B-T052
to	O
the	O
vast	O
amount	B-T081
of	O
genetic	B-T169
,	O
biochemical	B-T169
,	O
and	O
physiological	B-T169
studies	B-T062
of	O
host-pathogen	O
interactions	O
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
used	B-T169
avirulent	B-T080
wild	O
type	O
and	O
virulent	B-T080
mutant	O
isolates	O
of	O
puccinia	O
striiformis	O
to	O
characterize	B-T052
the	O
interactions	B-T169
in	O
wheat	O
carrying	B-T052
yellow	O
rust	O
yr2	O
resistance	O
.	O
	
both	O
conventional	B-T080
and	O
advanced	B-T080
microscopic	B-T080
techniques	B-T169
were	O
used	B-T169
for	O
a	O
detailed	B-T080
study	B-T062
of	O
morphology	B-T080
and	O
growth	O
of	O
fungal	B-T169
colonies	O
and	O
associated	B-T080
host	O
cell	O
responses	O
.	O
	
the	O
growth	O
of	O
the	O
wild	O
type	O
isolates	O
was	O
highly	B-T080
restricted	B-T169
due	O
to	O
hypersensitive	O
response	O
hr	O
,	O
plant	O
cell	O
death	O
indicated	B-T033
by	O
autofluorescence	O
and	O
change	B-T169
in	O
the	O
shape	B-T082
of	O
the	O
affected	B-T169
plant	O
cells	O
.	O
	
the	O
host	O
response	O
appeared	B-T080
post	B-T079
-	O
haustorial	O
,	O
but	O
large	B-T081
variation	B-T080
in	O
the	O
time	B-T079
and	O
stage	B-T079
of	O
arrest	O
was	O
observed	B-T169
for	O
individual	B-T098
fungal	B-T169
colonies	O
,	O
probably	B-T078
due	O
to	O
a	O
delay	B-T079
between	B-T082
detection	B-T061
and	O
response	O
.	O
	
some	O
colonies	O
were	O
stopped	B-T079
right	B-T079
after	I-T079
the	O
formation	B-T169
of	O
the	O
primary	B-T047
infection	I-T047
hyphae	O
whereas	O
others	O
formed	B-T169
highly	B-T080
branched	B-T082
mycelia	O
.	O
	
hr	O
was	O
first	O
observed	B-T169
in	O
host	O
cells	O
in	O
direct	B-T080
contact	O
with	O
fungal	O
structures	O
,	O
after	O
which	O
the	O
defense	O
responses	O
spread	B-T080
to	O
adjacent	B-T082
host	O
cells	O
,	O
and	O
eventually	O
led	O
to	O
encasement	B-T082
of	O
the	O
fungal	B-T169
colony	O
.	O
	
several	B-T081
cells	O
with	O
hr	O
contained	B-T052
haustoria	O
,	O
which	O
were	O
small	B-T081
and	O
underdeveloped	B-T080
,	O
but	O
some	B-T081
cells	O
contained	B-T052
normal	B-T080
sized	B-T082
haustoria	O
without	O
signs	O
of	O
hypersensitivity	O
.	O
	
the	O
growth	O
of	O
the	O
virulent	B-T080
mutants	O
in	O
the	O
resistant	B-T169
plants	O
was	O
similar	B-T080
to	O
the	O
growth	O
in	O
plants	O
without	O
yr2	O
resistance	O
,	O
which	O
is	O
a	O
strong	B-T080
indication	B-T078
that	O
the	O
incompatible	B-T080
phenotype	O
was	O
associated	B-T080
with	O
yr2	O
.	O
	
the	O
interaction	B-T169
between	B-T082
p	O
.	O
	
striiformis	O
and	O
wheat	O
with	O
yr2	O
resistance	O
was	O
highly	B-T080
variable	B-T080
in	O
time	B-T079
and	O
space	B-T082
,	O
which	O
demonstrate	B-T080
that	O
histological	O
studies	B-T062
are	O
important	B-T080
for	O
a	O
deeper	O
understanding	O
of	O
host-pathogen	O
interactions	O
and	O
plant	O
defense	O
mechanisms	B-T169
in	O
the	O
effects	B-T080
of	I-T080
messages	B-T170
about	O
the	O
causes	B-T169
of	O
obesity	B-T047
on	O
disciplinary	O
action	O
decisions	O
for	O
overweight	B-T047
employees	O
we	O
investigated	B-T169
the	O
impact	B-T080
of	O
messages	B-T170
about	O
the	O
causes	B-T169
of	O
obesity	B-T047
controllable	B-T033
or	O
uncontrollable	B-T080
on	O
the	O
disciplinary	O
action	O
consequences	B-T169
selected	O
for	O
obese	B-T047
employees	O
in	O
response	O
to	O
a	O
work-related	B-T033
mistake	B-T080
.	O
	
participants	B-T098
read	O
about	O
either	O
the	O
controllable	B-T033
or	O
uncontrollable	B-T080
causes	B-T169
of	O
obesity	B-T047
before	O
reviewing	B-T080
an	O
ostensible	B-T078
employee	O
file	O
that	O
included	O
a	O
description	O
of	O
an	O
employee	O
mistake	B-T080
.	O
	
depending	O
on	O
condition	O
,	O
the	O
file	O
contained	O
a	O
photo	O
of	O
the	O
employee	O
that	O
either	O
depicted	O
them	O
as	O
obese	B-T047
or	O
average	B-T081
weight	O
.	O
	
participants	B-T098
were	O
more	O
willing	O
to	O
withhold	B-T052
a	O
raise	O
or	O
promotion	O
from	O
an	O
obese	B-T047
employee	O
than	O
from	O
an	O
average	B-T081
-	O
weight	O
employee	O
.	O
	
further	O
,	O
there	O
was	O
little	O
evidence	B-T078
that	O
the	O
messages	B-T170
about	O
the	O
causes	B-T169
of	O
obesity	B-T047
affected	B-T169
participants	B-T098
'	O
perceived	B-T033
control	I-T033
and	O
self-efficacy	O
for	O
healthy	B-T080
behaviors	O
.	O
	
experience	O
is	O
instrumental	B-T081
in	O
tuning	B-T081
a	O
link	B-T052
between	O
language	O
and	O
cognition	O
evidence	B-T078
from	O
6-	O
to	O
7-	O
month-old	O
infants	O
'	O
object	O
categorization	O
at	B-T080
birth	I-T080
,	O
infants	O
not	O
only	O
prefer	O
listening	O
to	O
human	O
vocalizations	O
,	O
but	O
also	O
have	O
begun	B-T079
to	O
link	B-T052
these	O
vocalizations	O
to	O
cognition	O
for	O
infants	O
as	O
young	B-T079
as	O
three	B-T079
months	I-T079
of	O
age	O
,	O
listening	O
to	O
human	O
language	O
supports	O
object	O
categorization	O
,	O
a	O
core	B-T082
cognitive	B-T169
capacity	B-T081
.	O
	
this	O
precocious	B-T079
link	B-T082
is	O
initially	B-T079
broad	B-T082
at	O
3	O
and	O
4	O
months	O
,	O
vocalizations	O
of	O
both	B-T080
humans	O
and	O
nonhuman	O
primates	O
support	O
categorization	O
.	O
	
but	O
by	O
6	B-T079
months	I-T079
,	O
infants	O
have	O
narrowed	B-T080
the	O
link	B-T052
only	O
human	O
vocalizations	O
support	O
object	O
categorization	O
.	O
	
here	O
we	O
ask	O
what	O
guides	O
infants	O
as	O
they	O
tune	B-T081
their	O
initially	B-T079
broad	B-T082
link	B-T052
to	O
a	O
more	O
precise	B-T080
one	O
,	O
engaged	O
only	O
by	O
the	O
vocalizations	O
of	O
our	O
species	O
.	O
	
across	O
three	O
studies	B-T062
,	O
we	O
use	O
a	O
novel	B-T080
exposure	B-T080
paradigm	B-T062
to	O
examine	O
the	O
effects	B-T080
of	O
experience	O
.	O
	
we	O
document	O
that	O
merely	O
exposing	B-T080
infants	O
to	O
nonhuman	O
primate	O
vocalizations	O
enables	O
infants	O
to	O
preserve	O
the	O
early	B-T079
-	O
established	B-T080
link	B-T052
between	O
this	O
signal	O
and	O
categorization	O
.	O
	
in	O
contrast	O
,	O
exposing	B-T080
infants	O
to	O
backward	B-T169
speech	O
-	O
a	O
signal	O
that	O
fails	B-T169
to	O
support	O
categorization	O
at	O
any	O
age	O
-	O
offers	O
no	O
such	O
advantage	O
.	O
	
our	O
findings	B-T033
reveal	B-T080
the	O
power	B-T081
of	O
early	B-T079
experience	O
as	O
infants	O
specify	O
which	O
signals	O
,	O
from	O
an	O
initially	B-T079
broad	B-T082
set	O
,	O
they	O
will	O
continue	B-T078
to	O
link	B-T052
to	O
bone	B-T047
degeneration	I-T047
and	O
its	O
recovery	O
in	O
smp30/gnl	O
-	O
knockout	O
mice	O
senescence	B-T116
marker	I-T116
protein-30	I-T116
smp30	B-T116
decreases	O
androgen	O
-independently	O
with	O
aging	O
and	O
is	O
a	O
lactone	B-T109
-	O
hydrolyzing	B-T116
enzyme	I-T116
gluconolactonase	B-T116
gnl	B-T116
that	O
is	O
involved	O
in	O
vitamin	B-T109
c	I-T109
biosynthesis	B-T169
.	O
	
in	O
the	O
present	O
study	B-T062
,	O
bone	O
properties	O
of	O
smp30/gnl	O
knockout	O
ko	O
mice	O
with	O
deficiency	B-T169
in	O
vitamin	B-T109
c	I-T109
synthesis	B-T169
were	O
investigated	O
to	O
reveal	O
the	O
effects	O
of	O
smp30/gnl	B-T116
and	O
exogenous	B-T169
vitamin	B-T109
c	I-T109
supplementation	O
on	O
bone	O
formation	O
.	O
	
mineral	B-T081
content	I-T081
bmc	B-T081
and	O
mineral	O
density	O
bmd	O
of	O
the	O
mandible	O
and	O
femur	O
of	O
smp30/gnl	O
ko	O
and	O
wild-type	O
mice	O
at	O
2	O
and	O
3	O
months	B-T079
of	O
age	O
with	O
or	O
without	O
vitamin	B-T109
c	I-T109
supplementation	O
were	O
measured	O
by	O
dual-energy	O
x-ray	O
absorptiometry	O
.	O
	
body	O
and	O
bone	O
weight	B-T081
of	O
both	O
age	O
groups	O
decreased	O
and	O
became	O
significantly	O
lower	O
than	O
those	O
of	O
wild-type	O
mice	O
.	O
	
the	O
bones	O
of	O
smp30/gnl	O
ko	O
mice	O
were	O
rough	O
and	O
porous	O
,	O
with	O
bmc	B-T081
and	O
bmd	O
significantly	O
below	O
wild-type	O
.	O
	
oral	O
supplementation	O
with	O
vitamin	B-T109
c	I-T109
eliminated	O
differences	O
in	O
body	O
weight	O
,	O
bone	O
weight	O
,	O
bmc	B-T081
,	O
and	O
bmd	O
between	O
smp30/gnl	O
ko	O
and	O
wild-type	O
mice	O
at	O
each	O
age	O
.	O
	
these	O
results	O
indicate	O
that	O
bone	B-T047
degeneration	I-T047
in	O
smp30/gnl	O
ko	O
mice	O
was	O
caused	O
by	O
lack	O
of	O
vitamin	B-T109
c	I-T109
,	O
and	O
that	O
this	O
mouse	O
strain	O
is	O
an	O
appropriate	O
model	O
for	O
bone	O
metabolism	O
in	O
humans	O
,	O
which	O
have	O
no	O
ability	O
to	O
synthesize	B-T169
vitamin	B-T109
c	I-T109
.	O
	
utility	O
of	O
post-mortem	O
genetic	B-T062
testing	I-T062
in	O
cases	O
of	O
sudden	B-T047
arrhythmic	I-T047
death	I-T047
syndrome	I-T047
sudden	B-T047
arrhythmic	I-T047
death	I-T047
syndrome	I-T047
sads	B-T047
describes	O
a	O
sudden	O
death	O
with	O
negative	O
autopsy	O
and	O
toxicological	B-T169
analysis	B-T062
.	O
	
cardiac	B-T047
genetic	I-T047
disease	I-T047
is	O
a	O
likely	O
etiology	B-T169
.	O
	
this	O
study	B-T062
investigated	B-T169
the	O
clinical	B-T080
utility	I-T080
and	O
combined	O
yield	O
of	O
post-mortem	O
genetic	B-T062
testing	I-T062
molecular	O
autopsy	O
in	O
cases	O
of	O
sads	B-T047
and	O
comprehensive	B-T080
clinical	O
evaluation	O
of	O
surviving	B-T052
relatives	O
.	O
	
we	O
evaluated	O
302	O
expertly	O
validated	O
sads	B-T047
cases	O
with	O
suitable	O
dna	O
median	O
age	O
24	O
years	O
65%	O
males	O
who	O
underwent	O
next-generation	O
sequencing	O
using	O
an	O
extended	O
panel	B-T078
of	O
77	O
primary	O
electrical	O
disorder	O
and	O
cardiomyopathy	O
genes	O
.	O
	
pathogenic	B-T033
and	O
likely	O
pathogenic	B-T080
variants	I-T080
were	O
classified	O
using	O
american	O
college	O
of	O
medical	O
genetics	O
acmg	O
consensus	B-T170
guidelines	I-T170
.	O
	
the	O
yield	O
of	O
combined	O
molecular	O
autopsy	O
and	O
clinical	O
evaluation	O
in	O
82	O
surviving	O
families	O
was	O
evaluated	O
.	O
	
a	O
gene-level	O
rare	O
variant	O
association	O
analysis	O
was	O
conducted	O
in	O
sads	B-T047
cases	O
versus	O
controls	O
.	O
	
a	O
clinically	B-T080
actionable	I-T080
pathogenic	B-T033
or	O
likely	O
pathogenic	B-T080
variant	I-T080
was	O
identified	O
in	O
40	O
of	O
302	O
cases	O
13%	O
.	O
	
the	O
main	O
etiologies	B-T169
established	O
were	O
catecholaminergic	B-T047
polymorphic	I-T047
ventricular	I-T047
tachycardia	I-T047
and	O
long	B-T047
qt	I-T047
syndrome	I-T047
17	O
6%	O
and	O
11	O
4%	O
,	O
respectively	O
.	O
	
gene-based	O
rare	O
variants	O
association	O
analysis	O
showed	O
enrichment	O
of	O
rare	O
predicted	O
deleterious	B-T080
variants	I-T080
in	O
ryr2	O
p	O
=	O
5	O
10	O
.	O
	
combining	O
molecular	O
autopsy	O
with	O
clinical	O
evaluation	O
in	O
surviving	O
families	O
increased	O
diagnostic	B-T080
yield	I-T080
from	O
26%	O
to	O
39%	O
.	O
	
molecular	O
autopsy	O
for	O
electrical	O
disorder	O
and	O
cardiomyopathy	O
genes	O
,	O
using	O
acmg	O
guidelines	B-T170
for	O
variant	O
classification	O
,	O
identified	O
a	O
modest	O
but	O
realistic	O
yield	O
in	O
sads	B-T047
.	O
	
our	O
data	O
highlighted	O
the	O
predominant	O
role	O
of	O
catecholaminergic	B-T047
polymorphic	I-T047
ventricular	I-T047
tachycardia	I-T047
and	O
long	B-T047
qt	I-T047
syndrome	I-T047
,	O
especially	O
the	O
ryr2	O
gene	O
,	O
as	O
well	O
as	O
the	O
minimal	O
yield	O
from	O
other	O
genes	O
.	O
	
furthermore	O
,	O
we	O
showed	O
the	O
enhanced	O
utility	O
of	O
combined	O
clinical	O
and	O
genetic	O
evaluation	O
.	O
	
binding	B-T052
of	O
dead-box	B-T116
helicase	I-T116
dhh1	B-T116
to	O
the	O
5'utr	O
of	O
ash1	O
mrna	O
represses	O
localized	O
translation	O
of	O
ash1	O
in	O
yeast	O
cells	O
local	O
translation	O
of	O
specific	B-T080
mrnas	O
is	O
regulated	O
by	O
dynamic	O
changes	O
in	O
their	O
subcellular	O
localization	B-T169
,	O
and	O
these	O
changes	B-T169
are	O
due	O
to	O
complex	B-T080
mechanisms	B-T169
controlling	O
cytoplasmic	O
mrna	O
transport	O
.	O
	
the	O
budding	O
yeast	O
saccharomyces	O
cerevisiae	O
is	O
well	O
suited	O
to	O
studying	O
these	O
mechanisms	B-T169
because	O
many	O
of	O
its	O
transcripts	O
are	O
transported	O
from	O
the	O
mother	O
cell	O
to	O
the	O
budding	O
daughter	O
cell	O
.	O
	
here	O
,	O
we	O
investigated	B-T169
the	O
translational	O
control	O
of	O
ash1	O
mrna	O
after	O
transport	O
and	O
localization	B-T169
.	O
	
we	O
show	O
that	O
although	O
ash1	O
transcripts	O
were	O
translated	O
after	O
they	O
reached	O
the	O
bud-tip	O
,	O
some	O
mrnas	O
were	O
bound	O
by	O
the	O
rna-binding	O
protein	O
puf6	O
and	O
were	O
non-polysomal	O
.	O
	
we	O
also	O
found	O
that	O
the	O
dead-box	O
helicase	O
dhh1	O
complexed	O
with	O
the	O
untranslated	O
ash1	O
mrna	O
and	O
puf6	O
.	O
	
loss	O
of	O
dhh1	O
affected	O
local	O
translation	O
of	O
ash1	O
mrna	O
and	O
resulted	O
in	O
delocalization	O
of	O
ash1	O
transcript	O
in	O
the	O
bud	O
.	O
	
forcibly	O
shifting	O
the	O
non-polysomal	O
ash1	O
mrna	O
into	O
polysomes	O
was	O
associated	O
with	O
dhh1	O
dissociation	O
.	O
	
we	O
further	O
demonstrated	O
that	O
dhh1	O
is	O
not	O
recruited	O
to	O
ash1	O
mrna	O
co-transcriptionally	O
,	O
suggesting	O
that	O
it	O
could	O
bind	O
to	O
ash1	O
mrna	O
within	O
the	O
cytoplasm	O
.	O
	
of	O
note	O
,	O
dhh1	O
bound	O
to	O
the	O
5	O
utr	O
of	O
ash1	O
mrna	O
and	O
inhibited	O
its	O
translation	O
in	O
vitro	O
.	O
	
these	O
results	O
suggest	O
that	O
after	O
localization	O
to	O
the	O
bud	O
tip	O
,	O
a	O
portion	O
of	O
the	O
localized	O
ash1	O
mrna	O
becomes	O
translationally	O
inactive	O
,	O
because	O
of	O
binding	O
of	O
dhh1	O
and	O
puf6	O
to	O
the	O
5'	O
and	O
3'	O
utrs	O
of	O
ash1	O
mrna	O
the	O
abundance	B-T080
of	O
endofungal	O
bacterium	O
rhizobium	O
radiobacter	O
syn	O
.	O
	
agrobacterium	O
tumefaciens	O
increases	B-T169
in	O
its	O
fungal	B-T169
host	O
piriformospora	O
indica	O
during	O
the	O
tripartite	O
sebacinalean	O
symbiosis	O
with	O
higher	O
plants	O
rhizobium	O
radiobacter	O
syn	O
.	O
	
agrobacterium	O
tumefaciens	O
,	O
syn	O
.	O
	
""""	O
agrobacterium	O
fabrum	O
""""	O
is	O
an	O
endofungal	O
bacterium	O
of	O
the	O
fungal	B-T169
mutualist	O
piriformospora	O
syn	O
.	O
	
serendipita	O
indica	O
basidiomycota	O
,	O
which	O
together	O
form	O
a	O
tripartite	O
sebacinalean	O
symbiosis	O
with	O
a	O
broad	O
range	O
of	O
plants	O
.	O
	
r	O
.	O
	
radiobacter	O
strain	O
f4	O
rrf4	O
,	O
isolated	O
from	O
p	O
.	O
	
indica	O
dsm	O
11827	O
,	O
induces	B-T169
growth	O
promotion	B-T052
and	O
systemic	O
resistance	O
in	O
cereal	O
crops	O
,	O
including	O
barley	O
and	O
wheat	O
,	O
suggesting	O
that	O
r	O
.	O
	
radiobacter	O
contributes	O
to	O
a	O
successful	O
symbiosis	O
.	O
	
here	O
,	O
we	O
studied	O
the	O
impact	B-T080
of	O
endobacteria	O
on	O
the	O
morphology	B-T080
and	O
the	O
beneficial	O
activity	O
of	O
p	O
.	O
	
indica	O
during	O
interactions	B-T169
with	O
plants	O
.	O
	
low	O
numbers	O
of	O
endobacteria	O
were	O
detected	B-T033
in	O
the	O
axenically	O
grown	O
p	O
.	O
	
indica	O
long	B-T079
term	I-T079
lab-cultured	O
,	O
lcpiri	O
whereas	O
mycelia	O
colonizing	B-T033
the	O
plant	O
root	O
contained	O
increased	B-T081
numbers	O
of	O
bacteria	O
.	O
	
higher	O
numbers	O
of	O
endobacteria	O
were	O
also	O
found	O
in	O
axenic	O
cultures	O
of	O
p	O
.	O
	
indica	O
that	O
was	O
freshly	O
re-isolated	B-T169
ripiri	O
from	O
plant	O
roots	O
,	O
though	O
numbers	O
dropped	O
during	O
repeated	O
axenic	O
re-cultivation	O
.	O
	
prolonged	B-T079
treatments	B-T061
of	O
p	O
.	O
	
indica	O
cultures	O
with	O
various	O
antibiotics	O
could	O
not	O
completely	O
eliminate	O
the	O
bacterium	O
,	O
though	O
the	O
number	O
of	O
detectable	O
endobacteria	O
decreased	B-T081
significantly	B-T078
,	O
resulting	O
in	O
partial-cured	B-T033
p	O
.	O
	
indica	O
pcpiri	O
.	O
	
pcpiri	O
showed	O
reduced	B-T080
growth	O
in	O
axenic	O
cultures	O
and	O
poor	B-T080
sporulation	O
.	O
	
consistent	B-T078
with	I-T078
this	O
,	O
pcpiri	O
also	O
showed	O
reduced	B-T080
plant	O
growth	O
promotion	B-T052
and	O
reduced	B-T080
systemic	O
resistanc	O
e	O
against	O
powdery	O
mildew	O
infection	O
as	O
compared	O
with	O
ripiri	O
and	O
lcpiri	O
.	O
	
these	O
results	B-T169
are	O
consistent	B-T078
with	I-T078
the	O
assumption	O
that	O
the	O
endobacterium	O
r	O
.	O
	
radiobacter	O
improves	B-T033
p	O
.	O
	
indica's	O
fitness	O
and	O
thus	O
contributes	O
to	O
the	O
success	O
of	O
the	O
tripartite	O
sebacinalean	O
symbiosis	O
.	O
	
stem	O
cell	O
registry	B-T170
programme	B-T169
for	O
patients	O
with	O
ischemic	B-T047
cardiomyopathy	I-T047
undergoing	O
coronary	B-T061
artery	I-T061
bypass	I-T061
grafting	I-T061
what	O
benefits	B-T081
does	O
it	O
derive	O
standardization	B-T062
of	O
stem	B-T061
cell	I-T061
therapy	I-T061
requires	O
application	O
of	O
appropriate	O
methods	B-T062
to	O
evaluate	O
safety	O
and	O
efficac	O
y	O
,	O
including	O
long-term	B-T079
pharmacovigilance	B-T062
.	O
	
to	O
accomplish	O
this	O
objective	B-T170
,	O
a	O
long-term	B-T079
registry	O
programme	O
was	O
installed	O
.	O
	
we	O
analysed	O
150	O
patients	O
with	O
ischemic	B-T047
cardiomyopathy	I-T047
,	O
who	O
received	B-T080
intramyocardial	O
cd133+	O
bone	O
marrow	O
mononuclear	O
stem	O
cell	O
treatment	B-T061
combined	B-T080
with	O
coronary	B-T061
artery	I-T061
bypass	I-T061
grafting	I-T061
cabg	B-T061
or	O
cabg	B-T061
alone	B-T081
.	O
	
the	O
mortality	B-T081
rate	I-T081
,	O
major	B-T080
adverse	B-T033
cerebral	I-T033
and	O
cardiac	B-T033
events	I-T033
,	O
and	O
functional	O
outcome	O
parameters	O
were	O
evaluated	O
for	O
the	O
time	B-T079
period	I-T079
up	O
to	O
14	O
years	O
follow-up	O
.	O
	
as	O
a	O
result	O
,	O
we	O
have	O
stratified	B-T080
the	O
patient	O
population	B-T098
96	O
patients	O
into	O
responders	B-T033
and	O
non-responders	B-T033
.	O
	
furthermore	O
,	O
the	O
analysis	B-T062
of	O
relevant	B-T080
predictors	B-T078
of	O
good	B-T033
response	I-T033
to	O
cd133+	O
bone	O
marrow	O
mononuclear	O
stem	O
cell	O
treatment	B-T061
was	O
performed	B-T169
.	O
	
several	B-T081
positive	O
tendencies	O
related	O
to	O
stem	B-T061
cells	I-T061
transplantation	I-T061
were	O
demonstrated	O
.	O
	
first	O
,	O
no	B-T033
significant	I-T033
difference	B-T080
in	O
major	B-T080
adverse	B-T033
cardiovascular	I-T033
and	O
cerebral	B-T033
events	I-T033
was	O
observed	B-T169
between	O
stem	O
cell	O
and	O
control	O
group	O
up	O
to	O
14	O
years	O
follow-up	O
.	O
	
second	O
,	O
an	O
improvement	O
of	O
left	O
ventricle	O
ejection	O
fraction	O
lvef	O
in	O
stem	O
cell	O
group	B-T078
retained	B-T169
for	O
5	O
years	O
in	O
contrast	B-T080
with	O
cabg	B-T061
-	O
only	B-T081
group	B-T078
,	O
where	O
no	O
significant	O
changes	O
in	O
lvef	O
after	O
2	O
years	O
were	O
observed	O
.	O
	
in	O
addition	O
,	O
lvef	O
under	O
30%	O
and	O
left	O
ventricle	O
end	O
diastolic	O
diameter	O
above	O
60	O
mm	O
were	O
independent	O
predictors	B-T078
of	O
functional	B-T169
response	O
to	O
cd133+	O
cell	O
therapy	B-T061
.	O
	
participants	B-T098
with	O
overt	B-T047
heart	I-T047
failure	I-T047
benefit	B-T081
most	B-T081
from	O
cabg	B-T061
combined	B-T080
with	O
intramyocardial	O
injection	B-T061
of	O
cd133+	O
bone	O
marrow	O
mononuclear	O
cell	O
within	O
the	O
group	B-T078
.	O
	
an	O
improvement	O
lvef	O
in	O
stem	O
cell	O
group	B-T078
remained	O
for	O
5	O
years	O
in	O
contrast	B-T080
with	O
the	O
cabg	B-T061
-	O
only	B-T081
group	B-T078
.	O
	
the	O
patients	O
,	O
in	O
whom	O
the	O
improvement	O
of	O
both	O
lvef	O
and	O
lved	O
was	O
observed	B-T169
,	O
have	O
benefited	O
by	O
increased	B-T081
life	O
expectancy	O
.	O
	
effects	B-T080
of	O
environmental	B-T082
factors	B-T169
and	O
metallic	O
electrodes	O
on	O
ac	O
electrical	B-T081
conduction	I-T081
through	O
dna	O
molecule	O
deoxyribonucleic	O
acid	O
dna	O
is	O
one	O
of	O
the	O
best	O
candidate	O
materials	O
for	O
various	O
device	O
applications	B-T169
such	O
as	O
in	O
electrodes	O
for	O
rechargeable	O
batteries	O
,	O
biosensors	O
,	O
molecular	O
electronics	O
,	O
medical	O
-	O
and	O
biomedical	O
-	O
applications	B-T169
etc	O
.	O
	
hence	O
,	O
it	O
is	O
worthwhile	O
to	O
examine	O
the	O
mechanism	O
of	O
charge	O
transport	O
in	O
the	O
dna	O
molecule	O
,	O
however	O
,	O
still	O
a	O
question	O
without	O
a	O
clear	O
answer	O
is	O
dna	O
a	O
molecular	B-T080
conducting	O
material	O
wire	O
,	O
semiconductor	O
,	O
or	O
insulator	O
the	O
answer	O
,	O
after	O
the	O
published	O
data	O
,	O
is	O
still	O
ambiguous	O
without	O
any	O
confirmed	O
and	O
clear	O
scientific	O
answer	O
.	O
	
dna	O
is	O
found	O
to	O
be	O
always	O
surrounded	O
with	O
different	O
electric	O
charges	O
,	O
ions	O
,	O
and	O
dipoles	O
.	O
	
these	O
surrounding	O
charges	O
and	O
electric	O
barrier	O
due	O
to	O
metallic	O
electrodes	O
as	O
environmental	B-T082
factors	B-T169
efs	B-T169
play	O
a	O
substantial	O
role	O
when	O
measuring	B-T080
the	O
electrical	O
conductivity	O
through	O
λ-double	O
helix	O
dna	O
molecule	O
suspended	O
between	O
metallic	O
electrodes	O
.	O
	
we	O
found	O
that	O
strong	O
frequency	O
dependence	O
of	O
ac	O
-	O
complex	O
conductivity	O
comes	O
from	O
the	O
electrical	O
conduction	O
of	O
efs	O
.	O
	
this	O
leads	O
to	O
superimposing	O
serious	O
incorrect	O
experimental	O
data	O
to	O
measured	O
ones	O
.	O
	
at	O
1	O
mhz	O
,	O
we	O
carried	O
out	O
a	O
first	O
control	O
experiment	O
on	O
electrical	O
conductivity	O
with	O
and	O
without	O
the	O
presence	O
of	O
dna	O
molecule	O
.	O
	
if	O
there	O
are	O
possible	O
electrical	O
conduction	O
due	O
to	O
stray	O
ions	O
and	O
contribution	O
of	O
substrate	O
,	O
we	O
will	O
detected	O
them	O
.	O
	
this	O
control	O
experiment	O
revealed	O
that	O
there	O
is	O
an	O
important	O
role	O
played	O
by	O
the	O
environmental	O
-	O
charges	O
around	O
dna	O
molecule	O
and	O
any	O
experiment	O
should	O
consider	O
this	O
role	O
.	O
	
we	O
have	O
succeeded	O
to	O
measure	O
both	O
electrical	O
conductivity	O
due	O
to	O
efs	O
σ	O
env	O
and	O
electrical	O
conductivity	O
due	O
to	O
dna	O
molecule	O
σ	O
dna	O
independently	O
by	O
carrying	O
the	O
measurements	O
at	O
different	O
dna	O
-	O
lengths	O
and	O
subtracting	O
the	O
data	O
.	O
	
we	O
carried	O
out	O
measurements	O
as	O
a	O
function	O
of	O
frequency	O
f	O
and	O
temperature	O
t	O
in	O
the	O
ranges	O
0.1	O
hz	O
<	O
f	O
<	O
1	O
mhz	O
and	O
288	O
k	O
<	O
t	O
<	O
343	O
k	O
.	O
	
the	O
measured	O
conductivity	O
σ	O
mes	O
portrays	O
a	O
metal	O
-like	O
behavior	O
at	O
high	O
frequencies	O
near	O
1	O
mhz	O
.	O
	
however	O
,	O
we	O
found	O
that	O
σ	O
dna	O
was	O
far	O
from	O
this	O
behavior	O
because	O
the	O
conduction	O
due	O
to	O
efs	O
superimposes	O
σ	O
dna	O
,	O
in	O
particular	O
at	O
low	O
frequencies	O
.	O
	
by	O
measuring	B-T080
the	O
electrical	B-T081
conductivity	I-T081
at	O
different	O
lengths	O
40	O
,	O
60	O
,	O
80	O
,	O
and	O
100	O
nm	O
,	O
we	O
have	O
succeeded	O
not	O
only	O
to	O
separate	O
the	O
electrical	O
conduction	O
of	O
the	O
dna	O
molecule	O
from	O
all	O
efs	O
effects	O
that	O
surround	O
the	O
molecule	O
,	O
but	O
also	O
to	O
present	O
accurate	O
values	O
of	O
σ	O
dna	O
and	O
the	O
dielectric	O
constant	O
of	O
the	O
molecule	O
ε'dna	O
as	O
a	O
function	O
of	O
temperature	O
and	O
frequency	O
.	O
	
furthermore	O
,	O
in	O
order	O
to	O
explain	O
these	O
data	O
,	O
we	O
present	O
a	O
model	O
describing	O
the	O
electrical	O
conduction	O
through	O
dna	O
molecule	O
dna	O
is	O
a	O
classical	O
semiconductor	O
with	O
charges	O
,	O
dipoles	O
and	O
ions	O
that	O
result	O
in	O
creation	O
of	O
localized	O
energy	O
-	O
states	O
less	O
in	O
the	O
extended	O
bands	O
and	O
in	O
the	O
energy	O
gap	O
of	O
the	O
dna	O
molecule	O
.	O
	
this	O
model	O
explains	O
clearly	O
the	O
mechanism	O
of	O
charge	O
transfer	O
mechanism	O
in	O
the	O
dna	O
,	O
and	O
it	O
sheds	O
light	O
on	O
why	O
the	O
charge	O
transfer	O
through	O
the	O
dna	O
can	O
lead	O
to	O
insulating	O
,	O
semiconducting	O
,	O
or	O
metallic	O
behavior	O
on	O
the	O
same	O
time	O
.	O
	
the	O
model	O
considers	O
charges	O
on	O
dna	O
,	O
in	O
the	O
extended	O
bands	O
,	O
either	O
could	O
be	O
free	O
to	O
move	O
under	O
electric	O
field	O
or	O
localized	O
in	O
potential	O
wells/hills	O
.	O
	
localization	O
of	O
charges	O
in	O
dna	O
is	O
an	O
intrinsic	O
structural	O
-	O
property	O
of	O
this	O
solitaire	O
molecule	O
.	O
	
at	O
all	O
temperatures	O
,	O
the	O
expected	O
increase	O
in	O
thermal	O
-	O
induced	O
charge	O
is	O
attributed	O
to	O
the	O
delocalization	O
of	O
holes	O
or/and	O
electrons	O
in	O
potential	O
hills	O
or/and	O
potential	O
wells	O
which	O
accurately	O
accounts	O
for	O
the	O
total	O
electric	O
and	O
dielectric	O
behavior	O
through	O
dna	O
molecule	O
.	O
	
we	O
succeeded	O
to	O
fit	O
the	O
experiment	O
al	O
data	O
to	O
the	O
proposed	O
model	O
with	O
reasonable	O
magnitudes	O
of	O
potential	O
hills/wells	O
that	O
are	O
in	O
the	O
energy	O
range	O
from	O
0.068	O
next-generation	O
sequencing	O
approaches	B-T169
to	O
define	O
the	O
role	O
of	O
the	O
autophagy	O
lysosomal	O
pathway	O
in	O
human	O
disease	B-T047
the	O
example	O
of	O
lysoplex	B-T170
next-generation	O
sequencing	O
ngs	O
technologies	O
have	O
deeply	O
changed	O
the	O
throughput	B-T081
of	O
genetic	O
testing	O
allowing	O
analyzing	O
millions	O
of	O
dna	O
fragments	O
in	O
parallel	B-T080
.	O
	
one	O
key	O
application	B-T169
is	O
the	O
understanding	O
of	O
genetically	B-T169
heterogeneous	B-T033
and	O
complex	B-T047
diseases	I-T047
where	O
50-100	O
different	O
genes	O
may	O
converge	O
to	O
control	B-T080
the	O
same	O
pathways	O
.	O
	
these	O
disorders	B-T047
cannot	O
be	O
studied	O
using	O
traditional	B-T169
approaches	B-T169
,	O
based	O
on	O
gene-by-gene	O
sanger	O
sequencing	O
.	O
	
we	O
have	O
set	O
up	O
an	O
ngs	O
protocol	B-T170
based	O
on	O
a	O
specific	O
selection	B-T052
of	O
dna	O
regions	O
belonging	O
to	O
about	O
900	O
genes	O
of	O
the	O
autophagy-lysosomal	O
alp	O
pathway	O
.	O
	
we	O
here	O
specify	O
all	O
the	O
technical	O
steps	O
and	O
challenges	O
of	O
our	O
protocol	B-T170
,	O
named	O
lysoplex	B-T170
.	O
	
this	O
is	O
based	O
on	O
the	O
haloplex	O
technology	O
and	O
together	O
with	O
high-coverage	O
sequencing	O
empowers	O
a	O
high	O
and	O
uniform	O
coverage	O
of	O
alp	O
genes	O
.	O
	
lysoplex	B-T170
outplays	O
other	O
ngs	O
applications	B-T169
in	O
sensitivity	B-T081
and	I-T081
specificity	I-T081
,	O
providing	O
an	O
accurate	O
picture	O
of	O
all	O
variations	O
in	O
alp	O
genes	O
.	O
	
typical	O
skin	O
injuries	O
in	O
children	O
with	O
autism	O
spectrum	O
disorder	O
pediatric	B-T080
skin	O
injuries	O
have	O
primarily	O
been	O
described	O
in	O
typically	O
developing	O
children	O
.	O
	
our	O
objectives	B-T170
were	O
to	O
describe	O
the	O
prevalence	B-T081
and	O
pattern	B-T082
of	O
skin	O
injuries	O
of	O
children	O
with	O
autism	O
spectrum	O
disorder	O
asd	O
,	O
to	O
describe	O
how	O
this	O
compared	O
with	O
previously	O
demonstrated	O
skin	O
injury	O
locations	B-T033
in	O
typically	O
developing	O
children	O
,	O
and	O
to	O
identify	O
differences	B-T080
in	O
skin	O
injury	O
frequency	B-T079
and	O
locations	B-T033
between	O
autistic	O
children	O
with	O
and	O
without	O
self-injurious	O
behaviors	O
sibs	O
.	O
	
children	O
with	O
asd	O
were	O
recruited	O
between	O
september	B-T079
of	O
2011	O
and	O
september	B-T079
of	O
2014	O
.	O
	
demographic	B-T078
information	I-T078
was	O
obtained	O
from	O
the	O
caregiver	O
.	O
	
all	O
skin	O
injuries	O
and	O
their	O
locations	B-T033
were	O
documented	O
.	O
	
of	O
the	O
41	O
children	O
enrolled	O
,	O
half	O
were	O
reported	O
to	O
have	O
sibs	O
.	O
	
the	O
most	O
identified	O
skin	O
injury	O
locations	B-T033
were	O
the	O
legs	O
,	O
knees	O
,	O
and	O
back	O
.	O
	
children	O
with	O
autism	O
1	O
obtain	O
skin	O
injuries	O
frequently	O
and	O
in	O
similar	O
locations	B-T033
as	O
typically	O
developing	O
children	O
and	O
2	O
rarely	O
obtain	O
skin	O
injuries	O
to	O
locations	B-T033
that	O
are	O
considered	O
uncommon	O
for	O
accidental	O
injuries	O
despite	O
reports	O
of	O
is	O
total	B-T061
elbow	I-T061
arthroplasty	I-T061
safe	O
as	O
an	O
outpatient	B-T061
procedure	I-T061
ambulatory	O
surgery	O
centers	O
are	O
the	O
preferred	O
setting	O
for	O
many	O
procedures	B-T169
formerly	O
performed	B-T169
in	O
a	O
hospital	O
setting	O
.	O
	
this	O
study	B-T062
sought	O
to	O
determine	O
whether	O
outpatient	O
total	B-T061
elbow	I-T061
arthroplasty	I-T061
tea	B-T061
is	O
as	O
safe	O
as	O
inpatient	O
tea	B-T061
.	O
	
a	O
retrospective	B-T062
analysis	I-T062
was	O
performed	B-T169
of	O
inpatient	O
ip	O
versus	O
outpatient	O
op	O
tea	B-T061
by	O
a	O
single	B-T081
surgeon	O
over	O
a	O
period	O
of	O
18	O
years	B-T079
.	O
	
demographic	B-T062
,	O
social	B-T080
,	O
and	O
comorbidity	B-T081
measures	I-T081
as	O
well	O
as	O
complication	O
rates	B-T081
were	O
analyzed	B-T062
and	O
stratified	B-T080
by	O
ip	O
or	O
op	O
status	B-T080
.	O
	
bivariate	O
comparison	O
showed	O
increased	B-T081
prevalence	B-T081
of	O
coronary	B-T047
artery	I-T047
disease	I-T047
in	O
the	O
op	O
group	B-T098
32%	O
vs	O
.	O
	
7%	O
and	O
increased	B-T081
age	O
in	O
the	O
ip	O
group	B-T098
68	O
years	B-T079
vs	O
.	O
	
58	O
years	B-T079
.	O
	
all	O
other	O
demographic	B-T062
,	O
social	B-T080
,	O
and	O
comorbidity	B-T081
factors	I-T081
were	O
comparable	B-T052
between	O
the	O
ip	O
and	O
op	O
groups	B-T098
,	O
although	O
more	B-T081
infections	O
were	O
seen	B-T080
in	O
the	O
ip	O
group	B-T098
.	O
	
the	O
surgeons'	O
initial	O
learning	O
curve	O
occurred	B-T052
mostly	O
within	O
the	O
ip	O
group	B-T098
.	O
	
most	O
important	O
,	O
no	B-T033
difference	I-T033
in	O
complication	O
rate	B-T081
was	O
observed	B-T169
between	O
the	O
ip	O
and	O
op	O
groups	B-T098
.	O
	
developmental	B-T080
hypoxia	O
has	O
negligible	B-T080
effects	B-T080
on	O
long-term	B-T079
hypoxia	O
tolerance	B-T080
and	O
aerobic	O
metabolism	O
of	O
atlantic	O
salmon	O
salmo	O
salar	O
exposure	B-T080
to	I-T080
developmental	B-T080
hypoxia	O
can	O
have	O
long-term	B-T079
impacts	B-T080
on	O
the	O
physiological	O
performance	B-T052
of	O
fish	O
because	O
of	O
irreversible	B-T169
plasticity	O
.	O
	
wild	B-T170
and	O
captive-reared	B-T033
atlantic	O
salmon	O
salmo	O
salar	O
can	O
be	O
exposed	B-T080
to	I-T080
hypoxic	O
conditions	B-T080
during	O
development	B-T169
and	O
continue	B-T078
to	O
experience	O
fluctuating	B-T079
oxygen	O
levels	B-T080
as	O
juveniles	O
and	O
adults	O
.	O
	
here	O
,	O
we	O
examine	B-T033
whether	O
developmental	B-T080
hypoxia	O
impacts	B-T080
subsequent	B-T079
hypoxia	O
tolerance	B-T080
and	O
aerobic	B-T080
performance	B-T052
of	O
atlantic	O
salmon	O
.	O
	
individuals	O
at	O
8	O
were	O
exposed	B-T080
to	I-T080
50%	O
hypoxia	O
or	O
100%	O
normoxia	O
dissolved	O
oxygen	O
do	O
saturation	O
as	O
percent	O
of	O
air	O
saturation	O
from	O
fertilization	O
for	O
100	O
d	O
800	O
degree	O
days	O
and	O
then	O
raised	B-T080
in	O
normoxic	O
conditions	B-T080
for	O
a	O
further	O
15	O
mo	O
.	O
	
at	O
18	O
mo	O
after	O
fertilization	O
,	O
aerobic	B-T080
scope	O
was	O
calculated	B-T052
in	O
normoxia	O
100%	O
do	O
and	O
acute	B-T079
18	O
h	O
hypoxia	O
50%	O
do	O
from	O
the	O
difference	B-T080
between	O
the	O
minimum	B-T080
and	O
maximum	B-T081
oxygen	O
consumption	O
rates	B-T081
formula	O
see	O
text	O
and	O
formula	O
see	O
text	O
,	O
respectively	O
at	O
10	O
.	O
	
hypoxia	O
tolerance	B-T080
was	O
determined	B-T080
as	O
the	O
do	O
at	O
which	O
loss	O
of	O
equilibrium	O
loe	O
occurred	B-T052
in	O
a	O
constantly	O
decreasing	B-T033
do	O
environment	O
.	O
	
there	O
was	O
no	B-T033
difference	I-T033
in	O
formula	O
see	O
text	O
,	O
formula	O
see	O
text	O
,	O
or	O
aerobic	B-T080
scope	O
between	O
fish	O
raised	B-T080
in	O
hypoxia	O
or	O
normoxia	O
.	O
	
there	O
was	O
some	O
evidence	B-T078
that	O
hypoxia	O
tolerance	B-T080
was	O
lower	B-T052
higher	O
do	O
at	O
loe	O
in	O
hypoxia	O
-	O
raised	B-T080
fish	O
compared	O
with	O
those	O
raised	B-T080
in	O
normoxia	O
,	O
but	O
the	O
magnitude	B-T081
of	O
the	O
effect	B-T080
was	O
small	B-T081
12.52	O
do	O
vs	O
.	O
	
11.73	O
do	O
at	O
loe	O
.	O
	
acute	B-T079
hypoxia	O
significantly	O
reduced	B-T080
aerobic	B-T080
scope	O
by	O
reducing	B-T080
formula	O
see	O
text	O
,	O
while	O
formula	O
see	O
text	O
remained	O
unchanged	B-T033
.	O
	
interestingly	O
,	O
acute	B-T079
hypoxia	O
uncovered	O
individual	O
-level	O
relationships	B-T080
between	O
do	O
at	O
loe	O
and	O
formula	O
see	O
text	O
,	O
formula	O
see	O
text	O
,	O
and	O
aerobic	B-T080
scope	O
.	O
	
we	O
discuss	O
our	O
findings	B-T169
in	O
the	O
context	O
of	O
developmental	B-T080
trajectories	O
and	O
the	O
role	O
of	O
aerobic	B-T080
performance	B-T052
in	O
hypoxia	O
tolerance	B-T080
.	O
	
ldl	B-T109
particle	B-T081
number	I-T081
and	O
size	B-T081
and	O
cardiovascular	O
risk	B-T078
anything	O
new	O
under	O
the	O
sun	O
we	O
provide	O
here	O
an	O
up-to-date	O
perspective	O
on	O
the	O
potential	B-T080
use	B-T169
of	O
ldl	B-T109
particle	B-T081
number	I-T081
and	O
size	B-T081
as	O
complementary	O
risk	B-T033
factors	I-T033
to	O
predict	O
and	O
manage	O
cardiovascular	B-T047
disease	I-T047
cvd	B-T047
risk	B-T078
in	O
the	O
clinical	B-T080
realm	O
.	O
	
studies	B-T062
show	O
that	O
a	O
significant	B-T078
proportion	B-T081
of	O
the	O
population	B-T098
has	O
discordant	O
ldl	B-T109
particle	B-T081
number	I-T081
and	O
cholesterol	B-T109
indices	B-T170
non-hdl	B-T109
cholesterol	I-T109
hdl-c	B-T109
.	O
	
data	O
also	O
show	O
that	O
risk	O
prediction	O
may	O
be	O
improved	O
when	O
using	O
information	B-T078
on	O
ldl	B-T109
particle	B-T081
number	I-T081
in	O
patients	O
with	O
discordant	O
particle	B-T081
number	I-T081
and	O
cholesterol	B-T109
data	O
.	O
	
yet	O
,	O
most	O
of	O
the	O
current	O
cvd	B-T047
guidelines	B-T170
conclude	O
that	O
ldl	B-T109
particle	B-T081
number	I-T081
is	O
not	O
superior	O
to	O
cholesterol	B-T109
indices	B-T170
,	O
including	O
non-hdl-c	B-T109
concentrations	B-T081
,	O
in	O
predicting	O
cvd	B-T047
risk	B-T078
.	O
	
ldl	B-T109
particle	B-T081
size	I-T081
,	O
on	O
the	O
other	O
hand	O
,	O
has	O
not	O
been	O
independently	O
associated	B-T080
with	I-T080
cvd	B-T047
risk	B-T078
after	O
adjustment	B-T169
for	O
other	O
risk	B-T033
factors	I-T033
such	O
as	O
ldl	B-T109
cholesterol	I-T109
,	O
triglycerides	B-T109
,	O
and	O
hdl-c	B-T109
and	O
that	O
routine	O
use	O
of	O
information	B-T078
pertaining	O
to	O
particle	B-T081
size	I-T081
to	O
determine	O
and	O
manage	O
patients'	O
risk	B-T078
is	O
not	O
yet	O
justified	O
.	O
	
additional	B-T169
studies	B-T062
are	O
required	O
to	O
settle	O
the	O
debate	B-T052
on	O
which	O
of	O
cholesterol	B-T109
indices	B-T170
and	O
ldl	B-T109
particle	B-T081
number	I-T081
is	O
the	O
best	O
predictor	O
of	O
cvd	B-T047
risk	B-T078
,	O
and	O
if	O
such	O
measures	B-T081
should	O
be	O
integrated	O
in	O
clinical	B-T061
practice	I-T061
.	O
	
the	O
emerging	B-T052
contribution	I-T052
of	O
social	O
wasps	O
to	O
grape	B-T047
rot	I-T047
disease	I-T047
ecology	O
grape	B-T047
sour	I-T047
bunch	I-T047
rot	I-T047
is	O
a	O
polymicrobial	B-T047
disease	I-T047
of	O
vineyards	O
that	O
causes	O
millions	B-T081
of	O
dollars	B-T081
in	O
lost	B-T081
revenue	I-T081
per	B-T079
year	I-T079
due	O
to	O
decreased	B-T081
quality	B-T080
of	O
grapes	O
and	O
resultant	O
wine	O
.	O
	
the	O
disease	B-T047
is	O
associated	B-T080
with	I-T080
damaged	B-T169
berries	O
infected	B-T033
with	O
a	O
community	O
of	O
acetic	O
acid	O
bacteria	O
,	O
yeasts	O
,	O
and	O
filamentous	O
fungi	O
that	O
results	O
in	O
rotting	O
berries	O
with	O
high	B-T080
amounts	B-T081
of	O
undesirable	O
volatile	B-T080
acidity	O
.	O
	
many	O
insect	O
species	O
cause	O
the	O
initial	B-T079
grape	O
berry	O
damage	B-T169
that	O
can	O
lead	O
to	O
this	O
disease	B-T047
,	O
but	O
most	O
studies	B-T062
have	O
focused	B-T169
on	O
the	O
role	O
of	O
fruit	O
flies	O
in	O
facilitating	O
symptoms	O
and	O
vectoring	O
the	O
microorganisms	O
of	O
this	O
disease	B-T047
complex	B-T080
.	O
	
like	O
fruit	O
flies	O
,	O
social	O
wasps	O
are	O
abundant	B-T080
in	O
vineyards	O
where	O
they	O
feed	O
on	O
ripe	O
berries	O
and	O
cause	O
significant	B-T078
damage	B-T169
,	O
while	O
also	O
dispersing	B-T082
yeasts	O
involved	B-T169
in	O
wine	O
fermentation	O
.	O
	
despite	O
this	O
,	O
their	O
possible	O
role	O
in	O
disease	B-T047
facilitation	O
and	O
dispersal	B-T047
of	I-T047
grape	I-T047
rots	I-T047
has	O
not	O
been	O
explored	O
.	O
	
we	O
tested	B-T169
the	O
hypothesis	B-T078
that	O
the	O
paper	O
wasp	O
polistes	O
dominulus	O
could	O
facilitate	O
grape	B-T047
sour	I-T047
rot	I-T047
in	O
the	O
absence	B-T169
of	O
other	O
insect	O
vectors	O
.	O
	
using	O
marker	O
gene	O
sequencing	O
we	O
characterized	B-T052
the	O
bacterial	O
and	O
fungal	O
community	O
of	O
wild-caught	O
adults	O
.	O
	
we	O
used	O
a	O
sterilized	O
foraging	B-T082
arena	I-T082
to	O
determine	O
if	O
these	O
wasps	O
transfer	O
viable	B-T080
microorganisms	O
when	O
foraging	O
.	O
	
we	O
then	O
tested	B-T169
if	O
wasps	O
harboring	O
their	O
native	B-T098
microbial	O
community	O
,	O
or	O
those	O
inoculated	B-T061
with	O
sour	B-T047
rot	I-T047
,	O
had	O
an	O
effect	B-T080
on	O
grape	B-T047
sour	I-T047
rot	I-T047
incidence	B-T081
and	O
severity	B-T080
using	O
a	O
laboratory	O
foraging	O
arena	O
.	O
	
we	O
found	O
that	O
all	O
wasps	O
harbor	O
some	O
portion	O
of	O
the	O
sour	B-T047
rot	I-T047
microbial	O
community	O
and	O
that	O
they	O
have	O
the	O
ability	O
to	O
transfer	O
viable	B-T080
microorganisms	O
when	O
foraging	O
.	O
	
foraging	O
by	O
inoculated	B-T061
and	O
uninoculated	O
wasps	O
led	O
to	O
an	O
increase	B-T169
in	O
berry	B-T047
rot	I-T047
disease	I-T047
symptom	O
severity	B-T080
and	O
incidence	B-T081
.	O
	
our	O
results	B-T033
indicate	O
that	O
paper	O
wasps	O
can	O
facilitate	O
sour	B-T047
rot	I-T047
diseases	I-T047
in	O
the	O
absence	B-T169
of	O
other	O
vectors	O
and	O
that	O
the	O
mechanism	B-T169
of	O
this	O
facilitation	O
may	O
include	O
both	O
increasing	B-T169
host	O
susceptibility	O
and	O
transmitting	B-T169
these	O
microbial	O
communities	O
to	O
the	O
grapes	O
.	O
	
social	O
wasps	O
are	O
understudied	O
but	O
relevant	B-T080
players	I-T080
in	O
the	O
sour	B-T047
rot	I-T047
ecology	O
of	O
low-intensity	O
pulsed	O
ultrasound	O
reduces	O
periodontal	B-T047
atrophy	I-T047
in	O
occlusal	O
hypofunctional	O
teeth	O
to	O
clarify	O
whether	O
low-intensity	O
pulsed	O
ultrasound	O
lipus	O
exposure	O
has	O
recovery	O
effects	O
on	O
the	O
hypofunctional	O
periodontal	O
ligament	O
pdl	O
and	O
interradicular	O
alveolar	O
bone	O
irab	O
.	O
	
twelve-	O
week	B-T079
-old	O
male	O
sprague-dawley	O
rats	O
were	O
divided	O
into	O
three	O
groups	B-T098
n	O
=	O
5	O
each	O
a	O
normal	O
occlusion	O
c	O
group	B-T098
,	O
an	O
occlusal	O
hypofunction	O
h	O
group	B-T098
,	O
and	O
an	O
occlusal	B-T098
hypofunction	I-T098
group	I-T098
subjected	O
to	O
lipus	O
hl	O
treatment	B-T061
.	O
	
hypofunctional	O
occlusion	O
of	O
the	O
maxillary	O
first	O
molar	O
m1	O
of	O
the	O
h	B-T098
and	O
hl	B-T098
groups	I-T098
was	O
induced	O
by	O
the	O
bite-raising	O
technique	O
.	O
	
only	O
the	O
hl	B-T098
group	I-T098
was	O
irradiated	O
with	O
lipus	O
for	O
5	O
days	B-T079
.	O
	
the	O
irab	O
and	O
pdl	O
of	O
m1	O
were	O
examined	O
by	O
microcomputed	O
tomography	O
micro-ct	O
analysis	B-T062
.	O
	
to	O
quantify	O
mrna	O
expression	O
of	O
cytokines	B-T116
involved	O
in	O
pdl	O
proliferation	B-T169
and	O
development	B-T169
,	O
real-time	O
reverse	O
transcription	O
quantitative	O
pcr	O
qrt-pcr	O
was	O
performed	O
for	O
twist	O
family	O
bhlh	O
transcription	O
factor	O
1	O
twist1	O
,	O
periostin	O
,	O
and	O
connective	O
tissue	O
growth	O
factor	O
ctgf	O
in	O
the	O
pdl	O
samples	O
.	O
	
micro-ct	O
analysis	B-T062
showed	O
that	O
the	O
pdl	O
volume	B-T081
was	O
decreased	O
in	O
the	O
h	B-T098
group	I-T098
compared	O
with	O
that	O
of	O
the	O
c	B-T098
and	O
hl	B-T098
groups	I-T098
.	O
	
both	O
bone	O
volume	O
per	O
tissue	B-T081
volume	I-T081
bv	O
/	O
tv	B-T081
of	O
irab	O
was	O
decreased	O
in	O
the	O
h	B-T098
group	I-T098
compared	O
with	O
that	O
in	O
the	O
c	B-T098
group	I-T098
.	O
	
lipus	O
exposure	O
restored	O
bv	O
/	O
tv	B-T081
in	O
the	O
irab	O
of	O
the	O
hl	B-T098
group	I-T098
.	O
	
qrt-pcr	O
analysis	B-T062
showed	O
that	O
twist1	O
,	O
periostin	O
,	O
and	O
ctgf	O
mrna	O
levels	B-T080
were	O
decreased	O
in	O
the	O
h	B-T098
group	I-T098
and	O
increased	O
in	O
the	O
hl	B-T098
group	I-T098
.	O
	
lipus	O
exposure	O
reduced	O
the	O
atrophic	O
changes	B-T169
of	O
alveolar	O
bone	O
by	O
inducing	B-T169
the	O
upregulation	O
of	O
periostin	O
and	O
ctgf	O
expression	O
to	O
promote	O
pdl	O
healing	O
after	O
induction	B-T061
of	O
occlusal	O
hypofunction	O
.	O
	
radiologic	O
assessment	O
of	O
quality	O
of	O
root	B-T061
canal	I-T061
fillings	I-T061
and	O
periapical	B-T082
status	I-T082
in	O
an	O
austrian	B-T098
subpopulation	B-T098
-	O
an	O
observational	B-T062
study	I-T062
progress	B-T169
in	O
endodontic	B-T061
techniques	I-T061
and	O
methodological	O
advances	O
have	O
altered	O
root	B-T061
canal	I-T061
therapy	I-T061
over	O
the	O
last	O
decades	O
.	O
	
these	O
techniques	O
and	O
methods	O
need	O
periodical	B-T170
documentation	B-T170
.	O
	
this	O
observational	B-T062
study	I-T062
determined	O
the	O
current	O
prevalence	B-T081
of	O
endodontic	B-T061
treatments	I-T061
,	O
and	O
investigated	B-T169
the	O
relationship	O
of	O
various	O
factors	O
with	O
the	O
periapical	B-T082
status	I-T082
in	O
a	O
lower	O
austrian	B-T098
subpopulation	B-T098
.	O
	
one	O
thousand	O
orthopantomograms	O
of	O
first-time	O
university	O
adult	O
patients	O
radiographed	O
at	O
an	O
outpatient	O
clinic	O
were	O
evaluated	O
.	O
	
for	O
each	O
tooth	O
,	O
the	O
presence	B-T033
of	O
periradicular	B-T047
pathosis	I-T047
and/or	O
endodontic	B-T061
treatment	I-T061
was	O
recorded	O
,	O
as	O
was	O
the	O
quality	O
of	O
post-	O
endodontic	B-T061
treatment	I-T061
homogeneity	B-T080
and	O
length	O
of	O
root	B-T061
canal	I-T061
fillings	I-T061
preparation	B-T033
failures	I-T033
posts	O
/	O
screws	O
apicoectomies	B-T061
coronal	B-T061
restorations	I-T061
.	O
	
two	O
evaluators	O
,	O
blinded	B-T062
to	O
each	O
other	O
,	O
scored	B-T081
all	O
teeth	O
.	O
	
in	O
cases	O
of	O
disagreement	O
,	O
they	O
joined	O
for	O
a	O
consensus	O
score	B-T081
.	O
	
in	O
all	O
,	O
22	O
teeth	B-T081
were	I-T081
counted	I-T081
.	O
	
of	O
these	O
,	O
2	O
teeth	O
12.9	O
had	O
periapical	B-T047
pathosis	I-T047
,	O
while	O
2	O
teeth	O
had	O
undergone	O
root	B-T061
canal	I-T061
treatment	I-T061
.	O
	
of	O
the	O
endodontically	B-T047
treated	I-T047
teeth	I-T047
,	O
52%	O
showed	O
no	O
radiographic	O
signs	O
of	O
apical	B-T047
periodontitis	I-T047
,	O
while	O
44.9	O
had	O
overt	O
apical	B-T047
lesions	I-T047
,	O
and	O
3	O
revealed	O
widened	B-T047
periodontal	I-T047
ligament	I-T047
space	I-T047
.	O
	
the	O
majority	O
of	O
the	O
root	B-T061
canal	I-T061
fillings	I-T061
was	O
inhomogeneous	O
70.4	O
75.4	O
were	O
rated	O
too	O
short	O
,	O
and	O
3.8	O
too	O
long	O
.	O
	
the	O
presence	B-T033
of	O
apical	O
pathosis	B-T047
was	O
significantly	B-T080
correlated	I-T080
odds	B-T081
ratio	I-T081
or	B-T081
2.556	O
confidence	B-T081
interval	I-T081
ci	B-T081
2.076	O
p<0	O
with	O
poor	O
root	B-T061
canal	I-T061
fillings	I-T061
length	O
and	O
homogeneity	B-T080
.	O
	
posts	O
or	O
screws	O
positively	O
affected	O
periapical	B-T082
status	I-T082
or	B-T081
1.853	O
ci	O
1.219	O
p	O
=	O
0.004	O
,	O
but	O
endodontically	B-T047
treated	I-T047
posterior	I-T047
teeth	I-T047
were	O
infrequently	O
restored	B-T061
posts	O
,	O
7.5	O
screws	O
,	O
2.7	O
.	O
	
best	O
results	O
were	O
found	O
for	O
teeth	O
with	O
both	O
appropriate	O
endodontic	B-T061
treatment	I-T061
and	O
adequate	O
coronal	B-T061
restoration	I-T061
.	O
	
a	O
high	B-T081
prevalence	I-T081
of	O
periradicular	B-T033
radiolucencies	I-T033
was	O
observed	O
with	O
root	O
canal	O
filled	O
teeth	O
,	O
along	O
with	O
high	O
numbers	O
of	O
unmet	O
treatment	B-T061
needs	O
.	O
	
periapical	B-T082
health	B-T078
was	O
associated	B-T080
with	I-T080
adequate	O
root	B-T061
canal	I-T061
obturation	I-T061
and	O
high-grade	O
postendodontic	B-T061
restorations	I-T061
,	O
and	O
quality	O
regarding	O
these	O
latter	O
aspects	O
is	O
considered	O
mandatory	O
to	O
promote	O
periapical	B-T082
health	B-T078
.	O
	
chemical	O
composition	O
and	O
amino	B-T116
acid	I-T116
digestibility	B-T081
of	O
soybean	O
meal	O
produced	O
in	O
the	O
united	O
states	O
,	O
china	O
,	O
argentina	O
,	O
brazil	O
,	O
or	O
india	O
an	O
experiment	O
was	O
conducted	O
to	O
compare	O
nutritional	B-T080
composition	O
of	O
soybean	O
meal	O
sbm	O
produced	O
in	O
china	O
,	O
argentina	O
,	O
brazil	O
,	O
the	O
u.s	O
or	O
india	O
and	O
the	O
apparent	B-T081
ileal	I-T081
digestibility	I-T081
aid	B-T081
and	O
the	O
standardized	B-T081
ileal	I-T081
digestibility	I-T081
sid	B-T081
of	O
cp	B-T116
and	O
aa	B-T116
in	O
these	O
sbm	O
when	O
fed	O
to	O
growing	O
pigs	O
.	O
	
five	O
sources	O
of	O
sbm	O
from	O
china	O
,	O
argentina	O
,	O
brazil	O
,	O
and	O
the	O
u.s	O
and	O
4	O
sources	O
from	O
india	O
were	O
collected	O
for	O
a	O
total	O
of	O
24	O
sources	O
of	O
sbm	O
.	O
	
all	O
samples	O
were	O
analyzed	O
for	O
energy	B-T081
,	O
dm	O
,	O
and	O
nutrients	O
,	O
and	O
each	O
source	O
was	O
included	O
in	O
a	O
cornstarch	B-T109
based	I-T109
diet	I-T109
in	O
which	O
sbm	O
was	O
the	O
only	O
aa	B-T116
contributing	O
ingredient	O
.	O
	
an	O
n-free	O
diet	O
was	O
also	O
formulated	O
.	O
	
twenty-five	O
barrows	O
initial	O
bw	O
30.53	O
1.73	O
kg	O
were	O
equipped	O
with	O
a	O
t-cannula	O
in	O
the	O
distal	O
ileum	O
and	O
randomly	O
allotted	O
to	O
a	O
25	O
8	O
youden	B-T062
square	I-T062
design	I-T062
with	O
25	O
diets	O
and	O
8	O
periods	B-T079
.	O
	
results	O
indicate	O
that	O
the	O
concentration	B-T081
of	O
cp	B-T116
was	O
greater	O
<	O
0.05	O
in	O
sbm	O
from	O
brazil	O
and	O
india	O
49.3	O
and	O
49.5	O
,	O
respectively	O
than	O
in	O
sbm	O
from	O
china	O
,	O
argentina	O
,	O
or	O
the	O
u.s	O
.	O
	
45.1	O
,	O
46.7	O
,	O
and	O
47.3	O
,	O
respectively	O
,	O
as-fed	O
basis	O
.	O
	
the	O
concentration	B-T081
of	O
most	O
indispensable	O
aa	B-T116
followed	O
the	O
same	O
pattern	O
as	O
cp	B-T116
with	O
the	O
exception	O
that	O
sbm	O
from	O
the	O
u.s	O
.	O
	
contained	O
more	O
<	O
0.05	O
indispensable	O
aa	B-T116
than	O
sbm	O
from	O
china	O
or	O
argentina	O
.	O
	
however	O
,	O
sbm	O
from	O
india	O
contained	O
more	O
<	O
0.05	O
trypsin	B-T116
inhibitors	I-T116
than	O
sbm	O
from	O
the	O
other	O
countries	O
.	O
	
a	O
greater	O
<	O
0.05	O
aid	B-T081
and	O
sid	B-T081
of	O
cp	B-T116
and	O
most	O
aa	B-T116
was	O
observed	O
in	O
sbm	O
from	O
the	O
u.s	O
.	O
	
compared	O
with	O
sbm	O
from	O
brazil	O
,	O
argentina	O
,	O
and	O
india	O
,	O
but	O
there	O
were	O
no	O
differences	O
between	O
sbm	O
from	O
the	O
u.s	O
.	O
	
and	O
sbm	O
from	O
china	O
.	O
	
however	O
,	O
because	O
of	O
the	O
lower	O
concentration	B-T081
of	O
aa	B-T116
in	O
sbm	O
from	O
china	O
,	O
the	O
concentration	B-T081
of	O
standardized	B-T081
ileal	I-T081
digestible	I-T081
aa	B-T116
in	O
sbm	O
from	O
china	O
was	O
less	O
<	O
0.05	O
than	O
in	O
sbm	O
from	O
the	O
u.s	O
.	O
	
soybean	O
meal	O
from	O
the	O
u.s	O
.	O
	
or	O
brazil	O
had	O
less	O
<	O
0.05	O
variability	O
in	O
sid	B-T081
values	O
than	O
sbm	O
from	O
argentina	O
,	O
china	O
,	O
or	O
india	O
.	O
	
in	O
conclusion	O
,	O
the	O
sid	B-T081
of	O
cp	B-T116
and	O
aa	B-T116
is	O
dependent	O
on	O
the	O
country	O
where	O
the	O
sbm	O
is	O
produced	O
.	O
	
this	O
difference	O
and	O
the	O
variability	O
within	O
each	O
country	O
should	O
be	O
evaluated	O
when	O
formulating	B-T061
diets	I-T061
for	O
developing	B-T169
understanding	O
of	O
object	O
fall	B-T033
going	O
beyond	O
inhibitory	B-T052
processes	O
a	O
study	B-T062
is	O
reported	B-T170
where	O
118	O
participants	B-T098
aged	O
between	O
10	O
years	O
and	O
early	B-T079
20s	O
drew	O
the	O
trajectories	B-T079
they	O
expected	B-T170
objects	O
to	O
follow	B-T169
as	O
they	O
fell	B-T033
.	O
	
the	O
younger	B-T079
participants	B-T098
typically	B-T080
anticipated	B-T033
backward	B-T082
trajectories	B-T079
during	O
fall	B-T033
from	O
moving	O
carriers	O
while	O
forward	B-T082
but	O
non-parabolic	B-T079
trajectories	I-T079
were	O
relatively	B-T080
more	B-T081
frequent	B-T079
amongst	O
the	O
older	B-T098
participants	I-T098
.	O
	
both	O
patterns	B-T082
suggest	B-T078
strong	B-T080
sociocultural	O
influences	O
,	O
with	O
implications	B-T078
for	O
models	B-T170
that	O
regard	O
development	B-T169
in	O
this	O
area	B-T078
as	O
purely	B-T080
the	O
inhibition	B-T052
of	O
principles	O
established	B-T080
in	O
infancy	B-T079
.	O
	
statement	B-T078
of	O
contribution	B-T052
what	O
is	O
already	O
known	B-T080
on	O
this	O
subject	O
research	B-T062
with	O
infants	O
demonstrates	B-T080
an	O
early	B-T079
-	O
established	B-T080
belief	B-T078
that	O
dropped	B-T052
objects	O
fall	B-T033
straight	B-T082
down	B-T082
.	O
	
the	O
erroneous	B-T078
expectations	B-T078
that	O
pre-schoolers	O
hold	B-T052
about	O
object	O
fall	B-T033
are	O
consistent	B-T078
with	I-T078
failure	O
to	O
inhibit	B-T052
the	O
presumption	B-T078
of	O
straight	B-T082
-	O
down	B-T082
fall	B-T033
,	O
in	O
contexts	B-T078
where	O
it	O
is	O
inappropriate	B-T080
.	O
	
what	O
does	O
this	O
study	B-T062
add	O
the	O
research	B-T062
replicates	B-T169
and	O
extends	B-T169
research	B-T062
with	O
older	B-T098
participants	I-T098
,	O
which	O
indicates	B-T078
errors	B-T080
that	O
cannot	O
be	O
explained	O
via	O
failed	B-T169
inhibition	B-T052
of	O
straight	B-T082
-	O
down	B-T082
fall	B-T033
.	O
	
it	O
is	O
the	O
first	O
study	B-T062
to	O
trace	O
patterns	B-T082
of	O
errors	B-T080
across	O
late	B-T079
childhood	B-T079
,	O
adolescence	B-T079
and	O
early	B-T079
adulthood	B-T079
.	O
	
a	O
consequence	B-T169
of	I-T169
the	O
findings	B-T033
is	O
that	O
adequate	B-T080
modelling	O
in	O
developmental	O
psychology	O
must	O
consider	B-T078
multilayered	O
interactions	B-T169
between	O
prior	B-T079
representations	B-T052
and	O
sociocultural	O
experiences	O
.	O
	
attenuation	B-T052
of	O
high	B-T109
glucose	I-T109
-	O
induced	B-T169
rat	O
cardiomyocyte	O
apoptosis	O
by	O
exendin-4	B-T116
via	O
intervention	B-T061
of	O
ho-1	B-T116
/	O
nrf-2	B-T116
and	O
the	O
pi3k/akt	B-T169
signaling	I-T169
pathway	I-T169
exendin-4	B-T116
,	O
a	O
glucagon-like	O
peptide-1	O
receptor	O
agonist	O
,	O
demonstrated	O
cytoprotective	O
actions	O
beyond	O
glycemic	B-T033
control	I-T033
in	O
recent	O
studies	O
.	O
	
the	O
aims	B-T078
of	O
the	O
present	O
study	B-T062
were	O
to	O
investigate	B-T169
the	O
effects	B-T080
of	I-T080
exendin-4	B-T116
on	O
high	B-T109
glucose	I-T109
hg	B-T109
induced	B-T169
cardiomyocyte	O
apoptosis	O
and	O
the	O
possible	O
mechanisms	B-T169
.	O
	
rat	O
cardiomyocytes	O
were	O
divided	O
into	O
3	O
groups	O
normal	B-T109
glucose	I-T109
group	O
ng	B-T109
group	O
,	O
hg	B-T109
group	O
and	O
hg	B-T109
+	O
exendin-4	B-T116
group	O
hg	B-T109
+	O
ex	B-T116
group	O
.	O
	
cardiomyocyte	O
apoptosis	O
was	O
evaluated	O
by	O
double-staining	O
with	O
annexin	B-T109
v-fluorescein	I-T109
isothiocyanate	I-T109
fitc	B-T109
propidium	B-T109
iodide	I-T109
pi	B-T109
and	O
flow	O
cytometry	O
.	O
	
intracellular	B-T082
reactive	O
oxygen	O
species	O
ros	O
production	B-T169
was	O
detected	B-T033
by	O
2	B-T109
diacetate	I-T109
dchf-da	B-T109
incubation	O
and	O
fluorescence	O
microscopy	O
.	O
	
ly294002	B-T109
ly	B-T109
,	O
a	O
phosphoinositide	B-T116
3-kinase	I-T116
pi3k	B-T116
pathway	O
inhibitor	B-T080
,	O
was	O
added	O
to	O
the	O
medium	O
of	O
the	O
hg	B-T109
+	O
ex	B-T116
+	O
ly	B-T109
group	O
for	O
further	O
western	O
blot	O
analysis	O
.	O
	
the	O
proteins	B-T116
analyzed	B-T062
involved	O
oxidative	O
stress	O
-	O
associated	B-T116
proteins	I-T116
,	O
heme	B-T116
oxygenase-1	I-T116
ho-1	B-T116
and	O
nuclear	B-T116
factor	I-T116
e2-related	I-T116
factor	I-T116
2	I-T116
nrf-2	B-T116
,	O
and	O
apoptosis	O
-	O
associated	B-T116
proteins	I-T116
,	O
caspase-3	B-T116
,	O
bax/b-cell	B-T116
lymphoma	I-T116
2	I-T116
bcl-2	B-T116
and	O
p-akt	B-T116
/	O
akt	B-T116
.	O
	
hg	B-T109
treatment	B-T169
induced	B-T169
cardiomyocyte	O
apoptosis	O
p	O
=	O
0.00	O
and	O
clearly	O
upregulated	O
ros	O
production	B-T169
p	O
=	O
0.00	O
exendin-4	B-T116
co-incubation	O
also	O
ameliorated	O
cardiomyocyte	O
apoptosis	O
p	O
=	O
0.004	O
and	O
decreased	B-T081
ros	O
p	O
=	O
0.00	O
level	B-T080
significantly	B-T078
.	O
	
ho-1	B-T116
and	O
nrf-2	B-T116
protein	O
expression	O
levels	B-T080
decreased	B-T081
significantly	B-T078
in	O
the	O
hg	B-T109
group	O
p	O
<	O
0.05	O
,	O
but	O
the	O
levels	B-T080
were	O
elevated	B-T080
by	O
exendin-4	B-T116
intervention	B-T061
p	O
<	O
0.05	O
.	O
	
furthermore	O
,	O
exendin-4	B-T116
attenuated	B-T052
hg	B-T109
-	O
induced	B-T169
higher	O
protein	O
expression	O
,	O
including	O
cleaved	O
caspase-3	B-T116
and	O
bax	B-T116
,	O
increased	B-T081
the	O
expression	O
of	O
bcl-2	B-T116
protein	I-T116
p	O
<	O
0.05	O
.	O
	
however	O
,	O
these	O
impacts	B-T080
of	O
exendin-4	B-T116
were	O
counteracted	O
significantly	B-T078
by	O
co-incubation	O
with	O
ly294002	B-T109
.	O
	
in	O
addition	O
,	O
exendin-4	B-T116
ameliorated	O
hg	B-T109
-	O
induced	B-T169
p-akt	B-T116
/	O
akt	B-T116
lower	O
expression	O
,	O
and	O
this	O
impact	B-T080
was	O
also	O
suppressed	B-T169
by	O
ly294002	B-T109
.	O
	
exendin-4	B-T116
ameliorates	O
hg	B-T109
-	O
induced	B-T169
cardiomyocyte	O
apoptosis	O
,	O
and	O
the	O
mechanisms	B-T169
may	O
involve	O
anti-oxidative	O
stress	O
via	O
the	O
ho-1	B-T116
/	O
nrf-2	B-T116
system	O
,	O
as	O
well	O
as	O
intervention	B-T061
of	O
the	O
pi3k/akt	B-T169
signaling	I-T169
pathway	I-T169
.	O
	
kmap-o	O
framework	O
for	O
care	O
management	O
research	B-T062
of	O
patients	O
with	O
type	B-T047
2	I-T047
diabetes	I-T047
to	O
review	B-T080
impacts	B-T080
of	O
interventions	O
involving	O
self-management	O
education	O
,	O
health	O
coaching	O
,	O
and	O
motivational	B-T061
interviewing	I-T061
for	O
type	B-T047
2	I-T047
diabetes	I-T047
.	O
	
a	O
thorough	O
review	B-T078
of	O
the	O
scientific	B-T170
literature	I-T170
on	O
diabetes	B-T047
care	O
and	O
management	O
was	O
executed	O
by	O
a	O
research	B-T062
team	O
.	O
	
this	O
article	B-T170
summarizes	O
important	O
findings	B-T169
in	O
regard	O
to	O
the	O
validity	B-T081
of	O
developing	B-T169
a	O
comprehensive	B-T080
behavioral	B-T078
system	I-T078
as	O
a	O
framework	O
for	O
empirical	B-T080
investigation	O
.	O
	
the	O
behavioral	B-T078
system	I-T078
framework	O
consists	O
of	O
patients	O
'	O
knowledge	B-T033
k	B-T033
,	O
motivation	O
m	O
,	O
attitude	O
a	O
,	O
and	O
practice	O
p	O
as	O
predictor	B-T078
variables	B-T080
for	O
diabetes	B-T047
care	B-T170
outcomes	I-T170
o	B-T170
.	O
	
care	O
management	O
strategies	O
or	O
health	O
education	O
programs	O
serve	O
as	O
the	O
intervention	O
variable	B-T080
that	O
directly	O
influences	O
k	B-T033
,	O
m	O
,	O
a	O
,	O
and	O
p	O
and	O
then	O
indirectly	O
affects	O
the	O
variability	O
in	O
patient	O
care	B-T170
outcomes	I-T170
of	O
patients	O
with	O
type	B-T047
2	I-T047
diabetes	I-T047
.	O
	
this	O
review	B-T170
contributes	O
to	O
the	O
understanding	O
of	O
the	O
kmap-o	O
framework	O
and	O
how	O
it	O
can	O
guide	B-T170
the	O
care	O
management	O
of	O
patients	O
with	O
type	B-T047
2	I-T047
diabetes	I-T047
.	O
	
it	O
will	O
allow	O
the	O
tailoring	O
of	O
interventions	O
to	O
be	O
more	O
effective	O
through	O
knowledge	B-T033
enhancement	B-T052
,	O
increased	O
motivation	O
,	O
attitudinal	O
changes	B-T169
,	O
and	O
improved	B-T033
preventive	O
practice	O
to	O
reduce	B-T080
the	O
progression	O
of	O
type	B-T047
2	I-T047
diabetes	I-T047
and	O
comorbidities	B-T078
.	O
	
furthermore	O
,	O
the	O
use	B-T169
of	I-T169
health	O
information	O
technology	O
for	O
enhancing	B-T052
changes	B-T169
in	O
kmap	O
and	O
communications	O
is	O
advocated	O
in	O
health	O
promotion	O
and	O
bayesian	B-T081
and	O
phylogenic	B-T062
approaches	I-T062
for	O
studying	O
relationships	B-T080
among	O
table	O
olive	O
cultivars	O
to	O
enhance	O
table	O
olive	O
tree	O
authentication	B-T080
,	O
relationship	B-T080
,	O
and	O
productivity	B-T081
,	O
we	O
consider	O
the	O
analysis	B-T062
of	O
18	O
worldwide	O
table	O
olive	O
cultivars	O
olea	O
europaea	O
l	O
based	O
on	O
morphological	B-T080
,	O
biological	B-T080
,	O
and	O
physicochemical	O
markers	O
analyzed	O
by	O
bioinformatic	B-T170
and	O
biostatistic	B-T170
tools	I-T170
.	O
	
accordingly	O
,	O
we	O
assess	O
the	O
relationships	B-T080
between	O
the	O
studied	O
varieties	B-T080
,	O
on	O
the	O
one	O
hand	O
,	O
and	O
the	O
potential	O
productivity	B-T081
-	O
quantitative	B-T081
parameter	O
links	O
on	O
the	O
other	O
hand	O
.	O
	
the	O
bioinformatic	B-T170
analysis	B-T062
based	O
on	O
the	O
graphical	B-T170
representation	I-T170
of	O
the	O
matrix	B-T062
of	I-T062
euclidean	I-T062
distances	I-T062
,	O
the	O
principal	B-T081
components	I-T081
analysis	I-T081
,	O
unweighted	B-T062
pair	I-T062
group	I-T062
method	I-T062
with	O
arithmetic	B-T081
mean	I-T081
,	O
and	O
principal	B-T062
coordinate	I-T062
analysis	I-T062
pcoa	B-T062
revealed	O
three	O
major	O
clusters	B-T081
which	O
were	O
not	O
correlated	O
with	O
the	O
geographic	B-T082
origin	B-T033
.	O
	
the	O
statistical	B-T062
analysis	I-T062
based	O
on	O
kendall's	O
and	O
spearman	B-T081
correlation	I-T081
coefficients	I-T081
suggests	O
two	O
highly	O
significant	O
associations	B-T080
with	O
both	O
fruit	O
color	B-T080
and	O
pollinization	O
and	O
the	O
productivity	B-T081
character	O
.	O
	
these	O
results	B-T169
are	O
confirmed	O
by	O
the	O
multiple	B-T081
linear	I-T081
regression	I-T081
prediction	I-T081
models	I-T081
.	O
	
in	O
fact	O
,	O
based	O
on	O
the	O
coefficient	B-T081
of	I-T081
determination	I-T081
r	B-T081
2	I-T081
value	O
,	O
the	O
best	O
model	B-T170
demonstrated	O
the	O
power	B-T081
of	O
the	O
pollinization	O
on	O
the	O
tree	O
productivity	B-T081
r	B-T081
2	I-T081
=	O
0.846	O
.	O
	
moreover	O
,	O
the	O
derived	O
directed	B-T170
acyclic	I-T170
graph	I-T170
showed	O
that	O
only	O
two	O
direct	O
influences	O
are	O
detected	B-T033
effect	B-T080
of	O
tolerance	B-T080
on	O
fruit	O
and	O
stone	B-T080
symmetry	I-T080
on	O
side	O
and	O
effect	B-T080
of	O
tolerance	B-T080
on	O
stone	B-T080
form	I-T080
and	O
oil	B-T109
content	O
on	O
the	O
other	O
side	O
.	O
	
this	O
work	O
provides	O
better	O
understanding	O
of	O
the	O
diversity	B-T080
available	O
in	O
worldwide	O
table	O
olive	O
cultivars	O
and	O
supplies	O
an	O
important	O
contribution	O
for	O
olive	O
breeding	O
and	O
wiedemann-rautenstrauch	B-T047
syndrome	I-T047
with	O
bilateral	B-T082
tarsal	O
kink	O
three	O
sutures	B-T061
for	O
correction	B-T169
the	O
authors	O
describe	O
a	O
5-	O
month-old	B-T079
male	O
infant	O
with	O
wiedemann-rautenstrauch	B-T047
syndrome	I-T047
,	O
which	O
is	O
an	O
extremely	O
rare	B-T080
condition	B-T047
.	O
	
he	O
had	O
tarsal	O
kink	O
in	O
upper	O
eyelids	O
in	O
both	O
eyes	O
.	O
	
the	O
authors	O
treated	B-T169
bilateral	B-T082
tarsal	O
kink	O
with	O
an	O
everting	O
suture	B-T061
via	O
a	O
transconjunctival	B-T082
approach	I-T082
under	O
local	B-T061
anesthesia	I-T061
.	O
	
the	O
indications	B-T078
for	O
laparoscopic	B-T061
pancreatectomy	I-T061
laparoscopic	B-T061
pancreatectomy	I-T061
is	O
not	O
yet	O
established	O
as	O
a	O
routine	B-T061
procedure	I-T061
everywhere	O
in	O
germany	O
or	O
in	O
other	O
countries	O
.	O
	
few	O
data	B-T078
are	O
available	O
on	O
its	O
short-	B-T080
and	I-T080
long-term	I-T080
outcomes	I-T080
.	O
	
from	O
2008	O
onward	O
,	O
a	O
working	B-T098
group	I-T098
initiated	O
by	O
10	O
centers	O
and	O
currently	O
comprising	O
34	O
centers	O
has	O
gathered	O
data	B-T078
on	O
all	O
cases	B-T169
of	O
laparoscopic	B-T061
pancreatectomy	I-T061
.	O
	
procedures	B-T061
in	O
which	O
laparoscopy	B-T061
was	O
converted	O
to	O
open	B-T061
surgery	I-T061
are	O
also	O
included	O
.	O
	
the	O
registry	B-T170
now	O
contains	O
550	O
data	B-T078
sets	O
representing	O
267	O
cases	B-T169
of	O
benign	O
disease	O
,	O
244	O
malignancies	O
,	O
and	O
39	O
borderline	O
tumors	O
.	O
	
the	O
most	O
common	O
procedure	B-T061
was	O
laparoscopic	B-T061
left	I-T061
pancreatectomy	I-T061
,	O
followed	O
by	O
resection	B-T061
of	O
the	O
head	O
of	O
the	O
pancreas	O
and	O
tumor	O
enucleation	B-T061
.	O
	
the	O
most	O
common	O
intraoperative	O
complication	O
was	O
hemorrhage	O
,	O
with	O
a	O
frequency	O
of	O
3%	O
.	O
	
the	O
rate	B-T081
of	O
conversion	B-T169
to	O
open	B-T061
surgery	I-T061
was	O
35%	O
if	O
minilaparotomies	O
are	O
excluded	O
,	O
the	O
conversion	B-T169
rate	B-T081
was	O
only	O
16%	O
.	O
	
39%	O
of	O
patients	O
developed	O
a	O
pancreatic	B-T047
fistula	I-T047
after	O
surgery	B-T061
usually	O
grade	O
a	O
or	O
b	O
,	O
with	O
1.5	O
grade	O
c	O
and	O
3%	O
underwent	O
reoperation	B-T061
because	O
of	O
postoperative	O
hemorrhage	O
.	O
	
the	O
procedure-related	B-T033
mortality	I-T033
was	O
1.3	O
.	O
	
91%	O
of	O
the	O
patients	O
reported	O
only	O
very	O
mild	O
postoperative	O
pain	O
.	O
	
6.7	O
newly	O
developed	O
diabetes	B-T047
mellitus	I-T047
after	O
the	O
procedure	B-T061
.	O
	
the	O
patient	O
cohort	B-T098
in	O
the	O
registry	B-T170
consists	O
of	O
persons	B-T098
who	O
were	O
selected	O
to	O
undergo	O
laparoscopic	B-T061
pancreatectomy	I-T061
by	O
the	O
participating	O
hospital	O
teams	O
,	O
and	O
the	O
data	B-T078
are	O
thus	O
inherently	O
affected	O
by	O
selection	B-T081
bias	I-T081
.	O
	
the	O
operative	B-T061
procedures	I-T061
that	O
they	O
underwent	O
reflect	O
the	O
current	O
practice	O
of	O
laparoscopic	B-T061
pancreatectomy	I-T061
in	O
germany	O
.	O
	
the	O
complication	O
rates	B-T081
are	O
similar	O
to	O
those	O
of	O
open	B-T061
surgery	I-T061
.	O
	
selection	B-T081
bias	I-T081
can	O
be	O
avoided	O
only	O
by	O
a	O
randomized	B-T062
trial	I-T062
.	O
	
associations	O
of	O
neurod2	O
polymorphisms	O
and	O
change	B-T169
of	O
cognitive	O
dysfunctions	O
in	O
schizophrenia	O
and	O
schizoaffective	O
disorder	O
after	O
eight	O
weeks	B-T079
of	O
antipsychotic	O
treatment	B-T061
neurod2	O
is	O
a	O
neurospecific	B-T082
helix-loop-helix	I-T082
transcription	B-T116
factor	I-T116
which	O
has	O
an	O
impact	B-T080
on	O
the	O
regulation	O
of	O
glutamatergic	B-T116
and	O
gabaergic	B-T116
genes	O
.	O
	
we	O
investigated	B-T169
an	O
association	O
of	O
neurod2	O
with	O
neurocognitive	O
dysfunctions	O
in	O
schizophrenia	O
and	O
schizoaffective	O
disorder	O
patients	O
before	O
and	O
during	O
treatment	B-T061
with	O
different	O
second-generation	O
antipsychotics	O
.	O
	
patients	O
were	O
genotyped	O
for	O
four	O
different	O
polymorphisms	O
of	O
the	O
neurod2	O
gene	O
rs9889354	O
,	O
rs1877032	O
,	O
rs12453682	O
and	O
rs11078918	O
.	O
	
cognitive	O
function	O
was	O
assessed	B-T052
at	O
baseline	B-T081
and	O
week	B-T079
8	O
.	O
	
results	B-T169
of	O
individual	O
neuropsychological	O
tests	O
were	O
assigned	O
to	O
six	O
cognitive	B-T170
domains	I-T170
reaction	B-T079
time	I-T079
and	O
quality	B-T080
executive	O
function	O
working	B-T078
,	O
verbal	O
and	O
visual	O
memory	O
and	O
a	O
general	O
cognitive	B-T169
index	B-T170
.	O
	
167	O
patients	O
were	O
included	O
in	O
the	O
study	B-T062
.	O
	
the	O
neurod2	O
exonic	O
polymorphism	O
rs11078918	O
showed	O
significant	O
associations	O
with	O
verbal	O
memory	O
and	O
executive	O
functions	O
,	O
whereas	O
the	O
neurod2	O
polymorphism	O
rs12453682	O
was	O
significantly	O
associated	O
with	O
working	B-T078
and	O
verbal	O
memory	O
,	O
executive	O
functions	O
and	O
with	O
a	O
cognitive	B-T169
index	B-T170
.	O
	
significant	O
associations	O
were	O
found	O
at	O
baseline	B-T081
and	O
after	O
eight	O
weeks	B-T079
.	O
	
moreover	O
,	O
significant	O
associations	O
between	O
the	O
change	B-T169
in	O
neuropsychological	O
test	O
results	B-T169
during	O
antipsychotic	O
treatment	B-T061
and	O
the	O
neurod2	O
polymorphisms	O
rs11078918	O
and	O
rs12453682	O
were	O
observed	O
.	O
	
our	O
findings	O
suggest	O
that	O
the	O
neurod2	O
gene	O
could	O
play	O
a	O
role	O
in	O
the	O
pathophysiology	B-T169
of	O
neurocognitive	O
dysfunctions	O
as	O
well	O
as	O
in	O
the	O
change	B-T169
of	O
cognitive	O
symptoms	O
under	O
antipsychotic	O
treatment	B-T061
in	O
schizophrenia	O
and	O
schizoaffective	O
disorder	O
.	O
	
new	B-T080
diterpenoids	B-T109
from	O
clerodendranthus	O
spicatus	O
two	O
new	B-T080
diterpenoids	B-T109
,	O
neoorthosiphonones	B-T109
b	I-T109
and	O
c	B-T109
1	B-T109
and	O
2	B-T109
,	O
and	O
one	O
known	O
diterpenoid	B-T109
,	O
were	O
isolated	B-T169
from	O
the	O
aerial	O
parts	O
of	O
clerodendranthus	O
spicatus	O
.	O
	
their	O
structures	B-T082
including	O
absolute	B-T080
configurations	B-T082
were	O
determined	B-T080
by	I-T080
comprehensive	O
spectroscopic	O
analyses	O
and	O
x-ray	O
crystallographic	O
methods	O
.	O
	
no	O
compound	B-T080
was	O
found	O
to	O
inhibit	B-T080
fibronectin	B-T116
production	O
at	O
the	O
concentration	B-T081
stalk	O
versus	O
base	O
invasion	B-T033
in	O
pt1	B-T033
papillary	O
cancers	O
of	O
the	O
bladder	O
improved	O
substaging	O
system	O
predicting	O
risk	B-T078
of	O
progression	O
pathologic	B-T033
stage	I-T033
t1	I-T033
pt1	B-T033
bladder	O
cancers	O
are	O
a	O
clinically	B-T080
heterogeneous	B-T080
group	I-T080
.	O
	
however	O
,	O
current	O
staging	O
guidelines	O
for	O
superficially	B-T082
invasive	O
cancers	O
do	O
not	O
acknowledge	O
the	O
variability	O
in	O
type	O
and	O
extent	O
of	O
lamina	B-T033
propria	I-T033
invasion	I-T033
in	O
papillary	O
urothelial	O
carcinomas	O
puc	O
,	O
and	O
historically	O
proposed	O
substaging	O
systems	O
showed	O
either	O
high	O
inter-observer	B-T081
variation	I-T081
or	O
limited	B-T169
value	I-T169
in	O
predicting	O
patient	O
outcomes	O
.	O
	
herein	O
we	O
reappraise	O
pt1	B-T033
puc	O
substaging	O
,	O
aiming	B-T078
to	O
identify	B-T080
a	O
novel	B-T080
scheme	B-T170
which	O
is	O
reproducible	B-T080
and	O
prognostically	B-T170
meaningful	O
.	O
	
stage	B-T033
pt1	I-T033
puc	O
diagnosed	B-T033
during	O
years	B-T079
1999-2015	O
were	O
retrospectively	B-T062
reviewed	I-T062
and	O
characterized	B-T052
as	O
focal	B-T082
invasion	O
confined	O
to	O
papillary	O
stalk	O
,	O
focal	B-T082
invasion	B-T033
of	O
tumor	O
base	O
,	O
or	O
extensive	O
invasion	B-T033
of	O
tumor	O
base	O
.	O
	
cases	B-T169
with	O
concurrent	B-T079
flat	B-T033
carcinoma	I-T033
in-situ	I-T033
,	O
angiolymphatic	B-T033
invasion	I-T033
,	O
absent	B-T169
muscularis	O
propria	O
,	O
or	O
clinically	B-T080
advanced	O
disease	O
were	O
excluded	B-T169
.	O
	
we	O
calculated	O
cumulative	B-T080
incidence	B-T081
of	O
recurrence	B-T033
,	O
progression	O
,	O
and	O
death	O
by	O
tumor	O
subtype	O
and	O
evaluated	O
differential	B-T033
risks	I-T033
using	O
log-rank	B-T170
tests	I-T170
and	O
kaplan-meier	B-T081
curves	I-T081
stratified	B-T080
by	O
type	B-T080
and	O
extent	O
of	O
invasion	O
.	O
	
among	O
62	O
patients	O
satisfying	O
inclusion	B-T080
criteria	B-T078
,	O
22	O
of	O
29	O
patients	O
with	O
base	O
extensive	B-T080
invasion	B-T033
progressed	B-T169
while	O
4	O
of	O
13	O
with	O
base	O
focal	B-T082
and	O
0	O
of	O
20	O
with	O
stalk	O
only	O
invasion	B-T033
progressed	B-T169
.	O
	
there	O
was	O
strong	O
evidence	O
that	O
base	O
extensive	O
patients	O
had	O
higher	O
risk	B-T078
of	O
progression	O
and	O
death	O
due	O
to	O
bladder	O
cancer	O
than	O
base	O
focal	B-T082
or	O
stalk	O
only	O
counterparts	O
p<0	O
.	O
	
however	O
,	O
tumor	O
subtype	O
was	O
not	O
significantly	O
associated	O
with	O
risk	B-T078
of	O
recurrence	B-T033
p=0	O
.	O
	
we	O
propose	O
an	O
innovative	O
substaging	O
approach	O
for	O
reporting	O
site	O
and	O
extent	O
of	O
lamina	B-T033
propria	I-T033
invasion	I-T033
in	O
patients	O
with	O
pt1	B-T033
puc	O
allowing	O
patient	O
stratification	B-T080
for	O
risk	B-T078
of	O
progression	O
.	O
	
basic	B-T062
science	I-T062
and	O
pathogenesis	O
of	O
ageing	O
with	O
hiv	B-T047
potential	O
mechanisms	B-T169
and	O
biomarkers	O
the	O
increased	O
prevalence	B-T081
of	O
age	O
-related	O
comorbidities	B-T078
and	O
mortality	B-T081
is	O
worrisome	B-T033
in	O
ageing	O
hiv-infected	B-T047
patients	O
.	O
	
here	O
,	O
we	O
aim	B-T078
to	O
analyse	B-T062
the	O
different	O
ageing	O
mechanisms	B-T169
with	O
regard	O
to	O
hiv	B-T047
infection	I-T047
.	O
	
ageing	O
results	O
from	O
the	O
time	B-T079
-	O
dependent	B-T169
accumulation	B-T033
of	O
random	O
cellular	O
damage	O
.	O
	
epigenetic	O
modifications	O
and	O
mitochondrial	O
dna	O
haplogroups	O
modulate	B-T082
ageing	O
.	O
	
in	O
antiretroviral	B-T061
treatment	I-T061
-controlled	O
patients	O
,	O
epigenetic	O
clock	O
appears	O
to	O
be	O
advanced	O
,	O
and	O
some	O
haplogroups	O
are	O
associated	O
with	O
hiv	B-T047
infection	I-T047
severity	B-T080
.	O
	
telomere	O
shortening	O
is	O
enhanced	O
in	O
hiv-infected	B-T047
patients	O
because	O
of	O
hiv	O
and	O
some	O
nucleoside	O
analogue	O
reverse	O
transcriptase	O
inhibitors	O
.	O
	
mitochondria	O
-related	O
oxidative	O
stress	O
and	O
mitochondrial	O
dna	O
mutations	O
are	O
increased	O
during	O
ageing	O
and	O
also	O
by	O
some	O
nucleoside	O
analogue	O
reverse	O
transcriptase	O
inhibitors	O
.	O
	
overall	O
,	O
increased	O
inflammation	O
or	O
'	O
inflammageing	O
'	O
is	O
a	O
major	O
driver	O
of	O
ageing	O
and	O
could	O
result	O
from	O
cell	O
senescence	O
with	O
secreted	O
proinflammatory	O
mediators	O
,	O
altered	O
gut	O
microbiota	O
,	O
and	O
coinfections	B-T047
.	O
	
in	O
hiv-infected	B-T047
patients	O
,	O
the	O
level	B-T080
of	O
inflammation	O
and	O
innate	O
immunity	O
activation	B-T052
is	O
enhanced	O
and	O
related	O
to	O
most	O
comorbidities	B-T078
and	O
to	O
mortality	B-T081
.	O
	
this	O
status	O
could	O
result	O
,	O
in	O
addition	O
to	O
age	O
,	O
from	O
the	O
virus	O
itself	O
or	O
viral	B-T116
protein	I-T116
released	O
from	O
reservoirs	B-T078
,	O
from	O
hiv	O
-enhanced	O
gut	O
permeability	O
and	O
dysbiosis	O
,	O
from	O
antiretroviral	B-T061
treatment	I-T061
,	O
from	O
frequent	O
cytomegalovirus	O
and	O
hepatitis	O
c	O
virus	O
coinfections	B-T047
,	O
and	O
also	O
from	O
personal	O
and	O
environmental	B-T169
factors	I-T169
,	O
as	O
central	O
fat	B-T033
accumulation	I-T033
or	O
smoking	O
.	O
	
adaptive	O
immune	O
activation	B-T052
and	O
immunosenescence	O
are	O
associated	O
with	O
comorbidities	B-T078
and	O
mortality	B-T081
in	O
the	O
general	B-T098
population	I-T098
but	O
are	O
less	O
predictive	B-T080
in	O
hiv-infected	B-T047
patients	O
.	O
	
biomarkers	O
to	O
evaluate	O
ageing	O
in	O
hiv-infected	B-T047
patients	O
are	O
required	O
.	O
	
numerous	O
systemic	B-T169
or	O
cellular	O
inflammatory	O
,	O
immune	B-T169
activation	B-T052
,	O
oxidative	O
stress	O
,	O
or	O
senescence	O
markers	O
can	O
be	O
tested	B-T169
in	O
serum	O
or	O
peripheral	O
blood	O
mononuclear	O
cells	O
.	O
	
the	O
novel	O
european	O
study	B-T062
to	O
establish	O
biomarkers	O
of	O
human	B-T170
ageing	I-T170
mark-age	I-T170
algorithm	I-T170
,	O
evaluating	O
the	O
biological	B-T080
age	O
,	O
is	O
currently	O
assessed	O
in	O
hiv-infected	B-T047
patients	O
and	O
reveals	O
an	O
advanced	O
biological	B-T080
age	O
.	O
	
some	O
enhanced	O
inflammatory	B-T169
or	O
innate	O
immune	O
activation	B-T052
markers	O
are	O
interesting	O
but	O
still	O
not	O
validated	O
for	O
the	O
patient's	O
follow-up	O
.	O
	
to	O
be	O
able	O
to	O
assess	O
patients	O
'	O
biological	B-T080
age	O
is	O
an	O
important	O
objective	O
to	O
improve	O
their	O
mesothelial	O
cell	O
adherence	B-T169
to	O
vascular	O
prostheses	O
and	O
their	O
subsequent	B-T079
growth	O
in	B-T080
vitro	I-T080
cell	O
seeding	O
may	O
decrease	B-T081
the	O
thrombogenicity	O
of	O
implanted	O
vascular	O
grafts	O
,	O
but	O
its	O
application	O
is	O
hampered	O
by	O
the	O
limited	O
availability	B-T169
of	I-T169
autologous	B-T080
endothelial	O
cells	O
.	O
	
human	O
peritoneal	O
mesothelial	O
cells	O
have	O
blood	O
flow	O
supporting	B-T080
qualities	I-T080
and	O
are	O
readily	B-T169
available	I-T169
.	O
	
this	O
study	O
investigated	B-T169
the	O
adherence	B-T169
of	O
mesothelial	O
cells	O
to	O
vascular	O
prostheses	O
and	O
their	O
subsequent	B-T079
growth	O
in	B-T080
vitro	I-T080
.	O
	
circular	B-T082
pieces	B-T081
of	O
various	O
vascular	B-T080
prosthetic	O
materials	O
were	O
seeded	O
with	O
51chromium-labeled	O
mesothelial	O
and	O
endothelial	O
cells	O
and	O
left	O
for	O
either	O
5	O
,	O
15	O
,	O
30	O
,	O
60	O
,	O
and	O
120	O
minutes	B-T079
.	O
	
the	O
unattached	B-T033
cells	O
were	O
removed	B-T080
and	O
the	O
degree	B-T081
of	O
cell	O
attachment	B-T052
was	O
measured	B-T080
.	O
	
the	O
number	B-T081
of	O
mesothelial	O
cells	O
to	O
dacron	B-T109
increased	B-T081
during	O
the	O
first	O
60	O
min	B-T079
up	O
to	O
35.2	O
%	O
of	O
the	O
seeded	O
inoculum	O
where	O
after	O
a	O
plateau	B-T081
was	O
reached	B-T033
.	O
	
scanning	O
electron	O
microscopy	O
showed	O
spreaded	B-T080
mesothelial	O
cells	O
adherent	B-T169
to	O
the	O
dacron	B-T109
fibers	I-T109
.	O
	
a	O
significant	B-T078
increase	B-T169
in	O
adherence	B-T169
was	O
observed	B-T169
after	O
preincubation	O
of	O
dacron	B-T109
with	O
10	O
μg/ml	O
fibronectin	B-T116
,	O
but	O
no	B-T033
improvement	I-T033
was	O
found	B-T033
after	O
preincubation	O
with	O
human	O
serum	B-T116
albumin	I-T116
or	O
gelatin	B-T116
.	O
	
mesothelial	O
cells	O
adhered	O
better	O
to	O
gelcoated	B-T080
than	O
to	O
gelsealed	B-T080
or	O
plain	B-T109
dacron	I-T109
.	O
	
the	O
adherence	B-T169
of	O
mesothelial	O
cells	O
to	O
eptfe	B-T109
teflon	B-T109
was	O
significantly	B-T078
poorer	B-T080
.	O
	
no	B-T033
significant	I-T033
differences	B-T080
in	O
adherence	B-T169
were	O
found	B-T033
between	O
mesothelial	O
and	O
endothelial	O
cells	O
.	O
	
mesothelial	O
cell	O
growth	O
on	O
dacron	B-T109
resulted	B-T169
in	O
a	O
modest	B-T169
increase	I-T169
in	O
the	O
number	B-T081
of	O
viable	O
cells	O
during	O
27	O
days	B-T079
,	O
which	O
implies	O
biocompatibility	O
of	O
dacron	B-T109
and	O
mesothelial	O
cells	O
in	B-T080
vitro	I-T080
.	O
	
anterolateral	B-T082
entorhinal	O
cortex	O
volume	B-T081
predicted	O
by	O
altered	O
intra-item	B-T170
configural	I-T170
processing	I-T170
recent	O
functional	O
imaging	O
studies	O
have	O
proposed	O
that	O
the	O
human	O
entorhinal	O
cortex	O
is	O
subdivided	O
into	O
functionally	O
distinct	O
anterolateral	B-T082
alerc	O
and	O
posteromedial	B-T082
pmerc	O
subregions	O
.	O
	
the	O
alerc	O
overlaps	O
with	O
regions	O
that	O
are	O
affected	O
earliest	O
by	O
alzheimer's	B-T047
disease	I-T047
pathology	O
,	O
yet	O
its	O
cognitive	O
function	O
remains	O
poorly	O
understood	O
.	O
	
previous	O
human	O
fmri	O
studies	O
have	O
focused	O
on	O
its	O
role	O
in	O
object	O
memory	O
,	O
but	O
rodent	O
studies	O
on	O
the	O
putatively	O
homologous	O
lateral	O
entorhinal	O
cortex	O
suggest	O
that	O
it	O
also	O
plays	O
an	O
important	O
role	O
in	O
representing	O
spatial	B-T082
properties	I-T082
of	O
objects	O
.	O
	
in	O
order	O
to	O
investigate	O
the	O
cognitive	B-T033
effects	I-T033
of	O
human	O
alerc	O
volume	B-T081
differences	O
,	O
we	O
developed	O
an	O
eyetracking-based	O
task	O
to	O
evaluate	O
intra-item	B-T170
configural	I-T170
processing	I-T170
i.e	O
,	O
processing	B-T052
the	O
arrangement	B-T082
of	O
an	O
object's	O
features	O
,	O
and	O
used	O
manual	O
segmentation	O
based	O
on	O
a	O
recently-	O
developed	B-T170
protocol	I-T170
to	O
delineate	O
the	O
alerc	O
/	O
pmerc	O
as	O
well	O
as	O
other	O
medial	O
temporal	O
lobe	O
mtl	O
subregions	O
.	O
	
in	O
a	O
group	O
of	O
older	O
adult	O
men	B-T098
and	O
women	B-T098
at	O
varying	O
stages	B-T079
of	O
brain	B-T047
atrophy	I-T047
and	O
cognitive	O
decline	O
,	O
we	O
found	O
that	O
intra-item	B-T170
configural	I-T170
processing	I-T170
-	O
regardless	O
of	O
an	O
object's	O
novelty	O
-	O
was	O
strongly	O
predicted	O
by	O
alerc	O
volume	B-T081
,	O
but	O
not	O
by	O
the	O
volume	B-T081
of	O
any	O
other	O
mtl	O
subregion	O
.	O
	
these	O
results	O
provide	O
the	O
first	O
evidence	O
that	O
the	O
human	O
alerc	O
plays	O
a	O
role	O
in	O
supporting	O
a	O
distinct	O
aspect	O
of	O
object	O
processing	B-T052
,	O
namely	O
attending	O
to	O
the	O
arrangement	B-T082
of	O
an	O
object's	O
component	O
features.significance	O
statement	O
alzheimer's	B-T047
disease	I-T047
pathology	O
appears	O
earliest	O
in	O
brain	O
regions	O
that	O
overlap	O
with	O
the	O
anterolateral	B-T082
entorhinal	O
cortex	O
alerc	O
.	O
	
however	O
,	O
the	O
cognitive	O
role	O
of	O
the	O
alerc	O
is	O
poorly	O
understood	O
.	O
	
previous	O
human	B-T062
studies	I-T062
treat	B-T061
the	O
alerc	O
as	O
an	O
extension	O
of	O
the	O
neighboring	O
perirhinal	O
cortex	O
,	O
supporting	O
object	O
memory	O
.	O
	
animal	O
studies	O
suggest	O
that	O
the	O
alerc	O
may	O
support	O
the	O
spatial	B-T082
properties	I-T082
of	O
objects	O
.	O
	
in	O
a	O
group	O
of	O
older	O
adult	O
humans	O
at	O
the	O
earliest	B-T079
stages	I-T079
of	O
cognitive	O
decline	O
,	O
we	O
show	O
that	O
alerc	O
volume	B-T081
selectively	O
predicted	O
configural	B-T170
processing	I-T170
attention	O
to	O
the	O
spatial	B-T082
arrangement	I-T082
of	O
an	O
object's	O
parts	O
.	O
	
this	O
is	O
the	O
first	O
study	O
to	O
demonstrate	O
a	O
cognitive	O
role	O
related	O
to	O
alerc	O
volume	B-T081
in	O
humans	O
.	O
	
this	O
task	O
can	O
be	O
adapted	O
to	O
serve	O
as	O
an	O
early	B-T170
detection	I-T170
method	I-T170
for	O
alzheimer's	B-T047
disease	I-T047
pathology	O
.	O
	
alcohol	O
brief	O
intervention	O
in	O
primary	O
care	O
blood	O
pressure	O
outcomes	B-T033
in	O
hypertensive	B-T047
patients	O
in	O
clinical	B-T062
trials	I-T062
alcohol	O
brief	O
intervention	O
bi	O
in	O
adult	O
primary	O
care	O
has	O
been	O
efficacious	B-T080
in	O
reducing	B-T080
alcohol	O
consumption	O
,	O
but	O
we	O
know	O
little	O
about	O
its	O
impact	B-T080
on	O
health	B-T080
outcomes	I-T080
.	O
	
hypertension	B-T047
is	O
a	O
prevalent	O
and	O
costly	O
chronic	B-T033
condition	I-T033
in	O
the	O
u.s	O
.	O
	
and	O
worldwide	B-T080
,	O
and	O
alcohol	O
use	O
is	O
a	O
modifiable	O
hypertension	B-T047
risk	B-T033
factor	I-T033
.	O
	
to	O
evaluate	O
the	O
effect	B-T080
of	O
receiving	O
bi	O
for	O
unhealthy	O
drinking	O
on	O
blood	O
pressure	O
bp	O
control	O
among	O
adult	O
hypertensive	B-T047
patients	O
by	O
analyzing	O
secondary	O
data	O
from	O
a	O
clustered	B-T062
,	O
randomized	B-T062
controlled	I-T062
trial	I-T062
on	O
alcohol	O
screening	O
,	O
brief	O
intervention	O
and	O
referral	O
to	O
treatment	O
sbirt	O
implementation	B-T052
by	O
primary	O
care	O
physicians	O
pcp	O
intervention	O
arm	O
and	O
non-physician	O
providers	O
and	O
medical	O
assistants	O
npp	O
ma	O
intervention	O
arm	O
in	O
a	O
large	O
,	O
integrated	O
health	O
care	O
delivery	O
system	O
.	O
	
observational	B-T062
,	O
prospective	B-T062
cohort	I-T062
study	I-T062
.	O
	
3811	O
adult	O
hypertensive	B-T047
primary	O
care	O
patients	O
screening	O
positive	O
for	O
past-year	B-T079
heavy	O
drinking	O
at	O
baseline	B-T081
,	O
of	O
which	O
1422	O
37%	O
had	O
an	O
electronic	B-T170
health	I-T170
record	I-T170
bp	O
measure	O
at	O
baseline	B-T081
and	O
18-month	B-T079
follow-up	O
.	O
	
change	B-T033
in	I-T033
bp	I-T033
and	O
controlled	O
bp	O
systolic/diastolic	O
bp	O
<140/90	O
mmhg	B-T081
.	O
	
overall	O
no	O
significant	O
associations	B-T080
were	O
found	O
between	O
alcohol	O
bi	O
and	O
bp	B-T033
change	I-T033
at	O
18-month	B-T079
follow-up	O
when	O
analyzing	O
the	O
combined	O
sample	O
of	O
subjects	B-T098
in	O
both	O
intervention	O
arms	O
.	O
	
however	O
,	O
moderation	O
analyses	O
found	O
that	O
receiving	O
bi	O
for	O
positive	O
past-year	B-T079
unhealthy	O
drinking	O
was	O
positively	O
associated	B-T080
with	I-T080
better	O
bp	O
control	O
at	O
18months	B-T079
in	O
the	O
pcp	O
intervention	O
arm	O
,	O
and	O
for	O
those	O
with	O
lower	O
heavy	O
drinking	O
frequency	B-T079
and	O
poor	O
bp	O
control	O
at	O
the	O
index	O
screening	O
.	O
	
our	O
findings	O
suggest	O
that	O
hypertensive	B-T047
patients	O
may	O
benefit	B-T081
from	O
receiving	O
physician	O
brief	O
intervention	O
for	O
unhealthy	O
alcohol	O
use	O
in	O
primary	O
care	O
.	O
	
findings	O
also	O
highlight	O
potential	O
population-level	B-T081
benefits	I-T081
of	O
alcohol	O
bi	O
if	O
widely	O
applied	O
,	O
suggesting	O
a	O
need	O
for	O
the	O
development	O
of	O
innovative	O
strategies	O
to	O
facilitate	O
sbirt	O
delivery	O
in	O
primary	O
care	O
unusual	B-T080
asymptomatic	B-T047
presentation	I-T047
of	O
bladder	O
cancer	O
metastatic	O
to	O
the	O
penis	O
penile	O
metastasis	O
is	O
an	O
extremely	B-T047
rare	I-T047
event	I-T047
and	O
mainly	O
originate	O
from	O
primary	O
pelvic	O
tumor	B-T082
sites	I-T082
such	O
us	O
urinary	O
bladder	O
,	O
gastro-intestinal	O
tract	O
and	O
prostate	O
and	O
more	O
rarely	O
from	O
respiratory	O
system	O
,	O
bone	O
tumors	O
and	O
melanoma	O
.	O
	
here	O
we	O
describe	O
the	O
unusual	B-T080
presentation	B-T078
of	O
two	O
bladder	O
urothelial	O
cancer	O
metastatic	B-T169
to	I-T169
the	O
penis	O
with	O
no	B-T033
relevant	I-T033
clinical	I-T033
symptoms	I-T033
.	O
	
namely	O
,	O
a	O
69	O
years-old	O
man	O
with	O
a	O
warthy	O
lesions	B-T033
of	O
the	O
foreskin	O
and	O
the	O
glans	O
misunderstood	O
for	O
a	O
condylomata	B-T047
that	O
at	O
histological	O
and	O
immunohistochemical	O
analysis	O
showed	O
a	O
bladder	O
urothelial	O
carcinoma	O
and	O
a	O
71	O
years-old	O
man	O
with	O
reddish	B-T080
skin	B-T033
lesion	I-T033
of	I-T033
the	I-T033
glans	I-T033
,	O
a	O
previous	O
history	B-T033
of	I-T033
bladder	I-T033
and	O
urethral	O
carcinoma	O
and	O
histological	B-T033
pagetoid	I-T033
spread	I-T033
of	O
urothelial	O
cancer	O
to	O
the	O
glans	O
.	O
	
recurrent	O
bladder	O
urothelial	O
carcinoma	O
is	O
usually	O
a	O
visceral	O
disease	B-T047
that	O
rarely	O
presents	O
as	O
a	O
superficial	O
asymptomatic	B-T033
skin	B-T047
lesion	I-T047
.	O
	
the	O
two	O
reported	O
cases	B-T033
were	I-T033
asymptomatic	I-T033
superficial	O
penis	O
metastases	O
with	O
a	O
relatively	O
slow	O
growth	O
and	O
a	O
fairy	B-T033
good	I-T033
prognosis	I-T033
after	O
conservative	B-T169
surgical	I-T169
approach	I-T169
.	O
	
accurate	O
clinical	O
examination	O
of	O
the	O
penis	O
is	O
mandatory	O
for	O
males	O
with	O
history	B-T033
of	I-T033
bladder	I-T033
cancer	I-T033
.	O
	
the	O
bachelorette	O
female	O
siamese	O
fighting	O
fish	O
avoid	B-T169
males	O
exposed	B-T080
to	I-T080
an	O
estrogen	B-T109
mimic	B-T169
due	O
to	O
improper	B-T080
disposal	B-T052
and	O
a	O
lack	B-T080
of	O
removal	B-T052
during	O
the	O
wastewater	O
treatment	B-T169
process	I-T169
,	O
endocrine	B-T169
disrupting	B-T080
chemicals	O
enter	O
aquatic	O
ecosystems	O
where	O
they	O
exert	O
detrimental	O
effects	B-T080
on	O
fish	O
behavior	O
and	O
physiology	O
.	O
	
perhaps	O
the	O
most	O
well-studied	O
and	O
prevalent	B-T081
edc	O
is	O
17α-ethinylestradiol	B-T109
ee2	B-T109
,	O
an	O
active	O
ingredient	O
in	O
oral	O
contraceptives	O
,	O
which	O
is	O
known	O
to	O
cause	O
dramatic	O
reductions	B-T080
in	O
male	O
-typical	O
behaviors	O
.	O
	
while	O
it	O
is	O
likely	O
that	O
alterations	B-T078
in	O
male	O
courtship	O
behavior	O
decrease	B-T081
reproductive	O
fitness	O
,	O
this	O
is	O
rarely	O
explicitly	O
examined	O
.	O
	
to	O
this	O
end	O
,	O
whether	O
ee2	B-T109
exposure	B-T080
reduces	B-T080
male	O
attractiveness	O
to	O
female	O
siamese	O
fighting	O
fish	O
,	O
betta	O
splendens	O
,	O
was	O
investigated	B-T169
by	O
showing	O
females	O
video	B-T170
images	B-T170
of	O
exposed	B-T098
and	O
unexposed	B-T098
males	O
.	O
	
females	O
were	O
randomly	O
assigned	O
to	O
one	O
of	O
two	O
exposure	B-T080
conditions	B-T080
exposed	B-T080
to	I-T080
ee2	B-T109
,	O
control	O
and	O
each	O
subject	O
then	O
viewed	O
four	B-T081
different	B-T080
video	B-T170
combinations	B-T080
of	O
male	O
conspecifics	B-T078
courting	O
exposed	B-T098
+	O
exposed	B-T098
courting	O
unexposed	B-T098
+	O
unexposed	B-T098
courting	O
unexposed	B-T098
+	O
exposed	B-T098
swimming	O
unexposed	B-T098
+	O
exposed	B-T098
.	O
	
females	O
,	O
regardless	O
of	O
whether	O
or	O
not	O
they	O
were	O
exposed	B-T080
to	I-T080
ee2	B-T109
,	O
directed	O
markedly	O
less	O
behavior	O
towards	O
exposed	B-T098
males	O
,	O
especially	O
when	O
they	O
viewed	O
an	O
exposed	B-T098
male	O
and	O
an	O
unexposed	B-T098
male	O
simultaneously	B-T079
.	O
	
these	O
findings	O
demonstrate	O
that	O
ee2	B-T109
can	O
have	O
significant	B-T078
individual	B-T081
-	O
and	O
population-level	B-T098
consequences	B-T169
on	O
fitness	B-T078
by	O
disrupting	B-T080
sexual	O
selection	O
and	O
,	O
ultimately	O
,	O
the	O
success	O
of	O
exposed	B-T098
males	O
.	O
	
targeting	B-T169
accuracy	B-T080
of	O
single-isocenter	B-T082
intensity-modulated	B-T061
radiosurgery	B-T061
for	O
multiple	O
lesions	B-T033
to	O
investigate	B-T169
the	O
targeting	B-T169
accuracy	B-T080
of	O
intensity-modulated	B-T061
srs	B-T061
imrs	B-T061
plans	B-T170
designed	O
to	O
simultaneously	O
treat	O
multiple	O
brain	O
metastases	O
with	O
a	O
single	B-T082
isocenter	I-T082
.	O
	
a	O
home-made	O
acrylic	O
phantom	O
able	O
to	O
support	O
a	O
film	O
ebt3	O
in	O
its	O
coronal	B-T082
plane	I-T082
was	O
used	O
.	O
	
the	O
phantom	O
was	O
ct	O
scanned	O
and	O
three	O
coplanar	O
small	O
targets	B-T169
a	O
central	B-T082
and	O
two	O
peripheral	B-T082
were	O
outlined	O
in	O
the	O
eclipse	B-T061
system	I-T061
.	O
	
peripheral	B-T082
targets	B-T169
were	O
6	O
cm	O
apart	O
from	O
the	O
central	B-T082
one	O
.	O
	
a	O
reference	O
imrs	B-T061
plan	B-T170
was	O
designed	O
to	O
simultaneously	O
treat	O
the	O
three	O
targets	B-T169
,	O
but	O
only	O
a	O
single	B-T082
isocenter	I-T082
located	O
at	O
the	O
center	O
of	O
the	O
central	B-T082
target	B-T169
was	O
used	O
.	O
	
after	O
positioning	B-T082
the	O
phantom	O
on	O
the	O
linac	O
using	O
the	O
room	B-T082
lasers	O
,	O
a	O
cbct	O
scan	O
was	O
acquired	O
and	O
the	O
reference	O
plan	B-T170
were	O
mapped	B-T052
on	O
it	O
,	O
by	O
placing	O
the	O
planned	O
isocenter	B-T082
at	O
the	O
intersection	B-T078
of	O
the	O
landmarks	O
used	O
in	O
the	O
film	O
showing	O
the	O
linac	O
isocenter	B-T082
.	O
	
the	O
mapped	B-T052
plan	B-T170
was	O
then	O
recalculated	B-T052
and	O
delivered	B-T169
.	O
	
the	O
film	O
dose	B-T061
distribution	I-T061
was	O
derived	O
using	O
a	O
cloud	B-T170
computing	I-T170
application	I-T170
www.radiochromic	B-T170
that	O
uses	O
a	O
triple-channel	O
dosimetry	O
algorithm	B-T170
.	O
	
comparison	O
of	O
dose	B-T061
distributions	I-T061
using	O
the	O
gamma	B-T081
index	I-T081
5%/1	O
mm	O
were	O
performed	O
over	O
a	O
5	O
5	O
cm	O
region	O
centered	O
over	O
each	O
target	B-T169
.	O
	
2d	B-T169
shifts	I-T169
required	O
to	O
get	O
the	O
best	O
gamma	O
passing	O
rates	O
on	O
the	O
peripheral	B-T082
target	B-T169
regions	O
were	O
compared	O
with	O
the	O
reported	O
ones	O
for	O
the	O
central	B-T082
target	B-T169
.	O
	
the	O
experiment	B-T062
was	O
repeated	O
ten	O
times	O
in	O
different	O
sessions	B-T061
.	O
	
average	O
2d	B-T169
shifts	I-T169
required	O
to	O
achieve	O
optimal	O
gamma	O
passing	O
rates	O
99%	O
,	O
97%	O
,	O
99%	O
were	O
0.7	O
mm	O
sd	O
0.3	O
mm	O
,	O
0.8	O
mm	O
sd	O
0.4	O
mm	O
and	O
0.8	O
mm	O
sd	O
0.3	O
mm	O
,	O
for	O
the	O
central	B-T082
and	O
the	O
two	O
peripheral	B-T082
targets	B-T169
,	O
respectively	O
.	O
	
no	O
statistical	O
differences	O
p	O
>	O
0.05	O
were	O
found	O
for	O
targeting	B-T169
accuracy	B-T080
between	O
the	O
central	B-T082
and	O
the	O
two	O
peripheral	B-T082
targets	B-T169
.	O
	
the	O
study	B-T062
revealed	O
a	O
targeting	B-T169
accuracy	B-T080
within	O
1	O
mm	O
for	O
off-	O
isocenter	B-T082
targets	B-T169
within	O
6	O
cm	O
of	O
the	O
linac	O
isocenter	B-T082
,	O
when	O
a	O
single-isocenter	B-T082
imrs	B-T061
plan	B-T170
physical	O
activity	O
limits	B-T169
the	O
effects	B-T080
of	I-T080
age	O
and	O
alzheimer's	B-T047
disease	I-T047
on	O
postural	O
control	O
the	O
aim	B-T078
was	O
to	O
study	O
the	O
possible	O
influence	O
of	O
physical	O
activity	O
on	O
the	O
postural	B-T169
performance	B-T052
of	O
subjects	B-T098
with	O
alzheimer's	B-T047
disease	I-T047
ad	B-T047
.	O
	
the	O
postural	B-T169
performance	B-T052
i.e	O
.	O
	
surface	B-T081
area	I-T081
of	O
the	O
center	B-T082
of	I-T082
foot	I-T082
pressure	I-T082
displacement	I-T082
of	O
3	O
groups	B-T078
was	O
compared	B-T052
alzheimer	B-T078
active	I-T078
group	I-T078
aa	B-T078
,	O
alzheimer	B-T078
non-active	I-T078
group	I-T078
ana	B-T078
and	O
healthy	B-T078
non-active	I-T078
group	I-T078
hna	B-T078
.	O
	
the	O
aa	B-T098
group's	I-T098
postural	B-T169
performance	B-T052
was	O
superior	B-T082
to	O
that	O
of	O
the	O
ana	B-T078
and	O
hna	B-T078
groups	I-T078
.	O
	
ad	B-T047
disturbed	O
postural	B-T169
performance	B-T052
but	O
participation	B-T169
in	O
regular	B-T080
physical	O
activity	O
made	O
it	O
possible	O
to	O
limit	B-T169
the	O
disturbing	B-T080
effects	I-T080
of	O
ad	B-T047
to	O
a	O
surprising	O
extent	O
,	O
since	O
the	O
postural	B-T169
performance	B-T052
of	O
active	B-T098
ad	I-T098
subjects	I-T098
was	O
also	O
superior	B-T082
to	O
that	O
of	O
healthy	B-T098
subjects	I-T098
.	O
	
lamp-2	B-T116
mediates	O
oxidative	O
stress	O
-dependent	O
cell	O
death	O
in	O
zn	O
-	O
treated	B-T061
lung	O
epithelium	O
cells	O
zinc	O
is	O
an	O
essential	O
element	O
for	O
the	O
biological	O
system	O
.	O
	
however	O
,	O
excessive	O
exogenous	B-T169
zn	O
would	O
disrupt	O
cellular	O
zn	O
homeostasis	O
and	O
cause	O
toxicity	O
.	O
	
in	O
particular	O
,	O
zinc	O
salts	O
or	O
zno	O
nanoparticles	O
exposure	O
could	O
induce	O
respiratory	O
injury	O
.	O
	
although	O
previous	O
studies	O
have	O
indicated	O
that	O
organelle	O
damage	O
including	O
mitochondria	O
or	O
lysosomes	O
and	O
reactive	O
oxygen	O
species	O
ros	O
production	O
are	O
involved	O
in	O
zn	O
-induced	O
toxicity	O
,	O
the	O
interplay	O
between	O
mitochondria	O
/	O
lysosomes	O
damage	O
and	O
ros	O
production	O
is	O
obscure	O
.	O
	
herein	O
,	O
we	O
demonstrated	O
that	O
zn	O
could	O
induce	O
deglycosylation	O
of	O
lysosome-associated	B-T116
membrane	I-T116
protein	I-T116
1	I-T116
and	O
2	B-T116
lamp-1	B-T116
and	O
lamp-2	B-T116
,	O
which	O
primarily	O
locate	O
in	O
late	O
endosomes	O
/	O
lysosomes	O
,	O
in	O
a549	O
lung	O
epithelium	O
cells	O
.	O
	
intriguingly	O
,	O
lamp-2	O
knockdown	O
further	O
aggravated	B-T080
zn	O
-mediated	O
ros	O
production	O
and	O
cell	O
death	O
,	O
indicating	O
lamp-2	B-T116
not	O
lamp-1	B-T116
was	O
involved	O
in	O
zn	O
-induced	O
toxicity	O
.	O
	
our	O
results	O
provide	O
a	O
new	O
insight	O
that	O
lamp-2	B-T116
contributes	O
to	O
the	O
ros	O
clearance	O
and	O
cell	O
death	O
induced	O
by	O
zn	O
treatment	B-T061
,	O
which	O
would	O
help	O
us	O
to	O
get	O
a	O
better	O
understanding	O
of	O
zn	O
-induced	O
toxicity	O
in	O
respiratory	O
system	O
.	O
	
fluorescence	O
hyperspectral	O
imaging	O
fhsi	O
using	O
a	O
spectrally	B-T080
resolved	B-T033
detector	O
array	O
the	O
ability	O
to	O
resolve	O
multiple	B-T081
fluorescent	O
emissions	O
from	O
different	B-T080
biological	B-T080
targets	B-T169
in	O
video	O
rate	O
applications	O
,	O
such	O
as	O
endoscopy	O
and	O
intraoperative	O
imaging	O
,	O
has	O
traditionally	O
been	O
limited	B-T169
by	O
the	O
use	O
of	O
filter-based	B-T080
imaging	O
systems	O
.	O
	
hyperspectral	O
imaging	O
hsi	O
facilitates	O
the	O
detection	B-T061
of	O
both	O
spatial	B-T082
and	O
spectral	B-T081
information	B-T078
in	O
a	O
single	B-T052
data	I-T052
acquisition	I-T052
,	O
however	O
,	O
instrumentation	B-T080
for	O
hsi	O
is	O
typically	O
complex	B-T080
,	O
bulky	B-T081
and	O
expensive	B-T080
.	O
	
we	O
sought	O
to	O
overcome	B-T052
these	O
limitations	B-T169
using	O
a	O
novel	B-T080
robust	B-T080
and	O
low	B-T081
cost	I-T081
hsi	O
camera	O
based	O
on	O
a	O
spectrally	O
resolved	O
detector	O
array	O
srda	O
.	O
	
we	O
integrated	O
this	O
hsi	O
camera	O
into	O
a	O
wide-field	B-T033
reflectance-based	O
imaging	O
system	O
operating	B-T169
in	O
the	O
near-infrared	B-T080
range	B-T081
to	O
assess	O
the	O
suitability	O
for	O
in	O
vivo	O
imaging	O
of	O
exogenous	B-T169
fluorescent	O
contrast	O
agents	O
.	O
	
using	O
this	O
fluorescence	O
hsi	O
fhsi	O
system	B-T169
,	O
we	O
were	O
able	O
to	O
accurately	B-T080
resolve	O
the	O
presence	B-T080
and	O
concentration	B-T081
of	O
at	O
least	O
7	O
fluorescent	O
dyes	O
in	O
solution	O
.	O
	
we	O
also	O
demonstrate	O
high	B-T080
spectral	O
unmixing	O
precision	B-T080
,	O
signal	O
linearity	B-T080
with	O
dye	O
concentration	B-T081
and	O
at	O
depth	B-T082
in	O
tissue	O
mimicking	O
phantoms	O
,	O
and	O
delineate	B-T033
4	O
fluorescent	O
dyes	O
in	B-T082
vivo	I-T082
.	O
	
our	O
approach	O
,	O
including	B-T169
statistical	B-T080
background	O
removal	O
,	O
could	O
be	O
directly	B-T080
generalised	B-T082
to	O
broader	O
spectral	O
ranges	B-T081
,	O
for	O
example	O
,	O
to	O
resolve	O
tissue	O
reflectance	O
or	O
autofluorescence	O
and	O
in	O
future	B-T079
be	O
tailored	O
to	O
video	O
rate	O
applications	O
requiring	O
snapshot	O
hsi	O
data	B-T052
acquisition	I-T052
.	O
	
biochemical	B-T169
studies	B-T062
of	O
amylase	B-T116
,	O
lipase	B-T116
and	O
protease	B-T116
in	O
callosobruchus	O
maculatus	O
coleoptera	O
chrysomelidae	O
populations	B-T098
fed	O
with	O
vigna	O
unguiculata	O
grain	O
cultivated	B-T062
with	O
diazotrophic	O
bacteria	O
strains	O
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
enzymatic	O
activity	O
of	O
homogenates	O
of	O
insects	O
fed	O
on	O
grain	O
of	O
cowpea	O
,	O
vigna	O
unguiculata	O
l	O
,	O
cultivars	O
grown	O
with	O
different	O
nitrogen	O
sources	O
.	O
	
for	O
the	O
experiment	O
we	O
used	O
aliquots	O
of	O
the	O
homogenate	O
of	O
100	O
unsexed	O
adult	O
insects	O
,	O
emerged	O
from	O
10	O
g	O
of	O
grain	O
obtained	O
from	O
four	O
cowpea	O
cultivars	O
'	O
brs	O
acauã	O
'	O
,	O
'	O
brs	O
carijó	O
'	O
,	O
'	O
brs	O
pujante	O
'	O
,	O
and	O
'	O
brs	O
tapaihum	O
'	O
grown	O
under	O
different	O
regimes	O
of	O
nitrogen	O
sources	O
mineral	O
fertilizer	O
,	O
inoculation	O
with	O
strains	O
of	O
diazotrophs	O
br	O
3267	O
,	O
br	O
3262	O
,	O
br	O
3299	O
inpa	O
03-11b	O
,	O
03-84	O
ufla	O
,	O
as	O
well	O
as	O
the	O
control	O
with	O
soil	O
nitrogen	O
.	O
	
the	O
parameters	O
evaluated	O
were	O
enzymatic	O
activities	O
of	O
insect	O
protease	B-T116
,	O
amylase	B-T116
and	O
lipase	B-T116
and	O
the	O
starch	B-T109
content	O
of	O
the	O
grains	O
.	O
	
there	O
were	O
differences	O
in	O
the	O
enzymatic	O
activity	O
of	O
amylase	B-T116
,	O
lipase	B-T116
and	O
protease	B-T116
of	O
insect	O
homogenate	O
according	O
to	O
the	O
food	O
source	O
.	O
	
a	O
lower	O
activity	O
of	O
the	O
enzyme	O
amylase	B-T116
from	O
c	O
.	O
	
maculatus	O
homogenate	O
was	O
observed	O
when	O
insects	O
were	O
fed	O
grain	O
of	O
the	O
cultivar	O
brs	O
carijó	O
.	O
	
a	O
lower	O
activity	O
of	O
lipase	O
enzyme	O
from	O
c	O
.	O
	
maculatus	O
homogenate	O
was	O
observed	O
when	O
the	O
insects	O
fed	O
on	O
grain	O
from	O
the	O
interaction	O
of	O
the	O
cultivar	O
tapaihum	O
inoculated	O
with	O
br	O
3262	O
diazotrophs	O
.	O
	
the	O
lowest	O
proteolytic	O
activity	O
was	O
observed	O
in	O
homogenate	O
of	O
insects	O
fed	O
on	O
interaction	O
of	O
'	O
brs	O
carijó	O
'	O
inoculated	O
with	O
br	O
3262	O
diazotroph	O
s	O
.	O
	
starch	B-T109
content	O
correlated	O
positively	O
with	O
the	O
amylase	O
activity	O
of	O
c	O
.	O
	
maculatus	O
homogenate	O
.	O
	
the	O
cultivar	O
brs	O
carijó	O
had	O
a	O
different	O
behavior	O
from	O
the	O
other	O
cultivars	O
,	O
according	O
to	O
the	O
cluster	B-T062
analysis	I-T062
.	O
	
the	O
correlation	B-T081
of	I-T081
the	I-T081
results	I-T081
of	O
the	O
survey	B-T170
snot-20	I-T170
of	O
objective	B-T078
studies	I-T078
of	O
nasal	B-T033
obstruction	I-T033
and	O
the	O
geometry	O
of	O
the	O
nasal	O
cavities	O
in	O
this	O
paper	O
were	O
verified	O
the	O
correlation	B-T081
between	I-T081
the	I-T081
results	I-T081
of	O
the	O
survey	B-T170
snot-20	I-T170
and	O
the	O
results	B-T033
of	I-T033
the	I-T033
objective	I-T033
tests	I-T033
of	O
nasal	B-T033
obstruction	I-T033
which	O
are	O
rhinomanometry	O
and	O
acoustic	O
rhinometry	O
before	O
and	O
after	O
surgical	B-T061
treatment	I-T061
,	O
such	O
as	O
septoplasty	B-T061
,	O
septoconchoplasty	O
,	O
ethmoidectomy	B-T061
and	O
septoethmoidectomy	O
.	O
	
the	O
material	O
used	O
in	O
this	O
study	O
was	O
233	O
patients	O
diagnosed	B-T033
routinely	O
in	O
the	O
rhinomanometry	O
laboratory	O
of	O
the	O
department	O
of	O
otolaryngology	O
at	O
the	O
medical	O
university	O
of	O
warsaw	O
,	O
reporting	O
rhinological	B-T047
problems	I-T047
.	O
	
data	B-T078
were	O
obtained	O
from	O
70	O
women	B-T098
31	O
ranging	O
in	O
ages	O
from	O
18	O
to	O
81	O
years	O
of	O
age	O
and	O
153	O
men	B-T098
68	O
ranging	O
in	O
ages	O
from	O
16	O
to	O
81	O
years	O
of	O
age	O
.	O
	
the	O
researches	O
presented	O
in	O
the	O
study	O
were	O
made	O
using	O
the	O
device	O
rhinometrics	O
sre	O
2100	O
which	O
combines	O
the	O
rhinomanometer	O
rhinostream	O
and	O
acoustic	O
rhinometer	O
rhinoscan	O
interacoustics	O
as	O
denmark	O
.	O
	
survey	B-T170
snot-20	I-T170
sino-nasal	B-T170
outcome	I-T170
test-20	I-T170
in	O
polish	O
was	O
completed	O
by	O
patients	O
before	B-T079
surgery	I-T079
and	O
during	B-T079
the	I-T079
postoperative	I-T079
control	I-T079
visits	I-T079
.	O
	
the	O
calculated	O
correlations	O
between	O
the	O
objective	B-T033
parameter	I-T033
,	O
which	O
was	O
the	O
resistance	B-T169
to	O
the	O
flow	B-T033
of	I-T033
air	I-T033
through	I-T033
the	I-T033
nasal	I-T033
cavity	I-T033
,	O
and	O
the	O
subjective	B-T033
feelings	I-T033
of	I-T033
respondents	I-T033
expressed	O
in	O
the	O
survey	B-T170
snot-20	I-T170
were	O
generally	B-T080
weak	I-T080
,	O
and	O
statistical	B-T081
significance	I-T081
was	O
achieved	O
with	O
respect	O
to	O
the	O
first	B-T062
question	I-T062
survey	I-T062
the	O
severity	B-T033
of	I-T033
the	I-T033
nose	I-T033
obstruction	I-T033
for	O
all	O
components	O
of	O
resistance	B-T169
flow	I-T169
.	O
	
the	O
feeling	O
of	O
nasal	B-T033
obstruction	I-T033
is	O
the	O
most	O
reproducible	O
and	O
reliable	O
complaint	O
reported	O
by	O
the	O
patient	O
with	O
rhinological	B-T047
problems	I-T047
.	O
	
emergency	O
department	O
use	B-T169
and	O
barriers	B-T080
to	O
wellness	B-T078
a	O
survey	B-T170
of	O
emergency	O
department	O
frequent	B-T079
users	B-T098
there	O
is	O
no	O
common	O
understanding	O
of	O
how	O
needs	B-T080
of	O
emergency	O
department	O
ed	O
frequent	B-T079
users	B-T098
differ	O
from	O
other	O
patients	O
.	O
	
this	O
study	B-T062
sought	O
to	O
examine	O
how	O
to	O
best	O
serve	O
this	O
population	B-T098
.	O
	
examinations	O
of	O
why	O
ed	O
frequent	B-T079
users	B-T098
present	B-T033
to	O
the	O
ed	O
,	O
what	O
barriers	B-T080
to	O
care	O
exist	O
,	O
and	O
what	O
service	O
offerings	O
may	O
help	O
these	O
patients	O
achieve	O
an	O
optimal	B-T080
level	B-T080
of	O
health	B-T078
were	O
conducted	O
.	O
	
we	O
performed	O
a	O
prospective	B-T062
study	I-T062
of	O
frequent	B-T079
ed	O
users	B-T098
in	O
an	O
adult	O
only	O
,	O
level	O
1	O
trauma	O
center	O
with	O
approximately	B-T080
90	O
visits	O
per	B-T079
year	I-T079
.	O
	
frequent	B-T079
ed	O
users	B-T098
were	O
defined	O
as	O
those	O
who	O
make	O
four	O
or	O
more	O
ed	O
visits	O
in	O
a	O
12	O
month	B-T079
period	B-T079
.	O
	
participants	B-T098
were	O
administered	B-T169
a	O
piloted	O
structured	O
interview	O
by	O
a	O
trained	O
researcher	O
querying	B-T170
demographics	O
,	O
ed	O
usage	B-T169
,	O
perceived	B-T080
barriers	I-T080
to	O
care	O
,	O
and	O
potential	O
aids	B-T080
to	O
maintaining	O
health	O
.	O
	
of	O
1	O
screened	O
patients	O
,	O
297	O
were	O
identified	B-T080
as	O
frequent	B-T079
ed	O
users	B-T098
.	O
	
one	O
hundred	O
frequent	B-T079
ed	O
users	B-T098
were	O
enrolled	O
.	O
	
the	O
mean	O
age	O
was	O
48	O
years	B-T079
95%	O
ci	B-T081
45-51	O
.	O
	
the	O
majority	O
of	O
subjects	B-T098
were	O
female	B-T098
64%	O
,	O
64/100	O
,	O
95%	O
ci	B-T081
55-73%	O
,	O
white	B-T098
61%	O
,	O
60/98	O
,	O
95%	O
ci	B-T081
52-71%	O
and	O
insured	B-T170
by	O
medicaid	O
55%	O
,	O
47/86	O
,	O
95%	O
ci	B-T081
44-65%	O
or	O
medicare	O
23%	O
,	O
20/86	O
,	O
95%	O
ci	B-T081
14-32%	O
.	O
	
subjects	B-T098
had	O
a	O
median	B-T081
of	O
6	O
ed	O
visits	O
,	O
and	O
2	O
inpatient	B-T169
admissions	I-T169
in	O
the	O
past	B-T079
12	O
months	B-T079
at	O
this	O
hospital	O
.	O
	
most	O
frequent	B-T079
ed	O
users	B-T098
61%	O
,	O
59/96	O
,	O
95%	O
ci	B-T081
52-71%	O
stated	O
the	O
primary	B-T078
reason	I-T078
for	O
their	O
visit	O
was	O
that	O
they	O
felt	O
that	O
their	O
health	B-T033
problem	I-T033
could	O
only	O
be	O
treated	B-T169
in	O
an	O
ed	O
.	O
	
transportation	B-T078
presented	O
as	O
a	O
major	B-T080
barrier	B-T080
to	O
few	B-T081
patients	O
7%	O
,	O
7/95	O
,	O
95%	O
ci	B-T081
3-14%	O
.	O
	
subjects	B-T098
stated	O
that	O
""""	O
after-hours	O
options	O
,	O
besides	O
the	O
ed	O
for	O
minor	B-T080
health	B-T078
issues	I-T078
""""	O
63%	O
,	O
60/95	O
,	O
95%	O
ci	B-T081
53-73%	O
and	O
having	O
"""a"	O
nurse	O
to	O
work	O
with	O
you	O
one-on-one	B-T061
to	O
help	O
manage	O
health	O
care	O
needs	B-T080
""""	O
53%	O
,	O
50/95	O
,	O
95%	O
ci	B-T081
43-63%	O
would	O
be	O
most	O
helpful	O
in	O
achieving	O
optimal	B-T080
health	B-T078
.	O
	
this	O
study	B-T062
characterized	B-T052
ed	O
frequent	B-T079
users	B-T098
and	O
identified	B-T080
several	B-T081
opportunities	B-T062
to	O
better	O
serve	O
this	O
population	B-T098
.	O
	
by	O
understanding	O
barriers	B-T080
to	O
care	O
from	O
the	O
patient	O
perspective	O
,	O
health	O
systems	O
can	O
potentially	O
address	O
unmet	O
needs	B-T080
that	O
prevent	B-T080
wellness	B-T078
in	O
this	O
contralateral	B-T082
superior	O
cerebellar	O
artery	O
syndrome	O
a	O
consequence	B-T169
of	I-T169
brain	O
herniation	O
vascular	O
compromise	B-T033
is	O
a	O
well-known	O
consequence	B-T169
of	I-T169
brain	O
herniation	O
syndromes	B-T047
.	O
	
transtentorial	B-T082
brain	O
herniation	O
most	O
often	O
involves	O
posterior	O
cerebral	O
arteries	O
.	O
	
however	O
,	O
isolated	B-T169
involvement	B-T169
of	O
contralateral	B-T082
superior	O
cerebellar	O
artery	O
sca	O
during	O
unilateral	B-T082
impending	B-T079
brain	O
herniation	O
is	O
reported	O
only	O
once	O
and	O
we	O
present	O
another	O
case	O
of	O
this	O
exceedingly	O
rare	B-T080
entity	O
.	O
	
a	O
24-year-old	O
man	B-T098
was	O
referred	O
to	O
us	O
with	O
impending	B-T079
herniation	O
due	O
to	O
a	O
multiloculated	B-T082
hydrocephalus	B-T047
,	O
and	O
during	O
the	O
course	O
of	O
illness	O
,	O
he	O
developed	O
an	O
isolated	B-T169
sca	O
ischemia	O
in	O
the	O
opposite	O
side	O
of	O
the	O
most	O
dilated	B-T033
entrapped	O
horn	O
.	O
	
in	O
the	O
current	O
article	B-T170
we	O
discuss	O
the	O
probable	O
pathophysiologic	B-T169
mechanisms	B-T169
of	O
this	O
phenomenon	O
,	O
as	O
well	O
as	O
recommending	O
more	O
inclusive	B-T169
brain	O
studies	O
in	O
cases	O
suspected	B-T078
of	O
kernohan-woltman	O
notch	O
phenomenon	O
in	O
unilateral	B-T082
brain	O
herniation	O
.	O
	
the	O
rationale	B-T078
for	O
this	O
commentary	B-T170
is	O
that	O
contralateral	B-T082
sca	O
transient	B-T047
ischemia	I-T047
or	O
infarct	O
might	O
be	O
the	O
underdiagnosed	B-T033
underlying	O
pathomechanism	O
of	O
ipsilateral	B-T082
hemiparesis	O
occurring	O
in	O
many	O
cases	O
of	O
this	O
somehow	O
vague	B-T080
phenomenon	O
.	O
	
the	O
effects	B-T080
of	I-T080
clinical	O
supervision	O
on	O
supervisees	B-T098
and	O
patients	O
in	O
cognitive-behavioral	B-T061
therapy	I-T061
a	O
study	B-T170
protocol	I-T170
for	O
a	O
systematic	B-T170
review	I-T170
clinical	O
supervision	O
by	O
a	O
senior	O
therapist	O
is	O
a	O
very	O
common	O
practice	O
in	O
psychotherapist	O
training	O
and	O
psychiatric	B-T061
care	I-T061
settings	O
.	O
	
though	O
clinical	O
supervision	O
is	O
advocated	O
by	O
most	O
educational	O
and	O
governing	O
institutions	O
,	O
the	O
effects	O
of	O
clinical	O
supervision	O
on	O
the	O
supervisees	B-T098
'	O
competence	B-T080
,	O
e.g	O
,	O
attitudes	O
,	O
behaviors	O
,	O
and	O
skills	O
,	O
as	O
well	O
as	O
on	O
treatment	B-T080
outcomes	I-T080
and	O
other	O
patient	O
variables	O
are	O
debated	O
and	O
largely	O
unknown	O
.	O
	
evidence-based	B-T169
practice	I-T169
is	O
advocated	O
in	O
clinical	B-T082
settings	I-T082
but	O
has	O
not	O
yet	O
been	O
fully	O
implemented	O
in	O
educational	O
or	O
clinical	O
training	O
settings	O
.	O
	
the	O
aim	O
of	O
this	O
systematic	B-T170
review	I-T170
is	O
to	O
synthesize	O
and	O
present	O
the	O
empirical	B-T170
literature	I-T170
regarding	O
effects	O
of	O
clinical	O
supervision	O
in	O
cognitive-behavioral	B-T061
therapy	I-T061
.	O
	
this	O
study	O
will	O
include	O
a	O
systematic	B-T170
review	I-T170
of	O
the	O
literature	B-T170
to	O
identify	O
studies	O
that	O
have	O
empirically	O
investigated	O
the	O
effects	O
of	O
supervision	O
on	O
supervised	O
psychotherapists	O
and/or	O
the	O
supervisees'	O
patients	O
.	O
	
a	O
comprehensive	O
search	O
strategy	O
will	O
be	O
conducted	O
to	O
identify	O
published	O
controlled	O
studies	O
indexed	B-T170
in	O
the	O
medline	B-T170
,	O
embase	B-T170
,	O
psycinfo	B-T170
,	O
and	O
cochrane	B-T170
library	I-T170
databases	I-T170
.	O
	
data	B-T078
on	O
supervision	O
outcomes	O
in	O
both	O
psychotherapists	O
and	O
their	O
patients	O
will	O
be	O
extracted	O
,	O
synthesized	O
,	O
and	O
reported	B-T170
.	O
	
risk	O
of	O
bias	O
and	O
quality	O
of	O
the	O
included	O
studies	O
will	O
be	O
assessed	O
systematically	O
.	O
	
this	O
systematic	B-T170
review	I-T170
will	O
rigorously	O
follow	O
established	O
guidelines	B-T170
for	O
systematic	B-T170
reviews	I-T170
in	O
order	O
to	O
summarize	O
and	O
present	O
the	O
evidence	O
base	O
for	O
clinical	O
supervision	O
in	O
cognitive-behavioral	B-T061
therapy	I-T061
and	O
may	O
aid	O
further	O
research	B-T062
higher	B-T033
risk	I-T033
of	I-T033
revision	B-T079
for	O
infection	O
using	O
systemic	B-T169
clindamycin	B-T109
prophylaxis	B-T061
than	O
with	O
cloxacillin	B-T109
background	O
and	O
purpose	O
-	O
clindamycin	B-T109
has	O
not	O
been	O
compared	O
with	O
other	O
antibiotics	O
for	O
prophylaxis	B-T061
in	O
arthroplasty	B-T061
.	O
	
since	O
2009	O
,	O
the	O
swedish	B-T170
knee	I-T170
arthroplasty	I-T170
register	I-T170
skar	O
has	O
been	O
collecting	O
information	O
on	O
the	O
prophylactic	O
antibiotic	O
regime	O
used	O
at	O
every	O
individual	O
operation	O
.	O
	
in	O
sweden	O
,	O
when	O
there	O
is	O
allergy	O
to	O
penicillin	O
,	O
clindamycin	O
has	O
been	O
the	O
recommended	O
alternative	O
.	O
	
we	O
examined	O
whether	O
there	O
were	O
differences	O
in	O
the	O
rate	O
of	O
revision	O
due	O
to	O
infection	O
depending	O
on	O
which	O
antibiotic	O
was	O
used	O
as	O
systemic	O
prophylaxis	O
.	O
	
patients	O
and	O
methods	O
-	O
patients	O
who	O
had	O
a	O
total	O
knee	O
arthroplasty	O
tka	O
performed	O
due	O
to	O
osteoarthritis	O
oa	O
during	O
the	O
years	O
2009-2015	O
were	O
included	O
in	O
the	O
study	O
.	O
	
information	O
on	O
which	O
antibiotic	O
was	O
used	O
was	O
available	O
for	O
80	O
operations	O
55	O
patients	O
.	O
	
survival	O
statistics	O
were	O
used	O
to	O
calculate	O
the	O
rate	O
of	O
revision	O
due	O
to	O
infection	O
until	O
the	O
end	O
of	O
2015	O
,	O
comparing	O
the	O
group	O
of	O
patients	O
who	O
received	O
cloxacillin	O
with	O
those	O
who	O
received	O
clindamycin	O
as	O
systemic	O
prophylaxis	O
.	O
	
results	O
-	O
cloxacillin	O
was	O
used	O
in	O
90%	O
of	O
the	O
cases	O
,	O
clindamycin	O
in	O
7%	O
,	O
and	O
cephalosporins	O
in	O
2%	O
.	O
	
the	O
risk	O
of	O
being	O
revised	O
due	O
to	O
infection	O
was	O
higher	O
when	O
clindamycin	O
was	O
used	O
than	O
when	O
cloxacillin	O
was	O
used	O
rr	O
=1	O
,	O
95%	O
ci	O
1.2	O
p	O
=	O
0.001	O
.	O
	
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
revision	O
rate	O
for	O
other	O
causes	O
p	O
=	O
0.2	O
.	O
	
interpretation	O
-	O
we	O
advise	O
that	O
patients	O
reporting	O
allergic	O
reaction	O
to	O
penicillin	O
should	O
have	O
their	O
allergic	O
history	O
explored	O
.	O
	
in	O
the	O
absence	O
of	O
a	O
clear	O
history	O
of	O
type-i	O
allergic	O
reaction	O
e.g	O
.	O
	
urticaria	O
,	O
anaphylaxis	O
,	O
or	O
bronchospasm	O
,	O
we	O
suggest	O
the	O
use	O
of	O
a	O
third-generation	O
cephalosporin	O
instead	O
of	O
clindamycin	O
as	O
perioperative	O
prophylaxis	O
when	O
undergoing	O
a	O
tkr	O
.	O
	
no	O
recommendation	O
can	O
be	O
given	O
regarding	O
patients	O
with	O
type-1	O
allergy	O
pcvmzm	B-T062
using	O
the	O
probabilistic	B-T062
classification	I-T062
vector	I-T062
machines	I-T062
model	I-T062
combined	I-T062
with	I-T062
a	I-T062
zernike	I-T062
moments	I-T062
descriptor	O
to	O
predict	B-T078
protein-protein	O
interactions	O
from	O
protein	O
sequences	O
protein-protein	O
interactions	O
ppis	O
are	O
essential	O
for	O
most	O
living	O
organisms	O
'	O
process	O
.	O
	
thus	O
,	O
detecting	O
ppis	O
is	O
extremely	O
important	O
to	O
understand	O
the	O
molecular	B-T080
mechanisms	B-T169
of	O
biological	B-T169
systems	I-T169
.	O
	
although	O
many	O
ppis	O
data	O
have	O
been	O
generated	O
by	O
high-throughput	B-T170
technologies	I-T170
for	O
a	O
variety	O
of	O
organisms	O
,	O
the	O
whole	O
interatom	O
is	O
still	O
far	O
from	O
complete	O
.	O
	
in	O
addition	O
,	O
the	O
high-throughput	B-T170
technologies	I-T170
for	O
detecting	O
ppis	O
has	O
some	O
unavoidable	B-T169
defects	I-T169
,	O
including	O
time	B-T079
consumption	I-T079
,	O
high	O
cost	B-T081
,	O
and	O
high	O
error	B-T081
rate	I-T081
.	O
	
in	O
recent	O
years	O
,	O
with	O
the	O
development	O
of	O
machine	O
learning	O
,	O
computational	B-T062
methods	I-T062
have	O
been	O
broadly	O
used	O
to	O
predict	O
ppis	O
,	O
and	O
can	O
achieve	O
good	O
prediction	B-T078
rate	O
.	O
	
in	O
this	O
paper	O
,	O
we	O
present	O
here	O
pcvmzm	B-T062
,	O
a	O
computational	B-T062
method	I-T062
based	O
on	O
a	O
probabilistic	B-T081
classification	I-T081
vector	I-T081
machines	I-T081
pcvm	I-T081
model	I-T081
and	O
zernike	B-T081
moments	I-T081
zm	I-T081
descriptor	I-T081
for	O
predicting	B-T078
the	O
ppis	O
from	O
protein	B-T116
amino	O
acids	O
sequences	O
.	O
	
specifically	O
,	O
a	O
zernike	B-T081
moments	I-T081
zm	I-T081
descriptor	I-T081
is	O
used	O
to	O
extract	O
protein	B-T116
evolutionary	O
information	B-T078
from	O
position-specific	B-T081
scoring	I-T081
matrix	I-T081
pssm	B-T081
generated	O
by	O
position-specific	B-T170
iterated	I-T170
basic	I-T170
local	I-T170
alignment	I-T170
search	I-T170
tool	I-T170
psi-blast	I-T170
.	O
	
then	O
,	O
pcvm	B-T081
classifier	I-T081
is	O
used	O
to	O
infer	O
the	O
interactions	O
among	O
protein	B-T116
.	O
	
when	O
performed	O
on	O
ppis	O
datasets	O
of	O
yeast	O
and	O
h	O
.	O
	
pylori	O
,	O
the	O
proposed	O
method	O
can	O
achieve	O
the	O
average	O
prediction	B-T078
accuracy	B-T080
of	O
94.48	O
and	O
91.25	O
,	O
respectively	O
.	O
	
in	O
order	O
to	O
further	O
evaluate	O
the	O
performance	O
of	O
the	O
proposed	O
method	O
,	O
the	O
state-of-the-art	B-T170
support	B-T081
vector	I-T081
machines	I-T081
svm	B-T081
classifier	I-T081
is	O
used	O
and	O
compares	O
with	O
the	O
pcvm	B-T081
model	I-T081
.	O
	
experimental	B-T033
results	I-T033
on	O
the	O
yeast	O
dataset	O
show	O
that	O
the	O
performance	O
of	O
pcvm	B-T081
classifier	I-T081
is	O
better	O
than	O
that	O
of	O
svm	B-T081
classifier	I-T081
.	O
	
the	O
experimental	B-T033
results	I-T033
indicate	O
that	O
our	O
proposed	O
method	O
is	O
robust	O
,	O
powerful	O
and	O
feasible	O
,	O
which	O
can	O
be	O
used	O
as	O
a	O
helpful	O
tool	O
for	O
proteomics	B-T062
research	I-T062
.	O
	
conditional	B-T080
knockdown	O
of	O
endogenous	B-T169
micrornas	O
in	O
cho	O
cells	O
using	O
tet-on-sandi	O
sponge	O
vectors	O
micrornas	O
mirnas	O
are	O
small	O
,	O
noncoding	O
rnas	O
of	O
about	O
22	O
nucleotides	O
in	O
length	O
and	O
have	O
proven	O
to	O
be	O
useful	O
targets	B-T169
for	O
genetic	O
modifications	O
for	O
desirable	O
phenotype	O
in	O
the	O
biotech	O
industry	O
.	O
	
the	O
use	O
of	O
constitutively	O
expressed	O
""""	O
mirna	O
"sponge"""	O
vectors	O
in	O
which	O
multiple	O
,	O
tandem	O
mirna	O
binding	O
sites	O
containing	O
transcripts	O
are	O
transcriptionally	O
regulated	O
by	O
a	O
constitutive	O
promoter	O
for	O
down	O
regulating	O
the	O
levels	O
of	O
endogenous	B-T169
micrornas	O
in	O
chinese	O
hamster	O
ovary	O
cho	O
cells	O
has	O
shown	O
to	O
be	O
more	O
advantageous	O
than	O
using	O
synthetic	O
antisense	O
oligonucleotides	O
.	O
	
the	O
application	O
of	O
mirna	O
sponges	O
in	O
biotechnological	O
processes	O
,	O
however	O
,	O
could	O
be	O
more	O
effective	B-T080
,	O
if	O
expression	O
of	O
mirna	O
sponges	O
could	O
be	O
tuned	O
.	O
	
in	O
this	O
chapter	O
,	O
we	O
present	O
a	O
method	O
for	O
the	O
generation	O
of	O
stable	O
cho	O
cell	O
lines	O
expressing	O
a	O
tet-on-sandi-mirna-sponge	O
that	O
is	O
in	O
theory	O
expressed	O
only	O
in	O
the	O
presence	O
of	O
an	O
forest	O
protected	O
areas	O
governance	B-T080
in	O
zimbabwe	O
shift	O
needed	O
away	O
from	O
a	O
long	B-T033
history	I-T033
of	O
local	B-T082
community	O
exclusion	B-T052
in	O
this	O
literature	O
review	O
based	O
paper	O
we	O
explored	O
the	O
concept	B-T078
of	O
exclusion	B-T052
of	O
local	B-T082
communities	O
from	O
accessing	B-T078
resources	B-T078
in	O
forest	O
protected	O
areas	O
fpas	O
in	O
zimbabwe	O
.	O
	
we	O
discussed	O
the	O
colonial	B-T170
and	O
post	B-T079
-	O
colonial	B-T170
forms	I-T170
,	O
causes	O
and	O
mechanisms	B-T169
of	O
exclusion	B-T052
and	O
their	O
social	B-T078
,	O
economic	B-T081
and	O
ecological	O
outcomes	O
.	O
	
we	O
examined	B-T033
the	O
range	B-T081
of	O
powers	O
embodied	O
in	O
and	O
exercised	O
through	O
various	O
mechanisms	O
,	O
processes	O
and	O
social	O
relations	O
and	O
their	O
impact	B-T080
on	O
local	B-T082
communities	O
'	O
access	B-T078
to	O
fpa	O
resources	B-T078
and	O
associated	O
benefits	B-T081
along	O
the	O
historical	B-T079
trajectory	B-T169
of	O
forest	O
governance	B-T080
in	O
zimbabwe	O
.	O
	
results	O
showed	O
that	O
the	O
forms	B-T080
and	O
extent	B-T082
of	O
exclusion	B-T052
changed	B-T081
over	B-T079
time	B-T079
in	O
tandem	O
with	O
the	O
shifting	B-T169
political	B-T078
and	O
economic	O
landscape	O
.	O
	
during	O
the	O
colonial	B-T079
period	I-T079
,	O
it	O
was	O
total	O
exclusion	B-T052
whereby	O
people	B-T098
were	O
evicted	B-T052
from	O
forest	O
land	O
as	O
well	O
as	O
being	O
denied	B-T080
access	B-T078
to	O
basic	B-T169
resources	B-T078
for	O
their	O
livelihoods	O
.	O
	
local	B-T082
communities	O
'	O
access	B-T078
to	O
low	B-T080
value	B-T081
fpa	O
resources	B-T078
improved	B-T033
during	O
the	O
post-colonial	B-T079
period	I-T079
but	O
access	B-T078
to	O
high	B-T080
value	B-T081
resources	B-T078
like	O
commercial	O
timber	O
as	O
well	O
as	O
sharing	O
income	B-T081
benefits	B-T081
derived	B-T080
from	O
fpa	O
commercial	B-T052
activities	I-T052
remained	O
a	O
pipe	O
dream	O
.	O
	
regulation	O
,	O
legitimation	O
,	O
force	O
and	O
markets	O
constituted	O
the	O
mixture	O
of	O
the	O
power	O
elements	O
that	O
fpa	O
governing	B-T080
authorities	O
used	O
to	O
exclude	B-T052
local	B-T082
communities	O
.	O
	
these	O
powers	O
remained	O
intact	B-T080
despite	O
attempts	O
at	O
collaborative	O
governance	B-T080
in	O
the	O
1990s	O
.	O
	
however	O
,	O
from	O
the	O
year	O
2000	O
,	O
local	B-T082
communities	O
expressed	O
their	O
dissatisfaction	O
with	O
the	O
centralised	O
exclusionary	O
governance	O
system	O
by	O
invading	O
the	O
fpas	O
rendering	O
them	O
ungovernable	B-T033
.	O
	
there	O
is	O
therefore	O
a	O
need	O
for	O
policy	B-T170
reform	B-T169
within	O
the	O
fpa	O
sector	O
to	O
improve	B-T033
the	O
current	B-T079
dire	O
situation	O
.	O
	
renal	B-T047
arterial	I-T047
mycotic	I-T047
aneurysm	I-T047
after	O
kidney	B-T061
transplantation	I-T061
mycotic	B-T047
aneurysm	I-T047
is	O
a	O
rare	O
condition	O
mostly	O
attributable	B-T078
to	O
candida	O
or	O
aspergillus	O
species	O
.	O
	
about	O
20	O
cases	O
of	O
candida	O
-related	O
arteritis	O
have	O
been	O
reported	O
in	O
kidney	B-T061
transplant	I-T061
patients	O
.	O
	
herein	O
,	O
we	O
report	B-T170
the	O
case	O
of	O
a	O
40-year-	O
old	O
man	O
who	O
received	O
a	O
kidney	O
from	O
a	O
deceased	O
donor	B-T098
in	O
whom	O
an	O
accidental	B-T169
digestive	O
wound	O
was	O
made	O
during	O
organ	O
retrieval	O
.	O
	
he	O
presented	O
with	O
sudden	O
anuria	B-T047
47	O
days	O
after	O
renal	B-T061
transplantation	I-T061
revealing	O
a	O
large	O
mycotic	B-T047
aneurysm	I-T047
of	O
the	O
kidney	O
graft	O
renal	O
artery	O
.	O
	
organs	O
derived	O
from	O
donors	B-T098
in	O
whom	O
a	O
digestive	O
breach	O
is	O
noticed	O
should	O
be	O
used	B-T169
with	I-T169
caution	I-T169
.	O
	
risk	B-T081
of	I-T081
cancer	I-T081
in	O
patients	O
with	O
heart	B-T047
failure	I-T047
who	O
use	O
digoxin	B-T109
a	O
10-year	O
follow-up	B-T062
study	I-T062
and	O
cell	O
-based	O
verification	B-T169
heart	B-T047
failure	I-T047
hf	B-T047
is	O
the	O
leading	O
cause	B-T033
of	I-T033
death	I-T033
in	O
the	O
world	B-T098
and	O
digoxin	B-T109
remains	O
one	O
of	O
the	O
oldest	O
therapies	B-T061
for	O
hf	B-T047
.	O
	
however	O
,	O
its	O
safety	O
and	O
efficacy	B-T080
have	O
been	O
controversial	O
since	O
its	O
initial	O
use	B-T169
and	O
there	O
is	O
uncertainty	B-T033
about	O
its	O
long-term	B-T079
efficacy	B-T080
and	O
safety	O
.	O
	
recently	O
,	O
the	O
repositioning	B-T061
of	O
cardiac	B-T109
glycosides	I-T109
is	O
to	O
function	B-T169
in	O
anti-tumor	B-T061
activity	I-T061
via	O
multiple	B-T081
working	O
pathways	O
.	O
	
it	O
is	O
interesting	O
to	O
compare	B-T052
the	O
potential	B-T080
effects	B-T080
of	O
digoxin	B-T109
in	O
clinical	B-T080
patients	O
and	O
cell	O
lines	O
.	O
	
first	O
,	O
we	O
analyze	O
patient	B-T170
information	I-T170
retrieved	O
from	O
the	O
national	B-T170
health	I-T170
insurance	I-T170
research	I-T170
database	I-T170
of	O
taiwan	O
between	O
january	O
1	O
,	O
2000	O
and	O
december	O
31	O
,	O
2000	O
.	O
	
this	O
retrospective	B-T062
study	I-T062
included	O
a	O
study	O
cohort	B-T098
1	O
patients	O
and	O
a	O
comparison	B-T052
cohort	B-T098
.	O
	
our	O
analytical	B-T078
data	I-T078
suggested	O
that	O
patients	O
taking	O
digoxin	B-T109
are	O
at	O
an	O
increased	B-T081
risk	B-T081
of	I-T081
cancers	I-T081
,	O
including	O
breast	O
,	O
liver	O
,	O
and	O
lung	O
cancers	O
,	O
during	O
the	O
10-year	O
follow-up	O
period	O
.	O
	
in	O
contrast	O
to	O
the	O
anti-tumor	B-T061
function	I-T061
of	O
digoxin	B-T109
,	O
we	O
further	O
examined	O
the	O
potential	B-T080
pathway	B-T169
of	O
digoxin	B-T109
via	O
the	O
cell	O
-based	O
strategy	O
using	O
several	O
breast	O
cancer	O
cell	O
lines	O
,	O
including	O
mcf-7	O
,	O
bt-474	O
,	O
mad-mb-231	O
,	O
and	O
zr-75-1	O
.	O
	
digoxin	B-T109
consistently	O
exerted	O
its	O
cytotoxicity	O
to	O
these	O
four	O
cell	O
lines	O
with	O
various	O
range	O
of	O
concentration	B-T081
.	O
	
however	O
,	O
the	O
proliferation	B-T169
of	O
zr-75-1	O
cells	O
was	O
the	O
only	O
cell	O
lines	O
induced	O
by	O
digoxin	B-T109
and	O
the	O
others	O
were	O
dramatically	O
suppressed	B-T169
by	O
digoxin	B-T109
.	O
	
the	O
responsiveness	B-T169
of	O
srsf3	O
to	O
digoxin	B-T109
might	O
be	O
involved	O
with	O
cell-type	B-T170
differences	B-T080
.	O
	
in	O
summary	O
,	O
we	O
combined	O
a	O
cohort	B-T081
study	I-T081
for	O
digoxin	B-T109
treatment	B-T061
for	O
hf	B-T047
patients	O
with	O
a	O
cell	O
-based	O
strategy	O
that	O
addresses	O
the	O
translation	O
issue	O
,	O
which	O
revealed	O
the	O
complexity	B-T080
of	O
personalized	B-T061
medicine	I-T061
.	O
	
comparison	O
and	O
outcome	O
analysis	O
of	O
patients	O
with	O
takotsubo	B-T047
cardiomyopathy	I-T047
triggered	B-T080
by	I-T080
emotional	O
stress	O
or	O
physical	O
stress	O
background	O
previous	O
studies	O
revealed	O
that	O
takotsubo	B-T047
cardiomyopathy	I-T047
ttc	B-T047
is	O
triggered	B-T080
by	I-T080
physical	O
and	O
emotional	O
stresses	O
.	O
	
this	O
study	O
was	O
performed	O
to	O
determine	O
the	O
short-	B-T079
and	O
long-term	B-T079
prognostic	O
impact	O
of	O
emotional-	O
and	O
physical	O
stress	O
associated	B-T080
with	I-T080
ttc	B-T047
.	O
	
methods	O
and	O
results	O
our	O
institutional	B-T170
database	I-T170
constituted	O
a	O
collective	O
of	O
84	O
patients	O
diagnosed	B-T033
with	O
ttc	B-T047
between	O
2003	O
and	O
2015	O
.	O
	
the	O
patients	O
were	O
divided	O
into	O
two	O
groups	B-T078
as	O
per	O
the	O
presence	O
of	O
emotional	O
stress	O
n	O
=	O
24	O
,	O
21%	O
or	O
physical	O
stress	O
n	O
=	O
60	O
,	O
52.6	O
.	O
	
the	O
endpoint	B-T080
was	O
a	O
composite	B-T080
of	O
in-hospital	B-T033
events	I-T033
thromboembolic	O
events	O
and	O
life-threatening	B-T033
arrhythmias	B-T033
,	O
myocardial	B-T047
infarction	I-T047
,	O
all-	O
cause	B-T033
of	I-T033
mortality	I-T033
,	O
re-hospitalization	O
due	O
to	O
heart	B-T047
failure	I-T047
,	O
stroke	B-T047
,	O
and	O
recurrence	O
of	O
ttc	B-T047
.	O
	
a	O
kaplan-meier	B-T081
analysis	I-T081
indicated	O
a	O
significantly	O
lower	O
event-free	O
survival	B-T081
rate	I-T081
over	O
a	O
mean	O
follow-up	O
of	O
5	O
years	O
in	O
the	O
emotional	O
group	B-T078
than	O
the	O
physical	O
stress	O
group	B-T078
log-rank	O
,	O
p	O
<	O
0.01	O
.	O
	
multivariate	B-T170
cox	I-T170
regression	I-T170
analysis	I-T170
revealed	O
only	O
emotional	O
stress	O
hr	O
0.4	O
,	O
95%	O
ci	O
0.2	O
,	O
p	O
<	O
0.05	O
as	O
a	O
negative	B-T033
independent	I-T033
predictor	I-T033
of	O
the	O
primary	O
endpoint	B-T080
.	O
	
conclusion	O
rates	O
of	O
in-hospital	B-T033
events	I-T033
and	O
short-	B-T079
as	O
well	O
as	O
long-term	B-T079
events	O
were	O
significantly	O
lower	O
in	O
ttc	B-T047
patients	O
suffering	O
from	O
emotional	O
stress	O
as	O
compared	O
to	O
patients	O
with	O
physical	O
stress	O
.	O
	
surviving	B-T169
moment	B-T079
to	O
moment	B-T079
the	O
experience	O
of	O
living	B-T078
in	O
a	O
state	B-T033
of	O
ambivalence	O
for	O
those	O
with	O
recurrent	B-T079
suicide	B-T033
attempts	I-T033
this	O
qualitative	B-T062
study	I-T062
aimed	O
to	O
capture	O
the	O
experience	O
of	O
living	B-T078
in	O
the	O
ambivalent	O
space	O
between	O
life	B-T078
and	O
death	B-T078
for	O
adults	O
with	O
recurrent	B-T079
suicide	B-T033
attempts	I-T033
rsa	B-T033
.	O
	
it	O
sought	O
to	O
expand	B-T082
upon	O
an	O
earlier	O
study	B-T062
that	O
explored	O
the	O
processes	O
involved	B-T169
in	O
transitioning	B-T052
away	O
from	O
rsa	B-T033
among	O
adults	O
,	O
which	O
revealed	B-T080
that	O
occupying	O
this	O
ambivalent	O
space	O
is	O
a	O
crucial	O
part	O
of	O
this	O
process	O
.	O
	
interpretive	B-T062
phenomenological	I-T062
analysis	I-T062
ipa	B-T062
was	O
used	O
.	O
	
this	O
methodology	B-T078
was	O
designed	B-T052
to	O
explore	O
the	O
lived	O
experiences	O
and	O
meaning	O
making	O
and	O
enabled	O
interpretation	B-T062
of	O
the	O
multidimensional	B-T082
subjective	B-T080
experiences	O
of	O
rsa	B-T033
participants	B-T098
.	O
	
in-depth	O
semi-structured	O
interviews	O
were	O
conducted	B-T052
with	O
eight	O
adult	B-T098
women	I-T098
with	O
a	O
history	B-T169
of	O
rsa	B-T033
who	O
had	O
participated	B-T169
in	O
a	O
therapeutic	B-T061
intervention	I-T061
at	O
the	O
research	B-T062
site	B-T082
skills	O
for	O
safer	B-T078
living	I-T078
a	O
psychosocial	B-T169
/	O
psychoeducational	O
intervention	O
for	O
people	B-T098
with	O
recurrent	B-T079
suicide	B-T033
attempts	I-T033
sfsl	B-T078
/	O
pisa	B-T033
.	O
	
the	O
six	O
stages	B-T079
of	O
ipa	B-T062
were	O
followed	O
to	O
analyse	B-T062
the	O
interview	O
data	B-T078
.	O
	
analysis	B-T062
revealed	B-T080
the	O
superordinate	O
theme	O
,	O
'	O
surviving	B-T169
moment	B-T079
to	O
moment	B-T079
'	O
,	O
which	O
refers	O
to	O
a	O
precarious	B-T033
state	I-T033
of	O
making	O
decisions	O
about	O
one's	O
life	B-T078
and	O
destiny	B-T079
on	O
a	O
moment	B-T079
-to-	O
moment	B-T079
basis	O
without	O
clear	O
commitment	O
to	O
either	O
life	B-T078
or	O
death	B-T078
.	O
	
two	O
subordinate	O
themes	O
were	O
identified	B-T080
'	O
deciding	B-T080
not	O
to	O
die	B-T033
in	O
the	O
moment	B-T079
'	O
when	O
the	O
participants	B-T098
were	O
more	O
invested	B-T169
in	O
dying	B-T033
than	O
living	B-T078
and	O
'	O
deciding	B-T080
to	O
live	B-T078
in	O
the	O
moment	B-T079
'	O
when	O
they	O
were	O
more	O
invested	B-T169
in	O
living	B-T078
than	O
dying	B-T033
.	O
	
the	O
study	B-T062
illuminated	O
the	O
complex	B-T080
process	O
of	O
making	O
decisions	O
about	O
ones'	O
destiny	B-T079
on	O
a	O
moment	B-T079
-to-	O
moment	B-T079
basis	O
.	O
	
it	O
revealed	B-T080
the	O
torment	O
experienced	O
when	O
occupying	O
this	O
state	B-T033
,	O
while	O
paradoxically	B-T080
,	O
also	O
revealing	O
how	O
indecision	B-T033
about	O
life	B-T078
and	O
death	B-T078
provided	B-T052
a	O
lifeline	B-T078
opportunity	B-T080
for	O
those	O
with	O
rsa	B-T033
.	O
	
clinicians	O
who	O
recognize	O
the	O
subtle	O
distinctions	O
associated	B-T080
with	I-T080
this	O
in-between	O
state	B-T033
can	O
tailor	O
their	O
interventions	B-T061
accordingly	O
.	O
	
surviving	B-T169
moment	B-T079
to	O
moment	B-T079
is	O
characterized	B-T052
by	O
a	O
state	B-T033
of	O
emotional	B-T033
flux	I-T033
and	O
uncertainty	B-T033
about	O
one's	O
destiny	B-T079
,	O
where	O
the	O
person	B-T098
has	O
not	O
fully	O
committed	O
to	O
either	O
life	B-T078
or	O
death	B-T078
.	O
	
within	O
this	O
state	B-T033
,	O
there	O
are	O
two	O
interlinked	O
subprocesses	O
,	O
whereby	O
the	O
person	B-T098
is	O
leaning	B-T078
more	O
towards	O
death	B-T078
or	O
life	B-T078
.	O
	
a	O
critical	O
feature	B-T080
in	O
working	O
with	O
this	O
client	O
group	O
is	O
to	O
recognize	O
their	O
ambiguity	B-T080
and	O
the	O
fragility	B-T033
and	O
temporality	O
of	O
their	O
decisions	O
about	O
their	O
destiny	B-T079
.	O
	
the	O
practitioner	O
has	O
an	O
opportunity	B-T080
to	O
be	O
a	O
catalyst	O
in	O
the	O
momentum	O
towards	O
life	B-T078
by	O
demonstrating	O
understanding	O
of	O
this	O
survival	B-T169
struggle	B-T033
and	O
tailoring	B-T061
intervention	I-T061
to	O
fit	O
with	O
the	O
nuanced	O
processes	O
within	O
this	O
does	O
a	O
policy	B-T170
of	O
earlier	B-T061
induction	I-T061
affect	O
labour	O
outcomes	B-T169
in	O
women	B-T098
induced	B-T169
for	O
postmaturity	B-T047
a	O
retrospective	B-T080
analysis	B-T062
in	O
a	O
tertiary	O
hospital	O
in	O
the	O
north	B-T082
of	O
england	O
to	O
investigate	B-T169
whether	O
a	O
change	B-T169
in	O
the	O
management	O
of	O
postmature	O
pregnancy	O
to	O
earlier	B-T061
induction	I-T061
affects	O
the	O
length	O
of	O
labour	O
and	O
the	O
induction	B-T061
process	I-T061
.	O
	
secondly	O
,	O
to	O
assess	B-T052
the	O
feasibility	B-T062
of	O
the	O
research	B-T062
process	I-T062
to	O
inform	O
a	O
future	B-T079
larger	B-T062
study	I-T062
.	O
	
a	O
change	B-T169
in	O
management	O
of	O
postmature	O
pregnancy	O
in	O
an	O
nhs	O
hospital	O
in	O
october	B-T079
2013	O
,	O
from	O
induction	B-T061
at	O
42	O
weeks	B-T079
gestation	O
to	O
induction	B-T061
between	O
41-42	O
weeks	B-T079
,	O
provided	B-T052
an	O
opportunity	B-T062
to	O
conduct	O
a	O
retrospective	B-T080
analysis	B-T062
.	O
	
pre-existing	B-T080
data	B-T078
from	O
the	O
maternity	O
database	B-T170
and	O
casenotes	B-T170
were	O
collected	B-T169
and	O
primary	B-T062
outcomes	I-T062
analysed	B-T062
using	O
the	O
mann-whitney	B-T170
test	I-T170
and	O
the	O
hodges-lehman	B-T081
confidence	I-T081
interval	I-T081
for	O
differences	B-T080
in	O
medians	B-T081
.	O
	
a	O
large	O
city	O
based	O
tertiary	O
referral	O
hospital	O
in	O
the	O
north	B-T082
of	O
england	O
.	O
	
125	O
women	B-T098
induced	B-T169
before	O
the	O
change	B-T169
in	O
policy	B-T170
were	O
compared	B-T052
with	O
309	O
women	B-T098
induced	B-T169
after	O
the	O
change	B-T169
.	O
	
primary	B-T062
outcomes	I-T062
were	O
length	B-T081
of	O
1st	B-T079
and	O
2nd	B-T079
stage	I-T079
of	I-T079
labour	I-T079
,	O
overall	O
length	O
of	O
labour	O
,	O
length	B-T081
of	O
induction	B-T061
to	O
established	B-T080
labour	O
and	O
length	B-T081
of	O
induction	B-T061
to	O
birth	O
.	O
	
the	O
median	B-T081
overall	O
length	O
of	O
labour	O
for	O
women	B-T098
induced	B-T169
at	O
42	O
weeks	B-T079
was	O
6.5	O
hours	B-T079
,	O
while	O
for	O
women	B-T098
induced	B-T169
at	O
41-42	O
weeks	B-T079
this	O
was	O
5.2	O
hours	B-T079
.	O
	
the	O
difference	B-T080
was	O
not	O
statistically	B-T081
significant	I-T081
p=0	O
,	O
95%	O
ci	B-T081
for	O
median	B-T081
difference	B-T080
-0	O
to	O
1.93	O
hours	B-T079
with	O
a	O
small	B-T081
effect	I-T081
size	I-T081
pearson's	B-T081
r=-0	O
.	O
	
the	O
median	B-T081
length	B-T081
of	O
induction	B-T061
to	O
birth	O
was	O
13.6	O
hours	B-T079
for	O
women	B-T098
induced	B-T169
at	O
42	O
weeks	B-T079
and	O
16.5	O
hours	B-T079
for	O
women	B-T098
induced	B-T169
at	O
41-42	O
weeks	B-T079
.	O
	
this	O
difference	B-T080
was	O
also	O
not	O
statistically	B-T081
significant	I-T081
p=0	O
,	O
95%	O
ci	B-T081
for	O
median	B-T081
difference	B-T080
-7	O
to	O
1.20	O
hours	B-T079
with	O
a	O
small	B-T081
effect	I-T081
size	I-T081
pearson's	B-T081
r=-0	O
.	O
	
this	O
study	B-T062
demonstrated	O
no	O
statistically	B-T081
significant	I-T081
difference	B-T080
s	O
in	O
length	O
of	O
labour	O
and	O
induction	B-T061
following	O
a	O
change	B-T169
in	O
the	O
management	O
of	O
postmature	O
pregnancy	O
to	O
earlier	B-T061
induction	I-T061
.	O
	
a	O
large	B-T062
study	I-T062
is	O
needed	O
to	O
establish	B-T080
definitively	O
the	O
effects	B-T080
of	I-T080
earlier	B-T061
induction	I-T061
on	O
labour	O
outcomes	B-T169
.	O
	
liquid	O
chromatography-mass	O
spectrometry	O
-based	O
quantitative	O
proteomics	O
analysis	O
reveals	O
chondroprotective	O
effects	O
of	O
astragaloside	O
iv	O
in	O
interleukin-1β	O
-	O
induced	O
sw1353	O
chondrocyte-like	O
cells	O
chondrocyte	O
apoptosis	O
played	O
a	O
key	O
role	O
on	O
the	O
progression	O
of	O
osteoarthritis	O
oa	O
.	O
	
safe	O
and	O
effective	O
drugs	O
are	O
urgently	O
needed	O
for	O
the	O
treatment	O
of	O
oa	O
.	O
	
previous	O
study	O
reported	O
that	O
astragaloside	O
iv	O
asg-iv	O
had	O
exerted	O
a	O
protective	O
effect	O
against	O
articular	O
cartilage	O
degeneration	O
by	O
promoting	O
rapid	O
proliferation	O
of	O
chondrocyte	O
.	O
	
therefore	O
,	O
the	O
aim	O
of	O
our	O
study	O
is	O
to	O
explore	O
the	O
effects	O
and	O
mechanisms	O
of	O
asg-iv	O
in	O
chondrocyte	O
apoptosis	O
.	O
	
isobaric	O
tags	O
for	O
relative	O
and	O
absolute	O
quantitation	O
itraq	O
quantitative	O
proteomics	O
was	O
used	O
to	O
quantitatively	O
detect	O
and	O
map	O
proteins	O
in	O
sw1353	O
chondrocyte-like	O
cells	O
pre-treated	O
with	O
asg-iv	O
or	O
interleukin-1β	O
il-1β	O
or	O
asg-iv	O
+	O
il-1β	O
.	O
	
the	O
itraq-labeled	O
peptides	O
were	O
fractionated	O
by	O
high-accuracy	O
liquid	O
chromatography-mass	O
spectrometry	O
lc-ms	O
.	O
	
cell	O
apoptosis	O
and	O
differentially	O
expressed	O
proteins	O
was	O
detected	O
by	O
flow	O
cytometry	O
fcm	O
,	O
quantitative	O
real-time	O
polymerase	O
chain	O
reaction	O
qrt-pcr	O
,	O
and	O
western	O
blotting	O
,	O
respectively	O
.	O
	
the	O
apoptosis	O
of	O
the	O
il-1β	O
-	O
induced	O
sw1353	O
cells	O
treated	O
with	O
asg-iv	O
was	O
greatly	O
inhibited	O
.	O
	
bioinformatics	O
analysis	O
revealed	O
that	O
gamma	O
actin	O
1	O
actg1	O
and	O
yes	O
associated	O
protein	O
1	O
yap1	O
,	O
participating	O
in	O
the	O
hippo	O
signaling	O
pathway	O
and	O
vitronectin	O
vtn	O
and	O
collagen	O
type	O
i	O
alpha	O
1	O
chain	O
col1a1	O
,	O
involving	O
in	O
the	O
extracellular	O
matrix	O
ecm	O
interaction	O
signaling	O
pathway	O
,	O
were	O
all	O
significantly	O
up-regulated	O
in	O
the	O
il-1β	O
-	O
induced	O
sw1353	O
cells	O
after	O
treatment	O
with	O
asg-iv	O
.	O
	
the	O
qrt-pcr	O
and	O
western	O
blotting	O
results	O
confirmed	O
the	O
up-regulation	O
of	O
these	O
four	O
genes	O
.	O
	
asg-iv	O
played	O
a	O
positive	O
role	O
in	O
human	O
osteoarthritic	O
chondrocyte	O
apoptosis	O
,	O
possibly	O
through	O
modulation	O
of	O
the	O
hippo	O
signaling	O
pathway	O
by	O
up-regulating	O
yap1	O
and	O
actg1	O
expression	O
,	O
and	O
also	O
by	O
up-regulating	O
vtn	O
and	O
col1a1	O
,	O
which	O
are	O
involved	O
in	O
the	O
ecm-receptor	O
interaction	O
pathway	O
.	O
	
taken	O
together	O
,	O
all	O
the	O
results	O
suggested	O
that	O
asg-iv	O
had	O
a	O
novel	O
therapeutic	O
potential	O
for	O
the	O
treatment	O
of	O
oa	B-T047
open-label	B-T062
,	O
multicentre	I-T062
safety	I-T062
study	I-T062
of	O
vemurafenib	B-T109
in	O
3219	O
patients	O
with	O
braf	O
mutation	O
-	O
positive	B-T033
metastatic	O
melanoma	O
2-year	O
follow-up	O
data	B-T078
and	O
long-term	B-T079
responders'	B-T062
analysis	I-T062
the	O
orally	B-T082
available	O
braf	B-T116
kinase	I-T116
inhibitor	I-T116
vemurafenib	B-T109
is	O
an	O
effective	B-T080
and	O
tolerable	B-T080
treatment	B-T061
option	I-T061
for	O
patients	O
with	O
metastatic	O
melanoma	O
harbouring	O
braf	O
mutations	O
.	O
	
we	O
assessed	B-T052
the	O
safety	B-T080
of	O
vemurafenib	B-T109
in	O
a	O
large	B-T081
population	B-T098
of	O
patients	O
with	O
few	O
alternative	O
treatment	B-T061
options	I-T061
we	O
report	O
updated	O
2-year	O
safety	B-T080
.	O
	
this	O
was	O
an	O
open-label	B-T062
,	O
multicentre	I-T062
study	I-T062
of	O
vemurafenib	B-T109
960	O
mg	O
bid	O
in	O
patients	O
with	O
previously	O
treated	B-T169
or	O
untreated	B-T033
braf	O
mutation	O
-	O
positive	B-T033
metastatic	O
melanoma	O
cobas	O
4800	O
braf	O
v600	O
mutation	O
test	O
.	O
	
the	O
primary	B-T080
end-point	B-T080
was	O
safety	B-T080
efficacy	O
end-points	B-T080
were	O
secondary	B-T080
.	O
	
an	O
exploratory	B-T062
analysis	I-T062
was	O
performed	O
to	O
assess	O
safety	B-T080
outcomes	B-T080
in	O
patients	O
with	O
long	B-T080
duration	B-T079
of	I-T079
response	I-T079
dor	B-T079
12	O
or	O
24	O
months	B-T079
.	O
	
after	O
a	O
median	B-T082
follow-up	O
of	O
32.2	O
months	B-T079
95%	O
ci	O
,	O
31.1	O
months	B-T079
,	O
3079/3219	O
patients	O
96%	O
had	O
discontinued	B-T033
treatment	I-T033
.	O
	
adverse	O
events	O
aes	O
were	O
largely	O
consistent	B-T078
with	I-T078
previous	O
reports	O
the	O
most	O
common	O
all-grade	O
treatment	B-T169
-related	O
aes	O
were	O
arthralgia	O
37%	O
,	O
alopecia	B-T047
25%	O
and	O
hyperkeratosis	B-T047
23%	O
the	O
most	O
common	O
grade	O
3/4	O
treatment	B-T169
-related	O
aes	O
were	O
squamous	O
cell	O
carcinoma	O
of	O
the	O
skin	O
8%	O
and	O
keratoacanthoma	O
8%	O
.	O
	
in	O
the	O
exploratory	B-T062
analysis	I-T062
,	O
patients	O
with	O
dor	B-T079
12	O
months	B-T079
n	O
=	O
287	O
or	O
24	O
months	B-T079
n	O
=	O
133	O
were	O
more	O
likely	O
to	O
experience	O
grade	O
3/4	O
aes	O
than	O
the	O
overall	B-T080
population	B-T098
.	O
	
no	O
new	O
specific	B-T080
safety	O
signals	O
were	O
observed	O
with	O
longer	O
vemurafenib	B-T109
exposure	O
.	O
	
after	O
2	O
years'	O
follow-up	O
,	O
safety	O
was	O
maintained	O
in	O
this	O
large	O
group	O
of	O
patients	O
with	O
braf	O
mutation	O
-	O
positive	O
metastatic	O
melanoma	O
who	O
are	O
more	O
representative	O
of	O
routine	O
clinical	O
practice	O
than	O
typical	O
clinical	O
trial	O
populations	O
.	O
	
these	O
data	O
suggest	O
that	O
long-term	O
vemurafenib	B-T033
treatment	O
is	O
effective	O
and	O
tolerable	O
without	O
the	O
development	O
of	O
new	O
safety	O
signals	O
collecting	B-T062
and	O
reporting	B-T062
safety	I-T062
data	I-T062
and	O
monitoring	B-T062
trial	I-T062
conduct	I-T062
in	O
pragmatic	B-T062
trials	I-T062
pragmatic	B-T062
trials	I-T062
offer	O
the	O
opportunity	B-T062
to	O
obtain	O
real-life	B-T078
data	B-T078
on	O
the	O
relative	O
effectiveness	B-T080
and	O
safety	O
of	O
a	O
treatment	B-T061
before	O
or	O
after	O
market	O
authorisation	O
.	O
	
this	O
is	O
the	O
penultimate	B-T078
paper	I-T078
in	O
a	O
series	O
of	O
eight	O
,	O
describing	O
the	O
impact	O
of	O
design	O
choices	B-T052
on	O
the	O
practical	O
implementation	B-T052
of	O
pragmatic	B-T062
trials	I-T062
.	O
	
this	O
paper	B-T078
focuses	O
on	O
the	O
practical	O
challenges	O
of	O
collecting	B-T062
and	O
reporting	B-T062
safety	I-T062
data	I-T062
and	O
of	O
monitoring	B-T062
trial	I-T062
conduct	I-T062
while	O
maintaining	O
routine	O
clinical	B-T061
care	I-T061
practice	I-T061
.	O
	
current	O
ich	B-T170
guidance	O
recommends	O
that	O
,	O
all	O
serious	B-T033
adverse	I-T033
events	I-T033
saes	B-T033
and	O
all	O
drug	O
-related	O
events	O
must	O
be	O
reported	O
in	O
an	O
interventional	B-T061
trial	B-T062
.	O
	
in	O
line	O
with	O
current	O
guidance	O
,	O
we	O
propose	O
a	O
risk	B-T078
based	O
approach	B-T082
to	O
the	O
collection	B-T062
of	O
non	B-T033
-	O
drug	O
related	O
non-serious	B-T033
aes	I-T033
,	O
and	O
even	O
serious	B-T080
events	I-T080
not	O
related	O
to	O
treatment	B-T061
based	O
on	O
the	O
risk	B-T078
profile	B-T169
of	O
the	O
medicine	O
/class	O
in	O
the	O
patient	O
population	B-T098
of	O
interest	O
.	O
	
different	O
options	O
available	O
to	O
support	O
the	O
collection	B-T062
and	O
reporting	B-T062
of	I-T062
safety	I-T062
data	I-T062
whilst	O
minimizing	O
study	B-T062
-related	O
follow-up	O
visits	O
are	O
discussed	O
.	O
	
a	O
risk	B-T078
-based	O
approach	B-T082
to	O
monitoring	B-T062
trial	I-T062
conduct	I-T062
is	O
also	O
discussed	O
,	O
highlighting	O
the	O
difference	O
in	O
the	O
balance	O
of	O
risks	B-T078
likely	O
to	O
occur	O
in	O
a	O
pragmatic	B-T062
trial	I-T062
compared	O
to	O
traditional	O
clinical	B-T062
trials	I-T062
,	O
and	O
the	O
careful	O
consideration	O
that	O
must	O
be	O
given	O
to	O
the	O
mitigation	O
and	O
management	O
of	O
these	O
risks	O
in	O
order	O
to	O
maintain	O
routine	O
a	O
pilot	B-T062
study	I-T062
of	O
intraocular	B-T061
lens	I-T061
explantation	I-T061
in	O
69	O
eyes	O
in	O
chinese	O
patients	O
to	O
study	O
the	O
effects	O
of	O
intraocular	B-T061
lens	I-T061
iol	I-T061
explantation	I-T061
and	O
demographic	O
characteristics	O
.	O
	
retrospective	B-T080
non-comparative	B-T062
case	I-T062
series	I-T062
.	O
	
clinical	B-T170
data	I-T170
recorded	O
from	O
patient	O
charts	O
included	O
the	O
following	O
demographic	O
,	O
preoperative	O
and	O
postoperative	B-T079
characteristics	B-T080
complications	O
surgical	O
methods	O
,	O
and	O
changes	O
in	O
visual	O
acuity	O
.	O
	
a	O
total	O
of	O
69	O
eyes	O
in	O
67	O
chinese	B-T098
patients	O
who	O
received	O
iol	B-T061
explants	I-T061
were	O
studied	O
.	O
	
the	O
patients	O
'	O
mean	O
age	O
at	O
the	O
time	B-T079
of	I-T079
explantation	I-T079
was	O
46.1	O
years	O
old	O
sd	O
22.5	O
6-85	O
,	O
and	O
37	O
patients	O
were	O
female	O
55.2	O
.	O
	
regarding	O
employment	B-T080
,	O
47.8	O
were	O
farmers	O
,	O
23.9	O
were	O
retired	O
,	O
16.4	O
were	O
students	B-T098
,	O
4.5	O
were	O
unemployed	B-T033
,	O
3%	O
were	O
workers	B-T098
,	O
and	O
4.5	O
were	O
other	O
including	O
staff	O
members	O
,	O
teachers	O
and	O
officers	B-T078
.	O
	
the	O
main	O
reasons	O
for	O
explantation	B-T061
were	O
dislocation	O
/	O
decentration	B-T033
in	O
41	O
cases	O
59.4	O
and	O
retinal	B-T047
detachment	I-T047
in	O
10	O
cases	O
14.5	O
.	O
	
the	O
third	O
most	O
prevalent	B-T169
cause	I-T169
was	O
incorrect	B-T033
lens	I-T033
power	I-T033
in	O
7	O
eyes	O
10.1	O
.	O
	
the	O
remaining	O
reasons	O
were	O
endophthalmitis	B-T047
in	O
6	O
cases	O
8.7	O
,	O
posterior	B-T047
capsular	I-T047
opacity	I-T047
in	O
3	O
eyes	O
4.3	O
,	O
and	O
impacting	B-T080
retinal	B-T061
surgery	I-T061
operation	I-T061
in	O
2	O
cases	O
2.9	O
.	O
	
the	O
main	O
comorbidities	B-T078
were	O
high	B-T047
myopia	I-T047
in	O
18	O
eyes	O
26.1	O
,	O
trauma	O
in	O
8	O
eyes	O
11.6	O
,	O
retinal	B-T047
detachment	I-T047
in	O
6	O
eyes	O
8.7	O
,	O
congenital	O
cataracts	O
in	O
8	O
eyes	O
11.6	O
,	O
and	O
marfan's	B-T047
syndrome	I-T047
in	O
2	O
eyes	O
2.9	O
.	O
	
the	O
mean	B-T079
time	I-T079
from	I-T079
implantation	I-T079
to	I-T079
explantation	I-T079
was	O
4.0y	O
sd	O
4.2	O
0.005	O
.	O
	
treatment	O
after	O
explantation	O
included	O
posterior	B-T061
chamber	I-T061
iol	I-T061
implantation	I-T061
in	O
44	O
eyes	O
63.8	O
and	O
aphakia	O
in	O
25	O
eyes	O
36.2	O
.	O
	
after	B-T033
surgery	I-T033
,	O
the	O
best	B-T033
corrected	I-T033
visual	I-T033
ability	I-T033
bcva	B-T033
was	O
improved	O
in	O
50	O
cases	O
72.5	O
,	O
including	O
28	O
patients	O
40.6	O
in	O
whom	O
visual	O
ability	O
was	O
improved	O
by	O
more	O
than	O
two	O
lines	O
.	O
	
dislocation	O
/	O
decentration	B-T033
is	O
the	O
main	B-T169
cause	I-T169
for	O
explantation	B-T061
,	O
and	O
high	B-T047
myopia	I-T047
is	O
a	O
main	B-T033
risk	I-T033
factor	I-T033
.	O
	
posterior	B-T061
chamber	I-T061
iol	I-T061
implantation	I-T061
remains	O
the	O
most	O
elected	O
treatment	O
after	O
explantation	O
.	O
	
improvement	O
of	O
older	B-T098
-	O
person	B-T098
-	O
specific	B-T080
qol	B-T078
after	O
hearing	O
aid	O
fitting	B-T061
and	O
its	O
relation	B-T080
to	O
social	B-T033
interaction	I-T033
this	O
study	B-T062
aimed	B-T078
to	O
investigate	B-T169
whether	O
hearing	O
aids	O
use	O
is	O
associated	B-T080
with	I-T080
improvement	O
of	O
older	B-T098
-	O
person	B-T098
-	O
specific	B-T080
qol	B-T078
and	O
whether	O
social	B-T033
interactions	I-T033
modify	B-T169
the	O
association	B-T080
.	O
	
the	O
whoqol-old	B-T170
questionnaire	I-T170
was	O
answered	B-T170
by	O
105	O
older	B-T098
adults	I-T098
aged	O
60	O
to	O
90	O
years	O
who	O
were	O
newly	B-T078
fitted	B-T061
hearing	O
aids	O
on	O
the	O
day	O
of	O
fitting	B-T061
and	O
at	O
2	O
-	O
6	O
months	O
afterward	B-T079
.	O
	
the	O
associations	B-T080
between	O
the	O
daily	O
hours	O
of	O
hearing	O
aid	O
usage	B-T169
and	O
social	O
relations	O
with	O
changes	B-T169
in	O
the	O
whoqol-old	B-T170
total	B-T081
score	I-T081
after	O
hearing	O
aids	O
fitting	B-T061
were	O
estimated	B-T081
adjusting	B-T061
for	O
possible	B-T033
confounders	B-T169
.	O
	
older	B-T098
persons	B-T098
with	O
hearing	B-T033
loss	I-T033
experienced	B-T052
significant	B-T078
increases	B-T169
in	O
whoqol-old	B-T170
total	B-T081
score	I-T081
after	O
hearing	O
aid	O
fitting	B-T061
.	O
	
regular	B-T080
use	B-T169
of	I-T169
hearing	O
aid	O
was	O
associated	B-T080
with	I-T080
a	O
greater	B-T081
increase	B-T169
in	O
the	O
total	B-T081
score	I-T081
.	O
	
the	O
combined	B-T080
categorical	B-T170
variable	B-T080
of	O
social	O
relations	O
and	O
hearing	O
aid	O
usage	B-T169
revealed	B-T080
no	O
separate	B-T080
effects	B-T080
of	O
these	O
two	O
variables	B-T080
,	O
but	O
a	O
combined	B-T080
effect	B-T080
only	O
those	O
with	O
frequent	B-T079
social	B-T033
interactions	I-T033
who	O
used	O
their	O
hearing	O
aid	O
regularly	B-T080
had	O
a	O
significantly	B-T078
greater	B-T081
increase	B-T169
in	O
whoqol-old	B-T170
total	B-T081
score	I-T081
.	O
	
this	O
study's	B-T062
findings	B-T169
indicate	B-T080
that	O
hearing	O
aid	O
fitting	B-T061
may	O
be	O
associated	B-T080
with	I-T080
a	O
subsequent	B-T079
improvement	O
in	O
older	B-T098
-	O
person	B-T098
-	O
specific	B-T080
qol	B-T078
by	O
improvements	O
in	O
hearing	O
due	O
to	O
the	O
hearing	O
aid	O
,	O
and	O
possibly	B-T033
enhanced	B-T052
communication	O
opportunities	B-T080
.	O
	
enhancing	O
comparative	B-T062
effectiveness	I-T062
research	I-T062
with	O
automated	B-T169
pediatric	B-T080
pneumonia	B-T047
detection	B-T061
in	O
a	O
multi-institutional	O
clinical	B-T080
repository	O
a	O
phis	B-T170
+	O
pilot	B-T062
study	I-T062
community-acquired	B-T047
pneumonia	I-T047
is	O
a	O
leading	O
cause	O
of	O
pediatric	B-T080
morbidity	B-T081
.	O
	
administrative	B-T169
data	B-T078
are	O
often	O
used	O
to	O
conduct	O
comparative	B-T062
effectiveness	I-T062
research	I-T062
cer	B-T062
with	O
sufficient	O
sample	B-T081
sizes	I-T081
to	O
enhance	O
detection	B-T033
of	O
important	B-T080
outcomes	B-T169
.	O
	
however	O
,	O
such	O
studies	O
are	O
prone	O
to	O
misclassification	B-T080
errors	I-T080
because	O
of	O
the	O
variable	B-T080
accuracy	B-T080
of	O
discharge	B-T033
diagnosis	I-T033
codes	B-T170
.	O
	
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
develop	O
an	O
automated	B-T169
,	O
scalable	B-T169
,	O
and	O
accurate	B-T080
method	B-T170
to	O
determine	B-T080
the	O
presence	B-T033
or	O
absence	B-T169
of	O
pneumonia	B-T047
in	O
children	O
using	O
chest	O
imaging	O
reports	B-T170
.	O
	
the	O
multi-institutional	O
phis	B-T170
+	O
clinical	B-T080
repository	O
was	O
developed	O
to	O
support	O
pediatric	B-T080
cer	B-T062
by	O
expanding	O
an	O
administrative	B-T169
database	B-T170
of	O
children's	O
hospitals	O
with	O
detailed	O
clinical	B-T080
data	B-T078
.	O
	
to	O
develop	O
a	O
scalable	B-T169
approach	O
to	O
find	B-T033
patients	O
with	O
bacterial	B-T047
pneumonia	I-T047
more	O
accurately	O
,	O
we	O
developed	O
a	O
natural	O
language	O
processing	O
nlp	O
application	B-T080
to	O
extract	O
relevant	B-T080
information	B-T078
from	O
chest	O
diagnostic	O
imaging	O
reports	B-T170
.	O
	
domain	B-T169
experts	O
established	B-T080
a	O
reference	B-T081
standard	I-T081
by	O
manually	B-T033
annotating	B-T169
282	O
reports	B-T170
to	O
train	O
and	O
then	O
test	O
the	O
nlp	O
application	B-T080
.	O
	
findings	O
of	O
pleural	B-T047
effusion	I-T047
,	O
pulmonary	B-T033
infiltrate	I-T033
,	O
and	O
pneumonia	B-T047
were	O
automatically	B-T033
extracted	O
from	O
the	O
reports	B-T170
and	O
then	O
used	O
to	O
automatically	B-T033
classify	O
whether	O
a	O
report	B-T170
was	O
consistent	B-T078
with	I-T078
bacterial	B-T047
pneumonia	I-T047
.	O
	
compared	B-T052
with	O
the	O
annotated	O
diagnostic	O
imaging	O
reports	B-T170
reference	B-T081
standard	I-T081
,	O
the	O
most	O
accurate	B-T080
implementation	B-T052
of	O
machine	O
learning	O
algorithms	B-T170
in	O
our	O
nlp	O
application	B-T080
allowed	O
extracting	O
relevant	B-T080
findings	B-T169
with	O
a	O
sensitivity	B-T081
of	O
939	O
and	O
a	O
positive	B-T033
predictive	B-T080
value	I-T080
of	O
925	O
.	O
	
it	O
allowed	O
classifying	O
reports	B-T170
with	O
a	O
sensitivity	B-T081
of	O
71	O
,	O
a	O
positive	B-T033
predictive	B-T080
value	I-T080
of	O
86	O
,	O
and	O
a	O
specificity	B-T081
of	O
962	O
.	O
	
when	O
compared	B-T052
with	O
each	O
of	O
the	O
domain	B-T169
experts	O
manually	B-T033
annotating	B-T169
these	O
reports	B-T170
,	O
the	O
nlp	O
application	B-T080
allowed	O
for	O
significantly	B-T081
higher	I-T081
sensitivity	B-T081
71	O
vs	O
527	O
and	O
similar	O
positive	B-T033
predictive	B-T080
value	I-T080
and	O
specificity	B-T081
.	O
	
nlp	O
-based	O
pneumonia	B-T047
information	B-T078
extraction	O
of	O
pediatric	B-T080
diagnostic	O
imaging	O
reports	B-T170
performed	B-T169
better	O
than	O
domain	B-T169
experts	O
in	O
this	O
pilot	B-T062
study	I-T062
.	O
	
nlp	O
is	O
an	O
efficient	O
method	O
to	O
extract	O
information	B-T078
from	O
a	O
large	O
collection	B-T169
of	O
imaging	B-T170
reports	I-T170
to	O
facilitate	O
determination	O
of	O
volatile	B-T109
organic	I-T109
compounds	I-T109
exhaled	O
by	O
cell	O
lines	O
derived	B-T080
from	O
hematological	O
malignancies	O
background	O
the	O
gas	O
human	O
exhaled	O
contains	O
many	O
volatile	B-T109
organic	I-T109
compounds	I-T109
vocs	B-T109
,	O
which	O
is	O
related	O
to	O
the	O
health	B-T080
status	I-T080
of	O
body	O
.	O
	
analysis	B-T062
of	O
vocs	B-T109
has	O
been	O
proposed	O
as	O
a	O
noninvasive	O
diagnostic	O
tool	O
for	O
certain	O
cancers	O
.	O
	
detailed	O
research	O
on	O
the	O
vocs	B-T109
in	O
gas	O
exhaled	O
by	O
cell	O
can	O
characterize	O
cell	B-T170
type	I-T170
specific	O
metabolites	O
and	O
may	O
be	O
helpful	O
to	O
detect	O
the	O
cancer	O
markers	O
in	O
clinical	O
practice	O
.	O
	
methods	O
solid	O
phase	O
microextraction	O
-	O
gas	O
chromatography	O
-	O
mass	O
spectrometry	O
was	O
used	O
to	O
detect	O
vocs	B-T109
in	O
the	O
headspace	O
of	O
tissue	O
culture	O
flask	O
in	O
non-hodgkin's	O
lymphoma	O
cell	O
line	O
jeko	O
and	O
acute	O
mononuclear	O
leukemia	O
cell	O
line	O
shi-1	O
,	O
to	O
elaborate	O
the	O
characteristic	O
gaseous	O
biomarkers	O
of	O
hematological	O
malignancies	O
.	O
	
while	O
macrophage	O
cells	O
and	O
lymphocytic	O
cells	O
were	O
acted	O
as	O
control	O
.	O
	
the	O
blank	B-T078
group	I-T078
was	O
only	O
the	O
rpmi	O
1640	O
medium	O
containing	O
10%	O
fetal	O
calf	O
serum	O
that	O
without	O
cells	O
.	O
	
results	O
comparing	O
to	O
control	O
group	O
,	O
the	O
concentration	B-T081
of	O
dimethyl	O
sulphide	O
,	O
2	O
,	O
methylbenzene	B-T109
,	O
o-xylene	B-T109
,	O
dodecane	B-T109
and	O
1	O
in	O
jeko	O
cells	O
were	O
relatively	O
higher	O
,	O
while	O
the	O
concentration	O
of	O
ethanol	B-T109
,	O
hexanal	B-T109
and	O
benzaldehyde	B-T109
was	O
lower	O
.	O
	
in	O
shi-1	O
cells	O
,	O
the	O
levels	O
of	O
2	O
,	O
benzene	B-T109
,	O
4-methyldecane	O
,	O
chloroform	B-T109
,	O
3	O
dodecane	O
and	O
hexadecane	B-T109
were	O
significantly	O
elevated	O
,	O
but	O
the	O
levels	O
of	O
hexanol	B-T109
and	O
cyclohexanol	B-T109
were	O
distinctly	O
reduced	O
.	O
	
conclusions	O
this	O
pilot	B-T062
study	I-T062
revealed	O
that	O
the	O
malignant	O
hematological	O
cells	O
could	O
change	O
the	O
components	O
of	O
vocs	B-T109
in	O
the	O
cell	O
culture	O
flask	O
in	O
a	O
cell	B-T170
type	I-T170
specific	O
pattern	O
.	O
	
the	O
traits	O
of	O
vocs	B-T109
in	O
our	O
setting	O
offered	O
new	O
strategy	O
for	O
hematological	O
malignancies	O
tracing	O
,	O
and	O
would	O
act	O
as	O
potential	O
biomarkers	O
in	O
diagnosis	B-T033
of	O
malignant	B-T080
hematological	B-T047
diseases	I-T047
.	O
	
intratympanic	B-T169
steroid	I-T169
delivery	I-T169
by	O
an	O
indwelling	O
catheter	O
in	O
refractory	O
severe	O
sudden	O
sensorineural	O
hearing	O
loss	O
many	O
studies	O
over	O
the	O
last	O
decade	O
showed	O
favorable	O
outcomes	O
with	O
intratympanic	O
it	O
steroid	B-T109
treatment	O
,	O
alone	O
as	O
salvage	O
treatment	O
or	O
in	O
combination	O
with	O
conventional	O
systemic	O
therapy	O
st	O
.	O
	
however	O
,	O
in	O
severe	O
to	O
profound	O
sensorineural	O
hearing	O
loss	O
resistant	O
to	O
st	O
,	O
the	O
optimal	O
infusion	O
mode	O
,	O
the	O
type	O
and	O
concentration	O
of	O
the	O
solution	O
,	O
the	O
preferable	O
drug	O
,	O
its	O
total	O
amount	O
,	O
and	O
the	O
duration	O
and	O
fractionation	O
of	O
the	O
treatment	O
are	O
still	O
debated	O
.	O
	
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
the	O
feasibility	O
and	O
the	O
outcomes	O
of	O
a	O
direct	O
and	O
constant	O
it	O
delivery	O
of	O
dexamethasone	O
dex	O
by	O
means	O
of	O
a	O
new	O
indwelling	O
catheter	O
.	O
	
a	O
prospective	O
case-control	O
study	O
in	O
a	O
tertiary	O
referral	O
university	O
hospital	O
.	O
	
ninety-nine	O
subjects	O
treated	O
with	O
st	O
only	O
and	O
28	O
with	O
additional	O
it	O
dex	O
have	O
been	O
included	O
in	O
the	O
study	O
.	O
	
a	O
4	O
fr	O
catheter	O
inserted	O
in	O
a	O
sub-annular	O
fashion	O
with	O
a	O
minimal	O
postero-inferior	O
tympanotomy	O
through	O
and	O
endocanalar	O
approach	O
under	O
local	O
anesthesia	O
.	O
	
dex	O
4mg/ml	O
delivered	O
daily	O
,	O
up	O
to	O
7	O
days	O
.	O
	
daily	O
bone	O
and	O
air-conducted	O
pure	O
tone	O
and	O
speech	O
audiometry	O
were	O
performed	O
with	O
a	O
follow-up	O
at	O
1	O
,	O
3	O
,	O
6	O
months	O
after	O
treatment	O
.	O
	
twenty-one	O
out	O
of	O
28	O
patients	O
75%	O
refractory	B-T047
to	O
st	O
gained	O
on	O
average	O
24.0db	O
hl	O
after	O
it	O
-	O
dex	O
,	O
compared	O
to	O
35.4	O
average	O
6.7db	O
hl	O
of	O
those	O
receiving	O
only	O
medical	O
st	O
p<0	O
.	O
	
no	O
significant	O
side	O
effects	O
were	O
noted	O
.	O
	
in	O
severe	I-T047
to	O
profound	O
sudden	I-T047
deafness	O
refractory	O
to	O
conventional	O
st	O
,	O
the	O
daily	O
perfusion	O
of	O
4mg/ml	O
dex	O
through	O
an	O
intratympanic	O
catheter	O
is	O
an	O
easy	O
,	O
well	O
accepted	O
procedure	O
that	O
enables	O
patients	O
to	O
receive	O
a	O
drug	O
in	O
the	O
middle	O
ear	O
in	O
a	O
repeatable	O
or	O
sustained	O
form	O
,	O
with	O
minimal	O
discomfort	O
and	O
a	O
partial	O
rescue	O
67.86	O
and	O
a	O
speech	O
recognition	O
gain	O
of	O
design	B-T052
,	O
synthesis	B-T052
and	O
anti-tumor	O
activity	O
study	B-T062
of	O
novel	O
histone	B-T116
deacetylase	I-T116
inhibitors	I-T116
containing	O
isatin	B-T109
-based	O
caps	O
and	O
o-phenylenediamine	B-T109
-based	O
zinc	O
binding	O
groups	O
as	O
a	O
hot	O
topic	O
of	O
epigenetic	O
studies	O
,	O
histone	B-T116
deacetylases	I-T116
hdacs	B-T116
are	O
related	O
to	O
lots	O
of	O
diseases	B-T047
,	O
especially	O
cancer	O
.	O
	
further	O
researches	B-T062
indicated	O
that	O
different	B-T080
hdac	B-T116
isoforms	I-T116
played	O
various	O
roles	O
in	O
a	O
wide	O
range	O
of	O
tumor	B-T033
types	I-T033
.	O
	
herein	O
a	O
novel	O
series	B-T081
of	O
hdac	B-T116
inhibitors	I-T116
with	O
isatin	B-T109
-based	O
caps	O
and	O
o-phenylenediamine	B-T109
-based	O
zinc	O
binding	O
groups	O
have	O
been	O
designed	B-T052
and	O
synthesized	B-T052
through	B-T169
scaffold	O
hopping	O
strategy	O
.	O
	
among	O
these	O
compounds	O
,	O
the	O
most	O
potent	O
compound	O
9n	O
exhibited	O
similar	O
if	O
not	O
better	B-T080
hdac	B-T116
inhibition	O
and	O
antiproliferative	O
activities	O
against	O
multiple	B-T081
tumor	O
cell	O
lines	O
compared	B-T052
with	O
the	O
positive	O
control	O
entinostat	B-T109
ms-275	B-T109
.	O
	
additionally	O
,	O
compared	B-T052
with	O
ms-275	B-T109
ic50	B-T081
values	B-T081
for	O
hdac1	B-T116
,	O
2	B-T116
and	O
3	B-T116
were	O
0.163	O
,	O
0.396	O
and	O
0.605µm	O
,	O
respectively	O
,	O
compound	O
9n	O
with	O
ic50	B-T081
values	B-T081
of	O
0.032	O
,	O
0.256	O
and	O
0.311µm	O
for	O
hdac1	B-T116
,	O
2	B-T116
and	O
3	B-T116
respectively	O
,	O
showed	O
a	O
moderate	O
hdac1	B-T116
selectivity	B-T080
.	O
	
efficacy	B-T080
of	O
42	O
pharmacologic	O
cotreatment	B-T061
strategies	O
added	O
to	O
antipsychotic	O
monotherapy	B-T061
in	O
schizophrenia	O
systematic	O
overview	O
and	O
quality	B-T080
appraisal	O
of	O
the	O
meta-analytic	B-T062
evidence	B-T078
limited	O
treatment	B-T061
responses	O
in	O
schizophrenia	O
prompted	O
the	O
testing	O
of	O
combining	O
an	O
antipsychotic	O
drug	O
treatment	B-T061
with	O
a	O
second	O
psychotropic	O
medication	O
.	O
	
a	O
comprehensive	O
evaluation	O
of	O
the	O
efficacy	B-T080
of	O
multiple	O
medication	O
combinations	O
is	O
missing	O
.	O
	
to	O
summarize	O
and	O
compare	O
the	O
meta-analytically	B-T062
determined	O
efficacy	B-T080
of	O
pharmacologic	O
combination	O
strategies	O
of	O
antipsychotic	O
drugs	O
in	O
adults	O
with	O
schizophrenia	O
.	O
	
systematic	O
search	O
of	O
pubmed	B-T170
and	O
psycinfo	B-T170
until	O
may	O
13	O
,	O
2016	O
.	O
	
meta-analyses	B-T062
of	O
randomized	B-T062
clinical	I-T062
trials	I-T062
comparing	O
the	O
efficacy	B-T080
of	O
antipsychotic	O
drugs	O
combined	O
with	O
other	O
antipsychotic	O
or	O
nonantipsychotic	O
medications	O
vs	O
placebos	O
or	O
antipsychotic	O
monotherapy	B-T061
among	O
adults	O
with	O
schizophrenia	O
.	O
	
independent	O
reviewers	B-T098
extracted	O
the	O
data	B-T078
and	O
assessed	O
the	O
quality	B-T080
of	O
the	O
methods	B-T170
of	O
the	O
included	O
meta-analyses	B-T062
using	O
a	O
measurement	B-T170
tool	I-T170
to	I-T170
assess	I-T170
systematic	I-T170
reviews	I-T170
amstar	B-T170
,	O
adding	O
6	O
new	O
items	O
to	O
rate	O
their	O
quality	B-T080
.	O
	
effect	B-T081
sizes	I-T081
,	O
expressed	O
as	O
standardized	O
mean	O
difference	O
/hedges	O
g	O
or	O
risk	B-T081
ratio	I-T081
,	O
were	O
compared	O
separately	O
for	O
combinations	O
with	O
any	O
antipsychotic	O
drug	O
and	O
for	O
combinations	O
with	O
clozapine	B-T109
.	O
	
the	O
primary	O
outcome	O
was	O
total	O
symptom	O
reduction	B-T080
.	O
	
secondary	O
outcomes	O
included	O
positive	B-T033
and	O
negative	B-T033
symptoms	O
,	O
treatment	O
recommendations	O
by	O
authors	O
,	O
study-defined	O
inefficacies	B-T033
,	O
cognitive	B-T169
and	O
depressive	O
symptoms	O
,	O
discontinuation	O
of	O
treatment	B-T061
because	O
of	O
any	O
cause	O
,	O
and	O
inefficacies	B-T033
or	O
intolerabilities	O
.	O
	
of	O
3397	O
publications	O
,	O
29	O
meta-analyses	B-T062
testing	O
42	O
combination	O
strategies	O
in	O
381	O
individual	B-T098
trials	O
and	O
among	O
19	O
833	O
participants	B-T098
were	O
included	O
.	O
	
for	O
total	O
symptom	O
reductions	B-T061
,	O
32	O
strategies	O
that	O
augmented	O
any	O
antipsychotic	O
drug	O
and	O
5	O
strategies	O
that	O
augmented	O
clozapine	B-T109
were	O
examined	O
.	O
	
fourteen	O
combination	O
treatments	B-T061
outperformed	O
controls	O
standard	O
mean	O
difference	O
/hedges	O
g	O
,	O
-1	O
95%	O
ci	B-T081
,	O
-2	O
to	O
-0	O
to	O
-0	O
95%	O
ci	B-T081
,	O
-0	O
to	O
-0	O
p	O
=	O
05	O
.	O
	
no	O
combination	O
strategies	O
with	O
clozapine	B-T109
outperformed	O
controls	O
.	O
	
the	O
quality	B-T080
of	O
the	O
methods	B-T170
of	O
the	O
meta-analyses	B-T062
was	O
generally	O
high	B-T080
mean	B-T033
score	I-T033
,	O
9	O
of	O
a	O
maximum	B-T081
score	I-T081
of	O
11	O
but	O
the	O
quality	B-T080
of	O
the	O
meta-analyzed	B-T062
studies	I-T062
was	O
low	B-T080
mean	B-T033
score	I-T033
,	O
2.8	O
of	O
a	O
maximum	B-T081
score	I-T081
of	O
8	O
.	O
	
treatment	O
recommendations	O
correlated	O
with	O
the	O
effect	B-T081
size	I-T081
correlation	B-T081
coefficient	I-T081
,	O
0.22	O
95%	O
ci	B-T081
,	O
0.35	O
p	O
<	O
001	O
,	O
yet	O
effect	B-T081
sizes	I-T081
were	O
inversely	O
correlated	O
with	O
study	O
quality	B-T080
correlation	B-T081
coefficient	I-T081
,	O
-0	O
95%	O
ci	B-T081
,	O
0.01	O
to	O
-0	O
p	O
=	O
02	O
.	O
	
meta-analyses	B-T062
of	O
21	O
interventions	O
fully	O
or	O
partially	O
recommended	O
their	O
use	O
,	O
with	O
recommendations	B-T078
being	O
positively	B-T033
correlated	O
with	O
the	O
effect	B-T081
sizes	I-T081
of	O
the	O
pooled	O
intervention	O
.	O
	
however	O
,	O
the	O
effect	B-T081
sizes	I-T081
were	O
inversely	O
correlated	O
with	O
meta-analyzed	B-T062
study	I-T062
quality	B-T080
,	O
reducing	B-T080
confidence	O
in	O
these	O
recommendations	B-T078
.	O
	
higher	B-T080
-	O
quality	B-T080
trials	O
and	O
patient	O
-based	O
meta-analyses	B-T062
are	O
needed	O
to	O
determine	O
whether	O
subpopulations	B-T098
might	O
benefit	O
from	O
combination	O
treatment	B-T061
,	O
as	O
no	O
single	O
strategy	O
can	O
be	O
recommended	O
for	O
patients	O
with	O
schizophrenia	O
based	O
on	O
the	O
current	O
meta-analytic	B-T062
literature	B-T170
.	O
	
involvement	B-T169
of	O
vascular	O
aldosterone	B-T116
synthase	I-T116
in	O
phosphate	O
-	O
induced	B-T169
osteogenic	B-T033
transformation	I-T033
of	O
vascular	O
smooth	O
muscle	O
cells	O
vascular	O
calcification	O
resulting	O
from	O
hyperphosphatemia	B-T047
is	O
a	O
major	O
determinant	O
of	O
mortality	B-T081
in	O
chronic	B-T047
kidney	I-T047
disease	I-T047
ckd	B-T047
.	O
	
vascular	O
calcification	O
is	O
driven	O
by	O
aldosterone	B-T109
-sensitive	O
osteogenic	B-T033
transformation	I-T033
of	O
vascular	O
smooth	O
muscle	O
cells	O
vsmcs	O
.	O
	
we	O
show	O
that	O
even	O
in	O
absence	B-T169
of	O
exogenous	B-T169
aldosterone	B-T109
,	O
silencing	O
and	O
pharmacological	O
inhibition	O
spironolactone	B-T109
,	O
eplerenone	B-T109
of	O
the	O
mineralocorticoid	B-T116
receptor	I-T116
mr	B-T116
ameliorated	O
phosphate	O
-	O
induced	B-T169
osteo-	B-T033
/	O
chondrogenic	B-T033
transformation	I-T033
of	O
primary	B-T080
human	O
aortic	O
smooth	O
muscle	O
cells	O
haosmcs	O
.	O
	
high	O
phosphate	O
concentrations	B-T081
up-regulated	O
aldosterone	B-T116
synthase	I-T116
cyp11b2	B-T116
expression	O
in	O
haosmcs	O
.	O
	
silencing	O
and	O
deficiency	B-T047
of	O
cyp11b2	B-T116
in	O
vsmcs	O
ameliorated	O
phosphate	O
-	O
induced	B-T169
osteogenic	O
reprogramming	O
and	O
calcification	O
.	O
	
phosphate	O
treatment	B-T169
was	O
followed	O
by	O
nuclear	O
export	O
of	O
apex1	B-T116
,	O
a	O
cyp11b2	O
transcriptional	B-T116
repressor	I-T116
.	O
	
apex1	B-T116
silencing	O
up-regulated	O
cyp11b2	O
expression	O
and	O
stimulated	O
osteo-	B-T033
/	O
chondrogenic	B-T033
transformation	I-T033
.	O
	
apex1	B-T116
overexpression	O
blunted	O
the	O
phosphate	O
-	O
induced	B-T169
osteo-	B-T033
/	O
chondrogenic	B-T033
transformation	I-T033
and	O
calcification	O
of	O
haosmcs	O
.	O
	
cyp11b2	O
expression	O
was	O
higher	O
in	O
aortic	O
tissue	O
of	O
hyperphosphatemic	B-T047
klotho-hypomorphic	O
kl/kl	O
mice	O
than	O
in	O
wild-type	O
mice	O
.	O
	
in	O
adrenalectomized	O
kl/kl	O
mice	O
,	O
spironolactone	B-T109
treatment	B-T169
still	O
significantly	O
ameliorated	O
aortic	O
osteoinductive	O
reprogramming	O
.	O
	
our	O
findings	B-T169
suggest	O
that	O
vsmcs	O
express	O
aldosterone	B-T116
synthase	I-T116
,	O
which	O
is	O
up-regulated	O
by	O
phosphate	O
-	O
induced	B-T169
disruption	B-T169
of	O
apex1	B-T116
-dependent	O
gene	O
suppression	O
.	O
	
vascular	O
cyp11b2	B-T116
may	O
contribute	O
to	O
stimulation	O
of	O
vsmcs	O
osteo-	B-T033
/	O
chondrogenic	B-T033
transformation	I-T033
during	O
fairness	B-T080
the	O
hidden	O
challenge	O
for	O
competency-based	O
postgraduate	O
medical	O
education	O
programs	O
competency-based	O
medical	O
education	O
systems	O
allow	O
institutions	O
to	O
individualize	B-T169
teaching	O
practices	O
to	O
meet	O
the	O
needs	B-T080
of	O
diverse	B-T098
learners	I-T098
.	O
	
yet	O
,	O
the	O
focus	O
on	O
continuous	O
improvement	O
and	O
individualization	B-T169
of	O
curricula	B-T170
does	O
not	O
exempt	O
programs	B-T169
from	O
treating	O
learners	B-T098
in	O
a	O
fair	B-T033
manner	I-T033
.	O
	
when	O
learners	B-T098
fail	O
to	O
meet	O
key	O
competencies	B-T080
and	O
are	O
placed	O
on	O
probation	O
or	O
dismissed	B-T052
from	O
training	O
programs	O
,	O
issues	B-T033
of	O
fairness	B-T080
may	O
form	O
the	O
basis	O
of	O
their	O
legal	B-T170
claims	I-T170
.	O
	
in	O
a	O
literature	O
search	O
,	O
we	O
found	O
no	O
in-depth	O
examination	O
of	O
fairness	B-T080
.	O
	
in	O
this	O
paper	O
,	O
we	O
utilize	O
a	O
systems	O
lens	O
to	O
examine	B-T033
fairness	B-T080
within	O
postgraduate	O
medical	O
education	O
contexts	B-T078
,	O
focusing	O
on	O
educational	B-T033
opportunities	I-T033
,	O
assessment	O
practices	O
,	O
decision-making	O
processes	O
,	O
fairness	B-T080
from	O
a	O
legal	B-T169
standpoint	I-T169
,	O
and	O
fairness	B-T080
in	O
the	O
context	B-T078
of	O
the	O
learning	B-T082
environment	I-T082
.	O
	
while	O
we	O
provide	O
examples	O
of	O
fairness	B-T080
issues	B-T033
within	O
us	O
training	O
programs	O
,	O
concerns	O
regarding	O
fairness	B-T080
are	O
relevant	O
in	O
any	O
medical	O
education	O
system	O
which	O
utilizes	O
a	O
competency-based	B-T078
education	I-T078
framework	I-T078
.	O
	
assessment	O
oversight	O
committees	O
and	O
annual	O
programmatic	O
evaluations	O
,	O
while	O
recommended	O
,	O
will	O
not	O
guarantee	O
fairness	B-T080
within	O
postgraduate	O
medical	O
education	O
programs	O
,	O
but	O
they	O
can	O
provide	O
a	O
window	O
into	O
'hidden'	O
threats	O
to	O
fairness	B-T080
,	O
as	O
everything	O
from	O
training	O
experiences	O
to	O
assessment	O
practices	O
may	O
be	O
examined	B-T033
by	O
these	O
committees	O
.	O
	
one	O
of	O
the	O
first	O
steps	O
programs	B-T169
can	O
take	O
is	O
to	O
recognize	O
that	O
threats	O
to	O
fairness	B-T080
may	O
exist	O
in	O
any	O
educational	O
program	O
,	O
including	O
their	O
own	O
,	O
and	O
begin	O
conversations	O
about	O
how	O
to	O
address	O
these	O
us3	B-T116
and	O
us9	B-T116
proteins	B-T116
contribute	O
to	O
the	O
stromal	B-T033
invasion	I-T033
of	O
bovine	O
herpesvirus	O
1	O
in	O
the	O
respiratory	O
mucosa	O
bovine	B-T047
herpesvirus	I-T047
1	I-T047
bhv-1	I-T047
infection	I-T047
may	O
lead	O
to	O
conjunctivitis	B-T047
,	O
upper	O
respiratory	O
tract	O
problems	B-T033
,	O
pneumonia	B-T047
,	O
genital	B-T047
disorders	I-T047
and	O
abortion	B-T033
.	O
	
bhv-1	O
is	O
able	O
to	O
spread	B-T080
quickly	O
in	O
a	O
plaque	B-T033
-wise	O
manner	B-T169
and	O
invade	B-T169
by	O
breaching	O
the	O
basement	O
membrane	O
bm	O
barrier	O
in	O
the	O
respiratory	O
mucosa	O
.	O
	
bhv-1	O
us3	B-T116
,	O
a	O
serine/threonine	B-T116
kinase	I-T116
,	O
induces	B-T169
a	O
dramatic	O
cytoskeletal	O
reorganization	O
and	O
bhv-1	O
us9	B-T116
,	O
a	O
tail-anchored	B-T116
membrane	I-T116
protein	I-T116
,	O
is	O
required	O
for	O
axonal	O
transport	O
of	O
viruses	O
in	O
neurons	O
.	O
	
in	O
this	O
study	B-T062
,	O
we	O
investigated	B-T169
the	O
role	O
of	O
us3	B-T116
and	O
us9	B-T116
during	O
bhv-1	B-T047
infection	I-T047
in	O
the	O
respiratory	O
mucosa	O
.	O
	
first	O
,	O
we	O
constructed	O
and	O
characterized	B-T052
bhv-1	O
us3	O
null	O
,	O
us9	O
null	O
and	O
revertant	O
viruses	O
.	O
	
then	O
,	O
we	O
analysed	B-T062
the	O
viral	O
replication	O
and	O
plaque	B-T033
size	B-T082
latitude	O
in	O
madin-darby	O
bovine	O
kidney	O
mdbk	O
cells	O
and	O
the	O
respiratory	O
mucosa	O
as	O
well	O
as	O
viral	O
penetration	O
depth	O
underneath	O
the	O
bm	O
of	O
the	O
respiratory	O
mucosa	O
when	O
inoculated	B-T061
with	O
these	O
recombinant	O
viruses	O
.	O
	
knockout	O
of	O
us3	O
resulted	O
in	O
a	O
1	O
log10	O
reduction	B-T080
in	O
viral	B-T081
titre	I-T081
and	O
plaque	B-T033
size	B-T082
latitude	B-T081
in	O
mdbk	O
cells	O
and	O
the	O
trachea	O
mucosa	O
.	O
	
there	O
were	O
no	B-T033
defects	B-T169
in	O
the	O
cell-to-cell	O
spread	O
observed	B-T169
for	O
bhv-1	O
us9	O
null	O
virus	O
.	O
	
both	O
bhv-1	O
us3	O
null	O
and	O
us9	O
null	O
viruses	O
showed	O
a	O
significant	B-T078
reduction	B-T080
of	O
plaque	B-T033
penetration	B-T169
underneath	O
the	O
bm	O
however	O
,	O
penetration	B-T169
was	O
not	O
completely	O
inhibited	B-T052
.	O
	
in	O
conclusion	B-T078
,	O
the	O
current	O
findings	B-T062
demonstrated	O
that	O
us3	O
and	O
us9	O
play	O
an	O
important	O
role	O
in	O
the	O
invasion	B-T033
of	O
bhv-1	O
through	O
the	O
bm	O
of	O
the	O
respiratory	O
mucosa	O
,	O
which	O
shows	O
the	O
way	O
forward	O
for	O
research	B-T062
-based	O
attenuation	B-T052
of	O
viruses	O
in	O
order	O
to	O
make	O
safer	O
and	O
better	B-T080
-	O
performing	B-T169
vaccines	O
.	O
	
traumatic	O
brain	O
injury	O
and	O
depression	O
in	O
a	O
community	O
-	O
based	B-T169
sample	O
a	O
cohort	B-T081
study	I-T081
across	O
the	O
adult	O
life	O
span	O
to	O
determine	O
whether	O
self-reported	O
traumatic	O
brain	O
injuries	O
tbis	O
are	O
associated	B-T080
with	I-T080
""""	O
cases	O
""""	O
of	O
clinically	B-T033
significant	I-T033
depression	O
in	O
the	O
general	O
community	O
.	O
	
to	O
examine	O
interactions	B-T169
between	O
variables	B-T081
previously	O
linked	O
to	O
depression	O
after	O
a	O
tbi	O
.	O
	
population	B-T098
-based	O
community	O
study	B-T062
canberra	O
and	O
queanbeyan	O
,	O
australia	O
.	O
	
three	B-T081
age	B-T098
cohorts	I-T098
young	B-T079
,	O
middle-aged	O
,	O
and	O
older	B-T098
adults	O
aged	O
20-24	O
,	O
40-44	O
,	O
and	O
60-64	O
years	O
at	O
baseline	B-T081
randomly	B-T080
selected	B-T052
from	O
the	O
electoral	O
roll	O
and	O
followed	B-T079
across	O
3	O
waves	O
4	O
years	B-T079
apart	I-T079
.	O
	
a	O
total	O
of	O
7397	O
,	O
6621	O
,	O
and	O
6042	O
people	B-T098
provided	O
their	O
tbi	O
history	O
in	O
waves	O
1	O
to	O
3	O
.	O
	
lifetime	B-T079
tbilifetime	O
sustained	B-T169
at	O
any	O
time	B-T079
since	B-T079
birth	O
,	O
recent	B-T079
tbirecent	O
in	O
the	O
preceding	B-T079
4	O
years	B-T079
,	O
and	O
multiple	B-T081
tbimultiple	O
more	O
than	O
1	O
tbis	O
,	O
current	B-T079
depression	O
,	O
and	O
known	O
risk	B-T033
factors	I-T033
for	O
depression	O
age	O
,	O
sex	O
,	O
marital	O
/	O
employment	B-T033
status	I-T033
,	O
prior	B-T033
history	I-T033
of	O
depression	O
,	O
medical	B-T033
conditions	I-T033
,	O
recent	O
life	O
events	O
,	O
alcohol	O
consumption	O
,	O
social	O
support	O
,	O
physical	O
activity	O
.	O
	
generalized	O
estimating	O
equations	O
demonstrated	O
a	O
significant	O
association	B-T080
between	O
sustaining	O
a	O
tbi	O
and	O
experiencing	O
clinically	B-T033
significant	I-T033
depression	O
cases	O
,	O
even	O
after	O
controlling	O
for	O
multiple	B-T081
demographic	B-T078
and	O
health	B-T078
/	O
lifestyle	O
factors	B-T169
.	O
	
there	O
is	O
an	O
enduring	O
association	B-T080
between	O
depression	O
and	O
tbi	O
,	O
suggesting	O
that	O
,	O
following	O
a	O
tbi	O
,	O
individuals	B-T098
should	O
be	O
monitored	O
and	O
supported	O
to	O
optimize	O
their	O
long-term	B-T079
psychological	O
health	O
.	O
	
cs	B-T109
-	O
peg	B-T109
decorated	O
plga	B-T109
nano-prototype	I-T109
for	O
delivery	O
of	O
bioactive	O
compounds	O
a	O
novel	B-T080
approach	B-T082
for	O
induction	B-T169
of	O
apoptosis	O
in	O
hepg2	O
cell	O
line	O
polymer	O
-	O
based	B-T169
nanoparticles	O
are	O
used	B-T169
as	O
vectors	B-T082
for	O
cancer	O
drug	B-T169
delivery	I-T169
.	O
	
the	O
bioactive	O
compounds	O
quercetin	B-T109
,	O
ellagic	B-T109
acid	I-T109
and	O
gallic	B-T109
acid	I-T109
are	O
well	O
known	O
to	O
be	O
not	O
only	O
antioxidants	O
but	O
also	O
chemopreventive	O
candidates	O
against	B-T080
various	B-T081
types	B-T080
of	O
cancers	O
.	O
	
to	O
circumvent	O
the	O
low	B-T080
bioavailability	B-T081
and	O
the	O
short	B-T081
half-life	B-T079
time	B-T079
obstacles	B-T169
,	O
we	O
hypothesized	O
a	O
novel	B-T080
plga	B-T109
nano-platform	I-T109
functionalized	B-T169
with	O
cs	B-T109
and	O
peg	B-T109
to	O
encapsulate	B-T080
these	O
phytochemicals	B-T109
.	O
	
this	O
encapsulation	O
will	O
protect	B-T033
the	O
compounds	O
from	O
the	O
phagocytic	O
uptake	O
and	O
deliver	O
plga-cs-peg	O
nano-prototype	O
with	O
high	O
biodegradability	B-T080
and	O
biosafety	B-T080
.	O
	
three	O
consequent	O
types	B-T080
of	O
plga-based	O
nanocomposites	O
were	O
prepared	B-T052
and	O
characterized	B-T052
.	O
	
furthermore	O
,	O
we	O
investigated	B-T169
the	O
newly	O
synthesized	B-T052
nano-formulations	O
against	B-T080
human	O
hepatocellular	O
carcinoma	O
hepg2	O
and	O
colorectal	O
cancer	O
hct	O
116	O
cell	O
lines	O
using	B-T169
cell	O
growth	O
inhibition	O
assays	O
,	O
followed	B-T079
by	I-T079
apoptosis	O
and	O
necrosis	O
assays	O
using	B-T169
flow	O
cytometry	O
to	O
detect	O
the	O
underlying	O
mechanism	B-T169
of	O
hepg2	O
cell	O
death	O
.	O
	
through	O
malvern	O
zeta	O
sizer	O
,	O
we	O
recorded	O
that	O
the	O
average	B-T081
diameters	B-T081
of	O
the	O
nano-prototypes	O
ranged	O
from	O
150	O
to	O
300nm	O
.	O
	
the	O
cytotoxic	O
activity	O
of	O
quercetin	B-T109
,	O
ellagic	B-T109
acid	I-T109
,	O
and	O
gallic	B-T109
acid	I-T109
-	O
encapsulated	B-T080
plga	B-T109
,	O
plga-cs	O
,	O
and	O
plga-cs-peg	O
nano-prototypes	O
it	O
has	O
been	O
found	B-T033
that	O
they	O
reduce	B-T080
the	O
ic50s	B-T081
of	O
the	O
hepg2	O
cells	O
values	B-T081
by	O
2.2	O
,	O
2.9	O
,	O
2.8	O
folds	B-T081
,	O
1	O
,	O
1.5	O
,	O
2.7	O
folds	B-T081
,	O
and	O
0.9	O
,	O
0.7	O
,	O
1.5	O
folds	B-T081
,	O
respectively	O
.	O
	
mechanistically	O
,	O
the	O
nano-platforms	O
of	O
quercetin	B-T109
seem	O
to	O
be	O
dependent	B-T080
on	O
both	O
apoptosis	O
and	O
necrosis	O
,	O
while	O
those	O
of	O
ellagic	B-T109
acid	I-T109
and	O
gallic	B-T109
acid	I-T109
are	O
mainly	O
dependent	B-T080
on	O
apoptosis	O
.	O
	
cs	B-T109
-	O
peg	B-T109
-blended	O
plga	B-T109
nano-delivery	B-T169
system	I-T169
of	O
quercetin	B-T109
,	O
ellagic	B-T109
acid	I-T109
and	O
gallic	B-T109
acid	I-T109
can	O
potentiate	B-T052
apoptosis-mediated	O
cell	O
death	O
in	O
hepg2	O
cell	O
line	O
.	O
	
fingerprint	O
-based	O
background	B-T033
checks	I-T033
for	O
personal	O
care	O
workers	O
stakeholder	B-T098
views	B-T078
of	O
policy	B-T170
criteria	B-T078
decision	B-T098
makers	I-T098
face	O
difficult	O
choices	O
when	O
tasked	O
with	O
identifying	O
and	O
implementing	B-T052
appropriate	O
mechanisms	B-T169
for	O
protecting	B-T033
the	O
elderly	B-T098
and	O
other	O
vulnerable	B-T033
adults	I-T033
from	O
abuse	O
.	O
	
a	O
pilot	B-T062
project	I-T062
involving	O
fingerprint	O
-based	O
criminal	B-T098
history	O
background	B-T033
checks	I-T033
for	O
personal	O
care	O
workers	O
in	O
michigan	O
has	O
supplied	O
an	O
opportunity	B-T062
to	O
examine	O
one	O
such	O
mechanism	B-T169
.	O
	
in	O
conjunction	B-T078
with	O
the	O
pilot	B-T062
project	I-T062
,	O
we	O
have	O
conducted	O
a	O
stakeholder	O
analysis	B-T062
with	O
the	O
aim	O
of	O
informing	O
decision	B-T098
makers	I-T098
about	O
stakeholder	B-T098
perceptions	O
of	O
standard	B-T170
policy	B-T170
criteria	B-T078
like	O
effectiveness	B-T080
,	O
efficiency	B-T081
,	O
and	O
equity	B-T080
.	O
	
we	O
employed	O
focus	O
groups	O
and	O
a	O
web-based	B-T170
survey	I-T170
to	O
collect	B-T062
data	B-T078
from	O
stakeholders	B-T098
.	O
	
while	O
stakeholders	B-T098
generally	O
see	O
fingerprint	O
-based	O
background	B-T033
checks	I-T033
for	O
personal	O
care	O
workers	O
as	O
potentially	O
effective	B-T080
and	O
as	O
a	O
net	B-T081
benefit	I-T081
,	O
they	O
also	O
point	O
to	O
a	O
variety	O
of	O
contingencies	O
.	O
	
they	O
also	O
recognize	O
difficulties	B-T033
and	O
constraints	B-T169
for	O
government	O
involvement	B-T169
.	O
	
this	O
preliminary	B-T062
analysis	I-T062
provides	O
solid	O
foundational	B-T078
information	I-T078
for	O
decision	B-T098
makers	I-T098
and	O
for	O
more	O
extensive	O
benefit-cost	O
analysis	O
.	O
	
penetrating	B-T169
craniomaxillofacial	O
injury	O
caused	O
by	O
a	O
pneumatic	O
nail	O
gun	O
craniomaxillofacial	O
injuries	O
can	O
be	O
complex	O
,	O
requiring	O
a	O
multidisciplinary	O
approach	O
.	O
	
the	O
primary	O
survey	O
is	O
always	O
the	O
first	O
step	O
in	O
trauma	O
management	O
prior	O
to	O
proceeding	O
with	O
further	O
evaluation	O
and	O
treatment	O
.	O
	
a	O
26-	O
year	O
-old	O
man	O
presented	O
with	O
a	O
penetrating	O
nail	O
gun	O
injury	O
through	O
the	O
oral	O
and	O
nasal	O
cavities	O
.	O
	
he	O
did	O
not	O
present	O
in	O
extremis	O
but	O
required	O
elective	O
endotracheal	O
intubation	O
for	O
intraoperative	O
assessment	O
and	O
treatment	O
.	O
	
airway	O
management	O
was	O
enhanced	O
by	O
the	O
use	O
of	O
lingual	O
nerve	O
and	O
inferior	O
alveolar	O
nerve	O
blocks	O
via	O
the	O
vazirani-akinosi	O
technique	O
to	O
maintain	O
spontaneous	O
respiration	O
while	O
the	O
tongue	O
was	O
distracted	O
from	O
the	O
palate	O
.	O
	
the	O
nail	O
was	O
removed	O
and	O
rapid	O
sequence	O
induction	O
initiated	O
for	O
orotracheal	O
intubation	O
.	O
	
local	O
nerve	O
blocks	O
can	O
be	O
an	O
effective	O
tool	O
in	O
the	O
armamentarium	O
of	O
the	O
craniomaxillofacial	O
trauma	O
surgeon	O
in	O
managing	O
blunt	O
and	O
penetrating	O
injuries	O
.	O
	
we	O
demonstrate	O
its	O
utility	O
in	O
airway	O
management	O
when	O
a	O
penetrating	O
foreign	O
body	O
in	O
the	O
upper	O
airway	O
precludes	O
orotracheal	O
or	O
nasotracheal	O
design	O
of	O
a	O
candidate	O
vibrational	O
signal	O
for	O
mating	O
disruption	B-T169
against	O
the	O
glassy-winged	O
sharpshooter	O
,	O
homalodisca	O
vitripennis	O
the	O
glassy-winged	O
sharpshooter	O
gwss	O
,	O
homalodisca	O
vitripennis	O
,	O
is	O
an	O
important	O
pest	O
of	O
grapevines	O
due	O
to	O
its	O
ability	O
to	O
transmit	B-T169
xylella	O
fastidiosa	O
,	O
the	O
causal	O
agent	O
of	O
pierce's	B-T047
disease	I-T047
.	O
	
gwss	O
mating	O
communication	O
is	O
based	O
on	O
vibrational	O
signals	O
therefore	O
,	O
vibrational	B-T080
mating	O
disruption	B-T169
could	O
be	O
an	O
alternative	O
to	O
insecticides	O
for	O
suppression	O
of	O
gwss	O
population	B-T098
.	O
	
our	O
objectives	B-T170
were	O
to	O
identify	O
spectral	B-T081
features	B-T080
of	O
female	O
signal	O
that	O
elicit	O
male	O
signaling	O
,	O
design	O
disruptive	B-T080
signals	O
able	O
to	O
alter	B-T169
male	O
perception	O
and	O
acceptance	O
of	O
a	O
female	O
,	O
and	O
determine	O
the	O
signal	B-T081
intensity	I-T081
required	O
for	O
future	O
field	O
applications	O
.	O
	
results	B-T033
showed	O
that	O
male	O
responses	O
to	O
playback	B-T052
of	O
modified	B-T169
female	O
signals	O
were	O
significantly	B-T078
reduced	B-T080
by	O
60-75%when	O
part	O
of	O
the	O
female	O
signal	O
spectral	O
components	O
above	O
or	O
below	O
400	O
hz	O
were	O
deleted	O
.	O
	
playback	B-T052
bioassays	O
showed	O
that	O
transmission	O
of	O
an	O
80	O
hz	O
pure	O
frequency	B-T079
tone	I-T079
to	O
plants	O
completely	O
suppressed	B-T169
male	O
signaling	O
to	O
female	O
signal	B-T052
playback	I-T052
,	O
even	O
if	O
the	O
disruptive	B-T080
signal	B-T082
amplitude	I-T082
was	O
10	O
db	O
lower	O
than	O
the	O
female	O
signal	B-T052
playback	I-T052
.	O
	
although	O
the	O
mechanism	B-T169
underlying	O
cessation	B-T052
of	O
male	O
signaling	O
activity	O
in	O
the	O
presence	B-T033
of	O
disruption	B-T169
is	O
not	O
yet	O
understood	O
,	O
results	B-T033
suggest	O
that	O
an	O
80	O
hz	O
vibrational	O
signal	O
should	O
be	O
tested	O
in	O
laboratory	O
and	O
field	B-T062
experiments	I-T062
to	O
assess	B-T052
its	O
efficacy	B-T080
in	O
disrupting	O
mating	O
of	O
barriers	B-T080
and	O
facilitators	B-T080
to	O
smoking	O
cessation	O
in	O
a	O
cancer	O
context	B-T078
a	O
qualitative	B-T062
study	I-T062
of	O
patient	O
,	O
family	O
and	O
professional	O
views	B-T080
continued	B-T078
smoking	O
after	O
cancer	O
adversely	O
affects	O
quality	O
of	O
life	O
and	O
survival	B-T169
,	O
but	O
one	O
fifth	O
of	O
cancer	O
survivors	O
still	O
smoke	O
.	O
	
despite	O
its	O
demands	O
,	O
cancer	O
presents	O
an	O
opportunity	O
for	O
positive	B-T033
behaviour	O
change	O
.	O
	
smoking	O
often	O
occurs	O
in	O
social	B-T098
groups	I-T098
,	O
therefore	O
interventions	B-T061
which	O
target	B-T169
families	O
and	O
individuals	B-T098
may	O
be	O
more	O
successful	B-T080
.	O
	
this	O
qualitative	B-T062
study	I-T062
explored	O
patients	O
,	O
family	O
members	O
and	O
health	O
professionals	O
'	O
views	B-T080
and	O
experiences	O
of	O
smoking	O
and	O
smoking	O
cessation	O
after	O
cancer	O
,	O
in	O
order	O
to	O
inform	O
future	O
interventions	B-T061
.	O
	
in-depth	O
qualitative	O
interviews	O
n	O
=	O
67	O
with	O
29	O
patients	O
,	O
14	O
family	O
members	O
and	O
24	O
health	O
professionals	O
.	O
	
data	B-T078
were	O
analysed	O
using	O
the	O
'framework'	B-T169
method	I-T169
.	O
	
few	O
patient	O
s	O
and	O
family	O
members	O
had	O
used	O
national	O
health	O
service	O
nhs	O
smoking	O
cessation	O
services	O
and	O
more	O
than	O
half	O
still	O
smoked	O
.	O
	
most	O
recalled	O
little	O
'	O
smoking	O
-related'	O
discussion	B-T061
with	O
clinicians	O
but	O
were	O
receptive	O
to	O
talking	O
openly	O
.	O
	
clinicians	O
revealed	O
several	O
barriers	B-T080
to	O
discussion	B-T061
.	O
	
participants	B-T098
'	O
continued	B-T078
smoking	O
was	O
explained	O
by	O
the	O
stress	B-T033
of	O
diagnosis	O
desire	O
to	O
maintain	O
personal	O
control	B-T080
and	O
lack	B-T080
of	O
connection	O
between	O
smoking	O
,	O
cancer	O
and	O
health	B-T078
.	O
	
a	O
range	O
of	O
barriers	B-T080
to	O
smoking	O
cessation	O
exist	O
for	O
patients	O
and	O
family	O
members	O
.	O
	
these	O
are	O
insufficiently	B-T080
assessed	B-T052
and	O
considered	O
by	O
clinicians	O
.	O
	
interventions	B-T061
improving	B-T080
the	O
sexual	O
health	O
of	O
young	O
people	O
with	O
mobility	B-T033
impairments	I-T033
challenges	O
and	O
recommendations	B-T078
this	O
mixed-method	B-T062
study	I-T062
a	O
describes	O
challenges	O
to	O
providing	B-T052
sexual	O
health	O
services	O
to	O
youth	O
with	O
mobility	B-T033
impairments	I-T033
from	O
the	O
perspective	B-T082
of	O
health	O
care	O
providers	O
and	O
experts	O
and	O
b	O
describes	O
and	O
compares	B-T052
sexual	O
health	O
-related	O
experiences	O
of	O
youth	O
with	O
mobility	B-T033
impairments	I-T033
.	O
	
secondary	O
data	O
analysis	O
of	O
my	O
path	O
,	O
a	O
study	B-T062
focused	B-T169
on	O
the	O
transition	B-T052
to	O
adulthood	B-T079
for	O
youth	O
with	O
mobility	B-T033
impairments	I-T033
.	O
	
using	O
an	O
exploratory	B-T062
sequential	I-T062
design	I-T062
,	O
qualitative	O
data	O
n	O
=	O
10	O
were	O
analyzed	B-T062
using	O
systematic	B-T169
content	B-T062
analysis	I-T062
followed	O
by	O
quantitative	O
analysis	O
of	O
survey	O
data	O
n	O
=	O
337	O
.	O
	
challenges	O
included	B-T169
not	B-T080
talking	I-T080
about	O
sex	O
,	O
managing	O
sexual	O
development	O
,	O
adaptation	O
and	O
instruction	B-T170
,	O
parent	O
roles	O
,	O
and	O
safety	O
.	O
	
survey	B-T170
data	B-T078
showed	O
that	O
youth	O
with	O
mobility	B-T033
impairments	I-T033
are	O
diverse	B-T080
in	O
their	O
experiences	O
with	O
sexual	O
behavior	O
and	O
sources	B-T033
of	O
sexual	O
health	O
information	B-T078
.	O
	
although	O
connected	B-T052
with	O
primary	O
care	O
providers	O
,	O
few	O
received	B-T080
information	B-T078
about	O
sexual	O
health	O
.	O
	
interventions	O
to	O
improve	B-T033
youths	O
'	O
well-being	B-T078
should	O
include	B-T052
comprehensive	O
care	O
and	O
education	O
that	O
promotes	B-T052
and	O
supports	O
healthy	B-T080
sexual	O
development	O
.	O
	
understanding	O
the	O
interrelationship	B-T080
between	O
the	O
synthesis	O
of	O
urea	B-T109
and	O
gluconeogenesis	O
by	O
formulating	O
an	O
overall	B-T080
balanced	O
equation	O
it	O
is	O
well	O
known	O
that	O
a	O
strong	O
metabolic	B-T169
interrelationship	B-T080
exists	O
between	O
ureagenesis	O
and	O
gluconeogenesis	O
.	O
	
in	O
this	O
paper	O
,	O
we	O
present	O
a	O
detailed	O
,	O
overall	B-T080
equation	O
,	O
describing	O
a	O
possible	O
metabolic	B-T169
link	B-T082
between	O
ureagenesis	O
and	O
gluconeogenesis	O
.	O
	
we	O
adopted	O
a	O
guided	B-T082
approach	I-T082
in	O
which	O
we	O
strongly	O
suggest	O
that	O
students	B-T098
,	O
when	O
faced	O
with	O
the	O
problem	B-T033
of	O
obtaining	B-T052
the	O
overall	B-T080
equation	O
of	O
a	O
metabolic	B-T169
pathway	I-T169
,	O
carefully	O
account	O
for	O
all	O
atoms	O
and	O
charges	O
of	O
the	O
single	O
reactions	B-T169
,	O
as	O
well	O
as	O
the	O
cellular	O
localizations	O
of	O
the	O
substrates	O
,	O
and	O
the	O
related	O
transport	O
systems	B-T169
.	O
	
if	O
this	O
suggestion	O
is	O
always	O
taken	O
into	O
account	O
,	O
a	O
balanced	B-T169
,	O
overall	B-T080
equation	O
of	O
a	O
metabolic	B-T169
pathway	I-T169
will	O
be	O
obtained	O
,	O
which	O
strongly	O
facilitates	O
the	O
discussion	O
of	O
its	O
physiological	B-T169
role	O
.	O
	
unfortunately	O
,	O
textbooks	O
often	O
report	B-T170
unbalanced	O
overall	B-T080
equations	O
of	O
metabolic	B-T169
pathways	I-T169
,	O
including	O
ureagenesis	O
and	O
gluconeogenesis	O
.	O
	
most	O
likely	O
the	O
reason	O
is	O
that	O
metabolism	O
and	O
enzymology	B-T169
have	O
been	O
neglected	O
for	O
about	O
three	O
decades	O
,	O
owing	O
to	O
the	O
remarkable	O
advances	O
of	O
molecular	O
biology	O
and	O
molecular	O
genetics	O
.	O
	
in	O
this	O
paper	B-T170
,	O
we	O
strongly	O
suggest	O
that	O
students	B-T098
,	O
when	O
faced	O
with	O
the	O
problem	O
of	O
obtaining	O
the	O
overall	B-T080
reaction	B-T169
of	O
a	O
metabolic	B-T169
pathway	I-T169
,	O
carefully	O
control	O
if	O
the	O
single	O
reactions	B-T169
are	O
properly	O
balanced	B-T169
for	O
atoms	O
and	O
charges	O
.	O
	
following	O
this	O
suggestion	B-T078
,	O
we	O
were	O
able	O
to	O
obtain	O
an	O
overall	B-T080
equation	O
describing	O
the	O
metabolic	B-T169
interrelationship	B-T080
between	O
ureagenesis	O
and	O
gluconeogenesis	O
,	O
in	O
which	O
urea	B-T109
and	O
glucose	B-T109
are	O
the	O
final	B-T079
products	O
.	O
	
the	O
aim	O
is	O
to	O
better	O
rationalize	B-T169
this	O
topic	B-T078
and	O
to	O
convince	O
students	B-T098
and	O
teachers	O
that	O
metabolism	O
is	O
an	O
important	O
and	O
rewarding	O
chapter	B-T078
of	O
human	O
physiology	O
.	O
	
delineation	O
of	O
b-cell	O
epitopes	O
of	O
salmonella	O
enterica	O
serovar	O
typhi	O
hemolysin	B-T116
e	I-T116
potential	B-T080
antibody	B-T116
therapeutic	B-T061
target	B-T169
hemolysin	B-T116
e	I-T116
hlye	B-T116
is	O
an	O
immunogenic	B-T169
novel	B-T080
pore	O
-forming	O
toxin	B-T109
involved	O
in	O
the	O
pathogenesis	O
of	O
typhoid	B-T047
fever	I-T047
.	O
	
thus	O
,	O
mapping	B-T052
of	O
b-cell	O
epitopes	O
of	O
salmonella	O
enterica	O
serovar	O
typhi	O
s	O
.	O
	
typhi	O
is	O
critical	B-T080
to	O
identify	O
key	O
immunogenic	B-T082
regions	I-T082
of	O
hlye	B-T116
.	O
	
a	O
random	O
20-mer	O
peptide	B-T116
library	I-T116
was	O
used	O
for	O
biopanning	O
with	O
enriched	O
anti-hlye	B-T116
polyclonal	I-T116
antibodies	I-T116
from	O
typhoid	B-T047
patient	O
sera	O
.	O
	
bioinformatic	O
tools	B-T170
were	O
used	O
to	O
refine	O
,	O
analyze	B-T062
and	O
map	B-T052
the	O
enriched	O
peptide	O
sequences	O
against	O
the	O
protein	B-T116
to	O
identify	O
the	O
epitopes	O
.	O
	
the	O
analysis	B-T062
identified	O
both	O
linear	B-T082
and	O
conformational	B-T082
epitopes	O
on	O
the	O
hlye	B-T116
protein	I-T116
.	O
	
the	O
predicted	B-T078
linear	B-T082
gaaagivag	O
and	O
conformational	B-T082
epitope	O
pysqesvlsadsqnqk	O
were	O
further	O
validated	O
against	O
the	O
pooled	O
sera	O
.	O
	
the	O
identified	O
epitopes	O
were	O
then	O
used	O
to	O
isolate	B-T061
epitope	O
specific	O
monoclonal	B-T116
antibodies	I-T116
by	O
antibody	B-T116
phage	O
display	O
.	O
	
monoclonal	B-T116
scfv	I-T116
antibodies	B-T116
were	O
enriched	O
for	O
both	O
linear	B-T082
and	O
conformational	B-T082
epitopes	O
.	O
	
molecular	B-T170
docking	I-T170
was	O
performed	O
to	O
elucidate	O
the	O
antigen-antibody	O
interaction	O
of	O
the	O
monoclonal	B-T116
antibodies	I-T116
against	O
the	O
epitopes	O
on	O
the	O
hlye	B-T116
monomer	B-T116
and	O
oligomer	O
structure	O
.	O
	
an	O
in-depth	O
view	O
of	O
the	O
mechanistic	O
and	O
positional	B-T033
characteristics	B-T080
of	O
the	O
antibodies	B-T116
and	O
epitope	O
for	O
hlye	B-T116
was	O
successfully	O
accomplished	O
by	O
a	O
combination	B-T080
of	O
phage	O
display	O
and	O
bioinformatic	O
analysis	B-T062
.	O
	
the	O
predicted	B-T078
function	B-T169
and	O
structure	B-T082
of	O
the	O
antibodies	B-T116
highlights	O
the	O
possibility	O
of	O
utilizing	O
the	O
antibodies	B-T116
as	O
neutralizing	O
agents	O
for	O
typhoid	B-T047
fever	I-T047
.	O
	
comparison	B-T052
of	O
electrospun	O
and	O
solvent	O
cast	O
polylactic	B-T109
acid	I-T109
pla	B-T109
poly	O
alcohol	O
pva	O
inserts	O
as	O
potential	O
ocular	O
drug	O
delivery	O
vehicles	O
the	O
purpose	O
of	O
this	O
work	O
was	O
to	O
develop	O
,	O
characterize	O
and	O
compare	O
electrospun	O
nanofiber	O
inserts	O
enis	O
and	O
solvent	O
cast	O
polymeric	O
inserts	O
scis	O
for	O
ocular	O
drug	O
delivery	O
.	O
	
eni	O
and	O
sci	O
of	O
1%	O
,	O
5%	O
and	O
10%	O
w/w	O
dexamethasone	B-T109
were	O
fabricated	O
using	O
a	O
blend	O
of	O
poly-lactic	B-T109
acid	I-T109
pla	B-T109
and	O
poly-vinyl	O
alcohol	O
pva	O
.	O
	
inserts	O
were	O
characterized	O
for	O
morphology	B-T080
,	O
thickness	B-T080
,	O
ph	B-T081
,	O
drug	O
content	O
,	O
drug	B-T080
crystallinity	I-T080
,	O
in	B-T080
vitro	I-T080
drug	O
release	O
,	O
sterility	B-T080
,	O
dimethylformamide	B-T109
dmf	B-T109
and	O
chloroform	B-T109
content	O
,	O
and	O
cytotoxicity	O
.	O
	
the	O
thickness	B-T080
of	O
1%	O
,	O
5%	O
,	O
and	O
10%	O
dexamethasone	B-T109
-loaded	O
enis	O
were	O
found	O
to	O
be	O
50μm	O
,	O
62.5μm	O
,	O
and	O
93.3μm	O
,	O
respectively	O
,	O
with	O
good	O
folding	B-T033
endurance	I-T033
.	O
	
scis	O
were	O
brittle	B-T033
,	O
with	O
thickness	B-T080
values	O
>200μm	O
.	O
	
drug	O
release	O
rates	B-T081
from	O
1%	O
,	O
5%	O
and	O
10%	O
enis	O
were	O
found	O
to	O
be	O
0.62μg	O
,	O
1.46μg	O
,	O
and	O
2.30μg	O
,	O
respectively	O
,	O
while	O
those	O
from	O
scis	O
were	O
erratic	O
.	O
	
dmf	B-T109
content	O
in	O
enis	O
and	O
scis	O
were	O
0.007	O
w/w	O
and	O
0.123	O
w/w	O
,	O
respectively	O
,	O
while	O
chloroform	B-T109
was	O
not	B-T033
detected	I-T033
.	O
	
no	B-T033
cytotoxicity	O
was	O
observed	O
from	O
enis	O
in	O
cultured	O
bovine	O
corneal	O
endothelial	O
cells	O
for	O
up	O
to	O
24h	O
.	O
	
we	O
conclude	O
that	O
enis	O
are	O
better	O
than	O
scis	O
and	O
could	O
be	O
utilized	O
as	O
a	O
potential	O
delivery	O
system	O
for	O
treating	B-T169
anterior	B-T082
segment	I-T082
ocular	B-T047
diseases	I-T047
.	O
	
quantitative	B-T081
regulation	O
of	O
histone	B-T116
variant	I-T116
h2a.z	I-T116
during	B-T079
cell	O
cycle	O
by	O
ubiquitin	O
proteasome	O
system	O
and	O
sumo-targeted	O
ubiquitin	O
ligases	O
quantitative	B-T081
control	B-T169
of	O
histones	B-T116
and	O
histone	B-T116
variants	I-T116
during	B-T079
cell	O
cycle	O
is	O
relevant	B-T080
to	O
their	O
epigenetic	O
functions	O
.	O
	
we	O
found	O
that	O
the	O
level	B-T080
of	O
yeast	B-T116
histone	I-T116
variant	I-T116
h2a.z	I-T116
in	O
the	O
g2/m-phase	O
is	O
actively	B-T169
kept	O
low	O
by	O
the	O
ubiquitin	O
proteasome	O
system	O
and	O
sumo-targeted	O
ubiquitin	O
ligases	O
.	O
	
overexpression	O
of	O
h2a.z	B-T116
induced	O
defects	O
in	O
mitotic	O
progression	O
,	O
suggesting	B-T078
functional	B-T169
importance	B-T080
of	O
this	O
quantitative	B-T081
control	B-T169
.	O
	
tyrphostin	O
ag-related	O
compounds	O
attenuate	O
h2o2	O
-	O
induced	B-T169
trpm2	B-T116
-	O
dependent	B-T080
and	O
-	O
independent	B-T169
cellular	O
responses	O
trpm2	B-T116
is	O
a	O
ca	B-T116
channel	I-T116
that	O
is	O
activated	B-T052
by	O
h2o2	O
.	O
	
trpm2	B-T116
-mediated	O
ca	O
signaling	O
has	O
been	O
implicated	O
in	O
the	O
aggravation	B-T033
of	O
inflammatory	B-T047
diseases	I-T047
.	O
	
therefore	O
,	O
the	O
development	B-T169
of	O
trpm2	B-T116
inhibitors	O
to	O
prevent	O
the	O
aggravation	B-T033
of	O
these	O
diseases	B-T047
is	O
expected	O
.	O
	
we	O
recently	O
reported	O
that	O
some	O
tyrphostin	O
ag-related	O
compounds	O
inhibited	B-T080
the	O
h2o2	O
-	O
induced	B-T169
activation	B-T052
of	O
trpm2	B-T116
by	O
scavenging	O
the	O
intracellular	O
hydroxyl	O
radical	O
.	O
	
in	O
the	O
present	O
study	O
,	O
we	O
examined	O
the	O
effects	B-T080
of	I-T080
ag-related	O
compounds	O
on	O
h2o2	O
-	O
induced	B-T169
cellular	O
responses	O
in	O
human	O
monocytic	O
u937	O
cells	O
,	O
which	O
functionally	B-T169
express	O
trpm2	B-T116
.	O
	
the	O
effects	B-T080
of	I-T080
ag-related	O
compounds	O
on	O
h2o2	O
-	O
induced	B-T169
changes	B-T169
in	O
intracellular	B-T082
ca	O
concentrations	B-T081
,	O
extracellular	B-T116
signal-regulated	I-T116
kinase	I-T116
erk	B-T116
activation	B-T052
,	O
and	O
cxcl8	B-T116
secretion	O
were	O
assessed	O
using	O
u937	O
cells	O
.	O
	
ca	O
influxes	O
via	O
trpm2	B-T116
in	O
response	O
to	O
h2o2	O
were	O
blocked	O
by	O
ag-related	O
compounds	O
.	O
	
ag-related	O
compounds	O
also	O
inhibited	B-T080
the	O
h2o2	O
-	O
induced	B-T169
activation	B-T052
of	O
erk	B-T116
,	O
and	O
subsequent	O
secretion	O
of	O
cxcl8	B-T116
mediated	O
by	O
trpm2	B-T116
-	O
dependent	B-T080
and	O
-	O
independent	B-T169
mechanisms	B-T169
.	O
	
our	O
results	O
show	O
that	O
ag-related	O
compounds	O
inhibit	B-T080
h2o2	O
-	O
induced	B-T169
cxcl8	B-T116
secretion	O
following	O
erk	B-T116
activation	B-T052
,	O
which	O
is	O
mediated	O
by	O
trpm2	B-T116
-	O
dependent	B-T080
and	O
-	O
independent	B-T169
mechanisms	B-T169
in	O
u937	O
cells	O
.	O
	
we	O
previously	O
reported	O
that	O
ag-related	O
compounds	O
blocked	O
h2o2	O
-	O
induced	B-T169
trpm2	B-T116
activation	B-T052
by	O
scavenging	O
the	O
hydroxyl	O
radical	O
.	O
	
the	O
inhibitory	B-T052
effects	B-T080
of	O
ag-related	O
compounds	O
on	O
trpm2	B-T116
-	O
independent	B-T169
responses	O
may	O
be	O
due	O
to	O
scavenging	O
of	O
the	O
hydroxyl	O
radical	O
.	O
	
shared	O
decision	O
making	O
in	O
the	O
uk	O
moving	O
towards	O
wider	O
uptake	O
shared	O
decision	O
making	O
sdm	O
is	O
firmly	O
on	O
the	O
policy	B-T170
agenda	B-T170
in	O
the	O
uk	O
and	O
a	O
recent	O
legal	B-T169
ruling	O
has	O
confirmed	O
its	O
importance	O
.	O
	
policymakers	O
,	O
ethicists	O
,	O
professional	O
regulators	O
and	O
societies	O
,	O
patient	O
organisations	O
and	O
now	O
the	O
courts	O
are	O
committed	O
to	O
ensuring	O
that	O
sdm	O
becomes	O
the	O
norm	B-T080
throughout	O
the	O
nhs	O
,	O
but	O
an	O
unfavourable	O
economic	O
climate	O
makes	O
this	O
especially	O
challenging	O
.	O
	
considerable	O
progress	B-T169
has	O
been	O
made	O
over	O
the	O
last	O
few	O
years	B-T079
,	O
with	O
new	O
learning	O
from	O
demonstration	O
sites	B-T082
,	O
various	O
initiatives	O
in	O
capacity	O
building	O
and	O
training	O
,	O
wider	O
availability	O
of	O
patient	O
decision	B-T170
aids	I-T170
,	O
and	O
important	O
leadership	O
initiatives	O
.	O
	
enthusiasm	O
for	O
this	O
way	O
of	O
working	O
is	O
growing	O
among	O
clinicians	O
,	O
patients	O
and	O
managers	O
,	O
but	O
it	O
could	O
be	O
undermined	O
if	O
sdm	O
comes	O
to	O
be	O
seen	O
primarily	O
as	O
a	O
means	O
of	O
cost	O
control	O
.	O
	
lactate	B-T109
induces	O
osteoblast	O
differentiation	O
by	O
stabilization	O
of	O
hif1α	B-T116
aerobic	O
glycolysis	O
is	O
involved	O
in	O
osteoblast	O
differentiation	O
induced	O
by	O
wnt	O
signaling	O
or	O
pth	B-T116
treatment	B-T169
.	O
	
however	O
,	O
it	O
is	O
still	O
unclear	O
whether	O
lactate	B-T109
,	O
the	O
end	O
product	O
of	O
aerobic	O
glycolysis	O
,	O
plays	O
any	O
role	O
in	O
osteoblast	O
differentiation	O
.	O
	
herein	O
we	O
report	O
that	O
in	O
cultures	O
of	O
osteoblast-lineage	O
cells	O
,	O
lactate	B-T109
promoted	O
alkaline	B-T116
phosphatase	I-T116
-positive	O
cell	O
formation	O
,	O
increased	O
the	O
activity	O
of	O
alkaline	B-T116
phosphatase	I-T116
,	O
and	O
induced	O
the	O
expression	O
of	O
osteocalcin	B-T116
.	O
	
this	O
osteoblast	O
differentiation	O
-inducing	O
effect	O
of	O
lactate	B-T109
can	O
be	O
inhibited	B-T080
by	O
blocking	B-T169
its	O
entry	O
into	O
cells	O
with	O
mct1	B-T116
sirna	O
or	O
inhibitors	O
,	O
and	O
by	O
interfering	O
with	O
its	O
metabolism	O
by	O
using	O
specific	O
sirnas	O
for	O
ldhb	B-T116
and	O
pdh	B-T116
.	O
	
moreover	O
,	O
lactate	B-T109
stabilized	O
hif1α	B-T116
expression	O
and	O
inhibited	B-T080
hif1α	B-T116
activity	O
,	O
with	O
bay87-2243	O
lowering	O
the	O
osteoblast	O
differentiation	O
-inducing	O
effect	O
of	O
lactate	B-T109
.	O
	
thus	O
,	O
these	O
findings	B-T033
reveal	O
an	O
unrecognized	O
role	O
for	O
aerobic	O
glycolysis	O
in	O
osteoblast	O
differentiation	O
via	O
its	O
end	O
product	O
,	O
committee	O
opinion	O
no	O
.	O
	
701	O
summary	O
choosing	O
the	O
route	B-T082
of	O
hysterectomy	B-T061
for	O
benign	B-T080
disease	B-T047
hysterectomy	B-T061
is	O
one	O
of	O
the	O
most	O
frequently	O
performed	O
surgical	B-T061
procedures	I-T061
in	O
the	O
united	O
states	O
.	O
	
selection	B-T052
of	O
the	O
route	B-T082
of	O
hysterectomy	B-T061
for	O
benign	B-T080
causes	O
can	O
be	O
influenced	O
by	O
the	O
size	B-T082
and	O
shape	B-T082
of	O
the	O
vagina	O
and	O
uterus	O
accessibility	O
to	O
the	O
uterus	O
extent	O
of	O
extrauterine	B-T047
disease	I-T047
the	O
need	O
for	O
concurrent	O
procedures	O
surgeon	O
training	O
and	O
experience	O
average	O
case	B-T081
volume	I-T081
available	O
hospital	O
technology	O
,	O
devices	O
,	O
and	O
support	O
whether	O
the	O
case	O
is	O
emergent	O
or	O
scheduled	O
and	O
preference	O
of	O
the	O
informed	O
patient	O
.	O
	
vaginal	B-T061
and	O
laparoscopic	B-T061
procedures	I-T061
are	O
considered	O
""""	O
minimally	B-T169
invasive	I-T169
""""	O
surgical	B-T169
approaches	I-T169
because	O
they	O
do	O
not	O
require	O
a	O
large	O
abdominal	B-T061
incision	I-T061
and	O
,	O
thus	O
,	O
typically	O
are	O
associated	O
with	O
shortened	O
hospitalization	O
and	O
postoperative	B-T033
recovery	I-T033
times	I-T033
compared	O
with	O
open	O
abdominal	B-T061
hysterectomy	I-T061
.	O
	
minimally	B-T169
invasive	I-T169
approaches	I-T169
to	O
hysterectomy	B-T061
should	O
be	O
performed	O
,	O
whenever	O
feasible	O
,	O
based	O
on	O
their	O
well-documented	O
advantages	O
over	O
abdominal	B-T061
hysterectomy	I-T061
.	O
	
the	O
vaginal	B-T082
approach	I-T082
is	O
preferred	O
among	O
the	O
minimally	B-T169
invasive	I-T169
approaches	I-T169
.	O
	
laparoscopic	B-T061
hysterectomy	I-T061
is	O
a	O
preferable	O
alternative	O
to	O
open	O
abdominal	B-T061
hysterectomy	I-T061
for	O
those	O
patients	O
in	O
whom	O
a	O
vaginal	B-T061
hysterectomy	I-T061
is	O
not	O
indicated	O
or	O
feasible	O
.	O
	
although	O
minimally	B-T169
invasive	I-T169
approaches	I-T169
to	O
hysterectomy	B-T061
are	O
the	O
preferred	O
route	B-T082
,	O
open	B-T061
abdominal	B-T061
hysterectomy	I-T061
remains	O
an	O
important	O
surgical	O
option	O
for	O
some	O
patients	O
.	O
	
the	O
obstetrician	O
-	O
gynecologist	O
should	O
discuss	O
the	O
options	O
with	O
patients	O
and	O
make	O
clear	O
recommendations	O
on	O
which	O
route	B-T082
of	O
hysterectomy	B-T061
will	O
maximize	O
benefits	B-T081
and	O
minimize	O
risks	B-T078
given	O
the	O
specific	O
clinical	O
situation	O
.	O
	
the	O
relative	O
advantages	O
and	O
disadvantages	O
of	O
the	O
approaches	B-T169
to	O
hysterectomy	B-T061
should	O
be	O
discussed	O
in	O
the	O
context	O
of	O
the	O
patient	O
's	O
values	O
and	O
preferences	B-T080
,	O
and	O
the	O
patient	O
and	O
health	O
care	O
provider	O
measuring	B-T080
nonlinear	B-T080
signal	O
combination	B-T080
using	O
eeg	O
relatively	B-T080
little	O
is	O
known	O
about	O
the	O
processes	O
,	O
both	O
linear	B-T082
and	O
nonlinear	B-T080
,	O
by	O
which	O
signals	O
are	O
combined	B-T080
beyond	O
v1	O
.	O
	
by	O
presenting	O
two	O
stimulus	O
components	O
simultaneously	B-T079
,	O
flickering	B-T033
at	O
different	B-T080
temporal	B-T079
frequencies	I-T079
frequency	B-T081
tagging	O
while	O
measuring	B-T080
steady-state	O
visual	O
evoked	O
potentials	O
,	O
we	O
can	O
assess	O
responses	O
to	O
the	O
individual	O
components	O
,	O
including	O
direct	B-T080
measurements	B-T169
of	O
suppression	O
on	O
each	O
other	O
,	O
and	O
various	O
nonlinear	B-T080
responses	O
to	O
their	O
combination	B-T080
found	O
at	O
intermodulation	B-T080
frequencies	B-T081
.	O
	
the	O
result	O
is	O
a	O
rather	O
rich	O
dataset	B-T170
of	O
frequencies	B-T081
at	O
which	O
responses	O
can	O
be	O
found	O
.	O
	
we	O
presented	O
pairs	B-T080
of	O
sinusoidal	B-T082
gratings	I-T082
at	O
different	B-T080
temporal	B-T079
frequencies	I-T079
,	O
forming	O
plaid	B-T033
patterns	I-T033
that	O
were	O
""""	O
coherent	B-T033
""""	O
looking	B-T082
like	I-T082
a	I-T082
checkerboar	I-T082
d	O
and	O
""""	O
noncoherent	B-T033
""""	O
looking	O
like	O
a	O
pair	B-T080
of	O
transparently	B-T080
overlaid	B-T082
gratings	I-T082
,	O
and	O
found	O
clear	O
intermodulation	B-T080
responses	O
to	O
compound	B-T080
stimuli	O
,	O
indicating	O
nonlinear	B-T080
summation	O
.	O
	
this	O
might	O
have	O
been	O
attributed	O
to	O
cross-orientation	B-T082
suppression	O
except	O
that	O
the	O
pattern	B-T082
of	O
intermodulation	B-T080
responses	O
differed	B-T080
for	O
coherent	B-T033
and	O
noncoherent	B-T033
patterns	B-T082
,	O
whereas	O
the	O
effects	B-T080
of	I-T080
suppression	O
measured	O
at	O
the	O
component	O
frequencies	B-T081
did	O
not	O
.	O
	
a	O
two-stage	B-T170
model	I-T170
of	O
nonlinear	B-T080
summation	O
involving	O
conjunction	B-T078
detection	B-T061
with	O
a	O
logical	O
and	B-T170
gate	I-T170
described	O
the	O
data	B-T078
well	O
,	O
capturing	O
the	O
difference	B-T081
between	O
coherent	B-T033
and	O
noncoherent	B-T033
plaids	B-T082
over	O
a	O
wide	O
array	B-T082
of	O
possible	B-T033
response	B-T079
frequencies	I-T079
.	O
	
multistimulus	B-T080
frequency	B-T081
-tagged	O
eeg	O
in	O
combination	B-T080
with	O
computational	O
modeling	O
may	O
be	O
a	O
very	O
valuable	O
tool	O
in	O
studying	O
the	O
conjunction	B-T078
of	O
these	O
signals	O
.	O
	
in	O
the	O
current	O
study	B-T062
the	O
results	O
suggest	O
a	O
second-order	O
mechanism	O
responding	O
selectively	B-T080
to	O
coherent	B-T033
plaid	B-T033
patterns	I-T033
.	O
	
sleep	B-T033
loss	I-T033
promotes	B-T052
astrocytic	O
phagocytosis	O
and	O
microglial	O
activation	O
in	O
mouse	O
cerebral	O
cortex	O
we	O
previously	O
found	O
that	O
mertk	B-T116
and	O
its	O
ligand	B-T116
gas6	I-T116
,	O
astrocytic	O
genes	O
involved	O
in	O
phagocytosis	O
,	O
are	O
upregulated	O
after	B-T079
acute	B-T079
sleep	B-T033
deprivation	I-T033
.	O
	
these	O
results	O
suggested	O
that	O
astrocytes	O
may	O
engage	O
in	O
phagocytic	O
activity	O
during	B-T079
extended	B-T082
wake	O
,	O
but	O
direct	B-T080
evidence	B-T078
was	O
lacking	B-T080
.	O
	
studies	B-T062
in	O
humans	O
and	O
rodents	O
also	O
found	B-T033
that	O
sleep	B-T033
loss	I-T033
increases	B-T169
peripheral	B-T082
markers	O
of	O
inflammation	O
,	O
but	O
whether	O
these	O
changes	B-T169
are	O
associated	B-T080
with	I-T080
neuroinflammation	O
and/or	O
activation	O
of	O
microglia	O
,	O
the	O
brain's	O
resident	O
innate	O
immune	O
cells	O
,	O
was	O
unknown	B-T080
.	O
	
here	O
we	O
used	B-T169
serial	O
block-face	O
scanning	O
electron	O
microscopy	O
to	O
obtain	O
3d	O
volume	B-T081
measurements	B-T169
of	O
synapses	O
and	O
surrounding	B-T082
astrocytic	O
processes	O
in	O
mouse	O
frontal	O
cortex	O
after	B-T079
6-8	O
h	O
of	O
sleep	O
,	O
spontaneous	B-T169
wake	O
,	O
or	O
sleep	B-T033
deprivation	I-T033
sd	B-T033
and	O
after	B-T079
chronic	B-T169
5	I-T169
d	I-T169
sleep	I-T169
restriction	I-T169
csr	B-T169
.	O
	
astrocytic	O
phagocytosis	O
,	O
mainly	O
of	O
presynaptic	O
components	O
of	O
large	O
synapses	O
,	O
increased	B-T081
after	B-T079
both	B-T080
acute	B-T079
and	O
chronic	B-T079
sleep	B-T033
loss	I-T033
relative	B-T080
to	O
sleep	O
and	O
wake	O
.	O
	
mertk	B-T116
expression	O
and	O
lipid	O
peroxidation	O
in	O
synaptoneurosomes	O
also	O
increased	B-T081
to	O
a	O
similar	B-T080
extent	B-T082
after	B-T079
short	B-T081
and	O
long	B-T080
sleep	B-T033
loss	I-T033
,	O
suggesting	O
that	O
astrocytic	O
phagocytosis	O
may	O
represent	B-T052
the	O
brain's	O
response	O
to	O
the	O
increase	B-T169
in	O
synaptic	O
activity	O
associated	B-T080
with	I-T080
prolonged	B-T079
wake	O
,	O
clearing	B-T080
worn	O
components	O
of	O
heavily	O
used	B-T169
synapses	O
.	O
	
using	B-T169
confocal	O
microscopy	O
,	O
we	O
then	O
found	B-T033
that	O
csr	B-T169
but	O
not	B-T169
sd	B-T033
mice	O
show	O
morphological	B-T082
signs	O
of	O
microglial	O
activation	O
and	O
enhanced	B-T052
microglial	O
phagocytosis	O
of	O
synaptic	O
elements	O
,	O
without	B-T080
obvious	O
signs	O
of	O
neuroinflammation	O
in	O
the	O
csf	O
.	O
	
because	O
low	B-T080
-	O
level	B-T080
sustained	B-T169
microglia	O
activation	O
can	O
lead	O
to	O
abnormal	B-T033
responses	O
to	O
a	O
secondary	B-T080
insult	O
,	O
these	O
results	B-T169
suggest	B-T078
that	O
chronic	B-T079
sleep	B-T033
loss	I-T033
,	O
through	B-T169
microglia	O
priming	O
,	O
may	O
predispose	O
the	O
brain	O
to	O
further	B-T082
damage	B-T169
significance	O
statement	O
we	O
find	B-T033
that	O
astrocytic	O
phagocytosis	O
of	O
synaptic	O
elements	O
,	O
mostly	O
of	O
presynaptic	O
origin	O
and	O
in	O
large	B-T081
synapses	O
,	O
is	O
upregulated	O
already	O
after	B-T079
a	O
few	B-T081
hours	B-T079
of	O
sleep	B-T033
deprivation	I-T033
and	O
shows	O
a	O
further	B-T082
significant	B-T078
increase	B-T169
after	B-T079
prolonged	B-T079
and	O
severe	B-T080
sleep	B-T033
loss	I-T033
,	O
suggesting	O
that	O
it	O
may	O
promote	B-T052
the	O
housekeeping	O
of	O
heavily	O
used	B-T169
and	O
strong	B-T080
synapses	O
in	O
response	O
to	O
the	O
increased	B-T081
neuronal	O
activity	O
of	O
extended	B-T082
wake	O
.	O
	
by	O
contrast	B-T080
,	O
chronic	B-T169
sleep	I-T169
restriction	I-T169
but	O
not	B-T169
acute	B-T079
sleep	B-T033
loss	I-T033
activates	O
microglia	O
,	O
promotes	B-T052
their	O
phagocytic	O
activity	O
,	O
and	O
does	O
so	O
in	O
the	O
absence	B-T169
of	O
overt	O
signs	O
of	O
neuroinflammation	O
,	O
suggesting	O
that	O
like	O
many	O
other	B-T080
stressors	B-T078
,	O
extended	B-T082
sleep	B-T033
disruption	I-T033
may	O
lead	O
to	O
a	O
state	B-T169
of	O
sustained	B-T169
microglia	O
activation	O
,	O
perhaps	O
increasing	B-T169
the	O
brain's	O
susceptibility	B-T169
to	O
other	B-T080
forms	B-T169
of	O
reflections	B-T062
on	O
hip	B-T061
fracture	I-T061
recovery	I-T061
from	O
older	B-T098
adults	I-T098
enrolled	O
in	O
a	O
clinical	B-T062
trial	I-T062
this	O
study	B-T062
describes	O
patients'	O
perspectives	O
on	O
recovery	B-T052
during	O
participation	B-T169
in	O
a	O
randomized	B-T062
controlled	I-T062
trial	I-T062
that	O
tested	B-T170
a	O
postoperative	B-T079
hip	O
fracture	O
management	B-T169
program	I-T169
b4	O
clinic	O
,	O
compared	B-T052
with	O
usual	O
care	O
,	O
on	O
mobility	B-T080
.	O
	
semistructured	B-T082
qualitative	B-T080
interviews	B-T052
were	O
conducted	O
with	O
50	O
older	B-T098
adults	I-T098
with	O
hip	O
fracture	O
from	O
both	O
groups	B-T098
twice	O
over	O
12	O
months	O
.	O
	
a	O
total	B-T080
of	O
32	O
women	B-T098
64%	O
and	O
18	O
men	B-T098
36%	O
participated	B-T169
in	O
the	O
study	B-T062
with	O
a	O
mean	B-T081
age	O
at	O
baseline	B-T081
of	O
82	O
range	B-T081
=	O
65-98	O
years	O
.	O
	
a	O
total	B-T080
of	O
40	O
participants	B-T098
reported	O
recovery	B-T052
goals	B-T170
at	O
some	O
point	O
during	O
their	O
recovery	B-T052
from	O
hip	O
fracture	O
but	O
only	O
18	O
participants	B-T098
realized	B-T078
their	O
goals	B-T170
within	O
12	O
months	O
.	O
	
recovering	O
mobility	B-T080
,	O
returning	B-T080
to	O
prefracture	B-T052
activities	I-T052
,	O
and	O
obtaining	B-T169
stable	B-T080
health	B-T078
were	O
the	O
most	B-T081
commonly	B-T081
reported	O
goals	B-T170
.	O
	
participants	B-T098
described	O
good	B-T080
social	O
support	O
,	O
access	B-T082
to	O
physiotherapy	B-T061
,	O
and	O
positive	B-T033
perspective	O
as	O
most	B-T081
important	B-T080
to	O
recovery	B-T052
.	O
	
these	O
factors	B-T169
were	O
influenced	O
by	O
participants	B-T098
'	O
knowledge	B-T170
,	O
resources	B-T078
,	O
and	O
monthly	O
contact	B-T078
with	O
study	B-T062
staff	O
perceived	O
as	O
a	O
form	O
of	O
social	O
support	O
.	O
	
the	O
most	B-T081
frequently	B-T079
reported	O
barriers	B-T080
to	O
participants	B-T098
'	O
recovery	B-T052
were	O
the	O
onset	B-T080
of	I-T080
complications	O
,	O
pain	O
,	O
and	O
limited	B-T033
access	I-T033
to	O
physiotherapy	B-T061
.	O
	
potential	B-T080
implications	B-T078
of	O
these	O
findings	B-T033
include	B-T052
design	B-T052
and	O
modification	B-T033
of	O
new	O
or	O
preexisting	B-T080
fracture	O
programs	B-T169
,	O
prioritizing	B-T079
patient	O
engagement	O
and	O
enhanced	B-T052
knowledge	B-T170
for	O
future	B-T079
clinical	B-T062
research	I-T062
in	O
hip	B-T061
fracture	I-T061
recovery	I-T061
.	O
	
it	O
takes	O
biking	O
to	O
learn	O
physical	O
activity	O
improves	B-T033
learning	O
a	O
second	B-T033
language	I-T033
recent	O
studies	B-T062
have	O
shown	O
that	O
concurrent	B-T079
physical	O
activity	O
enhances	B-T052
learning	O
a	O
completely	O
unfamiliar	O
l2	B-T033
vocabulary	B-T170
as	O
compared	O
to	O
learning	O
it	O
in	O
a	O
static	B-T080
condition	B-T080
.	O
	
in	O
this	O
paper	O
we	O
report	O
a	O
study	B-T062
whose	O
aim	O
is	O
twofold	O
to	O
test	O
for	O
possible	B-T033
positive	B-T033
effects	B-T080
of	I-T080
physical	O
activity	O
when	O
l2	B-T033
learning	O
has	O
already	O
reached	O
some	O
level	B-T080
of	O
proficiency	B-T080
,	O
and	O
to	O
test	O
whether	O
the	O
assumed	O
better	B-T080
performance	B-T052
when	O
engaged	O
in	O
physical	O
activity	O
is	O
limited	O
to	O
the	O
linguistic	O
level	B-T080
probed	O
at	O
training	B-T080
i.e	O
.	O
	
l2	B-T033
vocabulary	B-T170
tested	B-T169
by	O
means	O
of	O
a	O
word-picture	B-T062
verification	I-T062
task	I-T062
,	O
or	O
whether	O
it	O
extends	O
also	O
to	O
the	O
sentence	B-T170
level	B-T080
which	O
was	O
tested	B-T169
by	O
means	O
of	O
a	O
sentence	B-T062
semantic	I-T062
judgment	I-T062
task	I-T062
.	O
	
the	O
results	O
show	O
that	O
chinese	B-T098
speakers	I-T098
with	O
basic	B-T033
knowledge	I-T033
of	O
english	O
benefited	B-T081
from	O
physical	O
activity	O
while	O
learning	O
a	O
set	O
of	O
new	O
words	B-T170
.	O
	
furthermore	O
,	O
their	O
better	B-T080
performance	B-T052
emerged	O
also	O
at	O
the	O
sentential	B-T170
level	B-T080
,	O
as	O
shown	O
by	O
their	O
performance	B-T052
in	O
a	O
semantic	B-T062
judgment	I-T062
task	I-T062
.	O
	
finally	O
,	O
an	O
interesting	O
temporal	O
asymmetry	O
between	O
the	O
lexical	B-T078
and	O
the	O
sentential	B-T170
level	B-T080
emerges	O
,	O
with	O
the	O
difference	O
between	O
the	O
experimental	B-T078
and	O
control	O
group	O
emerging	O
from	O
the	O
1st	O
testing	O
session	O
at	O
the	O
lexical	B-T078
level	B-T080
but	O
after	O
several	O
weeks	O
at	O
the	O
sentential	B-T170
level	B-T080
.	O
	
the	O
added	B-T169
value	B-T081
of	O
cardiac	B-T033
index	I-T033
and	O
pulse	O
pressure	O
variation	B-T080
monitoring	O
to	O
mean	B-T033
arterial	I-T033
pressure	I-T033
-	O
guided	B-T061
volume	I-T061
therapy	I-T061
in	O
moderate-risk	B-T061
abdominal	I-T061
surgery	I-T061
coguide	B-T061
a	O
pragmatic	B-T062
multicentre	B-T062
randomised	B-T062
controlled	I-T062
trial	I-T062
there	O
is	O
disagreement	O
regarding	O
the	O
benefits	B-T081
of	O
goal-directed	B-T061
therapy	I-T061
in	O
moderate-risk	B-T061
abdominal	I-T061
surgery	I-T061
.	O
	
therefore	O
,	O
we	O
tested	B-T170
the	O
hypothesis	B-T078
that	O
the	O
addition	B-T169
of	O
non-invasive	B-T169
cardiac	B-T033
index	I-T033
and	O
pulse	O
pressure	O
variation	B-T080
monitoring	O
to	O
mean	B-T033
arterial	I-T033
pressure	I-T033
-based	O
goal-directed	B-T061
therapy	I-T061
would	O
reduce	B-T080
the	O
incidence	B-T081
of	O
postoperative	O
complications	O
in	O
patients	O
having	O
moderate-risk	B-T061
abdominal	I-T061
surgery	I-T061
.	O
	
in	O
this	O
pragmatic	B-T062
multicentre	B-T062
randomised	B-T062
controlled	I-T062
trial	I-T062
,	O
we	O
randomly	B-T062
allocated	I-T062
244	O
patients	O
by	O
envelope	B-T170
drawing	I-T170
in	O
a	O
1	O
fashion	O
,	O
stratified	B-T080
per	O
centre	O
.	O
	
all	O
patients	O
had	O
mean	B-T033
arterial	I-T033
pressure	I-T033
,	O
cardiac	B-T033
index	I-T033
and	O
pulse	O
pressure	O
variation	B-T080
measured	B-T080
continuously	B-T078
.	O
	
in	O
one	O
group	B-T078
,	O
healthcare	O
professionals	O
were	O
blinded	B-T062
to	O
cardiac	B-T033
index	I-T033
and	O
pulse	O
pressure	O
variation	B-T080
values	B-T081
and	O
were	O
asked	O
to	O
guide	O
haemodynamic	B-T061
therapy	I-T061
only	O
based	O
on	O
mean	B-T033
arterial	I-T033
pressure	I-T033
control	O
group	O
.	O
	
in	O
the	O
second	O
group	B-T078
,	O
cardiac	B-T033
index	I-T033
and	O
pulse	O
pressure	O
variation	B-T080
values	B-T081
were	O
displayed	B-T169
and	O
kept	O
within	O
target	B-T169
ranges	B-T081
following	O
a	O
pre-defined	B-T170
algorithm	I-T170
ci-ppv	B-T078
group	I-T078
.	O
	
the	O
primary	O
endpoint	O
was	O
the	O
incidence	B-T081
of	O
postoperative	O
complications	O
within	B-T033
30	I-T033
days	I-T033
.	O
	
one	O
hundred	O
and	O
seventy-five	O
patients	O
were	O
eligible	B-T080
for	O
final	B-T079
analysis	B-T062
.	O
	
overall	B-T080
complication	O
rates	O
were	O
similar	O
42/94	O
44.7	O
vs	O
.	O
	
38/81	O
46.9	O
in	O
the	O
control	O
and	O
ci-ppv	B-T078
groups	I-T078
,	O
respectively	O
p	O
=	O
0.95	O
.	O
	
the	O
ci-ppv	B-T078
group	I-T078
had	O
lower	B-T080
mean	B-T081
sd	B-T081
pulse	O
pressure	O
variation	B-T080
values	B-T081
9.5	O
2.0	O
vs	O
.	O
	
11.9	O
4.6	O
p	O
=	O
0.003	O
and	O
higher	B-T080
mean	B-T081
sd	B-T081
cardiac	B-T033
indices	I-T033
2.76	O
0.62	O
l	O
min	O
m	O
vs	O
.	O
	
2.53	O
0.66	O
l	O
min	O
m	O
p	O
=	O
0.004	O
than	O
the	O
control	O
group	O
.	O
	
in	O
moderate-risk	B-T061
abdominal	I-T061
surgery	I-T061
,	O
we	O
observed	B-T169
no	O
additional	B-T170
value	I-T170
of	O
cardiac	B-T033
index	I-T033
and	O
pulse	O
pressure	O
variation	B-T080
-	O
guided	B-T061
haemodynamic	I-T061
therapy	I-T061
to	O
mean	B-T033
arterial	I-T033
pressure	I-T033
-	O
guided	B-T061
volume	I-T061
therapy	I-T061
with	O
regard	O
to	O
postoperative	O
complications	O
.	O
	
anterior	O
single	O
implants	O
with	O
different	O
neck	B-T082
designs	B-T052
5	O
year	B-T079
results	O
of	O
a	O
randomized	B-T062
clinical	I-T062
trial	I-T062
the	O
design	B-T052
of	O
the	O
implant	O
neck	O
might	O
be	O
significant	O
for	O
preservation	O
of	O
marginal	B-T082
bone	O
.	O
	
to	O
compare	O
the	O
5-year	B-T079
radiographic	O
and	O
clinical	B-T080
outcome	B-T169
of	O
single	O
anterior	O
implants	O
provided	O
with	O
a	O
smooth	B-T080
neck	O
,	O
a	O
rough	O
neck	O
or	O
a	O
scalloped	O
rough	O
neck	O
.	O
	
93	O
patients	O
with	O
a	O
missing	O
anterior	O
tooth	O
in	O
the	O
maxilla	O
were	O
included	O
.	O
	
at	O
random	O
,	O
patients	O
received	O
an	O
implant	O
with	O
a	O
1.5	O
mm	O
smooth	B-T082
neck	I-T082
""""	O
smooth	O
group	O
""""	O
,	O
a	O
rough	B-T082
neck	I-T082
with	O
grooves	O
""""	O
rough	B-T082
group	O
""""	O
or	O
a	O
scalloped	O
rough	O
neck	I-T082
with	O
grooves	O
""""	O
scalloped	O
group	O
""""	O
.	O
	
implants	O
were	O
installed	O
in	O
healed	O
sites	O
.	O
	
follow-up	O
visits	O
were	O
conducted	O
after	O
final	O
crown	O
delivery	O
and	O
1	O
year	O
and	O
5	O
years	O
later	O
.	O
	
scalloped	O
implants	O
showed	O
significantly	O
more	O
initial	O
marginal	O
bone	O
resorption	O
.	O
	
the	O
total	O
amount	O
of	O
bone	O
loss	O
was	O
1.26	O
0.90	O
mm	O
in	O
the	O
smooth	O
group	O
,	O
1.20	O
1.1	O
mm	O
in	O
the	O
rough	O
group	O
and	O
2.28	O
0.97	O
mm	O
in	O
the	O
scalloped	O
group	O
p	O
<	O
05	O
.	O
	
survival	O
rates	O
were	O
96.2	O
for	O
the	O
smooth	O
and	O
scalloped	O
group	O
and	O
100%	O
for	O
the	O
rough	O
group	O
.	O
	
scalloped	O
implants	O
showed	O
deeper	O
pocket	O
depths	O
,	O
more	O
bleeding	O
and	O
more	O
technical	O
complications	O
.	O
	
there	O
were	O
no	O
differences	O
in	O
esthetic	O
outcome	O
nor	O
in	O
patient	O
satisfaction	O
.	O
	
for	O
anterior	O
single	O
tooth	O
replacements	O
,	O
scalloped	O
implants	O
show	O
less	O
favorable	O
radiographic	O
and	O
clinical	O
outcome	O
compared	O
to	O
regular	O
implants	O
with	O
a	O
smooth	O
neck	O
or	O
rough	O
neck	B-T082
recessive	O
mutations	O
in	O
msto1	B-T116
cause	O
mitochondrial	O
dynamics	O
impairment	B-T169
,	O
leading	O
to	O
myopathy	B-T047
and	O
ataxia	O
we	O
report	O
here	O
the	O
first	O
families	O
carrying	O
recessive	O
variants	B-T080
in	O
the	O
msto1	O
gene	O
compound	B-T033
heterozygous	I-T033
mutations	O
were	O
identified	O
in	O
two	O
sisters	O
and	O
in	O
an	O
unrelated	O
singleton	O
case	O
,	O
who	O
presented	O
a	O
multisystem	O
complex	O
phenotype	O
mainly	O
characterized	O
by	O
myopathy	O
and	O
cerebellar	O
ataxia	O
.	O
	
human	O
msto1	O
is	O
a	O
poorly	O
studied	O
protein	O
,	O
suggested	O
to	O
have	O
mitochondrial	O
localization	O
and	O
to	O
regulate	O
morphology	O
and	O
distribution	O
of	O
mitochondria	O
.	O
	
as	O
for	O
other	O
mutations	O
affecting	O
genes	O
involved	O
in	O
mitochondrial	O
dynamics	O
,	O
no	O
biochemical	O
defects	O
typical	O
of	O
mitochondrial	O
disorders	O
were	O
reported	O
.	O
	
studies	O
in	O
patients	O
'	O
fibroblasts	O
revealed	O
that	O
msto1	O
protein	O
levels	O
were	O
strongly	O
reduced	O
,	O
the	O
mitochondrial	O
network	O
was	O
fragmented	O
and	O
the	O
fusion	O
events	O
among	O
mitochondria	O
were	O
decreased	O
,	O
confirming	O
the	O
deleterious	O
effect	O
of	O
the	O
identified	B-T080
variants	O
and	O
the	O
role	O
of	O
msto1	O
in	O
modulating	O
mitochondrial	O
dynamics	O
.	O
	
we	O
also	O
found	O
that	O
msto1	O
is	O
mainly	O
a	O
cytosolic	O
protein	O
.	O
	
these	O
findings	O
indicate	O
recessive	O
mutations	O
in	O
msto1	O
as	O
a	O
new	O
cause	O
for	O
inherited	O
neuromuscular	O
disorders	O
with	O
multisystem	O
features	O
.	O
	
this	O
article	O
is	O
protected	O
by	O
copyright	O
.	O
	
all	O
rights	O
a	O
miniature	O
bird	O
-borne	O
passive	O
air	O
sampler	O
for	O
monitoring	O
halogenated	O
flame	O
retardants	O
birds	O
have	O
been	O
used	O
intensively	O
as	O
biomonitors	O
of	O
halogenated	O
flame	O
retardants	O
hfrs	O
,	O
and	O
several	O
studies	B-T062
have	O
reported	O
elevated	O
tissue	O
concentrations	B-T081
and	O
inter-	O
individual	B-T098
variability	O
for	O
these	O
contaminants	O
.	O
	
while	O
diet	O
is	O
known	O
to	O
be	O
an	O
important	O
exposure	B-T080
pathway	O
for	O
hfrs	O
in	O
birds	O
,	O
it	O
has	O
been	O
suggested	B-T078
that	O
exposure	B-T080
through	O
air	O
may	O
represent	B-T052
an	O
underestimated	O
source	B-T033
of	O
hfrs	O
for	O
certain	O
species	O
.	O
	
however	O
,	O
a	O
method	B-T170
was	O
not	B-T080
available	I-T080
for	O
measuring	B-T080
the	O
atmospheric	O
exposure	B-T080
of	O
individual	B-T098
birds	O
to	O
hfrs	O
or	O
other	O
semi-volatile	B-T080
contaminants	O
.	O
	
the	O
goal	B-T170
of	O
this	O
study	B-T062
was	O
to	O
develop	O
a	O
bird	O
-borne	O
passive	O
air	O
sampler	O
pas	O
enabling	O
the	O
determination	O
of	O
individual	B-T098
atmospheric	O
exposure	B-T080
to	O
gas	O
-	O
and	O
particle-phase	O
hfrs	O
using	O
the	O
ring-billed	O
gull	O
larus	O
delawarensis	O
nesting	O
in	O
the	O
montreal	O
area	O
qc	O
,	O
canada	O
.	O
	
the	O
new	O
miniaturized	O
elliptical-shaped	B-T082
pas	O
mean	B-T081
weight	I-T081
2.72g	O
was	O
tested	B-T169
using	O
two	O
sorbent	O
types	O
during	O
three	O
exposure	B-T079
periods	I-T079
one	O
,	O
two	O
and	O
three	O
weeks	O
.	O
	
results	B-T169
showed	O
that	O
pas	O
using	O
polyurethane	B-T109
foam	I-T109
puf	B-T109
combined	O
with	O
a	O
glass	O
fiber	O
filter	O
collected	O
all	O
major	O
polybrominated	B-T109
diphenyl	I-T109
ethers	I-T109
pbdes	B-T109
and	O
exhibited	O
better	B-T052
performance	I-T052
for	O
collecting	B-T169
highly	B-T080
hydrophobic	I-T080
decabde	B-T109
mixture	O
congeners	O
compared	B-T052
to	I-T052
the	O
pas	O
using	O
polydimethylsiloxane	B-T109
pdms	B-T109
.	O
	
emerging	O
hfrs	O
including	O
hexabromobenzene	B-T109
,	O
dechlorane	B-T109
604	I-T109
component	I-T109
b	I-T109
,	O
and	O
dechlorane	B-T109
plus	I-T109
dp	B-T109
isomers	O
also	O
were	O
sampled	O
by	O
the	O
puf	B-T109
-based	O
pas	O
.	O
	
sampling	O
rates	B-T081
for	O
most	O
hfrs	O
were	O
comparable	B-T052
between	O
the	O
three	O
exposure	B-T079
periods	I-T079
.	O
	
this	O
novel	O
bird	O
-borne	O
pas	O
provides	O
valuable	B-T078
information	I-T078
on	O
the	O
non-dietary	B-T080
exposure	I-T080
of	O
free-ranging	B-T033
birds	O
to	O
post	B-T079
endodontic	O
pain	O
following	O
single-visit	O
root	B-T061
canal	I-T061
preparation	I-T061
with	O
rotary	O
vs	O
reciprocating	O
instruments	O
a	O
meta-analysis	B-T062
of	O
randomized	B-T062
clinical	I-T062
trials	I-T062
in	O
endodontic	B-T061
therapy	I-T061
,	O
continuous	O
rotary	O
instrumentation	O
reduced	O
debris	O
compared	O
to	O
reciprocal	O
instrumentation	O
,	O
which	O
might	O
affect	O
the	O
incidence	B-T081
of	O
post-endodontic	O
pain	O
pp	O
.	O
	
the	O
aim	O
of	O
our	O
study	B-T062
was	O
to	O
assess	O
whether	O
pp	O
incidence	B-T081
and	O
levels	O
were	O
influenced	O
by	O
the	O
choice	O
of	O
rotary	O
or	O
reciprocal	O
instruments	O
.	O
	
in	O
this	O
meta-analysis	B-T062
the	O
pubmed	B-T170
and	O
em	B-T170
databases	I-T170
were	O
searched	O
for	O
prospective	O
clinical	B-T062
randomized	I-T062
trials	I-T062
published	O
before	O
april	O
20	O
,	O
2016	O
,	O
using	O
combinations	O
of	O
the	O
keywords	O
root	B-T061
canal	I-T061
preparation	I-T061
/	O
instrumentation	O
/	O
treatment	B-T061
/	O
therapy	B-T061
post-operative	B-T079
/	O
endodontic	O
pain	O
reciprocal	O
and	O
rotary	O
instruments	O
.	O
	
three	O
studies	B-T062
were	O
included	O
,	O
involving	O
a	O
total	O
of	O
1	O
patients	O
,	O
659	O
treated	O
with	O
reciprocating	O
instruments	O
and	O
658	O
treated	O
with	O
rotary	O
instruments	O
.	O
	
pp	O
was	O
reported	O
in	O
139	O
patients	O
in	O
the	O
reciprocating	B-T098
group	I-T098
and	O
172	O
in	O
the	O
rotary	B-T098
group	I-T098
.	O
	
the	O
pp	O
incidence	B-T081
odds	O
ratio	O
was	O
1.27	O
with	O
95%	O
confidence	B-T081
interval	I-T081
ci	B-T081
0.25	O
,	O
6.52	O
favoring	O
rotary	O
instruments	O
.	O
	
the	O
mild	B-T080
,	O
moderate	B-T080
and	O
severe	B-T080
pp	O
levels	O
odds	O
ratios	O
were	O
0.31	O
0.11	O
,	O
0.84	O
,	O
2.24	O
0.66	O
,	O
7.59	O
and	O
11.71	O
0.63	O
,	O
218.15	O
,	O
respectively	O
.	O
	
no	O
evidence	O
of	O
publication	O
bias	O
was	O
found	O
.	O
	
rotary	O
instrument	O
choice	O
in	O
endodontic	B-T061
therapy	I-T061
is	O
associated	B-T080
with	I-T080
a	O
lower	O
incidence	B-T081
of	O
pp	O
than	O
reciprocating	O
instruments	O
,	O
while	O
reciprocating	O
instruments	O
are	O
associated	B-T080
with	I-T080
less	O
mild	O
pp	O
incidence	B-T081
.	O
	
high	O
throughput	O
resistance	O
profiling	B-T169
of	O
plasmodium	O
falciparum	O
infections	O
based	O
on	O
custom	O
dual	O
indexing	O
and	O
illumina	O
next	O
generation	O
sequencing-technology	O
genetic	O
polymorphisms	O
in	O
p	O
.	O
	
falciparum	O
can	O
be	O
used	O
to	O
indicate	O
the	O
parasite's	O
susceptibility	O
to	O
antimalarial	O
drugs	O
as	O
well	O
as	O
its	O
geographical	O
origin	O
.	O
	
both	O
of	O
these	O
factors	O
are	O
key	O
to	O
monitoring	O
development	O
and	O
spread	O
of	O
antimalarial	O
drug	O
resistance	O
.	O
	
in	O
this	O
study	O
,	O
we	O
combine	O
multiplex	O
pcr	O
,	O
custom	O
designed	O
dual	O
indexing	O
and	O
miseq	O
sequencing	O
for	O
high	O
throughput	O
snp	O
-	O
profiling	O
of	O
457	O
malaria	O
infections	O
from	O
guinea-bissau	O
,	O
at	O
the	O
cost	O
of	O
10	O
usd	O
per	O
sample	O
.	O
	
by	O
amplifying	O
and	O
sequencing	O
15	O
genetic	O
fragments	O
,	O
we	O
cover	O
20	O
resistance	O
-conferring	O
snps	O
occurring	O
in	O
pfcrt	O
,	O
pfmdr1	O
,	O
pfdhfr	O
,	O
pfdhps	O
,	O
as	O
well	O
as	O
the	O
entire	O
length	O
of	O
pfk13	O
,	O
and	O
the	O
mitochondrial	O
barcode	O
for	O
parasite	O
origin	O
.	O
	
snps	O
of	O
interest	O
were	O
sequenced	O
with	O
an	O
average	O
depth	O
of	O
2	O
reads	O
,	O
and	O
bases	O
were	O
called	O
for	O
the	O
various	O
snp	O
-	O
positions	O
with	O
a	O
p-value	O
below	O
0.05	O
,	O
for	O
89.8	O
of	O
samples	O
.	O
	
the	O
snp	O
data	O
indicates	O
that	O
artemisinin	O
resistance	O
-conferring	O
snps	O
in	O
pfk13	O
are	O
absent	O
from	O
the	O
studied	O
area	O
of	O
guinea-bissau	O
,	O
while	O
the	O
pfmdr1	O
86	O
n	O
allele	O
is	O
found	O
at	O
a	O
high	O
prevalence	O
.	O
	
the	O
mitochondrial	O
barcodes	O
are	O
unanimous	O
and	O
accommodate	O
a	O
west	O
african	O
origin	O
of	O
the	O
parasites	O
.	O
	
with	O
this	O
method	O
,	O
very	O
reliable	O
high	O
throughput	O
surveillance	O
of	O
antimalarial	O
drug	O
resistance	O
becomes	O
more	O
affordable	O
than	O
ever	O
a	O
systematic	B-T170
review	I-T170
investigating	B-T169
psychosocial	B-T078
aspects	I-T078
of	O
egg	B-T061
sharing	I-T061
in	O
the	O
united	O
kingdom	O
and	O
their	O
potential	B-T080
effects	B-T080
on	O
egg	B-T061
donation	I-T061
numbers	B-T081
this	O
review	B-T170
aims	O
to	O
provide	O
an	O
up-to-date	O
knowledge	B-T170
of	O
the	O
psychosocial	B-T078
aspects	I-T078
of	O
egg	B-T061
donation	I-T061
from	O
the	O
perspectives	O
of	O
the	O
egg	B-T098
share	I-T098
donor	I-T098
and	O
their	O
recipient	B-T098
.	O
	
it	O
explores	O
the	O
motives	O
,	O
experiences	O
and	O
attitudes	O
of	O
egg	B-T098
sharers	I-T098
and	O
their	O
views	O
towards	O
donor	B-T098
anonymity	B-T078
and	O
disclosure	O
.	O
	
conclusions	B-T078
are	O
made	O
on	O
how	O
these	O
findings	B-T033
can	O
guide	B-T170
clinical	I-T170
practice	I-T170
and	O
improve	O
egg	B-T061
sharing	I-T061
numbers	B-T081
.	O
	
a	O
systematic	B-T169
search	B-T052
of	O
peer-reviewed	B-T170
journals	I-T170
of	O
four	O
computerized	B-T170
databases	I-T170
was	O
undertaken	O
.	O
	
eleven	O
studies	B-T062
were	O
included	O
in	O
the	O
review	B-T170
.	O
	
psychosocial	B-T078
aspects	I-T078
towards	O
donation	B-T061
were	O
positive	B-T033
from	O
the	O
egg	B-T098
share	I-T098
donor	I-T098
and	O
recipient	B-T098
.	O
	
concerns	B-T078
raised	B-T080
were	O
whether	O
participating	B-T169
in	O
the	O
egg	B-T061
sharing	I-T061
scheme	B-T170
would	O
impact	B-T080
on	O
their	O
success	B-T080
rates	B-T081
,	O
as	O
well	O
as	O
frustration	O
expressed	B-T078
by	O
a	O
minority	B-T098
regarding	O
the	O
lack	B-T033
of	I-T033
knowledge	I-T033
of	O
egg	B-T061
sharing	I-T061
outside	O
of	O
fertility	O
clinics	O
.	O
	
the	O
2005	O
legislative	B-T170
changes	B-T169
in	O
the	O
uk	O
have	O
not	O
caused	O
the	O
anticipated	O
dramatic	O
decrease	B-T081
in	O
egg	B-T061
donation	I-T061
however	O
,	O
oocyte	B-T061
donation	I-T061
still	O
falls	O
short	O
of	O
demand	B-T061
.	O
	
egg	B-T061
sharing	I-T061
provides	O
a	O
practical	B-T169
option	I-T169
for	O
more	O
patients	O
to	O
access	B-T169
ivf	B-T061
,	O
whilst	O
also	O
providing	O
more	O
donor	B-T098
oocytes	I-T098
.	O
	
improved	O
information	O
provision	O
will	O
result	B-T169
in	O
greater	O
awareness	O
of	O
egg	B-T061
sharing	I-T061
,	O
with	O
the	O
potential	B-T080
to	O
recruit	B-T052
more	O
donors	O
and	O
meet	O
the	O
needs	O
of	O
recipients	B-T098
currently	B-T079
on	O
long	O
waiting	B-T170
lists	I-T170
.	O
	
medication	B-T061
regimen	I-T061
complexity	B-T078
and	O
prevalence	B-T081
of	O
potentially	B-T080
inappropriate	I-T080
medicines	I-T080
in	O
older	B-T098
patients	O
after	O
hospitalisation	O
background	O
there	O
is	O
a	O
relative	B-T080
paucity	O
of	O
information	B-T078
to	O
characterise	O
potential	B-T080
changes	B-T169
in	O
medication	B-T061
regimen	I-T061
complexity	B-T078
and	O
prevalence	B-T081
of	O
prescribing	O
of	O
potentially	B-T080
inappropriate	I-T080
medications	I-T080
after	O
hospitalisation	O
,	O
both	O
in	O
australia	O
and	O
elsewhere	O
.	O
	
objective	B-T170
to	O
evaluate	O
medication	B-T061
regimen	I-T061
complexity	B-T078
and	O
the	O
prevalence	B-T081
of	O
potentially	B-T080
inappropriate	I-T080
medications	I-T080
before	B-T079
and	O
after	O
admission	O
to	O
hospital	O
.	O
	
setting	O
general	O
medical	O
units	O
of	O
a	O
tertiary	O
care	O
hospital	O
in	O
australia	O
.	O
	
methods	O
retrospective	B-T062
cohort	I-T062
study	I-T062
of	O
patients	O
aged	O
65	O
years	O
and	O
above	O
.	O
	
medication	O
complexity	B-T078
was	O
measured	B-T080
by	O
using	O
the	O
medication	B-T170
regimen	I-T170
complexity	I-T170
index	I-T170
mrci	B-T170
.	O
	
main	B-T080
outcome	I-T080
measure	I-T080
the	O
primary	B-T080
outcome	I-T080
was	O
the	O
change	B-T169
in	O
the	O
medication	B-T170
regimen	I-T170
complexity	I-T170
index	I-T170
for	O
all	O
prescribed	O
medications	O
after	O
hospitalization	O
.	O
	
results	O
a	O
convenience	B-T062
sample	I-T062
of	O
100	O
patients	O
was	O
included	B-T169
in	O
the	O
study	B-T062
.	O
	
there	O
was	O
a	O
significant	B-T078
change	B-T169
in	O
the	O
mean	B-T081
medication	O
complexity	B-T078
score	B-T081
as	O
measured	B-T080
using	O
the	O
mrci	B-T170
,	O
increasing	B-T081
from	O
29	O
at	O
the	O
time	B-T079
of	I-T079
admission	I-T079
to	O
32	O
at	O
the	O
time	B-T079
of	I-T079
discharge	I-T079
p	O
<	O
0.05	O
.	O
	
factors	B-T169
such	O
as	O
baseline	B-T081
medication	B-T061
regimen	I-T061
complexity	B-T078
pre-admission	B-T079
mrci	B-T170
and	O
length	B-T079
of	I-T079
stay	I-T079
in	I-T079
the	I-T079
hospitals	I-T079
appear	B-T080
to	O
influence	O
the	O
change	B-T169
in	O
medication	O
complexity	B-T078
.	O
	
however	O
,	O
the	O
proportion	B-T081
of	O
patients	O
prescribed	O
at	O
least	O
one	O
potentially	B-T080
inappropriate	I-T080
medicine	I-T080
pim	B-T080
decreased	B-T081
significantly	I-T081
,	O
from	O
52%	O
pre-hospitalization	O
to	O
42%	O
at	B-T079
discharge	I-T079
p	O
=	O
0.04	O
.	O
	
conclusions	O
relative	B-T080
to	O
the	O
time	B-T079
of	I-T079
admission	I-T079
,	O
overall	B-T080
medication	O
complexity	B-T078
increased	B-T081
and	O
the	O
proportion	B-T081
of	O
patients	O
who	O
were	O
prescribed	O
pims	B-T080
decreased	B-T081
after	O
